data_2km2_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2km2 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 122' ' ' ALA . . . . . . . . 0 N--CA 1.49 2.258 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.452 ' HG ' ' N ' ' A' ' 5' ' ' VAL . 0.3 OUTLIER -67.62 154.67 40.94 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.537 -0.979 . . . . 0.0 111.218 -179.467 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.452 ' N ' ' HG ' ' A' ' 4' ' ' LEU . 76.5 t -118.16 136.92 53.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.397 -0.814 . . . . 0.0 109.666 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -119.59 164.4 15.91 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.699 -1.25 . . . . 0.0 111.305 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.0 p -153.08 166.35 32.74 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.477 -0.764 . . . . 0.0 109.898 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.426 ' ND2' ' O ' ' B' ' 3' ' ' GLY . 55.4 t30 60.81 38.54 17.93 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.273 -0.892 . . . . 0.0 109.759 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.536 ' O ' ' C ' ' A' ' 10' ' ' ASN . 61.5 mt -89.74 -3.35 58.23 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.705 -0.622 . . . . 0.0 111.849 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.536 ' C ' ' O ' ' A' ' 9' ' ' LEU . 8.2 m120 6.09 78.1 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.634 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 3.6 tt -100.24 129.78 46.28 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.303 -0.873 . . . . 0.0 110.035 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.3 mtpp -97.95 164.86 16.51 Favored Pre-proline 0 C--N 1.297 -1.694 0 O-C-N 121.445 -0.784 . . . . 0.0 110.37 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -66.93 147.28 80.14 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 123.991 1.521 . . . . 0.0 110.265 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.66 7.84 62.76 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -115.42 146.83 41.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.833 -1.393 . . . . 0.0 110.287 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 48.8 t -106.54 137.93 43.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.341 -0.85 . . . . 0.0 110.438 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 45.5 tp -117.84 130.06 56.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.316 -0.865 . . . . 0.0 109.79 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.418 ' CZ ' ' OE1' ' A' ' 86' ' ' GLU . 77.5 ttt180 -118.95 128.74 54.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.941 -1.099 . . . . 0.0 110.633 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 25.1 t -121.13 125.29 73.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.256 -0.902 . . . . 0.0 110.725 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.45 ' HA ' ' HG2' ' A' ' 86' ' ' GLU . 75.8 ttt180 -109.86 129.01 55.69 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -149.19 -170.0 16.34 Favored Glycine 0 N--CA 1.486 1.974 0 C-N-CA 119.146 -1.502 . . . . 0.0 110.131 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.429 ' OE1' ' NZ ' ' A' ' 129' ' ' LYS . 84.3 tt0 -129.59 123.28 30.94 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.786 -0.832 . . . . 0.0 109.709 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.455 ' CG1' ' HB2' ' A' ' 27' ' ' ALA . 99.1 t -79.19 129.5 37.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.144 -0.973 . . . . 0.0 109.713 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.76 163.16 1.5 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.009 -1.057 . . . . 0.0 110.049 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.84 -18.26 47.09 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.977 1.514 . . . . 0.0 110.327 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' A' ' 28' ' ' LYS . 63.9 t0 -113.61 56.76 0.69 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.244 -0.91 . . . . 0.0 109.284 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.455 ' HB2' ' CG1' ' A' ' 23' ' ' VAL . . . -59.8 84.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.602 -0.686 . . . . 0.0 110.227 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.462 ' HA ' ' HB3' ' A' ' 49' ' ' PHE . 85.1 tttt -109.64 -33.94 6.63 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.024 -1.047 . . . . 0.0 111.835 -179.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.2 t -146.22 140.45 26.58 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.626 -1.296 . . . . 0.0 111.671 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.5 ' CE2' ' HB2' ' A' ' 126' ' ' PHE . 83.3 m-85 -139.56 146.47 39.91 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.393 -0.817 . . . . 0.0 110.188 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.407 ' HB ' ' O ' ' A' ' 123' ' ' ASP . 63.7 t -133.44 130.0 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.96 -1.088 . . . . 0.0 109.798 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.45 ' HB2' ' HB2' ' A' ' 45' ' ' PHE . 94.7 mt -131.75 144.58 51.06 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.027 -1.046 . . . . 0.0 110.374 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -146.13 108.75 4.5 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.232 -0.917 . . . . 0.0 110.122 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.451 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -124.25 111.27 15.65 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.154 -0.966 . . . . 0.0 110.107 179.511 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -159.81 -122.84 0.67 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.43 ' O ' ' HB2' ' A' ' 119' ' ' TYR . 0.1 OUTLIER -130.4 -46.12 1.09 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.396 -1.061 . . . . 0.0 108.864 179.518 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.432 ' HB2' ' HB2' ' A' ' 40' ' ' ASN . 87.6 m-20 -122.18 164.0 18.57 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.8 t -56.46 -42.33 78.03 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.293 -0.879 . . . . 0.0 111.631 -178.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.465 ' HB3' ' N ' ' A' ' 66' ' ' GLY . 92.4 m-20 -92.06 -0.11 57.46 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.89 -1.131 . . . . 0.0 111.002 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.455 ' N ' ' ND2' ' A' ' 40' ' ' ASN . 2.8 m-80 -117.37 61.7 0.75 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.95 -1.094 . . . . 0.0 109.854 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.7 mt -90.3 137.84 32.02 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.742 -0.599 . . . . 0.0 109.795 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.405 ' SG ' ' N ' ' A' ' 43' ' ' LEU . 6.8 p -88.62 -30.0 19.54 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.248 -0.907 . . . . 0.0 109.751 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.451 ' HB2' ' CD1' ' A' ' 34' ' ' LEU . 69.6 mt -137.09 138.14 40.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.904 . . . . 0.0 110.963 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -135.84 126.48 27.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.404 -0.81 . . . . 0.0 110.125 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.45 ' HB2' ' HB2' ' A' ' 32' ' ' LEU . 91.9 m-85 -113.01 141.96 46.26 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.996 -1.065 . . . . 0.0 110.024 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -154.72 69.94 5.86 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 120.996 -1.065 . . . . 0.0 110.986 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.42 147.46 65.13 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.68 1.358 . . . . 0.0 110.081 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.43 ' NH2' ' HB1' ' A' ' 51' ' ' ALA . 82.9 mtp180 -137.82 111.34 8.08 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.007 -1.058 . . . . 0.0 110.66 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.462 ' HB3' ' HA ' ' A' ' 28' ' ' LYS . 85.6 t80 -62.06 -46.31 89.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.312 -0.868 . . . . 0.0 110.03 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -164.64 99.45 0.79 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -0.909 . . . . 0.0 110.078 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.43 ' HB1' ' NH2' ' A' ' 48' ' ' ARG . . . -109.97 -89.81 0.48 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.254 -0.904 . . . . 0.0 109.911 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -63.1 -42.37 99.56 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.927 -1.108 . . . . 0.0 109.075 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 161.81 38.46 0.02 OUTLIER Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -117.54 -171.63 2.08 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.28 -1.13 . . . . 0.0 110.015 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.474 ' O ' ' C ' ' A' ' 56' ' ' ASN . . . -145.22 152.62 40.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.337 -0.852 . . . . 0.0 110.454 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.489 ' HB3' ' CD1' ' A' ' 77' ' ' PHE . 36.2 m120 23.09 56.79 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 45.9 m -112.91 132.62 55.25 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.338 -0.851 . . . . 0.0 109.042 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.42 HD13 HG21 ' A' ' 58' ' ' ILE . 75.1 mt -117.03 135.55 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.147 -0.971 . . . . 0.0 111.774 -177.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.412 ' CG1' ' OE2' ' A' ' 71' ' ' GLU . 47.4 t -110.9 130.36 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.369 -0.832 . . . . 0.0 109.539 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 75.1 m -130.94 126.17 35.38 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.036 -1.04 . . . . 0.0 110.695 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.444 ' CB ' ' HA ' ' A' ' 71' ' ' GLU . 3.6 p-10 -151.35 173.29 14.68 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.245 -0.909 . . . . 0.0 110.727 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.454 ' O ' ' CA ' ' A' ' 69' ' ' GLY . 69.0 m -131.77 155.2 48.14 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.506 -0.746 . . . . 0.0 109.858 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.479 ' CD ' ' HA2' ' A' ' 66' ' ' GLY . 8.9 ttmt -135.2 150.45 50.11 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.679 -1.263 . . . . 0.0 111.367 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -124.49 105.51 9.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.426 -0.797 . . . . 0.0 109.937 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 57.58 27.01 58.08 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.479 ' HA2' ' CD ' ' A' ' 63' ' ' LYS . . . 75.46 23.19 74.01 Favored Glycine 0 N--CA 1.488 2.129 0 O-C-N 120.777 -1.425 . . . . 0.0 109.771 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.501 ' HB3' ' CD1' ' A' ' 68' ' ' TRP . . . -81.2 -85.32 0.1 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.189 -1.183 . . . . 0.0 110.835 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.501 ' CD1' ' HB3' ' A' ' 67' ' ' ALA . 10.3 m95 -135.35 -146.89 0.25 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.884 -1.135 . . . . 0.0 109.849 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.454 ' CA ' ' O ' ' A' ' 62' ' ' SER . . . 167.38 129.45 1.07 Allowed Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.641 -1.266 . . . . 0.0 110.544 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.3 m -81.51 80.2 7.93 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.45 -1.029 . . . . 0.0 109.824 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.444 ' HA ' ' CB ' ' A' ' 61' ' ' ASN . 83.5 tt0 -72.37 124.75 25.79 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.201 -0.937 . . . . 0.0 111.134 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -109.53 -162.0 0.79 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.381 -0.824 . . . . 0.0 109.624 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 62.5 ttp85 -145.91 117.38 8.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.185 -0.947 . . . . 0.0 110.697 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -110.4 125.73 53.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.207 -0.933 . . . . 0.0 109.711 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -105.83 45.7 0.96 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.168 -0.957 . . . . 0.0 111.85 -178.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 51.7 t -121.41 133.01 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 120.965 -1.085 . . . . 0.0 109.843 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.532 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 11.3 p90 -143.02 82.03 12.32 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.102 -0.999 . . . . 0.0 111.248 -178.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -79.99 41.29 1.09 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.495 1.26 . . . . 0.0 111.378 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -149.83 163.24 38.56 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.701 -1.249 . . . . 0.0 110.971 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 13.6 mp0 -129.94 164.58 39.5 Favored Pre-proline 0 N--CA 1.492 1.668 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.79 148.86 65.82 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 123.593 1.312 . . . . 0.0 110.859 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 63.42 41.75 99.26 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 25.1 t -137.36 137.32 38.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.198 -1.178 . . . . 0.0 111.276 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 27.6 m -79.18 135.51 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.472 -0.767 . . . . 0.0 109.53 179.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.66 154.58 37.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.974 -1.079 . . . . 0.0 110.6 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.45 ' HG2' ' HA ' ' A' ' 20' ' ' ARG . 97.4 mt-10 -121.05 140.11 52.39 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.473 -0.767 . . . . 0.0 109.65 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.9 t -122.64 130.28 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.101 -0.999 . . . . 0.0 110.36 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 22.2 m -92.73 125.0 37.15 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.439 -0.788 . . . . 0.0 109.821 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 95.8 mt -122.05 125.0 72.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.045 -1.035 . . . . 0.0 110.246 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 53.9 m -121.76 124.55 44.47 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.392 -0.817 . . . . 0.0 108.913 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.414 ' CD1' ' CD2' ' A' ' 96' ' ' LEU . 65.7 t80 -110.51 112.84 25.02 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.142 -0.974 . . . . 0.0 110.333 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -121.04 150.32 41.36 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.612 -0.68 . . . . 0.0 109.226 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -64.35 -33.65 76.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.773 -1.204 . . . . 0.0 110.064 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.74 -46.02 90.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.969 -1.082 . . . . 0.0 109.558 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -168.63 175.59 6.07 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.425 -0.797 . . . . 0.0 109.764 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.414 ' CD2' ' CD1' ' A' ' 91' ' ' PHE . 79.1 mt -107.71 128.6 54.72 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.158 -0.964 . . . . 0.0 110.414 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.5 m -109.93 126.67 54.14 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.162 -0.961 . . . . 0.0 110.176 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 59.2 t -133.16 128.42 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 120.775 -1.203 . . . . 0.0 110.496 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -123.24 147.7 46.65 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.996 -1.065 . . . . 0.0 111.01 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.483 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 1.1 mp -100.84 167.73 10.35 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.587 -0.696 . . . . 0.0 109.636 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.483 ' HD2' ' HB3' ' A' ' 100' ' ' LEU . 41.7 Cg_endo -65.97 -22.63 55.21 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 123.408 1.215 . . . . 0.0 110.42 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -152.09 78.23 1.23 Allowed 'General case' 0 N--CA 1.486 1.325 0 O-C-N 121.129 -0.982 . . . . 0.0 109.8 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -177.91 -171.91 41.81 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -87.59 -150.8 0.17 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.379 -1.071 . . . . 0.0 110.009 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 64.3 tt0 -128.92 146.23 51.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.238 -0.914 . . . . 0.0 110.661 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -130.38 134.27 47.02 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.279 -0.888 . . . . 0.0 109.968 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -114.83 144.7 43.11 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.204 -0.935 . . . . 0.0 110.859 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.457 ' CE2' ' O ' ' A' ' 109' ' ' PRO . 56.7 t80 -129.17 133.65 25.41 Favored Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.457 ' O ' ' CE2' ' A' ' 108' ' ' PHE . 44.9 Cg_endo -66.83 138.79 49.82 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.359 1.189 . . . . 0.0 110.389 -178.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' A' ' 110' ' ' ASN . 5.2 p-10 -100.39 78.49 2.03 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.318 -0.864 . . . . 0.0 110.263 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.403 ' C ' ' O ' ' A' ' 110' ' ' ASN . 79.6 ttt180 -41.46 -32.65 0.35 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.429 -0.794 . . . . 0.0 110.797 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 95.0 mt -78.93 149.67 32.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.369 -0.832 . . . . 0.0 110.313 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -104.42 40.56 1.45 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.408 -0.808 . . . . 0.0 109.874 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 56.4 tp -71.16 125.93 28.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.203 -0.935 . . . . 0.0 109.766 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -96.75 -5.34 38.81 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.489 -0.757 . . . . 0.0 111.086 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.434 ' HA ' ' O ' ' A' ' 11' ' ' LEU . . . -141.46 142.0 33.66 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.874 -1.141 . . . . 0.0 111.473 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.421 ' HB ' ' HB3' ' A' ' 11' ' ' LEU . 48.1 mm -102.73 121.29 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.401 ' ND2' ' N ' ' A' ' 118' ' ' ASN . 6.5 m-80 -117.94 -18.82 9.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.993 -1.067 . . . . 0.0 111.465 -178.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.43 ' HB2' ' O ' ' A' ' 36' ' ' LYS . 42.9 t80 -113.71 130.04 56.48 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.907 -1.121 . . . . 0.0 111.14 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.479 ' CB ' ' CD1' ' A' ' 9' ' ' LEU . 48.2 ttp -142.42 114.22 8.05 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -136.05 139.0 42.73 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.95 -1.094 . . . . 0.0 110.905 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.435 ' O ' ' HA3' ' A' ' 3' ' ' GLY . . . -141.83 131.92 24.72 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.51 -0.744 . . . . 0.0 109.137 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.407 ' O ' ' HB ' ' A' ' 31' ' ' VAL . 62.2 t0 -151.35 122.4 7.67 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.567 -0.708 . . . . 0.0 109.246 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.447 ' HA3' ' HA ' ' A' ' 30' ' ' PHE . . . 174.57 -148.98 10.14 Favored Glycine 0 N--CA 1.488 2.153 0 C-N-CA 119.192 -1.48 . . . . 0.0 110.165 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 30' ' ' PHE . 87.7 m-20 -86.35 9.16 18.78 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.672 -0.899 . . . . 0.0 110.283 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.5 ' HB2' ' CE2' ' A' ' 30' ' ' PHE . 51.1 t80 -104.06 141.77 35.63 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.122 -0.986 . . . . 0.0 109.662 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -116.08 120.05 37.81 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.168 -1.013 . . . . 0.0 111.108 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.426 ' O ' ' CG2' ' A' ' 128' ' ' ILE . 19.0 tt -95.47 119.57 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.232 -0.917 . . . . 0.0 109.923 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.429 ' NZ ' ' OE1' ' A' ' 22' ' ' GLU . 98.2 mttt -100.82 -15.4 17.63 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.128 -0.983 . . . . 0.0 111.571 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -155.54 146.89 22.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.808 -1.183 . . . . 0.0 111.425 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 43.2 t -124.91 129.37 73.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -118.96 140.07 50.61 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.961 -1.087 . . . . 0.0 110.521 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -106.36 119.61 39.72 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.415 -0.803 . . . . 0.0 109.976 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.9 t0 . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.538 -179.997 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.162 0.506 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 2' ' ' CYS . . . . . 0.427 ' N ' ' OD1' ' B' ' 123' ' ' ASP . 0.5 OUTLIER -157.71 104.22 1.95 Allowed 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.059 -1.026 . . . . 0.0 110.226 179.898 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 3' ' ' GLY . . . . . 0.426 ' O ' ' ND2' ' A' ' 8' ' ' ASN . . . 179.51 127.48 1.11 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . 0.459 ' HG ' ' N ' ' B' ' 5' ' ' VAL . 0.3 OUTLIER -67.27 154.42 41.34 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.728 -0.866 . . . . 0.0 111.342 -179.046 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . 0.459 ' N ' ' HG ' ' B' ' 4' ' ' LEU . 72.7 t -118.11 137.08 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.578 -0.701 . . . . 0.0 109.676 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -119.56 164.81 15.27 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.772 -1.205 . . . . 0.0 111.309 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 14.1 p -153.23 166.37 32.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.292 -0.88 . . . . 0.0 109.645 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 54.8 t30 60.75 38.94 17.88 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.345 -0.847 . . . . 0.0 109.681 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . 0.553 ' O ' ' C ' ' B' ' 10' ' ' ASN . 63.2 mt -91.41 1.32 57.21 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.646 -0.659 . . . . 0.0 111.77 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' ASN . . . . . 0.553 ' C ' ' O ' ' B' ' 9' ' ' LEU . 7.9 m120 -0.16 80.65 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.565 0 CA-C-O 121.599 0.714 . . . . 0.0 112.715 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' B' ' 116' ' ' ALA . 3.4 tt -100.67 129.9 46.65 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.585 -0.697 . . . . 0.0 109.898 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . 0.404 ' HB3' ' HD2' ' B' ' 13' ' ' PRO . 3.3 mtpp -98.31 165.18 15.71 Favored Pre-proline 0 C--N 1.295 -1.783 0 O-C-N 121.481 -0.762 . . . . 0.0 110.441 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' B' ' 12' ' ' LYS . 45.3 Cg_endo -66.88 147.38 80.49 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.96 1.505 . . . . 0.0 110.389 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.81 7.06 63.16 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 110.259 -1.137 . . . . 0.0 110.259 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -114.99 146.78 40.87 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.841 -1.388 . . . . 0.0 110.507 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' CYS . . . . . . . . . . . . . 49.4 t -106.44 137.86 43.65 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.413 -0.804 . . . . 0.0 110.561 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 45.3 tp -117.86 130.03 56.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.358 -0.839 . . . . 0.0 109.694 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . 0.413 ' CZ ' ' OE1' ' B' ' 86' ' ' GLU . 76.9 ttt180 -118.91 129.4 55.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.02 -1.05 . . . . 0.0 110.498 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 24.9 t -121.75 125.07 72.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.279 -0.888 . . . . 0.0 110.682 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . 0.445 ' HA ' ' HG2' ' B' ' 86' ' ' GLU . 76.1 ttt180 -109.55 128.88 55.51 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.34 -0.85 . . . . 0.0 108.869 178.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -149.4 -170.01 16.49 Favored Glycine 0 N--CA 1.486 1.988 0 C-N-CA 118.997 -1.573 . . . . 0.0 110.086 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . 0.426 ' OE1' ' NZ ' ' B' ' 129' ' ' LYS . 84.6 tt0 -129.54 123.38 31.27 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.678 -0.895 . . . . 0.0 109.774 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.454 ' CG1' ' HB2' ' B' ' 27' ' ' ALA . 99.2 t -79.36 129.65 37.25 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 121.287 -0.883 . . . . 0.0 109.6 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.77 163.26 1.48 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.16 -0.962 . . . . 0.0 110.027 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -67.74 -18.81 47.78 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.952 1.501 . . . . 0.0 110.196 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' B' ' 28' ' ' LYS . 64.1 t0 -113.3 56.94 0.68 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.244 -0.91 . . . . 0.0 109.391 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . 0.454 ' HB2' ' CG1' ' B' ' 23' ' ' VAL . . . -59.96 84.89 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.679 -0.638 . . . . 0.0 110.163 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . 0.466 ' HA ' ' HB3' ' B' ' 49' ' ' PHE . 85.2 tttt -109.78 -33.49 6.73 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.065 -1.022 . . . . 0.0 111.777 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 37.1 t -146.58 140.1 25.84 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.674 -1.266 . . . . 0.0 111.535 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' PHE . . . . . 0.49 ' CE2' ' HB2' ' B' ' 126' ' ' PHE . 83.9 m-85 -139.3 146.04 39.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.439 -0.788 . . . . 0.0 110.142 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.401 ' HB ' ' O ' ' B' ' 123' ' ' ASP . 62.9 t -133.04 129.77 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.907 -1.121 . . . . 0.0 109.893 178.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.454 ' HB2' ' HB2' ' B' ' 45' ' ' PHE . 94.9 mt -131.31 144.64 51.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.103 -0.998 . . . . 0.0 110.565 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -146.07 108.87 4.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.302 -0.874 . . . . 0.0 110.238 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.452 ' CD1' ' HB2' ' B' ' 43' ' ' LEU . 0.3 OUTLIER -124.19 110.19 14.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.178 -0.951 . . . . 0.0 110.047 179.472 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -157.78 -122.39 0.7 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . 0.428 ' O ' ' HB2' ' B' ' 119' ' ' TYR . 0.1 OUTLIER -130.83 -46.12 1.04 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.571 -0.958 . . . . 0.0 108.707 179.177 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . 0.427 ' HB2' ' HB2' ' B' ' 40' ' ' ASN . 87.3 m-20 -122.2 164.14 18.35 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 28.4 t -56.88 -41.99 79.02 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.312 -0.867 . . . . 0.0 111.372 -178.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' ASN . . . . . 0.466 ' HB3' ' N ' ' B' ' 66' ' ' GLY . 92.1 m-20 -92.31 0.02 57.42 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.862 -1.149 . . . . 0.0 111.002 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' ASN . . . . . 0.454 ' ND2' ' N ' ' B' ' 40' ' ' ASN . 2.7 m-80 -117.62 61.88 0.75 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.026 -1.046 . . . . 0.0 109.594 -178.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 95.7 mt -90.33 139.33 30.77 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.757 -0.59 . . . . 0.0 109.651 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' CYS . . . . . . . . . . . . . 7.4 p -90.8 -28.91 17.91 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.183 -0.948 . . . . 0.0 109.557 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.452 ' HB2' ' CD1' ' B' ' 34' ' ' LEU . 70.7 mt -137.54 137.62 38.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.359 -0.838 . . . . 0.0 110.954 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -135.42 126.77 28.43 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.388 -0.82 . . . . 0.0 110.094 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.454 ' HB2' ' HB2' ' B' ' 32' ' ' LEU . 91.6 m-85 -113.44 141.32 47.24 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.93 -1.106 . . . . 0.0 109.994 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -154.2 69.87 6.19 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 120.96 -1.088 . . . . 0.0 111.069 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' B' ' 58' ' ' ILE . 52.6 Cg_endo -69.35 147.09 64.72 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.757 1.399 . . . . 0.0 110.159 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.431 ' NH2' ' HB1' ' B' ' 51' ' ' ALA . 83.0 mtp180 -137.42 111.51 8.4 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.974 -1.079 . . . . 0.0 110.62 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' PHE . . . . . 0.466 ' HB3' ' HA ' ' B' ' 28' ' ' LYS . 85.6 t80 -62.22 -46.31 89.44 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.242 -0.911 . . . . 0.0 109.958 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -164.51 99.33 0.81 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.11 -0.994 . . . . 0.0 110.065 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . 0.431 ' HB1' ' NH2' ' B' ' 48' ' ' ARG . . . -109.88 -89.78 0.48 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.09 -1.006 . . . . 0.0 109.956 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -63.12 -42.17 99.47 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.065 -1.022 . . . . 0.0 109.167 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 161.43 38.92 0.02 OUTLIER Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -118.21 -171.66 2.11 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.254 -1.145 . . . . 0.0 109.93 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.5 ' O ' ' C ' ' B' ' 56' ' ' ASN . . . -143.81 157.83 44.11 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.399 -0.813 . . . . 0.0 109.874 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' ASN . . . . . 0.5 ' C ' ' O ' ' B' ' 55' ' ' ALA . 35.8 m120 15.06 59.9 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.423 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -179.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 47.8 m -113.4 132.34 55.66 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' ILE . . . . . 0.416 HD13 HG21 ' B' ' 58' ' ' ILE . 76.1 mt -116.94 135.99 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.039 -1.038 . . . . 0.0 111.802 -177.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.419 ' CG1' ' OE2' ' B' ' 71' ' ' GLU . 48.3 t -110.94 130.44 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.397 -0.815 . . . . 0.0 109.635 179.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 74.5 m -131.19 124.5 30.76 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.055 -1.028 . . . . 0.0 110.957 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' ASN . . . . . 0.443 ' CB ' ' HA ' ' B' ' 71' ' ' GLU . 3.6 p-10 -149.75 173.11 14.08 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.351 -0.843 . . . . 0.0 110.963 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' SER . . . . . 0.452 ' O ' ' CA ' ' B' ' 69' ' ' GLY . 69.7 m -131.16 155.34 47.19 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.464 -0.772 . . . . 0.0 109.919 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . 0.482 ' CD ' ' HA2' ' B' ' 66' ' ' GLY . 8.8 ttmt -135.34 150.33 49.93 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.707 -1.246 . . . . 0.0 111.372 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -124.54 104.77 8.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.389 -0.819 . . . . 0.0 110.149 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 58.24 27.18 59.99 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . 0.482 ' HA2' ' CD ' ' B' ' 63' ' ' LYS . . . 75.34 23.16 74.41 Favored Glycine 0 N--CA 1.488 2.151 0 O-C-N 120.82 -1.4 . . . . 0.0 109.794 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' ALA . . . . . 0.497 ' HB3' ' CD1' ' B' ' 68' ' ' TRP . . . -81.1 -85.04 0.1 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.154 -1.203 . . . . 0.0 110.873 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' TRP . . . . . 0.497 ' CD1' ' HB3' ' B' ' 67' ' ' ALA . 10.8 m95 -135.2 -145.38 0.22 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.915 -1.116 . . . . 0.0 110.057 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . 0.452 ' CA ' ' O ' ' B' ' 62' ' ' SER . . . 165.3 129.34 1.04 Allowed Glycine 0 N--CA 1.49 2.267 0 C-N-CA 119.594 -1.289 . . . . 0.0 110.577 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 18.5 m -81.63 80.21 8.03 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.626 -0.926 . . . . 0.0 109.865 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.443 ' HA ' ' CB ' ' B' ' 61' ' ' ASN . 83.3 tt0 -71.95 125.57 27.55 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.24 -0.913 . . . . 0.0 110.948 -179.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -110.53 -161.94 0.78 Allowed 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.372 -0.83 . . . . 0.0 109.397 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 62.4 ttp85 -146.05 117.04 7.76 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.01 -1.056 . . . . 0.0 110.761 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -109.94 125.82 53.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.305 -0.872 . . . . 0.0 109.768 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -105.86 45.89 0.95 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.054 -1.029 . . . . 0.0 111.776 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 51.6 t -121.46 132.66 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.841 -1.162 . . . . 0.0 109.88 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 77' ' ' PHE . . . . . 0.54 ' N ' ' CD1' ' B' ' 77' ' ' PHE . 11.3 p90 -142.74 82.14 12.64 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 120.988 -1.07 . . . . 0.0 111.346 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . 0.405 ' HB3' ' O ' ' B' ' 102' ' ' ASP . 56.2 Cg_endo -80.16 41.66 1.17 Allowed 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 123.522 1.275 . . . . 0.0 111.429 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -149.91 163.84 37.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.653 -1.279 . . . . 0.0 110.848 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -130.67 164.53 41.01 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 81' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.8 149.3 66.43 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.633 1.333 . . . . 0.0 110.838 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 63.09 41.61 99.74 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 25.6 t -137.04 137.3 39.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.263 -1.139 . . . . 0.0 111.299 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 27.5 m -79.1 135.42 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.409 -0.807 . . . . 0.0 109.522 178.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.48 154.6 37.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.944 -1.097 . . . . 0.0 110.673 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 86' ' ' GLU . . . . . 0.445 ' HG2' ' HA ' ' B' ' 20' ' ' ARG . 97.3 mt-10 -121.08 140.18 52.31 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.381 -0.824 . . . . 0.0 109.612 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 47.2 t -122.76 129.88 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.068 -1.02 . . . . 0.0 110.502 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 88' ' ' CYS . . . . . . . . . . . . . 24.5 m -92.35 125.06 36.85 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.369 -0.832 . . . . 0.0 109.899 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 96.5 mt -122.2 124.99 72.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.114 -0.991 . . . . 0.0 110.315 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 53.9 m -121.72 124.3 43.92 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.483 -0.761 . . . . 0.0 109.02 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 91' ' ' PHE . . . . . 0.41 ' CD1' ' CD2' ' B' ' 96' ' ' LEU . 65.6 t80 -110.21 112.94 25.23 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.144 -0.973 . . . . 0.0 110.32 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -121.39 149.51 42.88 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.558 -0.714 . . . . 0.0 109.307 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -63.79 -33.16 75.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.796 -1.19 . . . . 0.0 110.088 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.0 -45.96 89.95 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.032 -1.043 . . . . 0.0 109.457 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -168.81 175.49 5.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.524 -0.735 . . . . 0.0 109.766 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 96' ' ' LEU . . . . . 0.41 ' CD2' ' CD1' ' B' ' 91' ' ' PHE . 79.4 mt -107.48 128.3 54.37 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.211 -0.931 . . . . 0.0 110.685 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 2.6 m -109.67 126.84 54.1 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.014 -1.053 . . . . 0.0 110.358 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 63.6 t -132.96 128.85 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.016 -1.053 . . . . 0.0 110.427 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -123.98 147.03 48.1 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.987 -1.07 . . . . 0.0 110.965 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 100' ' ' LEU . . . . . 0.486 ' HB3' ' HD2' ' B' ' 101' ' ' PRO . 1.1 mp -100.36 167.85 10.28 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.585 -0.697 . . . . 0.0 109.581 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 101' ' ' PRO . . . . . 0.486 ' HD2' ' HB3' ' B' ' 100' ' ' LEU . 41.0 Cg_endo -66.02 -22.73 54.77 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.564 1.297 . . . . 0.0 110.451 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 102' ' ' ASP . . . . . 0.405 ' O ' ' HB3' ' B' ' 78' ' ' PRO . 47.5 t0 -152.11 80.06 1.25 Allowed 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.122 -0.986 . . . . 0.0 109.751 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 179.41 -172.49 44.42 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 104' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -87.13 -150.68 0.16 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.211 -1.17 . . . . 0.0 110.284 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -129.01 146.05 51.09 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.925 . . . . 0.0 110.64 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -130.51 134.34 46.98 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.343 -0.848 . . . . 0.0 109.865 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -114.85 144.62 43.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.296 -0.878 . . . . 0.0 110.891 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 108' ' ' PHE . . . . . 0.453 ' CE2' ' O ' ' B' ' 109' ' ' PRO . 56.4 t80 -129.22 133.84 25.61 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 109' ' ' PRO . . . . . 0.453 ' O ' ' CE2' ' B' ' 108' ' ' PHE . 44.1 Cg_endo -66.93 138.91 49.74 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.312 1.164 . . . . 0.0 110.353 -178.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 110' ' ' ASN . . . . . 0.49 ' ND2' ' O ' ' B' ' 110' ' ' ASN . 5.3 p-10 -100.58 78.58 2.01 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.359 -0.838 . . . . 0.0 110.175 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . 0.406 ' C ' ' O ' ' B' ' 110' ' ' ASN . 79.5 ttt180 -41.61 -32.71 0.39 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.4 -0.812 . . . . 0.0 110.757 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 95.3 mt -78.99 149.2 32.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.274 -0.892 . . . . 0.0 110.452 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -103.78 40.71 1.39 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.323 -0.861 . . . . 0.0 110.035 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 56.4 tp -71.29 125.67 27.57 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.124 -0.985 . . . . 0.0 109.862 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -96.58 -4.86 40.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.58 -0.7 . . . . 0.0 111.087 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 116' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' B' ' 11' ' ' LEU . . . -142.03 142.04 32.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.868 -1.145 . . . . 0.0 111.499 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 117' ' ' ILE . . . . . 0.412 ' HB ' ' HB3' ' B' ' 11' ' ' LEU . 48.4 mm -102.72 121.15 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -118.02 -18.9 9.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.86 -1.15 . . . . 0.0 111.412 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 119' ' ' TYR . . . . . 0.429 ' O ' ' HA ' ' B' ' 34' ' ' LEU . 43.0 t80 -113.42 129.72 56.47 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.972 -1.08 . . . . 0.0 111.229 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 120' ' ' MET . . . . . 0.472 ' CB ' ' CD1' ' B' ' 9' ' ' LEU . 47.2 ttp -142.06 114.08 8.1 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -135.91 139.15 43.08 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.883 -1.136 . . . . 0.0 110.868 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 122' ' ' ALA . . . . . 0.425 ' O ' ' HA3' ' B' ' 3' ' ' GLY . . . -141.96 131.41 23.77 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 123' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' B' ' 2' ' ' CYS . 62.2 t0 -150.99 122.14 7.74 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.464 -0.773 . . . . 0.0 109.224 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 124' ' ' GLY . . . . . 0.435 ' HA3' ' HA ' ' B' ' 30' ' ' PHE . . . 174.99 -149.02 9.98 Favored Glycine 0 N--CA 1.489 2.19 0 C-N-CA 118.969 -1.586 . . . . 0.0 110.026 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . 0.473 ' HB2' ' CZ ' ' B' ' 30' ' ' PHE . 87.6 m-20 -86.4 8.95 19.57 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.698 -0.884 . . . . 0.0 110.318 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 126' ' ' PHE . . . . . 0.49 ' HB2' ' CE2' ' B' ' 30' ' ' PHE . 51.2 t80 -103.86 141.53 35.96 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.136 -0.977 . . . . 0.0 109.768 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -115.93 120.22 38.48 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.119 -1.033 . . . . 0.0 111.089 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . 0.42 ' O ' ' CG2' ' B' ' 128' ' ' ILE . 18.9 tt -95.86 119.31 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.147 -0.97 . . . . 0.0 109.999 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 129' ' ' LYS . . . . . 0.426 ' NZ ' ' OE1' ' B' ' 22' ' ' GLU . 98.2 mttt -100.83 -15.55 17.57 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.021 -1.049 . . . . 0.0 111.591 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 130' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -154.54 146.79 23.8 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.689 -1.257 . . . . 0.0 111.445 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 42.5 t -124.76 129.04 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 132' ' ' ALA . . . . . . . . . . . . . . . -118.79 139.79 51.02 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.564 -1.335 . . . . 0.0 110.504 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -105.98 119.73 39.95 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.429 -0.794 . . . . 0.0 109.955 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 5.7 t0 . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.597 -179.989 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.442 ' HA2' ' CB ' ' A' ' 123' ' ' ASP . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.418 ' HA ' ' HB3' ' B' ' 8' ' ' ASN . 60.8 tp -61.44 132.22 52.75 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.719 -1.459 . . . . 0.0 110.032 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.9 t -117.41 154.71 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.49 -0.756 . . . . 0.0 110.599 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.449 ' HB3' ' HB3' ' A' ' 120' ' ' MET . . . -141.92 156.51 45.49 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.345 -0.847 . . . . 0.0 110.573 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.45 ' O ' ' HB3' ' A' ' 8' ' ' ASN . 8.2 p -151.71 170.27 20.14 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.52 -0.737 . . . . 0.0 109.613 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.45 ' HB3' ' O ' ' A' ' 7' ' ' SER . 14.3 t30 60.46 32.89 20.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.456 -0.778 . . . . 0.0 109.529 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.507 ' CD1' ' CB ' ' A' ' 120' ' ' MET . 74.3 mt -84.99 -15.19 45.06 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.554 -0.716 . . . . 0.0 111.991 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.496 ' C ' ' O ' ' A' ' 9' ' ' LEU . 53.4 p-10 5.43 63.06 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.503 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.471 ' N ' ' O ' ' A' ' 9' ' ' LEU . 11.7 mt -92.37 126.61 37.53 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 120.865 -1.147 . . . . 0.0 109.355 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -90.84 165.06 23.41 Favored Pre-proline 0 C--N 1.301 -1.537 0 O-C-N 121.365 -0.834 . . . . 0.0 110.44 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 91' ' ' PHE . 49.7 Cg_endo -68.68 152.63 74.28 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 124.039 1.547 . . . . 0.0 110.554 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.04 -20.73 42.33 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -100.12 152.69 19.96 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.16 -1.2 . . . . 0.0 110.108 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.2 m -97.91 139.02 34.37 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.225 -0.922 . . . . 0.0 110.806 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 58.8 tp -124.13 131.41 53.54 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.238 -0.914 . . . . 0.0 110.029 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 95.4 mtm-85 -128.91 139.96 51.89 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.014 -1.054 . . . . 0.0 111.017 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 90.2 t -129.4 122.51 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.096 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 47.3 ttp180 -107.03 127.84 53.83 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.103 -0.998 . . . . 0.0 110.66 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -143.02 -159.24 7.86 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 119.449 -1.358 . . . . 0.0 110.715 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 84' ' ' VAL . 84.4 tt0 -138.03 147.53 44.23 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.833 -0.804 . . . . 0.0 109.135 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 50.3 t -108.78 124.12 65.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 120.903 -1.123 . . . . 0.0 110.123 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.54 162.01 1.88 Allowed Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.166 -0.959 . . . . 0.0 109.024 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -66.95 -19.47 52.11 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 O-C-N 123.833 1.438 . . . . 0.0 110.65 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 28' ' ' LYS . 89.2 m-20 -112.65 40.04 2.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.115 -0.991 . . . . 0.0 110.656 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.435 ' HA ' ' HB3' ' A' ' 125' ' ' ASP . . . -54.0 92.67 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.065 -1.022 . . . . 0.0 110.051 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.423 ' N ' ' O ' ' A' ' 26' ' ' ASP . 87.6 tttt -106.21 -34.43 7.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.164 -0.96 . . . . 0.0 111.612 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 39.5 t -150.48 133.73 16.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.847 -1.158 . . . . 0.0 111.297 -178.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.43 ' HA ' ' HA3' ' A' ' 124' ' ' GLY . 47.1 t80 -156.18 155.27 32.16 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.481 -0.762 . . . . 0.0 110.526 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.436 ' CG1' ' OD1' ' A' ' 123' ' ' ASP . 9.3 p -139.4 133.9 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.096 -1.003 . . . . 0.0 111.007 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.7 tp -126.73 131.08 51.43 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.372 -0.83 . . . . 0.0 109.875 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -136.72 137.21 39.69 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.855 -1.153 . . . . 0.0 111.421 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -138.45 113.64 9.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.241 -0.912 . . . . 0.0 109.648 178.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.452 ' O ' ' HB3' ' A' ' 119' ' ' TYR . . . -165.58 -163.35 18.79 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.459 ' HG3' ' CD1' ' A' ' 114' ' ' LEU . 99.1 mttt -68.32 -43.99 76.39 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.939 -1.33 . . . . 0.0 110.514 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -153.57 -167.03 2.56 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.779 0.8 . . . . 0.0 111.93 -178.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.3 t -60.28 -44.63 95.18 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.685 -0.634 . . . . 0.0 112.486 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.407 ' HB3' ' N ' ' A' ' 66' ' ' GLY . 82.6 m-20 -89.49 -14.01 36.24 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.763 -1.211 . . . . 0.0 110.317 -179.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -107.27 71.89 0.85 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.342 -0.849 . . . . 0.0 109.348 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.6 mt -101.59 141.41 34.5 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.261 0.553 . . . . 0.0 110.388 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.44 ' O ' ' CB ' ' A' ' 62' ' ' SER . 0.5 OUTLIER -85.78 -51.93 6.1 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.24 -0.913 . . . . 0.0 110.049 179.652 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.407 ' HA ' HD23 ' A' ' 43' ' ' LEU . 84.7 mt -128.07 140.29 52.03 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.994 -1.066 . . . . 0.0 110.914 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.423 ' N ' ' O ' ' A' ' 61' ' ' ASN . 66.0 t-80 -120.88 112.14 18.42 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -104.78 127.61 52.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.056 -1.028 . . . . 0.0 109.743 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.5 81.11 13.91 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.082 -1.011 . . . . 0.0 111.025 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.83 148.23 64.18 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.076 1.566 . . . . 0.0 110.139 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -144.95 107.57 4.43 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.925 -1.109 . . . . 0.0 111.689 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -62.3 -45.0 95.21 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.209 -0.932 . . . . 0.0 109.57 178.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -136.57 93.58 2.89 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.635 -0.666 . . . . 0.0 109.892 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -87.5 -151.04 0.17 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.191 -0.943 . . . . 0.0 110.136 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -66.02 -8.52 23.55 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.076 -1.015 . . . . 0.0 111.444 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 174.29 -27.53 0.08 OUTLIER Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -77.97 -179.31 6.0 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.05 -1.264 . . . . 0.0 109.13 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.428 ' O ' ' C ' ' A' ' 56' ' ' ASN . . . -143.76 149.84 37.7 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.173 -0.955 . . . . 0.0 110.988 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.428 ' C ' ' O ' ' A' ' 55' ' ' ALA . 87.6 m-20 29.51 59.31 0.16 Allowed 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 178.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 98.2 m -121.18 128.88 52.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.94 -1.1 . . . . 0.0 110.645 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 95.6 mt -111.13 126.05 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.701 -0.624 . . . . 0.0 110.383 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.1 m -116.5 135.43 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.015 -1.053 . . . . 0.0 109.955 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 35.4 m -103.03 136.15 43.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.141 -0.974 . . . . 0.0 110.053 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.423 ' O ' ' N ' ' A' ' 44' ' ' HIS . 1.4 t-20 -146.95 158.6 43.97 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.074 -1.016 . . . . 0.0 110.987 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 42' ' ' CYS . 53.2 p -139.05 158.25 44.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.447 -0.783 . . . . 0.0 110.236 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.469 ' CD ' ' HA2' ' A' ' 66' ' ' GLY . 26.2 ttmt -142.47 152.7 42.99 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.312 -0.867 . . . . 0.0 110.563 178.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -125.04 94.66 4.24 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.358 -0.839 . . . . 0.0 109.071 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 64.47 28.43 73.13 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.469 ' HA2' ' CD ' ' A' ' 63' ' ' LYS . . . 73.98 24.76 73.15 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.2 -79.03 0.13 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.434 -1.039 . . . . 0.0 110.347 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -141.98 -144.67 0.16 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.341 -0.849 . . . . 0.0 109.66 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 163.76 110.57 0.24 Allowed Glycine 0 N--CA 1.493 2.497 0 C-N-CA 119.67 -1.253 . . . . 0.0 110.078 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.08 71.97 10.12 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.364 -1.08 . . . . 0.0 110.32 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -61.3 143.99 54.7 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.553 -0.717 . . . . 0.0 111.729 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -124.73 -154.38 0.61 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.465 -0.772 . . . . 0.0 109.314 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 78.3 ttt-85 -143.88 116.18 8.5 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.757 -1.214 . . . . 0.0 112.021 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -109.32 122.64 47.79 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.33 -0.856 . . . . 0.0 109.577 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -113.88 88.4 2.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.896 -1.127 . . . . 0.0 110.377 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.6 p -141.33 142.46 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.369 -0.832 . . . . 0.0 110.475 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -151.65 77.87 7.04 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.171 -0.956 . . . . 0.0 109.857 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.473 ' CB ' ' HB2' ' A' ' 102' ' ' ASP . 54.7 Cg_endo -83.3 -0.96 10.11 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.218 1.641 . . . . 0.0 111.934 -178.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.502 ' CE1' ' HG2' ' A' ' 101' ' ' PRO . 44.0 m-85 -139.13 -171.9 3.21 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.912 -1.118 . . . . 0.0 110.357 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.458 ' HB2' ' HD2' ' A' ' 81' ' ' PRO . 2.7 pm0 -143.6 166.66 18.53 Favored Pre-proline 0 C--N 1.301 -1.506 0 O-C-N 121.189 -0.944 . . . . 0.0 110.342 -178.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 80' ' ' GLN . 43.9 Cg_endo -65.7 151.13 85.41 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.931 1.49 . . . . 0.0 109.655 179.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.35 23.75 70.06 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 38.9 t -140.56 143.39 35.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.262 -1.14 . . . . 0.0 109.518 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.442 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 20.2 m -78.28 153.63 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.159 -0.963 . . . . 0.0 110.753 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -160.87 147.83 15.31 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.343 -0.848 . . . . 0.0 109.92 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -122.19 146.78 46.92 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.434 -0.791 . . . . 0.0 108.945 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 71.1 t -126.94 135.2 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.011 -1.056 . . . . 0.0 110.896 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 2.3 t -109.3 129.02 55.53 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.307 -0.871 . . . . 0.0 109.42 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 86.8 mt -129.15 127.33 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.118 -0.989 . . . . 0.0 110.589 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.0 m -115.56 132.12 56.73 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.177 -0.952 . . . . 0.0 109.691 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.434 ' CZ ' ' HB3' ' A' ' 114' ' ' LEU . 47.8 t80 -113.26 123.38 50.03 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.13 -0.981 . . . . 0.0 110.266 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -109.62 147.68 32.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -0.912 . . . . 0.0 109.769 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -58.11 -21.68 47.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.333 -0.854 . . . . 0.0 111.225 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -116.62 -13.34 10.85 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.724 -1.235 . . . . 0.0 110.781 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -147.29 -167.68 2.85 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.08 -1.013 . . . . 0.0 110.981 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' A' ' 107' ' ' LYS . 7.2 tt -151.76 115.63 4.91 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 54.4 m -106.65 130.37 54.4 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.768 -1.208 . . . . 0.0 110.309 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.413 HG21 ' CD2' ' A' ' 96' ' ' LEU . 52.5 t -121.4 132.34 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.458 -0.776 . . . . 0.0 110.185 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -122.68 127.04 48.77 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.851 -1.156 . . . . 0.0 110.659 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.4 mt -95.9 161.27 27.95 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.502 ' HG2' ' CE1' ' A' ' 79' ' ' PHE . 39.4 Cg_endo -65.62 -22.7 57.68 Favored 'Trans proline' 0 C--N 1.301 -1.95 0 O-C-N 123.448 1.236 . . . . 0.0 109.828 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.486 ' OD2' ' CD1' ' A' ' 104' ' ' TYR . 29.0 t70 -63.67 -40.26 96.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.287 -0.883 . . . . 0.0 109.995 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 126.59 -6.57 7.49 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.486 ' CD1' ' OD2' ' A' ' 102' ' ' ASP . 47.2 m-85 -87.07 142.29 28.04 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.005 -1.291 . . . . 0.0 110.224 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -128.43 140.26 51.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.321 -0.862 . . . . 0.0 111.327 -179.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -131.87 150.46 52.15 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 11.7 ptpt -132.9 136.01 45.91 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.798 -1.189 . . . . 0.0 111.384 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 20.1 m-30 -108.44 147.41 35.62 Favored Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 121.533 -0.729 . . . . 0.0 109.648 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.414 ' O ' ' N ' ' A' ' 111' ' ' ARG . 41.2 Cg_endo -65.64 150.68 86.19 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 O-C-N 124.0 1.526 . . . . 0.0 111.017 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -65.82 62.31 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.84 -0.537 . . . . 0.0 111.68 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.414 ' N ' ' O ' ' A' ' 109' ' ' PRO . 20.8 ptt180 -68.74 -24.76 64.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.061 -1.025 . . . . 0.0 109.663 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.419 ' C ' ' CD1' ' A' ' 112' ' ' LEU . 1.2 tm? -111.21 128.77 56.02 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.297 -0.877 . . . . 0.0 109.107 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -90.27 69.42 7.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.795 -1.191 . . . . 0.0 110.812 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.459 ' CD1' ' HG3' ' A' ' 36' ' ' LYS . 53.4 tp -84.84 131.44 34.53 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.377 -0.827 . . . . 0.0 109.35 178.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -92.17 -19.48 22.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.725 -1.234 . . . . 0.0 109.846 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 11' ' ' LEU . . . -171.76 156.6 4.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -0.907 . . . . 0.0 109.479 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.41 ' CG1' HD21 ' A' ' 114' ' ' LEU . 66.5 mt -101.94 116.36 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.884 -1.135 . . . . 0.0 110.76 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 -111.63 -23.97 10.36 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.143 -0.973 . . . . 0.0 109.914 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.452 ' HB3' ' O ' ' A' ' 35' ' ' GLY . 90.2 t80 -106.84 126.75 52.7 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.378 -0.826 . . . . 0.0 111.228 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.507 ' CB ' ' CD1' ' A' ' 9' ' ' LEU . 66.3 ttp -136.67 125.56 24.16 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -141.59 136.76 31.37 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.959 -1.088 . . . . 0.0 110.393 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -147.37 123.46 10.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.351 -0.843 . . . . 0.0 110.204 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.442 ' CB ' ' HA2' ' A' ' 3' ' ' GLY . 20.5 p-10 -151.11 121.93 7.56 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.956 -1.09 . . . . 0.0 110.956 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.43 ' HA3' ' HA ' ' A' ' 30' ' ' PHE . . . 178.28 -148.08 8.3 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.435 ' HB3' ' HA ' ' A' ' 27' ' ' ALA . 80.9 m-20 -81.69 8.72 9.21 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.482 -1.011 . . . . 0.0 110.924 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -106.29 142.65 35.62 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.974 -1.078 . . . . 0.0 110.205 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -110.97 125.3 53.56 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 118.945 -1.102 . . . . 0.0 110.91 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 9.0 tt -100.26 121.18 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.162 -0.961 . . . . 0.0 109.601 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -101.0 -17.55 16.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.343 -0.848 . . . . 0.0 112.323 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -159.39 147.72 17.7 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.484 -1.385 . . . . 0.0 112.252 -178.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' B' ' 130' ' ' CYS . 45.4 t -127.13 127.1 69.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -128.68 129.75 46.23 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.813 -1.179 . . . . 0.0 110.214 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -64.25 -102.76 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.238 -0.914 . . . . 0.0 110.118 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.8 t70 . . . . . 0 N--CA 1.493 1.71 0 O-C-N 120.599 -1.313 . . . . 0.0 110.19 179.64 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.265 0.555 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 2' ' ' CYS . . . . . . . . . . . . . 35.6 t -148.27 83.31 1.49 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.356 -0.84 . . . . 0.0 110.148 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' GLY . . . . . 0.443 ' HA2' ' CB ' ' B' ' 123' ' ' ASP . . . 93.9 38.85 5.07 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 120.198 -1.001 . . . . 0.0 111.1 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 60.5 tp -61.69 132.26 52.65 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.729 -1.454 . . . . 0.0 109.906 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 3.1 t -117.16 154.58 18.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.643 -0.66 . . . . 0.0 110.602 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' ALA . . . . . 0.441 ' HB3' ' HB3' ' B' ' 120' ' ' MET . . . -141.99 156.53 45.45 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.423 -0.798 . . . . 0.0 110.548 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' SER . . . . . 0.446 ' O ' ' HB3' ' B' ' 8' ' ' ASN . 7.9 p -151.89 170.04 20.81 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.579 -0.701 . . . . 0.0 109.579 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . 0.446 ' HB3' ' O ' ' B' ' 7' ' ' SER . 16.1 t30 60.79 32.99 20.2 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.521 -0.737 . . . . 0.0 109.287 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . 0.507 ' CD1' ' CB ' ' B' ' 120' ' ' MET . 73.2 mt -86.15 -11.59 52.18 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.622 -0.674 . . . . 0.0 111.834 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' ASN . . . . . 0.491 ' C ' ' O ' ' B' ' 9' ' ' LEU . 53.5 p-10 -0.28 66.14 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.486 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -178.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.495 ' N ' ' O ' ' B' ' 9' ' ' LEU . 11.6 mt -93.37 126.54 38.55 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.087 -1.008 . . . . 0.0 109.202 178.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -90.83 165.3 22.68 Favored Pre-proline 0 C--N 1.3 -1.566 0 O-C-N 121.345 -0.847 . . . . 0.0 110.402 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' B' ' 91' ' ' PHE . 48.9 Cg_endo -68.65 152.64 74.4 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.967 1.509 . . . . 0.0 110.548 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.08 -20.73 42.25 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -100.04 152.84 19.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.184 -1.186 . . . . 0.0 110.047 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' CYS . . . . . . . . . . . . . 2.2 m -98.16 139.12 34.43 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.185 -0.947 . . . . 0.0 110.708 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.402 ' CD1' ' HA ' ' B' ' 133' ' ' PHE . 58.7 tp -124.18 131.38 53.53 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.253 -0.904 . . . . 0.0 110.063 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 95.5 mtm-85 -128.93 139.87 51.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.878 -1.139 . . . . 0.0 110.937 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 91.4 t -129.33 122.65 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.09 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 47.3 ttp180 -107.13 127.69 53.72 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.15 -0.969 . . . . 0.0 110.665 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -142.86 -159.25 7.87 Favored Glycine 0 N--CA 1.49 2.269 0 C-N-CA 119.409 -1.377 . . . . 0.0 110.685 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . 0.431 ' HA ' ' HA ' ' B' ' 84' ' ' VAL . 84.6 tt0 -138.03 147.46 44.16 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.822 -0.811 . . . . 0.0 109.215 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 50.1 t -108.74 124.11 65.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 O-C-N 120.984 -1.073 . . . . 0.0 110.148 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.71 161.88 2.02 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.103 -0.998 . . . . 0.0 108.985 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . 0.4 ' O ' ' HB2' ' B' ' 81' ' ' PRO . 43.6 Cg_endo -66.76 -19.58 53.11 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 O-C-N 123.7 1.368 . . . . 0.0 110.606 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' B' ' 28' ' ' LYS . 89.2 m-20 -112.64 40.14 2.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.183 -0.948 . . . . 0.0 110.664 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . 0.433 ' HA ' ' HB3' ' B' ' 125' ' ' ASP . . . -53.98 92.53 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.109 -0.994 . . . . 0.0 110.172 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' B' ' 26' ' ' ASP . 87.6 tttt -106.28 -34.28 7.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.125 -0.984 . . . . 0.0 111.588 -179.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 39.7 t -150.52 133.2 15.81 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.848 -1.158 . . . . 0.0 111.312 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' PHE . . . . . 0.434 ' HA ' ' HA3' ' B' ' 124' ' ' GLY . 48.4 t80 -155.54 155.42 33.36 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.52 -0.737 . . . . 0.0 110.632 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.438 ' CG1' ' OD1' ' B' ' 123' ' ' ASP . 9.1 p -139.5 133.64 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.162 -0.961 . . . . 0.0 111.044 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 15.8 tp -126.66 131.02 51.52 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.32 -0.862 . . . . 0.0 109.877 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -136.61 137.48 40.17 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.958 -1.089 . . . . 0.0 111.407 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -138.94 109.68 6.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.143 -0.973 . . . . 0.0 109.859 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . 0.457 ' O ' ' HB3' ' B' ' 119' ' ' TYR . . . -160.18 -162.31 12.25 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . 0.463 ' HG3' ' CD1' ' B' ' 114' ' ' LEU . 99.1 mttt -68.81 -43.85 74.75 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.146 -1.208 . . . . 0.0 110.228 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -153.56 -167.2 2.62 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.786 0.803 . . . . 0.0 111.881 -178.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 11.6 t -59.91 -44.77 94.08 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' ASN . . . . . 0.405 ' HB3' ' N ' ' B' ' 66' ' ' GLY . 83.0 m-20 -89.69 -13.81 36.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.707 -1.246 . . . . 0.0 110.315 -179.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' ASN . . . . . 0.4 ' ND2' ' N ' ' B' ' 40' ' ' ASN . 5.7 m-80 -107.45 71.74 0.84 Allowed 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.913 0.864 . . . . 0.0 109.318 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 95.0 mt -101.12 144.05 30.49 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.782 -0.573 . . . . 0.0 110.13 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' CYS . . . . . 0.425 ' O ' ' CB ' ' B' ' 62' ' ' SER . 0.5 OUTLIER -89.31 -50.42 6.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.168 -0.958 . . . . 0.0 109.636 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 85.5 mt -128.93 140.19 51.78 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.913 -1.117 . . . . 0.0 110.813 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' HIS . . . . . 0.429 ' N ' ' O ' ' B' ' 61' ' ' ASN . 65.9 t-80 -120.91 112.3 18.61 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -104.86 127.69 52.77 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.165 -0.959 . . . . 0.0 109.664 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.46 80.99 14.08 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 120.989 -1.07 . . . . 0.0 111.06 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.79 148.08 64.12 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.062 1.559 . . . . 0.0 110.132 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -144.8 107.72 4.5 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.879 -1.138 . . . . 0.0 111.628 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -62.51 -44.86 95.34 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.057 -1.027 . . . . 0.0 109.575 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 28.9 t30 -136.63 93.24 2.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.729 -0.607 . . . . 0.0 110.005 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -87.35 -151.08 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.258 -0.901 . . . . 0.0 110.209 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -66.15 -6.93 15.06 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.019 -1.051 . . . . 0.0 111.458 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 171.8 -26.8 0.1 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -78.29 -179.41 6.23 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.994 -1.297 . . . . 0.0 108.997 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.486 ' O ' ' C ' ' B' ' 56' ' ' ASN . . . -141.8 156.7 45.55 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.121 -0.987 . . . . 0.0 110.202 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' ASN . . . . . 0.486 ' C ' ' O ' ' B' ' 55' ' ' ALA . 87.1 m-20 18.51 63.88 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 97.8 m -122.05 128.91 51.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 110.532 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' ILE . . . . . . . . . . . . . 96.1 mt -111.43 126.27 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.698 -0.626 . . . . 0.0 110.356 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.402 HG22 ' O ' ' B' ' 59' ' ' VAL . 25.4 m -116.55 135.33 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.053 -1.029 . . . . 0.0 110.052 179.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 35.2 m -103.01 135.88 43.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.21 -0.931 . . . . 0.0 110.255 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' ASN . . . . . 0.429 ' O ' ' N ' ' B' ' 44' ' ' HIS . 1.4 t-20 -146.74 158.45 43.91 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.083 -1.011 . . . . 0.0 111.134 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' B' ' 42' ' ' CYS . 53.3 p -138.85 158.45 44.19 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.454 -0.779 . . . . 0.0 110.266 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . 0.469 ' CD ' ' HA2' ' B' ' 66' ' ' GLY . 26.3 ttmt -142.56 152.7 42.85 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.289 -0.882 . . . . 0.0 110.498 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -124.92 94.73 4.27 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.304 -0.872 . . . . 0.0 109.055 178.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 64.3 28.59 73.22 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . 0.469 ' HA2' ' CD ' ' B' ' 63' ' ' LYS . . . 73.88 24.73 73.45 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.06 -79.0 0.13 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.341 -1.093 . . . . 0.0 110.435 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -142.18 -144.69 0.16 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.255 -0.903 . . . . 0.0 109.624 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 163.63 110.4 0.24 Allowed Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.545 -1.312 . . . . 0.0 110.1 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.83 71.99 9.91 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.317 -1.108 . . . . 0.0 110.319 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -61.4 144.09 54.68 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.463 -0.773 . . . . 0.0 111.817 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -124.84 -154.38 0.61 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.318 -0.864 . . . . 0.0 109.314 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 78.3 ttt-85 -143.79 116.24 8.58 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.709 -1.244 . . . . 0.0 111.99 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -109.42 122.74 48.05 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.371 -0.83 . . . . 0.0 109.557 178.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -114.03 88.52 2.87 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.925 -1.11 . . . . 0.0 110.271 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 7.6 p -141.4 142.38 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.309 -0.87 . . . . 0.0 110.53 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -151.47 77.81 7.18 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.139 -0.976 . . . . 0.0 109.899 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . 0.48 ' CB ' ' HB2' ' B' ' 102' ' ' ASP . 54.6 Cg_endo -83.36 -0.65 9.95 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.185 1.624 . . . . 0.0 112.078 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 79' ' ' PHE . . . . . 0.499 ' CE1' ' HG2' ' B' ' 101' ' ' PRO . 44.3 m-85 -139.32 -171.74 3.19 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.955 -1.091 . . . . 0.0 110.439 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.449 ' HB2' ' HD2' ' B' ' 81' ' ' PRO . 2.6 pm0 -143.67 166.9 17.27 Favored Pre-proline 0 C--N 1.302 -1.457 0 O-C-N 121.284 -0.885 . . . . 0.0 110.323 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 81' ' ' PRO . . . . . 0.449 ' HD2' ' HB2' ' B' ' 80' ' ' GLN . 43.2 Cg_endo -65.71 151.2 85.17 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.904 1.476 . . . . 0.0 109.63 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.4 23.61 70.26 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.024 -1.631 . . . . 0.0 109.024 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 38.6 t -140.49 143.43 35.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.333 -1.098 . . . . 0.0 109.572 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' B' ' 22' ' ' GLU . 20.0 m -78.33 153.51 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.126 -0.983 . . . . 0.0 110.834 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -160.72 147.74 15.51 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.383 -0.823 . . . . 0.0 109.917 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -122.09 146.66 46.99 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.307 -0.871 . . . . 0.0 108.928 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 70.4 t -126.81 135.21 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.05 -1.031 . . . . 0.0 110.902 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 88' ' ' CYS . . . . . . . . . . . . . 2.4 t -109.14 129.15 55.48 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.362 -0.836 . . . . 0.0 109.498 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 87.0 mt -129.12 127.22 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.148 -0.97 . . . . 0.0 110.617 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 5.7 m -115.48 132.13 56.72 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.15 -0.969 . . . . 0.0 109.816 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 91' ' ' PHE . . . . . 0.429 ' CZ ' ' HB3' ' B' ' 114' ' ' LEU . 47.7 t80 -113.23 123.62 50.61 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.111 -0.993 . . . . 0.0 110.339 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -109.88 147.8 32.71 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.162 -0.961 . . . . 0.0 109.77 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -58.26 -21.54 48.96 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.322 -0.861 . . . . 0.0 111.201 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -116.7 -13.3 10.8 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.704 -1.247 . . . . 0.0 110.829 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -147.39 -167.68 2.85 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.096 -1.003 . . . . 0.0 110.899 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 96' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' B' ' 107' ' ' LYS . 7.2 tt -151.72 115.75 4.96 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 54.1 m -106.77 130.37 54.49 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.738 -1.227 . . . . 0.0 110.375 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 98' ' ' VAL . . . . . 0.43 HG21 ' CD2' ' B' ' 96' ' ' LEU . 51.8 t -121.58 132.46 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.51 -0.743 . . . . 0.0 110.13 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -122.57 127.53 49.58 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.977 -1.077 . . . . 0.0 110.616 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 3.4 mt -96.41 161.14 27.9 Favored Pre-proline 0 C--N 1.303 -1.454 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 101' ' ' PRO . . . . . 0.499 ' HG2' ' CE1' ' B' ' 79' ' ' PHE . 39.7 Cg_endo -65.54 -22.73 58.24 Favored 'Trans proline' 0 C--N 1.301 -1.952 0 O-C-N 123.448 1.236 . . . . 0.0 109.841 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 102' ' ' ASP . . . . . 0.489 ' OD2' ' CD1' ' B' ' 104' ' ' TYR . 28.9 t70 -63.6 -40.22 96.37 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.337 -0.852 . . . . 0.0 110.02 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 126.44 -6.42 7.57 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 104' ' ' TYR . . . . . 0.489 ' CD1' ' OD2' ' B' ' 102' ' ' ASP . 47.3 m-85 -87.22 142.29 28.01 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.984 -1.304 . . . . 0.0 110.193 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -128.19 140.22 52.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.401 -0.812 . . . . 0.0 111.393 -179.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -131.88 150.61 52.1 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 107' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' B' ' 96' ' ' LEU . 11.7 ptpt -132.98 135.89 45.75 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 118.757 -1.177 . . . . 0.0 111.394 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 108' ' ' PHE . . . . . . . . . . . . . 20.2 m-30 -108.33 147.54 35.82 Favored Pre-proline 0 C--N 1.304 -1.398 0 O-C-N 121.453 -0.78 . . . . 0.0 109.649 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 109' ' ' PRO . . . . . 0.41 ' O ' ' N ' ' B' ' 111' ' ' ARG . 40.9 Cg_endo -65.63 150.8 86.09 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 O-C-N 123.982 1.517 . . . . 0.0 111.042 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 110' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -65.95 62.46 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.881 -0.512 . . . . 0.0 111.583 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . 0.41 ' N ' ' O ' ' B' ' 109' ' ' PRO . 20.8 ptt180 -68.94 -24.48 64.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.032 -1.043 . . . . 0.0 109.558 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 112' ' ' LEU . . . . . 0.408 ' C ' ' CD1' ' B' ' 112' ' ' LEU . 1.2 tm? -111.43 128.7 56.07 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.396 -0.815 . . . . 0.0 109.099 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -90.27 69.5 7.09 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.835 -1.165 . . . . 0.0 110.77 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 114' ' ' LEU . . . . . 0.463 ' CD1' ' HG3' ' B' ' 36' ' ' LYS . 53.4 tp -85.12 131.29 34.47 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.53 -0.731 . . . . 0.0 109.381 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -92.0 -19.58 22.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.717 -1.24 . . . . 0.0 109.775 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 116' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' B' ' 11' ' ' LEU . . . -171.83 156.74 4.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.227 -0.921 . . . . 0.0 109.475 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 117' ' ' ILE . . . . . 0.403 ' CG1' HD21 ' B' ' 114' ' ' LEU . 66.3 mt -101.98 116.36 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.88 -1.137 . . . . 0.0 110.733 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 -111.64 -24.05 10.31 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.155 -0.966 . . . . 0.0 109.817 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 119' ' ' TYR . . . . . 0.457 ' HB3' ' O ' ' B' ' 35' ' ' GLY . 90.1 t80 -106.8 126.75 52.7 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.335 -0.853 . . . . 0.0 111.254 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 120' ' ' MET . . . . . 0.507 ' CB ' ' CD1' ' B' ' 9' ' ' LEU . 66.0 ttp -136.75 125.55 24.03 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -141.59 136.72 31.32 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.034 -1.041 . . . . 0.0 110.388 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -147.27 123.59 10.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.364 -0.835 . . . . 0.0 110.281 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 123' ' ' ASP . . . . . 0.443 ' CB ' ' HA2' ' B' ' 3' ' ' GLY . 20.5 p-10 -151.12 122.13 7.66 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.003 -1.061 . . . . 0.0 110.994 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 124' ' ' GLY . . . . . 0.434 ' HA3' ' HA ' ' B' ' 30' ' ' PHE . . . 178.03 -148.12 8.41 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . 0.433 ' HB3' ' HA ' ' B' ' 27' ' ' ALA . 80.8 m-20 -81.73 8.71 9.33 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.537 -0.978 . . . . 0.0 110.889 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 126' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -106.2 142.67 35.49 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.03 -1.044 . . . . 0.0 110.233 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -111.02 125.13 53.41 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.024 -1.071 . . . . 0.0 110.885 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 8.9 tt -100.2 121.26 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.256 -0.902 . . . . 0.0 109.679 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -100.87 -19.53 15.89 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.337 -0.852 . . . . 0.0 112.2 -178.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 130' ' ' CYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 131' ' ' VAL . 0.0 OUTLIER -156.8 148.43 22.53 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 118.324 -1.35 . . . . 0.0 112.507 -178.9 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 45.6 t -127.45 127.05 68.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 177.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 132' ' ' ALA . . . . . . . . . . . . . . . -128.67 129.77 46.29 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.856 -1.152 . . . . 0.0 110.266 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . 0.402 ' HA ' ' CD1' ' B' ' 17' ' ' LEU . 3.2 m-30 -64.28 -102.76 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.172 -0.955 . . . . 0.0 110.062 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.9 t70 . . . . . 0 N--CA 1.493 1.715 0 O-C-N 120.521 -1.362 . . . . 0.0 110.252 179.697 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.467 ' HA3' ' O ' ' A' ' 122' ' ' ALA . . . . . . . . 0 N--CA 1.492 2.381 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.463 ' CD1' ' O ' ' A' ' 128' ' ' ILE . 77.7 mt -79.42 144.49 34.05 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.354 -1.086 . . . . 0.0 112.215 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.3 m -110.52 150.35 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.56 -0.713 . . . . 0.0 109.498 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.38 156.32 47.08 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.72 -1.238 . . . . 0.0 112.387 -178.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.445 ' O ' ' HB3' ' A' ' 8' ' ' ASN . 17.3 m -155.39 173.25 16.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.538 -0.726 . . . . 0.0 109.853 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.445 ' HB3' ' O ' ' A' ' 7' ' ' SER . 37.3 t-20 62.25 26.76 16.05 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.137 -0.977 . . . . 0.0 109.768 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.51 ' O ' ' C ' ' A' ' 10' ' ' ASN . 63.2 mt -82.25 -12.64 57.94 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.832 -0.542 . . . . 0.0 111.669 -178.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.51 ' C ' ' O ' ' A' ' 9' ' ' LEU . 77.0 m-20 16.81 68.39 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.821 0 CA-C-O 121.35 0.595 . . . . 0.0 112.323 -179.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.488 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 34.0 tp -96.07 132.88 40.99 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.53 -0.731 . . . . 0.0 110.404 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.29 169.69 6.61 Favored Pre-proline 0 C--N 1.296 -1.758 0 O-C-N 121.584 -0.697 . . . . 0.0 109.815 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.426 ' HA ' ' O ' ' A' ' 91' ' ' PHE . 54.9 Cg_endo -72.6 155.61 54.43 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.08 1.568 . . . . 0.0 108.882 178.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.64 -10.11 59.02 Favored Glycine 0 N--CA 1.488 2.154 0 C-N-CA 119.359 -1.4 . . . . 0.0 109.965 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -115.12 146.65 41.13 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.084 -1.245 . . . . 0.0 108.921 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.437 ' O ' ' N ' ' A' ' 134' ' ' ASP . 1.6 t -96.55 140.46 31.14 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.969 -1.082 . . . . 0.0 110.723 -179.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 56.1 tp -111.0 126.92 55.3 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.277 -0.889 . . . . 0.0 110.544 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -120.17 126.72 51.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.241 -0.912 . . . . 0.0 109.871 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.3 t -127.95 129.73 69.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.217 -0.927 . . . . 0.0 110.711 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.445 ' HA ' ' HG2' ' A' ' 86' ' ' GLU . 72.1 ttt180 -109.31 130.15 55.5 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.215 -0.928 . . . . 0.0 109.933 178.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.436 ' CA ' ' O ' ' A' ' 127' ' ' LYS . . . -134.35 173.8 21.24 Favored Glycine 0 C--N 1.294 -1.773 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -125.48 121.26 33.25 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.402 ' O ' ' HA2' ' A' ' 82' ' ' GLY . 70.9 t -85.36 131.89 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.147 -0.971 . . . . 0.0 109.909 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.04 154.04 90.75 Favored Pre-proline 0 N--CA 1.496 1.863 0 O-C-N 121.309 -0.869 . . . . 0.0 109.996 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.412 ' O ' ' HB2' ' A' ' 81' ' ' PRO . 44.4 Cg_endo -67.48 -22.27 45.3 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.613 1.323 . . . . 0.0 110.736 -179.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -101.31 14.05 33.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.007 -1.058 . . . . 0.0 110.186 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.483 ' HA ' ' HB3' ' A' ' 125' ' ' ASP . . . -63.77 142.3 58.45 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.301 -0.874 . . . . 0.0 111.695 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -129.14 -34.84 1.85 Allowed 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 42.2 t -165.68 139.92 4.65 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 121.377 -0.827 . . . . 0.0 110.538 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.452 ' CZ ' ' HG3' ' A' ' 47' ' ' PRO . 42.2 p90 -143.57 161.09 39.38 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.171 -0.956 . . . . 0.0 109.067 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.4 m -126.72 140.52 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 120.662 -1.274 . . . . 0.0 111.935 -178.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.428 HD23 ' HB1' ' A' ' 122' ' ' ALA . 52.7 mt -118.75 133.19 56.02 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.573 -0.704 . . . . 0.0 109.713 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.402 ' OD1' ' ND1' ' A' ' 44' ' ' HIS . 93.8 m-20 -124.92 135.09 52.52 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.84 -1.162 . . . . 0.0 111.597 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.451 HD12 ' HB3' ' A' ' 43' ' ' LEU . 0.6 OUTLIER -144.69 110.77 5.47 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.693 0.759 . . . . 0.0 109.206 178.526 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -165.02 -142.84 3.53 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.496 ' O ' ' HB2' ' A' ' 119' ' ' TYR . 47.9 pttt -109.15 -32.81 7.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.152 -1.205 . . . . 0.0 109.412 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.426 ' N ' ' CG ' ' A' ' 36' ' ' LYS . 36.5 m-20 -138.52 171.73 13.93 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.946 0.879 . . . . 0.0 110.501 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 42.4 t -60.07 -41.94 93.49 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.786 -0.571 . . . . 0.0 110.931 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.472 ' HB3' ' N ' ' A' ' 66' ' ' GLY . 82.1 m-20 -91.5 -6.41 52.62 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.033 -1.042 . . . . 0.0 111.372 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -115.29 60.46 0.7 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.88 -1.138 . . . . 0.0 111.05 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 61.3 mt -84.88 147.35 26.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.35 -0.844 . . . . 0.0 109.903 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 81.6 m -88.55 -41.7 12.54 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.865 -1.147 . . . . 0.0 109.347 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.451 ' HB3' HD12 ' A' ' 34' ' ' LEU . 15.1 tp -132.17 128.98 39.17 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.644 -0.66 . . . . 0.0 110.862 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.402 ' ND1' ' OD1' ' A' ' 33' ' ' ASN . 20.3 t60 -121.37 112.85 19.09 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -104.72 122.18 45.15 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.023 -1.048 . . . . 0.0 110.691 -178.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -139.37 85.75 15.02 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.297 -0.877 . . . . 0.0 111.218 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.452 ' HG3' ' CZ ' ' A' ' 30' ' ' PHE . 55.9 Cg_endo -71.16 145.13 48.39 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.961 1.506 . . . . 0.0 110.193 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -128.21 92.34 3.43 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.763 -1.21 . . . . 0.0 110.425 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -63.37 -40.59 97.66 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.425 -0.797 . . . . 0.0 109.571 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -137.82 92.02 2.64 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.198 -0.939 . . . . 0.0 109.024 178.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.66 -146.9 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.405 -0.809 . . . . 0.0 109.703 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -108.28 31.65 5.41 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.291 -0.88 . . . . 0.0 109.94 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 166.63 -32.17 0.21 Allowed Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.251 -1.452 . . . . 0.0 109.87 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -89.74 -168.86 2.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.134 -1.215 . . . . 0.0 110.285 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.466 ' O ' ' C ' ' A' ' 56' ' ' ASN . . . -150.82 144.94 25.39 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.407 -0.808 . . . . 0.0 109.496 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.466 ' C ' ' O ' ' A' ' 55' ' ' ALA . 95.1 m-20 25.19 64.09 0.06 Allowed 'General case' 0 N--CA 1.506 2.368 0 CA-C-O 121.137 0.494 . . . . 0.0 111.783 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.8 m -127.24 126.79 43.34 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.434 -0.791 . . . . 0.0 110.283 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.409 HD11 ' O ' ' A' ' 76' ' ' VAL . 83.1 mt -119.96 131.52 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 CA-C-O 121.173 0.511 . . . . 0.0 110.852 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.3 m -124.18 153.03 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 120.996 -1.065 . . . . 0.0 110.135 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 57.1 m -111.03 145.84 37.78 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.058 -1.026 . . . . 0.0 110.453 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -155.91 170.64 21.65 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.271 -0.893 . . . . 0.0 111.393 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.4 m -149.49 157.34 43.2 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.405 -0.809 . . . . 0.0 109.084 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.458 ' CD ' ' HA2' ' A' ' 66' ' ' GLY . 7.7 ttmt -134.67 140.71 46.22 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.766 -1.209 . . . . 0.0 110.479 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -122.07 105.79 10.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.288 -0.883 . . . . 0.0 109.728 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.64 28.9 74.07 Favored Glycine 0 N--CA 1.484 1.834 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.472 ' N ' ' HB3' ' A' ' 39' ' ' ASN . . . 91.45 -2.38 77.71 Favored Glycine 0 N--CA 1.482 1.723 0 C-N-CA 119.323 -1.417 . . . . 0.0 109.583 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.449 ' O ' ' C ' ' A' ' 68' ' ' TRP . . . -106.77 90.33 3.29 Favored 'General case' 0 N--CA 1.483 1.196 0 O-C-N 121.045 -1.268 . . . . 0.0 109.9 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.456 ' HA ' ' HA ' ' A' ' 63' ' ' LYS . 2.0 m-90 -19.66 -104.48 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.444 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 130.63 -99.87 0.45 Allowed Glycine 0 N--CA 1.489 2.199 0 O-C-N 119.863 -1.773 . . . . 0.0 110.941 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.3 t -93.77 143.41 26.36 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.258 -1.142 . . . . 0.0 111.528 -178.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -153.28 108.93 3.27 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.036 -1.04 . . . . 0.0 110.749 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.493 ' NE2' ' CZ ' ' A' ' 108' ' ' PHE . 10.1 pt20 -125.18 -151.19 0.47 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.275 -1.516 . . . . 0.0 111.01 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -140.59 132.92 28.31 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.959 -1.088 . . . . 0.0 111.095 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.431 ' OE2' ' CD1' ' A' ' 106' ' ' PHE . 82.0 tt0 -143.09 81.72 1.73 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.244 -0.91 . . . . 0.0 110.165 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.97 99.8 2.8 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.094 -1.004 . . . . 0.0 110.37 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.409 ' O ' HD11 ' A' ' 58' ' ' ILE . 4.2 p -140.24 138.2 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.019 -1.051 . . . . 0.0 109.143 178.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.588 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 4.1 p90 -153.15 87.04 3.99 Favored Pre-proline 0 C--N 1.303 -1.421 0 O-C-N 120.938 -1.101 . . . . 0.0 110.8 -178.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.47 ' O ' ' CD1' ' A' ' 79' ' ' PHE . 50.0 Cg_endo -86.13 11.01 3.44 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 124.229 1.647 . . . . 0.0 110.577 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.47 ' CD1' ' O ' ' A' ' 78' ' ' PRO . 42.5 m-85 -148.14 -175.31 4.84 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.146 -0.971 . . . . 0.0 110.622 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.457 ' CG ' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -140.45 174.03 4.38 Favored Pre-proline 0 N--CA 1.493 1.69 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.457 ' HD2' ' CG ' ' A' ' 80' ' ' GLN . 41.6 Cg_endo -64.3 145.94 89.31 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.084 1.044 . . . . 0.0 109.782 179.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . 75.54 35.86 45.53 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.7 m -130.62 155.23 46.91 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.226 -1.161 . . . . 0.0 111.225 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 53.0 t -104.13 126.24 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.181 -0.949 . . . . 0.0 109.542 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -145.11 154.79 42.84 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.139 -0.976 . . . . 0.0 110.074 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.445 ' HG2' ' HA ' ' A' ' 20' ' ' ARG . 97.4 mt-10 -121.01 149.23 43.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.133 -0.979 . . . . 0.0 110.836 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.4 t -126.02 127.81 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.206 -0.934 . . . . 0.0 110.895 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 1.7 m -99.38 131.65 45.25 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 95.8 mt -122.32 130.62 74.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.239 -0.913 . . . . 0.0 111.196 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 23.5 m -124.58 128.52 49.03 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.426 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 55.8 t80 -115.66 122.89 46.94 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.345 -0.847 . . . . 0.0 111.447 -178.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -115.52 147.64 40.44 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.215 -0.928 . . . . 0.0 110.073 178.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 64.2 tp60 -59.57 -24.8 64.05 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.193 -0.942 . . . . 0.0 110.78 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.482 ' O ' ' ND2' ' A' ' 95' ' ' ASN . . . -101.52 -13.15 18.01 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.824 -1.172 . . . . 0.0 111.52 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.482 ' ND2' ' O ' ' A' ' 94' ' ' ALA . 0.9 OUTLIER -162.37 163.14 27.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.926 -1.109 . . . . 0.0 111.344 -178.037 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 46.3 tp -115.23 130.14 56.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.184 -0.947 . . . . 0.0 108.753 177.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 79.9 m -122.0 130.85 53.65 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.827 -1.17 . . . . 0.0 111.717 -178.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 55.4 t -129.75 128.27 65.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.104 -0.998 . . . . 0.0 110.382 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -114.27 145.87 41.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.031 -1.043 . . . . 0.0 110.172 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.438 ' CG ' ' HD2' ' A' ' 101' ' ' PRO . 0.1 OUTLIER -104.47 169.02 7.69 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.198 -0.938 . . . . 0.0 109.021 178.959 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.438 ' HD2' ' CG ' ' A' ' 100' ' ' LEU . 42.1 Cg_endo -68.63 -25.5 34.31 Favored 'Trans proline' 0 C--N 1.301 -1.948 0 O-C-N 123.619 1.326 . . . . 0.0 109.382 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -68.62 -28.13 66.63 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.191 -0.943 . . . . 0.0 110.953 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 117.24 -10.59 14.86 Favored Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.687 -1.244 . . . . 0.0 110.049 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -82.15 144.64 30.6 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.856 -1.379 . . . . 0.0 110.601 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -135.74 148.16 48.72 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.115 -0.991 . . . . 0.0 111.566 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.431 ' CD1' ' OE2' ' A' ' 74' ' ' GLU . 97.1 m-85 -131.76 151.58 51.55 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.327 -0.858 . . . . 0.0 108.765 178.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -126.02 141.78 51.81 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.749 -1.22 . . . . 0.0 112.283 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.493 ' CZ ' ' NE2' ' A' ' 72' ' ' GLN . 1.9 m-85 -112.55 144.58 31.2 Favored Pre-proline 0 N--CA 1.492 1.631 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 159.99 51.4 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 123.428 1.225 . . . . 0.0 111.745 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 2.5 t-20 -71.96 53.8 0.26 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.565 -0.71 . . . . 0.0 112.254 -178.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 75.5 mtt85 -65.05 -38.25 90.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.768 -1.207 . . . . 0.0 109.102 177.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 97.2 mt -92.05 133.62 35.57 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.638 -0.664 . . . . 0.0 110.87 -178.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -96.08 18.75 12.86 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.587 -0.696 . . . . 0.0 111.038 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 47.9 tp -63.99 131.65 48.25 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.032 -1.043 . . . . 0.0 110.353 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -89.76 -12.96 37.79 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.964 -1.085 . . . . 0.0 111.67 -178.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.488 ' HA ' ' O ' ' A' ' 11' ' ' LEU . . . -160.51 155.51 24.43 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 118.234 -1.386 . . . . 0.0 111.925 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.43 ' HB ' ' HB3' ' A' ' 11' ' ' LEU . 41.1 mm -99.62 119.47 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.227 -0.921 . . . . 0.0 109.486 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 25.8 m-80 -111.02 -29.89 7.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.439 -0.788 . . . . 0.0 111.422 -178.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.496 ' HB2' ' O ' ' A' ' 36' ' ' LYS . 57.2 t80 -108.17 129.75 55.16 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.255 -0.903 . . . . 0.0 110.226 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.437 ' HB3' ' CD1' ' A' ' 9' ' ' LEU . 58.1 ttp -140.69 130.99 25.05 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.61 144.91 25.55 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 119.048 -1.061 . . . . 0.0 110.866 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.467 ' O ' ' HA3' ' A' ' 3' ' ' GLY . . . -142.09 124.79 15.92 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -150.62 134.16 16.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.617 -0.677 . . . . 0.0 109.243 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 158.42 -155.32 26.36 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -178.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.483 ' HB3' ' HA ' ' A' ' 27' ' ' ALA . 97.3 m-20 -73.74 -7.21 51.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.767 -0.843 . . . . 0.0 110.061 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.423 ' CZ ' ' HA3' ' A' ' 21' ' ' GLY . 33.5 t80 -98.91 138.43 36.04 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.216 -0.928 . . . . 0.0 110.172 -178.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.436 ' O ' ' CA ' ' A' ' 21' ' ' GLY . 75.5 mmtt -106.78 144.02 34.03 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.046 -1.034 . . . . 0.0 111.967 -178.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.463 ' O ' ' CD1' ' A' ' 4' ' ' LEU . 5.0 tt -126.27 106.97 16.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -103.45 -4.73 23.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.08 -1.013 . . . . 0.0 111.879 -178.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -154.68 135.34 13.54 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 118.486 -1.286 . . . . 0.0 111.613 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 51.4 t -128.35 131.11 69.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -132.08 139.92 48.67 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.79 -1.194 . . . . 0.0 110.504 -178.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -98.97 120.89 40.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.091 -1.006 . . . . 0.0 110.83 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 16' ' ' CYS . 64.4 t0 . . . . . 0 C--N 1.303 -1.418 0 CA-C-O 118.022 -0.989 . . . . 0.0 110.465 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.316 0.579 . . . . 0.0 110.139 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 2' ' ' CYS . . . . . 0.405 ' N ' ' HB3' ' B' ' 123' ' ' ASP . 0.7 OUTLIER -136.14 84.36 2.07 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.363 -0.836 . . . . 0.0 110.43 179.741 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' GLY . . . . . 0.458 ' HA3' ' O ' ' B' ' 122' ' ' ALA . . . 176.16 170.05 38.4 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . 0.459 ' CD1' ' O ' ' B' ' 128' ' ' ILE . 78.8 mt -80.32 145.08 32.28 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.29 -1.123 . . . . 0.0 111.948 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 29.6 m -110.67 149.79 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.686 -0.634 . . . . 0.0 109.453 178.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.1 155.98 47.5 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.857 -1.152 . . . . 0.0 112.421 -178.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' SER . . . . . 0.443 ' O ' ' HB3' ' B' ' 8' ' ' ASN . 15.2 m -155.02 173.02 17.16 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.34 -0.85 . . . . 0.0 109.774 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . 0.443 ' HB3' ' O ' ' B' ' 7' ' ' SER . 34.8 t-20 62.12 27.84 16.77 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.098 -1.001 . . . . 0.0 109.697 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . 0.539 ' O ' ' C ' ' B' ' 10' ' ' ASN . 58.1 mt -85.58 -4.32 59.13 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.695 -0.628 . . . . 0.0 111.918 -178.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' ASN . . . . . 0.539 ' C ' ' O ' ' B' ' 9' ' ' LEU . 76.6 m-20 5.5 73.93 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.85 0 CA-C-O 122.0 0.905 . . . . 0.0 112.149 -177.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' B' ' 116' ' ' ALA . 34.5 tp -97.88 132.65 43.28 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.756 -0.59 . . . . 0.0 109.986 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.63 169.64 6.61 Favored Pre-proline 0 C--N 1.29 -1.99 0 O-C-N 121.648 -0.658 . . . . 0.0 109.765 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' B' ' 91' ' ' PHE . 56.4 Cg_endo -72.55 155.7 54.58 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.016 1.535 . . . . 0.0 108.985 178.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.61 -10.37 59.19 Favored Glycine 0 N--CA 1.488 2.146 0 C-N-CA 119.53 -1.319 . . . . 0.0 109.821 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -115.16 147.12 40.66 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.92 -1.341 . . . . 0.0 109.235 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' CYS . . . . . 0.433 ' O ' ' N ' ' B' ' 134' ' ' ASP . 1.6 t -96.51 140.82 30.59 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.937 -1.102 . . . . 0.0 111.041 -178.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 56.1 tp -111.07 126.87 55.28 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.141 -0.974 . . . . 0.0 110.515 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -120.13 126.25 50.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.099 -1.001 . . . . 0.0 109.974 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 32.8 t -127.82 129.23 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.237 -0.914 . . . . 0.0 110.893 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . 0.456 ' HA ' ' HG2' ' B' ' 86' ' ' GLU . 72.7 ttt180 -108.81 129.85 55.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.284 -0.885 . . . . 0.0 110.094 178.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . 0.441 ' CA ' ' O ' ' B' ' 127' ' ' LYS . . . -134.35 173.14 21.53 Favored Glycine 0 C--N 1.297 -1.607 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . 0.403 ' O ' ' HB2' ' B' ' 127' ' ' LYS . 83.6 tt0 -124.86 120.89 32.96 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.525 -0.985 . . . . 0.0 108.844 179.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 69.6 t -84.35 132.63 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.026 -1.046 . . . . 0.0 109.887 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.65 154.59 89.46 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.29 -0.881 . . . . 0.0 110.039 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . 0.404 ' O ' ' HB2' ' B' ' 81' ' ' PRO . 43.7 Cg_endo -67.89 -22.15 42.89 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.422 1.222 . . . . 0.0 110.89 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -101.67 13.73 34.04 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.187 -0.946 . . . . 0.0 109.69 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . 0.474 ' HA ' ' HB3' ' B' ' 125' ' ' ASP . . . -63.54 142.02 58.55 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.154 -0.966 . . . . 0.0 111.617 -178.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -127.74 -37.8 1.93 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 42.7 t -162.13 140.84 9.24 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.345 -0.847 . . . . 0.0 110.645 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' PHE . . . . . 0.434 ' CZ ' ' HG3' ' B' ' 47' ' ' PRO . 42.0 p90 -143.9 161.16 39.41 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.225 -0.922 . . . . 0.0 108.952 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 11.1 m -126.67 140.5 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 120.549 -1.344 . . . . 0.0 111.888 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.441 HD23 ' HB1' ' B' ' 122' ' ' ALA . 56.6 mt -118.06 133.98 55.41 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.502 -0.749 . . . . 0.0 109.599 179.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -124.89 135.08 52.54 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.794 -1.191 . . . . 0.0 111.946 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' B' ' 34' ' ' LEU . 0.6 OUTLIER -144.67 106.9 4.34 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.486 -0.759 . . . . 0.0 109.939 178.346 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -159.42 -142.06 3.3 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . 0.473 ' O ' ' HB2' ' B' ' 119' ' ' TYR . 47.6 pttt -108.82 -32.7 7.2 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.443 -1.033 . . . . 0.0 109.063 178.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . 0.417 ' N ' ' CG ' ' B' ' 36' ' ' LYS . 34.6 m-20 -139.44 171.55 14.1 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.982 0.896 . . . . 0.0 110.462 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 43.9 t -59.89 -41.94 92.7 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.623 -0.673 . . . . 0.0 111.331 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' ASN . . . . . 0.473 ' HB3' ' N ' ' B' ' 66' ' ' GLY . 83.1 m-20 -91.53 -6.21 52.86 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.02 -1.05 . . . . 0.0 111.112 -178.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -115.89 62.92 0.7 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.196 -0.94 . . . . 0.0 110.529 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 55.9 mt -87.19 148.88 24.97 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.357 -0.839 . . . . 0.0 109.29 178.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' CYS . . . . . . . . . . . . . 82.4 m -91.01 -40.27 11.75 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.111 -0.993 . . . . 0.0 109.284 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.44 ' HB3' HD12 ' B' ' 34' ' ' LEU . 15.2 tp -133.31 128.86 36.66 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.52 -0.737 . . . . 0.0 110.437 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' HIS . . . . . . . . . . . . . 18.6 t60 -121.46 113.12 19.4 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -104.62 122.04 44.79 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.056 -1.028 . . . . 0.0 110.942 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -139.03 85.38 16.01 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.159 -0.963 . . . . 0.0 111.444 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' PRO . . . . . 0.434 ' HG3' ' CZ ' ' B' ' 30' ' ' PHE . 57.0 Cg_endo -71.13 144.74 47.59 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.935 1.492 . . . . 0.0 110.031 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -128.65 92.43 3.41 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.738 -1.226 . . . . 0.0 110.286 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -63.94 -39.67 94.68 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.488 -0.757 . . . . 0.0 109.905 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 59.8 t-20 -138.47 91.42 2.54 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.189 -0.945 . . . . 0.0 108.721 178.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.48 -146.12 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.268 -0.895 . . . . 0.0 109.77 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -108.58 31.72 5.4 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.33 -0.856 . . . . 0.0 110.056 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 166.61 -32.14 0.21 Allowed Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.276 -1.44 . . . . 0.0 110.033 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -89.54 -169.13 2.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -1.146 . . . . 0.0 109.983 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.493 ' O ' ' C ' ' B' ' 56' ' ' ASN . . . -148.96 150.94 33.73 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 178.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' ASN . . . . . 0.493 ' C ' ' O ' ' B' ' 55' ' ' ALA . 92.4 m-20 16.67 66.91 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.617 0 CA-C-O 121.689 0.757 . . . . 0.0 112.429 -178.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 12.4 m -127.06 126.1 42.46 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.903 0.859 . . . . 0.0 110.578 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' ILE . . . . . . . . . . . . . 86.5 mt -119.79 131.87 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.542 -0.724 . . . . 0.0 110.555 -178.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 13.9 m -124.26 153.25 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.191 -0.943 . . . . 0.0 110.186 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 58.2 m -110.94 146.88 35.82 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.739 -1.226 . . . . 0.0 110.484 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' ASN . . . . . 0.404 ' HA ' ' O ' ' B' ' 70' ' ' THR . 23.6 t-20 -156.27 170.72 21.61 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.036 -1.04 . . . . 0.0 111.214 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 19.8 m -149.26 157.06 43.04 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . 0.478 ' CD ' ' HA2' ' B' ' 66' ' ' GLY . 7.1 ttmt -134.58 140.4 46.07 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.092 -1.005 . . . . 0.0 110.448 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -122.13 105.04 9.9 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.256 -0.902 . . . . 0.0 109.858 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.99 29.42 74.97 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . 0.478 ' HA2' ' CD ' ' B' ' 63' ' ' LYS . . . 90.77 -1.37 78.26 Favored Glycine 0 N--CA 1.484 1.839 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' ALA . . . . . 0.436 ' O ' ' C ' ' B' ' 68' ' ' TRP . . . -107.22 89.71 3.08 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.197 -1.178 . . . . 0.0 109.849 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' TRP . . . . . 0.451 ' HA ' ' HA ' ' B' ' 63' ' ' LYS . 1.9 m-90 -19.77 -104.34 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.36 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 130.41 -99.57 0.44 Allowed Glycine 0 N--CA 1.488 2.16 0 C-N-CA 118.641 -1.742 . . . . 0.0 110.795 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 70' ' ' THR . . . . . 0.404 ' O ' ' HA ' ' B' ' 61' ' ' ASN . 13.0 t -94.74 140.83 29.36 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.356 -1.085 . . . . 0.0 112.107 -178.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -150.65 108.7 3.73 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.205 -0.935 . . . . 0.0 111.283 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 72' ' ' GLN . . . . . 0.474 ' NE2' ' CZ ' ' B' ' 108' ' ' PHE . 9.6 pt20 -124.64 -151.86 0.49 Allowed 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.324 -1.485 . . . . 0.0 110.999 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -140.5 132.87 28.37 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.002 -1.062 . . . . 0.0 111.109 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 74' ' ' GLU . . . . . 0.448 ' OE2' ' CD1' ' B' ' 106' ' ' PHE . 82.1 tt0 -142.85 81.64 1.73 Allowed 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.183 -0.948 . . . . 0.0 110.324 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.9 99.9 2.79 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.011 -1.056 . . . . 0.0 110.484 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 4.1 p -140.07 137.65 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.313 -0.867 . . . . 0.0 109.249 178.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 77' ' ' PHE . . . . . 0.605 ' N ' ' CD1' ' B' ' 77' ' ' PHE . 4.2 p90 -152.73 86.91 4.16 Favored Pre-proline 0 C--N 1.302 -1.492 0 O-C-N 121.023 -1.048 . . . . 0.0 110.88 -178.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . 0.472 ' O ' ' CD1' ' B' ' 79' ' ' PHE . 50.5 Cg_endo -86.02 10.98 3.46 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.245 1.655 . . . . 0.0 110.56 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 79' ' ' PHE . . . . . 0.472 ' CD1' ' O ' ' B' ' 78' ' ' PRO . 40.5 m-85 -148.1 -175.58 4.95 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.024 -1.047 . . . . 0.0 110.774 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.455 ' CG ' ' HD2' ' B' ' 81' ' ' PRO . 0.0 OUTLIER -139.81 174.46 4.04 Favored Pre-proline 0 N--CA 1.488 1.446 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.779 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 81' ' ' PRO . . . . . 0.455 ' HD2' ' CG ' ' B' ' 80' ' ' GLN . 41.0 Cg_endo -64.35 145.96 89.12 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 N-CA-C 109.406 -1.036 . . . . 0.0 109.406 178.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 75.45 35.41 47.51 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 33.4 m -130.39 155.06 47.01 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.131 -1.217 . . . . 0.0 111.308 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 58.7 t -103.81 126.37 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.281 -0.887 . . . . 0.0 109.749 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -145.02 154.91 43.02 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.134 -0.979 . . . . 0.0 110.151 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 86' ' ' GLU . . . . . 0.456 ' HG2' ' HA ' ' B' ' 20' ' ' ARG . 97.8 mt-10 -120.79 149.36 42.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.346 -0.846 . . . . 0.0 110.853 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 21.5 t -125.62 128.27 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.132 -0.98 . . . . 0.0 110.734 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 88' ' ' CYS . . . . . . . . . . . . . 1.6 m -100.11 131.5 46.03 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 96.0 mt -122.43 130.7 74.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.098 -1.001 . . . . 0.0 111.22 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 22.6 m -124.11 128.67 49.62 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 91' ' ' PHE . . . . . 0.418 ' O ' ' HA ' ' B' ' 13' ' ' PRO . 55.6 t80 -115.62 122.76 46.6 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.584 -0.847 . . . . 0.0 111.355 -178.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -115.16 147.08 40.72 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.13 -0.981 . . . . 0.0 110.063 178.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 63.3 tp60 -59.33 -24.3 63.21 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.887 -1.133 . . . . 0.0 110.886 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 94' ' ' ALA . . . . . 0.467 ' O ' ' ND2' ' B' ' 95' ' ' ASN . . . -101.85 -13.7 17.56 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.904 -1.122 . . . . 0.0 111.284 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 95' ' ' ASN . . . . . 0.467 ' ND2' ' O ' ' B' ' 94' ' ' ALA . 0.9 OUTLIER -161.79 163.4 29.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.029 -1.045 . . . . 0.0 111.296 -178.251 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 96' ' ' LEU . . . . . . . . . . . . . 46.2 tp -115.59 129.57 56.56 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.248 -0.908 . . . . 0.0 108.596 177.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 78.1 m -121.72 131.64 54.19 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.82 -1.175 . . . . 0.0 111.356 -178.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 53.8 t -130.29 127.91 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.398 -0.814 . . . . 0.0 110.108 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -114.65 145.08 42.43 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.948 -1.095 . . . . 0.0 110.203 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 100' ' ' LEU . . . . . 0.444 ' CG ' ' HD2' ' B' ' 101' ' ' PRO . 0.1 OUTLIER -103.96 168.63 8.34 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.353 -0.842 . . . . 0.0 109.023 179.218 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 101' ' ' PRO . . . . . 0.444 ' HD2' ' CG ' ' B' ' 100' ' ' LEU . 41.9 Cg_endo -68.23 -25.28 36.95 Favored 'Trans proline' 0 C--N 1.301 -1.933 0 O-C-N 123.645 1.34 . . . . 0.0 109.376 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -68.27 -28.57 67.31 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.484 -0.76 . . . . 0.0 110.894 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 117.28 -10.65 14.77 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 104' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -81.72 144.55 31.05 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.897 -1.355 . . . . 0.0 110.804 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 73.5 tt0 -135.88 147.93 48.39 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.178 -0.951 . . . . 0.0 111.955 -179.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 106' ' ' PHE . . . . . 0.448 ' CD1' ' OE2' ' B' ' 74' ' ' GLU . 96.6 m-85 -131.95 151.16 51.9 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -125.74 142.27 51.59 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.718 -1.239 . . . . 0.0 112.07 -178.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 108' ' ' PHE . . . . . 0.474 ' CZ ' ' NE2' ' B' ' 72' ' ' GLN . 1.8 m-85 -113.16 144.65 31.57 Favored Pre-proline 0 N--CA 1.494 1.728 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -69.76 160.28 50.27 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 123.467 1.246 . . . . 0.0 111.652 -178.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 110' ' ' ASN . . . . . 0.442 ' HB2' ' O ' ' B' ' 94' ' ' ALA . 2.3 t-20 -72.11 53.78 0.28 Allowed 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.81 -0.556 . . . . 0.0 112.158 -178.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 75.1 mtt85 -65.27 -38.61 90.81 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.847 -1.158 . . . . 0.0 109.056 177.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 98.2 mt -91.5 134.08 34.95 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.358 -0.839 . . . . 0.0 111.157 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -96.13 18.78 12.85 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.414 -0.804 . . . . 0.0 110.997 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 50.6 tp -63.86 131.89 49.15 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.059 -1.026 . . . . 0.0 110.24 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -89.7 -12.83 38.33 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.042 -1.036 . . . . 0.0 111.849 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 116' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' B' ' 11' ' ' LEU . . . -161.2 155.69 23.16 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.372 -1.455 . . . . 0.0 111.787 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 117' ' ' ILE . . . . . 0.443 ' HB ' ' HB3' ' B' ' 11' ' ' LEU . 41.3 mm -100.1 119.8 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.228 -0.92 . . . . 0.0 109.649 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -111.04 -30.42 7.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.404 -0.81 . . . . 0.0 111.351 -178.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 119' ' ' TYR . . . . . 0.473 ' HB2' ' O ' ' B' ' 36' ' ' LYS . 57.8 t80 -107.03 131.03 54.54 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.013 -1.054 . . . . 0.0 110.219 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 120' ' ' MET . . . . . 0.457 ' HB3' ' CD1' ' B' ' 9' ' ' LEU . 55.5 ttp -141.91 130.89 23.11 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -151.14 144.4 24.75 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.054 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 122' ' ' ALA . . . . . 0.458 ' O ' ' HA3' ' B' ' 3' ' ' GLY . . . -141.68 125.02 16.51 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 123' ' ' ASP . . . . . 0.405 ' HB3' ' N ' ' B' ' 2' ' ' CYS . 65.1 m-20 -150.72 134.33 16.48 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.481 -0.762 . . . . 0.0 109.192 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 158.3 -155.48 26.5 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.044 -1.55 . . . . 0.0 109.554 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . 0.474 ' HB3' ' HA ' ' B' ' 27' ' ' ALA . 96.4 m-20 -73.25 -7.4 51.35 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.584 -0.951 . . . . 0.0 110.294 179.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 126' ' ' PHE . . . . . 0.418 ' CZ ' ' HA3' ' B' ' 21' ' ' GLY . 33.9 t80 -99.09 138.77 35.72 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.525 -0.734 . . . . 0.0 110.092 -178.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . 0.441 ' O ' ' CA ' ' B' ' 21' ' ' GLY . 75.7 mmtt -106.88 144.19 33.87 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 118.945 -1.102 . . . . 0.0 112.074 -178.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . 0.459 ' O ' ' CD1' ' B' ' 4' ' ' LEU . 5.1 tt -125.88 106.67 16.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -102.84 -5.6 23.42 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.888 -1.132 . . . . 0.0 111.771 -178.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 130' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -153.55 134.99 14.25 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 118.26 -1.376 . . . . 0.0 112.05 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 50.6 t -127.49 131.75 69.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 132' ' ' ALA . . . . . . . . . . . . . . . -131.91 139.91 48.89 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.446 -1.408 . . . . 0.0 110.477 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -98.79 121.08 40.28 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.8 -1.188 . . . . 0.0 110.959 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . 0.433 ' N ' ' O ' ' B' ' 16' ' ' CYS . 62.1 t0 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.407 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.485 ' HA3' ' O ' ' A' ' 122' ' ' ALA . . . . . . . . 0 N--CA 1.485 1.918 0 N-CA-C 107.98 -2.048 . . . . 0.0 107.98 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.478 ' N ' ' CD1' ' A' ' 4' ' ' LEU . 11.1 mp -93.44 142.21 27.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.071 -1.252 . . . . 0.0 110.43 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.3 t -108.56 131.54 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 121.198 -0.939 . . . . 0.0 110.117 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.52 ' HB1' HD12 ' A' ' 9' ' ' LEU . . . -130.41 172.61 11.68 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.951 -1.093 . . . . 0.0 111.822 -178.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.416 ' O ' ' CB ' ' A' ' 8' ' ' ASN . 30.5 p -155.07 167.2 31.15 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.45 -0.781 . . . . 0.0 110.001 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' B' ' 3' ' ' GLY . 20.2 t-20 63.43 40.01 8.74 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.384 0.611 . . . . 0.0 110.446 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.52 HD12 ' HB1' ' A' ' 6' ' ' ALA . 56.5 mt -99.66 16.2 24.24 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.314 -0.867 . . . . 0.0 110.316 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.476 ' C ' ' O ' ' A' ' 9' ' ' LEU . 51.0 t-20 -18.76 88.8 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.381 0 CA-C-O 121.996 0.903 . . . . 0.0 112.674 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.424 HD13 ' CE2' ' A' ' 133' ' ' PHE . 5.2 tt -100.5 134.68 43.1 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.584 -0.698 . . . . 0.0 109.96 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.443 ' HD2' ' HD2' ' A' ' 13' ' ' PRO . 0.6 OUTLIER -111.55 171.22 4.51 Favored Pre-proline 0 C--N 1.297 -1.695 0 O-C-N 121.069 -1.019 . . . . 0.0 109.784 179.031 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.451 ' HA ' ' O ' ' A' ' 91' ' ' PHE . 44.2 Cg_endo -66.19 144.63 75.77 Favored 'Trans proline' 0 C--N 1.299 -2.045 0 O-C-N 123.89 1.468 . . . . 0.0 110.278 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 104.44 -24.72 28.04 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -90.08 150.2 22.17 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.241 -1.153 . . . . 0.0 110.471 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.423 ' SG ' ' N ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -106.31 159.34 16.2 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.417 -0.802 . . . . 0.0 109.99 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.423 ' N ' ' SG ' ' A' ' 16' ' ' CYS . 0.6 OUTLIER -134.77 123.39 23.53 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.682 -1.261 . . . . 0.0 110.364 179.659 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -117.04 132.65 56.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.226 -0.921 . . . . 0.0 109.888 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.408 ' CG1' HD11 ' A' ' 128' ' ' ILE . 54.7 t -122.12 108.99 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.511 -0.743 . . . . 0.0 111.136 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 77.3 ttt-85 -110.0 123.17 49.19 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.764 -1.21 . . . . 0.0 110.575 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -147.11 -161.3 9.3 Favored Glycine 0 N--CA 1.489 2.188 0 C-N-CA 119.365 -1.398 . . . . 0.0 110.172 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -127.31 134.72 49.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.455 -1.026 . . . . 0.0 109.305 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.469 ' CG1' ' CB ' ' A' ' 27' ' ' ALA . 93.8 t -101.88 129.5 53.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 121.073 -1.017 . . . . 0.0 109.593 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.52 161.89 1.92 Allowed Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.323 -0.861 . . . . 0.0 110.281 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.52 -20.22 54.15 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 O-C-N 123.69 1.363 . . . . 0.0 109.573 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -111.76 44.03 1.44 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.661 -0.65 . . . . 0.0 110.393 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.469 ' CB ' ' CG1' ' A' ' 23' ' ' VAL . . . -71.15 91.09 0.9 Allowed 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 118.918 -1.113 . . . . 0.0 109.563 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -98.71 -20.93 16.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.385 -0.822 . . . . 0.0 109.985 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.1 t -150.11 143.5 25.13 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.882 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.482 ' CZ ' ' HB2' ' A' ' 32' ' ' LEU . 40.7 t80 -147.79 134.95 20.44 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.448 -0.782 . . . . 0.0 110.289 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 67.4 t -127.47 131.0 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.824 -1.172 . . . . 0.0 110.307 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.482 ' HB2' ' CZ ' ' A' ' 30' ' ' PHE . 5.0 tp -138.58 141.81 39.21 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.519 -0.738 . . . . 0.0 110.383 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.421 ' HB2' HD13 ' A' ' 41' ' ' LEU . 1.5 p-10 -154.25 143.09 20.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.053 -1.029 . . . . 0.0 110.7 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.5 pp -136.13 118.48 15.69 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.496 -0.753 . . . . 0.0 109.628 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 119' ' ' TYR . . . -142.85 -136.49 3.19 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.822 -1.18 . . . . 0.0 110.602 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.456 ' CG ' ' N ' ' A' ' 37' ' ' ASP . 24.0 pttt -127.64 -37.14 1.99 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.371 -1.076 . . . . 0.0 111.101 -179.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.456 ' N ' ' CG ' ' A' ' 36' ' ' LYS . 86.3 m-20 -115.25 -83.59 0.62 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.125 -0.985 . . . . 0.0 110.309 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.2 t -151.58 -53.6 0.13 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 60.6 m-20 -93.85 -4.06 50.74 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.343 -0.848 . . . . 0.0 109.004 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -91.18 68.72 6.05 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.175 -0.953 . . . . 0.0 109.854 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.421 HD13 ' HB2' ' A' ' 33' ' ' ASN . 75.8 mt -106.47 133.02 51.8 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.438 -0.789 . . . . 0.0 110.676 -179.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 69.8 m -85.1 -36.01 21.43 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.564 -0.71 . . . . 0.0 110.253 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.442 HD22 HD11 ' A' ' 96' ' ' LEU . 79.5 mt -129.97 129.16 43.42 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 119.454 -0.898 . . . . 0.0 111.542 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.439 ' HB3' ' OD1' ' A' ' 61' ' ' ASN . 60.1 t-80 -126.3 123.98 39.3 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.343 -0.848 . . . . 0.0 109.41 178.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -110.79 131.6 54.91 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.177 -0.952 . . . . 0.0 109.443 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -149.27 78.04 8.77 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 120.926 -1.109 . . . . 0.0 111.285 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.407 ' HD2' ' O ' ' A' ' 30' ' ' PHE . 47.2 Cg_endo -69.78 144.66 54.61 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.779 1.41 . . . . 0.0 110.014 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -144.46 88.18 1.92 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.865 -1.147 . . . . 0.0 110.869 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.41 ' O ' ' HA ' ' A' ' 55' ' ' ALA . 33.0 t80 -61.78 -46.4 89.74 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.332 0.587 . . . . 0.0 110.393 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -133.72 99.12 4.37 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.294 -0.879 . . . . 0.0 110.008 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -118.78 -69.1 0.87 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.003 -1.061 . . . . 0.0 110.893 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -105.13 -15.67 15.01 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.42 -0.8 . . . . 0.0 110.617 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 159.68 -12.91 0.19 Allowed Glycine 0 N--CA 1.494 2.543 0 C-N-CA 119.866 -1.159 . . . . 0.0 110.514 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -75.78 -179.95 5.08 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.849 -1.383 . . . . 0.0 109.444 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' A' ' 49' ' ' PHE . . . -129.67 -7.46 4.58 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.146 -0.971 . . . . 0.0 111.723 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 43.2 p30 -163.48 72.82 0.29 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.007 -1.058 . . . . 0.0 110.279 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 73.4 m -124.66 130.46 52.46 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.943 -1.098 . . . . 0.0 111.327 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.407 HD11 HG23 ' A' ' 58' ' ' ILE . 98.3 mt -121.76 130.64 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.28 -0.888 . . . . 0.0 111.089 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.0 t -114.31 129.98 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.297 -0.877 . . . . 0.0 110.495 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 33.8 m -129.16 122.1 29.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.319 -0.863 . . . . 0.0 110.067 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.476 ' HB3' ' HG2' ' A' ' 71' ' ' GLU . 4.9 p-10 -138.94 175.0 9.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.422 -0.799 . . . . 0.0 109.985 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.3 m -129.9 155.12 46.56 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.524 ' CD ' ' HA2' ' A' ' 66' ' ' GLY . 6.9 ttmt -135.47 149.29 49.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.495 -1.378 . . . . 0.0 112.128 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -129.19 100.43 5.61 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.44 21.28 68.51 Favored Glycine 0 N--CA 1.487 2.075 0 C-N-CA 119.801 -1.19 . . . . 0.0 110.62 179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.524 ' HA2' ' CD ' ' A' ' 63' ' ' LYS . . . 74.52 24.56 72.48 Favored Glycine 0 N--CA 1.488 2.162 0 C-N-CA 119.145 -1.503 . . . . 0.0 110.275 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -105.4 -74.35 0.65 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.897 -1.355 . . . . 0.0 110.742 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -69.22 -178.47 1.33 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.698 -0.626 . . . . 0.0 109.975 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 166.53 44.79 0.02 OUTLIER Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.0 m -62.39 100.39 0.18 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.066 -1.256 . . . . 0.0 110.504 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.476 ' HG2' ' HB3' ' A' ' 61' ' ' ASN . 89.5 mt-10 -84.97 123.15 30.19 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.336 -0.853 . . . . 0.0 110.903 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -101.39 -168.49 1.56 Allowed 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -146.27 122.27 10.71 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 118.04 -1.464 . . . . 0.0 111.695 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -108.67 132.71 53.64 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.59 60.27 0.6 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.795 -1.19 . . . . 0.0 111.234 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.6 p -135.23 151.25 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.942 -1.098 . . . . 0.0 110.4 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.497 ' CG ' ' O ' ' A' ' 77' ' ' PHE . 8.4 p90 -144.46 71.98 15.82 Favored Pre-proline 0 C--N 1.302 -1.475 0 O-C-N 121.098 -1.001 . . . . 0.0 109.874 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.443 ' CB ' ' HB2' ' A' ' 102' ' ' ASP . 39.9 Cg_endo -65.43 -13.8 41.67 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.892 1.469 . . . . 0.0 110.33 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -117.92 167.24 11.6 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.444 -0.785 . . . . 0.0 110.641 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.88 168.02 15.66 Favored Pre-proline 0 C--N 1.297 -1.674 0 O-C-N 121.546 -0.721 . . . . 0.0 109.598 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -65.65 148.66 87.32 Favored 'Trans proline' 0 C--N 1.298 -2.086 0 O-C-N 123.852 1.448 . . . . 0.0 110.671 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 62.29 42.44 99.72 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.6 t -148.32 137.56 21.96 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.097 -1.237 . . . . 0.0 109.988 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.5 m -78.06 140.22 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.01 -1.056 . . . . 0.0 108.997 178.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.98 153.55 38.09 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.158 -0.963 . . . . 0.0 109.707 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -122.46 152.65 40.06 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.234 -0.916 . . . . 0.0 110.044 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.0 t -128.98 139.34 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.489 -0.757 . . . . 0.0 111.503 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . 0.411 ' HB3' ' HB2' ' A' ' 99' ' ' LYS . 4.8 t -114.26 115.73 27.89 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.427 -0.796 . . . . 0.0 109.943 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 86.6 mt -121.22 128.1 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.141 -0.974 . . . . 0.0 110.014 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.447 ' HB ' ' HB ' ' A' ' 97' ' ' THR . 33.5 m -123.06 134.88 54.25 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.033 -1.042 . . . . 0.0 109.426 179.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.469 ' CD1' ' CD2' ' A' ' 96' ' ' LEU . 80.8 t80 -104.67 118.25 36.11 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.177 -0.952 . . . . 0.0 110.25 -179.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -112.52 143.21 44.06 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.399 -0.921 . . . . 0.0 109.452 178.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 71.6 tp60 -59.58 -26.51 65.47 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.522 -0.736 . . . . 0.0 110.668 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.89 -22.48 23.12 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.225 -0.922 . . . . 0.0 111.634 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 45.4 p30 -174.61 -171.58 0.58 Allowed 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.093 -1.005 . . . . 0.0 108.981 -178.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 108' ' ' PHE . 75.9 mt -122.49 135.06 54.57 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.002 -1.061 . . . . 0.0 110.58 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.447 ' HB ' ' HB ' ' A' ' 90' ' ' THR . 29.5 m -109.26 122.72 47.95 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.1 -1.0 . . . . 0.0 109.031 178.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 44.8 t -124.7 128.14 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.742 -1.224 . . . . 0.0 109.611 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.411 ' HB2' ' HB3' ' A' ' 88' ' ' CYS . 98.4 mttt -122.61 147.62 46.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.298 -0.877 . . . . 0.0 110.925 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.437 HD13 ' HG3' ' A' ' 78' ' ' PRO . 27.5 mt -107.28 166.63 10.7 Favored Pre-proline 0 N--CA 1.493 1.696 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 100' ' ' LEU . 38.8 Cg_endo -63.31 -24.32 71.86 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.368 1.194 . . . . 0.0 110.92 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.443 ' HB2' ' CB ' ' A' ' 78' ' ' PRO . 36.9 t70 -76.52 -10.26 59.26 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.074 -1.016 . . . . 0.0 110.84 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 104.34 -8.0 47.88 Favored Glycine 0 N--CA 1.496 2.656 0 C-N-CA 119.821 -1.18 . . . . 0.0 110.753 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -73.0 135.41 44.95 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.787 -1.419 . . . . 0.0 110.28 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -124.88 142.49 51.41 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.881 -1.137 . . . . 0.0 110.75 179.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -133.67 146.15 50.59 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 98.1 mttt -121.79 146.36 47.14 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.831 -1.168 . . . . 0.0 112.971 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.542 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 98.0 m-85 -117.22 150.23 45.89 Favored Pre-proline 0 N--CA 1.493 1.722 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.08 149.85 65.43 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.689 1.363 . . . . 0.0 111.142 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -71.04 62.74 0.3 Allowed 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.611 -0.681 . . . . 0.0 111.652 -178.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 79.6 mtp85 -65.39 -39.89 92.79 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.995 -1.066 . . . . 0.0 110.381 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -95.75 130.4 42.68 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.131 -0.981 . . . . 0.0 110.361 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -87.95 7.26 31.84 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.501 -0.749 . . . . 0.0 111.026 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.6 tt -57.82 128.68 38.32 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.224 -0.99 . . . . 0.0 109.222 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -106.32 -5.59 18.98 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.498 -0.751 . . . . 0.0 111.295 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -137.84 132.35 32.43 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.715 -1.24 . . . . 0.0 110.472 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.438 ' O ' ' HA ' ' A' ' 10' ' ' ASN . 95.6 mt -111.29 128.89 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 O-C-N 120.894 -1.129 . . . . 0.0 110.45 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -126.66 -27.62 3.08 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.026 -1.046 . . . . 0.0 111.645 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.412 ' O ' ' N ' ' A' ' 35' ' ' GLY . 69.4 t80 -92.67 126.09 37.6 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.007 -1.058 . . . . 0.0 110.466 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 27.1 ttm -141.01 134.73 30.28 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.993 -1.067 . . . . 0.0 109.573 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -159.11 147.95 18.34 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.26 -0.976 . . . . 0.0 109.686 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.485 ' O ' ' HA3' ' A' ' 3' ' ' GLY . . . -147.3 156.21 42.71 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -155.74 160.74 40.57 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 179.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.473 ' HA3' ' HA ' ' A' ' 30' ' ' PHE . . . 143.09 -157.27 26.83 Favored Glycine 0 C--N 1.295 -1.725 0 C-N-CA 118.548 -1.787 . . . . 0.0 110.439 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.455 ' CB ' ' HA ' ' A' ' 27' ' ' ALA . 63.1 m-20 -91.34 11.39 23.84 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.845 -0.797 . . . . 0.0 110.753 -179.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.423 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 12.3 t80 -107.42 151.25 25.78 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.822 -1.174 . . . . 0.0 110.681 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -120.8 124.8 45.96 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.564 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.473 ' O ' HG21 ' A' ' 128' ' ' ILE . 17.7 tt -102.49 126.74 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.928 . . . . 0.0 110.329 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 28.0 pttt -118.63 -4.81 10.75 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.795 -1.191 . . . . 0.0 111.053 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.461 ' HA ' ' O ' ' B' ' 131' ' ' VAL . 0.0 OUTLIER -154.35 131.96 11.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.74 -1.225 . . . . 0.0 111.928 -179.32 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' B' ' 130' ' ' CYS . 53.4 t -128.78 134.63 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.569 -0.707 . . . . 0.0 109.658 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.444 ' HA ' ' HB2' ' B' ' 130' ' ' CYS . . . -142.38 142.92 32.49 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.497 -1.377 . . . . 0.0 110.392 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.424 ' CE2' HD13 ' A' ' 11' ' ' LEU . 3.1 m-85 -76.47 -86.73 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.813 -1.179 . . . . 0.0 111.248 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 46.4 t0 . . . . . 0 C--N 1.296 -1.723 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.384 -179.169 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.85 0 CA-C-O 121.115 0.483 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 2' ' ' CYS . . . . . 0.41 ' O ' ' HA ' ' B' ' 123' ' ' ASP . 34.2 m -114.71 39.29 2.88 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.022 -1.049 . . . . 0.0 109.264 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' GLY . . . . . 0.534 ' O ' ' ND2' ' A' ' 8' ' ' ASN . . . 79.86 168.93 37.97 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 108.031 -2.028 . . . . 0.0 108.031 -178.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . 0.489 ' N ' ' CD1' ' B' ' 4' ' ' LEU . 11.0 mp -93.07 141.69 28.13 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.965 -1.315 . . . . 0.0 110.751 -179.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 41.9 t -107.82 131.6 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.382 0 O-C-N 121.082 -1.011 . . . . 0.0 110.242 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' ALA . . . . . 0.493 ' HB1' HD12 ' B' ' 9' ' ' LEU . . . -130.5 173.11 11.18 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.044 -1.035 . . . . 0.0 112.011 -178.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 27.1 p -155.34 168.25 27.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.426 -0.797 . . . . 0.0 109.802 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . 0.436 ' ND2' ' O ' ' A' ' 3' ' ' GLY . 20.2 t-20 62.61 41.09 9.77 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.589 -0.695 . . . . 0.0 110.416 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . 0.493 HD12 ' HB1' ' B' ' 6' ' ' ALA . 54.8 mt -101.19 17.03 23.57 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.437 -0.79 . . . . 0.0 110.04 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' ASN . . . . . 0.472 ' C ' ' O ' ' B' ' 9' ' ' LEU . 51.2 t-20 -20.0 89.04 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.39 0 CA-C-O 121.95 0.881 . . . . 0.0 112.77 -179.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 5.2 tt -100.44 134.16 43.8 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.703 -0.623 . . . . 0.0 109.885 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . 0.448 ' HD2' ' HD2' ' B' ' 13' ' ' PRO . 0.5 OUTLIER -111.34 171.09 4.6 Favored Pre-proline 0 C--N 1.293 -1.883 0 O-C-N 121.244 -0.91 . . . . 0.0 109.94 179.126 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . 0.448 ' HD2' ' HD2' ' B' ' 12' ' ' LYS . 44.1 Cg_endo -65.94 144.35 76.25 Favored 'Trans proline' 0 C--N 1.301 -1.942 0 O-C-N 123.919 1.484 . . . . 0.0 110.115 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 104.32 -24.01 30.16 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -90.92 149.83 21.74 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.194 -1.18 . . . . 0.0 110.591 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' CYS . . . . . 0.419 ' SG ' ' N ' ' B' ' 17' ' ' LEU . 0.0 OUTLIER -106.86 159.62 16.12 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.48 -0.763 . . . . 0.0 109.72 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.419 ' N ' ' SG ' ' B' ' 16' ' ' CYS . 0.6 OUTLIER -135.0 122.64 22.14 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.621 -1.299 . . . . 0.0 110.383 179.845 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -115.77 133.35 56.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.361 -0.837 . . . . 0.0 109.816 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 55.2 t -122.82 109.19 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.29 -0.881 . . . . 0.0 111.13 -178.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 77.2 ttt-85 -109.82 123.28 49.29 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.993 -1.067 . . . . 0.0 110.631 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -147.22 -161.4 9.38 Favored Glycine 0 N--CA 1.487 2.075 0 C-N-CA 119.456 -1.354 . . . . 0.0 110.009 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 71.3 tt0 -127.22 136.38 51.95 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.575 -0.956 . . . . 0.0 109.081 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.441 ' CG1' ' CB ' ' B' ' 27' ' ' ALA . 90.5 t -103.98 129.15 56.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 O-C-N 121.174 -0.954 . . . . 0.0 109.789 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.04 161.15 1.93 Allowed Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.506 -0.746 . . . . 0.0 110.172 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . 0.401 ' HA ' ' CA ' ' B' ' 82' ' ' GLY . 42.7 Cg_endo -66.02 -20.16 57.39 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.802 1.422 . . . . 0.0 109.775 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -112.2 44.31 1.44 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.693 -0.629 . . . . 0.0 110.388 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . 0.464 ' HA ' ' CB ' ' B' ' 125' ' ' ASP . . . -71.84 91.25 1.15 Allowed 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 118.95 -1.1 . . . . 0.0 109.415 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -98.71 -20.58 16.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.491 -0.755 . . . . 0.0 109.777 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 24.8 t -149.65 143.31 25.42 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.076 -1.015 . . . . 0.0 111.046 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' PHE . . . . . 0.488 ' CZ ' ' HB2' ' B' ' 32' ' ' LEU . 41.0 t80 -147.69 134.75 20.35 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.508 -0.745 . . . . 0.0 110.162 179.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 76.9 t -127.74 131.05 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.852 -1.155 . . . . 0.0 110.437 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.488 ' HB2' ' CZ ' ' B' ' 30' ' ' PHE . 5.1 tp -138.53 142.58 39.3 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.384 -0.823 . . . . 0.0 110.361 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' ASN . . . . . 0.409 ' HB2' HD13 ' B' ' 41' ' ' LEU . 1.3 p-10 -155.11 142.59 19.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.964 -1.085 . . . . 0.0 110.671 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 1.5 pp -135.92 119.2 16.69 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.227 -0.921 . . . . 0.0 109.679 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -143.53 -137.58 3.28 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 119.922 -1.133 . . . . 0.0 110.392 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . 0.44 ' CG ' ' N ' ' B' ' 37' ' ' ASP . 24.6 pttt -126.86 -37.47 2.12 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.246 -1.149 . . . . 0.0 111.174 -178.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . 0.451 ' O ' ' CD1' ' B' ' 119' ' ' TYR . 88.3 m-20 -114.25 -84.14 0.61 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.976 -1.078 . . . . 0.0 109.958 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 7.7 t -150.76 -54.22 0.15 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.403 -0.811 . . . . 0.0 109.023 178.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 58.3 m-20 -92.6 -4.5 53.29 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.372 -0.83 . . . . 0.0 108.824 178.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -90.96 69.07 6.3 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.271 -0.893 . . . . 0.0 110.017 -178.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.409 HD13 ' HB2' ' B' ' 33' ' ' ASN . 77.5 mt -105.8 135.93 46.33 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.434 -0.791 . . . . 0.0 110.674 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' CYS . . . . . . . . . . . . . 74.2 m -88.83 -34.31 17.08 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.336 -0.852 . . . . 0.0 109.561 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.451 ' HA ' HD23 ' B' ' 43' ' ' LEU . 74.6 mt -131.25 129.71 41.92 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.192 -1.003 . . . . 0.0 111.276 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' HIS . . . . . 0.426 ' HB3' ' OD1' ' B' ' 61' ' ' ASN . 61.1 t-80 -127.0 123.28 36.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.506 -0.746 . . . . 0.0 109.297 178.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -110.15 131.31 55.17 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.133 -0.979 . . . . 0.0 109.762 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -148.51 78.08 9.37 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.074 -1.016 . . . . 0.0 111.506 -179.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' PRO . . . . . 0.413 ' HG2' ' HB3' ' B' ' 30' ' ' PHE . 47.8 Cg_endo -69.83 144.96 55.31 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 123.627 1.33 . . . . 0.0 109.839 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -145.26 88.51 1.87 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.898 -1.127 . . . . 0.0 110.566 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' PHE . . . . . 0.429 ' O ' ' HA ' ' B' ' 55' ' ' ALA . 33.8 t80 -61.65 -45.78 92.58 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.277 0.56 . . . . 0.0 110.417 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 27.1 t30 -134.79 98.67 4.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.286 -0.884 . . . . 0.0 110.239 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -118.74 -68.08 0.94 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.056 -1.028 . . . . 0.0 110.977 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -105.63 -15.2 15.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.295 -0.878 . . . . 0.0 110.886 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 159.52 -14.21 0.21 Allowed Glycine 0 N--CA 1.495 2.585 0 C-N-CA 119.913 -1.137 . . . . 0.0 110.277 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -74.45 179.67 4.5 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.752 -1.44 . . . . 0.0 109.045 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.429 ' HA ' ' O ' ' B' ' 49' ' ' PHE . . . -129.03 -11.11 4.77 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.066 -1.021 . . . . 0.0 111.387 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' ASN . . . . . . . . . . . . . 41.1 p30 -158.91 72.89 0.59 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.187 -0.945 . . . . 0.0 110.714 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 80.7 m -124.45 130.93 53.36 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 120.494 -1.379 . . . . 0.0 111.575 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' ILE . . . . . 0.416 HD11 HG23 ' B' ' 58' ' ' ILE . 98.1 mt -122.15 130.77 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.47 -0.769 . . . . 0.0 111.209 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 12.9 t -114.48 129.62 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.416 -0.802 . . . . 0.0 110.677 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 33.2 m -128.5 121.69 29.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.293 -0.879 . . . . 0.0 110.137 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' ASN . . . . . 0.505 ' HB3' ' HG2' ' B' ' 71' ' ' GLU . 3.8 p-10 -139.32 174.16 10.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.134 -0.979 . . . . 0.0 110.188 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 7.2 m -129.18 155.15 45.97 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.476 -0.765 . . . . 0.0 108.953 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . 0.52 ' CD ' ' HA2' ' B' ' 66' ' ' GLY . 6.8 ttmt -135.14 150.19 50.14 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.508 -1.37 . . . . 0.0 112.114 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -129.7 100.38 5.48 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 64.52 21.3 66.68 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.843 -1.17 . . . . 0.0 110.435 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . 0.52 ' HA2' ' CD ' ' B' ' 63' ' ' LYS . . . 74.68 25.6 69.44 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.251 -1.452 . . . . 0.0 110.473 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -105.95 -73.27 0.69 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.989 -1.3 . . . . 0.0 110.583 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -70.59 -177.06 1.41 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.653 -0.655 . . . . 0.0 109.887 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 164.94 46.4 0.02 OUTLIER Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 15.8 m -63.85 100.81 0.32 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.271 -1.134 . . . . 0.0 110.462 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.505 ' HG2' ' HB3' ' B' ' 61' ' ' ASN . 86.4 mt-10 -85.49 123.32 30.79 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.274 -0.891 . . . . 0.0 111.017 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -101.23 -167.81 1.47 Allowed 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -147.3 120.7 9.02 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 117.991 -1.484 . . . . 0.0 111.822 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -106.86 132.83 52.37 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.49 60.84 0.6 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.926 -1.109 . . . . 0.0 111.128 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 4.6 p -136.51 151.24 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.9 -1.125 . . . . 0.0 110.251 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 77' ' ' PHE . . . . . 0.494 ' O ' ' CG ' ' B' ' 77' ' ' PHE . 9.1 p90 -144.98 71.65 14.84 Favored Pre-proline 0 C--N 1.303 -1.444 0 O-C-N 121.204 -0.935 . . . . 0.0 109.99 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . 0.445 ' CB ' ' HB2' ' B' ' 102' ' ' ASP . 41.0 Cg_endo -64.71 -14.38 44.39 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.088 1.573 . . . . 0.0 110.422 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -116.89 167.24 11.3 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.191 -0.943 . . . . 0.0 110.408 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.77 167.66 16.9 Favored Pre-proline 0 C--N 1.3 -1.554 0 O-C-N 121.707 -0.621 . . . . 0.0 109.387 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 81' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -65.94 148.41 85.94 Favored 'Trans proline' 0 C--N 1.297 -2.165 0 O-C-N 123.946 1.498 . . . . 0.0 110.391 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . 0.401 ' CA ' ' HA ' ' B' ' 25' ' ' PRO . . . 62.47 43.18 99.4 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 15.9 t -149.32 138.73 21.57 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.196 -1.179 . . . . 0.0 110.043 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 15.4 m -79.1 140.08 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.136 -0.978 . . . . 0.0 109.156 178.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.71 154.13 39.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.063 -1.023 . . . . 0.0 109.81 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -123.29 152.66 41.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.049 -1.032 . . . . 0.0 109.993 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 46.9 t -128.4 138.52 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.399 -0.813 . . . . 0.0 111.457 -178.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 88' ' ' CYS . . . . . 0.422 ' HB3' ' HB2' ' B' ' 99' ' ' LYS . 4.7 t -113.49 114.73 26.95 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.422 -0.799 . . . . 0.0 109.845 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 87.1 mt -120.69 128.42 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.252 -0.905 . . . . 0.0 110.0 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 90' ' ' THR . . . . . 0.482 ' HB ' ' HB ' ' B' ' 97' ' ' THR . 27.8 m -123.09 134.94 54.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.222 -0.924 . . . . 0.0 109.628 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 91' ' ' PHE . . . . . 0.455 ' CD1' ' CD2' ' B' ' 96' ' ' LEU . 79.4 t80 -104.84 117.35 33.82 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.326 -0.858 . . . . 0.0 110.246 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -112.17 143.57 43.0 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.058 -1.026 . . . . 0.0 109.402 178.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 72.5 tp60 -60.69 -25.11 66.15 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.533 -0.729 . . . . 0.0 110.833 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.07 -22.35 21.86 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.973 -1.079 . . . . 0.0 111.499 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 45.6 p30 -174.39 -172.5 0.68 Allowed 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.163 -0.961 . . . . 0.0 108.947 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 96' ' ' LEU . . . . . 0.513 ' HB2' ' HB2' ' B' ' 108' ' ' PHE . 74.9 mt -121.72 134.93 54.95 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 120.993 -1.067 . . . . 0.0 110.697 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 97' ' ' THR . . . . . 0.482 ' HB ' ' HB ' ' B' ' 90' ' ' THR . 32.9 m -109.4 123.14 48.84 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.233 -0.917 . . . . 0.0 108.989 178.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 46.3 t -125.19 128.37 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.852 -1.155 . . . . 0.0 109.588 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 99' ' ' LYS . . . . . 0.422 ' HB2' ' HB3' ' B' ' 88' ' ' CYS . 98.5 mttt -122.89 146.27 47.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.179 -0.951 . . . . 0.0 110.899 -178.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 100' ' ' LEU . . . . . 0.432 HD13 ' HG3' ' B' ' 78' ' ' PRO . 25.0 mt -105.5 166.67 10.95 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -63.16 -25.43 72.72 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.239 1.126 . . . . 0.0 110.945 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 102' ' ' ASP . . . . . 0.445 ' HB2' ' CB ' ' B' ' 78' ' ' PRO . 36.3 t70 -74.42 -11.94 60.37 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.947 -1.096 . . . . 0.0 110.94 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 106.08 -8.5 42.07 Favored Glycine 0 N--CA 1.493 2.475 0 C-N-CA 119.887 -1.149 . . . . 0.0 110.683 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 104' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -72.3 136.48 46.25 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.933 -1.334 . . . . 0.0 110.25 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 71.4 tt0 -125.62 142.28 51.59 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.057 -1.027 . . . . 0.0 110.527 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -133.35 146.14 51.02 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.507 -0.746 . . . . 0.0 109.163 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 107' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' B' ' 96' ' ' LEU . 98.1 mttt -122.06 146.13 47.49 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.768 -1.208 . . . . 0.0 112.812 -178.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 108' ' ' PHE . . . . . 0.513 ' HB2' ' HB2' ' B' ' 96' ' ' LEU . 98.0 m-85 -117.09 150.28 45.78 Favored Pre-proline 0 N--CA 1.492 1.671 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.85 148.52 64.66 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.593 1.312 . . . . 0.0 111.261 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 110' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -69.77 62.85 0.19 Allowed 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.586 -0.696 . . . . 0.0 111.621 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 79.3 mtp85 -65.41 -39.78 92.58 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.919 -1.113 . . . . 0.0 110.277 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 112' ' ' LEU . . . . . 0.402 ' CD2' ' N ' ' B' ' 112' ' ' LEU . 4.5 mm? -95.87 130.01 42.95 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.18 -0.95 . . . . 0.0 110.702 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -87.38 7.4 29.12 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.643 -0.66 . . . . 0.0 111.069 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 3.5 tt -58.07 129.2 40.85 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.053 -1.029 . . . . 0.0 109.239 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -106.65 -5.56 18.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.559 -0.713 . . . . 0.0 111.36 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 116' ' ' ALA . . . . . . . . . . . . . . . -137.82 132.32 32.44 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.74 -1.225 . . . . 0.0 110.418 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 117' ' ' ILE . . . . . 0.426 ' O ' ' HA ' ' B' ' 10' ' ' ASN . 95.9 mt -111.72 128.71 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.927 -1.108 . . . . 0.0 110.269 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -126.1 -28.52 3.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.138 -0.976 . . . . 0.0 111.818 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 119' ' ' TYR . . . . . 0.451 ' CD1' ' O ' ' B' ' 37' ' ' ASP . 66.6 t80 -91.96 127.31 37.38 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.882 -1.136 . . . . 0.0 110.346 -179.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 26.5 ttm -142.0 134.26 27.79 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.115 -0.991 . . . . 0.0 109.592 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -158.89 147.71 18.53 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.101 -0.999 . . . . 0.0 109.448 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 122' ' ' ALA . . . . . 0.487 ' O ' ' HA3' ' B' ' 3' ' ' GLY . . . -147.14 155.0 41.78 Favored 'General case' 0 C--N 1.29 -1.995 0 O-C-N 121.472 -0.768 . . . . 0.0 108.975 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 123' ' ' ASP . . . . . 0.41 ' HA ' ' O ' ' B' ' 2' ' ' CYS . 9.6 p-10 -154.51 156.53 36.84 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 124' ' ' GLY . . . . . 0.487 ' HA3' ' HA ' ' B' ' 30' ' ' PHE . . . 148.93 -157.17 27.16 Favored Glycine 0 C--N 1.296 -1.693 0 C-N-CA 118.382 -1.866 . . . . 0.0 110.149 178.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . 0.464 ' CB ' ' HA ' ' B' ' 27' ' ' ALA . 63.1 m-20 -91.55 12.1 21.98 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 122.015 -0.697 . . . . 0.0 110.383 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 126' ' ' PHE . . . . . 0.422 ' HB3' ' CD1' ' B' ' 30' ' ' PHE . 11.5 t80 -108.58 151.4 26.17 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.668 -1.27 . . . . 0.0 110.402 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -121.23 124.57 44.97 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.268 -0.895 . . . . 0.0 110.356 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . 0.46 ' O ' HG21 ' B' ' 128' ' ' ILE . 18.0 tt -101.86 127.3 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.156 -0.965 . . . . 0.0 110.39 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 29.1 pttt -119.11 -4.3 10.56 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.783 -1.198 . . . . 0.0 111.126 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 130' ' ' CYS . . . . . 0.444 ' HB2' ' HA ' ' A' ' 132' ' ' ALA . 0.0 OUTLIER -154.29 130.96 10.71 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 118.947 -1.101 . . . . 0.0 111.91 -179.084 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 130' ' ' CYS . 54.7 t -128.05 133.85 66.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.659 -0.651 . . . . 0.0 109.956 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 132' ' ' ALA . . . . . . . . . . . . . . . -141.45 142.87 33.64 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 120.249 -1.532 . . . . 0.0 110.395 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -76.19 -88.56 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.096 -1.002 . . . . 0.0 111.084 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 48.4 t0 . . . . . 0 C--N 1.296 -1.749 0 CA-C-O 118.096 -0.954 . . . . 0.0 110.356 -179.388 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.446 ' CA ' ' O ' ' A' ' 122' ' ' ALA . . . . . . . . 0 N--CA 1.497 2.704 0 CA-C-O 121.851 0.695 . . . . 0.0 112.271 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 84.2 mt -63.76 137.12 57.93 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.627 -1.514 . . . . 0.0 109.25 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.6 t -110.07 132.46 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.364 -0.835 . . . . 0.0 109.804 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.427 ' HB1' HD11 ' A' ' 9' ' ' LEU . . . -134.82 161.33 35.51 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.845 -1.16 . . . . 0.0 110.112 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.442 ' O ' ' HB3' ' A' ' 8' ' ' ASN . 15.2 p -153.38 169.95 21.86 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.539 -0.726 . . . . 0.0 109.999 -178.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.442 ' HB3' ' O ' ' A' ' 7' ' ' SER . 57.2 t30 65.74 39.08 4.94 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.263 0.554 . . . . 0.0 109.683 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 11' ' ' LEU . 85.7 mt -104.95 32.41 4.2 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.385 -0.822 . . . . 0.0 109.83 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -40.59 93.87 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.275 0 O-C-N 121.603 -0.686 . . . . 0.0 111.666 -178.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.477 ' HG ' ' CD1' ' A' ' 133' ' ' PHE . 0.2 OUTLIER -114.77 131.23 56.86 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.347 179.304 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.0 mttt -97.65 171.9 5.46 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.528 -0.733 . . . . 0.0 111.007 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -67.79 150.42 78.88 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 O-C-N 123.911 1.48 . . . . 0.0 110.095 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.59 -15.03 35.22 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.424 ' HB3' ' CB ' ' A' ' 134' ' ' ASP . 90.3 mt-10 -114.51 150.11 35.38 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.802 -1.41 . . . . 0.0 109.75 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 45.8 t -109.78 145.45 36.64 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.199 -0.938 . . . . 0.0 110.337 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 48.1 tp -112.48 134.17 54.16 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -121.86 129.55 52.68 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.934 -1.104 . . . . 0.0 110.108 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.425 HG13 ' CD1' ' A' ' 128' ' ' ILE . 65.2 t -126.28 127.7 70.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.161 -0.962 . . . . 0.0 111.02 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.429 ' HG3' ' HG2' ' A' ' 86' ' ' GLU . 70.3 ttt180 -107.27 122.12 45.91 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 177.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 127' ' ' LYS . . . -135.14 -178.57 15.77 Favored Glycine 0 N--CA 1.487 2.083 0 C-N-CA 118.939 -1.601 . . . . 0.0 111.661 -177.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -126.07 140.53 52.51 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 122.028 -0.689 . . . . 0.0 110.321 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.4 t -101.75 126.88 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.501 -0.749 . . . . 0.0 109.812 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.06 154.82 37.24 Favored Pre-proline 0 N--CA 1.497 1.922 0 O-C-N 120.989 -1.069 . . . . 0.0 110.48 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -67.45 -18.39 49.35 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 124.026 1.54 . . . . 0.0 111.208 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -119.77 52.23 1.12 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.924 -1.11 . . . . 0.0 108.69 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.43 ' HA ' ' HB3' ' A' ' 125' ' ' ASP . . . -78.21 153.01 32.32 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.575 0.702 . . . . 0.0 112.215 -178.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.402 ' N ' ' OD2' ' A' ' 125' ' ' ASP . 98.1 mttt -137.85 -39.66 0.56 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.539 -0.726 . . . . 0.0 109.953 179.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 40.1 p -161.58 160.0 28.37 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.967 -1.083 . . . . 0.0 111.756 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.45 ' HA ' ' HA3' ' A' ' 124' ' ' GLY . 67.3 t80 -153.86 150.82 28.81 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.49 -0.756 . . . . 0.0 109.878 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 45' ' ' PHE . 11.4 p -134.75 150.5 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.047 -1.033 . . . . 0.0 110.94 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 78.2 mt -118.2 147.22 43.6 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.487 -0.758 . . . . 0.0 108.995 179.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -143.25 108.54 5.02 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.015 -1.074 . . . . 0.0 111.004 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.435 ' HA ' ' O ' ' A' ' 119' ' ' TYR . 0.5 OUTLIER -131.14 121.28 24.63 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.401 -0.812 . . . . 0.0 109.494 179.254 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.447 ' O ' ' CB ' ' A' ' 119' ' ' TYR . . . -168.54 -171.5 34.44 Favored Glycine 0 N--CA 1.484 1.843 0 C-N-CA 118.652 -1.737 . . . . 0.0 109.977 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.409 ' HB2' ' CB ' ' A' ' 40' ' ' ASN . 34.9 mtpt -65.85 -41.52 91.58 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 122.284 1.04 . . . . 0.0 108.53 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.16 -167.33 2.17 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.851 0.834 . . . . 0.0 111.825 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.3 t -57.67 -41.98 82.66 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.636 -0.665 . . . . 0.0 112.766 -177.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -99.92 -7.34 25.35 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.234 -1.541 . . . . 0.0 110.663 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.409 ' CB ' ' HB2' ' A' ' 36' ' ' LYS . 7.1 m-80 -105.03 73.11 1.03 Allowed 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.032 -1.043 . . . . 0.0 109.096 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.414 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 60.1 mt -101.68 127.45 48.43 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.332 0.587 . . . . 0.0 110.362 -178.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 3.3 t -84.59 -43.91 14.02 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.123 -0.985 . . . . 0.0 110.488 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.482 HD21 HD21 ' A' ' 96' ' ' LEU . 20.4 tp -129.41 133.79 47.53 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.219 -0.926 . . . . 0.0 110.584 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.402 ' CB ' ' O ' ' A' ' 61' ' ' ASN . 9.3 t60 -126.73 112.77 15.8 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.525 ' CD2' ' HD3' ' A' ' 47' ' ' PRO . 43.2 t80 -111.71 115.77 29.63 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.822 -1.173 . . . . 0.0 110.481 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -130.45 73.76 80.91 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.348 -0.845 . . . . 0.0 111.601 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.525 ' HD3' ' CD2' ' A' ' 45' ' ' PHE . 43.5 Cg_endo -66.5 143.05 67.63 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.416 1.219 . . . . 0.0 109.52 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -137.63 126.32 23.8 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.912 -1.117 . . . . 0.0 110.847 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -72.21 -60.1 2.4 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.113 -0.992 . . . . 0.0 110.005 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -115.47 121.68 43.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.282 -0.886 . . . . 0.0 109.335 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.59 -162.46 0.96 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.838 -1.164 . . . . 0.0 111.123 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -83.45 8.92 12.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.404 -0.81 . . . . 0.0 110.165 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 173.76 -34.07 0.11 Allowed Glycine 0 N--CA 1.487 2.095 0 N-CA-C 108.589 -1.804 . . . . 0.0 108.589 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -80.85 -178.59 6.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.235 -1.156 . . . . 0.0 110.14 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.426 ' O ' ' C ' ' A' ' 56' ' ' ASN . . . -131.18 140.34 49.9 Favored 'General case' 0 C--N 1.293 -1.855 0 O-C-N 121.871 -0.518 . . . . 0.0 110.042 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.426 ' C ' ' O ' ' A' ' 55' ' ' ALA . 3.2 m120 27.81 73.52 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 179.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 96.2 m -127.51 131.18 50.14 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.913 -1.117 . . . . 0.0 110.526 178.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.494 ' HB ' ' HB3' ' A' ' 74' ' ' GLU . 82.4 mt -103.56 129.03 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.894 -0.504 . . . . 0.0 110.656 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 24.6 t -110.84 128.99 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.329 -0.857 . . . . 0.0 109.494 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.8 t -127.74 131.24 49.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.474 -0.766 . . . . 0.0 110.376 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.402 ' O ' ' CB ' ' A' ' 44' ' ' HIS . 1.5 p-10 -151.19 172.42 15.85 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.973 -1.079 . . . . 0.0 109.835 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.435 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 59.2 p -136.04 153.26 51.4 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.209 -0.932 . . . . 0.0 109.785 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.514 ' CD ' ' HA2' ' A' ' 66' ' ' GLY . 10.0 ttmt -133.29 145.79 50.79 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 120.692 -1.255 . . . . 0.0 111.876 -178.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.419 ' HB2' HD22 ' A' ' 112' ' ' LEU . 30.2 t0 -123.85 107.79 11.77 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.182 -0.949 . . . . 0.0 109.407 178.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 59.2 29.24 65.39 Favored Glycine 0 N--CA 1.485 1.91 0 C-N-CA 119.357 -1.401 . . . . 0.0 110.05 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.514 ' HA2' ' CD ' ' A' ' 63' ' ' LYS . . . 62.41 26.25 67.83 Favored Glycine 0 N--CA 1.488 2.108 0 O-C-N 120.997 -1.296 . . . . 0.0 110.621 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -89.98 -75.12 0.46 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.969 -1.312 . . . . 0.0 110.466 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 43.7 m95 -122.83 -170.46 2.1 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.792 -1.193 . . . . 0.0 110.777 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.435 ' HA2' ' O ' ' A' ' 62' ' ' SER . . . 173.49 114.62 0.35 Allowed Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.408 -1.377 . . . . 0.0 110.555 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 52.9 m -77.2 121.01 23.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.382 -1.069 . . . . 0.0 110.452 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -101.63 123.52 45.78 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.146 -0.971 . . . . 0.0 110.486 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -115.88 -170.27 1.76 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.826 -1.171 . . . . 0.0 110.378 179.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 47.3 ttp180 -144.4 116.4 8.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.952 -1.092 . . . . 0.0 111.587 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.494 ' HB3' ' HB ' ' A' ' 58' ' ' ILE . 77.5 tt0 -103.12 139.45 38.62 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.253 -0.904 . . . . 0.0 110.128 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.72 38.7 2.29 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.927 -1.108 . . . . 0.0 111.712 -179.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.463 ' O ' ' CD1' ' A' ' 58' ' ' ILE . 48.1 t -132.47 130.29 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.622 -1.299 . . . . 0.0 111.625 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -159.21 96.16 1.69 Allowed Pre-proline 0 N--CA 1.5 2.05 0 O-C-N 120.904 -1.122 . . . . 0.0 110.79 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -81.49 45.91 2.1 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.998 1.525 . . . . 0.0 111.7 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -128.85 152.8 48.1 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.615 -1.303 . . . . 0.0 111.725 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 15.4 mp0 -135.87 160.21 68.27 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.688 -0.632 . . . . 0.0 109.682 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -66.22 145.48 78.44 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.855 1.45 . . . . 0.0 110.79 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 64.5 40.25 97.52 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.1 p -133.54 148.77 51.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.976 -1.308 . . . . 0.0 111.627 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.6 p -101.26 136.47 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.505 -0.747 . . . . 0.0 109.233 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -153.91 155.07 35.0 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.121 -0.987 . . . . 0.0 110.368 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.429 ' HG2' ' HG3' ' A' ' 20' ' ' ARG . 99.0 mt-10 -119.36 139.18 52.4 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.896 -1.128 . . . . 0.0 110.597 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.6 t -125.95 132.68 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.411 -0.805 . . . . 0.0 110.68 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 77.8 m -107.77 134.41 50.77 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.176 -0.953 . . . . 0.0 109.107 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.439 HG21 HD13 ' A' ' 89' ' ' ILE . 89.1 mt -121.22 127.93 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.747 -1.221 . . . . 0.0 111.019 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 45.6 m -129.35 128.97 44.18 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.302 -0.874 . . . . 0.0 109.972 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.434 ' HA ' HD13 ' A' ' 96' ' ' LEU . 42.4 t80 -112.43 127.38 56.02 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.104 -0.997 . . . . 0.0 111.868 -179.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 95' ' ' ASN . 88.8 m-20 -119.09 156.02 30.48 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.496 -0.752 . . . . 0.0 109.911 179.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 -60.95 -23.88 65.65 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.454 -0.779 . . . . 0.0 112.73 -178.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -105.36 -26.54 11.93 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.436 -1.415 . . . . 0.0 110.428 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.409 ' O ' ' HB2' ' A' ' 92' ' ' ASP . 34.5 m-20 -152.57 172.61 16.33 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 119.069 -1.052 . . . . 0.0 111.866 -179.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.482 HD21 HD21 ' A' ' 43' ' ' LEU . 54.6 tp -119.13 129.42 55.02 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.4 m -114.58 125.25 53.56 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 120.781 -1.199 . . . . 0.0 111.115 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 43.3 t -120.18 127.93 75.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -114.42 119.24 36.22 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 118.589 -1.244 . . . . 0.0 109.774 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.0 mp -100.35 170.7 6.34 Favored Pre-proline 0 C--N 1.298 -1.645 0 O-C-N 121.91 -0.494 . . . . 0.0 109.755 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.05 -22.13 62.53 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 O-C-N 123.893 1.47 . . . . 0.0 111.122 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -66.04 -34.24 77.64 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.805 -1.185 . . . . 0.0 109.787 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 112.4 -27.0 10.41 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -73.22 145.23 46.37 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.145 -1.209 . . . . 0.0 109.381 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -113.64 143.33 44.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.844 -1.16 . . . . 0.0 111.022 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -120.44 147.86 44.55 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 98.2 mttt -120.77 145.11 47.88 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.01 -1.076 . . . . 0.0 111.555 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.431 ' HB3' HD23 ' A' ' 96' ' ' LEU . 15.0 t80 -125.55 129.59 24.35 Favored Pre-proline 0 C--N 1.293 -1.885 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -64.73 140.78 69.31 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 O-C-N 123.02 1.01 . . . . 0.0 109.965 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.51 ' ND2' ' O ' ' A' ' 110' ' ' ASN . 4.1 p-10 -92.02 82.4 5.1 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.023 -1.048 . . . . 0.0 109.473 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -54.72 -27.39 40.37 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.536 -1.353 . . . . 0.0 109.224 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.419 HD22 ' HB2' ' A' ' 64' ' ' ASP . 83.4 mt -104.65 132.33 51.02 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.338 -0.851 . . . . 0.0 109.851 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -87.7 61.06 6.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.009 -1.057 . . . . 0.0 110.415 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 52.0 tp -80.84 129.67 34.65 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.358 -0.839 . . . . 0.0 109.537 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -87.27 -12.36 46.86 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.162 -0.962 . . . . 0.0 111.549 -178.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' A' ' 11' ' ' LEU . . . -160.23 158.45 29.99 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.794 -1.191 . . . . 0.0 111.661 -178.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 49.9 mm -109.41 126.06 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.525 -0.734 . . . . 0.0 109.891 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -112.09 -26.65 8.74 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.566 -1.334 . . . . 0.0 110.787 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.447 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 10.5 t80 -110.21 126.26 53.95 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.229 -0.92 . . . . 0.0 110.401 -179.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 50.0 ttp -132.98 130.66 39.8 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.5 142.24 21.0 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.026 -1.046 . . . . 0.0 110.521 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.446 ' O ' ' CA ' ' A' ' 3' ' ' GLY . . . -148.02 132.03 17.22 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.35 -0.844 . . . . 0.0 111.391 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.436 ' HB3' ' HA3' ' A' ' 3' ' ' GLY . 15.2 p-10 -148.46 147.6 29.33 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.358 -0.839 . . . . 0.0 110.483 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.45 ' HA3' ' HA ' ' A' ' 30' ' ' PHE . . . 155.79 -145.44 12.34 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.43 ' HB3' ' HA ' ' A' ' 27' ' ' ALA . 88.2 m-20 -94.31 11.46 30.31 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.288 -1.125 . . . . 0.0 111.544 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.434 ' CZ ' ' HA3' ' A' ' 21' ' ' GLY . 24.7 t80 -112.87 143.74 43.62 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.964 -1.085 . . . . 0.0 109.319 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.445 ' O ' ' HA3' ' A' ' 21' ' ' GLY . 51.8 mttp -117.01 140.99 48.82 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.891 -1.131 . . . . 0.0 111.359 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.425 ' CD1' HG13 ' A' ' 19' ' ' VAL . 4.1 tt -111.57 122.41 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -101.55 -9.94 20.55 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.021 -1.049 . . . . 0.0 112.384 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.402 ' HA ' ' O ' ' B' ' 131' ' ' VAL . 0.1 OUTLIER -158.14 150.12 21.78 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.224 -1.547 . . . . 0.0 112.004 179.889 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 47.9 t -128.86 133.48 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -136.38 133.1 36.4 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.715 -1.241 . . . . 0.0 111.302 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.477 ' CD1' ' HG ' ' A' ' 11' ' ' LEU . 47.7 m-85 -110.9 148.22 32.93 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.402 -0.811 . . . . 0.0 111.313 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.424 ' CB ' ' HB3' ' A' ' 15' ' ' GLU . 47.1 t0 . . . . . 0 N--CA 1.496 1.873 0 CA-C-O 118.114 -0.946 . . . . 0.0 111.186 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 121.341 0.591 . . . . 0.0 110.441 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 2' ' ' CYS . . . . . 0.512 ' O ' ' O ' ' B' ' 3' ' ' GLY . 1.3 m -96.95 54.88 1.29 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.023 -1.048 . . . . 0.0 110.664 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' GLY . . . . . 0.512 ' O ' ' O ' ' B' ' 2' ' ' CYS . . . 42.43 111.3 0.0 OUTLIER Glycine 0 N--CA 1.497 2.717 0 CA-C-O 121.891 0.717 . . . . 0.0 112.308 178.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 86.2 mt -63.78 136.99 57.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.571 -1.547 . . . . 0.0 109.458 178.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 37.5 t -109.72 132.35 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.454 -0.779 . . . . 0.0 109.861 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' ALA . . . . . 0.439 ' HB1' HD11 ' B' ' 9' ' ' LEU . . . -134.7 161.12 36.05 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.766 -1.209 . . . . 0.0 110.214 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' SER . . . . . 0.453 ' O ' ' HB3' ' B' ' 8' ' ' ASN . 15.8 p -153.2 170.37 20.71 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.293 -0.879 . . . . 0.0 110.038 -178.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . 0.453 ' HB3' ' O ' ' B' ' 7' ' ' SER . 57.2 t30 65.43 39.05 5.36 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.241 0.543 . . . . 0.0 109.756 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . 0.439 HD11 ' HB1' ' B' ' 6' ' ' ALA . 82.6 mt -104.62 32.27 4.2 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.345 -0.847 . . . . 0.0 109.8 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 -40.24 93.97 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.495 -0.753 . . . . 0.0 111.708 -178.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.481 ' HG ' ' CD1' ' B' ' 133' ' ' PHE . 0.2 OUTLIER -115.01 131.05 57.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.649 -0.657 . . . . 0.0 110.286 179.603 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -97.75 172.54 4.79 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.506 -0.746 . . . . 0.0 110.765 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.25 150.69 76.75 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 O-C-N 123.95 1.5 . . . . 0.0 110.392 178.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.3 -14.98 36.2 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . 0.41 ' OE1' HD13 ' B' ' 11' ' ' LEU . 90.4 mt-10 -114.37 150.25 34.89 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.822 -1.399 . . . . 0.0 109.668 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' CYS . . . . . . . . . . . . . 52.3 t -109.89 145.62 36.52 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.129 -0.982 . . . . 0.0 110.036 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 46.3 tp -112.75 133.92 54.52 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -121.74 129.23 52.55 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.937 -1.102 . . . . 0.0 109.982 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.42 HG13 ' CD1' ' B' ' 128' ' ' ILE . 61.6 t -125.54 127.2 71.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.32 -0.862 . . . . 0.0 111.122 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . 0.432 ' HG3' ' HG2' ' B' ' 86' ' ' GLU . 70.2 ttt180 -107.02 122.13 45.84 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . 0.451 ' HA3' ' O ' ' B' ' 127' ' ' LYS . . . -135.17 -177.83 15.24 Favored Glycine 0 N--CA 1.484 1.842 0 C-N-CA 118.881 -1.628 . . . . 0.0 111.562 -177.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -126.66 140.76 52.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.697 -0.884 . . . . 0.0 110.203 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 6.4 t -101.92 127.39 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.293 -0.88 . . . . 0.0 109.846 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.35 155.51 36.02 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 120.953 -1.092 . . . . 0.0 110.588 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.77 -18.4 47.51 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 O-C-N 124.122 1.591 . . . . 0.0 111.113 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -119.88 52.62 1.11 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.023 -1.048 . . . . 0.0 108.8 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . 0.425 ' HA ' ' HB3' ' B' ' 125' ' ' ASP . . . -78.59 152.31 31.89 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.585 0.707 . . . . 0.0 112.144 -178.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . 0.403 ' N ' ' OD2' ' B' ' 125' ' ' ASP . 98.0 mttt -137.12 -40.66 0.59 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.671 -0.643 . . . . 0.0 110.105 178.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 35.8 p -160.14 160.9 33.49 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.871 -1.143 . . . . 0.0 111.321 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' PHE . . . . . 0.471 ' HA ' ' HA3' ' B' ' 124' ' ' GLY . 64.8 t80 -154.58 150.52 27.82 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.278 -0.889 . . . . 0.0 109.623 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' B' ' 45' ' ' PHE . 11.5 p -134.41 150.97 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 120.781 -1.2 . . . . 0.0 110.974 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 76.5 mt -118.09 147.12 43.59 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -143.14 108.11 4.93 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 120.834 -1.166 . . . . 0.0 110.974 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.442 ' HA ' ' O ' ' B' ' 119' ' ' TYR . 0.5 OUTLIER -131.29 116.35 17.5 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.283 -0.885 . . . . 0.0 109.835 179.546 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' B' ' 119' ' ' TYR . . . -161.63 -169.93 25.62 Favored Glycine 0 N--CA 1.485 1.919 0 C-N-CA 118.53 -1.795 . . . . 0.0 110.494 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt -66.69 -42.26 86.75 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -156.62 -167.06 2.28 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.75 0.786 . . . . 0.0 111.778 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 38.6 t -57.83 -41.9 83.24 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -100.31 -7.27 24.72 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 120.394 -1.441 . . . . 0.0 110.564 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -104.92 72.18 1.0 Allowed 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.903 -1.123 . . . . 0.0 109.129 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.442 ' HA ' ' HA3' ' B' ' 35' ' ' GLY . 60.1 mt -100.32 130.13 46.39 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.231 0.539 . . . . 0.0 110.031 -178.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' CYS . . . . . . . . . . . . . 2.1 t -88.63 -42.58 11.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.066 -1.021 . . . . 0.0 109.919 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.445 HD21 HD21 ' B' ' 96' ' ' LEU . 19.7 tp -129.76 133.91 47.29 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.144 -0.972 . . . . 0.0 110.456 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' HIS . . . . . 0.403 ' CB ' ' O ' ' B' ' 61' ' ' ASN . 9.0 t60 -127.27 112.75 15.44 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.521 ' CD2' ' HD3' ' B' ' 47' ' ' PRO . 43.3 t80 -111.69 115.25 28.79 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.133 -0.979 . . . . 0.0 110.436 -179.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -129.84 73.42 81.47 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 121.372 -0.83 . . . . 0.0 111.413 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' PRO . . . . . 0.521 ' HD3' ' CD2' ' B' ' 45' ' ' PHE . 41.4 Cg_endo -66.24 143.03 69.24 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.263 1.138 . . . . 0.0 109.259 179.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -137.9 126.63 23.78 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.91 -1.119 . . . . 0.0 110.713 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -72.59 -60.97 1.97 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.137 -0.977 . . . . 0.0 109.988 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -114.54 120.99 42.08 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.488 -0.758 . . . . 0.0 109.25 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.09 -162.11 0.92 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.84 -1.162 . . . . 0.0 111.32 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -84.18 11.42 8.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.433 -0.792 . . . . 0.0 110.122 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 170.42 -33.48 0.16 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -81.45 -178.55 6.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.013 -1.286 . . . . 0.0 110.029 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.473 ' O ' ' C ' ' B' ' 56' ' ' ASN . . . -129.6 146.91 51.36 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' ASN . . . . . 0.473 ' C ' ' O ' ' B' ' 55' ' ' ALA . 3.3 m120 17.53 77.36 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.175 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -179.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 97.0 m -128.1 130.86 48.84 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.236 -0.915 . . . . 0.0 110.328 178.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' ILE . . . . . 0.46 ' CD1' ' O ' ' B' ' 76' ' ' VAL . 82.7 mt -104.01 129.24 56.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 121.775 -0.578 . . . . 0.0 110.818 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 25.0 t -110.29 129.17 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.193 -0.942 . . . . 0.0 109.899 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 1.7 t -127.98 129.6 47.02 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.661 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' ASN . . . . . 0.403 ' O ' ' CB ' ' B' ' 44' ' ' HIS . 1.5 p-10 -149.69 171.75 16.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.151 -0.968 . . . . 0.0 110.194 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' SER . . . . . 0.431 ' O ' ' HA2' ' B' ' 69' ' ' GLY . 60.5 p -135.47 153.61 51.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.243 -0.91 . . . . 0.0 109.56 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . 0.512 ' CD ' ' HA2' ' B' ' 66' ' ' GLY . 10.1 ttmt -132.93 145.9 51.31 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 120.703 -1.248 . . . . 0.0 111.701 -178.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' ASP . . . . . 0.413 ' HB2' HD22 ' B' ' 112' ' ' LEU . 30.4 t0 -123.83 107.48 11.44 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.212 -0.93 . . . . 0.0 109.263 178.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 59.64 28.74 65.78 Favored Glycine 0 N--CA 1.484 1.878 0 C-N-CA 119.576 -1.297 . . . . 0.0 110.15 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . 0.512 ' HA2' ' CD ' ' B' ' 63' ' ' LYS . . . 62.84 25.83 68.12 Favored Glycine 0 N--CA 1.488 2.105 0 O-C-N 120.872 -1.369 . . . . 0.0 110.575 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -89.48 -75.65 0.44 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.835 -1.391 . . . . 0.0 110.236 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' TRP . . . . . . . . . . . . . 43.6 m95 -122.46 -166.29 1.4 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.871 -1.143 . . . . 0.0 110.985 -178.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . 0.431 ' HA2' ' O ' ' B' ' 62' ' ' SER . . . 167.87 114.33 0.3 Allowed Glycine 0 N--CA 1.486 2.032 0 C-N-CA 119.359 -1.4 . . . . 0.0 110.546 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 43.2 m -77.31 120.87 22.93 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.946 -0.738 . . . . 0.0 110.531 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -101.29 123.73 45.86 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.266 -0.896 . . . . 0.0 110.396 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -116.03 -171.05 1.91 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.84 -1.163 . . . . 0.0 110.295 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 47.7 ttp180 -143.78 116.02 8.47 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.205 -0.934 . . . . 0.0 111.42 -178.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 74' ' ' GLU . . . . . 0.443 ' HB3' ' HB ' ' B' ' 58' ' ' ILE . 78.1 tt0 -102.98 139.25 38.78 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.215 -0.928 . . . . 0.0 110.035 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.82 39.43 2.13 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.951 -1.093 . . . . 0.0 111.461 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 76' ' ' VAL . . . . . 0.46 ' O ' ' CD1' ' B' ' 58' ' ' ILE . 48.9 t -132.97 129.9 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 120.919 -1.113 . . . . 0.0 111.738 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -159.05 96.43 1.71 Allowed Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 120.922 -1.112 . . . . 0.0 110.809 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -81.66 46.6 2.28 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.925 1.487 . . . . 0.0 111.53 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -129.58 153.06 48.42 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.719 -1.238 . . . . 0.0 111.502 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 15.4 mp0 -136.41 160.5 66.57 Favored Pre-proline 0 N--CA 1.486 1.374 0 O-C-N 121.666 -0.646 . . . . 0.0 109.467 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 81' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -66.68 145.15 74.74 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.75 1.395 . . . . 0.0 110.958 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 64.78 39.95 97.0 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 12.7 p -132.77 147.78 52.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.011 -1.288 . . . . 0.0 111.913 -178.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 12.7 p -100.15 136.64 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.438 -0.789 . . . . 0.0 109.408 178.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -154.02 155.43 35.52 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.051 -1.031 . . . . 0.0 110.171 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 86' ' ' GLU . . . . . 0.432 ' HG2' ' HG3' ' B' ' 20' ' ' ARG . 98.3 mt-10 -119.67 139.07 52.81 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.856 -1.153 . . . . 0.0 110.499 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 55.9 t -125.62 132.78 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.517 -0.739 . . . . 0.0 110.601 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 88' ' ' CYS . . . . . . . . . . . . . 75.1 m -107.57 134.98 49.79 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.166 -0.959 . . . . 0.0 109.355 178.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.432 HG21 HD13 ' B' ' 89' ' ' ILE . 87.2 mt -121.59 128.26 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.882 -1.136 . . . . 0.0 110.958 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 90' ' ' THR . . . . . 0.404 ' O ' HD11 ' B' ' 96' ' ' LEU . 50.1 m -129.08 128.83 44.34 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.28 -0.887 . . . . 0.0 109.914 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 91' ' ' PHE . . . . . 0.425 ' HA ' HD13 ' B' ' 96' ' ' LEU . 41.1 t80 -112.38 127.35 55.99 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.995 -1.066 . . . . 0.0 111.637 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . 0.402 ' HB2' ' O ' ' B' ' 95' ' ' ASN . 88.9 m-20 -119.59 155.79 31.59 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.4 -0.813 . . . . 0.0 109.805 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -60.76 -23.84 65.28 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.404 -0.81 . . . . 0.0 112.761 -178.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -105.23 -26.95 11.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.366 -1.459 . . . . 0.0 110.474 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 95' ' ' ASN . . . . . 0.402 ' O ' ' HB2' ' B' ' 92' ' ' ASP . 34.5 m-20 -152.36 172.57 16.26 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 122.082 0.944 . . . . 0.0 112.02 -178.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 96' ' ' LEU . . . . . 0.445 HD21 HD21 ' B' ' 43' ' ' LEU . 54.1 tp -119.07 129.25 54.99 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 97' ' ' THR . . . . . 0.403 HG22 ' OE2' ' B' ' 105' ' ' GLU . 18.3 m -114.45 125.44 53.83 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 120.784 -1.198 . . . . 0.0 111.0 -179.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 44.7 t -120.53 128.06 75.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -114.5 118.99 35.32 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 118.542 -1.263 . . . . 0.0 110.142 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 5.1 mp -100.0 170.49 6.67 Favored Pre-proline 0 C--N 1.302 -1.466 0 O-C-N 121.889 -0.507 . . . . 0.0 110.009 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.72 -23.04 63.56 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.788 1.414 . . . . 0.0 110.998 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -64.95 -34.45 78.46 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.667 -1.271 . . . . 0.0 110.039 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 112.07 -27.22 10.42 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 104' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -72.91 144.67 47.26 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.198 -1.178 . . . . 0.0 109.443 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 105' ' ' GLU . . . . . 0.403 ' OE2' HG22 ' B' ' 97' ' ' THR . 68.2 tt0 -113.57 143.71 44.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.958 -1.089 . . . . 0.0 111.221 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -120.72 148.04 44.49 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 107' ' ' LYS . . . . . 0.43 ' HA ' ' O ' ' B' ' 96' ' ' LEU . 98.1 mttt -120.78 145.23 47.76 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.05 -1.031 . . . . 0.0 111.173 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 108' ' ' PHE . . . . . 0.41 ' HB3' HD23 ' B' ' 96' ' ' LEU . 15.7 t80 -126.13 129.83 24.13 Favored Pre-proline 0 C--N 1.291 -1.959 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -64.95 141.01 68.88 Favored 'Trans proline' 0 C--N 1.298 -2.131 0 O-C-N 123.071 1.038 . . . . 0.0 110.362 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 110' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' B' ' 110' ' ' ASN . 4.0 p-10 -91.84 82.16 5.19 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.158 -1.017 . . . . 0.0 109.689 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -54.36 -27.38 35.87 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.443 -1.411 . . . . 0.0 109.273 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 112' ' ' LEU . . . . . 0.413 HD22 ' HB2' ' B' ' 64' ' ' ASP . 82.5 mt -104.96 131.86 51.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.476 -0.765 . . . . 0.0 110.008 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -87.01 61.69 6.94 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.138 -0.977 . . . . 0.0 110.431 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 51.7 tp -81.24 130.03 34.85 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.247 -0.908 . . . . 0.0 109.571 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -87.18 -13.03 45.11 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.125 -0.984 . . . . 0.0 111.369 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 116' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' B' ' 11' ' ' LEU . . . -159.73 158.89 32.11 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.765 -1.21 . . . . 0.0 111.898 -178.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 49.7 mm -109.39 125.97 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.442 -0.786 . . . . 0.0 109.858 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -111.66 -26.91 8.76 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.542 -1.349 . . . . 0.0 110.667 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 119' ' ' TYR . . . . . 0.473 ' N ' ' O ' ' B' ' 35' ' ' GLY . 9.5 t80 -110.18 126.4 54.06 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.364 -0.934 . . . . 0.0 110.76 -178.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 49.8 ttp -133.19 129.83 38.3 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.444 -0.785 . . . . 0.0 108.976 179.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -152.75 142.31 21.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.905 -1.122 . . . . 0.0 110.578 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 122' ' ' ALA . . . . . 0.463 ' O ' ' CA ' ' B' ' 3' ' ' GLY . . . -147.41 132.47 18.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.013 -1.054 . . . . 0.0 111.351 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 123' ' ' ASP . . . . . 0.442 ' HB3' ' HA3' ' B' ' 3' ' ' GLY . 15.3 p-10 -148.58 147.45 29.03 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.091 -1.006 . . . . 0.0 110.551 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 124' ' ' GLY . . . . . 0.471 ' HA3' ' HA ' ' B' ' 30' ' ' PHE . . . 155.97 -144.43 10.89 Favored Glycine 0 N--CA 1.496 2.639 0 C-N-CA 119.808 -1.187 . . . . 0.0 110.177 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . 0.425 ' HB3' ' HA ' ' B' ' 27' ' ' ALA . 87.2 m-20 -95.09 10.82 34.35 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.241 -1.152 . . . . 0.0 111.351 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 126' ' ' PHE . . . . . 0.421 ' CZ ' ' HA3' ' B' ' 21' ' ' GLY . 24.4 t80 -112.52 143.71 43.22 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.876 -1.14 . . . . 0.0 109.519 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . 0.451 ' O ' ' HA3' ' B' ' 21' ' ' GLY . 52.0 mttp -116.56 141.11 48.61 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 118.81 -1.156 . . . . 0.0 111.521 -179.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . 0.42 ' CD1' HG13 ' B' ' 19' ' ' VAL . 4.1 tt -111.57 122.88 66.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.776 -0.578 . . . . 0.0 109.543 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -101.92 -11.8 18.71 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.078 -1.014 . . . . 0.0 112.196 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 130' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -155.89 150.61 26.14 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.271 -1.518 . . . . 0.0 112.024 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 130' ' ' CYS . 45.4 t -129.31 133.05 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.588 -0.695 . . . . 0.0 109.162 178.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 132' ' ' ALA . . . . . . . . . . . . . . . -136.19 132.66 36.23 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.713 -1.242 . . . . 0.0 111.39 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . 0.481 ' CD1' ' HG ' ' B' ' 11' ' ' LEU . 47.6 m-85 -110.48 147.98 33.0 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.275 -0.891 . . . . 0.0 111.105 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . 0.401 ' CB ' ' HB3' ' B' ' 15' ' ' GLU . 47.8 t0 . . . . . 0 N--CA 1.496 1.867 0 CA-C-O 118.137 -0.935 . . . . 0.0 111.127 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.419 HD21 HG23 ' A' ' 128' ' ' ILE . 49.3 tp -59.77 133.7 56.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.88 -1.365 . . . . 0.0 110.7 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.7 t -118.04 130.11 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.361 -0.837 . . . . 0.0 110.071 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -118.81 153.01 35.17 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.325 -0.859 . . . . 0.0 109.555 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.457 ' O ' ' HB3' ' A' ' 8' ' ' ASN . 18.1 p -148.78 171.98 15.37 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.261 -0.899 . . . . 0.0 110.314 -178.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.457 ' HB3' ' O ' ' A' ' 7' ' ' SER . 14.7 t30 61.08 35.49 18.7 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.335 0.588 . . . . 0.0 110.272 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.525 ' O ' ' C ' ' A' ' 10' ' ' ASN . 87.7 mt -91.16 -17.97 25.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.215 -0.928 . . . . 0.0 110.893 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.525 ' C ' ' O ' ' A' ' 9' ' ' LEU . 7.6 m120 11.24 77.47 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.506 0 CA-C-O 121.522 0.677 . . . . 0.0 112.791 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.489 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 19.2 mt -98.93 128.05 45.0 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.686 -0.634 . . . . 0.0 110.765 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -96.35 169.68 8.6 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.18 -0.95 . . . . 0.0 110.47 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -66.13 146.65 82.38 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.976 1.514 . . . . 0.0 110.156 178.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.23 -7.78 56.84 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -117.92 147.28 43.28 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.953 -1.322 . . . . 0.0 109.998 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.8 m -109.63 145.13 36.97 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.963 -1.086 . . . . 0.0 111.606 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.5 tp -121.2 133.78 55.18 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -122.94 141.75 51.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.743 -1.223 . . . . 0.0 111.183 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 69.0 t -124.27 120.27 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 119.894 -0.723 . . . . 0.0 110.382 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -116.85 122.06 43.28 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.1 -1.0 . . . . 0.0 109.549 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.486 ' O ' HG12 ' A' ' 84' ' ' VAL . . . -144.71 -150.15 5.17 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.432 -1.365 . . . . 0.0 109.897 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -133.34 147.01 51.82 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.741 -1.446 . . . . 0.0 110.529 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 51.1 t -110.23 128.79 66.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.5 -0.75 . . . . 0.0 109.898 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.94 147.25 74.09 Favored Pre-proline 0 C--N 1.301 -1.528 0 O-C-N 121.061 -1.024 . . . . 0.0 109.2 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.455 ' HA ' ' N ' ' A' ' 82' ' ' GLY . 40.6 Cg_endo -65.89 -20.69 58.04 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.729 1.384 . . . . 0.0 110.141 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -116.77 29.63 7.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.439 -0.788 . . . . 0.0 109.228 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.458 ' HA ' ' HB3' ' A' ' 125' ' ' ASP . . . -63.74 99.09 0.21 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.514 -0.741 . . . . 0.0 110.884 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -66.52 -43.97 83.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.468 -0.77 . . . . 0.0 110.401 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.5 t -165.03 147.61 8.15 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.461 -0.774 . . . . 0.0 110.26 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.466 ' CD2' ' HB2' ' A' ' 126' ' ' PHE . 49.6 p90 -148.95 156.22 41.97 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.42 HG23 ' HB2' ' A' ' 46' ' ' ASN . 53.3 t -133.43 137.85 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.534 -1.354 . . . . 0.0 112.369 -177.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 93.2 mt -112.37 133.09 54.66 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.47 ' OD1' ' CE1' ' A' ' 44' ' ' HIS . 80.8 m-20 -125.78 135.89 52.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.013 -1.054 . . . . 0.0 110.968 -178.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.409 ' HA ' ' O ' ' A' ' 119' ' ' TYR . 0.7 OUTLIER -145.17 114.16 6.93 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.077 -1.014 . . . . 0.0 110.934 179.415 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.466 ' O ' ' N ' ' A' ' 119' ' ' TYR . . . -163.45 -132.31 1.33 Allowed Glycine 0 N--CA 1.496 2.66 0 N-CA-C 108.233 -1.947 . . . . 0.0 108.233 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.424 ' CA ' ' HB2' ' A' ' 119' ' ' TYR . 42.1 mtpt -112.08 -46.03 3.25 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.093 -1.24 . . . . 0.0 108.05 178.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -123.67 164.41 19.15 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.882 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.23 -32.18 68.08 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.339 -0.851 . . . . 0.0 110.982 -179.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.443 ' HB3' ' N ' ' A' ' 66' ' ' GLY . 87.1 m-20 -94.98 -9.07 35.09 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.877 -1.14 . . . . 0.0 111.186 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.439 ' N ' ' ND2' ' A' ' 40' ' ' ASN . 2.9 m-80 -113.56 66.42 0.66 Allowed 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.158 -0.964 . . . . 0.0 110.138 -178.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.444 HD12 ' HB3' ' A' ' 33' ' ' ASN . 47.0 mt -96.24 133.25 40.81 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 2.1 m -85.41 -31.24 23.0 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.993 -1.067 . . . . 0.0 109.784 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 25.3 tp -128.5 129.19 45.7 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.611 -0.681 . . . . 0.0 109.982 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.47 ' CE1' ' OD1' ' A' ' 33' ' ' ASN . 63.5 t60 -128.23 127.73 43.4 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.102 -0.999 . . . . 0.0 110.305 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.483 ' CD2' ' HD3' ' A' ' 47' ' ' PRO . 83.7 t80 -123.39 122.88 39.41 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.975 -1.078 . . . . 0.0 110.043 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.42 ' HB2' HG23 ' A' ' 31' ' ' VAL . 1.4 t-20 -142.71 84.23 11.03 Favored Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 121.154 -0.966 . . . . 0.0 110.954 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.483 ' HD3' ' CD2' ' A' ' 45' ' ' PHE . 52.7 Cg_endo -70.64 142.77 44.84 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.657 1.346 . . . . 0.0 109.489 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -127.0 97.59 5.01 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.921 -1.112 . . . . 0.0 110.394 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -61.03 -45.44 94.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.132 -0.98 . . . . 0.0 109.139 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -159.63 103.36 1.55 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.309 -0.869 . . . . 0.0 109.413 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -113.82 -104.17 0.4 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.045 -1.034 . . . . 0.0 110.695 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -65.88 -41.47 91.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.663 -1.273 . . . . 0.0 109.872 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 168.54 39.54 0.02 OUTLIER Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.402 ' N ' ' OD1' ' A' ' 54' ' ' ASP . 8.9 m-20 -114.08 -179.42 3.63 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.353 -1.087 . . . . 0.0 109.115 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.423 ' O ' ' C ' ' A' ' 56' ' ' ASN . . . -142.14 143.99 33.27 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.977 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.423 ' C ' ' O ' ' A' ' 55' ' ' ALA . 81.2 m-20 27.55 49.4 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 178.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 55.2 m -118.48 130.51 55.98 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.84 -1.162 . . . . 0.0 109.352 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.477 HG23 ' CE1' ' A' ' 45' ' ' PHE . 86.8 mt -115.6 135.26 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.203 -0.936 . . . . 0.0 110.933 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 64.6 t -102.05 126.09 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.382 -0.824 . . . . 0.0 110.265 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 80.2 m -116.76 121.27 41.1 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.142 -0.974 . . . . 0.0 109.251 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.434 ' O ' ' HB3' ' A' ' 44' ' ' HIS . 2.5 p-10 -151.63 179.1 8.69 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.952 -1.093 . . . . 0.0 111.163 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.455 ' O ' ' CA ' ' A' ' 69' ' ' GLY . 15.1 m -133.91 154.18 51.25 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.325 -0.86 . . . . 0.0 109.874 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.486 ' CD ' ' HA2' ' A' ' 66' ' ' GLY . 18.3 ttmt -128.53 143.67 51.01 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.491 -1.381 . . . . 0.0 111.277 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -122.34 95.61 4.71 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.463 -0.773 . . . . 0.0 109.161 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 71.21 19.87 77.68 Favored Glycine 0 N--CA 1.484 1.834 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.486 ' HA2' ' CD ' ' A' ' 63' ' ' LYS . . . 72.29 32.72 62.32 Favored Glycine 0 N--CA 1.486 2.009 0 C-N-CA 119.386 -1.388 . . . . 0.0 110.694 179.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -101.86 -74.55 0.62 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.855 -1.379 . . . . 0.0 111.122 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 14.1 m0 -124.16 -147.83 0.38 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.14 -0.975 . . . . 0.0 110.627 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.455 ' CA ' ' O ' ' A' ' 62' ' ' SER . . . 158.64 144.65 4.01 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.429 ' HB ' ' CZ ' ' A' ' 111' ' ' ARG . 6.5 t -81.53 80.47 7.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.455 -1.026 . . . . 0.0 109.729 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.433 ' HA ' ' HB3' ' A' ' 61' ' ' ASN . 78.6 tt0 -71.07 111.56 6.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.249 -0.907 . . . . 0.0 110.875 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -122.79 -164.94 1.24 Allowed 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.333 -0.855 . . . . 0.0 109.556 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -137.65 130.92 30.73 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.431 -0.907 . . . . 0.0 110.583 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -131.83 83.43 2.09 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.309 -0.87 . . . . 0.0 109.508 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.74 88.08 0.1 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.216 -0.928 . . . . 0.0 110.611 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.423 ' O ' HD11 ' A' ' 58' ' ' ILE . 6.2 p -134.6 141.49 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.449 -0.782 . . . . 0.0 109.682 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -157.11 89.21 2.57 Favored Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 120.55 -1.344 . . . . 0.0 110.891 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.403 ' CB ' ' OD2' ' A' ' 102' ' ' ASP . 51.0 Cg_endo -77.39 -6.63 16.51 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.845 1.445 . . . . 0.0 111.978 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -142.21 -167.3 2.44 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.79 -1.194 . . . . 0.0 111.293 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.416 ' CB ' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -139.48 172.53 6.3 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.481 -0.762 . . . . 0.0 109.723 179.753 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.416 ' HD2' ' CB ' ' A' ' 80' ' ' GLN . 44.3 Cg_endo -67.22 147.42 78.68 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.807 1.425 . . . . 0.0 111.294 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.455 ' N ' ' HA ' ' A' ' 25' ' ' PRO . . . 78.71 23.56 64.29 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.4 t -137.01 147.45 46.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.083 -1.245 . . . . 0.0 111.113 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.486 HG12 ' O ' ' A' ' 21' ' ' GLY . 73.3 t -79.23 130.26 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.529 -0.732 . . . . 0.0 110.116 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -130.82 142.24 50.38 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.946 -1.096 . . . . 0.0 109.692 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.404 ' O ' ' HG3' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -120.22 127.29 52.29 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.519 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 73.4 t -121.52 132.26 71.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 118.985 -1.086 . . . . 0.0 111.019 -177.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 11.8 t -97.04 117.74 31.9 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.493 -0.754 . . . . 0.0 109.368 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 72.7 mt -111.51 125.24 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.082 -1.012 . . . . 0.0 109.468 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 57.7 m -122.36 129.38 52.06 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.361 -0.837 . . . . 0.0 109.665 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.468 ' CB ' HD12 ' A' ' 117' ' ' ILE . 72.5 t80 -106.76 118.28 36.27 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.052 -1.03 . . . . 0.0 110.822 -179.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -115.73 152.08 33.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.467 -0.771 . . . . 0.0 109.378 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 69.9 tp60 -62.73 -38.83 92.07 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.968 -1.082 . . . . 0.0 110.521 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.34 -39.35 89.15 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.949 -1.094 . . . . 0.0 110.563 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -166.7 178.8 5.74 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.322 -0.862 . . . . 0.0 110.068 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 49.5 tp -102.08 129.86 48.52 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.375 -0.828 . . . . 0.0 109.197 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 98.9 m -115.4 122.67 46.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.717 -1.239 . . . . 0.0 111.22 -179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 7.0 m -120.84 129.51 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.382 -0.824 . . . . 0.0 109.36 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -113.53 124.79 53.21 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.797 -1.19 . . . . 0.0 109.396 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.438 ' N ' HD12 ' A' ' 100' ' ' LEU . 8.0 mp -85.42 164.37 40.89 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.301 -0.874 . . . . 0.0 109.57 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -66.14 -32.85 42.21 Favored 'Trans proline' 0 C--N 1.302 -1.905 0 O-C-N 123.858 1.452 . . . . 0.0 110.486 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.403 ' OD2' ' CB ' ' A' ' 78' ' ' PRO . 99.7 m-20 -74.45 -25.32 59.34 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.106 -0.996 . . . . 0.0 110.208 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 121.3 3.11 10.66 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.761 -1.209 . . . . 0.0 111.095 178.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -83.9 135.8 34.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.598 -1.531 . . . . 0.0 110.249 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 64.5 tt0 -132.49 148.56 52.39 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.434 -0.791 . . . . 0.0 111.129 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -141.0 156.4 46.05 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.602 -0.686 . . . . 0.0 109.21 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -123.92 141.0 52.43 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.007 -1.058 . . . . 0.0 110.867 -178.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -123.71 143.35 41.63 Favored Pre-proline 0 N--CA 1.494 1.733 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.84 144.28 47.88 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.299 1.158 . . . . 0.0 109.184 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.485 ' ND2' ' O ' ' A' ' 110' ' ' ASN . 6.0 p-10 -95.0 82.76 3.84 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 120.934 -1.104 . . . . 0.0 110.584 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.429 ' CZ ' ' HB ' ' A' ' 70' ' ' THR . 98.2 mtt180 -55.77 -22.11 22.51 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.818 -1.176 . . . . 0.0 109.111 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.4 mt -96.9 141.92 29.51 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.319 -0.863 . . . . 0.0 108.704 178.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -97.02 62.42 1.83 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.748 -1.22 . . . . 0.0 109.875 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.409 ' CD1' ' HD2' ' A' ' 36' ' ' LYS . 64.9 tp -82.33 130.04 35.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.353 -0.842 . . . . 0.0 111.08 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.94 -17.23 29.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.409 -0.807 . . . . 0.0 109.87 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.489 ' HA ' ' O ' ' A' ' 11' ' ' LEU . . . -163.22 144.08 9.36 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.723 -1.236 . . . . 0.0 111.682 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.468 HD12 ' CB ' ' A' ' 91' ' ' PHE . 93.1 mt -98.87 124.59 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.386 -0.821 . . . . 0.0 108.981 178.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.466 ' ND2' ' N ' ' A' ' 118' ' ' ASN . 0.1 OUTLIER -125.59 13.0 8.08 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.592 -0.692 . . . . 0.0 110.772 -179.361 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.466 ' N ' ' O ' ' A' ' 35' ' ' GLY . 7.8 t80 -131.62 128.82 39.92 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.974 -1.079 . . . . 0.0 110.261 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 62.5 ttp -142.78 130.8 21.79 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.347 -0.846 . . . . 0.0 109.85 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -140.88 144.53 35.32 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.229 -0.92 . . . . 0.0 109.76 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -132.11 108.95 9.64 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.281 -0.887 . . . . 0.0 109.458 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -137.65 129.16 28.19 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.531 -0.731 . . . . 0.0 109.649 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 154.13 -157.93 27.81 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 108.841 -1.704 . . . . 0.0 108.841 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.458 ' HB3' ' HA ' ' A' ' 27' ' ' ALA . 87.6 m-20 -78.38 -0.22 28.22 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.3 -1.118 . . . . 0.0 110.552 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.466 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 42.7 t80 -95.4 142.28 27.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.09 -1.006 . . . . 0.0 109.859 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -112.95 140.12 48.02 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 118.815 -1.154 . . . . 0.0 110.538 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.419 HG23 HD21 ' A' ' 4' ' ' LEU . 20.6 tt -108.51 122.79 63.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.625 -0.672 . . . . 0.0 109.755 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -105.74 -23.07 12.81 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.328 -0.857 . . . . 0.0 110.97 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.418 ' HA ' ' O ' ' B' ' 131' ' ' VAL . 0.1 OUTLIER -153.03 154.88 35.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.82 -1.175 . . . . 0.0 112.136 -178.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' B' ' 130' ' ' CYS . 42.8 t -123.71 135.91 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -124.29 146.35 48.84 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.867 -1.145 . . . . 0.0 110.574 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.474 ' CZ ' HD23 ' A' ' 11' ' ' LEU . 0.4 OUTLIER -94.39 -139.92 0.23 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.349 -0.844 . . . . 0.0 109.798 179.786 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 49.0 t0 . . . . . 0 N--CA 1.492 1.673 0 O-C-N 120.631 -1.293 . . . . 0.0 110.437 -179.589 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.218 0.532 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 2' ' ' CYS . . . . . . . . . . . . . 49.6 t -145.17 84.85 1.72 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.095 -1.003 . . . . 0.0 110.608 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 84.84 43.37 6.81 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . 0.415 HD21 HG23 ' B' ' 128' ' ' ILE . 50.1 tp -60.18 133.66 56.31 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.918 -1.342 . . . . 0.0 110.577 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 46.7 t -117.95 130.07 73.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.363 -0.836 . . . . 0.0 110.111 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -118.94 152.51 36.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.926 . . . . 0.0 109.485 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' SER . . . . . 0.471 ' O ' ' HB3' ' B' ' 8' ' ' ASN . 17.1 p -148.6 172.26 14.82 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.102 -0.999 . . . . 0.0 110.25 -179.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . 0.471 ' HB3' ' O ' ' B' ' 7' ' ' SER . 13.6 t30 61.34 35.47 17.96 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.404 0.621 . . . . 0.0 110.303 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . 0.538 ' O ' ' C ' ' B' ' 10' ' ' ASN . 88.5 mt -92.52 -12.51 31.73 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.362 -0.836 . . . . 0.0 111.153 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' ASN . . . . . 0.538 ' C ' ' O ' ' B' ' 9' ' ' LEU . 7.3 m120 2.85 80.42 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.491 0 CA-C-O 122.144 0.973 . . . . 0.0 112.953 -178.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' B' ' 9' ' ' LEU . 18.7 mt -98.96 127.96 45.01 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.642 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -96.35 169.76 8.47 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.204 -0.935 . . . . 0.0 110.549 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.16 146.74 82.48 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 124.004 1.529 . . . . 0.0 110.18 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.86 -7.48 57.41 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.084 -1.207 . . . . 0.0 110.084 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -117.94 147.5 43.09 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.905 -1.35 . . . . 0.0 109.827 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' CYS . . . . . . . . . . . . . 6.2 m -110.11 145.25 37.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.085 -1.009 . . . . 0.0 111.365 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 46.9 tp -121.33 133.83 55.13 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -122.97 141.63 51.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.867 -1.146 . . . . 0.0 111.21 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 69.4 t -124.09 120.91 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 119.902 -0.719 . . . . 0.0 110.354 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -117.44 121.81 42.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.259 -0.901 . . . . 0.0 109.602 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . 0.476 ' O ' HG12 ' B' ' 84' ' ' VAL . . . -144.65 -149.93 5.14 Favored Glycine 0 N--CA 1.494 2.511 0 C-N-CA 119.486 -1.34 . . . . 0.0 109.897 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -133.72 146.47 50.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.814 -1.403 . . . . 0.0 110.685 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 50.9 t -109.71 128.63 65.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.501 -0.749 . . . . 0.0 109.961 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.79 147.01 73.5 Favored Pre-proline 0 C--N 1.299 -1.602 0 O-C-N 121.093 -1.004 . . . . 0.0 109.253 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . 0.458 ' HA ' ' N ' ' B' ' 82' ' ' GLY . 40.4 Cg_endo -66.05 -20.1 57.2 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.714 1.376 . . . . 0.0 110.116 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -117.15 29.44 7.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.292 -0.88 . . . . 0.0 109.246 178.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . 0.45 ' HA ' ' HB3' ' B' ' 125' ' ' ASP . . . -63.53 99.29 0.2 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.51 -0.744 . . . . 0.0 110.898 -179.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -66.46 -45.54 79.38 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.42 -0.8 . . . . 0.0 110.254 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 33.4 t -162.57 148.23 12.5 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.491 -0.756 . . . . 0.0 110.301 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' PHE . . . . . 0.468 ' CD2' ' HB2' ' B' ' 126' ' ' PHE . 49.8 p90 -149.16 156.02 41.54 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 177.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.401 HG23 ' HB2' ' B' ' 46' ' ' ASN . 53.8 t -133.3 138.14 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.372 -1.455 . . . . 0.0 112.373 -177.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 93.6 mt -112.57 133.29 54.7 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' ASN . . . . . 0.455 ' OD1' ' CE1' ' B' ' 44' ' ' HIS . 80.8 m-20 -125.89 136.0 52.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.967 -1.083 . . . . 0.0 110.995 -178.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.418 ' HA ' ' O ' ' B' ' 119' ' ' TYR . 0.7 OUTLIER -145.28 111.19 5.5 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.16 -0.962 . . . . 0.0 111.071 179.397 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . 0.461 ' O ' ' N ' ' B' ' 119' ' ' TYR . . . -159.16 -131.18 1.22 Allowed Glycine 0 N--CA 1.495 2.609 0 N-CA-C 108.526 -1.83 . . . . 0.0 108.526 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . 0.418 ' CA ' ' HB2' ' B' ' 119' ' ' TYR . 42.3 mtpt -112.93 -46.32 3.12 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -123.42 164.42 18.91 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.878 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.34 -32.37 68.47 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.242 -0.911 . . . . 0.0 111.035 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' ASN . . . . . 0.436 ' HB3' ' N ' ' B' ' 66' ' ' GLY . 86.9 m-20 -94.82 -8.98 35.84 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.045 -1.034 . . . . 0.0 111.085 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' ASN . . . . . 0.443 ' ND2' ' N ' ' B' ' 40' ' ' ASN . 3.0 m-80 -113.85 66.19 0.66 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.145 -0.972 . . . . 0.0 110.061 -178.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.449 HD12 ' HB3' ' B' ' 33' ' ' ASN . 45.4 mt -95.51 135.53 37.04 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' CYS . . . . . . . . . . . . . 1.7 m -88.81 -29.84 19.43 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.956 -1.09 . . . . 0.0 109.274 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 25.9 tp -128.94 128.99 44.88 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.539 -0.726 . . . . 0.0 109.874 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' HIS . . . . . 0.455 ' CE1' ' OD1' ' B' ' 33' ' ' ASN . 63.0 t60 -128.2 127.51 43.03 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.205 -0.935 . . . . 0.0 110.403 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.492 ' CE2' ' HD3' ' B' ' 47' ' ' PRO . 83.3 t80 -123.35 122.71 39.0 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.173 -0.954 . . . . 0.0 110.161 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' ASN . . . . . 0.401 ' HB2' HG23 ' B' ' 31' ' ' VAL . 1.4 t-20 -142.47 84.41 11.21 Favored Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 121.157 -0.964 . . . . 0.0 110.958 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' PRO . . . . . 0.492 ' HD3' ' CE2' ' B' ' 45' ' ' PHE . 52.9 Cg_endo -70.76 142.9 44.6 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 123.621 1.327 . . . . 0.0 109.421 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -127.15 97.5 4.96 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.023 -1.048 . . . . 0.0 110.347 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -60.84 -45.18 95.49 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.313 -0.867 . . . . 0.0 109.176 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -159.94 103.54 1.5 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.385 -0.822 . . . . 0.0 109.395 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -114.15 -103.92 0.41 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.052 -1.03 . . . . 0.0 110.73 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -66.08 -41.12 91.12 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.641 -1.287 . . . . 0.0 109.892 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 168.14 39.56 0.02 OUTLIER Glycine 0 N--CA 1.485 1.921 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -113.99 -179.44 3.63 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.485 -1.009 . . . . 0.0 109.134 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.46 ' O ' ' C ' ' B' ' 56' ' ' ASN . . . -140.68 150.3 43.32 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.162 -0.961 . . . . 0.0 110.256 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' ASN . . . . . 0.46 ' C ' ' O ' ' B' ' 55' ' ' ALA . 80.3 m-20 17.09 54.62 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' THR . . . . . 0.4 ' N ' ' O ' ' B' ' 55' ' ' ALA . 54.0 m -120.12 130.09 54.47 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.131 -0.981 . . . . 0.0 109.237 178.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' ILE . . . . . 0.481 HG23 ' CE1' ' B' ' 45' ' ' PHE . 85.3 mt -115.78 135.23 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.166 -0.959 . . . . 0.0 110.948 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 69.3 t -101.69 126.33 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.433 -0.792 . . . . 0.0 110.36 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 79.0 m -117.26 120.94 39.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.261 -0.899 . . . . 0.0 109.297 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' ASN . . . . . 0.438 ' HB3' ' HA ' ' B' ' 71' ' ' GLU . 2.4 p-10 -151.32 179.03 8.67 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.057 -1.027 . . . . 0.0 111.265 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' SER . . . . . 0.456 ' O ' ' CA ' ' B' ' 69' ' ' GLY . 15.8 m -133.94 153.83 51.5 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.361 -0.837 . . . . 0.0 109.892 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . 0.486 ' CD ' ' HA2' ' B' ' 66' ' ' GLY . 17.8 ttmt -128.4 143.5 51.01 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.453 -1.404 . . . . 0.0 111.228 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -122.42 94.95 4.45 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.527 -0.733 . . . . 0.0 109.351 178.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 71.81 19.87 78.38 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . 0.486 ' HA2' ' CD ' ' B' ' 63' ' ' LYS . . . 72.08 32.33 63.27 Favored Glycine 0 N--CA 1.488 2.118 0 O-C-N 120.833 -1.393 . . . . 0.0 110.598 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -101.07 -74.95 0.6 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.737 -1.449 . . . . 0.0 111.174 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' TRP . . . . . . . . . . . . . 13.6 m0 -123.99 -147.76 0.38 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.136 -0.978 . . . . 0.0 110.454 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . 0.456 ' CA ' ' O ' ' B' ' 62' ' ' SER . . . 158.61 145.4 4.23 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 70' ' ' THR . . . . . 0.43 ' OG1' ' NH2' ' B' ' 111' ' ' ARG . 6.9 t -81.88 80.08 8.26 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.153 -1.204 . . . . 0.0 109.759 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.438 ' HA ' ' HB3' ' B' ' 61' ' ' ASN . 79.4 tt0 -70.58 111.84 6.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.914 . . . . 0.0 110.858 -179.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -123.06 -165.07 1.26 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.36 -0.837 . . . . 0.0 109.52 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -137.7 130.18 29.56 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.348 -0.941 . . . . 0.0 110.588 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -131.03 83.45 2.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.266 -0.896 . . . . 0.0 109.747 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.66 88.03 0.09 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.124 -0.985 . . . . 0.0 110.74 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 76' ' ' VAL . . . . . 0.42 ' O ' HD11 ' B' ' 58' ' ' ILE . 5.9 p -134.55 141.45 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.518 -0.739 . . . . 0.0 109.864 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -157.24 89.53 2.51 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 120.733 -1.23 . . . . 0.0 110.833 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . 0.404 ' CB ' ' OD2' ' B' ' 102' ' ' ASP . 53.3 Cg_endo -77.65 -6.23 16.0 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 O-C-N 123.884 1.465 . . . . 0.0 112.165 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -142.55 -167.08 2.42 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.858 -1.151 . . . . 0.0 111.401 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.416 ' CB ' ' HD2' ' B' ' 81' ' ' PRO . 0.0 OUTLIER -139.66 172.39 6.49 Favored Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.382 -0.823 . . . . 0.0 109.758 179.77 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 81' ' ' PRO . . . . . 0.416 ' HD2' ' CB ' ' B' ' 80' ' ' GLN . 43.8 Cg_endo -67.09 147.27 79.21 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.789 1.415 . . . . 0.0 111.223 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . 0.458 ' N ' ' HA ' ' B' ' 25' ' ' PRO . . . 78.82 23.65 63.82 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 9.5 t -137.1 147.15 45.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.211 -1.17 . . . . 0.0 111.212 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . 0.476 HG12 ' O ' ' B' ' 21' ' ' GLY . 72.3 t -79.07 130.0 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.619 -0.676 . . . . 0.0 109.979 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -130.53 142.16 50.48 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.108 -0.995 . . . . 0.0 109.736 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 86' ' ' GLU . . . . . 0.4 ' O ' ' HG3' ' B' ' 86' ' ' GLU . 0.2 OUTLIER -120.15 127.14 52.21 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.512 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 76.8 t -121.63 131.93 71.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 119.142 -1.023 . . . . 0.0 111.063 -177.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 88' ' ' CYS . . . . . . . . . . . . . 12.7 t -96.85 117.87 32.05 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.485 -0.759 . . . . 0.0 109.525 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 70.7 mt -111.6 124.89 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.149 -0.969 . . . . 0.0 109.533 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 56.6 m -122.16 129.23 52.12 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.276 -0.89 . . . . 0.0 109.665 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 91' ' ' PHE . . . . . 0.466 ' CB ' HD12 ' B' ' 117' ' ' ILE . 72.3 t80 -106.62 117.98 35.47 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.209 -0.932 . . . . 0.0 110.891 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -115.27 151.76 33.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.686 -0.634 . . . . 0.0 109.465 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 69.6 tp60 -62.67 -38.84 91.93 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.933 -1.104 . . . . 0.0 110.488 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.29 -39.15 89.17 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.967 -1.083 . . . . 0.0 110.589 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -166.91 178.72 5.65 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.265 -0.897 . . . . 0.0 109.917 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 96' ' ' LEU . . . . . . . . . . . . . 46.7 tp -102.08 129.69 48.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.389 -0.82 . . . . 0.0 109.284 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 98.8 m -115.23 122.77 47.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.725 -1.234 . . . . 0.0 111.162 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 7.0 m -121.06 129.55 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.408 -0.807 . . . . 0.0 109.312 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -113.46 125.2 53.96 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.757 -1.214 . . . . 0.0 109.342 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 100' ' ' LEU . . . . . 0.44 HD12 ' N ' ' B' ' 100' ' ' LEU . 7.9 mp -85.52 165.0 37.97 Favored Pre-proline 0 C--N 1.302 -1.495 0 O-C-N 121.195 -0.94 . . . . 0.0 109.598 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -66.6 -32.81 37.88 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.991 1.521 . . . . 0.0 110.37 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 102' ' ' ASP . . . . . 0.404 ' OD2' ' CB ' ' B' ' 78' ' ' PRO . 99.6 m-20 -74.54 -25.21 59.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.999 -1.063 . . . . 0.0 110.156 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 121.22 2.77 10.86 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.53 -1.319 . . . . 0.0 111.057 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 104' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -83.67 136.01 34.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.581 -1.541 . . . . 0.0 110.123 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -132.58 148.72 52.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.452 -0.78 . . . . 0.0 110.949 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -141.08 156.51 45.98 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -124.1 141.1 52.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.007 -1.058 . . . . 0.0 110.93 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 108' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -123.58 143.76 42.48 Favored Pre-proline 0 N--CA 1.493 1.699 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -71.23 144.17 45.71 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 N-CA-C 109.14 -1.138 . . . . 0.0 109.14 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 110' ' ' ASN . . . . . 0.486 ' ND2' ' O ' ' B' ' 110' ' ' ASN . 6.1 p-10 -94.92 83.19 3.93 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.933 -1.104 . . . . 0.0 110.572 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . 0.43 ' NH2' ' OG1' ' B' ' 70' ' ' THR . 98.1 mtt180 -56.11 -22.23 26.95 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.704 -1.248 . . . . 0.0 109.08 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 56.5 mt -97.05 141.61 29.99 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -96.71 61.96 1.92 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.706 -1.246 . . . . 0.0 110.018 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 114' ' ' LEU . . . . . 0.406 ' CD1' ' HD2' ' B' ' 36' ' ' LYS . 64.3 tp -81.89 129.53 34.79 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.332 -0.855 . . . . 0.0 111.078 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.5 -17.4 30.38 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.407 -0.808 . . . . 0.0 109.746 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 116' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' B' ' 11' ' ' LEU . . . -163.05 144.29 9.72 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.76 -1.213 . . . . 0.0 111.765 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 117' ' ' ILE . . . . . 0.466 HD12 ' CB ' ' B' ' 91' ' ' PHE . 91.7 mt -98.92 124.5 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.37 -0.831 . . . . 0.0 108.908 178.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 118' ' ' ASN . . . . . 0.458 ' ND2' ' N ' ' B' ' 118' ' ' ASN . 0.1 OUTLIER -125.82 13.21 7.95 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.647 -0.658 . . . . 0.0 110.827 -179.319 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 119' ' ' TYR . . . . . 0.461 ' N ' ' O ' ' B' ' 35' ' ' GLY . 8.0 t80 -131.81 128.73 39.36 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.086 -1.009 . . . . 0.0 110.112 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 62.6 ttp -142.74 130.74 21.8 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.44 -0.788 . . . . 0.0 109.797 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -140.83 144.71 35.52 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.249 -0.907 . . . . 0.0 109.757 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -132.23 108.97 9.59 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.353 -0.842 . . . . 0.0 109.538 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -137.97 128.62 26.68 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.372 -0.83 . . . . 0.0 109.61 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 124' ' ' GLY . . . . . 0.406 ' HA3' ' HA ' ' B' ' 30' ' ' PHE . . . 154.79 -157.74 27.8 Favored Glycine 0 N--CA 1.483 1.794 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . 0.45 ' HB3' ' HA ' ' B' ' 27' ' ' ALA . 87.5 m-20 -78.55 0.02 27.84 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.405 -1.056 . . . . 0.0 110.495 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 126' ' ' PHE . . . . . 0.468 ' HB2' ' CD2' ' B' ' 30' ' ' PHE . 42.6 t80 -95.79 142.13 28.43 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.984 -1.073 . . . . 0.0 109.73 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -112.8 139.83 48.1 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 118.896 -1.121 . . . . 0.0 110.502 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . 0.415 HG23 HD21 ' B' ' 4' ' ' LEU . 20.6 tt -108.12 123.08 63.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.61 -0.681 . . . . 0.0 109.685 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -106.03 -23.33 12.66 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.403 -0.811 . . . . 0.0 111.028 -179.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 130' ' ' CYS . . . . . 0.441 ' HA ' ' O ' ' A' ' 131' ' ' VAL . 0.1 OUTLIER -153.05 155.32 36.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.95 -1.094 . . . . 0.0 112.177 -179.071 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 130' ' ' CYS . 44.3 t -123.93 136.02 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 132' ' ' ALA . . . . . . . . . . . . . . . -124.53 146.21 49.12 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.518 -1.363 . . . . 0.0 110.666 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . 0.478 ' CZ ' HD23 ' B' ' 11' ' ' LEU . 0.4 OUTLIER -94.08 -139.87 0.22 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.286 -0.884 . . . . 0.0 109.739 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 49.5 t0 . . . . . 0 N--CA 1.493 1.717 0 O-C-N 120.668 -1.27 . . . . 0.0 110.462 -179.6 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.409 ' O ' ' ND2' ' B' ' 8' ' ' ASN . . . . . . . . 0 N--CA 1.503 3.156 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 48.5 mt -97.9 128.2 44.34 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.946 -1.326 . . . . 0.0 109.265 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.9 t -96.37 135.36 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.106 -0.996 . . . . 0.0 109.741 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.429 ' CB ' HD13 ' A' ' 9' ' ' LEU . . . -124.36 145.03 49.69 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.241 -0.912 . . . . 0.0 111.083 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.407 ' O ' ' HB3' ' A' ' 8' ' ' ASN . 32.9 p -145.74 170.19 17.0 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' B' ' 3' ' ' GLY . 40.0 t-20 59.49 32.21 21.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.338 -0.851 . . . . 0.0 109.189 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.506 ' O ' ' C ' ' A' ' 10' ' ' ASN . 96.3 mt -90.7 2.73 55.7 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.65 -0.656 . . . . 0.0 111.834 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.506 ' C ' ' O ' ' A' ' 9' ' ' LEU . 36.3 t-20 -1.08 76.81 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.564 0 N-CA-C 113.723 1.008 . . . . 0.0 113.723 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.472 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 5.7 tt -92.37 130.89 37.93 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.062 -1.024 . . . . 0.0 109.376 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.451 ' O ' HD21 ' A' ' 11' ' ' LEU . 0.5 OUTLIER -100.43 165.79 13.78 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.266 -0.896 . . . . 0.0 111.189 -179.579 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.458 ' HA ' ' O ' ' A' ' 91' ' ' PHE . 52.0 Cg_endo -69.24 147.28 65.87 Favored 'Trans proline' 0 C--N 1.301 -1.94 0 O-C-N 124.165 1.613 . . . . 0.0 110.764 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.33 1.17 59.36 Favored Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.969 -1.11 . . . . 0.0 110.529 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -115.5 147.95 40.05 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.744 -1.445 . . . . 0.0 110.291 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.2 m -97.39 146.83 24.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.066 -1.021 . . . . 0.0 110.647 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.406 ' HB3' ' O ' ' A' ' 89' ' ' ILE . 52.7 tp -133.38 133.83 42.93 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.534 -0.729 . . . . 0.0 109.989 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 78.1 mtt85 -123.03 152.1 41.29 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.202 -0.936 . . . . 0.0 110.387 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 t -141.18 102.06 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 C-N-CA 119.939 -0.705 . . . . 0.0 110.671 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 -99.48 130.3 45.73 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.205 -0.935 . . . . 0.0 110.296 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.409 ' HA3' ' CZ ' ' A' ' 126' ' ' PHE . . . -144.12 -171.78 14.39 Favored Glycine 0 N--CA 1.496 2.645 0 C-N-CA 119.82 -1.181 . . . . 0.0 110.504 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -123.85 153.71 40.68 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.468 -1.019 . . . . 0.0 109.317 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 68.9 t -118.58 133.34 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.038 -1.039 . . . . 0.0 111.554 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.99 150.33 61.64 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 120.939 -1.101 . . . . 0.0 109.472 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.429 ' HA ' ' CA ' ' A' ' 82' ' ' GLY . 40.9 Cg_endo -66.43 -18.47 54.87 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.777 1.409 . . . . 0.0 111.309 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -125.01 28.86 6.29 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.977 -1.077 . . . . 0.0 108.811 178.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.473 ' CB ' ' HB3' ' A' ' 125' ' ' ASP . . . -62.67 105.64 0.68 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.287 0.565 . . . . 0.0 111.903 -178.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -64.49 -48.13 76.36 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.519 -0.738 . . . . 0.0 109.922 178.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 86.8 p -166.68 159.84 14.38 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.91 0.862 . . . . 0.0 111.535 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.511 ' CZ ' ' CG ' ' A' ' 47' ' ' PRO . 48.1 p90 -151.22 162.55 40.68 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.496 ' HA ' ' O ' ' A' ' 45' ' ' PHE . 2.2 p -139.81 138.02 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.444 -1.41 . . . . 0.0 112.688 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 90.3 mt -122.95 143.76 49.69 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -151.29 162.96 39.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.785 -1.197 . . . . 0.0 110.757 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.423 ' O ' ' CD1' ' A' ' 34' ' ' LEU . 3.8 pp -154.67 129.6 9.45 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.267 -0.895 . . . . 0.0 110.413 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.438 ' HA3' ' HA ' ' A' ' 41' ' ' LEU . . . -166.15 -153.65 7.84 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.406 ' O ' ' HB2' ' A' ' 119' ' ' TYR . 60.2 pttt -103.36 -30.42 10.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.061 -1.259 . . . . 0.0 110.146 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.481 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 21.9 t70 -143.84 167.8 21.45 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.232 -0.917 . . . . 0.0 110.466 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.5 t -51.27 -46.93 62.58 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.485 -0.759 . . . . 0.0 112.769 -177.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.422 ' HB3' ' N ' ' A' ' 66' ' ' GLY . 27.9 m-20 -91.12 -2.45 57.58 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.485 -1.384 . . . . 0.0 110.427 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.404 ' HB3' ' HE2' ' A' ' 36' ' ' LYS . 5.5 m-80 -110.41 56.16 0.63 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.111 -0.993 . . . . 0.0 110.51 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.481 ' CD2' ' O ' ' A' ' 37' ' ' ASP . 3.6 mm? -86.15 138.62 31.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.316 -0.865 . . . . 0.0 110.085 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.9 m -87.2 -28.14 22.58 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.3 -0.875 . . . . 0.0 110.244 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.5 tp -140.94 136.2 31.99 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 121.207 -0.933 . . . . 0.0 110.82 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.49 ' O ' ' HA ' ' A' ' 60' ' ' CYS . 19.9 m-70 -121.95 117.59 26.8 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.098 -1.001 . . . . 0.0 109.228 178.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.52 ' CE1' ' CG2' ' A' ' 58' ' ' ILE . 39.7 t80 -113.55 124.09 51.54 Favored 'General case' 0 C--N 1.293 -1.882 0 O-C-N 121.15 -0.969 . . . . 0.0 108.928 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -156.27 76.48 4.56 Favored Pre-proline 0 N--CA 1.497 1.925 0 O-C-N 120.843 -1.161 . . . . 0.0 111.005 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.563 ' HB3' HG12 ' A' ' 58' ' ' ILE . 56.2 Cg_endo -70.51 147.14 57.37 Favored 'Trans proline' 0 C--N 1.301 -1.96 0 O-C-N 124.256 1.661 . . . . 0.0 110.447 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -122.59 120.42 33.71 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.139 -0.976 . . . . 0.0 109.731 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -59.04 -49.28 78.49 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.843 -1.16 . . . . 0.0 108.011 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -145.8 95.73 2.69 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.26 -136.38 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.244 -0.91 . . . . 0.0 109.329 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 83.0 m-70 -62.04 -28.7 69.78 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 120.78 -1.2 . . . . 0.0 109.014 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 173.82 35.08 0.04 OUTLIER Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.668 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -113.42 -173.57 2.29 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.734 -1.45 . . . . 0.0 109.98 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.488 ' O ' ' C ' ' A' ' 56' ' ' ASN . . . -135.46 135.01 40.18 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.47 -0.769 . . . . 0.0 110.335 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.488 ' C ' ' O ' ' A' ' 55' ' ' ALA . 6.7 m120 18.55 65.79 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.288 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 20.1 m -102.36 115.11 29.88 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.186 -0.946 . . . . 0.0 108.847 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.563 HG12 ' HB3' ' A' ' 47' ' ' PRO . 52.4 mt -96.86 122.46 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.2 -0.937 . . . . 0.0 108.732 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.3 t -114.13 129.69 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.319 -0.863 . . . . 0.0 110.928 -177.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 44' ' ' HIS . 0.9 OUTLIER -107.11 126.39 52.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.378 -0.826 . . . . 0.0 109.899 179.237 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.443 ' O ' ' N ' ' A' ' 44' ' ' HIS . 2.6 t-20 -133.36 150.0 51.84 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.167 -0.958 . . . . 0.0 111.015 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.446 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 54.2 m -123.15 145.57 48.49 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.517 ' CD ' ' HA2' ' A' ' 66' ' ' GLY . 21.5 ttmt -135.45 144.36 46.41 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.688 -1.258 . . . . 0.0 111.22 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -120.84 97.75 5.69 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 69.3 20.15 74.89 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.517 ' HA2' ' CD ' ' A' ' 63' ' ' LYS . . . 79.06 23.78 62.96 Favored Glycine 0 N--CA 1.485 1.962 0 O-C-N 120.763 -1.434 . . . . 0.0 110.403 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.3 -80.31 0.2 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.92 -1.341 . . . . 0.0 111.979 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 2.4 m-90 -130.63 -145.11 0.27 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.173 -0.954 . . . . 0.0 110.67 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.446 ' HA2' ' O ' ' A' ' 62' ' ' SER . . . 164.35 143.61 3.77 Favored Glycine 0 N--CA 1.483 1.781 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 99.8 m -92.66 116.79 29.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.593 -0.946 . . . . 0.0 110.271 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -98.44 120.98 39.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.956 -1.09 . . . . 0.0 109.713 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.412 ' O ' ' CB ' ' A' ' 73' ' ' ARG . 1.0 OUTLIER -165.01 133.54 3.34 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.055 -1.028 . . . . 0.0 110.622 -179.716 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.412 ' CB ' ' O ' ' A' ' 72' ' ' GLN . 2.5 mtt-85 172.55 168.73 0.12 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.249 -0.907 . . . . 0.0 111.333 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -110.92 -179.92 3.87 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.367 -0.833 . . . . 0.0 109.975 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -101.61 100.81 11.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.169 -0.957 . . . . 0.0 109.618 178.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.453 HG11 HD11 ' A' ' 58' ' ' ILE . 2.6 p -125.06 134.1 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.097 -1.002 . . . . 0.0 110.121 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.499 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 12.5 p90 -140.52 87.07 11.9 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.029 -1.044 . . . . 0.0 111.951 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.407 ' HD3' HG22 ' A' ' 76' ' ' VAL . 51.5 Cg_endo -85.03 7.94 4.9 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 124.192 1.627 . . . . 0.0 110.498 178.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -144.48 178.01 8.25 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.268 -0.895 . . . . 0.0 110.291 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.422 ' CG ' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -143.08 172.44 5.68 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.438 -0.789 . . . . 0.0 109.794 179.427 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.422 ' HD2' ' CG ' ' A' ' 80' ' ' GLN . 44.8 Cg_endo -66.64 152.49 80.57 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.907 1.478 . . . . 0.0 110.684 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.429 ' CA ' ' HA ' ' A' ' 25' ' ' PRO . . . 73.6 22.67 78.18 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.239 -1.545 . . . . 0.0 109.239 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.8 m -138.0 149.46 46.1 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.199 -1.177 . . . . 0.0 111.087 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.7 m -76.46 138.91 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.603 -0.685 . . . . 0.0 110.466 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -146.0 144.22 29.96 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.083 -1.011 . . . . 0.0 110.473 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -123.96 146.42 48.5 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.207 -0.933 . . . . 0.0 110.414 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 53.7 t -130.42 131.2 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.332 -0.855 . . . . 0.0 110.27 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . 0.404 ' HB3' ' HB3' ' A' ' 99' ' ' LYS . 4.9 t -93.69 126.38 38.83 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.186 -0.946 . . . . 0.0 110.454 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.406 ' O ' ' HB3' ' A' ' 17' ' ' LEU . 97.4 mt -120.34 127.04 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.265 -0.897 . . . . 0.0 109.976 179.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 27.6 m -127.72 134.15 49.55 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.0 -1.063 . . . . 0.0 108.945 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.458 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 69.0 t80 -114.49 116.98 29.71 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.718 -1.239 . . . . 0.0 111.204 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -113.0 146.19 39.52 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 65.3 tp60 -56.1 -37.74 69.79 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.983 -1.073 . . . . 0.0 110.576 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.83 -43.38 68.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.013 -1.054 . . . . 0.0 111.291 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -155.18 179.22 9.36 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.993 -1.067 . . . . 0.0 110.852 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.456 ' HB3' ' HB2' ' A' ' 108' ' ' PHE . 53.4 tp -110.82 124.91 52.95 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.392 -0.817 . . . . 0.0 108.958 178.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.3 m -107.3 127.66 53.75 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.164 -0.96 . . . . 0.0 110.966 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 50.6 t -131.4 130.98 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.219 -0.926 . . . . 0.0 109.712 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.404 ' HB3' ' HB3' ' A' ' 88' ' ' CYS . 86.0 tttt -116.69 126.68 53.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.929 -1.107 . . . . 0.0 110.76 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.0 mt -76.17 160.64 77.64 Favored Pre-proline 0 C--N 1.303 -1.453 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -66.67 -24.19 48.14 Favored 'Trans proline' 0 C--N 1.302 -1.912 0 O-C-N 123.657 1.346 . . . . 0.0 110.289 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -155.99 73.67 0.83 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.354 -0.841 . . . . 0.0 110.134 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -178.91 -166.83 35.56 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.427 -1.368 . . . . 0.0 110.635 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -77.17 -165.5 0.58 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.489 -1.007 . . . . 0.0 110.671 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -129.07 159.41 36.05 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.313 -0.867 . . . . 0.0 110.821 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -132.25 153.13 50.94 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.256 -0.903 . . . . 0.0 110.921 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -129.05 146.51 51.0 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.778 0.799 . . . . 0.0 111.57 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.456 ' HB2' ' HB3' ' A' ' 96' ' ' LEU . 0.4 OUTLIER -118.19 140.42 27.99 Favored Pre-proline 0 C--N 1.302 -1.462 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.579 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -71.4 161.96 43.88 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 O-C-N 123.645 1.34 . . . . 0.0 110.615 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -71.81 59.04 0.33 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.488 -0.758 . . . . 0.0 111.404 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 15.6 tpt85 -62.99 -39.8 95.85 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.056 -1.027 . . . . 0.0 109.022 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 82.8 mt -105.9 124.26 49.28 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.681 -0.637 . . . . 0.0 109.533 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -86.71 69.71 10.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.916 -1.115 . . . . 0.0 109.803 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 35.5 tp -95.04 129.73 42.01 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.62 -0.675 . . . . 0.0 110.063 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -92.23 -13.11 30.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.234 -0.916 . . . . 0.0 110.553 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 11' ' ' LEU . . . -162.91 153.11 16.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.015 -1.053 . . . . 0.0 110.786 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 87.0 mt -109.48 128.1 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.997 -1.064 . . . . 0.0 110.663 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -120.52 -21.92 6.61 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.188 -0.945 . . . . 0.0 111.041 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.417 ' N ' ' O ' ' A' ' 35' ' ' GLY . 83.2 t80 -105.82 125.45 51.0 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.166 -0.959 . . . . 0.0 111.283 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 62.0 ttp -143.13 133.02 24.05 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.305 -0.872 . . . . 0.0 108.759 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -144.12 142.67 30.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.624 -1.297 . . . . 0.0 110.71 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -140.12 111.26 7.04 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.526 -0.734 . . . . 0.0 109.797 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.474 ' N ' ' OD1' ' A' ' 123' ' ' ASP . 26.5 p-10 -147.0 143.65 28.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.249 -0.907 . . . . 0.0 110.093 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 152.04 -157.08 27.05 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.473 ' HB3' ' CB ' ' A' ' 27' ' ' ALA . 87.1 m-20 -76.31 -1.16 25.29 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.283 -1.128 . . . . 0.0 110.141 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.409 ' CZ ' ' HA3' ' A' ' 21' ' ' GLY . 28.2 t80 -99.8 133.71 43.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.962 -1.086 . . . . 0.0 109.528 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -106.18 136.27 46.18 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.956 -1.09 . . . . 0.0 111.322 -178.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 15.0 tt -101.04 125.2 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.266 -0.896 . . . . 0.0 110.836 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -103.35 -18.58 14.79 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.268 -0.895 . . . . 0.0 111.655 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -159.31 149.88 19.44 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.402 -1.436 . . . . 0.0 113.258 -179.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 46.2 t -125.81 133.21 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 177.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -146.05 149.71 34.59 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.403 -1.436 . . . . 0.0 111.342 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -105.3 128.07 53.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.624 -0.673 . . . . 0.0 110.453 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 23.1 t0 . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.521 179.342 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.226 0.536 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 2' ' ' CYS . . . . . 0.452 ' HA ' ' HB2' ' B' ' 123' ' ' ASP . 1.3 m -90.05 56.9 3.59 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.224 -0.923 . . . . 0.0 110.653 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' GLY . . . . . 0.532 ' O ' ' ND2' ' A' ' 8' ' ' ASN . . . 32.43 -148.43 0.01 OUTLIER Glycine 0 N--CA 1.505 3.268 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 9' ' ' LEU . 49.2 mt -98.53 128.75 44.98 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.652 -1.499 . . . . 0.0 109.053 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 62.9 t -96.63 135.6 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.049 -1.032 . . . . 0.0 109.651 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' ALA . . . . . 0.433 ' CB ' HD13 ' B' ' 9' ' ' LEU . . . -124.7 145.2 49.81 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.184 -0.948 . . . . 0.0 111.023 -178.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' SER . . . . . 0.433 ' O ' ' HB3' ' B' ' 8' ' ' ASN . 33.2 p -145.9 170.38 16.71 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . 0.433 ' HB3' ' O ' ' B' ' 7' ' ' SER . 41.3 t-20 59.36 32.12 21.61 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.186 -0.946 . . . . 0.0 109.276 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . 0.521 ' O ' ' C ' ' B' ' 10' ' ' ASN . 96.6 mt -91.47 5.28 50.05 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.656 -0.653 . . . . 0.0 111.598 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' ASN . . . . . 0.521 ' C ' ' O ' ' B' ' 9' ' ' LEU . 37.3 t-20 -4.47 78.66 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.531 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.484 ' O ' ' HA ' ' B' ' 116' ' ' ALA . 5.8 tt -92.95 131.18 38.19 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.223 -0.923 . . . . 0.0 109.258 179.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . 0.444 ' O ' HD21 ' B' ' 11' ' ' LEU . 0.5 OUTLIER -100.76 165.51 14.17 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.249 -0.907 . . . . 0.0 111.182 -179.53 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . 0.456 ' HA ' ' O ' ' B' ' 91' ' ' PHE . 52.3 Cg_endo -68.96 147.31 67.71 Favored 'Trans proline' 0 C--N 1.301 -1.967 0 O-C-N 124.069 1.563 . . . . 0.0 110.736 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.37 0.89 59.4 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.979 -1.105 . . . . 0.0 110.729 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -115.33 147.86 39.96 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.852 -1.381 . . . . 0.0 110.277 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' CYS . . . . . . . . . . . . . 1.2 m -97.29 146.69 24.89 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.175 -0.953 . . . . 0.0 110.806 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.407 ' HB3' ' O ' ' B' ' 89' ' ' ILE . 53.3 tp -133.15 133.8 43.33 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.592 -0.693 . . . . 0.0 110.146 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 78.0 mtt85 -122.88 151.95 41.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.238 -0.913 . . . . 0.0 110.439 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 t -141.22 102.31 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.54 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -99.82 130.52 46.03 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.319 -0.863 . . . . 0.0 109.969 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . 0.409 ' HA3' ' CZ ' ' B' ' 126' ' ' PHE . . . -144.26 -171.75 14.46 Favored Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.884 -1.151 . . . . 0.0 110.495 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -124.08 153.74 40.97 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.492 -1.005 . . . . 0.0 109.336 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 69.9 t -118.59 133.34 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.908 -1.12 . . . . 0.0 111.422 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.98 150.51 60.64 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.025 -1.047 . . . . 0.0 109.517 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . 0.42 ' HA ' ' CA ' ' B' ' 82' ' ' GLY . 41.4 Cg_endo -66.83 -18.22 52.6 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.817 1.43 . . . . 0.0 111.374 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -125.17 29.29 6.13 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.0 -1.062 . . . . 0.0 108.671 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . 0.468 ' CB ' ' HB3' ' B' ' 125' ' ' ASP . . . -63.14 105.27 0.68 Allowed 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.353 0.597 . . . . 0.0 111.965 -178.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -64.08 -49.86 70.62 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.358 -0.838 . . . . 0.0 109.846 178.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 87.4 p -163.93 160.25 21.8 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.305 -0.872 . . . . 0.0 111.661 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' PHE . . . . . 0.518 ' CZ ' ' CG ' ' B' ' 47' ' ' PRO . 47.9 p90 -151.64 161.75 42.15 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' B' ' 45' ' ' PHE . 2.2 p -139.06 138.69 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.375 -1.453 . . . . 0.0 112.787 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.413 HD22 ' HB2' ' B' ' 122' ' ' ALA . 89.4 mt -123.86 143.44 50.35 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.467 -0.771 . . . . 0.0 108.925 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -151.14 163.14 39.5 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.83 -1.168 . . . . 0.0 110.709 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.45 ' O ' ' CD1' ' B' ' 34' ' ' LEU . 3.8 pp -154.78 126.32 7.44 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.205 -0.934 . . . . 0.0 110.767 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . 0.428 ' HA3' ' HA ' ' B' ' 41' ' ' LEU . . . -160.98 -152.43 6.6 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . 0.413 ' HE2' ' HB3' ' B' ' 40' ' ' ASN . 60.4 pttt -104.08 -30.58 10.15 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.389 -1.065 . . . . 0.0 109.702 178.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . 0.477 ' O ' ' CD2' ' B' ' 41' ' ' LEU . 22.4 t70 -143.98 167.68 21.79 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.248 -0.907 . . . . 0.0 110.52 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 5.7 t -51.37 -46.34 62.72 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.389 -0.819 . . . . 0.0 112.808 -177.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' ASN . . . . . 0.433 ' HB3' ' N ' ' B' ' 66' ' ' GLY . 28.0 m-20 -91.79 -2.66 56.82 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.503 -1.373 . . . . 0.0 110.209 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' ASN . . . . . 0.413 ' HB3' ' HE2' ' B' ' 36' ' ' LYS . 5.7 m-80 -110.15 56.06 0.63 Allowed 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.241 -0.912 . . . . 0.0 110.41 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.477 ' CD2' ' O ' ' B' ' 37' ' ' ASP . 3.6 mm? -85.76 139.84 30.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.304 -0.873 . . . . 0.0 110.105 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' CYS . . . . . . . . . . . . . 1.7 m -89.63 -27.01 20.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 109.895 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 14.4 tp -141.44 135.82 30.69 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 121.188 -0.945 . . . . 0.0 110.812 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' HIS . . . . . 0.481 ' O ' ' HA ' ' B' ' 60' ' ' CYS . 20.4 m-70 -121.66 117.49 26.8 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.13 -0.981 . . . . 0.0 109.284 178.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.518 ' CE1' ' CG2' ' B' ' 58' ' ' ILE . 39.6 t80 -113.66 122.62 47.73 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.07 -1.019 . . . . 0.0 109.086 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -154.41 76.83 5.52 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 120.955 -1.09 . . . . 0.0 111.104 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' PRO . . . . . 0.543 ' HB3' HG12 ' B' ' 58' ' ' ILE . 55.4 Cg_endo -70.69 147.1 56.13 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 124.119 1.589 . . . . 0.0 110.427 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -122.55 120.59 34.27 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.144 -0.972 . . . . 0.0 109.809 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -59.27 -48.61 80.97 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.92 -1.113 . . . . 0.0 108.199 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -146.69 95.48 2.6 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.46 -136.91 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.447 -0.783 . . . . 0.0 109.097 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -61.75 -26.87 68.33 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.668 -1.27 . . . . 0.0 109.272 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 171.14 35.77 0.03 OUTLIER Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.642 -1.266 . . . . 0.0 110.563 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -113.94 -173.65 2.32 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.836 -1.391 . . . . 0.0 109.79 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.505 ' O ' ' C ' ' B' ' 56' ' ' ASN . . . -134.75 138.51 44.4 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.427 -0.796 . . . . 0.0 109.827 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' ASN . . . . . 0.505 ' C ' ' O ' ' B' ' 55' ' ' ALA . 6.5 m120 13.29 68.09 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.233 0 CA-C-O 121.535 0.683 . . . . 0.0 112.834 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 19.6 m -102.99 114.88 29.54 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.443 -0.786 . . . . 0.0 108.928 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' ILE . . . . . 0.543 HG12 ' HB3' ' B' ' 47' ' ' PRO . 52.0 mt -96.84 122.52 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.111 -0.993 . . . . 0.0 108.729 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 56.0 t -113.82 130.0 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.383 -0.823 . . . . 0.0 111.105 -178.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' CYS . . . . . 0.481 ' HA ' ' O ' ' B' ' 44' ' ' HIS . 0.8 OUTLIER -107.77 125.16 51.07 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.295 -0.878 . . . . 0.0 109.939 179.262 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' ASN . . . . . 0.443 ' O ' ' N ' ' B' ' 44' ' ' HIS . 2.8 t-20 -132.06 149.86 52.3 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.189 -0.944 . . . . 0.0 111.109 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' SER . . . . . 0.443 ' O ' ' HA2' ' B' ' 69' ' ' GLY . 54.4 m -123.02 145.52 48.44 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.153 -0.967 . . . . 0.0 108.532 179.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . 0.51 ' CD ' ' HA2' ' B' ' 66' ' ' GLY . 21.4 ttmt -135.12 144.87 47.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.655 -1.278 . . . . 0.0 111.092 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -121.17 97.81 5.69 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 69.32 20.05 74.82 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . 0.51 ' HA2' ' CD ' ' B' ' 63' ' ' LYS . . . 79.38 23.56 62.72 Favored Glycine 0 N--CA 1.487 2.064 0 C-N-CA 119.278 -1.439 . . . . 0.0 110.337 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.27 -80.33 0.2 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.875 -1.368 . . . . 0.0 111.867 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' TRP . . . . . . . . . . . . . 2.4 m-90 -130.54 -144.97 0.27 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.22 -0.925 . . . . 0.0 110.711 -178.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' B' ' 62' ' ' SER . . . 164.05 143.26 3.65 Favored Glycine 0 N--CA 1.483 1.828 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 99.6 m -92.25 117.46 29.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.567 -0.96 . . . . 0.0 110.326 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -98.97 120.91 40.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.013 -1.055 . . . . 0.0 109.646 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -165.04 133.53 3.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.997 -1.065 . . . . 0.0 110.551 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 2.5 mtt-85 172.73 169.11 0.12 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.34 -0.85 . . . . 0.0 111.246 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -111.06 180.0 3.89 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.38 -0.825 . . . . 0.0 109.942 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -101.44 100.6 11.08 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.078 -1.014 . . . . 0.0 109.683 178.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 76' ' ' VAL . . . . . 0.45 HG11 HD11 ' B' ' 58' ' ' ILE . 2.6 p -124.76 134.15 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.983 -1.073 . . . . 0.0 110.127 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 77' ' ' PHE . . . . . 0.506 ' N ' ' CD1' ' B' ' 77' ' ' PHE . 11.9 p90 -140.4 87.26 11.98 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 120.942 -1.099 . . . . 0.0 111.782 -179.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . 0.412 ' HD3' HG22 ' B' ' 76' ' ' VAL . 50.3 Cg_endo -85.15 7.56 5.08 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 124.136 1.598 . . . . 0.0 110.427 178.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -144.01 178.18 8.04 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.216 -0.927 . . . . 0.0 110.488 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.414 ' CG ' ' HD2' ' B' ' 81' ' ' PRO . 0.0 OUTLIER -143.09 172.38 5.75 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.351 -0.843 . . . . 0.0 109.792 179.597 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 81' ' ' PRO . . . . . 0.414 ' HD2' ' CG ' ' B' ' 80' ' ' GLN . 44.0 Cg_endo -66.59 152.85 79.87 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.771 1.406 . . . . 0.0 110.764 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . 0.42 ' CA ' ' HA ' ' B' ' 25' ' ' PRO . . . 73.22 22.68 78.66 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 66.1 m -138.06 149.01 45.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.095 -1.238 . . . . 0.0 111.16 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 33.5 m -76.06 139.15 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.663 -0.648 . . . . 0.0 110.614 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -146.32 143.93 29.46 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.055 -1.028 . . . . 0.0 110.431 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -123.69 146.83 47.96 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.228 -0.92 . . . . 0.0 110.445 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 54.4 t -130.78 131.19 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.394 -0.816 . . . . 0.0 110.049 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 88' ' ' CYS . . . . . . . . . . . . . 4.5 t -93.79 126.64 39.09 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.168 -0.957 . . . . 0.0 110.404 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.439 HD13 HG21 ' B' ' 89' ' ' ILE . 97.2 mt -120.55 127.11 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.137 -0.977 . . . . 0.0 110.019 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 27.5 m -127.85 134.15 49.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.081 -1.012 . . . . 0.0 109.001 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 91' ' ' PHE . . . . . 0.456 ' O ' ' HA ' ' B' ' 13' ' ' PRO . 70.6 t80 -114.49 116.47 28.9 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 118.813 -1.155 . . . . 0.0 111.491 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -112.92 146.28 39.26 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 65.0 tp60 -56.24 -37.74 70.13 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 120.896 -1.128 . . . . 0.0 110.546 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.48 -43.45 69.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.157 -0.965 . . . . 0.0 111.348 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -155.53 178.91 9.71 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.075 -1.016 . . . . 0.0 110.744 -178.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 96' ' ' LEU . . . . . 0.439 ' HB3' ' HB2' ' B' ' 108' ' ' PHE . 53.5 tp -110.26 124.76 52.21 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.313 -0.867 . . . . 0.0 109.159 178.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 2.9 m -107.34 127.35 53.49 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.157 -0.964 . . . . 0.0 110.938 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 50.1 t -131.26 130.79 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -0.909 . . . . 0.0 109.81 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -116.58 126.15 52.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.874 -1.141 . . . . 0.0 111.093 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 4.0 mt -75.46 160.35 79.78 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.392 -0.818 . . . . 0.0 108.849 178.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -66.59 -24.35 48.55 Favored 'Trans proline' 0 C--N 1.302 -1.908 0 O-C-N 123.701 1.369 . . . . 0.0 110.217 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -155.81 75.39 0.9 Allowed 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.336 -0.852 . . . . 0.0 110.177 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 178.54 -167.12 37.41 Favored Glycine 0 N--CA 1.495 2.619 0 C-N-CA 119.407 -1.378 . . . . 0.0 110.548 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 104' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -77.0 -165.4 0.55 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.476 -1.014 . . . . 0.0 110.958 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 69.4 tt0 -129.53 159.03 37.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.348 -0.845 . . . . 0.0 110.527 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -132.03 153.19 50.63 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.476 -0.765 . . . . 0.0 110.936 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -129.2 146.73 51.06 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.354 -0.841 . . . . 0.0 111.537 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 108' ' ' PHE . . . . . 0.439 ' HB2' ' HB3' ' B' ' 96' ' ' LEU . 0.4 OUTLIER -118.29 140.34 27.96 Favored Pre-proline 0 C--N 1.301 -1.537 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.669 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -71.51 162.19 43.05 Favored 'Trans proline' 0 C--N 1.301 -1.938 0 O-C-N 123.575 1.303 . . . . 0.0 110.574 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 110' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -72.0 59.29 0.37 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.559 -0.713 . . . . 0.0 111.266 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 15.3 tpt85 -63.34 -39.58 94.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.099 -1.0 . . . . 0.0 109.015 178.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 81.2 mt -105.91 124.34 49.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.69 -0.631 . . . . 0.0 109.551 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -86.77 69.88 10.34 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.918 -1.114 . . . . 0.0 109.743 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 36.5 tp -95.09 129.75 42.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.626 -0.671 . . . . 0.0 110.079 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -92.25 -12.92 31.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.18 -0.95 . . . . 0.0 110.7 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 116' ' ' ALA . . . . . 0.484 ' HA ' ' O ' ' B' ' 11' ' ' LEU . . . -162.97 153.44 16.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.016 -1.052 . . . . 0.0 110.626 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 117' ' ' ILE . . . . . 0.405 ' HB ' ' HB3' ' B' ' 11' ' ' LEU . 89.4 mt -109.92 128.08 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.072 -1.018 . . . . 0.0 110.707 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -120.36 -21.8 6.75 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.18 -0.95 . . . . 0.0 111.121 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 119' ' ' TYR . . . . . 0.406 ' N ' ' O ' ' B' ' 35' ' ' GLY . 83.2 t80 -106.09 125.75 51.37 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.032 -1.042 . . . . 0.0 111.18 -179.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 61.5 ttp -143.41 133.04 23.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.352 -0.843 . . . . 0.0 108.728 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -144.28 142.91 30.75 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.65 -1.281 . . . . 0.0 110.686 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 122' ' ' ALA . . . . . 0.417 ' O ' ' HA3' ' B' ' 3' ' ' GLY . . . -140.48 111.27 6.91 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.566 -0.709 . . . . 0.0 109.701 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 123' ' ' ASP . . . . . 0.465 ' N ' ' OD1' ' B' ' 123' ' ' ASP . 26.3 p-10 -147.42 142.59 27.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.389 -0.82 . . . . 0.0 109.894 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 153.48 -157.22 27.25 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.821 -1.711 . . . . 0.0 108.821 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . 0.468 ' HB3' ' CB ' ' B' ' 27' ' ' ALA . 86.9 m-20 -76.35 -0.94 24.45 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.263 -1.139 . . . . 0.0 110.161 179.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 126' ' ' PHE . . . . . 0.409 ' CZ ' ' HA3' ' B' ' 21' ' ' GLY . 28.2 t80 -100.03 133.7 44.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.005 -1.059 . . . . 0.0 109.473 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -106.27 135.88 46.97 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.976 -1.078 . . . . 0.0 111.307 -178.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 14.9 tt -100.47 125.61 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.267 -0.896 . . . . 0.0 110.877 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -103.43 -19.99 14.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.151 -0.968 . . . . 0.0 111.624 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 130' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -156.87 150.25 24.24 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.345 -1.472 . . . . 0.0 113.456 -179.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 46.3 t -125.81 133.37 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 177.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 132' ' ' ALA . . . . . . . . . . . . . . . -146.13 149.72 34.55 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.278 -1.514 . . . . 0.0 111.13 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -105.52 128.01 53.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.587 -0.696 . . . . 0.0 110.441 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 23.0 t0 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.755 179.346 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 122' ' ' ALA . . . . . . . . 0 N--CA 1.493 2.464 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.1 pp -67.7 156.4 37.01 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.264 -1.139 . . . . 0.0 111.615 -178.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.4 t -118.63 132.73 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -110.04 178.98 4.24 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.871 -1.143 . . . . 0.0 110.985 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.408 ' O ' ' HB3' ' A' ' 8' ' ' ASN . 27.7 p -155.95 171.08 20.69 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.417 ' HB3' ' HA ' ' B' ' 4' ' ' LEU . 63.6 t30 58.25 35.88 25.27 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.288 -0.882 . . . . 0.0 110.545 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.505 ' O ' ' C ' ' A' ' 10' ' ' ASN . 78.5 mt -87.29 -5.61 58.85 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.488 -0.757 . . . . 0.0 111.156 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.505 ' C ' ' O ' ' A' ' 9' ' ' LEU . 4.9 m120 6.34 66.33 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.748 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.412 ' N ' ' O ' ' A' ' 9' ' ' LEU . 11.2 mt -93.07 129.05 39.15 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.048 -1.033 . . . . 0.0 110.514 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.425 ' CB ' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -98.79 171.74 5.45 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.295 -0.878 . . . . 0.0 110.783 -179.971 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.425 ' HD2' ' CB ' ' A' ' 12' ' ' LYS . 39.4 Cg_endo -65.17 148.13 88.77 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.221 1.643 . . . . 0.0 109.378 178.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.8 -16.01 54.98 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -111.35 142.09 44.04 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.177 -1.19 . . . . 0.0 109.699 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 58.2 m -109.77 153.19 24.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.196 -0.94 . . . . 0.0 110.181 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 57.5 tp -118.28 130.7 56.2 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.221 -0.924 . . . . 0.0 110.349 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -110.99 125.75 54.05 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.577 -0.702 . . . . 0.0 109.489 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 74.0 t -121.16 123.29 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.92 -1.113 . . . . 0.0 110.158 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -123.56 128.44 49.73 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.215 -0.928 . . . . 0.0 109.645 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -146.86 -152.83 5.74 Favored Glycine 0 N--CA 1.489 2.226 0 C-N-CA 119.292 -1.433 . . . . 0.0 110.292 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -136.5 142.34 43.51 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.656 -0.908 . . . . 0.0 109.467 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.452 ' CG1' ' HA ' ' A' ' 81' ' ' PRO . 34.8 t -108.48 132.98 54.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 O-C-N 121.334 -0.854 . . . . 0.0 111.131 -178.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.92 152.57 96.73 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.528 -0.732 . . . . 0.0 109.871 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -65.79 -28.3 51.4 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 123.955 1.503 . . . . 0.0 110.631 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -97.34 16.15 20.89 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.267 -0.895 . . . . 0.0 109.945 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.481 ' HA ' ' HB3' ' A' ' 125' ' ' ASP . . . -61.75 98.76 0.1 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.107 -0.996 . . . . 0.0 110.874 -179.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -95.04 -15.61 23.33 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.513 -0.742 . . . . 0.0 110.682 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 42.1 t -167.38 142.25 3.88 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 118.725 -1.19 . . . . 0.0 111.454 -178.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.504 ' CE2' ' HB2' ' A' ' 32' ' ' LEU . 10.6 t80 -149.34 157.63 43.49 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.429 -0.794 . . . . 0.0 109.993 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.405 ' CG1' ' O ' ' A' ' 123' ' ' ASP . 2.5 p -129.09 131.16 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.909 -1.119 . . . . 0.0 110.837 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.504 ' HB2' ' CE2' ' A' ' 30' ' ' PHE . 12.7 tp -131.42 129.68 41.57 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.61 -0.681 . . . . 0.0 109.165 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -161.24 153.19 19.64 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.433 -1.417 . . . . 0.0 111.027 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 120' ' ' MET . 0.4 OUTLIER -143.61 128.09 17.96 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.673 0.749 . . . . 0.0 109.656 179.261 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.426 ' HA3' ' HA ' ' A' ' 41' ' ' LEU . . . -163.79 -160.38 11.67 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.47 ' O ' ' CD1' ' A' ' 119' ' ' TYR . 40.3 mtpt -67.45 -42.17 83.51 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 122.394 1.092 . . . . 0.0 108.212 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -157.45 -168.93 2.73 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.73 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.2 t -62.36 -42.8 99.69 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.781 -0.575 . . . . 0.0 112.296 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.451 ' HB3' ' N ' ' A' ' 66' ' ' GLY . 92.9 m-20 -87.06 -14.5 41.29 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.867 -1.146 . . . . 0.0 110.786 -178.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.411 ' HB2' ' HB2' ' A' ' 36' ' ' LYS . 5.6 m-80 -113.21 70.02 0.71 Allowed 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.867 0.841 . . . . 0.0 108.82 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.426 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 72.5 mt -100.72 139.09 36.89 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -83.96 -25.66 29.87 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.944 -1.097 . . . . 0.0 110.723 -179.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.436 HD12 ' CD2' ' A' ' 34' ' ' LEU . 2.8 pp -155.71 136.29 13.33 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.265 -0.897 . . . . 0.0 110.216 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.447 ' HB3' ' O ' ' A' ' 61' ' ' ASN . 38.6 t60 -133.27 121.46 22.49 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.48 -0.763 . . . . 0.0 109.786 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -115.5 133.69 55.8 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.077 -1.015 . . . . 0.0 110.487 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -137.75 78.1 37.35 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 120.999 -1.063 . . . . 0.0 110.393 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -67.15 142.41 61.05 Favored 'Trans proline' 0 C--N 1.302 -1.88 0 O-C-N 123.865 1.455 . . . . 0.0 109.978 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -128.03 122.5 32.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.115 -0.991 . . . . 0.0 110.189 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -60.23 -46.74 88.72 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 118.605 -1.238 . . . . 0.0 108.403 178.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -147.53 102.15 3.42 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.617 -0.677 . . . . 0.0 110.017 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -84.97 -144.03 0.09 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.301 -0.875 . . . . 0.0 108.977 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -50.14 -29.4 9.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.102 -0.999 . . . . 0.0 109.373 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 170.48 38.64 0.03 OUTLIER Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -112.24 -172.52 2.06 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.035 -1.273 . . . . 0.0 109.917 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.466 ' O ' ' C ' ' A' ' 56' ' ' ASN . . . -139.79 137.19 34.82 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.181 -0.949 . . . . 0.0 110.596 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.466 ' C ' ' O ' ' A' ' 55' ' ' ALA . 92.4 m-20 24.79 60.67 0.05 Allowed 'General case' 0 N--CA 1.509 2.507 0 CA-C-O 121.412 0.625 . . . . 0.0 112.208 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 8.8 m -113.05 141.39 46.93 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.323 -0.86 . . . . 0.0 109.862 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.453 ' CG2' ' HB2' ' A' ' 74' ' ' GLU . 18.9 tt -136.75 138.85 45.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.211 -0.931 . . . . 0.0 110.318 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 55.4 t -119.57 127.2 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.302 -0.874 . . . . 0.0 110.312 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 47.9 t -96.08 126.94 41.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.368 -0.833 . . . . 0.0 110.337 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.447 ' O ' ' HB3' ' A' ' 44' ' ' HIS . 23.8 t-20 -136.34 148.78 48.07 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.408 -0.807 . . . . 0.0 110.295 -179.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.422 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 71.1 m -125.3 150.45 47.11 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.805 -1.184 . . . . 0.0 108.948 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.466 ' CD ' ' HA2' ' A' ' 66' ' ' GLY . 19.0 ttmt -138.63 148.25 43.85 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.672 -1.268 . . . . 0.0 111.718 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -120.97 97.48 5.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.675 -0.64 . . . . 0.0 110.44 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.99 24.11 73.02 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.466 ' HA2' ' CD ' ' A' ' 63' ' ' LYS . . . 75.07 25.12 69.72 Favored Glycine 0 N--CA 1.48 1.606 0 C-N-CA 119.137 -1.506 . . . . 0.0 110.515 178.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -87.08 -81.02 0.24 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.988 -1.301 . . . . 0.0 110.649 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.428 ' O ' ' HG3' ' A' ' 63' ' ' LYS . 41.3 m95 -124.08 -156.59 0.72 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.075 -1.016 . . . . 0.0 110.445 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 62' ' ' SER . . . 163.86 114.9 0.31 Allowed Glycine 0 N--CA 1.487 2.05 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.6 m -80.65 121.5 25.93 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.541 -0.976 . . . . 0.0 110.412 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -91.27 129.19 37.29 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.175 -0.953 . . . . 0.0 110.913 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -112.26 -172.36 2.03 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.12 -0.988 . . . . 0.0 109.358 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -147.79 126.31 12.44 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 118.416 -1.314 . . . . 0.0 112.437 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.453 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 95.8 mt-10 -115.47 145.59 42.45 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -119.49 48.62 1.48 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.769 -1.207 . . . . 0.0 109.093 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.3 m -119.39 132.39 69.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.426 -0.796 . . . . 0.0 110.931 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -161.51 80.16 2.06 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.392 -0.818 . . . . 0.0 109.57 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -81.17 8.3 4.44 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 124.163 1.612 . . . . 0.0 111.37 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -132.14 179.12 6.3 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.937 -1.102 . . . . 0.0 110.212 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.432 ' HB3' ' HD2' ' A' ' 81' ' ' PRO . 0.7 OUTLIER -144.16 177.23 1.87 Allowed Pre-proline 0 C--N 1.296 -1.741 0 O-C-N 121.545 -0.722 . . . . 0.0 109.221 -179.222 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.452 ' HA ' ' CG1' ' A' ' 23' ' ' VAL . 50.3 Cg_endo -71.26 157.29 57.46 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.531 1.279 . . . . 0.0 109.748 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 68.7 26.93 74.2 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.879 -1.688 . . . . 0.0 108.879 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.0 m -133.76 151.99 51.75 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.466 -1.02 . . . . 0.0 110.068 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 69.4 t -95.53 129.63 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.254 -0.903 . . . . 0.0 110.236 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -149.5 147.1 27.81 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.272 -0.893 . . . . 0.0 110.516 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -122.33 142.87 50.04 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.227 -0.921 . . . . 0.0 109.451 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 39.8 t -127.54 132.64 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.061 -1.024 . . . . 0.0 111.131 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -95.26 140.19 30.51 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.316 -0.865 . . . . 0.0 111.205 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.6 mt -124.64 128.58 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.612 -0.68 . . . . 0.0 110.417 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.503 ' HB ' ' HB ' ' A' ' 97' ' ' THR . 52.5 m -121.98 128.81 51.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.167 -0.958 . . . . 0.0 109.859 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -109.3 117.89 35.25 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.216 -0.928 . . . . 0.0 111.087 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -125.29 150.56 46.99 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.509 -0.744 . . . . 0.0 110.418 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.443 ' NE2' ' O ' ' A' ' 114' ' ' LEU . 75.8 mm-40 -62.52 -37.94 88.02 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.349 -0.844 . . . . 0.0 110.252 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.01 -40.84 95.51 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.211 -0.931 . . . . 0.0 110.113 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.437 ' C ' ' OD1' ' A' ' 95' ' ' ASN . 11.0 p30 -169.02 -171.67 1.38 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.378 -0.826 . . . . 0.0 110.521 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 20.3 tp -112.12 132.87 54.61 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.409 -0.807 . . . . 0.0 109.599 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.503 ' HB ' ' HB ' ' A' ' 90' ' ' THR . 23.2 m -117.14 126.44 52.82 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.871 -1.143 . . . . 0.0 110.94 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 41.2 t -123.21 129.82 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.181 -0.949 . . . . 0.0 109.674 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -115.36 126.93 55.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.169 -0.957 . . . . 0.0 110.735 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.8 mp -100.34 164.55 16.09 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.581 -0.7 . . . . 0.0 109.833 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -64.91 -24.01 61.26 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.732 1.385 . . . . 0.0 110.371 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -77.37 -14.59 59.68 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.243 -0.911 . . . . 0.0 110.478 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.96 -13.2 59.08 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -70.93 135.32 47.87 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.922 -1.34 . . . . 0.0 109.977 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -124.66 138.7 54.29 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.437 -0.79 . . . . 0.0 110.175 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -126.43 134.46 50.98 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.093 -1.004 . . . . 0.0 109.636 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -112.83 145.06 41.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.069 -1.02 . . . . 0.0 111.049 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.52 ' CE2' ' O ' ' A' ' 109' ' ' PRO . 3.1 t80 -134.23 136.95 26.96 Favored Pre-proline 0 C--N 1.301 -1.521 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.52 ' O ' ' CE2' ' A' ' 108' ' ' PHE . 38.5 Cg_endo -64.18 133.98 40.44 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.642 1.338 . . . . 0.0 110.643 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.454 ' ND2' ' O ' ' A' ' 110' ' ' ASN . 6.2 p-10 -85.98 83.58 7.75 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.202 -0.936 . . . . 0.0 110.397 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -55.92 -20.8 17.4 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.937 -1.102 . . . . 0.0 109.657 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 97.5 mt -101.97 133.3 46.98 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.225 -0.922 . . . . 0.0 109.92 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -88.71 67.29 8.33 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.242 -0.911 . . . . 0.0 110.887 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.443 ' O ' ' NE2' ' A' ' 93' ' ' GLN . 33.8 tp -87.38 120.45 28.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.232 -0.917 . . . . 0.0 109.368 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -82.84 -13.73 55.63 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.678 -1.264 . . . . 0.0 110.469 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -157.59 157.54 33.88 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.806 -1.184 . . . . 0.0 111.267 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.42 HD13 HD13 ' A' ' 34' ' ' LEU . 95.1 mt -108.57 126.81 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.45 -0.781 . . . . 0.0 109.607 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -111.17 -27.74 8.58 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.998 -1.064 . . . . 0.0 111.255 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.47 ' CD1' ' O ' ' A' ' 36' ' ' LYS . 3.0 m-85 -117.15 140.86 49.0 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.935 -1.103 . . . . 0.0 112.503 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.449 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 54.8 ttp -138.76 129.64 26.52 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -136.61 136.42 39.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.398 -1.439 . . . . 0.0 111.097 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.445 ' O ' ' HA3' ' A' ' 3' ' ' GLY . . . -149.5 116.34 5.94 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.405 ' O ' ' CG1' ' A' ' 31' ' ' VAL . 65.8 t0 -147.02 118.67 8.0 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.611 -0.681 . . . . 0.0 109.384 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 179.62 -151.72 10.34 Favored Glycine 0 N--CA 1.489 2.206 0 C-N-CA 119.612 -1.28 . . . . 0.0 110.385 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.481 ' HB3' ' HA ' ' A' ' 27' ' ' ALA . 99.6 m-20 -74.46 -2.82 27.23 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.96 -0.729 . . . . 0.0 111.122 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.476 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 24.8 t80 -96.62 137.79 35.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.997 -1.064 . . . . 0.0 110.334 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -110.75 120.53 42.72 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 118.43 -1.308 . . . . 0.0 111.098 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.409 ' O ' HG22 ' A' ' 128' ' ' ILE . 7.6 tt -101.37 114.26 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.223 -0.923 . . . . 0.0 110.242 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -97.85 -13.58 21.21 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 120.904 -1.122 . . . . 0.0 110.999 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -147.92 148.41 30.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.748 -1.22 . . . . 0.0 112.59 -179.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 52.6 t -133.42 131.33 57.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -127.99 146.71 50.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.628 -1.295 . . . . 0.0 110.785 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -109.24 127.65 54.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.567 -0.708 . . . . 0.0 110.106 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 59.5 t0 . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 117.948 -1.025 . . . . 0.0 111.123 179.249 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.813 0 CA-C-O 120.849 0.357 . . . . 0.0 110.687 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 2' ' ' CYS . . . . . 0.452 ' O ' ' O ' ' B' ' 126' ' ' PHE . 99.1 m -141.64 -123.78 0.1 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.812 -1.18 . . . . 0.0 109.91 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 3' ' ' GLY . . . . . 0.446 ' HA3' ' O ' ' B' ' 122' ' ' ALA . . . 176.28 121.56 0.67 Allowed Glycine 0 N--CA 1.494 2.534 0 N-CA-C 108.679 -1.768 . . . . 0.0 108.679 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . 0.417 ' HA ' ' HB3' ' A' ' 8' ' ' ASN . 1.2 pp -68.22 156.6 37.26 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.233 -1.157 . . . . 0.0 111.49 -178.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 45.5 t -118.84 132.59 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.706 -0.621 . . . . 0.0 109.399 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -110.09 178.57 4.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.738 -1.226 . . . . 0.0 111.26 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' SER . . . . . 0.438 ' O ' ' HB3' ' B' ' 8' ' ' ASN . 26.3 p -155.45 170.9 20.88 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . 0.438 ' HB3' ' O ' ' B' ' 7' ' ' SER . 63.5 t30 59.16 35.2 23.58 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.366 -0.834 . . . . 0.0 110.539 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . 0.505 ' O ' ' C ' ' B' ' 10' ' ' ASN . 81.1 mt -88.1 -1.58 58.09 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.29 -0.881 . . . . 0.0 111.306 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' ASN . . . . . 0.505 ' C ' ' O ' ' B' ' 9' ' ' LEU . 4.7 m120 -0.05 69.38 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.751 0 N-CA-C 113.874 1.065 . . . . 0.0 113.874 -178.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.456 ' N ' ' O ' ' B' ' 9' ' ' LEU . 11.1 mt -93.81 128.65 40.17 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.312 -0.867 . . . . 0.0 110.442 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . 0.41 ' CB ' ' HD2' ' B' ' 13' ' ' PRO . 0.0 OUTLIER -98.68 171.73 5.47 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.285 -0.885 . . . . 0.0 110.872 -179.786 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . 0.41 ' HD2' ' CB ' ' B' ' 12' ' ' LYS . 40.7 Cg_endo -65.34 147.99 87.97 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.242 1.654 . . . . 0.0 109.501 178.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.11 -16.25 54.0 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -111.17 142.06 43.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.065 -1.256 . . . . 0.0 109.951 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' CYS . . . . . . . . . . . . . 57.7 m -109.46 153.75 23.61 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.162 -0.961 . . . . 0.0 110.277 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 56.6 tp -118.68 130.8 56.04 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.245 -0.91 . . . . 0.0 110.366 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -111.05 125.87 54.21 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.553 -0.717 . . . . 0.0 109.483 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 79.1 t -121.06 122.61 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.946 -1.096 . . . . 0.0 110.253 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -123.02 128.62 50.42 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.145 -0.972 . . . . 0.0 109.691 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -147.35 -152.92 5.77 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.42 -1.372 . . . . 0.0 110.349 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 -136.5 142.37 43.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.597 -0.943 . . . . 0.0 109.527 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.454 ' CG1' ' HA ' ' B' ' 81' ' ' PRO . 32.0 t -108.47 132.7 55.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 O-C-N 121.495 -0.753 . . . . 0.0 111.122 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.62 152.36 96.71 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.582 -0.699 . . . . 0.0 110.057 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -65.35 -29.13 54.54 Favored 'Trans proline' 0 C--N 1.303 -1.858 0 O-C-N 124.042 1.548 . . . . 0.0 110.466 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -96.85 16.46 19.21 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.429 -0.794 . . . . 0.0 110.104 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . 0.484 ' HA ' ' HB3' ' B' ' 125' ' ' ASP . . . -62.61 99.13 0.14 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.269 -0.895 . . . . 0.0 110.697 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -95.16 -17.98 21.31 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.399 -0.813 . . . . 0.0 110.785 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 39.4 t -163.82 142.77 7.84 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.977 -1.089 . . . . 0.0 111.452 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' PHE . . . . . 0.498 ' CE2' ' HB2' ' B' ' 32' ' ' LEU . 9.9 t80 -149.74 157.51 43.29 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.381 -0.825 . . . . 0.0 110.017 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 2.5 p -128.89 131.74 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 120.766 -1.209 . . . . 0.0 110.989 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.498 ' HB2' ' CE2' ' B' ' 30' ' ' PHE . 12.7 tp -131.42 129.8 41.73 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.524 -0.735 . . . . 0.0 109.16 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -161.3 153.74 20.26 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 118.287 -1.365 . . . . 0.0 110.851 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.47 ' HA ' ' HA ' ' B' ' 120' ' ' MET . 0.4 OUTLIER -144.57 124.96 13.86 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.636 0.731 . . . . 0.0 109.804 179.411 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . 0.43 ' HA3' ' HA ' ' B' ' 41' ' ' LEU . . . -159.7 -159.35 9.72 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . 0.467 ' O ' ' CD1' ' B' ' 119' ' ' TYR . 40.6 mtpt -67.81 -42.34 81.7 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -156.55 -167.59 2.45 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.879 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 8.7 t -62.97 -42.87 99.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.774 -0.579 . . . . 0.0 112.41 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' ASN . . . . . 0.462 ' HB3' ' N ' ' B' ' 66' ' ' GLY . 92.0 m-20 -87.3 -14.52 40.65 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.983 -1.073 . . . . 0.0 110.751 -178.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' ASN . . . . . 0.405 ' ND2' ' N ' ' B' ' 40' ' ' ASN . 6.1 m-80 -112.67 70.06 0.71 Allowed 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.43 ' HA ' ' HA3' ' B' ' 35' ' ' GLY . 73.0 mt -100.29 142.03 32.32 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -88.33 -23.5 23.4 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.832 -1.167 . . . . 0.0 110.359 -178.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.429 HD12 ' CD2' ' B' ' 34' ' ' LEU . 2.8 pp -156.57 135.93 12.19 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.26 -0.9 . . . . 0.0 110.154 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' HIS . . . . . 0.435 ' HB3' ' O ' ' B' ' 61' ' ' ASN . 37.7 t60 -133.19 121.29 22.31 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.691 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -115.51 133.88 55.61 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.136 -0.978 . . . . 0.0 110.296 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -137.8 78.25 36.73 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.046 -1.034 . . . . 0.0 110.3 178.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -67.14 142.53 61.54 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.851 1.448 . . . . 0.0 109.772 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -128.31 121.98 30.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.126 -0.984 . . . . 0.0 110.014 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -60.12 -46.87 88.19 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 118.35 -1.34 . . . . 0.0 108.344 178.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -147.18 102.35 3.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.699 -0.626 . . . . 0.0 109.97 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.37 -144.02 0.1 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.279 -0.888 . . . . 0.0 108.992 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -50.18 -28.72 7.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.085 -1.01 . . . . 0.0 109.409 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 169.55 38.81 0.03 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -112.25 -172.62 2.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.046 -1.267 . . . . 0.0 109.889 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.499 ' O ' ' C ' ' B' ' 56' ' ' ASN . . . -138.46 142.11 39.45 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.306 -0.871 . . . . 0.0 109.949 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' ASN . . . . . 0.499 ' C ' ' O ' ' B' ' 55' ' ' ALA . 92.0 m-20 16.41 64.33 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.569 0 CA-C-O 121.83 0.824 . . . . 0.0 112.51 -178.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 9.7 m -113.84 141.0 47.87 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.654 -0.654 . . . . 0.0 109.758 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' ILE . . . . . 0.454 ' CG2' ' HB2' ' B' ' 74' ' ' GLU . 18.7 tt -136.72 138.11 46.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.192 -0.942 . . . . 0.0 110.335 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 55.4 t -118.38 127.76 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.258 -0.901 . . . . 0.0 110.306 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 47.9 t -96.56 126.03 41.45 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.373 -0.83 . . . . 0.0 110.226 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' ASN . . . . . 0.435 ' O ' ' HB3' ' B' ' 44' ' ' HIS . 24.1 t-20 -135.58 148.68 49.16 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.42 -0.8 . . . . 0.0 110.527 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' SER . . . . . 0.415 ' O ' ' HA2' ' B' ' 69' ' ' GLY . 72.1 m -125.06 150.93 46.29 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.677 -1.264 . . . . 0.0 109.042 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . 0.486 ' CD ' ' HA2' ' B' ' 66' ' ' GLY . 18.6 ttmt -138.93 148.03 43.04 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.651 -1.281 . . . . 0.0 111.526 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -120.85 97.67 5.65 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.612 -0.68 . . . . 0.0 110.312 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 67.08 23.65 73.01 Favored Glycine 0 N--CA 1.487 2.061 0 C-N-CA 119.491 -1.338 . . . . 0.0 110.131 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . 0.486 ' HA2' ' CD ' ' B' ' 63' ' ' LYS . . . 75.18 24.85 70.19 Favored Glycine 0 N--CA 1.487 2.081 0 O-C-N 120.846 -1.385 . . . . 0.0 110.305 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' ALA . . . . . 0.4 ' HB1' ' CD1' ' B' ' 68' ' ' TRP . . . -86.55 -81.56 0.22 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.964 -1.315 . . . . 0.0 110.662 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' TRP . . . . . 0.428 ' O ' ' HG3' ' B' ' 63' ' ' LYS . 41.2 m95 -124.05 -156.11 0.7 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.13 -0.981 . . . . 0.0 110.374 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' B' ' 62' ' ' SER . . . 163.35 114.69 0.31 Allowed Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 5.4 m -80.46 120.96 25.14 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.538 -0.978 . . . . 0.0 110.492 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -90.59 128.92 36.74 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.272 -0.892 . . . . 0.0 111.082 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -112.06 -172.14 1.98 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.951 -1.093 . . . . 0.0 109.282 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -147.7 127.36 13.35 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 118.257 -1.377 . . . . 0.0 112.34 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 74' ' ' GLU . . . . . 0.454 ' HB2' ' CG2' ' B' ' 58' ' ' ILE . 96.0 mt-10 -116.37 145.11 43.47 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -119.48 48.42 1.52 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.986 -1.071 . . . . 0.0 109.112 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 33.8 m -119.37 132.14 70.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-O 121.561 0.696 . . . . 0.0 110.679 -179.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -161.35 81.29 2.01 Favored Pre-proline 0 C--N 1.301 -1.519 0 O-C-N 121.743 -0.598 . . . . 0.0 109.548 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -82.23 8.77 4.31 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 121.843 1.696 . . . . 0.0 111.234 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -132.79 178.99 6.43 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.918 -1.114 . . . . 0.0 110.403 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.448 ' HB3' ' HD2' ' B' ' 81' ' ' PRO . 0.7 OUTLIER -144.02 177.26 1.87 Allowed Pre-proline 0 C--N 1.297 -1.705 0 O-C-N 121.553 -0.717 . . . . 0.0 109.19 -179.25 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 81' ' ' PRO . . . . . 0.454 ' HA ' ' CG1' ' B' ' 23' ' ' VAL . 54.0 Cg_endo -71.34 157.15 57.5 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.699 1.368 . . . . 0.0 109.412 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 68.5 26.62 74.25 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 6.5 m -133.37 151.73 51.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.505 -0.997 . . . . 0.0 110.039 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 70.7 t -95.72 129.26 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.259 -0.901 . . . . 0.0 110.23 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -149.27 147.3 28.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.221 -0.924 . . . . 0.0 110.473 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -122.12 143.29 49.63 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.243 -0.911 . . . . 0.0 109.4 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 39.5 t -127.41 132.29 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.069 -1.02 . . . . 0.0 111.293 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 88' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -94.78 139.83 30.74 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.344 -0.848 . . . . 0.0 111.166 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 96.8 mt -124.85 128.55 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.675 -0.64 . . . . 0.0 110.254 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 90' ' ' THR . . . . . 0.473 ' HB ' ' HB ' ' B' ' 97' ' ' THR . 52.1 m -122.36 128.75 51.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.157 -0.964 . . . . 0.0 109.811 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 91' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -109.02 118.5 36.94 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.157 -0.964 . . . . 0.0 111.049 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -125.58 150.65 47.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.516 -0.74 . . . . 0.0 110.356 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . 0.431 ' NE2' ' O ' ' B' ' 114' ' ' LEU . 75.2 mm-40 -62.65 -37.62 87.1 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.359 -0.838 . . . . 0.0 110.246 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.27 -40.84 94.44 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.195 -0.94 . . . . 0.0 110.116 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 95' ' ' ASN . . . . . 0.424 ' C ' ' OD1' ' B' ' 95' ' ' ASN . 10.5 p30 -168.77 -171.04 1.29 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.419 -0.8 . . . . 0.0 110.506 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 96' ' ' LEU . . . . . . . . . . . . . 20.3 tp -112.82 132.85 55.09 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.26 -0.9 . . . . 0.0 109.324 179.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 97' ' ' THR . . . . . 0.473 ' HB ' ' HB ' ' B' ' 90' ' ' THR . 22.1 m -117.24 126.58 52.98 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.979 -1.076 . . . . 0.0 110.831 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 40.8 t -123.18 130.39 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.234 -0.916 . . . . 0.0 109.66 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -115.75 127.53 55.18 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.076 -1.015 . . . . 0.0 110.69 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 mp -101.08 164.29 16.34 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.576 -0.702 . . . . 0.0 109.71 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -64.87 -24.16 61.37 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.696 1.366 . . . . 0.0 110.217 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -77.22 -14.16 59.82 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.312 -0.868 . . . . 0.0 110.567 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.27 -13.08 60.21 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 104' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -71.11 135.84 47.88 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.915 -1.344 . . . . 0.0 109.893 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -124.89 139.18 54.07 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.394 -0.816 . . . . 0.0 110.033 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -127.07 134.5 50.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.085 -1.01 . . . . 0.0 109.452 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -113.03 145.2 41.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.045 -1.035 . . . . 0.0 111.011 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 108' ' ' PHE . . . . . 0.522 ' CE2' ' O ' ' B' ' 109' ' ' PRO . 2.9 t80 -134.34 136.89 26.72 Favored Pre-proline 0 C--N 1.3 -1.56 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 109' ' ' PRO . . . . . 0.522 ' O ' ' CE2' ' B' ' 108' ' ' PHE . 37.6 Cg_endo -64.05 134.8 44.49 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.757 1.399 . . . . 0.0 110.682 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 110' ' ' ASN . . . . . 0.469 ' ND2' ' O ' ' B' ' 110' ' ' ASN . 6.4 p-10 -87.04 83.87 7.41 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.032 -1.042 . . . . 0.0 110.279 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -55.99 -21.37 20.83 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.972 -1.08 . . . . 0.0 109.537 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 97.4 mt -101.57 133.12 46.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.138 -0.976 . . . . 0.0 109.896 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -88.59 67.35 8.45 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.301 -0.874 . . . . 0.0 110.763 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 114' ' ' LEU . . . . . 0.431 ' O ' ' NE2' ' B' ' 93' ' ' GLN . 36.2 tp -87.14 121.22 29.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.308 -0.87 . . . . 0.0 109.059 178.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -83.5 -13.97 53.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.624 -1.298 . . . . 0.0 110.474 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 116' ' ' ALA . . . . . . . . . . . . . . . -157.05 157.8 35.3 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.965 -1.084 . . . . 0.0 110.904 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 117' ' ' ILE . . . . . 0.416 HD13 HD13 ' B' ' 34' ' ' LEU . 95.5 mt -108.89 126.87 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.288 -0.882 . . . . 0.0 109.532 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -111.2 -27.04 8.87 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.851 -1.156 . . . . 0.0 111.348 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 119' ' ' TYR . . . . . 0.467 ' CD1' ' O ' ' B' ' 36' ' ' LYS . 2.8 m-85 -117.42 141.2 48.62 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.91 -1.119 . . . . 0.0 112.48 -178.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 120' ' ' MET . . . . . 0.47 ' HA ' ' HA ' ' B' ' 34' ' ' LEU . 54.2 ttp -139.07 129.95 26.3 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -136.96 136.56 38.66 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.429 -1.419 . . . . 0.0 111.221 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 122' ' ' ALA . . . . . 0.446 ' O ' ' HA3' ' B' ' 3' ' ' GLY . . . -149.35 116.32 5.99 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -146.68 118.68 8.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.387 -0.82 . . . . 0.0 109.431 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 179.33 -152.27 10.93 Favored Glycine 0 N--CA 1.487 2.084 0 C-N-CA 119.392 -1.385 . . . . 0.0 110.464 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . 0.484 ' HB3' ' HA ' ' B' ' 27' ' ' ALA . 99.7 m-20 -74.28 -2.93 27.13 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.844 -0.798 . . . . 0.0 111.067 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 126' ' ' PHE . . . . . 0.481 ' HB3' ' CD1' ' B' ' 30' ' ' PHE . 24.6 t80 -96.24 138.27 34.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.001 -1.062 . . . . 0.0 110.288 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -111.13 120.3 41.87 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 118.477 -1.289 . . . . 0.0 111.003 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . 0.429 HG22 ' O ' ' B' ' 128' ' ' ILE . 7.8 tt -100.9 114.85 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.046 -1.034 . . . . 0.0 110.282 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -98.39 -13.3 20.7 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.739 -1.225 . . . . 0.0 110.957 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 130' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -147.89 148.22 30.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.762 -1.211 . . . . 0.0 112.538 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 53.1 t -133.28 130.69 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 132' ' ' ALA . . . . . . . . . . . . . . . -127.39 146.72 50.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.418 -1.426 . . . . 0.0 110.861 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -108.75 127.65 54.19 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.505 -0.747 . . . . 0.0 110.033 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 58.4 t0 . . . . . 0 N--CA 1.497 1.906 0 CA-C-O 117.876 -1.059 . . . . 0.0 111.354 179.141 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.4 ' HA2' ' HA ' ' A' ' 123' ' ' ASP . . . . . . . . 0 N--CA 1.491 2.342 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.451 ' HA ' ' HB3' ' B' ' 8' ' ' ASN . 30.9 tp -61.58 133.43 55.65 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.031 -1.276 . . . . 0.0 110.702 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.1 t -123.15 133.49 68.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.47 -0.768 . . . . 0.0 109.866 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.47 148.56 44.28 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.167 -0.958 . . . . 0.0 110.235 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.439 ' O ' ' HB3' ' A' ' 8' ' ' ASN . 74.4 m -142.02 167.69 21.52 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.32 -0.862 . . . . 0.0 109.397 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.439 ' HB3' ' O ' ' A' ' 7' ' ' SER . 7.4 t30 60.57 32.85 20.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.415 -0.803 . . . . 0.0 109.628 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.493 ' O ' ' C ' ' A' ' 10' ' ' ASN . 1.0 OUTLIER -84.65 -2.84 58.06 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.731 -0.605 . . . . 0.0 111.552 -179.393 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.493 ' C ' ' O ' ' A' ' 9' ' ' LEU . 87.9 m-20 11.29 63.73 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.623 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 14.0 tp -78.55 143.27 36.67 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.846 -1.159 . . . . 0.0 109.824 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.8 mtmt -127.22 158.62 68.67 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 120.969 -1.082 . . . . 0.0 109.915 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -66.49 147.31 82.17 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.83 1.437 . . . . 0.0 110.557 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.53 -9.18 41.2 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -122.98 147.49 46.57 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.927 -1.337 . . . . 0.0 110.204 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 56.8 m -93.3 142.81 26.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.325 -0.859 . . . . 0.0 110.771 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 42.6 tp -120.17 128.5 53.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.394 -0.816 . . . . 0.0 108.908 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -123.37 143.1 50.33 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.878 -1.139 . . . . 0.0 111.656 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.5 t -128.52 116.12 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.641 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -111.79 125.24 53.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.088 -1.008 . . . . 0.0 109.959 178.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.41 ' HA3' ' O ' ' A' ' 127' ' ' LYS . . . -144.96 -155.78 6.59 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -135.23 145.89 48.07 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.281 -1.129 . . . . 0.0 108.966 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 39.9 t -111.45 130.94 64.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 O-C-N 121.124 -0.985 . . . . 0.0 110.562 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.66 153.15 72.4 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.512 -0.743 . . . . 0.0 110.291 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.413 ' HA ' ' N ' ' A' ' 82' ' ' GLY . 43.5 Cg_endo -67.23 -20.34 49.48 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.992 1.522 . . . . 0.0 110.469 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 49.9 p-10 -119.11 25.2 10.33 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.293 -0.879 . . . . 0.0 110.416 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.43 ' HA ' ' HB3' ' A' ' 125' ' ' ASP . . . -60.05 104.87 0.34 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.898 -1.126 . . . . 0.0 110.315 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -95.52 -15.23 23.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.332 -0.855 . . . . 0.0 111.073 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.8 t -160.54 132.94 6.2 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.722 -1.236 . . . . 0.0 111.719 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.483 ' CZ ' ' HB2' ' A' ' 32' ' ' LEU . 14.8 t80 -136.72 144.98 44.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.589 -0.695 . . . . 0.0 109.595 178.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.8 t -126.37 131.46 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.03 -1.044 . . . . 0.0 110.836 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.483 ' HB2' ' CZ ' ' A' ' 30' ' ' PHE . 20.9 tp -135.76 135.52 40.03 Favored 'General case' 0 N--CA 1.484 1.235 0 O-C-N 121.47 -0.769 . . . . 0.0 109.997 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.435 ' HB2' ' CD1' ' A' ' 41' ' ' LEU . 28.5 p30 -142.95 155.37 44.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.787 -1.195 . . . . 0.0 110.508 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.421 HD12 HD13 ' A' ' 43' ' ' LEU . 0.6 OUTLIER -153.58 111.84 3.62 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.29 -0.881 . . . . 0.0 110.19 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.487 ' O ' ' CB ' ' A' ' 119' ' ' TYR . . . -161.04 -173.41 29.63 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.634 -1.786 . . . . 0.0 108.634 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.422 ' O ' ' HB2' ' A' ' 119' ' ' TYR . 98.7 mttt -78.61 -44.66 23.43 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.87 -1.37 . . . . 0.0 110.482 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.414 ' HB2' ' HB2' ' A' ' 40' ' ' ASN . 85.3 m-20 -119.8 165.03 15.09 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.761 -177.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.7 t -56.98 -45.7 82.74 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.604 -0.685 . . . . 0.0 112.425 -178.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.433 ' HB3' ' N ' ' A' ' 66' ' ' GLY . 55.6 m-20 -89.46 -0.92 57.84 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.491 -1.381 . . . . 0.0 110.242 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.414 ' HB2' ' HB2' ' A' ' 37' ' ' ASP . 5.2 m-80 -111.52 58.37 0.62 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.269 -0.895 . . . . 0.0 109.713 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.435 ' CD1' ' HB2' ' A' ' 33' ' ' ASN . 71.9 mt -83.15 134.08 35.0 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 83.6 m -81.73 -40.44 22.72 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.998 -1.064 . . . . 0.0 110.224 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.421 HD13 HD12 ' A' ' 34' ' ' LEU . 83.0 mt -131.87 140.21 49.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.218 -0.926 . . . . 0.0 110.262 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 62.9 t-80 -140.46 139.54 35.2 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.199 -0.938 . . . . 0.0 110.425 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -127.92 146.41 50.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.114 -0.991 . . . . 0.0 110.224 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -152.83 61.07 3.6 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 109.909 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.01 147.2 67.15 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 124.144 1.602 . . . . 0.0 110.573 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 91.7 mtm-85 -135.53 125.69 26.21 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.11 -0.994 . . . . 0.0 110.637 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -61.93 -46.81 87.69 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.018 -1.051 . . . . 0.0 108.988 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -148.52 84.51 1.49 Allowed 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.52 -117.41 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.264 -0.898 . . . . 0.0 110.176 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 25.5 m80 -77.97 -13.06 60.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.583 -1.323 . . . . 0.0 110.458 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 164.75 -22.27 0.14 Allowed Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.611 -1.281 . . . . 0.0 110.459 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -60.85 -179.16 0.12 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.777 -1.425 . . . . 0.0 110.118 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.522 ' O ' ' C ' ' A' ' 56' ' ' ASN . . . -122.21 135.66 54.8 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.619 -0.676 . . . . 0.0 109.985 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.522 ' C ' ' O ' ' A' ' 55' ' ' ALA . 1.9 m-20 14.33 74.83 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.48 0 CA-C-O 121.297 0.57 . . . . 0.0 112.122 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 47.2 m -110.13 130.3 55.56 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.203 -0.935 . . . . 0.0 110.392 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.41 ' O ' HG21 ' A' ' 58' ' ' ILE . 19.6 tt -128.71 131.0 68.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.596 -0.69 . . . . 0.0 109.975 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.8 m -125.81 129.34 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.147 -0.971 . . . . 0.0 110.136 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 11.3 t -86.13 130.67 34.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.263 -0.898 . . . . 0.0 109.355 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -137.21 144.63 42.95 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.004 -1.06 . . . . 0.0 111.327 -179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.2 m -119.13 153.95 34.03 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.477 ' CD ' ' HA2' ' A' ' 66' ' ' GLY . 16.6 ttmt -136.69 134.97 37.79 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.876 -1.14 . . . . 0.0 110.437 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -114.32 102.38 10.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.267 -0.895 . . . . 0.0 109.34 178.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.11 27.4 72.27 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.477 ' HA2' ' CD ' ' A' ' 63' ' ' LYS . . . 93.08 2.05 66.65 Favored Glycine 0 N--CA 1.484 1.852 0 C-N-CA 119.624 -1.274 . . . . 0.0 110.005 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.463 ' O ' ' C ' ' A' ' 68' ' ' TRP . . . -109.55 84.4 1.92 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.987 -1.302 . . . . 0.0 109.723 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.463 ' C ' ' O ' ' A' ' 67' ' ' ALA . 60.2 m95 -6.13 -117.94 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.761 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 129.86 -113.39 1.47 Allowed Glycine 0 N--CA 1.488 2.102 0 O-C-N 119.849 -1.782 . . . . 0.0 109.9 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 21.7 m -78.69 121.45 24.73 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.261 -1.141 . . . . 0.0 111.266 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -126.83 131.18 51.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.398 -0.814 . . . . 0.0 109.684 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.51 156.51 38.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.063 -1.023 . . . . 0.0 110.159 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -134.82 88.86 2.47 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.33 -0.856 . . . . 0.0 109.74 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -114.03 125.88 54.5 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.369 -0.832 . . . . 0.0 109.952 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -93.32 85.54 5.02 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.857 -1.152 . . . . 0.0 110.239 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.4 p -127.16 132.11 70.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.231 -0.918 . . . . 0.0 110.151 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.524 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 13.0 p90 -144.9 81.67 10.56 Favored Pre-proline 0 N--CA 1.487 1.398 0 O-C-N 121.211 -0.931 . . . . 0.0 110.326 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.463 ' CB ' ' HB2' ' A' ' 102' ' ' ASP . 49.8 Cg_endo -72.71 -3.38 13.42 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.844 1.444 . . . . 0.0 111.365 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.402 ' CE1' ' HG2' ' A' ' 101' ' ' PRO . 3.8 m-85 -133.95 179.68 6.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.008 -1.058 . . . . 0.0 111.068 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.443 ' CG ' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -131.41 172.39 7.45 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.562 -0.711 . . . . 0.0 109.464 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.443 ' HD2' ' CG ' ' A' ' 80' ' ' GLN . 52.3 Cg_endo -71.11 150.09 59.42 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.634 1.333 . . . . 0.0 110.09 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.413 ' N ' ' HA ' ' A' ' 25' ' ' PRO . . . 76.03 26.87 63.39 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 44.7 m -131.76 152.05 51.22 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.12 -1.224 . . . . 0.0 111.016 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 p -91.29 133.38 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.452 -0.78 . . . . 0.0 109.564 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.66 155.62 38.73 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.891 -1.131 . . . . 0.0 110.933 -179.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -122.62 149.6 43.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.331 -0.856 . . . . 0.0 109.724 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.9 t -124.26 130.22 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.103 -0.998 . . . . 0.0 110.403 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 1.4 t -98.82 122.73 42.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.506 -0.746 . . . . 0.0 110.051 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 98.0 mt -122.43 128.63 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.105 -0.997 . . . . 0.0 110.841 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 63.7 m -119.37 128.33 53.98 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.439 ' CZ ' ' CD1' ' A' ' 114' ' ' LEU . 73.6 t80 -109.4 115.11 29.35 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.788 -1.195 . . . . 0.0 111.376 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' A' ' 95' ' ' ASN . 79.7 m-20 -118.54 142.36 47.68 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -60.28 -29.89 69.11 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.782 -1.199 . . . . 0.0 110.523 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.47 -40.68 80.9 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 120.918 -1.114 . . . . 0.0 109.214 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.411 ' O ' ' HB2' ' A' ' 92' ' ' ASP . 0.4 OUTLIER -169.95 172.23 6.68 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.959 -0.697 . . . . 0.0 110.461 -179.096 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.414 ' O ' ' HA ' ' A' ' 107' ' ' LYS . 38.1 tp -102.17 124.53 47.93 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.159 -0.963 . . . . 0.0 110.227 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.446 HG23 ' OE2' ' A' ' 105' ' ' GLU . 11.1 m -107.33 125.35 51.06 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.124 -0.985 . . . . 0.0 109.267 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 36.7 t -131.38 131.61 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.857 -1.152 . . . . 0.0 110.417 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -120.01 143.56 47.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.177 -0.952 . . . . 0.0 110.491 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.417 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 0.5 OUTLIER -111.04 169.57 6.17 Favored Pre-proline 0 C--N 1.301 -1.532 0 O-C-N 121.45 -0.781 . . . . 0.0 109.118 179.226 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' A' ' 100' ' ' LEU . 39.8 Cg_endo -63.96 -23.79 67.73 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 123.626 1.329 . . . . 0.0 110.858 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.463 ' HB2' ' CB ' ' A' ' 78' ' ' PRO . 20.8 t0 -75.01 -12.31 60.3 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.012 -1.055 . . . . 0.0 110.974 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 99.15 -10.32 61.7 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.708 -1.234 . . . . 0.0 110.66 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.43 ' CE2' ' OD2' ' A' ' 102' ' ' ASP . 19.4 m-85 -79.78 140.68 36.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.815 -1.403 . . . . 0.0 109.843 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.446 ' OE2' HG23 ' A' ' 97' ' ' THR . 85.2 tt0 -120.86 143.43 48.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.307 -0.871 . . . . 0.0 110.679 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -129.94 147.99 51.75 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.458 -0.776 . . . . 0.0 109.599 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.426 ' C ' ' CD1' ' A' ' 108' ' ' PHE . 98.3 mttt -127.58 145.79 50.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.035 -1.041 . . . . 0.0 111.478 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.494 ' N ' ' CD1' ' A' ' 108' ' ' PHE . 19.2 m-85 -129.81 140.35 38.39 Favored Pre-proline 0 N--CA 1.489 1.508 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.5 140.36 39.71 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 123.407 1.214 . . . . 0.0 109.786 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.459 ' ND2' ' O ' ' A' ' 110' ' ' ASN . 6.0 p-10 -102.3 82.85 2.24 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 122.212 1.006 . . . . 0.0 110.178 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 96.6 mtt-85 -57.17 -22.89 43.69 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.535 -1.353 . . . . 0.0 108.963 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.447 ' HB2' HD21 ' A' ' 114' ' ' LEU . 89.1 mt -81.96 143.82 31.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.753 -0.592 . . . . 0.0 110.413 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -101.63 39.03 1.5 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.131 -0.981 . . . . 0.0 109.561 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.447 HD21 ' HB2' ' A' ' 112' ' ' LEU . 0.8 OUTLIER -73.77 128.05 34.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.435 -0.79 . . . . 0.0 110.914 -179.146 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -88.04 -16.19 34.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.067 -1.021 . . . . 0.0 110.215 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.483 ' HA ' ' O ' ' A' ' 11' ' ' LEU . . . -158.23 155.13 28.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.042 -1.036 . . . . 0.0 111.251 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 31.6 mm -107.1 130.33 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.203 -0.935 . . . . 0.0 110.18 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.508 ' ND2' ' N ' ' A' ' 118' ' ' ASN . 0.5 OUTLIER -108.92 -15.19 14.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.151 -0.968 . . . . 0.0 110.909 -179.205 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.487 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 4.0 t80 -120.21 129.49 54.11 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.973 -1.079 . . . . 0.0 111.487 -178.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 55.3 ttp -141.35 128.44 20.81 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 178.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.07 149.6 30.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.736 -1.228 . . . . 0.0 111.414 -178.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -152.1 129.07 11.02 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.403 -0.811 . . . . 0.0 109.976 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.4 ' HA ' ' HA2' ' A' ' 3' ' ' GLY . 68.0 t0 -147.4 114.81 6.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.311 -0.868 . . . . 0.0 109.377 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.45 ' HA3' ' HA ' ' A' ' 30' ' ' PHE . . . -177.03 -145.32 5.67 Favored Glycine 0 N--CA 1.485 1.947 0 C-N-CA 119.174 -1.489 . . . . 0.0 110.327 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.43 ' HB3' ' HA ' ' A' ' 27' ' ' ALA . 80.2 m-20 -89.04 12.89 14.3 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.781 -0.835 . . . . 0.0 110.707 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.483 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 15.1 t80 -105.8 137.47 43.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.008 -1.057 . . . . 0.0 110.401 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.41 ' O ' ' HA3' ' A' ' 21' ' ' GLY . 98.7 mttt -103.9 109.56 21.35 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.244 -0.91 . . . . 0.0 111.758 -178.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 8.7 tt -99.67 117.5 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.028 -1.045 . . . . 0.0 109.432 177.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -109.41 -14.39 14.43 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.164 -0.96 . . . . 0.0 111.733 -178.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.54 142.56 30.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.669 -1.27 . . . . 0.0 112.001 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 59.6 t -126.65 132.99 69.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -138.97 143.73 38.66 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.507 -1.37 . . . . 0.0 111.514 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.411 ' CE1' HD12 ' A' ' 11' ' ' LEU . 0.5 OUTLIER -73.79 -125.9 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.629 -0.67 . . . . 0.0 109.723 179.642 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 47.2 t0 . . . . . 0 N--CA 1.491 1.592 0 O-C-N 120.528 -1.357 . . . . 0.0 110.116 179.674 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 1' ' ' ALA . . . . . 0.443 ' HB2' ' HB2' ' B' ' 4' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.448 0.642 . . . . 0.0 110.513 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 2' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -126.93 84.15 2.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.472 -0.767 . . . . 0.0 109.643 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 3' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' B' ' 123' ' ' ASP . . . 92.19 34.51 7.1 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . 0.443 ' HB2' ' HB2' ' B' ' 1' ' ' ALA . 31.0 tp -62.1 133.04 54.75 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.143 -1.21 . . . . 0.0 110.705 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 39.5 t -122.77 133.18 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.558 -0.714 . . . . 0.0 109.944 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.26 148.13 44.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.133 -0.98 . . . . 0.0 110.396 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' SER . . . . . 0.453 ' O ' ' HB3' ' B' ' 8' ' ' ASN . 74.9 m -141.69 167.41 22.21 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.22 -0.925 . . . . 0.0 109.343 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . 0.453 ' HB3' ' O ' ' B' ' 7' ' ' SER . 7.6 t30 60.97 33.14 19.89 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.79 0.805 . . . . 0.0 109.509 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . 0.496 ' O ' ' C ' ' B' ' 10' ' ' ASN . 1.0 OUTLIER -86.58 3.48 44.2 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.74 -0.6 . . . . 0.0 111.583 -179.476 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' ASN . . . . . 0.496 ' C ' ' O ' ' B' ' 9' ' ' LEU . 87.3 m-20 2.22 67.67 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.612 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -178.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.477 ' O ' ' HA ' ' B' ' 116' ' ' ALA . 14.0 tp -79.45 143.34 35.07 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.228 -0.92 . . . . 0.0 109.605 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 6.8 mtmt -127.71 158.67 69.5 Favored Pre-proline 0 C--N 1.296 -1.755 0 O-C-N 121.178 -0.951 . . . . 0.0 109.873 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -66.57 147.27 81.77 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.846 1.445 . . . . 0.0 110.658 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.4 -8.95 41.46 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 120.105 -1.045 . . . . 0.0 110.498 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -122.99 147.45 46.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.879 -1.365 . . . . 0.0 110.202 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' CYS . . . . . . . . . . . . . 56.9 m -93.22 142.93 26.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.242 -0.911 . . . . 0.0 110.727 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 43.6 tp -120.34 128.17 53.01 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.403 -0.811 . . . . 0.0 109.004 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -123.05 143.07 50.2 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.871 -1.143 . . . . 0.0 111.751 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 2.5 t -128.3 116.25 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.73 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -112.18 124.84 53.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.02 -1.05 . . . . 0.0 109.938 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' B' ' 127' ' ' LYS . . . -144.66 -155.88 6.61 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.676 -1.369 . . . . 0.0 109.676 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -134.85 146.12 48.96 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.252 -1.146 . . . . 0.0 109.087 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 39.8 t -111.65 130.31 65.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 121.119 -0.988 . . . . 0.0 110.693 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.95 153.12 67.31 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.392 -0.818 . . . . 0.0 110.452 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . 0.414 ' HA ' ' N ' ' B' ' 82' ' ' GLY . 43.1 Cg_endo -67.23 -20.18 49.63 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.936 1.493 . . . . 0.0 110.555 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 49.5 p-10 -119.42 25.06 10.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.284 -0.885 . . . . 0.0 110.408 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . 0.447 ' HA ' ' HB3' ' B' ' 125' ' ' ASP . . . -59.94 104.47 0.3 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.905 -1.122 . . . . 0.0 110.311 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -94.97 -15.92 23.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.355 -0.841 . . . . 0.0 111.157 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 8.0 t -159.63 133.39 7.28 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.724 -1.235 . . . . 0.0 111.686 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' PHE . . . . . 0.485 ' CD1' ' HB3' ' B' ' 126' ' ' PHE . 14.4 t80 -137.08 144.65 43.22 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.569 -0.707 . . . . 0.0 109.565 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 43.1 t -126.36 131.14 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.975 -1.078 . . . . 0.0 110.944 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.479 ' HB2' ' CZ ' ' B' ' 30' ' ' PHE . 20.6 tp -135.38 135.74 40.9 Favored 'General case' 0 C--N 1.308 -1.234 0 O-C-N 121.525 -0.735 . . . . 0.0 110.181 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' ASN . . . . . 0.42 ' HB2' ' CD1' ' B' ' 41' ' ' LEU . 28.3 p30 -143.02 155.6 44.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.809 -1.182 . . . . 0.0 110.623 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' B' ' 34' ' ' LEU . 0.6 OUTLIER -153.79 110.21 3.33 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.277 -0.889 . . . . 0.0 110.276 179.967 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . 0.482 ' O ' ' CB ' ' B' ' 119' ' ' TYR . . . -158.36 -172.98 26.18 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . 0.443 ' O ' ' HB2' ' B' ' 119' ' ' TYR . 98.8 mttt -78.89 -44.57 22.49 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.876 -1.367 . . . . 0.0 110.415 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . 0.42 ' HB2' ' HB2' ' B' ' 40' ' ' ASN . 84.8 m-20 -119.76 164.91 15.25 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.685 -178.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 11.8 t -56.97 -45.85 82.6 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.634 -0.666 . . . . 0.0 112.294 -178.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' ASN . . . . . 0.433 ' HB3' ' N ' ' B' ' 66' ' ' GLY . 54.8 m-20 -89.24 -0.87 57.8 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.473 -1.392 . . . . 0.0 110.294 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' ASN . . . . . 0.42 ' HB2' ' HB2' ' B' ' 37' ' ' ASP . 5.0 m-80 -111.63 58.16 0.63 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.184 -0.947 . . . . 0.0 109.678 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.42 ' CD1' ' HB2' ' B' ' 33' ' ' ASN . 72.6 mt -82.31 138.25 34.59 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' CYS . . . . . . . . . . . . . 79.5 m -87.42 -38.22 16.32 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.88 -1.138 . . . . 0.0 109.618 -178.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.417 HD11 HD22 ' B' ' 96' ' ' LEU . 83.8 mt -132.58 139.78 47.96 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.142 -0.974 . . . . 0.0 110.016 179.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' HIS . . . . . . . . . . . . . 63.2 t-80 -140.09 140.09 36.01 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.135 -0.978 . . . . 0.0 110.328 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -128.47 146.03 50.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.192 -0.942 . . . . 0.0 110.2 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -152.26 61.16 3.87 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.379 -0.826 . . . . 0.0 109.984 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -69.23 146.67 64.21 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.067 1.562 . . . . 0.0 110.69 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 91.5 mtm-85 -134.94 125.83 27.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.164 -0.96 . . . . 0.0 110.681 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -61.93 -46.62 88.54 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.129 -0.982 . . . . 0.0 109.036 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -148.58 84.36 1.48 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.5 -117.2 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.2 -0.938 . . . . 0.0 110.241 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -77.83 -13.97 59.72 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.633 -1.292 . . . . 0.0 110.405 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 165.53 -22.2 0.13 Allowed Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.568 -1.301 . . . . 0.0 110.494 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -60.51 -179.0 0.1 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.881 -1.364 . . . . 0.0 110.162 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.533 ' O ' ' C ' ' B' ' 56' ' ' ASN . . . -121.98 137.47 54.79 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.57 -0.706 . . . . 0.0 109.598 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' ASN . . . . . 0.533 ' C ' ' O ' ' B' ' 55' ' ' ALA . 1.9 m-20 11.25 76.2 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.514 0 CA-C-O 121.451 0.643 . . . . 0.0 112.107 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 45.2 m -110.46 130.16 55.62 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.381 -0.825 . . . . 0.0 110.328 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' ILE . . . . . 0.411 ' O ' HG21 ' B' ' 58' ' ' ILE . 19.6 tt -128.79 130.7 68.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.476 -0.765 . . . . 0.0 110.032 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 21.5 m -125.4 129.24 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.154 -0.967 . . . . 0.0 110.349 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 11.2 t -86.03 130.64 34.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.142 -0.974 . . . . 0.0 109.343 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -137.2 144.73 43.01 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.059 -1.025 . . . . 0.0 111.266 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 5.3 m -119.36 153.74 34.69 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . 0.477 ' CD ' ' HA2' ' B' ' 66' ' ' GLY . 16.6 ttmt -136.56 134.82 37.88 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.862 -1.149 . . . . 0.0 110.412 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -113.87 102.45 10.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.222 -0.924 . . . . 0.0 109.609 178.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 64.84 27.71 72.46 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . 0.477 ' HA2' ' CD ' ' B' ' 63' ' ' LYS . . . 93.01 1.85 66.97 Favored Glycine 0 N--CA 1.485 1.937 0 C-N-CA 119.561 -1.304 . . . . 0.0 109.99 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 67' ' ' ALA . . . . . 0.454 ' O ' ' O ' ' B' ' 68' ' ' TRP . . . -109.45 86.21 2.25 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.977 -1.308 . . . . 0.0 109.526 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 68' ' ' TRP . . . . . 0.454 ' O ' ' O ' ' B' ' 67' ' ' ALA . 61.8 m95 -9.0 -116.59 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.828 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -178.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 129.28 -113.37 1.51 Allowed Glycine 0 N--CA 1.488 2.161 0 O-C-N 119.775 -1.828 . . . . 0.0 110.005 -178.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 21.6 m -78.91 121.31 24.7 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.198 -1.177 . . . . 0.0 111.266 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -126.72 131.0 51.45 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.404 -0.81 . . . . 0.0 109.778 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.45 156.51 38.78 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.926 -1.109 . . . . 0.0 110.205 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 -134.64 88.74 2.47 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.247 -0.908 . . . . 0.0 109.727 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 74' ' ' GLU . . . . . 0.401 ' O ' ' CG2' ' B' ' 58' ' ' ILE . 89.3 mt-10 -113.94 126.18 54.86 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.238 -0.914 . . . . 0.0 109.865 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -93.49 85.28 4.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.09 -1.006 . . . . 0.0 110.232 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 2.4 p -127.22 132.25 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.324 -0.86 . . . . 0.0 110.203 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 77' ' ' PHE . . . . . 0.509 ' N ' ' CD1' ' B' ' 77' ' ' PHE . 13.6 p90 -144.98 81.7 10.46 Favored Pre-proline 0 N--CA 1.486 1.352 0 O-C-N 121.248 -0.908 . . . . 0.0 110.288 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . 0.451 ' CB ' ' HB2' ' B' ' 102' ' ' ASP . 52.4 Cg_endo -72.91 -3.12 13.04 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.967 1.509 . . . . 0.0 111.236 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 79' ' ' PHE . . . . . 0.4 ' CE1' ' HG2' ' B' ' 101' ' ' PRO . 3.8 m-85 -134.13 179.6 6.15 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.998 -1.064 . . . . 0.0 111.024 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.46 ' CG ' ' HD2' ' B' ' 81' ' ' PRO . 0.0 OUTLIER -131.2 172.57 7.13 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.574 -0.704 . . . . 0.0 109.521 179.781 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 81' ' ' PRO . . . . . 0.46 ' HD2' ' CG ' ' B' ' 80' ' ' GLN . 51.0 Cg_endo -71.02 150.06 59.88 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.643 1.338 . . . . 0.0 110.105 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . 0.414 ' N ' ' HA ' ' B' ' 25' ' ' PRO . . . 75.95 26.94 63.4 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 45.3 m -131.83 151.94 51.34 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.933 -1.334 . . . . 0.0 111.06 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 13.1 p -90.95 133.54 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.437 -0.789 . . . . 0.0 109.59 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.69 155.86 39.18 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.808 -1.183 . . . . 0.0 110.894 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -122.91 149.56 44.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.375 -0.828 . . . . 0.0 109.61 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 47.0 t -124.15 130.43 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.128 -0.982 . . . . 0.0 110.386 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 88' ' ' CYS . . . . . . . . . . . . . 1.4 t -99.2 122.91 43.02 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.354 -0.841 . . . . 0.0 110.042 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 98.2 mt -122.55 128.65 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.199 -0.938 . . . . 0.0 110.731 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 63.2 m -119.41 128.29 53.9 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 91' ' ' PHE . . . . . 0.438 ' CZ ' ' CD1' ' B' ' 114' ' ' LEU . 73.7 t80 -109.23 115.59 30.3 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 118.62 -1.232 . . . . 0.0 111.343 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' B' ' 95' ' ' ASN . 79.2 m-20 -118.89 142.39 47.79 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -60.04 -30.31 69.11 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.668 -1.27 . . . . 0.0 110.491 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.15 -40.48 82.37 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.045 -1.035 . . . . 0.0 109.279 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 95' ' ' ASN . . . . . 0.403 ' O ' ' HB2' ' B' ' 92' ' ' ASP . 0.4 OUTLIER -170.32 171.88 6.45 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.502 -178.997 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 96' ' ' LEU . . . . . 0.417 HD22 HD11 ' B' ' 43' ' ' LEU . 38.8 tp -101.83 125.13 48.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.236 -0.915 . . . . 0.0 110.17 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 97' ' ' THR . . . . . 0.443 HG23 ' OE2' ' B' ' 105' ' ' GLU . 10.5 m -107.93 125.25 51.27 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.099 -1.001 . . . . 0.0 109.266 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 38.8 t -131.43 131.43 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.858 -1.151 . . . . 0.0 110.478 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -119.7 143.9 47.5 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.168 -0.957 . . . . 0.0 110.579 179.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 100' ' ' LEU . . . . . 0.419 ' HB3' ' HD2' ' B' ' 101' ' ' PRO . 0.5 OUTLIER -111.16 169.69 6.04 Favored Pre-proline 0 C--N 1.3 -1.57 0 O-C-N 121.517 -0.739 . . . . 0.0 109.133 179.222 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 101' ' ' PRO . . . . . 0.419 ' HD2' ' HB3' ' B' ' 100' ' ' LEU . 38.8 Cg_endo -64.07 -24.11 66.77 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 123.603 1.318 . . . . 0.0 110.772 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 102' ' ' ASP . . . . . 0.451 ' HB2' ' CB ' ' B' ' 78' ' ' PRO . 20.5 t0 -74.83 -11.95 60.27 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.941 -1.099 . . . . 0.0 111.085 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 98.86 -10.42 62.28 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.635 -1.269 . . . . 0.0 110.645 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 104' ' ' TYR . . . . . 0.443 ' CE2' ' OD2' ' B' ' 102' ' ' ASP . 19.5 m-85 -79.73 141.02 36.74 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.754 -1.439 . . . . 0.0 109.657 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 105' ' ' GLU . . . . . 0.443 ' OE2' HG23 ' B' ' 97' ' ' THR . 85.2 tt0 -121.06 143.48 49.05 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.308 -0.87 . . . . 0.0 110.554 -179.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -130.08 148.07 51.89 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.336 -0.853 . . . . 0.0 109.505 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 107' ' ' LYS . . . . . 0.422 ' C ' ' CD1' ' B' ' 108' ' ' PHE . 98.3 mttt -127.7 145.62 50.84 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.079 -1.013 . . . . 0.0 111.454 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 108' ' ' PHE . . . . . 0.502 ' CD1' ' N ' ' B' ' 108' ' ' PHE . 20.1 m-85 -129.64 140.18 37.88 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -70.28 140.18 40.14 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 O-C-N 123.385 1.203 . . . . 0.0 109.83 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 110' ' ' ASN . . . . . 0.46 ' ND2' ' O ' ' B' ' 110' ' ' ASN . 6.1 p-10 -102.16 83.02 2.28 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 122.246 1.022 . . . . 0.0 110.216 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 96.6 mtt-85 -57.11 -22.7 41.73 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.488 -1.383 . . . . 0.0 108.98 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 112' ' ' LEU . . . . . 0.438 ' HB2' HD21 ' B' ' 114' ' ' LEU . 89.7 mt -82.26 143.7 31.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.584 -0.698 . . . . 0.0 110.454 179.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -101.44 38.83 1.52 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.105 -0.997 . . . . 0.0 109.541 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 114' ' ' LEU . . . . . 0.438 ' CD1' ' CZ ' ' B' ' 91' ' ' PHE . 0.8 OUTLIER -73.6 128.07 34.49 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.427 -0.795 . . . . 0.0 110.923 -179.193 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -88.26 -16.05 34.22 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.114 -0.991 . . . . 0.0 110.162 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 116' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' B' ' 11' ' ' LEU . . . -158.25 155.19 28.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.005 -1.059 . . . . 0.0 111.072 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 31.8 mm -107.17 130.2 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.215 -0.928 . . . . 0.0 110.228 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 118' ' ' ASN . . . . . 0.509 ' N ' ' ND2' ' B' ' 118' ' ' ASN . 0.5 OUTLIER -108.85 -15.01 14.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.069 -1.019 . . . . 0.0 110.933 -179.244 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 119' ' ' TYR . . . . . 0.482 ' CB ' ' O ' ' B' ' 35' ' ' GLY . 4.0 t80 -120.28 129.7 54.14 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.993 -1.067 . . . . 0.0 111.461 -178.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 51.8 ttp -141.47 128.37 20.6 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.21 149.37 30.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.707 -1.246 . . . . 0.0 111.342 -178.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -151.99 129.17 11.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.578 -0.702 . . . . 0.0 110.116 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 123' ' ' ASP . . . . . 0.412 ' HA ' ' HA2' ' B' ' 3' ' ' GLY . 68.0 t0 -147.4 114.63 6.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.366 -0.834 . . . . 0.0 109.453 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 124' ' ' GLY . . . . . 0.462 ' HA3' ' HA ' ' B' ' 30' ' ' PHE . . . -176.95 -145.36 5.67 Favored Glycine 0 N--CA 1.484 1.869 0 C-N-CA 119.069 -1.538 . . . . 0.0 110.209 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . 0.447 ' HB3' ' HA ' ' B' ' 27' ' ' ALA . 79.7 m-20 -88.86 12.87 13.99 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.913 -0.757 . . . . 0.0 110.705 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 126' ' ' PHE . . . . . 0.485 ' HB3' ' CD1' ' B' ' 30' ' ' PHE . 14.9 t80 -105.76 137.66 43.27 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.092 -1.005 . . . . 0.0 110.269 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . 0.407 ' O ' ' HA3' ' B' ' 21' ' ' GLY . 98.5 mttt -103.94 109.45 21.2 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.272 -0.892 . . . . 0.0 111.746 -178.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 8.8 tt -99.65 117.41 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.036 -1.04 . . . . 0.0 109.486 177.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -109.32 -14.64 14.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.111 -0.993 . . . . 0.0 111.872 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 130' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.17 143.55 31.14 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.637 -1.289 . . . . 0.0 111.815 -179.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 66.1 t -127.3 133.58 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 132' ' ' ALA . . . . . . . . . . . . . . . -139.48 143.39 37.49 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 119.984 -1.697 . . . . 0.0 111.721 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . 0.406 ' CE1' HD12 ' B' ' 11' ' ' LEU . 0.5 OUTLIER -73.17 -125.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.633 -0.667 . . . . 0.0 109.821 179.758 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 47.1 t0 . . . . . 0 N--CA 1.492 1.628 0 O-C-N 120.515 -1.365 . . . . 0.0 110.161 179.716 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.418 ' C ' ' ND2' ' B' ' 8' ' ' ASN . . . . . . . . 0 N--CA 1.488 2.104 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 34.9 tp -58.54 128.51 37.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.915 -1.344 . . . . 0.0 109.866 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 54.5 t -120.43 131.17 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.43 -0.794 . . . . 0.0 109.877 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -124.49 164.18 20.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.926 -1.108 . . . . 0.0 110.98 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.467 ' O ' ' HB3' ' A' ' 8' ' ' ASN . 26.9 p -151.19 172.22 16.16 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.666 -0.646 . . . . 0.0 109.306 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.467 ' HB3' ' O ' ' A' ' 7' ' ' SER . 32.0 t30 61.79 33.01 18.02 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.577 -0.702 . . . . 0.0 109.85 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.525 ' O ' ' C ' ' A' ' 10' ' ' ASN . 94.8 mt -85.09 -9.69 57.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.539 -0.726 . . . . 0.0 111.124 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.525 ' C ' ' O ' ' A' ' 9' ' ' LEU . 0.7 OUTLIER 5.79 67.82 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.686 0 CA-C-O 121.551 0.691 . . . . 0.0 112.829 -179.771 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.512 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 31.8 tp -87.64 139.0 30.98 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.51 167.46 9.03 Favored Pre-proline 0 C--N 1.294 -1.831 0 O-C-N 120.975 -1.078 . . . . 0.0 111.378 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 115' ' ' GLU . 44.3 Cg_endo -67.49 147.31 76.8 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 124.266 1.666 . . . . 0.0 110.77 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.81 -4.04 63.1 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -115.99 146.79 41.83 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.937 -1.331 . . . . 0.0 109.827 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.3 m -99.02 142.63 30.27 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.163 -0.961 . . . . 0.0 110.443 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 51.2 tp -118.27 128.2 54.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.405 -0.809 . . . . 0.0 109.698 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -128.92 133.43 47.87 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.008 -1.057 . . . . 0.0 111.17 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 56.1 t -121.1 127.24 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.319 -0.863 . . . . 0.0 109.577 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 53.2 ttt-85 -109.05 124.89 51.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.206 -0.934 . . . . 0.0 110.019 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -148.88 -163.4 10.88 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -137.94 141.81 40.55 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.409 -1.053 . . . . 0.0 110.269 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.447 ' CG1' ' HB1' ' A' ' 27' ' ' ALA . 23.8 t -97.4 130.97 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.198 -0.939 . . . . 0.0 110.809 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.87 168.22 1.56 Allowed Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.448 -0.783 . . . . 0.0 110.096 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -68.68 -19.8 41.2 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.909 1.478 . . . . 0.0 109.89 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 28' ' ' LYS . 48.2 t0 -112.97 57.19 0.67 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.485 -0.76 . . . . 0.0 109.371 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.483 ' HA ' ' HB3' ' A' ' 125' ' ' ASP . . . -69.73 63.62 0.19 Allowed 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.688 0.756 . . . . 0.0 109.797 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.435 ' N ' ' O ' ' A' ' 26' ' ' ASP . 87.8 tttt -63.12 -43.92 97.08 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.702 -0.624 . . . . 0.0 110.401 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.3 t -164.05 137.63 5.4 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.006 -1.058 . . . . 0.0 111.174 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.445 ' HA ' ' HA3' ' A' ' 124' ' ' GLY . 26.1 t80 -134.04 145.54 49.51 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.547 -0.721 . . . . 0.0 109.981 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.45 HG12 ' ND2' ' A' ' 46' ' ' ASN . 17.3 m -127.13 133.08 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 120.785 -1.197 . . . . 0.0 110.774 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.1 tp -129.42 135.09 48.24 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.463 -0.773 . . . . 0.0 110.139 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -142.19 145.77 34.51 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.763 -1.21 . . . . 0.0 110.78 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.436 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 1.1 pp -149.47 123.87 9.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.366 -0.834 . . . . 0.0 110.679 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.519 ' O ' ' HB3' ' A' ' 119' ' ' TYR . . . -166.11 -160.38 13.3 Favored Glycine 0 N--CA 1.493 2.433 0 N-CA-C 108.959 -1.657 . . . . 0.0 108.959 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.449 ' O ' ' HB2' ' A' ' 119' ' ' TYR . 60.2 mtpt -71.85 -40.8 68.76 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.021 -1.282 . . . . 0.0 109.149 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -153.27 -167.02 2.59 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.768 0.794 . . . . 0.0 111.562 -178.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 41.2 t -62.0 -46.03 91.0 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.662 -0.649 . . . . 0.0 112.573 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.438 ' HB3' ' N ' ' A' ' 66' ' ' GLY . 74.0 m-20 -94.5 0.08 55.04 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.762 -1.211 . . . . 0.0 110.437 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -113.03 62.79 0.64 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.245 -0.909 . . . . 0.0 109.378 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.413 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 92.1 mt -104.14 133.97 48.18 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.315 0.578 . . . . 0.0 109.917 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 63.3 m -83.62 -40.22 19.3 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.151 -0.968 . . . . 0.0 109.271 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.3 mt -131.42 140.89 49.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.213 -0.929 . . . . 0.0 111.337 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.476 ' HB3' ' HB3' ' A' ' 61' ' ' ASN . 82.0 t60 -131.84 103.14 6.16 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -102.36 142.0 34.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -0.931 . . . . 0.0 110.8 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.45 ' ND2' HG12 ' A' ' 31' ' ' VAL . 1.2 t-20 -155.23 85.36 3.49 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.391 -0.818 . . . . 0.0 110.603 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.431 ' HA ' HG12 ' A' ' 58' ' ' ILE . 46.5 Cg_endo -67.48 147.74 77.68 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.891 1.469 . . . . 0.0 110.75 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -132.31 107.99 8.91 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.291 -0.881 . . . . 0.0 111.156 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -62.08 -48.08 81.78 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.248 -0.908 . . . . 0.0 109.486 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 -150.83 97.74 2.52 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.313 -0.867 . . . . 0.0 109.472 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -105.18 -126.61 0.23 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.187 -0.945 . . . . 0.0 110.329 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 40.3 m170 -61.73 -35.38 77.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.72 -1.237 . . . . 0.0 110.843 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 172.61 32.42 0.03 OUTLIER Glycine 0 N--CA 1.493 2.451 0 C-N-CA 119.104 -1.522 . . . . 0.0 111.072 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -117.59 -166.26 1.17 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.852 -1.381 . . . . 0.0 109.469 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 56' ' ' ASN . . . -153.67 144.08 22.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.252 -0.905 . . . . 0.0 110.373 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.475 ' C ' ' O ' ' A' ' 55' ' ' ALA . 87.0 m-20 25.85 56.65 0.05 Allowed 'General case' 0 N--CA 1.504 2.23 0 CA-C-O 120.987 0.422 . . . . 0.0 111.983 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 86.0 m -119.69 133.24 55.71 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.235 -0.915 . . . . 0.0 110.477 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.431 HG12 ' HA ' ' A' ' 47' ' ' PRO . 96.6 mt -119.29 134.06 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.496 -0.753 . . . . 0.0 111.114 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.5 t -112.74 127.94 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.211 -0.931 . . . . 0.0 109.025 178.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 2.2 t -94.57 122.88 37.61 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.185 -0.947 . . . . 0.0 110.313 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.476 ' HB3' ' HB3' ' A' ' 44' ' ' HIS . 6.8 t-20 -121.21 147.52 45.5 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.321 -0.862 . . . . 0.0 109.114 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.3 t -135.65 142.76 45.22 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.022 -1.049 . . . . 0.0 110.141 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.475 ' CD ' ' HA2' ' A' ' 66' ' ' GLY . 27.0 ttmt -142.94 127.39 17.82 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 118.883 -1.127 . . . . 0.0 111.67 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.449 ' HB2' HD22 ' A' ' 112' ' ' LEU . 30.1 t0 -107.04 103.23 12.6 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 64.48 20.74 66.02 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.475 ' HA2' ' CD ' ' A' ' 63' ' ' LYS . . . 68.89 36.58 82.14 Favored Glycine 0 N--CA 1.488 2.123 0 C-N-CA 119.2 -1.476 . . . . 0.0 110.007 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.51 14.16 6.54 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.731 -1.452 . . . . 0.0 112.263 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -139.63 -74.6 0.36 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.452 -1.405 . . . . 0.0 110.421 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.68 32.85 49.03 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.1 m -59.81 121.36 11.53 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.077 -1.249 . . . . 0.0 109.49 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -116.66 133.36 56.11 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.226 -0.921 . . . . 0.0 112.039 -178.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -127.42 -162.53 1.17 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.369 -0.832 . . . . 0.0 108.971 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -141.83 140.72 33.03 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 118.484 -1.286 . . . . 0.0 112.027 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -127.92 124.29 37.02 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.897 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -101.96 46.33 0.93 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.871 -1.143 . . . . 0.0 111.017 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 75.9 t -122.46 127.06 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.063 -1.023 . . . . 0.0 109.716 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.466 ' CD2' ' O ' ' A' ' 77' ' ' PHE . 83.2 t80 -162.23 74.71 2.22 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 120.922 -1.112 . . . . 0.0 110.91 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.494 ' HD2' ' CE2' ' A' ' 79' ' ' PHE . 55.6 Cg_endo -80.2 43.1 1.45 Allowed 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.899 1.473 . . . . 0.0 110.951 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.494 ' CE2' ' HD2' ' A' ' 78' ' ' PRO . 70.6 m-85 -127.6 151.57 48.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.884 -1.135 . . . . 0.0 109.399 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.4 ' HB3' ' HD2' ' A' ' 81' ' ' PRO . 0.1 OUTLIER -127.39 168.71 14.12 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.034 -1.041 . . . . 0.0 110.251 -179.86 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 80' ' ' GLN . 51.4 Cg_endo -69.75 147.58 63.22 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.958 1.504 . . . . 0.0 110.015 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 56.39 41.38 87.75 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.829 -1.309 . . . . 0.0 109.829 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 37.2 t -134.35 142.15 47.12 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.037 -1.273 . . . . 0.0 110.617 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.2 p -89.16 136.8 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.387 -0.821 . . . . 0.0 109.65 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -154.66 151.74 29.13 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.109 -0.994 . . . . 0.0 110.035 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.401 ' O ' ' HD3' ' A' ' 101' ' ' PRO . 90.5 mt-10 -116.32 138.38 51.37 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 91.6 t -116.15 128.38 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.909 -1.119 . . . . 0.0 110.823 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 1.7 t -99.64 129.4 45.78 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.3 -0.875 . . . . 0.0 109.837 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 97.8 mt -122.25 127.66 75.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.356 -0.84 . . . . 0.0 110.067 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.403 ' HB ' ' HB ' ' A' ' 97' ' ' THR . 89.2 m -120.56 127.61 52.31 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.242 -0.911 . . . . 0.0 109.286 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -113.85 112.09 22.8 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.06 -1.025 . . . . 0.0 110.854 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -119.59 149.01 42.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.527 -0.733 . . . . 0.0 109.467 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -63.22 -34.4 77.57 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.94 -1.1 . . . . 0.0 109.94 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.54 -40.69 96.05 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.2 -0.937 . . . . 0.0 109.991 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -171.39 178.14 3.32 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.314 -0.866 . . . . 0.0 110.412 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 95.4 mt -105.0 131.53 52.4 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.397 -0.814 . . . . 0.0 110.078 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.463 ' CG2' ' OE2' ' A' ' 105' ' ' GLU . 44.1 m -121.01 129.62 53.46 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.081 -1.012 . . . . 0.0 109.838 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 56.4 t -125.82 129.04 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 120.86 -1.15 . . . . 0.0 109.255 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -116.62 126.14 52.82 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.066 -1.054 . . . . 0.0 109.934 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 12.3 mt -99.08 162.12 22.49 Favored Pre-proline 0 C--N 1.296 -1.746 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 86' ' ' GLU . 39.6 Cg_endo -64.7 -21.61 64.92 Favored 'Trans proline' 0 C--N 1.3 -2.018 0 O-C-N 123.765 1.403 . . . . 0.0 110.223 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -65.52 -32.78 74.57 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.277 -0.889 . . . . 0.0 109.279 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 117.3 -18.25 12.2 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -73.74 136.12 43.65 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.133 -1.216 . . . . 0.0 110.319 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.463 ' OE2' ' CG2' ' A' ' 97' ' ' THR . 78.9 tt0 -127.57 144.25 51.09 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -129.51 156.37 44.26 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.975 -1.078 . . . . 0.0 110.146 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -107.39 131.49 54.19 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.244 -0.91 . . . . 0.0 110.953 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -121.77 126.4 26.41 Favored Pre-proline 0 C--N 1.301 -1.529 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -65.7 139.89 59.75 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 123.32 1.169 . . . . 0.0 110.397 -179.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.444 ' ND2' ' O ' ' A' ' 110' ' ' ASN . 4.5 p-10 -97.67 82.58 3.08 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 122.513 1.149 . . . . 0.0 109.791 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -58.05 -24.23 57.6 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 120.368 -1.458 . . . . 0.0 109.371 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.449 HD22 ' HB2' ' A' ' 64' ' ' ASP . 86.7 mt -86.79 144.12 27.19 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.288 -0.882 . . . . 0.0 111.078 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -94.09 30.57 1.86 Allowed 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.718 0.77 . . . . 0.0 109.568 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 46.9 tp -61.99 136.17 57.85 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.58 0.705 . . . . 0.0 111.135 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.415 ' O ' ' HD3' ' A' ' 13' ' ' PRO . 10.0 pt-20 -98.29 -13.98 20.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.451 -0.781 . . . . 0.0 110.932 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.512 ' HA ' ' O ' ' A' ' 11' ' ' LEU . . . -163.45 157.29 19.63 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.44 -1.413 . . . . 0.0 111.972 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 84.9 mt -104.8 124.8 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.355 -0.841 . . . . 0.0 109.994 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -117.67 -20.95 8.72 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.082 -1.011 . . . . 0.0 110.989 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.519 ' HB3' ' O ' ' A' ' 35' ' ' GLY . 38.9 t80 -110.73 125.67 53.75 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.419 -0.801 . . . . 0.0 110.547 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.436 ' HB3' ' CD1' ' A' ' 9' ' ' LEU . 48.3 ttp -146.93 133.04 19.29 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.237 -0.914 . . . . 0.0 109.818 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.83 154.23 33.56 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.997 -1.064 . . . . 0.0 110.496 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -146.12 120.08 9.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.306 -0.871 . . . . 0.0 109.889 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.443 ' O ' ' CG2' ' A' ' 31' ' ' VAL . 55.6 t0 -135.29 106.32 6.66 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.347 -0.846 . . . . 0.0 109.594 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.445 ' HA3' ' HA ' ' A' ' 30' ' ' PHE . . . -171.54 -144.61 4.51 Favored Glycine 0 N--CA 1.484 1.844 0 C-N-CA 119.237 -1.458 . . . . 0.0 110.02 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.483 ' HB3' ' HA ' ' A' ' 27' ' ' ALA . 94.2 m-20 -90.07 14.1 13.24 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.644 -0.915 . . . . 0.0 110.873 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.408 ' HB3' ' CE1' ' A' ' 30' ' ' PHE . 28.1 t80 -107.89 135.28 49.55 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.899 -1.126 . . . . 0.0 109.748 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -105.15 121.3 43.54 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 118.874 -1.13 . . . . 0.0 110.421 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.402 ' O ' ' CG2' ' A' ' 128' ' ' ILE . 10.7 tt -93.79 115.92 33.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.511 -0.743 . . . . 0.0 110.592 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.409 ' O ' ' HB2' ' B' ' 133' ' ' PHE . 98.7 mttt -101.54 -18.35 15.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.091 -1.006 . . . . 0.0 110.517 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -157.79 143.99 17.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.82 -1.175 . . . . 0.0 111.484 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 42.5 t -116.58 132.22 66.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.412 ' HA ' ' HB2' ' B' ' 130' ' ' CYS . . . -121.95 144.61 48.76 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.738 -1.226 . . . . 0.0 111.906 -177.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -83.37 -136.64 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 61.0 t0 . . . . . 0 N--CA 1.49 1.571 0 O-C-N 120.69 -1.256 . . . . 0.0 110.201 179.831 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 121.272 0.558 . . . . 0.0 110.088 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 2' ' ' CYS . . . . . . . . . . . . . 3.3 t -122.5 -135.65 0.3 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.248 -0.907 . . . . 0.0 108.72 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 3' ' ' GLY . . . . . 0.406 ' C ' ' ND2' ' A' ' 8' ' ' ASN . . . 90.41 23.26 32.02 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . 0.426 ' HA ' ' HB3' ' A' ' 8' ' ' ASN . 36.0 tp -60.0 128.21 35.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.03 -1.276 . . . . 0.0 109.882 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 53.7 t -120.34 130.44 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 119.731 -0.788 . . . . 0.0 109.759 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -123.6 164.6 18.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.155 -0.966 . . . . 0.0 110.902 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' SER . . . . . 0.45 ' O ' ' HB3' ' B' ' 8' ' ' ASN . 26.2 p -151.72 172.52 15.99 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . 0.45 ' HB3' ' O ' ' B' ' 7' ' ' SER . 31.8 t30 61.59 32.84 18.53 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.571 -0.706 . . . . 0.0 109.819 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . 0.529 ' O ' ' C ' ' B' ' 10' ' ' ASN . 96.3 mt -85.79 -5.97 59.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.529 -0.732 . . . . 0.0 111.198 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' ASN . . . . . 0.529 ' C ' ' O ' ' B' ' 9' ' ' LEU . 0.6 OUTLIER -0.16 70.53 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.714 0 CA-C-O 121.86 0.838 . . . . 0.0 112.817 -178.62 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' B' ' 116' ' ' ALA . 32.4 tp -88.34 138.61 31.28 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.24 167.53 8.95 Favored Pre-proline 0 C--N 1.292 -1.895 0 O-C-N 120.917 -1.114 . . . . 0.0 111.321 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' B' ' 115' ' ' GLU . 45.6 Cg_endo -67.96 147.05 73.42 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 124.195 1.629 . . . . 0.0 110.584 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.23 -3.96 62.15 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -116.46 147.32 41.83 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.965 -1.314 . . . . 0.0 109.862 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' CYS . . . . . . . . . . . . . 2.3 m -99.27 142.92 30.13 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.168 -0.958 . . . . 0.0 110.497 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 52.7 tp -118.5 128.1 54.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.474 -0.766 . . . . 0.0 109.618 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -128.96 133.59 47.87 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.994 -1.066 . . . . 0.0 111.155 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 55.7 t -121.38 126.55 75.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.341 -0.849 . . . . 0.0 109.604 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 52.9 ttt-85 -108.45 125.06 51.34 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.203 -0.935 . . . . 0.0 110.061 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -148.74 -162.3 10.17 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -139.0 142.74 38.3 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.585 -0.95 . . . . 0.0 110.23 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.444 ' CG1' ' HB1' ' B' ' 27' ' ' ALA . 23.2 t -98.47 130.83 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.308 -0.87 . . . . 0.0 110.721 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.76 167.89 1.67 Allowed Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.41 -0.806 . . . . 0.0 110.16 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -68.58 -19.55 42.11 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.882 1.464 . . . . 0.0 109.924 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' B' ' 28' ' ' LYS . 47.4 t0 -113.09 56.93 0.67 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.535 -0.728 . . . . 0.0 109.444 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . 0.494 ' HA ' ' HB3' ' B' ' 125' ' ' ASP . . . -69.51 63.72 0.17 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.488 -0.757 . . . . 0.0 109.791 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' B' ' 26' ' ' ASP . 88.3 tttt -63.24 -45.14 92.97 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.713 -0.617 . . . . 0.0 110.201 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 13.6 t -161.97 139.01 8.33 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.087 -1.008 . . . . 0.0 111.438 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' PHE . . . . . 0.448 ' HA ' ' HA3' ' B' ' 124' ' ' GLY . 25.9 t80 -135.08 144.96 47.49 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.356 -0.84 . . . . 0.0 109.925 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.447 ' CG2' ' O ' ' B' ' 123' ' ' ASP . 18.4 m -126.63 133.2 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 120.905 -1.122 . . . . 0.0 110.761 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 19.9 tp -129.33 135.85 49.27 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 121.55 -0.719 . . . . 0.0 110.069 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -142.81 145.55 33.32 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.755 -1.216 . . . . 0.0 110.797 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' B' ' 34' ' ' LEU . 1.1 pp -149.89 119.93 7.2 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.3 -0.875 . . . . 0.0 111.008 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . 0.506 ' O ' ' HB3' ' B' ' 119' ' ' TYR . . . -160.81 -158.81 9.51 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.151 -1.579 . . . . 0.0 109.151 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . 0.433 ' O ' ' HB2' ' B' ' 119' ' ' TYR . 60.1 mtpt -72.93 -40.36 65.5 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.083 -1.245 . . . . 0.0 108.868 177.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -153.17 -167.28 2.67 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.68 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 40.2 t -61.98 -46.1 90.71 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.602 -0.686 . . . . 0.0 112.531 -178.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' ASN . . . . . 0.41 ' HB3' ' N ' ' B' ' 66' ' ' GLY . 70.7 m-20 -94.65 0.42 55.08 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.644 -1.285 . . . . 0.0 110.5 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -113.15 62.45 0.64 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.256 -0.902 . . . . 0.0 109.536 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.428 ' HA ' ' HA3' ' B' ' 35' ' ' GLY . 92.1 mt -103.46 136.94 42.26 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 121.249 0.547 . . . . 0.0 109.554 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' CYS . . . . . . . . . . . . . 65.7 m -87.78 -38.64 15.58 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.218 -0.926 . . . . 0.0 108.764 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 94.6 mt -132.06 140.98 49.06 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.158 -0.964 . . . . 0.0 111.096 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' HIS . . . . . 0.463 ' HB3' ' HB3' ' B' ' 61' ' ' ASN . 81.8 t60 -132.03 102.95 6.03 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -102.09 141.83 34.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.234 -0.916 . . . . 0.0 110.727 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' ASN . . . . . 0.447 ' ND2' HG12 ' B' ' 31' ' ' VAL . 1.2 t-20 -154.85 84.97 3.67 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.366 -0.834 . . . . 0.0 110.658 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' PRO . . . . . 0.443 ' HA ' HG12 ' B' ' 58' ' ' ILE . 46.3 Cg_endo -67.23 148.32 80.24 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.847 1.446 . . . . 0.0 110.692 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -132.93 107.86 8.56 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.307 -0.87 . . . . 0.0 111.036 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -61.97 -47.89 82.8 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.414 -0.804 . . . . 0.0 109.496 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -151.05 97.98 2.52 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.499 -0.751 . . . . 0.0 109.653 178.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -105.54 -126.55 0.24 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.074 -1.016 . . . . 0.0 110.333 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' HIS . . . . . . . . . . . . . 41.2 m170 -61.23 -34.35 74.98 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.696 -1.253 . . . . 0.0 110.946 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 170.48 33.12 0.02 OUTLIER Glycine 0 N--CA 1.492 2.397 0 C-N-CA 119.167 -1.492 . . . . 0.0 111.062 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -117.5 -166.02 1.15 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.982 -1.305 . . . . 0.0 109.301 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.503 ' O ' ' C ' ' B' ' 56' ' ' ASN . . . -152.15 149.14 28.44 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.218 -0.926 . . . . 0.0 109.674 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' ASN . . . . . 0.503 ' C ' ' O ' ' B' ' 55' ' ' ALA . 85.6 m-20 16.85 60.24 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.345 0 CA-C-O 121.473 0.654 . . . . 0.0 112.562 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' B' ' 55' ' ' ALA . 77.8 m -120.08 132.84 55.58 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.411 -0.806 . . . . 0.0 110.49 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' ILE . . . . . 0.443 HG12 ' HA ' ' B' ' 47' ' ' PRO . 97.0 mt -119.36 133.75 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.498 -0.751 . . . . 0.0 111.386 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 54.9 t -111.9 128.13 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.317 -0.864 . . . . 0.0 109.28 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 1.9 t -94.96 122.46 37.63 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.982 -1.074 . . . . 0.0 110.313 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' ASN . . . . . 0.463 ' HB3' ' HB3' ' B' ' 44' ' ' HIS . 6.8 t-20 -120.52 148.19 44.17 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.42 -0.8 . . . . 0.0 109.211 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 34.8 t -136.4 142.83 43.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.957 -1.09 . . . . 0.0 110.237 -178.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . 0.47 ' CD ' ' HA2' ' B' ' 66' ' ' GLY . 27.0 ttmt -143.17 127.15 17.34 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 118.931 -1.108 . . . . 0.0 111.93 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' ASP . . . . . 0.433 ' HB2' HD22 ' B' ' 112' ' ' LEU . 26.8 t0 -106.55 104.13 13.74 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 63.76 20.13 63.79 Favored Glycine 0 N--CA 1.483 1.82 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . 0.47 ' HA2' ' CD ' ' B' ' 63' ' ' LYS . . . 69.57 36.27 76.23 Favored Glycine 0 N--CA 1.487 2.062 0 O-C-N 120.624 -1.515 . . . . 0.0 110.084 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -127.85 12.45 6.76 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.732 -1.452 . . . . 0.0 112.378 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 68' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -138.08 -74.71 0.4 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.615 -1.303 . . . . 0.0 110.505 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.81 32.46 49.89 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -59.58 121.58 11.93 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.134 -1.216 . . . . 0.0 109.486 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -117.12 133.46 55.98 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.156 -0.965 . . . . 0.0 112.062 -178.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -127.31 -162.96 1.21 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.399 -0.813 . . . . 0.0 109.157 178.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -141.44 139.79 33.46 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.676 -1.265 . . . . 0.0 112.066 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -126.75 124.56 40.02 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.969 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -102.29 46.55 0.92 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.834 -1.166 . . . . 0.0 110.945 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 76.5 t -122.8 127.44 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.097 -1.002 . . . . 0.0 109.739 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 77' ' ' PHE . . . . . 0.469 ' CD2' ' O ' ' B' ' 77' ' ' PHE . 83.4 t80 -162.47 74.13 2.16 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 120.962 -1.086 . . . . 0.0 110.878 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . 0.493 ' HD2' ' CE2' ' B' ' 79' ' ' PHE . 55.7 Cg_endo -79.71 43.63 1.54 Allowed 'Trans proline' 0 C--N 1.302 -1.877 0 O-C-N 123.914 1.481 . . . . 0.0 111.08 179.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 79' ' ' PHE . . . . . 0.493 ' CE2' ' HD2' ' B' ' 78' ' ' PRO . 68.4 m-85 -128.22 151.25 49.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.85 -1.156 . . . . 0.0 109.463 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.24 168.23 15.47 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.095 -1.003 . . . . 0.0 110.329 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 81' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -69.43 147.29 64.63 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.994 1.523 . . . . 0.0 109.959 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 56.76 41.56 90.68 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 37.4 t -134.39 143.01 47.37 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.05 -1.265 . . . . 0.0 110.637 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 7.1 p -90.14 136.62 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.38 -0.825 . . . . 0.0 109.614 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -154.34 150.91 28.45 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.121 -0.987 . . . . 0.0 110.043 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -115.84 137.59 51.95 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 78.2 t -115.5 128.34 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.925 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 88' ' ' CYS . . . . . . . . . . . . . 1.9 t -99.69 129.48 45.83 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.292 -0.88 . . . . 0.0 109.876 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 98.0 mt -122.38 127.21 75.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.319 -0.863 . . . . 0.0 110.111 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 90' ' ' THR . . . . . 0.404 ' HB ' ' HB ' ' B' ' 97' ' ' THR . 92.7 m -120.3 127.25 52.2 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.135 -0.978 . . . . 0.0 109.137 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 91' ' ' PHE . . . . . 0.4 ' O ' ' HA ' ' B' ' 13' ' ' PRO . 66.0 t80 -113.46 112.67 24.0 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.243 -0.983 . . . . 0.0 110.833 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -120.14 148.62 43.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.472 -0.768 . . . . 0.0 109.64 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -63.17 -33.8 76.26 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.021 -1.049 . . . . 0.0 109.91 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.8 -40.85 95.91 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.257 -0.902 . . . . 0.0 109.999 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -171.75 178.22 3.14 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.302 -0.874 . . . . 0.0 110.484 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 96' ' ' LEU . . . . . . . . . . . . . 94.7 mt -105.09 131.62 52.36 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.349 -0.845 . . . . 0.0 110.134 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 97' ' ' THR . . . . . 0.456 ' CG2' ' OE2' ' B' ' 105' ' ' GLU . 44.6 m -121.05 129.49 53.37 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.171 -0.956 . . . . 0.0 109.779 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 59.9 t -125.63 128.83 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.94 -1.1 . . . . 0.0 109.241 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -116.35 126.51 53.6 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.069 -1.052 . . . . 0.0 109.765 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 12.2 mt -99.67 162.0 22.62 Favored Pre-proline 0 C--N 1.296 -1.736 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -64.57 -21.58 65.59 Favored 'Trans proline' 0 C--N 1.299 -2.046 0 O-C-N 123.757 1.399 . . . . 0.0 110.275 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -65.76 -32.85 74.63 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.287 -0.883 . . . . 0.0 109.268 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 117.92 -18.54 11.48 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 104' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -73.62 136.25 43.89 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.178 -1.189 . . . . 0.0 110.37 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 105' ' ' GLU . . . . . 0.456 ' OE2' ' CG2' ' B' ' 97' ' ' THR . 79.0 tt0 -127.51 143.62 51.16 Favored 'General case' 0 C--N 1.298 -1.63 0 O-C-N 121.443 -0.786 . . . . 0.0 109.001 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -128.99 155.83 44.75 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.887 -1.133 . . . . 0.0 110.221 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -106.96 132.37 52.97 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.21 -0.931 . . . . 0.0 111.003 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 108' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -122.8 126.61 26.02 Favored Pre-proline 0 C--N 1.301 -1.51 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -65.68 139.74 59.19 Favored 'Trans proline' 0 C--N 1.303 -1.844 0 O-C-N 123.286 1.15 . . . . 0.0 110.391 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 110' ' ' ASN . . . . . 0.443 ' ND2' ' O ' ' B' ' 110' ' ' ASN . 4.7 p-10 -97.52 82.64 3.12 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 122.488 1.137 . . . . 0.0 109.653 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -58.05 -24.23 57.61 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 120.263 -1.523 . . . . 0.0 109.433 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 112' ' ' LEU . . . . . 0.433 HD22 ' HB2' ' B' ' 64' ' ' ASP . 87.2 mt -86.84 143.44 27.46 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.355 -0.841 . . . . 0.0 111.218 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -93.39 30.53 1.69 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.612 -0.68 . . . . 0.0 109.579 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 46.7 tp -62.21 135.62 57.57 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.706 0.765 . . . . 0.0 111.443 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 115' ' ' GLU . . . . . 0.427 ' O ' ' HD3' ' B' ' 13' ' ' PRO . 9.8 pt-20 -97.19 -15.52 20.84 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.485 -0.759 . . . . 0.0 110.974 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 116' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' B' ' 11' ' ' LEU . . . -162.36 157.12 22.21 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.47 -1.394 . . . . 0.0 112.129 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 85.0 mt -104.31 124.68 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.373 -0.829 . . . . 0.0 110.006 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -117.68 -20.74 8.81 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.14 -0.975 . . . . 0.0 110.982 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 119' ' ' TYR . . . . . 0.506 ' HB3' ' O ' ' B' ' 35' ' ' GLY . 38.9 t80 -110.87 125.35 53.53 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.264 -0.897 . . . . 0.0 110.638 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 120' ' ' MET . . . . . 0.447 ' HB3' ' CD1' ' B' ' 9' ' ' LEU . 48.5 ttp -146.75 133.21 19.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.226 -0.921 . . . . 0.0 109.878 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -154.01 154.29 33.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.061 -1.024 . . . . 0.0 110.659 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -146.03 120.58 9.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.279 -0.888 . . . . 0.0 109.879 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 123' ' ' ASP . . . . . 0.447 ' O ' ' CG2' ' B' ' 31' ' ' VAL . 55.0 t0 -135.42 106.57 6.72 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.381 -0.824 . . . . 0.0 109.559 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 124' ' ' GLY . . . . . 0.448 ' HA3' ' HA ' ' B' ' 30' ' ' PHE . . . -171.52 -144.26 4.37 Favored Glycine 0 N--CA 1.486 1.981 0 C-N-CA 119.26 -1.448 . . . . 0.0 110.227 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . 0.494 ' HB3' ' HA ' ' B' ' 27' ' ' ALA . 93.8 m-20 -90.56 14.43 13.2 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.697 -0.884 . . . . 0.0 110.859 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 126' ' ' PHE . . . . . 0.415 ' HB3' ' CE1' ' B' ' 30' ' ' PHE . 27.3 t80 -108.17 135.57 49.29 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.015 -1.053 . . . . 0.0 109.661 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -105.56 120.86 42.69 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.006 -1.077 . . . . 0.0 110.367 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . 0.405 ' O ' ' CG2' ' B' ' 128' ' ' ILE . 10.3 tt -93.58 116.38 34.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.639 -0.663 . . . . 0.0 110.524 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -102.06 -19.41 15.18 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.104 -0.997 . . . . 0.0 110.497 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 130' ' ' CYS . . . . . 0.412 ' HB2' ' HA ' ' A' ' 132' ' ' ALA . 0.0 OUTLIER -155.93 144.18 19.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.883 -1.136 . . . . 0.0 111.591 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 40.2 t -116.88 131.87 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 132' ' ' ALA . . . . . . . . . . . . . . . -121.65 144.32 48.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.572 -1.33 . . . . 0.0 111.746 -177.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . 0.409 ' HB2' ' O ' ' A' ' 129' ' ' LYS . 3.0 t80 -83.17 -135.58 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.758 -0.589 . . . . 0.0 109.433 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 61.5 t0 . . . . . 0 N--CA 1.492 1.628 0 O-C-N 120.697 -1.252 . . . . 0.0 110.147 179.504 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.208 0.528 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.432 ' N ' ' OD1' ' A' ' 123' ' ' ASP . 0.5 OUTLIER -158.02 101.4 1.76 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.184 -0.948 . . . . 0.0 110.634 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 122' ' ' ALA . . . -176.84 128.25 1.31 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.452 ' HG ' ' N ' ' A' ' 5' ' ' VAL . 0.3 OUTLIER -67.62 154.67 40.94 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.537 -0.979 . . . . 0.0 111.218 -179.467 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.452 ' N ' ' HG ' ' A' ' 4' ' ' LEU . 76.5 t -118.16 136.92 53.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.397 -0.814 . . . . 0.0 109.666 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -119.59 164.4 15.91 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.699 -1.25 . . . . 0.0 111.305 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.0 p -153.08 166.35 32.74 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.477 -0.764 . . . . 0.0 109.898 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.426 ' ND2' ' O ' ' B' ' 3' ' ' GLY . 55.4 t30 60.81 38.54 17.93 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.273 -0.892 . . . . 0.0 109.759 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.536 ' O ' ' C ' ' A' ' 10' ' ' ASN . 61.5 mt -89.74 -3.35 58.23 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.705 -0.622 . . . . 0.0 111.849 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.536 ' C ' ' O ' ' A' ' 9' ' ' LEU . 8.2 m120 6.09 78.1 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.634 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 3.6 tt -100.24 129.78 46.28 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.303 -0.873 . . . . 0.0 110.035 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.3 mtpp -97.95 164.86 16.51 Favored Pre-proline 0 C--N 1.297 -1.694 0 O-C-N 121.445 -0.784 . . . . 0.0 110.37 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -66.93 147.28 80.14 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 123.991 1.521 . . . . 0.0 110.265 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.66 7.84 62.76 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -115.42 146.83 41.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.833 -1.393 . . . . 0.0 110.287 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 48.8 t -106.54 137.93 43.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.341 -0.85 . . . . 0.0 110.438 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 45.5 tp -117.84 130.06 56.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.316 -0.865 . . . . 0.0 109.79 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.418 ' CZ ' ' OE1' ' A' ' 86' ' ' GLU . 77.5 ttt180 -118.95 128.74 54.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.941 -1.099 . . . . 0.0 110.633 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 25.1 t -121.13 125.29 73.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.256 -0.902 . . . . 0.0 110.725 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.45 ' HA ' ' HG2' ' A' ' 86' ' ' GLU . 75.8 ttt180 -109.86 129.01 55.69 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -149.19 -170.0 16.34 Favored Glycine 0 N--CA 1.486 1.974 0 C-N-CA 119.146 -1.502 . . . . 0.0 110.131 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.429 ' OE1' ' NZ ' ' A' ' 129' ' ' LYS . 84.3 tt0 -129.59 123.28 30.94 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.786 -0.832 . . . . 0.0 109.709 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.455 ' CG1' ' HB2' ' A' ' 27' ' ' ALA . 99.1 t -79.19 129.5 37.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.144 -0.973 . . . . 0.0 109.713 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.76 163.16 1.5 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.009 -1.057 . . . . 0.0 110.049 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.84 -18.26 47.09 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.977 1.514 . . . . 0.0 110.327 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' A' ' 28' ' ' LYS . 63.9 t0 -113.61 56.76 0.69 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.244 -0.91 . . . . 0.0 109.284 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.455 ' HB2' ' CG1' ' A' ' 23' ' ' VAL . . . -59.8 84.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.602 -0.686 . . . . 0.0 110.227 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.462 ' HA ' ' HB3' ' A' ' 49' ' ' PHE . 85.1 tttt -109.64 -33.94 6.63 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.024 -1.047 . . . . 0.0 111.835 -179.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.2 t -146.22 140.45 26.58 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.626 -1.296 . . . . 0.0 111.671 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.5 ' CE2' ' HB2' ' A' ' 126' ' ' PHE . 83.3 m-85 -139.56 146.47 39.91 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.393 -0.817 . . . . 0.0 110.188 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.407 ' HB ' ' O ' ' A' ' 123' ' ' ASP . 63.7 t -133.44 130.0 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.96 -1.088 . . . . 0.0 109.798 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.45 ' HB2' ' HB2' ' A' ' 45' ' ' PHE . 94.7 mt -131.75 144.58 51.06 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.027 -1.046 . . . . 0.0 110.374 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -146.13 108.75 4.5 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.232 -0.917 . . . . 0.0 110.122 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.451 ' CD1' ' HB2' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -124.25 111.27 15.65 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.154 -0.966 . . . . 0.0 110.107 179.511 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -159.81 -122.84 0.67 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.43 ' O ' ' HB2' ' A' ' 119' ' ' TYR . 0.1 OUTLIER -130.4 -46.12 1.09 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.396 -1.061 . . . . 0.0 108.864 179.518 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.432 ' HB2' ' HB2' ' A' ' 40' ' ' ASN . 87.6 m-20 -122.18 164.0 18.57 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.8 t -56.46 -42.33 78.03 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.293 -0.879 . . . . 0.0 111.631 -178.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.465 ' HB3' ' N ' ' A' ' 66' ' ' GLY . 92.4 m-20 -92.06 -0.11 57.46 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.89 -1.131 . . . . 0.0 111.002 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.455 ' N ' ' ND2' ' A' ' 40' ' ' ASN . 2.8 m-80 -117.37 61.7 0.75 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.95 -1.094 . . . . 0.0 109.854 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.7 mt -90.3 137.84 32.02 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.742 -0.599 . . . . 0.0 109.795 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.405 ' SG ' ' N ' ' A' ' 43' ' ' LEU . 6.8 p -88.62 -30.0 19.54 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.248 -0.907 . . . . 0.0 109.751 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.451 ' HB2' ' CD1' ' A' ' 34' ' ' LEU . 69.6 mt -137.09 138.14 40.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.904 . . . . 0.0 110.963 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -135.84 126.48 27.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.404 -0.81 . . . . 0.0 110.125 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.45 ' HB2' ' HB2' ' A' ' 32' ' ' LEU . 91.9 m-85 -113.01 141.96 46.26 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.996 -1.065 . . . . 0.0 110.024 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -154.72 69.94 5.86 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 120.996 -1.065 . . . . 0.0 110.986 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.42 147.46 65.13 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.68 1.358 . . . . 0.0 110.081 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.43 ' NH2' ' HB1' ' A' ' 51' ' ' ALA . 82.9 mtp180 -137.82 111.34 8.08 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.007 -1.058 . . . . 0.0 110.66 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.462 ' HB3' ' HA ' ' A' ' 28' ' ' LYS . 85.6 t80 -62.06 -46.31 89.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.312 -0.868 . . . . 0.0 110.03 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -164.64 99.45 0.79 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -0.909 . . . . 0.0 110.078 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.43 ' HB1' ' NH2' ' A' ' 48' ' ' ARG . . . -109.97 -89.81 0.48 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.254 -0.904 . . . . 0.0 109.911 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -63.1 -42.37 99.56 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.927 -1.108 . . . . 0.0 109.075 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 161.81 38.46 0.02 OUTLIER Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -117.54 -171.63 2.08 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.28 -1.13 . . . . 0.0 110.015 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.474 ' O ' ' C ' ' A' ' 56' ' ' ASN . . . -145.22 152.62 40.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.337 -0.852 . . . . 0.0 110.454 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.489 ' HB3' ' CD1' ' A' ' 77' ' ' PHE . 36.2 m120 23.09 56.79 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 45.9 m -112.91 132.62 55.25 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.338 -0.851 . . . . 0.0 109.042 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.42 HD13 HG21 ' A' ' 58' ' ' ILE . 75.1 mt -117.03 135.55 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.147 -0.971 . . . . 0.0 111.774 -177.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.412 ' CG1' ' OE2' ' A' ' 71' ' ' GLU . 47.4 t -110.9 130.36 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.369 -0.832 . . . . 0.0 109.539 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 75.1 m -130.94 126.17 35.38 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.036 -1.04 . . . . 0.0 110.695 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.444 ' CB ' ' HA ' ' A' ' 71' ' ' GLU . 3.6 p-10 -151.35 173.29 14.68 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.245 -0.909 . . . . 0.0 110.727 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.454 ' O ' ' CA ' ' A' ' 69' ' ' GLY . 69.0 m -131.77 155.2 48.14 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.506 -0.746 . . . . 0.0 109.858 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.479 ' CD ' ' HA2' ' A' ' 66' ' ' GLY . 8.9 ttmt -135.2 150.45 50.11 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.679 -1.263 . . . . 0.0 111.367 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -124.49 105.51 9.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.426 -0.797 . . . . 0.0 109.937 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 57.58 27.01 58.08 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.479 ' HA2' ' CD ' ' A' ' 63' ' ' LYS . . . 75.46 23.19 74.01 Favored Glycine 0 N--CA 1.488 2.129 0 O-C-N 120.777 -1.425 . . . . 0.0 109.771 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.501 ' HB3' ' CD1' ' A' ' 68' ' ' TRP . . . -81.2 -85.32 0.1 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.189 -1.183 . . . . 0.0 110.835 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.501 ' CD1' ' HB3' ' A' ' 67' ' ' ALA . 10.3 m95 -135.35 -146.89 0.25 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.884 -1.135 . . . . 0.0 109.849 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.454 ' CA ' ' O ' ' A' ' 62' ' ' SER . . . 167.38 129.45 1.07 Allowed Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.641 -1.266 . . . . 0.0 110.544 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.3 m -81.51 80.2 7.93 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.45 -1.029 . . . . 0.0 109.824 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.444 ' HA ' ' CB ' ' A' ' 61' ' ' ASN . 83.5 tt0 -72.37 124.75 25.79 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.201 -0.937 . . . . 0.0 111.134 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -109.53 -162.0 0.79 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.381 -0.824 . . . . 0.0 109.624 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 62.5 ttp85 -145.91 117.38 8.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.185 -0.947 . . . . 0.0 110.697 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -110.4 125.73 53.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.207 -0.933 . . . . 0.0 109.711 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -105.83 45.7 0.96 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.168 -0.957 . . . . 0.0 111.85 -178.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 51.7 t -121.41 133.01 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 120.965 -1.085 . . . . 0.0 109.843 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.532 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 11.3 p90 -143.02 82.03 12.32 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.102 -0.999 . . . . 0.0 111.248 -178.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -79.99 41.29 1.09 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.495 1.26 . . . . 0.0 111.378 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -149.83 163.24 38.56 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.701 -1.249 . . . . 0.0 110.971 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 13.6 mp0 -129.94 164.58 39.5 Favored Pre-proline 0 N--CA 1.492 1.668 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.79 148.86 65.82 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 123.593 1.312 . . . . 0.0 110.859 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 63.42 41.75 99.26 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 25.1 t -137.36 137.32 38.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.198 -1.178 . . . . 0.0 111.276 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 27.6 m -79.18 135.51 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.472 -0.767 . . . . 0.0 109.53 179.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.66 154.58 37.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.974 -1.079 . . . . 0.0 110.6 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.45 ' HG2' ' HA ' ' A' ' 20' ' ' ARG . 97.4 mt-10 -121.05 140.11 52.39 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.473 -0.767 . . . . 0.0 109.65 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.9 t -122.64 130.28 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.101 -0.999 . . . . 0.0 110.36 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 22.2 m -92.73 125.0 37.15 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.439 -0.788 . . . . 0.0 109.821 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 95.8 mt -122.05 125.0 72.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.045 -1.035 . . . . 0.0 110.246 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 53.9 m -121.76 124.55 44.47 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.392 -0.817 . . . . 0.0 108.913 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.414 ' CD1' ' CD2' ' A' ' 96' ' ' LEU . 65.7 t80 -110.51 112.84 25.02 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.142 -0.974 . . . . 0.0 110.333 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -121.04 150.32 41.36 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.612 -0.68 . . . . 0.0 109.226 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -64.35 -33.65 76.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.773 -1.204 . . . . 0.0 110.064 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.74 -46.02 90.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.969 -1.082 . . . . 0.0 109.558 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -168.63 175.59 6.07 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.425 -0.797 . . . . 0.0 109.764 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.414 ' CD2' ' CD1' ' A' ' 91' ' ' PHE . 79.1 mt -107.71 128.6 54.72 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.158 -0.964 . . . . 0.0 110.414 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.5 m -109.93 126.67 54.14 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.162 -0.961 . . . . 0.0 110.176 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 59.2 t -133.16 128.42 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 120.775 -1.203 . . . . 0.0 110.496 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -123.24 147.7 46.65 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.996 -1.065 . . . . 0.0 111.01 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.483 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 1.1 mp -100.84 167.73 10.35 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.587 -0.696 . . . . 0.0 109.636 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.483 ' HD2' ' HB3' ' A' ' 100' ' ' LEU . 41.7 Cg_endo -65.97 -22.63 55.21 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 123.408 1.215 . . . . 0.0 110.42 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -152.09 78.23 1.23 Allowed 'General case' 0 N--CA 1.486 1.325 0 O-C-N 121.129 -0.982 . . . . 0.0 109.8 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -177.91 -171.91 41.81 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -87.59 -150.8 0.17 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.379 -1.071 . . . . 0.0 110.009 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 64.3 tt0 -128.92 146.23 51.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.238 -0.914 . . . . 0.0 110.661 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -130.38 134.27 47.02 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.279 -0.888 . . . . 0.0 109.968 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -114.83 144.7 43.11 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.204 -0.935 . . . . 0.0 110.859 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.457 ' CE2' ' O ' ' A' ' 109' ' ' PRO . 56.7 t80 -129.17 133.65 25.41 Favored Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.457 ' O ' ' CE2' ' A' ' 108' ' ' PHE . 44.9 Cg_endo -66.83 138.79 49.82 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.359 1.189 . . . . 0.0 110.389 -178.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' A' ' 110' ' ' ASN . 5.2 p-10 -100.39 78.49 2.03 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.318 -0.864 . . . . 0.0 110.263 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.403 ' C ' ' O ' ' A' ' 110' ' ' ASN . 79.6 ttt180 -41.46 -32.65 0.35 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.429 -0.794 . . . . 0.0 110.797 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 95.0 mt -78.93 149.67 32.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.369 -0.832 . . . . 0.0 110.313 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -104.42 40.56 1.45 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.408 -0.808 . . . . 0.0 109.874 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 56.4 tp -71.16 125.93 28.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.203 -0.935 . . . . 0.0 109.766 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -96.75 -5.34 38.81 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.489 -0.757 . . . . 0.0 111.086 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.434 ' HA ' ' O ' ' A' ' 11' ' ' LEU . . . -141.46 142.0 33.66 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.874 -1.141 . . . . 0.0 111.473 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.421 ' HB ' ' HB3' ' A' ' 11' ' ' LEU . 48.1 mm -102.73 121.29 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.401 ' ND2' ' N ' ' A' ' 118' ' ' ASN . 6.5 m-80 -117.94 -18.82 9.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.993 -1.067 . . . . 0.0 111.465 -178.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.43 ' HB2' ' O ' ' A' ' 36' ' ' LYS . 42.9 t80 -113.71 130.04 56.48 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.907 -1.121 . . . . 0.0 111.14 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.479 ' CB ' ' CD1' ' A' ' 9' ' ' LEU . 48.2 ttp -142.42 114.22 8.05 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -136.05 139.0 42.73 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.95 -1.094 . . . . 0.0 110.905 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.435 ' O ' ' HA3' ' A' ' 3' ' ' GLY . . . -141.83 131.92 24.72 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.51 -0.744 . . . . 0.0 109.137 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 2' ' ' CYS . 62.2 t0 -151.35 122.4 7.67 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.567 -0.708 . . . . 0.0 109.246 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.447 ' HA3' ' HA ' ' A' ' 30' ' ' PHE . . . 174.57 -148.98 10.14 Favored Glycine 0 N--CA 1.488 2.153 0 C-N-CA 119.192 -1.48 . . . . 0.0 110.165 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 30' ' ' PHE . 87.7 m-20 -86.35 9.16 18.78 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.672 -0.899 . . . . 0.0 110.283 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.5 ' HB2' ' CE2' ' A' ' 30' ' ' PHE . 51.1 t80 -104.06 141.77 35.63 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.122 -0.986 . . . . 0.0 109.662 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -116.08 120.05 37.81 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.168 -1.013 . . . . 0.0 111.108 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.426 ' O ' ' CG2' ' A' ' 128' ' ' ILE . 19.0 tt -95.47 119.57 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.232 -0.917 . . . . 0.0 109.923 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.429 ' NZ ' ' OE1' ' A' ' 22' ' ' GLU . 98.2 mttt -100.82 -15.4 17.63 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.128 -0.983 . . . . 0.0 111.571 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -155.54 146.89 22.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.808 -1.183 . . . . 0.0 111.425 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 43.2 t -124.91 129.37 73.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -118.96 140.07 50.61 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.961 -1.087 . . . . 0.0 110.521 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -106.36 119.61 39.72 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.415 -0.803 . . . . 0.0 109.976 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.9 t0 . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.538 -179.997 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.162 0.506 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' CYS . . . . . 0.427 ' N ' ' OD1' ' B' ' 123' ' ' ASP . 0.5 OUTLIER -157.71 104.22 1.95 Allowed 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.059 -1.026 . . . . 0.0 110.226 179.898 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . 0.426 ' O ' ' ND2' ' A' ' 8' ' ' ASN . . . 179.51 127.48 1.11 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . 0.459 ' HG ' ' N ' ' B' ' 5' ' ' VAL . 0.3 OUTLIER -67.27 154.42 41.34 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.728 -0.866 . . . . 0.0 111.342 -179.046 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.459 ' N ' ' HG ' ' B' ' 4' ' ' LEU . 72.7 t -118.11 137.08 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.578 -0.701 . . . . 0.0 109.676 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -119.56 164.81 15.27 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.772 -1.205 . . . . 0.0 111.309 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 14.1 p -153.23 166.37 32.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.292 -0.88 . . . . 0.0 109.645 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 54.8 t30 60.75 38.94 17.88 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.345 -0.847 . . . . 0.0 109.681 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . 0.553 ' O ' ' C ' ' B' ' 10' ' ' ASN . 63.2 mt -91.41 1.32 57.21 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.646 -0.659 . . . . 0.0 111.77 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . 0.553 ' C ' ' O ' ' B' ' 9' ' ' LEU . 7.9 m120 -0.16 80.65 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.565 0 CA-C-O 121.599 0.714 . . . . 0.0 112.715 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' B' ' 116' ' ' ALA . 3.4 tt -100.67 129.9 46.65 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.585 -0.697 . . . . 0.0 109.898 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . 0.404 ' HB3' ' HD2' ' B' ' 13' ' ' PRO . 3.3 mtpp -98.31 165.18 15.71 Favored Pre-proline 0 C--N 1.295 -1.783 0 O-C-N 121.481 -0.762 . . . . 0.0 110.441 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' B' ' 12' ' ' LYS . 45.3 Cg_endo -66.88 147.38 80.49 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.96 1.505 . . . . 0.0 110.389 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.81 7.06 63.16 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 110.259 -1.137 . . . . 0.0 110.259 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -114.99 146.78 40.87 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.841 -1.388 . . . . 0.0 110.507 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' CYS . . . . . . . . . . . . . 49.4 t -106.44 137.86 43.65 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.413 -0.804 . . . . 0.0 110.561 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 45.3 tp -117.86 130.03 56.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.358 -0.839 . . . . 0.0 109.694 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . 0.413 ' CZ ' ' OE1' ' B' ' 86' ' ' GLU . 76.9 ttt180 -118.91 129.4 55.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.02 -1.05 . . . . 0.0 110.498 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 24.9 t -121.75 125.07 72.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.279 -0.888 . . . . 0.0 110.682 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . 0.445 ' HA ' ' HG2' ' B' ' 86' ' ' GLU . 76.1 ttt180 -109.55 128.88 55.51 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.34 -0.85 . . . . 0.0 108.869 178.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -149.4 -170.01 16.49 Favored Glycine 0 N--CA 1.486 1.988 0 C-N-CA 118.997 -1.573 . . . . 0.0 110.086 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . 0.426 ' OE1' ' NZ ' ' B' ' 129' ' ' LYS . 84.6 tt0 -129.54 123.38 31.27 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.678 -0.895 . . . . 0.0 109.774 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.454 ' CG1' ' HB2' ' B' ' 27' ' ' ALA . 99.2 t -79.36 129.65 37.25 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 121.287 -0.883 . . . . 0.0 109.6 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.77 163.26 1.48 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.16 -0.962 . . . . 0.0 110.027 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -67.74 -18.81 47.78 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.952 1.501 . . . . 0.0 110.196 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' B' ' 28' ' ' LYS . 64.1 t0 -113.3 56.94 0.68 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.244 -0.91 . . . . 0.0 109.391 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . 0.454 ' HB2' ' CG1' ' B' ' 23' ' ' VAL . . . -59.96 84.89 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.679 -0.638 . . . . 0.0 110.163 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . 0.466 ' HA ' ' HB3' ' B' ' 49' ' ' PHE . 85.2 tttt -109.78 -33.49 6.73 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.065 -1.022 . . . . 0.0 111.777 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 37.1 t -146.58 140.1 25.84 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.674 -1.266 . . . . 0.0 111.535 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' PHE . . . . . 0.49 ' CE2' ' HB2' ' B' ' 126' ' ' PHE . 83.9 m-85 -139.3 146.04 39.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.439 -0.788 . . . . 0.0 110.142 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.401 ' HB ' ' O ' ' B' ' 123' ' ' ASP . 62.9 t -133.04 129.77 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.907 -1.121 . . . . 0.0 109.893 178.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.454 ' HB2' ' HB2' ' B' ' 45' ' ' PHE . 94.9 mt -131.31 144.64 51.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.103 -0.998 . . . . 0.0 110.565 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -146.07 108.87 4.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.302 -0.874 . . . . 0.0 110.238 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.452 ' CD1' ' HB2' ' B' ' 43' ' ' LEU . 0.3 OUTLIER -124.19 110.19 14.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.178 -0.951 . . . . 0.0 110.047 179.472 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -157.78 -122.39 0.7 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . 0.428 ' O ' ' HB2' ' B' ' 119' ' ' TYR . 0.1 OUTLIER -130.83 -46.12 1.04 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.571 -0.958 . . . . 0.0 108.707 179.177 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . 0.427 ' HB2' ' HB2' ' B' ' 40' ' ' ASN . 87.3 m-20 -122.2 164.14 18.35 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 28.4 t -56.88 -41.99 79.02 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.312 -0.867 . . . . 0.0 111.372 -178.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' ASN . . . . . 0.466 ' HB3' ' N ' ' B' ' 66' ' ' GLY . 92.1 m-20 -92.31 0.02 57.42 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.862 -1.149 . . . . 0.0 111.002 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' ASN . . . . . 0.454 ' ND2' ' N ' ' B' ' 40' ' ' ASN . 2.7 m-80 -117.62 61.88 0.75 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.026 -1.046 . . . . 0.0 109.594 -178.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 95.7 mt -90.33 139.33 30.77 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.757 -0.59 . . . . 0.0 109.651 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' CYS . . . . . . . . . . . . . 7.4 p -90.8 -28.91 17.91 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.183 -0.948 . . . . 0.0 109.557 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.452 ' HB2' ' CD1' ' B' ' 34' ' ' LEU . 70.7 mt -137.54 137.62 38.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.359 -0.838 . . . . 0.0 110.954 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -135.42 126.77 28.43 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.388 -0.82 . . . . 0.0 110.094 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.454 ' HB2' ' HB2' ' B' ' 32' ' ' LEU . 91.6 m-85 -113.44 141.32 47.24 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.93 -1.106 . . . . 0.0 109.994 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -154.2 69.87 6.19 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 120.96 -1.088 . . . . 0.0 111.069 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' B' ' 58' ' ' ILE . 52.6 Cg_endo -69.35 147.09 64.72 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.757 1.399 . . . . 0.0 110.159 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.431 ' NH2' ' HB1' ' B' ' 51' ' ' ALA . 83.0 mtp180 -137.42 111.51 8.4 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.974 -1.079 . . . . 0.0 110.62 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' PHE . . . . . 0.466 ' HB3' ' HA ' ' B' ' 28' ' ' LYS . 85.6 t80 -62.22 -46.31 89.44 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.242 -0.911 . . . . 0.0 109.958 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -164.51 99.33 0.81 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.11 -0.994 . . . . 0.0 110.065 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . 0.431 ' HB1' ' NH2' ' B' ' 48' ' ' ARG . . . -109.88 -89.78 0.48 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.09 -1.006 . . . . 0.0 109.956 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -63.12 -42.17 99.47 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.065 -1.022 . . . . 0.0 109.167 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 161.43 38.92 0.02 OUTLIER Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -118.21 -171.66 2.11 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.254 -1.145 . . . . 0.0 109.93 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.5 ' O ' ' C ' ' B' ' 56' ' ' ASN . . . -143.81 157.83 44.11 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.399 -0.813 . . . . 0.0 109.874 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' ASN . . . . . 0.5 ' C ' ' O ' ' B' ' 55' ' ' ALA . 35.8 m120 15.06 59.9 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.423 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -179.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 47.8 m -113.4 132.34 55.66 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' ILE . . . . . 0.416 HD13 HG21 ' B' ' 58' ' ' ILE . 76.1 mt -116.94 135.99 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.039 -1.038 . . . . 0.0 111.802 -177.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.419 ' CG1' ' OE2' ' B' ' 71' ' ' GLU . 48.3 t -110.94 130.44 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.397 -0.815 . . . . 0.0 109.635 179.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 74.5 m -131.19 124.5 30.76 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.055 -1.028 . . . . 0.0 110.957 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' ASN . . . . . 0.443 ' CB ' ' HA ' ' B' ' 71' ' ' GLU . 3.6 p-10 -149.75 173.11 14.08 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.351 -0.843 . . . . 0.0 110.963 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' SER . . . . . 0.452 ' O ' ' CA ' ' B' ' 69' ' ' GLY . 69.7 m -131.16 155.34 47.19 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.464 -0.772 . . . . 0.0 109.919 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . 0.482 ' CD ' ' HA2' ' B' ' 66' ' ' GLY . 8.8 ttmt -135.34 150.33 49.93 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.707 -1.246 . . . . 0.0 111.372 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -124.54 104.77 8.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.389 -0.819 . . . . 0.0 110.149 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 58.24 27.18 59.99 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . 0.482 ' HA2' ' CD ' ' B' ' 63' ' ' LYS . . . 75.34 23.16 74.41 Favored Glycine 0 N--CA 1.488 2.151 0 O-C-N 120.82 -1.4 . . . . 0.0 109.794 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' ALA . . . . . 0.497 ' HB3' ' CD1' ' B' ' 68' ' ' TRP . . . -81.1 -85.04 0.1 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.154 -1.203 . . . . 0.0 110.873 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' TRP . . . . . 0.497 ' CD1' ' HB3' ' B' ' 67' ' ' ALA . 10.8 m95 -135.2 -145.38 0.22 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.915 -1.116 . . . . 0.0 110.057 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . 0.452 ' CA ' ' O ' ' B' ' 62' ' ' SER . . . 165.3 129.34 1.04 Allowed Glycine 0 N--CA 1.49 2.267 0 C-N-CA 119.594 -1.289 . . . . 0.0 110.577 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 18.5 m -81.63 80.21 8.03 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.626 -0.926 . . . . 0.0 109.865 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.443 ' HA ' ' CB ' ' B' ' 61' ' ' ASN . 83.3 tt0 -71.95 125.57 27.55 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.24 -0.913 . . . . 0.0 110.948 -179.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -110.53 -161.94 0.78 Allowed 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.372 -0.83 . . . . 0.0 109.397 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 62.4 ttp85 -146.05 117.04 7.76 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.01 -1.056 . . . . 0.0 110.761 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -109.94 125.82 53.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.305 -0.872 . . . . 0.0 109.768 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -105.86 45.89 0.95 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.054 -1.029 . . . . 0.0 111.776 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 51.6 t -121.46 132.66 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.841 -1.162 . . . . 0.0 109.88 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' PHE . . . . . 0.54 ' N ' ' CD1' ' B' ' 77' ' ' PHE . 11.3 p90 -142.74 82.14 12.64 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 120.988 -1.07 . . . . 0.0 111.346 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . 0.405 ' HB3' ' O ' ' B' ' 102' ' ' ASP . 56.2 Cg_endo -80.16 41.66 1.17 Allowed 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 123.522 1.275 . . . . 0.0 111.429 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -149.91 163.84 37.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.653 -1.279 . . . . 0.0 110.848 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -130.67 164.53 41.01 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.8 149.3 66.43 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.633 1.333 . . . . 0.0 110.838 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 63.09 41.61 99.74 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 25.6 t -137.04 137.3 39.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.263 -1.139 . . . . 0.0 111.299 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 27.5 m -79.1 135.42 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.409 -0.807 . . . . 0.0 109.522 178.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.48 154.6 37.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.944 -1.097 . . . . 0.0 110.673 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' GLU . . . . . 0.445 ' HG2' ' HA ' ' B' ' 20' ' ' ARG . 97.3 mt-10 -121.08 140.18 52.31 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.381 -0.824 . . . . 0.0 109.612 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 47.2 t -122.76 129.88 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.068 -1.02 . . . . 0.0 110.502 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' CYS . . . . . . . . . . . . . 24.5 m -92.35 125.06 36.85 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.369 -0.832 . . . . 0.0 109.899 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 96.5 mt -122.2 124.99 72.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.114 -0.991 . . . . 0.0 110.315 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 53.9 m -121.72 124.3 43.92 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.483 -0.761 . . . . 0.0 109.02 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' PHE . . . . . 0.41 ' CD1' ' CD2' ' B' ' 96' ' ' LEU . 65.6 t80 -110.21 112.94 25.23 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.144 -0.973 . . . . 0.0 110.32 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -121.39 149.51 42.88 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.558 -0.714 . . . . 0.0 109.307 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -63.79 -33.16 75.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.796 -1.19 . . . . 0.0 110.088 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.0 -45.96 89.95 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.032 -1.043 . . . . 0.0 109.457 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -168.81 175.49 5.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.524 -0.735 . . . . 0.0 109.766 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' LEU . . . . . 0.41 ' CD2' ' CD1' ' B' ' 91' ' ' PHE . 79.4 mt -107.48 128.3 54.37 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.211 -0.931 . . . . 0.0 110.685 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 2.6 m -109.67 126.84 54.1 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.014 -1.053 . . . . 0.0 110.358 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 63.6 t -132.96 128.85 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.016 -1.053 . . . . 0.0 110.427 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -123.98 147.03 48.1 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.987 -1.07 . . . . 0.0 110.965 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . 0.486 ' HB3' ' HD2' ' B' ' 101' ' ' PRO . 1.1 mp -100.36 167.85 10.28 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.585 -0.697 . . . . 0.0 109.581 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' PRO . . . . . 0.486 ' HD2' ' HB3' ' B' ' 100' ' ' LEU . 41.0 Cg_endo -66.02 -22.73 54.77 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.564 1.297 . . . . 0.0 110.451 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' ASP . . . . . 0.405 ' O ' ' HB3' ' B' ' 78' ' ' PRO . 47.5 t0 -152.11 80.06 1.25 Allowed 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.122 -0.986 . . . . 0.0 109.751 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 179.41 -172.49 44.42 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -87.13 -150.68 0.16 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.211 -1.17 . . . . 0.0 110.284 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -129.01 146.05 51.09 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.925 . . . . 0.0 110.64 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -130.51 134.34 46.98 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.343 -0.848 . . . . 0.0 109.865 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -114.85 144.62 43.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.296 -0.878 . . . . 0.0 110.891 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' PHE . . . . . 0.453 ' CE2' ' O ' ' B' ' 109' ' ' PRO . 56.4 t80 -129.22 133.84 25.61 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . 0.453 ' O ' ' CE2' ' B' ' 108' ' ' PHE . 44.1 Cg_endo -66.93 138.91 49.74 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.312 1.164 . . . . 0.0 110.353 -178.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' ASN . . . . . 0.49 ' ND2' ' O ' ' B' ' 110' ' ' ASN . 5.3 p-10 -100.58 78.58 2.01 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.359 -0.838 . . . . 0.0 110.175 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . 0.406 ' C ' ' O ' ' B' ' 110' ' ' ASN . 79.5 ttt180 -41.61 -32.71 0.39 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.4 -0.812 . . . . 0.0 110.757 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 95.3 mt -78.99 149.2 32.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.274 -0.892 . . . . 0.0 110.452 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -103.78 40.71 1.39 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.323 -0.861 . . . . 0.0 110.035 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 56.4 tp -71.29 125.67 27.57 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.124 -0.985 . . . . 0.0 109.862 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -96.58 -4.86 40.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.58 -0.7 . . . . 0.0 111.087 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' B' ' 11' ' ' LEU . . . -142.03 142.04 32.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.868 -1.145 . . . . 0.0 111.499 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' ILE . . . . . 0.412 ' HB ' ' HB3' ' B' ' 11' ' ' LEU . 48.4 mm -102.72 121.15 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -118.02 -18.9 9.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.86 -1.15 . . . . 0.0 111.412 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 119' ' ' TYR . . . . . 0.429 ' O ' ' HA ' ' B' ' 34' ' ' LEU . 43.0 t80 -113.42 129.72 56.47 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.972 -1.08 . . . . 0.0 111.229 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 120' ' ' MET . . . . . 0.472 ' CB ' ' CD1' ' B' ' 9' ' ' LEU . 47.2 ttp -142.06 114.08 8.1 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -135.91 139.15 43.08 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.883 -1.136 . . . . 0.0 110.868 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 122' ' ' ALA . . . . . 0.425 ' O ' ' HA3' ' B' ' 3' ' ' GLY . . . -141.96 131.41 23.77 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' B' ' 2' ' ' CYS . 62.2 t0 -150.99 122.14 7.74 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.464 -0.773 . . . . 0.0 109.224 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 124' ' ' GLY . . . . . 0.435 ' HA3' ' HA ' ' B' ' 30' ' ' PHE . . . 174.99 -149.02 9.98 Favored Glycine 0 N--CA 1.489 2.19 0 C-N-CA 118.969 -1.586 . . . . 0.0 110.026 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . 0.473 ' HB2' ' CZ ' ' B' ' 30' ' ' PHE . 87.6 m-20 -86.4 8.95 19.57 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.698 -0.884 . . . . 0.0 110.318 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 126' ' ' PHE . . . . . 0.49 ' HB2' ' CE2' ' B' ' 30' ' ' PHE . 51.2 t80 -103.86 141.53 35.96 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.136 -0.977 . . . . 0.0 109.768 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -115.93 120.22 38.48 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.119 -1.033 . . . . 0.0 111.089 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . 0.42 ' O ' ' CG2' ' B' ' 128' ' ' ILE . 18.9 tt -95.86 119.31 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.147 -0.97 . . . . 0.0 109.999 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 129' ' ' LYS . . . . . 0.426 ' NZ ' ' OE1' ' B' ' 22' ' ' GLU . 98.2 mttt -100.83 -15.55 17.57 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.021 -1.049 . . . . 0.0 111.591 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 130' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -154.54 146.79 23.8 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.689 -1.257 . . . . 0.0 111.445 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 42.5 t -124.76 129.04 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 132' ' ' ALA . . . . . . . . . . . . . . . -118.79 139.79 51.02 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.564 -1.335 . . . . 0.0 110.504 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -105.98 119.73 39.95 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.429 -0.794 . . . . 0.0 109.955 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 5.7 t0 . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.597 -179.989 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.362 0.601 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 35.9 t -148.36 84.08 1.5 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.291 -0.881 . . . . 0.0 109.95 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.442 ' HA2' ' CB ' ' A' ' 123' ' ' ASP . . . 93.6 38.48 5.26 Favored Glycine 0 N--CA 1.491 2.307 0 C-N-CA 120.121 -1.038 . . . . 0.0 111.135 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.418 ' HA ' ' HB3' ' B' ' 8' ' ' ASN . 60.8 tp -61.44 132.22 52.75 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.719 -1.459 . . . . 0.0 110.032 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.9 t -117.41 154.71 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.49 -0.756 . . . . 0.0 110.599 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.449 ' HB3' ' HB3' ' A' ' 120' ' ' MET . . . -141.92 156.51 45.49 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.345 -0.847 . . . . 0.0 110.573 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.45 ' O ' ' HB3' ' A' ' 8' ' ' ASN . 8.2 p -151.71 170.27 20.14 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.52 -0.737 . . . . 0.0 109.613 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.45 ' HB3' ' O ' ' A' ' 7' ' ' SER . 14.3 t30 60.46 32.89 20.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.456 -0.778 . . . . 0.0 109.529 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.507 ' CD1' ' CB ' ' A' ' 120' ' ' MET . 74.3 mt -84.99 -15.19 45.06 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.554 -0.716 . . . . 0.0 111.991 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.496 ' C ' ' O ' ' A' ' 9' ' ' LEU . 53.4 p-10 5.43 63.06 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.503 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.471 ' N ' ' O ' ' A' ' 9' ' ' LEU . 11.7 mt -92.37 126.61 37.53 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 120.865 -1.147 . . . . 0.0 109.355 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -90.84 165.06 23.41 Favored Pre-proline 0 C--N 1.301 -1.537 0 O-C-N 121.365 -0.834 . . . . 0.0 110.44 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 91' ' ' PHE . 49.7 Cg_endo -68.68 152.63 74.28 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 124.039 1.547 . . . . 0.0 110.554 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.04 -20.73 42.33 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -100.12 152.69 19.96 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.16 -1.2 . . . . 0.0 110.108 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.2 m -97.91 139.02 34.37 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.225 -0.922 . . . . 0.0 110.806 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 58.8 tp -124.13 131.41 53.54 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.238 -0.914 . . . . 0.0 110.029 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 95.4 mtm-85 -128.91 139.96 51.89 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.014 -1.054 . . . . 0.0 111.017 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 90.2 t -129.4 122.51 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.096 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 47.3 ttp180 -107.03 127.84 53.83 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.103 -0.998 . . . . 0.0 110.66 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -143.02 -159.24 7.86 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 119.449 -1.358 . . . . 0.0 110.715 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 84' ' ' VAL . 84.4 tt0 -138.03 147.53 44.23 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.833 -0.804 . . . . 0.0 109.135 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 50.3 t -108.78 124.12 65.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 120.903 -1.123 . . . . 0.0 110.123 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.54 162.01 1.88 Allowed Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.166 -0.959 . . . . 0.0 109.024 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -66.95 -19.47 52.11 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 O-C-N 123.833 1.438 . . . . 0.0 110.65 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 28' ' ' LYS . 89.2 m-20 -112.65 40.04 2.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.115 -0.991 . . . . 0.0 110.656 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.435 ' HA ' ' HB3' ' A' ' 125' ' ' ASP . . . -54.0 92.67 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.065 -1.022 . . . . 0.0 110.051 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.423 ' N ' ' O ' ' A' ' 26' ' ' ASP . 87.6 tttt -106.21 -34.43 7.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.164 -0.96 . . . . 0.0 111.612 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 39.5 t -150.48 133.73 16.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.847 -1.158 . . . . 0.0 111.297 -178.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.43 ' HA ' ' HA3' ' A' ' 124' ' ' GLY . 47.1 t80 -156.18 155.27 32.16 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.481 -0.762 . . . . 0.0 110.526 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.436 ' CG1' ' OD1' ' A' ' 123' ' ' ASP . 9.3 p -139.4 133.9 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.096 -1.003 . . . . 0.0 111.007 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.7 tp -126.73 131.08 51.43 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.372 -0.83 . . . . 0.0 109.875 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -136.72 137.21 39.69 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.855 -1.153 . . . . 0.0 111.421 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -138.45 113.64 9.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.241 -0.912 . . . . 0.0 109.648 178.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.452 ' O ' ' HB3' ' A' ' 119' ' ' TYR . . . -165.58 -163.35 18.79 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.459 ' HG3' ' CD1' ' A' ' 114' ' ' LEU . 99.1 mttt -68.32 -43.99 76.39 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.939 -1.33 . . . . 0.0 110.514 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -153.57 -167.03 2.56 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.779 0.8 . . . . 0.0 111.93 -178.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.3 t -60.28 -44.63 95.18 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.685 -0.634 . . . . 0.0 112.486 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.407 ' HB3' ' N ' ' A' ' 66' ' ' GLY . 82.6 m-20 -89.49 -14.01 36.24 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.763 -1.211 . . . . 0.0 110.317 -179.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -107.27 71.89 0.85 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.342 -0.849 . . . . 0.0 109.348 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.6 mt -101.59 141.41 34.5 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.261 0.553 . . . . 0.0 110.388 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.44 ' O ' ' CB ' ' A' ' 62' ' ' SER . 0.5 OUTLIER -85.78 -51.93 6.1 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.24 -0.913 . . . . 0.0 110.049 179.652 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.407 ' HA ' HD23 ' A' ' 43' ' ' LEU . 84.7 mt -128.07 140.29 52.03 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.994 -1.066 . . . . 0.0 110.914 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.423 ' N ' ' O ' ' A' ' 61' ' ' ASN . 66.0 t-80 -120.88 112.14 18.42 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -104.78 127.61 52.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.056 -1.028 . . . . 0.0 109.743 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.5 81.11 13.91 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.082 -1.011 . . . . 0.0 111.025 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.83 148.23 64.18 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.076 1.566 . . . . 0.0 110.139 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -144.95 107.57 4.43 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.925 -1.109 . . . . 0.0 111.689 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -62.3 -45.0 95.21 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.209 -0.932 . . . . 0.0 109.57 178.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -136.57 93.58 2.89 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.635 -0.666 . . . . 0.0 109.892 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -87.5 -151.04 0.17 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.191 -0.943 . . . . 0.0 110.136 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -66.02 -8.52 23.55 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.076 -1.015 . . . . 0.0 111.444 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 174.29 -27.53 0.08 OUTLIER Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -77.97 -179.31 6.0 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.05 -1.264 . . . . 0.0 109.13 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.428 ' O ' ' C ' ' A' ' 56' ' ' ASN . . . -143.76 149.84 37.7 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.173 -0.955 . . . . 0.0 110.988 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.428 ' C ' ' O ' ' A' ' 55' ' ' ALA . 87.6 m-20 29.51 59.31 0.16 Allowed 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 178.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 98.2 m -121.18 128.88 52.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.94 -1.1 . . . . 0.0 110.645 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 95.6 mt -111.13 126.05 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.701 -0.624 . . . . 0.0 110.383 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.1 m -116.5 135.43 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.015 -1.053 . . . . 0.0 109.955 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 35.4 m -103.03 136.15 43.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.141 -0.974 . . . . 0.0 110.053 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.423 ' O ' ' N ' ' A' ' 44' ' ' HIS . 1.4 t-20 -146.95 158.6 43.97 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.074 -1.016 . . . . 0.0 110.987 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 42' ' ' CYS . 53.2 p -139.05 158.25 44.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.447 -0.783 . . . . 0.0 110.236 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.469 ' CD ' ' HA2' ' A' ' 66' ' ' GLY . 26.2 ttmt -142.47 152.7 42.99 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.312 -0.867 . . . . 0.0 110.563 178.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -125.04 94.66 4.24 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.358 -0.839 . . . . 0.0 109.071 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 64.47 28.43 73.13 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.469 ' HA2' ' CD ' ' A' ' 63' ' ' LYS . . . 73.98 24.76 73.15 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.2 -79.03 0.13 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.434 -1.039 . . . . 0.0 110.347 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -141.98 -144.67 0.16 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.341 -0.849 . . . . 0.0 109.66 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 163.76 110.57 0.24 Allowed Glycine 0 N--CA 1.493 2.497 0 C-N-CA 119.67 -1.253 . . . . 0.0 110.078 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.08 71.97 10.12 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.364 -1.08 . . . . 0.0 110.32 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -61.3 143.99 54.7 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.553 -0.717 . . . . 0.0 111.729 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -124.73 -154.38 0.61 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.465 -0.772 . . . . 0.0 109.314 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 78.3 ttt-85 -143.88 116.18 8.5 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.757 -1.214 . . . . 0.0 112.021 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -109.32 122.64 47.79 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.33 -0.856 . . . . 0.0 109.577 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -113.88 88.4 2.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.896 -1.127 . . . . 0.0 110.377 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.6 p -141.33 142.46 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.369 -0.832 . . . . 0.0 110.475 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -151.65 77.87 7.04 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.171 -0.956 . . . . 0.0 109.857 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.473 ' CB ' ' HB2' ' A' ' 102' ' ' ASP . 54.7 Cg_endo -83.3 -0.96 10.11 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.218 1.641 . . . . 0.0 111.934 -178.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.502 ' CE1' ' HG2' ' A' ' 101' ' ' PRO . 44.0 m-85 -139.13 -171.9 3.21 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.912 -1.118 . . . . 0.0 110.357 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.458 ' HB2' ' HD2' ' A' ' 81' ' ' PRO . 2.7 pm0 -143.6 166.66 18.53 Favored Pre-proline 0 C--N 1.301 -1.506 0 O-C-N 121.189 -0.944 . . . . 0.0 110.342 -178.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 80' ' ' GLN . 43.9 Cg_endo -65.7 151.13 85.41 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.931 1.49 . . . . 0.0 109.655 179.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.35 23.75 70.06 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 38.9 t -140.56 143.39 35.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.262 -1.14 . . . . 0.0 109.518 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.442 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 20.2 m -78.28 153.63 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.159 -0.963 . . . . 0.0 110.753 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -160.87 147.83 15.31 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.343 -0.848 . . . . 0.0 109.92 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -122.19 146.78 46.92 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.434 -0.791 . . . . 0.0 108.945 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 71.1 t -126.94 135.2 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.011 -1.056 . . . . 0.0 110.896 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 2.3 t -109.3 129.02 55.53 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.307 -0.871 . . . . 0.0 109.42 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 86.8 mt -129.15 127.33 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.118 -0.989 . . . . 0.0 110.589 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.0 m -115.56 132.12 56.73 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.177 -0.952 . . . . 0.0 109.691 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.434 ' CZ ' ' HB3' ' A' ' 114' ' ' LEU . 47.8 t80 -113.26 123.38 50.03 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.13 -0.981 . . . . 0.0 110.266 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -109.62 147.68 32.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -0.912 . . . . 0.0 109.769 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -58.11 -21.68 47.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.333 -0.854 . . . . 0.0 111.225 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -116.62 -13.34 10.85 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.724 -1.235 . . . . 0.0 110.781 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -147.29 -167.68 2.85 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.08 -1.013 . . . . 0.0 110.981 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' A' ' 107' ' ' LYS . 7.2 tt -151.76 115.63 4.91 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 54.4 m -106.65 130.37 54.4 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.768 -1.208 . . . . 0.0 110.309 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.413 HG21 ' CD2' ' A' ' 96' ' ' LEU . 52.5 t -121.4 132.34 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.458 -0.776 . . . . 0.0 110.185 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -122.68 127.04 48.77 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.851 -1.156 . . . . 0.0 110.659 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.4 mt -95.9 161.27 27.95 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.502 ' HG2' ' CE1' ' A' ' 79' ' ' PHE . 39.4 Cg_endo -65.62 -22.7 57.68 Favored 'Trans proline' 0 C--N 1.301 -1.95 0 O-C-N 123.448 1.236 . . . . 0.0 109.828 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.486 ' OD2' ' CD1' ' A' ' 104' ' ' TYR . 29.0 t70 -63.67 -40.26 96.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.287 -0.883 . . . . 0.0 109.995 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 126.59 -6.57 7.49 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.486 ' CD1' ' OD2' ' A' ' 102' ' ' ASP . 47.2 m-85 -87.07 142.29 28.04 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.005 -1.291 . . . . 0.0 110.224 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -128.43 140.26 51.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.321 -0.862 . . . . 0.0 111.327 -179.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -131.87 150.46 52.15 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 11.7 ptpt -132.9 136.01 45.91 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.798 -1.189 . . . . 0.0 111.384 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 20.1 m-30 -108.44 147.41 35.62 Favored Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 121.533 -0.729 . . . . 0.0 109.648 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.414 ' O ' ' N ' ' A' ' 111' ' ' ARG . 41.2 Cg_endo -65.64 150.68 86.19 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 O-C-N 124.0 1.526 . . . . 0.0 111.017 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -65.82 62.31 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.84 -0.537 . . . . 0.0 111.68 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.414 ' N ' ' O ' ' A' ' 109' ' ' PRO . 20.8 ptt180 -68.74 -24.76 64.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.061 -1.025 . . . . 0.0 109.663 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.419 ' C ' ' CD1' ' A' ' 112' ' ' LEU . 1.2 tm? -111.21 128.77 56.02 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.297 -0.877 . . . . 0.0 109.107 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -90.27 69.42 7.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.795 -1.191 . . . . 0.0 110.812 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.459 ' CD1' ' HG3' ' A' ' 36' ' ' LYS . 53.4 tp -84.84 131.44 34.53 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.377 -0.827 . . . . 0.0 109.35 178.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -92.17 -19.48 22.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.725 -1.234 . . . . 0.0 109.846 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 11' ' ' LEU . . . -171.76 156.6 4.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -0.907 . . . . 0.0 109.479 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.41 ' CG1' HD21 ' A' ' 114' ' ' LEU . 66.5 mt -101.94 116.36 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.884 -1.135 . . . . 0.0 110.76 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 -111.63 -23.97 10.36 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.143 -0.973 . . . . 0.0 109.914 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.452 ' HB3' ' O ' ' A' ' 35' ' ' GLY . 90.2 t80 -106.84 126.75 52.7 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.378 -0.826 . . . . 0.0 111.228 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.507 ' CB ' ' CD1' ' A' ' 9' ' ' LEU . 66.3 ttp -136.67 125.56 24.16 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -141.59 136.76 31.37 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.959 -1.088 . . . . 0.0 110.393 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -147.37 123.46 10.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.351 -0.843 . . . . 0.0 110.204 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.442 ' CB ' ' HA2' ' A' ' 3' ' ' GLY . 20.5 p-10 -151.11 121.93 7.56 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.956 -1.09 . . . . 0.0 110.956 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.43 ' HA3' ' HA ' ' A' ' 30' ' ' PHE . . . 178.28 -148.08 8.3 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.435 ' HB3' ' HA ' ' A' ' 27' ' ' ALA . 80.9 m-20 -81.69 8.72 9.21 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.482 -1.011 . . . . 0.0 110.924 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -106.29 142.65 35.62 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.974 -1.078 . . . . 0.0 110.205 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -110.97 125.3 53.56 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 118.945 -1.102 . . . . 0.0 110.91 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 9.0 tt -100.26 121.18 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.162 -0.961 . . . . 0.0 109.601 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -101.0 -17.55 16.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.343 -0.848 . . . . 0.0 112.323 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -159.39 147.72 17.7 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.484 -1.385 . . . . 0.0 112.252 -178.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' B' ' 130' ' ' CYS . 45.4 t -127.13 127.1 69.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -128.68 129.75 46.23 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.813 -1.179 . . . . 0.0 110.214 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -64.25 -102.76 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.238 -0.914 . . . . 0.0 110.118 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.8 t70 . . . . . 0 N--CA 1.493 1.71 0 O-C-N 120.599 -1.313 . . . . 0.0 110.19 179.64 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.265 0.555 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' CYS . . . . . . . . . . . . . 35.6 t -148.27 83.31 1.49 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.356 -0.84 . . . . 0.0 110.148 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . 0.443 ' HA2' ' CB ' ' B' ' 123' ' ' ASP . . . 93.9 38.85 5.07 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 120.198 -1.001 . . . . 0.0 111.1 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 60.5 tp -61.69 132.26 52.65 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.729 -1.454 . . . . 0.0 109.906 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 3.1 t -117.16 154.58 18.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.643 -0.66 . . . . 0.0 110.602 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . 0.441 ' HB3' ' HB3' ' B' ' 120' ' ' MET . . . -141.99 156.53 45.45 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.423 -0.798 . . . . 0.0 110.548 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' SER . . . . . 0.446 ' O ' ' HB3' ' B' ' 8' ' ' ASN . 7.9 p -151.89 170.04 20.81 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.579 -0.701 . . . . 0.0 109.579 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . 0.446 ' HB3' ' O ' ' B' ' 7' ' ' SER . 16.1 t30 60.79 32.99 20.2 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.521 -0.737 . . . . 0.0 109.287 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . 0.507 ' CD1' ' CB ' ' B' ' 120' ' ' MET . 73.2 mt -86.15 -11.59 52.18 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.622 -0.674 . . . . 0.0 111.834 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . 0.491 ' C ' ' O ' ' B' ' 9' ' ' LEU . 53.5 p-10 -0.28 66.14 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.486 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -178.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.495 ' N ' ' O ' ' B' ' 9' ' ' LEU . 11.6 mt -93.37 126.54 38.55 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.087 -1.008 . . . . 0.0 109.202 178.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -90.83 165.3 22.68 Favored Pre-proline 0 C--N 1.3 -1.566 0 O-C-N 121.345 -0.847 . . . . 0.0 110.402 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' B' ' 91' ' ' PHE . 48.9 Cg_endo -68.65 152.64 74.4 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.967 1.509 . . . . 0.0 110.548 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.08 -20.73 42.25 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -100.04 152.84 19.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.184 -1.186 . . . . 0.0 110.047 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' CYS . . . . . . . . . . . . . 2.2 m -98.16 139.12 34.43 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.185 -0.947 . . . . 0.0 110.708 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.402 ' CD1' ' HA ' ' B' ' 133' ' ' PHE . 58.7 tp -124.18 131.38 53.53 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.253 -0.904 . . . . 0.0 110.063 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 95.5 mtm-85 -128.93 139.87 51.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.878 -1.139 . . . . 0.0 110.937 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 91.4 t -129.33 122.65 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.09 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 47.3 ttp180 -107.13 127.69 53.72 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.15 -0.969 . . . . 0.0 110.665 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -142.86 -159.25 7.87 Favored Glycine 0 N--CA 1.49 2.269 0 C-N-CA 119.409 -1.377 . . . . 0.0 110.685 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . 0.431 ' HA ' ' HA ' ' B' ' 84' ' ' VAL . 84.6 tt0 -138.03 147.46 44.16 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.822 -0.811 . . . . 0.0 109.215 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 50.1 t -108.74 124.11 65.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 O-C-N 120.984 -1.073 . . . . 0.0 110.148 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.71 161.88 2.02 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.103 -0.998 . . . . 0.0 108.985 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.4 ' O ' ' HB2' ' B' ' 81' ' ' PRO . 43.6 Cg_endo -66.76 -19.58 53.11 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 O-C-N 123.7 1.368 . . . . 0.0 110.606 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' B' ' 28' ' ' LYS . 89.2 m-20 -112.64 40.14 2.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.183 -0.948 . . . . 0.0 110.664 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . 0.433 ' HA ' ' HB3' ' B' ' 125' ' ' ASP . . . -53.98 92.53 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.109 -0.994 . . . . 0.0 110.172 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' B' ' 26' ' ' ASP . 87.6 tttt -106.28 -34.28 7.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.125 -0.984 . . . . 0.0 111.588 -179.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 39.7 t -150.52 133.2 15.81 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.848 -1.158 . . . . 0.0 111.312 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' PHE . . . . . 0.434 ' HA ' ' HA3' ' B' ' 124' ' ' GLY . 48.4 t80 -155.54 155.42 33.36 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.52 -0.737 . . . . 0.0 110.632 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.438 ' CG1' ' OD1' ' B' ' 123' ' ' ASP . 9.1 p -139.5 133.64 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.162 -0.961 . . . . 0.0 111.044 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 15.8 tp -126.66 131.02 51.52 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.32 -0.862 . . . . 0.0 109.877 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -136.61 137.48 40.17 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.958 -1.089 . . . . 0.0 111.407 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -138.94 109.68 6.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.143 -0.973 . . . . 0.0 109.859 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . 0.457 ' O ' ' HB3' ' B' ' 119' ' ' TYR . . . -160.18 -162.31 12.25 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . 0.463 ' HG3' ' CD1' ' B' ' 114' ' ' LEU . 99.1 mttt -68.81 -43.85 74.75 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.146 -1.208 . . . . 0.0 110.228 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -153.56 -167.2 2.62 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.786 0.803 . . . . 0.0 111.881 -178.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 11.6 t -59.91 -44.77 94.08 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' ASN . . . . . 0.405 ' HB3' ' N ' ' B' ' 66' ' ' GLY . 83.0 m-20 -89.69 -13.81 36.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.707 -1.246 . . . . 0.0 110.315 -179.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' ASN . . . . . 0.4 ' ND2' ' N ' ' B' ' 40' ' ' ASN . 5.7 m-80 -107.45 71.74 0.84 Allowed 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.913 0.864 . . . . 0.0 109.318 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 95.0 mt -101.12 144.05 30.49 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.782 -0.573 . . . . 0.0 110.13 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' CYS . . . . . 0.425 ' O ' ' CB ' ' B' ' 62' ' ' SER . 0.5 OUTLIER -89.31 -50.42 6.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.168 -0.958 . . . . 0.0 109.636 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 85.5 mt -128.93 140.19 51.78 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.913 -1.117 . . . . 0.0 110.813 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' HIS . . . . . 0.429 ' N ' ' O ' ' B' ' 61' ' ' ASN . 65.9 t-80 -120.91 112.3 18.61 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -104.86 127.69 52.77 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.165 -0.959 . . . . 0.0 109.664 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.46 80.99 14.08 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 120.989 -1.07 . . . . 0.0 111.06 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.79 148.08 64.12 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.062 1.559 . . . . 0.0 110.132 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -144.8 107.72 4.5 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.879 -1.138 . . . . 0.0 111.628 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -62.51 -44.86 95.34 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.057 -1.027 . . . . 0.0 109.575 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 28.9 t30 -136.63 93.24 2.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.729 -0.607 . . . . 0.0 110.005 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -87.35 -151.08 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.258 -0.901 . . . . 0.0 110.209 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -66.15 -6.93 15.06 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.019 -1.051 . . . . 0.0 111.458 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 171.8 -26.8 0.1 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -78.29 -179.41 6.23 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.994 -1.297 . . . . 0.0 108.997 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.486 ' O ' ' C ' ' B' ' 56' ' ' ASN . . . -141.8 156.7 45.55 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.121 -0.987 . . . . 0.0 110.202 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' ASN . . . . . 0.486 ' C ' ' O ' ' B' ' 55' ' ' ALA . 87.1 m-20 18.51 63.88 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 97.8 m -122.05 128.91 51.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 110.532 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' ILE . . . . . . . . . . . . . 96.1 mt -111.43 126.27 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.698 -0.626 . . . . 0.0 110.356 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.402 HG22 ' O ' ' B' ' 59' ' ' VAL . 25.4 m -116.55 135.33 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.053 -1.029 . . . . 0.0 110.052 179.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 35.2 m -103.01 135.88 43.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.21 -0.931 . . . . 0.0 110.255 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' ASN . . . . . 0.429 ' O ' ' N ' ' B' ' 44' ' ' HIS . 1.4 t-20 -146.74 158.45 43.91 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.083 -1.011 . . . . 0.0 111.134 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' B' ' 42' ' ' CYS . 53.3 p -138.85 158.45 44.19 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.454 -0.779 . . . . 0.0 110.266 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . 0.469 ' CD ' ' HA2' ' B' ' 66' ' ' GLY . 26.3 ttmt -142.56 152.7 42.85 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.289 -0.882 . . . . 0.0 110.498 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -124.92 94.73 4.27 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.304 -0.872 . . . . 0.0 109.055 178.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 64.3 28.59 73.22 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . 0.469 ' HA2' ' CD ' ' B' ' 63' ' ' LYS . . . 73.88 24.73 73.45 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.06 -79.0 0.13 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.341 -1.093 . . . . 0.0 110.435 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -142.18 -144.69 0.16 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.255 -0.903 . . . . 0.0 109.624 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 163.63 110.4 0.24 Allowed Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.545 -1.312 . . . . 0.0 110.1 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.83 71.99 9.91 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.317 -1.108 . . . . 0.0 110.319 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -61.4 144.09 54.68 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.463 -0.773 . . . . 0.0 111.817 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -124.84 -154.38 0.61 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.318 -0.864 . . . . 0.0 109.314 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 78.3 ttt-85 -143.79 116.24 8.58 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.709 -1.244 . . . . 0.0 111.99 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -109.42 122.74 48.05 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.371 -0.83 . . . . 0.0 109.557 178.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -114.03 88.52 2.87 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.925 -1.11 . . . . 0.0 110.271 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 7.6 p -141.4 142.38 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.309 -0.87 . . . . 0.0 110.53 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -151.47 77.81 7.18 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.139 -0.976 . . . . 0.0 109.899 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . 0.48 ' CB ' ' HB2' ' B' ' 102' ' ' ASP . 54.6 Cg_endo -83.36 -0.65 9.95 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.185 1.624 . . . . 0.0 112.078 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' PHE . . . . . 0.499 ' CE1' ' HG2' ' B' ' 101' ' ' PRO . 44.3 m-85 -139.32 -171.74 3.19 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.955 -1.091 . . . . 0.0 110.439 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.449 ' HB2' ' HD2' ' B' ' 81' ' ' PRO . 2.6 pm0 -143.67 166.9 17.27 Favored Pre-proline 0 C--N 1.302 -1.457 0 O-C-N 121.284 -0.885 . . . . 0.0 110.323 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' PRO . . . . . 0.449 ' HD2' ' HB2' ' B' ' 80' ' ' GLN . 43.2 Cg_endo -65.71 151.2 85.17 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.904 1.476 . . . . 0.0 109.63 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.4 23.61 70.26 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.024 -1.631 . . . . 0.0 109.024 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 38.6 t -140.49 143.43 35.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.333 -1.098 . . . . 0.0 109.572 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' B' ' 22' ' ' GLU . 20.0 m -78.33 153.51 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.126 -0.983 . . . . 0.0 110.834 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -160.72 147.74 15.51 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.383 -0.823 . . . . 0.0 109.917 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -122.09 146.66 46.99 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.307 -0.871 . . . . 0.0 108.928 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 70.4 t -126.81 135.21 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.05 -1.031 . . . . 0.0 110.902 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' CYS . . . . . . . . . . . . . 2.4 t -109.14 129.15 55.48 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.362 -0.836 . . . . 0.0 109.498 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 87.0 mt -129.12 127.22 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.148 -0.97 . . . . 0.0 110.617 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 5.7 m -115.48 132.13 56.72 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.15 -0.969 . . . . 0.0 109.816 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' PHE . . . . . 0.429 ' CZ ' ' HB3' ' B' ' 114' ' ' LEU . 47.7 t80 -113.23 123.62 50.61 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.111 -0.993 . . . . 0.0 110.339 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -109.88 147.8 32.71 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.162 -0.961 . . . . 0.0 109.77 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -58.26 -21.54 48.96 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.322 -0.861 . . . . 0.0 111.201 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -116.7 -13.3 10.8 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.704 -1.247 . . . . 0.0 110.829 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -147.39 -167.68 2.85 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.096 -1.003 . . . . 0.0 110.899 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 96' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' B' ' 107' ' ' LYS . 7.2 tt -151.72 115.75 4.96 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 54.1 m -106.77 130.37 54.49 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.738 -1.227 . . . . 0.0 110.375 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 98' ' ' VAL . . . . . 0.43 HG21 ' CD2' ' B' ' 96' ' ' LEU . 51.8 t -121.58 132.46 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.51 -0.743 . . . . 0.0 110.13 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -122.57 127.53 49.58 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.977 -1.077 . . . . 0.0 110.616 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 3.4 mt -96.41 161.14 27.9 Favored Pre-proline 0 C--N 1.303 -1.454 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' PRO . . . . . 0.499 ' HG2' ' CE1' ' B' ' 79' ' ' PHE . 39.7 Cg_endo -65.54 -22.73 58.24 Favored 'Trans proline' 0 C--N 1.301 -1.952 0 O-C-N 123.448 1.236 . . . . 0.0 109.841 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' ASP . . . . . 0.489 ' OD2' ' CD1' ' B' ' 104' ' ' TYR . 28.9 t70 -63.6 -40.22 96.37 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.337 -0.852 . . . . 0.0 110.02 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 126.44 -6.42 7.57 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' TYR . . . . . 0.489 ' CD1' ' OD2' ' B' ' 102' ' ' ASP . 47.3 m-85 -87.22 142.29 28.01 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.984 -1.304 . . . . 0.0 110.193 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -128.19 140.22 52.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.401 -0.812 . . . . 0.0 111.393 -179.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -131.88 150.61 52.1 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' B' ' 96' ' ' LEU . 11.7 ptpt -132.98 135.89 45.75 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 118.757 -1.177 . . . . 0.0 111.394 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 108' ' ' PHE . . . . . . . . . . . . . 20.2 m-30 -108.33 147.54 35.82 Favored Pre-proline 0 C--N 1.304 -1.398 0 O-C-N 121.453 -0.78 . . . . 0.0 109.649 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . 0.41 ' O ' ' N ' ' B' ' 111' ' ' ARG . 40.9 Cg_endo -65.63 150.8 86.09 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 O-C-N 123.982 1.517 . . . . 0.0 111.042 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 110' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -65.95 62.46 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.881 -0.512 . . . . 0.0 111.583 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . 0.41 ' N ' ' O ' ' B' ' 109' ' ' PRO . 20.8 ptt180 -68.94 -24.48 64.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.032 -1.043 . . . . 0.0 109.558 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . 0.408 ' C ' ' CD1' ' B' ' 112' ' ' LEU . 1.2 tm? -111.43 128.7 56.07 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.396 -0.815 . . . . 0.0 109.099 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -90.27 69.5 7.09 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.835 -1.165 . . . . 0.0 110.77 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 114' ' ' LEU . . . . . 0.463 ' CD1' ' HG3' ' B' ' 36' ' ' LYS . 53.4 tp -85.12 131.29 34.47 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.53 -0.731 . . . . 0.0 109.381 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -92.0 -19.58 22.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.717 -1.24 . . . . 0.0 109.775 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 116' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' B' ' 11' ' ' LEU . . . -171.83 156.74 4.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.227 -0.921 . . . . 0.0 109.475 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 117' ' ' ILE . . . . . 0.403 ' CG1' HD21 ' B' ' 114' ' ' LEU . 66.3 mt -101.98 116.36 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.88 -1.137 . . . . 0.0 110.733 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 -111.64 -24.05 10.31 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.155 -0.966 . . . . 0.0 109.817 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 119' ' ' TYR . . . . . 0.457 ' HB3' ' O ' ' B' ' 35' ' ' GLY . 90.1 t80 -106.8 126.75 52.7 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.335 -0.853 . . . . 0.0 111.254 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 120' ' ' MET . . . . . 0.507 ' CB ' ' CD1' ' B' ' 9' ' ' LEU . 66.0 ttp -136.75 125.55 24.03 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -141.59 136.72 31.32 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.034 -1.041 . . . . 0.0 110.388 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -147.27 123.59 10.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.364 -0.835 . . . . 0.0 110.281 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . 0.443 ' CB ' ' HA2' ' B' ' 3' ' ' GLY . 20.5 p-10 -151.12 122.13 7.66 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.003 -1.061 . . . . 0.0 110.994 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 124' ' ' GLY . . . . . 0.434 ' HA3' ' HA ' ' B' ' 30' ' ' PHE . . . 178.03 -148.12 8.41 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . 0.433 ' HB3' ' HA ' ' B' ' 27' ' ' ALA . 80.8 m-20 -81.73 8.71 9.33 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.537 -0.978 . . . . 0.0 110.889 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 126' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -106.2 142.67 35.49 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.03 -1.044 . . . . 0.0 110.233 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -111.02 125.13 53.41 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.024 -1.071 . . . . 0.0 110.885 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 8.9 tt -100.2 121.26 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.256 -0.902 . . . . 0.0 109.679 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -100.87 -19.53 15.89 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.337 -0.852 . . . . 0.0 112.2 -178.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 130' ' ' CYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 131' ' ' VAL . 0.0 OUTLIER -156.8 148.43 22.53 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 118.324 -1.35 . . . . 0.0 112.507 -178.9 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 45.6 t -127.45 127.05 68.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 177.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 132' ' ' ALA . . . . . . . . . . . . . . . -128.67 129.77 46.29 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.856 -1.152 . . . . 0.0 110.266 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . 0.402 ' HA ' ' CD1' ' B' ' 17' ' ' LEU . 3.2 m-30 -64.28 -102.76 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.172 -0.955 . . . . 0.0 110.062 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.9 t70 . . . . . 0 N--CA 1.493 1.715 0 O-C-N 120.521 -1.362 . . . . 0.0 110.252 179.697 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 121.164 0.507 . . . . 0.0 110.513 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -136.95 83.57 2.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.289 -0.882 . . . . 0.0 110.615 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.467 ' HA3' ' O ' ' A' ' 122' ' ' ALA . . . 177.21 169.21 38.1 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.463 ' CD1' ' O ' ' A' ' 128' ' ' ILE . 77.7 mt -79.42 144.49 34.05 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.354 -1.086 . . . . 0.0 112.215 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.3 m -110.52 150.35 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.56 -0.713 . . . . 0.0 109.498 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.38 156.32 47.08 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.72 -1.238 . . . . 0.0 112.387 -178.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.445 ' O ' ' HB3' ' A' ' 8' ' ' ASN . 17.3 m -155.39 173.25 16.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.538 -0.726 . . . . 0.0 109.853 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.445 ' HB3' ' O ' ' A' ' 7' ' ' SER . 37.3 t-20 62.25 26.76 16.05 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.137 -0.977 . . . . 0.0 109.768 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.51 ' O ' ' C ' ' A' ' 10' ' ' ASN . 63.2 mt -82.25 -12.64 57.94 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.832 -0.542 . . . . 0.0 111.669 -178.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.51 ' C ' ' O ' ' A' ' 9' ' ' LEU . 77.0 m-20 16.81 68.39 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.821 0 CA-C-O 121.35 0.595 . . . . 0.0 112.323 -179.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.488 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 34.0 tp -96.07 132.88 40.99 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.53 -0.731 . . . . 0.0 110.404 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.29 169.69 6.61 Favored Pre-proline 0 C--N 1.296 -1.758 0 O-C-N 121.584 -0.697 . . . . 0.0 109.815 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.426 ' HA ' ' O ' ' A' ' 91' ' ' PHE . 54.9 Cg_endo -72.6 155.61 54.43 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.08 1.568 . . . . 0.0 108.882 178.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.64 -10.11 59.02 Favored Glycine 0 N--CA 1.488 2.154 0 C-N-CA 119.359 -1.4 . . . . 0.0 109.965 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -115.12 146.65 41.13 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.084 -1.245 . . . . 0.0 108.921 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.437 ' O ' ' N ' ' A' ' 134' ' ' ASP . 1.6 t -96.55 140.46 31.14 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.969 -1.082 . . . . 0.0 110.723 -179.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 56.1 tp -111.0 126.92 55.3 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.277 -0.889 . . . . 0.0 110.544 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -120.17 126.72 51.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.241 -0.912 . . . . 0.0 109.871 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.3 t -127.95 129.73 69.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.217 -0.927 . . . . 0.0 110.711 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.445 ' HA ' ' HG2' ' A' ' 86' ' ' GLU . 72.1 ttt180 -109.31 130.15 55.5 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.215 -0.928 . . . . 0.0 109.933 178.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.436 ' CA ' ' O ' ' A' ' 127' ' ' LYS . . . -134.35 173.8 21.24 Favored Glycine 0 C--N 1.294 -1.773 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -125.48 121.26 33.25 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.402 ' O ' ' HA2' ' A' ' 82' ' ' GLY . 70.9 t -85.36 131.89 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.147 -0.971 . . . . 0.0 109.909 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.04 154.04 90.75 Favored Pre-proline 0 N--CA 1.496 1.863 0 O-C-N 121.309 -0.869 . . . . 0.0 109.996 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.412 ' O ' ' HB2' ' A' ' 81' ' ' PRO . 44.4 Cg_endo -67.48 -22.27 45.3 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.613 1.323 . . . . 0.0 110.736 -179.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -101.31 14.05 33.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.007 -1.058 . . . . 0.0 110.186 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.483 ' HA ' ' HB3' ' A' ' 125' ' ' ASP . . . -63.77 142.3 58.45 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.301 -0.874 . . . . 0.0 111.695 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -129.14 -34.84 1.85 Allowed 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 42.2 t -165.68 139.92 4.65 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 121.377 -0.827 . . . . 0.0 110.538 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.452 ' CZ ' ' HG3' ' A' ' 47' ' ' PRO . 42.2 p90 -143.57 161.09 39.38 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.171 -0.956 . . . . 0.0 109.067 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.4 m -126.72 140.52 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 120.662 -1.274 . . . . 0.0 111.935 -178.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.428 HD23 ' HB1' ' A' ' 122' ' ' ALA . 52.7 mt -118.75 133.19 56.02 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.573 -0.704 . . . . 0.0 109.713 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.402 ' OD1' ' ND1' ' A' ' 44' ' ' HIS . 93.8 m-20 -124.92 135.09 52.52 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.84 -1.162 . . . . 0.0 111.597 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.451 HD12 ' HB3' ' A' ' 43' ' ' LEU . 0.6 OUTLIER -144.69 110.77 5.47 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.693 0.759 . . . . 0.0 109.206 178.526 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -165.02 -142.84 3.53 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.496 ' O ' ' HB2' ' A' ' 119' ' ' TYR . 47.9 pttt -109.15 -32.81 7.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.152 -1.205 . . . . 0.0 109.412 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.426 ' N ' ' CG ' ' A' ' 36' ' ' LYS . 36.5 m-20 -138.52 171.73 13.93 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.946 0.879 . . . . 0.0 110.501 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 42.4 t -60.07 -41.94 93.49 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.786 -0.571 . . . . 0.0 110.931 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.472 ' HB3' ' N ' ' A' ' 66' ' ' GLY . 82.1 m-20 -91.5 -6.41 52.62 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.033 -1.042 . . . . 0.0 111.372 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -115.29 60.46 0.7 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.88 -1.138 . . . . 0.0 111.05 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 61.3 mt -84.88 147.35 26.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.35 -0.844 . . . . 0.0 109.903 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 81.6 m -88.55 -41.7 12.54 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.865 -1.147 . . . . 0.0 109.347 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.451 ' HB3' HD12 ' A' ' 34' ' ' LEU . 15.1 tp -132.17 128.98 39.17 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.644 -0.66 . . . . 0.0 110.862 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.402 ' ND1' ' OD1' ' A' ' 33' ' ' ASN . 20.3 t60 -121.37 112.85 19.09 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -104.72 122.18 45.15 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.023 -1.048 . . . . 0.0 110.691 -178.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -139.37 85.75 15.02 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.297 -0.877 . . . . 0.0 111.218 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.452 ' HG3' ' CZ ' ' A' ' 30' ' ' PHE . 55.9 Cg_endo -71.16 145.13 48.39 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.961 1.506 . . . . 0.0 110.193 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -128.21 92.34 3.43 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.763 -1.21 . . . . 0.0 110.425 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -63.37 -40.59 97.66 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.425 -0.797 . . . . 0.0 109.571 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -137.82 92.02 2.64 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.198 -0.939 . . . . 0.0 109.024 178.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.66 -146.9 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.405 -0.809 . . . . 0.0 109.703 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -108.28 31.65 5.41 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.291 -0.88 . . . . 0.0 109.94 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 166.63 -32.17 0.21 Allowed Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.251 -1.452 . . . . 0.0 109.87 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -89.74 -168.86 2.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.134 -1.215 . . . . 0.0 110.285 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.466 ' O ' ' C ' ' A' ' 56' ' ' ASN . . . -150.82 144.94 25.39 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.407 -0.808 . . . . 0.0 109.496 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.466 ' C ' ' O ' ' A' ' 55' ' ' ALA . 95.1 m-20 25.19 64.09 0.06 Allowed 'General case' 0 N--CA 1.506 2.368 0 CA-C-O 121.137 0.494 . . . . 0.0 111.783 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.8 m -127.24 126.79 43.34 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.434 -0.791 . . . . 0.0 110.283 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.409 HD11 ' O ' ' A' ' 76' ' ' VAL . 83.1 mt -119.96 131.52 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 CA-C-O 121.173 0.511 . . . . 0.0 110.852 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.3 m -124.18 153.03 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 120.996 -1.065 . . . . 0.0 110.135 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 57.1 m -111.03 145.84 37.78 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.058 -1.026 . . . . 0.0 110.453 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -155.91 170.64 21.65 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.271 -0.893 . . . . 0.0 111.393 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.4 m -149.49 157.34 43.2 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.405 -0.809 . . . . 0.0 109.084 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.458 ' CD ' ' HA2' ' A' ' 66' ' ' GLY . 7.7 ttmt -134.67 140.71 46.22 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.766 -1.209 . . . . 0.0 110.479 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -122.07 105.79 10.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.288 -0.883 . . . . 0.0 109.728 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.64 28.9 74.07 Favored Glycine 0 N--CA 1.484 1.834 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.472 ' N ' ' HB3' ' A' ' 39' ' ' ASN . . . 91.45 -2.38 77.71 Favored Glycine 0 N--CA 1.482 1.723 0 C-N-CA 119.323 -1.417 . . . . 0.0 109.583 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.449 ' O ' ' C ' ' A' ' 68' ' ' TRP . . . -106.77 90.33 3.29 Favored 'General case' 0 N--CA 1.483 1.196 0 O-C-N 121.045 -1.268 . . . . 0.0 109.9 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.456 ' HA ' ' HA ' ' A' ' 63' ' ' LYS . 2.0 m-90 -19.66 -104.48 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.444 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 130.63 -99.87 0.45 Allowed Glycine 0 N--CA 1.489 2.199 0 O-C-N 119.863 -1.773 . . . . 0.0 110.941 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.3 t -93.77 143.41 26.36 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.258 -1.142 . . . . 0.0 111.528 -178.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -153.28 108.93 3.27 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.036 -1.04 . . . . 0.0 110.749 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.493 ' NE2' ' CZ ' ' A' ' 108' ' ' PHE . 10.1 pt20 -125.18 -151.19 0.47 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.275 -1.516 . . . . 0.0 111.01 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -140.59 132.92 28.31 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.959 -1.088 . . . . 0.0 111.095 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.431 ' OE2' ' CD1' ' A' ' 106' ' ' PHE . 82.0 tt0 -143.09 81.72 1.73 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.244 -0.91 . . . . 0.0 110.165 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.97 99.8 2.8 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.094 -1.004 . . . . 0.0 110.37 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.409 ' O ' HD11 ' A' ' 58' ' ' ILE . 4.2 p -140.24 138.2 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.019 -1.051 . . . . 0.0 109.143 178.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.588 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 4.1 p90 -153.15 87.04 3.99 Favored Pre-proline 0 C--N 1.303 -1.421 0 O-C-N 120.938 -1.101 . . . . 0.0 110.8 -178.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.47 ' O ' ' CD1' ' A' ' 79' ' ' PHE . 50.0 Cg_endo -86.13 11.01 3.44 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 124.229 1.647 . . . . 0.0 110.577 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.47 ' CD1' ' O ' ' A' ' 78' ' ' PRO . 42.5 m-85 -148.14 -175.31 4.84 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.146 -0.971 . . . . 0.0 110.622 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.457 ' CG ' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -140.45 174.03 4.38 Favored Pre-proline 0 N--CA 1.493 1.69 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.457 ' HD2' ' CG ' ' A' ' 80' ' ' GLN . 41.6 Cg_endo -64.3 145.94 89.31 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.084 1.044 . . . . 0.0 109.782 179.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 23' ' ' VAL . . . 75.54 35.86 45.53 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.7 m -130.62 155.23 46.91 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.226 -1.161 . . . . 0.0 111.225 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 53.0 t -104.13 126.24 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.181 -0.949 . . . . 0.0 109.542 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -145.11 154.79 42.84 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.139 -0.976 . . . . 0.0 110.074 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.445 ' HG2' ' HA ' ' A' ' 20' ' ' ARG . 97.4 mt-10 -121.01 149.23 43.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.133 -0.979 . . . . 0.0 110.836 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.4 t -126.02 127.81 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.206 -0.934 . . . . 0.0 110.895 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 1.7 m -99.38 131.65 45.25 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 95.8 mt -122.32 130.62 74.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.239 -0.913 . . . . 0.0 111.196 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 23.5 m -124.58 128.52 49.03 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.426 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 55.8 t80 -115.66 122.89 46.94 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.345 -0.847 . . . . 0.0 111.447 -178.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -115.52 147.64 40.44 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.215 -0.928 . . . . 0.0 110.073 178.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 64.2 tp60 -59.57 -24.8 64.05 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.193 -0.942 . . . . 0.0 110.78 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.482 ' O ' ' ND2' ' A' ' 95' ' ' ASN . . . -101.52 -13.15 18.01 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.824 -1.172 . . . . 0.0 111.52 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.482 ' ND2' ' O ' ' A' ' 94' ' ' ALA . 0.9 OUTLIER -162.37 163.14 27.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.926 -1.109 . . . . 0.0 111.344 -178.037 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 46.3 tp -115.23 130.14 56.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.184 -0.947 . . . . 0.0 108.753 177.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 79.9 m -122.0 130.85 53.65 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.827 -1.17 . . . . 0.0 111.717 -178.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 55.4 t -129.75 128.27 65.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.104 -0.998 . . . . 0.0 110.382 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -114.27 145.87 41.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.031 -1.043 . . . . 0.0 110.172 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.438 ' CG ' ' HD2' ' A' ' 101' ' ' PRO . 0.1 OUTLIER -104.47 169.02 7.69 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.198 -0.938 . . . . 0.0 109.021 178.959 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.438 ' HD2' ' CG ' ' A' ' 100' ' ' LEU . 42.1 Cg_endo -68.63 -25.5 34.31 Favored 'Trans proline' 0 C--N 1.301 -1.948 0 O-C-N 123.619 1.326 . . . . 0.0 109.382 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -68.62 -28.13 66.63 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.191 -0.943 . . . . 0.0 110.953 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 117.24 -10.59 14.86 Favored Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.687 -1.244 . . . . 0.0 110.049 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -82.15 144.64 30.6 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.856 -1.379 . . . . 0.0 110.601 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -135.74 148.16 48.72 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.115 -0.991 . . . . 0.0 111.566 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.431 ' CD1' ' OE2' ' A' ' 74' ' ' GLU . 97.1 m-85 -131.76 151.58 51.55 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.327 -0.858 . . . . 0.0 108.765 178.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -126.02 141.78 51.81 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.749 -1.22 . . . . 0.0 112.283 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.493 ' CZ ' ' NE2' ' A' ' 72' ' ' GLN . 1.9 m-85 -112.55 144.58 31.2 Favored Pre-proline 0 N--CA 1.492 1.631 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 159.99 51.4 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 123.428 1.225 . . . . 0.0 111.745 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 2.5 t-20 -71.96 53.8 0.26 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.565 -0.71 . . . . 0.0 112.254 -178.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 75.5 mtt85 -65.05 -38.25 90.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.768 -1.207 . . . . 0.0 109.102 177.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 97.2 mt -92.05 133.62 35.57 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.638 -0.664 . . . . 0.0 110.87 -178.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -96.08 18.75 12.86 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.587 -0.696 . . . . 0.0 111.038 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 47.9 tp -63.99 131.65 48.25 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.032 -1.043 . . . . 0.0 110.353 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -89.76 -12.96 37.79 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.964 -1.085 . . . . 0.0 111.67 -178.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.488 ' HA ' ' O ' ' A' ' 11' ' ' LEU . . . -160.51 155.51 24.43 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 118.234 -1.386 . . . . 0.0 111.925 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.43 ' HB ' ' HB3' ' A' ' 11' ' ' LEU . 41.1 mm -99.62 119.47 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.227 -0.921 . . . . 0.0 109.486 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 25.8 m-80 -111.02 -29.89 7.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.439 -0.788 . . . . 0.0 111.422 -178.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.496 ' HB2' ' O ' ' A' ' 36' ' ' LYS . 57.2 t80 -108.17 129.75 55.16 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.255 -0.903 . . . . 0.0 110.226 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.437 ' HB3' ' CD1' ' A' ' 9' ' ' LEU . 58.1 ttp -140.69 130.99 25.05 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.61 144.91 25.55 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 119.048 -1.061 . . . . 0.0 110.866 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.467 ' O ' ' HA3' ' A' ' 3' ' ' GLY . . . -142.09 124.79 15.92 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -150.62 134.16 16.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.617 -0.677 . . . . 0.0 109.243 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 158.42 -155.32 26.36 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -178.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.483 ' HB3' ' HA ' ' A' ' 27' ' ' ALA . 97.3 m-20 -73.74 -7.21 51.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.767 -0.843 . . . . 0.0 110.061 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.423 ' CZ ' ' HA3' ' A' ' 21' ' ' GLY . 33.5 t80 -98.91 138.43 36.04 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.216 -0.928 . . . . 0.0 110.172 -178.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.436 ' O ' ' CA ' ' A' ' 21' ' ' GLY . 75.5 mmtt -106.78 144.02 34.03 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.046 -1.034 . . . . 0.0 111.967 -178.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.463 ' O ' ' CD1' ' A' ' 4' ' ' LEU . 5.0 tt -126.27 106.97 16.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -103.45 -4.73 23.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.08 -1.013 . . . . 0.0 111.879 -178.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -154.68 135.34 13.54 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 118.486 -1.286 . . . . 0.0 111.613 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 51.4 t -128.35 131.11 69.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -132.08 139.92 48.67 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.79 -1.194 . . . . 0.0 110.504 -178.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -98.97 120.89 40.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.091 -1.006 . . . . 0.0 110.83 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 16' ' ' CYS . 64.4 t0 . . . . . 0 C--N 1.303 -1.418 0 CA-C-O 118.022 -0.989 . . . . 0.0 110.465 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.316 0.579 . . . . 0.0 110.139 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' CYS . . . . . 0.405 ' N ' ' HB3' ' B' ' 123' ' ' ASP . 0.7 OUTLIER -136.14 84.36 2.07 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.363 -0.836 . . . . 0.0 110.43 179.741 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . 0.458 ' HA3' ' O ' ' B' ' 122' ' ' ALA . . . 176.16 170.05 38.4 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . 0.459 ' CD1' ' O ' ' B' ' 128' ' ' ILE . 78.8 mt -80.32 145.08 32.28 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.29 -1.123 . . . . 0.0 111.948 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 29.6 m -110.67 149.79 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.686 -0.634 . . . . 0.0 109.453 178.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.1 155.98 47.5 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.857 -1.152 . . . . 0.0 112.421 -178.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' SER . . . . . 0.443 ' O ' ' HB3' ' B' ' 8' ' ' ASN . 15.2 m -155.02 173.02 17.16 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.34 -0.85 . . . . 0.0 109.774 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . 0.443 ' HB3' ' O ' ' B' ' 7' ' ' SER . 34.8 t-20 62.12 27.84 16.77 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.098 -1.001 . . . . 0.0 109.697 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . 0.539 ' O ' ' C ' ' B' ' 10' ' ' ASN . 58.1 mt -85.58 -4.32 59.13 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.695 -0.628 . . . . 0.0 111.918 -178.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . 0.539 ' C ' ' O ' ' B' ' 9' ' ' LEU . 76.6 m-20 5.5 73.93 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.85 0 CA-C-O 122.0 0.905 . . . . 0.0 112.149 -177.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' B' ' 116' ' ' ALA . 34.5 tp -97.88 132.65 43.28 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.756 -0.59 . . . . 0.0 109.986 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.63 169.64 6.61 Favored Pre-proline 0 C--N 1.29 -1.99 0 O-C-N 121.648 -0.658 . . . . 0.0 109.765 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' B' ' 91' ' ' PHE . 56.4 Cg_endo -72.55 155.7 54.58 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.016 1.535 . . . . 0.0 108.985 178.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.61 -10.37 59.19 Favored Glycine 0 N--CA 1.488 2.146 0 C-N-CA 119.53 -1.319 . . . . 0.0 109.821 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -115.16 147.12 40.66 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.92 -1.341 . . . . 0.0 109.235 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' CYS . . . . . 0.433 ' O ' ' N ' ' B' ' 134' ' ' ASP . 1.6 t -96.51 140.82 30.59 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.937 -1.102 . . . . 0.0 111.041 -178.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 56.1 tp -111.07 126.87 55.28 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.141 -0.974 . . . . 0.0 110.515 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -120.13 126.25 50.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.099 -1.001 . . . . 0.0 109.974 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 32.8 t -127.82 129.23 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.237 -0.914 . . . . 0.0 110.893 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . 0.456 ' HA ' ' HG2' ' B' ' 86' ' ' GLU . 72.7 ttt180 -108.81 129.85 55.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.284 -0.885 . . . . 0.0 110.094 178.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . 0.441 ' CA ' ' O ' ' B' ' 127' ' ' LYS . . . -134.35 173.14 21.53 Favored Glycine 0 C--N 1.297 -1.607 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . 0.403 ' O ' ' HB2' ' B' ' 127' ' ' LYS . 83.6 tt0 -124.86 120.89 32.96 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.525 -0.985 . . . . 0.0 108.844 179.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 69.6 t -84.35 132.63 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.026 -1.046 . . . . 0.0 109.887 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.65 154.59 89.46 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.29 -0.881 . . . . 0.0 110.039 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.404 ' O ' ' HB2' ' B' ' 81' ' ' PRO . 43.7 Cg_endo -67.89 -22.15 42.89 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.422 1.222 . . . . 0.0 110.89 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -101.67 13.73 34.04 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.187 -0.946 . . . . 0.0 109.69 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . 0.474 ' HA ' ' HB3' ' B' ' 125' ' ' ASP . . . -63.54 142.02 58.55 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.154 -0.966 . . . . 0.0 111.617 -178.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -127.74 -37.8 1.93 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 42.7 t -162.13 140.84 9.24 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.345 -0.847 . . . . 0.0 110.645 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' PHE . . . . . 0.434 ' CZ ' ' HG3' ' B' ' 47' ' ' PRO . 42.0 p90 -143.9 161.16 39.41 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.225 -0.922 . . . . 0.0 108.952 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 11.1 m -126.67 140.5 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 120.549 -1.344 . . . . 0.0 111.888 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.441 HD23 ' HB1' ' B' ' 122' ' ' ALA . 56.6 mt -118.06 133.98 55.41 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.502 -0.749 . . . . 0.0 109.599 179.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -124.89 135.08 52.54 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.794 -1.191 . . . . 0.0 111.946 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' B' ' 34' ' ' LEU . 0.6 OUTLIER -144.67 106.9 4.34 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.486 -0.759 . . . . 0.0 109.939 178.346 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -159.42 -142.06 3.3 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . 0.473 ' O ' ' HB2' ' B' ' 119' ' ' TYR . 47.6 pttt -108.82 -32.7 7.2 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.443 -1.033 . . . . 0.0 109.063 178.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . 0.417 ' N ' ' CG ' ' B' ' 36' ' ' LYS . 34.6 m-20 -139.44 171.55 14.1 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.982 0.896 . . . . 0.0 110.462 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 43.9 t -59.89 -41.94 92.7 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.623 -0.673 . . . . 0.0 111.331 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' ASN . . . . . 0.473 ' HB3' ' N ' ' B' ' 66' ' ' GLY . 83.1 m-20 -91.53 -6.21 52.86 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.02 -1.05 . . . . 0.0 111.112 -178.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -115.89 62.92 0.7 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.196 -0.94 . . . . 0.0 110.529 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 55.9 mt -87.19 148.88 24.97 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.357 -0.839 . . . . 0.0 109.29 178.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' CYS . . . . . . . . . . . . . 82.4 m -91.01 -40.27 11.75 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.111 -0.993 . . . . 0.0 109.284 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.44 ' HB3' HD12 ' B' ' 34' ' ' LEU . 15.2 tp -133.31 128.86 36.66 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.52 -0.737 . . . . 0.0 110.437 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' HIS . . . . . . . . . . . . . 18.6 t60 -121.46 113.12 19.4 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -104.62 122.04 44.79 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.056 -1.028 . . . . 0.0 110.942 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -139.03 85.38 16.01 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.159 -0.963 . . . . 0.0 111.444 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' PRO . . . . . 0.434 ' HG3' ' CZ ' ' B' ' 30' ' ' PHE . 57.0 Cg_endo -71.13 144.74 47.59 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.935 1.492 . . . . 0.0 110.031 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -128.65 92.43 3.41 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.738 -1.226 . . . . 0.0 110.286 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -63.94 -39.67 94.68 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.488 -0.757 . . . . 0.0 109.905 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 59.8 t-20 -138.47 91.42 2.54 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.189 -0.945 . . . . 0.0 108.721 178.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.48 -146.12 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.268 -0.895 . . . . 0.0 109.77 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -108.58 31.72 5.4 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.33 -0.856 . . . . 0.0 110.056 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 166.61 -32.14 0.21 Allowed Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.276 -1.44 . . . . 0.0 110.033 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -89.54 -169.13 2.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -1.146 . . . . 0.0 109.983 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.493 ' O ' ' C ' ' B' ' 56' ' ' ASN . . . -148.96 150.94 33.73 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 178.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' ASN . . . . . 0.493 ' C ' ' O ' ' B' ' 55' ' ' ALA . 92.4 m-20 16.67 66.91 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.617 0 CA-C-O 121.689 0.757 . . . . 0.0 112.429 -178.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 12.4 m -127.06 126.1 42.46 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.903 0.859 . . . . 0.0 110.578 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' ILE . . . . . . . . . . . . . 86.5 mt -119.79 131.87 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.542 -0.724 . . . . 0.0 110.555 -178.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 13.9 m -124.26 153.25 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.191 -0.943 . . . . 0.0 110.186 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 58.2 m -110.94 146.88 35.82 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.739 -1.226 . . . . 0.0 110.484 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' ASN . . . . . 0.404 ' HA ' ' O ' ' B' ' 70' ' ' THR . 23.6 t-20 -156.27 170.72 21.61 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.036 -1.04 . . . . 0.0 111.214 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 19.8 m -149.26 157.06 43.04 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . 0.478 ' CD ' ' HA2' ' B' ' 66' ' ' GLY . 7.1 ttmt -134.58 140.4 46.07 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.092 -1.005 . . . . 0.0 110.448 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -122.13 105.04 9.9 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.256 -0.902 . . . . 0.0 109.858 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.99 29.42 74.97 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . 0.478 ' HA2' ' CD ' ' B' ' 63' ' ' LYS . . . 90.77 -1.37 78.26 Favored Glycine 0 N--CA 1.484 1.839 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' ALA . . . . . 0.436 ' O ' ' C ' ' B' ' 68' ' ' TRP . . . -107.22 89.71 3.08 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.197 -1.178 . . . . 0.0 109.849 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' TRP . . . . . 0.451 ' HA ' ' HA ' ' B' ' 63' ' ' LYS . 1.9 m-90 -19.77 -104.34 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.36 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 130.41 -99.57 0.44 Allowed Glycine 0 N--CA 1.488 2.16 0 C-N-CA 118.641 -1.742 . . . . 0.0 110.795 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' THR . . . . . 0.404 ' O ' ' HA ' ' B' ' 61' ' ' ASN . 13.0 t -94.74 140.83 29.36 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.356 -1.085 . . . . 0.0 112.107 -178.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -150.65 108.7 3.73 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.205 -0.935 . . . . 0.0 111.283 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' GLN . . . . . 0.474 ' NE2' ' CZ ' ' B' ' 108' ' ' PHE . 9.6 pt20 -124.64 -151.86 0.49 Allowed 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.324 -1.485 . . . . 0.0 110.999 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -140.5 132.87 28.37 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.002 -1.062 . . . . 0.0 111.109 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' GLU . . . . . 0.448 ' OE2' ' CD1' ' B' ' 106' ' ' PHE . 82.1 tt0 -142.85 81.64 1.73 Allowed 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.183 -0.948 . . . . 0.0 110.324 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.9 99.9 2.79 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.011 -1.056 . . . . 0.0 110.484 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 4.1 p -140.07 137.65 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.313 -0.867 . . . . 0.0 109.249 178.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' PHE . . . . . 0.605 ' N ' ' CD1' ' B' ' 77' ' ' PHE . 4.2 p90 -152.73 86.91 4.16 Favored Pre-proline 0 C--N 1.302 -1.492 0 O-C-N 121.023 -1.048 . . . . 0.0 110.88 -178.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . 0.472 ' O ' ' CD1' ' B' ' 79' ' ' PHE . 50.5 Cg_endo -86.02 10.98 3.46 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.245 1.655 . . . . 0.0 110.56 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' PHE . . . . . 0.472 ' CD1' ' O ' ' B' ' 78' ' ' PRO . 40.5 m-85 -148.1 -175.58 4.95 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.024 -1.047 . . . . 0.0 110.774 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.455 ' CG ' ' HD2' ' B' ' 81' ' ' PRO . 0.0 OUTLIER -139.81 174.46 4.04 Favored Pre-proline 0 N--CA 1.488 1.446 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.779 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' PRO . . . . . 0.455 ' HD2' ' CG ' ' B' ' 80' ' ' GLN . 41.0 Cg_endo -64.35 145.96 89.12 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 N-CA-C 109.406 -1.036 . . . . 0.0 109.406 178.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 75.45 35.41 47.51 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 33.4 m -130.39 155.06 47.01 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.131 -1.217 . . . . 0.0 111.308 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 58.7 t -103.81 126.37 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.281 -0.887 . . . . 0.0 109.749 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -145.02 154.91 43.02 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.134 -0.979 . . . . 0.0 110.151 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' GLU . . . . . 0.456 ' HG2' ' HA ' ' B' ' 20' ' ' ARG . 97.8 mt-10 -120.79 149.36 42.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.346 -0.846 . . . . 0.0 110.853 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 21.5 t -125.62 128.27 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.132 -0.98 . . . . 0.0 110.734 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 88' ' ' CYS . . . . . . . . . . . . . 1.6 m -100.11 131.5 46.03 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 96.0 mt -122.43 130.7 74.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.098 -1.001 . . . . 0.0 111.22 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 22.6 m -124.11 128.67 49.62 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' PHE . . . . . 0.418 ' O ' ' HA ' ' B' ' 13' ' ' PRO . 55.6 t80 -115.62 122.76 46.6 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.584 -0.847 . . . . 0.0 111.355 -178.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -115.16 147.08 40.72 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.13 -0.981 . . . . 0.0 110.063 178.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 63.3 tp60 -59.33 -24.3 63.21 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.887 -1.133 . . . . 0.0 110.886 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 94' ' ' ALA . . . . . 0.467 ' O ' ' ND2' ' B' ' 95' ' ' ASN . . . -101.85 -13.7 17.56 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.904 -1.122 . . . . 0.0 111.284 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . 0.467 ' ND2' ' O ' ' B' ' 94' ' ' ALA . 0.9 OUTLIER -161.79 163.4 29.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.029 -1.045 . . . . 0.0 111.296 -178.251 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 96' ' ' LEU . . . . . . . . . . . . . 46.2 tp -115.59 129.57 56.56 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.248 -0.908 . . . . 0.0 108.596 177.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 78.1 m -121.72 131.64 54.19 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.82 -1.175 . . . . 0.0 111.356 -178.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 53.8 t -130.29 127.91 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.398 -0.814 . . . . 0.0 110.108 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -114.65 145.08 42.43 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.948 -1.095 . . . . 0.0 110.203 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . 0.444 ' CG ' ' HD2' ' B' ' 101' ' ' PRO . 0.1 OUTLIER -103.96 168.63 8.34 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.353 -0.842 . . . . 0.0 109.023 179.218 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' PRO . . . . . 0.444 ' HD2' ' CG ' ' B' ' 100' ' ' LEU . 41.9 Cg_endo -68.23 -25.28 36.95 Favored 'Trans proline' 0 C--N 1.301 -1.933 0 O-C-N 123.645 1.34 . . . . 0.0 109.376 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -68.27 -28.57 67.31 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.484 -0.76 . . . . 0.0 110.894 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 117.28 -10.65 14.77 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 104' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -81.72 144.55 31.05 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.897 -1.355 . . . . 0.0 110.804 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 73.5 tt0 -135.88 147.93 48.39 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.178 -0.951 . . . . 0.0 111.955 -179.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 106' ' ' PHE . . . . . 0.448 ' CD1' ' OE2' ' B' ' 74' ' ' GLU . 96.6 m-85 -131.95 151.16 51.9 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -125.74 142.27 51.59 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.718 -1.239 . . . . 0.0 112.07 -178.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 108' ' ' PHE . . . . . 0.474 ' CZ ' ' NE2' ' B' ' 72' ' ' GLN . 1.8 m-85 -113.16 144.65 31.57 Favored Pre-proline 0 N--CA 1.494 1.728 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -69.76 160.28 50.27 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 123.467 1.246 . . . . 0.0 111.652 -178.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 110' ' ' ASN . . . . . 0.442 ' HB2' ' O ' ' B' ' 94' ' ' ALA . 2.3 t-20 -72.11 53.78 0.28 Allowed 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.81 -0.556 . . . . 0.0 112.158 -178.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 75.1 mtt85 -65.27 -38.61 90.81 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.847 -1.158 . . . . 0.0 109.056 177.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 98.2 mt -91.5 134.08 34.95 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.358 -0.839 . . . . 0.0 111.157 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -96.13 18.78 12.85 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.414 -0.804 . . . . 0.0 110.997 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 50.6 tp -63.86 131.89 49.15 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.059 -1.026 . . . . 0.0 110.24 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -89.7 -12.83 38.33 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.042 -1.036 . . . . 0.0 111.849 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 116' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' B' ' 11' ' ' LEU . . . -161.2 155.69 23.16 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.372 -1.455 . . . . 0.0 111.787 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 117' ' ' ILE . . . . . 0.443 ' HB ' ' HB3' ' B' ' 11' ' ' LEU . 41.3 mm -100.1 119.8 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.228 -0.92 . . . . 0.0 109.649 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -111.04 -30.42 7.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.404 -0.81 . . . . 0.0 111.351 -178.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 119' ' ' TYR . . . . . 0.473 ' HB2' ' O ' ' B' ' 36' ' ' LYS . 57.8 t80 -107.03 131.03 54.54 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.013 -1.054 . . . . 0.0 110.219 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 120' ' ' MET . . . . . 0.457 ' HB3' ' CD1' ' B' ' 9' ' ' LEU . 55.5 ttp -141.91 130.89 23.11 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -151.14 144.4 24.75 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.054 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 122' ' ' ALA . . . . . 0.458 ' O ' ' HA3' ' B' ' 3' ' ' GLY . . . -141.68 125.02 16.51 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . 0.405 ' HB3' ' N ' ' B' ' 2' ' ' CYS . 65.1 m-20 -150.72 134.33 16.48 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.481 -0.762 . . . . 0.0 109.192 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 158.3 -155.48 26.5 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.044 -1.55 . . . . 0.0 109.554 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . 0.474 ' HB3' ' HA ' ' B' ' 27' ' ' ALA . 96.4 m-20 -73.25 -7.4 51.35 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.584 -0.951 . . . . 0.0 110.294 179.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 126' ' ' PHE . . . . . 0.418 ' CZ ' ' HA3' ' B' ' 21' ' ' GLY . 33.9 t80 -99.09 138.77 35.72 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.525 -0.734 . . . . 0.0 110.092 -178.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . 0.441 ' O ' ' CA ' ' B' ' 21' ' ' GLY . 75.7 mmtt -106.88 144.19 33.87 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 118.945 -1.102 . . . . 0.0 112.074 -178.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . 0.459 ' O ' ' CD1' ' B' ' 4' ' ' LEU . 5.1 tt -125.88 106.67 16.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -102.84 -5.6 23.42 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.888 -1.132 . . . . 0.0 111.771 -178.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 130' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -153.55 134.99 14.25 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 118.26 -1.376 . . . . 0.0 112.05 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 50.6 t -127.49 131.75 69.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 132' ' ' ALA . . . . . . . . . . . . . . . -131.91 139.91 48.89 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.446 -1.408 . . . . 0.0 110.477 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -98.79 121.08 40.28 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.8 -1.188 . . . . 0.0 110.959 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . 0.433 ' N ' ' O ' ' B' ' 16' ' ' CYS . 62.1 t0 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.407 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 120.877 0.37 . . . . 0.0 110.745 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.425 ' O ' ' CB ' ' A' ' 123' ' ' ASP . 37.2 m -113.81 37.35 3.3 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.191 -0.943 . . . . 0.0 109.177 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.485 ' HA3' ' O ' ' A' ' 122' ' ' ALA . . . 81.45 169.76 42.76 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 107.98 -2.048 . . . . 0.0 107.98 -178.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.478 ' N ' ' CD1' ' A' ' 4' ' ' LEU . 11.1 mp -93.44 142.21 27.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.071 -1.252 . . . . 0.0 110.43 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.3 t -108.56 131.54 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 121.198 -0.939 . . . . 0.0 110.117 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.52 ' HB1' HD12 ' A' ' 9' ' ' LEU . . . -130.41 172.61 11.68 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.951 -1.093 . . . . 0.0 111.822 -178.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.416 ' O ' ' CB ' ' A' ' 8' ' ' ASN . 30.5 p -155.07 167.2 31.15 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.45 -0.781 . . . . 0.0 110.001 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' B' ' 3' ' ' GLY . 20.2 t-20 63.43 40.01 8.74 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.384 0.611 . . . . 0.0 110.446 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.52 HD12 ' HB1' ' A' ' 6' ' ' ALA . 56.5 mt -99.66 16.2 24.24 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.314 -0.867 . . . . 0.0 110.316 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.476 ' C ' ' O ' ' A' ' 9' ' ' LEU . 51.0 t-20 -18.76 88.8 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.381 0 CA-C-O 121.996 0.903 . . . . 0.0 112.674 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.424 HD13 ' CE2' ' A' ' 133' ' ' PHE . 5.2 tt -100.5 134.68 43.1 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.584 -0.698 . . . . 0.0 109.96 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.443 ' HD2' ' HD2' ' A' ' 13' ' ' PRO . 0.6 OUTLIER -111.55 171.22 4.51 Favored Pre-proline 0 C--N 1.297 -1.695 0 O-C-N 121.069 -1.019 . . . . 0.0 109.784 179.031 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.451 ' HA ' ' O ' ' A' ' 91' ' ' PHE . 44.2 Cg_endo -66.19 144.63 75.77 Favored 'Trans proline' 0 C--N 1.299 -2.045 0 O-C-N 123.89 1.468 . . . . 0.0 110.278 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 104.44 -24.72 28.04 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -90.08 150.2 22.17 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.241 -1.153 . . . . 0.0 110.471 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.423 ' SG ' ' N ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -106.31 159.34 16.2 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.417 -0.802 . . . . 0.0 109.99 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.423 ' N ' ' SG ' ' A' ' 16' ' ' CYS . 0.6 OUTLIER -134.77 123.39 23.53 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.682 -1.261 . . . . 0.0 110.364 179.659 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -117.04 132.65 56.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.226 -0.921 . . . . 0.0 109.888 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.408 ' CG1' HD11 ' A' ' 128' ' ' ILE . 54.7 t -122.12 108.99 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.511 -0.743 . . . . 0.0 111.136 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 77.3 ttt-85 -110.0 123.17 49.19 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.764 -1.21 . . . . 0.0 110.575 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -147.11 -161.3 9.3 Favored Glycine 0 N--CA 1.489 2.188 0 C-N-CA 119.365 -1.398 . . . . 0.0 110.172 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -127.31 134.72 49.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.455 -1.026 . . . . 0.0 109.305 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.469 ' CG1' ' CB ' ' A' ' 27' ' ' ALA . 93.8 t -101.88 129.5 53.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 121.073 -1.017 . . . . 0.0 109.593 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.52 161.89 1.92 Allowed Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.323 -0.861 . . . . 0.0 110.281 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.52 -20.22 54.15 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 O-C-N 123.69 1.363 . . . . 0.0 109.573 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -111.76 44.03 1.44 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.661 -0.65 . . . . 0.0 110.393 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.469 ' CB ' ' CG1' ' A' ' 23' ' ' VAL . . . -71.15 91.09 0.9 Allowed 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 118.918 -1.113 . . . . 0.0 109.563 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -98.71 -20.93 16.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.385 -0.822 . . . . 0.0 109.985 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.1 t -150.11 143.5 25.13 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.882 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.482 ' CZ ' ' HB2' ' A' ' 32' ' ' LEU . 40.7 t80 -147.79 134.95 20.44 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.448 -0.782 . . . . 0.0 110.289 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 67.4 t -127.47 131.0 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.824 -1.172 . . . . 0.0 110.307 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.482 ' HB2' ' CZ ' ' A' ' 30' ' ' PHE . 5.0 tp -138.58 141.81 39.21 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.519 -0.738 . . . . 0.0 110.383 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.421 ' HB2' HD13 ' A' ' 41' ' ' LEU . 1.5 p-10 -154.25 143.09 20.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.053 -1.029 . . . . 0.0 110.7 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.5 pp -136.13 118.48 15.69 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.496 -0.753 . . . . 0.0 109.628 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 119' ' ' TYR . . . -142.85 -136.49 3.19 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.822 -1.18 . . . . 0.0 110.602 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.456 ' CG ' ' N ' ' A' ' 37' ' ' ASP . 24.0 pttt -127.64 -37.14 1.99 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.371 -1.076 . . . . 0.0 111.101 -179.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.456 ' N ' ' CG ' ' A' ' 36' ' ' LYS . 86.3 m-20 -115.25 -83.59 0.62 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.125 -0.985 . . . . 0.0 110.309 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.2 t -151.58 -53.6 0.13 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 60.6 m-20 -93.85 -4.06 50.74 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.343 -0.848 . . . . 0.0 109.004 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -91.18 68.72 6.05 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.175 -0.953 . . . . 0.0 109.854 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.421 HD13 ' HB2' ' A' ' 33' ' ' ASN . 75.8 mt -106.47 133.02 51.8 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.438 -0.789 . . . . 0.0 110.676 -179.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 69.8 m -85.1 -36.01 21.43 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.564 -0.71 . . . . 0.0 110.253 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.442 HD22 HD11 ' A' ' 96' ' ' LEU . 79.5 mt -129.97 129.16 43.42 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 119.454 -0.898 . . . . 0.0 111.542 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.439 ' HB3' ' OD1' ' A' ' 61' ' ' ASN . 60.1 t-80 -126.3 123.98 39.3 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.343 -0.848 . . . . 0.0 109.41 178.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -110.79 131.6 54.91 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.177 -0.952 . . . . 0.0 109.443 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -149.27 78.04 8.77 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 120.926 -1.109 . . . . 0.0 111.285 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.407 ' HD2' ' O ' ' A' ' 30' ' ' PHE . 47.2 Cg_endo -69.78 144.66 54.61 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.779 1.41 . . . . 0.0 110.014 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -144.46 88.18 1.92 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.865 -1.147 . . . . 0.0 110.869 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.41 ' O ' ' HA ' ' A' ' 55' ' ' ALA . 33.0 t80 -61.78 -46.4 89.74 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.332 0.587 . . . . 0.0 110.393 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -133.72 99.12 4.37 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.294 -0.879 . . . . 0.0 110.008 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -118.78 -69.1 0.87 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.003 -1.061 . . . . 0.0 110.893 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -105.13 -15.67 15.01 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.42 -0.8 . . . . 0.0 110.617 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 159.68 -12.91 0.19 Allowed Glycine 0 N--CA 1.494 2.543 0 C-N-CA 119.866 -1.159 . . . . 0.0 110.514 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -75.78 -179.95 5.08 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.849 -1.383 . . . . 0.0 109.444 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' A' ' 49' ' ' PHE . . . -129.67 -7.46 4.58 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.146 -0.971 . . . . 0.0 111.723 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 43.2 p30 -163.48 72.82 0.29 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.007 -1.058 . . . . 0.0 110.279 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 73.4 m -124.66 130.46 52.46 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.943 -1.098 . . . . 0.0 111.327 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.407 HD11 HG23 ' A' ' 58' ' ' ILE . 98.3 mt -121.76 130.64 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.28 -0.888 . . . . 0.0 111.089 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.0 t -114.31 129.98 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.297 -0.877 . . . . 0.0 110.495 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 33.8 m -129.16 122.1 29.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.319 -0.863 . . . . 0.0 110.067 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.476 ' HB3' ' HG2' ' A' ' 71' ' ' GLU . 4.9 p-10 -138.94 175.0 9.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.422 -0.799 . . . . 0.0 109.985 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.3 m -129.9 155.12 46.56 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.524 ' CD ' ' HA2' ' A' ' 66' ' ' GLY . 6.9 ttmt -135.47 149.29 49.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.495 -1.378 . . . . 0.0 112.128 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -129.19 100.43 5.61 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.44 21.28 68.51 Favored Glycine 0 N--CA 1.487 2.075 0 C-N-CA 119.801 -1.19 . . . . 0.0 110.62 179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.524 ' HA2' ' CD ' ' A' ' 63' ' ' LYS . . . 74.52 24.56 72.48 Favored Glycine 0 N--CA 1.488 2.162 0 C-N-CA 119.145 -1.503 . . . . 0.0 110.275 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -105.4 -74.35 0.65 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.897 -1.355 . . . . 0.0 110.742 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -69.22 -178.47 1.33 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.698 -0.626 . . . . 0.0 109.975 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 166.53 44.79 0.02 OUTLIER Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.0 m -62.39 100.39 0.18 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.066 -1.256 . . . . 0.0 110.504 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.476 ' HG2' ' HB3' ' A' ' 61' ' ' ASN . 89.5 mt-10 -84.97 123.15 30.19 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.336 -0.853 . . . . 0.0 110.903 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -101.39 -168.49 1.56 Allowed 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -146.27 122.27 10.71 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 118.04 -1.464 . . . . 0.0 111.695 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -108.67 132.71 53.64 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.59 60.27 0.6 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.795 -1.19 . . . . 0.0 111.234 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.6 p -135.23 151.25 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.942 -1.098 . . . . 0.0 110.4 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.497 ' CG ' ' O ' ' A' ' 77' ' ' PHE . 8.4 p90 -144.46 71.98 15.82 Favored Pre-proline 0 C--N 1.302 -1.475 0 O-C-N 121.098 -1.001 . . . . 0.0 109.874 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.443 ' CB ' ' HB2' ' A' ' 102' ' ' ASP . 39.9 Cg_endo -65.43 -13.8 41.67 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.892 1.469 . . . . 0.0 110.33 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -117.92 167.24 11.6 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.444 -0.785 . . . . 0.0 110.641 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.88 168.02 15.66 Favored Pre-proline 0 C--N 1.297 -1.674 0 O-C-N 121.546 -0.721 . . . . 0.0 109.598 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -65.65 148.66 87.32 Favored 'Trans proline' 0 C--N 1.298 -2.086 0 O-C-N 123.852 1.448 . . . . 0.0 110.671 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 62.29 42.44 99.72 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.6 t -148.32 137.56 21.96 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.097 -1.237 . . . . 0.0 109.988 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.5 m -78.06 140.22 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.01 -1.056 . . . . 0.0 108.997 178.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.98 153.55 38.09 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.158 -0.963 . . . . 0.0 109.707 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -122.46 152.65 40.06 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.234 -0.916 . . . . 0.0 110.044 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.0 t -128.98 139.34 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.489 -0.757 . . . . 0.0 111.503 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . 0.411 ' HB3' ' HB2' ' A' ' 99' ' ' LYS . 4.8 t -114.26 115.73 27.89 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.427 -0.796 . . . . 0.0 109.943 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 86.6 mt -121.22 128.1 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.141 -0.974 . . . . 0.0 110.014 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.447 ' HB ' ' HB ' ' A' ' 97' ' ' THR . 33.5 m -123.06 134.88 54.25 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.033 -1.042 . . . . 0.0 109.426 179.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.469 ' CD1' ' CD2' ' A' ' 96' ' ' LEU . 80.8 t80 -104.67 118.25 36.11 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.177 -0.952 . . . . 0.0 110.25 -179.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -112.52 143.21 44.06 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.399 -0.921 . . . . 0.0 109.452 178.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 71.6 tp60 -59.58 -26.51 65.47 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.522 -0.736 . . . . 0.0 110.668 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.89 -22.48 23.12 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.225 -0.922 . . . . 0.0 111.634 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 45.4 p30 -174.61 -171.58 0.58 Allowed 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.093 -1.005 . . . . 0.0 108.981 -178.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 108' ' ' PHE . 75.9 mt -122.49 135.06 54.57 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.002 -1.061 . . . . 0.0 110.58 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.447 ' HB ' ' HB ' ' A' ' 90' ' ' THR . 29.5 m -109.26 122.72 47.95 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.1 -1.0 . . . . 0.0 109.031 178.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 44.8 t -124.7 128.14 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.742 -1.224 . . . . 0.0 109.611 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.411 ' HB2' ' HB3' ' A' ' 88' ' ' CYS . 98.4 mttt -122.61 147.62 46.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.298 -0.877 . . . . 0.0 110.925 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.437 HD13 ' HG3' ' A' ' 78' ' ' PRO . 27.5 mt -107.28 166.63 10.7 Favored Pre-proline 0 N--CA 1.493 1.696 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 100' ' ' LEU . 38.8 Cg_endo -63.31 -24.32 71.86 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.368 1.194 . . . . 0.0 110.92 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.443 ' HB2' ' CB ' ' A' ' 78' ' ' PRO . 36.9 t70 -76.52 -10.26 59.26 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.074 -1.016 . . . . 0.0 110.84 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 104.34 -8.0 47.88 Favored Glycine 0 N--CA 1.496 2.656 0 C-N-CA 119.821 -1.18 . . . . 0.0 110.753 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -73.0 135.41 44.95 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.787 -1.419 . . . . 0.0 110.28 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -124.88 142.49 51.41 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.881 -1.137 . . . . 0.0 110.75 179.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -133.67 146.15 50.59 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 98.1 mttt -121.79 146.36 47.14 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.831 -1.168 . . . . 0.0 112.971 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.542 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 98.0 m-85 -117.22 150.23 45.89 Favored Pre-proline 0 N--CA 1.493 1.722 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.08 149.85 65.43 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.689 1.363 . . . . 0.0 111.142 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -71.04 62.74 0.3 Allowed 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.611 -0.681 . . . . 0.0 111.652 -178.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 79.6 mtp85 -65.39 -39.89 92.79 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.995 -1.066 . . . . 0.0 110.381 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -95.75 130.4 42.68 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.131 -0.981 . . . . 0.0 110.361 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -87.95 7.26 31.84 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.501 -0.749 . . . . 0.0 111.026 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.6 tt -57.82 128.68 38.32 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.224 -0.99 . . . . 0.0 109.222 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -106.32 -5.59 18.98 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.498 -0.751 . . . . 0.0 111.295 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -137.84 132.35 32.43 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.715 -1.24 . . . . 0.0 110.472 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.438 ' O ' ' HA ' ' A' ' 10' ' ' ASN . 95.6 mt -111.29 128.89 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 O-C-N 120.894 -1.129 . . . . 0.0 110.45 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -126.66 -27.62 3.08 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.026 -1.046 . . . . 0.0 111.645 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.412 ' O ' ' N ' ' A' ' 35' ' ' GLY . 69.4 t80 -92.67 126.09 37.6 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.007 -1.058 . . . . 0.0 110.466 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 27.1 ttm -141.01 134.73 30.28 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.993 -1.067 . . . . 0.0 109.573 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -159.11 147.95 18.34 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.26 -0.976 . . . . 0.0 109.686 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.485 ' O ' ' HA3' ' A' ' 3' ' ' GLY . . . -147.3 156.21 42.71 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 2' ' ' CYS . 10.2 p-10 -155.74 160.74 40.57 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.473 ' HA3' ' HA ' ' A' ' 30' ' ' PHE . . . 143.09 -157.27 26.83 Favored Glycine 0 C--N 1.295 -1.725 0 C-N-CA 118.548 -1.787 . . . . 0.0 110.439 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.455 ' CB ' ' HA ' ' A' ' 27' ' ' ALA . 63.1 m-20 -91.34 11.39 23.84 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.845 -0.797 . . . . 0.0 110.753 -179.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.423 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 12.3 t80 -107.42 151.25 25.78 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.822 -1.174 . . . . 0.0 110.681 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -120.8 124.8 45.96 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.564 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.473 ' O ' HG21 ' A' ' 128' ' ' ILE . 17.7 tt -102.49 126.74 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.928 . . . . 0.0 110.329 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 28.0 pttt -118.63 -4.81 10.75 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.795 -1.191 . . . . 0.0 111.053 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.461 ' HA ' ' O ' ' B' ' 131' ' ' VAL . 0.0 OUTLIER -154.35 131.96 11.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.74 -1.225 . . . . 0.0 111.928 -179.32 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' B' ' 130' ' ' CYS . 53.4 t -128.78 134.63 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.569 -0.707 . . . . 0.0 109.658 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.444 ' HA ' ' HB2' ' B' ' 130' ' ' CYS . . . -142.38 142.92 32.49 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.497 -1.377 . . . . 0.0 110.392 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.424 ' CE2' HD13 ' A' ' 11' ' ' LEU . 3.1 m-85 -76.47 -86.73 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.813 -1.179 . . . . 0.0 111.248 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 46.4 t0 . . . . . 0 C--N 1.296 -1.723 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.384 -179.169 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.85 0 CA-C-O 121.115 0.483 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' CYS . . . . . 0.41 ' O ' ' HA ' ' B' ' 123' ' ' ASP . 34.2 m -114.71 39.29 2.88 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.022 -1.049 . . . . 0.0 109.264 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . 0.534 ' O ' ' ND2' ' A' ' 8' ' ' ASN . . . 79.86 168.93 37.97 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 108.031 -2.028 . . . . 0.0 108.031 -178.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . 0.489 ' N ' ' CD1' ' B' ' 4' ' ' LEU . 11.0 mp -93.07 141.69 28.13 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.965 -1.315 . . . . 0.0 110.751 -179.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 41.9 t -107.82 131.6 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.382 0 O-C-N 121.082 -1.011 . . . . 0.0 110.242 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . 0.493 ' HB1' HD12 ' B' ' 9' ' ' LEU . . . -130.5 173.11 11.18 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.044 -1.035 . . . . 0.0 112.011 -178.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 27.1 p -155.34 168.25 27.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.426 -0.797 . . . . 0.0 109.802 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . 0.436 ' ND2' ' O ' ' A' ' 3' ' ' GLY . 20.2 t-20 62.61 41.09 9.77 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.589 -0.695 . . . . 0.0 110.416 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . 0.493 HD12 ' HB1' ' B' ' 6' ' ' ALA . 54.8 mt -101.19 17.03 23.57 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.437 -0.79 . . . . 0.0 110.04 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . 0.472 ' C ' ' O ' ' B' ' 9' ' ' LEU . 51.2 t-20 -20.0 89.04 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.39 0 CA-C-O 121.95 0.881 . . . . 0.0 112.77 -179.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 5.2 tt -100.44 134.16 43.8 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.703 -0.623 . . . . 0.0 109.885 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . 0.448 ' HD2' ' HD2' ' B' ' 13' ' ' PRO . 0.5 OUTLIER -111.34 171.09 4.6 Favored Pre-proline 0 C--N 1.293 -1.883 0 O-C-N 121.244 -0.91 . . . . 0.0 109.94 179.126 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . 0.448 ' HD2' ' HD2' ' B' ' 12' ' ' LYS . 44.1 Cg_endo -65.94 144.35 76.25 Favored 'Trans proline' 0 C--N 1.301 -1.942 0 O-C-N 123.919 1.484 . . . . 0.0 110.115 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 104.32 -24.01 30.16 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -90.92 149.83 21.74 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.194 -1.18 . . . . 0.0 110.591 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' CYS . . . . . 0.419 ' SG ' ' N ' ' B' ' 17' ' ' LEU . 0.0 OUTLIER -106.86 159.62 16.12 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.48 -0.763 . . . . 0.0 109.72 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.419 ' N ' ' SG ' ' B' ' 16' ' ' CYS . 0.6 OUTLIER -135.0 122.64 22.14 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.621 -1.299 . . . . 0.0 110.383 179.845 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -115.77 133.35 56.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.361 -0.837 . . . . 0.0 109.816 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 55.2 t -122.82 109.19 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.29 -0.881 . . . . 0.0 111.13 -178.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 77.2 ttt-85 -109.82 123.28 49.29 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.993 -1.067 . . . . 0.0 110.631 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -147.22 -161.4 9.38 Favored Glycine 0 N--CA 1.487 2.075 0 C-N-CA 119.456 -1.354 . . . . 0.0 110.009 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 71.3 tt0 -127.22 136.38 51.95 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.575 -0.956 . . . . 0.0 109.081 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.441 ' CG1' ' CB ' ' B' ' 27' ' ' ALA . 90.5 t -103.98 129.15 56.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 O-C-N 121.174 -0.954 . . . . 0.0 109.789 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.04 161.15 1.93 Allowed Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.506 -0.746 . . . . 0.0 110.172 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.401 ' HA ' ' CA ' ' B' ' 82' ' ' GLY . 42.7 Cg_endo -66.02 -20.16 57.39 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.802 1.422 . . . . 0.0 109.775 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -112.2 44.31 1.44 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.693 -0.629 . . . . 0.0 110.388 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . 0.464 ' HA ' ' CB ' ' B' ' 125' ' ' ASP . . . -71.84 91.25 1.15 Allowed 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 118.95 -1.1 . . . . 0.0 109.415 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -98.71 -20.58 16.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.491 -0.755 . . . . 0.0 109.777 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 24.8 t -149.65 143.31 25.42 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.076 -1.015 . . . . 0.0 111.046 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' PHE . . . . . 0.488 ' CZ ' ' HB2' ' B' ' 32' ' ' LEU . 41.0 t80 -147.69 134.75 20.35 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.508 -0.745 . . . . 0.0 110.162 179.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 76.9 t -127.74 131.05 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.852 -1.155 . . . . 0.0 110.437 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.488 ' HB2' ' CZ ' ' B' ' 30' ' ' PHE . 5.1 tp -138.53 142.58 39.3 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.384 -0.823 . . . . 0.0 110.361 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' ASN . . . . . 0.409 ' HB2' HD13 ' B' ' 41' ' ' LEU . 1.3 p-10 -155.11 142.59 19.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.964 -1.085 . . . . 0.0 110.671 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 1.5 pp -135.92 119.2 16.69 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.227 -0.921 . . . . 0.0 109.679 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -143.53 -137.58 3.28 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 119.922 -1.133 . . . . 0.0 110.392 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . 0.44 ' CG ' ' N ' ' B' ' 37' ' ' ASP . 24.6 pttt -126.86 -37.47 2.12 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.246 -1.149 . . . . 0.0 111.174 -178.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . 0.451 ' O ' ' CD1' ' B' ' 119' ' ' TYR . 88.3 m-20 -114.25 -84.14 0.61 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.976 -1.078 . . . . 0.0 109.958 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 7.7 t -150.76 -54.22 0.15 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.403 -0.811 . . . . 0.0 109.023 178.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 58.3 m-20 -92.6 -4.5 53.29 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.372 -0.83 . . . . 0.0 108.824 178.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -90.96 69.07 6.3 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.271 -0.893 . . . . 0.0 110.017 -178.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.409 HD13 ' HB2' ' B' ' 33' ' ' ASN . 77.5 mt -105.8 135.93 46.33 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.434 -0.791 . . . . 0.0 110.674 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' CYS . . . . . . . . . . . . . 74.2 m -88.83 -34.31 17.08 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.336 -0.852 . . . . 0.0 109.561 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.451 ' HA ' HD23 ' B' ' 43' ' ' LEU . 74.6 mt -131.25 129.71 41.92 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.192 -1.003 . . . . 0.0 111.276 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' HIS . . . . . 0.426 ' HB3' ' OD1' ' B' ' 61' ' ' ASN . 61.1 t-80 -127.0 123.28 36.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.506 -0.746 . . . . 0.0 109.297 178.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -110.15 131.31 55.17 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.133 -0.979 . . . . 0.0 109.762 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -148.51 78.08 9.37 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.074 -1.016 . . . . 0.0 111.506 -179.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' PRO . . . . . 0.413 ' HG2' ' HB3' ' B' ' 30' ' ' PHE . 47.8 Cg_endo -69.83 144.96 55.31 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 123.627 1.33 . . . . 0.0 109.839 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -145.26 88.51 1.87 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.898 -1.127 . . . . 0.0 110.566 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' PHE . . . . . 0.429 ' O ' ' HA ' ' B' ' 55' ' ' ALA . 33.8 t80 -61.65 -45.78 92.58 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.277 0.56 . . . . 0.0 110.417 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 27.1 t30 -134.79 98.67 4.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.286 -0.884 . . . . 0.0 110.239 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -118.74 -68.08 0.94 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.056 -1.028 . . . . 0.0 110.977 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -105.63 -15.2 15.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.295 -0.878 . . . . 0.0 110.886 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 159.52 -14.21 0.21 Allowed Glycine 0 N--CA 1.495 2.585 0 C-N-CA 119.913 -1.137 . . . . 0.0 110.277 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -74.45 179.67 4.5 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.752 -1.44 . . . . 0.0 109.045 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.429 ' HA ' ' O ' ' B' ' 49' ' ' PHE . . . -129.03 -11.11 4.77 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.066 -1.021 . . . . 0.0 111.387 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' ASN . . . . . . . . . . . . . 41.1 p30 -158.91 72.89 0.59 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.187 -0.945 . . . . 0.0 110.714 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 80.7 m -124.45 130.93 53.36 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 120.494 -1.379 . . . . 0.0 111.575 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' ILE . . . . . 0.416 HD11 HG23 ' B' ' 58' ' ' ILE . 98.1 mt -122.15 130.77 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.47 -0.769 . . . . 0.0 111.209 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 12.9 t -114.48 129.62 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.416 -0.802 . . . . 0.0 110.677 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 33.2 m -128.5 121.69 29.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.293 -0.879 . . . . 0.0 110.137 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' ASN . . . . . 0.505 ' HB3' ' HG2' ' B' ' 71' ' ' GLU . 3.8 p-10 -139.32 174.16 10.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.134 -0.979 . . . . 0.0 110.188 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 7.2 m -129.18 155.15 45.97 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.476 -0.765 . . . . 0.0 108.953 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . 0.52 ' CD ' ' HA2' ' B' ' 66' ' ' GLY . 6.8 ttmt -135.14 150.19 50.14 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.508 -1.37 . . . . 0.0 112.114 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -129.7 100.38 5.48 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 64.52 21.3 66.68 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.843 -1.17 . . . . 0.0 110.435 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . 0.52 ' HA2' ' CD ' ' B' ' 63' ' ' LYS . . . 74.68 25.6 69.44 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.251 -1.452 . . . . 0.0 110.473 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -105.95 -73.27 0.69 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.989 -1.3 . . . . 0.0 110.583 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -70.59 -177.06 1.41 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.653 -0.655 . . . . 0.0 109.887 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 164.94 46.4 0.02 OUTLIER Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 15.8 m -63.85 100.81 0.32 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.271 -1.134 . . . . 0.0 110.462 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.505 ' HG2' ' HB3' ' B' ' 61' ' ' ASN . 86.4 mt-10 -85.49 123.32 30.79 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.274 -0.891 . . . . 0.0 111.017 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -101.23 -167.81 1.47 Allowed 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -147.3 120.7 9.02 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 117.991 -1.484 . . . . 0.0 111.822 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -106.86 132.83 52.37 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.49 60.84 0.6 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.926 -1.109 . . . . 0.0 111.128 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 4.6 p -136.51 151.24 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.9 -1.125 . . . . 0.0 110.251 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' PHE . . . . . 0.494 ' O ' ' CG ' ' B' ' 77' ' ' PHE . 9.1 p90 -144.98 71.65 14.84 Favored Pre-proline 0 C--N 1.303 -1.444 0 O-C-N 121.204 -0.935 . . . . 0.0 109.99 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . 0.445 ' CB ' ' HB2' ' B' ' 102' ' ' ASP . 41.0 Cg_endo -64.71 -14.38 44.39 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.088 1.573 . . . . 0.0 110.422 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -116.89 167.24 11.3 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.191 -0.943 . . . . 0.0 110.408 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.77 167.66 16.9 Favored Pre-proline 0 C--N 1.3 -1.554 0 O-C-N 121.707 -0.621 . . . . 0.0 109.387 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -65.94 148.41 85.94 Favored 'Trans proline' 0 C--N 1.297 -2.165 0 O-C-N 123.946 1.498 . . . . 0.0 110.391 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . 0.401 ' CA ' ' HA ' ' B' ' 25' ' ' PRO . . . 62.47 43.18 99.4 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 15.9 t -149.32 138.73 21.57 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.196 -1.179 . . . . 0.0 110.043 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 15.4 m -79.1 140.08 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.136 -0.978 . . . . 0.0 109.156 178.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.71 154.13 39.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.063 -1.023 . . . . 0.0 109.81 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -123.29 152.66 41.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.049 -1.032 . . . . 0.0 109.993 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 46.9 t -128.4 138.52 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.399 -0.813 . . . . 0.0 111.457 -178.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 88' ' ' CYS . . . . . 0.422 ' HB3' ' HB2' ' B' ' 99' ' ' LYS . 4.7 t -113.49 114.73 26.95 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.422 -0.799 . . . . 0.0 109.845 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 87.1 mt -120.69 128.42 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.252 -0.905 . . . . 0.0 110.0 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 90' ' ' THR . . . . . 0.482 ' HB ' ' HB ' ' B' ' 97' ' ' THR . 27.8 m -123.09 134.94 54.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.222 -0.924 . . . . 0.0 109.628 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' PHE . . . . . 0.455 ' CD1' ' CD2' ' B' ' 96' ' ' LEU . 79.4 t80 -104.84 117.35 33.82 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.326 -0.858 . . . . 0.0 110.246 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -112.17 143.57 43.0 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.058 -1.026 . . . . 0.0 109.402 178.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 72.5 tp60 -60.69 -25.11 66.15 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.533 -0.729 . . . . 0.0 110.833 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.07 -22.35 21.86 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.973 -1.079 . . . . 0.0 111.499 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 45.6 p30 -174.39 -172.5 0.68 Allowed 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.163 -0.961 . . . . 0.0 108.947 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 96' ' ' LEU . . . . . 0.513 ' HB2' ' HB2' ' B' ' 108' ' ' PHE . 74.9 mt -121.72 134.93 54.95 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 120.993 -1.067 . . . . 0.0 110.697 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 97' ' ' THR . . . . . 0.482 ' HB ' ' HB ' ' B' ' 90' ' ' THR . 32.9 m -109.4 123.14 48.84 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.233 -0.917 . . . . 0.0 108.989 178.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 46.3 t -125.19 128.37 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.852 -1.155 . . . . 0.0 109.588 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 99' ' ' LYS . . . . . 0.422 ' HB2' ' HB3' ' B' ' 88' ' ' CYS . 98.5 mttt -122.89 146.27 47.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.179 -0.951 . . . . 0.0 110.899 -178.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . 0.432 HD13 ' HG3' ' B' ' 78' ' ' PRO . 25.0 mt -105.5 166.67 10.95 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -63.16 -25.43 72.72 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.239 1.126 . . . . 0.0 110.945 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' ASP . . . . . 0.445 ' HB2' ' CB ' ' B' ' 78' ' ' PRO . 36.3 t70 -74.42 -11.94 60.37 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.947 -1.096 . . . . 0.0 110.94 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 106.08 -8.5 42.07 Favored Glycine 0 N--CA 1.493 2.475 0 C-N-CA 119.887 -1.149 . . . . 0.0 110.683 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 104' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -72.3 136.48 46.25 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.933 -1.334 . . . . 0.0 110.25 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 71.4 tt0 -125.62 142.28 51.59 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.057 -1.027 . . . . 0.0 110.527 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -133.35 146.14 51.02 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.507 -0.746 . . . . 0.0 109.163 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 107' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' B' ' 96' ' ' LEU . 98.1 mttt -122.06 146.13 47.49 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.768 -1.208 . . . . 0.0 112.812 -178.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 108' ' ' PHE . . . . . 0.513 ' HB2' ' HB2' ' B' ' 96' ' ' LEU . 98.0 m-85 -117.09 150.28 45.78 Favored Pre-proline 0 N--CA 1.492 1.671 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.85 148.52 64.66 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.593 1.312 . . . . 0.0 111.261 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 110' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -69.77 62.85 0.19 Allowed 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.586 -0.696 . . . . 0.0 111.621 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 79.3 mtp85 -65.41 -39.78 92.58 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.919 -1.113 . . . . 0.0 110.277 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . 0.402 ' CD2' ' N ' ' B' ' 112' ' ' LEU . 4.5 mm? -95.87 130.01 42.95 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.18 -0.95 . . . . 0.0 110.702 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -87.38 7.4 29.12 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.643 -0.66 . . . . 0.0 111.069 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 3.5 tt -58.07 129.2 40.85 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.053 -1.029 . . . . 0.0 109.239 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -106.65 -5.56 18.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.559 -0.713 . . . . 0.0 111.36 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 116' ' ' ALA . . . . . . . . . . . . . . . -137.82 132.32 32.44 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.74 -1.225 . . . . 0.0 110.418 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 117' ' ' ILE . . . . . 0.426 ' O ' ' HA ' ' B' ' 10' ' ' ASN . 95.9 mt -111.72 128.71 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.927 -1.108 . . . . 0.0 110.269 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -126.1 -28.52 3.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.138 -0.976 . . . . 0.0 111.818 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 119' ' ' TYR . . . . . 0.451 ' CD1' ' O ' ' B' ' 37' ' ' ASP . 66.6 t80 -91.96 127.31 37.38 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.882 -1.136 . . . . 0.0 110.346 -179.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 26.5 ttm -142.0 134.26 27.79 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.115 -0.991 . . . . 0.0 109.592 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -158.89 147.71 18.53 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.101 -0.999 . . . . 0.0 109.448 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 122' ' ' ALA . . . . . 0.487 ' O ' ' HA3' ' B' ' 3' ' ' GLY . . . -147.14 155.0 41.78 Favored 'General case' 0 C--N 1.29 -1.995 0 O-C-N 121.472 -0.768 . . . . 0.0 108.975 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . 0.41 ' HA ' ' O ' ' B' ' 2' ' ' CYS . 9.6 p-10 -154.51 156.53 36.84 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 124' ' ' GLY . . . . . 0.487 ' HA3' ' HA ' ' B' ' 30' ' ' PHE . . . 148.93 -157.17 27.16 Favored Glycine 0 C--N 1.296 -1.693 0 C-N-CA 118.382 -1.866 . . . . 0.0 110.149 178.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . 0.464 ' CB ' ' HA ' ' B' ' 27' ' ' ALA . 63.1 m-20 -91.55 12.1 21.98 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 122.015 -0.697 . . . . 0.0 110.383 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 126' ' ' PHE . . . . . 0.422 ' HB3' ' CD1' ' B' ' 30' ' ' PHE . 11.5 t80 -108.58 151.4 26.17 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.668 -1.27 . . . . 0.0 110.402 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -121.23 124.57 44.97 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.268 -0.895 . . . . 0.0 110.356 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . 0.46 ' O ' HG21 ' B' ' 128' ' ' ILE . 18.0 tt -101.86 127.3 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.156 -0.965 . . . . 0.0 110.39 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 29.1 pttt -119.11 -4.3 10.56 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.783 -1.198 . . . . 0.0 111.126 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 130' ' ' CYS . . . . . 0.444 ' HB2' ' HA ' ' A' ' 132' ' ' ALA . 0.0 OUTLIER -154.29 130.96 10.71 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 118.947 -1.101 . . . . 0.0 111.91 -179.084 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 130' ' ' CYS . 54.7 t -128.05 133.85 66.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.659 -0.651 . . . . 0.0 109.956 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 132' ' ' ALA . . . . . . . . . . . . . . . -141.45 142.87 33.64 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 120.249 -1.532 . . . . 0.0 110.395 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -76.19 -88.56 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.096 -1.002 . . . . 0.0 111.084 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 48.4 t0 . . . . . 0 C--N 1.296 -1.749 0 CA-C-O 118.096 -0.954 . . . . 0.0 110.356 -179.388 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.865 0 CA-C-O 121.226 0.536 . . . . 0.0 110.472 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.51 ' O ' ' O ' ' A' ' 3' ' ' GLY . 1.3 m -96.85 54.11 1.27 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.145 -0.972 . . . . 0.0 110.808 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.51 ' O ' ' O ' ' A' ' 2' ' ' CYS . . . 43.39 111.2 0.0 OUTLIER Glycine 0 N--CA 1.497 2.704 0 CA-C-O 121.851 0.695 . . . . 0.0 112.271 178.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 84.2 mt -63.76 137.12 57.93 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.627 -1.514 . . . . 0.0 109.25 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.6 t -110.07 132.46 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.364 -0.835 . . . . 0.0 109.804 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.427 ' HB1' HD11 ' A' ' 9' ' ' LEU . . . -134.82 161.33 35.51 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.845 -1.16 . . . . 0.0 110.112 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.442 ' O ' ' HB3' ' A' ' 8' ' ' ASN . 15.2 p -153.38 169.95 21.86 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.539 -0.726 . . . . 0.0 109.999 -178.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.442 ' HB3' ' O ' ' A' ' 7' ' ' SER . 57.2 t30 65.74 39.08 4.94 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.263 0.554 . . . . 0.0 109.683 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 11' ' ' LEU . 85.7 mt -104.95 32.41 4.2 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.385 -0.822 . . . . 0.0 109.83 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -40.59 93.87 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.275 0 O-C-N 121.603 -0.686 . . . . 0.0 111.666 -178.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.477 ' HG ' ' CD1' ' A' ' 133' ' ' PHE . 0.2 OUTLIER -114.77 131.23 56.86 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.347 179.304 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.0 mttt -97.65 171.9 5.46 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.528 -0.733 . . . . 0.0 111.007 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -67.79 150.42 78.88 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 O-C-N 123.911 1.48 . . . . 0.0 110.095 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.59 -15.03 35.22 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.424 ' HB3' ' CB ' ' A' ' 134' ' ' ASP . 90.3 mt-10 -114.51 150.11 35.38 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.802 -1.41 . . . . 0.0 109.75 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 45.8 t -109.78 145.45 36.64 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.199 -0.938 . . . . 0.0 110.337 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 48.1 tp -112.48 134.17 54.16 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -121.86 129.55 52.68 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.934 -1.104 . . . . 0.0 110.108 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.425 HG13 ' CD1' ' A' ' 128' ' ' ILE . 65.2 t -126.28 127.7 70.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.161 -0.962 . . . . 0.0 111.02 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.429 ' HG3' ' HG2' ' A' ' 86' ' ' GLU . 70.3 ttt180 -107.27 122.12 45.91 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 177.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 127' ' ' LYS . . . -135.14 -178.57 15.77 Favored Glycine 0 N--CA 1.487 2.083 0 C-N-CA 118.939 -1.601 . . . . 0.0 111.661 -177.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -126.07 140.53 52.51 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 122.028 -0.689 . . . . 0.0 110.321 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.4 t -101.75 126.88 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.501 -0.749 . . . . 0.0 109.812 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.06 154.82 37.24 Favored Pre-proline 0 N--CA 1.497 1.922 0 O-C-N 120.989 -1.069 . . . . 0.0 110.48 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -67.45 -18.39 49.35 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 124.026 1.54 . . . . 0.0 111.208 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -119.77 52.23 1.12 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.924 -1.11 . . . . 0.0 108.69 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.43 ' HA ' ' HB3' ' A' ' 125' ' ' ASP . . . -78.21 153.01 32.32 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.575 0.702 . . . . 0.0 112.215 -178.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.402 ' N ' ' OD2' ' A' ' 125' ' ' ASP . 98.1 mttt -137.85 -39.66 0.56 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.539 -0.726 . . . . 0.0 109.953 179.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 40.1 p -161.58 160.0 28.37 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.967 -1.083 . . . . 0.0 111.756 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.45 ' HA ' ' HA3' ' A' ' 124' ' ' GLY . 67.3 t80 -153.86 150.82 28.81 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.49 -0.756 . . . . 0.0 109.878 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 45' ' ' PHE . 11.4 p -134.75 150.5 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.047 -1.033 . . . . 0.0 110.94 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 78.2 mt -118.2 147.22 43.6 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.487 -0.758 . . . . 0.0 108.995 179.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -143.25 108.54 5.02 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.015 -1.074 . . . . 0.0 111.004 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.435 ' HA ' ' O ' ' A' ' 119' ' ' TYR . 0.5 OUTLIER -131.14 121.28 24.63 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.401 -0.812 . . . . 0.0 109.494 179.254 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.447 ' O ' ' CB ' ' A' ' 119' ' ' TYR . . . -168.54 -171.5 34.44 Favored Glycine 0 N--CA 1.484 1.843 0 C-N-CA 118.652 -1.737 . . . . 0.0 109.977 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.409 ' HB2' ' CB ' ' A' ' 40' ' ' ASN . 34.9 mtpt -65.85 -41.52 91.58 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 122.284 1.04 . . . . 0.0 108.53 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.16 -167.33 2.17 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.851 0.834 . . . . 0.0 111.825 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.3 t -57.67 -41.98 82.66 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.636 -0.665 . . . . 0.0 112.766 -177.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -99.92 -7.34 25.35 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.234 -1.541 . . . . 0.0 110.663 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.409 ' CB ' ' HB2' ' A' ' 36' ' ' LYS . 7.1 m-80 -105.03 73.11 1.03 Allowed 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.032 -1.043 . . . . 0.0 109.096 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.414 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 60.1 mt -101.68 127.45 48.43 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.332 0.587 . . . . 0.0 110.362 -178.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 3.3 t -84.59 -43.91 14.02 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.123 -0.985 . . . . 0.0 110.488 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.482 HD21 HD21 ' A' ' 96' ' ' LEU . 20.4 tp -129.41 133.79 47.53 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.219 -0.926 . . . . 0.0 110.584 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.402 ' CB ' ' O ' ' A' ' 61' ' ' ASN . 9.3 t60 -126.73 112.77 15.8 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.525 ' CD2' ' HD3' ' A' ' 47' ' ' PRO . 43.2 t80 -111.71 115.77 29.63 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.822 -1.173 . . . . 0.0 110.481 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -130.45 73.76 80.91 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.348 -0.845 . . . . 0.0 111.601 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.525 ' HD3' ' CD2' ' A' ' 45' ' ' PHE . 43.5 Cg_endo -66.5 143.05 67.63 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.416 1.219 . . . . 0.0 109.52 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -137.63 126.32 23.8 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.912 -1.117 . . . . 0.0 110.847 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -72.21 -60.1 2.4 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.113 -0.992 . . . . 0.0 110.005 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -115.47 121.68 43.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.282 -0.886 . . . . 0.0 109.335 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.59 -162.46 0.96 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.838 -1.164 . . . . 0.0 111.123 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -83.45 8.92 12.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.404 -0.81 . . . . 0.0 110.165 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 173.76 -34.07 0.11 Allowed Glycine 0 N--CA 1.487 2.095 0 N-CA-C 108.589 -1.804 . . . . 0.0 108.589 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -80.85 -178.59 6.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.235 -1.156 . . . . 0.0 110.14 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.426 ' O ' ' C ' ' A' ' 56' ' ' ASN . . . -131.18 140.34 49.9 Favored 'General case' 0 C--N 1.293 -1.855 0 O-C-N 121.871 -0.518 . . . . 0.0 110.042 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.426 ' C ' ' O ' ' A' ' 55' ' ' ALA . 3.2 m120 27.81 73.52 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 179.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 96.2 m -127.51 131.18 50.14 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.913 -1.117 . . . . 0.0 110.526 178.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.494 ' HB ' ' HB3' ' A' ' 74' ' ' GLU . 82.4 mt -103.56 129.03 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.894 -0.504 . . . . 0.0 110.656 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 24.6 t -110.84 128.99 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.329 -0.857 . . . . 0.0 109.494 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.8 t -127.74 131.24 49.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.474 -0.766 . . . . 0.0 110.376 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.402 ' O ' ' CB ' ' A' ' 44' ' ' HIS . 1.5 p-10 -151.19 172.42 15.85 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.973 -1.079 . . . . 0.0 109.835 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.435 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 59.2 p -136.04 153.26 51.4 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.209 -0.932 . . . . 0.0 109.785 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.514 ' CD ' ' HA2' ' A' ' 66' ' ' GLY . 10.0 ttmt -133.29 145.79 50.79 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 120.692 -1.255 . . . . 0.0 111.876 -178.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.419 ' HB2' HD22 ' A' ' 112' ' ' LEU . 30.2 t0 -123.85 107.79 11.77 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.182 -0.949 . . . . 0.0 109.407 178.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 59.2 29.24 65.39 Favored Glycine 0 N--CA 1.485 1.91 0 C-N-CA 119.357 -1.401 . . . . 0.0 110.05 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.514 ' HA2' ' CD ' ' A' ' 63' ' ' LYS . . . 62.41 26.25 67.83 Favored Glycine 0 N--CA 1.488 2.108 0 O-C-N 120.997 -1.296 . . . . 0.0 110.621 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -89.98 -75.12 0.46 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.969 -1.312 . . . . 0.0 110.466 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 43.7 m95 -122.83 -170.46 2.1 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.792 -1.193 . . . . 0.0 110.777 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.435 ' HA2' ' O ' ' A' ' 62' ' ' SER . . . 173.49 114.62 0.35 Allowed Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.408 -1.377 . . . . 0.0 110.555 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 52.9 m -77.2 121.01 23.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.382 -1.069 . . . . 0.0 110.452 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -101.63 123.52 45.78 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.146 -0.971 . . . . 0.0 110.486 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -115.88 -170.27 1.76 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.826 -1.171 . . . . 0.0 110.378 179.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 47.3 ttp180 -144.4 116.4 8.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.952 -1.092 . . . . 0.0 111.587 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.494 ' HB3' ' HB ' ' A' ' 58' ' ' ILE . 77.5 tt0 -103.12 139.45 38.62 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.253 -0.904 . . . . 0.0 110.128 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.72 38.7 2.29 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.927 -1.108 . . . . 0.0 111.712 -179.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.463 ' O ' ' CD1' ' A' ' 58' ' ' ILE . 48.1 t -132.47 130.29 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.622 -1.299 . . . . 0.0 111.625 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -159.21 96.16 1.69 Allowed Pre-proline 0 N--CA 1.5 2.05 0 O-C-N 120.904 -1.122 . . . . 0.0 110.79 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -81.49 45.91 2.1 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.998 1.525 . . . . 0.0 111.7 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -128.85 152.8 48.1 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.615 -1.303 . . . . 0.0 111.725 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 15.4 mp0 -135.87 160.21 68.27 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.688 -0.632 . . . . 0.0 109.682 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -66.22 145.48 78.44 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.855 1.45 . . . . 0.0 110.79 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 64.5 40.25 97.52 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.1 p -133.54 148.77 51.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.976 -1.308 . . . . 0.0 111.627 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.6 p -101.26 136.47 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.505 -0.747 . . . . 0.0 109.233 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -153.91 155.07 35.0 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.121 -0.987 . . . . 0.0 110.368 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.429 ' HG2' ' HG3' ' A' ' 20' ' ' ARG . 99.0 mt-10 -119.36 139.18 52.4 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.896 -1.128 . . . . 0.0 110.597 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.6 t -125.95 132.68 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.411 -0.805 . . . . 0.0 110.68 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 77.8 m -107.77 134.41 50.77 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.176 -0.953 . . . . 0.0 109.107 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.439 HG21 HD13 ' A' ' 89' ' ' ILE . 89.1 mt -121.22 127.93 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.747 -1.221 . . . . 0.0 111.019 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 45.6 m -129.35 128.97 44.18 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.302 -0.874 . . . . 0.0 109.972 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.434 ' HA ' HD13 ' A' ' 96' ' ' LEU . 42.4 t80 -112.43 127.38 56.02 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.104 -0.997 . . . . 0.0 111.868 -179.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 95' ' ' ASN . 88.8 m-20 -119.09 156.02 30.48 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.496 -0.752 . . . . 0.0 109.911 179.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 -60.95 -23.88 65.65 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.454 -0.779 . . . . 0.0 112.73 -178.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -105.36 -26.54 11.93 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.436 -1.415 . . . . 0.0 110.428 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.409 ' O ' ' HB2' ' A' ' 92' ' ' ASP . 34.5 m-20 -152.57 172.61 16.33 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 119.069 -1.052 . . . . 0.0 111.866 -179.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.482 HD21 HD21 ' A' ' 43' ' ' LEU . 54.6 tp -119.13 129.42 55.02 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.4 m -114.58 125.25 53.56 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 120.781 -1.199 . . . . 0.0 111.115 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 43.3 t -120.18 127.93 75.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -114.42 119.24 36.22 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 118.589 -1.244 . . . . 0.0 109.774 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.0 mp -100.35 170.7 6.34 Favored Pre-proline 0 C--N 1.298 -1.645 0 O-C-N 121.91 -0.494 . . . . 0.0 109.755 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.05 -22.13 62.53 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 O-C-N 123.893 1.47 . . . . 0.0 111.122 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -66.04 -34.24 77.64 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.805 -1.185 . . . . 0.0 109.787 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 112.4 -27.0 10.41 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -73.22 145.23 46.37 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.145 -1.209 . . . . 0.0 109.381 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -113.64 143.33 44.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.844 -1.16 . . . . 0.0 111.022 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -120.44 147.86 44.55 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 98.2 mttt -120.77 145.11 47.88 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.01 -1.076 . . . . 0.0 111.555 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.431 ' HB3' HD23 ' A' ' 96' ' ' LEU . 15.0 t80 -125.55 129.59 24.35 Favored Pre-proline 0 C--N 1.293 -1.885 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -64.73 140.78 69.31 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 O-C-N 123.02 1.01 . . . . 0.0 109.965 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.51 ' ND2' ' O ' ' A' ' 110' ' ' ASN . 4.1 p-10 -92.02 82.4 5.1 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.023 -1.048 . . . . 0.0 109.473 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -54.72 -27.39 40.37 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.536 -1.353 . . . . 0.0 109.224 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.419 HD22 ' HB2' ' A' ' 64' ' ' ASP . 83.4 mt -104.65 132.33 51.02 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.338 -0.851 . . . . 0.0 109.851 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -87.7 61.06 6.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.009 -1.057 . . . . 0.0 110.415 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 52.0 tp -80.84 129.67 34.65 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.358 -0.839 . . . . 0.0 109.537 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -87.27 -12.36 46.86 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.162 -0.962 . . . . 0.0 111.549 -178.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' A' ' 11' ' ' LEU . . . -160.23 158.45 29.99 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.794 -1.191 . . . . 0.0 111.661 -178.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 49.9 mm -109.41 126.06 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.525 -0.734 . . . . 0.0 109.891 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -112.09 -26.65 8.74 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.566 -1.334 . . . . 0.0 110.787 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.447 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 10.5 t80 -110.21 126.26 53.95 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.229 -0.92 . . . . 0.0 110.401 -179.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 50.0 ttp -132.98 130.66 39.8 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.5 142.24 21.0 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.026 -1.046 . . . . 0.0 110.521 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.446 ' O ' ' CA ' ' A' ' 3' ' ' GLY . . . -148.02 132.03 17.22 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.35 -0.844 . . . . 0.0 111.391 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.436 ' HB3' ' HA3' ' A' ' 3' ' ' GLY . 15.2 p-10 -148.46 147.6 29.33 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.358 -0.839 . . . . 0.0 110.483 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.45 ' HA3' ' HA ' ' A' ' 30' ' ' PHE . . . 155.79 -145.44 12.34 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.43 ' HB3' ' HA ' ' A' ' 27' ' ' ALA . 88.2 m-20 -94.31 11.46 30.31 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.288 -1.125 . . . . 0.0 111.544 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.434 ' CZ ' ' HA3' ' A' ' 21' ' ' GLY . 24.7 t80 -112.87 143.74 43.62 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.964 -1.085 . . . . 0.0 109.319 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.445 ' O ' ' HA3' ' A' ' 21' ' ' GLY . 51.8 mttp -117.01 140.99 48.82 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.891 -1.131 . . . . 0.0 111.359 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.425 ' CD1' HG13 ' A' ' 19' ' ' VAL . 4.1 tt -111.57 122.41 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -101.55 -9.94 20.55 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.021 -1.049 . . . . 0.0 112.384 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.402 ' HA ' ' O ' ' B' ' 131' ' ' VAL . 0.1 OUTLIER -158.14 150.12 21.78 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.224 -1.547 . . . . 0.0 112.004 179.889 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 47.9 t -128.86 133.48 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -136.38 133.1 36.4 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.715 -1.241 . . . . 0.0 111.302 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.477 ' CD1' ' HG ' ' A' ' 11' ' ' LEU . 47.7 m-85 -110.9 148.22 32.93 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.402 -0.811 . . . . 0.0 111.313 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.424 ' CB ' ' HB3' ' A' ' 15' ' ' GLU . 47.1 t0 . . . . . 0 N--CA 1.496 1.873 0 CA-C-O 118.114 -0.946 . . . . 0.0 111.186 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 121.341 0.591 . . . . 0.0 110.441 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' CYS . . . . . 0.512 ' O ' ' O ' ' B' ' 3' ' ' GLY . 1.3 m -96.95 54.88 1.29 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.023 -1.048 . . . . 0.0 110.664 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . 0.512 ' O ' ' O ' ' B' ' 2' ' ' CYS . . . 42.43 111.3 0.0 OUTLIER Glycine 0 N--CA 1.497 2.717 0 CA-C-O 121.891 0.717 . . . . 0.0 112.308 178.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 86.2 mt -63.78 136.99 57.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.571 -1.547 . . . . 0.0 109.458 178.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 37.5 t -109.72 132.35 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.454 -0.779 . . . . 0.0 109.861 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . 0.439 ' HB1' HD11 ' B' ' 9' ' ' LEU . . . -134.7 161.12 36.05 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.766 -1.209 . . . . 0.0 110.214 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' SER . . . . . 0.453 ' O ' ' HB3' ' B' ' 8' ' ' ASN . 15.8 p -153.2 170.37 20.71 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.293 -0.879 . . . . 0.0 110.038 -178.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . 0.453 ' HB3' ' O ' ' B' ' 7' ' ' SER . 57.2 t30 65.43 39.05 5.36 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.241 0.543 . . . . 0.0 109.756 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . 0.439 HD11 ' HB1' ' B' ' 6' ' ' ALA . 82.6 mt -104.62 32.27 4.2 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.345 -0.847 . . . . 0.0 109.8 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 -40.24 93.97 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.495 -0.753 . . . . 0.0 111.708 -178.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.481 ' HG ' ' CD1' ' B' ' 133' ' ' PHE . 0.2 OUTLIER -115.01 131.05 57.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.649 -0.657 . . . . 0.0 110.286 179.603 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -97.75 172.54 4.79 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.506 -0.746 . . . . 0.0 110.765 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.25 150.69 76.75 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 O-C-N 123.95 1.5 . . . . 0.0 110.392 178.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.3 -14.98 36.2 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . 0.41 ' OE1' HD13 ' B' ' 11' ' ' LEU . 90.4 mt-10 -114.37 150.25 34.89 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.822 -1.399 . . . . 0.0 109.668 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' CYS . . . . . . . . . . . . . 52.3 t -109.89 145.62 36.52 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.129 -0.982 . . . . 0.0 110.036 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 46.3 tp -112.75 133.92 54.52 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -121.74 129.23 52.55 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.937 -1.102 . . . . 0.0 109.982 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.42 HG13 ' CD1' ' B' ' 128' ' ' ILE . 61.6 t -125.54 127.2 71.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.32 -0.862 . . . . 0.0 111.122 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . 0.432 ' HG3' ' HG2' ' B' ' 86' ' ' GLU . 70.2 ttt180 -107.02 122.13 45.84 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . 0.451 ' HA3' ' O ' ' B' ' 127' ' ' LYS . . . -135.17 -177.83 15.24 Favored Glycine 0 N--CA 1.484 1.842 0 C-N-CA 118.881 -1.628 . . . . 0.0 111.562 -177.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -126.66 140.76 52.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.697 -0.884 . . . . 0.0 110.203 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 6.4 t -101.92 127.39 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.293 -0.88 . . . . 0.0 109.846 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.35 155.51 36.02 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 120.953 -1.092 . . . . 0.0 110.588 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.77 -18.4 47.51 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 O-C-N 124.122 1.591 . . . . 0.0 111.113 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -119.88 52.62 1.11 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.023 -1.048 . . . . 0.0 108.8 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . 0.425 ' HA ' ' HB3' ' B' ' 125' ' ' ASP . . . -78.59 152.31 31.89 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.585 0.707 . . . . 0.0 112.144 -178.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . 0.403 ' N ' ' OD2' ' B' ' 125' ' ' ASP . 98.0 mttt -137.12 -40.66 0.59 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.671 -0.643 . . . . 0.0 110.105 178.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 35.8 p -160.14 160.9 33.49 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.871 -1.143 . . . . 0.0 111.321 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' PHE . . . . . 0.471 ' HA ' ' HA3' ' B' ' 124' ' ' GLY . 64.8 t80 -154.58 150.52 27.82 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.278 -0.889 . . . . 0.0 109.623 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' B' ' 45' ' ' PHE . 11.5 p -134.41 150.97 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 120.781 -1.2 . . . . 0.0 110.974 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 76.5 mt -118.09 147.12 43.59 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -143.14 108.11 4.93 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 120.834 -1.166 . . . . 0.0 110.974 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.442 ' HA ' ' O ' ' B' ' 119' ' ' TYR . 0.5 OUTLIER -131.29 116.35 17.5 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.283 -0.885 . . . . 0.0 109.835 179.546 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' B' ' 119' ' ' TYR . . . -161.63 -169.93 25.62 Favored Glycine 0 N--CA 1.485 1.919 0 C-N-CA 118.53 -1.795 . . . . 0.0 110.494 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt -66.69 -42.26 86.75 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -156.62 -167.06 2.28 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.75 0.786 . . . . 0.0 111.778 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 38.6 t -57.83 -41.9 83.24 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -100.31 -7.27 24.72 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 120.394 -1.441 . . . . 0.0 110.564 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -104.92 72.18 1.0 Allowed 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.903 -1.123 . . . . 0.0 109.129 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.442 ' HA ' ' HA3' ' B' ' 35' ' ' GLY . 60.1 mt -100.32 130.13 46.39 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.231 0.539 . . . . 0.0 110.031 -178.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' CYS . . . . . . . . . . . . . 2.1 t -88.63 -42.58 11.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.066 -1.021 . . . . 0.0 109.919 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.445 HD21 HD21 ' B' ' 96' ' ' LEU . 19.7 tp -129.76 133.91 47.29 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.144 -0.972 . . . . 0.0 110.456 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' HIS . . . . . 0.403 ' CB ' ' O ' ' B' ' 61' ' ' ASN . 9.0 t60 -127.27 112.75 15.44 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.521 ' CD2' ' HD3' ' B' ' 47' ' ' PRO . 43.3 t80 -111.69 115.25 28.79 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.133 -0.979 . . . . 0.0 110.436 -179.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -129.84 73.42 81.47 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 121.372 -0.83 . . . . 0.0 111.413 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' PRO . . . . . 0.521 ' HD3' ' CD2' ' B' ' 45' ' ' PHE . 41.4 Cg_endo -66.24 143.03 69.24 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.263 1.138 . . . . 0.0 109.259 179.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -137.9 126.63 23.78 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.91 -1.119 . . . . 0.0 110.713 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -72.59 -60.97 1.97 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.137 -0.977 . . . . 0.0 109.988 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -114.54 120.99 42.08 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.488 -0.758 . . . . 0.0 109.25 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.09 -162.11 0.92 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.84 -1.162 . . . . 0.0 111.32 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -84.18 11.42 8.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.433 -0.792 . . . . 0.0 110.122 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 170.42 -33.48 0.16 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -81.45 -178.55 6.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.013 -1.286 . . . . 0.0 110.029 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.473 ' O ' ' C ' ' B' ' 56' ' ' ASN . . . -129.6 146.91 51.36 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' ASN . . . . . 0.473 ' C ' ' O ' ' B' ' 55' ' ' ALA . 3.3 m120 17.53 77.36 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.175 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -179.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 97.0 m -128.1 130.86 48.84 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.236 -0.915 . . . . 0.0 110.328 178.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' ILE . . . . . 0.46 ' CD1' ' O ' ' B' ' 76' ' ' VAL . 82.7 mt -104.01 129.24 56.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 121.775 -0.578 . . . . 0.0 110.818 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 25.0 t -110.29 129.17 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.193 -0.942 . . . . 0.0 109.899 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 1.7 t -127.98 129.6 47.02 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.661 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' ASN . . . . . 0.403 ' O ' ' CB ' ' B' ' 44' ' ' HIS . 1.5 p-10 -149.69 171.75 16.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.151 -0.968 . . . . 0.0 110.194 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' SER . . . . . 0.431 ' O ' ' HA2' ' B' ' 69' ' ' GLY . 60.5 p -135.47 153.61 51.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.243 -0.91 . . . . 0.0 109.56 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . 0.512 ' CD ' ' HA2' ' B' ' 66' ' ' GLY . 10.1 ttmt -132.93 145.9 51.31 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 120.703 -1.248 . . . . 0.0 111.701 -178.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' ASP . . . . . 0.413 ' HB2' HD22 ' B' ' 112' ' ' LEU . 30.4 t0 -123.83 107.48 11.44 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.212 -0.93 . . . . 0.0 109.263 178.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 59.64 28.74 65.78 Favored Glycine 0 N--CA 1.484 1.878 0 C-N-CA 119.576 -1.297 . . . . 0.0 110.15 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . 0.512 ' HA2' ' CD ' ' B' ' 63' ' ' LYS . . . 62.84 25.83 68.12 Favored Glycine 0 N--CA 1.488 2.105 0 O-C-N 120.872 -1.369 . . . . 0.0 110.575 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -89.48 -75.65 0.44 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.835 -1.391 . . . . 0.0 110.236 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' TRP . . . . . . . . . . . . . 43.6 m95 -122.46 -166.29 1.4 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.871 -1.143 . . . . 0.0 110.985 -178.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . 0.431 ' HA2' ' O ' ' B' ' 62' ' ' SER . . . 167.87 114.33 0.3 Allowed Glycine 0 N--CA 1.486 2.032 0 C-N-CA 119.359 -1.4 . . . . 0.0 110.546 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 43.2 m -77.31 120.87 22.93 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.946 -0.738 . . . . 0.0 110.531 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -101.29 123.73 45.86 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.266 -0.896 . . . . 0.0 110.396 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -116.03 -171.05 1.91 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.84 -1.163 . . . . 0.0 110.295 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 47.7 ttp180 -143.78 116.02 8.47 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.205 -0.934 . . . . 0.0 111.42 -178.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' GLU . . . . . 0.443 ' HB3' ' HB ' ' B' ' 58' ' ' ILE . 78.1 tt0 -102.98 139.25 38.78 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.215 -0.928 . . . . 0.0 110.035 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.82 39.43 2.13 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.951 -1.093 . . . . 0.0 111.461 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' VAL . . . . . 0.46 ' O ' ' CD1' ' B' ' 58' ' ' ILE . 48.9 t -132.97 129.9 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 120.919 -1.113 . . . . 0.0 111.738 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -159.05 96.43 1.71 Allowed Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 120.922 -1.112 . . . . 0.0 110.809 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -81.66 46.6 2.28 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.925 1.487 . . . . 0.0 111.53 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -129.58 153.06 48.42 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.719 -1.238 . . . . 0.0 111.502 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 15.4 mp0 -136.41 160.5 66.57 Favored Pre-proline 0 N--CA 1.486 1.374 0 O-C-N 121.666 -0.646 . . . . 0.0 109.467 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -66.68 145.15 74.74 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.75 1.395 . . . . 0.0 110.958 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 64.78 39.95 97.0 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 12.7 p -132.77 147.78 52.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.011 -1.288 . . . . 0.0 111.913 -178.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 12.7 p -100.15 136.64 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.438 -0.789 . . . . 0.0 109.408 178.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -154.02 155.43 35.52 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.051 -1.031 . . . . 0.0 110.171 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' GLU . . . . . 0.432 ' HG2' ' HG3' ' B' ' 20' ' ' ARG . 98.3 mt-10 -119.67 139.07 52.81 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.856 -1.153 . . . . 0.0 110.499 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 55.9 t -125.62 132.78 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.517 -0.739 . . . . 0.0 110.601 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 88' ' ' CYS . . . . . . . . . . . . . 75.1 m -107.57 134.98 49.79 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.166 -0.959 . . . . 0.0 109.355 178.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.432 HG21 HD13 ' B' ' 89' ' ' ILE . 87.2 mt -121.59 128.26 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.882 -1.136 . . . . 0.0 110.958 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 90' ' ' THR . . . . . 0.404 ' O ' HD11 ' B' ' 96' ' ' LEU . 50.1 m -129.08 128.83 44.34 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.28 -0.887 . . . . 0.0 109.914 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 91' ' ' PHE . . . . . 0.425 ' HA ' HD13 ' B' ' 96' ' ' LEU . 41.1 t80 -112.38 127.35 55.99 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.995 -1.066 . . . . 0.0 111.637 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . 0.402 ' HB2' ' O ' ' B' ' 95' ' ' ASN . 88.9 m-20 -119.59 155.79 31.59 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.4 -0.813 . . . . 0.0 109.805 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -60.76 -23.84 65.28 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.404 -0.81 . . . . 0.0 112.761 -178.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -105.23 -26.95 11.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.366 -1.459 . . . . 0.0 110.474 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . 0.402 ' O ' ' HB2' ' B' ' 92' ' ' ASP . 34.5 m-20 -152.36 172.57 16.26 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 122.082 0.944 . . . . 0.0 112.02 -178.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 96' ' ' LEU . . . . . 0.445 HD21 HD21 ' B' ' 43' ' ' LEU . 54.1 tp -119.07 129.25 54.99 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 97' ' ' THR . . . . . 0.403 HG22 ' OE2' ' B' ' 105' ' ' GLU . 18.3 m -114.45 125.44 53.83 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 120.784 -1.198 . . . . 0.0 111.0 -179.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 44.7 t -120.53 128.06 75.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -114.5 118.99 35.32 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 118.542 -1.263 . . . . 0.0 110.142 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 5.1 mp -100.0 170.49 6.67 Favored Pre-proline 0 C--N 1.302 -1.466 0 O-C-N 121.889 -0.507 . . . . 0.0 110.009 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.72 -23.04 63.56 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.788 1.414 . . . . 0.0 110.998 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -64.95 -34.45 78.46 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.667 -1.271 . . . . 0.0 110.039 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 112.07 -27.22 10.42 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 104' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -72.91 144.67 47.26 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.198 -1.178 . . . . 0.0 109.443 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 105' ' ' GLU . . . . . 0.403 ' OE2' HG22 ' B' ' 97' ' ' THR . 68.2 tt0 -113.57 143.71 44.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.958 -1.089 . . . . 0.0 111.221 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -120.72 148.04 44.49 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 107' ' ' LYS . . . . . 0.43 ' HA ' ' O ' ' B' ' 96' ' ' LEU . 98.1 mttt -120.78 145.23 47.76 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.05 -1.031 . . . . 0.0 111.173 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 108' ' ' PHE . . . . . 0.41 ' HB3' HD23 ' B' ' 96' ' ' LEU . 15.7 t80 -126.13 129.83 24.13 Favored Pre-proline 0 C--N 1.291 -1.959 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -64.95 141.01 68.88 Favored 'Trans proline' 0 C--N 1.298 -2.131 0 O-C-N 123.071 1.038 . . . . 0.0 110.362 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 110' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' B' ' 110' ' ' ASN . 4.0 p-10 -91.84 82.16 5.19 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.158 -1.017 . . . . 0.0 109.689 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -54.36 -27.38 35.87 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.443 -1.411 . . . . 0.0 109.273 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . 0.413 HD22 ' HB2' ' B' ' 64' ' ' ASP . 82.5 mt -104.96 131.86 51.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.476 -0.765 . . . . 0.0 110.008 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -87.01 61.69 6.94 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.138 -0.977 . . . . 0.0 110.431 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 51.7 tp -81.24 130.03 34.85 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.247 -0.908 . . . . 0.0 109.571 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -87.18 -13.03 45.11 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.125 -0.984 . . . . 0.0 111.369 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 116' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' B' ' 11' ' ' LEU . . . -159.73 158.89 32.11 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.765 -1.21 . . . . 0.0 111.898 -178.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 49.7 mm -109.39 125.97 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.442 -0.786 . . . . 0.0 109.858 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -111.66 -26.91 8.76 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.542 -1.349 . . . . 0.0 110.667 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 119' ' ' TYR . . . . . 0.473 ' N ' ' O ' ' B' ' 35' ' ' GLY . 9.5 t80 -110.18 126.4 54.06 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.364 -0.934 . . . . 0.0 110.76 -178.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 49.8 ttp -133.19 129.83 38.3 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.444 -0.785 . . . . 0.0 108.976 179.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -152.75 142.31 21.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.905 -1.122 . . . . 0.0 110.578 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 122' ' ' ALA . . . . . 0.463 ' O ' ' CA ' ' B' ' 3' ' ' GLY . . . -147.41 132.47 18.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.013 -1.054 . . . . 0.0 111.351 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . 0.442 ' HB3' ' HA3' ' B' ' 3' ' ' GLY . 15.3 p-10 -148.58 147.45 29.03 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.091 -1.006 . . . . 0.0 110.551 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 124' ' ' GLY . . . . . 0.471 ' HA3' ' HA ' ' B' ' 30' ' ' PHE . . . 155.97 -144.43 10.89 Favored Glycine 0 N--CA 1.496 2.639 0 C-N-CA 119.808 -1.187 . . . . 0.0 110.177 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . 0.425 ' HB3' ' HA ' ' B' ' 27' ' ' ALA . 87.2 m-20 -95.09 10.82 34.35 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.241 -1.152 . . . . 0.0 111.351 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 126' ' ' PHE . . . . . 0.421 ' CZ ' ' HA3' ' B' ' 21' ' ' GLY . 24.4 t80 -112.52 143.71 43.22 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.876 -1.14 . . . . 0.0 109.519 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . 0.451 ' O ' ' HA3' ' B' ' 21' ' ' GLY . 52.0 mttp -116.56 141.11 48.61 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 118.81 -1.156 . . . . 0.0 111.521 -179.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . 0.42 ' CD1' HG13 ' B' ' 19' ' ' VAL . 4.1 tt -111.57 122.88 66.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.776 -0.578 . . . . 0.0 109.543 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -101.92 -11.8 18.71 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.078 -1.014 . . . . 0.0 112.196 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 130' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -155.89 150.61 26.14 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.271 -1.518 . . . . 0.0 112.024 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 130' ' ' CYS . 45.4 t -129.31 133.05 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.588 -0.695 . . . . 0.0 109.162 178.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 132' ' ' ALA . . . . . . . . . . . . . . . -136.19 132.66 36.23 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.713 -1.242 . . . . 0.0 111.39 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . 0.481 ' CD1' ' HG ' ' B' ' 11' ' ' LEU . 47.6 m-85 -110.48 147.98 33.0 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.275 -0.891 . . . . 0.0 111.105 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . 0.401 ' CB ' ' HB3' ' B' ' 15' ' ' GLU . 47.8 t0 . . . . . 0 N--CA 1.496 1.867 0 CA-C-O 118.137 -0.935 . . . . 0.0 111.127 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 121.138 0.494 . . . . 0.0 109.991 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 50.8 t -144.85 85.02 1.74 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.148 -0.97 . . . . 0.0 110.418 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 84.6 42.81 7.15 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 120.006 -1.093 . . . . 0.0 110.652 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.419 HD21 HG23 ' A' ' 128' ' ' ILE . 49.3 tp -59.77 133.7 56.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.88 -1.365 . . . . 0.0 110.7 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.7 t -118.04 130.11 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.361 -0.837 . . . . 0.0 110.071 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -118.81 153.01 35.17 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.325 -0.859 . . . . 0.0 109.555 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.457 ' O ' ' HB3' ' A' ' 8' ' ' ASN . 18.1 p -148.78 171.98 15.37 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.261 -0.899 . . . . 0.0 110.314 -178.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.457 ' HB3' ' O ' ' A' ' 7' ' ' SER . 14.7 t30 61.08 35.49 18.7 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.335 0.588 . . . . 0.0 110.272 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.525 ' O ' ' C ' ' A' ' 10' ' ' ASN . 87.7 mt -91.16 -17.97 25.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.215 -0.928 . . . . 0.0 110.893 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.525 ' C ' ' O ' ' A' ' 9' ' ' LEU . 7.6 m120 11.24 77.47 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.506 0 CA-C-O 121.522 0.677 . . . . 0.0 112.791 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.489 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 19.2 mt -98.93 128.05 45.0 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.686 -0.634 . . . . 0.0 110.765 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -96.35 169.68 8.6 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.18 -0.95 . . . . 0.0 110.47 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -66.13 146.65 82.38 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.976 1.514 . . . . 0.0 110.156 178.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.23 -7.78 56.84 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -117.92 147.28 43.28 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.953 -1.322 . . . . 0.0 109.998 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.8 m -109.63 145.13 36.97 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.963 -1.086 . . . . 0.0 111.606 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.5 tp -121.2 133.78 55.18 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -122.94 141.75 51.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.743 -1.223 . . . . 0.0 111.183 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 69.0 t -124.27 120.27 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 119.894 -0.723 . . . . 0.0 110.382 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -116.85 122.06 43.28 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.1 -1.0 . . . . 0.0 109.549 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.486 ' O ' HG12 ' A' ' 84' ' ' VAL . . . -144.71 -150.15 5.17 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.432 -1.365 . . . . 0.0 109.897 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -133.34 147.01 51.82 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.741 -1.446 . . . . 0.0 110.529 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 51.1 t -110.23 128.79 66.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.5 -0.75 . . . . 0.0 109.898 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.94 147.25 74.09 Favored Pre-proline 0 C--N 1.301 -1.528 0 O-C-N 121.061 -1.024 . . . . 0.0 109.2 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.455 ' HA ' ' N ' ' A' ' 82' ' ' GLY . 40.6 Cg_endo -65.89 -20.69 58.04 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.729 1.384 . . . . 0.0 110.141 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -116.77 29.63 7.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.439 -0.788 . . . . 0.0 109.228 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.458 ' HA ' ' HB3' ' A' ' 125' ' ' ASP . . . -63.74 99.09 0.21 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.514 -0.741 . . . . 0.0 110.884 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -66.52 -43.97 83.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.468 -0.77 . . . . 0.0 110.401 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.5 t -165.03 147.61 8.15 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.461 -0.774 . . . . 0.0 110.26 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.466 ' CD2' ' HB2' ' A' ' 126' ' ' PHE . 49.6 p90 -148.95 156.22 41.97 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.42 HG23 ' HB2' ' A' ' 46' ' ' ASN . 53.3 t -133.43 137.85 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.534 -1.354 . . . . 0.0 112.369 -177.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 93.2 mt -112.37 133.09 54.66 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.47 ' OD1' ' CE1' ' A' ' 44' ' ' HIS . 80.8 m-20 -125.78 135.89 52.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.013 -1.054 . . . . 0.0 110.968 -178.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.409 ' HA ' ' O ' ' A' ' 119' ' ' TYR . 0.7 OUTLIER -145.17 114.16 6.93 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.077 -1.014 . . . . 0.0 110.934 179.415 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.466 ' O ' ' N ' ' A' ' 119' ' ' TYR . . . -163.45 -132.31 1.33 Allowed Glycine 0 N--CA 1.496 2.66 0 N-CA-C 108.233 -1.947 . . . . 0.0 108.233 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.424 ' CA ' ' HB2' ' A' ' 119' ' ' TYR . 42.1 mtpt -112.08 -46.03 3.25 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.093 -1.24 . . . . 0.0 108.05 178.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -123.67 164.41 19.15 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.882 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.23 -32.18 68.08 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.339 -0.851 . . . . 0.0 110.982 -179.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.443 ' HB3' ' N ' ' A' ' 66' ' ' GLY . 87.1 m-20 -94.98 -9.07 35.09 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.877 -1.14 . . . . 0.0 111.186 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.439 ' N ' ' ND2' ' A' ' 40' ' ' ASN . 2.9 m-80 -113.56 66.42 0.66 Allowed 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.158 -0.964 . . . . 0.0 110.138 -178.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.444 HD12 ' HB3' ' A' ' 33' ' ' ASN . 47.0 mt -96.24 133.25 40.81 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 2.1 m -85.41 -31.24 23.0 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.993 -1.067 . . . . 0.0 109.784 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 25.3 tp -128.5 129.19 45.7 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.611 -0.681 . . . . 0.0 109.982 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.47 ' CE1' ' OD1' ' A' ' 33' ' ' ASN . 63.5 t60 -128.23 127.73 43.4 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.102 -0.999 . . . . 0.0 110.305 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.483 ' CD2' ' HD3' ' A' ' 47' ' ' PRO . 83.7 t80 -123.39 122.88 39.41 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.975 -1.078 . . . . 0.0 110.043 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.42 ' HB2' HG23 ' A' ' 31' ' ' VAL . 1.4 t-20 -142.71 84.23 11.03 Favored Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 121.154 -0.966 . . . . 0.0 110.954 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.483 ' HD3' ' CD2' ' A' ' 45' ' ' PHE . 52.7 Cg_endo -70.64 142.77 44.84 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.657 1.346 . . . . 0.0 109.489 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -127.0 97.59 5.01 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.921 -1.112 . . . . 0.0 110.394 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -61.03 -45.44 94.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.132 -0.98 . . . . 0.0 109.139 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -159.63 103.36 1.55 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.309 -0.869 . . . . 0.0 109.413 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -113.82 -104.17 0.4 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.045 -1.034 . . . . 0.0 110.695 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -65.88 -41.47 91.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.663 -1.273 . . . . 0.0 109.872 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 168.54 39.54 0.02 OUTLIER Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.402 ' N ' ' OD1' ' A' ' 54' ' ' ASP . 8.9 m-20 -114.08 -179.42 3.63 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.353 -1.087 . . . . 0.0 109.115 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.423 ' O ' ' C ' ' A' ' 56' ' ' ASN . . . -142.14 143.99 33.27 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.977 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.423 ' C ' ' O ' ' A' ' 55' ' ' ALA . 81.2 m-20 27.55 49.4 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 178.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 55.2 m -118.48 130.51 55.98 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.84 -1.162 . . . . 0.0 109.352 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.477 HG23 ' CE1' ' A' ' 45' ' ' PHE . 86.8 mt -115.6 135.26 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.203 -0.936 . . . . 0.0 110.933 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 64.6 t -102.05 126.09 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.382 -0.824 . . . . 0.0 110.265 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 80.2 m -116.76 121.27 41.1 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.142 -0.974 . . . . 0.0 109.251 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.434 ' O ' ' HB3' ' A' ' 44' ' ' HIS . 2.5 p-10 -151.63 179.1 8.69 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.952 -1.093 . . . . 0.0 111.163 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.455 ' O ' ' CA ' ' A' ' 69' ' ' GLY . 15.1 m -133.91 154.18 51.25 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.325 -0.86 . . . . 0.0 109.874 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.486 ' CD ' ' HA2' ' A' ' 66' ' ' GLY . 18.3 ttmt -128.53 143.67 51.01 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.491 -1.381 . . . . 0.0 111.277 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -122.34 95.61 4.71 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.463 -0.773 . . . . 0.0 109.161 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 71.21 19.87 77.68 Favored Glycine 0 N--CA 1.484 1.834 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.486 ' HA2' ' CD ' ' A' ' 63' ' ' LYS . . . 72.29 32.72 62.32 Favored Glycine 0 N--CA 1.486 2.009 0 C-N-CA 119.386 -1.388 . . . . 0.0 110.694 179.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -101.86 -74.55 0.62 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.855 -1.379 . . . . 0.0 111.122 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 14.1 m0 -124.16 -147.83 0.38 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.14 -0.975 . . . . 0.0 110.627 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.455 ' CA ' ' O ' ' A' ' 62' ' ' SER . . . 158.64 144.65 4.01 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.429 ' HB ' ' CZ ' ' A' ' 111' ' ' ARG . 6.5 t -81.53 80.47 7.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.455 -1.026 . . . . 0.0 109.729 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.433 ' HA ' ' HB3' ' A' ' 61' ' ' ASN . 78.6 tt0 -71.07 111.56 6.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.249 -0.907 . . . . 0.0 110.875 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -122.79 -164.94 1.24 Allowed 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.333 -0.855 . . . . 0.0 109.556 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -137.65 130.92 30.73 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.431 -0.907 . . . . 0.0 110.583 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -131.83 83.43 2.09 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.309 -0.87 . . . . 0.0 109.508 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.74 88.08 0.1 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.216 -0.928 . . . . 0.0 110.611 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.423 ' O ' HD11 ' A' ' 58' ' ' ILE . 6.2 p -134.6 141.49 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.449 -0.782 . . . . 0.0 109.682 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -157.11 89.21 2.57 Favored Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 120.55 -1.344 . . . . 0.0 110.891 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.403 ' CB ' ' OD2' ' A' ' 102' ' ' ASP . 51.0 Cg_endo -77.39 -6.63 16.51 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.845 1.445 . . . . 0.0 111.978 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -142.21 -167.3 2.44 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.79 -1.194 . . . . 0.0 111.293 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.416 ' CB ' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -139.48 172.53 6.3 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.481 -0.762 . . . . 0.0 109.723 179.753 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.416 ' HD2' ' CB ' ' A' ' 80' ' ' GLN . 44.3 Cg_endo -67.22 147.42 78.68 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.807 1.425 . . . . 0.0 111.294 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.455 ' N ' ' HA ' ' A' ' 25' ' ' PRO . . . 78.71 23.56 64.29 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.4 t -137.01 147.45 46.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.083 -1.245 . . . . 0.0 111.113 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.486 HG12 ' O ' ' A' ' 21' ' ' GLY . 73.3 t -79.23 130.26 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.529 -0.732 . . . . 0.0 110.116 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -130.82 142.24 50.38 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.946 -1.096 . . . . 0.0 109.692 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.404 ' O ' ' HG3' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -120.22 127.29 52.29 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.519 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 73.4 t -121.52 132.26 71.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 118.985 -1.086 . . . . 0.0 111.019 -177.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 11.8 t -97.04 117.74 31.9 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.493 -0.754 . . . . 0.0 109.368 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 72.7 mt -111.51 125.24 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.082 -1.012 . . . . 0.0 109.468 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 57.7 m -122.36 129.38 52.06 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.361 -0.837 . . . . 0.0 109.665 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.468 ' CB ' HD12 ' A' ' 117' ' ' ILE . 72.5 t80 -106.76 118.28 36.27 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.052 -1.03 . . . . 0.0 110.822 -179.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -115.73 152.08 33.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.467 -0.771 . . . . 0.0 109.378 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 69.9 tp60 -62.73 -38.83 92.07 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.968 -1.082 . . . . 0.0 110.521 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.34 -39.35 89.15 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.949 -1.094 . . . . 0.0 110.563 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -166.7 178.8 5.74 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.322 -0.862 . . . . 0.0 110.068 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 49.5 tp -102.08 129.86 48.52 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.375 -0.828 . . . . 0.0 109.197 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 98.9 m -115.4 122.67 46.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.717 -1.239 . . . . 0.0 111.22 -179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 7.0 m -120.84 129.51 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.382 -0.824 . . . . 0.0 109.36 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -113.53 124.79 53.21 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.797 -1.19 . . . . 0.0 109.396 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.438 ' N ' HD12 ' A' ' 100' ' ' LEU . 8.0 mp -85.42 164.37 40.89 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.301 -0.874 . . . . 0.0 109.57 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -66.14 -32.85 42.21 Favored 'Trans proline' 0 C--N 1.302 -1.905 0 O-C-N 123.858 1.452 . . . . 0.0 110.486 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.403 ' OD2' ' CB ' ' A' ' 78' ' ' PRO . 99.7 m-20 -74.45 -25.32 59.34 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.106 -0.996 . . . . 0.0 110.208 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 121.3 3.11 10.66 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.761 -1.209 . . . . 0.0 111.095 178.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -83.9 135.8 34.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.598 -1.531 . . . . 0.0 110.249 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 64.5 tt0 -132.49 148.56 52.39 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.434 -0.791 . . . . 0.0 111.129 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -141.0 156.4 46.05 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.602 -0.686 . . . . 0.0 109.21 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -123.92 141.0 52.43 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.007 -1.058 . . . . 0.0 110.867 -178.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -123.71 143.35 41.63 Favored Pre-proline 0 N--CA 1.494 1.733 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.84 144.28 47.88 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.299 1.158 . . . . 0.0 109.184 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.485 ' ND2' ' O ' ' A' ' 110' ' ' ASN . 6.0 p-10 -95.0 82.76 3.84 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 120.934 -1.104 . . . . 0.0 110.584 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.429 ' CZ ' ' HB ' ' A' ' 70' ' ' THR . 98.2 mtt180 -55.77 -22.11 22.51 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.818 -1.176 . . . . 0.0 109.111 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.4 mt -96.9 141.92 29.51 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.319 -0.863 . . . . 0.0 108.704 178.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -97.02 62.42 1.83 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.748 -1.22 . . . . 0.0 109.875 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.409 ' CD1' ' HD2' ' A' ' 36' ' ' LYS . 64.9 tp -82.33 130.04 35.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.353 -0.842 . . . . 0.0 111.08 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.94 -17.23 29.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.409 -0.807 . . . . 0.0 109.87 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.489 ' HA ' ' O ' ' A' ' 11' ' ' LEU . . . -163.22 144.08 9.36 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.723 -1.236 . . . . 0.0 111.682 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.468 HD12 ' CB ' ' A' ' 91' ' ' PHE . 93.1 mt -98.87 124.59 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.386 -0.821 . . . . 0.0 108.981 178.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.466 ' ND2' ' N ' ' A' ' 118' ' ' ASN . 0.1 OUTLIER -125.59 13.0 8.08 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.592 -0.692 . . . . 0.0 110.772 -179.361 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.466 ' N ' ' O ' ' A' ' 35' ' ' GLY . 7.8 t80 -131.62 128.82 39.92 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.974 -1.079 . . . . 0.0 110.261 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 62.5 ttp -142.78 130.8 21.79 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.347 -0.846 . . . . 0.0 109.85 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -140.88 144.53 35.32 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.229 -0.92 . . . . 0.0 109.76 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -132.11 108.95 9.64 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.281 -0.887 . . . . 0.0 109.458 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -137.65 129.16 28.19 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.531 -0.731 . . . . 0.0 109.649 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 154.13 -157.93 27.81 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 108.841 -1.704 . . . . 0.0 108.841 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.458 ' HB3' ' HA ' ' A' ' 27' ' ' ALA . 87.6 m-20 -78.38 -0.22 28.22 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.3 -1.118 . . . . 0.0 110.552 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.466 ' HB2' ' CD2' ' A' ' 30' ' ' PHE . 42.7 t80 -95.4 142.28 27.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.09 -1.006 . . . . 0.0 109.859 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -112.95 140.12 48.02 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 118.815 -1.154 . . . . 0.0 110.538 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.419 HG23 HD21 ' A' ' 4' ' ' LEU . 20.6 tt -108.51 122.79 63.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.625 -0.672 . . . . 0.0 109.755 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -105.74 -23.07 12.81 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.328 -0.857 . . . . 0.0 110.97 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.418 ' HA ' ' O ' ' B' ' 131' ' ' VAL . 0.1 OUTLIER -153.03 154.88 35.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.82 -1.175 . . . . 0.0 112.136 -178.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' B' ' 130' ' ' CYS . 42.8 t -123.71 135.91 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -124.29 146.35 48.84 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.867 -1.145 . . . . 0.0 110.574 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.474 ' CZ ' HD23 ' A' ' 11' ' ' LEU . 0.4 OUTLIER -94.39 -139.92 0.23 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.349 -0.844 . . . . 0.0 109.798 179.786 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 49.0 t0 . . . . . 0 N--CA 1.492 1.673 0 O-C-N 120.631 -1.293 . . . . 0.0 110.437 -179.589 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.218 0.532 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' CYS . . . . . . . . . . . . . 49.6 t -145.17 84.85 1.72 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.095 -1.003 . . . . 0.0 110.608 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 84.84 43.37 6.81 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . 0.415 HD21 HG23 ' B' ' 128' ' ' ILE . 50.1 tp -60.18 133.66 56.31 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.918 -1.342 . . . . 0.0 110.577 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 46.7 t -117.95 130.07 73.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.363 -0.836 . . . . 0.0 110.111 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -118.94 152.51 36.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.926 . . . . 0.0 109.485 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' SER . . . . . 0.471 ' O ' ' HB3' ' B' ' 8' ' ' ASN . 17.1 p -148.6 172.26 14.82 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.102 -0.999 . . . . 0.0 110.25 -179.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . 0.471 ' HB3' ' O ' ' B' ' 7' ' ' SER . 13.6 t30 61.34 35.47 17.96 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.404 0.621 . . . . 0.0 110.303 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . 0.538 ' O ' ' C ' ' B' ' 10' ' ' ASN . 88.5 mt -92.52 -12.51 31.73 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.362 -0.836 . . . . 0.0 111.153 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . 0.538 ' C ' ' O ' ' B' ' 9' ' ' LEU . 7.3 m120 2.85 80.42 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.491 0 CA-C-O 122.144 0.973 . . . . 0.0 112.953 -178.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' B' ' 9' ' ' LEU . 18.7 mt -98.96 127.96 45.01 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.642 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -96.35 169.76 8.47 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.204 -0.935 . . . . 0.0 110.549 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.16 146.74 82.48 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 124.004 1.529 . . . . 0.0 110.18 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.86 -7.48 57.41 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.084 -1.207 . . . . 0.0 110.084 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -117.94 147.5 43.09 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.905 -1.35 . . . . 0.0 109.827 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' CYS . . . . . . . . . . . . . 6.2 m -110.11 145.25 37.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.085 -1.009 . . . . 0.0 111.365 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 46.9 tp -121.33 133.83 55.13 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -122.97 141.63 51.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.867 -1.146 . . . . 0.0 111.21 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 69.4 t -124.09 120.91 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 119.902 -0.719 . . . . 0.0 110.354 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -117.44 121.81 42.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.259 -0.901 . . . . 0.0 109.602 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . 0.476 ' O ' HG12 ' B' ' 84' ' ' VAL . . . -144.65 -149.93 5.14 Favored Glycine 0 N--CA 1.494 2.511 0 C-N-CA 119.486 -1.34 . . . . 0.0 109.897 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -133.72 146.47 50.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.814 -1.403 . . . . 0.0 110.685 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 50.9 t -109.71 128.63 65.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.501 -0.749 . . . . 0.0 109.961 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.79 147.01 73.5 Favored Pre-proline 0 C--N 1.299 -1.602 0 O-C-N 121.093 -1.004 . . . . 0.0 109.253 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.458 ' HA ' ' N ' ' B' ' 82' ' ' GLY . 40.4 Cg_endo -66.05 -20.1 57.2 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.714 1.376 . . . . 0.0 110.116 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -117.15 29.44 7.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.292 -0.88 . . . . 0.0 109.246 178.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . 0.45 ' HA ' ' HB3' ' B' ' 125' ' ' ASP . . . -63.53 99.29 0.2 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.51 -0.744 . . . . 0.0 110.898 -179.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -66.46 -45.54 79.38 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.42 -0.8 . . . . 0.0 110.254 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 33.4 t -162.57 148.23 12.5 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.491 -0.756 . . . . 0.0 110.301 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' PHE . . . . . 0.468 ' CD2' ' HB2' ' B' ' 126' ' ' PHE . 49.8 p90 -149.16 156.02 41.54 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 177.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.401 HG23 ' HB2' ' B' ' 46' ' ' ASN . 53.8 t -133.3 138.14 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.372 -1.455 . . . . 0.0 112.373 -177.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 93.6 mt -112.57 133.29 54.7 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' ASN . . . . . 0.455 ' OD1' ' CE1' ' B' ' 44' ' ' HIS . 80.8 m-20 -125.89 136.0 52.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.967 -1.083 . . . . 0.0 110.995 -178.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.418 ' HA ' ' O ' ' B' ' 119' ' ' TYR . 0.7 OUTLIER -145.28 111.19 5.5 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.16 -0.962 . . . . 0.0 111.071 179.397 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . 0.461 ' O ' ' N ' ' B' ' 119' ' ' TYR . . . -159.16 -131.18 1.22 Allowed Glycine 0 N--CA 1.495 2.609 0 N-CA-C 108.526 -1.83 . . . . 0.0 108.526 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . 0.418 ' CA ' ' HB2' ' B' ' 119' ' ' TYR . 42.3 mtpt -112.93 -46.32 3.12 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -123.42 164.42 18.91 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.878 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.34 -32.37 68.47 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.242 -0.911 . . . . 0.0 111.035 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' ASN . . . . . 0.436 ' HB3' ' N ' ' B' ' 66' ' ' GLY . 86.9 m-20 -94.82 -8.98 35.84 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.045 -1.034 . . . . 0.0 111.085 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' ASN . . . . . 0.443 ' ND2' ' N ' ' B' ' 40' ' ' ASN . 3.0 m-80 -113.85 66.19 0.66 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.145 -0.972 . . . . 0.0 110.061 -178.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.449 HD12 ' HB3' ' B' ' 33' ' ' ASN . 45.4 mt -95.51 135.53 37.04 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' CYS . . . . . . . . . . . . . 1.7 m -88.81 -29.84 19.43 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.956 -1.09 . . . . 0.0 109.274 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 25.9 tp -128.94 128.99 44.88 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.539 -0.726 . . . . 0.0 109.874 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' HIS . . . . . 0.455 ' CE1' ' OD1' ' B' ' 33' ' ' ASN . 63.0 t60 -128.2 127.51 43.03 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.205 -0.935 . . . . 0.0 110.403 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.492 ' CE2' ' HD3' ' B' ' 47' ' ' PRO . 83.3 t80 -123.35 122.71 39.0 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.173 -0.954 . . . . 0.0 110.161 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . 0.401 ' HB2' HG23 ' B' ' 31' ' ' VAL . 1.4 t-20 -142.47 84.41 11.21 Favored Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 121.157 -0.964 . . . . 0.0 110.958 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' PRO . . . . . 0.492 ' HD3' ' CE2' ' B' ' 45' ' ' PHE . 52.9 Cg_endo -70.76 142.9 44.6 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 123.621 1.327 . . . . 0.0 109.421 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -127.15 97.5 4.96 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.023 -1.048 . . . . 0.0 110.347 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -60.84 -45.18 95.49 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.313 -0.867 . . . . 0.0 109.176 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -159.94 103.54 1.5 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.385 -0.822 . . . . 0.0 109.395 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -114.15 -103.92 0.41 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.052 -1.03 . . . . 0.0 110.73 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -66.08 -41.12 91.12 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.641 -1.287 . . . . 0.0 109.892 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 168.14 39.56 0.02 OUTLIER Glycine 0 N--CA 1.485 1.921 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -113.99 -179.44 3.63 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.485 -1.009 . . . . 0.0 109.134 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.46 ' O ' ' C ' ' B' ' 56' ' ' ASN . . . -140.68 150.3 43.32 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.162 -0.961 . . . . 0.0 110.256 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' ASN . . . . . 0.46 ' C ' ' O ' ' B' ' 55' ' ' ALA . 80.3 m-20 17.09 54.62 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' THR . . . . . 0.4 ' N ' ' O ' ' B' ' 55' ' ' ALA . 54.0 m -120.12 130.09 54.47 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.131 -0.981 . . . . 0.0 109.237 178.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' ILE . . . . . 0.481 HG23 ' CE1' ' B' ' 45' ' ' PHE . 85.3 mt -115.78 135.23 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.166 -0.959 . . . . 0.0 110.948 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 69.3 t -101.69 126.33 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.433 -0.792 . . . . 0.0 110.36 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 79.0 m -117.26 120.94 39.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.261 -0.899 . . . . 0.0 109.297 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' ASN . . . . . 0.438 ' HB3' ' HA ' ' B' ' 71' ' ' GLU . 2.4 p-10 -151.32 179.03 8.67 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.057 -1.027 . . . . 0.0 111.265 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' SER . . . . . 0.456 ' O ' ' CA ' ' B' ' 69' ' ' GLY . 15.8 m -133.94 153.83 51.5 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.361 -0.837 . . . . 0.0 109.892 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . 0.486 ' CD ' ' HA2' ' B' ' 66' ' ' GLY . 17.8 ttmt -128.4 143.5 51.01 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.453 -1.404 . . . . 0.0 111.228 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -122.42 94.95 4.45 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.527 -0.733 . . . . 0.0 109.351 178.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 71.81 19.87 78.38 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . 0.486 ' HA2' ' CD ' ' B' ' 63' ' ' LYS . . . 72.08 32.33 63.27 Favored Glycine 0 N--CA 1.488 2.118 0 O-C-N 120.833 -1.393 . . . . 0.0 110.598 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -101.07 -74.95 0.6 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.737 -1.449 . . . . 0.0 111.174 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' TRP . . . . . . . . . . . . . 13.6 m0 -123.99 -147.76 0.38 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.136 -0.978 . . . . 0.0 110.454 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . 0.456 ' CA ' ' O ' ' B' ' 62' ' ' SER . . . 158.61 145.4 4.23 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' THR . . . . . 0.43 ' OG1' ' NH2' ' B' ' 111' ' ' ARG . 6.9 t -81.88 80.08 8.26 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.153 -1.204 . . . . 0.0 109.759 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.438 ' HA ' ' HB3' ' B' ' 61' ' ' ASN . 79.4 tt0 -70.58 111.84 6.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.914 . . . . 0.0 110.858 -179.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -123.06 -165.07 1.26 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.36 -0.837 . . . . 0.0 109.52 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -137.7 130.18 29.56 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.348 -0.941 . . . . 0.0 110.588 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -131.03 83.45 2.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.266 -0.896 . . . . 0.0 109.747 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.66 88.03 0.09 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.124 -0.985 . . . . 0.0 110.74 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' VAL . . . . . 0.42 ' O ' HD11 ' B' ' 58' ' ' ILE . 5.9 p -134.55 141.45 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.518 -0.739 . . . . 0.0 109.864 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -157.24 89.53 2.51 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 120.733 -1.23 . . . . 0.0 110.833 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . 0.404 ' CB ' ' OD2' ' B' ' 102' ' ' ASP . 53.3 Cg_endo -77.65 -6.23 16.0 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 O-C-N 123.884 1.465 . . . . 0.0 112.165 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -142.55 -167.08 2.42 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.858 -1.151 . . . . 0.0 111.401 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.416 ' CB ' ' HD2' ' B' ' 81' ' ' PRO . 0.0 OUTLIER -139.66 172.39 6.49 Favored Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.382 -0.823 . . . . 0.0 109.758 179.77 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' PRO . . . . . 0.416 ' HD2' ' CB ' ' B' ' 80' ' ' GLN . 43.8 Cg_endo -67.09 147.27 79.21 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.789 1.415 . . . . 0.0 111.223 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . 0.458 ' N ' ' HA ' ' B' ' 25' ' ' PRO . . . 78.82 23.65 63.82 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 9.5 t -137.1 147.15 45.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.211 -1.17 . . . . 0.0 111.212 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . 0.476 HG12 ' O ' ' B' ' 21' ' ' GLY . 72.3 t -79.07 130.0 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.619 -0.676 . . . . 0.0 109.979 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -130.53 142.16 50.48 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.108 -0.995 . . . . 0.0 109.736 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' GLU . . . . . 0.4 ' O ' ' HG3' ' B' ' 86' ' ' GLU . 0.2 OUTLIER -120.15 127.14 52.21 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.512 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 76.8 t -121.63 131.93 71.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 119.142 -1.023 . . . . 0.0 111.063 -177.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 88' ' ' CYS . . . . . . . . . . . . . 12.7 t -96.85 117.87 32.05 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.485 -0.759 . . . . 0.0 109.525 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 70.7 mt -111.6 124.89 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.149 -0.969 . . . . 0.0 109.533 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 56.6 m -122.16 129.23 52.12 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.276 -0.89 . . . . 0.0 109.665 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 91' ' ' PHE . . . . . 0.466 ' CB ' HD12 ' B' ' 117' ' ' ILE . 72.3 t80 -106.62 117.98 35.47 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.209 -0.932 . . . . 0.0 110.891 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -115.27 151.76 33.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.686 -0.634 . . . . 0.0 109.465 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 69.6 tp60 -62.67 -38.84 91.93 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.933 -1.104 . . . . 0.0 110.488 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.29 -39.15 89.17 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.967 -1.083 . . . . 0.0 110.589 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -166.91 178.72 5.65 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.265 -0.897 . . . . 0.0 109.917 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 96' ' ' LEU . . . . . . . . . . . . . 46.7 tp -102.08 129.69 48.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.389 -0.82 . . . . 0.0 109.284 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 98.8 m -115.23 122.77 47.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.725 -1.234 . . . . 0.0 111.162 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 7.0 m -121.06 129.55 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.408 -0.807 . . . . 0.0 109.312 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -113.46 125.2 53.96 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.757 -1.214 . . . . 0.0 109.342 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . 0.44 HD12 ' N ' ' B' ' 100' ' ' LEU . 7.9 mp -85.52 165.0 37.97 Favored Pre-proline 0 C--N 1.302 -1.495 0 O-C-N 121.195 -0.94 . . . . 0.0 109.598 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -66.6 -32.81 37.88 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.991 1.521 . . . . 0.0 110.37 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' ASP . . . . . 0.404 ' OD2' ' CB ' ' B' ' 78' ' ' PRO . 99.6 m-20 -74.54 -25.21 59.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.999 -1.063 . . . . 0.0 110.156 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 121.22 2.77 10.86 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.53 -1.319 . . . . 0.0 111.057 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 104' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -83.67 136.01 34.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.581 -1.541 . . . . 0.0 110.123 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -132.58 148.72 52.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.452 -0.78 . . . . 0.0 110.949 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -141.08 156.51 45.98 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -124.1 141.1 52.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.007 -1.058 . . . . 0.0 110.93 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 108' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -123.58 143.76 42.48 Favored Pre-proline 0 N--CA 1.493 1.699 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -71.23 144.17 45.71 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 N-CA-C 109.14 -1.138 . . . . 0.0 109.14 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 110' ' ' ASN . . . . . 0.486 ' ND2' ' O ' ' B' ' 110' ' ' ASN . 6.1 p-10 -94.92 83.19 3.93 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.933 -1.104 . . . . 0.0 110.572 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . 0.43 ' NH2' ' OG1' ' B' ' 70' ' ' THR . 98.1 mtt180 -56.11 -22.23 26.95 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.704 -1.248 . . . . 0.0 109.08 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 56.5 mt -97.05 141.61 29.99 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -96.71 61.96 1.92 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.706 -1.246 . . . . 0.0 110.018 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 114' ' ' LEU . . . . . 0.406 ' CD1' ' HD2' ' B' ' 36' ' ' LYS . 64.3 tp -81.89 129.53 34.79 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.332 -0.855 . . . . 0.0 111.078 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.5 -17.4 30.38 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.407 -0.808 . . . . 0.0 109.746 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 116' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' B' ' 11' ' ' LEU . . . -163.05 144.29 9.72 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.76 -1.213 . . . . 0.0 111.765 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 117' ' ' ILE . . . . . 0.466 HD12 ' CB ' ' B' ' 91' ' ' PHE . 91.7 mt -98.92 124.5 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.37 -0.831 . . . . 0.0 108.908 178.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 118' ' ' ASN . . . . . 0.458 ' ND2' ' N ' ' B' ' 118' ' ' ASN . 0.1 OUTLIER -125.82 13.21 7.95 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.647 -0.658 . . . . 0.0 110.827 -179.319 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 119' ' ' TYR . . . . . 0.461 ' N ' ' O ' ' B' ' 35' ' ' GLY . 8.0 t80 -131.81 128.73 39.36 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.086 -1.009 . . . . 0.0 110.112 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 62.6 ttp -142.74 130.74 21.8 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.44 -0.788 . . . . 0.0 109.797 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -140.83 144.71 35.52 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.249 -0.907 . . . . 0.0 109.757 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -132.23 108.97 9.59 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.353 -0.842 . . . . 0.0 109.538 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -137.97 128.62 26.68 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.372 -0.83 . . . . 0.0 109.61 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 124' ' ' GLY . . . . . 0.406 ' HA3' ' HA ' ' B' ' 30' ' ' PHE . . . 154.79 -157.74 27.8 Favored Glycine 0 N--CA 1.483 1.794 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . 0.45 ' HB3' ' HA ' ' B' ' 27' ' ' ALA . 87.5 m-20 -78.55 0.02 27.84 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.405 -1.056 . . . . 0.0 110.495 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 126' ' ' PHE . . . . . 0.468 ' HB2' ' CD2' ' B' ' 30' ' ' PHE . 42.6 t80 -95.79 142.13 28.43 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.984 -1.073 . . . . 0.0 109.73 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -112.8 139.83 48.1 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 118.896 -1.121 . . . . 0.0 110.502 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . 0.415 HG23 HD21 ' B' ' 4' ' ' LEU . 20.6 tt -108.12 123.08 63.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.61 -0.681 . . . . 0.0 109.685 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -106.03 -23.33 12.66 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.403 -0.811 . . . . 0.0 111.028 -179.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 130' ' ' CYS . . . . . 0.441 ' HA ' ' O ' ' A' ' 131' ' ' VAL . 0.1 OUTLIER -153.05 155.32 36.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.95 -1.094 . . . . 0.0 112.177 -179.071 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 130' ' ' CYS . 44.3 t -123.93 136.02 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 132' ' ' ALA . . . . . . . . . . . . . . . -124.53 146.21 49.12 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.518 -1.363 . . . . 0.0 110.666 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . 0.478 ' CZ ' HD23 ' B' ' 11' ' ' LEU . 0.4 OUTLIER -94.08 -139.87 0.22 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.286 -0.884 . . . . 0.0 109.739 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 49.5 t0 . . . . . 0 N--CA 1.493 1.717 0 O-C-N 120.668 -1.27 . . . . 0.0 110.462 -179.6 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.196 0.522 . . . . 0.0 109.968 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.449 ' HA ' ' HB2' ' A' ' 123' ' ' ASP . 1.3 m -90.09 56.23 3.36 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.228 -0.92 . . . . 0.0 110.56 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 2' ' ' CYS . . . 32.87 -149.09 0.01 OUTLIER Glycine 0 N--CA 1.503 3.156 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 179.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 48.5 mt -97.9 128.2 44.34 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.946 -1.326 . . . . 0.0 109.265 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.9 t -96.37 135.36 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.106 -0.996 . . . . 0.0 109.741 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.429 ' CB ' HD13 ' A' ' 9' ' ' LEU . . . -124.36 145.03 49.69 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.241 -0.912 . . . . 0.0 111.083 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.407 ' O ' ' HB3' ' A' ' 8' ' ' ASN . 32.9 p -145.74 170.19 17.0 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' B' ' 3' ' ' GLY . 40.0 t-20 59.49 32.21 21.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.338 -0.851 . . . . 0.0 109.189 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.506 ' O ' ' C ' ' A' ' 10' ' ' ASN . 96.3 mt -90.7 2.73 55.7 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.65 -0.656 . . . . 0.0 111.834 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.506 ' C ' ' O ' ' A' ' 9' ' ' LEU . 36.3 t-20 -1.08 76.81 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.564 0 N-CA-C 113.723 1.008 . . . . 0.0 113.723 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.472 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 5.7 tt -92.37 130.89 37.93 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.062 -1.024 . . . . 0.0 109.376 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.451 ' O ' HD21 ' A' ' 11' ' ' LEU . 0.5 OUTLIER -100.43 165.79 13.78 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.266 -0.896 . . . . 0.0 111.189 -179.579 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.458 ' HA ' ' O ' ' A' ' 91' ' ' PHE . 52.0 Cg_endo -69.24 147.28 65.87 Favored 'Trans proline' 0 C--N 1.301 -1.94 0 O-C-N 124.165 1.613 . . . . 0.0 110.764 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.33 1.17 59.36 Favored Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.969 -1.11 . . . . 0.0 110.529 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -115.5 147.95 40.05 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.744 -1.445 . . . . 0.0 110.291 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.2 m -97.39 146.83 24.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.066 -1.021 . . . . 0.0 110.647 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.406 ' HB3' ' O ' ' A' ' 89' ' ' ILE . 52.7 tp -133.38 133.83 42.93 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.534 -0.729 . . . . 0.0 109.989 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 78.1 mtt85 -123.03 152.1 41.29 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.202 -0.936 . . . . 0.0 110.387 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 t -141.18 102.06 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 C-N-CA 119.939 -0.705 . . . . 0.0 110.671 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 -99.48 130.3 45.73 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.205 -0.935 . . . . 0.0 110.296 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.409 ' HA3' ' CZ ' ' A' ' 126' ' ' PHE . . . -144.12 -171.78 14.39 Favored Glycine 0 N--CA 1.496 2.645 0 C-N-CA 119.82 -1.181 . . . . 0.0 110.504 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -123.85 153.71 40.68 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.468 -1.019 . . . . 0.0 109.317 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 68.9 t -118.58 133.34 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.038 -1.039 . . . . 0.0 111.554 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.99 150.33 61.64 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 120.939 -1.101 . . . . 0.0 109.472 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.429 ' HA ' ' CA ' ' A' ' 82' ' ' GLY . 40.9 Cg_endo -66.43 -18.47 54.87 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.777 1.409 . . . . 0.0 111.309 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -125.01 28.86 6.29 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.977 -1.077 . . . . 0.0 108.811 178.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.473 ' CB ' ' HB3' ' A' ' 125' ' ' ASP . . . -62.67 105.64 0.68 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.287 0.565 . . . . 0.0 111.903 -178.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -64.49 -48.13 76.36 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.519 -0.738 . . . . 0.0 109.922 178.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 86.8 p -166.68 159.84 14.38 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.91 0.862 . . . . 0.0 111.535 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.511 ' CZ ' ' CG ' ' A' ' 47' ' ' PRO . 48.1 p90 -151.22 162.55 40.68 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.496 ' HA ' ' O ' ' A' ' 45' ' ' PHE . 2.2 p -139.81 138.02 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.444 -1.41 . . . . 0.0 112.688 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 90.3 mt -122.95 143.76 49.69 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -151.29 162.96 39.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.785 -1.197 . . . . 0.0 110.757 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.423 ' O ' ' CD1' ' A' ' 34' ' ' LEU . 3.8 pp -154.67 129.6 9.45 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.267 -0.895 . . . . 0.0 110.413 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.438 ' HA3' ' HA ' ' A' ' 41' ' ' LEU . . . -166.15 -153.65 7.84 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.406 ' O ' ' HB2' ' A' ' 119' ' ' TYR . 60.2 pttt -103.36 -30.42 10.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.061 -1.259 . . . . 0.0 110.146 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.481 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 21.9 t70 -143.84 167.8 21.45 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.232 -0.917 . . . . 0.0 110.466 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.5 t -51.27 -46.93 62.58 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.485 -0.759 . . . . 0.0 112.769 -177.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.422 ' HB3' ' N ' ' A' ' 66' ' ' GLY . 27.9 m-20 -91.12 -2.45 57.58 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.485 -1.384 . . . . 0.0 110.427 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.404 ' HB3' ' HE2' ' A' ' 36' ' ' LYS . 5.5 m-80 -110.41 56.16 0.63 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.111 -0.993 . . . . 0.0 110.51 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.481 ' CD2' ' O ' ' A' ' 37' ' ' ASP . 3.6 mm? -86.15 138.62 31.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.316 -0.865 . . . . 0.0 110.085 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.9 m -87.2 -28.14 22.58 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.3 -0.875 . . . . 0.0 110.244 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.5 tp -140.94 136.2 31.99 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 121.207 -0.933 . . . . 0.0 110.82 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.49 ' O ' ' HA ' ' A' ' 60' ' ' CYS . 19.9 m-70 -121.95 117.59 26.8 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.098 -1.001 . . . . 0.0 109.228 178.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.52 ' CE1' ' CG2' ' A' ' 58' ' ' ILE . 39.7 t80 -113.55 124.09 51.54 Favored 'General case' 0 C--N 1.293 -1.882 0 O-C-N 121.15 -0.969 . . . . 0.0 108.928 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -156.27 76.48 4.56 Favored Pre-proline 0 N--CA 1.497 1.925 0 O-C-N 120.843 -1.161 . . . . 0.0 111.005 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.563 ' HB3' HG12 ' A' ' 58' ' ' ILE . 56.2 Cg_endo -70.51 147.14 57.37 Favored 'Trans proline' 0 C--N 1.301 -1.96 0 O-C-N 124.256 1.661 . . . . 0.0 110.447 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -122.59 120.42 33.71 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.139 -0.976 . . . . 0.0 109.731 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -59.04 -49.28 78.49 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.843 -1.16 . . . . 0.0 108.011 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -145.8 95.73 2.69 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.26 -136.38 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.244 -0.91 . . . . 0.0 109.329 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 83.0 m-70 -62.04 -28.7 69.78 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 120.78 -1.2 . . . . 0.0 109.014 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 173.82 35.08 0.04 OUTLIER Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.668 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -113.42 -173.57 2.29 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.734 -1.45 . . . . 0.0 109.98 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.488 ' O ' ' C ' ' A' ' 56' ' ' ASN . . . -135.46 135.01 40.18 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.47 -0.769 . . . . 0.0 110.335 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.488 ' C ' ' O ' ' A' ' 55' ' ' ALA . 6.7 m120 18.55 65.79 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.288 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 20.1 m -102.36 115.11 29.88 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.186 -0.946 . . . . 0.0 108.847 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.563 HG12 ' HB3' ' A' ' 47' ' ' PRO . 52.4 mt -96.86 122.46 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.2 -0.937 . . . . 0.0 108.732 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.3 t -114.13 129.69 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.319 -0.863 . . . . 0.0 110.928 -177.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 44' ' ' HIS . 0.9 OUTLIER -107.11 126.39 52.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.378 -0.826 . . . . 0.0 109.899 179.237 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.443 ' O ' ' N ' ' A' ' 44' ' ' HIS . 2.6 t-20 -133.36 150.0 51.84 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.167 -0.958 . . . . 0.0 111.015 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.446 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 54.2 m -123.15 145.57 48.49 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.517 ' CD ' ' HA2' ' A' ' 66' ' ' GLY . 21.5 ttmt -135.45 144.36 46.41 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.688 -1.258 . . . . 0.0 111.22 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -120.84 97.75 5.69 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 69.3 20.15 74.89 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.517 ' HA2' ' CD ' ' A' ' 63' ' ' LYS . . . 79.06 23.78 62.96 Favored Glycine 0 N--CA 1.485 1.962 0 O-C-N 120.763 -1.434 . . . . 0.0 110.403 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.3 -80.31 0.2 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.92 -1.341 . . . . 0.0 111.979 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 2.4 m-90 -130.63 -145.11 0.27 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.173 -0.954 . . . . 0.0 110.67 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.446 ' HA2' ' O ' ' A' ' 62' ' ' SER . . . 164.35 143.61 3.77 Favored Glycine 0 N--CA 1.483 1.781 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 99.8 m -92.66 116.79 29.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.593 -0.946 . . . . 0.0 110.271 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -98.44 120.98 39.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.956 -1.09 . . . . 0.0 109.713 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.412 ' O ' ' CB ' ' A' ' 73' ' ' ARG . 1.0 OUTLIER -165.01 133.54 3.34 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.055 -1.028 . . . . 0.0 110.622 -179.716 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.412 ' CB ' ' O ' ' A' ' 72' ' ' GLN . 2.5 mtt-85 172.55 168.73 0.12 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.249 -0.907 . . . . 0.0 111.333 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -110.92 -179.92 3.87 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.367 -0.833 . . . . 0.0 109.975 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -101.61 100.81 11.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.169 -0.957 . . . . 0.0 109.618 178.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.453 HG11 HD11 ' A' ' 58' ' ' ILE . 2.6 p -125.06 134.1 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.097 -1.002 . . . . 0.0 110.121 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.499 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 12.5 p90 -140.52 87.07 11.9 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.029 -1.044 . . . . 0.0 111.951 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.407 ' HD3' HG22 ' A' ' 76' ' ' VAL . 51.5 Cg_endo -85.03 7.94 4.9 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 124.192 1.627 . . . . 0.0 110.498 178.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -144.48 178.01 8.25 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.268 -0.895 . . . . 0.0 110.291 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.422 ' CG ' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -143.08 172.44 5.68 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.438 -0.789 . . . . 0.0 109.794 179.427 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.422 ' HD2' ' CG ' ' A' ' 80' ' ' GLN . 44.8 Cg_endo -66.64 152.49 80.57 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.907 1.478 . . . . 0.0 110.684 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.429 ' CA ' ' HA ' ' A' ' 25' ' ' PRO . . . 73.6 22.67 78.18 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.239 -1.545 . . . . 0.0 109.239 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.8 m -138.0 149.46 46.1 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.199 -1.177 . . . . 0.0 111.087 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.7 m -76.46 138.91 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.603 -0.685 . . . . 0.0 110.466 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -146.0 144.22 29.96 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.083 -1.011 . . . . 0.0 110.473 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -123.96 146.42 48.5 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.207 -0.933 . . . . 0.0 110.414 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 53.7 t -130.42 131.2 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.332 -0.855 . . . . 0.0 110.27 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . 0.404 ' HB3' ' HB3' ' A' ' 99' ' ' LYS . 4.9 t -93.69 126.38 38.83 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.186 -0.946 . . . . 0.0 110.454 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.406 ' O ' ' HB3' ' A' ' 17' ' ' LEU . 97.4 mt -120.34 127.04 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.265 -0.897 . . . . 0.0 109.976 179.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 27.6 m -127.72 134.15 49.55 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.0 -1.063 . . . . 0.0 108.945 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.458 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 69.0 t80 -114.49 116.98 29.71 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.718 -1.239 . . . . 0.0 111.204 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -113.0 146.19 39.52 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 65.3 tp60 -56.1 -37.74 69.79 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.983 -1.073 . . . . 0.0 110.576 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.83 -43.38 68.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.013 -1.054 . . . . 0.0 111.291 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -155.18 179.22 9.36 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.993 -1.067 . . . . 0.0 110.852 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.456 ' HB3' ' HB2' ' A' ' 108' ' ' PHE . 53.4 tp -110.82 124.91 52.95 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.392 -0.817 . . . . 0.0 108.958 178.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.3 m -107.3 127.66 53.75 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.164 -0.96 . . . . 0.0 110.966 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 50.6 t -131.4 130.98 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.219 -0.926 . . . . 0.0 109.712 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.404 ' HB3' ' HB3' ' A' ' 88' ' ' CYS . 86.0 tttt -116.69 126.68 53.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.929 -1.107 . . . . 0.0 110.76 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.0 mt -76.17 160.64 77.64 Favored Pre-proline 0 C--N 1.303 -1.453 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -66.67 -24.19 48.14 Favored 'Trans proline' 0 C--N 1.302 -1.912 0 O-C-N 123.657 1.346 . . . . 0.0 110.289 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -155.99 73.67 0.83 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.354 -0.841 . . . . 0.0 110.134 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -178.91 -166.83 35.56 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.427 -1.368 . . . . 0.0 110.635 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -77.17 -165.5 0.58 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.489 -1.007 . . . . 0.0 110.671 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -129.07 159.41 36.05 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.313 -0.867 . . . . 0.0 110.821 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -132.25 153.13 50.94 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.256 -0.903 . . . . 0.0 110.921 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -129.05 146.51 51.0 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.778 0.799 . . . . 0.0 111.57 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.456 ' HB2' ' HB3' ' A' ' 96' ' ' LEU . 0.4 OUTLIER -118.19 140.42 27.99 Favored Pre-proline 0 C--N 1.302 -1.462 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.579 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -71.4 161.96 43.88 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 O-C-N 123.645 1.34 . . . . 0.0 110.615 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -71.81 59.04 0.33 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.488 -0.758 . . . . 0.0 111.404 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 15.6 tpt85 -62.99 -39.8 95.85 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.056 -1.027 . . . . 0.0 109.022 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 82.8 mt -105.9 124.26 49.28 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.681 -0.637 . . . . 0.0 109.533 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -86.71 69.71 10.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.916 -1.115 . . . . 0.0 109.803 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 35.5 tp -95.04 129.73 42.01 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.62 -0.675 . . . . 0.0 110.063 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -92.23 -13.11 30.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.234 -0.916 . . . . 0.0 110.553 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 11' ' ' LEU . . . -162.91 153.11 16.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.015 -1.053 . . . . 0.0 110.786 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 87.0 mt -109.48 128.1 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.997 -1.064 . . . . 0.0 110.663 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -120.52 -21.92 6.61 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.188 -0.945 . . . . 0.0 111.041 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.417 ' N ' ' O ' ' A' ' 35' ' ' GLY . 83.2 t80 -105.82 125.45 51.0 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.166 -0.959 . . . . 0.0 111.283 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 62.0 ttp -143.13 133.02 24.05 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.305 -0.872 . . . . 0.0 108.759 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -144.12 142.67 30.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.624 -1.297 . . . . 0.0 110.71 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -140.12 111.26 7.04 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.526 -0.734 . . . . 0.0 109.797 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.474 ' N ' ' OD1' ' A' ' 123' ' ' ASP . 26.5 p-10 -147.0 143.65 28.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.249 -0.907 . . . . 0.0 110.093 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 152.04 -157.08 27.05 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.473 ' HB3' ' CB ' ' A' ' 27' ' ' ALA . 87.1 m-20 -76.31 -1.16 25.29 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.283 -1.128 . . . . 0.0 110.141 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.409 ' CZ ' ' HA3' ' A' ' 21' ' ' GLY . 28.2 t80 -99.8 133.71 43.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.962 -1.086 . . . . 0.0 109.528 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -106.18 136.27 46.18 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.956 -1.09 . . . . 0.0 111.322 -178.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 15.0 tt -101.04 125.2 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.266 -0.896 . . . . 0.0 110.836 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -103.35 -18.58 14.79 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.268 -0.895 . . . . 0.0 111.655 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -159.31 149.88 19.44 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.402 -1.436 . . . . 0.0 113.258 -179.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 46.2 t -125.81 133.21 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 177.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -146.05 149.71 34.59 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.403 -1.436 . . . . 0.0 111.342 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -105.3 128.07 53.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.624 -0.673 . . . . 0.0 110.453 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 23.1 t0 . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.521 179.342 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.226 0.536 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' CYS . . . . . 0.452 ' HA ' ' HB2' ' B' ' 123' ' ' ASP . 1.3 m -90.05 56.9 3.59 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.224 -0.923 . . . . 0.0 110.653 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . 0.532 ' O ' ' ND2' ' A' ' 8' ' ' ASN . . . 32.43 -148.43 0.01 OUTLIER Glycine 0 N--CA 1.505 3.268 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 9' ' ' LEU . 49.2 mt -98.53 128.75 44.98 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.652 -1.499 . . . . 0.0 109.053 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 62.9 t -96.63 135.6 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.049 -1.032 . . . . 0.0 109.651 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . 0.433 ' CB ' HD13 ' B' ' 9' ' ' LEU . . . -124.7 145.2 49.81 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.184 -0.948 . . . . 0.0 111.023 -178.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' SER . . . . . 0.433 ' O ' ' HB3' ' B' ' 8' ' ' ASN . 33.2 p -145.9 170.38 16.71 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . 0.433 ' HB3' ' O ' ' B' ' 7' ' ' SER . 41.3 t-20 59.36 32.12 21.61 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.186 -0.946 . . . . 0.0 109.276 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . 0.521 ' O ' ' C ' ' B' ' 10' ' ' ASN . 96.6 mt -91.47 5.28 50.05 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.656 -0.653 . . . . 0.0 111.598 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . 0.521 ' C ' ' O ' ' B' ' 9' ' ' LEU . 37.3 t-20 -4.47 78.66 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.531 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.484 ' O ' ' HA ' ' B' ' 116' ' ' ALA . 5.8 tt -92.95 131.18 38.19 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.223 -0.923 . . . . 0.0 109.258 179.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . 0.444 ' O ' HD21 ' B' ' 11' ' ' LEU . 0.5 OUTLIER -100.76 165.51 14.17 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.249 -0.907 . . . . 0.0 111.182 -179.53 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . 0.456 ' HA ' ' O ' ' B' ' 91' ' ' PHE . 52.3 Cg_endo -68.96 147.31 67.71 Favored 'Trans proline' 0 C--N 1.301 -1.967 0 O-C-N 124.069 1.563 . . . . 0.0 110.736 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.37 0.89 59.4 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.979 -1.105 . . . . 0.0 110.729 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -115.33 147.86 39.96 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.852 -1.381 . . . . 0.0 110.277 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' CYS . . . . . . . . . . . . . 1.2 m -97.29 146.69 24.89 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.175 -0.953 . . . . 0.0 110.806 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.407 ' HB3' ' O ' ' B' ' 89' ' ' ILE . 53.3 tp -133.15 133.8 43.33 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.592 -0.693 . . . . 0.0 110.146 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 78.0 mtt85 -122.88 151.95 41.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.238 -0.913 . . . . 0.0 110.439 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 t -141.22 102.31 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.54 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -99.82 130.52 46.03 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.319 -0.863 . . . . 0.0 109.969 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . 0.409 ' HA3' ' CZ ' ' B' ' 126' ' ' PHE . . . -144.26 -171.75 14.46 Favored Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.884 -1.151 . . . . 0.0 110.495 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -124.08 153.74 40.97 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.492 -1.005 . . . . 0.0 109.336 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 69.9 t -118.59 133.34 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.908 -1.12 . . . . 0.0 111.422 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.98 150.51 60.64 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.025 -1.047 . . . . 0.0 109.517 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.42 ' HA ' ' CA ' ' B' ' 82' ' ' GLY . 41.4 Cg_endo -66.83 -18.22 52.6 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.817 1.43 . . . . 0.0 111.374 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -125.17 29.29 6.13 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.0 -1.062 . . . . 0.0 108.671 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . 0.468 ' CB ' ' HB3' ' B' ' 125' ' ' ASP . . . -63.14 105.27 0.68 Allowed 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.353 0.597 . . . . 0.0 111.965 -178.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -64.08 -49.86 70.62 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.358 -0.838 . . . . 0.0 109.846 178.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 87.4 p -163.93 160.25 21.8 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.305 -0.872 . . . . 0.0 111.661 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' PHE . . . . . 0.518 ' CZ ' ' CG ' ' B' ' 47' ' ' PRO . 47.9 p90 -151.64 161.75 42.15 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' B' ' 45' ' ' PHE . 2.2 p -139.06 138.69 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.375 -1.453 . . . . 0.0 112.787 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.413 HD22 ' HB2' ' B' ' 122' ' ' ALA . 89.4 mt -123.86 143.44 50.35 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.467 -0.771 . . . . 0.0 108.925 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -151.14 163.14 39.5 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.83 -1.168 . . . . 0.0 110.709 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.45 ' O ' ' CD1' ' B' ' 34' ' ' LEU . 3.8 pp -154.78 126.32 7.44 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.205 -0.934 . . . . 0.0 110.767 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . 0.428 ' HA3' ' HA ' ' B' ' 41' ' ' LEU . . . -160.98 -152.43 6.6 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . 0.413 ' HE2' ' HB3' ' B' ' 40' ' ' ASN . 60.4 pttt -104.08 -30.58 10.15 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.389 -1.065 . . . . 0.0 109.702 178.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . 0.477 ' O ' ' CD2' ' B' ' 41' ' ' LEU . 22.4 t70 -143.98 167.68 21.79 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.248 -0.907 . . . . 0.0 110.52 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 5.7 t -51.37 -46.34 62.72 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.389 -0.819 . . . . 0.0 112.808 -177.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' ASN . . . . . 0.433 ' HB3' ' N ' ' B' ' 66' ' ' GLY . 28.0 m-20 -91.79 -2.66 56.82 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.503 -1.373 . . . . 0.0 110.209 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' ASN . . . . . 0.413 ' HB3' ' HE2' ' B' ' 36' ' ' LYS . 5.7 m-80 -110.15 56.06 0.63 Allowed 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.241 -0.912 . . . . 0.0 110.41 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.477 ' CD2' ' O ' ' B' ' 37' ' ' ASP . 3.6 mm? -85.76 139.84 30.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.304 -0.873 . . . . 0.0 110.105 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' CYS . . . . . . . . . . . . . 1.7 m -89.63 -27.01 20.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 109.895 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 14.4 tp -141.44 135.82 30.69 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 121.188 -0.945 . . . . 0.0 110.812 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' HIS . . . . . 0.481 ' O ' ' HA ' ' B' ' 60' ' ' CYS . 20.4 m-70 -121.66 117.49 26.8 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.13 -0.981 . . . . 0.0 109.284 178.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.518 ' CE1' ' CG2' ' B' ' 58' ' ' ILE . 39.6 t80 -113.66 122.62 47.73 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.07 -1.019 . . . . 0.0 109.086 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -154.41 76.83 5.52 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 120.955 -1.09 . . . . 0.0 111.104 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' PRO . . . . . 0.543 ' HB3' HG12 ' B' ' 58' ' ' ILE . 55.4 Cg_endo -70.69 147.1 56.13 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 124.119 1.589 . . . . 0.0 110.427 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -122.55 120.59 34.27 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.144 -0.972 . . . . 0.0 109.809 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -59.27 -48.61 80.97 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.92 -1.113 . . . . 0.0 108.199 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -146.69 95.48 2.6 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.46 -136.91 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.447 -0.783 . . . . 0.0 109.097 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -61.75 -26.87 68.33 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.668 -1.27 . . . . 0.0 109.272 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 171.14 35.77 0.03 OUTLIER Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.642 -1.266 . . . . 0.0 110.563 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -113.94 -173.65 2.32 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.836 -1.391 . . . . 0.0 109.79 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.505 ' O ' ' C ' ' B' ' 56' ' ' ASN . . . -134.75 138.51 44.4 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.427 -0.796 . . . . 0.0 109.827 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' ASN . . . . . 0.505 ' C ' ' O ' ' B' ' 55' ' ' ALA . 6.5 m120 13.29 68.09 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.233 0 CA-C-O 121.535 0.683 . . . . 0.0 112.834 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 19.6 m -102.99 114.88 29.54 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.443 -0.786 . . . . 0.0 108.928 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' ILE . . . . . 0.543 HG12 ' HB3' ' B' ' 47' ' ' PRO . 52.0 mt -96.84 122.52 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.111 -0.993 . . . . 0.0 108.729 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 56.0 t -113.82 130.0 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.383 -0.823 . . . . 0.0 111.105 -178.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' CYS . . . . . 0.481 ' HA ' ' O ' ' B' ' 44' ' ' HIS . 0.8 OUTLIER -107.77 125.16 51.07 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.295 -0.878 . . . . 0.0 109.939 179.262 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' ASN . . . . . 0.443 ' O ' ' N ' ' B' ' 44' ' ' HIS . 2.8 t-20 -132.06 149.86 52.3 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.189 -0.944 . . . . 0.0 111.109 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' SER . . . . . 0.443 ' O ' ' HA2' ' B' ' 69' ' ' GLY . 54.4 m -123.02 145.52 48.44 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.153 -0.967 . . . . 0.0 108.532 179.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . 0.51 ' CD ' ' HA2' ' B' ' 66' ' ' GLY . 21.4 ttmt -135.12 144.87 47.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.655 -1.278 . . . . 0.0 111.092 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -121.17 97.81 5.69 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 69.32 20.05 74.82 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . 0.51 ' HA2' ' CD ' ' B' ' 63' ' ' LYS . . . 79.38 23.56 62.72 Favored Glycine 0 N--CA 1.487 2.064 0 C-N-CA 119.278 -1.439 . . . . 0.0 110.337 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.27 -80.33 0.2 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.875 -1.368 . . . . 0.0 111.867 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' TRP . . . . . . . . . . . . . 2.4 m-90 -130.54 -144.97 0.27 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.22 -0.925 . . . . 0.0 110.711 -178.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' B' ' 62' ' ' SER . . . 164.05 143.26 3.65 Favored Glycine 0 N--CA 1.483 1.828 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 99.6 m -92.25 117.46 29.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.567 -0.96 . . . . 0.0 110.326 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -98.97 120.91 40.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.013 -1.055 . . . . 0.0 109.646 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -165.04 133.53 3.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.997 -1.065 . . . . 0.0 110.551 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 2.5 mtt-85 172.73 169.11 0.12 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.34 -0.85 . . . . 0.0 111.246 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -111.06 180.0 3.89 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.38 -0.825 . . . . 0.0 109.942 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -101.44 100.6 11.08 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.078 -1.014 . . . . 0.0 109.683 178.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' VAL . . . . . 0.45 HG11 HD11 ' B' ' 58' ' ' ILE . 2.6 p -124.76 134.15 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.983 -1.073 . . . . 0.0 110.127 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' PHE . . . . . 0.506 ' N ' ' CD1' ' B' ' 77' ' ' PHE . 11.9 p90 -140.4 87.26 11.98 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 120.942 -1.099 . . . . 0.0 111.782 -179.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . 0.412 ' HD3' HG22 ' B' ' 76' ' ' VAL . 50.3 Cg_endo -85.15 7.56 5.08 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 124.136 1.598 . . . . 0.0 110.427 178.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -144.01 178.18 8.04 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.216 -0.927 . . . . 0.0 110.488 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.414 ' CG ' ' HD2' ' B' ' 81' ' ' PRO . 0.0 OUTLIER -143.09 172.38 5.75 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.351 -0.843 . . . . 0.0 109.792 179.597 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' PRO . . . . . 0.414 ' HD2' ' CG ' ' B' ' 80' ' ' GLN . 44.0 Cg_endo -66.59 152.85 79.87 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.771 1.406 . . . . 0.0 110.764 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . 0.42 ' CA ' ' HA ' ' B' ' 25' ' ' PRO . . . 73.22 22.68 78.66 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 66.1 m -138.06 149.01 45.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.095 -1.238 . . . . 0.0 111.16 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 33.5 m -76.06 139.15 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.663 -0.648 . . . . 0.0 110.614 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -146.32 143.93 29.46 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.055 -1.028 . . . . 0.0 110.431 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -123.69 146.83 47.96 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.228 -0.92 . . . . 0.0 110.445 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 54.4 t -130.78 131.19 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.394 -0.816 . . . . 0.0 110.049 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 88' ' ' CYS . . . . . . . . . . . . . 4.5 t -93.79 126.64 39.09 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.168 -0.957 . . . . 0.0 110.404 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.439 HD13 HG21 ' B' ' 89' ' ' ILE . 97.2 mt -120.55 127.11 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.137 -0.977 . . . . 0.0 110.019 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 27.5 m -127.85 134.15 49.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.081 -1.012 . . . . 0.0 109.001 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 91' ' ' PHE . . . . . 0.456 ' O ' ' HA ' ' B' ' 13' ' ' PRO . 70.6 t80 -114.49 116.47 28.9 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 118.813 -1.155 . . . . 0.0 111.491 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -112.92 146.28 39.26 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 65.0 tp60 -56.24 -37.74 70.13 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 120.896 -1.128 . . . . 0.0 110.546 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.48 -43.45 69.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.157 -0.965 . . . . 0.0 111.348 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -155.53 178.91 9.71 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.075 -1.016 . . . . 0.0 110.744 -178.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 96' ' ' LEU . . . . . 0.439 ' HB3' ' HB2' ' B' ' 108' ' ' PHE . 53.5 tp -110.26 124.76 52.21 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.313 -0.867 . . . . 0.0 109.159 178.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 2.9 m -107.34 127.35 53.49 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.157 -0.964 . . . . 0.0 110.938 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 50.1 t -131.26 130.79 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -0.909 . . . . 0.0 109.81 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -116.58 126.15 52.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.874 -1.141 . . . . 0.0 111.093 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 4.0 mt -75.46 160.35 79.78 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.392 -0.818 . . . . 0.0 108.849 178.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -66.59 -24.35 48.55 Favored 'Trans proline' 0 C--N 1.302 -1.908 0 O-C-N 123.701 1.369 . . . . 0.0 110.217 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -155.81 75.39 0.9 Allowed 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.336 -0.852 . . . . 0.0 110.177 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 178.54 -167.12 37.41 Favored Glycine 0 N--CA 1.495 2.619 0 C-N-CA 119.407 -1.378 . . . . 0.0 110.548 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 104' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -77.0 -165.4 0.55 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.476 -1.014 . . . . 0.0 110.958 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 69.4 tt0 -129.53 159.03 37.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.348 -0.845 . . . . 0.0 110.527 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -132.03 153.19 50.63 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.476 -0.765 . . . . 0.0 110.936 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -129.2 146.73 51.06 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.354 -0.841 . . . . 0.0 111.537 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 108' ' ' PHE . . . . . 0.439 ' HB2' ' HB3' ' B' ' 96' ' ' LEU . 0.4 OUTLIER -118.29 140.34 27.96 Favored Pre-proline 0 C--N 1.301 -1.537 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.669 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -71.51 162.19 43.05 Favored 'Trans proline' 0 C--N 1.301 -1.938 0 O-C-N 123.575 1.303 . . . . 0.0 110.574 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 110' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -72.0 59.29 0.37 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.559 -0.713 . . . . 0.0 111.266 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 15.3 tpt85 -63.34 -39.58 94.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.099 -1.0 . . . . 0.0 109.015 178.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 81.2 mt -105.91 124.34 49.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.69 -0.631 . . . . 0.0 109.551 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -86.77 69.88 10.34 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.918 -1.114 . . . . 0.0 109.743 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 36.5 tp -95.09 129.75 42.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.626 -0.671 . . . . 0.0 110.079 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -92.25 -12.92 31.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.18 -0.95 . . . . 0.0 110.7 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 116' ' ' ALA . . . . . 0.484 ' HA ' ' O ' ' B' ' 11' ' ' LEU . . . -162.97 153.44 16.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.016 -1.052 . . . . 0.0 110.626 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 117' ' ' ILE . . . . . 0.405 ' HB ' ' HB3' ' B' ' 11' ' ' LEU . 89.4 mt -109.92 128.08 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.072 -1.018 . . . . 0.0 110.707 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -120.36 -21.8 6.75 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.18 -0.95 . . . . 0.0 111.121 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 119' ' ' TYR . . . . . 0.406 ' N ' ' O ' ' B' ' 35' ' ' GLY . 83.2 t80 -106.09 125.75 51.37 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.032 -1.042 . . . . 0.0 111.18 -179.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 61.5 ttp -143.41 133.04 23.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.352 -0.843 . . . . 0.0 108.728 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -144.28 142.91 30.75 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.65 -1.281 . . . . 0.0 110.686 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 122' ' ' ALA . . . . . 0.417 ' O ' ' HA3' ' B' ' 3' ' ' GLY . . . -140.48 111.27 6.91 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.566 -0.709 . . . . 0.0 109.701 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . 0.465 ' N ' ' OD1' ' B' ' 123' ' ' ASP . 26.3 p-10 -147.42 142.59 27.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.389 -0.82 . . . . 0.0 109.894 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 153.48 -157.22 27.25 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.821 -1.711 . . . . 0.0 108.821 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . 0.468 ' HB3' ' CB ' ' B' ' 27' ' ' ALA . 86.9 m-20 -76.35 -0.94 24.45 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.263 -1.139 . . . . 0.0 110.161 179.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 126' ' ' PHE . . . . . 0.409 ' CZ ' ' HA3' ' B' ' 21' ' ' GLY . 28.2 t80 -100.03 133.7 44.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.005 -1.059 . . . . 0.0 109.473 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -106.27 135.88 46.97 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.976 -1.078 . . . . 0.0 111.307 -178.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 14.9 tt -100.47 125.61 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.267 -0.896 . . . . 0.0 110.877 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -103.43 -19.99 14.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.151 -0.968 . . . . 0.0 111.624 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 130' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -156.87 150.25 24.24 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.345 -1.472 . . . . 0.0 113.456 -179.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 46.3 t -125.81 133.37 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 177.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 132' ' ' ALA . . . . . . . . . . . . . . . -146.13 149.72 34.55 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.278 -1.514 . . . . 0.0 111.13 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -105.52 128.01 53.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.587 -0.696 . . . . 0.0 110.441 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 23.0 t0 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.755 179.346 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 120.903 0.382 . . . . 0.0 110.45 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.452 ' O ' ' O ' ' A' ' 126' ' ' PHE . 99.6 m -142.24 -124.1 0.1 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.883 -1.136 . . . . 0.0 110.285 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 122' ' ' ALA . . . 176.73 121.17 0.66 Allowed Glycine 0 N--CA 1.493 2.464 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.1 pp -67.7 156.4 37.01 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.264 -1.139 . . . . 0.0 111.615 -178.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.4 t -118.63 132.73 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -110.04 178.98 4.24 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.871 -1.143 . . . . 0.0 110.985 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.408 ' O ' ' HB3' ' A' ' 8' ' ' ASN . 27.7 p -155.95 171.08 20.69 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.417 ' HB3' ' HA ' ' B' ' 4' ' ' LEU . 63.6 t30 58.25 35.88 25.27 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.288 -0.882 . . . . 0.0 110.545 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.505 ' O ' ' C ' ' A' ' 10' ' ' ASN . 78.5 mt -87.29 -5.61 58.85 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.488 -0.757 . . . . 0.0 111.156 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.505 ' C ' ' O ' ' A' ' 9' ' ' LEU . 4.9 m120 6.34 66.33 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.748 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.412 ' N ' ' O ' ' A' ' 9' ' ' LEU . 11.2 mt -93.07 129.05 39.15 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.048 -1.033 . . . . 0.0 110.514 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.425 ' CB ' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -98.79 171.74 5.45 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.295 -0.878 . . . . 0.0 110.783 -179.971 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.425 ' HD2' ' CB ' ' A' ' 12' ' ' LYS . 39.4 Cg_endo -65.17 148.13 88.77 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.221 1.643 . . . . 0.0 109.378 178.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.8 -16.01 54.98 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -111.35 142.09 44.04 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.177 -1.19 . . . . 0.0 109.699 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 58.2 m -109.77 153.19 24.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.196 -0.94 . . . . 0.0 110.181 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 57.5 tp -118.28 130.7 56.2 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.221 -0.924 . . . . 0.0 110.349 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -110.99 125.75 54.05 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.577 -0.702 . . . . 0.0 109.489 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 74.0 t -121.16 123.29 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.92 -1.113 . . . . 0.0 110.158 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -123.56 128.44 49.73 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.215 -0.928 . . . . 0.0 109.645 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -146.86 -152.83 5.74 Favored Glycine 0 N--CA 1.489 2.226 0 C-N-CA 119.292 -1.433 . . . . 0.0 110.292 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -136.5 142.34 43.51 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.656 -0.908 . . . . 0.0 109.467 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.452 ' CG1' ' HA ' ' A' ' 81' ' ' PRO . 34.8 t -108.48 132.98 54.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 O-C-N 121.334 -0.854 . . . . 0.0 111.131 -178.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.92 152.57 96.73 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.528 -0.732 . . . . 0.0 109.871 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -65.79 -28.3 51.4 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 123.955 1.503 . . . . 0.0 110.631 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -97.34 16.15 20.89 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.267 -0.895 . . . . 0.0 109.945 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.481 ' HA ' ' HB3' ' A' ' 125' ' ' ASP . . . -61.75 98.76 0.1 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.107 -0.996 . . . . 0.0 110.874 -179.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -95.04 -15.61 23.33 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.513 -0.742 . . . . 0.0 110.682 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 42.1 t -167.38 142.25 3.88 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 118.725 -1.19 . . . . 0.0 111.454 -178.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.504 ' CE2' ' HB2' ' A' ' 32' ' ' LEU . 10.6 t80 -149.34 157.63 43.49 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.429 -0.794 . . . . 0.0 109.993 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.405 ' CG1' ' O ' ' A' ' 123' ' ' ASP . 2.5 p -129.09 131.16 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.909 -1.119 . . . . 0.0 110.837 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.504 ' HB2' ' CE2' ' A' ' 30' ' ' PHE . 12.7 tp -131.42 129.68 41.57 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.61 -0.681 . . . . 0.0 109.165 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -161.24 153.19 19.64 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.433 -1.417 . . . . 0.0 111.027 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 120' ' ' MET . 0.4 OUTLIER -143.61 128.09 17.96 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.673 0.749 . . . . 0.0 109.656 179.261 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.426 ' HA3' ' HA ' ' A' ' 41' ' ' LEU . . . -163.79 -160.38 11.67 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.47 ' O ' ' CD1' ' A' ' 119' ' ' TYR . 40.3 mtpt -67.45 -42.17 83.51 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 122.394 1.092 . . . . 0.0 108.212 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -157.45 -168.93 2.73 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.73 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.2 t -62.36 -42.8 99.69 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.781 -0.575 . . . . 0.0 112.296 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.451 ' HB3' ' N ' ' A' ' 66' ' ' GLY . 92.9 m-20 -87.06 -14.5 41.29 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.867 -1.146 . . . . 0.0 110.786 -178.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.411 ' HB2' ' HB2' ' A' ' 36' ' ' LYS . 5.6 m-80 -113.21 70.02 0.71 Allowed 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.867 0.841 . . . . 0.0 108.82 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.426 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 72.5 mt -100.72 139.09 36.89 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -83.96 -25.66 29.87 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.944 -1.097 . . . . 0.0 110.723 -179.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.436 HD12 ' CD2' ' A' ' 34' ' ' LEU . 2.8 pp -155.71 136.29 13.33 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.265 -0.897 . . . . 0.0 110.216 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.447 ' HB3' ' O ' ' A' ' 61' ' ' ASN . 38.6 t60 -133.27 121.46 22.49 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.48 -0.763 . . . . 0.0 109.786 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -115.5 133.69 55.8 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.077 -1.015 . . . . 0.0 110.487 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -137.75 78.1 37.35 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 120.999 -1.063 . . . . 0.0 110.393 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -67.15 142.41 61.05 Favored 'Trans proline' 0 C--N 1.302 -1.88 0 O-C-N 123.865 1.455 . . . . 0.0 109.978 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -128.03 122.5 32.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.115 -0.991 . . . . 0.0 110.189 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -60.23 -46.74 88.72 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 118.605 -1.238 . . . . 0.0 108.403 178.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -147.53 102.15 3.42 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.617 -0.677 . . . . 0.0 110.017 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -84.97 -144.03 0.09 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.301 -0.875 . . . . 0.0 108.977 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -50.14 -29.4 9.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.102 -0.999 . . . . 0.0 109.373 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 170.48 38.64 0.03 OUTLIER Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -112.24 -172.52 2.06 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.035 -1.273 . . . . 0.0 109.917 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.466 ' O ' ' C ' ' A' ' 56' ' ' ASN . . . -139.79 137.19 34.82 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.181 -0.949 . . . . 0.0 110.596 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.466 ' C ' ' O ' ' A' ' 55' ' ' ALA . 92.4 m-20 24.79 60.67 0.05 Allowed 'General case' 0 N--CA 1.509 2.507 0 CA-C-O 121.412 0.625 . . . . 0.0 112.208 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 8.8 m -113.05 141.39 46.93 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.323 -0.86 . . . . 0.0 109.862 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.453 ' CG2' ' HB2' ' A' ' 74' ' ' GLU . 18.9 tt -136.75 138.85 45.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.211 -0.931 . . . . 0.0 110.318 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 55.4 t -119.57 127.2 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.302 -0.874 . . . . 0.0 110.312 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 47.9 t -96.08 126.94 41.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.368 -0.833 . . . . 0.0 110.337 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.447 ' O ' ' HB3' ' A' ' 44' ' ' HIS . 23.8 t-20 -136.34 148.78 48.07 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.408 -0.807 . . . . 0.0 110.295 -179.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.422 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 71.1 m -125.3 150.45 47.11 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.805 -1.184 . . . . 0.0 108.948 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.466 ' CD ' ' HA2' ' A' ' 66' ' ' GLY . 19.0 ttmt -138.63 148.25 43.85 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.672 -1.268 . . . . 0.0 111.718 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -120.97 97.48 5.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.675 -0.64 . . . . 0.0 110.44 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.99 24.11 73.02 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.466 ' HA2' ' CD ' ' A' ' 63' ' ' LYS . . . 75.07 25.12 69.72 Favored Glycine 0 N--CA 1.48 1.606 0 C-N-CA 119.137 -1.506 . . . . 0.0 110.515 178.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -87.08 -81.02 0.24 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.988 -1.301 . . . . 0.0 110.649 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.428 ' O ' ' HG3' ' A' ' 63' ' ' LYS . 41.3 m95 -124.08 -156.59 0.72 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.075 -1.016 . . . . 0.0 110.445 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 62' ' ' SER . . . 163.86 114.9 0.31 Allowed Glycine 0 N--CA 1.487 2.05 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.6 m -80.65 121.5 25.93 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.541 -0.976 . . . . 0.0 110.412 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -91.27 129.19 37.29 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.175 -0.953 . . . . 0.0 110.913 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -112.26 -172.36 2.03 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.12 -0.988 . . . . 0.0 109.358 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -147.79 126.31 12.44 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 118.416 -1.314 . . . . 0.0 112.437 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.453 ' HB2' ' CG2' ' A' ' 58' ' ' ILE . 95.8 mt-10 -115.47 145.59 42.45 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -119.49 48.62 1.48 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.769 -1.207 . . . . 0.0 109.093 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.3 m -119.39 132.39 69.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.426 -0.796 . . . . 0.0 110.931 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -161.51 80.16 2.06 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.392 -0.818 . . . . 0.0 109.57 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -81.17 8.3 4.44 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 124.163 1.612 . . . . 0.0 111.37 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -132.14 179.12 6.3 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.937 -1.102 . . . . 0.0 110.212 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.432 ' HB3' ' HD2' ' A' ' 81' ' ' PRO . 0.7 OUTLIER -144.16 177.23 1.87 Allowed Pre-proline 0 C--N 1.296 -1.741 0 O-C-N 121.545 -0.722 . . . . 0.0 109.221 -179.222 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.452 ' HA ' ' CG1' ' A' ' 23' ' ' VAL . 50.3 Cg_endo -71.26 157.29 57.46 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.531 1.279 . . . . 0.0 109.748 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 68.7 26.93 74.2 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.879 -1.688 . . . . 0.0 108.879 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.0 m -133.76 151.99 51.75 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.466 -1.02 . . . . 0.0 110.068 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 69.4 t -95.53 129.63 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.254 -0.903 . . . . 0.0 110.236 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -149.5 147.1 27.81 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.272 -0.893 . . . . 0.0 110.516 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -122.33 142.87 50.04 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.227 -0.921 . . . . 0.0 109.451 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 39.8 t -127.54 132.64 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.061 -1.024 . . . . 0.0 111.131 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -95.26 140.19 30.51 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.316 -0.865 . . . . 0.0 111.205 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.6 mt -124.64 128.58 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.612 -0.68 . . . . 0.0 110.417 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.503 ' HB ' ' HB ' ' A' ' 97' ' ' THR . 52.5 m -121.98 128.81 51.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.167 -0.958 . . . . 0.0 109.859 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -109.3 117.89 35.25 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.216 -0.928 . . . . 0.0 111.087 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -125.29 150.56 46.99 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.509 -0.744 . . . . 0.0 110.418 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.443 ' NE2' ' O ' ' A' ' 114' ' ' LEU . 75.8 mm-40 -62.52 -37.94 88.02 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.349 -0.844 . . . . 0.0 110.252 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.01 -40.84 95.51 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.211 -0.931 . . . . 0.0 110.113 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.437 ' C ' ' OD1' ' A' ' 95' ' ' ASN . 11.0 p30 -169.02 -171.67 1.38 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.378 -0.826 . . . . 0.0 110.521 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 20.3 tp -112.12 132.87 54.61 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.409 -0.807 . . . . 0.0 109.599 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.503 ' HB ' ' HB ' ' A' ' 90' ' ' THR . 23.2 m -117.14 126.44 52.82 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.871 -1.143 . . . . 0.0 110.94 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 41.2 t -123.21 129.82 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.181 -0.949 . . . . 0.0 109.674 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -115.36 126.93 55.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.169 -0.957 . . . . 0.0 110.735 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.8 mp -100.34 164.55 16.09 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.581 -0.7 . . . . 0.0 109.833 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -64.91 -24.01 61.26 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.732 1.385 . . . . 0.0 110.371 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -77.37 -14.59 59.68 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.243 -0.911 . . . . 0.0 110.478 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.96 -13.2 59.08 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -70.93 135.32 47.87 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.922 -1.34 . . . . 0.0 109.977 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -124.66 138.7 54.29 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.437 -0.79 . . . . 0.0 110.175 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -126.43 134.46 50.98 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.093 -1.004 . . . . 0.0 109.636 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -112.83 145.06 41.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.069 -1.02 . . . . 0.0 111.049 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.52 ' CE2' ' O ' ' A' ' 109' ' ' PRO . 3.1 t80 -134.23 136.95 26.96 Favored Pre-proline 0 C--N 1.301 -1.521 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.52 ' O ' ' CE2' ' A' ' 108' ' ' PHE . 38.5 Cg_endo -64.18 133.98 40.44 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.642 1.338 . . . . 0.0 110.643 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.454 ' ND2' ' O ' ' A' ' 110' ' ' ASN . 6.2 p-10 -85.98 83.58 7.75 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.202 -0.936 . . . . 0.0 110.397 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -55.92 -20.8 17.4 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.937 -1.102 . . . . 0.0 109.657 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 97.5 mt -101.97 133.3 46.98 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.225 -0.922 . . . . 0.0 109.92 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -88.71 67.29 8.33 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.242 -0.911 . . . . 0.0 110.887 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.443 ' O ' ' NE2' ' A' ' 93' ' ' GLN . 33.8 tp -87.38 120.45 28.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.232 -0.917 . . . . 0.0 109.368 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -82.84 -13.73 55.63 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.678 -1.264 . . . . 0.0 110.469 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -157.59 157.54 33.88 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.806 -1.184 . . . . 0.0 111.267 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.42 HD13 HD13 ' A' ' 34' ' ' LEU . 95.1 mt -108.57 126.81 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.45 -0.781 . . . . 0.0 109.607 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -111.17 -27.74 8.58 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.998 -1.064 . . . . 0.0 111.255 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.47 ' CD1' ' O ' ' A' ' 36' ' ' LYS . 3.0 m-85 -117.15 140.86 49.0 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.935 -1.103 . . . . 0.0 112.503 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.449 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 54.8 ttp -138.76 129.64 26.52 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -136.61 136.42 39.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.398 -1.439 . . . . 0.0 111.097 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.445 ' O ' ' HA3' ' A' ' 3' ' ' GLY . . . -149.5 116.34 5.94 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.405 ' O ' ' CG1' ' A' ' 31' ' ' VAL . 65.8 t0 -147.02 118.67 8.0 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.611 -0.681 . . . . 0.0 109.384 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 179.62 -151.72 10.34 Favored Glycine 0 N--CA 1.489 2.206 0 C-N-CA 119.612 -1.28 . . . . 0.0 110.385 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.481 ' HB3' ' HA ' ' A' ' 27' ' ' ALA . 99.6 m-20 -74.46 -2.82 27.23 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.96 -0.729 . . . . 0.0 111.122 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.476 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 24.8 t80 -96.62 137.79 35.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.997 -1.064 . . . . 0.0 110.334 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -110.75 120.53 42.72 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 118.43 -1.308 . . . . 0.0 111.098 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.409 ' O ' HG22 ' A' ' 128' ' ' ILE . 7.6 tt -101.37 114.26 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.223 -0.923 . . . . 0.0 110.242 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -97.85 -13.58 21.21 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 120.904 -1.122 . . . . 0.0 110.999 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -147.92 148.41 30.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.748 -1.22 . . . . 0.0 112.59 -179.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 52.6 t -133.42 131.33 57.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -127.99 146.71 50.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.628 -1.295 . . . . 0.0 110.785 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -109.24 127.65 54.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.567 -0.708 . . . . 0.0 110.106 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 59.5 t0 . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 117.948 -1.025 . . . . 0.0 111.123 179.249 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.813 0 CA-C-O 120.849 0.357 . . . . 0.0 110.687 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' CYS . . . . . 0.452 ' O ' ' O ' ' B' ' 126' ' ' PHE . 99.1 m -141.64 -123.78 0.1 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.812 -1.18 . . . . 0.0 109.91 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . 0.446 ' HA3' ' O ' ' B' ' 122' ' ' ALA . . . 176.28 121.56 0.67 Allowed Glycine 0 N--CA 1.494 2.534 0 N-CA-C 108.679 -1.768 . . . . 0.0 108.679 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . 0.417 ' HA ' ' HB3' ' A' ' 8' ' ' ASN . 1.2 pp -68.22 156.6 37.26 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.233 -1.157 . . . . 0.0 111.49 -178.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 45.5 t -118.84 132.59 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.706 -0.621 . . . . 0.0 109.399 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -110.09 178.57 4.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.738 -1.226 . . . . 0.0 111.26 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' SER . . . . . 0.438 ' O ' ' HB3' ' B' ' 8' ' ' ASN . 26.3 p -155.45 170.9 20.88 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . 0.438 ' HB3' ' O ' ' B' ' 7' ' ' SER . 63.5 t30 59.16 35.2 23.58 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.366 -0.834 . . . . 0.0 110.539 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . 0.505 ' O ' ' C ' ' B' ' 10' ' ' ASN . 81.1 mt -88.1 -1.58 58.09 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.29 -0.881 . . . . 0.0 111.306 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . 0.505 ' C ' ' O ' ' B' ' 9' ' ' LEU . 4.7 m120 -0.05 69.38 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.751 0 N-CA-C 113.874 1.065 . . . . 0.0 113.874 -178.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.456 ' N ' ' O ' ' B' ' 9' ' ' LEU . 11.1 mt -93.81 128.65 40.17 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.312 -0.867 . . . . 0.0 110.442 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . 0.41 ' CB ' ' HD2' ' B' ' 13' ' ' PRO . 0.0 OUTLIER -98.68 171.73 5.47 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.285 -0.885 . . . . 0.0 110.872 -179.786 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . 0.41 ' HD2' ' CB ' ' B' ' 12' ' ' LYS . 40.7 Cg_endo -65.34 147.99 87.97 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.242 1.654 . . . . 0.0 109.501 178.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.11 -16.25 54.0 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -111.17 142.06 43.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.065 -1.256 . . . . 0.0 109.951 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' CYS . . . . . . . . . . . . . 57.7 m -109.46 153.75 23.61 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.162 -0.961 . . . . 0.0 110.277 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 56.6 tp -118.68 130.8 56.04 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.245 -0.91 . . . . 0.0 110.366 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -111.05 125.87 54.21 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.553 -0.717 . . . . 0.0 109.483 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 79.1 t -121.06 122.61 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.946 -1.096 . . . . 0.0 110.253 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -123.02 128.62 50.42 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.145 -0.972 . . . . 0.0 109.691 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -147.35 -152.92 5.77 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.42 -1.372 . . . . 0.0 110.349 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 -136.5 142.37 43.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.597 -0.943 . . . . 0.0 109.527 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.454 ' CG1' ' HA ' ' B' ' 81' ' ' PRO . 32.0 t -108.47 132.7 55.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 O-C-N 121.495 -0.753 . . . . 0.0 111.122 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.62 152.36 96.71 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.582 -0.699 . . . . 0.0 110.057 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -65.35 -29.13 54.54 Favored 'Trans proline' 0 C--N 1.303 -1.858 0 O-C-N 124.042 1.548 . . . . 0.0 110.466 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -96.85 16.46 19.21 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.429 -0.794 . . . . 0.0 110.104 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . 0.484 ' HA ' ' HB3' ' B' ' 125' ' ' ASP . . . -62.61 99.13 0.14 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.269 -0.895 . . . . 0.0 110.697 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -95.16 -17.98 21.31 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.399 -0.813 . . . . 0.0 110.785 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 39.4 t -163.82 142.77 7.84 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.977 -1.089 . . . . 0.0 111.452 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' PHE . . . . . 0.498 ' CE2' ' HB2' ' B' ' 32' ' ' LEU . 9.9 t80 -149.74 157.51 43.29 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.381 -0.825 . . . . 0.0 110.017 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 2.5 p -128.89 131.74 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 120.766 -1.209 . . . . 0.0 110.989 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.498 ' HB2' ' CE2' ' B' ' 30' ' ' PHE . 12.7 tp -131.42 129.8 41.73 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.524 -0.735 . . . . 0.0 109.16 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -161.3 153.74 20.26 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 118.287 -1.365 . . . . 0.0 110.851 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.47 ' HA ' ' HA ' ' B' ' 120' ' ' MET . 0.4 OUTLIER -144.57 124.96 13.86 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.636 0.731 . . . . 0.0 109.804 179.411 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . 0.43 ' HA3' ' HA ' ' B' ' 41' ' ' LEU . . . -159.7 -159.35 9.72 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . 0.467 ' O ' ' CD1' ' B' ' 119' ' ' TYR . 40.6 mtpt -67.81 -42.34 81.7 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -156.55 -167.59 2.45 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.879 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 8.7 t -62.97 -42.87 99.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.774 -0.579 . . . . 0.0 112.41 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' ASN . . . . . 0.462 ' HB3' ' N ' ' B' ' 66' ' ' GLY . 92.0 m-20 -87.3 -14.52 40.65 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.983 -1.073 . . . . 0.0 110.751 -178.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' ASN . . . . . 0.405 ' ND2' ' N ' ' B' ' 40' ' ' ASN . 6.1 m-80 -112.67 70.06 0.71 Allowed 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.43 ' HA ' ' HA3' ' B' ' 35' ' ' GLY . 73.0 mt -100.29 142.03 32.32 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -88.33 -23.5 23.4 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.832 -1.167 . . . . 0.0 110.359 -178.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.429 HD12 ' CD2' ' B' ' 34' ' ' LEU . 2.8 pp -156.57 135.93 12.19 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.26 -0.9 . . . . 0.0 110.154 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' HIS . . . . . 0.435 ' HB3' ' O ' ' B' ' 61' ' ' ASN . 37.7 t60 -133.19 121.29 22.31 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.691 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -115.51 133.88 55.61 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.136 -0.978 . . . . 0.0 110.296 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -137.8 78.25 36.73 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.046 -1.034 . . . . 0.0 110.3 178.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -67.14 142.53 61.54 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.851 1.448 . . . . 0.0 109.772 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -128.31 121.98 30.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.126 -0.984 . . . . 0.0 110.014 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -60.12 -46.87 88.19 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 118.35 -1.34 . . . . 0.0 108.344 178.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -147.18 102.35 3.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.699 -0.626 . . . . 0.0 109.97 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.37 -144.02 0.1 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.279 -0.888 . . . . 0.0 108.992 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -50.18 -28.72 7.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.085 -1.01 . . . . 0.0 109.409 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 169.55 38.81 0.03 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -112.25 -172.62 2.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.046 -1.267 . . . . 0.0 109.889 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.499 ' O ' ' C ' ' B' ' 56' ' ' ASN . . . -138.46 142.11 39.45 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.306 -0.871 . . . . 0.0 109.949 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' ASN . . . . . 0.499 ' C ' ' O ' ' B' ' 55' ' ' ALA . 92.0 m-20 16.41 64.33 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.569 0 CA-C-O 121.83 0.824 . . . . 0.0 112.51 -178.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 9.7 m -113.84 141.0 47.87 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.654 -0.654 . . . . 0.0 109.758 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' ILE . . . . . 0.454 ' CG2' ' HB2' ' B' ' 74' ' ' GLU . 18.7 tt -136.72 138.11 46.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.192 -0.942 . . . . 0.0 110.335 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 55.4 t -118.38 127.76 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.258 -0.901 . . . . 0.0 110.306 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 47.9 t -96.56 126.03 41.45 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.373 -0.83 . . . . 0.0 110.226 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' ASN . . . . . 0.435 ' O ' ' HB3' ' B' ' 44' ' ' HIS . 24.1 t-20 -135.58 148.68 49.16 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.42 -0.8 . . . . 0.0 110.527 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' SER . . . . . 0.415 ' O ' ' HA2' ' B' ' 69' ' ' GLY . 72.1 m -125.06 150.93 46.29 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.677 -1.264 . . . . 0.0 109.042 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . 0.486 ' CD ' ' HA2' ' B' ' 66' ' ' GLY . 18.6 ttmt -138.93 148.03 43.04 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.651 -1.281 . . . . 0.0 111.526 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -120.85 97.67 5.65 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.612 -0.68 . . . . 0.0 110.312 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 67.08 23.65 73.01 Favored Glycine 0 N--CA 1.487 2.061 0 C-N-CA 119.491 -1.338 . . . . 0.0 110.131 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . 0.486 ' HA2' ' CD ' ' B' ' 63' ' ' LYS . . . 75.18 24.85 70.19 Favored Glycine 0 N--CA 1.487 2.081 0 O-C-N 120.846 -1.385 . . . . 0.0 110.305 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' ALA . . . . . 0.4 ' HB1' ' CD1' ' B' ' 68' ' ' TRP . . . -86.55 -81.56 0.22 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.964 -1.315 . . . . 0.0 110.662 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' TRP . . . . . 0.428 ' O ' ' HG3' ' B' ' 63' ' ' LYS . 41.2 m95 -124.05 -156.11 0.7 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.13 -0.981 . . . . 0.0 110.374 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' B' ' 62' ' ' SER . . . 163.35 114.69 0.31 Allowed Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 5.4 m -80.46 120.96 25.14 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.538 -0.978 . . . . 0.0 110.492 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -90.59 128.92 36.74 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.272 -0.892 . . . . 0.0 111.082 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -112.06 -172.14 1.98 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.951 -1.093 . . . . 0.0 109.282 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -147.7 127.36 13.35 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 118.257 -1.377 . . . . 0.0 112.34 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' GLU . . . . . 0.454 ' HB2' ' CG2' ' B' ' 58' ' ' ILE . 96.0 mt-10 -116.37 145.11 43.47 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -119.48 48.42 1.52 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.986 -1.071 . . . . 0.0 109.112 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 33.8 m -119.37 132.14 70.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-O 121.561 0.696 . . . . 0.0 110.679 -179.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -161.35 81.29 2.01 Favored Pre-proline 0 C--N 1.301 -1.519 0 O-C-N 121.743 -0.598 . . . . 0.0 109.548 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -82.23 8.77 4.31 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 121.843 1.696 . . . . 0.0 111.234 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -132.79 178.99 6.43 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.918 -1.114 . . . . 0.0 110.403 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.448 ' HB3' ' HD2' ' B' ' 81' ' ' PRO . 0.7 OUTLIER -144.02 177.26 1.87 Allowed Pre-proline 0 C--N 1.297 -1.705 0 O-C-N 121.553 -0.717 . . . . 0.0 109.19 -179.25 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' PRO . . . . . 0.454 ' HA ' ' CG1' ' B' ' 23' ' ' VAL . 54.0 Cg_endo -71.34 157.15 57.5 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.699 1.368 . . . . 0.0 109.412 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 68.5 26.62 74.25 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 6.5 m -133.37 151.73 51.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.505 -0.997 . . . . 0.0 110.039 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 70.7 t -95.72 129.26 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.259 -0.901 . . . . 0.0 110.23 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -149.27 147.3 28.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.221 -0.924 . . . . 0.0 110.473 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -122.12 143.29 49.63 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.243 -0.911 . . . . 0.0 109.4 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 39.5 t -127.41 132.29 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.069 -1.02 . . . . 0.0 111.293 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 88' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -94.78 139.83 30.74 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.344 -0.848 . . . . 0.0 111.166 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 96.8 mt -124.85 128.55 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.675 -0.64 . . . . 0.0 110.254 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 90' ' ' THR . . . . . 0.473 ' HB ' ' HB ' ' B' ' 97' ' ' THR . 52.1 m -122.36 128.75 51.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.157 -0.964 . . . . 0.0 109.811 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 91' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -109.02 118.5 36.94 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.157 -0.964 . . . . 0.0 111.049 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -125.58 150.65 47.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.516 -0.74 . . . . 0.0 110.356 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . 0.431 ' NE2' ' O ' ' B' ' 114' ' ' LEU . 75.2 mm-40 -62.65 -37.62 87.1 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.359 -0.838 . . . . 0.0 110.246 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.27 -40.84 94.44 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.195 -0.94 . . . . 0.0 110.116 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . 0.424 ' C ' ' OD1' ' B' ' 95' ' ' ASN . 10.5 p30 -168.77 -171.04 1.29 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.419 -0.8 . . . . 0.0 110.506 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 96' ' ' LEU . . . . . . . . . . . . . 20.3 tp -112.82 132.85 55.09 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.26 -0.9 . . . . 0.0 109.324 179.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 97' ' ' THR . . . . . 0.473 ' HB ' ' HB ' ' B' ' 90' ' ' THR . 22.1 m -117.24 126.58 52.98 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.979 -1.076 . . . . 0.0 110.831 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 40.8 t -123.18 130.39 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.234 -0.916 . . . . 0.0 109.66 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -115.75 127.53 55.18 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.076 -1.015 . . . . 0.0 110.69 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 mp -101.08 164.29 16.34 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.576 -0.702 . . . . 0.0 109.71 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -64.87 -24.16 61.37 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.696 1.366 . . . . 0.0 110.217 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -77.22 -14.16 59.82 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.312 -0.868 . . . . 0.0 110.567 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.27 -13.08 60.21 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 104' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -71.11 135.84 47.88 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.915 -1.344 . . . . 0.0 109.893 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -124.89 139.18 54.07 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.394 -0.816 . . . . 0.0 110.033 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -127.07 134.5 50.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.085 -1.01 . . . . 0.0 109.452 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -113.03 145.2 41.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.045 -1.035 . . . . 0.0 111.011 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 108' ' ' PHE . . . . . 0.522 ' CE2' ' O ' ' B' ' 109' ' ' PRO . 2.9 t80 -134.34 136.89 26.72 Favored Pre-proline 0 C--N 1.3 -1.56 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . 0.522 ' O ' ' CE2' ' B' ' 108' ' ' PHE . 37.6 Cg_endo -64.05 134.8 44.49 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.757 1.399 . . . . 0.0 110.682 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 110' ' ' ASN . . . . . 0.469 ' ND2' ' O ' ' B' ' 110' ' ' ASN . 6.4 p-10 -87.04 83.87 7.41 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.032 -1.042 . . . . 0.0 110.279 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -55.99 -21.37 20.83 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.972 -1.08 . . . . 0.0 109.537 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 97.4 mt -101.57 133.12 46.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.138 -0.976 . . . . 0.0 109.896 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -88.59 67.35 8.45 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.301 -0.874 . . . . 0.0 110.763 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 114' ' ' LEU . . . . . 0.431 ' O ' ' NE2' ' B' ' 93' ' ' GLN . 36.2 tp -87.14 121.22 29.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.308 -0.87 . . . . 0.0 109.059 178.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -83.5 -13.97 53.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.624 -1.298 . . . . 0.0 110.474 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 116' ' ' ALA . . . . . . . . . . . . . . . -157.05 157.8 35.3 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.965 -1.084 . . . . 0.0 110.904 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 117' ' ' ILE . . . . . 0.416 HD13 HD13 ' B' ' 34' ' ' LEU . 95.5 mt -108.89 126.87 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.288 -0.882 . . . . 0.0 109.532 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -111.2 -27.04 8.87 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.851 -1.156 . . . . 0.0 111.348 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 119' ' ' TYR . . . . . 0.467 ' CD1' ' O ' ' B' ' 36' ' ' LYS . 2.8 m-85 -117.42 141.2 48.62 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.91 -1.119 . . . . 0.0 112.48 -178.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 120' ' ' MET . . . . . 0.47 ' HA ' ' HA ' ' B' ' 34' ' ' LEU . 54.2 ttp -139.07 129.95 26.3 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -136.96 136.56 38.66 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.429 -1.419 . . . . 0.0 111.221 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 122' ' ' ALA . . . . . 0.446 ' O ' ' HA3' ' B' ' 3' ' ' GLY . . . -149.35 116.32 5.99 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -146.68 118.68 8.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.387 -0.82 . . . . 0.0 109.431 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 179.33 -152.27 10.93 Favored Glycine 0 N--CA 1.487 2.084 0 C-N-CA 119.392 -1.385 . . . . 0.0 110.464 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . 0.484 ' HB3' ' HA ' ' B' ' 27' ' ' ALA . 99.7 m-20 -74.28 -2.93 27.13 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.844 -0.798 . . . . 0.0 111.067 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 126' ' ' PHE . . . . . 0.481 ' HB3' ' CD1' ' B' ' 30' ' ' PHE . 24.6 t80 -96.24 138.27 34.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.001 -1.062 . . . . 0.0 110.288 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -111.13 120.3 41.87 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 118.477 -1.289 . . . . 0.0 111.003 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . 0.429 HG22 ' O ' ' B' ' 128' ' ' ILE . 7.8 tt -100.9 114.85 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.046 -1.034 . . . . 0.0 110.282 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -98.39 -13.3 20.7 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.739 -1.225 . . . . 0.0 110.957 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 130' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -147.89 148.22 30.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.762 -1.211 . . . . 0.0 112.538 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 53.1 t -133.28 130.69 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 132' ' ' ALA . . . . . . . . . . . . . . . -127.39 146.72 50.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.418 -1.426 . . . . 0.0 110.861 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -108.75 127.65 54.19 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.505 -0.747 . . . . 0.0 110.033 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 58.4 t0 . . . . . 0 N--CA 1.497 1.906 0 CA-C-O 117.876 -1.059 . . . . 0.0 111.354 179.141 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.442 ' HB2' ' HB2' ' A' ' 4' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.421 0.629 . . . . 0.0 110.534 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -126.99 84.33 2.25 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.607 -0.683 . . . . 0.0 109.557 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.4 ' HA2' ' HA ' ' A' ' 123' ' ' ASP . . . 92.09 34.51 7.14 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.451 ' HA ' ' HB3' ' B' ' 8' ' ' ASN . 30.9 tp -61.58 133.43 55.65 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.031 -1.276 . . . . 0.0 110.702 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.1 t -123.15 133.49 68.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.47 -0.768 . . . . 0.0 109.866 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.47 148.56 44.28 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.167 -0.958 . . . . 0.0 110.235 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.439 ' O ' ' HB3' ' A' ' 8' ' ' ASN . 74.4 m -142.02 167.69 21.52 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.32 -0.862 . . . . 0.0 109.397 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.439 ' HB3' ' O ' ' A' ' 7' ' ' SER . 7.4 t30 60.57 32.85 20.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.415 -0.803 . . . . 0.0 109.628 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.493 ' O ' ' C ' ' A' ' 10' ' ' ASN . 1.0 OUTLIER -84.65 -2.84 58.06 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.731 -0.605 . . . . 0.0 111.552 -179.393 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.493 ' C ' ' O ' ' A' ' 9' ' ' LEU . 87.9 m-20 11.29 63.73 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.623 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 14.0 tp -78.55 143.27 36.67 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.846 -1.159 . . . . 0.0 109.824 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.8 mtmt -127.22 158.62 68.67 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 120.969 -1.082 . . . . 0.0 109.915 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -66.49 147.31 82.17 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.83 1.437 . . . . 0.0 110.557 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.53 -9.18 41.2 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -122.98 147.49 46.57 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.927 -1.337 . . . . 0.0 110.204 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 56.8 m -93.3 142.81 26.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.325 -0.859 . . . . 0.0 110.771 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 42.6 tp -120.17 128.5 53.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.394 -0.816 . . . . 0.0 108.908 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -123.37 143.1 50.33 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.878 -1.139 . . . . 0.0 111.656 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.5 t -128.52 116.12 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.641 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -111.79 125.24 53.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.088 -1.008 . . . . 0.0 109.959 178.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.41 ' HA3' ' O ' ' A' ' 127' ' ' LYS . . . -144.96 -155.78 6.59 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -135.23 145.89 48.07 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.281 -1.129 . . . . 0.0 108.966 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 39.9 t -111.45 130.94 64.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 O-C-N 121.124 -0.985 . . . . 0.0 110.562 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.66 153.15 72.4 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.512 -0.743 . . . . 0.0 110.291 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.413 ' HA ' ' N ' ' A' ' 82' ' ' GLY . 43.5 Cg_endo -67.23 -20.34 49.48 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.992 1.522 . . . . 0.0 110.469 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 49.9 p-10 -119.11 25.2 10.33 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.293 -0.879 . . . . 0.0 110.416 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.43 ' HA ' ' HB3' ' A' ' 125' ' ' ASP . . . -60.05 104.87 0.34 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.898 -1.126 . . . . 0.0 110.315 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -95.52 -15.23 23.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.332 -0.855 . . . . 0.0 111.073 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.8 t -160.54 132.94 6.2 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.722 -1.236 . . . . 0.0 111.719 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.483 ' CZ ' ' HB2' ' A' ' 32' ' ' LEU . 14.8 t80 -136.72 144.98 44.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.589 -0.695 . . . . 0.0 109.595 178.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.8 t -126.37 131.46 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.03 -1.044 . . . . 0.0 110.836 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.483 ' HB2' ' CZ ' ' A' ' 30' ' ' PHE . 20.9 tp -135.76 135.52 40.03 Favored 'General case' 0 N--CA 1.484 1.235 0 O-C-N 121.47 -0.769 . . . . 0.0 109.997 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.435 ' HB2' ' CD1' ' A' ' 41' ' ' LEU . 28.5 p30 -142.95 155.37 44.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.787 -1.195 . . . . 0.0 110.508 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.421 HD12 HD13 ' A' ' 43' ' ' LEU . 0.6 OUTLIER -153.58 111.84 3.62 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.29 -0.881 . . . . 0.0 110.19 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.487 ' O ' ' CB ' ' A' ' 119' ' ' TYR . . . -161.04 -173.41 29.63 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.634 -1.786 . . . . 0.0 108.634 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.422 ' O ' ' HB2' ' A' ' 119' ' ' TYR . 98.7 mttt -78.61 -44.66 23.43 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.87 -1.37 . . . . 0.0 110.482 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.414 ' HB2' ' HB2' ' A' ' 40' ' ' ASN . 85.3 m-20 -119.8 165.03 15.09 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.761 -177.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.7 t -56.98 -45.7 82.74 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.604 -0.685 . . . . 0.0 112.425 -178.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.433 ' HB3' ' N ' ' A' ' 66' ' ' GLY . 55.6 m-20 -89.46 -0.92 57.84 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.491 -1.381 . . . . 0.0 110.242 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.414 ' HB2' ' HB2' ' A' ' 37' ' ' ASP . 5.2 m-80 -111.52 58.37 0.62 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.269 -0.895 . . . . 0.0 109.713 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.435 ' CD1' ' HB2' ' A' ' 33' ' ' ASN . 71.9 mt -83.15 134.08 35.0 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 83.6 m -81.73 -40.44 22.72 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.998 -1.064 . . . . 0.0 110.224 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.421 HD13 HD12 ' A' ' 34' ' ' LEU . 83.0 mt -131.87 140.21 49.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.218 -0.926 . . . . 0.0 110.262 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 62.9 t-80 -140.46 139.54 35.2 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.199 -0.938 . . . . 0.0 110.425 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -127.92 146.41 50.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.114 -0.991 . . . . 0.0 110.224 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -152.83 61.07 3.6 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 109.909 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.01 147.2 67.15 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 124.144 1.602 . . . . 0.0 110.573 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 91.7 mtm-85 -135.53 125.69 26.21 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.11 -0.994 . . . . 0.0 110.637 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -61.93 -46.81 87.69 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.018 -1.051 . . . . 0.0 108.988 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -148.52 84.51 1.49 Allowed 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.52 -117.41 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.264 -0.898 . . . . 0.0 110.176 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 25.5 m80 -77.97 -13.06 60.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.583 -1.323 . . . . 0.0 110.458 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 164.75 -22.27 0.14 Allowed Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.611 -1.281 . . . . 0.0 110.459 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -60.85 -179.16 0.12 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.777 -1.425 . . . . 0.0 110.118 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.522 ' O ' ' C ' ' A' ' 56' ' ' ASN . . . -122.21 135.66 54.8 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.619 -0.676 . . . . 0.0 109.985 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.522 ' C ' ' O ' ' A' ' 55' ' ' ALA . 1.9 m-20 14.33 74.83 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.48 0 CA-C-O 121.297 0.57 . . . . 0.0 112.122 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 47.2 m -110.13 130.3 55.56 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.203 -0.935 . . . . 0.0 110.392 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.41 ' O ' HG21 ' A' ' 58' ' ' ILE . 19.6 tt -128.71 131.0 68.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.596 -0.69 . . . . 0.0 109.975 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.8 m -125.81 129.34 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.147 -0.971 . . . . 0.0 110.136 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 11.3 t -86.13 130.67 34.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.263 -0.898 . . . . 0.0 109.355 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -137.21 144.63 42.95 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.004 -1.06 . . . . 0.0 111.327 -179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.2 m -119.13 153.95 34.03 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.477 ' CD ' ' HA2' ' A' ' 66' ' ' GLY . 16.6 ttmt -136.69 134.97 37.79 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.876 -1.14 . . . . 0.0 110.437 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -114.32 102.38 10.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.267 -0.895 . . . . 0.0 109.34 178.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.11 27.4 72.27 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.477 ' HA2' ' CD ' ' A' ' 63' ' ' LYS . . . 93.08 2.05 66.65 Favored Glycine 0 N--CA 1.484 1.852 0 C-N-CA 119.624 -1.274 . . . . 0.0 110.005 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.463 ' O ' ' C ' ' A' ' 68' ' ' TRP . . . -109.55 84.4 1.92 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.987 -1.302 . . . . 0.0 109.723 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.463 ' C ' ' O ' ' A' ' 67' ' ' ALA . 60.2 m95 -6.13 -117.94 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.761 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 129.86 -113.39 1.47 Allowed Glycine 0 N--CA 1.488 2.102 0 O-C-N 119.849 -1.782 . . . . 0.0 109.9 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 21.7 m -78.69 121.45 24.73 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.261 -1.141 . . . . 0.0 111.266 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -126.83 131.18 51.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.398 -0.814 . . . . 0.0 109.684 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.51 156.51 38.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.063 -1.023 . . . . 0.0 110.159 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -134.82 88.86 2.47 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.33 -0.856 . . . . 0.0 109.74 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -114.03 125.88 54.5 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.369 -0.832 . . . . 0.0 109.952 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -93.32 85.54 5.02 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.857 -1.152 . . . . 0.0 110.239 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.4 p -127.16 132.11 70.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.231 -0.918 . . . . 0.0 110.151 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.524 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 13.0 p90 -144.9 81.67 10.56 Favored Pre-proline 0 N--CA 1.487 1.398 0 O-C-N 121.211 -0.931 . . . . 0.0 110.326 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.463 ' CB ' ' HB2' ' A' ' 102' ' ' ASP . 49.8 Cg_endo -72.71 -3.38 13.42 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.844 1.444 . . . . 0.0 111.365 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.402 ' CE1' ' HG2' ' A' ' 101' ' ' PRO . 3.8 m-85 -133.95 179.68 6.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.008 -1.058 . . . . 0.0 111.068 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.443 ' CG ' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -131.41 172.39 7.45 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.562 -0.711 . . . . 0.0 109.464 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.443 ' HD2' ' CG ' ' A' ' 80' ' ' GLN . 52.3 Cg_endo -71.11 150.09 59.42 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.634 1.333 . . . . 0.0 110.09 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.413 ' N ' ' HA ' ' A' ' 25' ' ' PRO . . . 76.03 26.87 63.39 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 44.7 m -131.76 152.05 51.22 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.12 -1.224 . . . . 0.0 111.016 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 p -91.29 133.38 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.452 -0.78 . . . . 0.0 109.564 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.66 155.62 38.73 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.891 -1.131 . . . . 0.0 110.933 -179.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -122.62 149.6 43.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.331 -0.856 . . . . 0.0 109.724 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.9 t -124.26 130.22 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.103 -0.998 . . . . 0.0 110.403 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 1.4 t -98.82 122.73 42.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.506 -0.746 . . . . 0.0 110.051 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 98.0 mt -122.43 128.63 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.105 -0.997 . . . . 0.0 110.841 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 63.7 m -119.37 128.33 53.98 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.439 ' CZ ' ' CD1' ' A' ' 114' ' ' LEU . 73.6 t80 -109.4 115.11 29.35 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.788 -1.195 . . . . 0.0 111.376 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' A' ' 95' ' ' ASN . 79.7 m-20 -118.54 142.36 47.68 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -60.28 -29.89 69.11 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.782 -1.199 . . . . 0.0 110.523 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.47 -40.68 80.9 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 120.918 -1.114 . . . . 0.0 109.214 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.411 ' O ' ' HB2' ' A' ' 92' ' ' ASP . 0.4 OUTLIER -169.95 172.23 6.68 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.959 -0.697 . . . . 0.0 110.461 -179.096 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.414 ' O ' ' HA ' ' A' ' 107' ' ' LYS . 38.1 tp -102.17 124.53 47.93 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.159 -0.963 . . . . 0.0 110.227 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.446 HG23 ' OE2' ' A' ' 105' ' ' GLU . 11.1 m -107.33 125.35 51.06 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.124 -0.985 . . . . 0.0 109.267 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 36.7 t -131.38 131.61 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.857 -1.152 . . . . 0.0 110.417 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -120.01 143.56 47.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.177 -0.952 . . . . 0.0 110.491 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.417 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 0.5 OUTLIER -111.04 169.57 6.17 Favored Pre-proline 0 C--N 1.301 -1.532 0 O-C-N 121.45 -0.781 . . . . 0.0 109.118 179.226 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' A' ' 100' ' ' LEU . 39.8 Cg_endo -63.96 -23.79 67.73 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 123.626 1.329 . . . . 0.0 110.858 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.463 ' HB2' ' CB ' ' A' ' 78' ' ' PRO . 20.8 t0 -75.01 -12.31 60.3 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.012 -1.055 . . . . 0.0 110.974 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 99.15 -10.32 61.7 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.708 -1.234 . . . . 0.0 110.66 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.43 ' CE2' ' OD2' ' A' ' 102' ' ' ASP . 19.4 m-85 -79.78 140.68 36.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.815 -1.403 . . . . 0.0 109.843 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.446 ' OE2' HG23 ' A' ' 97' ' ' THR . 85.2 tt0 -120.86 143.43 48.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.307 -0.871 . . . . 0.0 110.679 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -129.94 147.99 51.75 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.458 -0.776 . . . . 0.0 109.599 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.426 ' C ' ' CD1' ' A' ' 108' ' ' PHE . 98.3 mttt -127.58 145.79 50.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.035 -1.041 . . . . 0.0 111.478 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.494 ' N ' ' CD1' ' A' ' 108' ' ' PHE . 19.2 m-85 -129.81 140.35 38.39 Favored Pre-proline 0 N--CA 1.489 1.508 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.5 140.36 39.71 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 123.407 1.214 . . . . 0.0 109.786 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.459 ' ND2' ' O ' ' A' ' 110' ' ' ASN . 6.0 p-10 -102.3 82.85 2.24 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 122.212 1.006 . . . . 0.0 110.178 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 96.6 mtt-85 -57.17 -22.89 43.69 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.535 -1.353 . . . . 0.0 108.963 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.447 ' HB2' HD21 ' A' ' 114' ' ' LEU . 89.1 mt -81.96 143.82 31.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.753 -0.592 . . . . 0.0 110.413 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -101.63 39.03 1.5 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.131 -0.981 . . . . 0.0 109.561 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.447 HD21 ' HB2' ' A' ' 112' ' ' LEU . 0.8 OUTLIER -73.77 128.05 34.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.435 -0.79 . . . . 0.0 110.914 -179.146 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -88.04 -16.19 34.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.067 -1.021 . . . . 0.0 110.215 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.483 ' HA ' ' O ' ' A' ' 11' ' ' LEU . . . -158.23 155.13 28.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.042 -1.036 . . . . 0.0 111.251 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 31.6 mm -107.1 130.33 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.203 -0.935 . . . . 0.0 110.18 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.508 ' ND2' ' N ' ' A' ' 118' ' ' ASN . 0.5 OUTLIER -108.92 -15.19 14.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.151 -0.968 . . . . 0.0 110.909 -179.205 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.487 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 4.0 t80 -120.21 129.49 54.11 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.973 -1.079 . . . . 0.0 111.487 -178.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 55.3 ttp -141.35 128.44 20.81 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 178.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.07 149.6 30.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.736 -1.228 . . . . 0.0 111.414 -178.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -152.1 129.07 11.02 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.403 -0.811 . . . . 0.0 109.976 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.4 ' HA ' ' HA2' ' A' ' 3' ' ' GLY . 68.0 t0 -147.4 114.81 6.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.311 -0.868 . . . . 0.0 109.377 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.45 ' HA3' ' HA ' ' A' ' 30' ' ' PHE . . . -177.03 -145.32 5.67 Favored Glycine 0 N--CA 1.485 1.947 0 C-N-CA 119.174 -1.489 . . . . 0.0 110.327 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.43 ' HB3' ' HA ' ' A' ' 27' ' ' ALA . 80.2 m-20 -89.04 12.89 14.3 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.781 -0.835 . . . . 0.0 110.707 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.483 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 15.1 t80 -105.8 137.47 43.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.008 -1.057 . . . . 0.0 110.401 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.41 ' O ' ' HA3' ' A' ' 21' ' ' GLY . 98.7 mttt -103.9 109.56 21.35 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.244 -0.91 . . . . 0.0 111.758 -178.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 8.7 tt -99.67 117.5 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.028 -1.045 . . . . 0.0 109.432 177.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -109.41 -14.39 14.43 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.164 -0.96 . . . . 0.0 111.733 -178.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.54 142.56 30.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.669 -1.27 . . . . 0.0 112.001 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 59.6 t -126.65 132.99 69.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -138.97 143.73 38.66 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.507 -1.37 . . . . 0.0 111.514 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.411 ' CE1' HD12 ' A' ' 11' ' ' LEU . 0.5 OUTLIER -73.79 -125.9 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.629 -0.67 . . . . 0.0 109.723 179.642 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 47.2 t0 . . . . . 0 N--CA 1.491 1.592 0 O-C-N 120.528 -1.357 . . . . 0.0 110.116 179.674 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . 0.443 ' HB2' ' HB2' ' B' ' 4' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.448 0.642 . . . . 0.0 110.513 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -126.93 84.15 2.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.472 -0.767 . . . . 0.0 109.643 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' B' ' 123' ' ' ASP . . . 92.19 34.51 7.1 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . 0.443 ' HB2' ' HB2' ' B' ' 1' ' ' ALA . 31.0 tp -62.1 133.04 54.75 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.143 -1.21 . . . . 0.0 110.705 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 39.5 t -122.77 133.18 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.558 -0.714 . . . . 0.0 109.944 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.26 148.13 44.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.133 -0.98 . . . . 0.0 110.396 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' SER . . . . . 0.453 ' O ' ' HB3' ' B' ' 8' ' ' ASN . 74.9 m -141.69 167.41 22.21 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.22 -0.925 . . . . 0.0 109.343 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . 0.453 ' HB3' ' O ' ' B' ' 7' ' ' SER . 7.6 t30 60.97 33.14 19.89 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.79 0.805 . . . . 0.0 109.509 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . 0.496 ' O ' ' C ' ' B' ' 10' ' ' ASN . 1.0 OUTLIER -86.58 3.48 44.2 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.74 -0.6 . . . . 0.0 111.583 -179.476 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . 0.496 ' C ' ' O ' ' B' ' 9' ' ' LEU . 87.3 m-20 2.22 67.67 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.612 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -178.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.477 ' O ' ' HA ' ' B' ' 116' ' ' ALA . 14.0 tp -79.45 143.34 35.07 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.228 -0.92 . . . . 0.0 109.605 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 6.8 mtmt -127.71 158.67 69.5 Favored Pre-proline 0 C--N 1.296 -1.755 0 O-C-N 121.178 -0.951 . . . . 0.0 109.873 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -66.57 147.27 81.77 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.846 1.445 . . . . 0.0 110.658 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.4 -8.95 41.46 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 120.105 -1.045 . . . . 0.0 110.498 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -122.99 147.45 46.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.879 -1.365 . . . . 0.0 110.202 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' CYS . . . . . . . . . . . . . 56.9 m -93.22 142.93 26.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.242 -0.911 . . . . 0.0 110.727 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 43.6 tp -120.34 128.17 53.01 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.403 -0.811 . . . . 0.0 109.004 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -123.05 143.07 50.2 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.871 -1.143 . . . . 0.0 111.751 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 2.5 t -128.3 116.25 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.73 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -112.18 124.84 53.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.02 -1.05 . . . . 0.0 109.938 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' B' ' 127' ' ' LYS . . . -144.66 -155.88 6.61 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.676 -1.369 . . . . 0.0 109.676 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -134.85 146.12 48.96 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.252 -1.146 . . . . 0.0 109.087 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 39.8 t -111.65 130.31 65.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 121.119 -0.988 . . . . 0.0 110.693 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.95 153.12 67.31 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.392 -0.818 . . . . 0.0 110.452 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.414 ' HA ' ' N ' ' B' ' 82' ' ' GLY . 43.1 Cg_endo -67.23 -20.18 49.63 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.936 1.493 . . . . 0.0 110.555 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 49.5 p-10 -119.42 25.06 10.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.284 -0.885 . . . . 0.0 110.408 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . 0.447 ' HA ' ' HB3' ' B' ' 125' ' ' ASP . . . -59.94 104.47 0.3 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.905 -1.122 . . . . 0.0 110.311 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -94.97 -15.92 23.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.355 -0.841 . . . . 0.0 111.157 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 8.0 t -159.63 133.39 7.28 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.724 -1.235 . . . . 0.0 111.686 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' PHE . . . . . 0.485 ' CD1' ' HB3' ' B' ' 126' ' ' PHE . 14.4 t80 -137.08 144.65 43.22 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.569 -0.707 . . . . 0.0 109.565 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 43.1 t -126.36 131.14 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.975 -1.078 . . . . 0.0 110.944 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.479 ' HB2' ' CZ ' ' B' ' 30' ' ' PHE . 20.6 tp -135.38 135.74 40.9 Favored 'General case' 0 C--N 1.308 -1.234 0 O-C-N 121.525 -0.735 . . . . 0.0 110.181 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' ASN . . . . . 0.42 ' HB2' ' CD1' ' B' ' 41' ' ' LEU . 28.3 p30 -143.02 155.6 44.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.809 -1.182 . . . . 0.0 110.623 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' B' ' 34' ' ' LEU . 0.6 OUTLIER -153.79 110.21 3.33 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.277 -0.889 . . . . 0.0 110.276 179.967 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . 0.482 ' O ' ' CB ' ' B' ' 119' ' ' TYR . . . -158.36 -172.98 26.18 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . 0.443 ' O ' ' HB2' ' B' ' 119' ' ' TYR . 98.8 mttt -78.89 -44.57 22.49 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.876 -1.367 . . . . 0.0 110.415 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . 0.42 ' HB2' ' HB2' ' B' ' 40' ' ' ASN . 84.8 m-20 -119.76 164.91 15.25 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.685 -178.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 11.8 t -56.97 -45.85 82.6 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.634 -0.666 . . . . 0.0 112.294 -178.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' ASN . . . . . 0.433 ' HB3' ' N ' ' B' ' 66' ' ' GLY . 54.8 m-20 -89.24 -0.87 57.8 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.473 -1.392 . . . . 0.0 110.294 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' ASN . . . . . 0.42 ' HB2' ' HB2' ' B' ' 37' ' ' ASP . 5.0 m-80 -111.63 58.16 0.63 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.184 -0.947 . . . . 0.0 109.678 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.42 ' CD1' ' HB2' ' B' ' 33' ' ' ASN . 72.6 mt -82.31 138.25 34.59 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' CYS . . . . . . . . . . . . . 79.5 m -87.42 -38.22 16.32 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.88 -1.138 . . . . 0.0 109.618 -178.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.417 HD11 HD22 ' B' ' 96' ' ' LEU . 83.8 mt -132.58 139.78 47.96 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.142 -0.974 . . . . 0.0 110.016 179.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' HIS . . . . . . . . . . . . . 63.2 t-80 -140.09 140.09 36.01 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.135 -0.978 . . . . 0.0 110.328 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -128.47 146.03 50.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.192 -0.942 . . . . 0.0 110.2 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -152.26 61.16 3.87 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.379 -0.826 . . . . 0.0 109.984 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -69.23 146.67 64.21 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.067 1.562 . . . . 0.0 110.69 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 91.5 mtm-85 -134.94 125.83 27.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.164 -0.96 . . . . 0.0 110.681 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -61.93 -46.62 88.54 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.129 -0.982 . . . . 0.0 109.036 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -148.58 84.36 1.48 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.5 -117.2 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.2 -0.938 . . . . 0.0 110.241 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -77.83 -13.97 59.72 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.633 -1.292 . . . . 0.0 110.405 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 165.53 -22.2 0.13 Allowed Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.568 -1.301 . . . . 0.0 110.494 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -60.51 -179.0 0.1 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.881 -1.364 . . . . 0.0 110.162 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.533 ' O ' ' C ' ' B' ' 56' ' ' ASN . . . -121.98 137.47 54.79 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.57 -0.706 . . . . 0.0 109.598 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' ASN . . . . . 0.533 ' C ' ' O ' ' B' ' 55' ' ' ALA . 1.9 m-20 11.25 76.2 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.514 0 CA-C-O 121.451 0.643 . . . . 0.0 112.107 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 45.2 m -110.46 130.16 55.62 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.381 -0.825 . . . . 0.0 110.328 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' ILE . . . . . 0.411 ' O ' HG21 ' B' ' 58' ' ' ILE . 19.6 tt -128.79 130.7 68.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.476 -0.765 . . . . 0.0 110.032 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 21.5 m -125.4 129.24 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.154 -0.967 . . . . 0.0 110.349 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 11.2 t -86.03 130.64 34.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.142 -0.974 . . . . 0.0 109.343 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -137.2 144.73 43.01 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.059 -1.025 . . . . 0.0 111.266 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 5.3 m -119.36 153.74 34.69 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . 0.477 ' CD ' ' HA2' ' B' ' 66' ' ' GLY . 16.6 ttmt -136.56 134.82 37.88 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.862 -1.149 . . . . 0.0 110.412 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -113.87 102.45 10.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.222 -0.924 . . . . 0.0 109.609 178.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 64.84 27.71 72.46 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . 0.477 ' HA2' ' CD ' ' B' ' 63' ' ' LYS . . . 93.01 1.85 66.97 Favored Glycine 0 N--CA 1.485 1.937 0 C-N-CA 119.561 -1.304 . . . . 0.0 109.99 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' ALA . . . . . 0.454 ' O ' ' O ' ' B' ' 68' ' ' TRP . . . -109.45 86.21 2.25 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.977 -1.308 . . . . 0.0 109.526 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' TRP . . . . . 0.454 ' O ' ' O ' ' B' ' 67' ' ' ALA . 61.8 m95 -9.0 -116.59 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.828 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -178.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 129.28 -113.37 1.51 Allowed Glycine 0 N--CA 1.488 2.161 0 O-C-N 119.775 -1.828 . . . . 0.0 110.005 -178.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 21.6 m -78.91 121.31 24.7 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.198 -1.177 . . . . 0.0 111.266 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -126.72 131.0 51.45 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.404 -0.81 . . . . 0.0 109.778 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.45 156.51 38.78 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.926 -1.109 . . . . 0.0 110.205 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 -134.64 88.74 2.47 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.247 -0.908 . . . . 0.0 109.727 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' GLU . . . . . 0.401 ' O ' ' CG2' ' B' ' 58' ' ' ILE . 89.3 mt-10 -113.94 126.18 54.86 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.238 -0.914 . . . . 0.0 109.865 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -93.49 85.28 4.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.09 -1.006 . . . . 0.0 110.232 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 2.4 p -127.22 132.25 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.324 -0.86 . . . . 0.0 110.203 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' PHE . . . . . 0.509 ' N ' ' CD1' ' B' ' 77' ' ' PHE . 13.6 p90 -144.98 81.7 10.46 Favored Pre-proline 0 N--CA 1.486 1.352 0 O-C-N 121.248 -0.908 . . . . 0.0 110.288 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . 0.451 ' CB ' ' HB2' ' B' ' 102' ' ' ASP . 52.4 Cg_endo -72.91 -3.12 13.04 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.967 1.509 . . . . 0.0 111.236 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' PHE . . . . . 0.4 ' CE1' ' HG2' ' B' ' 101' ' ' PRO . 3.8 m-85 -134.13 179.6 6.15 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.998 -1.064 . . . . 0.0 111.024 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.46 ' CG ' ' HD2' ' B' ' 81' ' ' PRO . 0.0 OUTLIER -131.2 172.57 7.13 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.574 -0.704 . . . . 0.0 109.521 179.781 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' PRO . . . . . 0.46 ' HD2' ' CG ' ' B' ' 80' ' ' GLN . 51.0 Cg_endo -71.02 150.06 59.88 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.643 1.338 . . . . 0.0 110.105 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . 0.414 ' N ' ' HA ' ' B' ' 25' ' ' PRO . . . 75.95 26.94 63.4 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 45.3 m -131.83 151.94 51.34 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.933 -1.334 . . . . 0.0 111.06 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 13.1 p -90.95 133.54 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.437 -0.789 . . . . 0.0 109.59 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.69 155.86 39.18 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.808 -1.183 . . . . 0.0 110.894 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -122.91 149.56 44.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.375 -0.828 . . . . 0.0 109.61 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 47.0 t -124.15 130.43 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.128 -0.982 . . . . 0.0 110.386 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 88' ' ' CYS . . . . . . . . . . . . . 1.4 t -99.2 122.91 43.02 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.354 -0.841 . . . . 0.0 110.042 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 98.2 mt -122.55 128.65 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.199 -0.938 . . . . 0.0 110.731 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 63.2 m -119.41 128.29 53.9 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 91' ' ' PHE . . . . . 0.438 ' CZ ' ' CD1' ' B' ' 114' ' ' LEU . 73.7 t80 -109.23 115.59 30.3 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 118.62 -1.232 . . . . 0.0 111.343 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' B' ' 95' ' ' ASN . 79.2 m-20 -118.89 142.39 47.79 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -60.04 -30.31 69.11 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.668 -1.27 . . . . 0.0 110.491 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.15 -40.48 82.37 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.045 -1.035 . . . . 0.0 109.279 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . 0.403 ' O ' ' HB2' ' B' ' 92' ' ' ASP . 0.4 OUTLIER -170.32 171.88 6.45 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.502 -178.997 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 96' ' ' LEU . . . . . 0.417 HD22 HD11 ' B' ' 43' ' ' LEU . 38.8 tp -101.83 125.13 48.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.236 -0.915 . . . . 0.0 110.17 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 97' ' ' THR . . . . . 0.443 HG23 ' OE2' ' B' ' 105' ' ' GLU . 10.5 m -107.93 125.25 51.27 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.099 -1.001 . . . . 0.0 109.266 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 38.8 t -131.43 131.43 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.858 -1.151 . . . . 0.0 110.478 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -119.7 143.9 47.5 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.168 -0.957 . . . . 0.0 110.579 179.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . 0.419 ' HB3' ' HD2' ' B' ' 101' ' ' PRO . 0.5 OUTLIER -111.16 169.69 6.04 Favored Pre-proline 0 C--N 1.3 -1.57 0 O-C-N 121.517 -0.739 . . . . 0.0 109.133 179.222 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' PRO . . . . . 0.419 ' HD2' ' HB3' ' B' ' 100' ' ' LEU . 38.8 Cg_endo -64.07 -24.11 66.77 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 123.603 1.318 . . . . 0.0 110.772 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' ASP . . . . . 0.451 ' HB2' ' CB ' ' B' ' 78' ' ' PRO . 20.5 t0 -74.83 -11.95 60.27 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.941 -1.099 . . . . 0.0 111.085 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 98.86 -10.42 62.28 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.635 -1.269 . . . . 0.0 110.645 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 104' ' ' TYR . . . . . 0.443 ' CE2' ' OD2' ' B' ' 102' ' ' ASP . 19.5 m-85 -79.73 141.02 36.74 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.754 -1.439 . . . . 0.0 109.657 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 105' ' ' GLU . . . . . 0.443 ' OE2' HG23 ' B' ' 97' ' ' THR . 85.2 tt0 -121.06 143.48 49.05 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.308 -0.87 . . . . 0.0 110.554 -179.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -130.08 148.07 51.89 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.336 -0.853 . . . . 0.0 109.505 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 107' ' ' LYS . . . . . 0.422 ' C ' ' CD1' ' B' ' 108' ' ' PHE . 98.3 mttt -127.7 145.62 50.84 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.079 -1.013 . . . . 0.0 111.454 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 108' ' ' PHE . . . . . 0.502 ' CD1' ' N ' ' B' ' 108' ' ' PHE . 20.1 m-85 -129.64 140.18 37.88 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -70.28 140.18 40.14 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 O-C-N 123.385 1.203 . . . . 0.0 109.83 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 110' ' ' ASN . . . . . 0.46 ' ND2' ' O ' ' B' ' 110' ' ' ASN . 6.1 p-10 -102.16 83.02 2.28 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 122.246 1.022 . . . . 0.0 110.216 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 96.6 mtt-85 -57.11 -22.7 41.73 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.488 -1.383 . . . . 0.0 108.98 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . 0.438 ' HB2' HD21 ' B' ' 114' ' ' LEU . 89.7 mt -82.26 143.7 31.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.584 -0.698 . . . . 0.0 110.454 179.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -101.44 38.83 1.52 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.105 -0.997 . . . . 0.0 109.541 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 114' ' ' LEU . . . . . 0.438 ' CD1' ' CZ ' ' B' ' 91' ' ' PHE . 0.8 OUTLIER -73.6 128.07 34.49 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.427 -0.795 . . . . 0.0 110.923 -179.193 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -88.26 -16.05 34.22 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.114 -0.991 . . . . 0.0 110.162 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 116' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' B' ' 11' ' ' LEU . . . -158.25 155.19 28.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.005 -1.059 . . . . 0.0 111.072 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 31.8 mm -107.17 130.2 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.215 -0.928 . . . . 0.0 110.228 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 118' ' ' ASN . . . . . 0.509 ' N ' ' ND2' ' B' ' 118' ' ' ASN . 0.5 OUTLIER -108.85 -15.01 14.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.069 -1.019 . . . . 0.0 110.933 -179.244 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 119' ' ' TYR . . . . . 0.482 ' CB ' ' O ' ' B' ' 35' ' ' GLY . 4.0 t80 -120.28 129.7 54.14 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.993 -1.067 . . . . 0.0 111.461 -178.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 51.8 ttp -141.47 128.37 20.6 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.21 149.37 30.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.707 -1.246 . . . . 0.0 111.342 -178.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -151.99 129.17 11.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.578 -0.702 . . . . 0.0 110.116 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . 0.412 ' HA ' ' HA2' ' B' ' 3' ' ' GLY . 68.0 t0 -147.4 114.63 6.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.366 -0.834 . . . . 0.0 109.453 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 124' ' ' GLY . . . . . 0.462 ' HA3' ' HA ' ' B' ' 30' ' ' PHE . . . -176.95 -145.36 5.67 Favored Glycine 0 N--CA 1.484 1.869 0 C-N-CA 119.069 -1.538 . . . . 0.0 110.209 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . 0.447 ' HB3' ' HA ' ' B' ' 27' ' ' ALA . 79.7 m-20 -88.86 12.87 13.99 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.913 -0.757 . . . . 0.0 110.705 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 126' ' ' PHE . . . . . 0.485 ' HB3' ' CD1' ' B' ' 30' ' ' PHE . 14.9 t80 -105.76 137.66 43.27 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.092 -1.005 . . . . 0.0 110.269 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . 0.407 ' O ' ' HA3' ' B' ' 21' ' ' GLY . 98.5 mttt -103.94 109.45 21.2 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.272 -0.892 . . . . 0.0 111.746 -178.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 8.8 tt -99.65 117.41 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.036 -1.04 . . . . 0.0 109.486 177.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -109.32 -14.64 14.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.111 -0.993 . . . . 0.0 111.872 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 130' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.17 143.55 31.14 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.637 -1.289 . . . . 0.0 111.815 -179.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 66.1 t -127.3 133.58 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 132' ' ' ALA . . . . . . . . . . . . . . . -139.48 143.39 37.49 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 119.984 -1.697 . . . . 0.0 111.721 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . 0.406 ' CE1' HD12 ' B' ' 11' ' ' LEU . 0.5 OUTLIER -73.17 -125.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.633 -0.667 . . . . 0.0 109.821 179.758 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 47.1 t0 . . . . . 0 N--CA 1.492 1.628 0 O-C-N 120.515 -1.365 . . . . 0.0 110.161 179.716 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.246 0.546 . . . . 0.0 110.018 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 3.6 t -122.62 -134.21 0.29 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.223 -0.923 . . . . 0.0 109.062 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.418 ' C ' ' ND2' ' B' ' 8' ' ' ASN . . . 89.66 21.51 39.94 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 34.9 tp -58.54 128.51 37.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.915 -1.344 . . . . 0.0 109.866 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 54.5 t -120.43 131.17 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.43 -0.794 . . . . 0.0 109.877 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -124.49 164.18 20.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.926 -1.108 . . . . 0.0 110.98 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.467 ' O ' ' HB3' ' A' ' 8' ' ' ASN . 26.9 p -151.19 172.22 16.16 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.666 -0.646 . . . . 0.0 109.306 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.467 ' HB3' ' O ' ' A' ' 7' ' ' SER . 32.0 t30 61.79 33.01 18.02 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.577 -0.702 . . . . 0.0 109.85 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.525 ' O ' ' C ' ' A' ' 10' ' ' ASN . 94.8 mt -85.09 -9.69 57.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.539 -0.726 . . . . 0.0 111.124 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.525 ' C ' ' O ' ' A' ' 9' ' ' LEU . 0.7 OUTLIER 5.79 67.82 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.686 0 CA-C-O 121.551 0.691 . . . . 0.0 112.829 -179.771 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.512 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 31.8 tp -87.64 139.0 30.98 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.51 167.46 9.03 Favored Pre-proline 0 C--N 1.294 -1.831 0 O-C-N 120.975 -1.078 . . . . 0.0 111.378 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 115' ' ' GLU . 44.3 Cg_endo -67.49 147.31 76.8 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 124.266 1.666 . . . . 0.0 110.77 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.81 -4.04 63.1 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -115.99 146.79 41.83 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.937 -1.331 . . . . 0.0 109.827 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.3 m -99.02 142.63 30.27 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.163 -0.961 . . . . 0.0 110.443 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 51.2 tp -118.27 128.2 54.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.405 -0.809 . . . . 0.0 109.698 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -128.92 133.43 47.87 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.008 -1.057 . . . . 0.0 111.17 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 56.1 t -121.1 127.24 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.319 -0.863 . . . . 0.0 109.577 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 53.2 ttt-85 -109.05 124.89 51.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.206 -0.934 . . . . 0.0 110.019 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -148.88 -163.4 10.88 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -137.94 141.81 40.55 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.409 -1.053 . . . . 0.0 110.269 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.447 ' CG1' ' HB1' ' A' ' 27' ' ' ALA . 23.8 t -97.4 130.97 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.198 -0.939 . . . . 0.0 110.809 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.87 168.22 1.56 Allowed Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.448 -0.783 . . . . 0.0 110.096 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -68.68 -19.8 41.2 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.909 1.478 . . . . 0.0 109.89 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 28' ' ' LYS . 48.2 t0 -112.97 57.19 0.67 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.485 -0.76 . . . . 0.0 109.371 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.483 ' HA ' ' HB3' ' A' ' 125' ' ' ASP . . . -69.73 63.62 0.19 Allowed 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.688 0.756 . . . . 0.0 109.797 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.435 ' N ' ' O ' ' A' ' 26' ' ' ASP . 87.8 tttt -63.12 -43.92 97.08 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.702 -0.624 . . . . 0.0 110.401 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.3 t -164.05 137.63 5.4 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.006 -1.058 . . . . 0.0 111.174 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.445 ' HA ' ' HA3' ' A' ' 124' ' ' GLY . 26.1 t80 -134.04 145.54 49.51 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.547 -0.721 . . . . 0.0 109.981 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.45 HG12 ' ND2' ' A' ' 46' ' ' ASN . 17.3 m -127.13 133.08 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 120.785 -1.197 . . . . 0.0 110.774 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.1 tp -129.42 135.09 48.24 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.463 -0.773 . . . . 0.0 110.139 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -142.19 145.77 34.51 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.763 -1.21 . . . . 0.0 110.78 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.436 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 1.1 pp -149.47 123.87 9.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.366 -0.834 . . . . 0.0 110.679 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.519 ' O ' ' HB3' ' A' ' 119' ' ' TYR . . . -166.11 -160.38 13.3 Favored Glycine 0 N--CA 1.493 2.433 0 N-CA-C 108.959 -1.657 . . . . 0.0 108.959 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.449 ' O ' ' HB2' ' A' ' 119' ' ' TYR . 60.2 mtpt -71.85 -40.8 68.76 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.021 -1.282 . . . . 0.0 109.149 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -153.27 -167.02 2.59 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.768 0.794 . . . . 0.0 111.562 -178.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 41.2 t -62.0 -46.03 91.0 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.662 -0.649 . . . . 0.0 112.573 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.438 ' HB3' ' N ' ' A' ' 66' ' ' GLY . 74.0 m-20 -94.5 0.08 55.04 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.762 -1.211 . . . . 0.0 110.437 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -113.03 62.79 0.64 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.245 -0.909 . . . . 0.0 109.378 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.413 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 92.1 mt -104.14 133.97 48.18 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.315 0.578 . . . . 0.0 109.917 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 63.3 m -83.62 -40.22 19.3 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.151 -0.968 . . . . 0.0 109.271 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.3 mt -131.42 140.89 49.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.213 -0.929 . . . . 0.0 111.337 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.476 ' HB3' ' HB3' ' A' ' 61' ' ' ASN . 82.0 t60 -131.84 103.14 6.16 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -102.36 142.0 34.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -0.931 . . . . 0.0 110.8 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.45 ' ND2' HG12 ' A' ' 31' ' ' VAL . 1.2 t-20 -155.23 85.36 3.49 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.391 -0.818 . . . . 0.0 110.603 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.431 ' HA ' HG12 ' A' ' 58' ' ' ILE . 46.5 Cg_endo -67.48 147.74 77.68 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.891 1.469 . . . . 0.0 110.75 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -132.31 107.99 8.91 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.291 -0.881 . . . . 0.0 111.156 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -62.08 -48.08 81.78 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.248 -0.908 . . . . 0.0 109.486 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 -150.83 97.74 2.52 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.313 -0.867 . . . . 0.0 109.472 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -105.18 -126.61 0.23 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.187 -0.945 . . . . 0.0 110.329 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 40.3 m170 -61.73 -35.38 77.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.72 -1.237 . . . . 0.0 110.843 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 172.61 32.42 0.03 OUTLIER Glycine 0 N--CA 1.493 2.451 0 C-N-CA 119.104 -1.522 . . . . 0.0 111.072 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -117.59 -166.26 1.17 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.852 -1.381 . . . . 0.0 109.469 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 56' ' ' ASN . . . -153.67 144.08 22.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.252 -0.905 . . . . 0.0 110.373 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.475 ' C ' ' O ' ' A' ' 55' ' ' ALA . 87.0 m-20 25.85 56.65 0.05 Allowed 'General case' 0 N--CA 1.504 2.23 0 CA-C-O 120.987 0.422 . . . . 0.0 111.983 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 86.0 m -119.69 133.24 55.71 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.235 -0.915 . . . . 0.0 110.477 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.431 HG12 ' HA ' ' A' ' 47' ' ' PRO . 96.6 mt -119.29 134.06 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.496 -0.753 . . . . 0.0 111.114 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.5 t -112.74 127.94 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.211 -0.931 . . . . 0.0 109.025 178.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 2.2 t -94.57 122.88 37.61 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.185 -0.947 . . . . 0.0 110.313 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.476 ' HB3' ' HB3' ' A' ' 44' ' ' HIS . 6.8 t-20 -121.21 147.52 45.5 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.321 -0.862 . . . . 0.0 109.114 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.3 t -135.65 142.76 45.22 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.022 -1.049 . . . . 0.0 110.141 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.475 ' CD ' ' HA2' ' A' ' 66' ' ' GLY . 27.0 ttmt -142.94 127.39 17.82 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 118.883 -1.127 . . . . 0.0 111.67 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.449 ' HB2' HD22 ' A' ' 112' ' ' LEU . 30.1 t0 -107.04 103.23 12.6 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 64.48 20.74 66.02 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.475 ' HA2' ' CD ' ' A' ' 63' ' ' LYS . . . 68.89 36.58 82.14 Favored Glycine 0 N--CA 1.488 2.123 0 C-N-CA 119.2 -1.476 . . . . 0.0 110.007 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.51 14.16 6.54 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.731 -1.452 . . . . 0.0 112.263 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -139.63 -74.6 0.36 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.452 -1.405 . . . . 0.0 110.421 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.68 32.85 49.03 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.1 m -59.81 121.36 11.53 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.077 -1.249 . . . . 0.0 109.49 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -116.66 133.36 56.11 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.226 -0.921 . . . . 0.0 112.039 -178.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -127.42 -162.53 1.17 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.369 -0.832 . . . . 0.0 108.971 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -141.83 140.72 33.03 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 118.484 -1.286 . . . . 0.0 112.027 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -127.92 124.29 37.02 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.897 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -101.96 46.33 0.93 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.871 -1.143 . . . . 0.0 111.017 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 75.9 t -122.46 127.06 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.063 -1.023 . . . . 0.0 109.716 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.466 ' CD2' ' O ' ' A' ' 77' ' ' PHE . 83.2 t80 -162.23 74.71 2.22 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 120.922 -1.112 . . . . 0.0 110.91 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.494 ' HD2' ' CE2' ' A' ' 79' ' ' PHE . 55.6 Cg_endo -80.2 43.1 1.45 Allowed 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.899 1.473 . . . . 0.0 110.951 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.494 ' CE2' ' HD2' ' A' ' 78' ' ' PRO . 70.6 m-85 -127.6 151.57 48.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.884 -1.135 . . . . 0.0 109.399 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.4 ' HB3' ' HD2' ' A' ' 81' ' ' PRO . 0.1 OUTLIER -127.39 168.71 14.12 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.034 -1.041 . . . . 0.0 110.251 -179.86 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 80' ' ' GLN . 51.4 Cg_endo -69.75 147.58 63.22 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.958 1.504 . . . . 0.0 110.015 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 56.39 41.38 87.75 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.829 -1.309 . . . . 0.0 109.829 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 37.2 t -134.35 142.15 47.12 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.037 -1.273 . . . . 0.0 110.617 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.2 p -89.16 136.8 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.387 -0.821 . . . . 0.0 109.65 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -154.66 151.74 29.13 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.109 -0.994 . . . . 0.0 110.035 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.401 ' O ' ' HD3' ' A' ' 101' ' ' PRO . 90.5 mt-10 -116.32 138.38 51.37 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 91.6 t -116.15 128.38 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.909 -1.119 . . . . 0.0 110.823 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 1.7 t -99.64 129.4 45.78 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.3 -0.875 . . . . 0.0 109.837 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 97.8 mt -122.25 127.66 75.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.356 -0.84 . . . . 0.0 110.067 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.403 ' HB ' ' HB ' ' A' ' 97' ' ' THR . 89.2 m -120.56 127.61 52.31 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.242 -0.911 . . . . 0.0 109.286 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -113.85 112.09 22.8 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.06 -1.025 . . . . 0.0 110.854 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -119.59 149.01 42.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.527 -0.733 . . . . 0.0 109.467 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -63.22 -34.4 77.57 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.94 -1.1 . . . . 0.0 109.94 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.54 -40.69 96.05 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.2 -0.937 . . . . 0.0 109.991 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -171.39 178.14 3.32 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.314 -0.866 . . . . 0.0 110.412 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 95.4 mt -105.0 131.53 52.4 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.397 -0.814 . . . . 0.0 110.078 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.463 ' CG2' ' OE2' ' A' ' 105' ' ' GLU . 44.1 m -121.01 129.62 53.46 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.081 -1.012 . . . . 0.0 109.838 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 56.4 t -125.82 129.04 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 120.86 -1.15 . . . . 0.0 109.255 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -116.62 126.14 52.82 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.066 -1.054 . . . . 0.0 109.934 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 12.3 mt -99.08 162.12 22.49 Favored Pre-proline 0 C--N 1.296 -1.746 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 86' ' ' GLU . 39.6 Cg_endo -64.7 -21.61 64.92 Favored 'Trans proline' 0 C--N 1.3 -2.018 0 O-C-N 123.765 1.403 . . . . 0.0 110.223 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -65.52 -32.78 74.57 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.277 -0.889 . . . . 0.0 109.279 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 117.3 -18.25 12.2 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -73.74 136.12 43.65 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.133 -1.216 . . . . 0.0 110.319 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.463 ' OE2' ' CG2' ' A' ' 97' ' ' THR . 78.9 tt0 -127.57 144.25 51.09 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -129.51 156.37 44.26 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.975 -1.078 . . . . 0.0 110.146 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -107.39 131.49 54.19 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.244 -0.91 . . . . 0.0 110.953 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -121.77 126.4 26.41 Favored Pre-proline 0 C--N 1.301 -1.529 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -65.7 139.89 59.75 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 123.32 1.169 . . . . 0.0 110.397 -179.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.444 ' ND2' ' O ' ' A' ' 110' ' ' ASN . 4.5 p-10 -97.67 82.58 3.08 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 122.513 1.149 . . . . 0.0 109.791 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -58.05 -24.23 57.6 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 120.368 -1.458 . . . . 0.0 109.371 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.449 HD22 ' HB2' ' A' ' 64' ' ' ASP . 86.7 mt -86.79 144.12 27.19 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.288 -0.882 . . . . 0.0 111.078 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -94.09 30.57 1.86 Allowed 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.718 0.77 . . . . 0.0 109.568 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 46.9 tp -61.99 136.17 57.85 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.58 0.705 . . . . 0.0 111.135 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.415 ' O ' ' HD3' ' A' ' 13' ' ' PRO . 10.0 pt-20 -98.29 -13.98 20.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.451 -0.781 . . . . 0.0 110.932 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.512 ' HA ' ' O ' ' A' ' 11' ' ' LEU . . . -163.45 157.29 19.63 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.44 -1.413 . . . . 0.0 111.972 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 84.9 mt -104.8 124.8 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.355 -0.841 . . . . 0.0 109.994 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -117.67 -20.95 8.72 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.082 -1.011 . . . . 0.0 110.989 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.519 ' HB3' ' O ' ' A' ' 35' ' ' GLY . 38.9 t80 -110.73 125.67 53.75 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.419 -0.801 . . . . 0.0 110.547 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.436 ' HB3' ' CD1' ' A' ' 9' ' ' LEU . 48.3 ttp -146.93 133.04 19.29 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.237 -0.914 . . . . 0.0 109.818 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.83 154.23 33.56 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.997 -1.064 . . . . 0.0 110.496 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -146.12 120.08 9.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.306 -0.871 . . . . 0.0 109.889 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.443 ' O ' ' CG2' ' A' ' 31' ' ' VAL . 55.6 t0 -135.29 106.32 6.66 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.347 -0.846 . . . . 0.0 109.594 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.445 ' HA3' ' HA ' ' A' ' 30' ' ' PHE . . . -171.54 -144.61 4.51 Favored Glycine 0 N--CA 1.484 1.844 0 C-N-CA 119.237 -1.458 . . . . 0.0 110.02 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.483 ' HB3' ' HA ' ' A' ' 27' ' ' ALA . 94.2 m-20 -90.07 14.1 13.24 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.644 -0.915 . . . . 0.0 110.873 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.408 ' HB3' ' CE1' ' A' ' 30' ' ' PHE . 28.1 t80 -107.89 135.28 49.55 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.899 -1.126 . . . . 0.0 109.748 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -105.15 121.3 43.54 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 118.874 -1.13 . . . . 0.0 110.421 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.402 ' O ' ' CG2' ' A' ' 128' ' ' ILE . 10.7 tt -93.79 115.92 33.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.511 -0.743 . . . . 0.0 110.592 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.409 ' O ' ' HB2' ' B' ' 133' ' ' PHE . 98.7 mttt -101.54 -18.35 15.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.091 -1.006 . . . . 0.0 110.517 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -157.79 143.99 17.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.82 -1.175 . . . . 0.0 111.484 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 42.5 t -116.58 132.22 66.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.412 ' HA ' ' HB2' ' B' ' 130' ' ' CYS . . . -121.95 144.61 48.76 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.738 -1.226 . . . . 0.0 111.906 -177.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -83.37 -136.64 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 61.0 t0 . . . . . 0 N--CA 1.49 1.571 0 O-C-N 120.69 -1.256 . . . . 0.0 110.201 179.831 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 121.272 0.558 . . . . 0.0 110.088 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' CYS . . . . . . . . . . . . . 3.3 t -122.5 -135.65 0.3 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.248 -0.907 . . . . 0.0 108.72 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . 0.406 ' C ' ' ND2' ' A' ' 8' ' ' ASN . . . 90.41 23.26 32.02 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . 0.426 ' HA ' ' HB3' ' A' ' 8' ' ' ASN . 36.0 tp -60.0 128.21 35.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.03 -1.276 . . . . 0.0 109.882 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 53.7 t -120.34 130.44 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 119.731 -0.788 . . . . 0.0 109.759 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -123.6 164.6 18.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.155 -0.966 . . . . 0.0 110.902 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' SER . . . . . 0.45 ' O ' ' HB3' ' B' ' 8' ' ' ASN . 26.2 p -151.72 172.52 15.99 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . 0.45 ' HB3' ' O ' ' B' ' 7' ' ' SER . 31.8 t30 61.59 32.84 18.53 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.571 -0.706 . . . . 0.0 109.819 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . 0.529 ' O ' ' C ' ' B' ' 10' ' ' ASN . 96.3 mt -85.79 -5.97 59.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.529 -0.732 . . . . 0.0 111.198 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . 0.529 ' C ' ' O ' ' B' ' 9' ' ' LEU . 0.6 OUTLIER -0.16 70.53 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.714 0 CA-C-O 121.86 0.838 . . . . 0.0 112.817 -178.62 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' B' ' 116' ' ' ALA . 32.4 tp -88.34 138.61 31.28 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.24 167.53 8.95 Favored Pre-proline 0 C--N 1.292 -1.895 0 O-C-N 120.917 -1.114 . . . . 0.0 111.321 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' B' ' 115' ' ' GLU . 45.6 Cg_endo -67.96 147.05 73.42 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 124.195 1.629 . . . . 0.0 110.584 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.23 -3.96 62.15 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -116.46 147.32 41.83 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.965 -1.314 . . . . 0.0 109.862 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' CYS . . . . . . . . . . . . . 2.3 m -99.27 142.92 30.13 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.168 -0.958 . . . . 0.0 110.497 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 52.7 tp -118.5 128.1 54.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.474 -0.766 . . . . 0.0 109.618 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -128.96 133.59 47.87 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.994 -1.066 . . . . 0.0 111.155 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 55.7 t -121.38 126.55 75.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.341 -0.849 . . . . 0.0 109.604 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 52.9 ttt-85 -108.45 125.06 51.34 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.203 -0.935 . . . . 0.0 110.061 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -148.74 -162.3 10.17 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -139.0 142.74 38.3 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.585 -0.95 . . . . 0.0 110.23 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.444 ' CG1' ' HB1' ' B' ' 27' ' ' ALA . 23.2 t -98.47 130.83 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.308 -0.87 . . . . 0.0 110.721 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.76 167.89 1.67 Allowed Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.41 -0.806 . . . . 0.0 110.16 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -68.58 -19.55 42.11 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.882 1.464 . . . . 0.0 109.924 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' B' ' 28' ' ' LYS . 47.4 t0 -113.09 56.93 0.67 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.535 -0.728 . . . . 0.0 109.444 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . 0.494 ' HA ' ' HB3' ' B' ' 125' ' ' ASP . . . -69.51 63.72 0.17 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.488 -0.757 . . . . 0.0 109.791 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' B' ' 26' ' ' ASP . 88.3 tttt -63.24 -45.14 92.97 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.713 -0.617 . . . . 0.0 110.201 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 13.6 t -161.97 139.01 8.33 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.087 -1.008 . . . . 0.0 111.438 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' PHE . . . . . 0.448 ' HA ' ' HA3' ' B' ' 124' ' ' GLY . 25.9 t80 -135.08 144.96 47.49 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.356 -0.84 . . . . 0.0 109.925 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.447 ' CG2' ' O ' ' B' ' 123' ' ' ASP . 18.4 m -126.63 133.2 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 120.905 -1.122 . . . . 0.0 110.761 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 19.9 tp -129.33 135.85 49.27 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 121.55 -0.719 . . . . 0.0 110.069 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -142.81 145.55 33.32 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.755 -1.216 . . . . 0.0 110.797 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' B' ' 34' ' ' LEU . 1.1 pp -149.89 119.93 7.2 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.3 -0.875 . . . . 0.0 111.008 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . 0.506 ' O ' ' HB3' ' B' ' 119' ' ' TYR . . . -160.81 -158.81 9.51 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.151 -1.579 . . . . 0.0 109.151 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . 0.433 ' O ' ' HB2' ' B' ' 119' ' ' TYR . 60.1 mtpt -72.93 -40.36 65.5 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.083 -1.245 . . . . 0.0 108.868 177.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -153.17 -167.28 2.67 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.68 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 40.2 t -61.98 -46.1 90.71 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.602 -0.686 . . . . 0.0 112.531 -178.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' ASN . . . . . 0.41 ' HB3' ' N ' ' B' ' 66' ' ' GLY . 70.7 m-20 -94.65 0.42 55.08 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.644 -1.285 . . . . 0.0 110.5 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -113.15 62.45 0.64 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.256 -0.902 . . . . 0.0 109.536 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.428 ' HA ' ' HA3' ' B' ' 35' ' ' GLY . 92.1 mt -103.46 136.94 42.26 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 121.249 0.547 . . . . 0.0 109.554 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' CYS . . . . . . . . . . . . . 65.7 m -87.78 -38.64 15.58 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.218 -0.926 . . . . 0.0 108.764 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 94.6 mt -132.06 140.98 49.06 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.158 -0.964 . . . . 0.0 111.096 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' HIS . . . . . 0.463 ' HB3' ' HB3' ' B' ' 61' ' ' ASN . 81.8 t60 -132.03 102.95 6.03 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -102.09 141.83 34.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.234 -0.916 . . . . 0.0 110.727 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . 0.447 ' ND2' HG12 ' B' ' 31' ' ' VAL . 1.2 t-20 -154.85 84.97 3.67 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.366 -0.834 . . . . 0.0 110.658 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' PRO . . . . . 0.443 ' HA ' HG12 ' B' ' 58' ' ' ILE . 46.3 Cg_endo -67.23 148.32 80.24 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.847 1.446 . . . . 0.0 110.692 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -132.93 107.86 8.56 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.307 -0.87 . . . . 0.0 111.036 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -61.97 -47.89 82.8 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.414 -0.804 . . . . 0.0 109.496 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -151.05 97.98 2.52 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.499 -0.751 . . . . 0.0 109.653 178.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -105.54 -126.55 0.24 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.074 -1.016 . . . . 0.0 110.333 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' HIS . . . . . . . . . . . . . 41.2 m170 -61.23 -34.35 74.98 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.696 -1.253 . . . . 0.0 110.946 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 170.48 33.12 0.02 OUTLIER Glycine 0 N--CA 1.492 2.397 0 C-N-CA 119.167 -1.492 . . . . 0.0 111.062 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -117.5 -166.02 1.15 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.982 -1.305 . . . . 0.0 109.301 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.503 ' O ' ' C ' ' B' ' 56' ' ' ASN . . . -152.15 149.14 28.44 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.218 -0.926 . . . . 0.0 109.674 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' ASN . . . . . 0.503 ' C ' ' O ' ' B' ' 55' ' ' ALA . 85.6 m-20 16.85 60.24 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.345 0 CA-C-O 121.473 0.654 . . . . 0.0 112.562 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' B' ' 55' ' ' ALA . 77.8 m -120.08 132.84 55.58 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.411 -0.806 . . . . 0.0 110.49 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' ILE . . . . . 0.443 HG12 ' HA ' ' B' ' 47' ' ' PRO . 97.0 mt -119.36 133.75 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.498 -0.751 . . . . 0.0 111.386 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 54.9 t -111.9 128.13 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.317 -0.864 . . . . 0.0 109.28 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 1.9 t -94.96 122.46 37.63 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.982 -1.074 . . . . 0.0 110.313 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' ASN . . . . . 0.463 ' HB3' ' HB3' ' B' ' 44' ' ' HIS . 6.8 t-20 -120.52 148.19 44.17 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.42 -0.8 . . . . 0.0 109.211 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 34.8 t -136.4 142.83 43.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.957 -1.09 . . . . 0.0 110.237 -178.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . 0.47 ' CD ' ' HA2' ' B' ' 66' ' ' GLY . 27.0 ttmt -143.17 127.15 17.34 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 118.931 -1.108 . . . . 0.0 111.93 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' ASP . . . . . 0.433 ' HB2' HD22 ' B' ' 112' ' ' LEU . 26.8 t0 -106.55 104.13 13.74 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 63.76 20.13 63.79 Favored Glycine 0 N--CA 1.483 1.82 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . 0.47 ' HA2' ' CD ' ' B' ' 63' ' ' LYS . . . 69.57 36.27 76.23 Favored Glycine 0 N--CA 1.487 2.062 0 O-C-N 120.624 -1.515 . . . . 0.0 110.084 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -127.85 12.45 6.76 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.732 -1.452 . . . . 0.0 112.378 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -138.08 -74.71 0.4 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.615 -1.303 . . . . 0.0 110.505 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.81 32.46 49.89 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -59.58 121.58 11.93 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.134 -1.216 . . . . 0.0 109.486 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -117.12 133.46 55.98 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.156 -0.965 . . . . 0.0 112.062 -178.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -127.31 -162.96 1.21 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.399 -0.813 . . . . 0.0 109.157 178.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -141.44 139.79 33.46 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.676 -1.265 . . . . 0.0 112.066 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -126.75 124.56 40.02 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.969 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -102.29 46.55 0.92 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.834 -1.166 . . . . 0.0 110.945 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 76.5 t -122.8 127.44 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.097 -1.002 . . . . 0.0 109.739 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' PHE . . . . . 0.469 ' CD2' ' O ' ' B' ' 77' ' ' PHE . 83.4 t80 -162.47 74.13 2.16 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 120.962 -1.086 . . . . 0.0 110.878 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . 0.493 ' HD2' ' CE2' ' B' ' 79' ' ' PHE . 55.7 Cg_endo -79.71 43.63 1.54 Allowed 'Trans proline' 0 C--N 1.302 -1.877 0 O-C-N 123.914 1.481 . . . . 0.0 111.08 179.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' PHE . . . . . 0.493 ' CE2' ' HD2' ' B' ' 78' ' ' PRO . 68.4 m-85 -128.22 151.25 49.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.85 -1.156 . . . . 0.0 109.463 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.24 168.23 15.47 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.095 -1.003 . . . . 0.0 110.329 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -69.43 147.29 64.63 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.994 1.523 . . . . 0.0 109.959 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 56.76 41.56 90.68 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 37.4 t -134.39 143.01 47.37 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.05 -1.265 . . . . 0.0 110.637 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 7.1 p -90.14 136.62 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.38 -0.825 . . . . 0.0 109.614 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -154.34 150.91 28.45 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.121 -0.987 . . . . 0.0 110.043 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -115.84 137.59 51.95 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 78.2 t -115.5 128.34 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.925 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 88' ' ' CYS . . . . . . . . . . . . . 1.9 t -99.69 129.48 45.83 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.292 -0.88 . . . . 0.0 109.876 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 98.0 mt -122.38 127.21 75.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.319 -0.863 . . . . 0.0 110.111 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 90' ' ' THR . . . . . 0.404 ' HB ' ' HB ' ' B' ' 97' ' ' THR . 92.7 m -120.3 127.25 52.2 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.135 -0.978 . . . . 0.0 109.137 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 91' ' ' PHE . . . . . 0.4 ' O ' ' HA ' ' B' ' 13' ' ' PRO . 66.0 t80 -113.46 112.67 24.0 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.243 -0.983 . . . . 0.0 110.833 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -120.14 148.62 43.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.472 -0.768 . . . . 0.0 109.64 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -63.17 -33.8 76.26 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.021 -1.049 . . . . 0.0 109.91 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.8 -40.85 95.91 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.257 -0.902 . . . . 0.0 109.999 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -171.75 178.22 3.14 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.302 -0.874 . . . . 0.0 110.484 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 96' ' ' LEU . . . . . . . . . . . . . 94.7 mt -105.09 131.62 52.36 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.349 -0.845 . . . . 0.0 110.134 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 97' ' ' THR . . . . . 0.456 ' CG2' ' OE2' ' B' ' 105' ' ' GLU . 44.6 m -121.05 129.49 53.37 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.171 -0.956 . . . . 0.0 109.779 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 59.9 t -125.63 128.83 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.94 -1.1 . . . . 0.0 109.241 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -116.35 126.51 53.6 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.069 -1.052 . . . . 0.0 109.765 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 12.2 mt -99.67 162.0 22.62 Favored Pre-proline 0 C--N 1.296 -1.736 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -64.57 -21.58 65.59 Favored 'Trans proline' 0 C--N 1.299 -2.046 0 O-C-N 123.757 1.399 . . . . 0.0 110.275 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -65.76 -32.85 74.63 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.287 -0.883 . . . . 0.0 109.268 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 117.92 -18.54 11.48 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 104' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -73.62 136.25 43.89 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.178 -1.189 . . . . 0.0 110.37 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 105' ' ' GLU . . . . . 0.456 ' OE2' ' CG2' ' B' ' 97' ' ' THR . 79.0 tt0 -127.51 143.62 51.16 Favored 'General case' 0 C--N 1.298 -1.63 0 O-C-N 121.443 -0.786 . . . . 0.0 109.001 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -128.99 155.83 44.75 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.887 -1.133 . . . . 0.0 110.221 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -106.96 132.37 52.97 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.21 -0.931 . . . . 0.0 111.003 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 108' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -122.8 126.61 26.02 Favored Pre-proline 0 C--N 1.301 -1.51 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -65.68 139.74 59.19 Favored 'Trans proline' 0 C--N 1.303 -1.844 0 O-C-N 123.286 1.15 . . . . 0.0 110.391 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 110' ' ' ASN . . . . . 0.443 ' ND2' ' O ' ' B' ' 110' ' ' ASN . 4.7 p-10 -97.52 82.64 3.12 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 122.488 1.137 . . . . 0.0 109.653 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -58.05 -24.23 57.61 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 120.263 -1.523 . . . . 0.0 109.433 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . 0.433 HD22 ' HB2' ' B' ' 64' ' ' ASP . 87.2 mt -86.84 143.44 27.46 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.355 -0.841 . . . . 0.0 111.218 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -93.39 30.53 1.69 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.612 -0.68 . . . . 0.0 109.579 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 46.7 tp -62.21 135.62 57.57 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.706 0.765 . . . . 0.0 111.443 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 115' ' ' GLU . . . . . 0.427 ' O ' ' HD3' ' B' ' 13' ' ' PRO . 9.8 pt-20 -97.19 -15.52 20.84 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.485 -0.759 . . . . 0.0 110.974 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 116' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' B' ' 11' ' ' LEU . . . -162.36 157.12 22.21 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.47 -1.394 . . . . 0.0 112.129 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 85.0 mt -104.31 124.68 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.373 -0.829 . . . . 0.0 110.006 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -117.68 -20.74 8.81 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.14 -0.975 . . . . 0.0 110.982 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 119' ' ' TYR . . . . . 0.506 ' HB3' ' O ' ' B' ' 35' ' ' GLY . 38.9 t80 -110.87 125.35 53.53 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.264 -0.897 . . . . 0.0 110.638 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 120' ' ' MET . . . . . 0.447 ' HB3' ' CD1' ' B' ' 9' ' ' LEU . 48.5 ttp -146.75 133.21 19.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.226 -0.921 . . . . 0.0 109.878 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -154.01 154.29 33.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.061 -1.024 . . . . 0.0 110.659 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -146.03 120.58 9.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.279 -0.888 . . . . 0.0 109.879 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 123' ' ' ASP . . . . . 0.447 ' O ' ' CG2' ' B' ' 31' ' ' VAL . 55.0 t0 -135.42 106.57 6.72 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.381 -0.824 . . . . 0.0 109.559 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 124' ' ' GLY . . . . . 0.448 ' HA3' ' HA ' ' B' ' 30' ' ' PHE . . . -171.52 -144.26 4.37 Favored Glycine 0 N--CA 1.486 1.981 0 C-N-CA 119.26 -1.448 . . . . 0.0 110.227 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . 0.494 ' HB3' ' HA ' ' B' ' 27' ' ' ALA . 93.8 m-20 -90.56 14.43 13.2 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.697 -0.884 . . . . 0.0 110.859 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 126' ' ' PHE . . . . . 0.415 ' HB3' ' CE1' ' B' ' 30' ' ' PHE . 27.3 t80 -108.17 135.57 49.29 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.015 -1.053 . . . . 0.0 109.661 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -105.56 120.86 42.69 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.006 -1.077 . . . . 0.0 110.367 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . 0.405 ' O ' ' CG2' ' B' ' 128' ' ' ILE . 10.3 tt -93.58 116.38 34.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.639 -0.663 . . . . 0.0 110.524 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -102.06 -19.41 15.18 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.104 -0.997 . . . . 0.0 110.497 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 130' ' ' CYS . . . . . 0.412 ' HB2' ' HA ' ' A' ' 132' ' ' ALA . 0.0 OUTLIER -155.93 144.18 19.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.883 -1.136 . . . . 0.0 111.591 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 40.2 t -116.88 131.87 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 132' ' ' ALA . . . . . . . . . . . . . . . -121.65 144.32 48.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.572 -1.33 . . . . 0.0 111.746 -177.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . 0.409 ' HB2' ' O ' ' A' ' 129' ' ' LYS . 3.0 t80 -83.17 -135.58 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.758 -0.589 . . . . 0.0 109.433 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 61.5 t0 . . . . . 0 N--CA 1.492 1.628 0 O-C-N 120.697 -1.252 . . . . 0.0 110.147 179.504 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.43 ' HA3' ' O ' ' A' ' 122' ' ' ALA . . . . . . . . 0 N--CA 1.49 2.258 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.556 HD23 ' C ' ' A' ' 4' ' ' LEU . 0.3 OUTLIER -67.62 154.67 40.94 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.537 -0.979 . . . . 0.0 111.218 -179.467 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.456 ' N ' ' HG ' ' A' ' 4' ' ' LEU . 76.5 t -118.16 136.92 53.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.397 -0.814 . . . . 0.0 109.666 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.492 ' HB3' HD11 ' A' ' 9' ' ' LEU . . . -119.59 164.4 15.91 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.699 -1.25 . . . . 0.0 111.305 -178.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.4 ' O ' ' HB3' ' A' ' 8' ' ' ASN . 15.0 p -153.08 166.35 32.74 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.477 -0.764 . . . . 0.0 109.898 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.426 ' ND2' ' O ' ' B' ' 3' ' ' GLY . 55.4 t30 60.81 38.54 17.93 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.273 -0.892 . . . . 0.0 109.759 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.536 ' O ' ' C ' ' A' ' 10' ' ' ASN . 61.5 mt -89.74 -3.35 58.23 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.705 -0.622 . . . . 0.0 111.849 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.536 ' C ' ' O ' ' A' ' 9' ' ' LEU . 8.2 m120 6.09 78.1 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.634 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 3.6 tt -100.24 129.78 46.28 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.303 -0.873 . . . . 0.0 110.035 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.3 mtpp -97.95 164.86 16.51 Favored Pre-proline 0 C--N 1.297 -1.694 0 O-C-N 121.445 -0.784 . . . . 0.0 110.37 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -66.93 147.28 80.14 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 123.991 1.521 . . . . 0.0 110.265 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.66 7.84 62.76 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -115.42 146.83 41.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.833 -1.393 . . . . 0.0 110.287 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 48.8 t -106.54 137.93 43.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.341 -0.85 . . . . 0.0 110.438 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.547 HD12 ' O ' ' A' ' 132' ' ' ALA . 45.5 tp -117.84 130.06 56.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.316 -0.865 . . . . 0.0 109.79 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.418 ' CZ ' ' OE1' ' A' ' 86' ' ' GLU . 77.5 ttt180 -118.95 128.74 54.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.941 -1.099 . . . . 0.0 110.633 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 25.1 t -121.13 125.29 73.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.256 -0.902 . . . . 0.0 110.725 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.453 ' HA ' ' HG2' ' A' ' 86' ' ' GLU . 75.8 ttt180 -109.86 129.01 55.69 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.141 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -149.19 -170.0 16.34 Favored Glycine 0 N--CA 1.486 1.974 0 C-N-CA 119.146 -1.502 . . . . 0.0 110.131 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -129.59 123.28 30.94 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.786 -0.832 . . . . 0.0 109.709 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.544 HG22 ' HD1' ' A' ' 126' ' ' PHE . 99.1 t -79.19 129.5 37.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.144 -0.973 . . . . 0.0 109.713 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.461 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -54.76 163.16 1.5 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.009 -1.057 . . . . 0.0 110.049 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.461 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 42.7 Cg_endo -67.84 -18.26 47.09 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.977 1.514 . . . . 0.0 110.327 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' A' ' 28' ' ' LYS . 63.9 t0 -113.61 56.76 0.69 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.244 -0.91 . . . . 0.0 109.284 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.8 84.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.602 -0.686 . . . . 0.0 110.227 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.514 ' HA ' ' HB3' ' A' ' 49' ' ' PHE . 85.1 tttt -109.64 -33.94 6.63 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.024 -1.047 . . . . 0.0 111.835 -179.163 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.2 t -146.22 140.45 26.58 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.626 -1.296 . . . . 0.0 111.671 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.509 ' CE2' ' HB2' ' A' ' 126' ' ' PHE . 83.3 m-85 -139.56 146.47 39.91 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.393 -0.817 . . . . 0.0 110.188 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.421 ' HB ' ' O ' ' A' ' 123' ' ' ASP . 63.7 t -133.44 130.0 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.96 -1.088 . . . . 0.0 109.798 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.709 HD12 ' HB2' ' A' ' 45' ' ' PHE . 94.7 mt -131.75 144.58 51.06 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.027 -1.046 . . . . 0.0 110.374 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -146.13 108.75 4.5 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.232 -0.917 . . . . 0.0 110.122 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.593 HD11 ' HB2' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -124.25 111.27 15.65 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.154 -0.966 . . . . 0.0 110.107 179.511 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -159.81 -122.84 0.67 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.502 ' HD2' HD13 ' A' ' 114' ' ' LEU . 0.1 OUTLIER -130.4 -46.12 1.09 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.396 -1.061 . . . . 0.0 108.864 179.518 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.429 ' HB2' ' HB2' ' A' ' 40' ' ' ASN . 87.6 m-20 -122.18 164.0 18.57 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.8 t -56.46 -42.33 78.03 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.293 -0.879 . . . . 0.0 111.631 -178.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.478 ' HB3' ' N ' ' A' ' 66' ' ' GLY . 92.4 m-20 -92.06 -0.11 57.46 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.89 -1.131 . . . . 0.0 111.002 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.429 ' HB2' ' HB2' ' A' ' 37' ' ' ASP . 7.5 m120 -117.37 61.7 0.75 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.95 -1.094 . . . . 0.0 109.854 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.7 mt -90.3 137.84 32.02 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.742 -0.599 . . . . 0.0 109.795 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.405 ' SG ' ' N ' ' A' ' 43' ' ' LEU . 6.8 p -88.62 -30.0 19.54 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.248 -0.907 . . . . 0.0 109.751 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.71 HD11 HD13 ' A' ' 96' ' ' LEU . 69.6 mt -137.09 138.14 40.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.904 . . . . 0.0 110.963 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -135.84 126.48 27.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.404 -0.81 . . . . 0.0 110.125 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.709 ' HB2' HD12 ' A' ' 32' ' ' LEU . 91.9 m-85 -113.01 141.96 46.26 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.996 -1.065 . . . . 0.0 110.024 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -154.72 69.94 5.86 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 120.996 -1.065 . . . . 0.0 110.986 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.42 147.46 65.13 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.68 1.358 . . . . 0.0 110.081 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.414 ' NH2' ' HB1' ' A' ' 51' ' ' ALA . 82.9 mtp180 -137.82 111.34 8.08 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.007 -1.058 . . . . 0.0 110.66 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.514 ' HB3' ' HA ' ' A' ' 28' ' ' LYS . 85.6 t80 -62.06 -46.31 89.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.312 -0.868 . . . . 0.0 110.03 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -164.64 99.45 0.79 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -0.909 . . . . 0.0 110.078 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.414 ' HB1' ' NH2' ' A' ' 48' ' ' ARG . . . -109.97 -89.81 0.48 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.254 -0.904 . . . . 0.0 109.911 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -63.1 -42.37 99.56 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.927 -1.108 . . . . 0.0 109.075 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 161.81 38.46 0.02 OUTLIER Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -117.54 -171.63 2.08 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.28 -1.13 . . . . 0.0 110.015 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.474 ' O ' ' C ' ' A' ' 56' ' ' ASN . . . -145.22 152.62 40.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.337 -0.852 . . . . 0.0 110.454 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.516 ' HB3' ' CD1' ' A' ' 77' ' ' PHE . 36.2 m120 23.09 56.79 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 45.9 m -112.91 132.62 55.25 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.338 -0.851 . . . . 0.0 109.042 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.432 HD11 ' O ' ' A' ' 76' ' ' VAL . 75.1 mt -117.03 135.55 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.147 -0.971 . . . . 0.0 111.774 -177.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.412 ' CG1' ' OE2' ' A' ' 71' ' ' GLU . 47.4 t -110.9 130.36 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.369 -0.832 . . . . 0.0 109.539 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 75.1 m -130.94 126.17 35.38 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.036 -1.04 . . . . 0.0 110.695 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -151.35 173.29 14.68 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.245 -0.909 . . . . 0.0 110.727 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.454 ' O ' ' CA ' ' A' ' 69' ' ' GLY . 69.0 m -131.77 155.2 48.14 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.506 -0.746 . . . . 0.0 109.858 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.487 ' CD ' ' HA2' ' A' ' 66' ' ' GLY . 8.9 ttmt -135.2 150.45 50.11 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.679 -1.263 . . . . 0.0 111.367 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -124.49 105.51 9.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.426 -0.797 . . . . 0.0 109.937 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 57.58 27.01 58.08 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.487 ' HA2' ' CD ' ' A' ' 63' ' ' LYS . . . 75.46 23.19 74.01 Favored Glycine 0 N--CA 1.488 2.129 0 O-C-N 120.777 -1.425 . . . . 0.0 109.771 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.47 ' HB1' ' CD1' ' A' ' 68' ' ' TRP . . . -81.2 -85.32 0.1 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.189 -1.183 . . . . 0.0 110.835 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.47 ' CD1' ' HB1' ' A' ' 67' ' ' ALA . 10.3 m95 -135.35 -146.89 0.25 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.884 -1.135 . . . . 0.0 109.849 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.454 ' CA ' ' O ' ' A' ' 62' ' ' SER . . . 167.38 129.45 1.07 Allowed Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.641 -1.266 . . . . 0.0 110.544 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.3 m -81.51 80.2 7.93 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.45 -1.029 . . . . 0.0 109.824 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.412 ' OE2' ' CG1' ' A' ' 59' ' ' VAL . 83.5 tt0 -72.37 124.75 25.79 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.201 -0.937 . . . . 0.0 111.134 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -109.53 -162.0 0.79 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.381 -0.824 . . . . 0.0 109.624 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 62.5 ttp85 -145.91 117.38 8.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.185 -0.947 . . . . 0.0 110.697 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -110.4 125.73 53.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.207 -0.933 . . . . 0.0 109.711 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -105.83 45.7 0.96 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.168 -0.957 . . . . 0.0 111.85 -178.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.622 HG12 ' HD3' ' A' ' 78' ' ' PRO . 51.7 t -121.41 133.01 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 120.965 -1.085 . . . . 0.0 109.843 179.006 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.532 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 11.3 p90 -143.02 82.03 12.32 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.102 -0.999 . . . . 0.0 111.248 -178.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.622 ' HD3' HG12 ' A' ' 76' ' ' VAL . 56.5 Cg_endo -79.99 41.29 1.09 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.495 1.26 . . . . 0.0 111.378 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -149.83 163.24 38.56 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.701 -1.249 . . . . 0.0 110.971 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 13.6 mp0 -129.94 164.58 39.5 Favored Pre-proline 0 N--CA 1.492 1.668 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.79 148.86 65.82 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 123.593 1.312 . . . . 0.0 110.859 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 63.42 41.75 99.26 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 25.1 t -137.36 137.32 38.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.198 -1.178 . . . . 0.0 111.276 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 84' ' ' VAL . 27.6 m -79.18 135.51 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.472 -0.767 . . . . 0.0 109.53 179.013 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.66 154.58 37.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.974 -1.079 . . . . 0.0 110.6 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.453 ' HG2' ' HA ' ' A' ' 20' ' ' ARG . 97.4 mt-10 -121.05 140.11 52.39 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.473 -0.767 . . . . 0.0 109.65 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.9 t -122.64 130.28 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.101 -0.999 . . . . 0.0 110.36 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 22.2 m -92.73 125.0 37.15 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.439 -0.788 . . . . 0.0 109.821 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 95.8 mt -122.05 125.0 72.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.045 -1.035 . . . . 0.0 110.246 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 53.9 m -121.76 124.55 44.47 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.392 -0.817 . . . . 0.0 108.913 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.414 ' CD1' ' CD2' ' A' ' 96' ' ' LEU . 65.7 t80 -110.51 112.84 25.02 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.142 -0.974 . . . . 0.0 110.333 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -121.04 150.32 41.36 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.612 -0.68 . . . . 0.0 109.226 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -64.35 -33.65 76.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.773 -1.204 . . . . 0.0 110.064 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.74 -46.02 90.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.969 -1.082 . . . . 0.0 109.558 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -168.63 175.59 6.07 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.425 -0.797 . . . . 0.0 109.764 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.734 HD12 ' HD2' ' A' ' 108' ' ' PHE . 79.1 mt -107.71 128.6 54.72 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.158 -0.964 . . . . 0.0 110.414 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.5 m -109.93 126.67 54.14 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.162 -0.961 . . . . 0.0 110.176 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 59.2 t -133.16 128.42 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 120.775 -1.203 . . . . 0.0 110.496 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -123.24 147.7 46.65 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.996 -1.065 . . . . 0.0 111.01 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.492 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 1.1 mp -100.84 167.73 10.35 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.587 -0.696 . . . . 0.0 109.636 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.492 ' HD2' ' HB3' ' A' ' 100' ' ' LEU . 41.7 Cg_endo -65.97 -22.63 55.21 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 123.408 1.215 . . . . 0.0 110.42 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.419 ' O ' ' HB3' ' A' ' 78' ' ' PRO . 47.7 t0 -152.09 78.23 1.23 Allowed 'General case' 0 N--CA 1.486 1.325 0 O-C-N 121.129 -0.982 . . . . 0.0 109.8 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -177.91 -171.91 41.81 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -87.59 -150.8 0.17 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.379 -1.071 . . . . 0.0 110.009 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 64.3 tt0 -128.92 146.23 51.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.238 -0.914 . . . . 0.0 110.661 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -130.38 134.27 47.02 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.279 -0.888 . . . . 0.0 109.968 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -114.83 144.7 43.11 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.204 -0.935 . . . . 0.0 110.859 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.734 ' HD2' HD12 ' A' ' 96' ' ' LEU . 56.7 t80 -129.17 133.65 25.41 Favored Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.457 ' O ' ' CE2' ' A' ' 108' ' ' PHE . 44.9 Cg_endo -66.83 138.79 49.82 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.359 1.189 . . . . 0.0 110.389 -178.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' A' ' 110' ' ' ASN . 5.2 p-10 -100.39 78.49 2.03 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.318 -0.864 . . . . 0.0 110.263 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.403 ' C ' ' O ' ' A' ' 110' ' ' ASN . 79.6 ttt180 -41.46 -32.65 0.35 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.429 -0.794 . . . . 0.0 110.797 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 95.0 mt -78.93 149.67 32.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.369 -0.832 . . . . 0.0 110.313 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -104.42 40.56 1.45 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.408 -0.808 . . . . 0.0 109.874 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.502 HD13 ' HD2' ' A' ' 36' ' ' LYS . 56.4 tp -71.16 125.93 28.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.203 -0.935 . . . . 0.0 109.766 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -96.75 -5.34 38.81 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.489 -0.757 . . . . 0.0 111.086 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 11' ' ' LEU . . . -141.46 142.0 33.66 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.874 -1.141 . . . . 0.0 111.473 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.47 ' HB ' ' HB3' ' A' ' 11' ' ' LEU . 48.1 mm -102.73 121.29 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -117.94 -18.82 9.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.993 -1.067 . . . . 0.0 111.465 -178.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.467 ' O ' ' HA ' ' A' ' 34' ' ' LEU . 42.9 t80 -113.71 130.04 56.48 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.907 -1.121 . . . . 0.0 111.14 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.48 ' HB3' ' CD1' ' A' ' 9' ' ' LEU . 48.2 ttp -142.42 114.22 8.05 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.379 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -136.05 139.0 42.73 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.95 -1.094 . . . . 0.0 110.905 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.493 ' CB ' HD23 ' A' ' 32' ' ' LEU . . . -141.83 131.92 24.72 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.51 -0.744 . . . . 0.0 109.137 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.421 ' O ' ' HB ' ' A' ' 31' ' ' VAL . 62.2 t0 -151.35 122.4 7.67 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.567 -0.708 . . . . 0.0 109.246 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.481 ' HA3' ' HA ' ' A' ' 30' ' ' PHE . . . 174.57 -148.98 10.14 Favored Glycine 0 N--CA 1.488 2.153 0 C-N-CA 119.192 -1.48 . . . . 0.0 110.165 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.5 ' HB2' ' CZ ' ' A' ' 30' ' ' PHE . 87.7 m-20 -86.35 9.16 18.78 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.672 -0.899 . . . . 0.0 110.283 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.544 ' HD1' HG22 ' A' ' 23' ' ' VAL . 51.1 t80 -104.06 141.77 35.63 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.122 -0.986 . . . . 0.0 109.662 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -116.08 120.05 37.81 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.168 -1.013 . . . . 0.0 111.108 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.621 HG23 ' O ' ' A' ' 128' ' ' ILE . 19.0 tt -95.47 119.57 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.232 -0.917 . . . . 0.0 109.923 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -100.82 -15.4 17.63 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.128 -0.983 . . . . 0.0 111.571 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -155.54 146.89 22.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.808 -1.183 . . . . 0.0 111.425 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.501 HG22 HD11 ' A' ' 128' ' ' ILE . 43.2 t -124.91 129.37 73.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.547 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -118.96 140.07 50.61 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.961 -1.087 . . . . 0.0 110.521 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -106.36 119.61 39.72 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.415 -0.803 . . . . 0.0 109.976 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.9 t0 . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.538 -179.997 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.162 0.506 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 2' ' ' CYS . . . . . 0.427 ' N ' ' OD1' ' B' ' 123' ' ' ASP . 0.5 OUTLIER -157.71 104.22 1.95 Allowed 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.059 -1.026 . . . . 0.0 110.226 179.898 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 3' ' ' GLY . . . . . 0.426 ' O ' ' ND2' ' A' ' 8' ' ' ASN . . . 179.51 127.48 1.11 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.555 ' C ' HD23 ' B' ' 4' ' ' LEU . 0.3 OUTLIER -67.27 154.42 41.34 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.728 -0.866 . . . . 0.0 111.342 -179.046 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.46 ' N ' ' HG ' ' B' ' 4' ' ' LEU . 72.7 t -118.11 137.08 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.578 -0.701 . . . . 0.0 109.676 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 6' ' ' ALA . . . . . 0.474 ' HB3' HD11 ' B' ' 9' ' ' LEU . . . -119.56 164.81 15.27 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.772 -1.205 . . . . 0.0 111.309 -178.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 7' ' ' SER . . . . . 0.409 ' O ' ' HB3' ' B' ' 8' ' ' ASN . 14.1 p -153.23 166.37 32.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.292 -0.88 . . . . 0.0 109.645 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 8' ' ' ASN . . . . . 0.409 ' HB3' ' O ' ' B' ' 7' ' ' SER . 54.8 t30 60.75 38.94 17.88 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.345 -0.847 . . . . 0.0 109.681 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.553 ' O ' ' C ' ' B' ' 10' ' ' ASN . 63.2 mt -91.41 1.32 57.21 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.646 -0.659 . . . . 0.0 111.77 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 10' ' ' ASN . . . . . 0.553 ' C ' ' O ' ' B' ' 9' ' ' LEU . 7.9 m120 -0.16 80.65 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.565 0 CA-C-O 121.599 0.714 . . . . 0.0 112.715 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.499 ' O ' ' HA ' ' B' ' 116' ' ' ALA . 3.4 tt -100.67 129.9 46.65 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.585 -0.697 . . . . 0.0 109.898 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 3.3 mtpp -98.31 165.18 15.71 Favored Pre-proline 0 C--N 1.295 -1.783 0 O-C-N 121.481 -0.762 . . . . 0.0 110.441 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -66.88 147.38 80.49 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.96 1.505 . . . . 0.0 110.389 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.81 7.06 63.16 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 110.259 -1.137 . . . . 0.0 110.259 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -114.99 146.78 40.87 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.841 -1.388 . . . . 0.0 110.507 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 16' ' ' CYS . . . . . . . . . . . . . 49.4 t -106.44 137.86 43.65 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.413 -0.804 . . . . 0.0 110.561 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.537 HD12 ' O ' ' B' ' 132' ' ' ALA . 45.3 tp -117.86 130.03 56.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.358 -0.839 . . . . 0.0 109.694 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.413 ' CZ ' ' OE1' ' B' ' 86' ' ' GLU . 76.9 ttt180 -118.91 129.4 55.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.02 -1.05 . . . . 0.0 110.498 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 24.9 t -121.75 125.07 72.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.279 -0.888 . . . . 0.0 110.682 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 20' ' ' ARG . . . . . 0.455 ' HA ' ' HG2' ' B' ' 86' ' ' GLU . 76.1 ttt180 -109.55 128.88 55.51 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.34 -0.85 . . . . 0.0 108.869 178.208 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -149.4 -170.01 16.49 Favored Glycine 0 N--CA 1.486 1.988 0 C-N-CA 118.997 -1.573 . . . . 0.0 110.086 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -129.54 123.38 31.27 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.678 -0.895 . . . . 0.0 109.774 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.524 HG22 ' HD1' ' B' ' 126' ' ' PHE . 99.2 t -79.36 129.65 37.25 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 121.287 -0.883 . . . . 0.0 109.6 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.457 ' HB1' ' HD2' ' B' ' 25' ' ' PRO . . . -54.77 163.26 1.48 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.16 -0.962 . . . . 0.0 110.027 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 25' ' ' PRO . . . . . 0.457 ' HD2' ' HB1' ' B' ' 24' ' ' ALA . 42.6 Cg_endo -67.74 -18.81 47.78 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.952 1.501 . . . . 0.0 110.196 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 26' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' B' ' 28' ' ' LYS . 64.1 t0 -113.3 56.94 0.68 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.244 -0.91 . . . . 0.0 109.391 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.96 84.89 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.679 -0.638 . . . . 0.0 110.163 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 28' ' ' LYS . . . . . 0.508 ' HA ' ' HB3' ' B' ' 49' ' ' PHE . 85.2 tttt -109.78 -33.49 6.73 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.065 -1.022 . . . . 0.0 111.777 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 37.1 t -146.58 140.1 25.84 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.674 -1.266 . . . . 0.0 111.535 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 30' ' ' PHE . . . . . 0.505 ' CD2' ' HB2' ' B' ' 126' ' ' PHE . 83.9 m-85 -139.3 146.04 39.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.439 -0.788 . . . . 0.0 110.142 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.413 ' HB ' ' O ' ' B' ' 123' ' ' ASP . 62.9 t -133.04 129.77 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.907 -1.121 . . . . 0.0 109.893 178.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.692 HD12 ' HB2' ' B' ' 45' ' ' PHE . 94.9 mt -131.31 144.64 51.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.103 -0.998 . . . . 0.0 110.565 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -146.07 108.87 4.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.302 -0.874 . . . . 0.0 110.238 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.595 HD11 ' HB2' ' B' ' 43' ' ' LEU . 0.3 OUTLIER -124.19 110.19 14.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.178 -0.951 . . . . 0.0 110.047 179.472 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -157.78 -122.39 0.7 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 36' ' ' LYS . . . . . 0.497 ' HD2' HD13 ' B' ' 114' ' ' LEU . 0.1 OUTLIER -130.83 -46.12 1.04 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.571 -0.958 . . . . 0.0 108.707 179.177 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 37' ' ' ASP . . . . . 0.424 ' HB2' ' HB2' ' B' ' 40' ' ' ASN . 87.3 m-20 -122.2 164.14 18.35 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 28.4 t -56.88 -41.99 79.02 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.312 -0.867 . . . . 0.0 111.372 -178.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 39' ' ' ASN . . . . . 0.48 ' HB3' ' N ' ' B' ' 66' ' ' GLY . 92.1 m-20 -92.31 0.02 57.42 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.862 -1.149 . . . . 0.0 111.002 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 40' ' ' ASN . . . . . 0.424 ' HB2' ' HB2' ' B' ' 37' ' ' ASP . 7.5 m120 -117.62 61.88 0.75 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.026 -1.046 . . . . 0.0 109.594 -178.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 95.7 mt -90.33 139.33 30.77 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.757 -0.59 . . . . 0.0 109.651 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 42' ' ' CYS . . . . . . . . . . . . . 7.4 p -90.8 -28.91 17.91 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.183 -0.948 . . . . 0.0 109.557 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.71 HD11 HD13 ' B' ' 96' ' ' LEU . 70.7 mt -137.54 137.62 38.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.359 -0.838 . . . . 0.0 110.954 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 44' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -135.42 126.77 28.43 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.388 -0.82 . . . . 0.0 110.094 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.692 ' HB2' HD12 ' B' ' 32' ' ' LEU . 91.6 m-85 -113.44 141.32 47.24 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.93 -1.106 . . . . 0.0 109.994 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -154.2 69.87 6.19 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 120.96 -1.088 . . . . 0.0 111.069 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 47' ' ' PRO . . . . . 0.402 ' HG2' ' HB2' ' B' ' 30' ' ' PHE . 52.6 Cg_endo -69.35 147.09 64.72 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.757 1.399 . . . . 0.0 110.159 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.437 ' NH2' ' HB1' ' B' ' 51' ' ' ALA . 83.0 mtp180 -137.42 111.51 8.4 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.974 -1.079 . . . . 0.0 110.62 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 49' ' ' PHE . . . . . 0.508 ' HB3' ' HA ' ' B' ' 28' ' ' LYS . 85.6 t80 -62.22 -46.31 89.44 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.242 -0.911 . . . . 0.0 109.958 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -164.51 99.33 0.81 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.11 -0.994 . . . . 0.0 110.065 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 51' ' ' ALA . . . . . 0.437 ' HB1' ' NH2' ' B' ' 48' ' ' ARG . . . -109.88 -89.78 0.48 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.09 -1.006 . . . . 0.0 109.956 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 52' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -63.12 -42.17 99.47 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.065 -1.022 . . . . 0.0 109.167 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 161.43 38.92 0.02 OUTLIER Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -118.21 -171.66 2.11 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.254 -1.145 . . . . 0.0 109.93 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.5 ' O ' ' C ' ' B' ' 56' ' ' ASN . . . -143.81 157.83 44.11 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.399 -0.813 . . . . 0.0 109.874 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 56' ' ' ASN . . . . . 0.509 ' HB3' ' CD1' ' B' ' 77' ' ' PHE . 35.8 m120 15.06 59.9 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.423 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -179.26 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 47.8 m -113.4 132.34 55.66 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 58' ' ' ILE . . . . . 0.427 HD11 ' O ' ' B' ' 76' ' ' VAL . 76.1 mt -116.94 135.99 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.039 -1.038 . . . . 0.0 111.802 -177.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.419 ' CG1' ' OE2' ' B' ' 71' ' ' GLU . 48.3 t -110.94 130.44 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.397 -0.815 . . . . 0.0 109.635 179.103 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 74.5 m -131.19 124.5 30.76 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.055 -1.028 . . . . 0.0 110.957 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -149.75 173.11 14.08 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.351 -0.843 . . . . 0.0 110.963 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 62' ' ' SER . . . . . 0.452 ' O ' ' CA ' ' B' ' 69' ' ' GLY . 69.7 m -131.16 155.34 47.19 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.464 -0.772 . . . . 0.0 109.919 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 63' ' ' LYS . . . . . 0.492 ' CD ' ' HA2' ' B' ' 66' ' ' GLY . 8.8 ttmt -135.34 150.33 49.93 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.707 -1.246 . . . . 0.0 111.372 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -124.54 104.77 8.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.389 -0.819 . . . . 0.0 110.149 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 58.24 27.18 59.99 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 66' ' ' GLY . . . . . 0.492 ' HA2' ' CD ' ' B' ' 63' ' ' LYS . . . 75.34 23.16 74.41 Favored Glycine 0 N--CA 1.488 2.151 0 O-C-N 120.82 -1.4 . . . . 0.0 109.794 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 67' ' ' ALA . . . . . 0.463 ' HB1' ' CD1' ' B' ' 68' ' ' TRP . . . -81.1 -85.04 0.1 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.154 -1.203 . . . . 0.0 110.873 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 68' ' ' TRP . . . . . 0.463 ' CD1' ' HB1' ' B' ' 67' ' ' ALA . 10.8 m95 -135.2 -145.38 0.22 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.915 -1.116 . . . . 0.0 110.057 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 69' ' ' GLY . . . . . 0.452 ' CA ' ' O ' ' B' ' 62' ' ' SER . . . 165.3 129.34 1.04 Allowed Glycine 0 N--CA 1.49 2.267 0 C-N-CA 119.594 -1.289 . . . . 0.0 110.577 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 18.5 m -81.63 80.21 8.03 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.626 -0.926 . . . . 0.0 109.865 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 71' ' ' GLU . . . . . 0.419 ' OE2' ' CG1' ' B' ' 59' ' ' VAL . 83.3 tt0 -71.95 125.57 27.55 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.24 -0.913 . . . . 0.0 110.948 -179.182 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -110.53 -161.94 0.78 Allowed 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.372 -0.83 . . . . 0.0 109.397 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 62.4 ttp85 -146.05 117.04 7.76 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.01 -1.056 . . . . 0.0 110.761 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -109.94 125.82 53.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.305 -0.872 . . . . 0.0 109.768 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -105.86 45.89 0.95 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.054 -1.029 . . . . 0.0 111.776 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 76' ' ' VAL . . . . . 0.61 HG12 ' HD3' ' B' ' 78' ' ' PRO . 51.6 t -121.46 132.66 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.841 -1.162 . . . . 0.0 109.88 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 77' ' ' PHE . . . . . 0.54 ' N ' ' CD1' ' B' ' 77' ' ' PHE . 11.3 p90 -142.74 82.14 12.64 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 120.988 -1.07 . . . . 0.0 111.346 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 78' ' ' PRO . . . . . 0.61 ' HD3' HG12 ' B' ' 76' ' ' VAL . 56.2 Cg_endo -80.16 41.66 1.17 Allowed 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 123.522 1.275 . . . . 0.0 111.429 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -149.91 163.84 37.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.653 -1.279 . . . . 0.0 110.848 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -130.67 164.53 41.01 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 81' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.8 149.3 66.43 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.633 1.333 . . . . 0.0 110.838 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 63.09 41.61 99.74 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 25.6 t -137.04 137.3 39.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.263 -1.139 . . . . 0.0 111.299 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.43 HG23 ' O ' ' B' ' 84' ' ' VAL . 27.5 m -79.1 135.42 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.409 -0.807 . . . . 0.0 109.522 178.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.48 154.6 37.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.944 -1.097 . . . . 0.0 110.673 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 86' ' ' GLU . . . . . 0.455 ' HG2' ' HA ' ' B' ' 20' ' ' ARG . 97.3 mt-10 -121.08 140.18 52.31 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.381 -0.824 . . . . 0.0 109.612 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 47.2 t -122.76 129.88 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.068 -1.02 . . . . 0.0 110.502 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 88' ' ' CYS . . . . . . . . . . . . . 24.5 m -92.35 125.06 36.85 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.369 -0.832 . . . . 0.0 109.899 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 96.5 mt -122.2 124.99 72.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.114 -0.991 . . . . 0.0 110.315 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 53.9 m -121.72 124.3 43.92 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.483 -0.761 . . . . 0.0 109.02 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 91' ' ' PHE . . . . . 0.41 ' CD1' ' CD2' ' B' ' 96' ' ' LEU . 65.6 t80 -110.21 112.94 25.23 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.144 -0.973 . . . . 0.0 110.32 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -121.39 149.51 42.88 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.558 -0.714 . . . . 0.0 109.307 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -63.79 -33.16 75.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.796 -1.19 . . . . 0.0 110.088 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.0 -45.96 89.95 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.032 -1.043 . . . . 0.0 109.457 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -168.81 175.49 5.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.524 -0.735 . . . . 0.0 109.766 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 96' ' ' LEU . . . . . 0.719 HD12 ' HD2' ' B' ' 108' ' ' PHE . 79.4 mt -107.48 128.3 54.37 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.211 -0.931 . . . . 0.0 110.685 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 2.6 m -109.67 126.84 54.1 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.014 -1.053 . . . . 0.0 110.358 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 63.6 t -132.96 128.85 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.016 -1.053 . . . . 0.0 110.427 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -123.98 147.03 48.1 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.987 -1.07 . . . . 0.0 110.965 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 100' ' ' LEU . . . . . 0.488 ' HB3' ' HD2' ' B' ' 101' ' ' PRO . 1.1 mp -100.36 167.85 10.28 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.585 -0.697 . . . . 0.0 109.581 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 101' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' B' ' 100' ' ' LEU . 41.0 Cg_endo -66.02 -22.73 54.77 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.564 1.297 . . . . 0.0 110.451 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 102' ' ' ASP . . . . . 0.439 ' O ' ' HB3' ' B' ' 78' ' ' PRO . 47.5 t0 -152.11 80.06 1.25 Allowed 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.122 -0.986 . . . . 0.0 109.751 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 179.41 -172.49 44.42 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 104' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -87.13 -150.68 0.16 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.211 -1.17 . . . . 0.0 110.284 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -129.01 146.05 51.09 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.925 . . . . 0.0 110.64 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -130.51 134.34 46.98 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.343 -0.848 . . . . 0.0 109.865 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -114.85 144.62 43.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.296 -0.878 . . . . 0.0 110.891 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 108' ' ' PHE . . . . . 0.719 ' HD2' HD12 ' B' ' 96' ' ' LEU . 56.4 t80 -129.22 133.84 25.61 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 109' ' ' PRO . . . . . 0.453 ' O ' ' CE2' ' B' ' 108' ' ' PHE . 44.1 Cg_endo -66.93 138.91 49.74 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.312 1.164 . . . . 0.0 110.353 -178.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 110' ' ' ASN . . . . . 0.49 ' ND2' ' O ' ' B' ' 110' ' ' ASN . 5.3 p-10 -100.58 78.58 2.01 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.359 -0.838 . . . . 0.0 110.175 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 111' ' ' ARG . . . . . 0.406 ' C ' ' O ' ' B' ' 110' ' ' ASN . 79.5 ttt180 -41.61 -32.71 0.39 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.4 -0.812 . . . . 0.0 110.757 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 95.3 mt -78.99 149.2 32.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.274 -0.892 . . . . 0.0 110.452 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -103.78 40.71 1.39 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.323 -0.861 . . . . 0.0 110.035 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 114' ' ' LEU . . . . . 0.497 HD13 ' HD2' ' B' ' 36' ' ' LYS . 56.4 tp -71.29 125.67 27.57 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.124 -0.985 . . . . 0.0 109.862 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -96.58 -4.86 40.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.58 -0.7 . . . . 0.0 111.087 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 116' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' B' ' 11' ' ' LEU . . . -142.03 142.04 32.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.868 -1.145 . . . . 0.0 111.499 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 117' ' ' ILE . . . . . 0.472 ' HB ' ' HB3' ' B' ' 11' ' ' LEU . 48.4 mm -102.72 121.15 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -118.02 -18.9 9.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.86 -1.15 . . . . 0.0 111.412 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 119' ' ' TYR . . . . . 0.485 ' O ' ' HA ' ' B' ' 34' ' ' LEU . 43.0 t80 -113.42 129.72 56.47 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.972 -1.08 . . . . 0.0 111.229 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 120' ' ' MET . . . . . 0.472 ' CB ' ' CD1' ' B' ' 9' ' ' LEU . 47.2 ttp -142.06 114.08 8.1 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -135.91 139.15 43.08 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.883 -1.136 . . . . 0.0 110.868 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 122' ' ' ALA . . . . . 0.484 ' CB ' HD23 ' B' ' 32' ' ' LEU . . . -141.96 131.41 23.77 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 123' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' B' ' 2' ' ' CYS . 62.2 t0 -150.99 122.14 7.74 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.464 -0.773 . . . . 0.0 109.224 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 124' ' ' GLY . . . . . 0.474 ' HA3' ' HA ' ' B' ' 30' ' ' PHE . . . 174.99 -149.02 9.98 Favored Glycine 0 N--CA 1.489 2.19 0 C-N-CA 118.969 -1.586 . . . . 0.0 110.026 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 125' ' ' ASP . . . . . 0.491 ' HB2' ' CZ ' ' B' ' 30' ' ' PHE . 87.6 m-20 -86.4 8.95 19.57 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.698 -0.884 . . . . 0.0 110.318 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 126' ' ' PHE . . . . . 0.524 ' HD1' HG22 ' B' ' 23' ' ' VAL . 51.2 t80 -103.86 141.53 35.96 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.136 -0.977 . . . . 0.0 109.768 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -115.93 120.22 38.48 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.119 -1.033 . . . . 0.0 111.089 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 128' ' ' ILE . . . . . 0.619 ' O ' HG23 ' B' ' 128' ' ' ILE . 18.9 tt -95.86 119.31 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.147 -0.97 . . . . 0.0 109.999 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -100.83 -15.55 17.57 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.021 -1.049 . . . . 0.0 111.591 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 130' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -154.54 146.79 23.8 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.689 -1.257 . . . . 0.0 111.445 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.498 HG22 HD11 ' B' ' 128' ' ' ILE . 42.5 t -124.76 129.04 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 132' ' ' ALA . . . . . 0.537 ' O ' HD12 ' B' ' 17' ' ' LEU . . . -118.79 139.79 51.02 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.564 -1.335 . . . . 0.0 110.504 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -105.98 119.73 39.95 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.429 -0.794 . . . . 0.0 109.955 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 5.7 t0 . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.597 -179.989 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.466 ' HA2' ' CB ' ' A' ' 123' ' ' ASP . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.448 ' HA ' ' HB3' ' B' ' 8' ' ' ASN . 60.8 tp -61.44 132.22 52.75 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.719 -1.459 . . . . 0.0 110.032 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.9 t -117.41 154.71 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.49 -0.756 . . . . 0.0 110.599 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.451 ' HB3' ' HB3' ' A' ' 120' ' ' MET . . . -141.92 156.51 45.49 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.345 -0.847 . . . . 0.0 110.573 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.465 ' O ' ' HB3' ' A' ' 8' ' ' ASN . 8.2 p -151.71 170.27 20.14 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.52 -0.737 . . . . 0.0 109.613 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.465 ' HB3' ' O ' ' A' ' 7' ' ' SER . 11.9 t-20 60.46 32.89 20.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.456 -0.778 . . . . 0.0 109.529 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.507 ' CD1' ' CB ' ' A' ' 120' ' ' MET . 74.3 mt -84.99 -15.19 45.06 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.554 -0.716 . . . . 0.0 111.991 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.496 ' C ' ' O ' ' A' ' 9' ' ' LEU . 53.4 p-10 5.43 63.06 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.503 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.795 HD21 ' CD2' ' A' ' 133' ' ' PHE . 11.7 mt -92.37 126.61 37.53 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 120.865 -1.147 . . . . 0.0 109.355 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -90.84 165.06 23.41 Favored Pre-proline 0 C--N 1.301 -1.537 0 O-C-N 121.365 -0.834 . . . . 0.0 110.44 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 91' ' ' PHE . 49.7 Cg_endo -68.68 152.63 74.28 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 124.039 1.547 . . . . 0.0 110.554 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.04 -20.73 42.33 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -100.12 152.69 19.96 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.16 -1.2 . . . . 0.0 110.108 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.2 m -97.91 139.02 34.37 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.225 -0.922 . . . . 0.0 110.806 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.411 ' CD1' ' HA ' ' A' ' 133' ' ' PHE . 58.8 tp -124.13 131.41 53.54 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.238 -0.914 . . . . 0.0 110.029 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 95.4 mtm-85 -128.91 139.96 51.89 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.014 -1.054 . . . . 0.0 111.017 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.416 ' O ' ' HG3' ' A' ' 86' ' ' GLU . 90.2 t -129.4 122.51 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.096 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 47.3 ttp180 -107.03 127.84 53.83 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.103 -0.998 . . . . 0.0 110.66 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -143.02 -159.24 7.86 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 119.449 -1.358 . . . . 0.0 110.715 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 84' ' ' VAL . 84.4 tt0 -138.03 147.53 44.23 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.833 -0.804 . . . . 0.0 109.135 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.556 ' CG1' ' HB2' ' A' ' 27' ' ' ALA . 50.3 t -108.78 124.12 65.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 120.903 -1.123 . . . . 0.0 110.123 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.54 162.01 1.88 Allowed Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.166 -0.959 . . . . 0.0 109.024 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.406 ' O ' ' HB2' ' A' ' 81' ' ' PRO . 43.9 Cg_endo -66.95 -19.47 52.11 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 O-C-N 123.833 1.438 . . . . 0.0 110.65 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 28' ' ' LYS . 89.2 m-20 -112.65 40.04 2.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.115 -0.991 . . . . 0.0 110.656 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.556 ' HB2' ' CG1' ' A' ' 23' ' ' VAL . . . -54.0 92.67 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.065 -1.022 . . . . 0.0 110.051 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.423 ' N ' ' O ' ' A' ' 26' ' ' ASP . 87.6 tttt -106.21 -34.43 7.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.164 -0.96 . . . . 0.0 111.612 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 39.5 t -150.48 133.73 16.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.847 -1.158 . . . . 0.0 111.297 -178.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.427 ' HA ' ' HA3' ' A' ' 124' ' ' GLY . 47.1 t80 -156.18 155.27 32.16 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.481 -0.762 . . . . 0.0 110.526 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.476 HG13 ' O ' ' A' ' 31' ' ' VAL . 9.3 p -139.4 133.9 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.096 -1.003 . . . . 0.0 111.007 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.7 tp -126.73 131.08 51.43 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.372 -0.83 . . . . 0.0 109.875 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.696 ' HB3' HD22 ' A' ' 41' ' ' LEU . 31.8 m120 -136.72 137.21 39.69 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.855 -1.153 . . . . 0.0 111.421 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -138.45 113.64 9.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.241 -0.912 . . . . 0.0 109.648 178.35 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.476 ' O ' ' HB3' ' A' ' 119' ' ' TYR . . . -165.58 -163.35 18.79 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.669 ' HE3' HD12 ' A' ' 114' ' ' LEU . 99.1 mttt -68.32 -43.99 76.39 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.939 -1.33 . . . . 0.0 110.514 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -153.57 -167.03 2.56 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.779 0.8 . . . . 0.0 111.93 -178.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.3 t -60.28 -44.63 95.18 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.685 -0.634 . . . . 0.0 112.486 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.418 ' HB3' ' N ' ' A' ' 66' ' ' GLY . 82.6 m-20 -89.49 -14.01 36.24 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.763 -1.211 . . . . 0.0 110.317 -179.154 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -107.27 71.89 0.85 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.342 -0.849 . . . . 0.0 109.348 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.696 HD22 ' HB3' ' A' ' 33' ' ' ASN . 95.6 mt -101.59 141.41 34.5 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.261 0.553 . . . . 0.0 110.388 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.44 ' O ' ' CB ' ' A' ' 62' ' ' SER . 0.5 OUTLIER -85.78 -51.93 6.1 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.24 -0.913 . . . . 0.0 110.049 179.652 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.99 HD11 HD11 ' A' ' 96' ' ' LEU . 84.7 mt -128.07 140.29 52.03 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.994 -1.066 . . . . 0.0 110.914 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.423 ' N ' ' O ' ' A' ' 61' ' ' ASN . 11.9 t60 -120.88 112.14 18.42 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -104.78 127.61 52.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.056 -1.028 . . . . 0.0 109.743 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -142.5 81.11 13.91 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.082 -1.011 . . . . 0.0 111.025 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.83 148.23 64.18 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.076 1.566 . . . . 0.0 110.139 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -144.95 107.57 4.43 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.925 -1.109 . . . . 0.0 111.689 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -62.3 -45.0 95.21 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.209 -0.932 . . . . 0.0 109.57 178.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -136.57 93.58 2.89 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.635 -0.666 . . . . 0.0 109.892 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -87.5 -151.04 0.17 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.191 -0.943 . . . . 0.0 110.136 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -66.02 -8.52 23.55 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.076 -1.015 . . . . 0.0 111.444 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 174.29 -27.53 0.08 OUTLIER Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -77.97 -179.31 6.0 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.05 -1.264 . . . . 0.0 109.13 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.428 ' O ' ' C ' ' A' ' 56' ' ' ASN . . . -143.76 149.84 37.7 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.173 -0.955 . . . . 0.0 110.988 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.428 ' C ' ' O ' ' A' ' 55' ' ' ALA . 87.6 m-20 29.51 59.31 0.16 Allowed 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 178.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 98.2 m -121.18 128.88 52.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.94 -1.1 . . . . 0.0 110.645 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 95.6 mt -111.13 126.05 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.701 -0.624 . . . . 0.0 110.383 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.1 m -116.5 135.43 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.015 -1.053 . . . . 0.0 109.955 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 35.4 m -103.03 136.15 43.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.141 -0.974 . . . . 0.0 110.053 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.423 ' O ' ' N ' ' A' ' 44' ' ' HIS . 1.5 t30 -146.95 158.6 43.97 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.074 -1.016 . . . . 0.0 110.987 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 42' ' ' CYS . 53.2 p -139.05 158.25 44.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.447 -0.783 . . . . 0.0 110.236 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.477 ' CD ' ' HA2' ' A' ' 66' ' ' GLY . 26.2 ttmt -142.47 152.7 42.99 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.312 -0.867 . . . . 0.0 110.563 178.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -125.04 94.66 4.24 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.358 -0.839 . . . . 0.0 109.071 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 64.47 28.43 73.13 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.477 ' HA2' ' CD ' ' A' ' 63' ' ' LYS . . . 73.98 24.76 73.15 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.2 -79.03 0.13 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.434 -1.039 . . . . 0.0 110.347 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.41 ' O ' ' HG3' ' A' ' 63' ' ' LYS . 93.5 m95 -141.98 -144.67 0.16 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.341 -0.849 . . . . 0.0 109.66 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 163.76 110.57 0.24 Allowed Glycine 0 N--CA 1.493 2.497 0 C-N-CA 119.67 -1.253 . . . . 0.0 110.078 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.08 71.97 10.12 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.364 -1.08 . . . . 0.0 110.32 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -61.3 143.99 54.7 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.553 -0.717 . . . . 0.0 111.729 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -124.73 -154.38 0.61 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.465 -0.772 . . . . 0.0 109.314 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 78.3 ttt-85 -143.88 116.18 8.5 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.757 -1.214 . . . . 0.0 112.021 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -109.32 122.64 47.79 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.33 -0.856 . . . . 0.0 109.577 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -113.88 88.4 2.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.896 -1.127 . . . . 0.0 110.377 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.6 p -141.33 142.46 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.369 -0.832 . . . . 0.0 110.475 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -151.65 77.87 7.04 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.171 -0.956 . . . . 0.0 109.857 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.479 ' CB ' ' HB2' ' A' ' 102' ' ' ASP . 54.7 Cg_endo -83.3 -0.96 10.11 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.218 1.641 . . . . 0.0 111.934 -178.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.513 ' CE1' ' HG2' ' A' ' 101' ' ' PRO . 44.0 m-85 -139.13 -171.9 3.21 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.912 -1.118 . . . . 0.0 110.357 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.47 ' HB2' ' HD2' ' A' ' 81' ' ' PRO . 2.7 pm0 -143.6 166.66 18.53 Favored Pre-proline 0 C--N 1.301 -1.506 0 O-C-N 121.189 -0.944 . . . . 0.0 110.342 -178.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.47 ' HD2' ' HB2' ' A' ' 80' ' ' GLN . 43.9 Cg_endo -65.7 151.13 85.41 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.931 1.49 . . . . 0.0 109.655 179.199 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.35 23.75 70.06 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 38.9 t -140.56 143.39 35.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.262 -1.14 . . . . 0.0 109.518 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 20.2 m -78.28 153.63 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.159 -0.963 . . . . 0.0 110.753 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -160.87 147.83 15.31 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.343 -0.848 . . . . 0.0 109.92 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.416 ' HG3' ' O ' ' A' ' 19' ' ' VAL . 78.5 tt0 -122.19 146.78 46.92 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.434 -0.791 . . . . 0.0 108.945 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 71.1 t -126.94 135.2 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.011 -1.056 . . . . 0.0 110.896 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 2.3 t -109.3 129.02 55.53 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.307 -0.871 . . . . 0.0 109.42 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 86.8 mt -129.15 127.33 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.118 -0.989 . . . . 0.0 110.589 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.0 m -115.56 132.12 56.73 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.177 -0.952 . . . . 0.0 109.691 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.431 ' CZ ' ' HB3' ' A' ' 114' ' ' LEU . 47.8 t80 -113.26 123.38 50.03 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.13 -0.981 . . . . 0.0 110.266 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -109.62 147.68 32.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -0.912 . . . . 0.0 109.769 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -58.11 -21.68 47.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.333 -0.854 . . . . 0.0 111.225 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -116.62 -13.34 10.85 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.724 -1.235 . . . . 0.0 110.781 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -147.29 -167.68 2.85 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.08 -1.013 . . . . 0.0 110.981 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.99 HD11 HD11 ' A' ' 43' ' ' LEU . 7.2 tt -151.76 115.63 4.91 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 54.4 m -106.65 130.37 54.4 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.768 -1.208 . . . . 0.0 110.309 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.58 HG23 ' CD2' ' A' ' 96' ' ' LEU . 52.5 t -121.4 132.34 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.458 -0.776 . . . . 0.0 110.185 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -122.68 127.04 48.77 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.851 -1.156 . . . . 0.0 110.659 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.4 mt -95.9 161.27 27.95 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.513 ' HG2' ' CE1' ' A' ' 79' ' ' PHE . 39.4 Cg_endo -65.62 -22.7 57.68 Favored 'Trans proline' 0 C--N 1.301 -1.95 0 O-C-N 123.448 1.236 . . . . 0.0 109.828 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.486 ' OD2' ' CD1' ' A' ' 104' ' ' TYR . 29.0 t70 -63.67 -40.26 96.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.287 -0.883 . . . . 0.0 109.995 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 126.59 -6.57 7.49 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.486 ' CD1' ' OD2' ' A' ' 102' ' ' ASP . 47.2 m-85 -87.07 142.29 28.04 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.005 -1.291 . . . . 0.0 110.224 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -128.43 140.26 51.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.321 -0.862 . . . . 0.0 111.327 -179.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -131.87 150.46 52.15 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 11.7 ptpt -132.9 136.01 45.91 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.798 -1.189 . . . . 0.0 111.384 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 20.1 m-30 -108.44 147.41 35.62 Favored Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 121.533 -0.729 . . . . 0.0 109.648 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.414 ' O ' ' N ' ' A' ' 111' ' ' ARG . 41.2 Cg_endo -65.64 150.68 86.19 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 O-C-N 124.0 1.526 . . . . 0.0 111.017 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -65.82 62.31 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.84 -0.537 . . . . 0.0 111.68 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.414 ' N ' ' O ' ' A' ' 109' ' ' PRO . 20.8 ptt180 -68.74 -24.76 64.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.061 -1.025 . . . . 0.0 109.663 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.721 HD13 ' N ' ' A' ' 113' ' ' ASN . 1.2 tm? -111.21 128.77 56.02 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.297 -0.877 . . . . 0.0 109.107 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.721 ' N ' HD13 ' A' ' 112' ' ' LEU . 37.9 m-20 -90.27 69.42 7.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.795 -1.191 . . . . 0.0 110.812 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.669 HD12 ' HE3' ' A' ' 36' ' ' LYS . 53.4 tp -84.84 131.44 34.53 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.377 -0.827 . . . . 0.0 109.35 178.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -92.17 -19.48 22.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.725 -1.234 . . . . 0.0 109.846 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.611 ' O ' HD11 ' A' ' 114' ' ' LEU . . . -171.76 156.6 4.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -0.907 . . . . 0.0 109.479 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 66.5 mt -101.94 116.36 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.884 -1.135 . . . . 0.0 110.76 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 -111.63 -23.97 10.36 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.143 -0.973 . . . . 0.0 109.914 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.476 ' HB3' ' O ' ' A' ' 35' ' ' GLY . 90.2 t80 -106.84 126.75 52.7 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.378 -0.826 . . . . 0.0 111.228 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.507 ' CB ' ' CD1' ' A' ' 9' ' ' LEU . 66.3 ttp -136.67 125.56 24.16 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.069 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -141.59 136.76 31.37 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.959 -1.088 . . . . 0.0 110.393 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -147.37 123.46 10.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.351 -0.843 . . . . 0.0 110.204 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.466 ' CB ' ' HA2' ' A' ' 3' ' ' GLY . 20.5 p-10 -151.11 121.93 7.56 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.956 -1.09 . . . . 0.0 110.956 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.427 ' HA3' ' HA ' ' A' ' 30' ' ' PHE . . . 178.28 -148.08 8.3 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.474 ' HB3' ' HA ' ' A' ' 27' ' ' ALA . 80.9 m-20 -81.69 8.72 9.21 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.482 -1.011 . . . . 0.0 110.924 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.459 ' HD1' HG22 ' A' ' 23' ' ' VAL . 43.1 t80 -106.29 142.65 35.62 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.974 -1.078 . . . . 0.0 110.205 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -110.97 125.3 53.56 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 118.945 -1.102 . . . . 0.0 110.91 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.463 HD11 ' CG2' ' A' ' 131' ' ' VAL . 9.0 tt -100.26 121.18 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.162 -0.961 . . . . 0.0 109.601 178.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -101.0 -17.55 16.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.343 -0.848 . . . . 0.0 112.323 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -159.39 147.72 17.7 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.484 -1.385 . . . . 0.0 112.252 -178.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.463 ' CG2' HD11 ' A' ' 128' ' ' ILE . 45.4 t -127.13 127.1 69.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.194 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -128.68 129.75 46.23 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.813 -1.179 . . . . 0.0 110.214 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.795 ' CD2' HD21 ' A' ' 11' ' ' LEU . 3.2 m-30 -64.25 -102.76 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.238 -0.914 . . . . 0.0 110.118 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.8 t70 . . . . . 0 N--CA 1.493 1.71 0 O-C-N 120.599 -1.313 . . . . 0.0 110.19 179.64 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.265 0.555 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 2' ' ' CYS . . . . . . . . . . . . . 35.6 t -148.27 83.31 1.49 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.356 -0.84 . . . . 0.0 110.148 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 3' ' ' GLY . . . . . 0.468 ' HA2' ' CB ' ' B' ' 123' ' ' ASP . . . 93.9 38.85 5.07 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 120.198 -1.001 . . . . 0.0 111.1 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 60.5 tp -61.69 132.26 52.65 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.729 -1.454 . . . . 0.0 109.906 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 3.1 t -117.16 154.58 18.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.643 -0.66 . . . . 0.0 110.602 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 6' ' ' ALA . . . . . 0.444 ' HB3' ' HB3' ' B' ' 120' ' ' MET . . . -141.99 156.53 45.45 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.423 -0.798 . . . . 0.0 110.548 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 7' ' ' SER . . . . . 0.457 ' O ' ' HB3' ' B' ' 8' ' ' ASN . 7.9 p -151.89 170.04 20.81 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.579 -0.701 . . . . 0.0 109.579 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 8' ' ' ASN . . . . . 0.457 ' HB3' ' O ' ' B' ' 7' ' ' SER . 11.6 t-20 60.79 32.99 20.2 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.521 -0.737 . . . . 0.0 109.287 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.507 ' CD1' ' CB ' ' B' ' 120' ' ' MET . 73.2 mt -86.15 -11.59 52.18 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.622 -0.674 . . . . 0.0 111.834 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 10' ' ' ASN . . . . . 0.491 ' C ' ' O ' ' B' ' 9' ' ' LEU . 53.5 p-10 -0.28 66.14 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.486 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -178.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.801 HD21 ' CD2' ' B' ' 133' ' ' PHE . 11.6 mt -93.37 126.54 38.55 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.087 -1.008 . . . . 0.0 109.202 178.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -90.83 165.3 22.68 Favored Pre-proline 0 C--N 1.3 -1.566 0 O-C-N 121.345 -0.847 . . . . 0.0 110.402 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 13' ' ' PRO . . . . . 0.426 ' HA ' ' O ' ' B' ' 91' ' ' PHE . 48.9 Cg_endo -68.65 152.64 74.4 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.967 1.509 . . . . 0.0 110.548 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.08 -20.73 42.25 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -100.04 152.84 19.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.184 -1.186 . . . . 0.0 110.047 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 16' ' ' CYS . . . . . . . . . . . . . 2.2 m -98.16 139.12 34.43 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.185 -0.947 . . . . 0.0 110.708 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.419 ' CD1' ' HA ' ' B' ' 133' ' ' PHE . 58.7 tp -124.18 131.38 53.53 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.253 -0.904 . . . . 0.0 110.063 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 95.5 mtm-85 -128.93 139.87 51.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.878 -1.139 . . . . 0.0 110.937 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.409 ' O ' ' HG3' ' B' ' 86' ' ' GLU . 91.4 t -129.33 122.65 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.09 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 47.3 ttp180 -107.13 127.69 53.72 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.15 -0.969 . . . . 0.0 110.665 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -142.86 -159.25 7.87 Favored Glycine 0 N--CA 1.49 2.269 0 C-N-CA 119.409 -1.377 . . . . 0.0 110.685 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 22' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' B' ' 84' ' ' VAL . 84.6 tt0 -138.03 147.46 44.16 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.822 -0.811 . . . . 0.0 109.215 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.543 ' CG1' ' HB2' ' B' ' 27' ' ' ALA . 50.1 t -108.74 124.11 65.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 O-C-N 120.984 -1.073 . . . . 0.0 110.148 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.411 ' HB1' ' HD2' ' B' ' 25' ' ' PRO . . . -54.71 161.88 2.02 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.103 -0.998 . . . . 0.0 108.985 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 25' ' ' PRO . . . . . 0.412 ' O ' ' HB2' ' B' ' 81' ' ' PRO . 43.6 Cg_endo -66.76 -19.58 53.11 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 O-C-N 123.7 1.368 . . . . 0.0 110.606 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 26' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' B' ' 28' ' ' LYS . 89.2 m-20 -112.64 40.14 2.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.183 -0.948 . . . . 0.0 110.664 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 27' ' ' ALA . . . . . 0.543 ' HB2' ' CG1' ' B' ' 23' ' ' VAL . . . -53.98 92.53 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.109 -0.994 . . . . 0.0 110.172 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 28' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' B' ' 26' ' ' ASP . 87.6 tttt -106.28 -34.28 7.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.125 -0.984 . . . . 0.0 111.588 -179.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 39.7 t -150.52 133.2 15.81 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.848 -1.158 . . . . 0.0 111.312 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 30' ' ' PHE . . . . . 0.431 ' HA ' ' HA3' ' B' ' 124' ' ' GLY . 48.4 t80 -155.54 155.42 33.36 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.52 -0.737 . . . . 0.0 110.632 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.472 ' O ' HG13 ' B' ' 31' ' ' VAL . 9.1 p -139.5 133.64 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.162 -0.961 . . . . 0.0 111.044 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 15.8 tp -126.66 131.02 51.52 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.32 -0.862 . . . . 0.0 109.877 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 33' ' ' ASN . . . . . 0.683 ' HB3' HD22 ' B' ' 41' ' ' LEU . 31.7 m120 -136.61 137.48 40.17 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.958 -1.089 . . . . 0.0 111.407 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -138.94 109.68 6.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.143 -0.973 . . . . 0.0 109.859 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 35' ' ' GLY . . . . . 0.474 ' O ' ' HB3' ' B' ' 119' ' ' TYR . . . -160.18 -162.31 12.25 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 36' ' ' LYS . . . . . 0.692 ' HE3' HD12 ' B' ' 114' ' ' LEU . 99.1 mttt -68.81 -43.85 74.75 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.146 -1.208 . . . . 0.0 110.228 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -153.56 -167.2 2.62 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.786 0.803 . . . . 0.0 111.881 -178.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 11.6 t -59.91 -44.77 94.08 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 39' ' ' ASN . . . . . 0.412 ' HB3' ' N ' ' B' ' 66' ' ' GLY . 83.0 m-20 -89.69 -13.81 36.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.707 -1.246 . . . . 0.0 110.315 -179.099 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 40' ' ' ASN . . . . . 0.4 ' ND2' ' N ' ' B' ' 40' ' ' ASN . 5.7 m-80 -107.45 71.74 0.84 Allowed 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.913 0.864 . . . . 0.0 109.318 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.683 HD22 ' HB3' ' B' ' 33' ' ' ASN . 95.0 mt -101.12 144.05 30.49 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.782 -0.573 . . . . 0.0 110.13 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 42' ' ' CYS . . . . . 0.425 ' O ' ' CB ' ' B' ' 62' ' ' SER . 0.5 OUTLIER -89.31 -50.42 6.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.168 -0.958 . . . . 0.0 109.636 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.956 HD11 HD11 ' B' ' 96' ' ' LEU . 85.5 mt -128.93 140.19 51.78 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.913 -1.117 . . . . 0.0 110.813 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 44' ' ' HIS . . . . . 0.429 ' N ' ' O ' ' B' ' 61' ' ' ASN . 12.0 t60 -120.91 112.3 18.61 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -104.86 127.69 52.77 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.165 -0.959 . . . . 0.0 109.664 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -142.46 80.99 14.08 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 120.989 -1.07 . . . . 0.0 111.06 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 47' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.79 148.08 64.12 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.062 1.559 . . . . 0.0 110.132 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -144.8 107.72 4.5 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.879 -1.138 . . . . 0.0 111.628 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -62.51 -44.86 95.34 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.057 -1.027 . . . . 0.0 109.575 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 28.9 t30 -136.63 93.24 2.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.729 -0.607 . . . . 0.0 110.005 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -87.35 -151.08 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.258 -0.901 . . . . 0.0 110.209 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 52' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -66.15 -6.93 15.06 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.019 -1.051 . . . . 0.0 111.458 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 171.8 -26.8 0.1 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -78.29 -179.41 6.23 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.994 -1.297 . . . . 0.0 108.997 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.486 ' O ' ' C ' ' B' ' 56' ' ' ASN . . . -141.8 156.7 45.55 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.121 -0.987 . . . . 0.0 110.202 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 56' ' ' ASN . . . . . 0.486 ' C ' ' O ' ' B' ' 55' ' ' ALA . 87.1 m-20 18.51 63.88 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 97.8 m -122.05 128.91 51.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 110.532 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 58' ' ' ILE . . . . . . . . . . . . . 96.1 mt -111.43 126.27 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.698 -0.626 . . . . 0.0 110.356 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 25.4 m -116.55 135.33 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.053 -1.029 . . . . 0.0 110.052 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 35.2 m -103.01 135.88 43.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.21 -0.931 . . . . 0.0 110.255 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 61' ' ' ASN . . . . . 0.429 ' O ' ' N ' ' B' ' 44' ' ' HIS . 1.5 t30 -146.74 158.45 43.91 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.083 -1.011 . . . . 0.0 111.134 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 62' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' B' ' 42' ' ' CYS . 53.3 p -138.85 158.45 44.19 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.454 -0.779 . . . . 0.0 110.266 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 63' ' ' LYS . . . . . 0.477 ' CD ' ' HA2' ' B' ' 66' ' ' GLY . 26.3 ttmt -142.56 152.7 42.85 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.289 -0.882 . . . . 0.0 110.498 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -124.92 94.73 4.27 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.304 -0.872 . . . . 0.0 109.055 178.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 64.3 28.59 73.22 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 66' ' ' GLY . . . . . 0.477 ' HA2' ' CD ' ' B' ' 63' ' ' LYS . . . 73.88 24.73 73.45 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.06 -79.0 0.13 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.341 -1.093 . . . . 0.0 110.435 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 68' ' ' TRP . . . . . 0.408 ' O ' ' HG3' ' B' ' 63' ' ' LYS . 93.4 m95 -142.18 -144.69 0.16 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.255 -0.903 . . . . 0.0 109.624 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 163.63 110.4 0.24 Allowed Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.545 -1.312 . . . . 0.0 110.1 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.83 71.99 9.91 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.317 -1.108 . . . . 0.0 110.319 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -61.4 144.09 54.68 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.463 -0.773 . . . . 0.0 111.817 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -124.84 -154.38 0.61 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.318 -0.864 . . . . 0.0 109.314 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 78.3 ttt-85 -143.79 116.24 8.58 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.709 -1.244 . . . . 0.0 111.99 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -109.42 122.74 48.05 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.371 -0.83 . . . . 0.0 109.557 178.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -114.03 88.52 2.87 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.925 -1.11 . . . . 0.0 110.271 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 7.6 p -141.4 142.38 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.309 -0.87 . . . . 0.0 110.53 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -151.47 77.81 7.18 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.139 -0.976 . . . . 0.0 109.899 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 78' ' ' PRO . . . . . 0.486 ' CB ' ' HB2' ' B' ' 102' ' ' ASP . 54.6 Cg_endo -83.36 -0.65 9.95 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.185 1.624 . . . . 0.0 112.078 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 79' ' ' PHE . . . . . 0.511 ' CE1' ' HG2' ' B' ' 101' ' ' PRO . 44.3 m-85 -139.32 -171.74 3.19 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.955 -1.091 . . . . 0.0 110.439 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.457 ' HB2' ' HD2' ' B' ' 81' ' ' PRO . 2.6 pm0 -143.67 166.9 17.27 Favored Pre-proline 0 C--N 1.302 -1.457 0 O-C-N 121.284 -0.885 . . . . 0.0 110.323 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 81' ' ' PRO . . . . . 0.457 ' HD2' ' HB2' ' B' ' 80' ' ' GLN . 43.2 Cg_endo -65.71 151.2 85.17 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.904 1.476 . . . . 0.0 109.63 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.4 23.61 70.26 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.024 -1.631 . . . . 0.0 109.024 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 38.6 t -140.49 143.43 35.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.333 -1.098 . . . . 0.0 109.572 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' B' ' 22' ' ' GLU . 20.0 m -78.33 153.51 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.126 -0.983 . . . . 0.0 110.834 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -160.72 147.74 15.51 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.383 -0.823 . . . . 0.0 109.917 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 86' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' B' ' 19' ' ' VAL . 78.6 tt0 -122.09 146.66 46.99 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.307 -0.871 . . . . 0.0 108.928 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 70.4 t -126.81 135.21 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.05 -1.031 . . . . 0.0 110.902 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 88' ' ' CYS . . . . . . . . . . . . . 2.4 t -109.14 129.15 55.48 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.362 -0.836 . . . . 0.0 109.498 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 87.0 mt -129.12 127.22 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.148 -0.97 . . . . 0.0 110.617 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 5.7 m -115.48 132.13 56.72 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.15 -0.969 . . . . 0.0 109.816 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 91' ' ' PHE . . . . . 0.428 ' CZ ' ' HB3' ' B' ' 114' ' ' LEU . 47.7 t80 -113.23 123.62 50.61 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.111 -0.993 . . . . 0.0 110.339 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -109.88 147.8 32.71 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.162 -0.961 . . . . 0.0 109.77 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -58.26 -21.54 48.96 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.322 -0.861 . . . . 0.0 111.201 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -116.7 -13.3 10.8 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.704 -1.247 . . . . 0.0 110.829 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -147.39 -167.68 2.85 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.096 -1.003 . . . . 0.0 110.899 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 96' ' ' LEU . . . . . 0.956 HD11 HD11 ' B' ' 43' ' ' LEU . 7.2 tt -151.72 115.75 4.96 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 54.1 m -106.77 130.37 54.49 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.738 -1.227 . . . . 0.0 110.375 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 98' ' ' VAL . . . . . 0.587 HG23 ' CD2' ' B' ' 96' ' ' LEU . 51.8 t -121.58 132.46 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.51 -0.743 . . . . 0.0 110.13 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -122.57 127.53 49.58 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.977 -1.077 . . . . 0.0 110.616 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 3.4 mt -96.41 161.14 27.9 Favored Pre-proline 0 C--N 1.303 -1.454 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 101' ' ' PRO . . . . . 0.511 ' HG2' ' CE1' ' B' ' 79' ' ' PHE . 39.7 Cg_endo -65.54 -22.73 58.24 Favored 'Trans proline' 0 C--N 1.301 -1.952 0 O-C-N 123.448 1.236 . . . . 0.0 109.841 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 102' ' ' ASP . . . . . 0.489 ' OD2' ' CD1' ' B' ' 104' ' ' TYR . 28.9 t70 -63.6 -40.22 96.37 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.337 -0.852 . . . . 0.0 110.02 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 126.44 -6.42 7.57 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 104' ' ' TYR . . . . . 0.489 ' CD1' ' OD2' ' B' ' 102' ' ' ASP . 47.3 m-85 -87.22 142.29 28.01 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.984 -1.304 . . . . 0.0 110.193 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -128.19 140.22 52.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.401 -0.812 . . . . 0.0 111.393 -179.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -131.88 150.61 52.1 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 107' ' ' LYS . . . . . 0.459 ' HA ' ' O ' ' B' ' 96' ' ' LEU . 11.7 ptpt -132.98 135.89 45.75 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 118.757 -1.177 . . . . 0.0 111.394 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 108' ' ' PHE . . . . . . . . . . . . . 20.2 m-30 -108.33 147.54 35.82 Favored Pre-proline 0 C--N 1.304 -1.398 0 O-C-N 121.453 -0.78 . . . . 0.0 109.649 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 109' ' ' PRO . . . . . 0.414 ' O ' ' N ' ' B' ' 111' ' ' ARG . 40.9 Cg_endo -65.63 150.8 86.09 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 O-C-N 123.982 1.517 . . . . 0.0 111.042 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 110' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -65.95 62.46 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.881 -0.512 . . . . 0.0 111.583 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 111' ' ' ARG . . . . . 0.414 ' N ' ' O ' ' B' ' 109' ' ' PRO . 20.8 ptt180 -68.94 -24.48 64.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.032 -1.043 . . . . 0.0 109.558 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 112' ' ' LEU . . . . . 0.718 HD13 ' N ' ' B' ' 113' ' ' ASN . 1.2 tm? -111.43 128.7 56.07 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.396 -0.815 . . . . 0.0 109.099 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 113' ' ' ASN . . . . . 0.718 ' N ' HD13 ' B' ' 112' ' ' LEU . 37.8 m-20 -90.27 69.5 7.09 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.835 -1.165 . . . . 0.0 110.77 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 114' ' ' LEU . . . . . 0.692 HD12 ' HE3' ' B' ' 36' ' ' LYS . 53.4 tp -85.12 131.29 34.47 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.53 -0.731 . . . . 0.0 109.381 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -92.0 -19.58 22.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.717 -1.24 . . . . 0.0 109.775 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 116' ' ' ALA . . . . . 0.613 ' O ' HD11 ' B' ' 114' ' ' LEU . . . -171.83 156.74 4.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.227 -0.921 . . . . 0.0 109.475 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 66.3 mt -101.98 116.36 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.88 -1.137 . . . . 0.0 110.733 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 -111.64 -24.05 10.31 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.155 -0.966 . . . . 0.0 109.817 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 119' ' ' TYR . . . . . 0.474 ' HB3' ' O ' ' B' ' 35' ' ' GLY . 90.1 t80 -106.8 126.75 52.7 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.335 -0.853 . . . . 0.0 111.254 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 120' ' ' MET . . . . . 0.507 ' CB ' ' CD1' ' B' ' 9' ' ' LEU . 66.0 ttp -136.75 125.55 24.03 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.071 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -141.59 136.72 31.32 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.034 -1.041 . . . . 0.0 110.388 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -147.27 123.59 10.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.364 -0.835 . . . . 0.0 110.281 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 123' ' ' ASP . . . . . 0.468 ' CB ' ' HA2' ' B' ' 3' ' ' GLY . 20.5 p-10 -151.12 122.13 7.66 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.003 -1.061 . . . . 0.0 110.994 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 124' ' ' GLY . . . . . 0.431 ' HA3' ' HA ' ' B' ' 30' ' ' PHE . . . 178.03 -148.12 8.41 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 125' ' ' ASP . . . . . 0.463 ' HB3' ' HA ' ' B' ' 27' ' ' ALA . 80.8 m-20 -81.73 8.71 9.33 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.537 -0.978 . . . . 0.0 110.889 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 126' ' ' PHE . . . . . 0.468 ' HD1' HG22 ' B' ' 23' ' ' VAL . 43.7 t80 -106.2 142.67 35.49 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.03 -1.044 . . . . 0.0 110.233 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -111.02 125.13 53.41 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.024 -1.071 . . . . 0.0 110.885 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 128' ' ' ILE . . . . . 0.454 HD11 ' CG2' ' B' ' 131' ' ' VAL . 8.9 tt -100.2 121.26 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.256 -0.902 . . . . 0.0 109.679 178.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -100.87 -19.53 15.89 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.337 -0.852 . . . . 0.0 112.2 -178.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 130' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -156.8 148.43 22.53 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 118.324 -1.35 . . . . 0.0 112.507 -178.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.454 ' CG2' HD11 ' B' ' 128' ' ' ILE . 45.6 t -127.45 127.05 68.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 177.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 132' ' ' ALA . . . . . . . . . . . . . . . -128.67 129.77 46.29 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.856 -1.152 . . . . 0.0 110.266 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 133' ' ' PHE . . . . . 0.801 ' CD2' HD21 ' B' ' 11' ' ' LEU . 3.2 m-30 -64.28 -102.76 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.172 -0.955 . . . . 0.0 110.062 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.9 t70 . . . . . 0 N--CA 1.493 1.715 0 O-C-N 120.521 -1.362 . . . . 0.0 110.252 179.697 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 122' ' ' ALA . . . . . . . . 0 N--CA 1.492 2.381 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.771 HD22 HD23 ' B' ' 9' ' ' LEU . 77.7 mt -79.42 144.49 34.05 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.354 -1.086 . . . . 0.0 112.215 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.3 m -110.52 150.35 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.56 -0.713 . . . . 0.0 109.498 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.38 156.32 47.08 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.72 -1.238 . . . . 0.0 112.387 -178.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.458 ' O ' ' HB3' ' A' ' 8' ' ' ASN . 17.3 m -155.39 173.25 16.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.538 -0.726 . . . . 0.0 109.853 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.458 ' HB3' ' O ' ' A' ' 7' ' ' SER . 37.3 t-20 62.25 26.76 16.05 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.137 -0.977 . . . . 0.0 109.768 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.783 HD23 HD22 ' B' ' 4' ' ' LEU . 63.2 mt -82.25 -12.64 57.94 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.832 -0.542 . . . . 0.0 111.669 -178.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.51 ' C ' ' O ' ' A' ' 9' ' ' LEU . 18.1 m120 16.81 68.39 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.821 0 CA-C-O 121.35 0.595 . . . . 0.0 112.323 -179.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.515 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 34.0 tp -96.07 132.88 40.99 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.53 -0.731 . . . . 0.0 110.404 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.29 169.69 6.61 Favored Pre-proline 0 C--N 1.296 -1.758 0 O-C-N 121.584 -0.697 . . . . 0.0 109.815 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.441 ' HA ' ' O ' ' A' ' 91' ' ' PHE . 54.9 Cg_endo -72.6 155.61 54.43 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.08 1.568 . . . . 0.0 108.882 178.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.64 -10.11 59.02 Favored Glycine 0 N--CA 1.488 2.154 0 C-N-CA 119.359 -1.4 . . . . 0.0 109.965 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -115.12 146.65 41.13 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.084 -1.245 . . . . 0.0 108.921 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.437 ' O ' ' N ' ' A' ' 134' ' ' ASP . 1.6 t -96.55 140.46 31.14 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.969 -1.082 . . . . 0.0 110.723 -179.007 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.518 HD13 ' CE1' ' A' ' 133' ' ' PHE . 56.1 tp -111.0 126.92 55.3 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.277 -0.889 . . . . 0.0 110.544 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -120.17 126.72 51.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.241 -0.912 . . . . 0.0 109.871 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.3 t -127.95 129.73 69.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.217 -0.927 . . . . 0.0 110.711 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.444 ' HA ' ' HG2' ' A' ' 86' ' ' GLU . 72.1 ttt180 -109.31 130.15 55.5 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.215 -0.928 . . . . 0.0 109.933 178.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.436 ' CA ' ' O ' ' A' ' 127' ' ' LYS . . . -134.35 173.8 21.24 Favored Glycine 0 C--N 1.294 -1.773 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -125.48 121.26 33.25 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.458 HG22 ' HD1' ' A' ' 126' ' ' PHE . 70.9 t -85.36 131.89 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.147 -0.971 . . . . 0.0 109.909 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.04 154.04 90.75 Favored Pre-proline 0 N--CA 1.496 1.863 0 O-C-N 121.309 -0.869 . . . . 0.0 109.996 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.427 ' O ' ' HB2' ' A' ' 81' ' ' PRO . 44.4 Cg_endo -67.48 -22.27 45.3 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.613 1.323 . . . . 0.0 110.736 -179.03 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -101.31 14.05 33.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.007 -1.058 . . . . 0.0 110.186 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.454 ' HA ' ' HB3' ' A' ' 125' ' ' ASP . . . -63.77 142.3 58.45 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.301 -0.874 . . . . 0.0 111.695 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -129.14 -34.84 1.85 Allowed 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 42.2 t -165.68 139.92 4.65 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 121.377 -0.827 . . . . 0.0 110.538 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.474 ' CZ ' ' HG3' ' A' ' 47' ' ' PRO . 42.2 p90 -143.57 161.09 39.38 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.171 -0.956 . . . . 0.0 109.067 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.411 HG12 ' HB2' ' A' ' 46' ' ' ASN . 10.4 m -126.72 140.52 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 120.662 -1.274 . . . . 0.0 111.935 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 52.7 mt -118.75 133.19 56.02 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.573 -0.704 . . . . 0.0 109.713 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.415 ' CG ' HD13 ' A' ' 41' ' ' LEU . 93.8 m-20 -124.92 135.09 52.52 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.84 -1.162 . . . . 0.0 111.597 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.474 HD11 ' HB3' ' A' ' 43' ' ' LEU . 0.6 OUTLIER -144.69 110.77 5.47 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.693 0.759 . . . . 0.0 109.206 178.526 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -165.02 -142.84 3.53 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.531 ' O ' ' HB2' ' A' ' 119' ' ' TYR . 47.9 pttt -109.15 -32.81 7.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.152 -1.205 . . . . 0.0 109.412 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.426 ' N ' ' CG ' ' A' ' 36' ' ' LYS . 36.5 m-20 -138.52 171.73 13.93 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.946 0.879 . . . . 0.0 110.501 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 42.4 t -60.07 -41.94 93.49 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.786 -0.571 . . . . 0.0 110.931 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.485 ' HB3' ' N ' ' A' ' 66' ' ' GLY . 82.1 m-20 -91.5 -6.41 52.62 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.033 -1.042 . . . . 0.0 111.372 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -115.29 60.46 0.7 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.88 -1.138 . . . . 0.0 111.05 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.415 HD13 ' CG ' ' A' ' 33' ' ' ASN . 61.3 mt -84.88 147.35 26.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.35 -0.844 . . . . 0.0 109.903 179.034 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 81.6 m -88.55 -41.7 12.54 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.865 -1.147 . . . . 0.0 109.347 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.474 ' HB3' HD11 ' A' ' 34' ' ' LEU . 15.1 tp -132.17 128.98 39.17 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.644 -0.66 . . . . 0.0 110.862 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.402 ' ND1' ' OD1' ' A' ' 33' ' ' ASN . 20.3 t60 -121.37 112.85 19.09 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -104.72 122.18 45.15 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.023 -1.048 . . . . 0.0 110.691 -178.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.411 ' HB2' HG12 ' A' ' 31' ' ' VAL . 3.7 t-20 -139.37 85.75 15.02 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.297 -0.877 . . . . 0.0 111.218 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.474 ' HG3' ' CZ ' ' A' ' 30' ' ' PHE . 55.9 Cg_endo -71.16 145.13 48.39 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.961 1.506 . . . . 0.0 110.193 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -128.21 92.34 3.43 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.763 -1.21 . . . . 0.0 110.425 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -63.37 -40.59 97.66 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.425 -0.797 . . . . 0.0 109.571 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -137.82 92.02 2.64 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.198 -0.939 . . . . 0.0 109.024 178.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.66 -146.9 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.405 -0.809 . . . . 0.0 109.703 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -108.28 31.65 5.41 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.291 -0.88 . . . . 0.0 109.94 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 166.63 -32.17 0.21 Allowed Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.251 -1.452 . . . . 0.0 109.87 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -89.74 -168.86 2.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.134 -1.215 . . . . 0.0 110.285 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.466 ' O ' ' C ' ' A' ' 56' ' ' ASN . . . -150.82 144.94 25.39 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.407 -0.808 . . . . 0.0 109.496 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.466 ' C ' ' O ' ' A' ' 55' ' ' ALA . 95.1 m-20 25.19 64.09 0.06 Allowed 'General case' 0 N--CA 1.506 2.368 0 CA-C-O 121.137 0.494 . . . . 0.0 111.783 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.8 m -127.24 126.79 43.34 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.434 -0.791 . . . . 0.0 110.283 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 83.1 mt -119.96 131.52 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 CA-C-O 121.173 0.511 . . . . 0.0 110.852 -178.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.3 m -124.18 153.03 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 120.996 -1.065 . . . . 0.0 110.135 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 57.1 m -111.03 145.84 37.78 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.058 -1.026 . . . . 0.0 110.453 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -155.91 170.64 21.65 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.271 -0.893 . . . . 0.0 111.393 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.416 ' O ' ' HA ' ' A' ' 68' ' ' TRP . 19.4 m -149.49 157.34 43.2 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.405 -0.809 . . . . 0.0 109.084 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 68' ' ' TRP . 7.7 ttmt -134.67 140.71 46.22 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.766 -1.209 . . . . 0.0 110.479 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -122.07 105.79 10.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.288 -0.883 . . . . 0.0 109.728 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.64 28.9 74.07 Favored Glycine 0 N--CA 1.484 1.834 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.485 ' N ' ' HB3' ' A' ' 39' ' ' ASN . . . 91.45 -2.38 77.71 Favored Glycine 0 N--CA 1.482 1.723 0 C-N-CA 119.323 -1.417 . . . . 0.0 109.583 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.449 ' O ' ' C ' ' A' ' 68' ' ' TRP . . . -106.77 90.33 3.29 Favored 'General case' 0 N--CA 1.483 1.196 0 O-C-N 121.045 -1.268 . . . . 0.0 109.9 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.513 ' HA ' ' HA ' ' A' ' 63' ' ' LYS . 2.0 m-90 -19.66 -104.48 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.444 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 130.63 -99.87 0.45 Allowed Glycine 0 N--CA 1.489 2.199 0 O-C-N 119.863 -1.773 . . . . 0.0 110.941 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.3 t -93.77 143.41 26.36 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.258 -1.142 . . . . 0.0 111.528 -178.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -153.28 108.93 3.27 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.036 -1.04 . . . . 0.0 110.749 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -125.18 -151.19 0.47 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.275 -1.516 . . . . 0.0 111.01 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -140.59 132.92 28.31 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.959 -1.088 . . . . 0.0 111.095 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.431 ' OE2' ' CD1' ' A' ' 106' ' ' PHE . 82.0 tt0 -143.09 81.72 1.73 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.244 -0.91 . . . . 0.0 110.165 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.97 99.8 2.8 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.094 -1.004 . . . . 0.0 110.37 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.2 p -140.24 138.2 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.019 -1.051 . . . . 0.0 109.143 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.588 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 4.1 p90 -153.15 87.04 3.99 Favored Pre-proline 0 C--N 1.303 -1.421 0 O-C-N 120.938 -1.101 . . . . 0.0 110.8 -178.406 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.47 ' O ' ' CD1' ' A' ' 79' ' ' PHE . 50.0 Cg_endo -86.13 11.01 3.44 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 124.229 1.647 . . . . 0.0 110.577 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.47 ' CD1' ' O ' ' A' ' 78' ' ' PRO . 42.5 m-85 -148.14 -175.31 4.84 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.146 -0.971 . . . . 0.0 110.622 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.475 ' CG ' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -140.45 174.03 4.38 Favored Pre-proline 0 N--CA 1.493 1.69 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.475 ' HD2' ' CG ' ' A' ' 80' ' ' GLN . 41.6 Cg_endo -64.3 145.94 89.31 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.084 1.044 . . . . 0.0 109.782 179.022 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 75.54 35.86 45.53 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.7 m -130.62 155.23 46.91 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.226 -1.161 . . . . 0.0 111.225 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 53.0 t -104.13 126.24 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.181 -0.949 . . . . 0.0 109.542 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.463 ' HB1' ' HG3' ' A' ' 101' ' ' PRO . . . -145.11 154.79 42.84 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.139 -0.976 . . . . 0.0 110.074 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.444 ' HG2' ' HA ' ' A' ' 20' ' ' ARG . 97.4 mt-10 -121.01 149.23 43.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.133 -0.979 . . . . 0.0 110.836 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.4 t -126.02 127.81 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.206 -0.934 . . . . 0.0 110.895 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' CYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 1.7 m -99.38 131.65 45.25 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 95.8 mt -122.32 130.62 74.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.239 -0.913 . . . . 0.0 111.196 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 23.5 m -124.58 128.52 49.03 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.441 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 55.8 t80 -115.66 122.89 46.94 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.345 -0.847 . . . . 0.0 111.447 -178.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 95' ' ' ASN . 79.3 m-20 -115.52 147.64 40.44 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.215 -0.928 . . . . 0.0 110.073 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 64.2 tp60 -59.57 -24.8 64.05 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.193 -0.942 . . . . 0.0 110.78 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.482 ' O ' ' ND2' ' A' ' 95' ' ' ASN . . . -101.52 -13.15 18.01 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.824 -1.172 . . . . 0.0 111.52 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.482 ' ND2' ' O ' ' A' ' 94' ' ' ALA . 0.9 OUTLIER -162.37 163.14 27.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.926 -1.109 . . . . 0.0 111.344 -178.037 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.417 ' HB3' ' HB2' ' A' ' 108' ' ' PHE . 46.3 tp -115.23 130.14 56.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.184 -0.947 . . . . 0.0 108.753 177.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.493 HG23 ' OE2' ' A' ' 105' ' ' GLU . 79.9 m -122.0 130.85 53.65 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.827 -1.17 . . . . 0.0 111.717 -178.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 55.4 t -129.75 128.27 65.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.104 -0.998 . . . . 0.0 110.382 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -114.27 145.87 41.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.031 -1.043 . . . . 0.0 110.172 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.463 ' CG ' ' HD2' ' A' ' 101' ' ' PRO . 0.1 OUTLIER -104.47 169.02 7.69 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.198 -0.938 . . . . 0.0 109.021 178.959 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.463 ' HG3' ' HB1' ' A' ' 85' ' ' ALA . 42.1 Cg_endo -68.63 -25.5 34.31 Favored 'Trans proline' 0 C--N 1.301 -1.948 0 O-C-N 123.619 1.326 . . . . 0.0 109.382 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -68.62 -28.13 66.63 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.191 -0.943 . . . . 0.0 110.953 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 117.24 -10.59 14.86 Favored Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.687 -1.244 . . . . 0.0 110.049 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -82.15 144.64 30.6 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.856 -1.379 . . . . 0.0 110.601 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.493 ' OE2' HG23 ' A' ' 97' ' ' THR . 73.1 tt0 -135.74 148.16 48.72 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.115 -0.991 . . . . 0.0 111.566 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.431 ' CD1' ' OE2' ' A' ' 74' ' ' GLU . 97.1 m-85 -131.76 151.58 51.55 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.327 -0.858 . . . . 0.0 108.765 178.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -126.02 141.78 51.81 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.749 -1.22 . . . . 0.0 112.283 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.417 ' HB2' ' HB3' ' A' ' 96' ' ' LEU . 1.9 m-85 -112.55 144.58 31.2 Favored Pre-proline 0 N--CA 1.492 1.631 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 159.99 51.4 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 123.428 1.225 . . . . 0.0 111.745 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 59.3 t30 -71.96 53.8 0.26 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.565 -0.71 . . . . 0.0 112.254 -178.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 75.5 mtt85 -65.05 -38.25 90.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.768 -1.207 . . . . 0.0 109.102 177.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 97.2 mt -92.05 133.62 35.57 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.638 -0.664 . . . . 0.0 110.87 -178.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 35.2 m-20 -96.08 18.75 12.86 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.587 -0.696 . . . . 0.0 111.038 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 47.9 tp -63.99 131.65 48.25 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.032 -1.043 . . . . 0.0 110.353 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -89.76 -12.96 37.79 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.964 -1.085 . . . . 0.0 111.67 -178.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' A' ' 11' ' ' LEU . . . -160.51 155.51 24.43 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 118.234 -1.386 . . . . 0.0 111.925 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.485 ' HB ' ' HB3' ' A' ' 11' ' ' LEU . 41.1 mm -99.62 119.47 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.227 -0.921 . . . . 0.0 109.486 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.449 ' OD1' ' ND2' ' A' ' 10' ' ' ASN . 25.8 m-80 -111.02 -29.89 7.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.439 -0.788 . . . . 0.0 111.422 -178.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.531 ' HB2' ' O ' ' A' ' 36' ' ' LYS . 57.2 t80 -108.17 129.75 55.16 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.255 -0.903 . . . . 0.0 110.226 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.465 ' HB3' ' CD1' ' A' ' 9' ' ' LEU . 58.1 ttp -140.69 130.99 25.05 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.61 144.91 25.55 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 119.048 -1.061 . . . . 0.0 110.866 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.468 ' O ' ' HA3' ' A' ' 3' ' ' GLY . . . -142.09 124.79 15.92 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -150.62 134.16 16.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.617 -0.677 . . . . 0.0 109.243 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 158.42 -155.32 26.36 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -178.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.454 ' HB3' ' HA ' ' A' ' 27' ' ' ALA . 97.3 m-20 -73.74 -7.21 51.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.767 -0.843 . . . . 0.0 110.061 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.458 ' HD1' HG22 ' A' ' 23' ' ' VAL . 33.5 t80 -98.91 138.43 36.04 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.216 -0.928 . . . . 0.0 110.172 -178.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.436 ' O ' ' CA ' ' A' ' 21' ' ' GLY . 75.5 mmtt -106.78 144.02 34.03 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.046 -1.034 . . . . 0.0 111.967 -178.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.565 ' O ' HD12 ' A' ' 4' ' ' LEU . 5.0 tt -126.27 106.97 16.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -103.45 -4.73 23.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.08 -1.013 . . . . 0.0 111.879 -178.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -154.68 135.34 13.54 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 118.486 -1.286 . . . . 0.0 111.613 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.434 ' CG2' HD11 ' A' ' 128' ' ' ILE . 51.4 t -128.35 131.11 69.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -132.08 139.92 48.67 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.79 -1.194 . . . . 0.0 110.504 -178.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.518 ' CE1' HD13 ' A' ' 17' ' ' LEU . 32.4 m-85 -98.97 120.89 40.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.091 -1.006 . . . . 0.0 110.83 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 16' ' ' CYS . 64.4 t0 . . . . . 0 C--N 1.303 -1.418 0 CA-C-O 118.022 -0.989 . . . . 0.0 110.465 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.316 0.579 . . . . 0.0 110.139 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 2' ' ' CYS . . . . . 0.407 ' N ' ' HB3' ' B' ' 123' ' ' ASP . 0.7 OUTLIER -136.14 84.36 2.07 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.363 -0.836 . . . . 0.0 110.43 179.741 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 3' ' ' GLY . . . . . 0.457 ' HA3' ' O ' ' B' ' 122' ' ' ALA . . . 176.16 170.05 38.4 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.783 HD22 HD23 ' A' ' 9' ' ' LEU . 78.8 mt -80.32 145.08 32.28 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.29 -1.123 . . . . 0.0 111.948 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 29.6 m -110.67 149.79 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.686 -0.634 . . . . 0.0 109.453 178.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.1 155.98 47.5 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.857 -1.152 . . . . 0.0 112.421 -178.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 7' ' ' SER . . . . . 0.46 ' O ' ' HB3' ' B' ' 8' ' ' ASN . 15.2 m -155.02 173.02 17.16 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.34 -0.85 . . . . 0.0 109.774 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 8' ' ' ASN . . . . . 0.46 ' HB3' ' O ' ' B' ' 7' ' ' SER . 34.8 t-20 62.12 27.84 16.77 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.098 -1.001 . . . . 0.0 109.697 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.771 HD23 HD22 ' A' ' 4' ' ' LEU . 58.1 mt -85.58 -4.32 59.13 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.695 -0.628 . . . . 0.0 111.918 -178.46 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 10' ' ' ASN . . . . . 0.539 ' C ' ' O ' ' B' ' 9' ' ' LEU . 19.4 m120 5.5 73.93 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.85 0 CA-C-O 122.0 0.905 . . . . 0.0 112.149 -177.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.52 ' O ' ' HA ' ' B' ' 116' ' ' ALA . 34.5 tp -97.88 132.65 43.28 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.756 -0.59 . . . . 0.0 109.986 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.63 169.64 6.61 Favored Pre-proline 0 C--N 1.29 -1.99 0 O-C-N 121.648 -0.658 . . . . 0.0 109.765 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 13' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' B' ' 91' ' ' PHE . 56.4 Cg_endo -72.55 155.7 54.58 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.016 1.535 . . . . 0.0 108.985 178.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.61 -10.37 59.19 Favored Glycine 0 N--CA 1.488 2.146 0 C-N-CA 119.53 -1.319 . . . . 0.0 109.821 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -115.16 147.12 40.66 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.92 -1.341 . . . . 0.0 109.235 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 16' ' ' CYS . . . . . 0.417 ' O ' ' N ' ' B' ' 134' ' ' ASP . 1.6 t -96.51 140.82 30.59 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.937 -1.102 . . . . 0.0 111.041 -178.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.501 HD13 ' CE1' ' B' ' 133' ' ' PHE . 56.1 tp -111.07 126.87 55.28 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.141 -0.974 . . . . 0.0 110.515 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -120.13 126.25 50.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.099 -1.001 . . . . 0.0 109.974 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 32.8 t -127.82 129.23 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.237 -0.914 . . . . 0.0 110.893 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 20' ' ' ARG . . . . . 0.446 ' HA ' ' HG2' ' B' ' 86' ' ' GLU . 72.7 ttt180 -108.81 129.85 55.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.284 -0.885 . . . . 0.0 110.094 178.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.441 ' CA ' ' O ' ' B' ' 127' ' ' LYS . . . -134.35 173.14 21.53 Favored Glycine 0 C--N 1.297 -1.607 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 22' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' B' ' 127' ' ' LYS . 83.6 tt0 -124.86 120.89 32.96 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.525 -0.985 . . . . 0.0 108.844 179.026 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.456 HG22 ' HD1' ' B' ' 126' ' ' PHE . 69.6 t -84.35 132.63 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.026 -1.046 . . . . 0.0 109.887 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.65 154.59 89.46 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.29 -0.881 . . . . 0.0 110.039 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 25' ' ' PRO . . . . . 0.42 ' O ' ' HB2' ' B' ' 81' ' ' PRO . 43.7 Cg_endo -67.89 -22.15 42.89 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.422 1.222 . . . . 0.0 110.89 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -101.67 13.73 34.04 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.187 -0.946 . . . . 0.0 109.69 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 27' ' ' ALA . . . . . 0.462 ' HA ' ' HB3' ' B' ' 125' ' ' ASP . . . -63.54 142.02 58.55 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.154 -0.966 . . . . 0.0 111.617 -178.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -127.74 -37.8 1.93 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 42.7 t -162.13 140.84 9.24 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.345 -0.847 . . . . 0.0 110.645 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 30' ' ' PHE . . . . . 0.457 ' CZ ' ' HG3' ' B' ' 47' ' ' PRO . 42.0 p90 -143.9 161.16 39.41 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.225 -0.922 . . . . 0.0 108.952 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 11.1 m -126.67 140.5 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 120.549 -1.344 . . . . 0.0 111.888 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 56.6 mt -118.06 133.98 55.41 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.502 -0.749 . . . . 0.0 109.599 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 33' ' ' ASN . . . . . 0.425 ' CG ' HD13 ' B' ' 41' ' ' LEU . 93.8 m-20 -124.89 135.08 52.54 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.794 -1.191 . . . . 0.0 111.946 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.465 HD11 ' HB3' ' B' ' 43' ' ' LEU . 0.6 OUTLIER -144.67 106.9 4.34 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.486 -0.759 . . . . 0.0 109.939 178.346 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 35' ' ' GLY . . . . . 0.4 ' HA3' ' HA ' ' B' ' 41' ' ' LEU . . . -159.42 -142.06 3.3 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 36' ' ' LYS . . . . . 0.505 ' O ' ' HB2' ' B' ' 119' ' ' TYR . 47.6 pttt -108.82 -32.7 7.2 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.443 -1.033 . . . . 0.0 109.063 178.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 37' ' ' ASP . . . . . 0.417 ' N ' ' CG ' ' B' ' 36' ' ' LYS . 34.6 m-20 -139.44 171.55 14.1 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.982 0.896 . . . . 0.0 110.462 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 43.9 t -59.89 -41.94 92.7 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.623 -0.673 . . . . 0.0 111.331 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 39' ' ' ASN . . . . . 0.487 ' HB3' ' N ' ' B' ' 66' ' ' GLY . 83.1 m-20 -91.53 -6.21 52.86 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.02 -1.05 . . . . 0.0 111.112 -178.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -115.89 62.92 0.7 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.196 -0.94 . . . . 0.0 110.529 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.425 HD13 ' CG ' ' B' ' 33' ' ' ASN . 55.9 mt -87.19 148.88 24.97 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.357 -0.839 . . . . 0.0 109.29 178.234 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 42' ' ' CYS . . . . . . . . . . . . . 82.4 m -91.01 -40.27 11.75 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.111 -0.993 . . . . 0.0 109.284 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.465 ' HB3' HD11 ' B' ' 34' ' ' LEU . 15.2 tp -133.31 128.86 36.66 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.52 -0.737 . . . . 0.0 110.437 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 44' ' ' HIS . . . . . . . . . . . . . 18.6 t60 -121.46 113.12 19.4 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -104.62 122.04 44.79 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.056 -1.028 . . . . 0.0 110.942 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -139.03 85.38 16.01 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.159 -0.963 . . . . 0.0 111.444 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 47' ' ' PRO . . . . . 0.457 ' HG3' ' CZ ' ' B' ' 30' ' ' PHE . 57.0 Cg_endo -71.13 144.74 47.59 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.935 1.492 . . . . 0.0 110.031 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -128.65 92.43 3.41 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.738 -1.226 . . . . 0.0 110.286 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -63.94 -39.67 94.68 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.488 -0.757 . . . . 0.0 109.905 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 59.8 t-20 -138.47 91.42 2.54 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.189 -0.945 . . . . 0.0 108.721 178.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.48 -146.12 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.268 -0.895 . . . . 0.0 109.77 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 52' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -108.58 31.72 5.4 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.33 -0.856 . . . . 0.0 110.056 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 166.61 -32.14 0.21 Allowed Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.276 -1.44 . . . . 0.0 110.033 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -89.54 -169.13 2.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -1.146 . . . . 0.0 109.983 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.493 ' O ' ' C ' ' B' ' 56' ' ' ASN . . . -148.96 150.94 33.73 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 178.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 56' ' ' ASN . . . . . 0.493 ' C ' ' O ' ' B' ' 55' ' ' ALA . 92.4 m-20 16.67 66.91 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.617 0 CA-C-O 121.689 0.757 . . . . 0.0 112.429 -178.133 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 12.4 m -127.06 126.1 42.46 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.903 0.859 . . . . 0.0 110.578 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 58' ' ' ILE . . . . . . . . . . . . . 86.5 mt -119.79 131.87 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.542 -0.724 . . . . 0.0 110.555 -178.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 13.9 m -124.26 153.25 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.191 -0.943 . . . . 0.0 110.186 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 58.2 m -110.94 146.88 35.82 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.739 -1.226 . . . . 0.0 110.484 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 61' ' ' ASN . . . . . 0.435 ' HA ' ' O ' ' B' ' 70' ' ' THR . 23.6 t-20 -156.27 170.72 21.61 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.036 -1.04 . . . . 0.0 111.214 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 62' ' ' SER . . . . . 0.42 ' O ' ' HA ' ' B' ' 68' ' ' TRP . 19.8 m -149.26 157.06 43.04 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 63' ' ' LYS . . . . . 0.515 ' HA ' ' HA ' ' B' ' 68' ' ' TRP . 7.1 ttmt -134.58 140.4 46.07 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.092 -1.005 . . . . 0.0 110.448 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -122.13 105.04 9.9 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.256 -0.902 . . . . 0.0 109.858 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.99 29.42 74.97 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 66' ' ' GLY . . . . . 0.487 ' N ' ' HB3' ' B' ' 39' ' ' ASN . . . 90.77 -1.37 78.26 Favored Glycine 0 N--CA 1.484 1.839 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 67' ' ' ALA . . . . . 0.436 ' O ' ' C ' ' B' ' 68' ' ' TRP . . . -107.22 89.71 3.08 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.197 -1.178 . . . . 0.0 109.849 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 68' ' ' TRP . . . . . 0.515 ' HA ' ' HA ' ' B' ' 63' ' ' LYS . 1.9 m-90 -19.77 -104.34 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.36 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 130.41 -99.57 0.44 Allowed Glycine 0 N--CA 1.488 2.16 0 C-N-CA 118.641 -1.742 . . . . 0.0 110.795 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 70' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' B' ' 61' ' ' ASN . 13.0 t -94.74 140.83 29.36 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.356 -1.085 . . . . 0.0 112.107 -178.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -150.65 108.7 3.73 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.205 -0.935 . . . . 0.0 111.283 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -124.64 -151.86 0.49 Allowed 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.324 -1.485 . . . . 0.0 110.999 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -140.5 132.87 28.37 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.002 -1.062 . . . . 0.0 111.109 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 74' ' ' GLU . . . . . 0.448 ' OE2' ' CD1' ' B' ' 106' ' ' PHE . 82.1 tt0 -142.85 81.64 1.73 Allowed 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.183 -0.948 . . . . 0.0 110.324 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.9 99.9 2.79 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.011 -1.056 . . . . 0.0 110.484 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 4.1 p -140.07 137.65 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.313 -0.867 . . . . 0.0 109.249 178.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 77' ' ' PHE . . . . . 0.605 ' N ' ' CD1' ' B' ' 77' ' ' PHE . 4.2 p90 -152.73 86.91 4.16 Favored Pre-proline 0 C--N 1.302 -1.492 0 O-C-N 121.023 -1.048 . . . . 0.0 110.88 -178.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 78' ' ' PRO . . . . . 0.472 ' O ' ' CD1' ' B' ' 79' ' ' PHE . 50.5 Cg_endo -86.02 10.98 3.46 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.245 1.655 . . . . 0.0 110.56 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 79' ' ' PHE . . . . . 0.472 ' CD1' ' O ' ' B' ' 78' ' ' PRO . 40.5 m-85 -148.1 -175.58 4.95 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.024 -1.047 . . . . 0.0 110.774 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.477 ' CG ' ' HD2' ' B' ' 81' ' ' PRO . 0.0 OUTLIER -139.81 174.46 4.04 Favored Pre-proline 0 N--CA 1.488 1.446 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.779 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 81' ' ' PRO . . . . . 0.477 ' HD2' ' CG ' ' B' ' 80' ' ' GLN . 41.0 Cg_endo -64.35 145.96 89.12 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 N-CA-C 109.406 -1.036 . . . . 0.0 109.406 178.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 75.45 35.41 47.51 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 33.4 m -130.39 155.06 47.01 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.131 -1.217 . . . . 0.0 111.308 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 58.7 t -103.81 126.37 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.281 -0.887 . . . . 0.0 109.749 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 85' ' ' ALA . . . . . 0.463 ' HB1' ' HG3' ' B' ' 101' ' ' PRO . . . -145.02 154.91 43.02 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.134 -0.979 . . . . 0.0 110.151 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 86' ' ' GLU . . . . . 0.446 ' HG2' ' HA ' ' B' ' 20' ' ' ARG . 97.8 mt-10 -120.79 149.36 42.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.346 -0.846 . . . . 0.0 110.853 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 21.5 t -125.62 128.27 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.132 -0.98 . . . . 0.0 110.734 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 88' ' ' CYS . . . . . 0.436 ' HA ' ' O ' ' B' ' 17' ' ' LEU . 1.6 m -100.11 131.5 46.03 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 96.0 mt -122.43 130.7 74.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.098 -1.001 . . . . 0.0 111.22 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 22.6 m -124.11 128.67 49.62 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 91' ' ' PHE . . . . . 0.432 ' O ' ' HA ' ' B' ' 13' ' ' PRO . 55.6 t80 -115.62 122.76 46.6 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.584 -0.847 . . . . 0.0 111.355 -178.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -115.16 147.08 40.72 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.13 -0.981 . . . . 0.0 110.063 178.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 63.3 tp60 -59.33 -24.3 63.21 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.887 -1.133 . . . . 0.0 110.886 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 94' ' ' ALA . . . . . 0.467 ' O ' ' ND2' ' B' ' 95' ' ' ASN . . . -101.85 -13.7 17.56 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.904 -1.122 . . . . 0.0 111.284 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 95' ' ' ASN . . . . . 0.467 ' ND2' ' O ' ' B' ' 94' ' ' ALA . 0.9 OUTLIER -161.79 163.4 29.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.029 -1.045 . . . . 0.0 111.296 -178.251 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 96' ' ' LEU . . . . . 0.414 HD23 ' HB2' ' B' ' 108' ' ' PHE . 46.2 tp -115.59 129.57 56.56 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.248 -0.908 . . . . 0.0 108.596 177.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 97' ' ' THR . . . . . 0.487 HG23 ' OE2' ' B' ' 105' ' ' GLU . 78.1 m -121.72 131.64 54.19 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.82 -1.175 . . . . 0.0 111.356 -178.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 53.8 t -130.29 127.91 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.398 -0.814 . . . . 0.0 110.108 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -114.65 145.08 42.43 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.948 -1.095 . . . . 0.0 110.203 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 100' ' ' LEU . . . . . 0.469 ' CG ' ' HD2' ' B' ' 101' ' ' PRO . 0.1 OUTLIER -103.96 168.63 8.34 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.353 -0.842 . . . . 0.0 109.023 179.218 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 101' ' ' PRO . . . . . 0.469 ' HD2' ' CG ' ' B' ' 100' ' ' LEU . 41.9 Cg_endo -68.23 -25.28 36.95 Favored 'Trans proline' 0 C--N 1.301 -1.933 0 O-C-N 123.645 1.34 . . . . 0.0 109.376 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -68.27 -28.57 67.31 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.484 -0.76 . . . . 0.0 110.894 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 117.28 -10.65 14.77 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 104' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -81.72 144.55 31.05 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.897 -1.355 . . . . 0.0 110.804 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 105' ' ' GLU . . . . . 0.487 ' OE2' HG23 ' B' ' 97' ' ' THR . 73.5 tt0 -135.88 147.93 48.39 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.178 -0.951 . . . . 0.0 111.955 -179.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 106' ' ' PHE . . . . . 0.448 ' CD1' ' OE2' ' B' ' 74' ' ' GLU . 96.6 m-85 -131.95 151.16 51.9 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -125.74 142.27 51.59 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.718 -1.239 . . . . 0.0 112.07 -178.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 108' ' ' PHE . . . . . 0.414 ' HB2' HD23 ' B' ' 96' ' ' LEU . 1.8 m-85 -113.16 144.65 31.57 Favored Pre-proline 0 N--CA 1.494 1.728 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -69.76 160.28 50.27 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 123.467 1.246 . . . . 0.0 111.652 -178.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 110' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' B' ' 94' ' ' ALA . 58.4 t30 -72.11 53.78 0.28 Allowed 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.81 -0.556 . . . . 0.0 112.158 -178.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 75.1 mtt85 -65.27 -38.61 90.81 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.847 -1.158 . . . . 0.0 109.056 177.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 98.2 mt -91.5 134.08 34.95 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.358 -0.839 . . . . 0.0 111.157 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 -96.13 18.78 12.85 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.414 -0.804 . . . . 0.0 110.997 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 50.6 tp -63.86 131.89 49.15 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.059 -1.026 . . . . 0.0 110.24 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -89.7 -12.83 38.33 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.042 -1.036 . . . . 0.0 111.849 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 116' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' B' ' 11' ' ' LEU . . . -161.2 155.69 23.16 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.372 -1.455 . . . . 0.0 111.787 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 117' ' ' ILE . . . . . 0.502 ' HB ' ' HB3' ' B' ' 11' ' ' LEU . 41.3 mm -100.1 119.8 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.228 -0.92 . . . . 0.0 109.649 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 118' ' ' ASN . . . . . 0.429 ' OD1' ' ND2' ' B' ' 10' ' ' ASN . 23.4 m-80 -111.04 -30.42 7.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.404 -0.81 . . . . 0.0 111.351 -178.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 119' ' ' TYR . . . . . 0.505 ' HB2' ' O ' ' B' ' 36' ' ' LYS . 57.8 t80 -107.03 131.03 54.54 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.013 -1.054 . . . . 0.0 110.219 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 120' ' ' MET . . . . . 0.488 ' HB3' ' CD1' ' B' ' 9' ' ' LEU . 55.5 ttp -141.91 130.89 23.11 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -151.14 144.4 24.75 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.054 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 122' ' ' ALA . . . . . 0.457 ' O ' ' HA3' ' B' ' 3' ' ' GLY . . . -141.68 125.02 16.51 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 123' ' ' ASP . . . . . 0.407 ' HB3' ' N ' ' B' ' 2' ' ' CYS . 65.1 m-20 -150.72 134.33 16.48 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.481 -0.762 . . . . 0.0 109.192 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 158.3 -155.48 26.5 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.044 -1.55 . . . . 0.0 109.554 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 125' ' ' ASP . . . . . 0.462 ' HB3' ' HA ' ' B' ' 27' ' ' ALA . 96.4 m-20 -73.25 -7.4 51.35 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.584 -0.951 . . . . 0.0 110.294 179.186 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 126' ' ' PHE . . . . . 0.456 ' HD1' HG22 ' B' ' 23' ' ' VAL . 33.9 t80 -99.09 138.77 35.72 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.525 -0.734 . . . . 0.0 110.092 -178.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 127' ' ' LYS . . . . . 0.441 ' O ' ' CA ' ' B' ' 21' ' ' GLY . 75.7 mmtt -106.88 144.19 33.87 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 118.945 -1.102 . . . . 0.0 112.074 -178.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 128' ' ' ILE . . . . . 0.557 ' O ' HD12 ' B' ' 4' ' ' LEU . 5.1 tt -125.88 106.67 16.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.128 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -102.84 -5.6 23.42 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.888 -1.132 . . . . 0.0 111.771 -178.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 130' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -153.55 134.99 14.25 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 118.26 -1.376 . . . . 0.0 112.05 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.4 ' CG2' HD11 ' B' ' 128' ' ' ILE . 50.6 t -127.49 131.75 69.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 132' ' ' ALA . . . . . . . . . . . . . . . -131.91 139.91 48.89 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.446 -1.408 . . . . 0.0 110.477 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 133' ' ' PHE . . . . . 0.501 ' CE1' HD13 ' B' ' 17' ' ' LEU . 32.7 m-85 -98.79 121.08 40.28 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.8 -1.188 . . . . 0.0 110.959 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 134' ' ' ASP . . . . . 0.417 ' N ' ' O ' ' B' ' 16' ' ' CYS . 62.1 t0 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.407 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.486 ' HA3' ' O ' ' A' ' 122' ' ' ALA . . . . . . . . 0 N--CA 1.485 1.918 0 N-CA-C 107.98 -2.048 . . . . 0.0 107.98 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.578 HD12 ' N ' ' A' ' 4' ' ' LEU . 11.1 mp -93.44 142.21 27.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.071 -1.252 . . . . 0.0 110.43 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.3 t -108.56 131.54 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 121.198 -0.939 . . . . 0.0 110.117 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -130.41 172.61 11.68 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.951 -1.093 . . . . 0.0 111.822 -178.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.416 ' O ' ' CB ' ' A' ' 8' ' ' ASN . 30.5 p -155.07 167.2 31.15 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.45 -0.781 . . . . 0.0 110.001 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' B' ' 3' ' ' GLY . 20.2 t-20 63.43 40.01 8.74 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.384 0.611 . . . . 0.0 110.446 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.476 ' O ' ' C ' ' A' ' 10' ' ' ASN . 56.5 mt -99.66 16.2 24.24 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.314 -0.867 . . . . 0.0 110.316 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.498 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 51.0 t-20 -18.76 88.8 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.381 0 CA-C-O 121.996 0.903 . . . . 0.0 112.674 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.576 HD12 ' CZ ' ' A' ' 133' ' ' PHE . 5.2 tt -100.5 134.68 43.1 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.584 -0.698 . . . . 0.0 109.96 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.465 ' HD2' ' HD2' ' A' ' 13' ' ' PRO . 0.6 OUTLIER -111.55 171.22 4.51 Favored Pre-proline 0 C--N 1.297 -1.695 0 O-C-N 121.069 -1.019 . . . . 0.0 109.784 179.031 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.465 ' HD2' ' HD2' ' A' ' 12' ' ' LYS . 44.2 Cg_endo -66.19 144.63 75.77 Favored 'Trans proline' 0 C--N 1.299 -2.045 0 O-C-N 123.89 1.468 . . . . 0.0 110.278 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 104.44 -24.72 28.04 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -90.08 150.2 22.17 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.241 -1.153 . . . . 0.0 110.471 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.423 ' SG ' ' N ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -106.31 159.34 16.2 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.417 -0.802 . . . . 0.0 109.99 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.635 HD13 ' N ' ' A' ' 18' ' ' ARG . 0.6 OUTLIER -134.77 123.39 23.53 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.682 -1.261 . . . . 0.0 110.364 179.659 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.635 ' N ' HD13 ' A' ' 17' ' ' LEU . 79.5 ttt180 -117.04 132.65 56.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.226 -0.921 . . . . 0.0 109.888 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.492 HG13 ' CD1' ' A' ' 128' ' ' ILE . 54.7 t -122.12 108.99 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.511 -0.743 . . . . 0.0 111.136 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 77.3 ttt-85 -110.0 123.17 49.19 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.764 -1.21 . . . . 0.0 110.575 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -147.11 -161.3 9.3 Favored Glycine 0 N--CA 1.489 2.188 0 C-N-CA 119.365 -1.398 . . . . 0.0 110.172 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -127.31 134.72 49.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.455 -1.026 . . . . 0.0 109.305 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.635 HG22 ' CD1' ' A' ' 126' ' ' PHE . 93.8 t -101.88 129.5 53.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 121.073 -1.017 . . . . 0.0 109.593 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.52 161.89 1.92 Allowed Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.323 -0.861 . . . . 0.0 110.281 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.52 -20.22 54.15 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 O-C-N 123.69 1.363 . . . . 0.0 109.573 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -111.76 44.03 1.44 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.661 -0.65 . . . . 0.0 110.393 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.58 ' HB2' ' CG1' ' A' ' 23' ' ' VAL . . . -71.15 91.09 0.9 Allowed 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 118.918 -1.113 . . . . 0.0 109.563 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -98.71 -20.93 16.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.385 -0.822 . . . . 0.0 109.985 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.1 t -150.11 143.5 25.13 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.882 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.524 ' HA ' ' HA3' ' A' ' 124' ' ' GLY . 40.7 t80 -147.79 134.95 20.44 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.448 -0.782 . . . . 0.0 110.289 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.457 HG22 ' ND2' ' A' ' 46' ' ' ASN . 67.4 t -127.47 131.0 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.824 -1.172 . . . . 0.0 110.307 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.726 HD12 ' N ' ' A' ' 33' ' ' ASN . 5.0 tp -138.58 141.81 39.21 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.519 -0.738 . . . . 0.0 110.383 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.864 ' HB2' HD13 ' A' ' 41' ' ' LEU . 9.6 p30 -154.25 143.09 20.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.053 -1.029 . . . . 0.0 110.7 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.481 ' O ' HD12 ' A' ' 34' ' ' LEU . 1.5 pp -136.13 118.48 15.69 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.496 -0.753 . . . . 0.0 109.628 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.802 ' HA3' HD23 ' A' ' 41' ' ' LEU . . . -142.85 -136.49 3.19 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.822 -1.18 . . . . 0.0 110.602 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.456 ' CG ' ' N ' ' A' ' 37' ' ' ASP . 24.0 pttt -127.64 -37.14 1.99 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.371 -1.076 . . . . 0.0 111.101 -179.034 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.456 ' N ' ' CG ' ' A' ' 36' ' ' LYS . 86.3 m-20 -115.25 -83.59 0.62 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.125 -0.985 . . . . 0.0 110.309 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.2 t -151.58 -53.6 0.13 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 60.6 m-20 -93.85 -4.06 50.74 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.343 -0.848 . . . . 0.0 109.004 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.415 ' O ' ' HA3' ' A' ' 35' ' ' GLY . 12.3 m120 -91.18 68.72 6.05 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.175 -0.953 . . . . 0.0 109.854 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.864 HD13 ' HB2' ' A' ' 33' ' ' ASN . 75.8 mt -106.47 133.02 51.8 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.438 -0.789 . . . . 0.0 110.676 -179.237 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.528 ' O ' HD23 ' A' ' 43' ' ' LEU . 69.8 m -85.1 -36.01 21.43 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.564 -0.71 . . . . 0.0 110.253 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 1.047 HD21 HD13 ' A' ' 96' ' ' LEU . 79.5 mt -129.97 129.16 43.42 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 119.454 -0.898 . . . . 0.0 111.542 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.46 ' HB3' ' OD1' ' A' ' 61' ' ' ASN . 24.6 t60 -126.3 123.98 39.3 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.343 -0.848 . . . . 0.0 109.41 178.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -110.79 131.6 54.91 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.177 -0.952 . . . . 0.0 109.443 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.457 ' ND2' HG22 ' A' ' 31' ' ' VAL . 4.4 t-20 -149.27 78.04 8.77 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 120.926 -1.109 . . . . 0.0 111.285 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.428 ' HG2' ' HB3' ' A' ' 30' ' ' PHE . 47.2 Cg_endo -69.78 144.66 54.61 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.779 1.41 . . . . 0.0 110.014 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -144.46 88.18 1.92 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.865 -1.147 . . . . 0.0 110.869 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.48 ' O ' ' HA ' ' A' ' 55' ' ' ALA . 33.0 t80 -61.78 -46.4 89.74 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.332 0.587 . . . . 0.0 110.393 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -133.72 99.12 4.37 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.294 -0.879 . . . . 0.0 110.008 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -118.78 -69.1 0.87 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.003 -1.061 . . . . 0.0 110.893 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -105.13 -15.67 15.01 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.42 -0.8 . . . . 0.0 110.617 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 159.68 -12.91 0.19 Allowed Glycine 0 N--CA 1.494 2.543 0 C-N-CA 119.866 -1.159 . . . . 0.0 110.514 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -75.78 -179.95 5.08 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.849 -1.383 . . . . 0.0 109.444 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 49' ' ' PHE . . . -129.67 -7.46 4.58 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.146 -0.971 . . . . 0.0 111.723 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 43.2 p30 -163.48 72.82 0.29 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.007 -1.058 . . . . 0.0 110.279 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 73.4 m -124.66 130.46 52.46 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.943 -1.098 . . . . 0.0 111.327 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 98.3 mt -121.76 130.64 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.28 -0.888 . . . . 0.0 111.089 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.0 t -114.31 129.98 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.297 -0.877 . . . . 0.0 110.495 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 33.8 m -129.16 122.1 29.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.319 -0.863 . . . . 0.0 110.067 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.525 ' HB3' ' HG2' ' A' ' 71' ' ' GLU . 4.9 p-10 -138.94 175.0 9.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.422 -0.799 . . . . 0.0 109.985 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.3 m -129.9 155.12 46.56 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.536 ' CD ' ' HA2' ' A' ' 66' ' ' GLY . 6.9 ttmt -135.47 149.29 49.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.495 -1.378 . . . . 0.0 112.128 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.587 ' HB2' HD11 ' A' ' 112' ' ' LEU . 56.6 t0 -129.19 100.43 5.61 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.44 21.28 68.51 Favored Glycine 0 N--CA 1.487 2.075 0 C-N-CA 119.801 -1.19 . . . . 0.0 110.62 179.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.536 ' HA2' ' CD ' ' A' ' 63' ' ' LYS . . . 74.52 24.56 72.48 Favored Glycine 0 N--CA 1.488 2.162 0 C-N-CA 119.145 -1.503 . . . . 0.0 110.275 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -105.4 -74.35 0.65 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.897 -1.355 . . . . 0.0 110.742 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -69.22 -178.47 1.33 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.698 -0.626 . . . . 0.0 109.975 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 166.53 44.79 0.02 OUTLIER Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.0 m -62.39 100.39 0.18 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.066 -1.256 . . . . 0.0 110.504 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.525 ' HG2' ' HB3' ' A' ' 61' ' ' ASN . 89.5 mt-10 -84.97 123.15 30.19 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.336 -0.853 . . . . 0.0 110.903 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -101.39 -168.49 1.56 Allowed 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -146.27 122.27 10.71 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 118.04 -1.464 . . . . 0.0 111.695 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -108.67 132.71 53.64 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.59 60.27 0.6 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.795 -1.19 . . . . 0.0 111.234 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.546 HG22 ' HD3' ' A' ' 78' ' ' PRO . 4.6 p -135.23 151.25 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.942 -1.098 . . . . 0.0 110.4 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.497 ' CG ' ' O ' ' A' ' 77' ' ' PHE . 8.4 p90 -144.46 71.98 15.82 Favored Pre-proline 0 C--N 1.302 -1.475 0 O-C-N 121.098 -1.001 . . . . 0.0 109.874 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.546 ' HD3' HG22 ' A' ' 76' ' ' VAL . 39.9 Cg_endo -65.43 -13.8 41.67 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.892 1.469 . . . . 0.0 110.33 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -117.92 167.24 11.6 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.444 -0.785 . . . . 0.0 110.641 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.88 168.02 15.66 Favored Pre-proline 0 C--N 1.297 -1.674 0 O-C-N 121.546 -0.721 . . . . 0.0 109.598 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -65.65 148.66 87.32 Favored 'Trans proline' 0 C--N 1.298 -2.086 0 O-C-N 123.852 1.448 . . . . 0.0 110.671 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 62.29 42.44 99.72 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.6 t -148.32 137.56 21.96 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.097 -1.237 . . . . 0.0 109.988 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.5 m -78.06 140.22 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.01 -1.056 . . . . 0.0 108.997 178.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.98 153.55 38.09 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.158 -0.963 . . . . 0.0 109.707 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -122.46 152.65 40.06 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.234 -0.916 . . . . 0.0 110.044 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.0 t -128.98 139.34 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.489 -0.757 . . . . 0.0 111.503 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' CYS . . . . . 0.429 ' HB3' ' HB2' ' A' ' 99' ' ' LYS . 4.8 t -114.26 115.73 27.89 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.427 -0.796 . . . . 0.0 109.943 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 86.6 mt -121.22 128.1 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.141 -0.974 . . . . 0.0 110.014 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.479 ' HB ' ' HB ' ' A' ' 97' ' ' THR . 33.5 m -123.06 134.88 54.25 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.033 -1.042 . . . . 0.0 109.426 179.345 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.513 ' CE1' HD21 ' A' ' 96' ' ' LEU . 80.8 t80 -104.67 118.25 36.11 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.177 -0.952 . . . . 0.0 110.25 -179.19 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.402 ' HB2' ' OD1' ' A' ' 95' ' ' ASN . 86.7 m-20 -112.52 143.21 44.06 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.399 -0.921 . . . . 0.0 109.452 178.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 71.6 tp60 -59.58 -26.51 65.47 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.522 -0.736 . . . . 0.0 110.668 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.89 -22.48 23.12 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.225 -0.922 . . . . 0.0 111.634 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.402 ' OD1' ' HB2' ' A' ' 92' ' ' ASP . 45.4 p30 -174.61 -171.58 0.58 Allowed 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.093 -1.005 . . . . 0.0 108.981 -178.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 1.047 HD13 HD21 ' A' ' 43' ' ' LEU . 75.9 mt -122.49 135.06 54.57 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.002 -1.061 . . . . 0.0 110.58 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.479 ' HB ' ' HB ' ' A' ' 90' ' ' THR . 29.5 m -109.26 122.72 47.95 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.1 -1.0 . . . . 0.0 109.031 178.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 44.8 t -124.7 128.14 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.742 -1.224 . . . . 0.0 109.611 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.429 ' HB2' ' HB3' ' A' ' 88' ' ' CYS . 98.4 mttt -122.61 147.62 46.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.298 -0.877 . . . . 0.0 110.925 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.431 HD13 ' HG3' ' A' ' 78' ' ' PRO . 27.5 mt -107.28 166.63 10.7 Favored Pre-proline 0 N--CA 1.493 1.696 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -63.31 -24.32 71.86 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.368 1.194 . . . . 0.0 110.92 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.468 ' HB2' ' CB ' ' A' ' 78' ' ' PRO . 36.9 t70 -76.52 -10.26 59.26 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.074 -1.016 . . . . 0.0 110.84 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 104.34 -8.0 47.88 Favored Glycine 0 N--CA 1.496 2.656 0 C-N-CA 119.821 -1.18 . . . . 0.0 110.753 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -73.0 135.41 44.95 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.787 -1.419 . . . . 0.0 110.28 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.431 ' OE2' HG23 ' A' ' 97' ' ' THR . 71.8 tt0 -124.88 142.49 51.41 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.881 -1.137 . . . . 0.0 110.75 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -133.67 146.15 50.59 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 98.1 mttt -121.79 146.36 47.14 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.831 -1.168 . . . . 0.0 112.971 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.564 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 98.0 m-85 -117.22 150.23 45.89 Favored Pre-proline 0 N--CA 1.493 1.722 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.199 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.08 149.85 65.43 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.689 1.363 . . . . 0.0 111.142 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -71.04 62.74 0.3 Allowed 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.611 -0.681 . . . . 0.0 111.652 -178.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 79.6 mtp85 -65.39 -39.89 92.79 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.995 -1.066 . . . . 0.0 110.381 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.587 HD11 ' HB2' ' A' ' 64' ' ' ASP . 4.4 mm? -95.75 130.4 42.68 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.131 -0.981 . . . . 0.0 110.361 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -87.95 7.26 31.84 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.501 -0.749 . . . . 0.0 111.026 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.498 HD23 ' O ' ' A' ' 114' ' ' LEU . 3.6 tt -57.82 128.68 38.32 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.224 -0.99 . . . . 0.0 109.222 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -106.32 -5.59 18.98 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.498 -0.751 . . . . 0.0 111.295 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' A' ' 11' ' ' LEU . . . -137.84 132.35 32.43 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.715 -1.24 . . . . 0.0 110.472 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.498 ' O ' ' HA ' ' A' ' 10' ' ' ASN . 95.6 mt -111.29 128.89 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 O-C-N 120.894 -1.129 . . . . 0.0 110.45 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -126.66 -27.62 3.08 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.026 -1.046 . . . . 0.0 111.645 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.412 ' O ' ' N ' ' A' ' 35' ' ' GLY . 69.4 t80 -92.67 126.09 37.6 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.007 -1.058 . . . . 0.0 110.466 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.423 ' HB3' ' CD1' ' A' ' 9' ' ' LEU . 27.1 ttm -141.01 134.73 30.28 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.993 -1.067 . . . . 0.0 109.573 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -159.11 147.95 18.34 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.26 -0.976 . . . . 0.0 109.686 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.486 ' O ' ' HA3' ' A' ' 3' ' ' GLY . . . -147.3 156.21 42.71 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -155.74 160.74 40.57 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 179.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.524 ' HA3' ' HA ' ' A' ' 30' ' ' PHE . . . 143.09 -157.27 26.83 Favored Glycine 0 C--N 1.295 -1.725 0 C-N-CA 118.548 -1.787 . . . . 0.0 110.439 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.483 ' CB ' ' HA ' ' A' ' 27' ' ' ALA . 63.1 m-20 -91.34 11.39 23.84 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.845 -0.797 . . . . 0.0 110.753 -179.298 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.635 ' CD1' HG22 ' A' ' 23' ' ' VAL . 12.3 t80 -107.42 151.25 25.78 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.822 -1.174 . . . . 0.0 110.681 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -120.8 124.8 45.96 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.564 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.492 ' CD1' HG13 ' A' ' 19' ' ' VAL . 17.7 tt -102.49 126.74 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.928 . . . . 0.0 110.329 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 28.0 pttt -118.63 -4.81 10.75 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.795 -1.191 . . . . 0.0 111.053 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.497 ' HA ' ' O ' ' B' ' 131' ' ' VAL . 0.0 OUTLIER -154.35 131.96 11.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.74 -1.225 . . . . 0.0 111.928 -179.32 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' B' ' 130' ' ' CYS . 53.4 t -128.78 134.63 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.569 -0.707 . . . . 0.0 109.658 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.433 ' HA ' ' HB2' ' B' ' 130' ' ' CYS . . . -142.38 142.92 32.49 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.497 -1.377 . . . . 0.0 110.392 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.576 ' CZ ' HD12 ' A' ' 11' ' ' LEU . 3.1 m-85 -76.47 -86.73 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.813 -1.179 . . . . 0.0 111.248 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 46.4 t0 . . . . . 0 C--N 1.296 -1.723 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.384 -179.169 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.85 0 CA-C-O 121.115 0.483 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 2' ' ' CYS . . . . . 0.405 ' O ' ' HA ' ' B' ' 123' ' ' ASP . 34.2 m -114.71 39.29 2.88 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.022 -1.049 . . . . 0.0 109.264 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 3' ' ' GLY . . . . . 0.534 ' O ' ' ND2' ' A' ' 8' ' ' ASN . . . 79.86 168.93 37.97 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 108.031 -2.028 . . . . 0.0 108.031 -178.364 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.576 ' N ' HD12 ' B' ' 4' ' ' LEU . 11.0 mp -93.07 141.69 28.13 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.965 -1.315 . . . . 0.0 110.751 -179.101 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 41.9 t -107.82 131.6 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.382 0 O-C-N 121.082 -1.011 . . . . 0.0 110.242 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -130.5 173.11 11.18 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.044 -1.035 . . . . 0.0 112.011 -178.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 7' ' ' SER . . . . . 0.401 ' O ' ' HB3' ' B' ' 8' ' ' ASN . 27.1 p -155.34 168.25 27.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.426 -0.797 . . . . 0.0 109.802 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 8' ' ' ASN . . . . . 0.436 ' ND2' ' O ' ' A' ' 3' ' ' GLY . 20.2 t-20 62.61 41.09 9.77 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.589 -0.695 . . . . 0.0 110.416 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.472 ' O ' ' C ' ' B' ' 10' ' ' ASN . 54.8 mt -101.19 17.03 23.57 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.437 -0.79 . . . . 0.0 110.04 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 10' ' ' ASN . . . . . 0.479 ' HA ' ' O ' ' B' ' 117' ' ' ILE . 51.2 t-20 -20.0 89.04 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.39 0 CA-C-O 121.95 0.881 . . . . 0.0 112.77 -179.287 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.576 HD12 ' CZ ' ' B' ' 133' ' ' PHE . 5.2 tt -100.44 134.16 43.8 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.703 -0.623 . . . . 0.0 109.885 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 12' ' ' LYS . . . . . 0.47 ' HD2' ' HD2' ' B' ' 13' ' ' PRO . 0.5 OUTLIER -111.34 171.09 4.6 Favored Pre-proline 0 C--N 1.293 -1.883 0 O-C-N 121.244 -0.91 . . . . 0.0 109.94 179.126 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 13' ' ' PRO . . . . . 0.47 ' HD2' ' HD2' ' B' ' 12' ' ' LYS . 44.1 Cg_endo -65.94 144.35 76.25 Favored 'Trans proline' 0 C--N 1.301 -1.942 0 O-C-N 123.919 1.484 . . . . 0.0 110.115 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 104.32 -24.01 30.16 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -90.92 149.83 21.74 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.194 -1.18 . . . . 0.0 110.591 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 16' ' ' CYS . . . . . 0.419 ' SG ' ' N ' ' B' ' 17' ' ' LEU . 0.0 OUTLIER -106.86 159.62 16.12 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.48 -0.763 . . . . 0.0 109.72 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.639 HD13 ' N ' ' B' ' 18' ' ' ARG . 0.6 OUTLIER -135.0 122.64 22.14 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.621 -1.299 . . . . 0.0 110.383 179.845 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.639 ' N ' HD13 ' B' ' 17' ' ' LEU . 80.1 ttt180 -115.77 133.35 56.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.361 -0.837 . . . . 0.0 109.816 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.483 HG13 ' CD1' ' B' ' 128' ' ' ILE . 55.2 t -122.82 109.19 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.29 -0.881 . . . . 0.0 111.13 -178.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 77.2 ttt-85 -109.82 123.28 49.29 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.993 -1.067 . . . . 0.0 110.631 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -147.22 -161.4 9.38 Favored Glycine 0 N--CA 1.487 2.075 0 C-N-CA 119.456 -1.354 . . . . 0.0 110.009 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 71.3 tt0 -127.22 136.38 51.95 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.575 -0.956 . . . . 0.0 109.081 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.649 HG22 ' CD1' ' B' ' 126' ' ' PHE . 90.5 t -103.98 129.15 56.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 O-C-N 121.174 -0.954 . . . . 0.0 109.789 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.04 161.15 1.93 Allowed Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.506 -0.746 . . . . 0.0 110.172 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 25' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' B' ' 81' ' ' PRO . 42.7 Cg_endo -66.02 -20.16 57.39 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.802 1.422 . . . . 0.0 109.775 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -112.2 44.31 1.44 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.693 -0.629 . . . . 0.0 110.388 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 27' ' ' ALA . . . . . 0.565 ' HB2' ' CG1' ' B' ' 23' ' ' VAL . . . -71.84 91.25 1.15 Allowed 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 118.95 -1.1 . . . . 0.0 109.415 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -98.71 -20.58 16.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.491 -0.755 . . . . 0.0 109.777 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 24.8 t -149.65 143.31 25.42 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.076 -1.015 . . . . 0.0 111.046 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 30' ' ' PHE . . . . . 0.527 ' HA ' ' HA3' ' B' ' 124' ' ' GLY . 41.0 t80 -147.69 134.75 20.35 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.508 -0.745 . . . . 0.0 110.162 179.105 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.407 HG22 ' ND2' ' B' ' 46' ' ' ASN . 76.9 t -127.74 131.05 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.852 -1.155 . . . . 0.0 110.437 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.752 HD12 ' N ' ' B' ' 33' ' ' ASN . 5.1 tp -138.53 142.58 39.3 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.384 -0.823 . . . . 0.0 110.361 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 33' ' ' ASN . . . . . 0.885 ' HB2' HD13 ' B' ' 41' ' ' LEU . 11.1 p30 -155.11 142.59 19.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.964 -1.085 . . . . 0.0 110.671 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.486 HD12 ' O ' ' B' ' 34' ' ' LEU . 1.5 pp -135.92 119.2 16.69 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.227 -0.921 . . . . 0.0 109.679 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 35' ' ' GLY . . . . . 0.812 ' HA3' HD23 ' B' ' 41' ' ' LEU . . . -143.53 -137.58 3.28 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 119.922 -1.133 . . . . 0.0 110.392 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 36' ' ' LYS . . . . . 0.44 ' CG ' ' N ' ' B' ' 37' ' ' ASP . 24.6 pttt -126.86 -37.47 2.12 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.246 -1.149 . . . . 0.0 111.174 -178.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 37' ' ' ASP . . . . . 0.451 ' O ' ' CD1' ' B' ' 119' ' ' TYR . 88.3 m-20 -114.25 -84.14 0.61 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.976 -1.078 . . . . 0.0 109.958 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 7.7 t -150.76 -54.22 0.15 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.403 -0.811 . . . . 0.0 109.023 178.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 58.3 m-20 -92.6 -4.5 53.29 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.372 -0.83 . . . . 0.0 108.824 178.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 40' ' ' ASN . . . . . 0.421 ' O ' ' HA3' ' B' ' 35' ' ' GLY . 12.6 m120 -90.96 69.07 6.3 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.271 -0.893 . . . . 0.0 110.017 -178.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.885 HD13 ' HB2' ' B' ' 33' ' ' ASN . 77.5 mt -105.8 135.93 46.33 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.434 -0.791 . . . . 0.0 110.674 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 42' ' ' CYS . . . . . 0.577 ' O ' HD23 ' B' ' 43' ' ' LEU . 74.2 m -88.83 -34.31 17.08 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.336 -0.852 . . . . 0.0 109.561 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 1.027 HD21 HD13 ' B' ' 96' ' ' LEU . 74.6 mt -131.25 129.71 41.92 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.192 -1.003 . . . . 0.0 111.276 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 44' ' ' HIS . . . . . 0.448 ' HB3' ' OD1' ' B' ' 61' ' ' ASN . 23.0 t60 -127.0 123.28 36.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.506 -0.746 . . . . 0.0 109.297 178.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -110.15 131.31 55.17 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.133 -0.979 . . . . 0.0 109.762 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 46' ' ' ASN . . . . . 0.407 ' ND2' HG22 ' B' ' 31' ' ' VAL . 4.3 t-20 -148.51 78.08 9.37 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.074 -1.016 . . . . 0.0 111.506 -179.08 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 47' ' ' PRO . . . . . 0.443 ' HG2' ' HB3' ' B' ' 30' ' ' PHE . 47.8 Cg_endo -69.83 144.96 55.31 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 123.627 1.33 . . . . 0.0 109.839 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -145.26 88.51 1.87 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.898 -1.127 . . . . 0.0 110.566 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 49' ' ' PHE . . . . . 0.497 ' O ' ' HA ' ' B' ' 55' ' ' ALA . 33.8 t80 -61.65 -45.78 92.58 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.277 0.56 . . . . 0.0 110.417 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 27.1 t30 -134.79 98.67 4.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.286 -0.884 . . . . 0.0 110.239 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -118.74 -68.08 0.94 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.056 -1.028 . . . . 0.0 110.977 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 52' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -105.63 -15.2 15.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.295 -0.878 . . . . 0.0 110.886 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 159.52 -14.21 0.21 Allowed Glycine 0 N--CA 1.495 2.585 0 C-N-CA 119.913 -1.137 . . . . 0.0 110.277 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -74.45 179.67 4.5 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.752 -1.44 . . . . 0.0 109.045 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' B' ' 49' ' ' PHE . . . -129.03 -11.11 4.77 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.066 -1.021 . . . . 0.0 111.387 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 56' ' ' ASN . . . . . . . . . . . . . 41.1 p30 -158.91 72.89 0.59 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.187 -0.945 . . . . 0.0 110.714 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 80.7 m -124.45 130.93 53.36 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 120.494 -1.379 . . . . 0.0 111.575 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 58' ' ' ILE . . . . . 0.408 ' HA ' ' HA ' ' B' ' 47' ' ' PRO . 98.1 mt -122.15 130.77 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.47 -0.769 . . . . 0.0 111.209 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 12.9 t -114.48 129.62 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.416 -0.802 . . . . 0.0 110.677 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 33.2 m -128.5 121.69 29.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.293 -0.879 . . . . 0.0 110.137 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 61' ' ' ASN . . . . . 0.547 ' HB3' ' HG2' ' B' ' 71' ' ' GLU . 3.8 p-10 -139.32 174.16 10.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.134 -0.979 . . . . 0.0 110.188 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 7.2 m -129.18 155.15 45.97 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.476 -0.765 . . . . 0.0 108.953 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 63' ' ' LYS . . . . . 0.531 ' CD ' ' HA2' ' B' ' 66' ' ' GLY . 6.8 ttmt -135.14 150.19 50.14 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.508 -1.37 . . . . 0.0 112.114 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 64' ' ' ASP . . . . . 0.559 ' HB2' HD11 ' B' ' 112' ' ' LEU . 54.5 t0 -129.7 100.38 5.48 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 64.52 21.3 66.68 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.843 -1.17 . . . . 0.0 110.435 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 66' ' ' GLY . . . . . 0.531 ' HA2' ' CD ' ' B' ' 63' ' ' LYS . . . 74.68 25.6 69.44 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.251 -1.452 . . . . 0.0 110.473 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -105.95 -73.27 0.69 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.989 -1.3 . . . . 0.0 110.583 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 68' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -70.59 -177.06 1.41 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.653 -0.655 . . . . 0.0 109.887 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 164.94 46.4 0.02 OUTLIER Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 15.8 m -63.85 100.81 0.32 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.271 -1.134 . . . . 0.0 110.462 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 71' ' ' GLU . . . . . 0.547 ' HG2' ' HB3' ' B' ' 61' ' ' ASN . 86.4 mt-10 -85.49 123.32 30.79 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.274 -0.891 . . . . 0.0 111.017 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -101.23 -167.81 1.47 Allowed 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -147.3 120.7 9.02 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 117.991 -1.484 . . . . 0.0 111.822 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -106.86 132.83 52.37 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.49 60.84 0.6 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.926 -1.109 . . . . 0.0 111.128 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 76' ' ' VAL . . . . . 0.541 HG22 ' HD3' ' B' ' 78' ' ' PRO . 4.6 p -136.51 151.24 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.9 -1.125 . . . . 0.0 110.251 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 77' ' ' PHE . . . . . 0.494 ' O ' ' CG ' ' B' ' 77' ' ' PHE . 9.1 p90 -144.98 71.65 14.84 Favored Pre-proline 0 C--N 1.303 -1.444 0 O-C-N 121.204 -0.935 . . . . 0.0 109.99 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 78' ' ' PRO . . . . . 0.541 ' HD3' HG22 ' B' ' 76' ' ' VAL . 41.0 Cg_endo -64.71 -14.38 44.39 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.088 1.573 . . . . 0.0 110.422 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -116.89 167.24 11.3 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.191 -0.943 . . . . 0.0 110.408 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.77 167.66 16.9 Favored Pre-proline 0 C--N 1.3 -1.554 0 O-C-N 121.707 -0.621 . . . . 0.0 109.387 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 81' ' ' PRO . . . . . 0.418 ' HB2' ' O ' ' B' ' 25' ' ' PRO . 42.7 Cg_endo -65.94 148.41 85.94 Favored 'Trans proline' 0 C--N 1.297 -2.165 0 O-C-N 123.946 1.498 . . . . 0.0 110.391 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 62.47 43.18 99.4 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 15.9 t -149.32 138.73 21.57 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.196 -1.179 . . . . 0.0 110.043 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.409 ' H ' HG22 ' B' ' 84' ' ' VAL . 15.4 m -79.1 140.08 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.136 -0.978 . . . . 0.0 109.156 178.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.71 154.13 39.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.063 -1.023 . . . . 0.0 109.81 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -123.29 152.66 41.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.049 -1.032 . . . . 0.0 109.993 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 87' ' ' VAL . . . . . 0.43 HG12 HG13 ' B' ' 89' ' ' ILE . 46.9 t -128.4 138.52 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.399 -0.813 . . . . 0.0 111.457 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 88' ' ' CYS . . . . . 0.435 ' HB3' ' HB2' ' B' ' 99' ' ' LYS . 4.7 t -113.49 114.73 26.95 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.422 -0.799 . . . . 0.0 109.845 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.43 HG13 HG12 ' B' ' 87' ' ' VAL . 87.1 mt -120.69 128.42 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.252 -0.905 . . . . 0.0 110.0 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 90' ' ' THR . . . . . 0.512 ' HB ' ' HB ' ' B' ' 97' ' ' THR . 27.8 m -123.09 134.94 54.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.222 -0.924 . . . . 0.0 109.628 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 91' ' ' PHE . . . . . 0.491 ' CE1' HD21 ' B' ' 96' ' ' LEU . 79.4 t80 -104.84 117.35 33.82 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.326 -0.858 . . . . 0.0 110.246 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -112.17 143.57 43.0 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.058 -1.026 . . . . 0.0 109.402 178.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 72.5 tp60 -60.69 -25.11 66.15 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.533 -0.729 . . . . 0.0 110.833 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.07 -22.35 21.86 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.973 -1.079 . . . . 0.0 111.499 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 45.6 p30 -174.39 -172.5 0.68 Allowed 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.163 -0.961 . . . . 0.0 108.947 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 96' ' ' LEU . . . . . 1.027 HD13 HD21 ' B' ' 43' ' ' LEU . 74.9 mt -121.72 134.93 54.95 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 120.993 -1.067 . . . . 0.0 110.697 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 97' ' ' THR . . . . . 0.512 ' HB ' ' HB ' ' B' ' 90' ' ' THR . 32.9 m -109.4 123.14 48.84 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.233 -0.917 . . . . 0.0 108.989 178.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 46.3 t -125.19 128.37 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.852 -1.155 . . . . 0.0 109.588 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 99' ' ' LYS . . . . . 0.435 ' HB2' ' HB3' ' B' ' 88' ' ' CYS . 98.5 mttt -122.89 146.27 47.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.179 -0.951 . . . . 0.0 110.899 -178.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 100' ' ' LEU . . . . . 0.434 HD13 ' HG3' ' B' ' 78' ' ' PRO . 25.0 mt -105.5 166.67 10.95 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -63.16 -25.43 72.72 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.239 1.126 . . . . 0.0 110.945 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 102' ' ' ASP . . . . . 0.468 ' HB2' ' CB ' ' B' ' 78' ' ' PRO . 36.3 t70 -74.42 -11.94 60.37 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.947 -1.096 . . . . 0.0 110.94 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 106.08 -8.5 42.07 Favored Glycine 0 N--CA 1.493 2.475 0 C-N-CA 119.887 -1.149 . . . . 0.0 110.683 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 104' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -72.3 136.48 46.25 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.933 -1.334 . . . . 0.0 110.25 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 105' ' ' GLU . . . . . 0.432 ' OE2' HG23 ' B' ' 97' ' ' THR . 71.4 tt0 -125.62 142.28 51.59 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.057 -1.027 . . . . 0.0 110.527 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -133.35 146.14 51.02 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.507 -0.746 . . . . 0.0 109.163 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 107' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' B' ' 96' ' ' LEU . 98.1 mttt -122.06 146.13 47.49 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.768 -1.208 . . . . 0.0 112.812 -178.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 108' ' ' PHE . . . . . 0.541 ' HB2' ' HB2' ' B' ' 96' ' ' LEU . 98.0 m-85 -117.09 150.28 45.78 Favored Pre-proline 0 N--CA 1.492 1.671 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.155 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.85 148.52 64.66 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.593 1.312 . . . . 0.0 111.261 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 110' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -69.77 62.85 0.19 Allowed 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.586 -0.696 . . . . 0.0 111.621 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 79.3 mtp85 -65.41 -39.78 92.58 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.919 -1.113 . . . . 0.0 110.277 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 112' ' ' LEU . . . . . 0.559 HD11 ' HB2' ' B' ' 64' ' ' ASP . 4.5 mm? -95.87 130.01 42.95 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.18 -0.95 . . . . 0.0 110.702 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -87.38 7.4 29.12 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.643 -0.66 . . . . 0.0 111.069 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 114' ' ' LEU . . . . . 0.484 HD23 ' O ' ' B' ' 114' ' ' LEU . 3.5 tt -58.07 129.2 40.85 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.053 -1.029 . . . . 0.0 109.239 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -106.65 -5.56 18.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.559 -0.713 . . . . 0.0 111.36 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 116' ' ' ALA . . . . . 0.443 ' HA ' ' O ' ' B' ' 11' ' ' LEU . . . -137.82 132.32 32.44 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.74 -1.225 . . . . 0.0 110.418 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 117' ' ' ILE . . . . . 0.479 ' O ' ' HA ' ' B' ' 10' ' ' ASN . 95.9 mt -111.72 128.71 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.927 -1.108 . . . . 0.0 110.269 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -126.1 -28.52 3.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.138 -0.976 . . . . 0.0 111.818 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 119' ' ' TYR . . . . . 0.451 ' CD1' ' O ' ' B' ' 37' ' ' ASP . 66.6 t80 -91.96 127.31 37.38 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.882 -1.136 . . . . 0.0 110.346 -179.185 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 120' ' ' MET . . . . . 0.425 ' HB3' ' CD1' ' B' ' 9' ' ' LEU . 26.5 ttm -142.0 134.26 27.79 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.115 -0.991 . . . . 0.0 109.592 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -158.89 147.71 18.53 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.101 -0.999 . . . . 0.0 109.448 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 122' ' ' ALA . . . . . 0.491 ' O ' ' HA3' ' B' ' 3' ' ' GLY . . . -147.14 155.0 41.78 Favored 'General case' 0 C--N 1.29 -1.995 0 O-C-N 121.472 -0.768 . . . . 0.0 108.975 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 123' ' ' ASP . . . . . 0.405 ' HA ' ' O ' ' B' ' 2' ' ' CYS . 9.6 p-10 -154.51 156.53 36.84 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 124' ' ' GLY . . . . . 0.527 ' HA3' ' HA ' ' B' ' 30' ' ' PHE . . . 148.93 -157.17 27.16 Favored Glycine 0 C--N 1.296 -1.693 0 C-N-CA 118.382 -1.866 . . . . 0.0 110.149 178.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 125' ' ' ASP . . . . . 0.483 ' CB ' ' HA ' ' B' ' 27' ' ' ALA . 63.1 m-20 -91.55 12.1 21.98 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 122.015 -0.697 . . . . 0.0 110.383 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 126' ' ' PHE . . . . . 0.649 ' CD1' HG22 ' B' ' 23' ' ' VAL . 11.5 t80 -108.58 151.4 26.17 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.668 -1.27 . . . . 0.0 110.402 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -121.23 124.57 44.97 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.268 -0.895 . . . . 0.0 110.356 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 128' ' ' ILE . . . . . 0.483 ' CD1' HG13 ' B' ' 19' ' ' VAL . 18.0 tt -101.86 127.3 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.156 -0.965 . . . . 0.0 110.39 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 29.1 pttt -119.11 -4.3 10.56 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.783 -1.198 . . . . 0.0 111.126 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 130' ' ' CYS . . . . . 0.441 ' HA ' ' O ' ' A' ' 131' ' ' VAL . 0.0 OUTLIER -154.29 130.96 10.71 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 118.947 -1.101 . . . . 0.0 111.91 -179.084 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 130' ' ' CYS . 54.7 t -128.05 133.85 66.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.659 -0.651 . . . . 0.0 109.956 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 132' ' ' ALA . . . . . . . . . . . . . . . -141.45 142.87 33.64 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 120.249 -1.532 . . . . 0.0 110.395 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 133' ' ' PHE . . . . . 0.576 ' CZ ' HD12 ' B' ' 11' ' ' LEU . 3.0 m-85 -76.19 -88.56 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.096 -1.002 . . . . 0.0 111.084 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 48.4 t0 . . . . . 0 C--N 1.296 -1.749 0 CA-C-O 118.096 -0.954 . . . . 0.0 110.356 -179.388 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.472 ' HA3' ' HB3' ' A' ' 123' ' ' ASP . . . . . . . . 0 N--CA 1.497 2.704 0 CA-C-O 121.851 0.695 . . . . 0.0 112.271 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.933 HD12 HG23 ' A' ' 128' ' ' ILE . 84.2 mt -63.76 137.12 57.93 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.627 -1.514 . . . . 0.0 109.25 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.6 t -110.07 132.46 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.364 -0.835 . . . . 0.0 109.804 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -134.82 161.33 35.51 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.845 -1.16 . . . . 0.0 110.112 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.455 ' O ' ' HB3' ' A' ' 8' ' ' ASN . 15.2 p -153.38 169.95 21.86 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.539 -0.726 . . . . 0.0 109.999 -178.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.455 ' HB3' ' O ' ' A' ' 7' ' ' SER . 4.9 t-20 65.74 39.08 4.94 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.263 0.554 . . . . 0.0 109.683 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 11' ' ' LEU . 85.7 mt -104.95 32.41 4.2 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.385 -0.822 . . . . 0.0 109.83 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -40.59 93.87 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.275 0 O-C-N 121.603 -0.686 . . . . 0.0 111.666 -178.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.582 HD11 ' OE1' ' A' ' 15' ' ' GLU . 0.2 OUTLIER -114.77 131.23 56.86 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.347 179.304 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.0 mttt -97.65 171.9 5.46 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.528 -0.733 . . . . 0.0 111.007 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -67.79 150.42 78.88 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 O-C-N 123.911 1.48 . . . . 0.0 110.095 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.59 -15.03 35.22 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.582 ' OE1' HD11 ' A' ' 11' ' ' LEU . 90.3 mt-10 -114.51 150.11 35.38 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.802 -1.41 . . . . 0.0 109.75 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 45.8 t -109.78 145.45 36.64 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.199 -0.938 . . . . 0.0 110.337 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.849 HD12 ' O ' ' A' ' 132' ' ' ALA . 48.1 tp -112.48 134.17 54.16 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -121.86 129.55 52.68 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.934 -1.104 . . . . 0.0 110.108 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.481 HG13 HG13 ' A' ' 128' ' ' ILE . 65.2 t -126.28 127.7 70.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.161 -0.962 . . . . 0.0 111.02 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.448 ' HG3' ' HG2' ' A' ' 86' ' ' GLU . 70.3 ttt180 -107.27 122.12 45.91 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 177.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' A' ' 127' ' ' LYS . . . -135.14 -178.57 15.77 Favored Glycine 0 N--CA 1.487 2.083 0 C-N-CA 118.939 -1.601 . . . . 0.0 111.661 -177.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -126.07 140.53 52.51 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 122.028 -0.689 . . . . 0.0 110.321 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.4 t -101.75 126.88 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.501 -0.749 . . . . 0.0 109.812 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.06 154.82 37.24 Favored Pre-proline 0 N--CA 1.497 1.922 0 O-C-N 120.989 -1.069 . . . . 0.0 110.48 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -67.45 -18.39 49.35 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 124.026 1.54 . . . . 0.0 111.208 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -119.77 52.23 1.12 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.924 -1.11 . . . . 0.0 108.69 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.21 153.01 32.32 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.575 0.702 . . . . 0.0 112.215 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.402 ' N ' ' OD2' ' A' ' 125' ' ' ASP . 98.1 mttt -137.85 -39.66 0.56 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.539 -0.726 . . . . 0.0 109.953 179.041 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 40.1 p -161.58 160.0 28.37 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.967 -1.083 . . . . 0.0 111.756 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.477 ' HA ' ' HA3' ' A' ' 124' ' ' GLY . 67.3 t80 -153.86 150.82 28.81 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.49 -0.756 . . . . 0.0 109.878 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 45' ' ' PHE . 11.4 p -134.75 150.5 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.047 -1.033 . . . . 0.0 110.94 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.439 HD12 ' HB3' ' A' ' 45' ' ' PHE . 78.2 mt -118.2 147.22 43.6 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.487 -0.758 . . . . 0.0 108.995 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.572 ' OD1' HD22 ' A' ' 41' ' ' LEU . 62.9 t30 -143.25 108.54 5.02 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.015 -1.074 . . . . 0.0 111.004 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.639 HD11 ' HB3' ' A' ' 43' ' ' LEU . 0.5 OUTLIER -131.14 121.28 24.63 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.401 -0.812 . . . . 0.0 109.494 179.254 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.463 ' HA3' ' HA ' ' A' ' 41' ' ' LEU . . . -168.54 -171.5 34.44 Favored Glycine 0 N--CA 1.484 1.843 0 C-N-CA 118.652 -1.737 . . . . 0.0 109.977 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.463 ' HD2' HD13 ' A' ' 114' ' ' LEU . 34.9 mtpt -65.85 -41.52 91.58 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 122.284 1.04 . . . . 0.0 108.53 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.16 -167.33 2.17 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.851 0.834 . . . . 0.0 111.825 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.3 t -57.67 -41.98 82.66 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.636 -0.665 . . . . 0.0 112.766 -177.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -99.92 -7.34 25.35 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.234 -1.541 . . . . 0.0 110.663 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.425 ' HB2' ' HB2' ' A' ' 36' ' ' LYS . 7.1 m-80 -105.03 73.11 1.03 Allowed 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.032 -1.043 . . . . 0.0 109.096 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.572 HD22 ' OD1' ' A' ' 33' ' ' ASN . 60.1 mt -101.68 127.45 48.43 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.332 0.587 . . . . 0.0 110.362 -178.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 3.3 t -84.59 -43.91 14.02 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.123 -0.985 . . . . 0.0 110.488 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.719 HD22 HD21 ' A' ' 96' ' ' LEU . 20.4 tp -129.41 133.79 47.53 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.219 -0.926 . . . . 0.0 110.584 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.414 ' O ' ' HA ' ' A' ' 60' ' ' CYS . 9.3 t60 -126.73 112.77 15.8 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.556 ' CD2' ' HD3' ' A' ' 47' ' ' PRO . 43.2 t80 -111.71 115.77 29.63 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.822 -1.173 . . . . 0.0 110.481 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -130.45 73.76 80.91 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.348 -0.845 . . . . 0.0 111.601 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.556 ' HD3' ' CD2' ' A' ' 45' ' ' PHE . 43.5 Cg_endo -66.5 143.05 67.63 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.416 1.219 . . . . 0.0 109.52 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -137.63 126.32 23.8 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.912 -1.117 . . . . 0.0 110.847 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -72.21 -60.1 2.4 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.113 -0.992 . . . . 0.0 110.005 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -115.47 121.68 43.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.282 -0.886 . . . . 0.0 109.335 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.59 -162.46 0.96 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.838 -1.164 . . . . 0.0 111.123 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -83.45 8.92 12.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.404 -0.81 . . . . 0.0 110.165 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 173.76 -34.07 0.11 Allowed Glycine 0 N--CA 1.487 2.095 0 N-CA-C 108.589 -1.804 . . . . 0.0 108.589 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -80.85 -178.59 6.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.235 -1.156 . . . . 0.0 110.14 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.426 ' O ' ' C ' ' A' ' 56' ' ' ASN . . . -131.18 140.34 49.9 Favored 'General case' 0 C--N 1.293 -1.855 0 O-C-N 121.871 -0.518 . . . . 0.0 110.042 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.426 ' C ' ' O ' ' A' ' 55' ' ' ALA . 3.2 m120 27.81 73.52 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 179.083 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 96.2 m -127.51 131.18 50.14 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.913 -1.117 . . . . 0.0 110.526 178.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.527 ' HB ' ' HB3' ' A' ' 74' ' ' GLU . 82.4 mt -103.56 129.03 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.894 -0.504 . . . . 0.0 110.656 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 24.6 t -110.84 128.99 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.329 -0.857 . . . . 0.0 109.494 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' CYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 44' ' ' HIS . 1.8 t -127.74 131.24 49.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.474 -0.766 . . . . 0.0 110.376 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.402 ' O ' ' CB ' ' A' ' 44' ' ' HIS . 1.5 p-10 -151.19 172.42 15.85 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.973 -1.079 . . . . 0.0 109.835 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.469 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 59.2 p -136.04 153.26 51.4 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.209 -0.932 . . . . 0.0 109.785 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.527 ' CD ' ' HA2' ' A' ' 66' ' ' GLY . 10.0 ttmt -133.29 145.79 50.79 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 120.692 -1.255 . . . . 0.0 111.876 -178.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.504 ' OD2' HD22 ' A' ' 112' ' ' LEU . 30.2 t0 -123.85 107.79 11.77 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.182 -0.949 . . . . 0.0 109.407 178.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 59.2 29.24 65.39 Favored Glycine 0 N--CA 1.485 1.91 0 C-N-CA 119.357 -1.401 . . . . 0.0 110.05 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.527 ' HA2' ' CD ' ' A' ' 63' ' ' LYS . . . 62.41 26.25 67.83 Favored Glycine 0 N--CA 1.488 2.108 0 O-C-N 120.997 -1.296 . . . . 0.0 110.621 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -89.98 -75.12 0.46 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.969 -1.312 . . . . 0.0 110.466 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 43.7 m95 -122.83 -170.46 2.1 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.792 -1.193 . . . . 0.0 110.777 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.469 ' HA2' ' O ' ' A' ' 62' ' ' SER . . . 173.49 114.62 0.35 Allowed Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.408 -1.377 . . . . 0.0 110.555 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 52.9 m -77.2 121.01 23.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.382 -1.069 . . . . 0.0 110.452 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -101.63 123.52 45.78 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.146 -0.971 . . . . 0.0 110.486 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -115.88 -170.27 1.76 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.826 -1.171 . . . . 0.0 110.378 179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 47.3 ttp180 -144.4 116.4 8.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.952 -1.092 . . . . 0.0 111.587 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.527 ' HB3' ' HB ' ' A' ' 58' ' ' ILE . 77.5 tt0 -103.12 139.45 38.62 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.253 -0.904 . . . . 0.0 110.128 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.72 38.7 2.29 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.927 -1.108 . . . . 0.0 111.712 -179.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.463 ' O ' ' CD1' ' A' ' 58' ' ' ILE . 48.1 t -132.47 130.29 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.622 -1.299 . . . . 0.0 111.625 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -159.21 96.16 1.69 Allowed Pre-proline 0 N--CA 1.5 2.05 0 O-C-N 120.904 -1.122 . . . . 0.0 110.79 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -81.49 45.91 2.1 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.998 1.525 . . . . 0.0 111.7 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -128.85 152.8 48.1 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.615 -1.303 . . . . 0.0 111.725 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 15.4 mp0 -135.87 160.21 68.27 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.688 -0.632 . . . . 0.0 109.682 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -66.22 145.48 78.44 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.855 1.45 . . . . 0.0 110.79 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 64.5 40.25 97.52 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.1 p -133.54 148.77 51.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.976 -1.308 . . . . 0.0 111.627 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.6 p -101.26 136.47 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.505 -0.747 . . . . 0.0 109.233 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -153.91 155.07 35.0 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.121 -0.987 . . . . 0.0 110.368 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.448 ' HG2' ' HG3' ' A' ' 20' ' ' ARG . 99.0 mt-10 -119.36 139.18 52.4 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.896 -1.128 . . . . 0.0 110.597 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.6 t -125.95 132.68 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.411 -0.805 . . . . 0.0 110.68 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' CYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 77.8 m -107.77 134.41 50.77 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.176 -0.953 . . . . 0.0 109.107 179.041 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 89.1 mt -121.22 127.93 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.747 -1.221 . . . . 0.0 111.019 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.409 ' O ' HD12 ' A' ' 96' ' ' LEU . 45.6 m -129.35 128.97 44.18 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.302 -0.874 . . . . 0.0 109.972 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.587 ' HA ' HD12 ' A' ' 96' ' ' LEU . 42.4 t80 -112.43 127.38 56.02 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.104 -0.997 . . . . 0.0 111.868 -179.093 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 95' ' ' ASN . 88.8 m-20 -119.09 156.02 30.48 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.496 -0.752 . . . . 0.0 109.911 179.038 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 -60.95 -23.88 65.65 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.454 -0.779 . . . . 0.0 112.73 -178.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -105.36 -26.54 11.93 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.436 -1.415 . . . . 0.0 110.428 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.409 ' O ' ' HB2' ' A' ' 92' ' ' ASP . 34.5 m-20 -152.57 172.61 16.33 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 119.069 -1.052 . . . . 0.0 111.866 -179.035 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.719 HD21 HD22 ' A' ' 43' ' ' LEU . 54.6 tp -119.13 129.42 55.02 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.798 HG23 ' OE2' ' A' ' 105' ' ' GLU . 17.4 m -114.58 125.25 53.56 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 120.781 -1.199 . . . . 0.0 111.115 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 43.3 t -120.18 127.93 75.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 88' ' ' CYS . 88.2 tttt -114.42 119.24 36.22 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 118.589 -1.244 . . . . 0.0 109.774 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.0 mp -100.35 170.7 6.34 Favored Pre-proline 0 C--N 1.298 -1.645 0 O-C-N 121.91 -0.494 . . . . 0.0 109.755 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.05 -22.13 62.53 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 O-C-N 123.893 1.47 . . . . 0.0 111.122 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -66.04 -34.24 77.64 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.805 -1.185 . . . . 0.0 109.787 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 112.4 -27.0 10.41 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -73.22 145.23 46.37 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.145 -1.209 . . . . 0.0 109.381 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.798 ' OE2' HG23 ' A' ' 97' ' ' THR . 68.9 tt0 -113.64 143.33 44.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.844 -1.16 . . . . 0.0 111.022 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -120.44 147.86 44.55 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 98.2 mttt -120.77 145.11 47.88 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.01 -1.076 . . . . 0.0 111.555 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.463 ' HB3' HD23 ' A' ' 96' ' ' LEU . 15.0 t80 -125.55 129.59 24.35 Favored Pre-proline 0 C--N 1.293 -1.885 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -64.73 140.78 69.31 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 O-C-N 123.02 1.01 . . . . 0.0 109.965 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.51 ' ND2' ' O ' ' A' ' 110' ' ' ASN . 4.1 p-10 -92.02 82.4 5.1 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.023 -1.048 . . . . 0.0 109.473 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -54.72 -27.39 40.37 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.536 -1.353 . . . . 0.0 109.224 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.504 HD22 ' OD2' ' A' ' 64' ' ' ASP . 83.4 mt -104.65 132.33 51.02 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.338 -0.851 . . . . 0.0 109.851 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 -87.7 61.06 6.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.009 -1.057 . . . . 0.0 110.415 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.463 HD13 ' HD2' ' A' ' 36' ' ' LYS . 52.0 tp -80.84 129.67 34.65 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.358 -0.839 . . . . 0.0 109.537 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -87.27 -12.36 46.86 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.162 -0.962 . . . . 0.0 111.549 -178.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 11' ' ' LEU . . . -160.23 158.45 29.99 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.794 -1.191 . . . . 0.0 111.661 -178.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 49.9 mm -109.41 126.06 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.525 -0.734 . . . . 0.0 109.891 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -112.09 -26.65 8.74 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.566 -1.334 . . . . 0.0 110.787 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.483 ' O ' ' HA ' ' A' ' 34' ' ' LEU . 10.5 t80 -110.21 126.26 53.95 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.229 -0.92 . . . . 0.0 110.401 -179.02 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.402 ' CB ' HD12 ' A' ' 9' ' ' LEU . 50.0 ttp -132.98 130.66 39.8 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.5 142.24 21.0 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.026 -1.046 . . . . 0.0 110.521 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.446 ' O ' ' CA ' ' A' ' 3' ' ' GLY . . . -148.02 132.03 17.22 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.35 -0.844 . . . . 0.0 111.391 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.472 ' HB3' ' HA3' ' A' ' 3' ' ' GLY . 15.2 p-10 -148.46 147.6 29.33 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.358 -0.839 . . . . 0.0 110.483 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.477 ' HA3' ' HA ' ' A' ' 30' ' ' PHE . . . 155.79 -145.44 12.34 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.402 ' OD2' ' N ' ' A' ' 28' ' ' LYS . 88.2 m-20 -94.31 11.46 30.31 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.288 -1.125 . . . . 0.0 111.544 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.445 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 24.7 t80 -112.87 143.74 43.62 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.964 -1.085 . . . . 0.0 109.319 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.47 ' O ' ' HA3' ' A' ' 21' ' ' GLY . 51.8 mttp -117.01 140.99 48.82 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.891 -1.131 . . . . 0.0 111.359 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.933 HG23 HD12 ' A' ' 4' ' ' LEU . 4.1 tt -111.57 122.41 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -101.55 -9.94 20.55 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.021 -1.049 . . . . 0.0 112.384 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -158.14 150.12 21.78 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.224 -1.547 . . . . 0.0 112.004 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.427 HG22 HD11 ' A' ' 128' ' ' ILE . 47.9 t -128.86 133.48 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.849 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -136.38 133.1 36.4 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.715 -1.241 . . . . 0.0 111.302 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.51 ' CE1' HD13 ' A' ' 17' ' ' LEU . 47.7 m-85 -110.9 148.22 32.93 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.402 -0.811 . . . . 0.0 111.313 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.409 ' CB ' ' HB3' ' A' ' 15' ' ' GLU . 47.1 t0 . . . . . 0 N--CA 1.496 1.873 0 CA-C-O 118.114 -0.946 . . . . 0.0 111.186 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 1' ' ' ALA . . . . . 0.562 ' HB2' ' HE3' ' B' ' 127' ' ' LYS . . . . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 121.341 0.591 . . . . 0.0 110.441 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 2' ' ' CYS . . . . . 0.512 ' O ' ' O ' ' B' ' 3' ' ' GLY . 1.3 m -96.95 54.88 1.29 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.023 -1.048 . . . . 0.0 110.664 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 3' ' ' GLY . . . . . 0.512 ' O ' ' O ' ' B' ' 2' ' ' CYS . . . 42.43 111.3 0.0 OUTLIER Glycine 0 N--CA 1.497 2.717 0 CA-C-O 121.891 0.717 . . . . 0.0 112.308 178.086 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.971 HD12 HG23 ' B' ' 128' ' ' ILE . 86.2 mt -63.78 136.99 57.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.571 -1.547 . . . . 0.0 109.458 178.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 37.5 t -109.72 132.35 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.454 -0.779 . . . . 0.0 109.861 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -134.7 161.12 36.05 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.766 -1.209 . . . . 0.0 110.214 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 7' ' ' SER . . . . . 0.469 ' O ' ' HB3' ' B' ' 8' ' ' ASN . 15.8 p -153.2 170.37 20.71 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.293 -0.879 . . . . 0.0 110.038 -178.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 8' ' ' ASN . . . . . 0.469 ' HB3' ' O ' ' B' ' 7' ' ' SER . 4.9 t-20 65.43 39.05 5.36 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.241 0.543 . . . . 0.0 109.756 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' B' ' 11' ' ' LEU . 82.6 mt -104.62 32.27 4.2 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.345 -0.847 . . . . 0.0 109.8 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 -40.24 93.97 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.495 -0.753 . . . . 0.0 111.708 -178.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.586 HD11 ' OE1' ' B' ' 15' ' ' GLU . 0.2 OUTLIER -115.01 131.05 57.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.649 -0.657 . . . . 0.0 110.286 179.603 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -97.75 172.54 4.79 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.506 -0.746 . . . . 0.0 110.765 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.25 150.69 76.75 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 O-C-N 123.95 1.5 . . . . 0.0 110.392 178.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.3 -14.98 36.2 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 15' ' ' GLU . . . . . 0.586 ' OE1' HD11 ' B' ' 11' ' ' LEU . 90.4 mt-10 -114.37 150.25 34.89 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.822 -1.399 . . . . 0.0 109.668 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 16' ' ' CYS . . . . . . . . . . . . . 52.3 t -109.89 145.62 36.52 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.129 -0.982 . . . . 0.0 110.036 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.843 HD12 ' O ' ' B' ' 132' ' ' ALA . 46.3 tp -112.75 133.92 54.52 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -121.74 129.23 52.55 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.937 -1.102 . . . . 0.0 109.982 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.475 HG13 HG13 ' B' ' 128' ' ' ILE . 61.6 t -125.54 127.2 71.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.32 -0.862 . . . . 0.0 111.122 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 20' ' ' ARG . . . . . 0.459 ' HG3' ' HG2' ' B' ' 86' ' ' GLU . 70.2 ttt180 -107.02 122.13 45.84 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.475 ' HA3' ' O ' ' B' ' 127' ' ' LYS . . . -135.17 -177.83 15.24 Favored Glycine 0 N--CA 1.484 1.842 0 C-N-CA 118.881 -1.628 . . . . 0.0 111.562 -177.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -126.66 140.76 52.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.697 -0.884 . . . . 0.0 110.203 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 6.4 t -101.92 127.39 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.293 -0.88 . . . . 0.0 109.846 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.35 155.51 36.02 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 120.953 -1.092 . . . . 0.0 110.588 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.77 -18.4 47.51 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 O-C-N 124.122 1.591 . . . . 0.0 111.113 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -119.88 52.62 1.11 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.023 -1.048 . . . . 0.0 108.8 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 27' ' ' ALA . . . . . 0.409 ' HA ' ' HB3' ' B' ' 125' ' ' ASP . . . -78.59 152.31 31.89 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.585 0.707 . . . . 0.0 112.144 -178.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 28' ' ' LYS . . . . . 0.403 ' N ' ' OD2' ' B' ' 125' ' ' ASP . 98.0 mttt -137.12 -40.66 0.59 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.671 -0.643 . . . . 0.0 110.105 178.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 35.8 p -160.14 160.9 33.49 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.871 -1.143 . . . . 0.0 111.321 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 30' ' ' PHE . . . . . 0.492 ' HA ' ' HA3' ' B' ' 124' ' ' GLY . 64.8 t80 -154.58 150.52 27.82 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.278 -0.889 . . . . 0.0 109.623 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' B' ' 45' ' ' PHE . 11.5 p -134.41 150.97 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 120.781 -1.2 . . . . 0.0 110.974 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.471 HD12 ' HB3' ' B' ' 45' ' ' PHE . 76.5 mt -118.09 147.12 43.59 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 33' ' ' ASN . . . . . 0.571 ' OD1' HD22 ' B' ' 41' ' ' LEU . 63.2 t30 -143.14 108.11 4.93 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 120.834 -1.166 . . . . 0.0 110.974 -179.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.648 HD11 ' HB3' ' B' ' 43' ' ' LEU . 0.5 OUTLIER -131.29 116.35 17.5 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.283 -0.885 . . . . 0.0 109.835 179.546 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 35' ' ' GLY . . . . . 0.473 ' HA3' ' HA ' ' B' ' 41' ' ' LEU . . . -161.63 -169.93 25.62 Favored Glycine 0 N--CA 1.485 1.919 0 C-N-CA 118.53 -1.795 . . . . 0.0 110.494 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 36' ' ' LYS . . . . . 0.487 ' HD2' HD13 ' B' ' 114' ' ' LEU . 36.1 mtpt -66.69 -42.26 86.75 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -156.62 -167.06 2.28 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.75 0.786 . . . . 0.0 111.778 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 38.6 t -57.83 -41.9 83.24 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -100.31 -7.27 24.72 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 120.394 -1.441 . . . . 0.0 110.564 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 40' ' ' ASN . . . . . 0.407 ' HB2' ' HB2' ' B' ' 36' ' ' LYS . 7.3 m-80 -104.92 72.18 1.0 Allowed 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.903 -1.123 . . . . 0.0 109.129 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.571 HD22 ' OD1' ' B' ' 33' ' ' ASN . 60.1 mt -100.32 130.13 46.39 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.231 0.539 . . . . 0.0 110.031 -178.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 42' ' ' CYS . . . . . . . . . . . . . 2.1 t -88.63 -42.58 11.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.066 -1.021 . . . . 0.0 109.919 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.708 HD22 HD21 ' B' ' 96' ' ' LEU . 19.7 tp -129.76 133.91 47.29 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.144 -0.972 . . . . 0.0 110.456 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 44' ' ' HIS . . . . . 0.409 ' O ' ' HA ' ' B' ' 60' ' ' CYS . 9.0 t60 -127.27 112.75 15.44 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.553 ' CD2' ' HD3' ' B' ' 47' ' ' PRO . 43.3 t80 -111.69 115.25 28.79 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.133 -0.979 . . . . 0.0 110.436 -179.129 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -129.84 73.42 81.47 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 121.372 -0.83 . . . . 0.0 111.413 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 47' ' ' PRO . . . . . 0.553 ' HD3' ' CD2' ' B' ' 45' ' ' PHE . 41.4 Cg_endo -66.24 143.03 69.24 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.263 1.138 . . . . 0.0 109.259 179.061 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -137.9 126.63 23.78 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.91 -1.119 . . . . 0.0 110.713 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -72.59 -60.97 1.97 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.137 -0.977 . . . . 0.0 109.988 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -114.54 120.99 42.08 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.488 -0.758 . . . . 0.0 109.25 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.09 -162.11 0.92 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.84 -1.162 . . . . 0.0 111.32 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 52' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -84.18 11.42 8.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.433 -0.792 . . . . 0.0 110.122 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 170.42 -33.48 0.16 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -81.45 -178.55 6.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.013 -1.286 . . . . 0.0 110.029 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.473 ' O ' ' C ' ' B' ' 56' ' ' ASN . . . -129.6 146.91 51.36 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 56' ' ' ASN . . . . . 0.473 ' C ' ' O ' ' B' ' 55' ' ' ALA . 3.3 m120 17.53 77.36 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.175 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -179.073 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 97.0 m -128.1 130.86 48.84 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.236 -0.915 . . . . 0.0 110.328 178.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 58' ' ' ILE . . . . . 0.468 ' HB ' ' HB3' ' B' ' 74' ' ' GLU . 82.7 mt -104.01 129.24 56.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 121.775 -0.578 . . . . 0.0 110.818 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 25.0 t -110.29 129.17 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.193 -0.942 . . . . 0.0 109.899 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 60' ' ' CYS . . . . . 0.409 ' HA ' ' O ' ' B' ' 44' ' ' HIS . 1.7 t -127.98 129.6 47.02 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.661 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 61' ' ' ASN . . . . . 0.409 ' O ' ' HB3' ' B' ' 44' ' ' HIS . 1.5 p-10 -149.69 171.75 16.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.151 -0.968 . . . . 0.0 110.194 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 62' ' ' SER . . . . . 0.46 ' O ' ' HA2' ' B' ' 69' ' ' GLY . 60.5 p -135.47 153.61 51.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.243 -0.91 . . . . 0.0 109.56 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 63' ' ' LYS . . . . . 0.521 ' CD ' ' HA2' ' B' ' 66' ' ' GLY . 10.1 ttmt -132.93 145.9 51.31 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 120.703 -1.248 . . . . 0.0 111.701 -178.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 64' ' ' ASP . . . . . 0.517 ' OD2' HD22 ' B' ' 112' ' ' LEU . 30.4 t0 -123.83 107.48 11.44 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.212 -0.93 . . . . 0.0 109.263 178.272 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 59.64 28.74 65.78 Favored Glycine 0 N--CA 1.484 1.878 0 C-N-CA 119.576 -1.297 . . . . 0.0 110.15 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 66' ' ' GLY . . . . . 0.521 ' HA2' ' CD ' ' B' ' 63' ' ' LYS . . . 62.84 25.83 68.12 Favored Glycine 0 N--CA 1.488 2.105 0 O-C-N 120.872 -1.369 . . . . 0.0 110.575 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 67' ' ' ALA . . . . . 0.411 ' HB1' ' CD1' ' B' ' 68' ' ' TRP . . . -89.48 -75.65 0.44 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.835 -1.391 . . . . 0.0 110.236 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 68' ' ' TRP . . . . . 0.411 ' CD1' ' HB1' ' B' ' 67' ' ' ALA . 43.6 m95 -122.46 -166.29 1.4 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.871 -1.143 . . . . 0.0 110.985 -178.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 69' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' B' ' 62' ' ' SER . . . 167.87 114.33 0.3 Allowed Glycine 0 N--CA 1.486 2.032 0 C-N-CA 119.359 -1.4 . . . . 0.0 110.546 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 43.2 m -77.31 120.87 22.93 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.946 -0.738 . . . . 0.0 110.531 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -101.29 123.73 45.86 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.266 -0.896 . . . . 0.0 110.396 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -116.03 -171.05 1.91 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.84 -1.163 . . . . 0.0 110.295 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 47.7 ttp180 -143.78 116.02 8.47 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.205 -0.934 . . . . 0.0 111.42 -178.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 74' ' ' GLU . . . . . 0.468 ' HB3' ' HB ' ' B' ' 58' ' ' ILE . 78.1 tt0 -102.98 139.25 38.78 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.215 -0.928 . . . . 0.0 110.035 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.82 39.43 2.13 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.951 -1.093 . . . . 0.0 111.461 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 76' ' ' VAL . . . . . 0.46 ' O ' ' CD1' ' B' ' 58' ' ' ILE . 48.9 t -132.97 129.9 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 120.919 -1.113 . . . . 0.0 111.738 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -159.05 96.43 1.71 Allowed Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 120.922 -1.112 . . . . 0.0 110.809 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -81.66 46.6 2.28 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.925 1.487 . . . . 0.0 111.53 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -129.58 153.06 48.42 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.719 -1.238 . . . . 0.0 111.502 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 15.4 mp0 -136.41 160.5 66.57 Favored Pre-proline 0 N--CA 1.486 1.374 0 O-C-N 121.666 -0.646 . . . . 0.0 109.467 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 81' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -66.68 145.15 74.74 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.75 1.395 . . . . 0.0 110.958 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 64.78 39.95 97.0 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 12.7 p -132.77 147.78 52.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.011 -1.288 . . . . 0.0 111.913 -178.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 12.7 p -100.15 136.64 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.438 -0.789 . . . . 0.0 109.408 178.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -154.02 155.43 35.52 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.051 -1.031 . . . . 0.0 110.171 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 86' ' ' GLU . . . . . 0.459 ' HG2' ' HG3' ' B' ' 20' ' ' ARG . 98.3 mt-10 -119.67 139.07 52.81 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.856 -1.153 . . . . 0.0 110.499 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 55.9 t -125.62 132.78 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.517 -0.739 . . . . 0.0 110.601 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 88' ' ' CYS . . . . . 0.419 ' HB2' ' HB3' ' B' ' 99' ' ' LYS . 75.1 m -107.57 134.98 49.79 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.166 -0.959 . . . . 0.0 109.355 178.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 87.2 mt -121.59 128.26 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.882 -1.136 . . . . 0.0 110.958 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 90' ' ' THR . . . . . 0.415 ' O ' HD12 ' B' ' 96' ' ' LEU . 50.1 m -129.08 128.83 44.34 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.28 -0.887 . . . . 0.0 109.914 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 91' ' ' PHE . . . . . 0.568 ' HA ' HD12 ' B' ' 96' ' ' LEU . 41.1 t80 -112.38 127.35 55.99 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.995 -1.066 . . . . 0.0 111.637 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 92' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' B' ' 95' ' ' ASN . 88.9 m-20 -119.59 155.79 31.59 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.4 -0.813 . . . . 0.0 109.805 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -60.76 -23.84 65.28 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.404 -0.81 . . . . 0.0 112.761 -178.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -105.23 -26.95 11.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.366 -1.459 . . . . 0.0 110.474 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 95' ' ' ASN . . . . . 0.405 ' O ' ' HB2' ' B' ' 92' ' ' ASP . 34.5 m-20 -152.36 172.57 16.26 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 122.082 0.944 . . . . 0.0 112.02 -178.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 96' ' ' LEU . . . . . 0.708 HD21 HD22 ' B' ' 43' ' ' LEU . 54.1 tp -119.07 129.25 54.99 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 97' ' ' THR . . . . . 0.807 HG23 ' OE2' ' B' ' 105' ' ' GLU . 18.3 m -114.45 125.44 53.83 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 120.784 -1.198 . . . . 0.0 111.0 -179.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 44.7 t -120.53 128.06 75.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 99' ' ' LYS . . . . . 0.419 ' HB3' ' HB2' ' B' ' 88' ' ' CYS . 88.3 tttt -114.5 118.99 35.32 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 118.542 -1.263 . . . . 0.0 110.142 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 5.1 mp -100.0 170.49 6.67 Favored Pre-proline 0 C--N 1.302 -1.466 0 O-C-N 121.889 -0.507 . . . . 0.0 110.009 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.72 -23.04 63.56 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.788 1.414 . . . . 0.0 110.998 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -64.95 -34.45 78.46 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.667 -1.271 . . . . 0.0 110.039 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 112.07 -27.22 10.42 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 104' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -72.91 144.67 47.26 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.198 -1.178 . . . . 0.0 109.443 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 105' ' ' GLU . . . . . 0.807 ' OE2' HG23 ' B' ' 97' ' ' THR . 68.2 tt0 -113.57 143.71 44.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.958 -1.089 . . . . 0.0 111.221 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -120.72 148.04 44.49 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 107' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' B' ' 96' ' ' LEU . 98.1 mttt -120.78 145.23 47.76 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.05 -1.031 . . . . 0.0 111.173 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 108' ' ' PHE . . . . . 0.429 ' HB3' HD23 ' B' ' 96' ' ' LEU . 15.7 t80 -126.13 129.83 24.13 Favored Pre-proline 0 C--N 1.291 -1.959 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -64.95 141.01 68.88 Favored 'Trans proline' 0 C--N 1.298 -2.131 0 O-C-N 123.071 1.038 . . . . 0.0 110.362 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 110' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' B' ' 110' ' ' ASN . 4.0 p-10 -91.84 82.16 5.19 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.158 -1.017 . . . . 0.0 109.689 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -54.36 -27.38 35.87 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.443 -1.411 . . . . 0.0 109.273 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 112' ' ' LEU . . . . . 0.517 HD22 ' OD2' ' B' ' 64' ' ' ASP . 82.5 mt -104.96 131.86 51.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.476 -0.765 . . . . 0.0 110.008 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -87.01 61.69 6.94 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.138 -0.977 . . . . 0.0 110.431 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 114' ' ' LEU . . . . . 0.487 HD13 ' HD2' ' B' ' 36' ' ' LYS . 51.7 tp -81.24 130.03 34.85 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.247 -0.908 . . . . 0.0 109.571 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -87.18 -13.03 45.11 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.125 -0.984 . . . . 0.0 111.369 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 116' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' B' ' 11' ' ' LEU . . . -159.73 158.89 32.11 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.765 -1.21 . . . . 0.0 111.898 -178.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 49.7 mm -109.39 125.97 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.442 -0.786 . . . . 0.0 109.858 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -111.66 -26.91 8.76 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.542 -1.349 . . . . 0.0 110.667 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 119' ' ' TYR . . . . . 0.489 ' O ' ' HA ' ' B' ' 34' ' ' LEU . 9.5 t80 -110.18 126.4 54.06 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.364 -0.934 . . . . 0.0 110.76 -178.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 120' ' ' MET . . . . . 0.419 ' CB ' HD12 ' B' ' 9' ' ' LEU . 49.8 ttp -133.19 129.83 38.3 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.444 -0.785 . . . . 0.0 108.976 179.091 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -152.75 142.31 21.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.905 -1.122 . . . . 0.0 110.578 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 122' ' ' ALA . . . . . 0.463 ' O ' ' CA ' ' B' ' 3' ' ' GLY . . . -147.41 132.47 18.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.013 -1.054 . . . . 0.0 111.351 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 123' ' ' ASP . . . . . 0.482 ' HB3' ' HA3' ' B' ' 3' ' ' GLY . 15.3 p-10 -148.58 147.45 29.03 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.091 -1.006 . . . . 0.0 110.551 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 124' ' ' GLY . . . . . 0.492 ' HA3' ' HA ' ' B' ' 30' ' ' PHE . . . 155.97 -144.43 10.89 Favored Glycine 0 N--CA 1.496 2.639 0 C-N-CA 119.808 -1.187 . . . . 0.0 110.177 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 125' ' ' ASP . . . . . 0.409 ' HB3' ' HA ' ' B' ' 27' ' ' ALA . 87.2 m-20 -95.09 10.82 34.35 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.241 -1.152 . . . . 0.0 111.351 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 126' ' ' PHE . . . . . 0.425 ' HB3' ' CD1' ' B' ' 30' ' ' PHE . 24.4 t80 -112.52 143.71 43.22 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.876 -1.14 . . . . 0.0 109.519 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 127' ' ' LYS . . . . . 0.562 ' HE3' ' HB2' ' B' ' 1' ' ' ALA . 52.0 mttp -116.56 141.11 48.61 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 118.81 -1.156 . . . . 0.0 111.521 -179.174 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 128' ' ' ILE . . . . . 0.971 HG23 HD12 ' B' ' 4' ' ' LEU . 4.1 tt -111.57 122.88 66.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.776 -0.578 . . . . 0.0 109.543 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -101.92 -11.8 18.71 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.078 -1.014 . . . . 0.0 112.196 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 130' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -155.89 150.61 26.14 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.271 -1.518 . . . . 0.0 112.024 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.431 ' CG2' HD11 ' B' ' 128' ' ' ILE . 45.4 t -129.31 133.05 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.588 -0.695 . . . . 0.0 109.162 178.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 132' ' ' ALA . . . . . 0.843 ' O ' HD12 ' B' ' 17' ' ' LEU . . . -136.19 132.66 36.23 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.713 -1.242 . . . . 0.0 111.39 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 133' ' ' PHE . . . . . 0.489 ' CE1' HD13 ' B' ' 17' ' ' LEU . 47.6 m-85 -110.48 147.98 33.0 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.275 -0.891 . . . . 0.0 111.105 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 47.8 t0 . . . . . 0 N--CA 1.496 1.867 0 CA-C-O 118.137 -0.935 . . . . 0.0 111.127 -179.894 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.453 ' HA ' ' HB3' ' B' ' 8' ' ' ASN . 49.3 tp -59.77 133.7 56.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.88 -1.365 . . . . 0.0 110.7 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.7 t -118.04 130.11 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.361 -0.837 . . . . 0.0 110.071 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -118.81 153.01 35.17 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.325 -0.859 . . . . 0.0 109.555 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.467 ' O ' ' HB3' ' A' ' 8' ' ' ASN . 18.1 p -148.78 171.98 15.37 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.261 -0.899 . . . . 0.0 110.314 -178.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.467 ' HB3' ' O ' ' A' ' 7' ' ' SER . 19.6 t-20 61.08 35.49 18.7 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.335 0.588 . . . . 0.0 110.272 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.525 ' O ' ' C ' ' A' ' 10' ' ' ASN . 87.7 mt -91.16 -17.97 25.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.215 -0.928 . . . . 0.0 110.893 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.525 ' C ' ' O ' ' A' ' 9' ' ' LEU . 7.6 m120 11.24 77.47 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.506 0 CA-C-O 121.522 0.677 . . . . 0.0 112.791 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.617 HD21 ' CZ ' ' A' ' 133' ' ' PHE . 19.2 mt -98.93 128.05 45.0 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.686 -0.634 . . . . 0.0 110.765 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -96.35 169.68 8.6 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.18 -0.95 . . . . 0.0 110.47 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.438 ' HD3' ' O ' ' A' ' 115' ' ' GLU . 40.7 Cg_endo -66.13 146.65 82.38 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.976 1.514 . . . . 0.0 110.156 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.23 -7.78 56.84 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -117.92 147.28 43.28 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.953 -1.322 . . . . 0.0 109.998 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.8 m -109.63 145.13 36.97 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.963 -1.086 . . . . 0.0 111.606 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.708 HD12 ' O ' ' A' ' 132' ' ' ALA . 47.5 tp -121.2 133.78 55.18 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -122.94 141.75 51.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.743 -1.223 . . . . 0.0 111.183 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 69.0 t -124.27 120.27 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 119.894 -0.723 . . . . 0.0 110.382 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -116.85 122.06 43.28 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.1 -1.0 . . . . 0.0 109.549 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.526 ' O ' HG13 ' A' ' 84' ' ' VAL . . . -144.71 -150.15 5.17 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.432 -1.365 . . . . 0.0 109.897 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -133.34 147.01 51.82 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.741 -1.446 . . . . 0.0 110.529 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.561 HG22 ' HD1' ' A' ' 126' ' ' PHE . 51.1 t -110.23 128.79 66.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.5 -0.75 . . . . 0.0 109.898 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.94 147.25 74.09 Favored Pre-proline 0 C--N 1.301 -1.528 0 O-C-N 121.061 -1.024 . . . . 0.0 109.2 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.415 ' HA ' ' N ' ' A' ' 82' ' ' GLY . 40.6 Cg_endo -65.89 -20.69 58.04 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.729 1.384 . . . . 0.0 110.141 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -116.77 29.63 7.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.439 -0.788 . . . . 0.0 109.228 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.472 ' HA ' ' HB3' ' A' ' 125' ' ' ASP . . . -63.74 99.09 0.21 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.514 -0.741 . . . . 0.0 110.884 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -66.52 -43.97 83.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.468 -0.77 . . . . 0.0 110.401 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.5 t -165.03 147.61 8.15 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.461 -0.774 . . . . 0.0 110.26 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.489 ' CE1' ' HG2' ' A' ' 47' ' ' PRO . 49.6 p90 -148.95 156.22 41.97 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.567 HG22 ' CB ' ' A' ' 46' ' ' ASN . 53.3 t -133.43 137.85 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.534 -1.354 . . . . 0.0 112.369 -177.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 93.2 mt -112.37 133.09 54.66 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.47 ' OD1' ' CE1' ' A' ' 44' ' ' HIS . 80.8 m-20 -125.78 135.89 52.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.013 -1.054 . . . . 0.0 110.968 -178.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.493 HD11 ' HB3' ' A' ' 43' ' ' LEU . 0.7 OUTLIER -145.17 114.16 6.93 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.077 -1.014 . . . . 0.0 110.934 179.415 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.466 ' O ' ' N ' ' A' ' 119' ' ' TYR . . . -163.45 -132.31 1.33 Allowed Glycine 0 N--CA 1.496 2.66 0 N-CA-C 108.233 -1.947 . . . . 0.0 108.233 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.72 ' HD2' HD13 ' A' ' 114' ' ' LEU . 42.1 mtpt -112.08 -46.03 3.25 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.093 -1.24 . . . . 0.0 108.05 178.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -123.67 164.41 19.15 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.882 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.23 -32.18 68.08 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.339 -0.851 . . . . 0.0 110.982 -179.411 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.454 ' HB3' ' N ' ' A' ' 66' ' ' GLY . 87.1 m-20 -94.98 -9.07 35.09 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.877 -1.14 . . . . 0.0 111.186 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -113.56 66.42 0.66 Allowed 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.158 -0.964 . . . . 0.0 110.138 -178.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 47.0 mt -96.24 133.25 40.81 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 2.1 m -85.41 -31.24 23.0 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.993 -1.067 . . . . 0.0 109.784 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.872 HD13 ' CD2' ' A' ' 96' ' ' LEU . 25.3 tp -128.5 129.19 45.7 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.611 -0.681 . . . . 0.0 109.982 -179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.47 ' CE1' ' OD1' ' A' ' 33' ' ' ASN . 63.5 t60 -128.23 127.73 43.4 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.102 -0.999 . . . . 0.0 110.305 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.507 ' CE1' HG21 ' A' ' 58' ' ' ILE . 83.7 t80 -123.39 122.88 39.41 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.975 -1.078 . . . . 0.0 110.043 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.567 ' CB ' HG22 ' A' ' 31' ' ' VAL . 1.4 t-20 -142.71 84.23 11.03 Favored Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 121.154 -0.966 . . . . 0.0 110.954 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.504 ' HD3' ' CD2' ' A' ' 45' ' ' PHE . 52.7 Cg_endo -70.64 142.77 44.84 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.657 1.346 . . . . 0.0 109.489 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -127.0 97.59 5.01 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.921 -1.112 . . . . 0.0 110.394 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -61.03 -45.44 94.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.132 -0.98 . . . . 0.0 109.139 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -159.63 103.36 1.55 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.309 -0.869 . . . . 0.0 109.413 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -113.82 -104.17 0.4 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.045 -1.034 . . . . 0.0 110.695 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -65.88 -41.47 91.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.663 -1.273 . . . . 0.0 109.872 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 168.54 39.54 0.02 OUTLIER Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.402 ' N ' ' OD1' ' A' ' 54' ' ' ASP . 8.9 m-20 -114.08 -179.42 3.63 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.353 -1.087 . . . . 0.0 109.115 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.423 ' O ' ' C ' ' A' ' 56' ' ' ASN . . . -142.14 143.99 33.27 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.977 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.423 ' C ' ' O ' ' A' ' 55' ' ' ALA . 81.2 m-20 27.55 49.4 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 178.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 55.2 m -118.48 130.51 55.98 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.84 -1.162 . . . . 0.0 109.352 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.589 HD12 ' H ' ' A' ' 76' ' ' VAL . 86.8 mt -115.6 135.26 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.203 -0.936 . . . . 0.0 110.933 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 64.6 t -102.05 126.09 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.382 -0.824 . . . . 0.0 110.265 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 80.2 m -116.76 121.27 41.1 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.142 -0.974 . . . . 0.0 109.251 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.461 ' O ' ' HB3' ' A' ' 44' ' ' HIS . 2.5 p-10 -151.63 179.1 8.69 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.952 -1.093 . . . . 0.0 111.163 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.455 ' O ' ' CA ' ' A' ' 69' ' ' GLY . 15.1 m -133.91 154.18 51.25 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.325 -0.86 . . . . 0.0 109.874 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.497 ' CD ' ' HA2' ' A' ' 66' ' ' GLY . 18.3 ttmt -128.53 143.67 51.01 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.491 -1.381 . . . . 0.0 111.277 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.666 ' HB2' HD21 ' A' ' 112' ' ' LEU . 59.4 t0 -122.34 95.61 4.71 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.463 -0.773 . . . . 0.0 109.161 178.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 71.21 19.87 77.68 Favored Glycine 0 N--CA 1.484 1.834 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.497 ' HA2' ' CD ' ' A' ' 63' ' ' LYS . . . 72.29 32.72 62.32 Favored Glycine 0 N--CA 1.486 2.009 0 C-N-CA 119.386 -1.388 . . . . 0.0 110.694 179.191 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -101.86 -74.55 0.62 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.855 -1.379 . . . . 0.0 111.122 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 14.1 m0 -124.16 -147.83 0.38 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.14 -0.975 . . . . 0.0 110.627 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.455 ' CA ' ' O ' ' A' ' 62' ' ' SER . . . 158.64 144.65 4.01 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.631 ' O ' HG23 ' A' ' 70' ' ' THR . 6.5 t -81.53 80.47 7.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.455 -1.026 . . . . 0.0 109.729 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.452 ' HA ' ' HB3' ' A' ' 61' ' ' ASN . 78.6 tt0 -71.07 111.56 6.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.249 -0.907 . . . . 0.0 110.875 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -122.79 -164.94 1.24 Allowed 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.333 -0.855 . . . . 0.0 109.556 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -137.65 130.92 30.73 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.431 -0.907 . . . . 0.0 110.583 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -131.83 83.43 2.09 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.309 -0.87 . . . . 0.0 109.508 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.74 88.08 0.1 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.216 -0.928 . . . . 0.0 110.611 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.589 ' H ' HD12 ' A' ' 58' ' ' ILE . 6.2 p -134.6 141.49 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.449 -0.782 . . . . 0.0 109.682 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -157.11 89.21 2.57 Favored Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 120.55 -1.344 . . . . 0.0 110.891 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.403 ' CB ' ' OD2' ' A' ' 102' ' ' ASP . 51.0 Cg_endo -77.39 -6.63 16.51 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.845 1.445 . . . . 0.0 111.978 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -142.21 -167.3 2.44 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.79 -1.194 . . . . 0.0 111.293 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.422 ' CB ' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -139.48 172.53 6.3 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.481 -0.762 . . . . 0.0 109.723 179.753 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.422 ' HD2' ' CB ' ' A' ' 80' ' ' GLN . 44.3 Cg_endo -67.22 147.42 78.68 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.807 1.425 . . . . 0.0 111.294 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.415 ' N ' ' HA ' ' A' ' 25' ' ' PRO . . . 78.71 23.56 64.29 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.4 t -137.01 147.45 46.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.083 -1.245 . . . . 0.0 111.113 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.526 HG13 ' O ' ' A' ' 21' ' ' GLY . 73.3 t -79.23 130.26 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.529 -0.732 . . . . 0.0 110.116 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -130.82 142.24 50.38 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.946 -1.096 . . . . 0.0 109.692 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.405 ' O ' ' HG3' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -120.22 127.29 52.29 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.519 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 73.4 t -121.52 132.26 71.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 118.985 -1.086 . . . . 0.0 111.019 -177.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 11.8 t -97.04 117.74 31.9 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.493 -0.754 . . . . 0.0 109.368 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 72.7 mt -111.51 125.24 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.082 -1.012 . . . . 0.0 109.468 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 57.7 m -122.36 129.38 52.06 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.361 -0.837 . . . . 0.0 109.665 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -106.76 118.28 36.27 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.052 -1.03 . . . . 0.0 110.822 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -115.73 152.08 33.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.467 -0.771 . . . . 0.0 109.378 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 69.9 tp60 -62.73 -38.83 92.07 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.968 -1.082 . . . . 0.0 110.521 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.34 -39.35 89.15 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.949 -1.094 . . . . 0.0 110.563 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -166.7 178.8 5.74 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.322 -0.862 . . . . 0.0 110.068 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.872 ' CD2' HD13 ' A' ' 43' ' ' LEU . 49.5 tp -102.08 129.86 48.52 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.375 -0.828 . . . . 0.0 109.197 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 98.9 m -115.4 122.67 46.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.717 -1.239 . . . . 0.0 111.22 -179.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 7.0 m -120.84 129.51 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.382 -0.824 . . . . 0.0 109.36 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -113.53 124.79 53.21 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.797 -1.19 . . . . 0.0 109.396 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.0 mp -85.42 164.37 40.89 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.301 -0.874 . . . . 0.0 109.57 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -66.14 -32.85 42.21 Favored 'Trans proline' 0 C--N 1.302 -1.905 0 O-C-N 123.858 1.452 . . . . 0.0 110.486 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.403 ' OD2' ' CB ' ' A' ' 78' ' ' PRO . 99.7 m-20 -74.45 -25.32 59.34 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.106 -0.996 . . . . 0.0 110.208 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 121.3 3.11 10.66 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.761 -1.209 . . . . 0.0 111.095 178.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -83.9 135.8 34.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.598 -1.531 . . . . 0.0 110.249 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 64.5 tt0 -132.49 148.56 52.39 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.434 -0.791 . . . . 0.0 111.129 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -141.0 156.4 46.05 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.602 -0.686 . . . . 0.0 109.21 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 98.5 mttt -123.92 141.0 52.43 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.007 -1.058 . . . . 0.0 110.867 -178.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -123.71 143.35 41.63 Favored Pre-proline 0 N--CA 1.494 1.733 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.84 144.28 47.88 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.299 1.158 . . . . 0.0 109.184 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.485 ' ND2' ' O ' ' A' ' 110' ' ' ASN . 6.0 p-10 -95.0 82.76 3.84 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 120.934 -1.104 . . . . 0.0 110.584 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.427 ' CZ ' ' HB ' ' A' ' 70' ' ' THR . 98.2 mtt180 -55.77 -22.11 22.51 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.818 -1.176 . . . . 0.0 109.111 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.666 HD21 ' HB2' ' A' ' 64' ' ' ASP . 57.4 mt -96.9 141.92 29.51 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.319 -0.863 . . . . 0.0 108.704 178.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 49.9 m-20 -97.02 62.42 1.83 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.748 -1.22 . . . . 0.0 109.875 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.72 HD13 ' HD2' ' A' ' 36' ' ' LYS . 64.9 tp -82.33 130.04 35.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.353 -0.842 . . . . 0.0 111.08 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.438 ' O ' ' HD3' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -88.94 -17.23 29.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.409 -0.807 . . . . 0.0 109.87 179.487 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.51 ' HA ' ' O ' ' A' ' 11' ' ' LEU . . . -163.22 144.08 9.36 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.723 -1.236 . . . . 0.0 111.682 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.43 HD13 HD12 ' A' ' 34' ' ' LEU . 93.1 mt -98.87 124.59 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.386 -0.821 . . . . 0.0 108.981 178.342 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.59 13.0 8.08 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.592 -0.692 . . . . 0.0 110.772 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.472 ' O ' ' HA ' ' A' ' 34' ' ' LEU . 7.8 t80 -131.62 128.82 39.92 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.974 -1.079 . . . . 0.0 110.261 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 62.5 ttp -142.78 130.8 21.79 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.347 -0.846 . . . . 0.0 109.85 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -140.88 144.53 35.32 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.229 -0.92 . . . . 0.0 109.76 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -132.11 108.95 9.64 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.281 -0.887 . . . . 0.0 109.458 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -137.65 129.16 28.19 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.531 -0.731 . . . . 0.0 109.649 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.466 ' HA3' ' HA ' ' A' ' 30' ' ' PHE . . . 154.13 -157.93 27.81 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 108.841 -1.704 . . . . 0.0 108.841 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.472 ' HB3' ' HA ' ' A' ' 27' ' ' ALA . 87.6 m-20 -78.38 -0.22 28.22 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.3 -1.118 . . . . 0.0 110.552 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.561 ' HD1' HG22 ' A' ' 23' ' ' VAL . 42.7 t80 -95.4 142.28 27.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.09 -1.006 . . . . 0.0 109.859 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -112.95 140.12 48.02 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 118.815 -1.154 . . . . 0.0 110.538 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.531 HG23 ' O ' ' A' ' 128' ' ' ILE . 20.6 tt -108.51 122.79 63.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.625 -0.672 . . . . 0.0 109.755 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -105.74 -23.07 12.81 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.328 -0.857 . . . . 0.0 110.97 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.404 ' HA ' ' O ' ' B' ' 131' ' ' VAL . 0.1 OUTLIER -153.03 154.88 35.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.82 -1.175 . . . . 0.0 112.136 -178.983 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' B' ' 130' ' ' CYS . 42.8 t -123.71 135.91 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.003 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.708 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -124.29 146.35 48.84 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.867 -1.145 . . . . 0.0 110.574 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.617 ' CZ ' HD21 ' A' ' 11' ' ' LEU . 0.4 OUTLIER -94.39 -139.92 0.23 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.349 -0.844 . . . . 0.0 109.798 179.786 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 49.0 t0 . . . . . 0 N--CA 1.492 1.673 0 O-C-N 120.631 -1.293 . . . . 0.0 110.437 -179.589 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.218 0.532 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 2' ' ' CYS . . . . . . . . . . . . . 49.6 t -145.17 84.85 1.72 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.095 -1.003 . . . . 0.0 110.608 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 84.84 43.37 6.81 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.42 HD23 HD13 ' B' ' 128' ' ' ILE . 50.1 tp -60.18 133.66 56.31 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.918 -1.342 . . . . 0.0 110.577 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 46.7 t -117.95 130.07 73.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.363 -0.836 . . . . 0.0 110.111 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -118.94 152.51 36.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.926 . . . . 0.0 109.485 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 7' ' ' SER . . . . . 0.486 ' O ' ' HB3' ' B' ' 8' ' ' ASN . 17.1 p -148.6 172.26 14.82 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.102 -0.999 . . . . 0.0 110.25 -179.099 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 8' ' ' ASN . . . . . 0.486 ' HB3' ' O ' ' B' ' 7' ' ' SER . 19.8 t-20 61.34 35.47 17.96 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.404 0.621 . . . . 0.0 110.303 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.538 ' O ' ' C ' ' B' ' 10' ' ' ASN . 88.5 mt -92.52 -12.51 31.73 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.362 -0.836 . . . . 0.0 111.153 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 10' ' ' ASN . . . . . 0.538 ' C ' ' O ' ' B' ' 9' ' ' LEU . 7.3 m120 2.85 80.42 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.491 0 CA-C-O 122.144 0.973 . . . . 0.0 112.953 -178.02 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.613 HD21 ' CZ ' ' B' ' 133' ' ' PHE . 18.7 mt -98.96 127.96 45.01 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.642 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -96.35 169.76 8.47 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.204 -0.935 . . . . 0.0 110.549 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 13' ' ' PRO . . . . . 0.438 ' HD3' ' O ' ' B' ' 115' ' ' GLU . 40.6 Cg_endo -66.16 146.74 82.48 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 124.004 1.529 . . . . 0.0 110.18 178.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.86 -7.48 57.41 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.084 -1.207 . . . . 0.0 110.084 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -117.94 147.5 43.09 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.905 -1.35 . . . . 0.0 109.827 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 16' ' ' CYS . . . . . . . . . . . . . 6.2 m -110.11 145.25 37.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.085 -1.009 . . . . 0.0 111.365 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.711 HD12 ' O ' ' B' ' 132' ' ' ALA . 46.9 tp -121.33 133.83 55.13 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -122.97 141.63 51.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.867 -1.146 . . . . 0.0 111.21 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 69.4 t -124.09 120.91 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 119.902 -0.719 . . . . 0.0 110.354 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -117.44 121.81 42.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.259 -0.901 . . . . 0.0 109.602 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.53 ' O ' HG13 ' B' ' 84' ' ' VAL . . . -144.65 -149.93 5.14 Favored Glycine 0 N--CA 1.494 2.511 0 C-N-CA 119.486 -1.34 . . . . 0.0 109.897 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -133.72 146.47 50.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.814 -1.403 . . . . 0.0 110.685 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.579 HG22 ' HD1' ' B' ' 126' ' ' PHE . 50.9 t -109.71 128.63 65.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.501 -0.749 . . . . 0.0 109.961 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.79 147.01 73.5 Favored Pre-proline 0 C--N 1.299 -1.602 0 O-C-N 121.093 -1.004 . . . . 0.0 109.253 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 25' ' ' PRO . . . . . 0.427 ' HA ' ' N ' ' B' ' 82' ' ' GLY . 40.4 Cg_endo -66.05 -20.1 57.2 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.714 1.376 . . . . 0.0 110.116 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -117.15 29.44 7.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.292 -0.88 . . . . 0.0 109.246 178.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 27' ' ' ALA . . . . . 0.465 ' HA ' ' HB3' ' B' ' 125' ' ' ASP . . . -63.53 99.29 0.2 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.51 -0.744 . . . . 0.0 110.898 -179.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -66.46 -45.54 79.38 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.42 -0.8 . . . . 0.0 110.254 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 33.4 t -162.57 148.23 12.5 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.491 -0.756 . . . . 0.0 110.301 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 30' ' ' PHE . . . . . 0.49 ' CD2' ' HB2' ' B' ' 126' ' ' PHE . 49.8 p90 -149.16 156.02 41.54 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 177.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.567 HG22 ' CB ' ' B' ' 46' ' ' ASN . 53.8 t -133.3 138.14 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.372 -1.455 . . . . 0.0 112.373 -177.613 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 93.6 mt -112.57 133.29 54.7 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 33' ' ' ASN . . . . . 0.455 ' OD1' ' CE1' ' B' ' 44' ' ' HIS . 80.8 m-20 -125.89 136.0 52.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.967 -1.083 . . . . 0.0 110.995 -178.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.537 HD11 ' HB3' ' B' ' 43' ' ' LEU . 0.7 OUTLIER -145.28 111.19 5.5 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.16 -0.962 . . . . 0.0 111.071 179.397 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 35' ' ' GLY . . . . . 0.461 ' O ' ' N ' ' B' ' 119' ' ' TYR . . . -159.16 -131.18 1.22 Allowed Glycine 0 N--CA 1.495 2.609 0 N-CA-C 108.526 -1.83 . . . . 0.0 108.526 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 36' ' ' LYS . . . . . 0.708 ' HD2' HD13 ' B' ' 114' ' ' LEU . 42.3 mtpt -112.93 -46.32 3.12 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -123.42 164.42 18.91 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.878 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.34 -32.37 68.47 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.242 -0.911 . . . . 0.0 111.035 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 39' ' ' ASN . . . . . 0.446 ' HB3' ' N ' ' B' ' 66' ' ' GLY . 86.9 m-20 -94.82 -8.98 35.84 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.045 -1.034 . . . . 0.0 111.085 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 40' ' ' ASN . . . . . 0.405 ' ND2' ' N ' ' B' ' 65' ' ' GLY . 8.1 m120 -113.85 66.19 0.66 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.145 -0.972 . . . . 0.0 110.061 -178.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.416 ' HA ' ' HA3' ' B' ' 35' ' ' GLY . 45.4 mt -95.51 135.53 37.04 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 42' ' ' CYS . . . . . . . . . . . . . 1.7 m -88.81 -29.84 19.43 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.956 -1.09 . . . . 0.0 109.274 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.881 HD13 ' CD2' ' B' ' 96' ' ' LEU . 25.9 tp -128.94 128.99 44.88 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.539 -0.726 . . . . 0.0 109.874 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 44' ' ' HIS . . . . . 0.455 ' CE1' ' OD1' ' B' ' 33' ' ' ASN . 63.0 t60 -128.2 127.51 43.03 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.205 -0.935 . . . . 0.0 110.403 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.516 ' CE1' HG21 ' B' ' 58' ' ' ILE . 83.3 t80 -123.35 122.71 39.0 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.173 -0.954 . . . . 0.0 110.161 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 46' ' ' ASN . . . . . 0.567 ' CB ' HG22 ' B' ' 31' ' ' VAL . 1.4 t-20 -142.47 84.41 11.21 Favored Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 121.157 -0.964 . . . . 0.0 110.958 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 47' ' ' PRO . . . . . 0.508 ' HD3' ' CD2' ' B' ' 45' ' ' PHE . 52.9 Cg_endo -70.76 142.9 44.6 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 123.621 1.327 . . . . 0.0 109.421 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -127.15 97.5 4.96 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.023 -1.048 . . . . 0.0 110.347 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -60.84 -45.18 95.49 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.313 -0.867 . . . . 0.0 109.176 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -159.94 103.54 1.5 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.385 -0.822 . . . . 0.0 109.395 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -114.15 -103.92 0.41 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.052 -1.03 . . . . 0.0 110.73 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 52' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -66.08 -41.12 91.12 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.641 -1.287 . . . . 0.0 109.892 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 168.14 39.56 0.02 OUTLIER Glycine 0 N--CA 1.485 1.921 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -113.99 -179.44 3.63 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.485 -1.009 . . . . 0.0 109.134 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.46 ' O ' ' C ' ' B' ' 56' ' ' ASN . . . -140.68 150.3 43.32 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.162 -0.961 . . . . 0.0 110.256 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 56' ' ' ASN . . . . . 0.46 ' C ' ' O ' ' B' ' 55' ' ' ALA . 80.3 m-20 17.09 54.62 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 57' ' ' THR . . . . . 0.4 ' N ' ' O ' ' B' ' 55' ' ' ALA . 54.0 m -120.12 130.09 54.47 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.131 -0.981 . . . . 0.0 109.237 178.314 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 58' ' ' ILE . . . . . 0.59 HD12 ' H ' ' B' ' 76' ' ' VAL . 85.3 mt -115.78 135.23 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.166 -0.959 . . . . 0.0 110.948 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 69.3 t -101.69 126.33 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.433 -0.792 . . . . 0.0 110.36 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 79.0 m -117.26 120.94 39.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.261 -0.899 . . . . 0.0 109.297 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 61' ' ' ASN . . . . . 0.46 ' HB3' ' HA ' ' B' ' 71' ' ' GLU . 2.4 p-10 -151.32 179.03 8.67 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.057 -1.027 . . . . 0.0 111.265 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 62' ' ' SER . . . . . 0.456 ' O ' ' CA ' ' B' ' 69' ' ' GLY . 15.8 m -133.94 153.83 51.5 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.361 -0.837 . . . . 0.0 109.892 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 63' ' ' LYS . . . . . 0.498 ' CD ' ' HA2' ' B' ' 66' ' ' GLY . 17.8 ttmt -128.4 143.5 51.01 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.453 -1.404 . . . . 0.0 111.228 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 64' ' ' ASP . . . . . 0.668 ' HB2' HD21 ' B' ' 112' ' ' LEU . 58.5 t0 -122.42 94.95 4.45 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.527 -0.733 . . . . 0.0 109.351 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 65' ' ' GLY . . . . . 0.405 ' N ' ' ND2' ' B' ' 40' ' ' ASN . . . 71.81 19.87 78.38 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 66' ' ' GLY . . . . . 0.498 ' HA2' ' CD ' ' B' ' 63' ' ' LYS . . . 72.08 32.33 63.27 Favored Glycine 0 N--CA 1.488 2.118 0 O-C-N 120.833 -1.393 . . . . 0.0 110.598 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -101.07 -74.95 0.6 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.737 -1.449 . . . . 0.0 111.174 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 68' ' ' TRP . . . . . . . . . . . . . 13.6 m0 -123.99 -147.76 0.38 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.136 -0.978 . . . . 0.0 110.454 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 69' ' ' GLY . . . . . 0.456 ' CA ' ' O ' ' B' ' 62' ' ' SER . . . 158.61 145.4 4.23 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 70' ' ' THR . . . . . 0.623 HG23 ' O ' ' B' ' 70' ' ' THR . 6.9 t -81.88 80.08 8.26 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.153 -1.204 . . . . 0.0 109.759 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 71' ' ' GLU . . . . . 0.46 ' HA ' ' HB3' ' B' ' 61' ' ' ASN . 79.4 tt0 -70.58 111.84 6.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.914 . . . . 0.0 110.858 -179.195 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -123.06 -165.07 1.26 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.36 -0.837 . . . . 0.0 109.52 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -137.7 130.18 29.56 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.348 -0.941 . . . . 0.0 110.588 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -131.03 83.45 2.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.266 -0.896 . . . . 0.0 109.747 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.66 88.03 0.09 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.124 -0.985 . . . . 0.0 110.74 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 76' ' ' VAL . . . . . 0.59 ' H ' HD12 ' B' ' 58' ' ' ILE . 5.9 p -134.55 141.45 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.518 -0.739 . . . . 0.0 109.864 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -157.24 89.53 2.51 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 120.733 -1.23 . . . . 0.0 110.833 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 78' ' ' PRO . . . . . 0.404 ' CB ' ' OD2' ' B' ' 102' ' ' ASP . 53.3 Cg_endo -77.65 -6.23 16.0 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 O-C-N 123.884 1.465 . . . . 0.0 112.165 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -142.55 -167.08 2.42 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.858 -1.151 . . . . 0.0 111.401 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.423 ' CB ' ' HD2' ' B' ' 81' ' ' PRO . 0.0 OUTLIER -139.66 172.39 6.49 Favored Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.382 -0.823 . . . . 0.0 109.758 179.77 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 81' ' ' PRO . . . . . 0.423 ' HD2' ' CB ' ' B' ' 80' ' ' GLN . 43.8 Cg_endo -67.09 147.27 79.21 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.789 1.415 . . . . 0.0 111.223 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 82' ' ' GLY . . . . . 0.427 ' N ' ' HA ' ' B' ' 25' ' ' PRO . . . 78.82 23.65 63.82 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 9.5 t -137.1 147.15 45.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.211 -1.17 . . . . 0.0 111.212 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.53 HG13 ' O ' ' B' ' 21' ' ' GLY . 72.3 t -79.07 130.0 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.619 -0.676 . . . . 0.0 109.979 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -130.53 142.16 50.48 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.108 -0.995 . . . . 0.0 109.736 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 86' ' ' GLU . . . . . 0.402 ' O ' ' HG3' ' B' ' 86' ' ' GLU . 0.2 OUTLIER -120.15 127.14 52.21 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.512 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 76.8 t -121.63 131.93 71.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 119.142 -1.023 . . . . 0.0 111.063 -177.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 88' ' ' CYS . . . . . . . . . . . . . 12.7 t -96.85 117.87 32.05 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.485 -0.759 . . . . 0.0 109.525 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 70.7 mt -111.6 124.89 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.149 -0.969 . . . . 0.0 109.533 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 56.6 m -122.16 129.23 52.12 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.276 -0.89 . . . . 0.0 109.665 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 91' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -106.62 117.98 35.47 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.209 -0.932 . . . . 0.0 110.891 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -115.27 151.76 33.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.686 -0.634 . . . . 0.0 109.465 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 69.6 tp60 -62.67 -38.84 91.93 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.933 -1.104 . . . . 0.0 110.488 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.29 -39.15 89.17 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.967 -1.083 . . . . 0.0 110.589 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -166.91 178.72 5.65 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.265 -0.897 . . . . 0.0 109.917 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 96' ' ' LEU . . . . . 0.881 ' CD2' HD13 ' B' ' 43' ' ' LEU . 46.7 tp -102.08 129.69 48.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.389 -0.82 . . . . 0.0 109.284 179.021 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 98.8 m -115.23 122.77 47.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.725 -1.234 . . . . 0.0 111.162 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 7.0 m -121.06 129.55 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.408 -0.807 . . . . 0.0 109.312 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -113.46 125.2 53.96 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.757 -1.214 . . . . 0.0 109.342 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 7.9 mp -85.52 165.0 37.97 Favored Pre-proline 0 C--N 1.302 -1.495 0 O-C-N 121.195 -0.94 . . . . 0.0 109.598 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -66.6 -32.81 37.88 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.991 1.521 . . . . 0.0 110.37 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 102' ' ' ASP . . . . . 0.404 ' OD2' ' CB ' ' B' ' 78' ' ' PRO . 99.6 m-20 -74.54 -25.21 59.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.999 -1.063 . . . . 0.0 110.156 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 121.22 2.77 10.86 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.53 -1.319 . . . . 0.0 111.057 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 104' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -83.67 136.01 34.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.581 -1.541 . . . . 0.0 110.123 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -132.58 148.72 52.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.452 -0.78 . . . . 0.0 110.949 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -141.08 156.51 45.98 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -124.1 141.1 52.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.007 -1.058 . . . . 0.0 110.93 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 108' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -123.58 143.76 42.48 Favored Pre-proline 0 N--CA 1.493 1.699 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -71.23 144.17 45.71 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 N-CA-C 109.14 -1.138 . . . . 0.0 109.14 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 110' ' ' ASN . . . . . 0.486 ' ND2' ' O ' ' B' ' 110' ' ' ASN . 6.1 p-10 -94.92 83.19 3.93 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.933 -1.104 . . . . 0.0 110.572 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 111' ' ' ARG . . . . . 0.43 ' NH2' ' OG1' ' B' ' 70' ' ' THR . 98.1 mtt180 -56.11 -22.23 26.95 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.704 -1.248 . . . . 0.0 109.08 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 112' ' ' LEU . . . . . 0.668 HD21 ' HB2' ' B' ' 64' ' ' ASP . 56.5 mt -97.05 141.61 29.99 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 47.4 m-20 -96.71 61.96 1.92 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.706 -1.246 . . . . 0.0 110.018 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 114' ' ' LEU . . . . . 0.708 HD13 ' HD2' ' B' ' 36' ' ' LYS . 64.3 tp -81.89 129.53 34.79 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.332 -0.855 . . . . 0.0 111.078 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 115' ' ' GLU . . . . . 0.438 ' O ' ' HD3' ' B' ' 13' ' ' PRO . 0.0 OUTLIER -88.5 -17.4 30.38 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.407 -0.808 . . . . 0.0 109.746 179.504 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 116' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' B' ' 11' ' ' LEU . . . -163.05 144.29 9.72 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.76 -1.213 . . . . 0.0 111.765 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 117' ' ' ILE . . . . . 0.428 HD13 HD12 ' B' ' 34' ' ' LEU . 91.7 mt -98.92 124.5 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.37 -0.831 . . . . 0.0 108.908 178.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.82 13.21 7.95 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.647 -0.658 . . . . 0.0 110.827 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 119' ' ' TYR . . . . . 0.467 ' O ' ' HA ' ' B' ' 34' ' ' LEU . 8.0 t80 -131.81 128.73 39.36 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.086 -1.009 . . . . 0.0 110.112 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 62.6 ttp -142.74 130.74 21.8 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.44 -0.788 . . . . 0.0 109.797 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -140.83 144.71 35.52 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.249 -0.907 . . . . 0.0 109.757 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -132.23 108.97 9.59 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.353 -0.842 . . . . 0.0 109.538 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -137.97 128.62 26.68 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.372 -0.83 . . . . 0.0 109.61 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 124' ' ' GLY . . . . . 0.464 ' HA3' ' HA ' ' B' ' 30' ' ' PHE . . . 154.79 -157.74 27.8 Favored Glycine 0 N--CA 1.483 1.794 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 125' ' ' ASP . . . . . 0.465 ' HB3' ' HA ' ' B' ' 27' ' ' ALA . 87.5 m-20 -78.55 0.02 27.84 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.405 -1.056 . . . . 0.0 110.495 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 126' ' ' PHE . . . . . 0.579 ' HD1' HG22 ' B' ' 23' ' ' VAL . 42.6 t80 -95.79 142.13 28.43 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.984 -1.073 . . . . 0.0 109.73 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -112.8 139.83 48.1 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 118.896 -1.121 . . . . 0.0 110.502 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 128' ' ' ILE . . . . . 0.52 ' O ' HG23 ' B' ' 128' ' ' ILE . 20.6 tt -108.12 123.08 63.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.61 -0.681 . . . . 0.0 109.685 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -106.03 -23.33 12.66 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.403 -0.811 . . . . 0.0 111.028 -179.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 130' ' ' CYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 131' ' ' VAL . 0.1 OUTLIER -153.05 155.32 36.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.95 -1.094 . . . . 0.0 112.177 -179.071 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 130' ' ' CYS . 44.3 t -123.93 136.02 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 132' ' ' ALA . . . . . 0.711 ' O ' HD12 ' B' ' 17' ' ' LEU . . . -124.53 146.21 49.12 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.518 -1.363 . . . . 0.0 110.666 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 133' ' ' PHE . . . . . 0.613 ' CZ ' HD21 ' B' ' 11' ' ' LEU . 0.4 OUTLIER -94.08 -139.87 0.22 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.286 -0.884 . . . . 0.0 109.739 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 49.5 t0 . . . . . 0 N--CA 1.493 1.717 0 O-C-N 120.668 -1.27 . . . . 0.0 110.462 -179.6 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.409 ' O ' ' ND2' ' B' ' 8' ' ' ASN . . . . . . . . 0 N--CA 1.503 3.156 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.833 HD22 HD23 ' B' ' 9' ' ' LEU . 48.5 mt -97.9 128.2 44.34 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.946 -1.326 . . . . 0.0 109.265 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.9 t -96.37 135.36 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.106 -0.996 . . . . 0.0 109.741 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.938 ' HB1' HD11 ' A' ' 9' ' ' LEU . . . -124.36 145.03 49.69 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.241 -0.912 . . . . 0.0 111.083 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.414 ' O ' ' HB3' ' A' ' 8' ' ' ASN . 32.9 p -145.74 170.19 17.0 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' B' ' 3' ' ' GLY . 40.0 t-20 59.49 32.21 21.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.338 -0.851 . . . . 0.0 109.189 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.938 HD11 ' HB1' ' A' ' 6' ' ' ALA . 96.3 mt -90.7 2.73 55.7 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.65 -0.656 . . . . 0.0 111.834 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.506 ' C ' ' O ' ' A' ' 9' ' ' LEU . 36.3 t-20 -1.08 76.81 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.564 0 N-CA-C 113.723 1.008 . . . . 0.0 113.723 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.601 HD12 ' HE2' ' A' ' 133' ' ' PHE . 5.7 tt -92.37 130.89 37.93 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.062 -1.024 . . . . 0.0 109.376 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -100.43 165.79 13.78 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.266 -0.896 . . . . 0.0 111.189 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.472 ' HA ' ' O ' ' A' ' 91' ' ' PHE . 52.0 Cg_endo -69.24 147.28 65.87 Favored 'Trans proline' 0 C--N 1.301 -1.94 0 O-C-N 124.165 1.613 . . . . 0.0 110.764 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.33 1.17 59.36 Favored Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.969 -1.11 . . . . 0.0 110.529 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -115.5 147.95 40.05 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.744 -1.445 . . . . 0.0 110.291 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.2 m -97.39 146.83 24.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.066 -1.021 . . . . 0.0 110.647 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.419 ' HB3' ' O ' ' A' ' 89' ' ' ILE . 52.7 tp -133.38 133.83 42.93 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.534 -0.729 . . . . 0.0 109.989 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 78.1 mtt85 -123.03 152.1 41.29 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.202 -0.936 . . . . 0.0 110.387 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 t -141.18 102.06 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 C-N-CA 119.939 -0.705 . . . . 0.0 110.671 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 -99.48 130.3 45.73 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.205 -0.935 . . . . 0.0 110.296 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -144.12 -171.78 14.39 Favored Glycine 0 N--CA 1.496 2.645 0 C-N-CA 119.82 -1.181 . . . . 0.0 110.504 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' A' ' 127' ' ' LYS . 87.1 tt0 -123.85 153.71 40.68 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.468 -1.019 . . . . 0.0 109.317 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.485 HG22 ' HD1' ' A' ' 126' ' ' PHE . 68.9 t -118.58 133.34 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.038 -1.039 . . . . 0.0 111.554 -178.387 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.464 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . . . -58.99 150.33 61.64 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 120.939 -1.101 . . . . 0.0 109.472 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.43 -18.47 54.87 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.777 1.409 . . . . 0.0 111.309 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -125.01 28.86 6.29 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.977 -1.077 . . . . 0.0 108.811 178.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.504 ' CB ' ' HB3' ' A' ' 125' ' ' ASP . . . -62.67 105.64 0.68 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.287 0.565 . . . . 0.0 111.903 -178.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -64.49 -48.13 76.36 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.519 -0.738 . . . . 0.0 109.922 178.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 86.8 p -166.68 159.84 14.38 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.91 0.862 . . . . 0.0 111.535 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.545 ' CZ ' ' HG2' ' A' ' 47' ' ' PRO . 48.1 p90 -151.22 162.55 40.68 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 45' ' ' PHE . 2.2 p -139.81 138.02 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.444 -1.41 . . . . 0.0 112.688 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.477 ' CD2' ' HB1' ' A' ' 122' ' ' ALA . 90.3 mt -122.95 143.76 49.69 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.667 ' HB2' HD12 ' A' ' 41' ' ' LEU . 26.6 p30 -151.29 162.96 39.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.785 -1.197 . . . . 0.0 110.757 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.672 ' O ' HD12 ' A' ' 34' ' ' LEU . 3.8 pp -154.67 129.6 9.45 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.267 -0.895 . . . . 0.0 110.413 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' A' ' 41' ' ' LEU . . . -166.15 -153.65 7.84 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.432 ' HE2' ' HB3' ' A' ' 40' ' ' ASN . 60.2 pttt -103.36 -30.42 10.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.061 -1.259 . . . . 0.0 110.146 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.481 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 21.9 t70 -143.84 167.8 21.45 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.232 -0.917 . . . . 0.0 110.466 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.536 ' O ' HD23 ' A' ' 41' ' ' LEU . 5.5 t -51.27 -46.93 62.58 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.485 -0.759 . . . . 0.0 112.769 -177.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.441 ' HB3' ' N ' ' A' ' 66' ' ' GLY . 27.9 m-20 -91.12 -2.45 57.58 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.485 -1.384 . . . . 0.0 110.427 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.432 ' HB3' ' HE2' ' A' ' 36' ' ' LYS . 9.3 m120 -110.41 56.16 0.63 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.111 -0.993 . . . . 0.0 110.51 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.667 HD12 ' HB2' ' A' ' 33' ' ' ASN . 3.6 mm? -86.15 138.62 31.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.316 -0.865 . . . . 0.0 110.085 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.9 m -87.2 -28.14 22.58 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.3 -0.875 . . . . 0.0 110.244 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.5 tp -140.94 136.2 31.99 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 121.207 -0.933 . . . . 0.0 110.82 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.521 ' O ' ' HA ' ' A' ' 60' ' ' CYS . 19.9 m-70 -121.95 117.59 26.8 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.098 -1.001 . . . . 0.0 109.228 178.106 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.532 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 39.7 t80 -113.55 124.09 51.54 Favored 'General case' 0 C--N 1.293 -1.882 0 O-C-N 121.15 -0.969 . . . . 0.0 108.928 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -156.27 76.48 4.56 Favored Pre-proline 0 N--CA 1.497 1.925 0 O-C-N 120.843 -1.161 . . . . 0.0 111.005 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.61 ' HB3' HG12 ' A' ' 58' ' ' ILE . 56.2 Cg_endo -70.51 147.14 57.37 Favored 'Trans proline' 0 C--N 1.301 -1.96 0 O-C-N 124.256 1.661 . . . . 0.0 110.447 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -122.59 120.42 33.71 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.139 -0.976 . . . . 0.0 109.731 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -59.04 -49.28 78.49 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.843 -1.16 . . . . 0.0 108.011 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -145.8 95.73 2.69 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.26 -136.38 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.244 -0.91 . . . . 0.0 109.329 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 83.0 m-70 -62.04 -28.7 69.78 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 120.78 -1.2 . . . . 0.0 109.014 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 173.82 35.08 0.04 OUTLIER Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.668 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -113.42 -173.57 2.29 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.734 -1.45 . . . . 0.0 109.98 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.488 ' O ' ' C ' ' A' ' 56' ' ' ASN . . . -135.46 135.01 40.18 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.47 -0.769 . . . . 0.0 110.335 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.488 ' C ' ' O ' ' A' ' 55' ' ' ALA . 6.7 m120 18.55 65.79 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.288 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 20.1 m -102.36 115.11 29.88 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.186 -0.946 . . . . 0.0 108.847 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.61 HG12 ' HB3' ' A' ' 47' ' ' PRO . 52.4 mt -96.86 122.46 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.2 -0.937 . . . . 0.0 108.732 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.3 t -114.13 129.69 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.319 -0.863 . . . . 0.0 110.928 -177.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' CYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 44' ' ' HIS . 0.9 OUTLIER -107.11 126.39 52.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.378 -0.826 . . . . 0.0 109.899 179.237 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.443 ' O ' ' N ' ' A' ' 44' ' ' HIS . 2.6 t-20 -133.36 150.0 51.84 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.167 -0.958 . . . . 0.0 111.015 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.481 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 54.2 m -123.15 145.57 48.49 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.533 ' CD ' ' HA2' ' A' ' 66' ' ' GLY . 21.5 ttmt -135.45 144.36 46.41 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.688 -1.258 . . . . 0.0 111.22 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -120.84 97.75 5.69 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 69.3 20.15 74.89 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.533 ' HA2' ' CD ' ' A' ' 63' ' ' LYS . . . 79.06 23.78 62.96 Favored Glycine 0 N--CA 1.485 1.962 0 O-C-N 120.763 -1.434 . . . . 0.0 110.403 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.3 -80.31 0.2 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.92 -1.341 . . . . 0.0 111.979 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 2.4 m-90 -130.63 -145.11 0.27 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.173 -0.954 . . . . 0.0 110.67 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.481 ' HA2' ' O ' ' A' ' 62' ' ' SER . . . 164.35 143.61 3.77 Favored Glycine 0 N--CA 1.483 1.781 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 99.8 m -92.66 116.79 29.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.593 -0.946 . . . . 0.0 110.271 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -98.44 120.98 39.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.956 -1.09 . . . . 0.0 109.713 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.412 ' O ' ' CB ' ' A' ' 73' ' ' ARG . 8.4 tm0? -165.01 133.54 3.34 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.055 -1.028 . . . . 0.0 110.622 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.412 ' CB ' ' O ' ' A' ' 72' ' ' GLN . 2.5 mtt-85 172.55 168.73 0.12 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.249 -0.907 . . . . 0.0 111.333 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -110.92 -179.92 3.87 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.367 -0.833 . . . . 0.0 109.975 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -101.61 100.81 11.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.169 -0.957 . . . . 0.0 109.618 178.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.472 HG22 ' HD3' ' A' ' 78' ' ' PRO . 2.6 p -125.06 134.1 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.097 -1.002 . . . . 0.0 110.121 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.499 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 12.5 p90 -140.52 87.07 11.9 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.029 -1.044 . . . . 0.0 111.951 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.472 ' HD3' HG22 ' A' ' 76' ' ' VAL . 51.5 Cg_endo -85.03 7.94 4.9 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 124.192 1.627 . . . . 0.0 110.498 178.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -144.48 178.01 8.25 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.268 -0.895 . . . . 0.0 110.291 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.442 ' CG ' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -143.08 172.44 5.68 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.438 -0.789 . . . . 0.0 109.794 179.427 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.442 ' HD2' ' CG ' ' A' ' 80' ' ' GLN . 44.8 Cg_endo -66.64 152.49 80.57 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.907 1.478 . . . . 0.0 110.684 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.6 22.67 78.18 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.239 -1.545 . . . . 0.0 109.239 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.8 m -138.0 149.46 46.1 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.199 -1.177 . . . . 0.0 111.087 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.7 m -76.46 138.91 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.603 -0.685 . . . . 0.0 110.466 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -146.0 144.22 29.96 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.083 -1.011 . . . . 0.0 110.473 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -123.96 146.42 48.5 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.207 -0.933 . . . . 0.0 110.414 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 53.7 t -130.42 131.2 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.332 -0.855 . . . . 0.0 110.27 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' CYS . . . . . 0.419 ' HB3' ' HB3' ' A' ' 99' ' ' LYS . 4.9 t -93.69 126.38 38.83 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.186 -0.946 . . . . 0.0 110.454 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.419 ' O ' ' HB3' ' A' ' 17' ' ' LEU . 97.4 mt -120.34 127.04 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.265 -0.897 . . . . 0.0 109.976 179.429 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 27.6 m -127.72 134.15 49.55 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.0 -1.063 . . . . 0.0 108.945 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.472 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 69.0 t80 -114.49 116.98 29.71 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.718 -1.239 . . . . 0.0 111.204 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -113.0 146.19 39.52 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 65.3 tp60 -56.1 -37.74 69.79 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.983 -1.073 . . . . 0.0 110.576 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.83 -43.38 68.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.013 -1.054 . . . . 0.0 111.291 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -155.18 179.22 9.36 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.993 -1.067 . . . . 0.0 110.852 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.5 ' HB3' ' HB2' ' A' ' 108' ' ' PHE . 53.4 tp -110.82 124.91 52.95 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.392 -0.817 . . . . 0.0 108.958 178.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.659 HG23 ' OE2' ' A' ' 105' ' ' GLU . 3.3 m -107.3 127.66 53.75 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.164 -0.96 . . . . 0.0 110.966 -179.01 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.406 ' O ' ' HG3' ' A' ' 105' ' ' GLU . 50.6 t -131.4 130.98 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.219 -0.926 . . . . 0.0 109.712 179.097 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.419 ' HB3' ' HB3' ' A' ' 88' ' ' CYS . 86.0 tttt -116.69 126.68 53.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.929 -1.107 . . . . 0.0 110.76 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.423 HD12 ' O ' ' A' ' 104' ' ' TYR . 4.0 mt -76.17 160.64 77.64 Favored Pre-proline 0 C--N 1.303 -1.453 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -66.67 -24.19 48.14 Favored 'Trans proline' 0 C--N 1.302 -1.912 0 O-C-N 123.657 1.346 . . . . 0.0 110.289 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -155.99 73.67 0.83 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.354 -0.841 . . . . 0.0 110.134 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -178.91 -166.83 35.56 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.427 -1.368 . . . . 0.0 110.635 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.423 ' O ' HD12 ' A' ' 100' ' ' LEU . 72.3 m-85 -77.17 -165.5 0.58 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.489 -1.007 . . . . 0.0 110.671 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.659 ' OE2' HG23 ' A' ' 97' ' ' THR . 69.3 tt0 -129.07 159.41 36.05 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.313 -0.867 . . . . 0.0 110.821 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -132.25 153.13 50.94 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.256 -0.903 . . . . 0.0 110.921 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 98.2 mttt -129.05 146.51 51.0 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.778 0.799 . . . . 0.0 111.57 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.5 ' HB2' ' HB3' ' A' ' 96' ' ' LEU . 0.4 OUTLIER -118.19 140.42 27.99 Favored Pre-proline 0 C--N 1.302 -1.462 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.579 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -71.4 161.96 43.88 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 O-C-N 123.645 1.34 . . . . 0.0 110.615 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -71.81 59.04 0.33 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.488 -0.758 . . . . 0.0 111.404 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 15.6 tpt85 -62.99 -39.8 95.85 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.056 -1.027 . . . . 0.0 109.022 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.403 HD11 ' HB3' ' A' ' 62' ' ' SER . 82.8 mt -105.9 124.26 49.28 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.681 -0.637 . . . . 0.0 109.533 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -86.71 69.71 10.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.916 -1.115 . . . . 0.0 109.803 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 35.5 tp -95.04 129.73 42.01 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.62 -0.675 . . . . 0.0 110.063 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -92.23 -13.11 30.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.234 -0.916 . . . . 0.0 110.553 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.517 ' HA ' ' O ' ' A' ' 11' ' ' LEU . . . -162.91 153.11 16.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.015 -1.053 . . . . 0.0 110.786 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.653 HD13 HD13 ' A' ' 34' ' ' LEU . 87.0 mt -109.48 128.1 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.997 -1.064 . . . . 0.0 110.663 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -120.52 -21.92 6.61 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.188 -0.945 . . . . 0.0 111.041 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.432 ' HB2' ' O ' ' A' ' 36' ' ' LYS . 83.2 t80 -105.82 125.45 51.0 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.166 -0.959 . . . . 0.0 111.283 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 62.0 ttp -143.13 133.02 24.05 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.305 -0.872 . . . . 0.0 108.759 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -144.12 142.67 30.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.624 -1.297 . . . . 0.0 110.71 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.477 ' HB1' ' CD2' ' A' ' 32' ' ' LEU . . . -140.12 111.26 7.04 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.526 -0.734 . . . . 0.0 109.797 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.474 ' N ' ' OD1' ' A' ' 123' ' ' ASP . 26.5 p-10 -147.0 143.65 28.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.249 -0.907 . . . . 0.0 110.093 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.413 ' HA3' ' HA ' ' A' ' 30' ' ' PHE . . . 152.04 -157.08 27.05 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.504 ' HB3' ' CB ' ' A' ' 27' ' ' ALA . 87.1 m-20 -76.31 -1.16 25.29 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.283 -1.128 . . . . 0.0 110.141 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.485 ' HD1' HG22 ' A' ' 23' ' ' VAL . 28.2 t80 -99.8 133.71 43.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.962 -1.086 . . . . 0.0 109.528 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' A' ' 22' ' ' GLU . 75.7 mmtt -106.18 136.27 46.18 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.956 -1.09 . . . . 0.0 111.322 -178.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.482 HG23 ' O ' ' A' ' 128' ' ' ILE . 15.0 tt -101.04 125.2 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.266 -0.896 . . . . 0.0 110.836 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -103.35 -18.58 14.79 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.268 -0.895 . . . . 0.0 111.655 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -159.31 149.88 19.44 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.402 -1.436 . . . . 0.0 113.258 -179.068 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 46.2 t -125.81 133.21 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 177.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -146.05 149.71 34.59 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.403 -1.436 . . . . 0.0 111.342 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.601 ' HE2' HD12 ' A' ' 11' ' ' LEU . 59.7 m-85 -105.3 128.07 53.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.624 -0.673 . . . . 0.0 110.453 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 23.1 t0 . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.521 179.342 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.226 0.536 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 2' ' ' CYS . . . . . 0.547 ' HA ' ' HB2' ' B' ' 123' ' ' ASP . 1.3 m -90.05 56.9 3.59 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.224 -0.923 . . . . 0.0 110.653 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 3' ' ' GLY . . . . . 0.532 ' O ' ' ND2' ' A' ' 8' ' ' ASN . . . 32.43 -148.43 0.01 OUTLIER Glycine 0 N--CA 1.505 3.268 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.929 HD22 HD23 ' A' ' 9' ' ' LEU . 49.2 mt -98.53 128.75 44.98 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.652 -1.499 . . . . 0.0 109.053 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 62.9 t -96.63 135.6 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.049 -1.032 . . . . 0.0 109.651 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 6' ' ' ALA . . . . . 0.942 ' HB1' HD11 ' B' ' 9' ' ' LEU . . . -124.7 145.2 49.81 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.184 -0.948 . . . . 0.0 111.023 -178.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 7' ' ' SER . . . . . 0.444 ' O ' ' HB3' ' B' ' 8' ' ' ASN . 33.2 p -145.9 170.38 16.71 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 8' ' ' ASN . . . . . 0.444 ' HB3' ' O ' ' B' ' 7' ' ' SER . 41.3 t-20 59.36 32.12 21.61 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.186 -0.946 . . . . 0.0 109.276 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.942 HD11 ' HB1' ' B' ' 6' ' ' ALA . 96.6 mt -91.47 5.28 50.05 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.656 -0.653 . . . . 0.0 111.598 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 10' ' ' ASN . . . . . 0.521 ' C ' ' O ' ' B' ' 9' ' ' LEU . 37.3 t-20 -4.47 78.66 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.531 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.594 HD12 ' HE2' ' B' ' 133' ' ' PHE . 5.8 tt -92.95 131.18 38.19 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.223 -0.923 . . . . 0.0 109.258 179.299 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -100.76 165.51 14.17 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.249 -0.907 . . . . 0.0 111.182 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 13' ' ' PRO . . . . . 0.475 ' HA ' ' O ' ' B' ' 91' ' ' PHE . 52.3 Cg_endo -68.96 147.31 67.71 Favored 'Trans proline' 0 C--N 1.301 -1.967 0 O-C-N 124.069 1.563 . . . . 0.0 110.736 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.37 0.89 59.4 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.979 -1.105 . . . . 0.0 110.729 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -115.33 147.86 39.96 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.852 -1.381 . . . . 0.0 110.277 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 16' ' ' CYS . . . . . . . . . . . . . 1.2 m -97.29 146.69 24.89 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.175 -0.953 . . . . 0.0 110.806 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.418 ' HB3' ' O ' ' B' ' 89' ' ' ILE . 53.3 tp -133.15 133.8 43.33 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.592 -0.693 . . . . 0.0 110.146 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 78.0 mtt85 -122.88 151.95 41.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.238 -0.913 . . . . 0.0 110.439 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 t -141.22 102.31 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.54 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -99.82 130.52 46.03 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.319 -0.863 . . . . 0.0 109.969 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -144.26 -171.75 14.46 Favored Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.884 -1.151 . . . . 0.0 110.495 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -124.08 153.74 40.97 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.492 -1.005 . . . . 0.0 109.336 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.484 HG22 ' HD1' ' B' ' 126' ' ' PHE . 69.9 t -118.59 133.34 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.908 -1.12 . . . . 0.0 111.422 -178.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.479 ' HB3' ' HB2' ' B' ' 27' ' ' ALA . . . -58.98 150.51 60.64 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.025 -1.047 . . . . 0.0 109.517 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.83 -18.22 52.6 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.817 1.43 . . . . 0.0 111.374 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -125.17 29.29 6.13 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.0 -1.062 . . . . 0.0 108.671 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 27' ' ' ALA . . . . . 0.5 ' CB ' ' HB3' ' B' ' 125' ' ' ASP . . . -63.14 105.27 0.68 Allowed 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.353 0.597 . . . . 0.0 111.965 -178.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -64.08 -49.86 70.62 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.358 -0.838 . . . . 0.0 109.846 178.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 87.4 p -163.93 160.25 21.8 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.305 -0.872 . . . . 0.0 111.661 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 30' ' ' PHE . . . . . 0.542 ' CZ ' ' HG2' ' B' ' 47' ' ' PRO . 47.9 p90 -151.64 161.75 42.15 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' B' ' 45' ' ' PHE . 2.2 p -139.06 138.69 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.375 -1.453 . . . . 0.0 112.787 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.474 ' CD2' ' HB1' ' B' ' 122' ' ' ALA . 89.4 mt -123.86 143.44 50.35 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.467 -0.771 . . . . 0.0 108.925 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 33' ' ' ASN . . . . . 0.669 ' HB2' HD12 ' B' ' 41' ' ' LEU . 26.6 p30 -151.14 163.14 39.5 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.83 -1.168 . . . . 0.0 110.709 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.707 HD12 ' O ' ' B' ' 34' ' ' LEU . 3.8 pp -154.78 126.32 7.44 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.205 -0.934 . . . . 0.0 110.767 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 35' ' ' GLY . . . . . 0.47 ' HA3' ' HA ' ' B' ' 41' ' ' LEU . . . -160.98 -152.43 6.6 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 36' ' ' LYS . . . . . 0.426 ' HE2' ' HB3' ' B' ' 40' ' ' ASN . 60.4 pttt -104.08 -30.58 10.15 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.389 -1.065 . . . . 0.0 109.702 178.444 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 37' ' ' ASP . . . . . 0.477 ' O ' ' CD2' ' B' ' 41' ' ' LEU . 22.4 t70 -143.98 167.68 21.79 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.248 -0.907 . . . . 0.0 110.52 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 38' ' ' SER . . . . . 0.509 ' O ' HD23 ' B' ' 41' ' ' LEU . 5.7 t -51.37 -46.34 62.72 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.389 -0.819 . . . . 0.0 112.808 -177.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 39' ' ' ASN . . . . . 0.454 ' HB3' ' N ' ' B' ' 66' ' ' GLY . 28.0 m-20 -91.79 -2.66 56.82 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.503 -1.373 . . . . 0.0 110.209 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 40' ' ' ASN . . . . . 0.426 ' HB3' ' HE2' ' B' ' 36' ' ' LYS . 9.3 m120 -110.15 56.06 0.63 Allowed 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.241 -0.912 . . . . 0.0 110.41 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.669 HD12 ' HB2' ' B' ' 33' ' ' ASN . 3.6 mm? -85.76 139.84 30.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.304 -0.873 . . . . 0.0 110.105 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 42' ' ' CYS . . . . . . . . . . . . . 1.7 m -89.63 -27.01 20.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 109.895 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 14.4 tp -141.44 135.82 30.69 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 121.188 -0.945 . . . . 0.0 110.812 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 44' ' ' HIS . . . . . 0.512 ' O ' ' HA ' ' B' ' 60' ' ' CYS . 20.4 m-70 -121.66 117.49 26.8 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.13 -0.981 . . . . 0.0 109.284 178.2 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.531 ' O ' ' HA ' ' B' ' 31' ' ' VAL . 39.6 t80 -113.66 122.62 47.73 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.07 -1.019 . . . . 0.0 109.086 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -154.41 76.83 5.52 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 120.955 -1.09 . . . . 0.0 111.104 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 47' ' ' PRO . . . . . 0.589 ' HB3' HG12 ' B' ' 58' ' ' ILE . 55.4 Cg_endo -70.69 147.1 56.13 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 124.119 1.589 . . . . 0.0 110.427 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -122.55 120.59 34.27 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.144 -0.972 . . . . 0.0 109.809 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -59.27 -48.61 80.97 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.92 -1.113 . . . . 0.0 108.199 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -146.69 95.48 2.6 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.46 -136.91 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.447 -0.783 . . . . 0.0 109.097 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 52' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -61.75 -26.87 68.33 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.668 -1.27 . . . . 0.0 109.272 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 171.14 35.77 0.03 OUTLIER Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.642 -1.266 . . . . 0.0 110.563 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -113.94 -173.65 2.32 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.836 -1.391 . . . . 0.0 109.79 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.505 ' O ' ' C ' ' B' ' 56' ' ' ASN . . . -134.75 138.51 44.4 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.427 -0.796 . . . . 0.0 109.827 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 56' ' ' ASN . . . . . 0.505 ' C ' ' O ' ' B' ' 55' ' ' ALA . 6.5 m120 13.29 68.09 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.233 0 CA-C-O 121.535 0.683 . . . . 0.0 112.834 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 19.6 m -102.99 114.88 29.54 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.443 -0.786 . . . . 0.0 108.928 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 58' ' ' ILE . . . . . 0.589 HG12 ' HB3' ' B' ' 47' ' ' PRO . 52.0 mt -96.84 122.52 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.111 -0.993 . . . . 0.0 108.729 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.42 HG13 ' HG3' ' B' ' 71' ' ' GLU . 56.0 t -113.82 130.0 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.383 -0.823 . . . . 0.0 111.105 -178.202 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 60' ' ' CYS . . . . . 0.512 ' HA ' ' O ' ' B' ' 44' ' ' HIS . 0.8 OUTLIER -107.77 125.16 51.07 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.295 -0.878 . . . . 0.0 109.939 179.262 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 61' ' ' ASN . . . . . 0.447 ' HB3' ' HB2' ' B' ' 44' ' ' HIS . 2.8 t-20 -132.06 149.86 52.3 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.189 -0.944 . . . . 0.0 111.109 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 62' ' ' SER . . . . . 0.478 ' O ' ' HA2' ' B' ' 69' ' ' GLY . 54.4 m -123.02 145.52 48.44 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.153 -0.967 . . . . 0.0 108.532 179.05 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 63' ' ' LYS . . . . . 0.528 ' CD ' ' HA2' ' B' ' 66' ' ' GLY . 21.4 ttmt -135.12 144.87 47.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.655 -1.278 . . . . 0.0 111.092 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -121.17 97.81 5.69 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 69.32 20.05 74.82 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 66' ' ' GLY . . . . . 0.528 ' HA2' ' CD ' ' B' ' 63' ' ' LYS . . . 79.38 23.56 62.72 Favored Glycine 0 N--CA 1.487 2.064 0 C-N-CA 119.278 -1.439 . . . . 0.0 110.337 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.27 -80.33 0.2 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.875 -1.368 . . . . 0.0 111.867 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 68' ' ' TRP . . . . . . . . . . . . . 2.4 m-90 -130.54 -144.97 0.27 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.22 -0.925 . . . . 0.0 110.711 -178.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 69' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' B' ' 62' ' ' SER . . . 164.05 143.26 3.65 Favored Glycine 0 N--CA 1.483 1.828 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 99.6 m -92.25 117.46 29.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.567 -0.96 . . . . 0.0 110.326 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 71' ' ' GLU . . . . . 0.42 ' HG3' HG13 ' B' ' 59' ' ' VAL . 81.2 tt0 -98.97 120.91 40.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.013 -1.055 . . . . 0.0 109.646 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 8.4 tm0? -165.04 133.53 3.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.997 -1.065 . . . . 0.0 110.551 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 2.5 mtt-85 172.73 169.11 0.12 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.34 -0.85 . . . . 0.0 111.246 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -111.06 180.0 3.89 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.38 -0.825 . . . . 0.0 109.942 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -101.44 100.6 11.08 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.078 -1.014 . . . . 0.0 109.683 178.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 76' ' ' VAL . . . . . 0.487 HG22 ' HD3' ' B' ' 78' ' ' PRO . 2.6 p -124.76 134.15 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.983 -1.073 . . . . 0.0 110.127 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 77' ' ' PHE . . . . . 0.506 ' N ' ' CD1' ' B' ' 77' ' ' PHE . 11.9 p90 -140.4 87.26 11.98 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 120.942 -1.099 . . . . 0.0 111.782 -179.429 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 78' ' ' PRO . . . . . 0.487 ' HD3' HG22 ' B' ' 76' ' ' VAL . 50.3 Cg_endo -85.15 7.56 5.08 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 124.136 1.598 . . . . 0.0 110.427 178.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -144.01 178.18 8.04 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.216 -0.927 . . . . 0.0 110.488 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.434 ' CG ' ' HD2' ' B' ' 81' ' ' PRO . 0.0 OUTLIER -143.09 172.38 5.75 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.351 -0.843 . . . . 0.0 109.792 179.597 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 81' ' ' PRO . . . . . 0.434 ' HD2' ' CG ' ' B' ' 80' ' ' GLN . 44.0 Cg_endo -66.59 152.85 79.87 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.771 1.406 . . . . 0.0 110.764 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.22 22.68 78.66 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 66.1 m -138.06 149.01 45.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.095 -1.238 . . . . 0.0 111.16 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 33.5 m -76.06 139.15 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.663 -0.648 . . . . 0.0 110.614 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -146.32 143.93 29.46 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.055 -1.028 . . . . 0.0 110.431 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -123.69 146.83 47.96 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.228 -0.92 . . . . 0.0 110.445 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 54.4 t -130.78 131.19 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.394 -0.816 . . . . 0.0 110.049 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 88' ' ' CYS . . . . . 0.405 ' HB3' ' HB3' ' B' ' 99' ' ' LYS . 4.5 t -93.79 126.64 39.09 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.168 -0.957 . . . . 0.0 110.404 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.418 ' O ' ' HB3' ' B' ' 17' ' ' LEU . 97.2 mt -120.55 127.11 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.137 -0.977 . . . . 0.0 110.019 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 27.5 m -127.85 134.15 49.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.081 -1.012 . . . . 0.0 109.001 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 91' ' ' PHE . . . . . 0.475 ' O ' ' HA ' ' B' ' 13' ' ' PRO . 70.6 t80 -114.49 116.47 28.9 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 118.813 -1.155 . . . . 0.0 111.491 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -112.92 146.28 39.26 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 65.0 tp60 -56.24 -37.74 70.13 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 120.896 -1.128 . . . . 0.0 110.546 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.48 -43.45 69.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.157 -0.965 . . . . 0.0 111.348 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -155.53 178.91 9.71 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.075 -1.016 . . . . 0.0 110.744 -178.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 96' ' ' LEU . . . . . 0.484 ' HB3' ' HB2' ' B' ' 108' ' ' PHE . 53.5 tp -110.26 124.76 52.21 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.313 -0.867 . . . . 0.0 109.159 178.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 97' ' ' THR . . . . . 0.655 HG23 ' OE2' ' B' ' 105' ' ' GLU . 2.9 m -107.34 127.35 53.49 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.157 -0.964 . . . . 0.0 110.938 -178.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 98' ' ' VAL . . . . . 0.406 ' O ' ' HG3' ' B' ' 105' ' ' GLU . 50.1 t -131.26 130.79 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -0.909 . . . . 0.0 109.81 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 99' ' ' LYS . . . . . 0.405 ' HB3' ' HB3' ' B' ' 88' ' ' CYS . 85.8 tttt -116.58 126.15 52.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.874 -1.141 . . . . 0.0 111.093 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 100' ' ' LEU . . . . . 0.423 HD12 ' O ' ' B' ' 104' ' ' TYR . 4.0 mt -75.46 160.35 79.78 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.392 -0.818 . . . . 0.0 108.849 178.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -66.59 -24.35 48.55 Favored 'Trans proline' 0 C--N 1.302 -1.908 0 O-C-N 123.701 1.369 . . . . 0.0 110.217 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -155.81 75.39 0.9 Allowed 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.336 -0.852 . . . . 0.0 110.177 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 178.54 -167.12 37.41 Favored Glycine 0 N--CA 1.495 2.619 0 C-N-CA 119.407 -1.378 . . . . 0.0 110.548 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 104' ' ' TYR . . . . . 0.423 ' O ' HD12 ' B' ' 100' ' ' LEU . 73.7 m-85 -77.0 -165.4 0.55 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.476 -1.014 . . . . 0.0 110.958 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 105' ' ' GLU . . . . . 0.655 ' OE2' HG23 ' B' ' 97' ' ' THR . 69.4 tt0 -129.53 159.03 37.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.348 -0.845 . . . . 0.0 110.527 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -132.03 153.19 50.63 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.476 -0.765 . . . . 0.0 110.936 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 107' ' ' LYS . . . . . 0.428 ' HA ' ' O ' ' B' ' 96' ' ' LEU . 98.2 mttt -129.2 146.73 51.06 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.354 -0.841 . . . . 0.0 111.537 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 108' ' ' PHE . . . . . 0.484 ' HB2' ' HB3' ' B' ' 96' ' ' LEU . 0.4 OUTLIER -118.29 140.34 27.96 Favored Pre-proline 0 C--N 1.301 -1.537 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.669 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -71.51 162.19 43.05 Favored 'Trans proline' 0 C--N 1.301 -1.938 0 O-C-N 123.575 1.303 . . . . 0.0 110.574 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 110' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -72.0 59.29 0.37 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.559 -0.713 . . . . 0.0 111.266 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 15.3 tpt85 -63.34 -39.58 94.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.099 -1.0 . . . . 0.0 109.015 178.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 112' ' ' LEU . . . . . 0.401 HD11 ' HB3' ' B' ' 62' ' ' SER . 81.2 mt -105.91 124.34 49.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.69 -0.631 . . . . 0.0 109.551 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -86.77 69.88 10.34 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.918 -1.114 . . . . 0.0 109.743 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 36.5 tp -95.09 129.75 42.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.626 -0.671 . . . . 0.0 110.079 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -92.25 -12.92 31.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.18 -0.95 . . . . 0.0 110.7 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 116' ' ' ALA . . . . . 0.538 ' HA ' ' O ' ' B' ' 11' ' ' LEU . . . -162.97 153.44 16.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.016 -1.052 . . . . 0.0 110.626 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 117' ' ' ILE . . . . . 0.652 HD13 HD13 ' B' ' 34' ' ' LEU . 89.4 mt -109.92 128.08 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.072 -1.018 . . . . 0.0 110.707 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -120.36 -21.8 6.75 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.18 -0.95 . . . . 0.0 111.121 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 119' ' ' TYR . . . . . 0.418 ' HB2' ' O ' ' B' ' 36' ' ' LYS . 83.2 t80 -106.09 125.75 51.37 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.032 -1.042 . . . . 0.0 111.18 -179.115 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 61.5 ttp -143.41 133.04 23.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.352 -0.843 . . . . 0.0 108.728 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -144.28 142.91 30.75 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.65 -1.281 . . . . 0.0 110.686 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 122' ' ' ALA . . . . . 0.474 ' HB1' ' CD2' ' B' ' 32' ' ' LEU . . . -140.48 111.27 6.91 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.566 -0.709 . . . . 0.0 109.701 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 123' ' ' ASP . . . . . 0.547 ' HB2' ' HA ' ' B' ' 2' ' ' CYS . 26.3 p-10 -147.42 142.59 27.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.389 -0.82 . . . . 0.0 109.894 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 124' ' ' GLY . . . . . 0.418 ' HA3' ' HA ' ' B' ' 30' ' ' PHE . . . 153.48 -157.22 27.25 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.821 -1.711 . . . . 0.0 108.821 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 125' ' ' ASP . . . . . 0.5 ' HB3' ' CB ' ' B' ' 27' ' ' ALA . 86.9 m-20 -76.35 -0.94 24.45 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.263 -1.139 . . . . 0.0 110.161 179.011 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 126' ' ' PHE . . . . . 0.484 ' HD1' HG22 ' B' ' 23' ' ' VAL . 28.2 t80 -100.03 133.7 44.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.005 -1.059 . . . . 0.0 109.473 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -106.27 135.88 46.97 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.976 -1.078 . . . . 0.0 111.307 -178.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 128' ' ' ILE . . . . . 0.478 ' O ' HG23 ' B' ' 128' ' ' ILE . 14.9 tt -100.47 125.61 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.267 -0.896 . . . . 0.0 110.877 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -103.43 -19.99 14.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.151 -0.968 . . . . 0.0 111.624 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 130' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -156.87 150.25 24.24 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.345 -1.472 . . . . 0.0 113.456 -179.094 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 46.3 t -125.81 133.37 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 177.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 132' ' ' ALA . . . . . . . . . . . . . . . -146.13 149.72 34.55 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.278 -1.514 . . . . 0.0 111.13 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 133' ' ' PHE . . . . . 0.594 ' HE2' HD12 ' B' ' 11' ' ' LEU . 60.2 m-85 -105.52 128.01 53.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.587 -0.696 . . . . 0.0 110.441 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 23.0 t0 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.755 179.346 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.44 ' HA3' ' O ' ' A' ' 122' ' ' ALA . . . . . . . . 0 N--CA 1.493 2.464 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.439 HD21 HG23 ' A' ' 128' ' ' ILE . 1.1 pp -67.7 156.4 37.01 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.264 -1.139 . . . . 0.0 111.615 -178.509 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.4 t -118.63 132.73 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.6 ' HB3' HD11 ' A' ' 9' ' ' LEU . . . -110.04 178.98 4.24 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.871 -1.143 . . . . 0.0 110.985 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.42 ' O ' ' HB3' ' A' ' 8' ' ' ASN . 27.7 p -155.95 171.08 20.69 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.428 ' HB3' ' HA ' ' B' ' 4' ' ' LEU . 63.6 t30 58.25 35.88 25.27 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.288 -0.882 . . . . 0.0 110.545 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.6 HD11 ' HB3' ' A' ' 6' ' ' ALA . 78.5 mt -87.29 -5.61 58.85 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.488 -0.757 . . . . 0.0 111.156 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.505 ' C ' ' O ' ' A' ' 9' ' ' LEU . 4.9 m120 6.34 66.33 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.748 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.7 HD11 ' CE2' ' A' ' 133' ' ' PHE . 11.2 mt -93.07 129.05 39.15 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.048 -1.033 . . . . 0.0 110.514 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.43 ' CB ' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -98.79 171.74 5.45 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.295 -0.878 . . . . 0.0 110.783 -179.971 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.43 ' HD2' ' CB ' ' A' ' 12' ' ' LYS . 39.4 Cg_endo -65.17 148.13 88.77 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.221 1.643 . . . . 0.0 109.378 178.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.8 -16.01 54.98 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -111.35 142.09 44.04 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.177 -1.19 . . . . 0.0 109.699 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 58.2 m -109.77 153.19 24.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.196 -0.94 . . . . 0.0 110.181 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.493 HD12 ' O ' ' A' ' 132' ' ' ALA . 57.5 tp -118.28 130.7 56.2 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.221 -0.924 . . . . 0.0 110.349 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -110.99 125.75 54.05 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.577 -0.702 . . . . 0.0 109.489 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 74.0 t -121.16 123.29 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.92 -1.113 . . . . 0.0 110.158 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -123.56 128.44 49.73 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.215 -0.928 . . . . 0.0 109.645 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -146.86 -152.83 5.74 Favored Glycine 0 N--CA 1.489 2.226 0 C-N-CA 119.292 -1.433 . . . . 0.0 110.292 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -136.5 142.34 43.51 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.656 -0.908 . . . . 0.0 109.467 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.489 ' CG1' ' HA ' ' A' ' 81' ' ' PRO . 34.8 t -108.48 132.98 54.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 O-C-N 121.334 -0.854 . . . . 0.0 111.131 -178.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.92 152.57 96.73 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.528 -0.732 . . . . 0.0 109.871 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.404 ' HA ' ' HB2' ' A' ' 81' ' ' PRO . 42.9 Cg_endo -65.79 -28.3 51.4 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 123.955 1.503 . . . . 0.0 110.631 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -97.34 16.15 20.89 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.267 -0.895 . . . . 0.0 109.945 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.471 ' HA ' ' HB3' ' A' ' 125' ' ' ASP . . . -61.75 98.76 0.1 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.107 -0.996 . . . . 0.0 110.874 -179.007 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -95.04 -15.61 23.33 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.513 -0.742 . . . . 0.0 110.682 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 42.1 t -167.38 142.25 3.88 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 118.725 -1.19 . . . . 0.0 111.454 -178.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.532 ' CE2' ' HB2' ' A' ' 32' ' ' LEU . 10.6 t80 -149.34 157.63 43.49 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.429 -0.794 . . . . 0.0 109.993 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.533 HG12 ' O ' ' A' ' 123' ' ' ASP . 2.5 p -129.09 131.16 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.909 -1.119 . . . . 0.0 110.837 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.532 ' HB2' ' CE2' ' A' ' 30' ' ' PHE . 12.7 tp -131.42 129.68 41.57 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.61 -0.681 . . . . 0.0 109.165 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -161.24 153.19 19.64 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.433 -1.417 . . . . 0.0 111.027 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.779 HD12 HD13 ' A' ' 117' ' ' ILE . 0.4 OUTLIER -143.61 128.09 17.96 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.673 0.749 . . . . 0.0 109.656 179.261 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.457 ' HA3' ' HA ' ' A' ' 41' ' ' LEU . . . -163.79 -160.38 11.67 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.47 ' O ' ' CD1' ' A' ' 119' ' ' TYR . 40.3 mtpt -67.45 -42.17 83.51 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 122.394 1.092 . . . . 0.0 108.212 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -157.45 -168.93 2.73 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.73 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.2 t -62.36 -42.8 99.69 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.781 -0.575 . . . . 0.0 112.296 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.466 ' HB3' ' N ' ' A' ' 66' ' ' GLY . 92.9 m-20 -87.06 -14.5 41.29 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.867 -1.146 . . . . 0.0 110.786 -178.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.441 ' HB2' ' HB2' ' A' ' 36' ' ' LYS . 5.6 m-80 -113.21 70.02 0.71 Allowed 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.867 0.841 . . . . 0.0 108.82 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.457 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 72.5 mt -100.72 139.09 36.89 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.729 ' SG ' HD23 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -83.96 -25.66 29.87 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.944 -1.097 . . . . 0.0 110.723 -179.301 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.729 HD23 ' SG ' ' A' ' 42' ' ' CYS . 2.8 pp -155.71 136.29 13.33 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.265 -0.897 . . . . 0.0 110.216 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.466 ' HB3' ' O ' ' A' ' 61' ' ' ASN . 9.5 t-80 -133.27 121.46 22.49 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.48 -0.763 . . . . 0.0 109.786 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -115.5 133.69 55.8 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.077 -1.015 . . . . 0.0 110.487 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 52.2 t-20 -137.75 78.1 37.35 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 120.999 -1.063 . . . . 0.0 110.393 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -67.15 142.41 61.05 Favored 'Trans proline' 0 C--N 1.302 -1.88 0 O-C-N 123.865 1.455 . . . . 0.0 109.978 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -128.03 122.5 32.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.115 -0.991 . . . . 0.0 110.189 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -60.23 -46.74 88.72 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 118.605 -1.238 . . . . 0.0 108.403 178.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -147.53 102.15 3.42 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.617 -0.677 . . . . 0.0 110.017 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -84.97 -144.03 0.09 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.301 -0.875 . . . . 0.0 108.977 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -50.14 -29.4 9.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.102 -0.999 . . . . 0.0 109.373 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 170.48 38.64 0.03 OUTLIER Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -112.24 -172.52 2.06 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.035 -1.273 . . . . 0.0 109.917 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.466 ' O ' ' C ' ' A' ' 56' ' ' ASN . . . -139.79 137.19 34.82 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.181 -0.949 . . . . 0.0 110.596 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.466 ' C ' ' O ' ' A' ' 55' ' ' ALA . 92.4 m-20 24.79 60.67 0.05 Allowed 'General case' 0 N--CA 1.509 2.507 0 CA-C-O 121.412 0.625 . . . . 0.0 112.208 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 8.8 m -113.05 141.39 46.93 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.323 -0.86 . . . . 0.0 109.862 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.48 HG23 ' HB2' ' A' ' 74' ' ' GLU . 18.9 tt -136.75 138.85 45.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.211 -0.931 . . . . 0.0 110.318 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 55.4 t -119.57 127.2 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.302 -0.874 . . . . 0.0 110.312 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 47.9 t -96.08 126.94 41.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.368 -0.833 . . . . 0.0 110.337 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.466 ' O ' ' HB3' ' A' ' 44' ' ' HIS . 19.6 t30 -136.34 148.78 48.07 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.408 -0.807 . . . . 0.0 110.295 -179.3 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.456 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 71.1 m -125.3 150.45 47.11 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.805 -1.184 . . . . 0.0 108.948 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.477 ' CD ' ' HA2' ' A' ' 66' ' ' GLY . 19.0 ttmt -138.63 148.25 43.85 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.672 -1.268 . . . . 0.0 111.718 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -120.97 97.48 5.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.675 -0.64 . . . . 0.0 110.44 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.403 ' C ' ' HB3' ' A' ' 39' ' ' ASN . . . 66.99 24.11 73.02 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.477 ' HA2' ' CD ' ' A' ' 63' ' ' LYS . . . 75.07 25.12 69.72 Favored Glycine 0 N--CA 1.48 1.606 0 C-N-CA 119.137 -1.506 . . . . 0.0 110.515 178.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -87.08 -81.02 0.24 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.988 -1.301 . . . . 0.0 110.649 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.455 ' O ' ' HG3' ' A' ' 63' ' ' LYS . 41.3 m95 -124.08 -156.59 0.72 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.075 -1.016 . . . . 0.0 110.445 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.456 ' HA2' ' O ' ' A' ' 62' ' ' SER . . . 163.86 114.9 0.31 Allowed Glycine 0 N--CA 1.487 2.05 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.6 m -80.65 121.5 25.93 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.541 -0.976 . . . . 0.0 110.412 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -91.27 129.19 37.29 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.175 -0.953 . . . . 0.0 110.913 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -112.26 -172.36 2.03 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.12 -0.988 . . . . 0.0 109.358 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -147.79 126.31 12.44 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 118.416 -1.314 . . . . 0.0 112.437 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.48 ' HB2' HG23 ' A' ' 58' ' ' ILE . 95.8 mt-10 -115.47 145.59 42.45 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -119.49 48.62 1.48 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.769 -1.207 . . . . 0.0 109.093 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.3 m -119.39 132.39 69.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.426 -0.796 . . . . 0.0 110.931 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -161.51 80.16 2.06 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.392 -0.818 . . . . 0.0 109.57 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -81.17 8.3 4.44 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 124.163 1.612 . . . . 0.0 111.37 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.409 ' CD2' ' HB2' ' A' ' 85' ' ' ALA . 12.2 m-85 -132.14 179.12 6.3 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.937 -1.102 . . . . 0.0 110.212 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.424 ' HB3' ' HD2' ' A' ' 81' ' ' PRO . 0.7 OUTLIER -144.16 177.23 1.87 Allowed Pre-proline 0 C--N 1.296 -1.741 0 O-C-N 121.545 -0.722 . . . . 0.0 109.221 -179.222 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.489 ' HA ' ' CG1' ' A' ' 23' ' ' VAL . 50.3 Cg_endo -71.26 157.29 57.46 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.531 1.279 . . . . 0.0 109.748 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 68.7 26.93 74.2 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.879 -1.688 . . . . 0.0 108.879 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.0 m -133.76 151.99 51.75 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.466 -1.02 . . . . 0.0 110.068 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 69.4 t -95.53 129.63 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.254 -0.903 . . . . 0.0 110.236 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.409 ' HB2' ' CD2' ' A' ' 79' ' ' PHE . . . -149.5 147.1 27.81 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.272 -0.893 . . . . 0.0 110.516 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -122.33 142.87 50.04 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.227 -0.921 . . . . 0.0 109.451 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 39.8 t -127.54 132.64 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.061 -1.024 . . . . 0.0 111.131 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -95.26 140.19 30.51 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.316 -0.865 . . . . 0.0 111.205 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.6 mt -124.64 128.58 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.612 -0.68 . . . . 0.0 110.417 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.534 ' HB ' ' HB ' ' A' ' 97' ' ' THR . 52.5 m -121.98 128.81 51.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.167 -0.958 . . . . 0.0 109.859 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.411 ' HA ' HD12 ' A' ' 96' ' ' LEU . 62.1 t80 -109.3 117.89 35.25 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.216 -0.928 . . . . 0.0 111.087 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -125.29 150.56 46.99 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.509 -0.744 . . . . 0.0 110.418 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.443 ' NE2' ' O ' ' A' ' 114' ' ' LEU . 75.8 mm-40 -62.52 -37.94 88.02 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.349 -0.844 . . . . 0.0 110.252 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.01 -40.84 95.51 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.211 -0.931 . . . . 0.0 110.113 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.437 ' C ' ' OD1' ' A' ' 95' ' ' ASN . 11.0 p30 -169.02 -171.67 1.38 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.378 -0.826 . . . . 0.0 110.521 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 91' ' ' PHE . 20.3 tp -112.12 132.87 54.61 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.409 -0.807 . . . . 0.0 109.599 178.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.534 ' HB ' ' HB ' ' A' ' 90' ' ' THR . 23.2 m -117.14 126.44 52.82 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.871 -1.143 . . . . 0.0 110.94 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 41.2 t -123.21 129.82 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.181 -0.949 . . . . 0.0 109.674 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -115.36 126.93 55.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.169 -0.957 . . . . 0.0 110.735 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.8 mp -100.34 164.55 16.09 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.581 -0.7 . . . . 0.0 109.833 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -64.91 -24.01 61.26 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.732 1.385 . . . . 0.0 110.371 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -77.37 -14.59 59.68 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.243 -0.911 . . . . 0.0 110.478 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.96 -13.2 59.08 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -70.93 135.32 47.87 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.922 -1.34 . . . . 0.0 109.977 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -124.66 138.7 54.29 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.437 -0.79 . . . . 0.0 110.175 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -126.43 134.46 50.98 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.093 -1.004 . . . . 0.0 109.636 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -112.83 145.06 41.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.069 -1.02 . . . . 0.0 111.049 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.52 ' CE2' ' O ' ' A' ' 109' ' ' PRO . 3.1 t80 -134.23 136.95 26.96 Favored Pre-proline 0 C--N 1.301 -1.521 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.52 ' O ' ' CE2' ' A' ' 108' ' ' PHE . 38.5 Cg_endo -64.18 133.98 40.44 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.642 1.338 . . . . 0.0 110.643 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.454 ' ND2' ' O ' ' A' ' 110' ' ' ASN . 6.2 p-10 -85.98 83.58 7.75 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.202 -0.936 . . . . 0.0 110.397 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -55.92 -20.8 17.4 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.937 -1.102 . . . . 0.0 109.657 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 97.5 mt -101.97 133.3 46.98 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.225 -0.922 . . . . 0.0 109.92 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 29.9 m-20 -88.71 67.29 8.33 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.242 -0.911 . . . . 0.0 110.887 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.473 HD11 ' O ' ' A' ' 116' ' ' ALA . 33.8 tp -87.38 120.45 28.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.232 -0.917 . . . . 0.0 109.368 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.418 ' O ' ' HD3' ' A' ' 13' ' ' PRO . 16.6 pt-20 -82.84 -13.73 55.63 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.678 -1.264 . . . . 0.0 110.469 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.473 ' O ' HD11 ' A' ' 114' ' ' LEU . . . -157.59 157.54 33.88 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.806 -1.184 . . . . 0.0 111.267 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.779 HD13 HD12 ' A' ' 34' ' ' LEU . 95.1 mt -108.57 126.81 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.45 -0.781 . . . . 0.0 109.607 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -111.17 -27.74 8.58 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.998 -1.064 . . . . 0.0 111.255 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.47 ' CD1' ' O ' ' A' ' 36' ' ' LYS . 3.0 m-85 -117.15 140.86 49.0 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.935 -1.103 . . . . 0.0 112.503 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.442 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 54.8 ttp -138.76 129.64 26.52 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -136.61 136.42 39.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.398 -1.439 . . . . 0.0 111.097 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.44 ' O ' ' HA3' ' A' ' 3' ' ' GLY . . . -149.5 116.34 5.94 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.058 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.533 ' O ' HG12 ' A' ' 31' ' ' VAL . 65.8 t0 -147.02 118.67 8.0 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.611 -0.681 . . . . 0.0 109.384 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 179.62 -151.72 10.34 Favored Glycine 0 N--CA 1.489 2.206 0 C-N-CA 119.612 -1.28 . . . . 0.0 110.385 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.471 ' HB3' ' HA ' ' A' ' 27' ' ' ALA . 99.6 m-20 -74.46 -2.82 27.23 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.96 -0.729 . . . . 0.0 111.122 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.499 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 24.8 t80 -96.62 137.79 35.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.997 -1.064 . . . . 0.0 110.334 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -110.75 120.53 42.72 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 118.43 -1.308 . . . . 0.0 111.098 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.739 HD11 HG22 ' A' ' 131' ' ' VAL . 7.6 tt -101.37 114.26 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.223 -0.923 . . . . 0.0 110.242 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -97.85 -13.58 21.21 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 120.904 -1.122 . . . . 0.0 110.999 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -147.92 148.41 30.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.748 -1.22 . . . . 0.0 112.59 -179.24 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.739 HG22 HD11 ' A' ' 128' ' ' ILE . 52.6 t -133.42 131.33 57.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.088 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.493 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -127.99 146.71 50.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.628 -1.295 . . . . 0.0 110.785 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.7 ' CE2' HD11 ' A' ' 11' ' ' LEU . 10.0 m-85 -109.24 127.65 54.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.567 -0.708 . . . . 0.0 110.106 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 59.5 t0 . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 117.948 -1.025 . . . . 0.0 111.123 179.249 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.813 0 CA-C-O 120.849 0.357 . . . . 0.0 110.687 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 2' ' ' CYS . . . . . 0.452 ' O ' ' O ' ' B' ' 126' ' ' PHE . 99.1 m -141.64 -123.78 0.1 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.812 -1.18 . . . . 0.0 109.91 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 3' ' ' GLY . . . . . 0.44 ' HA3' ' O ' ' B' ' 122' ' ' ALA . . . 176.28 121.56 0.67 Allowed Glycine 0 N--CA 1.494 2.534 0 N-CA-C 108.679 -1.768 . . . . 0.0 108.679 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.433 HD21 HG23 ' B' ' 128' ' ' ILE . 1.2 pp -68.22 156.6 37.26 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.233 -1.157 . . . . 0.0 111.49 -178.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 45.5 t -118.84 132.59 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.706 -0.621 . . . . 0.0 109.399 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 6' ' ' ALA . . . . . 0.572 ' HB3' HD11 ' B' ' 9' ' ' LEU . . . -110.09 178.57 4.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.738 -1.226 . . . . 0.0 111.26 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 7' ' ' SER . . . . . 0.45 ' O ' ' HB3' ' B' ' 8' ' ' ASN . 26.3 p -155.45 170.9 20.88 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 8' ' ' ASN . . . . . 0.45 ' HB3' ' O ' ' B' ' 7' ' ' SER . 63.5 t30 59.16 35.2 23.58 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.366 -0.834 . . . . 0.0 110.539 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.572 HD11 ' HB3' ' B' ' 6' ' ' ALA . 81.1 mt -88.1 -1.58 58.09 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.29 -0.881 . . . . 0.0 111.306 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 10' ' ' ASN . . . . . 0.505 ' C ' ' O ' ' B' ' 9' ' ' LEU . 4.7 m120 -0.05 69.38 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.751 0 N-CA-C 113.874 1.065 . . . . 0.0 113.874 -178.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.681 HD11 ' CE2' ' B' ' 133' ' ' PHE . 11.1 mt -93.81 128.65 40.17 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.312 -0.867 . . . . 0.0 110.442 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 12' ' ' LYS . . . . . 0.412 ' CB ' ' HD2' ' B' ' 13' ' ' PRO . 0.0 OUTLIER -98.68 171.73 5.47 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.285 -0.885 . . . . 0.0 110.872 -179.786 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 13' ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' B' ' 115' ' ' GLU . 40.7 Cg_endo -65.34 147.99 87.97 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.242 1.654 . . . . 0.0 109.501 178.09 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.11 -16.25 54.0 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -111.17 142.06 43.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.065 -1.256 . . . . 0.0 109.951 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 16' ' ' CYS . . . . . . . . . . . . . 57.7 m -109.46 153.75 23.61 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.162 -0.961 . . . . 0.0 110.277 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.475 HD12 ' O ' ' B' ' 132' ' ' ALA . 56.6 tp -118.68 130.8 56.04 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.245 -0.91 . . . . 0.0 110.366 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -111.05 125.87 54.21 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.553 -0.717 . . . . 0.0 109.483 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 79.1 t -121.06 122.61 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.946 -1.096 . . . . 0.0 110.253 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -123.02 128.62 50.42 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.145 -0.972 . . . . 0.0 109.691 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -147.35 -152.92 5.77 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.42 -1.372 . . . . 0.0 110.349 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 -136.5 142.37 43.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.597 -0.943 . . . . 0.0 109.527 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.494 ' CG1' ' HA ' ' B' ' 81' ' ' PRO . 32.0 t -108.47 132.7 55.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 O-C-N 121.495 -0.753 . . . . 0.0 111.122 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.62 152.36 96.71 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.582 -0.699 . . . . 0.0 110.057 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -65.35 -29.13 54.54 Favored 'Trans proline' 0 C--N 1.303 -1.858 0 O-C-N 124.042 1.548 . . . . 0.0 110.466 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -96.85 16.46 19.21 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.429 -0.794 . . . . 0.0 110.104 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 27' ' ' ALA . . . . . 0.476 ' HA ' ' HB3' ' B' ' 125' ' ' ASP . . . -62.61 99.13 0.14 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.269 -0.895 . . . . 0.0 110.697 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -95.16 -17.98 21.31 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.399 -0.813 . . . . 0.0 110.785 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 39.4 t -163.82 142.77 7.84 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.977 -1.089 . . . . 0.0 111.452 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 30' ' ' PHE . . . . . 0.528 ' CE2' ' HB2' ' B' ' 32' ' ' LEU . 9.9 t80 -149.74 157.51 43.29 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.381 -0.825 . . . . 0.0 110.017 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.534 HG12 ' O ' ' B' ' 123' ' ' ASP . 2.5 p -128.89 131.74 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 120.766 -1.209 . . . . 0.0 110.989 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.528 ' HB2' ' CE2' ' B' ' 30' ' ' PHE . 12.7 tp -131.42 129.8 41.73 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.524 -0.735 . . . . 0.0 109.16 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -161.3 153.74 20.26 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 118.287 -1.365 . . . . 0.0 110.851 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.803 HD12 HD13 ' B' ' 117' ' ' ILE . 0.4 OUTLIER -144.57 124.96 13.86 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.636 0.731 . . . . 0.0 109.804 179.411 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 35' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' B' ' 41' ' ' LEU . . . -159.7 -159.35 9.72 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 36' ' ' LYS . . . . . 0.467 ' O ' ' CD1' ' B' ' 119' ' ' TYR . 40.6 mtpt -67.81 -42.34 81.7 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.424 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -156.55 -167.59 2.45 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.879 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 8.7 t -62.97 -42.87 99.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.774 -0.579 . . . . 0.0 112.41 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 39' ' ' ASN . . . . . 0.477 ' HB3' ' N ' ' B' ' 66' ' ' GLY . 92.0 m-20 -87.3 -14.52 40.65 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.983 -1.073 . . . . 0.0 110.751 -178.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 40' ' ' ASN . . . . . 0.435 ' HB2' ' HB2' ' B' ' 36' ' ' LYS . 6.1 m-80 -112.67 70.06 0.71 Allowed 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.458 ' HA ' ' HA3' ' B' ' 35' ' ' GLY . 73.0 mt -100.29 142.03 32.32 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 42' ' ' CYS . . . . . 0.69 ' SG ' HD23 ' B' ' 43' ' ' LEU . 0.0 OUTLIER -88.33 -23.5 23.4 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.832 -1.167 . . . . 0.0 110.359 -178.891 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.733 HD21 HD21 ' B' ' 34' ' ' LEU . 2.8 pp -156.57 135.93 12.19 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.26 -0.9 . . . . 0.0 110.154 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 44' ' ' HIS . . . . . 0.467 ' NE2' HG23 ' B' ' 31' ' ' VAL . 9.5 t-80 -133.19 121.29 22.31 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.691 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -115.51 133.88 55.61 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.136 -0.978 . . . . 0.0 110.296 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -137.8 78.25 36.73 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.046 -1.034 . . . . 0.0 110.3 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 47' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -67.14 142.53 61.54 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.851 1.448 . . . . 0.0 109.772 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -128.31 121.98 30.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.126 -0.984 . . . . 0.0 110.014 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -60.12 -46.87 88.19 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 118.35 -1.34 . . . . 0.0 108.344 178.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -147.18 102.35 3.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.699 -0.626 . . . . 0.0 109.97 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.37 -144.02 0.1 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.279 -0.888 . . . . 0.0 108.992 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 52' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -50.18 -28.72 7.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.085 -1.01 . . . . 0.0 109.409 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 169.55 38.81 0.03 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -112.25 -172.62 2.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.046 -1.267 . . . . 0.0 109.889 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.499 ' O ' ' C ' ' B' ' 56' ' ' ASN . . . -138.46 142.11 39.45 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.306 -0.871 . . . . 0.0 109.949 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 56' ' ' ASN . . . . . 0.499 ' C ' ' O ' ' B' ' 55' ' ' ALA . 92.0 m-20 16.41 64.33 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.569 0 CA-C-O 121.83 0.824 . . . . 0.0 112.51 -178.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 9.7 m -113.84 141.0 47.87 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.654 -0.654 . . . . 0.0 109.758 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 58' ' ' ILE . . . . . 0.476 HG23 ' HB2' ' B' ' 74' ' ' GLU . 18.7 tt -136.72 138.11 46.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.192 -0.942 . . . . 0.0 110.335 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 55.4 t -118.38 127.76 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.258 -0.901 . . . . 0.0 110.306 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 47.9 t -96.56 126.03 41.45 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.373 -0.83 . . . . 0.0 110.226 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 61' ' ' ASN . . . . . 0.451 ' O ' ' HB3' ' B' ' 44' ' ' HIS . 17.7 t30 -135.58 148.68 49.16 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.42 -0.8 . . . . 0.0 110.527 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 62' ' ' SER . . . . . 0.447 ' O ' ' HA2' ' B' ' 69' ' ' GLY . 72.1 m -125.06 150.93 46.29 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.677 -1.264 . . . . 0.0 109.042 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 63' ' ' LYS . . . . . 0.496 ' CD ' ' HA2' ' B' ' 66' ' ' GLY . 18.6 ttmt -138.93 148.03 43.04 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.651 -1.281 . . . . 0.0 111.526 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -120.85 97.67 5.65 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.612 -0.68 . . . . 0.0 110.312 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 67.08 23.65 73.01 Favored Glycine 0 N--CA 1.487 2.061 0 C-N-CA 119.491 -1.338 . . . . 0.0 110.131 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 66' ' ' GLY . . . . . 0.496 ' HA2' ' CD ' ' B' ' 63' ' ' LYS . . . 75.18 24.85 70.19 Favored Glycine 0 N--CA 1.487 2.081 0 O-C-N 120.846 -1.385 . . . . 0.0 110.305 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -86.55 -81.56 0.22 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.964 -1.315 . . . . 0.0 110.662 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 68' ' ' TRP . . . . . 0.457 ' O ' ' HG3' ' B' ' 63' ' ' LYS . 41.2 m95 -124.05 -156.11 0.7 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.13 -0.981 . . . . 0.0 110.374 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 69' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' B' ' 62' ' ' SER . . . 163.35 114.69 0.31 Allowed Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 5.4 m -80.46 120.96 25.14 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.538 -0.978 . . . . 0.0 110.492 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -90.59 128.92 36.74 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.272 -0.892 . . . . 0.0 111.082 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -112.06 -172.14 1.98 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.951 -1.093 . . . . 0.0 109.282 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -147.7 127.36 13.35 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 118.257 -1.377 . . . . 0.0 112.34 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 74' ' ' GLU . . . . . 0.476 ' HB2' HG23 ' B' ' 58' ' ' ILE . 96.0 mt-10 -116.37 145.11 43.47 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -119.48 48.42 1.52 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.986 -1.071 . . . . 0.0 109.112 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 33.8 m -119.37 132.14 70.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-O 121.561 0.696 . . . . 0.0 110.679 -179.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -161.35 81.29 2.01 Favored Pre-proline 0 C--N 1.301 -1.519 0 O-C-N 121.743 -0.598 . . . . 0.0 109.548 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -82.23 8.77 4.31 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 121.843 1.696 . . . . 0.0 111.234 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 79' ' ' PHE . . . . . 0.409 ' CD2' ' HB2' ' B' ' 85' ' ' ALA . 13.8 m-85 -132.79 178.99 6.43 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.918 -1.114 . . . . 0.0 110.403 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.451 ' HB3' ' HD2' ' B' ' 81' ' ' PRO . 0.7 OUTLIER -144.02 177.26 1.87 Allowed Pre-proline 0 C--N 1.297 -1.705 0 O-C-N 121.553 -0.717 . . . . 0.0 109.19 -179.25 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 81' ' ' PRO . . . . . 0.494 ' HA ' ' CG1' ' B' ' 23' ' ' VAL . 54.0 Cg_endo -71.34 157.15 57.5 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.699 1.368 . . . . 0.0 109.412 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 68.5 26.62 74.25 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 6.5 m -133.37 151.73 51.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.505 -0.997 . . . . 0.0 110.039 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 70.7 t -95.72 129.26 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.259 -0.901 . . . . 0.0 110.23 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 85' ' ' ALA . . . . . 0.409 ' HB2' ' CD2' ' B' ' 79' ' ' PHE . . . -149.27 147.3 28.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.221 -0.924 . . . . 0.0 110.473 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -122.12 143.29 49.63 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.243 -0.911 . . . . 0.0 109.4 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 39.5 t -127.41 132.29 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.069 -1.02 . . . . 0.0 111.293 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 88' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -94.78 139.83 30.74 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.344 -0.848 . . . . 0.0 111.166 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 96.8 mt -124.85 128.55 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.675 -0.64 . . . . 0.0 110.254 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 90' ' ' THR . . . . . 0.494 ' HB ' ' HB ' ' B' ' 97' ' ' THR . 52.1 m -122.36 128.75 51.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.157 -0.964 . . . . 0.0 109.811 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 91' ' ' PHE . . . . . 0.414 ' HA ' HD12 ' B' ' 96' ' ' LEU . 61.6 t80 -109.02 118.5 36.94 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.157 -0.964 . . . . 0.0 111.049 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -125.58 150.65 47.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.516 -0.74 . . . . 0.0 110.356 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 93' ' ' GLN . . . . . 0.431 ' NE2' ' O ' ' B' ' 114' ' ' LEU . 75.2 mm-40 -62.65 -37.62 87.1 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.359 -0.838 . . . . 0.0 110.246 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.27 -40.84 94.44 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.195 -0.94 . . . . 0.0 110.116 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 95' ' ' ASN . . . . . 0.424 ' C ' ' OD1' ' B' ' 95' ' ' ASN . 10.5 p30 -168.77 -171.04 1.29 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.419 -0.8 . . . . 0.0 110.506 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 96' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' B' ' 91' ' ' PHE . 20.3 tp -112.82 132.85 55.09 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.26 -0.9 . . . . 0.0 109.324 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 97' ' ' THR . . . . . 0.494 ' HB ' ' HB ' ' B' ' 90' ' ' THR . 22.1 m -117.24 126.58 52.98 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.979 -1.076 . . . . 0.0 110.831 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 40.8 t -123.18 130.39 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.234 -0.916 . . . . 0.0 109.66 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -115.75 127.53 55.18 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.076 -1.015 . . . . 0.0 110.69 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 mp -101.08 164.29 16.34 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.576 -0.702 . . . . 0.0 109.71 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -64.87 -24.16 61.37 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.696 1.366 . . . . 0.0 110.217 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -77.22 -14.16 59.82 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.312 -0.868 . . . . 0.0 110.567 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.27 -13.08 60.21 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 104' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -71.11 135.84 47.88 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.915 -1.344 . . . . 0.0 109.893 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -124.89 139.18 54.07 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.394 -0.816 . . . . 0.0 110.033 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -127.07 134.5 50.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.085 -1.01 . . . . 0.0 109.452 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -113.03 145.2 41.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.045 -1.035 . . . . 0.0 111.011 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 108' ' ' PHE . . . . . 0.522 ' CE2' ' O ' ' B' ' 109' ' ' PRO . 2.9 t80 -134.34 136.89 26.72 Favored Pre-proline 0 C--N 1.3 -1.56 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 109' ' ' PRO . . . . . 0.522 ' O ' ' CE2' ' B' ' 108' ' ' PHE . 37.6 Cg_endo -64.05 134.8 44.49 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.757 1.399 . . . . 0.0 110.682 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 110' ' ' ASN . . . . . 0.469 ' ND2' ' O ' ' B' ' 110' ' ' ASN . 6.4 p-10 -87.04 83.87 7.41 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.032 -1.042 . . . . 0.0 110.279 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -55.99 -21.37 20.83 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.972 -1.08 . . . . 0.0 109.537 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 97.4 mt -101.57 133.12 46.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.138 -0.976 . . . . 0.0 109.896 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -88.59 67.35 8.45 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.301 -0.874 . . . . 0.0 110.763 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 114' ' ' LEU . . . . . 0.469 HD11 ' O ' ' B' ' 116' ' ' ALA . 36.2 tp -87.14 121.22 29.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.308 -0.87 . . . . 0.0 109.059 178.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 115' ' ' GLU . . . . . 0.428 ' O ' ' HD3' ' B' ' 13' ' ' PRO . 16.5 pt-20 -83.5 -13.97 53.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.624 -1.298 . . . . 0.0 110.474 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 116' ' ' ALA . . . . . 0.469 ' O ' HD11 ' B' ' 114' ' ' LEU . . . -157.05 157.8 35.3 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.965 -1.084 . . . . 0.0 110.904 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 117' ' ' ILE . . . . . 0.803 HD13 HD12 ' B' ' 34' ' ' LEU . 95.5 mt -108.89 126.87 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.288 -0.882 . . . . 0.0 109.532 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -111.2 -27.04 8.87 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.851 -1.156 . . . . 0.0 111.348 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 119' ' ' TYR . . . . . 0.467 ' CD1' ' O ' ' B' ' 36' ' ' LYS . 2.8 m-85 -117.42 141.2 48.62 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.91 -1.119 . . . . 0.0 112.48 -178.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 120' ' ' MET . . . . . 0.461 ' HA ' ' HA ' ' B' ' 34' ' ' LEU . 54.2 ttp -139.07 129.95 26.3 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -136.96 136.56 38.66 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.429 -1.419 . . . . 0.0 111.221 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 122' ' ' ALA . . . . . 0.44 ' O ' ' HA3' ' B' ' 3' ' ' GLY . . . -149.35 116.32 5.99 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 123' ' ' ASP . . . . . 0.534 ' O ' HG12 ' B' ' 31' ' ' VAL . 64.9 t0 -146.68 118.68 8.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.387 -0.82 . . . . 0.0 109.431 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 179.33 -152.27 10.93 Favored Glycine 0 N--CA 1.487 2.084 0 C-N-CA 119.392 -1.385 . . . . 0.0 110.464 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 125' ' ' ASP . . . . . 0.476 ' HB3' ' HA ' ' B' ' 27' ' ' ALA . 99.7 m-20 -74.28 -2.93 27.13 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.844 -0.798 . . . . 0.0 111.067 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 126' ' ' PHE . . . . . 0.504 ' HB3' ' CD1' ' B' ' 30' ' ' PHE . 24.6 t80 -96.24 138.27 34.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.001 -1.062 . . . . 0.0 110.288 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -111.13 120.3 41.87 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 118.477 -1.289 . . . . 0.0 111.003 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 128' ' ' ILE . . . . . 0.739 HD11 HG22 ' B' ' 131' ' ' VAL . 7.8 tt -100.9 114.85 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.046 -1.034 . . . . 0.0 110.282 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -98.39 -13.3 20.7 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.739 -1.225 . . . . 0.0 110.957 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 130' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -147.89 148.22 30.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.762 -1.211 . . . . 0.0 112.538 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.739 HG22 HD11 ' B' ' 128' ' ' ILE . 53.1 t -133.28 130.69 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 132' ' ' ALA . . . . . 0.475 ' O ' HD12 ' B' ' 17' ' ' LEU . . . -127.39 146.72 50.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.418 -1.426 . . . . 0.0 110.861 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 133' ' ' PHE . . . . . 0.681 ' CE2' HD11 ' B' ' 11' ' ' LEU . 10.0 m-85 -108.75 127.65 54.19 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.505 -0.747 . . . . 0.0 110.033 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 58.4 t0 . . . . . 0 N--CA 1.497 1.906 0 CA-C-O 117.876 -1.059 . . . . 0.0 111.354 179.141 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.342 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.488 ' HA ' ' HB3' ' B' ' 8' ' ' ASN . 30.9 tp -61.58 133.43 55.65 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.031 -1.276 . . . . 0.0 110.702 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.1 t -123.15 133.49 68.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.47 -0.768 . . . . 0.0 109.866 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.47 148.56 44.28 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.167 -0.958 . . . . 0.0 110.235 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.453 ' O ' ' HB3' ' A' ' 8' ' ' ASN . 74.4 m -142.02 167.69 21.52 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.32 -0.862 . . . . 0.0 109.397 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.453 ' HB3' ' O ' ' A' ' 7' ' ' SER . 13.2 t-20 60.57 32.85 20.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.415 -0.803 . . . . 0.0 109.628 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.645 HD22 ' HB2' ' A' ' 120' ' ' MET . 1.0 OUTLIER -84.65 -2.84 58.06 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.731 -0.605 . . . . 0.0 111.552 -179.393 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.493 ' C ' ' O ' ' A' ' 9' ' ' LEU . 87.9 m-20 11.29 63.73 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.623 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.487 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 14.0 tp -78.55 143.27 36.67 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.846 -1.159 . . . . 0.0 109.824 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.8 mtmt -127.22 158.62 68.67 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 120.969 -1.082 . . . . 0.0 109.915 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -66.49 147.31 82.17 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.83 1.437 . . . . 0.0 110.557 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.53 -9.18 41.2 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -122.98 147.49 46.57 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.927 -1.337 . . . . 0.0 110.204 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 56.8 m -93.3 142.81 26.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.325 -0.859 . . . . 0.0 110.771 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 42.6 tp -120.17 128.5 53.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.394 -0.816 . . . . 0.0 108.908 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -123.37 143.1 50.33 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.878 -1.139 . . . . 0.0 111.656 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.5 t -128.52 116.12 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.641 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -111.79 125.24 53.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.088 -1.008 . . . . 0.0 109.959 178.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.471 ' O ' HG23 ' A' ' 84' ' ' VAL . . . -144.96 -155.78 6.59 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -135.23 145.89 48.07 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.281 -1.129 . . . . 0.0 108.966 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 39.9 t -111.45 130.94 64.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 O-C-N 121.124 -0.985 . . . . 0.0 110.562 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.66 153.15 72.4 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.512 -0.743 . . . . 0.0 110.291 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.407 ' O ' ' HB2' ' A' ' 81' ' ' PRO . 43.5 Cg_endo -67.23 -20.34 49.48 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.992 1.522 . . . . 0.0 110.469 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.401 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 49.9 p-10 -119.11 25.2 10.33 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.293 -0.879 . . . . 0.0 110.416 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.432 ' HA ' ' HB3' ' A' ' 125' ' ' ASP . . . -60.05 104.87 0.34 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.898 -1.126 . . . . 0.0 110.315 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 26' ' ' ASP . 64.2 mttp -95.52 -15.23 23.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.332 -0.855 . . . . 0.0 111.073 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.8 t -160.54 132.94 6.2 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.722 -1.236 . . . . 0.0 111.719 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.502 ' CD1' ' HB3' ' A' ' 126' ' ' PHE . 14.8 t80 -136.72 144.98 44.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.589 -0.695 . . . . 0.0 109.595 178.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.8 t -126.37 131.46 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.03 -1.044 . . . . 0.0 110.836 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.494 ' HB2' ' CZ ' ' A' ' 30' ' ' PHE . 20.9 tp -135.76 135.52 40.03 Favored 'General case' 0 N--CA 1.484 1.235 0 O-C-N 121.47 -0.769 . . . . 0.0 109.997 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.893 ' HB2' HD13 ' A' ' 41' ' ' LEU . 28.5 p30 -142.95 155.37 44.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.787 -1.195 . . . . 0.0 110.508 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.687 HD21 ' HB2' ' A' ' 43' ' ' LEU . 0.6 OUTLIER -153.58 111.84 3.62 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.29 -0.881 . . . . 0.0 110.19 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.487 ' O ' ' CB ' ' A' ' 119' ' ' TYR . . . -161.04 -173.41 29.63 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.634 -1.786 . . . . 0.0 108.634 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.431 ' O ' ' HB2' ' A' ' 119' ' ' TYR . 98.7 mttt -78.61 -44.66 23.43 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.87 -1.37 . . . . 0.0 110.482 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.419 ' HB2' ' HB2' ' A' ' 40' ' ' ASN . 85.3 m-20 -119.8 165.03 15.09 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.761 -177.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.7 t -56.98 -45.7 82.74 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.604 -0.685 . . . . 0.0 112.425 -178.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.45 ' HB3' ' N ' ' A' ' 66' ' ' GLY . 55.6 m-20 -89.46 -0.92 57.84 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.491 -1.381 . . . . 0.0 110.242 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.419 ' HB2' ' HB2' ' A' ' 37' ' ' ASP . 9.0 m120 -111.52 58.37 0.62 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.269 -0.895 . . . . 0.0 109.713 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.893 HD13 ' HB2' ' A' ' 33' ' ' ASN . 71.9 mt -83.15 134.08 35.0 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.63 ' SG ' HD22 ' A' ' 114' ' ' LEU . 83.6 m -81.73 -40.44 22.72 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.998 -1.064 . . . . 0.0 110.224 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.687 ' HB2' HD21 ' A' ' 34' ' ' LEU . 83.0 mt -131.87 140.21 49.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.218 -0.926 . . . . 0.0 110.262 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.416 ' HB3' ' O ' ' A' ' 61' ' ' ASN . 62.9 t-80 -140.46 139.54 35.2 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.199 -0.938 . . . . 0.0 110.425 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -127.92 146.41 50.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.114 -0.991 . . . . 0.0 110.224 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.411 ' HA ' ' O ' ' A' ' 30' ' ' PHE . 0.2 OUTLIER -152.83 61.07 3.6 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 109.909 179.46 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.486 ' HB3' HD12 ' A' ' 58' ' ' ILE . 52.4 Cg_endo -69.01 147.2 67.15 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 124.144 1.602 . . . . 0.0 110.573 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 91.7 mtm-85 -135.53 125.69 26.21 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.11 -0.994 . . . . 0.0 110.637 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -61.93 -46.81 87.69 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.018 -1.051 . . . . 0.0 108.988 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -148.52 84.51 1.49 Allowed 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.52 -117.41 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.264 -0.898 . . . . 0.0 110.176 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 25.5 m80 -77.97 -13.06 60.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.583 -1.323 . . . . 0.0 110.458 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 164.75 -22.27 0.14 Allowed Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.611 -1.281 . . . . 0.0 110.459 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -60.85 -179.16 0.12 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.777 -1.425 . . . . 0.0 110.118 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.522 ' O ' ' C ' ' A' ' 56' ' ' ASN . . . -122.21 135.66 54.8 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.619 -0.676 . . . . 0.0 109.985 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.522 ' C ' ' O ' ' A' ' 55' ' ' ALA . 1.9 m-20 14.33 74.83 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.48 0 CA-C-O 121.297 0.57 . . . . 0.0 112.122 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' A' ' 47' ' ' PRO . 47.2 m -110.13 130.3 55.56 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.203 -0.935 . . . . 0.0 110.392 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.486 HD12 ' HB3' ' A' ' 47' ' ' PRO . 19.6 tt -128.71 131.0 68.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.596 -0.69 . . . . 0.0 109.975 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 59' ' ' VAL . 21.8 m -125.81 129.34 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.147 -0.971 . . . . 0.0 110.136 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 11.3 t -86.13 130.67 34.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.263 -0.898 . . . . 0.0 109.355 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.416 ' O ' ' HB3' ' A' ' 44' ' ' HIS . 14.1 t-20 -137.21 144.63 42.95 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.004 -1.06 . . . . 0.0 111.327 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.2 m -119.13 153.95 34.03 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.483 ' CD ' ' HA2' ' A' ' 66' ' ' GLY . 16.6 ttmt -136.69 134.97 37.79 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.876 -1.14 . . . . 0.0 110.437 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -114.32 102.38 10.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.267 -0.895 . . . . 0.0 109.34 178.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.11 27.4 72.27 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.483 ' HA2' ' CD ' ' A' ' 63' ' ' LYS . . . 93.08 2.05 66.65 Favored Glycine 0 N--CA 1.484 1.852 0 C-N-CA 119.624 -1.274 . . . . 0.0 110.005 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.463 ' O ' ' C ' ' A' ' 68' ' ' TRP . . . -109.55 84.4 1.92 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.987 -1.302 . . . . 0.0 109.723 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.477 ' O ' ' HA ' ' A' ' 63' ' ' LYS . 60.2 m95 -6.13 -117.94 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.761 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 129.86 -113.39 1.47 Allowed Glycine 0 N--CA 1.488 2.102 0 O-C-N 119.849 -1.782 . . . . 0.0 109.9 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 21.7 m -78.69 121.45 24.73 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.261 -1.141 . . . . 0.0 111.266 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -126.83 131.18 51.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.398 -0.814 . . . . 0.0 109.684 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -125.51 156.51 38.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.063 -1.023 . . . . 0.0 110.159 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -134.82 88.86 2.47 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.33 -0.856 . . . . 0.0 109.74 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -114.03 125.88 54.5 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.369 -0.832 . . . . 0.0 109.952 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -93.32 85.54 5.02 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.857 -1.152 . . . . 0.0 110.239 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.625 HG22 ' HD3' ' A' ' 78' ' ' PRO . 2.4 p -127.16 132.11 70.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.231 -0.918 . . . . 0.0 110.151 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.524 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 13.0 p90 -144.9 81.67 10.56 Favored Pre-proline 0 N--CA 1.487 1.398 0 O-C-N 121.211 -0.931 . . . . 0.0 110.326 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.625 ' HD3' HG22 ' A' ' 76' ' ' VAL . 49.8 Cg_endo -72.71 -3.38 13.42 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.844 1.444 . . . . 0.0 111.365 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.531 ' CD2' ' HB2' ' A' ' 85' ' ' ALA . 3.8 m-85 -133.95 179.68 6.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.008 -1.058 . . . . 0.0 111.068 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.471 ' CG ' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -131.41 172.39 7.45 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.562 -0.711 . . . . 0.0 109.464 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.471 ' HD2' ' CG ' ' A' ' 80' ' ' GLN . 52.3 Cg_endo -71.11 150.09 59.42 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.634 1.333 . . . . 0.0 110.09 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.03 26.87 63.39 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 44.7 m -131.76 152.05 51.22 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.12 -1.224 . . . . 0.0 111.016 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 21' ' ' GLY . 12.6 p -91.29 133.38 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.452 -0.78 . . . . 0.0 109.564 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.531 ' HB2' ' CD2' ' A' ' 79' ' ' PHE . . . -151.66 155.62 38.73 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.891 -1.131 . . . . 0.0 110.933 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -122.62 149.6 43.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.331 -0.856 . . . . 0.0 109.724 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.9 t -124.26 130.22 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.103 -0.998 . . . . 0.0 110.403 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 1.4 t -98.82 122.73 42.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.506 -0.746 . . . . 0.0 110.051 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 98.0 mt -122.43 128.63 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.105 -0.997 . . . . 0.0 110.841 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 63.7 m -119.37 128.33 53.98 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.585 ' CZ ' HD11 ' A' ' 114' ' ' LEU . 73.6 t80 -109.4 115.11 29.35 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.788 -1.195 . . . . 0.0 111.376 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 95' ' ' ASN . 79.7 m-20 -118.54 142.36 47.68 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.375 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -60.28 -29.89 69.11 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.782 -1.199 . . . . 0.0 110.523 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.47 -40.68 80.9 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 120.918 -1.114 . . . . 0.0 109.214 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.413 ' O ' ' HB2' ' A' ' 92' ' ' ASP . 5.0 p30 -169.95 172.23 6.68 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.959 -0.697 . . . . 0.0 110.461 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.434 HD22 ' CD1' ' A' ' 43' ' ' LEU . 38.1 tp -102.17 124.53 47.93 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.159 -0.963 . . . . 0.0 110.227 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.442 HG23 ' OE2' ' A' ' 105' ' ' GLU . 11.1 m -107.33 125.35 51.06 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.124 -0.985 . . . . 0.0 109.267 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 36.7 t -131.38 131.61 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.857 -1.152 . . . . 0.0 110.417 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -120.01 143.56 47.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.177 -0.952 . . . . 0.0 110.491 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.51 HD23 ' HD2' ' A' ' 101' ' ' PRO . 0.5 OUTLIER -111.04 169.57 6.17 Favored Pre-proline 0 C--N 1.301 -1.532 0 O-C-N 121.45 -0.781 . . . . 0.0 109.118 179.226 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.51 ' HD2' HD23 ' A' ' 100' ' ' LEU . 39.8 Cg_endo -63.96 -23.79 67.73 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 123.626 1.329 . . . . 0.0 110.858 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.482 ' HB2' ' CB ' ' A' ' 78' ' ' PRO . 20.8 t0 -75.01 -12.31 60.3 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.012 -1.055 . . . . 0.0 110.974 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 99.15 -10.32 61.7 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.708 -1.234 . . . . 0.0 110.66 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.43 ' CE2' ' OD2' ' A' ' 102' ' ' ASP . 19.4 m-85 -79.78 140.68 36.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.815 -1.403 . . . . 0.0 109.843 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.442 ' OE2' HG23 ' A' ' 97' ' ' THR . 85.2 tt0 -120.86 143.43 48.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.307 -0.871 . . . . 0.0 110.679 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -129.94 147.99 51.75 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.458 -0.776 . . . . 0.0 109.599 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.426 ' C ' ' CD1' ' A' ' 108' ' ' PHE . 98.3 mttt -127.58 145.79 50.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.035 -1.041 . . . . 0.0 111.478 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.494 ' N ' ' CD1' ' A' ' 108' ' ' PHE . 19.2 m-85 -129.81 140.35 38.39 Favored Pre-proline 0 N--CA 1.489 1.508 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.101 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.5 140.36 39.71 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 123.407 1.214 . . . . 0.0 109.786 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.459 ' ND2' ' O ' ' A' ' 110' ' ' ASN . 6.0 p-10 -102.3 82.85 2.24 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 122.212 1.006 . . . . 0.0 110.178 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 96.6 mtt-85 -57.17 -22.89 43.69 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.535 -1.353 . . . . 0.0 108.963 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.755 ' HB3' HD23 ' A' ' 114' ' ' LEU . 89.1 mt -81.96 143.82 31.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.753 -0.592 . . . . 0.0 110.413 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 41.4 m-20 -101.63 39.03 1.5 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.131 -0.981 . . . . 0.0 109.561 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.755 HD23 ' HB3' ' A' ' 112' ' ' LEU . 0.8 OUTLIER -73.77 128.05 34.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.435 -0.79 . . . . 0.0 110.914 -179.146 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -88.04 -16.19 34.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.067 -1.021 . . . . 0.0 110.215 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' A' ' 11' ' ' LEU . . . -158.23 155.13 28.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.042 -1.036 . . . . 0.0 111.251 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.518 HD11 HD13 ' A' ' 114' ' ' LEU . 31.6 mm -107.1 130.33 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.203 -0.935 . . . . 0.0 110.18 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -108.92 -15.19 14.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.151 -0.968 . . . . 0.0 110.909 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.487 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 4.0 t80 -120.21 129.49 54.11 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.973 -1.079 . . . . 0.0 111.487 -178.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.645 ' HB2' HD22 ' A' ' 9' ' ' LEU . 55.3 ttp -141.35 128.44 20.81 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 178.191 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.07 149.6 30.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.736 -1.228 . . . . 0.0 111.414 -178.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -152.1 129.07 11.02 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.403 -0.811 . . . . 0.0 109.976 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -147.4 114.81 6.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.311 -0.868 . . . . 0.0 109.377 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.484 ' HA3' ' HA ' ' A' ' 30' ' ' PHE . . . -177.03 -145.32 5.67 Favored Glycine 0 N--CA 1.485 1.947 0 C-N-CA 119.174 -1.489 . . . . 0.0 110.327 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.432 ' HB3' ' HA ' ' A' ' 27' ' ' ALA . 80.2 m-20 -89.04 12.89 14.3 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.781 -0.835 . . . . 0.0 110.707 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.502 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 15.1 t80 -105.8 137.47 43.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.008 -1.057 . . . . 0.0 110.401 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.43 ' O ' ' HA3' ' A' ' 21' ' ' GLY . 98.7 mttt -103.9 109.56 21.35 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.244 -0.91 . . . . 0.0 111.758 -178.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.452 HG23 ' O ' ' A' ' 128' ' ' ILE . 8.7 tt -99.67 117.5 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.028 -1.045 . . . . 0.0 109.432 177.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -109.41 -14.39 14.43 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.164 -0.96 . . . . 0.0 111.733 -178.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.54 142.56 30.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.669 -1.27 . . . . 0.0 112.001 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 59.6 t -126.65 132.99 69.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -138.97 143.73 38.66 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.507 -1.37 . . . . 0.0 111.514 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -73.79 -125.9 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.629 -0.67 . . . . 0.0 109.723 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 47.2 t0 . . . . . 0 N--CA 1.491 1.592 0 O-C-N 120.528 -1.357 . . . . 0.0 110.116 179.674 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.448 0.642 . . . . 0.0 110.513 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 2' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -126.93 84.15 2.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.472 -0.767 . . . . 0.0 109.643 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 92.19 34.51 7.1 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 31.0 tp -62.1 133.04 54.75 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.143 -1.21 . . . . 0.0 110.705 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 39.5 t -122.77 133.18 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.558 -0.714 . . . . 0.0 109.944 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.26 148.13 44.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.133 -0.98 . . . . 0.0 110.396 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 7' ' ' SER . . . . . 0.463 ' O ' ' HB3' ' B' ' 8' ' ' ASN . 74.9 m -141.69 167.41 22.21 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.22 -0.925 . . . . 0.0 109.343 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 8' ' ' ASN . . . . . 0.488 ' HB3' ' HA ' ' A' ' 4' ' ' LEU . 13.5 t-20 60.97 33.14 19.89 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.79 0.805 . . . . 0.0 109.509 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.65 HD22 ' HB2' ' B' ' 120' ' ' MET . 1.0 OUTLIER -86.58 3.48 44.2 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.74 -0.6 . . . . 0.0 111.583 -179.476 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 10' ' ' ASN . . . . . 0.496 ' C ' ' O ' ' B' ' 9' ' ' LEU . 87.3 m-20 2.22 67.67 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.612 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -178.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.493 ' O ' ' HA ' ' B' ' 116' ' ' ALA . 14.0 tp -79.45 143.34 35.07 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.228 -0.92 . . . . 0.0 109.605 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 6.8 mtmt -127.71 158.67 69.5 Favored Pre-proline 0 C--N 1.296 -1.755 0 O-C-N 121.178 -0.951 . . . . 0.0 109.873 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -66.57 147.27 81.77 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.846 1.445 . . . . 0.0 110.658 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.4 -8.95 41.46 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 120.105 -1.045 . . . . 0.0 110.498 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -122.99 147.45 46.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.879 -1.365 . . . . 0.0 110.202 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 16' ' ' CYS . . . . . . . . . . . . . 56.9 m -93.22 142.93 26.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.242 -0.911 . . . . 0.0 110.727 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 43.6 tp -120.34 128.17 53.01 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.403 -0.811 . . . . 0.0 109.004 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -123.05 143.07 50.2 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.871 -1.143 . . . . 0.0 111.751 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 2.5 t -128.3 116.25 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.73 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -112.18 124.84 53.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.02 -1.05 . . . . 0.0 109.938 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.466 ' O ' HG23 ' B' ' 84' ' ' VAL . . . -144.66 -155.88 6.61 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.676 -1.369 . . . . 0.0 109.676 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -134.85 146.12 48.96 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.252 -1.146 . . . . 0.0 109.087 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 39.8 t -111.65 130.31 65.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 121.119 -0.988 . . . . 0.0 110.693 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.95 153.12 67.31 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.392 -0.818 . . . . 0.0 110.452 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 25' ' ' PRO . . . . . 0.414 ' O ' ' HB2' ' B' ' 81' ' ' PRO . 43.1 Cg_endo -67.23 -20.18 49.63 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.936 1.493 . . . . 0.0 110.555 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 26' ' ' ASP . . . . . 0.411 ' O ' ' HG3' ' B' ' 28' ' ' LYS . 49.5 p-10 -119.42 25.06 10.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.284 -0.885 . . . . 0.0 110.408 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 27' ' ' ALA . . . . . 0.441 ' HA ' ' HB3' ' B' ' 125' ' ' ASP . . . -59.94 104.47 0.3 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.905 -1.122 . . . . 0.0 110.311 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 28' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' B' ' 26' ' ' ASP . 64.3 mttp -94.97 -15.92 23.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.355 -0.841 . . . . 0.0 111.157 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 8.0 t -159.63 133.39 7.28 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.724 -1.235 . . . . 0.0 111.686 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 30' ' ' PHE . . . . . 0.506 ' CD1' ' HB3' ' B' ' 126' ' ' PHE . 14.4 t80 -137.08 144.65 43.22 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.569 -0.707 . . . . 0.0 109.565 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 43.1 t -126.36 131.14 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.975 -1.078 . . . . 0.0 110.944 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.492 ' HB2' ' CZ ' ' B' ' 30' ' ' PHE . 20.6 tp -135.38 135.74 40.9 Favored 'General case' 0 C--N 1.308 -1.234 0 O-C-N 121.525 -0.735 . . . . 0.0 110.181 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 33' ' ' ASN . . . . . 0.918 ' HB2' HD13 ' B' ' 41' ' ' LEU . 28.3 p30 -143.02 155.6 44.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.809 -1.182 . . . . 0.0 110.623 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.691 HD21 ' HB2' ' B' ' 43' ' ' LEU . 0.6 OUTLIER -153.79 110.21 3.33 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.277 -0.889 . . . . 0.0 110.276 179.967 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 35' ' ' GLY . . . . . 0.482 ' O ' ' CB ' ' B' ' 119' ' ' TYR . . . -158.36 -172.98 26.18 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 36' ' ' LYS . . . . . 0.451 ' O ' ' HB2' ' B' ' 119' ' ' TYR . 98.8 mttt -78.89 -44.57 22.49 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.876 -1.367 . . . . 0.0 110.415 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 37' ' ' ASP . . . . . 0.418 ' HB2' ' HB2' ' B' ' 40' ' ' ASN . 84.8 m-20 -119.76 164.91 15.25 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.685 -178.043 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 11.8 t -56.97 -45.85 82.6 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.634 -0.666 . . . . 0.0 112.294 -178.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 39' ' ' ASN . . . . . 0.452 ' HB3' ' N ' ' B' ' 66' ' ' GLY . 54.8 m-20 -89.24 -0.87 57.8 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.473 -1.392 . . . . 0.0 110.294 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 40' ' ' ASN . . . . . 0.418 ' HB2' ' HB2' ' B' ' 37' ' ' ASP . 9.0 m120 -111.63 58.16 0.63 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.184 -0.947 . . . . 0.0 109.678 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.918 HD13 ' HB2' ' B' ' 33' ' ' ASN . 72.6 mt -82.31 138.25 34.59 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.625 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 42' ' ' CYS . . . . . 0.628 ' SG ' HD22 ' B' ' 114' ' ' LEU . 79.5 m -87.42 -38.22 16.32 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.88 -1.138 . . . . 0.0 109.618 -178.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.691 ' HB2' HD21 ' B' ' 34' ' ' LEU . 83.8 mt -132.58 139.78 47.96 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.142 -0.974 . . . . 0.0 110.016 179.18 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 44' ' ' HIS . . . . . 0.405 ' HB3' ' O ' ' B' ' 61' ' ' ASN . 63.2 t-80 -140.09 140.09 36.01 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.135 -0.978 . . . . 0.0 110.328 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -128.47 146.03 50.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.192 -0.942 . . . . 0.0 110.2 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 46' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' B' ' 30' ' ' PHE . 0.2 OUTLIER -152.26 61.16 3.87 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.379 -0.826 . . . . 0.0 109.984 179.472 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 47' ' ' PRO . . . . . 0.492 ' HB3' HD12 ' B' ' 58' ' ' ILE . 52.2 Cg_endo -69.23 146.67 64.21 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.067 1.562 . . . . 0.0 110.69 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 91.5 mtm-85 -134.94 125.83 27.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.164 -0.96 . . . . 0.0 110.681 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -61.93 -46.62 88.54 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.129 -0.982 . . . . 0.0 109.036 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -148.58 84.36 1.48 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.5 -117.2 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.2 -0.938 . . . . 0.0 110.241 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 52' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -77.83 -13.97 59.72 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.633 -1.292 . . . . 0.0 110.405 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 165.53 -22.2 0.13 Allowed Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.568 -1.301 . . . . 0.0 110.494 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -60.51 -179.0 0.1 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.881 -1.364 . . . . 0.0 110.162 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.533 ' O ' ' C ' ' B' ' 56' ' ' ASN . . . -121.98 137.47 54.79 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.57 -0.706 . . . . 0.0 109.598 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 56' ' ' ASN . . . . . 0.533 ' C ' ' O ' ' B' ' 55' ' ' ALA . 1.9 m-20 11.25 76.2 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.514 0 CA-C-O 121.451 0.643 . . . . 0.0 112.107 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 57' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' B' ' 47' ' ' PRO . 45.2 m -110.46 130.16 55.62 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.381 -0.825 . . . . 0.0 110.328 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 58' ' ' ILE . . . . . 0.492 HD12 ' HB3' ' B' ' 47' ' ' PRO . 19.6 tt -128.79 130.7 68.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.476 -0.765 . . . . 0.0 110.032 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.486 HG23 ' O ' ' B' ' 59' ' ' VAL . 21.5 m -125.4 129.24 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.154 -0.967 . . . . 0.0 110.349 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 11.2 t -86.03 130.64 34.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.142 -0.974 . . . . 0.0 109.343 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 61' ' ' ASN . . . . . 0.405 ' O ' ' HB3' ' B' ' 44' ' ' HIS . 14.5 t-20 -137.2 144.73 43.01 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.059 -1.025 . . . . 0.0 111.266 -179.268 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 5.3 m -119.36 153.74 34.69 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 63' ' ' LYS . . . . . 0.483 ' CD ' ' HA2' ' B' ' 66' ' ' GLY . 16.6 ttmt -136.56 134.82 37.88 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.862 -1.149 . . . . 0.0 110.412 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -113.87 102.45 10.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.222 -0.924 . . . . 0.0 109.609 178.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 64.84 27.71 72.46 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 66' ' ' GLY . . . . . 0.483 ' HA2' ' CD ' ' B' ' 63' ' ' LYS . . . 93.01 1.85 66.97 Favored Glycine 0 N--CA 1.485 1.937 0 C-N-CA 119.561 -1.304 . . . . 0.0 109.99 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 67' ' ' ALA . . . . . 0.454 ' O ' ' O ' ' B' ' 68' ' ' TRP . . . -109.45 86.21 2.25 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.977 -1.308 . . . . 0.0 109.526 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 68' ' ' TRP . . . . . 0.468 ' O ' ' HA ' ' B' ' 63' ' ' LYS . 61.8 m95 -9.0 -116.59 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.828 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -178.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 129.28 -113.37 1.51 Allowed Glycine 0 N--CA 1.488 2.161 0 O-C-N 119.775 -1.828 . . . . 0.0 110.005 -178.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 21.6 m -78.91 121.31 24.7 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.198 -1.177 . . . . 0.0 111.266 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -126.72 131.0 51.45 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.404 -0.81 . . . . 0.0 109.778 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -125.45 156.51 38.78 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.926 -1.109 . . . . 0.0 110.205 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 -134.64 88.74 2.47 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.247 -0.908 . . . . 0.0 109.727 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 74' ' ' GLU . . . . . 0.401 ' O ' ' CG2' ' B' ' 58' ' ' ILE . 89.3 mt-10 -113.94 126.18 54.86 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.238 -0.914 . . . . 0.0 109.865 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -93.49 85.28 4.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.09 -1.006 . . . . 0.0 110.232 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 76' ' ' VAL . . . . . 0.623 HG22 ' HD3' ' B' ' 78' ' ' PRO . 2.4 p -127.22 132.25 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.324 -0.86 . . . . 0.0 110.203 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 77' ' ' PHE . . . . . 0.509 ' N ' ' CD1' ' B' ' 77' ' ' PHE . 13.6 p90 -144.98 81.7 10.46 Favored Pre-proline 0 N--CA 1.486 1.352 0 O-C-N 121.248 -0.908 . . . . 0.0 110.288 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 78' ' ' PRO . . . . . 0.623 ' HD3' HG22 ' B' ' 76' ' ' VAL . 52.4 Cg_endo -72.91 -3.12 13.04 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.967 1.509 . . . . 0.0 111.236 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 79' ' ' PHE . . . . . 0.535 ' CD2' ' HB2' ' B' ' 85' ' ' ALA . 3.8 m-85 -134.13 179.6 6.15 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.998 -1.064 . . . . 0.0 111.024 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.487 ' CG ' ' HD2' ' B' ' 81' ' ' PRO . 0.0 OUTLIER -131.2 172.57 7.13 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.574 -0.704 . . . . 0.0 109.521 179.781 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 81' ' ' PRO . . . . . 0.487 ' HD2' ' CG ' ' B' ' 80' ' ' GLN . 51.0 Cg_endo -71.02 150.06 59.88 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.643 1.338 . . . . 0.0 110.105 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 75.95 26.94 63.4 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 45.3 m -131.83 151.94 51.34 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.933 -1.334 . . . . 0.0 111.06 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.466 HG23 ' O ' ' B' ' 21' ' ' GLY . 13.1 p -90.95 133.54 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.437 -0.789 . . . . 0.0 109.59 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 85' ' ' ALA . . . . . 0.535 ' HB2' ' CD2' ' B' ' 79' ' ' PHE . . . -151.69 155.86 39.18 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.808 -1.183 . . . . 0.0 110.894 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -122.91 149.56 44.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.375 -0.828 . . . . 0.0 109.61 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 47.0 t -124.15 130.43 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.128 -0.982 . . . . 0.0 110.386 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 88' ' ' CYS . . . . . . . . . . . . . 1.4 t -99.2 122.91 43.02 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.354 -0.841 . . . . 0.0 110.042 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 98.2 mt -122.55 128.65 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.199 -0.938 . . . . 0.0 110.731 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 63.2 m -119.41 128.29 53.9 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 91' ' ' PHE . . . . . 0.579 ' CZ ' HD11 ' B' ' 114' ' ' LEU . 73.7 t80 -109.23 115.59 30.3 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 118.62 -1.232 . . . . 0.0 111.343 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 92' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' B' ' 95' ' ' ASN . 79.2 m-20 -118.89 142.39 47.79 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.192 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -60.04 -30.31 69.11 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.668 -1.27 . . . . 0.0 110.491 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.15 -40.48 82.37 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.045 -1.035 . . . . 0.0 109.279 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 95' ' ' ASN . . . . . 0.405 ' O ' ' HB2' ' B' ' 92' ' ' ASP . 5.2 p30 -170.32 171.88 6.45 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.502 -178.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 96' ' ' LEU . . . . . 0.432 HD22 ' CD1' ' B' ' 43' ' ' LEU . 38.8 tp -101.83 125.13 48.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.236 -0.915 . . . . 0.0 110.17 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 97' ' ' THR . . . . . 0.435 HG23 ' OE2' ' B' ' 105' ' ' GLU . 10.5 m -107.93 125.25 51.27 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.099 -1.001 . . . . 0.0 109.266 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 38.8 t -131.43 131.43 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.858 -1.151 . . . . 0.0 110.478 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -119.7 143.9 47.5 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.168 -0.957 . . . . 0.0 110.579 179.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 100' ' ' LEU . . . . . 0.486 HD23 ' HD2' ' B' ' 101' ' ' PRO . 0.5 OUTLIER -111.16 169.69 6.04 Favored Pre-proline 0 C--N 1.3 -1.57 0 O-C-N 121.517 -0.739 . . . . 0.0 109.133 179.222 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 101' ' ' PRO . . . . . 0.486 ' HD2' HD23 ' B' ' 100' ' ' LEU . 38.8 Cg_endo -64.07 -24.11 66.77 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 123.603 1.318 . . . . 0.0 110.772 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 102' ' ' ASP . . . . . 0.47 ' HB2' ' CB ' ' B' ' 78' ' ' PRO . 20.5 t0 -74.83 -11.95 60.27 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.941 -1.099 . . . . 0.0 111.085 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 98.86 -10.42 62.28 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.635 -1.269 . . . . 0.0 110.645 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 104' ' ' TYR . . . . . 0.443 ' CE2' ' OD2' ' B' ' 102' ' ' ASP . 19.5 m-85 -79.73 141.02 36.74 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.754 -1.439 . . . . 0.0 109.657 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 105' ' ' GLU . . . . . 0.435 ' OE2' HG23 ' B' ' 97' ' ' THR . 85.2 tt0 -121.06 143.48 49.05 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.308 -0.87 . . . . 0.0 110.554 -179.021 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -130.08 148.07 51.89 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.336 -0.853 . . . . 0.0 109.505 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 107' ' ' LYS . . . . . 0.422 ' C ' ' CD1' ' B' ' 108' ' ' PHE . 98.3 mttt -127.7 145.62 50.84 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.079 -1.013 . . . . 0.0 111.454 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 108' ' ' PHE . . . . . 0.502 ' CD1' ' N ' ' B' ' 108' ' ' PHE . 20.1 m-85 -129.64 140.18 37.88 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -70.28 140.18 40.14 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 O-C-N 123.385 1.203 . . . . 0.0 109.83 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 110' ' ' ASN . . . . . 0.46 ' ND2' ' O ' ' B' ' 110' ' ' ASN . 6.1 p-10 -102.16 83.02 2.28 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 122.246 1.022 . . . . 0.0 110.216 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 96.6 mtt-85 -57.11 -22.7 41.73 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.488 -1.383 . . . . 0.0 108.98 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 112' ' ' LEU . . . . . 0.735 ' HB3' HD23 ' B' ' 114' ' ' LEU . 89.7 mt -82.26 143.7 31.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.584 -0.698 . . . . 0.0 110.454 179.32 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 42.3 m-20 -101.44 38.83 1.52 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.105 -0.997 . . . . 0.0 109.541 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 114' ' ' LEU . . . . . 0.735 HD23 ' HB3' ' B' ' 112' ' ' LEU . 0.8 OUTLIER -73.6 128.07 34.49 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.427 -0.795 . . . . 0.0 110.923 -179.193 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -88.26 -16.05 34.22 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.114 -0.991 . . . . 0.0 110.162 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 116' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' B' ' 11' ' ' LEU . . . -158.25 155.19 28.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.005 -1.059 . . . . 0.0 111.072 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 117' ' ' ILE . . . . . 0.519 HD11 HD13 ' B' ' 114' ' ' LEU . 31.8 mm -107.17 130.2 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.215 -0.928 . . . . 0.0 110.228 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -108.85 -15.01 14.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.069 -1.019 . . . . 0.0 110.933 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 119' ' ' TYR . . . . . 0.482 ' CB ' ' O ' ' B' ' 35' ' ' GLY . 4.0 t80 -120.28 129.7 54.14 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.993 -1.067 . . . . 0.0 111.461 -178.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 120' ' ' MET . . . . . 0.65 ' HB2' HD22 ' B' ' 9' ' ' LEU . 51.8 ttp -141.47 128.37 20.6 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.203 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.21 149.37 30.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.707 -1.246 . . . . 0.0 111.342 -178.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -151.99 129.17 11.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.578 -0.702 . . . . 0.0 110.116 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -147.4 114.63 6.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.366 -0.834 . . . . 0.0 109.453 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 124' ' ' GLY . . . . . 0.502 ' HA3' ' HA ' ' B' ' 30' ' ' PHE . . . -176.95 -145.36 5.67 Favored Glycine 0 N--CA 1.484 1.869 0 C-N-CA 119.069 -1.538 . . . . 0.0 110.209 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 125' ' ' ASP . . . . . 0.441 ' HB3' ' HA ' ' B' ' 27' ' ' ALA . 79.7 m-20 -88.86 12.87 13.99 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.913 -0.757 . . . . 0.0 110.705 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 126' ' ' PHE . . . . . 0.506 ' HB3' ' CD1' ' B' ' 30' ' ' PHE . 14.9 t80 -105.76 137.66 43.27 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.092 -1.005 . . . . 0.0 110.269 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 127' ' ' LYS . . . . . 0.422 ' O ' ' HA3' ' B' ' 21' ' ' GLY . 98.5 mttt -103.94 109.45 21.2 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.272 -0.892 . . . . 0.0 111.746 -178.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 128' ' ' ILE . . . . . 0.44 ' O ' HG23 ' B' ' 128' ' ' ILE . 8.8 tt -99.65 117.41 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.036 -1.04 . . . . 0.0 109.486 177.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -109.32 -14.64 14.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.111 -0.993 . . . . 0.0 111.872 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 130' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.17 143.55 31.14 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.637 -1.289 . . . . 0.0 111.815 -179.36 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 66.1 t -127.3 133.58 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 132' ' ' ALA . . . . . . . . . . . . . . . -139.48 143.39 37.49 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 119.984 -1.697 . . . . 0.0 111.721 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -73.17 -125.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.633 -0.667 . . . . 0.0 109.821 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 47.1 t0 . . . . . 0 N--CA 1.492 1.628 0 O-C-N 120.515 -1.365 . . . . 0.0 110.161 179.716 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.434 ' O ' HG23 ' A' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.488 2.104 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 34.9 tp -58.54 128.51 37.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.915 -1.344 . . . . 0.0 109.866 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 3' ' ' GLY . 54.5 t -120.43 131.17 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.43 -0.794 . . . . 0.0 109.877 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -124.49 164.18 20.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.926 -1.108 . . . . 0.0 110.98 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.485 ' O ' ' HB3' ' A' ' 8' ' ' ASN . 26.9 p -151.19 172.22 16.16 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.666 -0.646 . . . . 0.0 109.306 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.485 ' HB3' ' O ' ' A' ' 7' ' ' SER . 12.1 t-20 61.79 33.01 18.02 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.577 -0.702 . . . . 0.0 109.85 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.525 ' O ' ' C ' ' A' ' 10' ' ' ASN . 94.8 mt -85.09 -9.69 57.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.539 -0.726 . . . . 0.0 111.124 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.525 ' C ' ' O ' ' A' ' 9' ' ' LEU . 0.7 OUTLIER 5.79 67.82 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.686 0 CA-C-O 121.551 0.691 . . . . 0.0 112.829 -179.771 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.508 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 31.8 tp -87.64 139.0 30.98 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.51 167.46 9.03 Favored Pre-proline 0 C--N 1.294 -1.831 0 O-C-N 120.975 -1.078 . . . . 0.0 111.378 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' A' ' 115' ' ' GLU . 44.3 Cg_endo -67.49 147.31 76.8 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 124.266 1.666 . . . . 0.0 110.77 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.81 -4.04 63.1 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -115.99 146.79 41.83 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.937 -1.331 . . . . 0.0 109.827 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.3 m -99.02 142.63 30.27 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.163 -0.961 . . . . 0.0 110.443 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.41 ' HA ' HD12 ' A' ' 17' ' ' LEU . 51.2 tp -118.27 128.2 54.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.405 -0.809 . . . . 0.0 109.698 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -128.92 133.43 47.87 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.008 -1.057 . . . . 0.0 111.17 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 56.1 t -121.1 127.24 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.319 -0.863 . . . . 0.0 109.577 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 53.2 ttt-85 -109.05 124.89 51.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.206 -0.934 . . . . 0.0 110.019 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -148.88 -163.4 10.88 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -137.94 141.81 40.55 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.409 -1.053 . . . . 0.0 110.269 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.663 ' CG1' ' HB2' ' A' ' 27' ' ' ALA . 23.8 t -97.4 130.97 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.198 -0.939 . . . . 0.0 110.809 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.597 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -58.87 168.22 1.56 Allowed Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.448 -0.783 . . . . 0.0 110.096 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.597 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 45.4 Cg_endo -68.68 -19.8 41.2 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.909 1.478 . . . . 0.0 109.89 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 28' ' ' LYS . 48.2 t0 -112.97 57.19 0.67 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.485 -0.76 . . . . 0.0 109.371 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.663 ' HB2' ' CG1' ' A' ' 23' ' ' VAL . . . -69.73 63.62 0.19 Allowed 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.688 0.756 . . . . 0.0 109.797 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.435 ' N ' ' O ' ' A' ' 26' ' ' ASP . 87.8 tttt -63.12 -43.92 97.08 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.702 -0.624 . . . . 0.0 110.401 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.3 t -164.05 137.63 5.4 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.006 -1.058 . . . . 0.0 111.174 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.483 ' HA ' ' HA3' ' A' ' 124' ' ' GLY . 26.1 t80 -134.04 145.54 49.51 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.547 -0.721 . . . . 0.0 109.981 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.543 HG22 ' O ' ' A' ' 123' ' ' ASP . 17.3 m -127.13 133.08 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 120.785 -1.197 . . . . 0.0 110.774 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.1 tp -129.42 135.09 48.24 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.463 -0.773 . . . . 0.0 110.139 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.527 ' HB2' HD13 ' A' ' 41' ' ' LEU . 12.2 p30 -142.19 145.77 34.51 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.763 -1.21 . . . . 0.0 110.78 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.493 HD13 HD13 ' A' ' 117' ' ' ILE . 1.1 pp -149.47 123.87 9.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.366 -0.834 . . . . 0.0 110.679 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.545 ' O ' ' HB3' ' A' ' 119' ' ' TYR . . . -166.11 -160.38 13.3 Favored Glycine 0 N--CA 1.493 2.433 0 N-CA-C 108.959 -1.657 . . . . 0.0 108.959 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.48 ' HD2' HD13 ' A' ' 114' ' ' LEU . 60.2 mtpt -71.85 -40.8 68.76 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.021 -1.282 . . . . 0.0 109.149 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -153.27 -167.02 2.59 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.768 0.794 . . . . 0.0 111.562 -178.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 41.2 t -62.0 -46.03 91.0 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.662 -0.649 . . . . 0.0 112.573 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.457 ' HB3' ' N ' ' A' ' 66' ' ' GLY . 74.0 m-20 -94.5 0.08 55.04 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.762 -1.211 . . . . 0.0 110.437 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -113.03 62.79 0.64 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.245 -0.909 . . . . 0.0 109.378 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.527 HD13 ' HB2' ' A' ' 33' ' ' ASN . 92.1 mt -104.14 133.97 48.18 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.315 0.578 . . . . 0.0 109.917 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.484 ' HA ' HD12 ' A' ' 112' ' ' LEU . 63.3 m -83.62 -40.22 19.3 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.151 -0.968 . . . . 0.0 109.271 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 1.101 HD11 HD13 ' A' ' 96' ' ' LEU . 94.3 mt -131.42 140.89 49.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.213 -0.929 . . . . 0.0 111.337 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.48 ' HB3' ' HB3' ' A' ' 61' ' ' ASN . 41.2 t-80 -131.84 103.14 6.16 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -102.36 142.0 34.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -0.931 . . . . 0.0 110.8 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.521 ' CG ' HG12 ' A' ' 31' ' ' VAL . 1.2 t-20 -155.23 85.36 3.49 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.391 -0.818 . . . . 0.0 110.603 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.438 ' CA ' HG12 ' A' ' 58' ' ' ILE . 46.5 Cg_endo -67.48 147.74 77.68 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.891 1.469 . . . . 0.0 110.75 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -132.31 107.99 8.91 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.291 -0.881 . . . . 0.0 111.156 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -62.08 -48.08 81.78 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.248 -0.908 . . . . 0.0 109.486 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 -150.83 97.74 2.52 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.313 -0.867 . . . . 0.0 109.472 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -105.18 -126.61 0.23 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.187 -0.945 . . . . 0.0 110.329 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 40.3 m170 -61.73 -35.38 77.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.72 -1.237 . . . . 0.0 110.843 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 172.61 32.42 0.03 OUTLIER Glycine 0 N--CA 1.493 2.451 0 C-N-CA 119.104 -1.522 . . . . 0.0 111.072 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -117.59 -166.26 1.17 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.852 -1.381 . . . . 0.0 109.469 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 56' ' ' ASN . . . -153.67 144.08 22.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.252 -0.905 . . . . 0.0 110.373 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.475 ' C ' ' O ' ' A' ' 55' ' ' ALA . 87.0 m-20 25.85 56.65 0.05 Allowed 'General case' 0 N--CA 1.504 2.23 0 CA-C-O 120.987 0.422 . . . . 0.0 111.983 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 86.0 m -119.69 133.24 55.71 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.235 -0.915 . . . . 0.0 110.477 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.438 HG12 ' CA ' ' A' ' 47' ' ' PRO . 96.6 mt -119.29 134.06 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.496 -0.753 . . . . 0.0 111.114 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.641 HG11 ' OE2' ' A' ' 71' ' ' GLU . 54.5 t -112.74 127.94 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.211 -0.931 . . . . 0.0 109.025 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 2.2 t -94.57 122.88 37.61 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.185 -0.947 . . . . 0.0 110.313 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.48 ' HB3' ' HB3' ' A' ' 44' ' ' HIS . 6.8 t-20 -121.21 147.52 45.5 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.321 -0.862 . . . . 0.0 109.114 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.3 t -135.65 142.76 45.22 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.022 -1.049 . . . . 0.0 110.141 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.492 ' CD ' ' HA2' ' A' ' 66' ' ' GLY . 27.0 ttmt -142.94 127.39 17.82 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 118.883 -1.127 . . . . 0.0 111.67 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -107.04 103.23 12.6 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 64.48 20.74 66.02 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.492 ' HA2' ' CD ' ' A' ' 63' ' ' LYS . . . 68.89 36.58 82.14 Favored Glycine 0 N--CA 1.488 2.123 0 C-N-CA 119.2 -1.476 . . . . 0.0 110.007 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.51 14.16 6.54 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.731 -1.452 . . . . 0.0 112.263 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -139.63 -74.6 0.36 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.452 -1.405 . . . . 0.0 110.421 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.68 32.85 49.03 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.1 m -59.81 121.36 11.53 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.077 -1.249 . . . . 0.0 109.49 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.641 ' OE2' HG11 ' A' ' 59' ' ' VAL . 83.3 tt0 -116.66 133.36 56.11 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.226 -0.921 . . . . 0.0 112.039 -178.446 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -127.42 -162.53 1.17 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.369 -0.832 . . . . 0.0 108.971 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -141.83 140.72 33.03 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 118.484 -1.286 . . . . 0.0 112.027 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -127.92 124.29 37.02 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.897 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -101.96 46.33 0.93 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.871 -1.143 . . . . 0.0 111.017 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.432 ' O ' HD12 ' A' ' 58' ' ' ILE . 75.9 t -122.46 127.06 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.063 -1.023 . . . . 0.0 109.716 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.466 ' CD2' ' O ' ' A' ' 77' ' ' PHE . 83.2 t80 -162.23 74.71 2.22 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 120.922 -1.112 . . . . 0.0 110.91 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.485 ' HD2' ' CE2' ' A' ' 79' ' ' PHE . 55.6 Cg_endo -80.2 43.1 1.45 Allowed 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.899 1.473 . . . . 0.0 110.951 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.485 ' CE2' ' HD2' ' A' ' 78' ' ' PRO . 70.6 m-85 -127.6 151.57 48.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.884 -1.135 . . . . 0.0 109.399 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.39 168.71 14.12 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.034 -1.041 . . . . 0.0 110.251 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.75 147.58 63.22 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.958 1.504 . . . . 0.0 110.015 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 56.39 41.38 87.75 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.829 -1.309 . . . . 0.0 109.829 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 37.2 t -134.35 142.15 47.12 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.037 -1.273 . . . . 0.0 110.617 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.424 HG13 ' O ' ' A' ' 84' ' ' VAL . 7.2 p -89.16 136.8 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.387 -0.821 . . . . 0.0 109.65 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -154.66 151.74 29.13 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.109 -0.994 . . . . 0.0 110.035 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.4 ' O ' ' HD3' ' A' ' 101' ' ' PRO . 90.5 mt-10 -116.32 138.38 51.37 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 91.6 t -116.15 128.38 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.909 -1.119 . . . . 0.0 110.823 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 1.7 t -99.64 129.4 45.78 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.3 -0.875 . . . . 0.0 109.837 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 97.8 mt -122.25 127.66 75.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.356 -0.84 . . . . 0.0 110.067 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.426 ' HB ' ' HB ' ' A' ' 97' ' ' THR . 89.2 m -120.56 127.61 52.31 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.242 -0.911 . . . . 0.0 109.286 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -113.85 112.09 22.8 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.06 -1.025 . . . . 0.0 110.854 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -119.59 149.01 42.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.527 -0.733 . . . . 0.0 109.467 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -63.22 -34.4 77.57 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.94 -1.1 . . . . 0.0 109.94 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.54 -40.69 96.05 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.2 -0.937 . . . . 0.0 109.991 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -171.39 178.14 3.32 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.314 -0.866 . . . . 0.0 110.412 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 1.101 HD13 HD11 ' A' ' 43' ' ' LEU . 95.4 mt -105.0 131.53 52.4 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.397 -0.814 . . . . 0.0 110.078 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.463 ' CG2' ' OE2' ' A' ' 105' ' ' GLU . 44.1 m -121.01 129.62 53.46 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.081 -1.012 . . . . 0.0 109.838 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 56.4 t -125.82 129.04 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 120.86 -1.15 . . . . 0.0 109.255 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -116.62 126.14 52.82 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.066 -1.054 . . . . 0.0 109.934 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 12.3 mt -99.08 162.12 22.49 Favored Pre-proline 0 C--N 1.296 -1.746 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 86' ' ' GLU . 39.6 Cg_endo -64.7 -21.61 64.92 Favored 'Trans proline' 0 C--N 1.3 -2.018 0 O-C-N 123.765 1.403 . . . . 0.0 110.223 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -65.52 -32.78 74.57 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.277 -0.889 . . . . 0.0 109.279 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 117.3 -18.25 12.2 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -73.74 136.12 43.65 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.133 -1.216 . . . . 0.0 110.319 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.463 ' OE2' ' CG2' ' A' ' 97' ' ' THR . 78.9 tt0 -127.57 144.25 51.09 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.091 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -129.51 156.37 44.26 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.975 -1.078 . . . . 0.0 110.146 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -107.39 131.49 54.19 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.244 -0.91 . . . . 0.0 110.953 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.414 ' CB ' ' HB2' ' A' ' 96' ' ' LEU . 0.5 OUTLIER -121.77 126.4 26.41 Favored Pre-proline 0 C--N 1.301 -1.529 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.753 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -65.7 139.89 59.75 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 123.32 1.169 . . . . 0.0 110.397 -179.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.444 ' ND2' ' O ' ' A' ' 110' ' ' ASN . 4.5 p-10 -97.67 82.58 3.08 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 122.513 1.149 . . . . 0.0 109.791 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -58.05 -24.23 57.6 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 120.368 -1.458 . . . . 0.0 109.371 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.484 HD12 ' HA ' ' A' ' 42' ' ' CYS . 86.7 mt -86.79 144.12 27.19 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.288 -0.882 . . . . 0.0 111.078 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 24.6 m-20 -94.09 30.57 1.86 Allowed 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.718 0.77 . . . . 0.0 109.568 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.588 HD11 ' O ' ' A' ' 116' ' ' ALA . 46.9 tp -61.99 136.17 57.85 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.58 0.705 . . . . 0.0 111.135 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.449 ' O ' ' HD3' ' A' ' 13' ' ' PRO . 10.0 pt-20 -98.29 -13.98 20.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.451 -0.781 . . . . 0.0 110.932 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.588 ' O ' HD11 ' A' ' 114' ' ' LEU . . . -163.45 157.29 19.63 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.44 -1.413 . . . . 0.0 111.972 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.493 HD13 HD13 ' A' ' 34' ' ' LEU . 84.9 mt -104.8 124.8 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.355 -0.841 . . . . 0.0 109.994 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -117.67 -20.95 8.72 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.082 -1.011 . . . . 0.0 110.989 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.545 ' HB3' ' O ' ' A' ' 35' ' ' GLY . 38.9 t80 -110.73 125.67 53.75 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.419 -0.801 . . . . 0.0 110.547 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.466 ' HB3' ' CD1' ' A' ' 9' ' ' LEU . 48.3 ttp -146.93 133.04 19.29 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.237 -0.914 . . . . 0.0 109.818 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.83 154.23 33.56 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.997 -1.064 . . . . 0.0 110.496 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -146.12 120.08 9.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.306 -0.871 . . . . 0.0 109.889 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.543 ' O ' HG22 ' A' ' 31' ' ' VAL . 55.6 t0 -135.29 106.32 6.66 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.347 -0.846 . . . . 0.0 109.594 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' A' ' 30' ' ' PHE . . . -171.54 -144.61 4.51 Favored Glycine 0 N--CA 1.484 1.844 0 C-N-CA 119.237 -1.458 . . . . 0.0 110.02 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.525 ' HB3' ' HA ' ' A' ' 27' ' ' ALA . 94.2 m-20 -90.07 14.1 13.24 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.644 -0.915 . . . . 0.0 110.873 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.43 ' HB3' ' CE1' ' A' ' 30' ' ' PHE . 28.1 t80 -107.89 135.28 49.55 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.899 -1.126 . . . . 0.0 109.748 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -105.15 121.3 43.54 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 118.874 -1.13 . . . . 0.0 110.421 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.618 HG23 ' O ' ' A' ' 128' ' ' ILE . 10.7 tt -93.79 115.92 33.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.511 -0.743 . . . . 0.0 110.592 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.422 ' O ' ' HB2' ' B' ' 133' ' ' PHE . 98.7 mttt -101.54 -18.35 15.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.091 -1.006 . . . . 0.0 110.517 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -157.79 143.99 17.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.82 -1.175 . . . . 0.0 111.484 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.438 HG22 HD11 ' A' ' 128' ' ' ILE . 42.5 t -116.58 132.22 66.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 178.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.41 ' HA ' ' HB2' ' B' ' 130' ' ' CYS . . . -121.95 144.61 48.76 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.738 -1.226 . . . . 0.0 111.906 -177.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -83.37 -136.64 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 61.0 t0 . . . . . 0 N--CA 1.49 1.571 0 O-C-N 120.69 -1.256 . . . . 0.0 110.201 179.831 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 121.272 0.558 . . . . 0.0 110.088 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 2' ' ' CYS . . . . . . . . . . . . . 3.3 t -122.5 -135.65 0.3 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.248 -0.907 . . . . 0.0 108.72 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 3' ' ' GLY . . . . . 0.405 ' O ' HG23 ' B' ' 5' ' ' VAL . . . 90.41 23.26 32.02 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.46 ' HA ' ' HB3' ' A' ' 8' ' ' ASN . 36.0 tp -60.0 128.21 35.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.03 -1.276 . . . . 0.0 109.882 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.405 HG23 ' O ' ' B' ' 3' ' ' GLY . 53.7 t -120.34 130.44 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 119.731 -0.788 . . . . 0.0 109.759 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -123.6 164.6 18.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.155 -0.966 . . . . 0.0 110.902 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 7' ' ' SER . . . . . 0.461 ' O ' ' HB3' ' B' ' 8' ' ' ASN . 26.2 p -151.72 172.52 15.99 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 8' ' ' ASN . . . . . 0.461 ' HB3' ' O ' ' B' ' 7' ' ' SER . 12.0 t-20 61.59 32.84 18.53 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.571 -0.706 . . . . 0.0 109.819 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.529 ' O ' ' C ' ' B' ' 10' ' ' ASN . 96.3 mt -85.79 -5.97 59.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.529 -0.732 . . . . 0.0 111.198 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 10' ' ' ASN . . . . . 0.529 ' C ' ' O ' ' B' ' 9' ' ' LEU . 0.6 OUTLIER -0.16 70.53 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.714 0 CA-C-O 121.86 0.838 . . . . 0.0 112.817 -178.62 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' B' ' 116' ' ' ALA . 32.4 tp -88.34 138.61 31.28 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.24 167.53 8.95 Favored Pre-proline 0 C--N 1.292 -1.895 0 O-C-N 120.917 -1.114 . . . . 0.0 111.321 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 13' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' B' ' 115' ' ' GLU . 45.6 Cg_endo -67.96 147.05 73.42 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 124.195 1.629 . . . . 0.0 110.584 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.23 -3.96 62.15 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -116.46 147.32 41.83 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.965 -1.314 . . . . 0.0 109.862 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 16' ' ' CYS . . . . . . . . . . . . . 2.3 m -99.27 142.92 30.13 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.168 -0.958 . . . . 0.0 110.497 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' B' ' 17' ' ' LEU . 52.7 tp -118.5 128.1 54.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.474 -0.766 . . . . 0.0 109.618 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -128.96 133.59 47.87 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.994 -1.066 . . . . 0.0 111.155 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 55.7 t -121.38 126.55 75.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.341 -0.849 . . . . 0.0 109.604 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 20' ' ' ARG . . . . . 0.404 ' HG3' ' HG2' ' B' ' 86' ' ' GLU . 52.9 ttt-85 -108.45 125.06 51.34 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.203 -0.935 . . . . 0.0 110.061 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -148.74 -162.3 10.17 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -139.0 142.74 38.3 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.585 -0.95 . . . . 0.0 110.23 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.672 ' CG1' ' HB2' ' B' ' 27' ' ' ALA . 23.2 t -98.47 130.83 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.308 -0.87 . . . . 0.0 110.721 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.599 ' HB1' ' HD2' ' B' ' 25' ' ' PRO . . . -58.76 167.89 1.67 Allowed Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.41 -0.806 . . . . 0.0 110.16 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 25' ' ' PRO . . . . . 0.599 ' HD2' ' HB1' ' B' ' 24' ' ' ALA . 45.9 Cg_endo -68.58 -19.55 42.11 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.882 1.464 . . . . 0.0 109.924 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 26' ' ' ASP . . . . . 0.442 ' O ' ' N ' ' B' ' 28' ' ' LYS . 47.4 t0 -113.09 56.93 0.67 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.535 -0.728 . . . . 0.0 109.444 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 27' ' ' ALA . . . . . 0.672 ' HB2' ' CG1' ' B' ' 23' ' ' VAL . . . -69.51 63.72 0.17 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.488 -0.757 . . . . 0.0 109.791 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 28' ' ' LYS . . . . . 0.442 ' N ' ' O ' ' B' ' 26' ' ' ASP . 88.3 tttt -63.24 -45.14 92.97 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.713 -0.617 . . . . 0.0 110.201 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 13.6 t -161.97 139.01 8.33 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.087 -1.008 . . . . 0.0 111.438 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 30' ' ' PHE . . . . . 0.497 ' HA ' ' HA3' ' B' ' 124' ' ' GLY . 25.9 t80 -135.08 144.96 47.49 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.356 -0.84 . . . . 0.0 109.925 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.555 HG22 ' O ' ' B' ' 123' ' ' ASP . 18.4 m -126.63 133.2 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 120.905 -1.122 . . . . 0.0 110.761 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 19.9 tp -129.33 135.85 49.27 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 121.55 -0.719 . . . . 0.0 110.069 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 33' ' ' ASN . . . . . 0.536 ' HB2' HD13 ' B' ' 41' ' ' LEU . 12.2 p30 -142.81 145.55 33.32 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.755 -1.216 . . . . 0.0 110.797 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.506 HD13 HD13 ' B' ' 117' ' ' ILE . 1.1 pp -149.89 119.93 7.2 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.3 -0.875 . . . . 0.0 111.008 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 35' ' ' GLY . . . . . 0.53 ' O ' ' HB3' ' B' ' 119' ' ' TYR . . . -160.81 -158.81 9.51 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.151 -1.579 . . . . 0.0 109.151 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 36' ' ' LYS . . . . . 0.486 ' HD2' HD13 ' B' ' 114' ' ' LEU . 60.1 mtpt -72.93 -40.36 65.5 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.083 -1.245 . . . . 0.0 108.868 177.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -153.17 -167.28 2.67 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.68 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 40.2 t -61.98 -46.1 90.71 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.602 -0.686 . . . . 0.0 112.531 -178.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 39' ' ' ASN . . . . . 0.43 ' HB3' ' N ' ' B' ' 66' ' ' GLY . 70.7 m-20 -94.65 0.42 55.08 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.644 -1.285 . . . . 0.0 110.5 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -113.15 62.45 0.64 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.256 -0.902 . . . . 0.0 109.536 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.536 HD13 ' HB2' ' B' ' 33' ' ' ASN . 92.1 mt -103.46 136.94 42.26 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 121.249 0.547 . . . . 0.0 109.554 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 42' ' ' CYS . . . . . 0.488 ' HA ' HD12 ' B' ' 112' ' ' LEU . 65.7 m -87.78 -38.64 15.58 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.218 -0.926 . . . . 0.0 108.764 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 1.027 HD11 HD13 ' B' ' 96' ' ' LEU . 94.6 mt -132.06 140.98 49.06 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.158 -0.964 . . . . 0.0 111.096 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 44' ' ' HIS . . . . . 0.466 ' HB3' ' HB3' ' B' ' 61' ' ' ASN . 81.8 t60 -132.03 102.95 6.03 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -102.09 141.83 34.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.234 -0.916 . . . . 0.0 110.727 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 46' ' ' ASN . . . . . 0.511 ' CG ' HG12 ' B' ' 31' ' ' VAL . 1.2 t-20 -154.85 84.97 3.67 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.366 -0.834 . . . . 0.0 110.658 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 47' ' ' PRO . . . . . 0.449 ' CA ' HG12 ' B' ' 58' ' ' ILE . 46.3 Cg_endo -67.23 148.32 80.24 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.847 1.446 . . . . 0.0 110.692 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -132.93 107.86 8.56 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.307 -0.87 . . . . 0.0 111.036 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -61.97 -47.89 82.8 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.414 -0.804 . . . . 0.0 109.496 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -151.05 97.98 2.52 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.499 -0.751 . . . . 0.0 109.653 178.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -105.54 -126.55 0.24 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.074 -1.016 . . . . 0.0 110.333 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 52' ' ' HIS . . . . . . . . . . . . . 41.2 m170 -61.23 -34.35 74.98 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.696 -1.253 . . . . 0.0 110.946 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 170.48 33.12 0.02 OUTLIER Glycine 0 N--CA 1.492 2.397 0 C-N-CA 119.167 -1.492 . . . . 0.0 111.062 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -117.5 -166.02 1.15 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.982 -1.305 . . . . 0.0 109.301 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.503 ' O ' ' C ' ' B' ' 56' ' ' ASN . . . -152.15 149.14 28.44 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.218 -0.926 . . . . 0.0 109.674 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 56' ' ' ASN . . . . . 0.503 ' C ' ' O ' ' B' ' 55' ' ' ALA . 85.6 m-20 16.85 60.24 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.345 0 CA-C-O 121.473 0.654 . . . . 0.0 112.562 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 77.8 m -120.08 132.84 55.58 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.411 -0.806 . . . . 0.0 110.49 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 58' ' ' ILE . . . . . 0.449 HG12 ' CA ' ' B' ' 47' ' ' PRO . 97.0 mt -119.36 133.75 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.498 -0.751 . . . . 0.0 111.386 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.638 HG11 ' OE2' ' B' ' 71' ' ' GLU . 54.9 t -111.9 128.13 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.317 -0.864 . . . . 0.0 109.28 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 1.9 t -94.96 122.46 37.63 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.982 -1.074 . . . . 0.0 110.313 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 61' ' ' ASN . . . . . 0.466 ' HB3' ' HB3' ' B' ' 44' ' ' HIS . 6.8 t-20 -120.52 148.19 44.17 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.42 -0.8 . . . . 0.0 109.211 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 34.8 t -136.4 142.83 43.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.957 -1.09 . . . . 0.0 110.237 -178.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 63' ' ' LYS . . . . . 0.486 ' CD ' ' HA2' ' B' ' 66' ' ' GLY . 27.0 ttmt -143.17 127.15 17.34 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 118.931 -1.108 . . . . 0.0 111.93 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -106.55 104.13 13.74 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 63.76 20.13 63.79 Favored Glycine 0 N--CA 1.483 1.82 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 66' ' ' GLY . . . . . 0.486 ' HA2' ' CD ' ' B' ' 63' ' ' LYS . . . 69.57 36.27 76.23 Favored Glycine 0 N--CA 1.487 2.062 0 O-C-N 120.624 -1.515 . . . . 0.0 110.084 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -127.85 12.45 6.76 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.732 -1.452 . . . . 0.0 112.378 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 68' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -138.08 -74.71 0.4 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.615 -1.303 . . . . 0.0 110.505 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.81 32.46 49.89 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -59.58 121.58 11.93 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.134 -1.216 . . . . 0.0 109.486 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 71' ' ' GLU . . . . . 0.638 ' OE2' HG11 ' B' ' 59' ' ' VAL . 83.5 tt0 -117.12 133.46 55.98 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.156 -0.965 . . . . 0.0 112.062 -178.475 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -127.31 -162.96 1.21 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.399 -0.813 . . . . 0.0 109.157 178.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -141.44 139.79 33.46 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.676 -1.265 . . . . 0.0 112.066 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -126.75 124.56 40.02 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.969 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -102.29 46.55 0.92 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.834 -1.166 . . . . 0.0 110.945 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 76' ' ' VAL . . . . . 0.446 ' O ' HD12 ' B' ' 58' ' ' ILE . 76.5 t -122.8 127.44 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.097 -1.002 . . . . 0.0 109.739 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 77' ' ' PHE . . . . . 0.469 ' CD2' ' O ' ' B' ' 77' ' ' PHE . 83.4 t80 -162.47 74.13 2.16 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 120.962 -1.086 . . . . 0.0 110.878 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 78' ' ' PRO . . . . . 0.486 ' HD2' ' CE2' ' B' ' 79' ' ' PHE . 55.7 Cg_endo -79.71 43.63 1.54 Allowed 'Trans proline' 0 C--N 1.302 -1.877 0 O-C-N 123.914 1.481 . . . . 0.0 111.08 179.075 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 79' ' ' PHE . . . . . 0.486 ' CE2' ' HD2' ' B' ' 78' ' ' PRO . 68.4 m-85 -128.22 151.25 49.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.85 -1.156 . . . . 0.0 109.463 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.24 168.23 15.47 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.095 -1.003 . . . . 0.0 110.329 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 81' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -69.43 147.29 64.63 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.994 1.523 . . . . 0.0 109.959 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 56.76 41.56 90.68 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 37.4 t -134.39 143.01 47.37 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.05 -1.265 . . . . 0.0 110.637 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.429 ' O ' HG13 ' B' ' 84' ' ' VAL . 7.1 p -90.14 136.62 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.38 -0.825 . . . . 0.0 109.614 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -154.34 150.91 28.45 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.121 -0.987 . . . . 0.0 110.043 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 86' ' ' GLU . . . . . 0.404 ' HG2' ' HG3' ' B' ' 20' ' ' ARG . 90.3 mt-10 -115.84 137.59 51.95 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 78.2 t -115.5 128.34 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.925 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 88' ' ' CYS . . . . . . . . . . . . . 1.9 t -99.69 129.48 45.83 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.292 -0.88 . . . . 0.0 109.876 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 98.0 mt -122.38 127.21 75.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.319 -0.863 . . . . 0.0 110.111 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 90' ' ' THR . . . . . 0.421 ' HB ' ' HB ' ' B' ' 97' ' ' THR . 92.7 m -120.3 127.25 52.2 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.135 -0.978 . . . . 0.0 109.137 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 91' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -113.46 112.67 24.0 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.243 -0.983 . . . . 0.0 110.833 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -120.14 148.62 43.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.472 -0.768 . . . . 0.0 109.64 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -63.17 -33.8 76.26 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.021 -1.049 . . . . 0.0 109.91 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.8 -40.85 95.91 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.257 -0.902 . . . . 0.0 109.999 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -171.75 178.22 3.14 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.302 -0.874 . . . . 0.0 110.484 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 96' ' ' LEU . . . . . 1.027 HD13 HD11 ' B' ' 43' ' ' LEU . 94.7 mt -105.09 131.62 52.36 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.349 -0.845 . . . . 0.0 110.134 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 97' ' ' THR . . . . . 0.456 ' CG2' ' OE2' ' B' ' 105' ' ' GLU . 44.6 m -121.05 129.49 53.37 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.171 -0.956 . . . . 0.0 109.779 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 59.9 t -125.63 128.83 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.94 -1.1 . . . . 0.0 109.241 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -116.35 126.51 53.6 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.069 -1.052 . . . . 0.0 109.765 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 12.2 mt -99.67 162.0 22.62 Favored Pre-proline 0 C--N 1.296 -1.736 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -64.57 -21.58 65.59 Favored 'Trans proline' 0 C--N 1.299 -2.046 0 O-C-N 123.757 1.399 . . . . 0.0 110.275 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -65.76 -32.85 74.63 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.287 -0.883 . . . . 0.0 109.268 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 117.92 -18.54 11.48 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 104' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -73.62 136.25 43.89 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.178 -1.189 . . . . 0.0 110.37 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 105' ' ' GLU . . . . . 0.456 ' OE2' ' CG2' ' B' ' 97' ' ' THR . 79.0 tt0 -127.51 143.62 51.16 Favored 'General case' 0 C--N 1.298 -1.63 0 O-C-N 121.443 -0.786 . . . . 0.0 109.001 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -128.99 155.83 44.75 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.887 -1.133 . . . . 0.0 110.221 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -106.96 132.37 52.97 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.21 -0.931 . . . . 0.0 111.003 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 108' ' ' PHE . . . . . 0.409 ' CB ' ' HB2' ' B' ' 96' ' ' LEU . 0.5 OUTLIER -122.8 126.61 26.02 Favored Pre-proline 0 C--N 1.301 -1.51 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.75 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -65.68 139.74 59.19 Favored 'Trans proline' 0 C--N 1.303 -1.844 0 O-C-N 123.286 1.15 . . . . 0.0 110.391 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 110' ' ' ASN . . . . . 0.443 ' ND2' ' O ' ' B' ' 110' ' ' ASN . 4.7 p-10 -97.52 82.64 3.12 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 122.488 1.137 . . . . 0.0 109.653 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -58.05 -24.23 57.61 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 120.263 -1.523 . . . . 0.0 109.433 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 112' ' ' LEU . . . . . 0.488 HD12 ' HA ' ' B' ' 42' ' ' CYS . 87.2 mt -86.84 143.44 27.46 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.355 -0.841 . . . . 0.0 111.218 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 24.1 m-20 -93.39 30.53 1.69 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.612 -0.68 . . . . 0.0 109.579 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 114' ' ' LEU . . . . . 0.584 HD11 ' O ' ' B' ' 116' ' ' ALA . 46.7 tp -62.21 135.62 57.57 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.706 0.765 . . . . 0.0 111.443 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 115' ' ' GLU . . . . . 0.465 ' O ' ' HD3' ' B' ' 13' ' ' PRO . 9.8 pt-20 -97.19 -15.52 20.84 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.485 -0.759 . . . . 0.0 110.974 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 116' ' ' ALA . . . . . 0.584 ' O ' HD11 ' B' ' 114' ' ' LEU . . . -162.36 157.12 22.21 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.47 -1.394 . . . . 0.0 112.129 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 117' ' ' ILE . . . . . 0.506 HD13 HD13 ' B' ' 34' ' ' LEU . 85.0 mt -104.31 124.68 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.373 -0.829 . . . . 0.0 110.006 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -117.68 -20.74 8.81 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.14 -0.975 . . . . 0.0 110.982 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 119' ' ' TYR . . . . . 0.53 ' HB3' ' O ' ' B' ' 35' ' ' GLY . 38.9 t80 -110.87 125.35 53.53 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.264 -0.897 . . . . 0.0 110.638 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 120' ' ' MET . . . . . 0.479 ' HB3' ' CD1' ' B' ' 9' ' ' LEU . 48.5 ttp -146.75 133.21 19.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.226 -0.921 . . . . 0.0 109.878 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -154.01 154.29 33.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.061 -1.024 . . . . 0.0 110.659 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -146.03 120.58 9.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.279 -0.888 . . . . 0.0 109.879 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 123' ' ' ASP . . . . . 0.555 ' O ' HG22 ' B' ' 31' ' ' VAL . 55.0 t0 -135.42 106.57 6.72 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.381 -0.824 . . . . 0.0 109.559 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 124' ' ' GLY . . . . . 0.497 ' HA3' ' HA ' ' B' ' 30' ' ' PHE . . . -171.52 -144.26 4.37 Favored Glycine 0 N--CA 1.486 1.981 0 C-N-CA 119.26 -1.448 . . . . 0.0 110.227 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 125' ' ' ASP . . . . . 0.525 ' HB3' ' HA ' ' B' ' 27' ' ' ALA . 93.8 m-20 -90.56 14.43 13.2 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.697 -0.884 . . . . 0.0 110.859 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 126' ' ' PHE . . . . . 0.435 ' HB3' ' CE1' ' B' ' 30' ' ' PHE . 27.3 t80 -108.17 135.57 49.29 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.015 -1.053 . . . . 0.0 109.661 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -105.56 120.86 42.69 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.006 -1.077 . . . . 0.0 110.367 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 128' ' ' ILE . . . . . 0.639 ' O ' HG23 ' B' ' 128' ' ' ILE . 10.3 tt -93.58 116.38 34.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.639 -0.663 . . . . 0.0 110.524 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -102.06 -19.41 15.18 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.104 -0.997 . . . . 0.0 110.497 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 130' ' ' CYS . . . . . 0.41 ' HB2' ' HA ' ' A' ' 132' ' ' ALA . 0.0 OUTLIER -155.93 144.18 19.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.883 -1.136 . . . . 0.0 111.591 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.419 HG22 HD11 ' B' ' 128' ' ' ILE . 40.2 t -116.88 131.87 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.038 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 132' ' ' ALA . . . . . . . . . . . . . . . -121.65 144.32 48.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.572 -1.33 . . . . 0.0 111.746 -177.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 133' ' ' PHE . . . . . 0.422 ' HB2' ' O ' ' A' ' 129' ' ' LYS . 3.0 t80 -83.17 -135.58 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.758 -0.589 . . . . 0.0 109.433 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 61.5 t0 . . . . . 0 N--CA 1.492 1.628 0 O-C-N 120.697 -1.252 . . . . 0.0 110.147 179.504 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.208 0.528 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.432 ' N ' ' OD1' ' A' ' 123' ' ' ASP . 0.5 OUTLIER -158.02 101.4 1.76 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.184 -0.948 . . . . 0.0 110.634 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.43 ' HA3' ' O ' ' A' ' 122' ' ' ALA . . . -176.84 128.25 1.31 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.556 HD23 ' C ' ' A' ' 4' ' ' LEU . 0.3 OUTLIER -67.62 154.67 40.94 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.537 -0.979 . . . . 0.0 111.218 -179.467 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.456 ' N ' ' HG ' ' A' ' 4' ' ' LEU . 76.5 t -118.16 136.92 53.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.397 -0.814 . . . . 0.0 109.666 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.492 ' HB3' HD11 ' A' ' 9' ' ' LEU . . . -119.59 164.4 15.91 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.699 -1.25 . . . . 0.0 111.305 -178.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.4 ' O ' ' HB3' ' A' ' 8' ' ' ASN . 15.0 p -153.08 166.35 32.74 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.477 -0.764 . . . . 0.0 109.898 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.426 ' ND2' ' O ' ' B' ' 3' ' ' GLY . 55.4 t30 60.81 38.54 17.93 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.273 -0.892 . . . . 0.0 109.759 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.536 ' O ' ' C ' ' A' ' 10' ' ' ASN . 61.5 mt -89.74 -3.35 58.23 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.705 -0.622 . . . . 0.0 111.849 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.536 ' C ' ' O ' ' A' ' 9' ' ' LEU . 8.2 m120 6.09 78.1 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.634 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 3.6 tt -100.24 129.78 46.28 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.303 -0.873 . . . . 0.0 110.035 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.3 mtpp -97.95 164.86 16.51 Favored Pre-proline 0 C--N 1.297 -1.694 0 O-C-N 121.445 -0.784 . . . . 0.0 110.37 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -66.93 147.28 80.14 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 123.991 1.521 . . . . 0.0 110.265 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.66 7.84 62.76 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -115.42 146.83 41.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.833 -1.393 . . . . 0.0 110.287 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 48.8 t -106.54 137.93 43.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.341 -0.85 . . . . 0.0 110.438 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.547 HD12 ' O ' ' A' ' 132' ' ' ALA . 45.5 tp -117.84 130.06 56.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.316 -0.865 . . . . 0.0 109.79 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.418 ' CZ ' ' OE1' ' A' ' 86' ' ' GLU . 77.5 ttt180 -118.95 128.74 54.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.941 -1.099 . . . . 0.0 110.633 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 25.1 t -121.13 125.29 73.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.256 -0.902 . . . . 0.0 110.725 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.453 ' HA ' ' HG2' ' A' ' 86' ' ' GLU . 75.8 ttt180 -109.86 129.01 55.69 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -149.19 -170.0 16.34 Favored Glycine 0 N--CA 1.486 1.974 0 C-N-CA 119.146 -1.502 . . . . 0.0 110.131 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -129.59 123.28 30.94 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.786 -0.832 . . . . 0.0 109.709 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.544 HG22 ' HD1' ' A' ' 126' ' ' PHE . 99.1 t -79.19 129.5 37.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.144 -0.973 . . . . 0.0 109.713 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.461 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -54.76 163.16 1.5 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.009 -1.057 . . . . 0.0 110.049 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.461 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 42.7 Cg_endo -67.84 -18.26 47.09 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.977 1.514 . . . . 0.0 110.327 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' A' ' 28' ' ' LYS . 63.9 t0 -113.61 56.76 0.69 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.244 -0.91 . . . . 0.0 109.284 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.8 84.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.602 -0.686 . . . . 0.0 110.227 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.514 ' HA ' ' HB3' ' A' ' 49' ' ' PHE . 85.1 tttt -109.64 -33.94 6.63 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.024 -1.047 . . . . 0.0 111.835 -179.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.2 t -146.22 140.45 26.58 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.626 -1.296 . . . . 0.0 111.671 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.509 ' CE2' ' HB2' ' A' ' 126' ' ' PHE . 83.3 m-85 -139.56 146.47 39.91 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.393 -0.817 . . . . 0.0 110.188 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.421 ' HB ' ' O ' ' A' ' 123' ' ' ASP . 63.7 t -133.44 130.0 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.96 -1.088 . . . . 0.0 109.798 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.709 HD12 ' HB2' ' A' ' 45' ' ' PHE . 94.7 mt -131.75 144.58 51.06 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.027 -1.046 . . . . 0.0 110.374 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -146.13 108.75 4.5 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.232 -0.917 . . . . 0.0 110.122 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.593 HD11 ' HB2' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -124.25 111.27 15.65 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.154 -0.966 . . . . 0.0 110.107 179.511 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -159.81 -122.84 0.67 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.502 ' HD2' HD13 ' A' ' 114' ' ' LEU . 0.1 OUTLIER -130.4 -46.12 1.09 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.396 -1.061 . . . . 0.0 108.864 179.518 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.429 ' HB2' ' HB2' ' A' ' 40' ' ' ASN . 87.6 m-20 -122.18 164.0 18.57 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.8 t -56.46 -42.33 78.03 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.293 -0.879 . . . . 0.0 111.631 -178.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.478 ' HB3' ' N ' ' A' ' 66' ' ' GLY . 92.4 m-20 -92.06 -0.11 57.46 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.89 -1.131 . . . . 0.0 111.002 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.429 ' HB2' ' HB2' ' A' ' 37' ' ' ASP . 7.5 m120 -117.37 61.7 0.75 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.95 -1.094 . . . . 0.0 109.854 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.7 mt -90.3 137.84 32.02 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.742 -0.599 . . . . 0.0 109.795 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.405 ' SG ' ' N ' ' A' ' 43' ' ' LEU . 6.8 p -88.62 -30.0 19.54 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.248 -0.907 . . . . 0.0 109.751 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.71 HD11 HD13 ' A' ' 96' ' ' LEU . 69.6 mt -137.09 138.14 40.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.904 . . . . 0.0 110.963 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -135.84 126.48 27.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.404 -0.81 . . . . 0.0 110.125 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.709 ' HB2' HD12 ' A' ' 32' ' ' LEU . 91.9 m-85 -113.01 141.96 46.26 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.996 -1.065 . . . . 0.0 110.024 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -154.72 69.94 5.86 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 120.996 -1.065 . . . . 0.0 110.986 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.42 147.46 65.13 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.68 1.358 . . . . 0.0 110.081 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.414 ' NH2' ' HB1' ' A' ' 51' ' ' ALA . 82.9 mtp180 -137.82 111.34 8.08 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.007 -1.058 . . . . 0.0 110.66 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.514 ' HB3' ' HA ' ' A' ' 28' ' ' LYS . 85.6 t80 -62.06 -46.31 89.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.312 -0.868 . . . . 0.0 110.03 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -164.64 99.45 0.79 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -0.909 . . . . 0.0 110.078 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.414 ' HB1' ' NH2' ' A' ' 48' ' ' ARG . . . -109.97 -89.81 0.48 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.254 -0.904 . . . . 0.0 109.911 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -63.1 -42.37 99.56 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.927 -1.108 . . . . 0.0 109.075 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 161.81 38.46 0.02 OUTLIER Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -117.54 -171.63 2.08 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.28 -1.13 . . . . 0.0 110.015 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.474 ' O ' ' C ' ' A' ' 56' ' ' ASN . . . -145.22 152.62 40.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.337 -0.852 . . . . 0.0 110.454 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.516 ' HB3' ' CD1' ' A' ' 77' ' ' PHE . 36.2 m120 23.09 56.79 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 45.9 m -112.91 132.62 55.25 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.338 -0.851 . . . . 0.0 109.042 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.432 HD11 ' O ' ' A' ' 76' ' ' VAL . 75.1 mt -117.03 135.55 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.147 -0.971 . . . . 0.0 111.774 -177.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.412 ' CG1' ' OE2' ' A' ' 71' ' ' GLU . 47.4 t -110.9 130.36 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.369 -0.832 . . . . 0.0 109.539 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 75.1 m -130.94 126.17 35.38 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.036 -1.04 . . . . 0.0 110.695 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -151.35 173.29 14.68 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.245 -0.909 . . . . 0.0 110.727 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.454 ' O ' ' CA ' ' A' ' 69' ' ' GLY . 69.0 m -131.77 155.2 48.14 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.506 -0.746 . . . . 0.0 109.858 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.487 ' CD ' ' HA2' ' A' ' 66' ' ' GLY . 8.9 ttmt -135.2 150.45 50.11 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.679 -1.263 . . . . 0.0 111.367 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -124.49 105.51 9.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.426 -0.797 . . . . 0.0 109.937 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 57.58 27.01 58.08 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.487 ' HA2' ' CD ' ' A' ' 63' ' ' LYS . . . 75.46 23.19 74.01 Favored Glycine 0 N--CA 1.488 2.129 0 O-C-N 120.777 -1.425 . . . . 0.0 109.771 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.47 ' HB1' ' CD1' ' A' ' 68' ' ' TRP . . . -81.2 -85.32 0.1 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.189 -1.183 . . . . 0.0 110.835 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.47 ' CD1' ' HB1' ' A' ' 67' ' ' ALA . 10.3 m95 -135.35 -146.89 0.25 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.884 -1.135 . . . . 0.0 109.849 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.454 ' CA ' ' O ' ' A' ' 62' ' ' SER . . . 167.38 129.45 1.07 Allowed Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.641 -1.266 . . . . 0.0 110.544 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.3 m -81.51 80.2 7.93 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.45 -1.029 . . . . 0.0 109.824 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.412 ' OE2' ' CG1' ' A' ' 59' ' ' VAL . 83.5 tt0 -72.37 124.75 25.79 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.201 -0.937 . . . . 0.0 111.134 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -109.53 -162.0 0.79 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.381 -0.824 . . . . 0.0 109.624 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 62.5 ttp85 -145.91 117.38 8.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.185 -0.947 . . . . 0.0 110.697 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -110.4 125.73 53.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.207 -0.933 . . . . 0.0 109.711 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -105.83 45.7 0.96 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.168 -0.957 . . . . 0.0 111.85 -178.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.622 HG12 ' HD3' ' A' ' 78' ' ' PRO . 51.7 t -121.41 133.01 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 120.965 -1.085 . . . . 0.0 109.843 179.006 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.532 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 11.3 p90 -143.02 82.03 12.32 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.102 -0.999 . . . . 0.0 111.248 -178.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.622 ' HD3' HG12 ' A' ' 76' ' ' VAL . 56.5 Cg_endo -79.99 41.29 1.09 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.495 1.26 . . . . 0.0 111.378 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -149.83 163.24 38.56 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.701 -1.249 . . . . 0.0 110.971 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 13.6 mp0 -129.94 164.58 39.5 Favored Pre-proline 0 N--CA 1.492 1.668 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.79 148.86 65.82 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 123.593 1.312 . . . . 0.0 110.859 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 63.42 41.75 99.26 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 25.1 t -137.36 137.32 38.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.198 -1.178 . . . . 0.0 111.276 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 84' ' ' VAL . 27.6 m -79.18 135.51 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.472 -0.767 . . . . 0.0 109.53 179.013 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.66 154.58 37.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.974 -1.079 . . . . 0.0 110.6 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.453 ' HG2' ' HA ' ' A' ' 20' ' ' ARG . 97.4 mt-10 -121.05 140.11 52.39 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.473 -0.767 . . . . 0.0 109.65 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.9 t -122.64 130.28 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.101 -0.999 . . . . 0.0 110.36 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 22.2 m -92.73 125.0 37.15 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.439 -0.788 . . . . 0.0 109.821 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 95.8 mt -122.05 125.0 72.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.045 -1.035 . . . . 0.0 110.246 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 53.9 m -121.76 124.55 44.47 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.392 -0.817 . . . . 0.0 108.913 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.414 ' CD1' ' CD2' ' A' ' 96' ' ' LEU . 65.7 t80 -110.51 112.84 25.02 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.142 -0.974 . . . . 0.0 110.333 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -121.04 150.32 41.36 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.612 -0.68 . . . . 0.0 109.226 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -64.35 -33.65 76.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.773 -1.204 . . . . 0.0 110.064 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.74 -46.02 90.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.969 -1.082 . . . . 0.0 109.558 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -168.63 175.59 6.07 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.425 -0.797 . . . . 0.0 109.764 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.734 HD12 ' HD2' ' A' ' 108' ' ' PHE . 79.1 mt -107.71 128.6 54.72 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.158 -0.964 . . . . 0.0 110.414 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.5 m -109.93 126.67 54.14 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.162 -0.961 . . . . 0.0 110.176 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 59.2 t -133.16 128.42 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 120.775 -1.203 . . . . 0.0 110.496 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -123.24 147.7 46.65 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.996 -1.065 . . . . 0.0 111.01 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.492 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 1.1 mp -100.84 167.73 10.35 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.587 -0.696 . . . . 0.0 109.636 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.492 ' HD2' ' HB3' ' A' ' 100' ' ' LEU . 41.7 Cg_endo -65.97 -22.63 55.21 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 123.408 1.215 . . . . 0.0 110.42 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.419 ' O ' ' HB3' ' A' ' 78' ' ' PRO . 47.7 t0 -152.09 78.23 1.23 Allowed 'General case' 0 N--CA 1.486 1.325 0 O-C-N 121.129 -0.982 . . . . 0.0 109.8 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -177.91 -171.91 41.81 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -87.59 -150.8 0.17 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.379 -1.071 . . . . 0.0 110.009 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 64.3 tt0 -128.92 146.23 51.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.238 -0.914 . . . . 0.0 110.661 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -130.38 134.27 47.02 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.279 -0.888 . . . . 0.0 109.968 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -114.83 144.7 43.11 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.204 -0.935 . . . . 0.0 110.859 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.734 ' HD2' HD12 ' A' ' 96' ' ' LEU . 56.7 t80 -129.17 133.65 25.41 Favored Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.457 ' O ' ' CE2' ' A' ' 108' ' ' PHE . 44.9 Cg_endo -66.83 138.79 49.82 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.359 1.189 . . . . 0.0 110.389 -178.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' A' ' 110' ' ' ASN . 5.2 p-10 -100.39 78.49 2.03 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.318 -0.864 . . . . 0.0 110.263 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.403 ' C ' ' O ' ' A' ' 110' ' ' ASN . 79.6 ttt180 -41.46 -32.65 0.35 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.429 -0.794 . . . . 0.0 110.797 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 95.0 mt -78.93 149.67 32.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.369 -0.832 . . . . 0.0 110.313 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -104.42 40.56 1.45 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.408 -0.808 . . . . 0.0 109.874 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.502 HD13 ' HD2' ' A' ' 36' ' ' LYS . 56.4 tp -71.16 125.93 28.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.203 -0.935 . . . . 0.0 109.766 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -96.75 -5.34 38.81 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.489 -0.757 . . . . 0.0 111.086 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 11' ' ' LEU . . . -141.46 142.0 33.66 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.874 -1.141 . . . . 0.0 111.473 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.47 ' HB ' ' HB3' ' A' ' 11' ' ' LEU . 48.1 mm -102.73 121.29 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -117.94 -18.82 9.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.993 -1.067 . . . . 0.0 111.465 -178.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.467 ' O ' ' HA ' ' A' ' 34' ' ' LEU . 42.9 t80 -113.71 130.04 56.48 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.907 -1.121 . . . . 0.0 111.14 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.48 ' HB3' ' CD1' ' A' ' 9' ' ' LEU . 48.2 ttp -142.42 114.22 8.05 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -136.05 139.0 42.73 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.95 -1.094 . . . . 0.0 110.905 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.493 ' CB ' HD23 ' A' ' 32' ' ' LEU . . . -141.83 131.92 24.72 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.51 -0.744 . . . . 0.0 109.137 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 2' ' ' CYS . 62.2 t0 -151.35 122.4 7.67 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.567 -0.708 . . . . 0.0 109.246 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.481 ' HA3' ' HA ' ' A' ' 30' ' ' PHE . . . 174.57 -148.98 10.14 Favored Glycine 0 N--CA 1.488 2.153 0 C-N-CA 119.192 -1.48 . . . . 0.0 110.165 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.5 ' HB2' ' CZ ' ' A' ' 30' ' ' PHE . 87.7 m-20 -86.35 9.16 18.78 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.672 -0.899 . . . . 0.0 110.283 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.544 ' HD1' HG22 ' A' ' 23' ' ' VAL . 51.1 t80 -104.06 141.77 35.63 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.122 -0.986 . . . . 0.0 109.662 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -116.08 120.05 37.81 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.168 -1.013 . . . . 0.0 111.108 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.621 HG23 ' O ' ' A' ' 128' ' ' ILE . 19.0 tt -95.47 119.57 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.232 -0.917 . . . . 0.0 109.923 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -100.82 -15.4 17.63 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.128 -0.983 . . . . 0.0 111.571 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -155.54 146.89 22.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.808 -1.183 . . . . 0.0 111.425 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.501 HG22 HD11 ' A' ' 128' ' ' ILE . 43.2 t -124.91 129.37 73.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.547 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -118.96 140.07 50.61 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.961 -1.087 . . . . 0.0 110.521 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -106.36 119.61 39.72 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.415 -0.803 . . . . 0.0 109.976 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.9 t0 . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.538 -179.997 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.162 0.506 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' CYS . . . . . 0.427 ' N ' ' OD1' ' B' ' 123' ' ' ASP . 0.5 OUTLIER -157.71 104.22 1.95 Allowed 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.059 -1.026 . . . . 0.0 110.226 179.898 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 3' ' ' GLY . . . . . 0.426 ' O ' ' ND2' ' A' ' 8' ' ' ASN . . . 179.51 127.48 1.11 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.555 ' C ' HD23 ' B' ' 4' ' ' LEU . 0.3 OUTLIER -67.27 154.42 41.34 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.728 -0.866 . . . . 0.0 111.342 -179.046 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.46 ' N ' ' HG ' ' B' ' 4' ' ' LEU . 72.7 t -118.11 137.08 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.578 -0.701 . . . . 0.0 109.676 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.474 ' HB3' HD11 ' B' ' 9' ' ' LEU . . . -119.56 164.81 15.27 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.772 -1.205 . . . . 0.0 111.309 -178.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 7' ' ' SER . . . . . 0.409 ' O ' ' HB3' ' B' ' 8' ' ' ASN . 14.1 p -153.23 166.37 32.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.292 -0.88 . . . . 0.0 109.645 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 8' ' ' ASN . . . . . 0.409 ' HB3' ' O ' ' B' ' 7' ' ' SER . 54.8 t30 60.75 38.94 17.88 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.345 -0.847 . . . . 0.0 109.681 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.553 ' O ' ' C ' ' B' ' 10' ' ' ASN . 63.2 mt -91.41 1.32 57.21 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.646 -0.659 . . . . 0.0 111.77 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 10' ' ' ASN . . . . . 0.553 ' C ' ' O ' ' B' ' 9' ' ' LEU . 7.9 m120 -0.16 80.65 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.565 0 CA-C-O 121.599 0.714 . . . . 0.0 112.715 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.499 ' O ' ' HA ' ' B' ' 116' ' ' ALA . 3.4 tt -100.67 129.9 46.65 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.585 -0.697 . . . . 0.0 109.898 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 3.3 mtpp -98.31 165.18 15.71 Favored Pre-proline 0 C--N 1.295 -1.783 0 O-C-N 121.481 -0.762 . . . . 0.0 110.441 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -66.88 147.38 80.49 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.96 1.505 . . . . 0.0 110.389 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.81 7.06 63.16 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 110.259 -1.137 . . . . 0.0 110.259 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -114.99 146.78 40.87 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.841 -1.388 . . . . 0.0 110.507 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 16' ' ' CYS . . . . . . . . . . . . . 49.4 t -106.44 137.86 43.65 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.413 -0.804 . . . . 0.0 110.561 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.537 HD12 ' O ' ' B' ' 132' ' ' ALA . 45.3 tp -117.86 130.03 56.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.358 -0.839 . . . . 0.0 109.694 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.413 ' CZ ' ' OE1' ' B' ' 86' ' ' GLU . 76.9 ttt180 -118.91 129.4 55.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.02 -1.05 . . . . 0.0 110.498 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 24.9 t -121.75 125.07 72.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.279 -0.888 . . . . 0.0 110.682 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 20' ' ' ARG . . . . . 0.455 ' HA ' ' HG2' ' B' ' 86' ' ' GLU . 76.1 ttt180 -109.55 128.88 55.51 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.34 -0.85 . . . . 0.0 108.869 178.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -149.4 -170.01 16.49 Favored Glycine 0 N--CA 1.486 1.988 0 C-N-CA 118.997 -1.573 . . . . 0.0 110.086 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -129.54 123.38 31.27 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.678 -0.895 . . . . 0.0 109.774 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.524 HG22 ' HD1' ' B' ' 126' ' ' PHE . 99.2 t -79.36 129.65 37.25 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 121.287 -0.883 . . . . 0.0 109.6 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.457 ' HB1' ' HD2' ' B' ' 25' ' ' PRO . . . -54.77 163.26 1.48 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.16 -0.962 . . . . 0.0 110.027 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.457 ' HD2' ' HB1' ' B' ' 24' ' ' ALA . 42.6 Cg_endo -67.74 -18.81 47.78 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.952 1.501 . . . . 0.0 110.196 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' B' ' 28' ' ' LYS . 64.1 t0 -113.3 56.94 0.68 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.244 -0.91 . . . . 0.0 109.391 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.96 84.89 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.679 -0.638 . . . . 0.0 110.163 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' LYS . . . . . 0.508 ' HA ' ' HB3' ' B' ' 49' ' ' PHE . 85.2 tttt -109.78 -33.49 6.73 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.065 -1.022 . . . . 0.0 111.777 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 37.1 t -146.58 140.1 25.84 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.674 -1.266 . . . . 0.0 111.535 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 30' ' ' PHE . . . . . 0.505 ' CD2' ' HB2' ' B' ' 126' ' ' PHE . 83.9 m-85 -139.3 146.04 39.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.439 -0.788 . . . . 0.0 110.142 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.413 ' HB ' ' O ' ' B' ' 123' ' ' ASP . 62.9 t -133.04 129.77 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.907 -1.121 . . . . 0.0 109.893 178.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.692 HD12 ' HB2' ' B' ' 45' ' ' PHE . 94.9 mt -131.31 144.64 51.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.103 -0.998 . . . . 0.0 110.565 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -146.07 108.87 4.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.302 -0.874 . . . . 0.0 110.238 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.595 HD11 ' HB2' ' B' ' 43' ' ' LEU . 0.3 OUTLIER -124.19 110.19 14.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.178 -0.951 . . . . 0.0 110.047 179.472 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -157.78 -122.39 0.7 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 36' ' ' LYS . . . . . 0.497 ' HD2' HD13 ' B' ' 114' ' ' LEU . 0.1 OUTLIER -130.83 -46.12 1.04 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.571 -0.958 . . . . 0.0 108.707 179.177 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 37' ' ' ASP . . . . . 0.424 ' HB2' ' HB2' ' B' ' 40' ' ' ASN . 87.3 m-20 -122.2 164.14 18.35 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 28.4 t -56.88 -41.99 79.02 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.312 -0.867 . . . . 0.0 111.372 -178.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 39' ' ' ASN . . . . . 0.48 ' HB3' ' N ' ' B' ' 66' ' ' GLY . 92.1 m-20 -92.31 0.02 57.42 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.862 -1.149 . . . . 0.0 111.002 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 40' ' ' ASN . . . . . 0.424 ' HB2' ' HB2' ' B' ' 37' ' ' ASP . 7.5 m120 -117.62 61.88 0.75 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.026 -1.046 . . . . 0.0 109.594 -178.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 95.7 mt -90.33 139.33 30.77 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.757 -0.59 . . . . 0.0 109.651 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 42' ' ' CYS . . . . . . . . . . . . . 7.4 p -90.8 -28.91 17.91 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.183 -0.948 . . . . 0.0 109.557 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.71 HD11 HD13 ' B' ' 96' ' ' LEU . 70.7 mt -137.54 137.62 38.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.359 -0.838 . . . . 0.0 110.954 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 44' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -135.42 126.77 28.43 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.388 -0.82 . . . . 0.0 110.094 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.692 ' HB2' HD12 ' B' ' 32' ' ' LEU . 91.6 m-85 -113.44 141.32 47.24 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.93 -1.106 . . . . 0.0 109.994 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -154.2 69.87 6.19 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 120.96 -1.088 . . . . 0.0 111.069 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 47' ' ' PRO . . . . . 0.402 ' HG2' ' HB2' ' B' ' 30' ' ' PHE . 52.6 Cg_endo -69.35 147.09 64.72 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.757 1.399 . . . . 0.0 110.159 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.437 ' NH2' ' HB1' ' B' ' 51' ' ' ALA . 83.0 mtp180 -137.42 111.51 8.4 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.974 -1.079 . . . . 0.0 110.62 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 49' ' ' PHE . . . . . 0.508 ' HB3' ' HA ' ' B' ' 28' ' ' LYS . 85.6 t80 -62.22 -46.31 89.44 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.242 -0.911 . . . . 0.0 109.958 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -164.51 99.33 0.81 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.11 -0.994 . . . . 0.0 110.065 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 51' ' ' ALA . . . . . 0.437 ' HB1' ' NH2' ' B' ' 48' ' ' ARG . . . -109.88 -89.78 0.48 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.09 -1.006 . . . . 0.0 109.956 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 52' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -63.12 -42.17 99.47 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.065 -1.022 . . . . 0.0 109.167 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 161.43 38.92 0.02 OUTLIER Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -118.21 -171.66 2.11 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.254 -1.145 . . . . 0.0 109.93 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.5 ' O ' ' C ' ' B' ' 56' ' ' ASN . . . -143.81 157.83 44.11 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.399 -0.813 . . . . 0.0 109.874 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 56' ' ' ASN . . . . . 0.509 ' HB3' ' CD1' ' B' ' 77' ' ' PHE . 35.8 m120 15.06 59.9 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.423 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -179.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 47.8 m -113.4 132.34 55.66 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 58' ' ' ILE . . . . . 0.427 HD11 ' O ' ' B' ' 76' ' ' VAL . 76.1 mt -116.94 135.99 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.039 -1.038 . . . . 0.0 111.802 -177.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.419 ' CG1' ' OE2' ' B' ' 71' ' ' GLU . 48.3 t -110.94 130.44 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.397 -0.815 . . . . 0.0 109.635 179.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 74.5 m -131.19 124.5 30.76 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.055 -1.028 . . . . 0.0 110.957 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -149.75 173.11 14.08 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.351 -0.843 . . . . 0.0 110.963 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 62' ' ' SER . . . . . 0.452 ' O ' ' CA ' ' B' ' 69' ' ' GLY . 69.7 m -131.16 155.34 47.19 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.464 -0.772 . . . . 0.0 109.919 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 63' ' ' LYS . . . . . 0.492 ' CD ' ' HA2' ' B' ' 66' ' ' GLY . 8.8 ttmt -135.34 150.33 49.93 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.707 -1.246 . . . . 0.0 111.372 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -124.54 104.77 8.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.389 -0.819 . . . . 0.0 110.149 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 58.24 27.18 59.99 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 66' ' ' GLY . . . . . 0.492 ' HA2' ' CD ' ' B' ' 63' ' ' LYS . . . 75.34 23.16 74.41 Favored Glycine 0 N--CA 1.488 2.151 0 O-C-N 120.82 -1.4 . . . . 0.0 109.794 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 67' ' ' ALA . . . . . 0.463 ' HB1' ' CD1' ' B' ' 68' ' ' TRP . . . -81.1 -85.04 0.1 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.154 -1.203 . . . . 0.0 110.873 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 68' ' ' TRP . . . . . 0.463 ' CD1' ' HB1' ' B' ' 67' ' ' ALA . 10.8 m95 -135.2 -145.38 0.22 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.915 -1.116 . . . . 0.0 110.057 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 69' ' ' GLY . . . . . 0.452 ' CA ' ' O ' ' B' ' 62' ' ' SER . . . 165.3 129.34 1.04 Allowed Glycine 0 N--CA 1.49 2.267 0 C-N-CA 119.594 -1.289 . . . . 0.0 110.577 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 18.5 m -81.63 80.21 8.03 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.626 -0.926 . . . . 0.0 109.865 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 71' ' ' GLU . . . . . 0.419 ' OE2' ' CG1' ' B' ' 59' ' ' VAL . 83.3 tt0 -71.95 125.57 27.55 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.24 -0.913 . . . . 0.0 110.948 -179.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -110.53 -161.94 0.78 Allowed 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.372 -0.83 . . . . 0.0 109.397 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 62.4 ttp85 -146.05 117.04 7.76 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.01 -1.056 . . . . 0.0 110.761 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -109.94 125.82 53.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.305 -0.872 . . . . 0.0 109.768 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -105.86 45.89 0.95 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.054 -1.029 . . . . 0.0 111.776 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 76' ' ' VAL . . . . . 0.61 HG12 ' HD3' ' B' ' 78' ' ' PRO . 51.6 t -121.46 132.66 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.841 -1.162 . . . . 0.0 109.88 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 77' ' ' PHE . . . . . 0.54 ' N ' ' CD1' ' B' ' 77' ' ' PHE . 11.3 p90 -142.74 82.14 12.64 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 120.988 -1.07 . . . . 0.0 111.346 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 78' ' ' PRO . . . . . 0.61 ' HD3' HG12 ' B' ' 76' ' ' VAL . 56.2 Cg_endo -80.16 41.66 1.17 Allowed 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 123.522 1.275 . . . . 0.0 111.429 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -149.91 163.84 37.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.653 -1.279 . . . . 0.0 110.848 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -130.67 164.53 41.01 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 81' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.8 149.3 66.43 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.633 1.333 . . . . 0.0 110.838 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 63.09 41.61 99.74 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 25.6 t -137.04 137.3 39.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.263 -1.139 . . . . 0.0 111.299 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.43 HG23 ' O ' ' B' ' 84' ' ' VAL . 27.5 m -79.1 135.42 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.409 -0.807 . . . . 0.0 109.522 178.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.48 154.6 37.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.944 -1.097 . . . . 0.0 110.673 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 86' ' ' GLU . . . . . 0.455 ' HG2' ' HA ' ' B' ' 20' ' ' ARG . 97.3 mt-10 -121.08 140.18 52.31 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.381 -0.824 . . . . 0.0 109.612 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 47.2 t -122.76 129.88 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.068 -1.02 . . . . 0.0 110.502 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 88' ' ' CYS . . . . . . . . . . . . . 24.5 m -92.35 125.06 36.85 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.369 -0.832 . . . . 0.0 109.899 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 96.5 mt -122.2 124.99 72.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.114 -0.991 . . . . 0.0 110.315 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 53.9 m -121.72 124.3 43.92 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.483 -0.761 . . . . 0.0 109.02 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 91' ' ' PHE . . . . . 0.41 ' CD1' ' CD2' ' B' ' 96' ' ' LEU . 65.6 t80 -110.21 112.94 25.23 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.144 -0.973 . . . . 0.0 110.32 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -121.39 149.51 42.88 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.558 -0.714 . . . . 0.0 109.307 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -63.79 -33.16 75.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.796 -1.19 . . . . 0.0 110.088 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.0 -45.96 89.95 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.032 -1.043 . . . . 0.0 109.457 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -168.81 175.49 5.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.524 -0.735 . . . . 0.0 109.766 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 96' ' ' LEU . . . . . 0.719 HD12 ' HD2' ' B' ' 108' ' ' PHE . 79.4 mt -107.48 128.3 54.37 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.211 -0.931 . . . . 0.0 110.685 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 2.6 m -109.67 126.84 54.1 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.014 -1.053 . . . . 0.0 110.358 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 63.6 t -132.96 128.85 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.016 -1.053 . . . . 0.0 110.427 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -123.98 147.03 48.1 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.987 -1.07 . . . . 0.0 110.965 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 100' ' ' LEU . . . . . 0.488 ' HB3' ' HD2' ' B' ' 101' ' ' PRO . 1.1 mp -100.36 167.85 10.28 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.585 -0.697 . . . . 0.0 109.581 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 101' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' B' ' 100' ' ' LEU . 41.0 Cg_endo -66.02 -22.73 54.77 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.564 1.297 . . . . 0.0 110.451 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 102' ' ' ASP . . . . . 0.439 ' O ' ' HB3' ' B' ' 78' ' ' PRO . 47.5 t0 -152.11 80.06 1.25 Allowed 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.122 -0.986 . . . . 0.0 109.751 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 179.41 -172.49 44.42 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 104' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -87.13 -150.68 0.16 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.211 -1.17 . . . . 0.0 110.284 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -129.01 146.05 51.09 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.925 . . . . 0.0 110.64 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -130.51 134.34 46.98 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.343 -0.848 . . . . 0.0 109.865 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -114.85 144.62 43.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.296 -0.878 . . . . 0.0 110.891 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 108' ' ' PHE . . . . . 0.719 ' HD2' HD12 ' B' ' 96' ' ' LEU . 56.4 t80 -129.22 133.84 25.61 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 109' ' ' PRO . . . . . 0.453 ' O ' ' CE2' ' B' ' 108' ' ' PHE . 44.1 Cg_endo -66.93 138.91 49.74 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.312 1.164 . . . . 0.0 110.353 -178.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 110' ' ' ASN . . . . . 0.49 ' ND2' ' O ' ' B' ' 110' ' ' ASN . 5.3 p-10 -100.58 78.58 2.01 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.359 -0.838 . . . . 0.0 110.175 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 111' ' ' ARG . . . . . 0.406 ' C ' ' O ' ' B' ' 110' ' ' ASN . 79.5 ttt180 -41.61 -32.71 0.39 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.4 -0.812 . . . . 0.0 110.757 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 95.3 mt -78.99 149.2 32.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.274 -0.892 . . . . 0.0 110.452 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -103.78 40.71 1.39 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.323 -0.861 . . . . 0.0 110.035 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 114' ' ' LEU . . . . . 0.497 HD13 ' HD2' ' B' ' 36' ' ' LYS . 56.4 tp -71.29 125.67 27.57 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.124 -0.985 . . . . 0.0 109.862 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -96.58 -4.86 40.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.58 -0.7 . . . . 0.0 111.087 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 116' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' B' ' 11' ' ' LEU . . . -142.03 142.04 32.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.868 -1.145 . . . . 0.0 111.499 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 117' ' ' ILE . . . . . 0.472 ' HB ' ' HB3' ' B' ' 11' ' ' LEU . 48.4 mm -102.72 121.15 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -118.02 -18.9 9.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.86 -1.15 . . . . 0.0 111.412 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 119' ' ' TYR . . . . . 0.485 ' O ' ' HA ' ' B' ' 34' ' ' LEU . 43.0 t80 -113.42 129.72 56.47 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.972 -1.08 . . . . 0.0 111.229 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 120' ' ' MET . . . . . 0.472 ' CB ' ' CD1' ' B' ' 9' ' ' LEU . 47.2 ttp -142.06 114.08 8.1 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -135.91 139.15 43.08 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.883 -1.136 . . . . 0.0 110.868 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 122' ' ' ALA . . . . . 0.484 ' CB ' HD23 ' B' ' 32' ' ' LEU . . . -141.96 131.41 23.77 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 123' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' B' ' 2' ' ' CYS . 62.2 t0 -150.99 122.14 7.74 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.464 -0.773 . . . . 0.0 109.224 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 124' ' ' GLY . . . . . 0.474 ' HA3' ' HA ' ' B' ' 30' ' ' PHE . . . 174.99 -149.02 9.98 Favored Glycine 0 N--CA 1.489 2.19 0 C-N-CA 118.969 -1.586 . . . . 0.0 110.026 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 125' ' ' ASP . . . . . 0.491 ' HB2' ' CZ ' ' B' ' 30' ' ' PHE . 87.6 m-20 -86.4 8.95 19.57 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.698 -0.884 . . . . 0.0 110.318 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 126' ' ' PHE . . . . . 0.524 ' HD1' HG22 ' B' ' 23' ' ' VAL . 51.2 t80 -103.86 141.53 35.96 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.136 -0.977 . . . . 0.0 109.768 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -115.93 120.22 38.48 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.119 -1.033 . . . . 0.0 111.089 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 128' ' ' ILE . . . . . 0.619 ' O ' HG23 ' B' ' 128' ' ' ILE . 18.9 tt -95.86 119.31 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.147 -0.97 . . . . 0.0 109.999 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -100.83 -15.55 17.57 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.021 -1.049 . . . . 0.0 111.591 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 130' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -154.54 146.79 23.8 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.689 -1.257 . . . . 0.0 111.445 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.498 HG22 HD11 ' B' ' 128' ' ' ILE . 42.5 t -124.76 129.04 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 132' ' ' ALA . . . . . 0.537 ' O ' HD12 ' B' ' 17' ' ' LEU . . . -118.79 139.79 51.02 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.564 -1.335 . . . . 0.0 110.504 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -105.98 119.73 39.95 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.429 -0.794 . . . . 0.0 109.955 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 5.7 t0 . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.597 -179.989 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.362 0.601 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 35.9 t -148.36 84.08 1.5 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.291 -0.881 . . . . 0.0 109.95 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.466 ' HA2' ' CB ' ' A' ' 123' ' ' ASP . . . 93.6 38.48 5.26 Favored Glycine 0 N--CA 1.491 2.307 0 C-N-CA 120.121 -1.038 . . . . 0.0 111.135 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.448 ' HA ' ' HB3' ' B' ' 8' ' ' ASN . 60.8 tp -61.44 132.22 52.75 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.719 -1.459 . . . . 0.0 110.032 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.9 t -117.41 154.71 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.49 -0.756 . . . . 0.0 110.599 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.451 ' HB3' ' HB3' ' A' ' 120' ' ' MET . . . -141.92 156.51 45.49 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.345 -0.847 . . . . 0.0 110.573 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.465 ' O ' ' HB3' ' A' ' 8' ' ' ASN . 8.2 p -151.71 170.27 20.14 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.52 -0.737 . . . . 0.0 109.613 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.465 ' HB3' ' O ' ' A' ' 7' ' ' SER . 11.9 t-20 60.46 32.89 20.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.456 -0.778 . . . . 0.0 109.529 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.507 ' CD1' ' CB ' ' A' ' 120' ' ' MET . 74.3 mt -84.99 -15.19 45.06 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.554 -0.716 . . . . 0.0 111.991 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.496 ' C ' ' O ' ' A' ' 9' ' ' LEU . 53.4 p-10 5.43 63.06 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.503 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.795 HD21 ' CD2' ' A' ' 133' ' ' PHE . 11.7 mt -92.37 126.61 37.53 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 120.865 -1.147 . . . . 0.0 109.355 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -90.84 165.06 23.41 Favored Pre-proline 0 C--N 1.301 -1.537 0 O-C-N 121.365 -0.834 . . . . 0.0 110.44 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 91' ' ' PHE . 49.7 Cg_endo -68.68 152.63 74.28 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 124.039 1.547 . . . . 0.0 110.554 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.04 -20.73 42.33 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -100.12 152.69 19.96 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.16 -1.2 . . . . 0.0 110.108 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.2 m -97.91 139.02 34.37 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.225 -0.922 . . . . 0.0 110.806 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.411 ' CD1' ' HA ' ' A' ' 133' ' ' PHE . 58.8 tp -124.13 131.41 53.54 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.238 -0.914 . . . . 0.0 110.029 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 95.4 mtm-85 -128.91 139.96 51.89 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.014 -1.054 . . . . 0.0 111.017 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.416 ' O ' ' HG3' ' A' ' 86' ' ' GLU . 90.2 t -129.4 122.51 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.096 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 47.3 ttp180 -107.03 127.84 53.83 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.103 -0.998 . . . . 0.0 110.66 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -143.02 -159.24 7.86 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 119.449 -1.358 . . . . 0.0 110.715 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 84' ' ' VAL . 84.4 tt0 -138.03 147.53 44.23 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.833 -0.804 . . . . 0.0 109.135 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.556 ' CG1' ' HB2' ' A' ' 27' ' ' ALA . 50.3 t -108.78 124.12 65.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 120.903 -1.123 . . . . 0.0 110.123 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.54 162.01 1.88 Allowed Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.166 -0.959 . . . . 0.0 109.024 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.406 ' O ' ' HB2' ' A' ' 81' ' ' PRO . 43.9 Cg_endo -66.95 -19.47 52.11 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 O-C-N 123.833 1.438 . . . . 0.0 110.65 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 28' ' ' LYS . 89.2 m-20 -112.65 40.04 2.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.115 -0.991 . . . . 0.0 110.656 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.556 ' HB2' ' CG1' ' A' ' 23' ' ' VAL . . . -54.0 92.67 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.065 -1.022 . . . . 0.0 110.051 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.423 ' N ' ' O ' ' A' ' 26' ' ' ASP . 87.6 tttt -106.21 -34.43 7.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.164 -0.96 . . . . 0.0 111.612 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 39.5 t -150.48 133.73 16.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.847 -1.158 . . . . 0.0 111.297 -178.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.427 ' HA ' ' HA3' ' A' ' 124' ' ' GLY . 47.1 t80 -156.18 155.27 32.16 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.481 -0.762 . . . . 0.0 110.526 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.476 HG13 ' O ' ' A' ' 31' ' ' VAL . 9.3 p -139.4 133.9 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.096 -1.003 . . . . 0.0 111.007 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.7 tp -126.73 131.08 51.43 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.372 -0.83 . . . . 0.0 109.875 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.696 ' HB3' HD22 ' A' ' 41' ' ' LEU . 31.8 m120 -136.72 137.21 39.69 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.855 -1.153 . . . . 0.0 111.421 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -138.45 113.64 9.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.241 -0.912 . . . . 0.0 109.648 178.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.476 ' O ' ' HB3' ' A' ' 119' ' ' TYR . . . -165.58 -163.35 18.79 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.669 ' HE3' HD12 ' A' ' 114' ' ' LEU . 99.1 mttt -68.32 -43.99 76.39 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.939 -1.33 . . . . 0.0 110.514 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -153.57 -167.03 2.56 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.779 0.8 . . . . 0.0 111.93 -178.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.3 t -60.28 -44.63 95.18 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.685 -0.634 . . . . 0.0 112.486 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.418 ' HB3' ' N ' ' A' ' 66' ' ' GLY . 82.6 m-20 -89.49 -14.01 36.24 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.763 -1.211 . . . . 0.0 110.317 -179.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -107.27 71.89 0.85 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.342 -0.849 . . . . 0.0 109.348 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.696 HD22 ' HB3' ' A' ' 33' ' ' ASN . 95.6 mt -101.59 141.41 34.5 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.261 0.553 . . . . 0.0 110.388 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.44 ' O ' ' CB ' ' A' ' 62' ' ' SER . 0.5 OUTLIER -85.78 -51.93 6.1 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.24 -0.913 . . . . 0.0 110.049 179.652 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.99 HD11 HD11 ' A' ' 96' ' ' LEU . 84.7 mt -128.07 140.29 52.03 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.994 -1.066 . . . . 0.0 110.914 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.423 ' N ' ' O ' ' A' ' 61' ' ' ASN . 11.9 t60 -120.88 112.14 18.42 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -104.78 127.61 52.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.056 -1.028 . . . . 0.0 109.743 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -142.5 81.11 13.91 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.082 -1.011 . . . . 0.0 111.025 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.83 148.23 64.18 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.076 1.566 . . . . 0.0 110.139 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -144.95 107.57 4.43 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.925 -1.109 . . . . 0.0 111.689 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -62.3 -45.0 95.21 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.209 -0.932 . . . . 0.0 109.57 178.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -136.57 93.58 2.89 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.635 -0.666 . . . . 0.0 109.892 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -87.5 -151.04 0.17 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.191 -0.943 . . . . 0.0 110.136 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -66.02 -8.52 23.55 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.076 -1.015 . . . . 0.0 111.444 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 174.29 -27.53 0.08 OUTLIER Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -77.97 -179.31 6.0 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.05 -1.264 . . . . 0.0 109.13 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.428 ' O ' ' C ' ' A' ' 56' ' ' ASN . . . -143.76 149.84 37.7 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.173 -0.955 . . . . 0.0 110.988 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.428 ' C ' ' O ' ' A' ' 55' ' ' ALA . 87.6 m-20 29.51 59.31 0.16 Allowed 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 178.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 98.2 m -121.18 128.88 52.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.94 -1.1 . . . . 0.0 110.645 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 95.6 mt -111.13 126.05 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.701 -0.624 . . . . 0.0 110.383 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.1 m -116.5 135.43 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.015 -1.053 . . . . 0.0 109.955 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 35.4 m -103.03 136.15 43.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.141 -0.974 . . . . 0.0 110.053 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.423 ' O ' ' N ' ' A' ' 44' ' ' HIS . 1.5 t30 -146.95 158.6 43.97 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.074 -1.016 . . . . 0.0 110.987 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 42' ' ' CYS . 53.2 p -139.05 158.25 44.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.447 -0.783 . . . . 0.0 110.236 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.477 ' CD ' ' HA2' ' A' ' 66' ' ' GLY . 26.2 ttmt -142.47 152.7 42.99 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.312 -0.867 . . . . 0.0 110.563 178.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -125.04 94.66 4.24 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.358 -0.839 . . . . 0.0 109.071 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 64.47 28.43 73.13 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.477 ' HA2' ' CD ' ' A' ' 63' ' ' LYS . . . 73.98 24.76 73.15 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.2 -79.03 0.13 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.434 -1.039 . . . . 0.0 110.347 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.41 ' O ' ' HG3' ' A' ' 63' ' ' LYS . 93.5 m95 -141.98 -144.67 0.16 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.341 -0.849 . . . . 0.0 109.66 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 163.76 110.57 0.24 Allowed Glycine 0 N--CA 1.493 2.497 0 C-N-CA 119.67 -1.253 . . . . 0.0 110.078 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.08 71.97 10.12 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.364 -1.08 . . . . 0.0 110.32 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -61.3 143.99 54.7 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.553 -0.717 . . . . 0.0 111.729 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -124.73 -154.38 0.61 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.465 -0.772 . . . . 0.0 109.314 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 78.3 ttt-85 -143.88 116.18 8.5 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.757 -1.214 . . . . 0.0 112.021 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -109.32 122.64 47.79 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.33 -0.856 . . . . 0.0 109.577 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -113.88 88.4 2.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.896 -1.127 . . . . 0.0 110.377 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.6 p -141.33 142.46 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.369 -0.832 . . . . 0.0 110.475 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -151.65 77.87 7.04 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.171 -0.956 . . . . 0.0 109.857 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.479 ' CB ' ' HB2' ' A' ' 102' ' ' ASP . 54.7 Cg_endo -83.3 -0.96 10.11 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.218 1.641 . . . . 0.0 111.934 -178.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.513 ' CE1' ' HG2' ' A' ' 101' ' ' PRO . 44.0 m-85 -139.13 -171.9 3.21 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.912 -1.118 . . . . 0.0 110.357 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.47 ' HB2' ' HD2' ' A' ' 81' ' ' PRO . 2.7 pm0 -143.6 166.66 18.53 Favored Pre-proline 0 C--N 1.301 -1.506 0 O-C-N 121.189 -0.944 . . . . 0.0 110.342 -178.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.47 ' HD2' ' HB2' ' A' ' 80' ' ' GLN . 43.9 Cg_endo -65.7 151.13 85.41 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.931 1.49 . . . . 0.0 109.655 179.199 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.35 23.75 70.06 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 38.9 t -140.56 143.39 35.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.262 -1.14 . . . . 0.0 109.518 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 20.2 m -78.28 153.63 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.159 -0.963 . . . . 0.0 110.753 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -160.87 147.83 15.31 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.343 -0.848 . . . . 0.0 109.92 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.416 ' HG3' ' O ' ' A' ' 19' ' ' VAL . 78.5 tt0 -122.19 146.78 46.92 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.434 -0.791 . . . . 0.0 108.945 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 71.1 t -126.94 135.2 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.011 -1.056 . . . . 0.0 110.896 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 2.3 t -109.3 129.02 55.53 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.307 -0.871 . . . . 0.0 109.42 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 86.8 mt -129.15 127.33 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.118 -0.989 . . . . 0.0 110.589 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.0 m -115.56 132.12 56.73 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.177 -0.952 . . . . 0.0 109.691 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.431 ' CZ ' ' HB3' ' A' ' 114' ' ' LEU . 47.8 t80 -113.26 123.38 50.03 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.13 -0.981 . . . . 0.0 110.266 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -109.62 147.68 32.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -0.912 . . . . 0.0 109.769 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -58.11 -21.68 47.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.333 -0.854 . . . . 0.0 111.225 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -116.62 -13.34 10.85 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.724 -1.235 . . . . 0.0 110.781 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -147.29 -167.68 2.85 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.08 -1.013 . . . . 0.0 110.981 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.99 HD11 HD11 ' A' ' 43' ' ' LEU . 7.2 tt -151.76 115.63 4.91 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 54.4 m -106.65 130.37 54.4 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.768 -1.208 . . . . 0.0 110.309 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.58 HG23 ' CD2' ' A' ' 96' ' ' LEU . 52.5 t -121.4 132.34 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.458 -0.776 . . . . 0.0 110.185 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -122.68 127.04 48.77 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.851 -1.156 . . . . 0.0 110.659 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.4 mt -95.9 161.27 27.95 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.513 ' HG2' ' CE1' ' A' ' 79' ' ' PHE . 39.4 Cg_endo -65.62 -22.7 57.68 Favored 'Trans proline' 0 C--N 1.301 -1.95 0 O-C-N 123.448 1.236 . . . . 0.0 109.828 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.486 ' OD2' ' CD1' ' A' ' 104' ' ' TYR . 29.0 t70 -63.67 -40.26 96.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.287 -0.883 . . . . 0.0 109.995 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 126.59 -6.57 7.49 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.486 ' CD1' ' OD2' ' A' ' 102' ' ' ASP . 47.2 m-85 -87.07 142.29 28.04 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.005 -1.291 . . . . 0.0 110.224 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -128.43 140.26 51.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.321 -0.862 . . . . 0.0 111.327 -179.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -131.87 150.46 52.15 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 11.7 ptpt -132.9 136.01 45.91 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.798 -1.189 . . . . 0.0 111.384 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 20.1 m-30 -108.44 147.41 35.62 Favored Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 121.533 -0.729 . . . . 0.0 109.648 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.414 ' O ' ' N ' ' A' ' 111' ' ' ARG . 41.2 Cg_endo -65.64 150.68 86.19 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 O-C-N 124.0 1.526 . . . . 0.0 111.017 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -65.82 62.31 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.84 -0.537 . . . . 0.0 111.68 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.414 ' N ' ' O ' ' A' ' 109' ' ' PRO . 20.8 ptt180 -68.74 -24.76 64.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.061 -1.025 . . . . 0.0 109.663 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.721 HD13 ' N ' ' A' ' 113' ' ' ASN . 1.2 tm? -111.21 128.77 56.02 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.297 -0.877 . . . . 0.0 109.107 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.721 ' N ' HD13 ' A' ' 112' ' ' LEU . 37.9 m-20 -90.27 69.42 7.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.795 -1.191 . . . . 0.0 110.812 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.669 HD12 ' HE3' ' A' ' 36' ' ' LYS . 53.4 tp -84.84 131.44 34.53 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.377 -0.827 . . . . 0.0 109.35 178.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -92.17 -19.48 22.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.725 -1.234 . . . . 0.0 109.846 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.611 ' O ' HD11 ' A' ' 114' ' ' LEU . . . -171.76 156.6 4.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -0.907 . . . . 0.0 109.479 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 66.5 mt -101.94 116.36 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.884 -1.135 . . . . 0.0 110.76 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 -111.63 -23.97 10.36 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.143 -0.973 . . . . 0.0 109.914 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.476 ' HB3' ' O ' ' A' ' 35' ' ' GLY . 90.2 t80 -106.84 126.75 52.7 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.378 -0.826 . . . . 0.0 111.228 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.507 ' CB ' ' CD1' ' A' ' 9' ' ' LEU . 66.3 ttp -136.67 125.56 24.16 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -141.59 136.76 31.37 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.959 -1.088 . . . . 0.0 110.393 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -147.37 123.46 10.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.351 -0.843 . . . . 0.0 110.204 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.466 ' CB ' ' HA2' ' A' ' 3' ' ' GLY . 20.5 p-10 -151.11 121.93 7.56 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.956 -1.09 . . . . 0.0 110.956 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.427 ' HA3' ' HA ' ' A' ' 30' ' ' PHE . . . 178.28 -148.08 8.3 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.474 ' HB3' ' HA ' ' A' ' 27' ' ' ALA . 80.9 m-20 -81.69 8.72 9.21 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.482 -1.011 . . . . 0.0 110.924 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.459 ' HD1' HG22 ' A' ' 23' ' ' VAL . 43.1 t80 -106.29 142.65 35.62 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.974 -1.078 . . . . 0.0 110.205 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -110.97 125.3 53.56 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 118.945 -1.102 . . . . 0.0 110.91 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.463 HD11 ' CG2' ' A' ' 131' ' ' VAL . 9.0 tt -100.26 121.18 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.162 -0.961 . . . . 0.0 109.601 178.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -101.0 -17.55 16.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.343 -0.848 . . . . 0.0 112.323 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -159.39 147.72 17.7 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.484 -1.385 . . . . 0.0 112.252 -178.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.463 ' CG2' HD11 ' A' ' 128' ' ' ILE . 45.4 t -127.13 127.1 69.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -128.68 129.75 46.23 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.813 -1.179 . . . . 0.0 110.214 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.795 ' CD2' HD21 ' A' ' 11' ' ' LEU . 3.2 m-30 -64.25 -102.76 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.238 -0.914 . . . . 0.0 110.118 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.8 t70 . . . . . 0 N--CA 1.493 1.71 0 O-C-N 120.599 -1.313 . . . . 0.0 110.19 179.64 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.265 0.555 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' CYS . . . . . . . . . . . . . 35.6 t -148.27 83.31 1.49 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.356 -0.84 . . . . 0.0 110.148 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' GLY . . . . . 0.468 ' HA2' ' CB ' ' B' ' 123' ' ' ASP . . . 93.9 38.85 5.07 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 120.198 -1.001 . . . . 0.0 111.1 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 60.5 tp -61.69 132.26 52.65 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.729 -1.454 . . . . 0.0 109.906 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 3.1 t -117.16 154.58 18.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.643 -0.66 . . . . 0.0 110.602 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.444 ' HB3' ' HB3' ' B' ' 120' ' ' MET . . . -141.99 156.53 45.45 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.423 -0.798 . . . . 0.0 110.548 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 7' ' ' SER . . . . . 0.457 ' O ' ' HB3' ' B' ' 8' ' ' ASN . 7.9 p -151.89 170.04 20.81 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.579 -0.701 . . . . 0.0 109.579 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 8' ' ' ASN . . . . . 0.457 ' HB3' ' O ' ' B' ' 7' ' ' SER . 11.6 t-20 60.79 32.99 20.2 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.521 -0.737 . . . . 0.0 109.287 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.507 ' CD1' ' CB ' ' B' ' 120' ' ' MET . 73.2 mt -86.15 -11.59 52.18 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.622 -0.674 . . . . 0.0 111.834 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 10' ' ' ASN . . . . . 0.491 ' C ' ' O ' ' B' ' 9' ' ' LEU . 53.5 p-10 -0.28 66.14 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.486 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -178.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.801 HD21 ' CD2' ' B' ' 133' ' ' PHE . 11.6 mt -93.37 126.54 38.55 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.087 -1.008 . . . . 0.0 109.202 178.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -90.83 165.3 22.68 Favored Pre-proline 0 C--N 1.3 -1.566 0 O-C-N 121.345 -0.847 . . . . 0.0 110.402 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 13' ' ' PRO . . . . . 0.426 ' HA ' ' O ' ' B' ' 91' ' ' PHE . 48.9 Cg_endo -68.65 152.64 74.4 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.967 1.509 . . . . 0.0 110.548 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.08 -20.73 42.25 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -100.04 152.84 19.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.184 -1.186 . . . . 0.0 110.047 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 16' ' ' CYS . . . . . . . . . . . . . 2.2 m -98.16 139.12 34.43 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.185 -0.947 . . . . 0.0 110.708 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.419 ' CD1' ' HA ' ' B' ' 133' ' ' PHE . 58.7 tp -124.18 131.38 53.53 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.253 -0.904 . . . . 0.0 110.063 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 95.5 mtm-85 -128.93 139.87 51.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.878 -1.139 . . . . 0.0 110.937 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.409 ' O ' ' HG3' ' B' ' 86' ' ' GLU . 91.4 t -129.33 122.65 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.09 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 47.3 ttp180 -107.13 127.69 53.72 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.15 -0.969 . . . . 0.0 110.665 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -142.86 -159.25 7.87 Favored Glycine 0 N--CA 1.49 2.269 0 C-N-CA 119.409 -1.377 . . . . 0.0 110.685 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 22' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' B' ' 84' ' ' VAL . 84.6 tt0 -138.03 147.46 44.16 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.822 -0.811 . . . . 0.0 109.215 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.543 ' CG1' ' HB2' ' B' ' 27' ' ' ALA . 50.1 t -108.74 124.11 65.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 O-C-N 120.984 -1.073 . . . . 0.0 110.148 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.411 ' HB1' ' HD2' ' B' ' 25' ' ' PRO . . . -54.71 161.88 2.02 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.103 -0.998 . . . . 0.0 108.985 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.412 ' O ' ' HB2' ' B' ' 81' ' ' PRO . 43.6 Cg_endo -66.76 -19.58 53.11 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 O-C-N 123.7 1.368 . . . . 0.0 110.606 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 26' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' B' ' 28' ' ' LYS . 89.2 m-20 -112.64 40.14 2.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.183 -0.948 . . . . 0.0 110.664 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 27' ' ' ALA . . . . . 0.543 ' HB2' ' CG1' ' B' ' 23' ' ' VAL . . . -53.98 92.53 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.109 -0.994 . . . . 0.0 110.172 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 28' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' B' ' 26' ' ' ASP . 87.6 tttt -106.28 -34.28 7.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.125 -0.984 . . . . 0.0 111.588 -179.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 39.7 t -150.52 133.2 15.81 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.848 -1.158 . . . . 0.0 111.312 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 30' ' ' PHE . . . . . 0.431 ' HA ' ' HA3' ' B' ' 124' ' ' GLY . 48.4 t80 -155.54 155.42 33.36 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.52 -0.737 . . . . 0.0 110.632 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.472 ' O ' HG13 ' B' ' 31' ' ' VAL . 9.1 p -139.5 133.64 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.162 -0.961 . . . . 0.0 111.044 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 15.8 tp -126.66 131.02 51.52 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.32 -0.862 . . . . 0.0 109.877 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 33' ' ' ASN . . . . . 0.683 ' HB3' HD22 ' B' ' 41' ' ' LEU . 31.7 m120 -136.61 137.48 40.17 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.958 -1.089 . . . . 0.0 111.407 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -138.94 109.68 6.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.143 -0.973 . . . . 0.0 109.859 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 35' ' ' GLY . . . . . 0.474 ' O ' ' HB3' ' B' ' 119' ' ' TYR . . . -160.18 -162.31 12.25 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 36' ' ' LYS . . . . . 0.692 ' HE3' HD12 ' B' ' 114' ' ' LEU . 99.1 mttt -68.81 -43.85 74.75 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.146 -1.208 . . . . 0.0 110.228 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -153.56 -167.2 2.62 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.786 0.803 . . . . 0.0 111.881 -178.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 11.6 t -59.91 -44.77 94.08 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 39' ' ' ASN . . . . . 0.412 ' HB3' ' N ' ' B' ' 66' ' ' GLY . 83.0 m-20 -89.69 -13.81 36.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.707 -1.246 . . . . 0.0 110.315 -179.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 40' ' ' ASN . . . . . 0.4 ' ND2' ' N ' ' B' ' 40' ' ' ASN . 5.7 m-80 -107.45 71.74 0.84 Allowed 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.913 0.864 . . . . 0.0 109.318 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.683 HD22 ' HB3' ' B' ' 33' ' ' ASN . 95.0 mt -101.12 144.05 30.49 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.782 -0.573 . . . . 0.0 110.13 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 42' ' ' CYS . . . . . 0.425 ' O ' ' CB ' ' B' ' 62' ' ' SER . 0.5 OUTLIER -89.31 -50.42 6.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.168 -0.958 . . . . 0.0 109.636 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.956 HD11 HD11 ' B' ' 96' ' ' LEU . 85.5 mt -128.93 140.19 51.78 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.913 -1.117 . . . . 0.0 110.813 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 44' ' ' HIS . . . . . 0.429 ' N ' ' O ' ' B' ' 61' ' ' ASN . 12.0 t60 -120.91 112.3 18.61 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -104.86 127.69 52.77 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.165 -0.959 . . . . 0.0 109.664 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -142.46 80.99 14.08 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 120.989 -1.07 . . . . 0.0 111.06 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 47' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.79 148.08 64.12 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.062 1.559 . . . . 0.0 110.132 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -144.8 107.72 4.5 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.879 -1.138 . . . . 0.0 111.628 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -62.51 -44.86 95.34 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.057 -1.027 . . . . 0.0 109.575 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 28.9 t30 -136.63 93.24 2.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.729 -0.607 . . . . 0.0 110.005 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -87.35 -151.08 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.258 -0.901 . . . . 0.0 110.209 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 52' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -66.15 -6.93 15.06 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.019 -1.051 . . . . 0.0 111.458 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 171.8 -26.8 0.1 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -78.29 -179.41 6.23 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.994 -1.297 . . . . 0.0 108.997 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.486 ' O ' ' C ' ' B' ' 56' ' ' ASN . . . -141.8 156.7 45.55 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.121 -0.987 . . . . 0.0 110.202 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 56' ' ' ASN . . . . . 0.486 ' C ' ' O ' ' B' ' 55' ' ' ALA . 87.1 m-20 18.51 63.88 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 97.8 m -122.05 128.91 51.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 110.532 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 58' ' ' ILE . . . . . . . . . . . . . 96.1 mt -111.43 126.27 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.698 -0.626 . . . . 0.0 110.356 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 25.4 m -116.55 135.33 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.053 -1.029 . . . . 0.0 110.052 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 35.2 m -103.01 135.88 43.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.21 -0.931 . . . . 0.0 110.255 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 61' ' ' ASN . . . . . 0.429 ' O ' ' N ' ' B' ' 44' ' ' HIS . 1.5 t30 -146.74 158.45 43.91 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.083 -1.011 . . . . 0.0 111.134 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 62' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' B' ' 42' ' ' CYS . 53.3 p -138.85 158.45 44.19 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.454 -0.779 . . . . 0.0 110.266 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 63' ' ' LYS . . . . . 0.477 ' CD ' ' HA2' ' B' ' 66' ' ' GLY . 26.3 ttmt -142.56 152.7 42.85 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.289 -0.882 . . . . 0.0 110.498 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -124.92 94.73 4.27 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.304 -0.872 . . . . 0.0 109.055 178.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 64.3 28.59 73.22 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 66' ' ' GLY . . . . . 0.477 ' HA2' ' CD ' ' B' ' 63' ' ' LYS . . . 73.88 24.73 73.45 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.06 -79.0 0.13 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.341 -1.093 . . . . 0.0 110.435 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 68' ' ' TRP . . . . . 0.408 ' O ' ' HG3' ' B' ' 63' ' ' LYS . 93.4 m95 -142.18 -144.69 0.16 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.255 -0.903 . . . . 0.0 109.624 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 163.63 110.4 0.24 Allowed Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.545 -1.312 . . . . 0.0 110.1 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.83 71.99 9.91 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.317 -1.108 . . . . 0.0 110.319 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -61.4 144.09 54.68 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.463 -0.773 . . . . 0.0 111.817 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -124.84 -154.38 0.61 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.318 -0.864 . . . . 0.0 109.314 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 78.3 ttt-85 -143.79 116.24 8.58 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.709 -1.244 . . . . 0.0 111.99 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -109.42 122.74 48.05 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.371 -0.83 . . . . 0.0 109.557 178.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -114.03 88.52 2.87 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.925 -1.11 . . . . 0.0 110.271 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 7.6 p -141.4 142.38 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.309 -0.87 . . . . 0.0 110.53 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -151.47 77.81 7.18 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.139 -0.976 . . . . 0.0 109.899 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 78' ' ' PRO . . . . . 0.486 ' CB ' ' HB2' ' B' ' 102' ' ' ASP . 54.6 Cg_endo -83.36 -0.65 9.95 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.185 1.624 . . . . 0.0 112.078 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 79' ' ' PHE . . . . . 0.511 ' CE1' ' HG2' ' B' ' 101' ' ' PRO . 44.3 m-85 -139.32 -171.74 3.19 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.955 -1.091 . . . . 0.0 110.439 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.457 ' HB2' ' HD2' ' B' ' 81' ' ' PRO . 2.6 pm0 -143.67 166.9 17.27 Favored Pre-proline 0 C--N 1.302 -1.457 0 O-C-N 121.284 -0.885 . . . . 0.0 110.323 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 81' ' ' PRO . . . . . 0.457 ' HD2' ' HB2' ' B' ' 80' ' ' GLN . 43.2 Cg_endo -65.71 151.2 85.17 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.904 1.476 . . . . 0.0 109.63 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.4 23.61 70.26 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.024 -1.631 . . . . 0.0 109.024 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 38.6 t -140.49 143.43 35.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.333 -1.098 . . . . 0.0 109.572 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' B' ' 22' ' ' GLU . 20.0 m -78.33 153.51 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.126 -0.983 . . . . 0.0 110.834 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -160.72 147.74 15.51 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.383 -0.823 . . . . 0.0 109.917 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 86' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' B' ' 19' ' ' VAL . 78.6 tt0 -122.09 146.66 46.99 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.307 -0.871 . . . . 0.0 108.928 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 70.4 t -126.81 135.21 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.05 -1.031 . . . . 0.0 110.902 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 88' ' ' CYS . . . . . . . . . . . . . 2.4 t -109.14 129.15 55.48 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.362 -0.836 . . . . 0.0 109.498 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 87.0 mt -129.12 127.22 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.148 -0.97 . . . . 0.0 110.617 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 5.7 m -115.48 132.13 56.72 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.15 -0.969 . . . . 0.0 109.816 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 91' ' ' PHE . . . . . 0.428 ' CZ ' ' HB3' ' B' ' 114' ' ' LEU . 47.7 t80 -113.23 123.62 50.61 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.111 -0.993 . . . . 0.0 110.339 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -109.88 147.8 32.71 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.162 -0.961 . . . . 0.0 109.77 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -58.26 -21.54 48.96 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.322 -0.861 . . . . 0.0 111.201 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -116.7 -13.3 10.8 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.704 -1.247 . . . . 0.0 110.829 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -147.39 -167.68 2.85 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.096 -1.003 . . . . 0.0 110.899 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 96' ' ' LEU . . . . . 0.956 HD11 HD11 ' B' ' 43' ' ' LEU . 7.2 tt -151.72 115.75 4.96 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 54.1 m -106.77 130.37 54.49 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.738 -1.227 . . . . 0.0 110.375 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 98' ' ' VAL . . . . . 0.587 HG23 ' CD2' ' B' ' 96' ' ' LEU . 51.8 t -121.58 132.46 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.51 -0.743 . . . . 0.0 110.13 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -122.57 127.53 49.58 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.977 -1.077 . . . . 0.0 110.616 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 3.4 mt -96.41 161.14 27.9 Favored Pre-proline 0 C--N 1.303 -1.454 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 101' ' ' PRO . . . . . 0.511 ' HG2' ' CE1' ' B' ' 79' ' ' PHE . 39.7 Cg_endo -65.54 -22.73 58.24 Favored 'Trans proline' 0 C--N 1.301 -1.952 0 O-C-N 123.448 1.236 . . . . 0.0 109.841 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 102' ' ' ASP . . . . . 0.489 ' OD2' ' CD1' ' B' ' 104' ' ' TYR . 28.9 t70 -63.6 -40.22 96.37 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.337 -0.852 . . . . 0.0 110.02 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 126.44 -6.42 7.57 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 104' ' ' TYR . . . . . 0.489 ' CD1' ' OD2' ' B' ' 102' ' ' ASP . 47.3 m-85 -87.22 142.29 28.01 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.984 -1.304 . . . . 0.0 110.193 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -128.19 140.22 52.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.401 -0.812 . . . . 0.0 111.393 -179.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -131.88 150.61 52.1 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 107' ' ' LYS . . . . . 0.459 ' HA ' ' O ' ' B' ' 96' ' ' LEU . 11.7 ptpt -132.98 135.89 45.75 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 118.757 -1.177 . . . . 0.0 111.394 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 108' ' ' PHE . . . . . . . . . . . . . 20.2 m-30 -108.33 147.54 35.82 Favored Pre-proline 0 C--N 1.304 -1.398 0 O-C-N 121.453 -0.78 . . . . 0.0 109.649 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 109' ' ' PRO . . . . . 0.414 ' O ' ' N ' ' B' ' 111' ' ' ARG . 40.9 Cg_endo -65.63 150.8 86.09 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 O-C-N 123.982 1.517 . . . . 0.0 111.042 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 110' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -65.95 62.46 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.881 -0.512 . . . . 0.0 111.583 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 111' ' ' ARG . . . . . 0.414 ' N ' ' O ' ' B' ' 109' ' ' PRO . 20.8 ptt180 -68.94 -24.48 64.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.032 -1.043 . . . . 0.0 109.558 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 112' ' ' LEU . . . . . 0.718 HD13 ' N ' ' B' ' 113' ' ' ASN . 1.2 tm? -111.43 128.7 56.07 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.396 -0.815 . . . . 0.0 109.099 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 113' ' ' ASN . . . . . 0.718 ' N ' HD13 ' B' ' 112' ' ' LEU . 37.8 m-20 -90.27 69.5 7.09 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.835 -1.165 . . . . 0.0 110.77 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 114' ' ' LEU . . . . . 0.692 HD12 ' HE3' ' B' ' 36' ' ' LYS . 53.4 tp -85.12 131.29 34.47 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.53 -0.731 . . . . 0.0 109.381 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -92.0 -19.58 22.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.717 -1.24 . . . . 0.0 109.775 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 116' ' ' ALA . . . . . 0.613 ' O ' HD11 ' B' ' 114' ' ' LEU . . . -171.83 156.74 4.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.227 -0.921 . . . . 0.0 109.475 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 66.3 mt -101.98 116.36 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.88 -1.137 . . . . 0.0 110.733 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 -111.64 -24.05 10.31 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.155 -0.966 . . . . 0.0 109.817 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 119' ' ' TYR . . . . . 0.474 ' HB3' ' O ' ' B' ' 35' ' ' GLY . 90.1 t80 -106.8 126.75 52.7 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.335 -0.853 . . . . 0.0 111.254 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 120' ' ' MET . . . . . 0.507 ' CB ' ' CD1' ' B' ' 9' ' ' LEU . 66.0 ttp -136.75 125.55 24.03 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -141.59 136.72 31.32 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.034 -1.041 . . . . 0.0 110.388 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -147.27 123.59 10.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.364 -0.835 . . . . 0.0 110.281 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 123' ' ' ASP . . . . . 0.468 ' CB ' ' HA2' ' B' ' 3' ' ' GLY . 20.5 p-10 -151.12 122.13 7.66 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.003 -1.061 . . . . 0.0 110.994 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 124' ' ' GLY . . . . . 0.431 ' HA3' ' HA ' ' B' ' 30' ' ' PHE . . . 178.03 -148.12 8.41 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 125' ' ' ASP . . . . . 0.463 ' HB3' ' HA ' ' B' ' 27' ' ' ALA . 80.8 m-20 -81.73 8.71 9.33 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.537 -0.978 . . . . 0.0 110.889 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 126' ' ' PHE . . . . . 0.468 ' HD1' HG22 ' B' ' 23' ' ' VAL . 43.7 t80 -106.2 142.67 35.49 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.03 -1.044 . . . . 0.0 110.233 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -111.02 125.13 53.41 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.024 -1.071 . . . . 0.0 110.885 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 128' ' ' ILE . . . . . 0.454 HD11 ' CG2' ' B' ' 131' ' ' VAL . 8.9 tt -100.2 121.26 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.256 -0.902 . . . . 0.0 109.679 178.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -100.87 -19.53 15.89 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.337 -0.852 . . . . 0.0 112.2 -178.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 130' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -156.8 148.43 22.53 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 118.324 -1.35 . . . . 0.0 112.507 -178.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.454 ' CG2' HD11 ' B' ' 128' ' ' ILE . 45.6 t -127.45 127.05 68.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 177.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 132' ' ' ALA . . . . . . . . . . . . . . . -128.67 129.77 46.29 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.856 -1.152 . . . . 0.0 110.266 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 133' ' ' PHE . . . . . 0.801 ' CD2' HD21 ' B' ' 11' ' ' LEU . 3.2 m-30 -64.28 -102.76 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.172 -0.955 . . . . 0.0 110.062 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.9 t70 . . . . . 0 N--CA 1.493 1.715 0 O-C-N 120.521 -1.362 . . . . 0.0 110.252 179.697 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 121.164 0.507 . . . . 0.0 110.513 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -136.95 83.57 2.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.289 -0.882 . . . . 0.0 110.615 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 122' ' ' ALA . . . 177.21 169.21 38.1 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.771 HD22 HD23 ' B' ' 9' ' ' LEU . 77.7 mt -79.42 144.49 34.05 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.354 -1.086 . . . . 0.0 112.215 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.3 m -110.52 150.35 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.56 -0.713 . . . . 0.0 109.498 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.38 156.32 47.08 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.72 -1.238 . . . . 0.0 112.387 -178.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.458 ' O ' ' HB3' ' A' ' 8' ' ' ASN . 17.3 m -155.39 173.25 16.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.538 -0.726 . . . . 0.0 109.853 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.458 ' HB3' ' O ' ' A' ' 7' ' ' SER . 37.3 t-20 62.25 26.76 16.05 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.137 -0.977 . . . . 0.0 109.768 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.783 HD23 HD22 ' B' ' 4' ' ' LEU . 63.2 mt -82.25 -12.64 57.94 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.832 -0.542 . . . . 0.0 111.669 -178.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.51 ' C ' ' O ' ' A' ' 9' ' ' LEU . 18.1 m120 16.81 68.39 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.821 0 CA-C-O 121.35 0.595 . . . . 0.0 112.323 -179.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.515 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 34.0 tp -96.07 132.88 40.99 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.53 -0.731 . . . . 0.0 110.404 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.29 169.69 6.61 Favored Pre-proline 0 C--N 1.296 -1.758 0 O-C-N 121.584 -0.697 . . . . 0.0 109.815 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.441 ' HA ' ' O ' ' A' ' 91' ' ' PHE . 54.9 Cg_endo -72.6 155.61 54.43 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.08 1.568 . . . . 0.0 108.882 178.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.64 -10.11 59.02 Favored Glycine 0 N--CA 1.488 2.154 0 C-N-CA 119.359 -1.4 . . . . 0.0 109.965 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -115.12 146.65 41.13 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.084 -1.245 . . . . 0.0 108.921 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.437 ' O ' ' N ' ' A' ' 134' ' ' ASP . 1.6 t -96.55 140.46 31.14 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.969 -1.082 . . . . 0.0 110.723 -179.007 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.518 HD13 ' CE1' ' A' ' 133' ' ' PHE . 56.1 tp -111.0 126.92 55.3 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.277 -0.889 . . . . 0.0 110.544 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -120.17 126.72 51.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.241 -0.912 . . . . 0.0 109.871 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.3 t -127.95 129.73 69.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.217 -0.927 . . . . 0.0 110.711 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.444 ' HA ' ' HG2' ' A' ' 86' ' ' GLU . 72.1 ttt180 -109.31 130.15 55.5 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.215 -0.928 . . . . 0.0 109.933 178.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.436 ' CA ' ' O ' ' A' ' 127' ' ' LYS . . . -134.35 173.8 21.24 Favored Glycine 0 C--N 1.294 -1.773 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -125.48 121.26 33.25 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.458 HG22 ' HD1' ' A' ' 126' ' ' PHE . 70.9 t -85.36 131.89 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.147 -0.971 . . . . 0.0 109.909 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.04 154.04 90.75 Favored Pre-proline 0 N--CA 1.496 1.863 0 O-C-N 121.309 -0.869 . . . . 0.0 109.996 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.427 ' O ' ' HB2' ' A' ' 81' ' ' PRO . 44.4 Cg_endo -67.48 -22.27 45.3 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.613 1.323 . . . . 0.0 110.736 -179.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -101.31 14.05 33.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.007 -1.058 . . . . 0.0 110.186 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.454 ' HA ' ' HB3' ' A' ' 125' ' ' ASP . . . -63.77 142.3 58.45 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.301 -0.874 . . . . 0.0 111.695 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -129.14 -34.84 1.85 Allowed 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 42.2 t -165.68 139.92 4.65 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 121.377 -0.827 . . . . 0.0 110.538 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.474 ' CZ ' ' HG3' ' A' ' 47' ' ' PRO . 42.2 p90 -143.57 161.09 39.38 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.171 -0.956 . . . . 0.0 109.067 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.411 HG12 ' HB2' ' A' ' 46' ' ' ASN . 10.4 m -126.72 140.52 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 120.662 -1.274 . . . . 0.0 111.935 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 52.7 mt -118.75 133.19 56.02 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.573 -0.704 . . . . 0.0 109.713 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.415 ' CG ' HD13 ' A' ' 41' ' ' LEU . 93.8 m-20 -124.92 135.09 52.52 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.84 -1.162 . . . . 0.0 111.597 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.474 HD11 ' HB3' ' A' ' 43' ' ' LEU . 0.6 OUTLIER -144.69 110.77 5.47 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.693 0.759 . . . . 0.0 109.206 178.526 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -165.02 -142.84 3.53 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.531 ' O ' ' HB2' ' A' ' 119' ' ' TYR . 47.9 pttt -109.15 -32.81 7.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.152 -1.205 . . . . 0.0 109.412 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.426 ' N ' ' CG ' ' A' ' 36' ' ' LYS . 36.5 m-20 -138.52 171.73 13.93 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.946 0.879 . . . . 0.0 110.501 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 42.4 t -60.07 -41.94 93.49 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.786 -0.571 . . . . 0.0 110.931 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.485 ' HB3' ' N ' ' A' ' 66' ' ' GLY . 82.1 m-20 -91.5 -6.41 52.62 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.033 -1.042 . . . . 0.0 111.372 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -115.29 60.46 0.7 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.88 -1.138 . . . . 0.0 111.05 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.415 HD13 ' CG ' ' A' ' 33' ' ' ASN . 61.3 mt -84.88 147.35 26.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.35 -0.844 . . . . 0.0 109.903 179.034 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 81.6 m -88.55 -41.7 12.54 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.865 -1.147 . . . . 0.0 109.347 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.474 ' HB3' HD11 ' A' ' 34' ' ' LEU . 15.1 tp -132.17 128.98 39.17 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.644 -0.66 . . . . 0.0 110.862 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.402 ' ND1' ' OD1' ' A' ' 33' ' ' ASN . 20.3 t60 -121.37 112.85 19.09 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -104.72 122.18 45.15 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.023 -1.048 . . . . 0.0 110.691 -178.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.411 ' HB2' HG12 ' A' ' 31' ' ' VAL . 3.7 t-20 -139.37 85.75 15.02 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.297 -0.877 . . . . 0.0 111.218 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.474 ' HG3' ' CZ ' ' A' ' 30' ' ' PHE . 55.9 Cg_endo -71.16 145.13 48.39 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.961 1.506 . . . . 0.0 110.193 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -128.21 92.34 3.43 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.763 -1.21 . . . . 0.0 110.425 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -63.37 -40.59 97.66 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.425 -0.797 . . . . 0.0 109.571 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -137.82 92.02 2.64 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.198 -0.939 . . . . 0.0 109.024 178.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.66 -146.9 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.405 -0.809 . . . . 0.0 109.703 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -108.28 31.65 5.41 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.291 -0.88 . . . . 0.0 109.94 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 166.63 -32.17 0.21 Allowed Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.251 -1.452 . . . . 0.0 109.87 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -89.74 -168.86 2.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.134 -1.215 . . . . 0.0 110.285 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.466 ' O ' ' C ' ' A' ' 56' ' ' ASN . . . -150.82 144.94 25.39 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.407 -0.808 . . . . 0.0 109.496 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.466 ' C ' ' O ' ' A' ' 55' ' ' ALA . 95.1 m-20 25.19 64.09 0.06 Allowed 'General case' 0 N--CA 1.506 2.368 0 CA-C-O 121.137 0.494 . . . . 0.0 111.783 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.8 m -127.24 126.79 43.34 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.434 -0.791 . . . . 0.0 110.283 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 83.1 mt -119.96 131.52 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 CA-C-O 121.173 0.511 . . . . 0.0 110.852 -178.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.3 m -124.18 153.03 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 120.996 -1.065 . . . . 0.0 110.135 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 57.1 m -111.03 145.84 37.78 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.058 -1.026 . . . . 0.0 110.453 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -155.91 170.64 21.65 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.271 -0.893 . . . . 0.0 111.393 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.416 ' O ' ' HA ' ' A' ' 68' ' ' TRP . 19.4 m -149.49 157.34 43.2 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.405 -0.809 . . . . 0.0 109.084 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 68' ' ' TRP . 7.7 ttmt -134.67 140.71 46.22 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.766 -1.209 . . . . 0.0 110.479 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -122.07 105.79 10.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.288 -0.883 . . . . 0.0 109.728 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.64 28.9 74.07 Favored Glycine 0 N--CA 1.484 1.834 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.485 ' N ' ' HB3' ' A' ' 39' ' ' ASN . . . 91.45 -2.38 77.71 Favored Glycine 0 N--CA 1.482 1.723 0 C-N-CA 119.323 -1.417 . . . . 0.0 109.583 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.449 ' O ' ' C ' ' A' ' 68' ' ' TRP . . . -106.77 90.33 3.29 Favored 'General case' 0 N--CA 1.483 1.196 0 O-C-N 121.045 -1.268 . . . . 0.0 109.9 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.513 ' HA ' ' HA ' ' A' ' 63' ' ' LYS . 2.0 m-90 -19.66 -104.48 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.444 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 130.63 -99.87 0.45 Allowed Glycine 0 N--CA 1.489 2.199 0 O-C-N 119.863 -1.773 . . . . 0.0 110.941 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.3 t -93.77 143.41 26.36 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.258 -1.142 . . . . 0.0 111.528 -178.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -153.28 108.93 3.27 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.036 -1.04 . . . . 0.0 110.749 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -125.18 -151.19 0.47 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.275 -1.516 . . . . 0.0 111.01 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -140.59 132.92 28.31 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.959 -1.088 . . . . 0.0 111.095 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.431 ' OE2' ' CD1' ' A' ' 106' ' ' PHE . 82.0 tt0 -143.09 81.72 1.73 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.244 -0.91 . . . . 0.0 110.165 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.97 99.8 2.8 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.094 -1.004 . . . . 0.0 110.37 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.2 p -140.24 138.2 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.019 -1.051 . . . . 0.0 109.143 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.588 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 4.1 p90 -153.15 87.04 3.99 Favored Pre-proline 0 C--N 1.303 -1.421 0 O-C-N 120.938 -1.101 . . . . 0.0 110.8 -178.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.47 ' O ' ' CD1' ' A' ' 79' ' ' PHE . 50.0 Cg_endo -86.13 11.01 3.44 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 124.229 1.647 . . . . 0.0 110.577 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.47 ' CD1' ' O ' ' A' ' 78' ' ' PRO . 42.5 m-85 -148.14 -175.31 4.84 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.146 -0.971 . . . . 0.0 110.622 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.475 ' CG ' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -140.45 174.03 4.38 Favored Pre-proline 0 N--CA 1.493 1.69 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.475 ' HD2' ' CG ' ' A' ' 80' ' ' GLN . 41.6 Cg_endo -64.3 145.94 89.31 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.084 1.044 . . . . 0.0 109.782 179.022 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 75.54 35.86 45.53 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.7 m -130.62 155.23 46.91 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.226 -1.161 . . . . 0.0 111.225 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 53.0 t -104.13 126.24 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.181 -0.949 . . . . 0.0 109.542 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.463 ' HB1' ' HG3' ' A' ' 101' ' ' PRO . . . -145.11 154.79 42.84 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.139 -0.976 . . . . 0.0 110.074 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.444 ' HG2' ' HA ' ' A' ' 20' ' ' ARG . 97.4 mt-10 -121.01 149.23 43.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.133 -0.979 . . . . 0.0 110.836 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.4 t -126.02 127.81 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.206 -0.934 . . . . 0.0 110.895 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' CYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 1.7 m -99.38 131.65 45.25 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 95.8 mt -122.32 130.62 74.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.239 -0.913 . . . . 0.0 111.196 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 23.5 m -124.58 128.52 49.03 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.441 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 55.8 t80 -115.66 122.89 46.94 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.345 -0.847 . . . . 0.0 111.447 -178.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 95' ' ' ASN . 79.3 m-20 -115.52 147.64 40.44 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.215 -0.928 . . . . 0.0 110.073 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 64.2 tp60 -59.57 -24.8 64.05 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.193 -0.942 . . . . 0.0 110.78 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.482 ' O ' ' ND2' ' A' ' 95' ' ' ASN . . . -101.52 -13.15 18.01 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.824 -1.172 . . . . 0.0 111.52 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.482 ' ND2' ' O ' ' A' ' 94' ' ' ALA . 0.9 OUTLIER -162.37 163.14 27.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.926 -1.109 . . . . 0.0 111.344 -178.037 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.417 ' HB3' ' HB2' ' A' ' 108' ' ' PHE . 46.3 tp -115.23 130.14 56.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.184 -0.947 . . . . 0.0 108.753 177.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.493 HG23 ' OE2' ' A' ' 105' ' ' GLU . 79.9 m -122.0 130.85 53.65 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.827 -1.17 . . . . 0.0 111.717 -178.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 55.4 t -129.75 128.27 65.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.104 -0.998 . . . . 0.0 110.382 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -114.27 145.87 41.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.031 -1.043 . . . . 0.0 110.172 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.463 ' CG ' ' HD2' ' A' ' 101' ' ' PRO . 0.1 OUTLIER -104.47 169.02 7.69 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.198 -0.938 . . . . 0.0 109.021 178.959 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.463 ' HG3' ' HB1' ' A' ' 85' ' ' ALA . 42.1 Cg_endo -68.63 -25.5 34.31 Favored 'Trans proline' 0 C--N 1.301 -1.948 0 O-C-N 123.619 1.326 . . . . 0.0 109.382 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -68.62 -28.13 66.63 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.191 -0.943 . . . . 0.0 110.953 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 117.24 -10.59 14.86 Favored Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.687 -1.244 . . . . 0.0 110.049 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -82.15 144.64 30.6 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.856 -1.379 . . . . 0.0 110.601 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.493 ' OE2' HG23 ' A' ' 97' ' ' THR . 73.1 tt0 -135.74 148.16 48.72 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.115 -0.991 . . . . 0.0 111.566 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.431 ' CD1' ' OE2' ' A' ' 74' ' ' GLU . 97.1 m-85 -131.76 151.58 51.55 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.327 -0.858 . . . . 0.0 108.765 178.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -126.02 141.78 51.81 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.749 -1.22 . . . . 0.0 112.283 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.417 ' HB2' ' HB3' ' A' ' 96' ' ' LEU . 1.9 m-85 -112.55 144.58 31.2 Favored Pre-proline 0 N--CA 1.492 1.631 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 159.99 51.4 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 123.428 1.225 . . . . 0.0 111.745 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 59.3 t30 -71.96 53.8 0.26 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.565 -0.71 . . . . 0.0 112.254 -178.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 75.5 mtt85 -65.05 -38.25 90.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.768 -1.207 . . . . 0.0 109.102 177.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 97.2 mt -92.05 133.62 35.57 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.638 -0.664 . . . . 0.0 110.87 -178.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 35.2 m-20 -96.08 18.75 12.86 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.587 -0.696 . . . . 0.0 111.038 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 47.9 tp -63.99 131.65 48.25 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.032 -1.043 . . . . 0.0 110.353 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -89.76 -12.96 37.79 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.964 -1.085 . . . . 0.0 111.67 -178.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' A' ' 11' ' ' LEU . . . -160.51 155.51 24.43 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 118.234 -1.386 . . . . 0.0 111.925 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.485 ' HB ' ' HB3' ' A' ' 11' ' ' LEU . 41.1 mm -99.62 119.47 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.227 -0.921 . . . . 0.0 109.486 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.449 ' OD1' ' ND2' ' A' ' 10' ' ' ASN . 25.8 m-80 -111.02 -29.89 7.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.439 -0.788 . . . . 0.0 111.422 -178.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.531 ' HB2' ' O ' ' A' ' 36' ' ' LYS . 57.2 t80 -108.17 129.75 55.16 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.255 -0.903 . . . . 0.0 110.226 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.465 ' HB3' ' CD1' ' A' ' 9' ' ' LEU . 58.1 ttp -140.69 130.99 25.05 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.61 144.91 25.55 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 119.048 -1.061 . . . . 0.0 110.866 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.468 ' O ' ' HA3' ' A' ' 3' ' ' GLY . . . -142.09 124.79 15.92 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -150.62 134.16 16.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.617 -0.677 . . . . 0.0 109.243 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 158.42 -155.32 26.36 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -178.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.454 ' HB3' ' HA ' ' A' ' 27' ' ' ALA . 97.3 m-20 -73.74 -7.21 51.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.767 -0.843 . . . . 0.0 110.061 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.458 ' HD1' HG22 ' A' ' 23' ' ' VAL . 33.5 t80 -98.91 138.43 36.04 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.216 -0.928 . . . . 0.0 110.172 -178.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.436 ' O ' ' CA ' ' A' ' 21' ' ' GLY . 75.5 mmtt -106.78 144.02 34.03 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.046 -1.034 . . . . 0.0 111.967 -178.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.565 ' O ' HD12 ' A' ' 4' ' ' LEU . 5.0 tt -126.27 106.97 16.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -103.45 -4.73 23.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.08 -1.013 . . . . 0.0 111.879 -178.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -154.68 135.34 13.54 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 118.486 -1.286 . . . . 0.0 111.613 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.434 ' CG2' HD11 ' A' ' 128' ' ' ILE . 51.4 t -128.35 131.11 69.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -132.08 139.92 48.67 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.79 -1.194 . . . . 0.0 110.504 -178.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.518 ' CE1' HD13 ' A' ' 17' ' ' LEU . 32.4 m-85 -98.97 120.89 40.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.091 -1.006 . . . . 0.0 110.83 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 16' ' ' CYS . 64.4 t0 . . . . . 0 C--N 1.303 -1.418 0 CA-C-O 118.022 -0.989 . . . . 0.0 110.465 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.316 0.579 . . . . 0.0 110.139 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' CYS . . . . . 0.407 ' N ' ' HB3' ' B' ' 123' ' ' ASP . 0.7 OUTLIER -136.14 84.36 2.07 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.363 -0.836 . . . . 0.0 110.43 179.741 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 3' ' ' GLY . . . . . 0.457 ' HA3' ' O ' ' B' ' 122' ' ' ALA . . . 176.16 170.05 38.4 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.783 HD22 HD23 ' A' ' 9' ' ' LEU . 78.8 mt -80.32 145.08 32.28 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.29 -1.123 . . . . 0.0 111.948 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 29.6 m -110.67 149.79 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.686 -0.634 . . . . 0.0 109.453 178.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.1 155.98 47.5 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.857 -1.152 . . . . 0.0 112.421 -178.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 7' ' ' SER . . . . . 0.46 ' O ' ' HB3' ' B' ' 8' ' ' ASN . 15.2 m -155.02 173.02 17.16 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.34 -0.85 . . . . 0.0 109.774 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 8' ' ' ASN . . . . . 0.46 ' HB3' ' O ' ' B' ' 7' ' ' SER . 34.8 t-20 62.12 27.84 16.77 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.098 -1.001 . . . . 0.0 109.697 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.771 HD23 HD22 ' A' ' 4' ' ' LEU . 58.1 mt -85.58 -4.32 59.13 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.695 -0.628 . . . . 0.0 111.918 -178.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 10' ' ' ASN . . . . . 0.539 ' C ' ' O ' ' B' ' 9' ' ' LEU . 19.4 m120 5.5 73.93 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.85 0 CA-C-O 122.0 0.905 . . . . 0.0 112.149 -177.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.52 ' O ' ' HA ' ' B' ' 116' ' ' ALA . 34.5 tp -97.88 132.65 43.28 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.756 -0.59 . . . . 0.0 109.986 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.63 169.64 6.61 Favored Pre-proline 0 C--N 1.29 -1.99 0 O-C-N 121.648 -0.658 . . . . 0.0 109.765 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 13' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' B' ' 91' ' ' PHE . 56.4 Cg_endo -72.55 155.7 54.58 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.016 1.535 . . . . 0.0 108.985 178.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.61 -10.37 59.19 Favored Glycine 0 N--CA 1.488 2.146 0 C-N-CA 119.53 -1.319 . . . . 0.0 109.821 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -115.16 147.12 40.66 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.92 -1.341 . . . . 0.0 109.235 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 16' ' ' CYS . . . . . 0.417 ' O ' ' N ' ' B' ' 134' ' ' ASP . 1.6 t -96.51 140.82 30.59 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.937 -1.102 . . . . 0.0 111.041 -178.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.501 HD13 ' CE1' ' B' ' 133' ' ' PHE . 56.1 tp -111.07 126.87 55.28 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.141 -0.974 . . . . 0.0 110.515 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -120.13 126.25 50.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.099 -1.001 . . . . 0.0 109.974 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 32.8 t -127.82 129.23 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.237 -0.914 . . . . 0.0 110.893 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 20' ' ' ARG . . . . . 0.446 ' HA ' ' HG2' ' B' ' 86' ' ' GLU . 72.7 ttt180 -108.81 129.85 55.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.284 -0.885 . . . . 0.0 110.094 178.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.441 ' CA ' ' O ' ' B' ' 127' ' ' LYS . . . -134.35 173.14 21.53 Favored Glycine 0 C--N 1.297 -1.607 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 22' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' B' ' 127' ' ' LYS . 83.6 tt0 -124.86 120.89 32.96 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.525 -0.985 . . . . 0.0 108.844 179.026 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.456 HG22 ' HD1' ' B' ' 126' ' ' PHE . 69.6 t -84.35 132.63 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.026 -1.046 . . . . 0.0 109.887 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.65 154.59 89.46 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.29 -0.881 . . . . 0.0 110.039 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.42 ' O ' ' HB2' ' B' ' 81' ' ' PRO . 43.7 Cg_endo -67.89 -22.15 42.89 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.422 1.222 . . . . 0.0 110.89 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -101.67 13.73 34.04 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.187 -0.946 . . . . 0.0 109.69 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 27' ' ' ALA . . . . . 0.462 ' HA ' ' HB3' ' B' ' 125' ' ' ASP . . . -63.54 142.02 58.55 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.154 -0.966 . . . . 0.0 111.617 -178.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -127.74 -37.8 1.93 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 42.7 t -162.13 140.84 9.24 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.345 -0.847 . . . . 0.0 110.645 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 30' ' ' PHE . . . . . 0.457 ' CZ ' ' HG3' ' B' ' 47' ' ' PRO . 42.0 p90 -143.9 161.16 39.41 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.225 -0.922 . . . . 0.0 108.952 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 11.1 m -126.67 140.5 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 120.549 -1.344 . . . . 0.0 111.888 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 56.6 mt -118.06 133.98 55.41 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.502 -0.749 . . . . 0.0 109.599 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 33' ' ' ASN . . . . . 0.425 ' CG ' HD13 ' B' ' 41' ' ' LEU . 93.8 m-20 -124.89 135.08 52.54 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.794 -1.191 . . . . 0.0 111.946 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.465 HD11 ' HB3' ' B' ' 43' ' ' LEU . 0.6 OUTLIER -144.67 106.9 4.34 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.486 -0.759 . . . . 0.0 109.939 178.346 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 35' ' ' GLY . . . . . 0.4 ' HA3' ' HA ' ' B' ' 41' ' ' LEU . . . -159.42 -142.06 3.3 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 36' ' ' LYS . . . . . 0.505 ' O ' ' HB2' ' B' ' 119' ' ' TYR . 47.6 pttt -108.82 -32.7 7.2 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.443 -1.033 . . . . 0.0 109.063 178.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 37' ' ' ASP . . . . . 0.417 ' N ' ' CG ' ' B' ' 36' ' ' LYS . 34.6 m-20 -139.44 171.55 14.1 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.982 0.896 . . . . 0.0 110.462 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 43.9 t -59.89 -41.94 92.7 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.623 -0.673 . . . . 0.0 111.331 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 39' ' ' ASN . . . . . 0.487 ' HB3' ' N ' ' B' ' 66' ' ' GLY . 83.1 m-20 -91.53 -6.21 52.86 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.02 -1.05 . . . . 0.0 111.112 -178.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -115.89 62.92 0.7 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.196 -0.94 . . . . 0.0 110.529 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.425 HD13 ' CG ' ' B' ' 33' ' ' ASN . 55.9 mt -87.19 148.88 24.97 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.357 -0.839 . . . . 0.0 109.29 178.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 42' ' ' CYS . . . . . . . . . . . . . 82.4 m -91.01 -40.27 11.75 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.111 -0.993 . . . . 0.0 109.284 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.465 ' HB3' HD11 ' B' ' 34' ' ' LEU . 15.2 tp -133.31 128.86 36.66 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.52 -0.737 . . . . 0.0 110.437 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 44' ' ' HIS . . . . . . . . . . . . . 18.6 t60 -121.46 113.12 19.4 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -104.62 122.04 44.79 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.056 -1.028 . . . . 0.0 110.942 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -139.03 85.38 16.01 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.159 -0.963 . . . . 0.0 111.444 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 47' ' ' PRO . . . . . 0.457 ' HG3' ' CZ ' ' B' ' 30' ' ' PHE . 57.0 Cg_endo -71.13 144.74 47.59 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.935 1.492 . . . . 0.0 110.031 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -128.65 92.43 3.41 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.738 -1.226 . . . . 0.0 110.286 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -63.94 -39.67 94.68 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.488 -0.757 . . . . 0.0 109.905 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 59.8 t-20 -138.47 91.42 2.54 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.189 -0.945 . . . . 0.0 108.721 178.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.48 -146.12 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.268 -0.895 . . . . 0.0 109.77 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 52' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -108.58 31.72 5.4 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.33 -0.856 . . . . 0.0 110.056 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 166.61 -32.14 0.21 Allowed Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.276 -1.44 . . . . 0.0 110.033 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -89.54 -169.13 2.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -1.146 . . . . 0.0 109.983 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.493 ' O ' ' C ' ' B' ' 56' ' ' ASN . . . -148.96 150.94 33.73 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 178.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 56' ' ' ASN . . . . . 0.493 ' C ' ' O ' ' B' ' 55' ' ' ALA . 92.4 m-20 16.67 66.91 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.617 0 CA-C-O 121.689 0.757 . . . . 0.0 112.429 -178.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 12.4 m -127.06 126.1 42.46 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.903 0.859 . . . . 0.0 110.578 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 58' ' ' ILE . . . . . . . . . . . . . 86.5 mt -119.79 131.87 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.542 -0.724 . . . . 0.0 110.555 -178.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 13.9 m -124.26 153.25 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.191 -0.943 . . . . 0.0 110.186 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 58.2 m -110.94 146.88 35.82 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.739 -1.226 . . . . 0.0 110.484 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 61' ' ' ASN . . . . . 0.435 ' HA ' ' O ' ' B' ' 70' ' ' THR . 23.6 t-20 -156.27 170.72 21.61 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.036 -1.04 . . . . 0.0 111.214 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 62' ' ' SER . . . . . 0.42 ' O ' ' HA ' ' B' ' 68' ' ' TRP . 19.8 m -149.26 157.06 43.04 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 63' ' ' LYS . . . . . 0.515 ' HA ' ' HA ' ' B' ' 68' ' ' TRP . 7.1 ttmt -134.58 140.4 46.07 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.092 -1.005 . . . . 0.0 110.448 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -122.13 105.04 9.9 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.256 -0.902 . . . . 0.0 109.858 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.99 29.42 74.97 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 66' ' ' GLY . . . . . 0.487 ' N ' ' HB3' ' B' ' 39' ' ' ASN . . . 90.77 -1.37 78.26 Favored Glycine 0 N--CA 1.484 1.839 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 67' ' ' ALA . . . . . 0.436 ' O ' ' C ' ' B' ' 68' ' ' TRP . . . -107.22 89.71 3.08 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.197 -1.178 . . . . 0.0 109.849 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 68' ' ' TRP . . . . . 0.515 ' HA ' ' HA ' ' B' ' 63' ' ' LYS . 1.9 m-90 -19.77 -104.34 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.36 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 130.41 -99.57 0.44 Allowed Glycine 0 N--CA 1.488 2.16 0 C-N-CA 118.641 -1.742 . . . . 0.0 110.795 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 70' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' B' ' 61' ' ' ASN . 13.0 t -94.74 140.83 29.36 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.356 -1.085 . . . . 0.0 112.107 -178.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -150.65 108.7 3.73 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.205 -0.935 . . . . 0.0 111.283 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -124.64 -151.86 0.49 Allowed 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.324 -1.485 . . . . 0.0 110.999 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -140.5 132.87 28.37 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.002 -1.062 . . . . 0.0 111.109 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 74' ' ' GLU . . . . . 0.448 ' OE2' ' CD1' ' B' ' 106' ' ' PHE . 82.1 tt0 -142.85 81.64 1.73 Allowed 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.183 -0.948 . . . . 0.0 110.324 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.9 99.9 2.79 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.011 -1.056 . . . . 0.0 110.484 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 4.1 p -140.07 137.65 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.313 -0.867 . . . . 0.0 109.249 178.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 77' ' ' PHE . . . . . 0.605 ' N ' ' CD1' ' B' ' 77' ' ' PHE . 4.2 p90 -152.73 86.91 4.16 Favored Pre-proline 0 C--N 1.302 -1.492 0 O-C-N 121.023 -1.048 . . . . 0.0 110.88 -178.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 78' ' ' PRO . . . . . 0.472 ' O ' ' CD1' ' B' ' 79' ' ' PHE . 50.5 Cg_endo -86.02 10.98 3.46 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.245 1.655 . . . . 0.0 110.56 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 79' ' ' PHE . . . . . 0.472 ' CD1' ' O ' ' B' ' 78' ' ' PRO . 40.5 m-85 -148.1 -175.58 4.95 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.024 -1.047 . . . . 0.0 110.774 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.477 ' CG ' ' HD2' ' B' ' 81' ' ' PRO . 0.0 OUTLIER -139.81 174.46 4.04 Favored Pre-proline 0 N--CA 1.488 1.446 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.779 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 81' ' ' PRO . . . . . 0.477 ' HD2' ' CG ' ' B' ' 80' ' ' GLN . 41.0 Cg_endo -64.35 145.96 89.12 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 N-CA-C 109.406 -1.036 . . . . 0.0 109.406 178.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 75.45 35.41 47.51 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 33.4 m -130.39 155.06 47.01 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.131 -1.217 . . . . 0.0 111.308 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 58.7 t -103.81 126.37 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.281 -0.887 . . . . 0.0 109.749 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 85' ' ' ALA . . . . . 0.463 ' HB1' ' HG3' ' B' ' 101' ' ' PRO . . . -145.02 154.91 43.02 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.134 -0.979 . . . . 0.0 110.151 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 86' ' ' GLU . . . . . 0.446 ' HG2' ' HA ' ' B' ' 20' ' ' ARG . 97.8 mt-10 -120.79 149.36 42.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.346 -0.846 . . . . 0.0 110.853 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 21.5 t -125.62 128.27 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.132 -0.98 . . . . 0.0 110.734 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 88' ' ' CYS . . . . . 0.436 ' HA ' ' O ' ' B' ' 17' ' ' LEU . 1.6 m -100.11 131.5 46.03 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 96.0 mt -122.43 130.7 74.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.098 -1.001 . . . . 0.0 111.22 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 22.6 m -124.11 128.67 49.62 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 91' ' ' PHE . . . . . 0.432 ' O ' ' HA ' ' B' ' 13' ' ' PRO . 55.6 t80 -115.62 122.76 46.6 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.584 -0.847 . . . . 0.0 111.355 -178.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -115.16 147.08 40.72 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.13 -0.981 . . . . 0.0 110.063 178.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 63.3 tp60 -59.33 -24.3 63.21 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.887 -1.133 . . . . 0.0 110.886 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 94' ' ' ALA . . . . . 0.467 ' O ' ' ND2' ' B' ' 95' ' ' ASN . . . -101.85 -13.7 17.56 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.904 -1.122 . . . . 0.0 111.284 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 95' ' ' ASN . . . . . 0.467 ' ND2' ' O ' ' B' ' 94' ' ' ALA . 0.9 OUTLIER -161.79 163.4 29.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.029 -1.045 . . . . 0.0 111.296 -178.251 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 96' ' ' LEU . . . . . 0.414 HD23 ' HB2' ' B' ' 108' ' ' PHE . 46.2 tp -115.59 129.57 56.56 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.248 -0.908 . . . . 0.0 108.596 177.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 97' ' ' THR . . . . . 0.487 HG23 ' OE2' ' B' ' 105' ' ' GLU . 78.1 m -121.72 131.64 54.19 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.82 -1.175 . . . . 0.0 111.356 -178.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 53.8 t -130.29 127.91 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.398 -0.814 . . . . 0.0 110.108 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -114.65 145.08 42.43 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.948 -1.095 . . . . 0.0 110.203 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 100' ' ' LEU . . . . . 0.469 ' CG ' ' HD2' ' B' ' 101' ' ' PRO . 0.1 OUTLIER -103.96 168.63 8.34 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.353 -0.842 . . . . 0.0 109.023 179.218 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 101' ' ' PRO . . . . . 0.469 ' HD2' ' CG ' ' B' ' 100' ' ' LEU . 41.9 Cg_endo -68.23 -25.28 36.95 Favored 'Trans proline' 0 C--N 1.301 -1.933 0 O-C-N 123.645 1.34 . . . . 0.0 109.376 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -68.27 -28.57 67.31 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.484 -0.76 . . . . 0.0 110.894 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 117.28 -10.65 14.77 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 104' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -81.72 144.55 31.05 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.897 -1.355 . . . . 0.0 110.804 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 105' ' ' GLU . . . . . 0.487 ' OE2' HG23 ' B' ' 97' ' ' THR . 73.5 tt0 -135.88 147.93 48.39 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.178 -0.951 . . . . 0.0 111.955 -179.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 106' ' ' PHE . . . . . 0.448 ' CD1' ' OE2' ' B' ' 74' ' ' GLU . 96.6 m-85 -131.95 151.16 51.9 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -125.74 142.27 51.59 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.718 -1.239 . . . . 0.0 112.07 -178.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 108' ' ' PHE . . . . . 0.414 ' HB2' HD23 ' B' ' 96' ' ' LEU . 1.8 m-85 -113.16 144.65 31.57 Favored Pre-proline 0 N--CA 1.494 1.728 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -69.76 160.28 50.27 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 123.467 1.246 . . . . 0.0 111.652 -178.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 110' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' B' ' 94' ' ' ALA . 58.4 t30 -72.11 53.78 0.28 Allowed 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.81 -0.556 . . . . 0.0 112.158 -178.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 75.1 mtt85 -65.27 -38.61 90.81 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.847 -1.158 . . . . 0.0 109.056 177.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 98.2 mt -91.5 134.08 34.95 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.358 -0.839 . . . . 0.0 111.157 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 -96.13 18.78 12.85 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.414 -0.804 . . . . 0.0 110.997 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 50.6 tp -63.86 131.89 49.15 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.059 -1.026 . . . . 0.0 110.24 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -89.7 -12.83 38.33 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.042 -1.036 . . . . 0.0 111.849 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 116' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' B' ' 11' ' ' LEU . . . -161.2 155.69 23.16 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.372 -1.455 . . . . 0.0 111.787 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 117' ' ' ILE . . . . . 0.502 ' HB ' ' HB3' ' B' ' 11' ' ' LEU . 41.3 mm -100.1 119.8 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.228 -0.92 . . . . 0.0 109.649 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 118' ' ' ASN . . . . . 0.429 ' OD1' ' ND2' ' B' ' 10' ' ' ASN . 23.4 m-80 -111.04 -30.42 7.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.404 -0.81 . . . . 0.0 111.351 -178.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 119' ' ' TYR . . . . . 0.505 ' HB2' ' O ' ' B' ' 36' ' ' LYS . 57.8 t80 -107.03 131.03 54.54 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.013 -1.054 . . . . 0.0 110.219 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 120' ' ' MET . . . . . 0.488 ' HB3' ' CD1' ' B' ' 9' ' ' LEU . 55.5 ttp -141.91 130.89 23.11 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -151.14 144.4 24.75 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.054 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 122' ' ' ALA . . . . . 0.457 ' O ' ' HA3' ' B' ' 3' ' ' GLY . . . -141.68 125.02 16.51 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 123' ' ' ASP . . . . . 0.407 ' HB3' ' N ' ' B' ' 2' ' ' CYS . 65.1 m-20 -150.72 134.33 16.48 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.481 -0.762 . . . . 0.0 109.192 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 158.3 -155.48 26.5 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.044 -1.55 . . . . 0.0 109.554 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 125' ' ' ASP . . . . . 0.462 ' HB3' ' HA ' ' B' ' 27' ' ' ALA . 96.4 m-20 -73.25 -7.4 51.35 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.584 -0.951 . . . . 0.0 110.294 179.186 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 126' ' ' PHE . . . . . 0.456 ' HD1' HG22 ' B' ' 23' ' ' VAL . 33.9 t80 -99.09 138.77 35.72 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.525 -0.734 . . . . 0.0 110.092 -178.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 127' ' ' LYS . . . . . 0.441 ' O ' ' CA ' ' B' ' 21' ' ' GLY . 75.7 mmtt -106.88 144.19 33.87 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 118.945 -1.102 . . . . 0.0 112.074 -178.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 128' ' ' ILE . . . . . 0.557 ' O ' HD12 ' B' ' 4' ' ' LEU . 5.1 tt -125.88 106.67 16.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.128 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -102.84 -5.6 23.42 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.888 -1.132 . . . . 0.0 111.771 -178.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 130' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -153.55 134.99 14.25 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 118.26 -1.376 . . . . 0.0 112.05 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.4 ' CG2' HD11 ' B' ' 128' ' ' ILE . 50.6 t -127.49 131.75 69.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 132' ' ' ALA . . . . . . . . . . . . . . . -131.91 139.91 48.89 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.446 -1.408 . . . . 0.0 110.477 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 133' ' ' PHE . . . . . 0.501 ' CE1' HD13 ' B' ' 17' ' ' LEU . 32.7 m-85 -98.79 121.08 40.28 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.8 -1.188 . . . . 0.0 110.959 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 134' ' ' ASP . . . . . 0.417 ' N ' ' O ' ' B' ' 16' ' ' CYS . 62.1 t0 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.407 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 120.877 0.37 . . . . 0.0 110.745 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.425 ' O ' ' CB ' ' A' ' 123' ' ' ASP . 37.2 m -113.81 37.35 3.3 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.191 -0.943 . . . . 0.0 109.177 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.486 ' HA3' ' O ' ' A' ' 122' ' ' ALA . . . 81.45 169.76 42.76 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 107.98 -2.048 . . . . 0.0 107.98 -178.09 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.578 HD12 ' N ' ' A' ' 4' ' ' LEU . 11.1 mp -93.44 142.21 27.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.071 -1.252 . . . . 0.0 110.43 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.3 t -108.56 131.54 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 121.198 -0.939 . . . . 0.0 110.117 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -130.41 172.61 11.68 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.951 -1.093 . . . . 0.0 111.822 -178.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.416 ' O ' ' CB ' ' A' ' 8' ' ' ASN . 30.5 p -155.07 167.2 31.15 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.45 -0.781 . . . . 0.0 110.001 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' B' ' 3' ' ' GLY . 20.2 t-20 63.43 40.01 8.74 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.384 0.611 . . . . 0.0 110.446 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.476 ' O ' ' C ' ' A' ' 10' ' ' ASN . 56.5 mt -99.66 16.2 24.24 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.314 -0.867 . . . . 0.0 110.316 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.498 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 51.0 t-20 -18.76 88.8 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.381 0 CA-C-O 121.996 0.903 . . . . 0.0 112.674 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.576 HD12 ' CZ ' ' A' ' 133' ' ' PHE . 5.2 tt -100.5 134.68 43.1 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.584 -0.698 . . . . 0.0 109.96 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.465 ' HD2' ' HD2' ' A' ' 13' ' ' PRO . 0.6 OUTLIER -111.55 171.22 4.51 Favored Pre-proline 0 C--N 1.297 -1.695 0 O-C-N 121.069 -1.019 . . . . 0.0 109.784 179.031 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.465 ' HD2' ' HD2' ' A' ' 12' ' ' LYS . 44.2 Cg_endo -66.19 144.63 75.77 Favored 'Trans proline' 0 C--N 1.299 -2.045 0 O-C-N 123.89 1.468 . . . . 0.0 110.278 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 104.44 -24.72 28.04 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -90.08 150.2 22.17 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.241 -1.153 . . . . 0.0 110.471 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.423 ' SG ' ' N ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -106.31 159.34 16.2 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.417 -0.802 . . . . 0.0 109.99 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.635 HD13 ' N ' ' A' ' 18' ' ' ARG . 0.6 OUTLIER -134.77 123.39 23.53 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.682 -1.261 . . . . 0.0 110.364 179.659 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.635 ' N ' HD13 ' A' ' 17' ' ' LEU . 79.5 ttt180 -117.04 132.65 56.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.226 -0.921 . . . . 0.0 109.888 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.492 HG13 ' CD1' ' A' ' 128' ' ' ILE . 54.7 t -122.12 108.99 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.511 -0.743 . . . . 0.0 111.136 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 77.3 ttt-85 -110.0 123.17 49.19 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.764 -1.21 . . . . 0.0 110.575 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -147.11 -161.3 9.3 Favored Glycine 0 N--CA 1.489 2.188 0 C-N-CA 119.365 -1.398 . . . . 0.0 110.172 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -127.31 134.72 49.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.455 -1.026 . . . . 0.0 109.305 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.635 HG22 ' CD1' ' A' ' 126' ' ' PHE . 93.8 t -101.88 129.5 53.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 121.073 -1.017 . . . . 0.0 109.593 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.52 161.89 1.92 Allowed Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.323 -0.861 . . . . 0.0 110.281 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.52 -20.22 54.15 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 O-C-N 123.69 1.363 . . . . 0.0 109.573 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -111.76 44.03 1.44 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.661 -0.65 . . . . 0.0 110.393 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.58 ' HB2' ' CG1' ' A' ' 23' ' ' VAL . . . -71.15 91.09 0.9 Allowed 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 118.918 -1.113 . . . . 0.0 109.563 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -98.71 -20.93 16.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.385 -0.822 . . . . 0.0 109.985 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.1 t -150.11 143.5 25.13 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.882 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.524 ' HA ' ' HA3' ' A' ' 124' ' ' GLY . 40.7 t80 -147.79 134.95 20.44 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.448 -0.782 . . . . 0.0 110.289 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.457 HG22 ' ND2' ' A' ' 46' ' ' ASN . 67.4 t -127.47 131.0 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.824 -1.172 . . . . 0.0 110.307 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.726 HD12 ' N ' ' A' ' 33' ' ' ASN . 5.0 tp -138.58 141.81 39.21 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.519 -0.738 . . . . 0.0 110.383 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.864 ' HB2' HD13 ' A' ' 41' ' ' LEU . 9.6 p30 -154.25 143.09 20.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.053 -1.029 . . . . 0.0 110.7 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.481 ' O ' HD12 ' A' ' 34' ' ' LEU . 1.5 pp -136.13 118.48 15.69 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.496 -0.753 . . . . 0.0 109.628 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.802 ' HA3' HD23 ' A' ' 41' ' ' LEU . . . -142.85 -136.49 3.19 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.822 -1.18 . . . . 0.0 110.602 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.456 ' CG ' ' N ' ' A' ' 37' ' ' ASP . 24.0 pttt -127.64 -37.14 1.99 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.371 -1.076 . . . . 0.0 111.101 -179.034 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.456 ' N ' ' CG ' ' A' ' 36' ' ' LYS . 86.3 m-20 -115.25 -83.59 0.62 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.125 -0.985 . . . . 0.0 110.309 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.2 t -151.58 -53.6 0.13 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 60.6 m-20 -93.85 -4.06 50.74 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.343 -0.848 . . . . 0.0 109.004 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.415 ' O ' ' HA3' ' A' ' 35' ' ' GLY . 12.3 m120 -91.18 68.72 6.05 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.175 -0.953 . . . . 0.0 109.854 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.864 HD13 ' HB2' ' A' ' 33' ' ' ASN . 75.8 mt -106.47 133.02 51.8 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.438 -0.789 . . . . 0.0 110.676 -179.237 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.528 ' O ' HD23 ' A' ' 43' ' ' LEU . 69.8 m -85.1 -36.01 21.43 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.564 -0.71 . . . . 0.0 110.253 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 1.047 HD21 HD13 ' A' ' 96' ' ' LEU . 79.5 mt -129.97 129.16 43.42 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 119.454 -0.898 . . . . 0.0 111.542 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.46 ' HB3' ' OD1' ' A' ' 61' ' ' ASN . 24.6 t60 -126.3 123.98 39.3 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.343 -0.848 . . . . 0.0 109.41 178.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -110.79 131.6 54.91 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.177 -0.952 . . . . 0.0 109.443 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.457 ' ND2' HG22 ' A' ' 31' ' ' VAL . 4.4 t-20 -149.27 78.04 8.77 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 120.926 -1.109 . . . . 0.0 111.285 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.428 ' HG2' ' HB3' ' A' ' 30' ' ' PHE . 47.2 Cg_endo -69.78 144.66 54.61 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.779 1.41 . . . . 0.0 110.014 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -144.46 88.18 1.92 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.865 -1.147 . . . . 0.0 110.869 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.48 ' O ' ' HA ' ' A' ' 55' ' ' ALA . 33.0 t80 -61.78 -46.4 89.74 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.332 0.587 . . . . 0.0 110.393 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -133.72 99.12 4.37 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.294 -0.879 . . . . 0.0 110.008 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -118.78 -69.1 0.87 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.003 -1.061 . . . . 0.0 110.893 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -105.13 -15.67 15.01 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.42 -0.8 . . . . 0.0 110.617 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 159.68 -12.91 0.19 Allowed Glycine 0 N--CA 1.494 2.543 0 C-N-CA 119.866 -1.159 . . . . 0.0 110.514 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -75.78 -179.95 5.08 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.849 -1.383 . . . . 0.0 109.444 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 49' ' ' PHE . . . -129.67 -7.46 4.58 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.146 -0.971 . . . . 0.0 111.723 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 43.2 p30 -163.48 72.82 0.29 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.007 -1.058 . . . . 0.0 110.279 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 73.4 m -124.66 130.46 52.46 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.943 -1.098 . . . . 0.0 111.327 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 98.3 mt -121.76 130.64 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.28 -0.888 . . . . 0.0 111.089 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.0 t -114.31 129.98 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.297 -0.877 . . . . 0.0 110.495 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 33.8 m -129.16 122.1 29.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.319 -0.863 . . . . 0.0 110.067 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.525 ' HB3' ' HG2' ' A' ' 71' ' ' GLU . 4.9 p-10 -138.94 175.0 9.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.422 -0.799 . . . . 0.0 109.985 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.3 m -129.9 155.12 46.56 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.536 ' CD ' ' HA2' ' A' ' 66' ' ' GLY . 6.9 ttmt -135.47 149.29 49.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.495 -1.378 . . . . 0.0 112.128 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.587 ' HB2' HD11 ' A' ' 112' ' ' LEU . 56.6 t0 -129.19 100.43 5.61 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.44 21.28 68.51 Favored Glycine 0 N--CA 1.487 2.075 0 C-N-CA 119.801 -1.19 . . . . 0.0 110.62 179.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.536 ' HA2' ' CD ' ' A' ' 63' ' ' LYS . . . 74.52 24.56 72.48 Favored Glycine 0 N--CA 1.488 2.162 0 C-N-CA 119.145 -1.503 . . . . 0.0 110.275 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -105.4 -74.35 0.65 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.897 -1.355 . . . . 0.0 110.742 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -69.22 -178.47 1.33 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.698 -0.626 . . . . 0.0 109.975 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 166.53 44.79 0.02 OUTLIER Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.0 m -62.39 100.39 0.18 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.066 -1.256 . . . . 0.0 110.504 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.525 ' HG2' ' HB3' ' A' ' 61' ' ' ASN . 89.5 mt-10 -84.97 123.15 30.19 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.336 -0.853 . . . . 0.0 110.903 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -101.39 -168.49 1.56 Allowed 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -146.27 122.27 10.71 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 118.04 -1.464 . . . . 0.0 111.695 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -108.67 132.71 53.64 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.59 60.27 0.6 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.795 -1.19 . . . . 0.0 111.234 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.546 HG22 ' HD3' ' A' ' 78' ' ' PRO . 4.6 p -135.23 151.25 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.942 -1.098 . . . . 0.0 110.4 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.497 ' CG ' ' O ' ' A' ' 77' ' ' PHE . 8.4 p90 -144.46 71.98 15.82 Favored Pre-proline 0 C--N 1.302 -1.475 0 O-C-N 121.098 -1.001 . . . . 0.0 109.874 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.546 ' HD3' HG22 ' A' ' 76' ' ' VAL . 39.9 Cg_endo -65.43 -13.8 41.67 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.892 1.469 . . . . 0.0 110.33 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -117.92 167.24 11.6 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.444 -0.785 . . . . 0.0 110.641 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.88 168.02 15.66 Favored Pre-proline 0 C--N 1.297 -1.674 0 O-C-N 121.546 -0.721 . . . . 0.0 109.598 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -65.65 148.66 87.32 Favored 'Trans proline' 0 C--N 1.298 -2.086 0 O-C-N 123.852 1.448 . . . . 0.0 110.671 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 62.29 42.44 99.72 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.6 t -148.32 137.56 21.96 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.097 -1.237 . . . . 0.0 109.988 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.5 m -78.06 140.22 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.01 -1.056 . . . . 0.0 108.997 178.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.98 153.55 38.09 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.158 -0.963 . . . . 0.0 109.707 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -122.46 152.65 40.06 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.234 -0.916 . . . . 0.0 110.044 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.0 t -128.98 139.34 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.489 -0.757 . . . . 0.0 111.503 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' CYS . . . . . 0.429 ' HB3' ' HB2' ' A' ' 99' ' ' LYS . 4.8 t -114.26 115.73 27.89 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.427 -0.796 . . . . 0.0 109.943 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 86.6 mt -121.22 128.1 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.141 -0.974 . . . . 0.0 110.014 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.479 ' HB ' ' HB ' ' A' ' 97' ' ' THR . 33.5 m -123.06 134.88 54.25 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.033 -1.042 . . . . 0.0 109.426 179.345 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.513 ' CE1' HD21 ' A' ' 96' ' ' LEU . 80.8 t80 -104.67 118.25 36.11 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.177 -0.952 . . . . 0.0 110.25 -179.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.402 ' HB2' ' OD1' ' A' ' 95' ' ' ASN . 86.7 m-20 -112.52 143.21 44.06 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.399 -0.921 . . . . 0.0 109.452 178.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 71.6 tp60 -59.58 -26.51 65.47 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.522 -0.736 . . . . 0.0 110.668 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.89 -22.48 23.12 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.225 -0.922 . . . . 0.0 111.634 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.402 ' OD1' ' HB2' ' A' ' 92' ' ' ASP . 45.4 p30 -174.61 -171.58 0.58 Allowed 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.093 -1.005 . . . . 0.0 108.981 -178.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 1.047 HD13 HD21 ' A' ' 43' ' ' LEU . 75.9 mt -122.49 135.06 54.57 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.002 -1.061 . . . . 0.0 110.58 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.479 ' HB ' ' HB ' ' A' ' 90' ' ' THR . 29.5 m -109.26 122.72 47.95 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.1 -1.0 . . . . 0.0 109.031 178.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 44.8 t -124.7 128.14 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.742 -1.224 . . . . 0.0 109.611 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.429 ' HB2' ' HB3' ' A' ' 88' ' ' CYS . 98.4 mttt -122.61 147.62 46.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.298 -0.877 . . . . 0.0 110.925 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.431 HD13 ' HG3' ' A' ' 78' ' ' PRO . 27.5 mt -107.28 166.63 10.7 Favored Pre-proline 0 N--CA 1.493 1.696 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -63.31 -24.32 71.86 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.368 1.194 . . . . 0.0 110.92 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.468 ' HB2' ' CB ' ' A' ' 78' ' ' PRO . 36.9 t70 -76.52 -10.26 59.26 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.074 -1.016 . . . . 0.0 110.84 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 104.34 -8.0 47.88 Favored Glycine 0 N--CA 1.496 2.656 0 C-N-CA 119.821 -1.18 . . . . 0.0 110.753 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -73.0 135.41 44.95 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.787 -1.419 . . . . 0.0 110.28 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.431 ' OE2' HG23 ' A' ' 97' ' ' THR . 71.8 tt0 -124.88 142.49 51.41 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.881 -1.137 . . . . 0.0 110.75 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -133.67 146.15 50.59 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 98.1 mttt -121.79 146.36 47.14 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.831 -1.168 . . . . 0.0 112.971 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.564 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 98.0 m-85 -117.22 150.23 45.89 Favored Pre-proline 0 N--CA 1.493 1.722 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.08 149.85 65.43 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.689 1.363 . . . . 0.0 111.142 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -71.04 62.74 0.3 Allowed 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.611 -0.681 . . . . 0.0 111.652 -178.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 79.6 mtp85 -65.39 -39.89 92.79 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.995 -1.066 . . . . 0.0 110.381 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.587 HD11 ' HB2' ' A' ' 64' ' ' ASP . 4.4 mm? -95.75 130.4 42.68 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.131 -0.981 . . . . 0.0 110.361 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -87.95 7.26 31.84 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.501 -0.749 . . . . 0.0 111.026 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.498 HD23 ' O ' ' A' ' 114' ' ' LEU . 3.6 tt -57.82 128.68 38.32 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.224 -0.99 . . . . 0.0 109.222 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -106.32 -5.59 18.98 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.498 -0.751 . . . . 0.0 111.295 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' A' ' 11' ' ' LEU . . . -137.84 132.35 32.43 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.715 -1.24 . . . . 0.0 110.472 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.498 ' O ' ' HA ' ' A' ' 10' ' ' ASN . 95.6 mt -111.29 128.89 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 O-C-N 120.894 -1.129 . . . . 0.0 110.45 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -126.66 -27.62 3.08 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.026 -1.046 . . . . 0.0 111.645 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.412 ' O ' ' N ' ' A' ' 35' ' ' GLY . 69.4 t80 -92.67 126.09 37.6 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.007 -1.058 . . . . 0.0 110.466 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.423 ' HB3' ' CD1' ' A' ' 9' ' ' LEU . 27.1 ttm -141.01 134.73 30.28 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.993 -1.067 . . . . 0.0 109.573 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -159.11 147.95 18.34 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.26 -0.976 . . . . 0.0 109.686 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.486 ' O ' ' HA3' ' A' ' 3' ' ' GLY . . . -147.3 156.21 42.71 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 2' ' ' CYS . 10.2 p-10 -155.74 160.74 40.57 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.524 ' HA3' ' HA ' ' A' ' 30' ' ' PHE . . . 143.09 -157.27 26.83 Favored Glycine 0 C--N 1.295 -1.725 0 C-N-CA 118.548 -1.787 . . . . 0.0 110.439 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.483 ' CB ' ' HA ' ' A' ' 27' ' ' ALA . 63.1 m-20 -91.34 11.39 23.84 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.845 -0.797 . . . . 0.0 110.753 -179.298 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.635 ' CD1' HG22 ' A' ' 23' ' ' VAL . 12.3 t80 -107.42 151.25 25.78 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.822 -1.174 . . . . 0.0 110.681 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -120.8 124.8 45.96 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.564 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.492 ' CD1' HG13 ' A' ' 19' ' ' VAL . 17.7 tt -102.49 126.74 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.928 . . . . 0.0 110.329 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 28.0 pttt -118.63 -4.81 10.75 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.795 -1.191 . . . . 0.0 111.053 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.497 ' HA ' ' O ' ' B' ' 131' ' ' VAL . 0.0 OUTLIER -154.35 131.96 11.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.74 -1.225 . . . . 0.0 111.928 -179.32 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' B' ' 130' ' ' CYS . 53.4 t -128.78 134.63 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.569 -0.707 . . . . 0.0 109.658 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.433 ' HA ' ' HB2' ' B' ' 130' ' ' CYS . . . -142.38 142.92 32.49 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.497 -1.377 . . . . 0.0 110.392 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.576 ' CZ ' HD12 ' A' ' 11' ' ' LEU . 3.1 m-85 -76.47 -86.73 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.813 -1.179 . . . . 0.0 111.248 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 46.4 t0 . . . . . 0 C--N 1.296 -1.723 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.384 -179.169 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.85 0 CA-C-O 121.115 0.483 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' CYS . . . . . 0.405 ' O ' ' HA ' ' B' ' 123' ' ' ASP . 34.2 m -114.71 39.29 2.88 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.022 -1.049 . . . . 0.0 109.264 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 3' ' ' GLY . . . . . 0.534 ' O ' ' ND2' ' A' ' 8' ' ' ASN . . . 79.86 168.93 37.97 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 108.031 -2.028 . . . . 0.0 108.031 -178.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.576 ' N ' HD12 ' B' ' 4' ' ' LEU . 11.0 mp -93.07 141.69 28.13 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.965 -1.315 . . . . 0.0 110.751 -179.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 41.9 t -107.82 131.6 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.382 0 O-C-N 121.082 -1.011 . . . . 0.0 110.242 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -130.5 173.11 11.18 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.044 -1.035 . . . . 0.0 112.011 -178.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 7' ' ' SER . . . . . 0.401 ' O ' ' HB3' ' B' ' 8' ' ' ASN . 27.1 p -155.34 168.25 27.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.426 -0.797 . . . . 0.0 109.802 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 8' ' ' ASN . . . . . 0.436 ' ND2' ' O ' ' A' ' 3' ' ' GLY . 20.2 t-20 62.61 41.09 9.77 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.589 -0.695 . . . . 0.0 110.416 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.472 ' O ' ' C ' ' B' ' 10' ' ' ASN . 54.8 mt -101.19 17.03 23.57 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.437 -0.79 . . . . 0.0 110.04 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 10' ' ' ASN . . . . . 0.479 ' HA ' ' O ' ' B' ' 117' ' ' ILE . 51.2 t-20 -20.0 89.04 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.39 0 CA-C-O 121.95 0.881 . . . . 0.0 112.77 -179.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.576 HD12 ' CZ ' ' B' ' 133' ' ' PHE . 5.2 tt -100.44 134.16 43.8 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.703 -0.623 . . . . 0.0 109.885 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 12' ' ' LYS . . . . . 0.47 ' HD2' ' HD2' ' B' ' 13' ' ' PRO . 0.5 OUTLIER -111.34 171.09 4.6 Favored Pre-proline 0 C--N 1.293 -1.883 0 O-C-N 121.244 -0.91 . . . . 0.0 109.94 179.126 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 13' ' ' PRO . . . . . 0.47 ' HD2' ' HD2' ' B' ' 12' ' ' LYS . 44.1 Cg_endo -65.94 144.35 76.25 Favored 'Trans proline' 0 C--N 1.301 -1.942 0 O-C-N 123.919 1.484 . . . . 0.0 110.115 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 104.32 -24.01 30.16 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -90.92 149.83 21.74 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.194 -1.18 . . . . 0.0 110.591 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 16' ' ' CYS . . . . . 0.419 ' SG ' ' N ' ' B' ' 17' ' ' LEU . 0.0 OUTLIER -106.86 159.62 16.12 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.48 -0.763 . . . . 0.0 109.72 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.639 HD13 ' N ' ' B' ' 18' ' ' ARG . 0.6 OUTLIER -135.0 122.64 22.14 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.621 -1.299 . . . . 0.0 110.383 179.845 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.639 ' N ' HD13 ' B' ' 17' ' ' LEU . 80.1 ttt180 -115.77 133.35 56.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.361 -0.837 . . . . 0.0 109.816 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.483 HG13 ' CD1' ' B' ' 128' ' ' ILE . 55.2 t -122.82 109.19 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.29 -0.881 . . . . 0.0 111.13 -178.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 77.2 ttt-85 -109.82 123.28 49.29 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.993 -1.067 . . . . 0.0 110.631 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -147.22 -161.4 9.38 Favored Glycine 0 N--CA 1.487 2.075 0 C-N-CA 119.456 -1.354 . . . . 0.0 110.009 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 71.3 tt0 -127.22 136.38 51.95 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.575 -0.956 . . . . 0.0 109.081 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.649 HG22 ' CD1' ' B' ' 126' ' ' PHE . 90.5 t -103.98 129.15 56.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 O-C-N 121.174 -0.954 . . . . 0.0 109.789 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.04 161.15 1.93 Allowed Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.506 -0.746 . . . . 0.0 110.172 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' B' ' 81' ' ' PRO . 42.7 Cg_endo -66.02 -20.16 57.39 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.802 1.422 . . . . 0.0 109.775 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -112.2 44.31 1.44 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.693 -0.629 . . . . 0.0 110.388 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 27' ' ' ALA . . . . . 0.565 ' HB2' ' CG1' ' B' ' 23' ' ' VAL . . . -71.84 91.25 1.15 Allowed 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 118.95 -1.1 . . . . 0.0 109.415 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -98.71 -20.58 16.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.491 -0.755 . . . . 0.0 109.777 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 24.8 t -149.65 143.31 25.42 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.076 -1.015 . . . . 0.0 111.046 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 30' ' ' PHE . . . . . 0.527 ' HA ' ' HA3' ' B' ' 124' ' ' GLY . 41.0 t80 -147.69 134.75 20.35 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.508 -0.745 . . . . 0.0 110.162 179.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.407 HG22 ' ND2' ' B' ' 46' ' ' ASN . 76.9 t -127.74 131.05 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.852 -1.155 . . . . 0.0 110.437 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.752 HD12 ' N ' ' B' ' 33' ' ' ASN . 5.1 tp -138.53 142.58 39.3 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.384 -0.823 . . . . 0.0 110.361 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 33' ' ' ASN . . . . . 0.885 ' HB2' HD13 ' B' ' 41' ' ' LEU . 11.1 p30 -155.11 142.59 19.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.964 -1.085 . . . . 0.0 110.671 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.486 HD12 ' O ' ' B' ' 34' ' ' LEU . 1.5 pp -135.92 119.2 16.69 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.227 -0.921 . . . . 0.0 109.679 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 35' ' ' GLY . . . . . 0.812 ' HA3' HD23 ' B' ' 41' ' ' LEU . . . -143.53 -137.58 3.28 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 119.922 -1.133 . . . . 0.0 110.392 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 36' ' ' LYS . . . . . 0.44 ' CG ' ' N ' ' B' ' 37' ' ' ASP . 24.6 pttt -126.86 -37.47 2.12 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.246 -1.149 . . . . 0.0 111.174 -178.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 37' ' ' ASP . . . . . 0.451 ' O ' ' CD1' ' B' ' 119' ' ' TYR . 88.3 m-20 -114.25 -84.14 0.61 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.976 -1.078 . . . . 0.0 109.958 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 7.7 t -150.76 -54.22 0.15 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.403 -0.811 . . . . 0.0 109.023 178.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 58.3 m-20 -92.6 -4.5 53.29 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.372 -0.83 . . . . 0.0 108.824 178.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 40' ' ' ASN . . . . . 0.421 ' O ' ' HA3' ' B' ' 35' ' ' GLY . 12.6 m120 -90.96 69.07 6.3 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.271 -0.893 . . . . 0.0 110.017 -178.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.885 HD13 ' HB2' ' B' ' 33' ' ' ASN . 77.5 mt -105.8 135.93 46.33 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.434 -0.791 . . . . 0.0 110.674 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 42' ' ' CYS . . . . . 0.577 ' O ' HD23 ' B' ' 43' ' ' LEU . 74.2 m -88.83 -34.31 17.08 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.336 -0.852 . . . . 0.0 109.561 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 1.027 HD21 HD13 ' B' ' 96' ' ' LEU . 74.6 mt -131.25 129.71 41.92 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.192 -1.003 . . . . 0.0 111.276 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 44' ' ' HIS . . . . . 0.448 ' HB3' ' OD1' ' B' ' 61' ' ' ASN . 23.0 t60 -127.0 123.28 36.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.506 -0.746 . . . . 0.0 109.297 178.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -110.15 131.31 55.17 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.133 -0.979 . . . . 0.0 109.762 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 46' ' ' ASN . . . . . 0.407 ' ND2' HG22 ' B' ' 31' ' ' VAL . 4.3 t-20 -148.51 78.08 9.37 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.074 -1.016 . . . . 0.0 111.506 -179.08 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 47' ' ' PRO . . . . . 0.443 ' HG2' ' HB3' ' B' ' 30' ' ' PHE . 47.8 Cg_endo -69.83 144.96 55.31 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 123.627 1.33 . . . . 0.0 109.839 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -145.26 88.51 1.87 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.898 -1.127 . . . . 0.0 110.566 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 49' ' ' PHE . . . . . 0.497 ' O ' ' HA ' ' B' ' 55' ' ' ALA . 33.8 t80 -61.65 -45.78 92.58 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.277 0.56 . . . . 0.0 110.417 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 27.1 t30 -134.79 98.67 4.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.286 -0.884 . . . . 0.0 110.239 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -118.74 -68.08 0.94 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.056 -1.028 . . . . 0.0 110.977 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 52' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -105.63 -15.2 15.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.295 -0.878 . . . . 0.0 110.886 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 159.52 -14.21 0.21 Allowed Glycine 0 N--CA 1.495 2.585 0 C-N-CA 119.913 -1.137 . . . . 0.0 110.277 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -74.45 179.67 4.5 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.752 -1.44 . . . . 0.0 109.045 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' B' ' 49' ' ' PHE . . . -129.03 -11.11 4.77 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.066 -1.021 . . . . 0.0 111.387 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 56' ' ' ASN . . . . . . . . . . . . . 41.1 p30 -158.91 72.89 0.59 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.187 -0.945 . . . . 0.0 110.714 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 80.7 m -124.45 130.93 53.36 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 120.494 -1.379 . . . . 0.0 111.575 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 58' ' ' ILE . . . . . 0.408 ' HA ' ' HA ' ' B' ' 47' ' ' PRO . 98.1 mt -122.15 130.77 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.47 -0.769 . . . . 0.0 111.209 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 12.9 t -114.48 129.62 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.416 -0.802 . . . . 0.0 110.677 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 33.2 m -128.5 121.69 29.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.293 -0.879 . . . . 0.0 110.137 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 61' ' ' ASN . . . . . 0.547 ' HB3' ' HG2' ' B' ' 71' ' ' GLU . 3.8 p-10 -139.32 174.16 10.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.134 -0.979 . . . . 0.0 110.188 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 7.2 m -129.18 155.15 45.97 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.476 -0.765 . . . . 0.0 108.953 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 63' ' ' LYS . . . . . 0.531 ' CD ' ' HA2' ' B' ' 66' ' ' GLY . 6.8 ttmt -135.14 150.19 50.14 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.508 -1.37 . . . . 0.0 112.114 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 64' ' ' ASP . . . . . 0.559 ' HB2' HD11 ' B' ' 112' ' ' LEU . 54.5 t0 -129.7 100.38 5.48 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 64.52 21.3 66.68 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.843 -1.17 . . . . 0.0 110.435 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 66' ' ' GLY . . . . . 0.531 ' HA2' ' CD ' ' B' ' 63' ' ' LYS . . . 74.68 25.6 69.44 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.251 -1.452 . . . . 0.0 110.473 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -105.95 -73.27 0.69 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.989 -1.3 . . . . 0.0 110.583 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 68' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -70.59 -177.06 1.41 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.653 -0.655 . . . . 0.0 109.887 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 164.94 46.4 0.02 OUTLIER Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 15.8 m -63.85 100.81 0.32 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.271 -1.134 . . . . 0.0 110.462 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 71' ' ' GLU . . . . . 0.547 ' HG2' ' HB3' ' B' ' 61' ' ' ASN . 86.4 mt-10 -85.49 123.32 30.79 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.274 -0.891 . . . . 0.0 111.017 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -101.23 -167.81 1.47 Allowed 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -147.3 120.7 9.02 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 117.991 -1.484 . . . . 0.0 111.822 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -106.86 132.83 52.37 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.49 60.84 0.6 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.926 -1.109 . . . . 0.0 111.128 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 76' ' ' VAL . . . . . 0.541 HG22 ' HD3' ' B' ' 78' ' ' PRO . 4.6 p -136.51 151.24 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.9 -1.125 . . . . 0.0 110.251 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 77' ' ' PHE . . . . . 0.494 ' O ' ' CG ' ' B' ' 77' ' ' PHE . 9.1 p90 -144.98 71.65 14.84 Favored Pre-proline 0 C--N 1.303 -1.444 0 O-C-N 121.204 -0.935 . . . . 0.0 109.99 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 78' ' ' PRO . . . . . 0.541 ' HD3' HG22 ' B' ' 76' ' ' VAL . 41.0 Cg_endo -64.71 -14.38 44.39 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.088 1.573 . . . . 0.0 110.422 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -116.89 167.24 11.3 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.191 -0.943 . . . . 0.0 110.408 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.77 167.66 16.9 Favored Pre-proline 0 C--N 1.3 -1.554 0 O-C-N 121.707 -0.621 . . . . 0.0 109.387 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 81' ' ' PRO . . . . . 0.418 ' HB2' ' O ' ' B' ' 25' ' ' PRO . 42.7 Cg_endo -65.94 148.41 85.94 Favored 'Trans proline' 0 C--N 1.297 -2.165 0 O-C-N 123.946 1.498 . . . . 0.0 110.391 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 62.47 43.18 99.4 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 15.9 t -149.32 138.73 21.57 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.196 -1.179 . . . . 0.0 110.043 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.409 ' H ' HG22 ' B' ' 84' ' ' VAL . 15.4 m -79.1 140.08 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.136 -0.978 . . . . 0.0 109.156 178.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.71 154.13 39.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.063 -1.023 . . . . 0.0 109.81 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -123.29 152.66 41.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.049 -1.032 . . . . 0.0 109.993 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 87' ' ' VAL . . . . . 0.43 HG12 HG13 ' B' ' 89' ' ' ILE . 46.9 t -128.4 138.52 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.399 -0.813 . . . . 0.0 111.457 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 88' ' ' CYS . . . . . 0.435 ' HB3' ' HB2' ' B' ' 99' ' ' LYS . 4.7 t -113.49 114.73 26.95 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.422 -0.799 . . . . 0.0 109.845 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.43 HG13 HG12 ' B' ' 87' ' ' VAL . 87.1 mt -120.69 128.42 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.252 -0.905 . . . . 0.0 110.0 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 90' ' ' THR . . . . . 0.512 ' HB ' ' HB ' ' B' ' 97' ' ' THR . 27.8 m -123.09 134.94 54.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.222 -0.924 . . . . 0.0 109.628 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 91' ' ' PHE . . . . . 0.491 ' CE1' HD21 ' B' ' 96' ' ' LEU . 79.4 t80 -104.84 117.35 33.82 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.326 -0.858 . . . . 0.0 110.246 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -112.17 143.57 43.0 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.058 -1.026 . . . . 0.0 109.402 178.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 72.5 tp60 -60.69 -25.11 66.15 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.533 -0.729 . . . . 0.0 110.833 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.07 -22.35 21.86 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.973 -1.079 . . . . 0.0 111.499 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 45.6 p30 -174.39 -172.5 0.68 Allowed 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.163 -0.961 . . . . 0.0 108.947 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 96' ' ' LEU . . . . . 1.027 HD13 HD21 ' B' ' 43' ' ' LEU . 74.9 mt -121.72 134.93 54.95 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 120.993 -1.067 . . . . 0.0 110.697 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 97' ' ' THR . . . . . 0.512 ' HB ' ' HB ' ' B' ' 90' ' ' THR . 32.9 m -109.4 123.14 48.84 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.233 -0.917 . . . . 0.0 108.989 178.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 46.3 t -125.19 128.37 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.852 -1.155 . . . . 0.0 109.588 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 99' ' ' LYS . . . . . 0.435 ' HB2' ' HB3' ' B' ' 88' ' ' CYS . 98.5 mttt -122.89 146.27 47.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.179 -0.951 . . . . 0.0 110.899 -178.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 100' ' ' LEU . . . . . 0.434 HD13 ' HG3' ' B' ' 78' ' ' PRO . 25.0 mt -105.5 166.67 10.95 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -63.16 -25.43 72.72 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.239 1.126 . . . . 0.0 110.945 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 102' ' ' ASP . . . . . 0.468 ' HB2' ' CB ' ' B' ' 78' ' ' PRO . 36.3 t70 -74.42 -11.94 60.37 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.947 -1.096 . . . . 0.0 110.94 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 106.08 -8.5 42.07 Favored Glycine 0 N--CA 1.493 2.475 0 C-N-CA 119.887 -1.149 . . . . 0.0 110.683 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 104' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -72.3 136.48 46.25 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.933 -1.334 . . . . 0.0 110.25 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 105' ' ' GLU . . . . . 0.432 ' OE2' HG23 ' B' ' 97' ' ' THR . 71.4 tt0 -125.62 142.28 51.59 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.057 -1.027 . . . . 0.0 110.527 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -133.35 146.14 51.02 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.507 -0.746 . . . . 0.0 109.163 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 107' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' B' ' 96' ' ' LEU . 98.1 mttt -122.06 146.13 47.49 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.768 -1.208 . . . . 0.0 112.812 -178.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 108' ' ' PHE . . . . . 0.541 ' HB2' ' HB2' ' B' ' 96' ' ' LEU . 98.0 m-85 -117.09 150.28 45.78 Favored Pre-proline 0 N--CA 1.492 1.671 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.155 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.85 148.52 64.66 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.593 1.312 . . . . 0.0 111.261 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 110' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -69.77 62.85 0.19 Allowed 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.586 -0.696 . . . . 0.0 111.621 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 79.3 mtp85 -65.41 -39.78 92.58 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.919 -1.113 . . . . 0.0 110.277 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 112' ' ' LEU . . . . . 0.559 HD11 ' HB2' ' B' ' 64' ' ' ASP . 4.5 mm? -95.87 130.01 42.95 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.18 -0.95 . . . . 0.0 110.702 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -87.38 7.4 29.12 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.643 -0.66 . . . . 0.0 111.069 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 114' ' ' LEU . . . . . 0.484 HD23 ' O ' ' B' ' 114' ' ' LEU . 3.5 tt -58.07 129.2 40.85 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.053 -1.029 . . . . 0.0 109.239 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -106.65 -5.56 18.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.559 -0.713 . . . . 0.0 111.36 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 116' ' ' ALA . . . . . 0.443 ' HA ' ' O ' ' B' ' 11' ' ' LEU . . . -137.82 132.32 32.44 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.74 -1.225 . . . . 0.0 110.418 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 117' ' ' ILE . . . . . 0.479 ' O ' ' HA ' ' B' ' 10' ' ' ASN . 95.9 mt -111.72 128.71 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.927 -1.108 . . . . 0.0 110.269 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -126.1 -28.52 3.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.138 -0.976 . . . . 0.0 111.818 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 119' ' ' TYR . . . . . 0.451 ' CD1' ' O ' ' B' ' 37' ' ' ASP . 66.6 t80 -91.96 127.31 37.38 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.882 -1.136 . . . . 0.0 110.346 -179.185 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 120' ' ' MET . . . . . 0.425 ' HB3' ' CD1' ' B' ' 9' ' ' LEU . 26.5 ttm -142.0 134.26 27.79 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.115 -0.991 . . . . 0.0 109.592 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -158.89 147.71 18.53 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.101 -0.999 . . . . 0.0 109.448 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 122' ' ' ALA . . . . . 0.491 ' O ' ' HA3' ' B' ' 3' ' ' GLY . . . -147.14 155.0 41.78 Favored 'General case' 0 C--N 1.29 -1.995 0 O-C-N 121.472 -0.768 . . . . 0.0 108.975 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 123' ' ' ASP . . . . . 0.405 ' HA ' ' O ' ' B' ' 2' ' ' CYS . 9.6 p-10 -154.51 156.53 36.84 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 124' ' ' GLY . . . . . 0.527 ' HA3' ' HA ' ' B' ' 30' ' ' PHE . . . 148.93 -157.17 27.16 Favored Glycine 0 C--N 1.296 -1.693 0 C-N-CA 118.382 -1.866 . . . . 0.0 110.149 178.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 125' ' ' ASP . . . . . 0.483 ' CB ' ' HA ' ' B' ' 27' ' ' ALA . 63.1 m-20 -91.55 12.1 21.98 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 122.015 -0.697 . . . . 0.0 110.383 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 126' ' ' PHE . . . . . 0.649 ' CD1' HG22 ' B' ' 23' ' ' VAL . 11.5 t80 -108.58 151.4 26.17 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.668 -1.27 . . . . 0.0 110.402 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -121.23 124.57 44.97 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.268 -0.895 . . . . 0.0 110.356 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 128' ' ' ILE . . . . . 0.483 ' CD1' HG13 ' B' ' 19' ' ' VAL . 18.0 tt -101.86 127.3 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.156 -0.965 . . . . 0.0 110.39 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 29.1 pttt -119.11 -4.3 10.56 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.783 -1.198 . . . . 0.0 111.126 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 130' ' ' CYS . . . . . 0.441 ' HA ' ' O ' ' A' ' 131' ' ' VAL . 0.0 OUTLIER -154.29 130.96 10.71 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 118.947 -1.101 . . . . 0.0 111.91 -179.084 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 130' ' ' CYS . 54.7 t -128.05 133.85 66.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.659 -0.651 . . . . 0.0 109.956 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 132' ' ' ALA . . . . . . . . . . . . . . . -141.45 142.87 33.64 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 120.249 -1.532 . . . . 0.0 110.395 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 133' ' ' PHE . . . . . 0.576 ' CZ ' HD12 ' B' ' 11' ' ' LEU . 3.0 m-85 -76.19 -88.56 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.096 -1.002 . . . . 0.0 111.084 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 48.4 t0 . . . . . 0 C--N 1.296 -1.749 0 CA-C-O 118.096 -0.954 . . . . 0.0 110.356 -179.388 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.549 ' HB2' ' HE3' ' A' ' 127' ' ' LYS . . . . . . . . 0 N--CA 1.496 1.865 0 CA-C-O 121.226 0.536 . . . . 0.0 110.472 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.51 ' O ' ' O ' ' A' ' 3' ' ' GLY . 1.3 m -96.85 54.11 1.27 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.145 -0.972 . . . . 0.0 110.808 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.51 ' O ' ' O ' ' A' ' 2' ' ' CYS . . . 43.39 111.2 0.0 OUTLIER Glycine 0 N--CA 1.497 2.704 0 CA-C-O 121.851 0.695 . . . . 0.0 112.271 178.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.933 HD12 HG23 ' A' ' 128' ' ' ILE . 84.2 mt -63.76 137.12 57.93 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.627 -1.514 . . . . 0.0 109.25 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.6 t -110.07 132.46 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.364 -0.835 . . . . 0.0 109.804 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -134.82 161.33 35.51 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.845 -1.16 . . . . 0.0 110.112 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.455 ' O ' ' HB3' ' A' ' 8' ' ' ASN . 15.2 p -153.38 169.95 21.86 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.539 -0.726 . . . . 0.0 109.999 -178.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.455 ' HB3' ' O ' ' A' ' 7' ' ' SER . 4.9 t-20 65.74 39.08 4.94 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.263 0.554 . . . . 0.0 109.683 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 11' ' ' LEU . 85.7 mt -104.95 32.41 4.2 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.385 -0.822 . . . . 0.0 109.83 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -40.59 93.87 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.275 0 O-C-N 121.603 -0.686 . . . . 0.0 111.666 -178.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.582 HD11 ' OE1' ' A' ' 15' ' ' GLU . 0.2 OUTLIER -114.77 131.23 56.86 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.347 179.304 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.0 mttt -97.65 171.9 5.46 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.528 -0.733 . . . . 0.0 111.007 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -67.79 150.42 78.88 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 O-C-N 123.911 1.48 . . . . 0.0 110.095 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.59 -15.03 35.22 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.582 ' OE1' HD11 ' A' ' 11' ' ' LEU . 90.3 mt-10 -114.51 150.11 35.38 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.802 -1.41 . . . . 0.0 109.75 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 45.8 t -109.78 145.45 36.64 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.199 -0.938 . . . . 0.0 110.337 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.849 HD12 ' O ' ' A' ' 132' ' ' ALA . 48.1 tp -112.48 134.17 54.16 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -121.86 129.55 52.68 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.934 -1.104 . . . . 0.0 110.108 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.481 HG13 HG13 ' A' ' 128' ' ' ILE . 65.2 t -126.28 127.7 70.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.161 -0.962 . . . . 0.0 111.02 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.448 ' HG3' ' HG2' ' A' ' 86' ' ' GLU . 70.3 ttt180 -107.27 122.12 45.91 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 177.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' A' ' 127' ' ' LYS . . . -135.14 -178.57 15.77 Favored Glycine 0 N--CA 1.487 2.083 0 C-N-CA 118.939 -1.601 . . . . 0.0 111.661 -177.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -126.07 140.53 52.51 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 122.028 -0.689 . . . . 0.0 110.321 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.4 t -101.75 126.88 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.501 -0.749 . . . . 0.0 109.812 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.06 154.82 37.24 Favored Pre-proline 0 N--CA 1.497 1.922 0 O-C-N 120.989 -1.069 . . . . 0.0 110.48 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -67.45 -18.39 49.35 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 124.026 1.54 . . . . 0.0 111.208 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -119.77 52.23 1.12 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.924 -1.11 . . . . 0.0 108.69 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.21 153.01 32.32 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.575 0.702 . . . . 0.0 112.215 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.402 ' N ' ' OD2' ' A' ' 125' ' ' ASP . 98.1 mttt -137.85 -39.66 0.56 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.539 -0.726 . . . . 0.0 109.953 179.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 40.1 p -161.58 160.0 28.37 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.967 -1.083 . . . . 0.0 111.756 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.477 ' HA ' ' HA3' ' A' ' 124' ' ' GLY . 67.3 t80 -153.86 150.82 28.81 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.49 -0.756 . . . . 0.0 109.878 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 45' ' ' PHE . 11.4 p -134.75 150.5 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.047 -1.033 . . . . 0.0 110.94 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.439 HD12 ' HB3' ' A' ' 45' ' ' PHE . 78.2 mt -118.2 147.22 43.6 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.487 -0.758 . . . . 0.0 108.995 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.572 ' OD1' HD22 ' A' ' 41' ' ' LEU . 62.9 t30 -143.25 108.54 5.02 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.015 -1.074 . . . . 0.0 111.004 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.639 HD11 ' HB3' ' A' ' 43' ' ' LEU . 0.5 OUTLIER -131.14 121.28 24.63 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.401 -0.812 . . . . 0.0 109.494 179.254 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.463 ' HA3' ' HA ' ' A' ' 41' ' ' LEU . . . -168.54 -171.5 34.44 Favored Glycine 0 N--CA 1.484 1.843 0 C-N-CA 118.652 -1.737 . . . . 0.0 109.977 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.463 ' HD2' HD13 ' A' ' 114' ' ' LEU . 34.9 mtpt -65.85 -41.52 91.58 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 122.284 1.04 . . . . 0.0 108.53 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.16 -167.33 2.17 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.851 0.834 . . . . 0.0 111.825 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.3 t -57.67 -41.98 82.66 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.636 -0.665 . . . . 0.0 112.766 -177.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -99.92 -7.34 25.35 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.234 -1.541 . . . . 0.0 110.663 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.425 ' HB2' ' HB2' ' A' ' 36' ' ' LYS . 7.1 m-80 -105.03 73.11 1.03 Allowed 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.032 -1.043 . . . . 0.0 109.096 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.572 HD22 ' OD1' ' A' ' 33' ' ' ASN . 60.1 mt -101.68 127.45 48.43 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.332 0.587 . . . . 0.0 110.362 -178.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 3.3 t -84.59 -43.91 14.02 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.123 -0.985 . . . . 0.0 110.488 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.719 HD22 HD21 ' A' ' 96' ' ' LEU . 20.4 tp -129.41 133.79 47.53 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.219 -0.926 . . . . 0.0 110.584 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.414 ' O ' ' HA ' ' A' ' 60' ' ' CYS . 9.3 t60 -126.73 112.77 15.8 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.556 ' CD2' ' HD3' ' A' ' 47' ' ' PRO . 43.2 t80 -111.71 115.77 29.63 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.822 -1.173 . . . . 0.0 110.481 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -130.45 73.76 80.91 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.348 -0.845 . . . . 0.0 111.601 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.556 ' HD3' ' CD2' ' A' ' 45' ' ' PHE . 43.5 Cg_endo -66.5 143.05 67.63 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.416 1.219 . . . . 0.0 109.52 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -137.63 126.32 23.8 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.912 -1.117 . . . . 0.0 110.847 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -72.21 -60.1 2.4 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.113 -0.992 . . . . 0.0 110.005 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -115.47 121.68 43.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.282 -0.886 . . . . 0.0 109.335 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.59 -162.46 0.96 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.838 -1.164 . . . . 0.0 111.123 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -83.45 8.92 12.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.404 -0.81 . . . . 0.0 110.165 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 173.76 -34.07 0.11 Allowed Glycine 0 N--CA 1.487 2.095 0 N-CA-C 108.589 -1.804 . . . . 0.0 108.589 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -80.85 -178.59 6.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.235 -1.156 . . . . 0.0 110.14 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.426 ' O ' ' C ' ' A' ' 56' ' ' ASN . . . -131.18 140.34 49.9 Favored 'General case' 0 C--N 1.293 -1.855 0 O-C-N 121.871 -0.518 . . . . 0.0 110.042 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.426 ' C ' ' O ' ' A' ' 55' ' ' ALA . 3.2 m120 27.81 73.52 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 179.083 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 96.2 m -127.51 131.18 50.14 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.913 -1.117 . . . . 0.0 110.526 178.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.527 ' HB ' ' HB3' ' A' ' 74' ' ' GLU . 82.4 mt -103.56 129.03 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.894 -0.504 . . . . 0.0 110.656 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 24.6 t -110.84 128.99 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.329 -0.857 . . . . 0.0 109.494 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' CYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 44' ' ' HIS . 1.8 t -127.74 131.24 49.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.474 -0.766 . . . . 0.0 110.376 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.402 ' O ' ' CB ' ' A' ' 44' ' ' HIS . 1.5 p-10 -151.19 172.42 15.85 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.973 -1.079 . . . . 0.0 109.835 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.469 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 59.2 p -136.04 153.26 51.4 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.209 -0.932 . . . . 0.0 109.785 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.527 ' CD ' ' HA2' ' A' ' 66' ' ' GLY . 10.0 ttmt -133.29 145.79 50.79 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 120.692 -1.255 . . . . 0.0 111.876 -178.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.504 ' OD2' HD22 ' A' ' 112' ' ' LEU . 30.2 t0 -123.85 107.79 11.77 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.182 -0.949 . . . . 0.0 109.407 178.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 59.2 29.24 65.39 Favored Glycine 0 N--CA 1.485 1.91 0 C-N-CA 119.357 -1.401 . . . . 0.0 110.05 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.527 ' HA2' ' CD ' ' A' ' 63' ' ' LYS . . . 62.41 26.25 67.83 Favored Glycine 0 N--CA 1.488 2.108 0 O-C-N 120.997 -1.296 . . . . 0.0 110.621 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -89.98 -75.12 0.46 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.969 -1.312 . . . . 0.0 110.466 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 43.7 m95 -122.83 -170.46 2.1 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.792 -1.193 . . . . 0.0 110.777 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.469 ' HA2' ' O ' ' A' ' 62' ' ' SER . . . 173.49 114.62 0.35 Allowed Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.408 -1.377 . . . . 0.0 110.555 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 52.9 m -77.2 121.01 23.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.382 -1.069 . . . . 0.0 110.452 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -101.63 123.52 45.78 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.146 -0.971 . . . . 0.0 110.486 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -115.88 -170.27 1.76 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.826 -1.171 . . . . 0.0 110.378 179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 47.3 ttp180 -144.4 116.4 8.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.952 -1.092 . . . . 0.0 111.587 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.527 ' HB3' ' HB ' ' A' ' 58' ' ' ILE . 77.5 tt0 -103.12 139.45 38.62 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.253 -0.904 . . . . 0.0 110.128 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.72 38.7 2.29 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.927 -1.108 . . . . 0.0 111.712 -179.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.463 ' O ' ' CD1' ' A' ' 58' ' ' ILE . 48.1 t -132.47 130.29 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.622 -1.299 . . . . 0.0 111.625 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -159.21 96.16 1.69 Allowed Pre-proline 0 N--CA 1.5 2.05 0 O-C-N 120.904 -1.122 . . . . 0.0 110.79 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -81.49 45.91 2.1 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.998 1.525 . . . . 0.0 111.7 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -128.85 152.8 48.1 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.615 -1.303 . . . . 0.0 111.725 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 15.4 mp0 -135.87 160.21 68.27 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.688 -0.632 . . . . 0.0 109.682 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -66.22 145.48 78.44 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.855 1.45 . . . . 0.0 110.79 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 64.5 40.25 97.52 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.1 p -133.54 148.77 51.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.976 -1.308 . . . . 0.0 111.627 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.6 p -101.26 136.47 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.505 -0.747 . . . . 0.0 109.233 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -153.91 155.07 35.0 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.121 -0.987 . . . . 0.0 110.368 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.448 ' HG2' ' HG3' ' A' ' 20' ' ' ARG . 99.0 mt-10 -119.36 139.18 52.4 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.896 -1.128 . . . . 0.0 110.597 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.6 t -125.95 132.68 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.411 -0.805 . . . . 0.0 110.68 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' CYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 77.8 m -107.77 134.41 50.77 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.176 -0.953 . . . . 0.0 109.107 179.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 89.1 mt -121.22 127.93 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.747 -1.221 . . . . 0.0 111.019 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.409 ' O ' HD12 ' A' ' 96' ' ' LEU . 45.6 m -129.35 128.97 44.18 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.302 -0.874 . . . . 0.0 109.972 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.587 ' HA ' HD12 ' A' ' 96' ' ' LEU . 42.4 t80 -112.43 127.38 56.02 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.104 -0.997 . . . . 0.0 111.868 -179.093 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 95' ' ' ASN . 88.8 m-20 -119.09 156.02 30.48 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.496 -0.752 . . . . 0.0 109.911 179.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 -60.95 -23.88 65.65 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.454 -0.779 . . . . 0.0 112.73 -178.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -105.36 -26.54 11.93 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.436 -1.415 . . . . 0.0 110.428 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.409 ' O ' ' HB2' ' A' ' 92' ' ' ASP . 34.5 m-20 -152.57 172.61 16.33 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 119.069 -1.052 . . . . 0.0 111.866 -179.035 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.719 HD21 HD22 ' A' ' 43' ' ' LEU . 54.6 tp -119.13 129.42 55.02 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.798 HG23 ' OE2' ' A' ' 105' ' ' GLU . 17.4 m -114.58 125.25 53.56 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 120.781 -1.199 . . . . 0.0 111.115 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 43.3 t -120.18 127.93 75.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 88' ' ' CYS . 88.2 tttt -114.42 119.24 36.22 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 118.589 -1.244 . . . . 0.0 109.774 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.0 mp -100.35 170.7 6.34 Favored Pre-proline 0 C--N 1.298 -1.645 0 O-C-N 121.91 -0.494 . . . . 0.0 109.755 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.05 -22.13 62.53 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 O-C-N 123.893 1.47 . . . . 0.0 111.122 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -66.04 -34.24 77.64 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.805 -1.185 . . . . 0.0 109.787 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 112.4 -27.0 10.41 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -73.22 145.23 46.37 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.145 -1.209 . . . . 0.0 109.381 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.798 ' OE2' HG23 ' A' ' 97' ' ' THR . 68.9 tt0 -113.64 143.33 44.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.844 -1.16 . . . . 0.0 111.022 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -120.44 147.86 44.55 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 98.2 mttt -120.77 145.11 47.88 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.01 -1.076 . . . . 0.0 111.555 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.463 ' HB3' HD23 ' A' ' 96' ' ' LEU . 15.0 t80 -125.55 129.59 24.35 Favored Pre-proline 0 C--N 1.293 -1.885 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -64.73 140.78 69.31 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 O-C-N 123.02 1.01 . . . . 0.0 109.965 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.51 ' ND2' ' O ' ' A' ' 110' ' ' ASN . 4.1 p-10 -92.02 82.4 5.1 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.023 -1.048 . . . . 0.0 109.473 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -54.72 -27.39 40.37 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.536 -1.353 . . . . 0.0 109.224 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.504 HD22 ' OD2' ' A' ' 64' ' ' ASP . 83.4 mt -104.65 132.33 51.02 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.338 -0.851 . . . . 0.0 109.851 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 -87.7 61.06 6.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.009 -1.057 . . . . 0.0 110.415 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.463 HD13 ' HD2' ' A' ' 36' ' ' LYS . 52.0 tp -80.84 129.67 34.65 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.358 -0.839 . . . . 0.0 109.537 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -87.27 -12.36 46.86 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.162 -0.962 . . . . 0.0 111.549 -178.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 11' ' ' LEU . . . -160.23 158.45 29.99 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.794 -1.191 . . . . 0.0 111.661 -178.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 49.9 mm -109.41 126.06 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.525 -0.734 . . . . 0.0 109.891 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -112.09 -26.65 8.74 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.566 -1.334 . . . . 0.0 110.787 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.483 ' O ' ' HA ' ' A' ' 34' ' ' LEU . 10.5 t80 -110.21 126.26 53.95 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.229 -0.92 . . . . 0.0 110.401 -179.02 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.402 ' CB ' HD12 ' A' ' 9' ' ' LEU . 50.0 ttp -132.98 130.66 39.8 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.5 142.24 21.0 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.026 -1.046 . . . . 0.0 110.521 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.446 ' O ' ' CA ' ' A' ' 3' ' ' GLY . . . -148.02 132.03 17.22 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.35 -0.844 . . . . 0.0 111.391 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.472 ' HB3' ' HA3' ' A' ' 3' ' ' GLY . 15.2 p-10 -148.46 147.6 29.33 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.358 -0.839 . . . . 0.0 110.483 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.477 ' HA3' ' HA ' ' A' ' 30' ' ' PHE . . . 155.79 -145.44 12.34 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.402 ' OD2' ' N ' ' A' ' 28' ' ' LYS . 88.2 m-20 -94.31 11.46 30.31 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.288 -1.125 . . . . 0.0 111.544 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.445 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 24.7 t80 -112.87 143.74 43.62 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.964 -1.085 . . . . 0.0 109.319 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.549 ' HE3' ' HB2' ' A' ' 1' ' ' ALA . 51.8 mttp -117.01 140.99 48.82 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.891 -1.131 . . . . 0.0 111.359 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.933 HG23 HD12 ' A' ' 4' ' ' LEU . 4.1 tt -111.57 122.41 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -101.55 -9.94 20.55 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.021 -1.049 . . . . 0.0 112.384 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -158.14 150.12 21.78 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.224 -1.547 . . . . 0.0 112.004 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.427 HG22 HD11 ' A' ' 128' ' ' ILE . 47.9 t -128.86 133.48 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.849 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -136.38 133.1 36.4 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.715 -1.241 . . . . 0.0 111.302 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.51 ' CE1' HD13 ' A' ' 17' ' ' LEU . 47.7 m-85 -110.9 148.22 32.93 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.402 -0.811 . . . . 0.0 111.313 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.409 ' CB ' ' HB3' ' A' ' 15' ' ' GLU . 47.1 t0 . . . . . 0 N--CA 1.496 1.873 0 CA-C-O 118.114 -0.946 . . . . 0.0 111.186 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.562 ' HB2' ' HE3' ' B' ' 127' ' ' LYS . . . . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 121.341 0.591 . . . . 0.0 110.441 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 2' ' ' CYS . . . . . 0.512 ' O ' ' O ' ' B' ' 3' ' ' GLY . 1.3 m -96.95 54.88 1.29 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.023 -1.048 . . . . 0.0 110.664 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 3' ' ' GLY . . . . . 0.512 ' O ' ' O ' ' B' ' 2' ' ' CYS . . . 42.43 111.3 0.0 OUTLIER Glycine 0 N--CA 1.497 2.717 0 CA-C-O 121.891 0.717 . . . . 0.0 112.308 178.086 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.971 HD12 HG23 ' B' ' 128' ' ' ILE . 86.2 mt -63.78 136.99 57.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.571 -1.547 . . . . 0.0 109.458 178.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 37.5 t -109.72 132.35 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.454 -0.779 . . . . 0.0 109.861 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -134.7 161.12 36.05 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.766 -1.209 . . . . 0.0 110.214 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 7' ' ' SER . . . . . 0.469 ' O ' ' HB3' ' B' ' 8' ' ' ASN . 15.8 p -153.2 170.37 20.71 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.293 -0.879 . . . . 0.0 110.038 -178.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 8' ' ' ASN . . . . . 0.469 ' HB3' ' O ' ' B' ' 7' ' ' SER . 4.9 t-20 65.43 39.05 5.36 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.241 0.543 . . . . 0.0 109.756 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' B' ' 11' ' ' LEU . 82.6 mt -104.62 32.27 4.2 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.345 -0.847 . . . . 0.0 109.8 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 -40.24 93.97 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.495 -0.753 . . . . 0.0 111.708 -178.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.586 HD11 ' OE1' ' B' ' 15' ' ' GLU . 0.2 OUTLIER -115.01 131.05 57.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.649 -0.657 . . . . 0.0 110.286 179.603 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -97.75 172.54 4.79 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.506 -0.746 . . . . 0.0 110.765 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.25 150.69 76.75 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 O-C-N 123.95 1.5 . . . . 0.0 110.392 178.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.3 -14.98 36.2 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 15' ' ' GLU . . . . . 0.586 ' OE1' HD11 ' B' ' 11' ' ' LEU . 90.4 mt-10 -114.37 150.25 34.89 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.822 -1.399 . . . . 0.0 109.668 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 16' ' ' CYS . . . . . . . . . . . . . 52.3 t -109.89 145.62 36.52 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.129 -0.982 . . . . 0.0 110.036 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.843 HD12 ' O ' ' B' ' 132' ' ' ALA . 46.3 tp -112.75 133.92 54.52 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -121.74 129.23 52.55 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.937 -1.102 . . . . 0.0 109.982 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.475 HG13 HG13 ' B' ' 128' ' ' ILE . 61.6 t -125.54 127.2 71.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.32 -0.862 . . . . 0.0 111.122 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 20' ' ' ARG . . . . . 0.459 ' HG3' ' HG2' ' B' ' 86' ' ' GLU . 70.2 ttt180 -107.02 122.13 45.84 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.475 ' HA3' ' O ' ' B' ' 127' ' ' LYS . . . -135.17 -177.83 15.24 Favored Glycine 0 N--CA 1.484 1.842 0 C-N-CA 118.881 -1.628 . . . . 0.0 111.562 -177.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -126.66 140.76 52.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.697 -0.884 . . . . 0.0 110.203 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 6.4 t -101.92 127.39 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.293 -0.88 . . . . 0.0 109.846 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.35 155.51 36.02 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 120.953 -1.092 . . . . 0.0 110.588 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.77 -18.4 47.51 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 O-C-N 124.122 1.591 . . . . 0.0 111.113 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -119.88 52.62 1.11 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.023 -1.048 . . . . 0.0 108.8 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' ALA . . . . . 0.409 ' HA ' ' HB3' ' B' ' 125' ' ' ASP . . . -78.59 152.31 31.89 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.585 0.707 . . . . 0.0 112.144 -178.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 28' ' ' LYS . . . . . 0.403 ' N ' ' OD2' ' B' ' 125' ' ' ASP . 98.0 mttt -137.12 -40.66 0.59 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.671 -0.643 . . . . 0.0 110.105 178.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 35.8 p -160.14 160.9 33.49 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.871 -1.143 . . . . 0.0 111.321 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 30' ' ' PHE . . . . . 0.492 ' HA ' ' HA3' ' B' ' 124' ' ' GLY . 64.8 t80 -154.58 150.52 27.82 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.278 -0.889 . . . . 0.0 109.623 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' B' ' 45' ' ' PHE . 11.5 p -134.41 150.97 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 120.781 -1.2 . . . . 0.0 110.974 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.471 HD12 ' HB3' ' B' ' 45' ' ' PHE . 76.5 mt -118.09 147.12 43.59 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 33' ' ' ASN . . . . . 0.571 ' OD1' HD22 ' B' ' 41' ' ' LEU . 63.2 t30 -143.14 108.11 4.93 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 120.834 -1.166 . . . . 0.0 110.974 -179.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.648 HD11 ' HB3' ' B' ' 43' ' ' LEU . 0.5 OUTLIER -131.29 116.35 17.5 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.283 -0.885 . . . . 0.0 109.835 179.546 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 35' ' ' GLY . . . . . 0.473 ' HA3' ' HA ' ' B' ' 41' ' ' LEU . . . -161.63 -169.93 25.62 Favored Glycine 0 N--CA 1.485 1.919 0 C-N-CA 118.53 -1.795 . . . . 0.0 110.494 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 36' ' ' LYS . . . . . 0.487 ' HD2' HD13 ' B' ' 114' ' ' LEU . 36.1 mtpt -66.69 -42.26 86.75 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -156.62 -167.06 2.28 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.75 0.786 . . . . 0.0 111.778 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 38.6 t -57.83 -41.9 83.24 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -100.31 -7.27 24.72 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 120.394 -1.441 . . . . 0.0 110.564 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 40' ' ' ASN . . . . . 0.407 ' HB2' ' HB2' ' B' ' 36' ' ' LYS . 7.3 m-80 -104.92 72.18 1.0 Allowed 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.903 -1.123 . . . . 0.0 109.129 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.571 HD22 ' OD1' ' B' ' 33' ' ' ASN . 60.1 mt -100.32 130.13 46.39 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.231 0.539 . . . . 0.0 110.031 -178.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 42' ' ' CYS . . . . . . . . . . . . . 2.1 t -88.63 -42.58 11.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.066 -1.021 . . . . 0.0 109.919 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.708 HD22 HD21 ' B' ' 96' ' ' LEU . 19.7 tp -129.76 133.91 47.29 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.144 -0.972 . . . . 0.0 110.456 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 44' ' ' HIS . . . . . 0.409 ' O ' ' HA ' ' B' ' 60' ' ' CYS . 9.0 t60 -127.27 112.75 15.44 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.553 ' CD2' ' HD3' ' B' ' 47' ' ' PRO . 43.3 t80 -111.69 115.25 28.79 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.133 -0.979 . . . . 0.0 110.436 -179.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -129.84 73.42 81.47 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 121.372 -0.83 . . . . 0.0 111.413 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 47' ' ' PRO . . . . . 0.553 ' HD3' ' CD2' ' B' ' 45' ' ' PHE . 41.4 Cg_endo -66.24 143.03 69.24 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.263 1.138 . . . . 0.0 109.259 179.061 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -137.9 126.63 23.78 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.91 -1.119 . . . . 0.0 110.713 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -72.59 -60.97 1.97 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.137 -0.977 . . . . 0.0 109.988 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -114.54 120.99 42.08 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.488 -0.758 . . . . 0.0 109.25 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.09 -162.11 0.92 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.84 -1.162 . . . . 0.0 111.32 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 52' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -84.18 11.42 8.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.433 -0.792 . . . . 0.0 110.122 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 170.42 -33.48 0.16 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -81.45 -178.55 6.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.013 -1.286 . . . . 0.0 110.029 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.473 ' O ' ' C ' ' B' ' 56' ' ' ASN . . . -129.6 146.91 51.36 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 56' ' ' ASN . . . . . 0.473 ' C ' ' O ' ' B' ' 55' ' ' ALA . 3.3 m120 17.53 77.36 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.175 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -179.073 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 97.0 m -128.1 130.86 48.84 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.236 -0.915 . . . . 0.0 110.328 178.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 58' ' ' ILE . . . . . 0.468 ' HB ' ' HB3' ' B' ' 74' ' ' GLU . 82.7 mt -104.01 129.24 56.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 121.775 -0.578 . . . . 0.0 110.818 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 25.0 t -110.29 129.17 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.193 -0.942 . . . . 0.0 109.899 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 60' ' ' CYS . . . . . 0.409 ' HA ' ' O ' ' B' ' 44' ' ' HIS . 1.7 t -127.98 129.6 47.02 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.661 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 61' ' ' ASN . . . . . 0.409 ' O ' ' HB3' ' B' ' 44' ' ' HIS . 1.5 p-10 -149.69 171.75 16.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.151 -0.968 . . . . 0.0 110.194 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 62' ' ' SER . . . . . 0.46 ' O ' ' HA2' ' B' ' 69' ' ' GLY . 60.5 p -135.47 153.61 51.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.243 -0.91 . . . . 0.0 109.56 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 63' ' ' LYS . . . . . 0.521 ' CD ' ' HA2' ' B' ' 66' ' ' GLY . 10.1 ttmt -132.93 145.9 51.31 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 120.703 -1.248 . . . . 0.0 111.701 -178.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 64' ' ' ASP . . . . . 0.517 ' OD2' HD22 ' B' ' 112' ' ' LEU . 30.4 t0 -123.83 107.48 11.44 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.212 -0.93 . . . . 0.0 109.263 178.272 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 59.64 28.74 65.78 Favored Glycine 0 N--CA 1.484 1.878 0 C-N-CA 119.576 -1.297 . . . . 0.0 110.15 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 66' ' ' GLY . . . . . 0.521 ' HA2' ' CD ' ' B' ' 63' ' ' LYS . . . 62.84 25.83 68.12 Favored Glycine 0 N--CA 1.488 2.105 0 O-C-N 120.872 -1.369 . . . . 0.0 110.575 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 67' ' ' ALA . . . . . 0.411 ' HB1' ' CD1' ' B' ' 68' ' ' TRP . . . -89.48 -75.65 0.44 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.835 -1.391 . . . . 0.0 110.236 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 68' ' ' TRP . . . . . 0.411 ' CD1' ' HB1' ' B' ' 67' ' ' ALA . 43.6 m95 -122.46 -166.29 1.4 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.871 -1.143 . . . . 0.0 110.985 -178.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 69' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' B' ' 62' ' ' SER . . . 167.87 114.33 0.3 Allowed Glycine 0 N--CA 1.486 2.032 0 C-N-CA 119.359 -1.4 . . . . 0.0 110.546 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 43.2 m -77.31 120.87 22.93 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.946 -0.738 . . . . 0.0 110.531 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -101.29 123.73 45.86 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.266 -0.896 . . . . 0.0 110.396 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -116.03 -171.05 1.91 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.84 -1.163 . . . . 0.0 110.295 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 47.7 ttp180 -143.78 116.02 8.47 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.205 -0.934 . . . . 0.0 111.42 -178.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 74' ' ' GLU . . . . . 0.468 ' HB3' ' HB ' ' B' ' 58' ' ' ILE . 78.1 tt0 -102.98 139.25 38.78 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.215 -0.928 . . . . 0.0 110.035 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.82 39.43 2.13 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.951 -1.093 . . . . 0.0 111.461 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 76' ' ' VAL . . . . . 0.46 ' O ' ' CD1' ' B' ' 58' ' ' ILE . 48.9 t -132.97 129.9 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 120.919 -1.113 . . . . 0.0 111.738 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -159.05 96.43 1.71 Allowed Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 120.922 -1.112 . . . . 0.0 110.809 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -81.66 46.6 2.28 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.925 1.487 . . . . 0.0 111.53 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -129.58 153.06 48.42 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.719 -1.238 . . . . 0.0 111.502 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 15.4 mp0 -136.41 160.5 66.57 Favored Pre-proline 0 N--CA 1.486 1.374 0 O-C-N 121.666 -0.646 . . . . 0.0 109.467 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 81' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -66.68 145.15 74.74 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.75 1.395 . . . . 0.0 110.958 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 64.78 39.95 97.0 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 12.7 p -132.77 147.78 52.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.011 -1.288 . . . . 0.0 111.913 -178.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 12.7 p -100.15 136.64 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.438 -0.789 . . . . 0.0 109.408 178.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -154.02 155.43 35.52 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.051 -1.031 . . . . 0.0 110.171 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 86' ' ' GLU . . . . . 0.459 ' HG2' ' HG3' ' B' ' 20' ' ' ARG . 98.3 mt-10 -119.67 139.07 52.81 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.856 -1.153 . . . . 0.0 110.499 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 55.9 t -125.62 132.78 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.517 -0.739 . . . . 0.0 110.601 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 88' ' ' CYS . . . . . 0.419 ' HB2' ' HB3' ' B' ' 99' ' ' LYS . 75.1 m -107.57 134.98 49.79 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.166 -0.959 . . . . 0.0 109.355 178.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 87.2 mt -121.59 128.26 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.882 -1.136 . . . . 0.0 110.958 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 90' ' ' THR . . . . . 0.415 ' O ' HD12 ' B' ' 96' ' ' LEU . 50.1 m -129.08 128.83 44.34 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.28 -0.887 . . . . 0.0 109.914 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 91' ' ' PHE . . . . . 0.568 ' HA ' HD12 ' B' ' 96' ' ' LEU . 41.1 t80 -112.38 127.35 55.99 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.995 -1.066 . . . . 0.0 111.637 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 92' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' B' ' 95' ' ' ASN . 88.9 m-20 -119.59 155.79 31.59 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.4 -0.813 . . . . 0.0 109.805 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -60.76 -23.84 65.28 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.404 -0.81 . . . . 0.0 112.761 -178.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -105.23 -26.95 11.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.366 -1.459 . . . . 0.0 110.474 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 95' ' ' ASN . . . . . 0.405 ' O ' ' HB2' ' B' ' 92' ' ' ASP . 34.5 m-20 -152.36 172.57 16.26 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 122.082 0.944 . . . . 0.0 112.02 -178.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 96' ' ' LEU . . . . . 0.708 HD21 HD22 ' B' ' 43' ' ' LEU . 54.1 tp -119.07 129.25 54.99 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 97' ' ' THR . . . . . 0.807 HG23 ' OE2' ' B' ' 105' ' ' GLU . 18.3 m -114.45 125.44 53.83 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 120.784 -1.198 . . . . 0.0 111.0 -179.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 44.7 t -120.53 128.06 75.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 99' ' ' LYS . . . . . 0.419 ' HB3' ' HB2' ' B' ' 88' ' ' CYS . 88.3 tttt -114.5 118.99 35.32 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 118.542 -1.263 . . . . 0.0 110.142 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 5.1 mp -100.0 170.49 6.67 Favored Pre-proline 0 C--N 1.302 -1.466 0 O-C-N 121.889 -0.507 . . . . 0.0 110.009 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.72 -23.04 63.56 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.788 1.414 . . . . 0.0 110.998 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -64.95 -34.45 78.46 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.667 -1.271 . . . . 0.0 110.039 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 112.07 -27.22 10.42 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 104' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -72.91 144.67 47.26 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.198 -1.178 . . . . 0.0 109.443 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 105' ' ' GLU . . . . . 0.807 ' OE2' HG23 ' B' ' 97' ' ' THR . 68.2 tt0 -113.57 143.71 44.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.958 -1.089 . . . . 0.0 111.221 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -120.72 148.04 44.49 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 107' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' B' ' 96' ' ' LEU . 98.1 mttt -120.78 145.23 47.76 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.05 -1.031 . . . . 0.0 111.173 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 108' ' ' PHE . . . . . 0.429 ' HB3' HD23 ' B' ' 96' ' ' LEU . 15.7 t80 -126.13 129.83 24.13 Favored Pre-proline 0 C--N 1.291 -1.959 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -64.95 141.01 68.88 Favored 'Trans proline' 0 C--N 1.298 -2.131 0 O-C-N 123.071 1.038 . . . . 0.0 110.362 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 110' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' B' ' 110' ' ' ASN . 4.0 p-10 -91.84 82.16 5.19 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.158 -1.017 . . . . 0.0 109.689 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -54.36 -27.38 35.87 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.443 -1.411 . . . . 0.0 109.273 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 112' ' ' LEU . . . . . 0.517 HD22 ' OD2' ' B' ' 64' ' ' ASP . 82.5 mt -104.96 131.86 51.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.476 -0.765 . . . . 0.0 110.008 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -87.01 61.69 6.94 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.138 -0.977 . . . . 0.0 110.431 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 114' ' ' LEU . . . . . 0.487 HD13 ' HD2' ' B' ' 36' ' ' LYS . 51.7 tp -81.24 130.03 34.85 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.247 -0.908 . . . . 0.0 109.571 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -87.18 -13.03 45.11 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.125 -0.984 . . . . 0.0 111.369 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 116' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' B' ' 11' ' ' LEU . . . -159.73 158.89 32.11 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.765 -1.21 . . . . 0.0 111.898 -178.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 49.7 mm -109.39 125.97 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.442 -0.786 . . . . 0.0 109.858 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -111.66 -26.91 8.76 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.542 -1.349 . . . . 0.0 110.667 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 119' ' ' TYR . . . . . 0.489 ' O ' ' HA ' ' B' ' 34' ' ' LEU . 9.5 t80 -110.18 126.4 54.06 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.364 -0.934 . . . . 0.0 110.76 -178.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 120' ' ' MET . . . . . 0.419 ' CB ' HD12 ' B' ' 9' ' ' LEU . 49.8 ttp -133.19 129.83 38.3 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.444 -0.785 . . . . 0.0 108.976 179.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -152.75 142.31 21.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.905 -1.122 . . . . 0.0 110.578 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 122' ' ' ALA . . . . . 0.463 ' O ' ' CA ' ' B' ' 3' ' ' GLY . . . -147.41 132.47 18.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.013 -1.054 . . . . 0.0 111.351 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 123' ' ' ASP . . . . . 0.482 ' HB3' ' HA3' ' B' ' 3' ' ' GLY . 15.3 p-10 -148.58 147.45 29.03 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.091 -1.006 . . . . 0.0 110.551 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 124' ' ' GLY . . . . . 0.492 ' HA3' ' HA ' ' B' ' 30' ' ' PHE . . . 155.97 -144.43 10.89 Favored Glycine 0 N--CA 1.496 2.639 0 C-N-CA 119.808 -1.187 . . . . 0.0 110.177 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 125' ' ' ASP . . . . . 0.409 ' HB3' ' HA ' ' B' ' 27' ' ' ALA . 87.2 m-20 -95.09 10.82 34.35 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.241 -1.152 . . . . 0.0 111.351 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 126' ' ' PHE . . . . . 0.425 ' HB3' ' CD1' ' B' ' 30' ' ' PHE . 24.4 t80 -112.52 143.71 43.22 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.876 -1.14 . . . . 0.0 109.519 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 127' ' ' LYS . . . . . 0.562 ' HE3' ' HB2' ' B' ' 1' ' ' ALA . 52.0 mttp -116.56 141.11 48.61 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 118.81 -1.156 . . . . 0.0 111.521 -179.174 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 128' ' ' ILE . . . . . 0.971 HG23 HD12 ' B' ' 4' ' ' LEU . 4.1 tt -111.57 122.88 66.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.776 -0.578 . . . . 0.0 109.543 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -101.92 -11.8 18.71 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.078 -1.014 . . . . 0.0 112.196 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 130' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -155.89 150.61 26.14 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.271 -1.518 . . . . 0.0 112.024 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.431 ' CG2' HD11 ' B' ' 128' ' ' ILE . 45.4 t -129.31 133.05 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.588 -0.695 . . . . 0.0 109.162 178.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 132' ' ' ALA . . . . . 0.843 ' O ' HD12 ' B' ' 17' ' ' LEU . . . -136.19 132.66 36.23 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.713 -1.242 . . . . 0.0 111.39 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 133' ' ' PHE . . . . . 0.489 ' CE1' HD13 ' B' ' 17' ' ' LEU . 47.6 m-85 -110.48 147.98 33.0 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.275 -0.891 . . . . 0.0 111.105 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 47.8 t0 . . . . . 0 N--CA 1.496 1.867 0 CA-C-O 118.137 -0.935 . . . . 0.0 111.127 -179.894 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 121.138 0.494 . . . . 0.0 109.991 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 50.8 t -144.85 85.02 1.74 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.148 -0.97 . . . . 0.0 110.418 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 84.6 42.81 7.15 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 120.006 -1.093 . . . . 0.0 110.652 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.453 ' HA ' ' HB3' ' B' ' 8' ' ' ASN . 49.3 tp -59.77 133.7 56.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.88 -1.365 . . . . 0.0 110.7 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.7 t -118.04 130.11 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.361 -0.837 . . . . 0.0 110.071 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -118.81 153.01 35.17 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.325 -0.859 . . . . 0.0 109.555 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.467 ' O ' ' HB3' ' A' ' 8' ' ' ASN . 18.1 p -148.78 171.98 15.37 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.261 -0.899 . . . . 0.0 110.314 -178.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.467 ' HB3' ' O ' ' A' ' 7' ' ' SER . 19.6 t-20 61.08 35.49 18.7 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.335 0.588 . . . . 0.0 110.272 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.525 ' O ' ' C ' ' A' ' 10' ' ' ASN . 87.7 mt -91.16 -17.97 25.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.215 -0.928 . . . . 0.0 110.893 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.525 ' C ' ' O ' ' A' ' 9' ' ' LEU . 7.6 m120 11.24 77.47 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.506 0 CA-C-O 121.522 0.677 . . . . 0.0 112.791 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.617 HD21 ' CZ ' ' A' ' 133' ' ' PHE . 19.2 mt -98.93 128.05 45.0 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.686 -0.634 . . . . 0.0 110.765 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -96.35 169.68 8.6 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.18 -0.95 . . . . 0.0 110.47 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.438 ' HD3' ' O ' ' A' ' 115' ' ' GLU . 40.7 Cg_endo -66.13 146.65 82.38 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.976 1.514 . . . . 0.0 110.156 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.23 -7.78 56.84 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -117.92 147.28 43.28 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.953 -1.322 . . . . 0.0 109.998 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.8 m -109.63 145.13 36.97 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.963 -1.086 . . . . 0.0 111.606 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.708 HD12 ' O ' ' A' ' 132' ' ' ALA . 47.5 tp -121.2 133.78 55.18 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -122.94 141.75 51.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.743 -1.223 . . . . 0.0 111.183 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 69.0 t -124.27 120.27 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 119.894 -0.723 . . . . 0.0 110.382 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -116.85 122.06 43.28 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.1 -1.0 . . . . 0.0 109.549 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.526 ' O ' HG13 ' A' ' 84' ' ' VAL . . . -144.71 -150.15 5.17 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.432 -1.365 . . . . 0.0 109.897 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -133.34 147.01 51.82 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.741 -1.446 . . . . 0.0 110.529 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.561 HG22 ' HD1' ' A' ' 126' ' ' PHE . 51.1 t -110.23 128.79 66.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.5 -0.75 . . . . 0.0 109.898 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.94 147.25 74.09 Favored Pre-proline 0 C--N 1.301 -1.528 0 O-C-N 121.061 -1.024 . . . . 0.0 109.2 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.415 ' HA ' ' N ' ' A' ' 82' ' ' GLY . 40.6 Cg_endo -65.89 -20.69 58.04 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.729 1.384 . . . . 0.0 110.141 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -116.77 29.63 7.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.439 -0.788 . . . . 0.0 109.228 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.472 ' HA ' ' HB3' ' A' ' 125' ' ' ASP . . . -63.74 99.09 0.21 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.514 -0.741 . . . . 0.0 110.884 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -66.52 -43.97 83.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.468 -0.77 . . . . 0.0 110.401 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.5 t -165.03 147.61 8.15 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.461 -0.774 . . . . 0.0 110.26 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.489 ' CE1' ' HG2' ' A' ' 47' ' ' PRO . 49.6 p90 -148.95 156.22 41.97 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.567 HG22 ' CB ' ' A' ' 46' ' ' ASN . 53.3 t -133.43 137.85 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.534 -1.354 . . . . 0.0 112.369 -177.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 93.2 mt -112.37 133.09 54.66 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.47 ' OD1' ' CE1' ' A' ' 44' ' ' HIS . 80.8 m-20 -125.78 135.89 52.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.013 -1.054 . . . . 0.0 110.968 -178.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.493 HD11 ' HB3' ' A' ' 43' ' ' LEU . 0.7 OUTLIER -145.17 114.16 6.93 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.077 -1.014 . . . . 0.0 110.934 179.415 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.466 ' O ' ' N ' ' A' ' 119' ' ' TYR . . . -163.45 -132.31 1.33 Allowed Glycine 0 N--CA 1.496 2.66 0 N-CA-C 108.233 -1.947 . . . . 0.0 108.233 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.72 ' HD2' HD13 ' A' ' 114' ' ' LEU . 42.1 mtpt -112.08 -46.03 3.25 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.093 -1.24 . . . . 0.0 108.05 178.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -123.67 164.41 19.15 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.882 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.23 -32.18 68.08 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.339 -0.851 . . . . 0.0 110.982 -179.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.454 ' HB3' ' N ' ' A' ' 66' ' ' GLY . 87.1 m-20 -94.98 -9.07 35.09 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.877 -1.14 . . . . 0.0 111.186 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -113.56 66.42 0.66 Allowed 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.158 -0.964 . . . . 0.0 110.138 -178.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 47.0 mt -96.24 133.25 40.81 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 2.1 m -85.41 -31.24 23.0 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.993 -1.067 . . . . 0.0 109.784 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.872 HD13 ' CD2' ' A' ' 96' ' ' LEU . 25.3 tp -128.5 129.19 45.7 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.611 -0.681 . . . . 0.0 109.982 -179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.47 ' CE1' ' OD1' ' A' ' 33' ' ' ASN . 63.5 t60 -128.23 127.73 43.4 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.102 -0.999 . . . . 0.0 110.305 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.507 ' CE1' HG21 ' A' ' 58' ' ' ILE . 83.7 t80 -123.39 122.88 39.41 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.975 -1.078 . . . . 0.0 110.043 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.567 ' CB ' HG22 ' A' ' 31' ' ' VAL . 1.4 t-20 -142.71 84.23 11.03 Favored Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 121.154 -0.966 . . . . 0.0 110.954 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.504 ' HD3' ' CD2' ' A' ' 45' ' ' PHE . 52.7 Cg_endo -70.64 142.77 44.84 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.657 1.346 . . . . 0.0 109.489 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -127.0 97.59 5.01 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.921 -1.112 . . . . 0.0 110.394 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -61.03 -45.44 94.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.132 -0.98 . . . . 0.0 109.139 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -159.63 103.36 1.55 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.309 -0.869 . . . . 0.0 109.413 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -113.82 -104.17 0.4 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.045 -1.034 . . . . 0.0 110.695 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -65.88 -41.47 91.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.663 -1.273 . . . . 0.0 109.872 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 168.54 39.54 0.02 OUTLIER Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.402 ' N ' ' OD1' ' A' ' 54' ' ' ASP . 8.9 m-20 -114.08 -179.42 3.63 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.353 -1.087 . . . . 0.0 109.115 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.423 ' O ' ' C ' ' A' ' 56' ' ' ASN . . . -142.14 143.99 33.27 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.977 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.423 ' C ' ' O ' ' A' ' 55' ' ' ALA . 81.2 m-20 27.55 49.4 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 178.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 55.2 m -118.48 130.51 55.98 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.84 -1.162 . . . . 0.0 109.352 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.589 HD12 ' H ' ' A' ' 76' ' ' VAL . 86.8 mt -115.6 135.26 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.203 -0.936 . . . . 0.0 110.933 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 64.6 t -102.05 126.09 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.382 -0.824 . . . . 0.0 110.265 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 80.2 m -116.76 121.27 41.1 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.142 -0.974 . . . . 0.0 109.251 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.461 ' O ' ' HB3' ' A' ' 44' ' ' HIS . 2.5 p-10 -151.63 179.1 8.69 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.952 -1.093 . . . . 0.0 111.163 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.455 ' O ' ' CA ' ' A' ' 69' ' ' GLY . 15.1 m -133.91 154.18 51.25 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.325 -0.86 . . . . 0.0 109.874 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.497 ' CD ' ' HA2' ' A' ' 66' ' ' GLY . 18.3 ttmt -128.53 143.67 51.01 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.491 -1.381 . . . . 0.0 111.277 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.666 ' HB2' HD21 ' A' ' 112' ' ' LEU . 59.4 t0 -122.34 95.61 4.71 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.463 -0.773 . . . . 0.0 109.161 178.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 71.21 19.87 77.68 Favored Glycine 0 N--CA 1.484 1.834 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.497 ' HA2' ' CD ' ' A' ' 63' ' ' LYS . . . 72.29 32.72 62.32 Favored Glycine 0 N--CA 1.486 2.009 0 C-N-CA 119.386 -1.388 . . . . 0.0 110.694 179.191 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -101.86 -74.55 0.62 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.855 -1.379 . . . . 0.0 111.122 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 14.1 m0 -124.16 -147.83 0.38 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.14 -0.975 . . . . 0.0 110.627 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.455 ' CA ' ' O ' ' A' ' 62' ' ' SER . . . 158.64 144.65 4.01 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.631 ' O ' HG23 ' A' ' 70' ' ' THR . 6.5 t -81.53 80.47 7.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.455 -1.026 . . . . 0.0 109.729 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.452 ' HA ' ' HB3' ' A' ' 61' ' ' ASN . 78.6 tt0 -71.07 111.56 6.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.249 -0.907 . . . . 0.0 110.875 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -122.79 -164.94 1.24 Allowed 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.333 -0.855 . . . . 0.0 109.556 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -137.65 130.92 30.73 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.431 -0.907 . . . . 0.0 110.583 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -131.83 83.43 2.09 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.309 -0.87 . . . . 0.0 109.508 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.74 88.08 0.1 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.216 -0.928 . . . . 0.0 110.611 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.589 ' H ' HD12 ' A' ' 58' ' ' ILE . 6.2 p -134.6 141.49 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.449 -0.782 . . . . 0.0 109.682 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -157.11 89.21 2.57 Favored Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 120.55 -1.344 . . . . 0.0 110.891 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.403 ' CB ' ' OD2' ' A' ' 102' ' ' ASP . 51.0 Cg_endo -77.39 -6.63 16.51 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.845 1.445 . . . . 0.0 111.978 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -142.21 -167.3 2.44 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.79 -1.194 . . . . 0.0 111.293 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.422 ' CB ' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -139.48 172.53 6.3 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.481 -0.762 . . . . 0.0 109.723 179.753 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.422 ' HD2' ' CB ' ' A' ' 80' ' ' GLN . 44.3 Cg_endo -67.22 147.42 78.68 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.807 1.425 . . . . 0.0 111.294 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.415 ' N ' ' HA ' ' A' ' 25' ' ' PRO . . . 78.71 23.56 64.29 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.4 t -137.01 147.45 46.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.083 -1.245 . . . . 0.0 111.113 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.526 HG13 ' O ' ' A' ' 21' ' ' GLY . 73.3 t -79.23 130.26 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.529 -0.732 . . . . 0.0 110.116 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -130.82 142.24 50.38 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.946 -1.096 . . . . 0.0 109.692 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.405 ' O ' ' HG3' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -120.22 127.29 52.29 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.519 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 73.4 t -121.52 132.26 71.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 118.985 -1.086 . . . . 0.0 111.019 -177.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 11.8 t -97.04 117.74 31.9 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.493 -0.754 . . . . 0.0 109.368 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 72.7 mt -111.51 125.24 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.082 -1.012 . . . . 0.0 109.468 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 57.7 m -122.36 129.38 52.06 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.361 -0.837 . . . . 0.0 109.665 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -106.76 118.28 36.27 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.052 -1.03 . . . . 0.0 110.822 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -115.73 152.08 33.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.467 -0.771 . . . . 0.0 109.378 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 69.9 tp60 -62.73 -38.83 92.07 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.968 -1.082 . . . . 0.0 110.521 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.34 -39.35 89.15 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.949 -1.094 . . . . 0.0 110.563 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -166.7 178.8 5.74 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.322 -0.862 . . . . 0.0 110.068 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.872 ' CD2' HD13 ' A' ' 43' ' ' LEU . 49.5 tp -102.08 129.86 48.52 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.375 -0.828 . . . . 0.0 109.197 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 98.9 m -115.4 122.67 46.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.717 -1.239 . . . . 0.0 111.22 -179.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 7.0 m -120.84 129.51 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.382 -0.824 . . . . 0.0 109.36 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -113.53 124.79 53.21 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.797 -1.19 . . . . 0.0 109.396 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.0 mp -85.42 164.37 40.89 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.301 -0.874 . . . . 0.0 109.57 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -66.14 -32.85 42.21 Favored 'Trans proline' 0 C--N 1.302 -1.905 0 O-C-N 123.858 1.452 . . . . 0.0 110.486 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.403 ' OD2' ' CB ' ' A' ' 78' ' ' PRO . 99.7 m-20 -74.45 -25.32 59.34 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.106 -0.996 . . . . 0.0 110.208 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 121.3 3.11 10.66 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.761 -1.209 . . . . 0.0 111.095 178.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -83.9 135.8 34.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.598 -1.531 . . . . 0.0 110.249 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 64.5 tt0 -132.49 148.56 52.39 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.434 -0.791 . . . . 0.0 111.129 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -141.0 156.4 46.05 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.602 -0.686 . . . . 0.0 109.21 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 98.5 mttt -123.92 141.0 52.43 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.007 -1.058 . . . . 0.0 110.867 -178.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -123.71 143.35 41.63 Favored Pre-proline 0 N--CA 1.494 1.733 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.84 144.28 47.88 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.299 1.158 . . . . 0.0 109.184 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.485 ' ND2' ' O ' ' A' ' 110' ' ' ASN . 6.0 p-10 -95.0 82.76 3.84 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 120.934 -1.104 . . . . 0.0 110.584 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.427 ' CZ ' ' HB ' ' A' ' 70' ' ' THR . 98.2 mtt180 -55.77 -22.11 22.51 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.818 -1.176 . . . . 0.0 109.111 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.666 HD21 ' HB2' ' A' ' 64' ' ' ASP . 57.4 mt -96.9 141.92 29.51 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.319 -0.863 . . . . 0.0 108.704 178.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 49.9 m-20 -97.02 62.42 1.83 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.748 -1.22 . . . . 0.0 109.875 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.72 HD13 ' HD2' ' A' ' 36' ' ' LYS . 64.9 tp -82.33 130.04 35.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.353 -0.842 . . . . 0.0 111.08 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.438 ' O ' ' HD3' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -88.94 -17.23 29.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.409 -0.807 . . . . 0.0 109.87 179.487 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.51 ' HA ' ' O ' ' A' ' 11' ' ' LEU . . . -163.22 144.08 9.36 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.723 -1.236 . . . . 0.0 111.682 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.43 HD13 HD12 ' A' ' 34' ' ' LEU . 93.1 mt -98.87 124.59 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.386 -0.821 . . . . 0.0 108.981 178.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.59 13.0 8.08 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.592 -0.692 . . . . 0.0 110.772 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.472 ' O ' ' HA ' ' A' ' 34' ' ' LEU . 7.8 t80 -131.62 128.82 39.92 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.974 -1.079 . . . . 0.0 110.261 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 62.5 ttp -142.78 130.8 21.79 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.347 -0.846 . . . . 0.0 109.85 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -140.88 144.53 35.32 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.229 -0.92 . . . . 0.0 109.76 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -132.11 108.95 9.64 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.281 -0.887 . . . . 0.0 109.458 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -137.65 129.16 28.19 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.531 -0.731 . . . . 0.0 109.649 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.466 ' HA3' ' HA ' ' A' ' 30' ' ' PHE . . . 154.13 -157.93 27.81 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 108.841 -1.704 . . . . 0.0 108.841 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.472 ' HB3' ' HA ' ' A' ' 27' ' ' ALA . 87.6 m-20 -78.38 -0.22 28.22 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.3 -1.118 . . . . 0.0 110.552 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.561 ' HD1' HG22 ' A' ' 23' ' ' VAL . 42.7 t80 -95.4 142.28 27.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.09 -1.006 . . . . 0.0 109.859 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -112.95 140.12 48.02 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 118.815 -1.154 . . . . 0.0 110.538 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.531 HG23 ' O ' ' A' ' 128' ' ' ILE . 20.6 tt -108.51 122.79 63.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.625 -0.672 . . . . 0.0 109.755 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -105.74 -23.07 12.81 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.328 -0.857 . . . . 0.0 110.97 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.404 ' HA ' ' O ' ' B' ' 131' ' ' VAL . 0.1 OUTLIER -153.03 154.88 35.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.82 -1.175 . . . . 0.0 112.136 -178.983 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' B' ' 130' ' ' CYS . 42.8 t -123.71 135.91 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.003 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.708 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -124.29 146.35 48.84 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.867 -1.145 . . . . 0.0 110.574 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.617 ' CZ ' HD21 ' A' ' 11' ' ' LEU . 0.4 OUTLIER -94.39 -139.92 0.23 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.349 -0.844 . . . . 0.0 109.798 179.786 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 49.0 t0 . . . . . 0 N--CA 1.492 1.673 0 O-C-N 120.631 -1.293 . . . . 0.0 110.437 -179.589 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.218 0.532 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' CYS . . . . . . . . . . . . . 49.6 t -145.17 84.85 1.72 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.095 -1.003 . . . . 0.0 110.608 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 84.84 43.37 6.81 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.42 HD23 HD13 ' B' ' 128' ' ' ILE . 50.1 tp -60.18 133.66 56.31 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.918 -1.342 . . . . 0.0 110.577 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 46.7 t -117.95 130.07 73.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.363 -0.836 . . . . 0.0 110.111 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -118.94 152.51 36.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.926 . . . . 0.0 109.485 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 7' ' ' SER . . . . . 0.486 ' O ' ' HB3' ' B' ' 8' ' ' ASN . 17.1 p -148.6 172.26 14.82 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.102 -0.999 . . . . 0.0 110.25 -179.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 8' ' ' ASN . . . . . 0.486 ' HB3' ' O ' ' B' ' 7' ' ' SER . 19.8 t-20 61.34 35.47 17.96 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.404 0.621 . . . . 0.0 110.303 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.538 ' O ' ' C ' ' B' ' 10' ' ' ASN . 88.5 mt -92.52 -12.51 31.73 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.362 -0.836 . . . . 0.0 111.153 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 10' ' ' ASN . . . . . 0.538 ' C ' ' O ' ' B' ' 9' ' ' LEU . 7.3 m120 2.85 80.42 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.491 0 CA-C-O 122.144 0.973 . . . . 0.0 112.953 -178.02 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.613 HD21 ' CZ ' ' B' ' 133' ' ' PHE . 18.7 mt -98.96 127.96 45.01 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.642 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -96.35 169.76 8.47 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.204 -0.935 . . . . 0.0 110.549 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 13' ' ' PRO . . . . . 0.438 ' HD3' ' O ' ' B' ' 115' ' ' GLU . 40.6 Cg_endo -66.16 146.74 82.48 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 124.004 1.529 . . . . 0.0 110.18 178.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.86 -7.48 57.41 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.084 -1.207 . . . . 0.0 110.084 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -117.94 147.5 43.09 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.905 -1.35 . . . . 0.0 109.827 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 16' ' ' CYS . . . . . . . . . . . . . 6.2 m -110.11 145.25 37.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.085 -1.009 . . . . 0.0 111.365 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.711 HD12 ' O ' ' B' ' 132' ' ' ALA . 46.9 tp -121.33 133.83 55.13 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -122.97 141.63 51.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.867 -1.146 . . . . 0.0 111.21 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 69.4 t -124.09 120.91 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 119.902 -0.719 . . . . 0.0 110.354 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -117.44 121.81 42.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.259 -0.901 . . . . 0.0 109.602 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.53 ' O ' HG13 ' B' ' 84' ' ' VAL . . . -144.65 -149.93 5.14 Favored Glycine 0 N--CA 1.494 2.511 0 C-N-CA 119.486 -1.34 . . . . 0.0 109.897 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -133.72 146.47 50.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.814 -1.403 . . . . 0.0 110.685 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.579 HG22 ' HD1' ' B' ' 126' ' ' PHE . 50.9 t -109.71 128.63 65.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.501 -0.749 . . . . 0.0 109.961 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.79 147.01 73.5 Favored Pre-proline 0 C--N 1.299 -1.602 0 O-C-N 121.093 -1.004 . . . . 0.0 109.253 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.427 ' HA ' ' N ' ' B' ' 82' ' ' GLY . 40.4 Cg_endo -66.05 -20.1 57.2 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.714 1.376 . . . . 0.0 110.116 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -117.15 29.44 7.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.292 -0.88 . . . . 0.0 109.246 178.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 27' ' ' ALA . . . . . 0.465 ' HA ' ' HB3' ' B' ' 125' ' ' ASP . . . -63.53 99.29 0.2 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.51 -0.744 . . . . 0.0 110.898 -179.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -66.46 -45.54 79.38 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.42 -0.8 . . . . 0.0 110.254 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 33.4 t -162.57 148.23 12.5 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.491 -0.756 . . . . 0.0 110.301 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 30' ' ' PHE . . . . . 0.49 ' CD2' ' HB2' ' B' ' 126' ' ' PHE . 49.8 p90 -149.16 156.02 41.54 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 177.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.567 HG22 ' CB ' ' B' ' 46' ' ' ASN . 53.8 t -133.3 138.14 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.372 -1.455 . . . . 0.0 112.373 -177.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 93.6 mt -112.57 133.29 54.7 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 33' ' ' ASN . . . . . 0.455 ' OD1' ' CE1' ' B' ' 44' ' ' HIS . 80.8 m-20 -125.89 136.0 52.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.967 -1.083 . . . . 0.0 110.995 -178.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.537 HD11 ' HB3' ' B' ' 43' ' ' LEU . 0.7 OUTLIER -145.28 111.19 5.5 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.16 -0.962 . . . . 0.0 111.071 179.397 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 35' ' ' GLY . . . . . 0.461 ' O ' ' N ' ' B' ' 119' ' ' TYR . . . -159.16 -131.18 1.22 Allowed Glycine 0 N--CA 1.495 2.609 0 N-CA-C 108.526 -1.83 . . . . 0.0 108.526 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 36' ' ' LYS . . . . . 0.708 ' HD2' HD13 ' B' ' 114' ' ' LEU . 42.3 mtpt -112.93 -46.32 3.12 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -123.42 164.42 18.91 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.878 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.34 -32.37 68.47 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.242 -0.911 . . . . 0.0 111.035 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 39' ' ' ASN . . . . . 0.446 ' HB3' ' N ' ' B' ' 66' ' ' GLY . 86.9 m-20 -94.82 -8.98 35.84 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.045 -1.034 . . . . 0.0 111.085 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 40' ' ' ASN . . . . . 0.405 ' ND2' ' N ' ' B' ' 65' ' ' GLY . 8.1 m120 -113.85 66.19 0.66 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.145 -0.972 . . . . 0.0 110.061 -178.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.416 ' HA ' ' HA3' ' B' ' 35' ' ' GLY . 45.4 mt -95.51 135.53 37.04 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 42' ' ' CYS . . . . . . . . . . . . . 1.7 m -88.81 -29.84 19.43 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.956 -1.09 . . . . 0.0 109.274 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.881 HD13 ' CD2' ' B' ' 96' ' ' LEU . 25.9 tp -128.94 128.99 44.88 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.539 -0.726 . . . . 0.0 109.874 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 44' ' ' HIS . . . . . 0.455 ' CE1' ' OD1' ' B' ' 33' ' ' ASN . 63.0 t60 -128.2 127.51 43.03 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.205 -0.935 . . . . 0.0 110.403 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.516 ' CE1' HG21 ' B' ' 58' ' ' ILE . 83.3 t80 -123.35 122.71 39.0 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.173 -0.954 . . . . 0.0 110.161 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 46' ' ' ASN . . . . . 0.567 ' CB ' HG22 ' B' ' 31' ' ' VAL . 1.4 t-20 -142.47 84.41 11.21 Favored Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 121.157 -0.964 . . . . 0.0 110.958 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 47' ' ' PRO . . . . . 0.508 ' HD3' ' CD2' ' B' ' 45' ' ' PHE . 52.9 Cg_endo -70.76 142.9 44.6 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 123.621 1.327 . . . . 0.0 109.421 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -127.15 97.5 4.96 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.023 -1.048 . . . . 0.0 110.347 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -60.84 -45.18 95.49 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.313 -0.867 . . . . 0.0 109.176 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -159.94 103.54 1.5 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.385 -0.822 . . . . 0.0 109.395 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -114.15 -103.92 0.41 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.052 -1.03 . . . . 0.0 110.73 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 52' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -66.08 -41.12 91.12 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.641 -1.287 . . . . 0.0 109.892 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 168.14 39.56 0.02 OUTLIER Glycine 0 N--CA 1.485 1.921 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -113.99 -179.44 3.63 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.485 -1.009 . . . . 0.0 109.134 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.46 ' O ' ' C ' ' B' ' 56' ' ' ASN . . . -140.68 150.3 43.32 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.162 -0.961 . . . . 0.0 110.256 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 56' ' ' ASN . . . . . 0.46 ' C ' ' O ' ' B' ' 55' ' ' ALA . 80.3 m-20 17.09 54.62 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 57' ' ' THR . . . . . 0.4 ' N ' ' O ' ' B' ' 55' ' ' ALA . 54.0 m -120.12 130.09 54.47 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.131 -0.981 . . . . 0.0 109.237 178.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 58' ' ' ILE . . . . . 0.59 HD12 ' H ' ' B' ' 76' ' ' VAL . 85.3 mt -115.78 135.23 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.166 -0.959 . . . . 0.0 110.948 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 69.3 t -101.69 126.33 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.433 -0.792 . . . . 0.0 110.36 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 79.0 m -117.26 120.94 39.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.261 -0.899 . . . . 0.0 109.297 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 61' ' ' ASN . . . . . 0.46 ' HB3' ' HA ' ' B' ' 71' ' ' GLU . 2.4 p-10 -151.32 179.03 8.67 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.057 -1.027 . . . . 0.0 111.265 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 62' ' ' SER . . . . . 0.456 ' O ' ' CA ' ' B' ' 69' ' ' GLY . 15.8 m -133.94 153.83 51.5 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.361 -0.837 . . . . 0.0 109.892 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 63' ' ' LYS . . . . . 0.498 ' CD ' ' HA2' ' B' ' 66' ' ' GLY . 17.8 ttmt -128.4 143.5 51.01 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.453 -1.404 . . . . 0.0 111.228 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 64' ' ' ASP . . . . . 0.668 ' HB2' HD21 ' B' ' 112' ' ' LEU . 58.5 t0 -122.42 94.95 4.45 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.527 -0.733 . . . . 0.0 109.351 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 65' ' ' GLY . . . . . 0.405 ' N ' ' ND2' ' B' ' 40' ' ' ASN . . . 71.81 19.87 78.38 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 66' ' ' GLY . . . . . 0.498 ' HA2' ' CD ' ' B' ' 63' ' ' LYS . . . 72.08 32.33 63.27 Favored Glycine 0 N--CA 1.488 2.118 0 O-C-N 120.833 -1.393 . . . . 0.0 110.598 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -101.07 -74.95 0.6 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.737 -1.449 . . . . 0.0 111.174 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 68' ' ' TRP . . . . . . . . . . . . . 13.6 m0 -123.99 -147.76 0.38 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.136 -0.978 . . . . 0.0 110.454 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 69' ' ' GLY . . . . . 0.456 ' CA ' ' O ' ' B' ' 62' ' ' SER . . . 158.61 145.4 4.23 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 70' ' ' THR . . . . . 0.623 HG23 ' O ' ' B' ' 70' ' ' THR . 6.9 t -81.88 80.08 8.26 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.153 -1.204 . . . . 0.0 109.759 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 71' ' ' GLU . . . . . 0.46 ' HA ' ' HB3' ' B' ' 61' ' ' ASN . 79.4 tt0 -70.58 111.84 6.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.914 . . . . 0.0 110.858 -179.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -123.06 -165.07 1.26 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.36 -0.837 . . . . 0.0 109.52 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -137.7 130.18 29.56 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.348 -0.941 . . . . 0.0 110.588 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -131.03 83.45 2.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.266 -0.896 . . . . 0.0 109.747 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.66 88.03 0.09 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.124 -0.985 . . . . 0.0 110.74 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 76' ' ' VAL . . . . . 0.59 ' H ' HD12 ' B' ' 58' ' ' ILE . 5.9 p -134.55 141.45 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.518 -0.739 . . . . 0.0 109.864 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -157.24 89.53 2.51 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 120.733 -1.23 . . . . 0.0 110.833 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 78' ' ' PRO . . . . . 0.404 ' CB ' ' OD2' ' B' ' 102' ' ' ASP . 53.3 Cg_endo -77.65 -6.23 16.0 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 O-C-N 123.884 1.465 . . . . 0.0 112.165 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -142.55 -167.08 2.42 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.858 -1.151 . . . . 0.0 111.401 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.423 ' CB ' ' HD2' ' B' ' 81' ' ' PRO . 0.0 OUTLIER -139.66 172.39 6.49 Favored Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.382 -0.823 . . . . 0.0 109.758 179.77 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 81' ' ' PRO . . . . . 0.423 ' HD2' ' CB ' ' B' ' 80' ' ' GLN . 43.8 Cg_endo -67.09 147.27 79.21 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.789 1.415 . . . . 0.0 111.223 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 82' ' ' GLY . . . . . 0.427 ' N ' ' HA ' ' B' ' 25' ' ' PRO . . . 78.82 23.65 63.82 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 9.5 t -137.1 147.15 45.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.211 -1.17 . . . . 0.0 111.212 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.53 HG13 ' O ' ' B' ' 21' ' ' GLY . 72.3 t -79.07 130.0 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.619 -0.676 . . . . 0.0 109.979 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -130.53 142.16 50.48 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.108 -0.995 . . . . 0.0 109.736 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 86' ' ' GLU . . . . . 0.402 ' O ' ' HG3' ' B' ' 86' ' ' GLU . 0.2 OUTLIER -120.15 127.14 52.21 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.512 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 76.8 t -121.63 131.93 71.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 119.142 -1.023 . . . . 0.0 111.063 -177.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 88' ' ' CYS . . . . . . . . . . . . . 12.7 t -96.85 117.87 32.05 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.485 -0.759 . . . . 0.0 109.525 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 70.7 mt -111.6 124.89 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.149 -0.969 . . . . 0.0 109.533 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 56.6 m -122.16 129.23 52.12 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.276 -0.89 . . . . 0.0 109.665 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 91' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -106.62 117.98 35.47 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.209 -0.932 . . . . 0.0 110.891 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -115.27 151.76 33.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.686 -0.634 . . . . 0.0 109.465 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 69.6 tp60 -62.67 -38.84 91.93 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.933 -1.104 . . . . 0.0 110.488 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.29 -39.15 89.17 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.967 -1.083 . . . . 0.0 110.589 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -166.91 178.72 5.65 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.265 -0.897 . . . . 0.0 109.917 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 96' ' ' LEU . . . . . 0.881 ' CD2' HD13 ' B' ' 43' ' ' LEU . 46.7 tp -102.08 129.69 48.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.389 -0.82 . . . . 0.0 109.284 179.021 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 98.8 m -115.23 122.77 47.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.725 -1.234 . . . . 0.0 111.162 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 7.0 m -121.06 129.55 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.408 -0.807 . . . . 0.0 109.312 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -113.46 125.2 53.96 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.757 -1.214 . . . . 0.0 109.342 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 7.9 mp -85.52 165.0 37.97 Favored Pre-proline 0 C--N 1.302 -1.495 0 O-C-N 121.195 -0.94 . . . . 0.0 109.598 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -66.6 -32.81 37.88 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.991 1.521 . . . . 0.0 110.37 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 102' ' ' ASP . . . . . 0.404 ' OD2' ' CB ' ' B' ' 78' ' ' PRO . 99.6 m-20 -74.54 -25.21 59.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.999 -1.063 . . . . 0.0 110.156 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 121.22 2.77 10.86 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.53 -1.319 . . . . 0.0 111.057 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 104' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -83.67 136.01 34.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.581 -1.541 . . . . 0.0 110.123 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -132.58 148.72 52.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.452 -0.78 . . . . 0.0 110.949 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -141.08 156.51 45.98 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -124.1 141.1 52.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.007 -1.058 . . . . 0.0 110.93 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 108' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -123.58 143.76 42.48 Favored Pre-proline 0 N--CA 1.493 1.699 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -71.23 144.17 45.71 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 N-CA-C 109.14 -1.138 . . . . 0.0 109.14 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 110' ' ' ASN . . . . . 0.486 ' ND2' ' O ' ' B' ' 110' ' ' ASN . 6.1 p-10 -94.92 83.19 3.93 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.933 -1.104 . . . . 0.0 110.572 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 111' ' ' ARG . . . . . 0.43 ' NH2' ' OG1' ' B' ' 70' ' ' THR . 98.1 mtt180 -56.11 -22.23 26.95 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.704 -1.248 . . . . 0.0 109.08 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 112' ' ' LEU . . . . . 0.668 HD21 ' HB2' ' B' ' 64' ' ' ASP . 56.5 mt -97.05 141.61 29.99 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 47.4 m-20 -96.71 61.96 1.92 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.706 -1.246 . . . . 0.0 110.018 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 114' ' ' LEU . . . . . 0.708 HD13 ' HD2' ' B' ' 36' ' ' LYS . 64.3 tp -81.89 129.53 34.79 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.332 -0.855 . . . . 0.0 111.078 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 115' ' ' GLU . . . . . 0.438 ' O ' ' HD3' ' B' ' 13' ' ' PRO . 0.0 OUTLIER -88.5 -17.4 30.38 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.407 -0.808 . . . . 0.0 109.746 179.504 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 116' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' B' ' 11' ' ' LEU . . . -163.05 144.29 9.72 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.76 -1.213 . . . . 0.0 111.765 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 117' ' ' ILE . . . . . 0.428 HD13 HD12 ' B' ' 34' ' ' LEU . 91.7 mt -98.92 124.5 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.37 -0.831 . . . . 0.0 108.908 178.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.82 13.21 7.95 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.647 -0.658 . . . . 0.0 110.827 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 119' ' ' TYR . . . . . 0.467 ' O ' ' HA ' ' B' ' 34' ' ' LEU . 8.0 t80 -131.81 128.73 39.36 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.086 -1.009 . . . . 0.0 110.112 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 62.6 ttp -142.74 130.74 21.8 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.44 -0.788 . . . . 0.0 109.797 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -140.83 144.71 35.52 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.249 -0.907 . . . . 0.0 109.757 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -132.23 108.97 9.59 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.353 -0.842 . . . . 0.0 109.538 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -137.97 128.62 26.68 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.372 -0.83 . . . . 0.0 109.61 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 124' ' ' GLY . . . . . 0.464 ' HA3' ' HA ' ' B' ' 30' ' ' PHE . . . 154.79 -157.74 27.8 Favored Glycine 0 N--CA 1.483 1.794 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 125' ' ' ASP . . . . . 0.465 ' HB3' ' HA ' ' B' ' 27' ' ' ALA . 87.5 m-20 -78.55 0.02 27.84 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.405 -1.056 . . . . 0.0 110.495 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 126' ' ' PHE . . . . . 0.579 ' HD1' HG22 ' B' ' 23' ' ' VAL . 42.6 t80 -95.79 142.13 28.43 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.984 -1.073 . . . . 0.0 109.73 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -112.8 139.83 48.1 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 118.896 -1.121 . . . . 0.0 110.502 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 128' ' ' ILE . . . . . 0.52 ' O ' HG23 ' B' ' 128' ' ' ILE . 20.6 tt -108.12 123.08 63.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.61 -0.681 . . . . 0.0 109.685 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -106.03 -23.33 12.66 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.403 -0.811 . . . . 0.0 111.028 -179.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 130' ' ' CYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 131' ' ' VAL . 0.1 OUTLIER -153.05 155.32 36.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.95 -1.094 . . . . 0.0 112.177 -179.071 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 130' ' ' CYS . 44.3 t -123.93 136.02 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 132' ' ' ALA . . . . . 0.711 ' O ' HD12 ' B' ' 17' ' ' LEU . . . -124.53 146.21 49.12 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.518 -1.363 . . . . 0.0 110.666 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 133' ' ' PHE . . . . . 0.613 ' CZ ' HD21 ' B' ' 11' ' ' LEU . 0.4 OUTLIER -94.08 -139.87 0.22 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.286 -0.884 . . . . 0.0 109.739 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 49.5 t0 . . . . . 0 N--CA 1.493 1.717 0 O-C-N 120.668 -1.27 . . . . 0.0 110.462 -179.6 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.196 0.522 . . . . 0.0 109.968 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.533 ' HA ' ' HB2' ' A' ' 123' ' ' ASP . 1.3 m -90.09 56.23 3.36 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.228 -0.92 . . . . 0.0 110.56 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 2' ' ' CYS . . . 32.87 -149.09 0.01 OUTLIER Glycine 0 N--CA 1.503 3.156 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 179.316 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.833 HD22 HD23 ' B' ' 9' ' ' LEU . 48.5 mt -97.9 128.2 44.34 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.946 -1.326 . . . . 0.0 109.265 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.9 t -96.37 135.36 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.106 -0.996 . . . . 0.0 109.741 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.938 ' HB1' HD11 ' A' ' 9' ' ' LEU . . . -124.36 145.03 49.69 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.241 -0.912 . . . . 0.0 111.083 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.414 ' O ' ' HB3' ' A' ' 8' ' ' ASN . 32.9 p -145.74 170.19 17.0 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' B' ' 3' ' ' GLY . 40.0 t-20 59.49 32.21 21.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.338 -0.851 . . . . 0.0 109.189 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.938 HD11 ' HB1' ' A' ' 6' ' ' ALA . 96.3 mt -90.7 2.73 55.7 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.65 -0.656 . . . . 0.0 111.834 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.506 ' C ' ' O ' ' A' ' 9' ' ' LEU . 36.3 t-20 -1.08 76.81 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.564 0 N-CA-C 113.723 1.008 . . . . 0.0 113.723 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.601 HD12 ' HE2' ' A' ' 133' ' ' PHE . 5.7 tt -92.37 130.89 37.93 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.062 -1.024 . . . . 0.0 109.376 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -100.43 165.79 13.78 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.266 -0.896 . . . . 0.0 111.189 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.472 ' HA ' ' O ' ' A' ' 91' ' ' PHE . 52.0 Cg_endo -69.24 147.28 65.87 Favored 'Trans proline' 0 C--N 1.301 -1.94 0 O-C-N 124.165 1.613 . . . . 0.0 110.764 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.33 1.17 59.36 Favored Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.969 -1.11 . . . . 0.0 110.529 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -115.5 147.95 40.05 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.744 -1.445 . . . . 0.0 110.291 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.2 m -97.39 146.83 24.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.066 -1.021 . . . . 0.0 110.647 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.419 ' HB3' ' O ' ' A' ' 89' ' ' ILE . 52.7 tp -133.38 133.83 42.93 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.534 -0.729 . . . . 0.0 109.989 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 78.1 mtt85 -123.03 152.1 41.29 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.202 -0.936 . . . . 0.0 110.387 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 t -141.18 102.06 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 C-N-CA 119.939 -0.705 . . . . 0.0 110.671 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 -99.48 130.3 45.73 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.205 -0.935 . . . . 0.0 110.296 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -144.12 -171.78 14.39 Favored Glycine 0 N--CA 1.496 2.645 0 C-N-CA 119.82 -1.181 . . . . 0.0 110.504 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' A' ' 127' ' ' LYS . 87.1 tt0 -123.85 153.71 40.68 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.468 -1.019 . . . . 0.0 109.317 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.485 HG22 ' HD1' ' A' ' 126' ' ' PHE . 68.9 t -118.58 133.34 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.038 -1.039 . . . . 0.0 111.554 -178.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.464 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . . . -58.99 150.33 61.64 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 120.939 -1.101 . . . . 0.0 109.472 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.43 -18.47 54.87 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.777 1.409 . . . . 0.0 111.309 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -125.01 28.86 6.29 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.977 -1.077 . . . . 0.0 108.811 178.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.504 ' CB ' ' HB3' ' A' ' 125' ' ' ASP . . . -62.67 105.64 0.68 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.287 0.565 . . . . 0.0 111.903 -178.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -64.49 -48.13 76.36 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.519 -0.738 . . . . 0.0 109.922 178.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 86.8 p -166.68 159.84 14.38 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.91 0.862 . . . . 0.0 111.535 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.545 ' CZ ' ' HG2' ' A' ' 47' ' ' PRO . 48.1 p90 -151.22 162.55 40.68 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 45' ' ' PHE . 2.2 p -139.81 138.02 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.444 -1.41 . . . . 0.0 112.688 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.477 ' CD2' ' HB1' ' A' ' 122' ' ' ALA . 90.3 mt -122.95 143.76 49.69 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.667 ' HB2' HD12 ' A' ' 41' ' ' LEU . 26.6 p30 -151.29 162.96 39.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.785 -1.197 . . . . 0.0 110.757 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.672 ' O ' HD12 ' A' ' 34' ' ' LEU . 3.8 pp -154.67 129.6 9.45 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.267 -0.895 . . . . 0.0 110.413 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' A' ' 41' ' ' LEU . . . -166.15 -153.65 7.84 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.432 ' HE2' ' HB3' ' A' ' 40' ' ' ASN . 60.2 pttt -103.36 -30.42 10.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.061 -1.259 . . . . 0.0 110.146 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.481 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 21.9 t70 -143.84 167.8 21.45 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.232 -0.917 . . . . 0.0 110.466 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.536 ' O ' HD23 ' A' ' 41' ' ' LEU . 5.5 t -51.27 -46.93 62.58 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.485 -0.759 . . . . 0.0 112.769 -177.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.441 ' HB3' ' N ' ' A' ' 66' ' ' GLY . 27.9 m-20 -91.12 -2.45 57.58 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.485 -1.384 . . . . 0.0 110.427 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.432 ' HB3' ' HE2' ' A' ' 36' ' ' LYS . 9.3 m120 -110.41 56.16 0.63 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.111 -0.993 . . . . 0.0 110.51 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.667 HD12 ' HB2' ' A' ' 33' ' ' ASN . 3.6 mm? -86.15 138.62 31.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.316 -0.865 . . . . 0.0 110.085 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.9 m -87.2 -28.14 22.58 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.3 -0.875 . . . . 0.0 110.244 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.5 tp -140.94 136.2 31.99 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 121.207 -0.933 . . . . 0.0 110.82 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.521 ' O ' ' HA ' ' A' ' 60' ' ' CYS . 19.9 m-70 -121.95 117.59 26.8 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.098 -1.001 . . . . 0.0 109.228 178.106 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.532 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 39.7 t80 -113.55 124.09 51.54 Favored 'General case' 0 C--N 1.293 -1.882 0 O-C-N 121.15 -0.969 . . . . 0.0 108.928 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -156.27 76.48 4.56 Favored Pre-proline 0 N--CA 1.497 1.925 0 O-C-N 120.843 -1.161 . . . . 0.0 111.005 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.61 ' HB3' HG12 ' A' ' 58' ' ' ILE . 56.2 Cg_endo -70.51 147.14 57.37 Favored 'Trans proline' 0 C--N 1.301 -1.96 0 O-C-N 124.256 1.661 . . . . 0.0 110.447 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -122.59 120.42 33.71 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.139 -0.976 . . . . 0.0 109.731 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -59.04 -49.28 78.49 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.843 -1.16 . . . . 0.0 108.011 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -145.8 95.73 2.69 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.26 -136.38 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.244 -0.91 . . . . 0.0 109.329 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 83.0 m-70 -62.04 -28.7 69.78 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 120.78 -1.2 . . . . 0.0 109.014 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 173.82 35.08 0.04 OUTLIER Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.668 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -113.42 -173.57 2.29 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.734 -1.45 . . . . 0.0 109.98 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.488 ' O ' ' C ' ' A' ' 56' ' ' ASN . . . -135.46 135.01 40.18 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.47 -0.769 . . . . 0.0 110.335 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.488 ' C ' ' O ' ' A' ' 55' ' ' ALA . 6.7 m120 18.55 65.79 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.288 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 20.1 m -102.36 115.11 29.88 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.186 -0.946 . . . . 0.0 108.847 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.61 HG12 ' HB3' ' A' ' 47' ' ' PRO . 52.4 mt -96.86 122.46 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.2 -0.937 . . . . 0.0 108.732 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.3 t -114.13 129.69 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.319 -0.863 . . . . 0.0 110.928 -177.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' CYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 44' ' ' HIS . 0.9 OUTLIER -107.11 126.39 52.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.378 -0.826 . . . . 0.0 109.899 179.237 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.443 ' O ' ' N ' ' A' ' 44' ' ' HIS . 2.6 t-20 -133.36 150.0 51.84 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.167 -0.958 . . . . 0.0 111.015 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.481 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 54.2 m -123.15 145.57 48.49 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.533 ' CD ' ' HA2' ' A' ' 66' ' ' GLY . 21.5 ttmt -135.45 144.36 46.41 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.688 -1.258 . . . . 0.0 111.22 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -120.84 97.75 5.69 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 69.3 20.15 74.89 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.533 ' HA2' ' CD ' ' A' ' 63' ' ' LYS . . . 79.06 23.78 62.96 Favored Glycine 0 N--CA 1.485 1.962 0 O-C-N 120.763 -1.434 . . . . 0.0 110.403 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.3 -80.31 0.2 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.92 -1.341 . . . . 0.0 111.979 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 2.4 m-90 -130.63 -145.11 0.27 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.173 -0.954 . . . . 0.0 110.67 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.481 ' HA2' ' O ' ' A' ' 62' ' ' SER . . . 164.35 143.61 3.77 Favored Glycine 0 N--CA 1.483 1.781 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 99.8 m -92.66 116.79 29.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.593 -0.946 . . . . 0.0 110.271 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -98.44 120.98 39.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.956 -1.09 . . . . 0.0 109.713 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.412 ' O ' ' CB ' ' A' ' 73' ' ' ARG . 8.4 tm0? -165.01 133.54 3.34 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.055 -1.028 . . . . 0.0 110.622 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.412 ' CB ' ' O ' ' A' ' 72' ' ' GLN . 2.5 mtt-85 172.55 168.73 0.12 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.249 -0.907 . . . . 0.0 111.333 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -110.92 -179.92 3.87 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.367 -0.833 . . . . 0.0 109.975 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -101.61 100.81 11.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.169 -0.957 . . . . 0.0 109.618 178.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.472 HG22 ' HD3' ' A' ' 78' ' ' PRO . 2.6 p -125.06 134.1 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.097 -1.002 . . . . 0.0 110.121 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.499 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 12.5 p90 -140.52 87.07 11.9 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.029 -1.044 . . . . 0.0 111.951 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.472 ' HD3' HG22 ' A' ' 76' ' ' VAL . 51.5 Cg_endo -85.03 7.94 4.9 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 124.192 1.627 . . . . 0.0 110.498 178.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -144.48 178.01 8.25 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.268 -0.895 . . . . 0.0 110.291 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.442 ' CG ' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -143.08 172.44 5.68 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.438 -0.789 . . . . 0.0 109.794 179.427 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.442 ' HD2' ' CG ' ' A' ' 80' ' ' GLN . 44.8 Cg_endo -66.64 152.49 80.57 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.907 1.478 . . . . 0.0 110.684 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.6 22.67 78.18 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.239 -1.545 . . . . 0.0 109.239 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.8 m -138.0 149.46 46.1 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.199 -1.177 . . . . 0.0 111.087 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.7 m -76.46 138.91 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.603 -0.685 . . . . 0.0 110.466 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -146.0 144.22 29.96 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.083 -1.011 . . . . 0.0 110.473 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -123.96 146.42 48.5 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.207 -0.933 . . . . 0.0 110.414 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 53.7 t -130.42 131.2 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.332 -0.855 . . . . 0.0 110.27 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' CYS . . . . . 0.419 ' HB3' ' HB3' ' A' ' 99' ' ' LYS . 4.9 t -93.69 126.38 38.83 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.186 -0.946 . . . . 0.0 110.454 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.419 ' O ' ' HB3' ' A' ' 17' ' ' LEU . 97.4 mt -120.34 127.04 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.265 -0.897 . . . . 0.0 109.976 179.429 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 27.6 m -127.72 134.15 49.55 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.0 -1.063 . . . . 0.0 108.945 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.472 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 69.0 t80 -114.49 116.98 29.71 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.718 -1.239 . . . . 0.0 111.204 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -113.0 146.19 39.52 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 65.3 tp60 -56.1 -37.74 69.79 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.983 -1.073 . . . . 0.0 110.576 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.83 -43.38 68.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.013 -1.054 . . . . 0.0 111.291 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -155.18 179.22 9.36 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.993 -1.067 . . . . 0.0 110.852 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.5 ' HB3' ' HB2' ' A' ' 108' ' ' PHE . 53.4 tp -110.82 124.91 52.95 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.392 -0.817 . . . . 0.0 108.958 178.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.659 HG23 ' OE2' ' A' ' 105' ' ' GLU . 3.3 m -107.3 127.66 53.75 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.164 -0.96 . . . . 0.0 110.966 -179.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.406 ' O ' ' HG3' ' A' ' 105' ' ' GLU . 50.6 t -131.4 130.98 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.219 -0.926 . . . . 0.0 109.712 179.097 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.419 ' HB3' ' HB3' ' A' ' 88' ' ' CYS . 86.0 tttt -116.69 126.68 53.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.929 -1.107 . . . . 0.0 110.76 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.423 HD12 ' O ' ' A' ' 104' ' ' TYR . 4.0 mt -76.17 160.64 77.64 Favored Pre-proline 0 C--N 1.303 -1.453 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -66.67 -24.19 48.14 Favored 'Trans proline' 0 C--N 1.302 -1.912 0 O-C-N 123.657 1.346 . . . . 0.0 110.289 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -155.99 73.67 0.83 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.354 -0.841 . . . . 0.0 110.134 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -178.91 -166.83 35.56 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.427 -1.368 . . . . 0.0 110.635 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.423 ' O ' HD12 ' A' ' 100' ' ' LEU . 72.3 m-85 -77.17 -165.5 0.58 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.489 -1.007 . . . . 0.0 110.671 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.659 ' OE2' HG23 ' A' ' 97' ' ' THR . 69.3 tt0 -129.07 159.41 36.05 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.313 -0.867 . . . . 0.0 110.821 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -132.25 153.13 50.94 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.256 -0.903 . . . . 0.0 110.921 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 98.2 mttt -129.05 146.51 51.0 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.778 0.799 . . . . 0.0 111.57 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.5 ' HB2' ' HB3' ' A' ' 96' ' ' LEU . 0.4 OUTLIER -118.19 140.42 27.99 Favored Pre-proline 0 C--N 1.302 -1.462 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.579 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -71.4 161.96 43.88 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 O-C-N 123.645 1.34 . . . . 0.0 110.615 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -71.81 59.04 0.33 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.488 -0.758 . . . . 0.0 111.404 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 15.6 tpt85 -62.99 -39.8 95.85 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.056 -1.027 . . . . 0.0 109.022 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.403 HD11 ' HB3' ' A' ' 62' ' ' SER . 82.8 mt -105.9 124.26 49.28 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.681 -0.637 . . . . 0.0 109.533 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -86.71 69.71 10.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.916 -1.115 . . . . 0.0 109.803 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 35.5 tp -95.04 129.73 42.01 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.62 -0.675 . . . . 0.0 110.063 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -92.23 -13.11 30.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.234 -0.916 . . . . 0.0 110.553 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.517 ' HA ' ' O ' ' A' ' 11' ' ' LEU . . . -162.91 153.11 16.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.015 -1.053 . . . . 0.0 110.786 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.653 HD13 HD13 ' A' ' 34' ' ' LEU . 87.0 mt -109.48 128.1 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.997 -1.064 . . . . 0.0 110.663 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -120.52 -21.92 6.61 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.188 -0.945 . . . . 0.0 111.041 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.432 ' HB2' ' O ' ' A' ' 36' ' ' LYS . 83.2 t80 -105.82 125.45 51.0 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.166 -0.959 . . . . 0.0 111.283 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 62.0 ttp -143.13 133.02 24.05 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.305 -0.872 . . . . 0.0 108.759 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -144.12 142.67 30.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.624 -1.297 . . . . 0.0 110.71 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.477 ' HB1' ' CD2' ' A' ' 32' ' ' LEU . . . -140.12 111.26 7.04 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.526 -0.734 . . . . 0.0 109.797 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.533 ' HB2' ' HA ' ' A' ' 2' ' ' CYS . 26.5 p-10 -147.0 143.65 28.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.249 -0.907 . . . . 0.0 110.093 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.413 ' HA3' ' HA ' ' A' ' 30' ' ' PHE . . . 152.04 -157.08 27.05 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.504 ' HB3' ' CB ' ' A' ' 27' ' ' ALA . 87.1 m-20 -76.31 -1.16 25.29 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.283 -1.128 . . . . 0.0 110.141 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.485 ' HD1' HG22 ' A' ' 23' ' ' VAL . 28.2 t80 -99.8 133.71 43.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.962 -1.086 . . . . 0.0 109.528 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' A' ' 22' ' ' GLU . 75.7 mmtt -106.18 136.27 46.18 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.956 -1.09 . . . . 0.0 111.322 -178.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.482 HG23 ' O ' ' A' ' 128' ' ' ILE . 15.0 tt -101.04 125.2 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.266 -0.896 . . . . 0.0 110.836 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -103.35 -18.58 14.79 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.268 -0.895 . . . . 0.0 111.655 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -159.31 149.88 19.44 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.402 -1.436 . . . . 0.0 113.258 -179.068 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 46.2 t -125.81 133.21 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 177.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -146.05 149.71 34.59 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.403 -1.436 . . . . 0.0 111.342 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.601 ' HE2' HD12 ' A' ' 11' ' ' LEU . 59.7 m-85 -105.3 128.07 53.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.624 -0.673 . . . . 0.0 110.453 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 23.1 t0 . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.521 179.342 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.226 0.536 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' CYS . . . . . 0.547 ' HA ' ' HB2' ' B' ' 123' ' ' ASP . 1.3 m -90.05 56.9 3.59 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.224 -0.923 . . . . 0.0 110.653 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 3' ' ' GLY . . . . . 0.532 ' O ' ' ND2' ' A' ' 8' ' ' ASN . . . 32.43 -148.43 0.01 OUTLIER Glycine 0 N--CA 1.505 3.268 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.929 HD22 HD23 ' A' ' 9' ' ' LEU . 49.2 mt -98.53 128.75 44.98 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.652 -1.499 . . . . 0.0 109.053 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 62.9 t -96.63 135.6 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.049 -1.032 . . . . 0.0 109.651 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.942 ' HB1' HD11 ' B' ' 9' ' ' LEU . . . -124.7 145.2 49.81 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.184 -0.948 . . . . 0.0 111.023 -178.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 7' ' ' SER . . . . . 0.444 ' O ' ' HB3' ' B' ' 8' ' ' ASN . 33.2 p -145.9 170.38 16.71 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 8' ' ' ASN . . . . . 0.444 ' HB3' ' O ' ' B' ' 7' ' ' SER . 41.3 t-20 59.36 32.12 21.61 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.186 -0.946 . . . . 0.0 109.276 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.942 HD11 ' HB1' ' B' ' 6' ' ' ALA . 96.6 mt -91.47 5.28 50.05 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.656 -0.653 . . . . 0.0 111.598 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 10' ' ' ASN . . . . . 0.521 ' C ' ' O ' ' B' ' 9' ' ' LEU . 37.3 t-20 -4.47 78.66 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.531 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.594 HD12 ' HE2' ' B' ' 133' ' ' PHE . 5.8 tt -92.95 131.18 38.19 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.223 -0.923 . . . . 0.0 109.258 179.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -100.76 165.51 14.17 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.249 -0.907 . . . . 0.0 111.182 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 13' ' ' PRO . . . . . 0.475 ' HA ' ' O ' ' B' ' 91' ' ' PHE . 52.3 Cg_endo -68.96 147.31 67.71 Favored 'Trans proline' 0 C--N 1.301 -1.967 0 O-C-N 124.069 1.563 . . . . 0.0 110.736 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.37 0.89 59.4 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.979 -1.105 . . . . 0.0 110.729 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -115.33 147.86 39.96 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.852 -1.381 . . . . 0.0 110.277 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 16' ' ' CYS . . . . . . . . . . . . . 1.2 m -97.29 146.69 24.89 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.175 -0.953 . . . . 0.0 110.806 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.418 ' HB3' ' O ' ' B' ' 89' ' ' ILE . 53.3 tp -133.15 133.8 43.33 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.592 -0.693 . . . . 0.0 110.146 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 78.0 mtt85 -122.88 151.95 41.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.238 -0.913 . . . . 0.0 110.439 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 t -141.22 102.31 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.54 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -99.82 130.52 46.03 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.319 -0.863 . . . . 0.0 109.969 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -144.26 -171.75 14.46 Favored Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.884 -1.151 . . . . 0.0 110.495 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -124.08 153.74 40.97 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.492 -1.005 . . . . 0.0 109.336 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.484 HG22 ' HD1' ' B' ' 126' ' ' PHE . 69.9 t -118.59 133.34 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.908 -1.12 . . . . 0.0 111.422 -178.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.479 ' HB3' ' HB2' ' B' ' 27' ' ' ALA . . . -58.98 150.51 60.64 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.025 -1.047 . . . . 0.0 109.517 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.83 -18.22 52.6 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.817 1.43 . . . . 0.0 111.374 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -125.17 29.29 6.13 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.0 -1.062 . . . . 0.0 108.671 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 27' ' ' ALA . . . . . 0.5 ' CB ' ' HB3' ' B' ' 125' ' ' ASP . . . -63.14 105.27 0.68 Allowed 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.353 0.597 . . . . 0.0 111.965 -178.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -64.08 -49.86 70.62 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.358 -0.838 . . . . 0.0 109.846 178.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 87.4 p -163.93 160.25 21.8 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.305 -0.872 . . . . 0.0 111.661 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 30' ' ' PHE . . . . . 0.542 ' CZ ' ' HG2' ' B' ' 47' ' ' PRO . 47.9 p90 -151.64 161.75 42.15 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' B' ' 45' ' ' PHE . 2.2 p -139.06 138.69 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.375 -1.453 . . . . 0.0 112.787 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.474 ' CD2' ' HB1' ' B' ' 122' ' ' ALA . 89.4 mt -123.86 143.44 50.35 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.467 -0.771 . . . . 0.0 108.925 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 33' ' ' ASN . . . . . 0.669 ' HB2' HD12 ' B' ' 41' ' ' LEU . 26.6 p30 -151.14 163.14 39.5 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.83 -1.168 . . . . 0.0 110.709 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.707 HD12 ' O ' ' B' ' 34' ' ' LEU . 3.8 pp -154.78 126.32 7.44 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.205 -0.934 . . . . 0.0 110.767 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 35' ' ' GLY . . . . . 0.47 ' HA3' ' HA ' ' B' ' 41' ' ' LEU . . . -160.98 -152.43 6.6 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 36' ' ' LYS . . . . . 0.426 ' HE2' ' HB3' ' B' ' 40' ' ' ASN . 60.4 pttt -104.08 -30.58 10.15 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.389 -1.065 . . . . 0.0 109.702 178.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 37' ' ' ASP . . . . . 0.477 ' O ' ' CD2' ' B' ' 41' ' ' LEU . 22.4 t70 -143.98 167.68 21.79 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.248 -0.907 . . . . 0.0 110.52 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 38' ' ' SER . . . . . 0.509 ' O ' HD23 ' B' ' 41' ' ' LEU . 5.7 t -51.37 -46.34 62.72 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.389 -0.819 . . . . 0.0 112.808 -177.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 39' ' ' ASN . . . . . 0.454 ' HB3' ' N ' ' B' ' 66' ' ' GLY . 28.0 m-20 -91.79 -2.66 56.82 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.503 -1.373 . . . . 0.0 110.209 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 40' ' ' ASN . . . . . 0.426 ' HB3' ' HE2' ' B' ' 36' ' ' LYS . 9.3 m120 -110.15 56.06 0.63 Allowed 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.241 -0.912 . . . . 0.0 110.41 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.669 HD12 ' HB2' ' B' ' 33' ' ' ASN . 3.6 mm? -85.76 139.84 30.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.304 -0.873 . . . . 0.0 110.105 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 42' ' ' CYS . . . . . . . . . . . . . 1.7 m -89.63 -27.01 20.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 109.895 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 14.4 tp -141.44 135.82 30.69 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 121.188 -0.945 . . . . 0.0 110.812 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 44' ' ' HIS . . . . . 0.512 ' O ' ' HA ' ' B' ' 60' ' ' CYS . 20.4 m-70 -121.66 117.49 26.8 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.13 -0.981 . . . . 0.0 109.284 178.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.531 ' O ' ' HA ' ' B' ' 31' ' ' VAL . 39.6 t80 -113.66 122.62 47.73 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.07 -1.019 . . . . 0.0 109.086 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -154.41 76.83 5.52 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 120.955 -1.09 . . . . 0.0 111.104 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 47' ' ' PRO . . . . . 0.589 ' HB3' HG12 ' B' ' 58' ' ' ILE . 55.4 Cg_endo -70.69 147.1 56.13 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 124.119 1.589 . . . . 0.0 110.427 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -122.55 120.59 34.27 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.144 -0.972 . . . . 0.0 109.809 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -59.27 -48.61 80.97 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.92 -1.113 . . . . 0.0 108.199 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -146.69 95.48 2.6 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.46 -136.91 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.447 -0.783 . . . . 0.0 109.097 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 52' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -61.75 -26.87 68.33 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.668 -1.27 . . . . 0.0 109.272 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 171.14 35.77 0.03 OUTLIER Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.642 -1.266 . . . . 0.0 110.563 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -113.94 -173.65 2.32 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.836 -1.391 . . . . 0.0 109.79 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.505 ' O ' ' C ' ' B' ' 56' ' ' ASN . . . -134.75 138.51 44.4 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.427 -0.796 . . . . 0.0 109.827 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 56' ' ' ASN . . . . . 0.505 ' C ' ' O ' ' B' ' 55' ' ' ALA . 6.5 m120 13.29 68.09 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.233 0 CA-C-O 121.535 0.683 . . . . 0.0 112.834 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 19.6 m -102.99 114.88 29.54 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.443 -0.786 . . . . 0.0 108.928 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 58' ' ' ILE . . . . . 0.589 HG12 ' HB3' ' B' ' 47' ' ' PRO . 52.0 mt -96.84 122.52 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.111 -0.993 . . . . 0.0 108.729 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.42 HG13 ' HG3' ' B' ' 71' ' ' GLU . 56.0 t -113.82 130.0 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.383 -0.823 . . . . 0.0 111.105 -178.202 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 60' ' ' CYS . . . . . 0.512 ' HA ' ' O ' ' B' ' 44' ' ' HIS . 0.8 OUTLIER -107.77 125.16 51.07 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.295 -0.878 . . . . 0.0 109.939 179.262 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 61' ' ' ASN . . . . . 0.447 ' HB3' ' HB2' ' B' ' 44' ' ' HIS . 2.8 t-20 -132.06 149.86 52.3 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.189 -0.944 . . . . 0.0 111.109 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 62' ' ' SER . . . . . 0.478 ' O ' ' HA2' ' B' ' 69' ' ' GLY . 54.4 m -123.02 145.52 48.44 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.153 -0.967 . . . . 0.0 108.532 179.05 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 63' ' ' LYS . . . . . 0.528 ' CD ' ' HA2' ' B' ' 66' ' ' GLY . 21.4 ttmt -135.12 144.87 47.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.655 -1.278 . . . . 0.0 111.092 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -121.17 97.81 5.69 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 69.32 20.05 74.82 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 66' ' ' GLY . . . . . 0.528 ' HA2' ' CD ' ' B' ' 63' ' ' LYS . . . 79.38 23.56 62.72 Favored Glycine 0 N--CA 1.487 2.064 0 C-N-CA 119.278 -1.439 . . . . 0.0 110.337 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.27 -80.33 0.2 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.875 -1.368 . . . . 0.0 111.867 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 68' ' ' TRP . . . . . . . . . . . . . 2.4 m-90 -130.54 -144.97 0.27 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.22 -0.925 . . . . 0.0 110.711 -178.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 69' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' B' ' 62' ' ' SER . . . 164.05 143.26 3.65 Favored Glycine 0 N--CA 1.483 1.828 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 99.6 m -92.25 117.46 29.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.567 -0.96 . . . . 0.0 110.326 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 71' ' ' GLU . . . . . 0.42 ' HG3' HG13 ' B' ' 59' ' ' VAL . 81.2 tt0 -98.97 120.91 40.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.013 -1.055 . . . . 0.0 109.646 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 8.4 tm0? -165.04 133.53 3.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.997 -1.065 . . . . 0.0 110.551 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 2.5 mtt-85 172.73 169.11 0.12 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.34 -0.85 . . . . 0.0 111.246 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -111.06 180.0 3.89 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.38 -0.825 . . . . 0.0 109.942 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -101.44 100.6 11.08 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.078 -1.014 . . . . 0.0 109.683 178.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 76' ' ' VAL . . . . . 0.487 HG22 ' HD3' ' B' ' 78' ' ' PRO . 2.6 p -124.76 134.15 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.983 -1.073 . . . . 0.0 110.127 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 77' ' ' PHE . . . . . 0.506 ' N ' ' CD1' ' B' ' 77' ' ' PHE . 11.9 p90 -140.4 87.26 11.98 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 120.942 -1.099 . . . . 0.0 111.782 -179.429 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 78' ' ' PRO . . . . . 0.487 ' HD3' HG22 ' B' ' 76' ' ' VAL . 50.3 Cg_endo -85.15 7.56 5.08 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 124.136 1.598 . . . . 0.0 110.427 178.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -144.01 178.18 8.04 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.216 -0.927 . . . . 0.0 110.488 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.434 ' CG ' ' HD2' ' B' ' 81' ' ' PRO . 0.0 OUTLIER -143.09 172.38 5.75 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.351 -0.843 . . . . 0.0 109.792 179.597 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 81' ' ' PRO . . . . . 0.434 ' HD2' ' CG ' ' B' ' 80' ' ' GLN . 44.0 Cg_endo -66.59 152.85 79.87 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.771 1.406 . . . . 0.0 110.764 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.22 22.68 78.66 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 66.1 m -138.06 149.01 45.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.095 -1.238 . . . . 0.0 111.16 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 33.5 m -76.06 139.15 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.663 -0.648 . . . . 0.0 110.614 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -146.32 143.93 29.46 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.055 -1.028 . . . . 0.0 110.431 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -123.69 146.83 47.96 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.228 -0.92 . . . . 0.0 110.445 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 54.4 t -130.78 131.19 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.394 -0.816 . . . . 0.0 110.049 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 88' ' ' CYS . . . . . 0.405 ' HB3' ' HB3' ' B' ' 99' ' ' LYS . 4.5 t -93.79 126.64 39.09 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.168 -0.957 . . . . 0.0 110.404 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.418 ' O ' ' HB3' ' B' ' 17' ' ' LEU . 97.2 mt -120.55 127.11 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.137 -0.977 . . . . 0.0 110.019 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 27.5 m -127.85 134.15 49.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.081 -1.012 . . . . 0.0 109.001 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 91' ' ' PHE . . . . . 0.475 ' O ' ' HA ' ' B' ' 13' ' ' PRO . 70.6 t80 -114.49 116.47 28.9 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 118.813 -1.155 . . . . 0.0 111.491 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -112.92 146.28 39.26 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 65.0 tp60 -56.24 -37.74 70.13 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 120.896 -1.128 . . . . 0.0 110.546 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.48 -43.45 69.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.157 -0.965 . . . . 0.0 111.348 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -155.53 178.91 9.71 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.075 -1.016 . . . . 0.0 110.744 -178.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 96' ' ' LEU . . . . . 0.484 ' HB3' ' HB2' ' B' ' 108' ' ' PHE . 53.5 tp -110.26 124.76 52.21 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.313 -0.867 . . . . 0.0 109.159 178.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 97' ' ' THR . . . . . 0.655 HG23 ' OE2' ' B' ' 105' ' ' GLU . 2.9 m -107.34 127.35 53.49 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.157 -0.964 . . . . 0.0 110.938 -178.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 98' ' ' VAL . . . . . 0.406 ' O ' ' HG3' ' B' ' 105' ' ' GLU . 50.1 t -131.26 130.79 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -0.909 . . . . 0.0 109.81 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 99' ' ' LYS . . . . . 0.405 ' HB3' ' HB3' ' B' ' 88' ' ' CYS . 85.8 tttt -116.58 126.15 52.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.874 -1.141 . . . . 0.0 111.093 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 100' ' ' LEU . . . . . 0.423 HD12 ' O ' ' B' ' 104' ' ' TYR . 4.0 mt -75.46 160.35 79.78 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.392 -0.818 . . . . 0.0 108.849 178.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -66.59 -24.35 48.55 Favored 'Trans proline' 0 C--N 1.302 -1.908 0 O-C-N 123.701 1.369 . . . . 0.0 110.217 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -155.81 75.39 0.9 Allowed 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.336 -0.852 . . . . 0.0 110.177 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 178.54 -167.12 37.41 Favored Glycine 0 N--CA 1.495 2.619 0 C-N-CA 119.407 -1.378 . . . . 0.0 110.548 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 104' ' ' TYR . . . . . 0.423 ' O ' HD12 ' B' ' 100' ' ' LEU . 73.7 m-85 -77.0 -165.4 0.55 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.476 -1.014 . . . . 0.0 110.958 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 105' ' ' GLU . . . . . 0.655 ' OE2' HG23 ' B' ' 97' ' ' THR . 69.4 tt0 -129.53 159.03 37.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.348 -0.845 . . . . 0.0 110.527 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -132.03 153.19 50.63 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.476 -0.765 . . . . 0.0 110.936 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 107' ' ' LYS . . . . . 0.428 ' HA ' ' O ' ' B' ' 96' ' ' LEU . 98.2 mttt -129.2 146.73 51.06 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.354 -0.841 . . . . 0.0 111.537 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 108' ' ' PHE . . . . . 0.484 ' HB2' ' HB3' ' B' ' 96' ' ' LEU . 0.4 OUTLIER -118.29 140.34 27.96 Favored Pre-proline 0 C--N 1.301 -1.537 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.669 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -71.51 162.19 43.05 Favored 'Trans proline' 0 C--N 1.301 -1.938 0 O-C-N 123.575 1.303 . . . . 0.0 110.574 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 110' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -72.0 59.29 0.37 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.559 -0.713 . . . . 0.0 111.266 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 15.3 tpt85 -63.34 -39.58 94.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.099 -1.0 . . . . 0.0 109.015 178.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 112' ' ' LEU . . . . . 0.401 HD11 ' HB3' ' B' ' 62' ' ' SER . 81.2 mt -105.91 124.34 49.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.69 -0.631 . . . . 0.0 109.551 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -86.77 69.88 10.34 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.918 -1.114 . . . . 0.0 109.743 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 36.5 tp -95.09 129.75 42.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.626 -0.671 . . . . 0.0 110.079 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -92.25 -12.92 31.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.18 -0.95 . . . . 0.0 110.7 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 116' ' ' ALA . . . . . 0.538 ' HA ' ' O ' ' B' ' 11' ' ' LEU . . . -162.97 153.44 16.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.016 -1.052 . . . . 0.0 110.626 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 117' ' ' ILE . . . . . 0.652 HD13 HD13 ' B' ' 34' ' ' LEU . 89.4 mt -109.92 128.08 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.072 -1.018 . . . . 0.0 110.707 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -120.36 -21.8 6.75 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.18 -0.95 . . . . 0.0 111.121 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 119' ' ' TYR . . . . . 0.418 ' HB2' ' O ' ' B' ' 36' ' ' LYS . 83.2 t80 -106.09 125.75 51.37 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.032 -1.042 . . . . 0.0 111.18 -179.115 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 61.5 ttp -143.41 133.04 23.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.352 -0.843 . . . . 0.0 108.728 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -144.28 142.91 30.75 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.65 -1.281 . . . . 0.0 110.686 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 122' ' ' ALA . . . . . 0.474 ' HB1' ' CD2' ' B' ' 32' ' ' LEU . . . -140.48 111.27 6.91 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.566 -0.709 . . . . 0.0 109.701 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 123' ' ' ASP . . . . . 0.547 ' HB2' ' HA ' ' B' ' 2' ' ' CYS . 26.3 p-10 -147.42 142.59 27.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.389 -0.82 . . . . 0.0 109.894 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 124' ' ' GLY . . . . . 0.418 ' HA3' ' HA ' ' B' ' 30' ' ' PHE . . . 153.48 -157.22 27.25 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.821 -1.711 . . . . 0.0 108.821 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 125' ' ' ASP . . . . . 0.5 ' HB3' ' CB ' ' B' ' 27' ' ' ALA . 86.9 m-20 -76.35 -0.94 24.45 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.263 -1.139 . . . . 0.0 110.161 179.011 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 126' ' ' PHE . . . . . 0.484 ' HD1' HG22 ' B' ' 23' ' ' VAL . 28.2 t80 -100.03 133.7 44.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.005 -1.059 . . . . 0.0 109.473 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -106.27 135.88 46.97 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.976 -1.078 . . . . 0.0 111.307 -178.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 128' ' ' ILE . . . . . 0.478 ' O ' HG23 ' B' ' 128' ' ' ILE . 14.9 tt -100.47 125.61 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.267 -0.896 . . . . 0.0 110.877 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -103.43 -19.99 14.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.151 -0.968 . . . . 0.0 111.624 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 130' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -156.87 150.25 24.24 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.345 -1.472 . . . . 0.0 113.456 -179.094 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 46.3 t -125.81 133.37 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 177.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 132' ' ' ALA . . . . . . . . . . . . . . . -146.13 149.72 34.55 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.278 -1.514 . . . . 0.0 111.13 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 133' ' ' PHE . . . . . 0.594 ' HE2' HD12 ' B' ' 11' ' ' LEU . 60.2 m-85 -105.52 128.01 53.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.587 -0.696 . . . . 0.0 110.441 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 23.0 t0 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.755 179.346 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 120.903 0.382 . . . . 0.0 110.45 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.452 ' O ' ' O ' ' A' ' 126' ' ' PHE . 99.6 m -142.24 -124.1 0.1 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.883 -1.136 . . . . 0.0 110.285 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.44 ' HA3' ' O ' ' A' ' 122' ' ' ALA . . . 176.73 121.17 0.66 Allowed Glycine 0 N--CA 1.493 2.464 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.439 HD21 HG23 ' A' ' 128' ' ' ILE . 1.1 pp -67.7 156.4 37.01 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.264 -1.139 . . . . 0.0 111.615 -178.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.4 t -118.63 132.73 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.6 ' HB3' HD11 ' A' ' 9' ' ' LEU . . . -110.04 178.98 4.24 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.871 -1.143 . . . . 0.0 110.985 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.42 ' O ' ' HB3' ' A' ' 8' ' ' ASN . 27.7 p -155.95 171.08 20.69 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.428 ' HB3' ' HA ' ' B' ' 4' ' ' LEU . 63.6 t30 58.25 35.88 25.27 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.288 -0.882 . . . . 0.0 110.545 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.6 HD11 ' HB3' ' A' ' 6' ' ' ALA . 78.5 mt -87.29 -5.61 58.85 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.488 -0.757 . . . . 0.0 111.156 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.505 ' C ' ' O ' ' A' ' 9' ' ' LEU . 4.9 m120 6.34 66.33 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.748 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.7 HD11 ' CE2' ' A' ' 133' ' ' PHE . 11.2 mt -93.07 129.05 39.15 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.048 -1.033 . . . . 0.0 110.514 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.43 ' CB ' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -98.79 171.74 5.45 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.295 -0.878 . . . . 0.0 110.783 -179.971 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.43 ' HD2' ' CB ' ' A' ' 12' ' ' LYS . 39.4 Cg_endo -65.17 148.13 88.77 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.221 1.643 . . . . 0.0 109.378 178.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.8 -16.01 54.98 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -111.35 142.09 44.04 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.177 -1.19 . . . . 0.0 109.699 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 58.2 m -109.77 153.19 24.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.196 -0.94 . . . . 0.0 110.181 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.493 HD12 ' O ' ' A' ' 132' ' ' ALA . 57.5 tp -118.28 130.7 56.2 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.221 -0.924 . . . . 0.0 110.349 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -110.99 125.75 54.05 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.577 -0.702 . . . . 0.0 109.489 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 74.0 t -121.16 123.29 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.92 -1.113 . . . . 0.0 110.158 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -123.56 128.44 49.73 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.215 -0.928 . . . . 0.0 109.645 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -146.86 -152.83 5.74 Favored Glycine 0 N--CA 1.489 2.226 0 C-N-CA 119.292 -1.433 . . . . 0.0 110.292 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -136.5 142.34 43.51 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.656 -0.908 . . . . 0.0 109.467 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.489 ' CG1' ' HA ' ' A' ' 81' ' ' PRO . 34.8 t -108.48 132.98 54.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 O-C-N 121.334 -0.854 . . . . 0.0 111.131 -178.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.92 152.57 96.73 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.528 -0.732 . . . . 0.0 109.871 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.404 ' HA ' ' HB2' ' A' ' 81' ' ' PRO . 42.9 Cg_endo -65.79 -28.3 51.4 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 123.955 1.503 . . . . 0.0 110.631 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -97.34 16.15 20.89 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.267 -0.895 . . . . 0.0 109.945 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.471 ' HA ' ' HB3' ' A' ' 125' ' ' ASP . . . -61.75 98.76 0.1 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.107 -0.996 . . . . 0.0 110.874 -179.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -95.04 -15.61 23.33 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.513 -0.742 . . . . 0.0 110.682 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 42.1 t -167.38 142.25 3.88 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 118.725 -1.19 . . . . 0.0 111.454 -178.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.532 ' CE2' ' HB2' ' A' ' 32' ' ' LEU . 10.6 t80 -149.34 157.63 43.49 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.429 -0.794 . . . . 0.0 109.993 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.533 HG12 ' O ' ' A' ' 123' ' ' ASP . 2.5 p -129.09 131.16 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.909 -1.119 . . . . 0.0 110.837 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.532 ' HB2' ' CE2' ' A' ' 30' ' ' PHE . 12.7 tp -131.42 129.68 41.57 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.61 -0.681 . . . . 0.0 109.165 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -161.24 153.19 19.64 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.433 -1.417 . . . . 0.0 111.027 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.779 HD12 HD13 ' A' ' 117' ' ' ILE . 0.4 OUTLIER -143.61 128.09 17.96 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.673 0.749 . . . . 0.0 109.656 179.261 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.457 ' HA3' ' HA ' ' A' ' 41' ' ' LEU . . . -163.79 -160.38 11.67 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.47 ' O ' ' CD1' ' A' ' 119' ' ' TYR . 40.3 mtpt -67.45 -42.17 83.51 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 122.394 1.092 . . . . 0.0 108.212 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -157.45 -168.93 2.73 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.73 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.2 t -62.36 -42.8 99.69 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.781 -0.575 . . . . 0.0 112.296 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.466 ' HB3' ' N ' ' A' ' 66' ' ' GLY . 92.9 m-20 -87.06 -14.5 41.29 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.867 -1.146 . . . . 0.0 110.786 -178.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.441 ' HB2' ' HB2' ' A' ' 36' ' ' LYS . 5.6 m-80 -113.21 70.02 0.71 Allowed 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.867 0.841 . . . . 0.0 108.82 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.457 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 72.5 mt -100.72 139.09 36.89 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.729 ' SG ' HD23 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -83.96 -25.66 29.87 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.944 -1.097 . . . . 0.0 110.723 -179.301 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.729 HD23 ' SG ' ' A' ' 42' ' ' CYS . 2.8 pp -155.71 136.29 13.33 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.265 -0.897 . . . . 0.0 110.216 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.466 ' HB3' ' O ' ' A' ' 61' ' ' ASN . 9.5 t-80 -133.27 121.46 22.49 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.48 -0.763 . . . . 0.0 109.786 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -115.5 133.69 55.8 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.077 -1.015 . . . . 0.0 110.487 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 52.2 t-20 -137.75 78.1 37.35 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 120.999 -1.063 . . . . 0.0 110.393 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -67.15 142.41 61.05 Favored 'Trans proline' 0 C--N 1.302 -1.88 0 O-C-N 123.865 1.455 . . . . 0.0 109.978 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -128.03 122.5 32.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.115 -0.991 . . . . 0.0 110.189 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -60.23 -46.74 88.72 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 118.605 -1.238 . . . . 0.0 108.403 178.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -147.53 102.15 3.42 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.617 -0.677 . . . . 0.0 110.017 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -84.97 -144.03 0.09 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.301 -0.875 . . . . 0.0 108.977 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -50.14 -29.4 9.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.102 -0.999 . . . . 0.0 109.373 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 170.48 38.64 0.03 OUTLIER Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -112.24 -172.52 2.06 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.035 -1.273 . . . . 0.0 109.917 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.466 ' O ' ' C ' ' A' ' 56' ' ' ASN . . . -139.79 137.19 34.82 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.181 -0.949 . . . . 0.0 110.596 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.466 ' C ' ' O ' ' A' ' 55' ' ' ALA . 92.4 m-20 24.79 60.67 0.05 Allowed 'General case' 0 N--CA 1.509 2.507 0 CA-C-O 121.412 0.625 . . . . 0.0 112.208 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 8.8 m -113.05 141.39 46.93 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.323 -0.86 . . . . 0.0 109.862 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.48 HG23 ' HB2' ' A' ' 74' ' ' GLU . 18.9 tt -136.75 138.85 45.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.211 -0.931 . . . . 0.0 110.318 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 55.4 t -119.57 127.2 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.302 -0.874 . . . . 0.0 110.312 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 47.9 t -96.08 126.94 41.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.368 -0.833 . . . . 0.0 110.337 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.466 ' O ' ' HB3' ' A' ' 44' ' ' HIS . 19.6 t30 -136.34 148.78 48.07 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.408 -0.807 . . . . 0.0 110.295 -179.3 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.456 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 71.1 m -125.3 150.45 47.11 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.805 -1.184 . . . . 0.0 108.948 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.477 ' CD ' ' HA2' ' A' ' 66' ' ' GLY . 19.0 ttmt -138.63 148.25 43.85 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.672 -1.268 . . . . 0.0 111.718 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -120.97 97.48 5.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.675 -0.64 . . . . 0.0 110.44 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.403 ' C ' ' HB3' ' A' ' 39' ' ' ASN . . . 66.99 24.11 73.02 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.477 ' HA2' ' CD ' ' A' ' 63' ' ' LYS . . . 75.07 25.12 69.72 Favored Glycine 0 N--CA 1.48 1.606 0 C-N-CA 119.137 -1.506 . . . . 0.0 110.515 178.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -87.08 -81.02 0.24 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.988 -1.301 . . . . 0.0 110.649 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.455 ' O ' ' HG3' ' A' ' 63' ' ' LYS . 41.3 m95 -124.08 -156.59 0.72 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.075 -1.016 . . . . 0.0 110.445 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.456 ' HA2' ' O ' ' A' ' 62' ' ' SER . . . 163.86 114.9 0.31 Allowed Glycine 0 N--CA 1.487 2.05 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.6 m -80.65 121.5 25.93 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.541 -0.976 . . . . 0.0 110.412 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -91.27 129.19 37.29 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.175 -0.953 . . . . 0.0 110.913 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -112.26 -172.36 2.03 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.12 -0.988 . . . . 0.0 109.358 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -147.79 126.31 12.44 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 118.416 -1.314 . . . . 0.0 112.437 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.48 ' HB2' HG23 ' A' ' 58' ' ' ILE . 95.8 mt-10 -115.47 145.59 42.45 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -119.49 48.62 1.48 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.769 -1.207 . . . . 0.0 109.093 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.3 m -119.39 132.39 69.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.426 -0.796 . . . . 0.0 110.931 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -161.51 80.16 2.06 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.392 -0.818 . . . . 0.0 109.57 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -81.17 8.3 4.44 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 124.163 1.612 . . . . 0.0 111.37 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.409 ' CD2' ' HB2' ' A' ' 85' ' ' ALA . 12.2 m-85 -132.14 179.12 6.3 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.937 -1.102 . . . . 0.0 110.212 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.424 ' HB3' ' HD2' ' A' ' 81' ' ' PRO . 0.7 OUTLIER -144.16 177.23 1.87 Allowed Pre-proline 0 C--N 1.296 -1.741 0 O-C-N 121.545 -0.722 . . . . 0.0 109.221 -179.222 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.489 ' HA ' ' CG1' ' A' ' 23' ' ' VAL . 50.3 Cg_endo -71.26 157.29 57.46 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.531 1.279 . . . . 0.0 109.748 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 68.7 26.93 74.2 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.879 -1.688 . . . . 0.0 108.879 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.0 m -133.76 151.99 51.75 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.466 -1.02 . . . . 0.0 110.068 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 69.4 t -95.53 129.63 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.254 -0.903 . . . . 0.0 110.236 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.409 ' HB2' ' CD2' ' A' ' 79' ' ' PHE . . . -149.5 147.1 27.81 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.272 -0.893 . . . . 0.0 110.516 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -122.33 142.87 50.04 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.227 -0.921 . . . . 0.0 109.451 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 39.8 t -127.54 132.64 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.061 -1.024 . . . . 0.0 111.131 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -95.26 140.19 30.51 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.316 -0.865 . . . . 0.0 111.205 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.6 mt -124.64 128.58 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.612 -0.68 . . . . 0.0 110.417 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.534 ' HB ' ' HB ' ' A' ' 97' ' ' THR . 52.5 m -121.98 128.81 51.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.167 -0.958 . . . . 0.0 109.859 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.411 ' HA ' HD12 ' A' ' 96' ' ' LEU . 62.1 t80 -109.3 117.89 35.25 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.216 -0.928 . . . . 0.0 111.087 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -125.29 150.56 46.99 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.509 -0.744 . . . . 0.0 110.418 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.443 ' NE2' ' O ' ' A' ' 114' ' ' LEU . 75.8 mm-40 -62.52 -37.94 88.02 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.349 -0.844 . . . . 0.0 110.252 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.01 -40.84 95.51 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.211 -0.931 . . . . 0.0 110.113 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.437 ' C ' ' OD1' ' A' ' 95' ' ' ASN . 11.0 p30 -169.02 -171.67 1.38 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.378 -0.826 . . . . 0.0 110.521 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 91' ' ' PHE . 20.3 tp -112.12 132.87 54.61 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.409 -0.807 . . . . 0.0 109.599 178.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.534 ' HB ' ' HB ' ' A' ' 90' ' ' THR . 23.2 m -117.14 126.44 52.82 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.871 -1.143 . . . . 0.0 110.94 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 41.2 t -123.21 129.82 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.181 -0.949 . . . . 0.0 109.674 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -115.36 126.93 55.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.169 -0.957 . . . . 0.0 110.735 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.8 mp -100.34 164.55 16.09 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.581 -0.7 . . . . 0.0 109.833 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -64.91 -24.01 61.26 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.732 1.385 . . . . 0.0 110.371 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -77.37 -14.59 59.68 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.243 -0.911 . . . . 0.0 110.478 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.96 -13.2 59.08 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -70.93 135.32 47.87 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.922 -1.34 . . . . 0.0 109.977 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -124.66 138.7 54.29 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.437 -0.79 . . . . 0.0 110.175 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -126.43 134.46 50.98 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.093 -1.004 . . . . 0.0 109.636 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -112.83 145.06 41.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.069 -1.02 . . . . 0.0 111.049 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.52 ' CE2' ' O ' ' A' ' 109' ' ' PRO . 3.1 t80 -134.23 136.95 26.96 Favored Pre-proline 0 C--N 1.301 -1.521 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.52 ' O ' ' CE2' ' A' ' 108' ' ' PHE . 38.5 Cg_endo -64.18 133.98 40.44 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.642 1.338 . . . . 0.0 110.643 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.454 ' ND2' ' O ' ' A' ' 110' ' ' ASN . 6.2 p-10 -85.98 83.58 7.75 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.202 -0.936 . . . . 0.0 110.397 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -55.92 -20.8 17.4 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.937 -1.102 . . . . 0.0 109.657 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 97.5 mt -101.97 133.3 46.98 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.225 -0.922 . . . . 0.0 109.92 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 29.9 m-20 -88.71 67.29 8.33 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.242 -0.911 . . . . 0.0 110.887 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.473 HD11 ' O ' ' A' ' 116' ' ' ALA . 33.8 tp -87.38 120.45 28.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.232 -0.917 . . . . 0.0 109.368 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.418 ' O ' ' HD3' ' A' ' 13' ' ' PRO . 16.6 pt-20 -82.84 -13.73 55.63 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.678 -1.264 . . . . 0.0 110.469 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.473 ' O ' HD11 ' A' ' 114' ' ' LEU . . . -157.59 157.54 33.88 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.806 -1.184 . . . . 0.0 111.267 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.779 HD13 HD12 ' A' ' 34' ' ' LEU . 95.1 mt -108.57 126.81 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.45 -0.781 . . . . 0.0 109.607 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -111.17 -27.74 8.58 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.998 -1.064 . . . . 0.0 111.255 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.47 ' CD1' ' O ' ' A' ' 36' ' ' LYS . 3.0 m-85 -117.15 140.86 49.0 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.935 -1.103 . . . . 0.0 112.503 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.442 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 54.8 ttp -138.76 129.64 26.52 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -136.61 136.42 39.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.398 -1.439 . . . . 0.0 111.097 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.44 ' O ' ' HA3' ' A' ' 3' ' ' GLY . . . -149.5 116.34 5.94 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.058 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.533 ' O ' HG12 ' A' ' 31' ' ' VAL . 65.8 t0 -147.02 118.67 8.0 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.611 -0.681 . . . . 0.0 109.384 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 179.62 -151.72 10.34 Favored Glycine 0 N--CA 1.489 2.206 0 C-N-CA 119.612 -1.28 . . . . 0.0 110.385 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.471 ' HB3' ' HA ' ' A' ' 27' ' ' ALA . 99.6 m-20 -74.46 -2.82 27.23 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.96 -0.729 . . . . 0.0 111.122 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.499 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 24.8 t80 -96.62 137.79 35.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.997 -1.064 . . . . 0.0 110.334 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -110.75 120.53 42.72 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 118.43 -1.308 . . . . 0.0 111.098 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.739 HD11 HG22 ' A' ' 131' ' ' VAL . 7.6 tt -101.37 114.26 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.223 -0.923 . . . . 0.0 110.242 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -97.85 -13.58 21.21 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 120.904 -1.122 . . . . 0.0 110.999 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -147.92 148.41 30.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.748 -1.22 . . . . 0.0 112.59 -179.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.739 HG22 HD11 ' A' ' 128' ' ' ILE . 52.6 t -133.42 131.33 57.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.088 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.493 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -127.99 146.71 50.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.628 -1.295 . . . . 0.0 110.785 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.7 ' CE2' HD11 ' A' ' 11' ' ' LEU . 10.0 m-85 -109.24 127.65 54.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.567 -0.708 . . . . 0.0 110.106 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 59.5 t0 . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 117.948 -1.025 . . . . 0.0 111.123 179.249 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.813 0 CA-C-O 120.849 0.357 . . . . 0.0 110.687 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 2' ' ' CYS . . . . . 0.452 ' O ' ' O ' ' B' ' 126' ' ' PHE . 99.1 m -141.64 -123.78 0.1 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.812 -1.18 . . . . 0.0 109.91 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 3' ' ' GLY . . . . . 0.44 ' HA3' ' O ' ' B' ' 122' ' ' ALA . . . 176.28 121.56 0.67 Allowed Glycine 0 N--CA 1.494 2.534 0 N-CA-C 108.679 -1.768 . . . . 0.0 108.679 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.433 HD21 HG23 ' B' ' 128' ' ' ILE . 1.2 pp -68.22 156.6 37.26 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.233 -1.157 . . . . 0.0 111.49 -178.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 45.5 t -118.84 132.59 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.706 -0.621 . . . . 0.0 109.399 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.572 ' HB3' HD11 ' B' ' 9' ' ' LEU . . . -110.09 178.57 4.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.738 -1.226 . . . . 0.0 111.26 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 7' ' ' SER . . . . . 0.45 ' O ' ' HB3' ' B' ' 8' ' ' ASN . 26.3 p -155.45 170.9 20.88 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 8' ' ' ASN . . . . . 0.45 ' HB3' ' O ' ' B' ' 7' ' ' SER . 63.5 t30 59.16 35.2 23.58 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.366 -0.834 . . . . 0.0 110.539 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.572 HD11 ' HB3' ' B' ' 6' ' ' ALA . 81.1 mt -88.1 -1.58 58.09 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.29 -0.881 . . . . 0.0 111.306 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 10' ' ' ASN . . . . . 0.505 ' C ' ' O ' ' B' ' 9' ' ' LEU . 4.7 m120 -0.05 69.38 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.751 0 N-CA-C 113.874 1.065 . . . . 0.0 113.874 -178.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.681 HD11 ' CE2' ' B' ' 133' ' ' PHE . 11.1 mt -93.81 128.65 40.17 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.312 -0.867 . . . . 0.0 110.442 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 12' ' ' LYS . . . . . 0.412 ' CB ' ' HD2' ' B' ' 13' ' ' PRO . 0.0 OUTLIER -98.68 171.73 5.47 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.285 -0.885 . . . . 0.0 110.872 -179.786 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 13' ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' B' ' 115' ' ' GLU . 40.7 Cg_endo -65.34 147.99 87.97 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.242 1.654 . . . . 0.0 109.501 178.09 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.11 -16.25 54.0 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -111.17 142.06 43.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.065 -1.256 . . . . 0.0 109.951 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 16' ' ' CYS . . . . . . . . . . . . . 57.7 m -109.46 153.75 23.61 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.162 -0.961 . . . . 0.0 110.277 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.475 HD12 ' O ' ' B' ' 132' ' ' ALA . 56.6 tp -118.68 130.8 56.04 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.245 -0.91 . . . . 0.0 110.366 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -111.05 125.87 54.21 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.553 -0.717 . . . . 0.0 109.483 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 79.1 t -121.06 122.61 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.946 -1.096 . . . . 0.0 110.253 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -123.02 128.62 50.42 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.145 -0.972 . . . . 0.0 109.691 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -147.35 -152.92 5.77 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.42 -1.372 . . . . 0.0 110.349 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 -136.5 142.37 43.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.597 -0.943 . . . . 0.0 109.527 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.494 ' CG1' ' HA ' ' B' ' 81' ' ' PRO . 32.0 t -108.47 132.7 55.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 O-C-N 121.495 -0.753 . . . . 0.0 111.122 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.62 152.36 96.71 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.582 -0.699 . . . . 0.0 110.057 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -65.35 -29.13 54.54 Favored 'Trans proline' 0 C--N 1.303 -1.858 0 O-C-N 124.042 1.548 . . . . 0.0 110.466 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -96.85 16.46 19.21 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.429 -0.794 . . . . 0.0 110.104 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' ALA . . . . . 0.476 ' HA ' ' HB3' ' B' ' 125' ' ' ASP . . . -62.61 99.13 0.14 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.269 -0.895 . . . . 0.0 110.697 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -95.16 -17.98 21.31 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.399 -0.813 . . . . 0.0 110.785 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 39.4 t -163.82 142.77 7.84 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.977 -1.089 . . . . 0.0 111.452 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 30' ' ' PHE . . . . . 0.528 ' CE2' ' HB2' ' B' ' 32' ' ' LEU . 9.9 t80 -149.74 157.51 43.29 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.381 -0.825 . . . . 0.0 110.017 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.534 HG12 ' O ' ' B' ' 123' ' ' ASP . 2.5 p -128.89 131.74 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 120.766 -1.209 . . . . 0.0 110.989 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.528 ' HB2' ' CE2' ' B' ' 30' ' ' PHE . 12.7 tp -131.42 129.8 41.73 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.524 -0.735 . . . . 0.0 109.16 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -161.3 153.74 20.26 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 118.287 -1.365 . . . . 0.0 110.851 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.803 HD12 HD13 ' B' ' 117' ' ' ILE . 0.4 OUTLIER -144.57 124.96 13.86 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.636 0.731 . . . . 0.0 109.804 179.411 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 35' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' B' ' 41' ' ' LEU . . . -159.7 -159.35 9.72 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 36' ' ' LYS . . . . . 0.467 ' O ' ' CD1' ' B' ' 119' ' ' TYR . 40.6 mtpt -67.81 -42.34 81.7 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.424 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -156.55 -167.59 2.45 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.879 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 8.7 t -62.97 -42.87 99.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.774 -0.579 . . . . 0.0 112.41 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 39' ' ' ASN . . . . . 0.477 ' HB3' ' N ' ' B' ' 66' ' ' GLY . 92.0 m-20 -87.3 -14.52 40.65 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.983 -1.073 . . . . 0.0 110.751 -178.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 40' ' ' ASN . . . . . 0.435 ' HB2' ' HB2' ' B' ' 36' ' ' LYS . 6.1 m-80 -112.67 70.06 0.71 Allowed 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.458 ' HA ' ' HA3' ' B' ' 35' ' ' GLY . 73.0 mt -100.29 142.03 32.32 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 42' ' ' CYS . . . . . 0.69 ' SG ' HD23 ' B' ' 43' ' ' LEU . 0.0 OUTLIER -88.33 -23.5 23.4 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.832 -1.167 . . . . 0.0 110.359 -178.891 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.733 HD21 HD21 ' B' ' 34' ' ' LEU . 2.8 pp -156.57 135.93 12.19 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.26 -0.9 . . . . 0.0 110.154 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 44' ' ' HIS . . . . . 0.467 ' NE2' HG23 ' B' ' 31' ' ' VAL . 9.5 t-80 -133.19 121.29 22.31 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.691 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -115.51 133.88 55.61 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.136 -0.978 . . . . 0.0 110.296 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -137.8 78.25 36.73 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.046 -1.034 . . . . 0.0 110.3 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 47' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -67.14 142.53 61.54 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.851 1.448 . . . . 0.0 109.772 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -128.31 121.98 30.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.126 -0.984 . . . . 0.0 110.014 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -60.12 -46.87 88.19 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 118.35 -1.34 . . . . 0.0 108.344 178.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -147.18 102.35 3.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.699 -0.626 . . . . 0.0 109.97 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.37 -144.02 0.1 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.279 -0.888 . . . . 0.0 108.992 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 52' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -50.18 -28.72 7.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.085 -1.01 . . . . 0.0 109.409 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 169.55 38.81 0.03 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -112.25 -172.62 2.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.046 -1.267 . . . . 0.0 109.889 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.499 ' O ' ' C ' ' B' ' 56' ' ' ASN . . . -138.46 142.11 39.45 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.306 -0.871 . . . . 0.0 109.949 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 56' ' ' ASN . . . . . 0.499 ' C ' ' O ' ' B' ' 55' ' ' ALA . 92.0 m-20 16.41 64.33 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.569 0 CA-C-O 121.83 0.824 . . . . 0.0 112.51 -178.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 9.7 m -113.84 141.0 47.87 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.654 -0.654 . . . . 0.0 109.758 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 58' ' ' ILE . . . . . 0.476 HG23 ' HB2' ' B' ' 74' ' ' GLU . 18.7 tt -136.72 138.11 46.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.192 -0.942 . . . . 0.0 110.335 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 55.4 t -118.38 127.76 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.258 -0.901 . . . . 0.0 110.306 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 47.9 t -96.56 126.03 41.45 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.373 -0.83 . . . . 0.0 110.226 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 61' ' ' ASN . . . . . 0.451 ' O ' ' HB3' ' B' ' 44' ' ' HIS . 17.7 t30 -135.58 148.68 49.16 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.42 -0.8 . . . . 0.0 110.527 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 62' ' ' SER . . . . . 0.447 ' O ' ' HA2' ' B' ' 69' ' ' GLY . 72.1 m -125.06 150.93 46.29 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.677 -1.264 . . . . 0.0 109.042 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 63' ' ' LYS . . . . . 0.496 ' CD ' ' HA2' ' B' ' 66' ' ' GLY . 18.6 ttmt -138.93 148.03 43.04 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.651 -1.281 . . . . 0.0 111.526 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -120.85 97.67 5.65 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.612 -0.68 . . . . 0.0 110.312 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 67.08 23.65 73.01 Favored Glycine 0 N--CA 1.487 2.061 0 C-N-CA 119.491 -1.338 . . . . 0.0 110.131 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 66' ' ' GLY . . . . . 0.496 ' HA2' ' CD ' ' B' ' 63' ' ' LYS . . . 75.18 24.85 70.19 Favored Glycine 0 N--CA 1.487 2.081 0 O-C-N 120.846 -1.385 . . . . 0.0 110.305 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -86.55 -81.56 0.22 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.964 -1.315 . . . . 0.0 110.662 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 68' ' ' TRP . . . . . 0.457 ' O ' ' HG3' ' B' ' 63' ' ' LYS . 41.2 m95 -124.05 -156.11 0.7 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.13 -0.981 . . . . 0.0 110.374 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 69' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' B' ' 62' ' ' SER . . . 163.35 114.69 0.31 Allowed Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 5.4 m -80.46 120.96 25.14 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.538 -0.978 . . . . 0.0 110.492 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -90.59 128.92 36.74 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.272 -0.892 . . . . 0.0 111.082 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -112.06 -172.14 1.98 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.951 -1.093 . . . . 0.0 109.282 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -147.7 127.36 13.35 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 118.257 -1.377 . . . . 0.0 112.34 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 74' ' ' GLU . . . . . 0.476 ' HB2' HG23 ' B' ' 58' ' ' ILE . 96.0 mt-10 -116.37 145.11 43.47 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -119.48 48.42 1.52 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.986 -1.071 . . . . 0.0 109.112 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 33.8 m -119.37 132.14 70.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-O 121.561 0.696 . . . . 0.0 110.679 -179.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -161.35 81.29 2.01 Favored Pre-proline 0 C--N 1.301 -1.519 0 O-C-N 121.743 -0.598 . . . . 0.0 109.548 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -82.23 8.77 4.31 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 121.843 1.696 . . . . 0.0 111.234 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 79' ' ' PHE . . . . . 0.409 ' CD2' ' HB2' ' B' ' 85' ' ' ALA . 13.8 m-85 -132.79 178.99 6.43 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.918 -1.114 . . . . 0.0 110.403 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.451 ' HB3' ' HD2' ' B' ' 81' ' ' PRO . 0.7 OUTLIER -144.02 177.26 1.87 Allowed Pre-proline 0 C--N 1.297 -1.705 0 O-C-N 121.553 -0.717 . . . . 0.0 109.19 -179.25 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 81' ' ' PRO . . . . . 0.494 ' HA ' ' CG1' ' B' ' 23' ' ' VAL . 54.0 Cg_endo -71.34 157.15 57.5 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.699 1.368 . . . . 0.0 109.412 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 68.5 26.62 74.25 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 6.5 m -133.37 151.73 51.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.505 -0.997 . . . . 0.0 110.039 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 70.7 t -95.72 129.26 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.259 -0.901 . . . . 0.0 110.23 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 85' ' ' ALA . . . . . 0.409 ' HB2' ' CD2' ' B' ' 79' ' ' PHE . . . -149.27 147.3 28.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.221 -0.924 . . . . 0.0 110.473 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -122.12 143.29 49.63 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.243 -0.911 . . . . 0.0 109.4 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 39.5 t -127.41 132.29 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.069 -1.02 . . . . 0.0 111.293 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 88' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -94.78 139.83 30.74 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.344 -0.848 . . . . 0.0 111.166 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 96.8 mt -124.85 128.55 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.675 -0.64 . . . . 0.0 110.254 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 90' ' ' THR . . . . . 0.494 ' HB ' ' HB ' ' B' ' 97' ' ' THR . 52.1 m -122.36 128.75 51.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.157 -0.964 . . . . 0.0 109.811 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 91' ' ' PHE . . . . . 0.414 ' HA ' HD12 ' B' ' 96' ' ' LEU . 61.6 t80 -109.02 118.5 36.94 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.157 -0.964 . . . . 0.0 111.049 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -125.58 150.65 47.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.516 -0.74 . . . . 0.0 110.356 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 93' ' ' GLN . . . . . 0.431 ' NE2' ' O ' ' B' ' 114' ' ' LEU . 75.2 mm-40 -62.65 -37.62 87.1 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.359 -0.838 . . . . 0.0 110.246 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.27 -40.84 94.44 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.195 -0.94 . . . . 0.0 110.116 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 95' ' ' ASN . . . . . 0.424 ' C ' ' OD1' ' B' ' 95' ' ' ASN . 10.5 p30 -168.77 -171.04 1.29 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.419 -0.8 . . . . 0.0 110.506 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 96' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' B' ' 91' ' ' PHE . 20.3 tp -112.82 132.85 55.09 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.26 -0.9 . . . . 0.0 109.324 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 97' ' ' THR . . . . . 0.494 ' HB ' ' HB ' ' B' ' 90' ' ' THR . 22.1 m -117.24 126.58 52.98 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.979 -1.076 . . . . 0.0 110.831 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 40.8 t -123.18 130.39 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.234 -0.916 . . . . 0.0 109.66 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -115.75 127.53 55.18 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.076 -1.015 . . . . 0.0 110.69 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 mp -101.08 164.29 16.34 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.576 -0.702 . . . . 0.0 109.71 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -64.87 -24.16 61.37 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.696 1.366 . . . . 0.0 110.217 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -77.22 -14.16 59.82 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.312 -0.868 . . . . 0.0 110.567 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.27 -13.08 60.21 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 104' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -71.11 135.84 47.88 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.915 -1.344 . . . . 0.0 109.893 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -124.89 139.18 54.07 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.394 -0.816 . . . . 0.0 110.033 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -127.07 134.5 50.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.085 -1.01 . . . . 0.0 109.452 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -113.03 145.2 41.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.045 -1.035 . . . . 0.0 111.011 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 108' ' ' PHE . . . . . 0.522 ' CE2' ' O ' ' B' ' 109' ' ' PRO . 2.9 t80 -134.34 136.89 26.72 Favored Pre-proline 0 C--N 1.3 -1.56 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 109' ' ' PRO . . . . . 0.522 ' O ' ' CE2' ' B' ' 108' ' ' PHE . 37.6 Cg_endo -64.05 134.8 44.49 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.757 1.399 . . . . 0.0 110.682 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 110' ' ' ASN . . . . . 0.469 ' ND2' ' O ' ' B' ' 110' ' ' ASN . 6.4 p-10 -87.04 83.87 7.41 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.032 -1.042 . . . . 0.0 110.279 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -55.99 -21.37 20.83 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.972 -1.08 . . . . 0.0 109.537 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 97.4 mt -101.57 133.12 46.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.138 -0.976 . . . . 0.0 109.896 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -88.59 67.35 8.45 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.301 -0.874 . . . . 0.0 110.763 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 114' ' ' LEU . . . . . 0.469 HD11 ' O ' ' B' ' 116' ' ' ALA . 36.2 tp -87.14 121.22 29.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.308 -0.87 . . . . 0.0 109.059 178.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 115' ' ' GLU . . . . . 0.428 ' O ' ' HD3' ' B' ' 13' ' ' PRO . 16.5 pt-20 -83.5 -13.97 53.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.624 -1.298 . . . . 0.0 110.474 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 116' ' ' ALA . . . . . 0.469 ' O ' HD11 ' B' ' 114' ' ' LEU . . . -157.05 157.8 35.3 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.965 -1.084 . . . . 0.0 110.904 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 117' ' ' ILE . . . . . 0.803 HD13 HD12 ' B' ' 34' ' ' LEU . 95.5 mt -108.89 126.87 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.288 -0.882 . . . . 0.0 109.532 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -111.2 -27.04 8.87 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.851 -1.156 . . . . 0.0 111.348 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 119' ' ' TYR . . . . . 0.467 ' CD1' ' O ' ' B' ' 36' ' ' LYS . 2.8 m-85 -117.42 141.2 48.62 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.91 -1.119 . . . . 0.0 112.48 -178.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 120' ' ' MET . . . . . 0.461 ' HA ' ' HA ' ' B' ' 34' ' ' LEU . 54.2 ttp -139.07 129.95 26.3 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -136.96 136.56 38.66 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.429 -1.419 . . . . 0.0 111.221 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 122' ' ' ALA . . . . . 0.44 ' O ' ' HA3' ' B' ' 3' ' ' GLY . . . -149.35 116.32 5.99 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 123' ' ' ASP . . . . . 0.534 ' O ' HG12 ' B' ' 31' ' ' VAL . 64.9 t0 -146.68 118.68 8.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.387 -0.82 . . . . 0.0 109.431 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 179.33 -152.27 10.93 Favored Glycine 0 N--CA 1.487 2.084 0 C-N-CA 119.392 -1.385 . . . . 0.0 110.464 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 125' ' ' ASP . . . . . 0.476 ' HB3' ' HA ' ' B' ' 27' ' ' ALA . 99.7 m-20 -74.28 -2.93 27.13 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.844 -0.798 . . . . 0.0 111.067 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 126' ' ' PHE . . . . . 0.504 ' HB3' ' CD1' ' B' ' 30' ' ' PHE . 24.6 t80 -96.24 138.27 34.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.001 -1.062 . . . . 0.0 110.288 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -111.13 120.3 41.87 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 118.477 -1.289 . . . . 0.0 111.003 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 128' ' ' ILE . . . . . 0.739 HD11 HG22 ' B' ' 131' ' ' VAL . 7.8 tt -100.9 114.85 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.046 -1.034 . . . . 0.0 110.282 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -98.39 -13.3 20.7 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.739 -1.225 . . . . 0.0 110.957 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 130' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -147.89 148.22 30.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.762 -1.211 . . . . 0.0 112.538 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.739 HG22 HD11 ' B' ' 128' ' ' ILE . 53.1 t -133.28 130.69 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 132' ' ' ALA . . . . . 0.475 ' O ' HD12 ' B' ' 17' ' ' LEU . . . -127.39 146.72 50.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.418 -1.426 . . . . 0.0 110.861 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 133' ' ' PHE . . . . . 0.681 ' CE2' HD11 ' B' ' 11' ' ' LEU . 10.0 m-85 -108.75 127.65 54.19 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.505 -0.747 . . . . 0.0 110.033 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 58.4 t0 . . . . . 0 N--CA 1.497 1.906 0 CA-C-O 117.876 -1.059 . . . . 0.0 111.354 179.141 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.421 0.629 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -126.99 84.33 2.25 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.607 -0.683 . . . . 0.0 109.557 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 92.09 34.51 7.14 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.488 ' HA ' ' HB3' ' B' ' 8' ' ' ASN . 30.9 tp -61.58 133.43 55.65 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.031 -1.276 . . . . 0.0 110.702 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.1 t -123.15 133.49 68.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.47 -0.768 . . . . 0.0 109.866 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.47 148.56 44.28 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.167 -0.958 . . . . 0.0 110.235 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.453 ' O ' ' HB3' ' A' ' 8' ' ' ASN . 74.4 m -142.02 167.69 21.52 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.32 -0.862 . . . . 0.0 109.397 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.453 ' HB3' ' O ' ' A' ' 7' ' ' SER . 13.2 t-20 60.57 32.85 20.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.415 -0.803 . . . . 0.0 109.628 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.645 HD22 ' HB2' ' A' ' 120' ' ' MET . 1.0 OUTLIER -84.65 -2.84 58.06 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.731 -0.605 . . . . 0.0 111.552 -179.393 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.493 ' C ' ' O ' ' A' ' 9' ' ' LEU . 87.9 m-20 11.29 63.73 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.623 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.487 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 14.0 tp -78.55 143.27 36.67 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.846 -1.159 . . . . 0.0 109.824 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.8 mtmt -127.22 158.62 68.67 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 120.969 -1.082 . . . . 0.0 109.915 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -66.49 147.31 82.17 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.83 1.437 . . . . 0.0 110.557 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.53 -9.18 41.2 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -122.98 147.49 46.57 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.927 -1.337 . . . . 0.0 110.204 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 56.8 m -93.3 142.81 26.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.325 -0.859 . . . . 0.0 110.771 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 42.6 tp -120.17 128.5 53.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.394 -0.816 . . . . 0.0 108.908 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -123.37 143.1 50.33 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.878 -1.139 . . . . 0.0 111.656 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.5 t -128.52 116.12 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.641 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -111.79 125.24 53.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.088 -1.008 . . . . 0.0 109.959 178.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.471 ' O ' HG23 ' A' ' 84' ' ' VAL . . . -144.96 -155.78 6.59 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -135.23 145.89 48.07 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.281 -1.129 . . . . 0.0 108.966 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 39.9 t -111.45 130.94 64.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 O-C-N 121.124 -0.985 . . . . 0.0 110.562 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.66 153.15 72.4 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.512 -0.743 . . . . 0.0 110.291 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.407 ' O ' ' HB2' ' A' ' 81' ' ' PRO . 43.5 Cg_endo -67.23 -20.34 49.48 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.992 1.522 . . . . 0.0 110.469 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.401 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 49.9 p-10 -119.11 25.2 10.33 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.293 -0.879 . . . . 0.0 110.416 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.432 ' HA ' ' HB3' ' A' ' 125' ' ' ASP . . . -60.05 104.87 0.34 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.898 -1.126 . . . . 0.0 110.315 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 26' ' ' ASP . 64.2 mttp -95.52 -15.23 23.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.332 -0.855 . . . . 0.0 111.073 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.8 t -160.54 132.94 6.2 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.722 -1.236 . . . . 0.0 111.719 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.502 ' CD1' ' HB3' ' A' ' 126' ' ' PHE . 14.8 t80 -136.72 144.98 44.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.589 -0.695 . . . . 0.0 109.595 178.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.8 t -126.37 131.46 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.03 -1.044 . . . . 0.0 110.836 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.494 ' HB2' ' CZ ' ' A' ' 30' ' ' PHE . 20.9 tp -135.76 135.52 40.03 Favored 'General case' 0 N--CA 1.484 1.235 0 O-C-N 121.47 -0.769 . . . . 0.0 109.997 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.893 ' HB2' HD13 ' A' ' 41' ' ' LEU . 28.5 p30 -142.95 155.37 44.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.787 -1.195 . . . . 0.0 110.508 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.687 HD21 ' HB2' ' A' ' 43' ' ' LEU . 0.6 OUTLIER -153.58 111.84 3.62 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.29 -0.881 . . . . 0.0 110.19 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.487 ' O ' ' CB ' ' A' ' 119' ' ' TYR . . . -161.04 -173.41 29.63 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.634 -1.786 . . . . 0.0 108.634 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.431 ' O ' ' HB2' ' A' ' 119' ' ' TYR . 98.7 mttt -78.61 -44.66 23.43 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.87 -1.37 . . . . 0.0 110.482 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.419 ' HB2' ' HB2' ' A' ' 40' ' ' ASN . 85.3 m-20 -119.8 165.03 15.09 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.761 -177.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.7 t -56.98 -45.7 82.74 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.604 -0.685 . . . . 0.0 112.425 -178.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.45 ' HB3' ' N ' ' A' ' 66' ' ' GLY . 55.6 m-20 -89.46 -0.92 57.84 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.491 -1.381 . . . . 0.0 110.242 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.419 ' HB2' ' HB2' ' A' ' 37' ' ' ASP . 9.0 m120 -111.52 58.37 0.62 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.269 -0.895 . . . . 0.0 109.713 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.893 HD13 ' HB2' ' A' ' 33' ' ' ASN . 71.9 mt -83.15 134.08 35.0 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.63 ' SG ' HD22 ' A' ' 114' ' ' LEU . 83.6 m -81.73 -40.44 22.72 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.998 -1.064 . . . . 0.0 110.224 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.687 ' HB2' HD21 ' A' ' 34' ' ' LEU . 83.0 mt -131.87 140.21 49.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.218 -0.926 . . . . 0.0 110.262 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.416 ' HB3' ' O ' ' A' ' 61' ' ' ASN . 62.9 t-80 -140.46 139.54 35.2 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.199 -0.938 . . . . 0.0 110.425 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -127.92 146.41 50.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.114 -0.991 . . . . 0.0 110.224 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.411 ' HA ' ' O ' ' A' ' 30' ' ' PHE . 0.2 OUTLIER -152.83 61.07 3.6 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 109.909 179.46 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.486 ' HB3' HD12 ' A' ' 58' ' ' ILE . 52.4 Cg_endo -69.01 147.2 67.15 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 124.144 1.602 . . . . 0.0 110.573 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 91.7 mtm-85 -135.53 125.69 26.21 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.11 -0.994 . . . . 0.0 110.637 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -61.93 -46.81 87.69 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.018 -1.051 . . . . 0.0 108.988 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -148.52 84.51 1.49 Allowed 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.52 -117.41 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.264 -0.898 . . . . 0.0 110.176 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 25.5 m80 -77.97 -13.06 60.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.583 -1.323 . . . . 0.0 110.458 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 164.75 -22.27 0.14 Allowed Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.611 -1.281 . . . . 0.0 110.459 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -60.85 -179.16 0.12 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.777 -1.425 . . . . 0.0 110.118 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.522 ' O ' ' C ' ' A' ' 56' ' ' ASN . . . -122.21 135.66 54.8 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.619 -0.676 . . . . 0.0 109.985 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.522 ' C ' ' O ' ' A' ' 55' ' ' ALA . 1.9 m-20 14.33 74.83 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.48 0 CA-C-O 121.297 0.57 . . . . 0.0 112.122 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' A' ' 47' ' ' PRO . 47.2 m -110.13 130.3 55.56 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.203 -0.935 . . . . 0.0 110.392 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.486 HD12 ' HB3' ' A' ' 47' ' ' PRO . 19.6 tt -128.71 131.0 68.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.596 -0.69 . . . . 0.0 109.975 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 59' ' ' VAL . 21.8 m -125.81 129.34 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.147 -0.971 . . . . 0.0 110.136 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 11.3 t -86.13 130.67 34.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.263 -0.898 . . . . 0.0 109.355 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.416 ' O ' ' HB3' ' A' ' 44' ' ' HIS . 14.1 t-20 -137.21 144.63 42.95 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.004 -1.06 . . . . 0.0 111.327 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.2 m -119.13 153.95 34.03 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.483 ' CD ' ' HA2' ' A' ' 66' ' ' GLY . 16.6 ttmt -136.69 134.97 37.79 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.876 -1.14 . . . . 0.0 110.437 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -114.32 102.38 10.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.267 -0.895 . . . . 0.0 109.34 178.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.11 27.4 72.27 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.483 ' HA2' ' CD ' ' A' ' 63' ' ' LYS . . . 93.08 2.05 66.65 Favored Glycine 0 N--CA 1.484 1.852 0 C-N-CA 119.624 -1.274 . . . . 0.0 110.005 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.463 ' O ' ' C ' ' A' ' 68' ' ' TRP . . . -109.55 84.4 1.92 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.987 -1.302 . . . . 0.0 109.723 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.477 ' O ' ' HA ' ' A' ' 63' ' ' LYS . 60.2 m95 -6.13 -117.94 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.761 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 129.86 -113.39 1.47 Allowed Glycine 0 N--CA 1.488 2.102 0 O-C-N 119.849 -1.782 . . . . 0.0 109.9 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 21.7 m -78.69 121.45 24.73 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.261 -1.141 . . . . 0.0 111.266 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -126.83 131.18 51.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.398 -0.814 . . . . 0.0 109.684 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -125.51 156.51 38.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.063 -1.023 . . . . 0.0 110.159 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -134.82 88.86 2.47 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.33 -0.856 . . . . 0.0 109.74 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -114.03 125.88 54.5 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.369 -0.832 . . . . 0.0 109.952 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -93.32 85.54 5.02 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.857 -1.152 . . . . 0.0 110.239 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.625 HG22 ' HD3' ' A' ' 78' ' ' PRO . 2.4 p -127.16 132.11 70.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.231 -0.918 . . . . 0.0 110.151 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.524 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 13.0 p90 -144.9 81.67 10.56 Favored Pre-proline 0 N--CA 1.487 1.398 0 O-C-N 121.211 -0.931 . . . . 0.0 110.326 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.625 ' HD3' HG22 ' A' ' 76' ' ' VAL . 49.8 Cg_endo -72.71 -3.38 13.42 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.844 1.444 . . . . 0.0 111.365 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.531 ' CD2' ' HB2' ' A' ' 85' ' ' ALA . 3.8 m-85 -133.95 179.68 6.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.008 -1.058 . . . . 0.0 111.068 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.471 ' CG ' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -131.41 172.39 7.45 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.562 -0.711 . . . . 0.0 109.464 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.471 ' HD2' ' CG ' ' A' ' 80' ' ' GLN . 52.3 Cg_endo -71.11 150.09 59.42 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.634 1.333 . . . . 0.0 110.09 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.03 26.87 63.39 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 44.7 m -131.76 152.05 51.22 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.12 -1.224 . . . . 0.0 111.016 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 21' ' ' GLY . 12.6 p -91.29 133.38 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.452 -0.78 . . . . 0.0 109.564 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.531 ' HB2' ' CD2' ' A' ' 79' ' ' PHE . . . -151.66 155.62 38.73 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.891 -1.131 . . . . 0.0 110.933 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -122.62 149.6 43.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.331 -0.856 . . . . 0.0 109.724 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.9 t -124.26 130.22 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.103 -0.998 . . . . 0.0 110.403 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 1.4 t -98.82 122.73 42.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.506 -0.746 . . . . 0.0 110.051 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 98.0 mt -122.43 128.63 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.105 -0.997 . . . . 0.0 110.841 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 63.7 m -119.37 128.33 53.98 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.585 ' CZ ' HD11 ' A' ' 114' ' ' LEU . 73.6 t80 -109.4 115.11 29.35 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.788 -1.195 . . . . 0.0 111.376 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 95' ' ' ASN . 79.7 m-20 -118.54 142.36 47.68 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.375 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -60.28 -29.89 69.11 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.782 -1.199 . . . . 0.0 110.523 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.47 -40.68 80.9 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 120.918 -1.114 . . . . 0.0 109.214 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.413 ' O ' ' HB2' ' A' ' 92' ' ' ASP . 5.0 p30 -169.95 172.23 6.68 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.959 -0.697 . . . . 0.0 110.461 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.434 HD22 ' CD1' ' A' ' 43' ' ' LEU . 38.1 tp -102.17 124.53 47.93 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.159 -0.963 . . . . 0.0 110.227 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.442 HG23 ' OE2' ' A' ' 105' ' ' GLU . 11.1 m -107.33 125.35 51.06 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.124 -0.985 . . . . 0.0 109.267 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 36.7 t -131.38 131.61 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.857 -1.152 . . . . 0.0 110.417 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -120.01 143.56 47.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.177 -0.952 . . . . 0.0 110.491 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.51 HD23 ' HD2' ' A' ' 101' ' ' PRO . 0.5 OUTLIER -111.04 169.57 6.17 Favored Pre-proline 0 C--N 1.301 -1.532 0 O-C-N 121.45 -0.781 . . . . 0.0 109.118 179.226 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.51 ' HD2' HD23 ' A' ' 100' ' ' LEU . 39.8 Cg_endo -63.96 -23.79 67.73 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 123.626 1.329 . . . . 0.0 110.858 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.482 ' HB2' ' CB ' ' A' ' 78' ' ' PRO . 20.8 t0 -75.01 -12.31 60.3 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.012 -1.055 . . . . 0.0 110.974 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 99.15 -10.32 61.7 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.708 -1.234 . . . . 0.0 110.66 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.43 ' CE2' ' OD2' ' A' ' 102' ' ' ASP . 19.4 m-85 -79.78 140.68 36.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.815 -1.403 . . . . 0.0 109.843 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.442 ' OE2' HG23 ' A' ' 97' ' ' THR . 85.2 tt0 -120.86 143.43 48.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.307 -0.871 . . . . 0.0 110.679 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -129.94 147.99 51.75 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.458 -0.776 . . . . 0.0 109.599 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.426 ' C ' ' CD1' ' A' ' 108' ' ' PHE . 98.3 mttt -127.58 145.79 50.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.035 -1.041 . . . . 0.0 111.478 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.494 ' N ' ' CD1' ' A' ' 108' ' ' PHE . 19.2 m-85 -129.81 140.35 38.39 Favored Pre-proline 0 N--CA 1.489 1.508 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.5 140.36 39.71 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 123.407 1.214 . . . . 0.0 109.786 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.459 ' ND2' ' O ' ' A' ' 110' ' ' ASN . 6.0 p-10 -102.3 82.85 2.24 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 122.212 1.006 . . . . 0.0 110.178 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 96.6 mtt-85 -57.17 -22.89 43.69 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.535 -1.353 . . . . 0.0 108.963 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.755 ' HB3' HD23 ' A' ' 114' ' ' LEU . 89.1 mt -81.96 143.82 31.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.753 -0.592 . . . . 0.0 110.413 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 41.4 m-20 -101.63 39.03 1.5 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.131 -0.981 . . . . 0.0 109.561 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.755 HD23 ' HB3' ' A' ' 112' ' ' LEU . 0.8 OUTLIER -73.77 128.05 34.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.435 -0.79 . . . . 0.0 110.914 -179.146 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -88.04 -16.19 34.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.067 -1.021 . . . . 0.0 110.215 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' A' ' 11' ' ' LEU . . . -158.23 155.13 28.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.042 -1.036 . . . . 0.0 111.251 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.518 HD11 HD13 ' A' ' 114' ' ' LEU . 31.6 mm -107.1 130.33 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.203 -0.935 . . . . 0.0 110.18 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -108.92 -15.19 14.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.151 -0.968 . . . . 0.0 110.909 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.487 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 4.0 t80 -120.21 129.49 54.11 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.973 -1.079 . . . . 0.0 111.487 -178.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.645 ' HB2' HD22 ' A' ' 9' ' ' LEU . 55.3 ttp -141.35 128.44 20.81 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 178.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.07 149.6 30.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.736 -1.228 . . . . 0.0 111.414 -178.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -152.1 129.07 11.02 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.403 -0.811 . . . . 0.0 109.976 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -147.4 114.81 6.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.311 -0.868 . . . . 0.0 109.377 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.484 ' HA3' ' HA ' ' A' ' 30' ' ' PHE . . . -177.03 -145.32 5.67 Favored Glycine 0 N--CA 1.485 1.947 0 C-N-CA 119.174 -1.489 . . . . 0.0 110.327 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.432 ' HB3' ' HA ' ' A' ' 27' ' ' ALA . 80.2 m-20 -89.04 12.89 14.3 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.781 -0.835 . . . . 0.0 110.707 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.502 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 15.1 t80 -105.8 137.47 43.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.008 -1.057 . . . . 0.0 110.401 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.43 ' O ' ' HA3' ' A' ' 21' ' ' GLY . 98.7 mttt -103.9 109.56 21.35 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.244 -0.91 . . . . 0.0 111.758 -178.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.452 HG23 ' O ' ' A' ' 128' ' ' ILE . 8.7 tt -99.67 117.5 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.028 -1.045 . . . . 0.0 109.432 177.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -109.41 -14.39 14.43 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.164 -0.96 . . . . 0.0 111.733 -178.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.54 142.56 30.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.669 -1.27 . . . . 0.0 112.001 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 59.6 t -126.65 132.99 69.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -138.97 143.73 38.66 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.507 -1.37 . . . . 0.0 111.514 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -73.79 -125.9 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.629 -0.67 . . . . 0.0 109.723 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 47.2 t0 . . . . . 0 N--CA 1.491 1.592 0 O-C-N 120.528 -1.357 . . . . 0.0 110.116 179.674 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.448 0.642 . . . . 0.0 110.513 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -126.93 84.15 2.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.472 -0.767 . . . . 0.0 109.643 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 92.19 34.51 7.1 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 31.0 tp -62.1 133.04 54.75 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.143 -1.21 . . . . 0.0 110.705 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 39.5 t -122.77 133.18 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.558 -0.714 . . . . 0.0 109.944 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.26 148.13 44.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.133 -0.98 . . . . 0.0 110.396 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 7' ' ' SER . . . . . 0.463 ' O ' ' HB3' ' B' ' 8' ' ' ASN . 74.9 m -141.69 167.41 22.21 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.22 -0.925 . . . . 0.0 109.343 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 8' ' ' ASN . . . . . 0.488 ' HB3' ' HA ' ' A' ' 4' ' ' LEU . 13.5 t-20 60.97 33.14 19.89 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.79 0.805 . . . . 0.0 109.509 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.65 HD22 ' HB2' ' B' ' 120' ' ' MET . 1.0 OUTLIER -86.58 3.48 44.2 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.74 -0.6 . . . . 0.0 111.583 -179.476 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 10' ' ' ASN . . . . . 0.496 ' C ' ' O ' ' B' ' 9' ' ' LEU . 87.3 m-20 2.22 67.67 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.612 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -178.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.493 ' O ' ' HA ' ' B' ' 116' ' ' ALA . 14.0 tp -79.45 143.34 35.07 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.228 -0.92 . . . . 0.0 109.605 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 6.8 mtmt -127.71 158.67 69.5 Favored Pre-proline 0 C--N 1.296 -1.755 0 O-C-N 121.178 -0.951 . . . . 0.0 109.873 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -66.57 147.27 81.77 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.846 1.445 . . . . 0.0 110.658 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.4 -8.95 41.46 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 120.105 -1.045 . . . . 0.0 110.498 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -122.99 147.45 46.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.879 -1.365 . . . . 0.0 110.202 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 16' ' ' CYS . . . . . . . . . . . . . 56.9 m -93.22 142.93 26.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.242 -0.911 . . . . 0.0 110.727 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 43.6 tp -120.34 128.17 53.01 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.403 -0.811 . . . . 0.0 109.004 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -123.05 143.07 50.2 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.871 -1.143 . . . . 0.0 111.751 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 2.5 t -128.3 116.25 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.73 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -112.18 124.84 53.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.02 -1.05 . . . . 0.0 109.938 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.466 ' O ' HG23 ' B' ' 84' ' ' VAL . . . -144.66 -155.88 6.61 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.676 -1.369 . . . . 0.0 109.676 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -134.85 146.12 48.96 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.252 -1.146 . . . . 0.0 109.087 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 39.8 t -111.65 130.31 65.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 121.119 -0.988 . . . . 0.0 110.693 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.95 153.12 67.31 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.392 -0.818 . . . . 0.0 110.452 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.414 ' O ' ' HB2' ' B' ' 81' ' ' PRO . 43.1 Cg_endo -67.23 -20.18 49.63 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.936 1.493 . . . . 0.0 110.555 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 26' ' ' ASP . . . . . 0.411 ' O ' ' HG3' ' B' ' 28' ' ' LYS . 49.5 p-10 -119.42 25.06 10.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.284 -0.885 . . . . 0.0 110.408 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 27' ' ' ALA . . . . . 0.441 ' HA ' ' HB3' ' B' ' 125' ' ' ASP . . . -59.94 104.47 0.3 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.905 -1.122 . . . . 0.0 110.311 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 28' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' B' ' 26' ' ' ASP . 64.3 mttp -94.97 -15.92 23.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.355 -0.841 . . . . 0.0 111.157 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 8.0 t -159.63 133.39 7.28 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.724 -1.235 . . . . 0.0 111.686 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 30' ' ' PHE . . . . . 0.506 ' CD1' ' HB3' ' B' ' 126' ' ' PHE . 14.4 t80 -137.08 144.65 43.22 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.569 -0.707 . . . . 0.0 109.565 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 43.1 t -126.36 131.14 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.975 -1.078 . . . . 0.0 110.944 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.492 ' HB2' ' CZ ' ' B' ' 30' ' ' PHE . 20.6 tp -135.38 135.74 40.9 Favored 'General case' 0 C--N 1.308 -1.234 0 O-C-N 121.525 -0.735 . . . . 0.0 110.181 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 33' ' ' ASN . . . . . 0.918 ' HB2' HD13 ' B' ' 41' ' ' LEU . 28.3 p30 -143.02 155.6 44.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.809 -1.182 . . . . 0.0 110.623 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.691 HD21 ' HB2' ' B' ' 43' ' ' LEU . 0.6 OUTLIER -153.79 110.21 3.33 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.277 -0.889 . . . . 0.0 110.276 179.967 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 35' ' ' GLY . . . . . 0.482 ' O ' ' CB ' ' B' ' 119' ' ' TYR . . . -158.36 -172.98 26.18 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 36' ' ' LYS . . . . . 0.451 ' O ' ' HB2' ' B' ' 119' ' ' TYR . 98.8 mttt -78.89 -44.57 22.49 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.876 -1.367 . . . . 0.0 110.415 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 37' ' ' ASP . . . . . 0.418 ' HB2' ' HB2' ' B' ' 40' ' ' ASN . 84.8 m-20 -119.76 164.91 15.25 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.685 -178.043 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 11.8 t -56.97 -45.85 82.6 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.634 -0.666 . . . . 0.0 112.294 -178.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 39' ' ' ASN . . . . . 0.452 ' HB3' ' N ' ' B' ' 66' ' ' GLY . 54.8 m-20 -89.24 -0.87 57.8 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.473 -1.392 . . . . 0.0 110.294 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 40' ' ' ASN . . . . . 0.418 ' HB2' ' HB2' ' B' ' 37' ' ' ASP . 9.0 m120 -111.63 58.16 0.63 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.184 -0.947 . . . . 0.0 109.678 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.918 HD13 ' HB2' ' B' ' 33' ' ' ASN . 72.6 mt -82.31 138.25 34.59 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 42' ' ' CYS . . . . . 0.628 ' SG ' HD22 ' B' ' 114' ' ' LEU . 79.5 m -87.42 -38.22 16.32 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.88 -1.138 . . . . 0.0 109.618 -178.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.691 ' HB2' HD21 ' B' ' 34' ' ' LEU . 83.8 mt -132.58 139.78 47.96 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.142 -0.974 . . . . 0.0 110.016 179.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 44' ' ' HIS . . . . . 0.405 ' HB3' ' O ' ' B' ' 61' ' ' ASN . 63.2 t-80 -140.09 140.09 36.01 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.135 -0.978 . . . . 0.0 110.328 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -128.47 146.03 50.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.192 -0.942 . . . . 0.0 110.2 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 46' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' B' ' 30' ' ' PHE . 0.2 OUTLIER -152.26 61.16 3.87 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.379 -0.826 . . . . 0.0 109.984 179.472 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 47' ' ' PRO . . . . . 0.492 ' HB3' HD12 ' B' ' 58' ' ' ILE . 52.2 Cg_endo -69.23 146.67 64.21 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.067 1.562 . . . . 0.0 110.69 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 91.5 mtm-85 -134.94 125.83 27.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.164 -0.96 . . . . 0.0 110.681 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -61.93 -46.62 88.54 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.129 -0.982 . . . . 0.0 109.036 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -148.58 84.36 1.48 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.5 -117.2 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.2 -0.938 . . . . 0.0 110.241 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 52' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -77.83 -13.97 59.72 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.633 -1.292 . . . . 0.0 110.405 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 165.53 -22.2 0.13 Allowed Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.568 -1.301 . . . . 0.0 110.494 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -60.51 -179.0 0.1 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.881 -1.364 . . . . 0.0 110.162 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.533 ' O ' ' C ' ' B' ' 56' ' ' ASN . . . -121.98 137.47 54.79 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.57 -0.706 . . . . 0.0 109.598 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 56' ' ' ASN . . . . . 0.533 ' C ' ' O ' ' B' ' 55' ' ' ALA . 1.9 m-20 11.25 76.2 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.514 0 CA-C-O 121.451 0.643 . . . . 0.0 112.107 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 57' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' B' ' 47' ' ' PRO . 45.2 m -110.46 130.16 55.62 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.381 -0.825 . . . . 0.0 110.328 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 58' ' ' ILE . . . . . 0.492 HD12 ' HB3' ' B' ' 47' ' ' PRO . 19.6 tt -128.79 130.7 68.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.476 -0.765 . . . . 0.0 110.032 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.486 HG23 ' O ' ' B' ' 59' ' ' VAL . 21.5 m -125.4 129.24 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.154 -0.967 . . . . 0.0 110.349 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 11.2 t -86.03 130.64 34.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.142 -0.974 . . . . 0.0 109.343 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 61' ' ' ASN . . . . . 0.405 ' O ' ' HB3' ' B' ' 44' ' ' HIS . 14.5 t-20 -137.2 144.73 43.01 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.059 -1.025 . . . . 0.0 111.266 -179.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 5.3 m -119.36 153.74 34.69 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 63' ' ' LYS . . . . . 0.483 ' CD ' ' HA2' ' B' ' 66' ' ' GLY . 16.6 ttmt -136.56 134.82 37.88 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.862 -1.149 . . . . 0.0 110.412 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -113.87 102.45 10.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.222 -0.924 . . . . 0.0 109.609 178.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 64.84 27.71 72.46 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 66' ' ' GLY . . . . . 0.483 ' HA2' ' CD ' ' B' ' 63' ' ' LYS . . . 93.01 1.85 66.97 Favored Glycine 0 N--CA 1.485 1.937 0 C-N-CA 119.561 -1.304 . . . . 0.0 109.99 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 67' ' ' ALA . . . . . 0.454 ' O ' ' O ' ' B' ' 68' ' ' TRP . . . -109.45 86.21 2.25 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.977 -1.308 . . . . 0.0 109.526 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 68' ' ' TRP . . . . . 0.468 ' O ' ' HA ' ' B' ' 63' ' ' LYS . 61.8 m95 -9.0 -116.59 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.828 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -178.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 129.28 -113.37 1.51 Allowed Glycine 0 N--CA 1.488 2.161 0 O-C-N 119.775 -1.828 . . . . 0.0 110.005 -178.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 21.6 m -78.91 121.31 24.7 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.198 -1.177 . . . . 0.0 111.266 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -126.72 131.0 51.45 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.404 -0.81 . . . . 0.0 109.778 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -125.45 156.51 38.78 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.926 -1.109 . . . . 0.0 110.205 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 -134.64 88.74 2.47 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.247 -0.908 . . . . 0.0 109.727 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 74' ' ' GLU . . . . . 0.401 ' O ' ' CG2' ' B' ' 58' ' ' ILE . 89.3 mt-10 -113.94 126.18 54.86 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.238 -0.914 . . . . 0.0 109.865 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -93.49 85.28 4.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.09 -1.006 . . . . 0.0 110.232 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 76' ' ' VAL . . . . . 0.623 HG22 ' HD3' ' B' ' 78' ' ' PRO . 2.4 p -127.22 132.25 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.324 -0.86 . . . . 0.0 110.203 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 77' ' ' PHE . . . . . 0.509 ' N ' ' CD1' ' B' ' 77' ' ' PHE . 13.6 p90 -144.98 81.7 10.46 Favored Pre-proline 0 N--CA 1.486 1.352 0 O-C-N 121.248 -0.908 . . . . 0.0 110.288 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 78' ' ' PRO . . . . . 0.623 ' HD3' HG22 ' B' ' 76' ' ' VAL . 52.4 Cg_endo -72.91 -3.12 13.04 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.967 1.509 . . . . 0.0 111.236 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 79' ' ' PHE . . . . . 0.535 ' CD2' ' HB2' ' B' ' 85' ' ' ALA . 3.8 m-85 -134.13 179.6 6.15 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.998 -1.064 . . . . 0.0 111.024 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.487 ' CG ' ' HD2' ' B' ' 81' ' ' PRO . 0.0 OUTLIER -131.2 172.57 7.13 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.574 -0.704 . . . . 0.0 109.521 179.781 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 81' ' ' PRO . . . . . 0.487 ' HD2' ' CG ' ' B' ' 80' ' ' GLN . 51.0 Cg_endo -71.02 150.06 59.88 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.643 1.338 . . . . 0.0 110.105 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 75.95 26.94 63.4 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 45.3 m -131.83 151.94 51.34 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.933 -1.334 . . . . 0.0 111.06 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.466 HG23 ' O ' ' B' ' 21' ' ' GLY . 13.1 p -90.95 133.54 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.437 -0.789 . . . . 0.0 109.59 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 85' ' ' ALA . . . . . 0.535 ' HB2' ' CD2' ' B' ' 79' ' ' PHE . . . -151.69 155.86 39.18 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.808 -1.183 . . . . 0.0 110.894 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -122.91 149.56 44.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.375 -0.828 . . . . 0.0 109.61 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 47.0 t -124.15 130.43 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.128 -0.982 . . . . 0.0 110.386 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 88' ' ' CYS . . . . . . . . . . . . . 1.4 t -99.2 122.91 43.02 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.354 -0.841 . . . . 0.0 110.042 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 98.2 mt -122.55 128.65 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.199 -0.938 . . . . 0.0 110.731 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 63.2 m -119.41 128.29 53.9 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 91' ' ' PHE . . . . . 0.579 ' CZ ' HD11 ' B' ' 114' ' ' LEU . 73.7 t80 -109.23 115.59 30.3 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 118.62 -1.232 . . . . 0.0 111.343 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 92' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' B' ' 95' ' ' ASN . 79.2 m-20 -118.89 142.39 47.79 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -60.04 -30.31 69.11 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.668 -1.27 . . . . 0.0 110.491 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.15 -40.48 82.37 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.045 -1.035 . . . . 0.0 109.279 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 95' ' ' ASN . . . . . 0.405 ' O ' ' HB2' ' B' ' 92' ' ' ASP . 5.2 p30 -170.32 171.88 6.45 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.502 -178.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 96' ' ' LEU . . . . . 0.432 HD22 ' CD1' ' B' ' 43' ' ' LEU . 38.8 tp -101.83 125.13 48.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.236 -0.915 . . . . 0.0 110.17 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 97' ' ' THR . . . . . 0.435 HG23 ' OE2' ' B' ' 105' ' ' GLU . 10.5 m -107.93 125.25 51.27 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.099 -1.001 . . . . 0.0 109.266 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 38.8 t -131.43 131.43 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.858 -1.151 . . . . 0.0 110.478 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -119.7 143.9 47.5 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.168 -0.957 . . . . 0.0 110.579 179.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 100' ' ' LEU . . . . . 0.486 HD23 ' HD2' ' B' ' 101' ' ' PRO . 0.5 OUTLIER -111.16 169.69 6.04 Favored Pre-proline 0 C--N 1.3 -1.57 0 O-C-N 121.517 -0.739 . . . . 0.0 109.133 179.222 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 101' ' ' PRO . . . . . 0.486 ' HD2' HD23 ' B' ' 100' ' ' LEU . 38.8 Cg_endo -64.07 -24.11 66.77 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 123.603 1.318 . . . . 0.0 110.772 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 102' ' ' ASP . . . . . 0.47 ' HB2' ' CB ' ' B' ' 78' ' ' PRO . 20.5 t0 -74.83 -11.95 60.27 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.941 -1.099 . . . . 0.0 111.085 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 98.86 -10.42 62.28 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.635 -1.269 . . . . 0.0 110.645 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 104' ' ' TYR . . . . . 0.443 ' CE2' ' OD2' ' B' ' 102' ' ' ASP . 19.5 m-85 -79.73 141.02 36.74 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.754 -1.439 . . . . 0.0 109.657 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 105' ' ' GLU . . . . . 0.435 ' OE2' HG23 ' B' ' 97' ' ' THR . 85.2 tt0 -121.06 143.48 49.05 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.308 -0.87 . . . . 0.0 110.554 -179.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -130.08 148.07 51.89 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.336 -0.853 . . . . 0.0 109.505 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 107' ' ' LYS . . . . . 0.422 ' C ' ' CD1' ' B' ' 108' ' ' PHE . 98.3 mttt -127.7 145.62 50.84 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.079 -1.013 . . . . 0.0 111.454 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 108' ' ' PHE . . . . . 0.502 ' CD1' ' N ' ' B' ' 108' ' ' PHE . 20.1 m-85 -129.64 140.18 37.88 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -70.28 140.18 40.14 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 O-C-N 123.385 1.203 . . . . 0.0 109.83 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 110' ' ' ASN . . . . . 0.46 ' ND2' ' O ' ' B' ' 110' ' ' ASN . 6.1 p-10 -102.16 83.02 2.28 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 122.246 1.022 . . . . 0.0 110.216 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 96.6 mtt-85 -57.11 -22.7 41.73 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.488 -1.383 . . . . 0.0 108.98 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 112' ' ' LEU . . . . . 0.735 ' HB3' HD23 ' B' ' 114' ' ' LEU . 89.7 mt -82.26 143.7 31.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.584 -0.698 . . . . 0.0 110.454 179.32 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 42.3 m-20 -101.44 38.83 1.52 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.105 -0.997 . . . . 0.0 109.541 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 114' ' ' LEU . . . . . 0.735 HD23 ' HB3' ' B' ' 112' ' ' LEU . 0.8 OUTLIER -73.6 128.07 34.49 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.427 -0.795 . . . . 0.0 110.923 -179.193 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -88.26 -16.05 34.22 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.114 -0.991 . . . . 0.0 110.162 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 116' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' B' ' 11' ' ' LEU . . . -158.25 155.19 28.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.005 -1.059 . . . . 0.0 111.072 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 117' ' ' ILE . . . . . 0.519 HD11 HD13 ' B' ' 114' ' ' LEU . 31.8 mm -107.17 130.2 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.215 -0.928 . . . . 0.0 110.228 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -108.85 -15.01 14.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.069 -1.019 . . . . 0.0 110.933 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 119' ' ' TYR . . . . . 0.482 ' CB ' ' O ' ' B' ' 35' ' ' GLY . 4.0 t80 -120.28 129.7 54.14 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.993 -1.067 . . . . 0.0 111.461 -178.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 120' ' ' MET . . . . . 0.65 ' HB2' HD22 ' B' ' 9' ' ' LEU . 51.8 ttp -141.47 128.37 20.6 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.203 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.21 149.37 30.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.707 -1.246 . . . . 0.0 111.342 -178.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -151.99 129.17 11.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.578 -0.702 . . . . 0.0 110.116 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -147.4 114.63 6.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.366 -0.834 . . . . 0.0 109.453 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 124' ' ' GLY . . . . . 0.502 ' HA3' ' HA ' ' B' ' 30' ' ' PHE . . . -176.95 -145.36 5.67 Favored Glycine 0 N--CA 1.484 1.869 0 C-N-CA 119.069 -1.538 . . . . 0.0 110.209 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 125' ' ' ASP . . . . . 0.441 ' HB3' ' HA ' ' B' ' 27' ' ' ALA . 79.7 m-20 -88.86 12.87 13.99 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.913 -0.757 . . . . 0.0 110.705 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 126' ' ' PHE . . . . . 0.506 ' HB3' ' CD1' ' B' ' 30' ' ' PHE . 14.9 t80 -105.76 137.66 43.27 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.092 -1.005 . . . . 0.0 110.269 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 127' ' ' LYS . . . . . 0.422 ' O ' ' HA3' ' B' ' 21' ' ' GLY . 98.5 mttt -103.94 109.45 21.2 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.272 -0.892 . . . . 0.0 111.746 -178.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 128' ' ' ILE . . . . . 0.44 ' O ' HG23 ' B' ' 128' ' ' ILE . 8.8 tt -99.65 117.41 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.036 -1.04 . . . . 0.0 109.486 177.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -109.32 -14.64 14.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.111 -0.993 . . . . 0.0 111.872 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 130' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.17 143.55 31.14 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.637 -1.289 . . . . 0.0 111.815 -179.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 66.1 t -127.3 133.58 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 132' ' ' ALA . . . . . . . . . . . . . . . -139.48 143.39 37.49 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 119.984 -1.697 . . . . 0.0 111.721 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -73.17 -125.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.633 -0.667 . . . . 0.0 109.821 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 47.1 t0 . . . . . 0 N--CA 1.492 1.628 0 O-C-N 120.515 -1.365 . . . . 0.0 110.161 179.716 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.246 0.546 . . . . 0.0 110.018 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 3.6 t -122.62 -134.21 0.29 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.223 -0.923 . . . . 0.0 109.062 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.434 ' O ' HG23 ' A' ' 5' ' ' VAL . . . 89.66 21.51 39.94 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 34.9 tp -58.54 128.51 37.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.915 -1.344 . . . . 0.0 109.866 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 3' ' ' GLY . 54.5 t -120.43 131.17 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.43 -0.794 . . . . 0.0 109.877 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -124.49 164.18 20.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.926 -1.108 . . . . 0.0 110.98 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.485 ' O ' ' HB3' ' A' ' 8' ' ' ASN . 26.9 p -151.19 172.22 16.16 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.666 -0.646 . . . . 0.0 109.306 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.485 ' HB3' ' O ' ' A' ' 7' ' ' SER . 12.1 t-20 61.79 33.01 18.02 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.577 -0.702 . . . . 0.0 109.85 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.525 ' O ' ' C ' ' A' ' 10' ' ' ASN . 94.8 mt -85.09 -9.69 57.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.539 -0.726 . . . . 0.0 111.124 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.525 ' C ' ' O ' ' A' ' 9' ' ' LEU . 0.7 OUTLIER 5.79 67.82 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.686 0 CA-C-O 121.551 0.691 . . . . 0.0 112.829 -179.771 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.508 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 31.8 tp -87.64 139.0 30.98 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.51 167.46 9.03 Favored Pre-proline 0 C--N 1.294 -1.831 0 O-C-N 120.975 -1.078 . . . . 0.0 111.378 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' A' ' 115' ' ' GLU . 44.3 Cg_endo -67.49 147.31 76.8 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 124.266 1.666 . . . . 0.0 110.77 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.81 -4.04 63.1 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -115.99 146.79 41.83 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.937 -1.331 . . . . 0.0 109.827 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.3 m -99.02 142.63 30.27 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.163 -0.961 . . . . 0.0 110.443 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.41 ' HA ' HD12 ' A' ' 17' ' ' LEU . 51.2 tp -118.27 128.2 54.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.405 -0.809 . . . . 0.0 109.698 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -128.92 133.43 47.87 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.008 -1.057 . . . . 0.0 111.17 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 56.1 t -121.1 127.24 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.319 -0.863 . . . . 0.0 109.577 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 53.2 ttt-85 -109.05 124.89 51.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.206 -0.934 . . . . 0.0 110.019 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -148.88 -163.4 10.88 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -137.94 141.81 40.55 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.409 -1.053 . . . . 0.0 110.269 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.663 ' CG1' ' HB2' ' A' ' 27' ' ' ALA . 23.8 t -97.4 130.97 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.198 -0.939 . . . . 0.0 110.809 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.597 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -58.87 168.22 1.56 Allowed Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.448 -0.783 . . . . 0.0 110.096 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.597 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 45.4 Cg_endo -68.68 -19.8 41.2 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.909 1.478 . . . . 0.0 109.89 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 28' ' ' LYS . 48.2 t0 -112.97 57.19 0.67 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.485 -0.76 . . . . 0.0 109.371 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.663 ' HB2' ' CG1' ' A' ' 23' ' ' VAL . . . -69.73 63.62 0.19 Allowed 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.688 0.756 . . . . 0.0 109.797 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.435 ' N ' ' O ' ' A' ' 26' ' ' ASP . 87.8 tttt -63.12 -43.92 97.08 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.702 -0.624 . . . . 0.0 110.401 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.3 t -164.05 137.63 5.4 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.006 -1.058 . . . . 0.0 111.174 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.483 ' HA ' ' HA3' ' A' ' 124' ' ' GLY . 26.1 t80 -134.04 145.54 49.51 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.547 -0.721 . . . . 0.0 109.981 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.543 HG22 ' O ' ' A' ' 123' ' ' ASP . 17.3 m -127.13 133.08 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 120.785 -1.197 . . . . 0.0 110.774 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.1 tp -129.42 135.09 48.24 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.463 -0.773 . . . . 0.0 110.139 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.527 ' HB2' HD13 ' A' ' 41' ' ' LEU . 12.2 p30 -142.19 145.77 34.51 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.763 -1.21 . . . . 0.0 110.78 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.493 HD13 HD13 ' A' ' 117' ' ' ILE . 1.1 pp -149.47 123.87 9.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.366 -0.834 . . . . 0.0 110.679 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.545 ' O ' ' HB3' ' A' ' 119' ' ' TYR . . . -166.11 -160.38 13.3 Favored Glycine 0 N--CA 1.493 2.433 0 N-CA-C 108.959 -1.657 . . . . 0.0 108.959 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.48 ' HD2' HD13 ' A' ' 114' ' ' LEU . 60.2 mtpt -71.85 -40.8 68.76 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.021 -1.282 . . . . 0.0 109.149 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -153.27 -167.02 2.59 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.768 0.794 . . . . 0.0 111.562 -178.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 41.2 t -62.0 -46.03 91.0 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.662 -0.649 . . . . 0.0 112.573 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.457 ' HB3' ' N ' ' A' ' 66' ' ' GLY . 74.0 m-20 -94.5 0.08 55.04 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.762 -1.211 . . . . 0.0 110.437 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -113.03 62.79 0.64 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.245 -0.909 . . . . 0.0 109.378 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.527 HD13 ' HB2' ' A' ' 33' ' ' ASN . 92.1 mt -104.14 133.97 48.18 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.315 0.578 . . . . 0.0 109.917 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.484 ' HA ' HD12 ' A' ' 112' ' ' LEU . 63.3 m -83.62 -40.22 19.3 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.151 -0.968 . . . . 0.0 109.271 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 1.101 HD11 HD13 ' A' ' 96' ' ' LEU . 94.3 mt -131.42 140.89 49.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.213 -0.929 . . . . 0.0 111.337 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.48 ' HB3' ' HB3' ' A' ' 61' ' ' ASN . 41.2 t-80 -131.84 103.14 6.16 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -102.36 142.0 34.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -0.931 . . . . 0.0 110.8 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.521 ' CG ' HG12 ' A' ' 31' ' ' VAL . 1.2 t-20 -155.23 85.36 3.49 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.391 -0.818 . . . . 0.0 110.603 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.438 ' CA ' HG12 ' A' ' 58' ' ' ILE . 46.5 Cg_endo -67.48 147.74 77.68 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.891 1.469 . . . . 0.0 110.75 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -132.31 107.99 8.91 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.291 -0.881 . . . . 0.0 111.156 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -62.08 -48.08 81.78 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.248 -0.908 . . . . 0.0 109.486 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 -150.83 97.74 2.52 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.313 -0.867 . . . . 0.0 109.472 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -105.18 -126.61 0.23 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.187 -0.945 . . . . 0.0 110.329 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 40.3 m170 -61.73 -35.38 77.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.72 -1.237 . . . . 0.0 110.843 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 172.61 32.42 0.03 OUTLIER Glycine 0 N--CA 1.493 2.451 0 C-N-CA 119.104 -1.522 . . . . 0.0 111.072 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -117.59 -166.26 1.17 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.852 -1.381 . . . . 0.0 109.469 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 56' ' ' ASN . . . -153.67 144.08 22.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.252 -0.905 . . . . 0.0 110.373 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.475 ' C ' ' O ' ' A' ' 55' ' ' ALA . 87.0 m-20 25.85 56.65 0.05 Allowed 'General case' 0 N--CA 1.504 2.23 0 CA-C-O 120.987 0.422 . . . . 0.0 111.983 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 86.0 m -119.69 133.24 55.71 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.235 -0.915 . . . . 0.0 110.477 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.438 HG12 ' CA ' ' A' ' 47' ' ' PRO . 96.6 mt -119.29 134.06 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.496 -0.753 . . . . 0.0 111.114 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.641 HG11 ' OE2' ' A' ' 71' ' ' GLU . 54.5 t -112.74 127.94 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.211 -0.931 . . . . 0.0 109.025 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 2.2 t -94.57 122.88 37.61 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.185 -0.947 . . . . 0.0 110.313 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.48 ' HB3' ' HB3' ' A' ' 44' ' ' HIS . 6.8 t-20 -121.21 147.52 45.5 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.321 -0.862 . . . . 0.0 109.114 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.3 t -135.65 142.76 45.22 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.022 -1.049 . . . . 0.0 110.141 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.492 ' CD ' ' HA2' ' A' ' 66' ' ' GLY . 27.0 ttmt -142.94 127.39 17.82 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 118.883 -1.127 . . . . 0.0 111.67 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -107.04 103.23 12.6 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 64.48 20.74 66.02 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.492 ' HA2' ' CD ' ' A' ' 63' ' ' LYS . . . 68.89 36.58 82.14 Favored Glycine 0 N--CA 1.488 2.123 0 C-N-CA 119.2 -1.476 . . . . 0.0 110.007 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.51 14.16 6.54 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.731 -1.452 . . . . 0.0 112.263 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -139.63 -74.6 0.36 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.452 -1.405 . . . . 0.0 110.421 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.68 32.85 49.03 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.1 m -59.81 121.36 11.53 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.077 -1.249 . . . . 0.0 109.49 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.641 ' OE2' HG11 ' A' ' 59' ' ' VAL . 83.3 tt0 -116.66 133.36 56.11 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.226 -0.921 . . . . 0.0 112.039 -178.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -127.42 -162.53 1.17 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.369 -0.832 . . . . 0.0 108.971 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -141.83 140.72 33.03 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 118.484 -1.286 . . . . 0.0 112.027 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -127.92 124.29 37.02 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.897 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -101.96 46.33 0.93 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.871 -1.143 . . . . 0.0 111.017 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.432 ' O ' HD12 ' A' ' 58' ' ' ILE . 75.9 t -122.46 127.06 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.063 -1.023 . . . . 0.0 109.716 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.466 ' CD2' ' O ' ' A' ' 77' ' ' PHE . 83.2 t80 -162.23 74.71 2.22 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 120.922 -1.112 . . . . 0.0 110.91 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.485 ' HD2' ' CE2' ' A' ' 79' ' ' PHE . 55.6 Cg_endo -80.2 43.1 1.45 Allowed 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.899 1.473 . . . . 0.0 110.951 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.485 ' CE2' ' HD2' ' A' ' 78' ' ' PRO . 70.6 m-85 -127.6 151.57 48.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.884 -1.135 . . . . 0.0 109.399 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.39 168.71 14.12 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.034 -1.041 . . . . 0.0 110.251 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.75 147.58 63.22 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.958 1.504 . . . . 0.0 110.015 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 56.39 41.38 87.75 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.829 -1.309 . . . . 0.0 109.829 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 37.2 t -134.35 142.15 47.12 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.037 -1.273 . . . . 0.0 110.617 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.424 HG13 ' O ' ' A' ' 84' ' ' VAL . 7.2 p -89.16 136.8 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.387 -0.821 . . . . 0.0 109.65 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -154.66 151.74 29.13 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.109 -0.994 . . . . 0.0 110.035 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.4 ' O ' ' HD3' ' A' ' 101' ' ' PRO . 90.5 mt-10 -116.32 138.38 51.37 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 91.6 t -116.15 128.38 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.909 -1.119 . . . . 0.0 110.823 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 1.7 t -99.64 129.4 45.78 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.3 -0.875 . . . . 0.0 109.837 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 97.8 mt -122.25 127.66 75.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.356 -0.84 . . . . 0.0 110.067 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.426 ' HB ' ' HB ' ' A' ' 97' ' ' THR . 89.2 m -120.56 127.61 52.31 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.242 -0.911 . . . . 0.0 109.286 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -113.85 112.09 22.8 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.06 -1.025 . . . . 0.0 110.854 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -119.59 149.01 42.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.527 -0.733 . . . . 0.0 109.467 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -63.22 -34.4 77.57 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.94 -1.1 . . . . 0.0 109.94 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.54 -40.69 96.05 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.2 -0.937 . . . . 0.0 109.991 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -171.39 178.14 3.32 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.314 -0.866 . . . . 0.0 110.412 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 1.101 HD13 HD11 ' A' ' 43' ' ' LEU . 95.4 mt -105.0 131.53 52.4 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.397 -0.814 . . . . 0.0 110.078 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.463 ' CG2' ' OE2' ' A' ' 105' ' ' GLU . 44.1 m -121.01 129.62 53.46 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.081 -1.012 . . . . 0.0 109.838 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 56.4 t -125.82 129.04 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 120.86 -1.15 . . . . 0.0 109.255 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -116.62 126.14 52.82 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.066 -1.054 . . . . 0.0 109.934 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 12.3 mt -99.08 162.12 22.49 Favored Pre-proline 0 C--N 1.296 -1.746 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 86' ' ' GLU . 39.6 Cg_endo -64.7 -21.61 64.92 Favored 'Trans proline' 0 C--N 1.3 -2.018 0 O-C-N 123.765 1.403 . . . . 0.0 110.223 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -65.52 -32.78 74.57 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.277 -0.889 . . . . 0.0 109.279 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 117.3 -18.25 12.2 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -73.74 136.12 43.65 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.133 -1.216 . . . . 0.0 110.319 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.463 ' OE2' ' CG2' ' A' ' 97' ' ' THR . 78.9 tt0 -127.57 144.25 51.09 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.091 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -129.51 156.37 44.26 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.975 -1.078 . . . . 0.0 110.146 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -107.39 131.49 54.19 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.244 -0.91 . . . . 0.0 110.953 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.414 ' CB ' ' HB2' ' A' ' 96' ' ' LEU . 0.5 OUTLIER -121.77 126.4 26.41 Favored Pre-proline 0 C--N 1.301 -1.529 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.753 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -65.7 139.89 59.75 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 123.32 1.169 . . . . 0.0 110.397 -179.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.444 ' ND2' ' O ' ' A' ' 110' ' ' ASN . 4.5 p-10 -97.67 82.58 3.08 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 122.513 1.149 . . . . 0.0 109.791 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -58.05 -24.23 57.6 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 120.368 -1.458 . . . . 0.0 109.371 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.484 HD12 ' HA ' ' A' ' 42' ' ' CYS . 86.7 mt -86.79 144.12 27.19 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.288 -0.882 . . . . 0.0 111.078 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 24.6 m-20 -94.09 30.57 1.86 Allowed 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.718 0.77 . . . . 0.0 109.568 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.588 HD11 ' O ' ' A' ' 116' ' ' ALA . 46.9 tp -61.99 136.17 57.85 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.58 0.705 . . . . 0.0 111.135 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.449 ' O ' ' HD3' ' A' ' 13' ' ' PRO . 10.0 pt-20 -98.29 -13.98 20.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.451 -0.781 . . . . 0.0 110.932 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.588 ' O ' HD11 ' A' ' 114' ' ' LEU . . . -163.45 157.29 19.63 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.44 -1.413 . . . . 0.0 111.972 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.493 HD13 HD13 ' A' ' 34' ' ' LEU . 84.9 mt -104.8 124.8 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.355 -0.841 . . . . 0.0 109.994 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -117.67 -20.95 8.72 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.082 -1.011 . . . . 0.0 110.989 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.545 ' HB3' ' O ' ' A' ' 35' ' ' GLY . 38.9 t80 -110.73 125.67 53.75 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.419 -0.801 . . . . 0.0 110.547 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.466 ' HB3' ' CD1' ' A' ' 9' ' ' LEU . 48.3 ttp -146.93 133.04 19.29 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.237 -0.914 . . . . 0.0 109.818 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.83 154.23 33.56 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.997 -1.064 . . . . 0.0 110.496 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -146.12 120.08 9.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.306 -0.871 . . . . 0.0 109.889 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.543 ' O ' HG22 ' A' ' 31' ' ' VAL . 55.6 t0 -135.29 106.32 6.66 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.347 -0.846 . . . . 0.0 109.594 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' A' ' 30' ' ' PHE . . . -171.54 -144.61 4.51 Favored Glycine 0 N--CA 1.484 1.844 0 C-N-CA 119.237 -1.458 . . . . 0.0 110.02 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.525 ' HB3' ' HA ' ' A' ' 27' ' ' ALA . 94.2 m-20 -90.07 14.1 13.24 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.644 -0.915 . . . . 0.0 110.873 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.43 ' HB3' ' CE1' ' A' ' 30' ' ' PHE . 28.1 t80 -107.89 135.28 49.55 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.899 -1.126 . . . . 0.0 109.748 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -105.15 121.3 43.54 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 118.874 -1.13 . . . . 0.0 110.421 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.618 HG23 ' O ' ' A' ' 128' ' ' ILE . 10.7 tt -93.79 115.92 33.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.511 -0.743 . . . . 0.0 110.592 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.422 ' O ' ' HB2' ' B' ' 133' ' ' PHE . 98.7 mttt -101.54 -18.35 15.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.091 -1.006 . . . . 0.0 110.517 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -157.79 143.99 17.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.82 -1.175 . . . . 0.0 111.484 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.438 HG22 HD11 ' A' ' 128' ' ' ILE . 42.5 t -116.58 132.22 66.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 178.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.41 ' HA ' ' HB2' ' B' ' 130' ' ' CYS . . . -121.95 144.61 48.76 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.738 -1.226 . . . . 0.0 111.906 -177.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -83.37 -136.64 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 61.0 t0 . . . . . 0 N--CA 1.49 1.571 0 O-C-N 120.69 -1.256 . . . . 0.0 110.201 179.831 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 121.272 0.558 . . . . 0.0 110.088 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' CYS . . . . . . . . . . . . . 3.3 t -122.5 -135.65 0.3 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.248 -0.907 . . . . 0.0 108.72 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' GLY . . . . . 0.405 ' O ' HG23 ' B' ' 5' ' ' VAL . . . 90.41 23.26 32.02 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.46 ' HA ' ' HB3' ' A' ' 8' ' ' ASN . 36.0 tp -60.0 128.21 35.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.03 -1.276 . . . . 0.0 109.882 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.405 HG23 ' O ' ' B' ' 3' ' ' GLY . 53.7 t -120.34 130.44 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 119.731 -0.788 . . . . 0.0 109.759 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -123.6 164.6 18.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.155 -0.966 . . . . 0.0 110.902 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 7' ' ' SER . . . . . 0.461 ' O ' ' HB3' ' B' ' 8' ' ' ASN . 26.2 p -151.72 172.52 15.99 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 8' ' ' ASN . . . . . 0.461 ' HB3' ' O ' ' B' ' 7' ' ' SER . 12.0 t-20 61.59 32.84 18.53 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.571 -0.706 . . . . 0.0 109.819 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.529 ' O ' ' C ' ' B' ' 10' ' ' ASN . 96.3 mt -85.79 -5.97 59.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.529 -0.732 . . . . 0.0 111.198 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 10' ' ' ASN . . . . . 0.529 ' C ' ' O ' ' B' ' 9' ' ' LEU . 0.6 OUTLIER -0.16 70.53 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.714 0 CA-C-O 121.86 0.838 . . . . 0.0 112.817 -178.62 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' B' ' 116' ' ' ALA . 32.4 tp -88.34 138.61 31.28 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.24 167.53 8.95 Favored Pre-proline 0 C--N 1.292 -1.895 0 O-C-N 120.917 -1.114 . . . . 0.0 111.321 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 13' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' B' ' 115' ' ' GLU . 45.6 Cg_endo -67.96 147.05 73.42 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 124.195 1.629 . . . . 0.0 110.584 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.23 -3.96 62.15 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -116.46 147.32 41.83 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.965 -1.314 . . . . 0.0 109.862 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 16' ' ' CYS . . . . . . . . . . . . . 2.3 m -99.27 142.92 30.13 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.168 -0.958 . . . . 0.0 110.497 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' B' ' 17' ' ' LEU . 52.7 tp -118.5 128.1 54.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.474 -0.766 . . . . 0.0 109.618 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -128.96 133.59 47.87 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.994 -1.066 . . . . 0.0 111.155 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 55.7 t -121.38 126.55 75.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.341 -0.849 . . . . 0.0 109.604 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 20' ' ' ARG . . . . . 0.404 ' HG3' ' HG2' ' B' ' 86' ' ' GLU . 52.9 ttt-85 -108.45 125.06 51.34 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.203 -0.935 . . . . 0.0 110.061 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -148.74 -162.3 10.17 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -139.0 142.74 38.3 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.585 -0.95 . . . . 0.0 110.23 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.672 ' CG1' ' HB2' ' B' ' 27' ' ' ALA . 23.2 t -98.47 130.83 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.308 -0.87 . . . . 0.0 110.721 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.599 ' HB1' ' HD2' ' B' ' 25' ' ' PRO . . . -58.76 167.89 1.67 Allowed Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.41 -0.806 . . . . 0.0 110.16 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.599 ' HD2' ' HB1' ' B' ' 24' ' ' ALA . 45.9 Cg_endo -68.58 -19.55 42.11 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.882 1.464 . . . . 0.0 109.924 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 26' ' ' ASP . . . . . 0.442 ' O ' ' N ' ' B' ' 28' ' ' LYS . 47.4 t0 -113.09 56.93 0.67 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.535 -0.728 . . . . 0.0 109.444 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 27' ' ' ALA . . . . . 0.672 ' HB2' ' CG1' ' B' ' 23' ' ' VAL . . . -69.51 63.72 0.17 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.488 -0.757 . . . . 0.0 109.791 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 28' ' ' LYS . . . . . 0.442 ' N ' ' O ' ' B' ' 26' ' ' ASP . 88.3 tttt -63.24 -45.14 92.97 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.713 -0.617 . . . . 0.0 110.201 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 13.6 t -161.97 139.01 8.33 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.087 -1.008 . . . . 0.0 111.438 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 30' ' ' PHE . . . . . 0.497 ' HA ' ' HA3' ' B' ' 124' ' ' GLY . 25.9 t80 -135.08 144.96 47.49 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.356 -0.84 . . . . 0.0 109.925 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.555 HG22 ' O ' ' B' ' 123' ' ' ASP . 18.4 m -126.63 133.2 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 120.905 -1.122 . . . . 0.0 110.761 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 19.9 tp -129.33 135.85 49.27 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 121.55 -0.719 . . . . 0.0 110.069 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 33' ' ' ASN . . . . . 0.536 ' HB2' HD13 ' B' ' 41' ' ' LEU . 12.2 p30 -142.81 145.55 33.32 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.755 -1.216 . . . . 0.0 110.797 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.506 HD13 HD13 ' B' ' 117' ' ' ILE . 1.1 pp -149.89 119.93 7.2 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.3 -0.875 . . . . 0.0 111.008 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 35' ' ' GLY . . . . . 0.53 ' O ' ' HB3' ' B' ' 119' ' ' TYR . . . -160.81 -158.81 9.51 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.151 -1.579 . . . . 0.0 109.151 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 36' ' ' LYS . . . . . 0.486 ' HD2' HD13 ' B' ' 114' ' ' LEU . 60.1 mtpt -72.93 -40.36 65.5 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.083 -1.245 . . . . 0.0 108.868 177.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -153.17 -167.28 2.67 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.68 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 40.2 t -61.98 -46.1 90.71 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.602 -0.686 . . . . 0.0 112.531 -178.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 39' ' ' ASN . . . . . 0.43 ' HB3' ' N ' ' B' ' 66' ' ' GLY . 70.7 m-20 -94.65 0.42 55.08 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.644 -1.285 . . . . 0.0 110.5 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -113.15 62.45 0.64 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.256 -0.902 . . . . 0.0 109.536 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.536 HD13 ' HB2' ' B' ' 33' ' ' ASN . 92.1 mt -103.46 136.94 42.26 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 121.249 0.547 . . . . 0.0 109.554 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 42' ' ' CYS . . . . . 0.488 ' HA ' HD12 ' B' ' 112' ' ' LEU . 65.7 m -87.78 -38.64 15.58 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.218 -0.926 . . . . 0.0 108.764 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 1.027 HD11 HD13 ' B' ' 96' ' ' LEU . 94.6 mt -132.06 140.98 49.06 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.158 -0.964 . . . . 0.0 111.096 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 44' ' ' HIS . . . . . 0.466 ' HB3' ' HB3' ' B' ' 61' ' ' ASN . 81.8 t60 -132.03 102.95 6.03 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -102.09 141.83 34.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.234 -0.916 . . . . 0.0 110.727 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 46' ' ' ASN . . . . . 0.511 ' CG ' HG12 ' B' ' 31' ' ' VAL . 1.2 t-20 -154.85 84.97 3.67 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.366 -0.834 . . . . 0.0 110.658 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 47' ' ' PRO . . . . . 0.449 ' CA ' HG12 ' B' ' 58' ' ' ILE . 46.3 Cg_endo -67.23 148.32 80.24 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.847 1.446 . . . . 0.0 110.692 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -132.93 107.86 8.56 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.307 -0.87 . . . . 0.0 111.036 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -61.97 -47.89 82.8 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.414 -0.804 . . . . 0.0 109.496 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -151.05 97.98 2.52 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.499 -0.751 . . . . 0.0 109.653 178.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -105.54 -126.55 0.24 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.074 -1.016 . . . . 0.0 110.333 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 52' ' ' HIS . . . . . . . . . . . . . 41.2 m170 -61.23 -34.35 74.98 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.696 -1.253 . . . . 0.0 110.946 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 170.48 33.12 0.02 OUTLIER Glycine 0 N--CA 1.492 2.397 0 C-N-CA 119.167 -1.492 . . . . 0.0 111.062 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -117.5 -166.02 1.15 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.982 -1.305 . . . . 0.0 109.301 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.503 ' O ' ' C ' ' B' ' 56' ' ' ASN . . . -152.15 149.14 28.44 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.218 -0.926 . . . . 0.0 109.674 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 56' ' ' ASN . . . . . 0.503 ' C ' ' O ' ' B' ' 55' ' ' ALA . 85.6 m-20 16.85 60.24 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.345 0 CA-C-O 121.473 0.654 . . . . 0.0 112.562 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 77.8 m -120.08 132.84 55.58 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.411 -0.806 . . . . 0.0 110.49 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 58' ' ' ILE . . . . . 0.449 HG12 ' CA ' ' B' ' 47' ' ' PRO . 97.0 mt -119.36 133.75 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.498 -0.751 . . . . 0.0 111.386 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.638 HG11 ' OE2' ' B' ' 71' ' ' GLU . 54.9 t -111.9 128.13 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.317 -0.864 . . . . 0.0 109.28 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 1.9 t -94.96 122.46 37.63 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.982 -1.074 . . . . 0.0 110.313 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 61' ' ' ASN . . . . . 0.466 ' HB3' ' HB3' ' B' ' 44' ' ' HIS . 6.8 t-20 -120.52 148.19 44.17 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.42 -0.8 . . . . 0.0 109.211 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 34.8 t -136.4 142.83 43.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.957 -1.09 . . . . 0.0 110.237 -178.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 63' ' ' LYS . . . . . 0.486 ' CD ' ' HA2' ' B' ' 66' ' ' GLY . 27.0 ttmt -143.17 127.15 17.34 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 118.931 -1.108 . . . . 0.0 111.93 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -106.55 104.13 13.74 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 63.76 20.13 63.79 Favored Glycine 0 N--CA 1.483 1.82 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 66' ' ' GLY . . . . . 0.486 ' HA2' ' CD ' ' B' ' 63' ' ' LYS . . . 69.57 36.27 76.23 Favored Glycine 0 N--CA 1.487 2.062 0 O-C-N 120.624 -1.515 . . . . 0.0 110.084 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -127.85 12.45 6.76 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.732 -1.452 . . . . 0.0 112.378 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 68' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -138.08 -74.71 0.4 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.615 -1.303 . . . . 0.0 110.505 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.81 32.46 49.89 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -59.58 121.58 11.93 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.134 -1.216 . . . . 0.0 109.486 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 71' ' ' GLU . . . . . 0.638 ' OE2' HG11 ' B' ' 59' ' ' VAL . 83.5 tt0 -117.12 133.46 55.98 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.156 -0.965 . . . . 0.0 112.062 -178.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -127.31 -162.96 1.21 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.399 -0.813 . . . . 0.0 109.157 178.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -141.44 139.79 33.46 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.676 -1.265 . . . . 0.0 112.066 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -126.75 124.56 40.02 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.969 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -102.29 46.55 0.92 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.834 -1.166 . . . . 0.0 110.945 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 76' ' ' VAL . . . . . 0.446 ' O ' HD12 ' B' ' 58' ' ' ILE . 76.5 t -122.8 127.44 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.097 -1.002 . . . . 0.0 109.739 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 77' ' ' PHE . . . . . 0.469 ' CD2' ' O ' ' B' ' 77' ' ' PHE . 83.4 t80 -162.47 74.13 2.16 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 120.962 -1.086 . . . . 0.0 110.878 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 78' ' ' PRO . . . . . 0.486 ' HD2' ' CE2' ' B' ' 79' ' ' PHE . 55.7 Cg_endo -79.71 43.63 1.54 Allowed 'Trans proline' 0 C--N 1.302 -1.877 0 O-C-N 123.914 1.481 . . . . 0.0 111.08 179.075 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 79' ' ' PHE . . . . . 0.486 ' CE2' ' HD2' ' B' ' 78' ' ' PRO . 68.4 m-85 -128.22 151.25 49.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.85 -1.156 . . . . 0.0 109.463 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.24 168.23 15.47 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.095 -1.003 . . . . 0.0 110.329 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 81' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -69.43 147.29 64.63 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.994 1.523 . . . . 0.0 109.959 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 56.76 41.56 90.68 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 37.4 t -134.39 143.01 47.37 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.05 -1.265 . . . . 0.0 110.637 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.429 ' O ' HG13 ' B' ' 84' ' ' VAL . 7.1 p -90.14 136.62 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.38 -0.825 . . . . 0.0 109.614 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -154.34 150.91 28.45 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.121 -0.987 . . . . 0.0 110.043 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 86' ' ' GLU . . . . . 0.404 ' HG2' ' HG3' ' B' ' 20' ' ' ARG . 90.3 mt-10 -115.84 137.59 51.95 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 78.2 t -115.5 128.34 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.925 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 88' ' ' CYS . . . . . . . . . . . . . 1.9 t -99.69 129.48 45.83 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.292 -0.88 . . . . 0.0 109.876 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 98.0 mt -122.38 127.21 75.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.319 -0.863 . . . . 0.0 110.111 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 90' ' ' THR . . . . . 0.421 ' HB ' ' HB ' ' B' ' 97' ' ' THR . 92.7 m -120.3 127.25 52.2 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.135 -0.978 . . . . 0.0 109.137 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 91' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -113.46 112.67 24.0 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.243 -0.983 . . . . 0.0 110.833 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -120.14 148.62 43.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.472 -0.768 . . . . 0.0 109.64 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -63.17 -33.8 76.26 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.021 -1.049 . . . . 0.0 109.91 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.8 -40.85 95.91 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.257 -0.902 . . . . 0.0 109.999 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -171.75 178.22 3.14 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.302 -0.874 . . . . 0.0 110.484 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 96' ' ' LEU . . . . . 1.027 HD13 HD11 ' B' ' 43' ' ' LEU . 94.7 mt -105.09 131.62 52.36 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.349 -0.845 . . . . 0.0 110.134 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 97' ' ' THR . . . . . 0.456 ' CG2' ' OE2' ' B' ' 105' ' ' GLU . 44.6 m -121.05 129.49 53.37 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.171 -0.956 . . . . 0.0 109.779 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 59.9 t -125.63 128.83 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.94 -1.1 . . . . 0.0 109.241 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -116.35 126.51 53.6 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.069 -1.052 . . . . 0.0 109.765 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 12.2 mt -99.67 162.0 22.62 Favored Pre-proline 0 C--N 1.296 -1.736 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -64.57 -21.58 65.59 Favored 'Trans proline' 0 C--N 1.299 -2.046 0 O-C-N 123.757 1.399 . . . . 0.0 110.275 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -65.76 -32.85 74.63 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.287 -0.883 . . . . 0.0 109.268 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 117.92 -18.54 11.48 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 104' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -73.62 136.25 43.89 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.178 -1.189 . . . . 0.0 110.37 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 105' ' ' GLU . . . . . 0.456 ' OE2' ' CG2' ' B' ' 97' ' ' THR . 79.0 tt0 -127.51 143.62 51.16 Favored 'General case' 0 C--N 1.298 -1.63 0 O-C-N 121.443 -0.786 . . . . 0.0 109.001 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -128.99 155.83 44.75 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.887 -1.133 . . . . 0.0 110.221 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -106.96 132.37 52.97 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.21 -0.931 . . . . 0.0 111.003 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 108' ' ' PHE . . . . . 0.409 ' CB ' ' HB2' ' B' ' 96' ' ' LEU . 0.5 OUTLIER -122.8 126.61 26.02 Favored Pre-proline 0 C--N 1.301 -1.51 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.75 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -65.68 139.74 59.19 Favored 'Trans proline' 0 C--N 1.303 -1.844 0 O-C-N 123.286 1.15 . . . . 0.0 110.391 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 110' ' ' ASN . . . . . 0.443 ' ND2' ' O ' ' B' ' 110' ' ' ASN . 4.7 p-10 -97.52 82.64 3.12 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 122.488 1.137 . . . . 0.0 109.653 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -58.05 -24.23 57.61 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 120.263 -1.523 . . . . 0.0 109.433 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 112' ' ' LEU . . . . . 0.488 HD12 ' HA ' ' B' ' 42' ' ' CYS . 87.2 mt -86.84 143.44 27.46 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.355 -0.841 . . . . 0.0 111.218 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 24.1 m-20 -93.39 30.53 1.69 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.612 -0.68 . . . . 0.0 109.579 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 114' ' ' LEU . . . . . 0.584 HD11 ' O ' ' B' ' 116' ' ' ALA . 46.7 tp -62.21 135.62 57.57 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.706 0.765 . . . . 0.0 111.443 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 115' ' ' GLU . . . . . 0.465 ' O ' ' HD3' ' B' ' 13' ' ' PRO . 9.8 pt-20 -97.19 -15.52 20.84 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.485 -0.759 . . . . 0.0 110.974 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 116' ' ' ALA . . . . . 0.584 ' O ' HD11 ' B' ' 114' ' ' LEU . . . -162.36 157.12 22.21 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.47 -1.394 . . . . 0.0 112.129 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 117' ' ' ILE . . . . . 0.506 HD13 HD13 ' B' ' 34' ' ' LEU . 85.0 mt -104.31 124.68 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.373 -0.829 . . . . 0.0 110.006 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -117.68 -20.74 8.81 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.14 -0.975 . . . . 0.0 110.982 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 119' ' ' TYR . . . . . 0.53 ' HB3' ' O ' ' B' ' 35' ' ' GLY . 38.9 t80 -110.87 125.35 53.53 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.264 -0.897 . . . . 0.0 110.638 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 120' ' ' MET . . . . . 0.479 ' HB3' ' CD1' ' B' ' 9' ' ' LEU . 48.5 ttp -146.75 133.21 19.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.226 -0.921 . . . . 0.0 109.878 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -154.01 154.29 33.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.061 -1.024 . . . . 0.0 110.659 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -146.03 120.58 9.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.279 -0.888 . . . . 0.0 109.879 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 123' ' ' ASP . . . . . 0.555 ' O ' HG22 ' B' ' 31' ' ' VAL . 55.0 t0 -135.42 106.57 6.72 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.381 -0.824 . . . . 0.0 109.559 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 124' ' ' GLY . . . . . 0.497 ' HA3' ' HA ' ' B' ' 30' ' ' PHE . . . -171.52 -144.26 4.37 Favored Glycine 0 N--CA 1.486 1.981 0 C-N-CA 119.26 -1.448 . . . . 0.0 110.227 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 125' ' ' ASP . . . . . 0.525 ' HB3' ' HA ' ' B' ' 27' ' ' ALA . 93.8 m-20 -90.56 14.43 13.2 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.697 -0.884 . . . . 0.0 110.859 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 126' ' ' PHE . . . . . 0.435 ' HB3' ' CE1' ' B' ' 30' ' ' PHE . 27.3 t80 -108.17 135.57 49.29 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.015 -1.053 . . . . 0.0 109.661 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -105.56 120.86 42.69 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.006 -1.077 . . . . 0.0 110.367 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 128' ' ' ILE . . . . . 0.639 ' O ' HG23 ' B' ' 128' ' ' ILE . 10.3 tt -93.58 116.38 34.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.639 -0.663 . . . . 0.0 110.524 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -102.06 -19.41 15.18 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.104 -0.997 . . . . 0.0 110.497 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 130' ' ' CYS . . . . . 0.41 ' HB2' ' HA ' ' A' ' 132' ' ' ALA . 0.0 OUTLIER -155.93 144.18 19.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.883 -1.136 . . . . 0.0 111.591 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.419 HG22 HD11 ' B' ' 128' ' ' ILE . 40.2 t -116.88 131.87 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.038 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 132' ' ' ALA . . . . . . . . . . . . . . . -121.65 144.32 48.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.572 -1.33 . . . . 0.0 111.746 -177.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 133' ' ' PHE . . . . . 0.422 ' HB2' ' O ' ' A' ' 129' ' ' LYS . 3.0 t80 -83.17 -135.58 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.758 -0.589 . . . . 0.0 109.433 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 61.5 t0 . . . . . 0 N--CA 1.492 1.628 0 O-C-N 120.697 -1.252 . . . . 0.0 110.147 179.504 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.43 ' HA3' ' O ' ' A' ' 122' ' ' ALA . . . . . . . . 0 N--CA 1.49 2.258 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.556 HD23 ' C ' ' A' ' 4' ' ' LEU . 0.3 OUTLIER -67.62 154.67 40.94 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.537 -0.979 . . . . 0.0 111.218 -179.467 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.456 ' N ' ' HG ' ' A' ' 4' ' ' LEU . 76.5 t -118.16 136.92 53.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.397 -0.814 . . . . 0.0 109.666 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.492 ' HB3' HD11 ' A' ' 9' ' ' LEU . . . -119.59 164.4 15.91 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.699 -1.25 . . . . 0.0 111.305 -178.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.4 ' O ' ' HB3' ' A' ' 8' ' ' ASN . 15.0 p -153.08 166.35 32.74 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.477 -0.764 . . . . 0.0 109.898 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.426 ' ND2' ' O ' ' B' ' 3' ' ' GLY . 55.4 t30 60.81 38.54 17.93 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.273 -0.892 . . . . 0.0 109.759 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.536 ' O ' ' C ' ' A' ' 10' ' ' ASN . 61.5 mt -89.74 -3.35 58.23 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.705 -0.622 . . . . 0.0 111.849 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.536 ' C ' ' O ' ' A' ' 9' ' ' LEU . 8.2 m120 6.09 78.1 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.634 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 3.6 tt -100.24 129.78 46.28 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.303 -0.873 . . . . 0.0 110.035 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.3 mtpp -97.95 164.86 16.51 Favored Pre-proline 0 C--N 1.297 -1.694 0 O-C-N 121.445 -0.784 . . . . 0.0 110.37 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -66.93 147.28 80.14 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 123.991 1.521 . . . . 0.0 110.265 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.66 7.84 62.76 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -115.42 146.83 41.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.833 -1.393 . . . . 0.0 110.287 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 48.8 t -106.54 137.93 43.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.341 -0.85 . . . . 0.0 110.438 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.547 HD12 ' O ' ' A' ' 132' ' ' ALA . 45.5 tp -117.84 130.06 56.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.316 -0.865 . . . . 0.0 109.79 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.418 ' CZ ' ' OE1' ' A' ' 86' ' ' GLU . 77.5 ttt180 -118.95 128.74 54.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.941 -1.099 . . . . 0.0 110.633 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 25.1 t -121.13 125.29 73.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.256 -0.902 . . . . 0.0 110.725 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.453 ' HA ' ' HG2' ' A' ' 86' ' ' GLU . 75.8 ttt180 -109.86 129.01 55.69 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -149.19 -170.0 16.34 Favored Glycine 0 N--CA 1.486 1.974 0 C-N-CA 119.146 -1.502 . . . . 0.0 110.131 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -129.59 123.28 30.94 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.786 -0.832 . . . . 0.0 109.709 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.544 HG22 ' HD1' ' A' ' 126' ' ' PHE . 99.1 t -79.19 129.5 37.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.144 -0.973 . . . . 0.0 109.713 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.461 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -54.76 163.16 1.5 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.009 -1.057 . . . . 0.0 110.049 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.461 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 42.7 Cg_endo -67.84 -18.26 47.09 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.977 1.514 . . . . 0.0 110.327 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' A' ' 28' ' ' LYS . 63.9 t0 -113.61 56.76 0.69 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.244 -0.91 . . . . 0.0 109.284 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.8 84.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.602 -0.686 . . . . 0.0 110.227 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.514 ' HA ' ' HB3' ' A' ' 49' ' ' PHE . 85.1 tttt -109.64 -33.94 6.63 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.024 -1.047 . . . . 0.0 111.835 -179.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.2 t -146.22 140.45 26.58 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.626 -1.296 . . . . 0.0 111.671 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.509 ' CE2' ' HB2' ' A' ' 126' ' ' PHE . 83.3 m-85 -139.56 146.47 39.91 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.393 -0.817 . . . . 0.0 110.188 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.421 ' HB ' ' O ' ' A' ' 123' ' ' ASP . 63.7 t -133.44 130.0 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.96 -1.088 . . . . 0.0 109.798 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.709 HD12 ' HB2' ' A' ' 45' ' ' PHE . 94.7 mt -131.75 144.58 51.06 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.027 -1.046 . . . . 0.0 110.374 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -146.13 108.75 4.5 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.232 -0.917 . . . . 0.0 110.122 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.593 HD11 ' HB2' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -124.25 111.27 15.65 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.154 -0.966 . . . . 0.0 110.107 179.511 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -159.81 -122.84 0.67 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.502 ' HD2' HD13 ' A' ' 114' ' ' LEU . 0.1 OUTLIER -130.4 -46.12 1.09 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.396 -1.061 . . . . 0.0 108.864 179.518 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.447 ' HB2' ' ND2' ' A' ' 40' ' ' ASN . 87.6 m-20 -122.18 164.0 18.57 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.8 t -56.46 -42.33 78.03 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.293 -0.879 . . . . 0.0 111.631 -178.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.478 ' HB3' ' N ' ' A' ' 66' ' ' GLY . 92.4 m-20 -92.06 -0.11 57.46 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.89 -1.131 . . . . 0.0 111.002 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.455 ' N ' ' ND2' ' A' ' 40' ' ' ASN . 2.8 m-80 -117.37 61.7 0.75 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.95 -1.094 . . . . 0.0 109.854 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.7 mt -90.3 137.84 32.02 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.742 -0.599 . . . . 0.0 109.795 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.405 ' SG ' ' N ' ' A' ' 43' ' ' LEU . 6.8 p -88.62 -30.0 19.54 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.248 -0.907 . . . . 0.0 109.751 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.71 HD11 HD13 ' A' ' 96' ' ' LEU . 69.6 mt -137.09 138.14 40.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.904 . . . . 0.0 110.963 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -135.84 126.48 27.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.404 -0.81 . . . . 0.0 110.125 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.709 ' HB2' HD12 ' A' ' 32' ' ' LEU . 91.9 m-85 -113.01 141.96 46.26 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.996 -1.065 . . . . 0.0 110.024 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -154.72 69.94 5.86 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 120.996 -1.065 . . . . 0.0 110.986 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.42 147.46 65.13 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.68 1.358 . . . . 0.0 110.081 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.414 ' NH2' ' HB1' ' A' ' 51' ' ' ALA . 82.9 mtp180 -137.82 111.34 8.08 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.007 -1.058 . . . . 0.0 110.66 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.514 ' HB3' ' HA ' ' A' ' 28' ' ' LYS . 85.6 t80 -62.06 -46.31 89.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.312 -0.868 . . . . 0.0 110.03 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -164.64 99.45 0.79 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -0.909 . . . . 0.0 110.078 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.414 ' HB1' ' NH2' ' A' ' 48' ' ' ARG . . . -109.97 -89.81 0.48 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.254 -0.904 . . . . 0.0 109.911 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -63.1 -42.37 99.56 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.927 -1.108 . . . . 0.0 109.075 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 161.81 38.46 0.02 OUTLIER Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -117.54 -171.63 2.08 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.28 -1.13 . . . . 0.0 110.015 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.474 ' O ' ' C ' ' A' ' 56' ' ' ASN . . . -145.22 152.62 40.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.337 -0.852 . . . . 0.0 110.454 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.516 ' HB3' ' CD1' ' A' ' 77' ' ' PHE . 36.2 m120 23.09 56.79 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 45.9 m -112.91 132.62 55.25 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.338 -0.851 . . . . 0.0 109.042 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.432 HD11 ' O ' ' A' ' 76' ' ' VAL . 75.1 mt -117.03 135.55 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.147 -0.971 . . . . 0.0 111.774 -177.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.412 ' CG1' ' OE2' ' A' ' 71' ' ' GLU . 47.4 t -110.9 130.36 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.369 -0.832 . . . . 0.0 109.539 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 75.1 m -130.94 126.17 35.38 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.036 -1.04 . . . . 0.0 110.695 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -151.35 173.29 14.68 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.245 -0.909 . . . . 0.0 110.727 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.454 ' O ' ' CA ' ' A' ' 69' ' ' GLY . 69.0 m -131.77 155.2 48.14 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.506 -0.746 . . . . 0.0 109.858 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.487 ' CD ' ' HA2' ' A' ' 66' ' ' GLY . 8.9 ttmt -135.2 150.45 50.11 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.679 -1.263 . . . . 0.0 111.367 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -124.49 105.51 9.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.426 -0.797 . . . . 0.0 109.937 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 57.58 27.01 58.08 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.487 ' HA2' ' CD ' ' A' ' 63' ' ' LYS . . . 75.46 23.19 74.01 Favored Glycine 0 N--CA 1.488 2.129 0 O-C-N 120.777 -1.425 . . . . 0.0 109.771 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.47 ' HB1' ' CD1' ' A' ' 68' ' ' TRP . . . -81.2 -85.32 0.1 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.189 -1.183 . . . . 0.0 110.835 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.47 ' CD1' ' HB1' ' A' ' 67' ' ' ALA . 10.3 m95 -135.35 -146.89 0.25 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.884 -1.135 . . . . 0.0 109.849 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.454 ' CA ' ' O ' ' A' ' 62' ' ' SER . . . 167.38 129.45 1.07 Allowed Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.641 -1.266 . . . . 0.0 110.544 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.3 m -81.51 80.2 7.93 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.45 -1.029 . . . . 0.0 109.824 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.412 ' OE2' ' CG1' ' A' ' 59' ' ' VAL . 83.5 tt0 -72.37 124.75 25.79 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.201 -0.937 . . . . 0.0 111.134 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -109.53 -162.0 0.79 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.381 -0.824 . . . . 0.0 109.624 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 62.5 ttp85 -145.91 117.38 8.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.185 -0.947 . . . . 0.0 110.697 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -110.4 125.73 53.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.207 -0.933 . . . . 0.0 109.711 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -105.83 45.7 0.96 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.168 -0.957 . . . . 0.0 111.85 -178.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.622 HG12 ' HD3' ' A' ' 78' ' ' PRO . 51.7 t -121.41 133.01 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 120.965 -1.085 . . . . 0.0 109.843 179.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.532 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 11.3 p90 -143.02 82.03 12.32 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.102 -0.999 . . . . 0.0 111.248 -178.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.622 ' HD3' HG12 ' A' ' 76' ' ' VAL . 56.5 Cg_endo -79.99 41.29 1.09 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.495 1.26 . . . . 0.0 111.378 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -149.83 163.24 38.56 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.701 -1.249 . . . . 0.0 110.971 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 13.6 mp0 -129.94 164.58 39.5 Favored Pre-proline 0 N--CA 1.492 1.668 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.79 148.86 65.82 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 123.593 1.312 . . . . 0.0 110.859 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 63.42 41.75 99.26 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 25.1 t -137.36 137.32 38.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.198 -1.178 . . . . 0.0 111.276 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 84' ' ' VAL . 27.6 m -79.18 135.51 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.472 -0.767 . . . . 0.0 109.53 179.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.66 154.58 37.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.974 -1.079 . . . . 0.0 110.6 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.453 ' HG2' ' HA ' ' A' ' 20' ' ' ARG . 97.4 mt-10 -121.05 140.11 52.39 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.473 -0.767 . . . . 0.0 109.65 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.9 t -122.64 130.28 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.101 -0.999 . . . . 0.0 110.36 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 22.2 m -92.73 125.0 37.15 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.439 -0.788 . . . . 0.0 109.821 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 95.8 mt -122.05 125.0 72.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.045 -1.035 . . . . 0.0 110.246 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 53.9 m -121.76 124.55 44.47 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.392 -0.817 . . . . 0.0 108.913 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.414 ' CD1' ' CD2' ' A' ' 96' ' ' LEU . 65.7 t80 -110.51 112.84 25.02 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.142 -0.974 . . . . 0.0 110.333 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -121.04 150.32 41.36 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.612 -0.68 . . . . 0.0 109.226 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -64.35 -33.65 76.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.773 -1.204 . . . . 0.0 110.064 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.74 -46.02 90.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.969 -1.082 . . . . 0.0 109.558 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -168.63 175.59 6.07 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.425 -0.797 . . . . 0.0 109.764 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.734 HD12 ' HD2' ' A' ' 108' ' ' PHE . 79.1 mt -107.71 128.6 54.72 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.158 -0.964 . . . . 0.0 110.414 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.5 m -109.93 126.67 54.14 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.162 -0.961 . . . . 0.0 110.176 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 59.2 t -133.16 128.42 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 120.775 -1.203 . . . . 0.0 110.496 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -123.24 147.7 46.65 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.996 -1.065 . . . . 0.0 111.01 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.492 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 1.1 mp -100.84 167.73 10.35 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.587 -0.696 . . . . 0.0 109.636 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.492 ' HD2' ' HB3' ' A' ' 100' ' ' LEU . 41.7 Cg_endo -65.97 -22.63 55.21 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 123.408 1.215 . . . . 0.0 110.42 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.419 ' O ' ' HB3' ' A' ' 78' ' ' PRO . 47.7 t0 -152.09 78.23 1.23 Allowed 'General case' 0 N--CA 1.486 1.325 0 O-C-N 121.129 -0.982 . . . . 0.0 109.8 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -177.91 -171.91 41.81 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -87.59 -150.8 0.17 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.379 -1.071 . . . . 0.0 110.009 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 64.3 tt0 -128.92 146.23 51.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.238 -0.914 . . . . 0.0 110.661 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -130.38 134.27 47.02 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.279 -0.888 . . . . 0.0 109.968 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -114.83 144.7 43.11 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.204 -0.935 . . . . 0.0 110.859 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.734 ' HD2' HD12 ' A' ' 96' ' ' LEU . 56.7 t80 -129.17 133.65 25.41 Favored Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.457 ' O ' ' CE2' ' A' ' 108' ' ' PHE . 44.9 Cg_endo -66.83 138.79 49.82 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.359 1.189 . . . . 0.0 110.389 -178.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' A' ' 110' ' ' ASN . 5.2 p-10 -100.39 78.49 2.03 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.318 -0.864 . . . . 0.0 110.263 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.403 ' C ' ' O ' ' A' ' 110' ' ' ASN . 79.6 ttt180 -41.46 -32.65 0.35 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.429 -0.794 . . . . 0.0 110.797 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 95.0 mt -78.93 149.67 32.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.369 -0.832 . . . . 0.0 110.313 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -104.42 40.56 1.45 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.408 -0.808 . . . . 0.0 109.874 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.502 HD13 ' HD2' ' A' ' 36' ' ' LYS . 56.4 tp -71.16 125.93 28.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.203 -0.935 . . . . 0.0 109.766 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -96.75 -5.34 38.81 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.489 -0.757 . . . . 0.0 111.086 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 11' ' ' LEU . . . -141.46 142.0 33.66 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.874 -1.141 . . . . 0.0 111.473 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.47 ' HB ' ' HB3' ' A' ' 11' ' ' LEU . 48.1 mm -102.73 121.29 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.401 ' ND2' ' N ' ' A' ' 118' ' ' ASN . 6.5 m-80 -117.94 -18.82 9.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.993 -1.067 . . . . 0.0 111.465 -178.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.467 ' O ' ' HA ' ' A' ' 34' ' ' LEU . 42.9 t80 -113.71 130.04 56.48 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.907 -1.121 . . . . 0.0 111.14 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.48 ' HB3' ' CD1' ' A' ' 9' ' ' LEU . 48.2 ttp -142.42 114.22 8.05 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -136.05 139.0 42.73 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.95 -1.094 . . . . 0.0 110.905 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.493 ' CB ' HD23 ' A' ' 32' ' ' LEU . . . -141.83 131.92 24.72 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.51 -0.744 . . . . 0.0 109.137 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.421 ' O ' ' HB ' ' A' ' 31' ' ' VAL . 62.2 t0 -151.35 122.4 7.67 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.567 -0.708 . . . . 0.0 109.246 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.481 ' HA3' ' HA ' ' A' ' 30' ' ' PHE . . . 174.57 -148.98 10.14 Favored Glycine 0 N--CA 1.488 2.153 0 C-N-CA 119.192 -1.48 . . . . 0.0 110.165 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.5 ' HB2' ' CZ ' ' A' ' 30' ' ' PHE . 87.7 m-20 -86.35 9.16 18.78 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.672 -0.899 . . . . 0.0 110.283 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.544 ' HD1' HG22 ' A' ' 23' ' ' VAL . 51.1 t80 -104.06 141.77 35.63 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.122 -0.986 . . . . 0.0 109.662 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -116.08 120.05 37.81 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.168 -1.013 . . . . 0.0 111.108 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.621 HG23 ' O ' ' A' ' 128' ' ' ILE . 19.0 tt -95.47 119.57 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.232 -0.917 . . . . 0.0 109.923 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -100.82 -15.4 17.63 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.128 -0.983 . . . . 0.0 111.571 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -155.54 146.89 22.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.808 -1.183 . . . . 0.0 111.425 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.501 HG22 HD11 ' A' ' 128' ' ' ILE . 43.2 t -124.91 129.37 73.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.547 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -118.96 140.07 50.61 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.961 -1.087 . . . . 0.0 110.521 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -106.36 119.61 39.72 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.415 -0.803 . . . . 0.0 109.976 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.9 t0 . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.538 -179.997 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.162 0.506 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 2' ' ' CYS . . . . . 0.427 ' N ' ' OD1' ' B' ' 123' ' ' ASP . 0.5 OUTLIER -157.71 104.22 1.95 Allowed 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.059 -1.026 . . . . 0.0 110.226 179.898 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' GLY . . . . . 0.426 ' O ' ' ND2' ' A' ' 8' ' ' ASN . . . 179.51 127.48 1.11 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.555 ' C ' HD23 ' B' ' 4' ' ' LEU . 0.3 OUTLIER -67.27 154.42 41.34 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.728 -0.866 . . . . 0.0 111.342 -179.046 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.46 ' N ' ' HG ' ' B' ' 4' ' ' LEU . 72.7 t -118.11 137.08 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.578 -0.701 . . . . 0.0 109.676 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' ALA . . . . . 0.474 ' HB3' HD11 ' B' ' 9' ' ' LEU . . . -119.56 164.81 15.27 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.772 -1.205 . . . . 0.0 111.309 -178.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' SER . . . . . 0.409 ' O ' ' HB3' ' B' ' 8' ' ' ASN . 14.1 p -153.23 166.37 32.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.292 -0.88 . . . . 0.0 109.645 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . 0.409 ' HB3' ' O ' ' B' ' 7' ' ' SER . 54.8 t30 60.75 38.94 17.88 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.345 -0.847 . . . . 0.0 109.681 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.553 ' O ' ' C ' ' B' ' 10' ' ' ASN . 63.2 mt -91.41 1.32 57.21 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.646 -0.659 . . . . 0.0 111.77 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' ASN . . . . . 0.553 ' C ' ' O ' ' B' ' 9' ' ' LEU . 7.9 m120 -0.16 80.65 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.565 0 CA-C-O 121.599 0.714 . . . . 0.0 112.715 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.499 ' O ' ' HA ' ' B' ' 116' ' ' ALA . 3.4 tt -100.67 129.9 46.65 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.585 -0.697 . . . . 0.0 109.898 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 3.3 mtpp -98.31 165.18 15.71 Favored Pre-proline 0 C--N 1.295 -1.783 0 O-C-N 121.481 -0.762 . . . . 0.0 110.441 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -66.88 147.38 80.49 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.96 1.505 . . . . 0.0 110.389 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.81 7.06 63.16 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 110.259 -1.137 . . . . 0.0 110.259 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -114.99 146.78 40.87 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.841 -1.388 . . . . 0.0 110.507 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' CYS . . . . . . . . . . . . . 49.4 t -106.44 137.86 43.65 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.413 -0.804 . . . . 0.0 110.561 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.537 HD12 ' O ' ' B' ' 132' ' ' ALA . 45.3 tp -117.86 130.03 56.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.358 -0.839 . . . . 0.0 109.694 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.413 ' CZ ' ' OE1' ' B' ' 86' ' ' GLU . 76.9 ttt180 -118.91 129.4 55.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.02 -1.05 . . . . 0.0 110.498 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 24.9 t -121.75 125.07 72.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.279 -0.888 . . . . 0.0 110.682 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.455 ' HA ' ' HG2' ' B' ' 86' ' ' GLU . 76.1 ttt180 -109.55 128.88 55.51 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.34 -0.85 . . . . 0.0 108.869 178.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -149.4 -170.01 16.49 Favored Glycine 0 N--CA 1.486 1.988 0 C-N-CA 118.997 -1.573 . . . . 0.0 110.086 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -129.54 123.38 31.27 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.678 -0.895 . . . . 0.0 109.774 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.524 HG22 ' HD1' ' B' ' 126' ' ' PHE . 99.2 t -79.36 129.65 37.25 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 121.287 -0.883 . . . . 0.0 109.6 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.457 ' HB1' ' HD2' ' B' ' 25' ' ' PRO . . . -54.77 163.26 1.48 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.16 -0.962 . . . . 0.0 110.027 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . 0.457 ' HD2' ' HB1' ' B' ' 24' ' ' ALA . 42.6 Cg_endo -67.74 -18.81 47.78 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.952 1.501 . . . . 0.0 110.196 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' B' ' 28' ' ' LYS . 64.1 t0 -113.3 56.94 0.68 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.244 -0.91 . . . . 0.0 109.391 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.96 84.89 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.679 -0.638 . . . . 0.0 110.163 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . 0.508 ' HA ' ' HB3' ' B' ' 49' ' ' PHE . 85.2 tttt -109.78 -33.49 6.73 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.065 -1.022 . . . . 0.0 111.777 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 37.1 t -146.58 140.1 25.84 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.674 -1.266 . . . . 0.0 111.535 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' PHE . . . . . 0.505 ' CD2' ' HB2' ' B' ' 126' ' ' PHE . 83.9 m-85 -139.3 146.04 39.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.439 -0.788 . . . . 0.0 110.142 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.413 ' HB ' ' O ' ' B' ' 123' ' ' ASP . 62.9 t -133.04 129.77 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.907 -1.121 . . . . 0.0 109.893 178.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.692 HD12 ' HB2' ' B' ' 45' ' ' PHE . 94.9 mt -131.31 144.64 51.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.103 -0.998 . . . . 0.0 110.565 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -146.07 108.87 4.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.302 -0.874 . . . . 0.0 110.238 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.595 HD11 ' HB2' ' B' ' 43' ' ' LEU . 0.3 OUTLIER -124.19 110.19 14.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.178 -0.951 . . . . 0.0 110.047 179.472 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -157.78 -122.39 0.7 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . 0.497 ' HD2' HD13 ' B' ' 114' ' ' LEU . 0.1 OUTLIER -130.83 -46.12 1.04 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.571 -0.958 . . . . 0.0 108.707 179.177 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . 0.424 ' HB2' ' HB2' ' B' ' 40' ' ' ASN . 87.3 m-20 -122.2 164.14 18.35 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 28.4 t -56.88 -41.99 79.02 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.312 -0.867 . . . . 0.0 111.372 -178.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' ASN . . . . . 0.48 ' HB3' ' N ' ' B' ' 66' ' ' GLY . 92.1 m-20 -92.31 0.02 57.42 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.862 -1.149 . . . . 0.0 111.002 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' ASN . . . . . 0.454 ' ND2' ' N ' ' B' ' 40' ' ' ASN . 2.7 m-80 -117.62 61.88 0.75 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.026 -1.046 . . . . 0.0 109.594 -178.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 95.7 mt -90.33 139.33 30.77 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.757 -0.59 . . . . 0.0 109.651 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' CYS . . . . . . . . . . . . . 7.4 p -90.8 -28.91 17.91 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.183 -0.948 . . . . 0.0 109.557 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.71 HD11 HD13 ' B' ' 96' ' ' LEU . 70.7 mt -137.54 137.62 38.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.359 -0.838 . . . . 0.0 110.954 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -135.42 126.77 28.43 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.388 -0.82 . . . . 0.0 110.094 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.692 ' HB2' HD12 ' B' ' 32' ' ' LEU . 91.6 m-85 -113.44 141.32 47.24 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.93 -1.106 . . . . 0.0 109.994 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -154.2 69.87 6.19 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 120.96 -1.088 . . . . 0.0 111.069 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' PRO . . . . . 0.402 ' HG2' ' HB2' ' B' ' 30' ' ' PHE . 52.6 Cg_endo -69.35 147.09 64.72 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.757 1.399 . . . . 0.0 110.159 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.437 ' NH2' ' HB1' ' B' ' 51' ' ' ALA . 83.0 mtp180 -137.42 111.51 8.4 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.974 -1.079 . . . . 0.0 110.62 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' PHE . . . . . 0.508 ' HB3' ' HA ' ' B' ' 28' ' ' LYS . 85.6 t80 -62.22 -46.31 89.44 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.242 -0.911 . . . . 0.0 109.958 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -164.51 99.33 0.81 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.11 -0.994 . . . . 0.0 110.065 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . 0.437 ' HB1' ' NH2' ' B' ' 48' ' ' ARG . . . -109.88 -89.78 0.48 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.09 -1.006 . . . . 0.0 109.956 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -63.12 -42.17 99.47 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.065 -1.022 . . . . 0.0 109.167 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 161.43 38.92 0.02 OUTLIER Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -118.21 -171.66 2.11 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.254 -1.145 . . . . 0.0 109.93 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.5 ' O ' ' C ' ' B' ' 56' ' ' ASN . . . -143.81 157.83 44.11 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.399 -0.813 . . . . 0.0 109.874 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' ASN . . . . . 0.509 ' HB3' ' CD1' ' B' ' 77' ' ' PHE . 35.8 m120 15.06 59.9 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.423 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -179.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 47.8 m -113.4 132.34 55.66 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' ILE . . . . . 0.427 HD11 ' O ' ' B' ' 76' ' ' VAL . 76.1 mt -116.94 135.99 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.039 -1.038 . . . . 0.0 111.802 -177.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.419 ' CG1' ' OE2' ' B' ' 71' ' ' GLU . 48.3 t -110.94 130.44 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.397 -0.815 . . . . 0.0 109.635 179.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 74.5 m -131.19 124.5 30.76 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.055 -1.028 . . . . 0.0 110.957 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -149.75 173.11 14.08 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.351 -0.843 . . . . 0.0 110.963 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' SER . . . . . 0.452 ' O ' ' CA ' ' B' ' 69' ' ' GLY . 69.7 m -131.16 155.34 47.19 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.464 -0.772 . . . . 0.0 109.919 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . 0.492 ' CD ' ' HA2' ' B' ' 66' ' ' GLY . 8.8 ttmt -135.34 150.33 49.93 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.707 -1.246 . . . . 0.0 111.372 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -124.54 104.77 8.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.389 -0.819 . . . . 0.0 110.149 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 58.24 27.18 59.99 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . 0.492 ' HA2' ' CD ' ' B' ' 63' ' ' LYS . . . 75.34 23.16 74.41 Favored Glycine 0 N--CA 1.488 2.151 0 O-C-N 120.82 -1.4 . . . . 0.0 109.794 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' ALA . . . . . 0.463 ' HB1' ' CD1' ' B' ' 68' ' ' TRP . . . -81.1 -85.04 0.1 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.154 -1.203 . . . . 0.0 110.873 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' TRP . . . . . 0.463 ' CD1' ' HB1' ' B' ' 67' ' ' ALA . 10.8 m95 -135.2 -145.38 0.22 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.915 -1.116 . . . . 0.0 110.057 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . 0.452 ' CA ' ' O ' ' B' ' 62' ' ' SER . . . 165.3 129.34 1.04 Allowed Glycine 0 N--CA 1.49 2.267 0 C-N-CA 119.594 -1.289 . . . . 0.0 110.577 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 18.5 m -81.63 80.21 8.03 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.626 -0.926 . . . . 0.0 109.865 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . 0.419 ' OE2' ' CG1' ' B' ' 59' ' ' VAL . 83.3 tt0 -71.95 125.57 27.55 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.24 -0.913 . . . . 0.0 110.948 -179.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -110.53 -161.94 0.78 Allowed 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.372 -0.83 . . . . 0.0 109.397 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 62.4 ttp85 -146.05 117.04 7.76 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.01 -1.056 . . . . 0.0 110.761 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -109.94 125.82 53.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.305 -0.872 . . . . 0.0 109.768 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -105.86 45.89 0.95 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.054 -1.029 . . . . 0.0 111.776 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 76' ' ' VAL . . . . . 0.61 HG12 ' HD3' ' B' ' 78' ' ' PRO . 51.6 t -121.46 132.66 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.841 -1.162 . . . . 0.0 109.88 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 77' ' ' PHE . . . . . 0.54 ' N ' ' CD1' ' B' ' 77' ' ' PHE . 11.3 p90 -142.74 82.14 12.64 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 120.988 -1.07 . . . . 0.0 111.346 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . 0.61 ' HD3' HG12 ' B' ' 76' ' ' VAL . 56.2 Cg_endo -80.16 41.66 1.17 Allowed 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 123.522 1.275 . . . . 0.0 111.429 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -149.91 163.84 37.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.653 -1.279 . . . . 0.0 110.848 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -130.67 164.53 41.01 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 81' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.8 149.3 66.43 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.633 1.333 . . . . 0.0 110.838 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 63.09 41.61 99.74 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 25.6 t -137.04 137.3 39.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.263 -1.139 . . . . 0.0 111.299 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.43 HG23 ' O ' ' B' ' 84' ' ' VAL . 27.5 m -79.1 135.42 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.409 -0.807 . . . . 0.0 109.522 178.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.48 154.6 37.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.944 -1.097 . . . . 0.0 110.673 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 86' ' ' GLU . . . . . 0.455 ' HG2' ' HA ' ' B' ' 20' ' ' ARG . 97.3 mt-10 -121.08 140.18 52.31 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.381 -0.824 . . . . 0.0 109.612 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 47.2 t -122.76 129.88 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.068 -1.02 . . . . 0.0 110.502 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 88' ' ' CYS . . . . . . . . . . . . . 24.5 m -92.35 125.06 36.85 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.369 -0.832 . . . . 0.0 109.899 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 96.5 mt -122.2 124.99 72.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.114 -0.991 . . . . 0.0 110.315 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 53.9 m -121.72 124.3 43.92 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.483 -0.761 . . . . 0.0 109.02 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 91' ' ' PHE . . . . . 0.41 ' CD1' ' CD2' ' B' ' 96' ' ' LEU . 65.6 t80 -110.21 112.94 25.23 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.144 -0.973 . . . . 0.0 110.32 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -121.39 149.51 42.88 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.558 -0.714 . . . . 0.0 109.307 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -63.79 -33.16 75.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.796 -1.19 . . . . 0.0 110.088 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.0 -45.96 89.95 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.032 -1.043 . . . . 0.0 109.457 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -168.81 175.49 5.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.524 -0.735 . . . . 0.0 109.766 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 96' ' ' LEU . . . . . 0.719 HD12 ' HD2' ' B' ' 108' ' ' PHE . 79.4 mt -107.48 128.3 54.37 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.211 -0.931 . . . . 0.0 110.685 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 2.6 m -109.67 126.84 54.1 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.014 -1.053 . . . . 0.0 110.358 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 63.6 t -132.96 128.85 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.016 -1.053 . . . . 0.0 110.427 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -123.98 147.03 48.1 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.987 -1.07 . . . . 0.0 110.965 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 100' ' ' LEU . . . . . 0.488 ' HB3' ' HD2' ' B' ' 101' ' ' PRO . 1.1 mp -100.36 167.85 10.28 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.585 -0.697 . . . . 0.0 109.581 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 101' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' B' ' 100' ' ' LEU . 41.0 Cg_endo -66.02 -22.73 54.77 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.564 1.297 . . . . 0.0 110.451 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 102' ' ' ASP . . . . . 0.439 ' O ' ' HB3' ' B' ' 78' ' ' PRO . 47.5 t0 -152.11 80.06 1.25 Allowed 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.122 -0.986 . . . . 0.0 109.751 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 179.41 -172.49 44.42 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 104' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -87.13 -150.68 0.16 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.211 -1.17 . . . . 0.0 110.284 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -129.01 146.05 51.09 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.925 . . . . 0.0 110.64 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -130.51 134.34 46.98 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.343 -0.848 . . . . 0.0 109.865 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -114.85 144.62 43.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.296 -0.878 . . . . 0.0 110.891 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 108' ' ' PHE . . . . . 0.719 ' HD2' HD12 ' B' ' 96' ' ' LEU . 56.4 t80 -129.22 133.84 25.61 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 109' ' ' PRO . . . . . 0.453 ' O ' ' CE2' ' B' ' 108' ' ' PHE . 44.1 Cg_endo -66.93 138.91 49.74 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.312 1.164 . . . . 0.0 110.353 -178.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 110' ' ' ASN . . . . . 0.49 ' ND2' ' O ' ' B' ' 110' ' ' ASN . 5.3 p-10 -100.58 78.58 2.01 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.359 -0.838 . . . . 0.0 110.175 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . 0.406 ' C ' ' O ' ' B' ' 110' ' ' ASN . 79.5 ttt180 -41.61 -32.71 0.39 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.4 -0.812 . . . . 0.0 110.757 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 95.3 mt -78.99 149.2 32.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.274 -0.892 . . . . 0.0 110.452 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -103.78 40.71 1.39 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.323 -0.861 . . . . 0.0 110.035 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 114' ' ' LEU . . . . . 0.497 HD13 ' HD2' ' B' ' 36' ' ' LYS . 56.4 tp -71.29 125.67 27.57 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.124 -0.985 . . . . 0.0 109.862 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -96.58 -4.86 40.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.58 -0.7 . . . . 0.0 111.087 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 116' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' B' ' 11' ' ' LEU . . . -142.03 142.04 32.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.868 -1.145 . . . . 0.0 111.499 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 117' ' ' ILE . . . . . 0.472 ' HB ' ' HB3' ' B' ' 11' ' ' LEU . 48.4 mm -102.72 121.15 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -118.02 -18.9 9.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.86 -1.15 . . . . 0.0 111.412 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 119' ' ' TYR . . . . . 0.485 ' O ' ' HA ' ' B' ' 34' ' ' LEU . 43.0 t80 -113.42 129.72 56.47 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.972 -1.08 . . . . 0.0 111.229 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 120' ' ' MET . . . . . 0.472 ' CB ' ' CD1' ' B' ' 9' ' ' LEU . 47.2 ttp -142.06 114.08 8.1 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -135.91 139.15 43.08 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.883 -1.136 . . . . 0.0 110.868 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 122' ' ' ALA . . . . . 0.484 ' CB ' HD23 ' B' ' 32' ' ' LEU . . . -141.96 131.41 23.77 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 123' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' B' ' 2' ' ' CYS . 62.2 t0 -150.99 122.14 7.74 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.464 -0.773 . . . . 0.0 109.224 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 124' ' ' GLY . . . . . 0.474 ' HA3' ' HA ' ' B' ' 30' ' ' PHE . . . 174.99 -149.02 9.98 Favored Glycine 0 N--CA 1.489 2.19 0 C-N-CA 118.969 -1.586 . . . . 0.0 110.026 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . 0.491 ' HB2' ' CZ ' ' B' ' 30' ' ' PHE . 87.6 m-20 -86.4 8.95 19.57 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.698 -0.884 . . . . 0.0 110.318 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 126' ' ' PHE . . . . . 0.524 ' HD1' HG22 ' B' ' 23' ' ' VAL . 51.2 t80 -103.86 141.53 35.96 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.136 -0.977 . . . . 0.0 109.768 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -115.93 120.22 38.48 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.119 -1.033 . . . . 0.0 111.089 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . 0.619 ' O ' HG23 ' B' ' 128' ' ' ILE . 18.9 tt -95.86 119.31 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.147 -0.97 . . . . 0.0 109.999 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -100.83 -15.55 17.57 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.021 -1.049 . . . . 0.0 111.591 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 130' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -154.54 146.79 23.8 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.689 -1.257 . . . . 0.0 111.445 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.498 HG22 HD11 ' B' ' 128' ' ' ILE . 42.5 t -124.76 129.04 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 132' ' ' ALA . . . . . 0.537 ' O ' HD12 ' B' ' 17' ' ' LEU . . . -118.79 139.79 51.02 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.564 -1.335 . . . . 0.0 110.504 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -105.98 119.73 39.95 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.429 -0.794 . . . . 0.0 109.955 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 5.7 t0 . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.597 -179.989 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.466 ' HA2' ' CB ' ' A' ' 123' ' ' ASP . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.448 ' HA ' ' HB3' ' B' ' 8' ' ' ASN . 60.8 tp -61.44 132.22 52.75 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.719 -1.459 . . . . 0.0 110.032 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.9 t -117.41 154.71 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.49 -0.756 . . . . 0.0 110.599 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.451 ' HB3' ' HB3' ' A' ' 120' ' ' MET . . . -141.92 156.51 45.49 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.345 -0.847 . . . . 0.0 110.573 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.465 ' O ' ' HB3' ' A' ' 8' ' ' ASN . 8.2 p -151.71 170.27 20.14 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.52 -0.737 . . . . 0.0 109.613 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.465 ' HB3' ' O ' ' A' ' 7' ' ' SER . 14.3 t30 60.46 32.89 20.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.456 -0.778 . . . . 0.0 109.529 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.507 ' CD1' ' CB ' ' A' ' 120' ' ' MET . 74.3 mt -84.99 -15.19 45.06 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.554 -0.716 . . . . 0.0 111.991 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.496 ' C ' ' O ' ' A' ' 9' ' ' LEU . 53.4 p-10 5.43 63.06 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.503 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.795 HD21 ' CD2' ' A' ' 133' ' ' PHE . 11.7 mt -92.37 126.61 37.53 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 120.865 -1.147 . . . . 0.0 109.355 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -90.84 165.06 23.41 Favored Pre-proline 0 C--N 1.301 -1.537 0 O-C-N 121.365 -0.834 . . . . 0.0 110.44 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 91' ' ' PHE . 49.7 Cg_endo -68.68 152.63 74.28 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 124.039 1.547 . . . . 0.0 110.554 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.04 -20.73 42.33 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -100.12 152.69 19.96 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.16 -1.2 . . . . 0.0 110.108 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.2 m -97.91 139.02 34.37 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.225 -0.922 . . . . 0.0 110.806 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.411 ' CD1' ' HA ' ' A' ' 133' ' ' PHE . 58.8 tp -124.13 131.41 53.54 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.238 -0.914 . . . . 0.0 110.029 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 95.4 mtm-85 -128.91 139.96 51.89 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.014 -1.054 . . . . 0.0 111.017 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.416 ' O ' ' HG3' ' A' ' 86' ' ' GLU . 90.2 t -129.4 122.51 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.096 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 47.3 ttp180 -107.03 127.84 53.83 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.103 -0.998 . . . . 0.0 110.66 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -143.02 -159.24 7.86 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 119.449 -1.358 . . . . 0.0 110.715 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 84' ' ' VAL . 84.4 tt0 -138.03 147.53 44.23 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.833 -0.804 . . . . 0.0 109.135 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.556 ' CG1' ' HB2' ' A' ' 27' ' ' ALA . 50.3 t -108.78 124.12 65.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 120.903 -1.123 . . . . 0.0 110.123 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.54 162.01 1.88 Allowed Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.166 -0.959 . . . . 0.0 109.024 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.406 ' O ' ' HB2' ' A' ' 81' ' ' PRO . 43.9 Cg_endo -66.95 -19.47 52.11 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 O-C-N 123.833 1.438 . . . . 0.0 110.65 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 28' ' ' LYS . 89.2 m-20 -112.65 40.04 2.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.115 -0.991 . . . . 0.0 110.656 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.556 ' HB2' ' CG1' ' A' ' 23' ' ' VAL . . . -54.0 92.67 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.065 -1.022 . . . . 0.0 110.051 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.423 ' N ' ' O ' ' A' ' 26' ' ' ASP . 87.6 tttt -106.21 -34.43 7.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.164 -0.96 . . . . 0.0 111.612 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 39.5 t -150.48 133.73 16.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.847 -1.158 . . . . 0.0 111.297 -178.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.427 ' HA ' ' HA3' ' A' ' 124' ' ' GLY . 47.1 t80 -156.18 155.27 32.16 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.481 -0.762 . . . . 0.0 110.526 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.476 HG13 ' O ' ' A' ' 31' ' ' VAL . 9.3 p -139.4 133.9 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.096 -1.003 . . . . 0.0 111.007 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.7 tp -126.73 131.08 51.43 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.372 -0.83 . . . . 0.0 109.875 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.696 ' HB3' HD22 ' A' ' 41' ' ' LEU . 76.9 m-20 -136.72 137.21 39.69 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.855 -1.153 . . . . 0.0 111.421 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -138.45 113.64 9.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.241 -0.912 . . . . 0.0 109.648 178.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.476 ' O ' ' HB3' ' A' ' 119' ' ' TYR . . . -165.58 -163.35 18.79 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.669 ' HE3' HD12 ' A' ' 114' ' ' LEU . 99.1 mttt -68.32 -43.99 76.39 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.939 -1.33 . . . . 0.0 110.514 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -153.57 -167.03 2.56 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.779 0.8 . . . . 0.0 111.93 -178.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.3 t -60.28 -44.63 95.18 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.685 -0.634 . . . . 0.0 112.486 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.418 ' HB3' ' N ' ' A' ' 66' ' ' GLY . 82.6 m-20 -89.49 -14.01 36.24 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.763 -1.211 . . . . 0.0 110.317 -179.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -107.27 71.89 0.85 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.342 -0.849 . . . . 0.0 109.348 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.696 HD22 ' HB3' ' A' ' 33' ' ' ASN . 95.6 mt -101.59 141.41 34.5 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.261 0.553 . . . . 0.0 110.388 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.44 ' O ' ' CB ' ' A' ' 62' ' ' SER . 0.5 OUTLIER -85.78 -51.93 6.1 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.24 -0.913 . . . . 0.0 110.049 179.652 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.99 HD11 HD11 ' A' ' 96' ' ' LEU . 84.7 mt -128.07 140.29 52.03 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.994 -1.066 . . . . 0.0 110.914 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.423 ' N ' ' O ' ' A' ' 61' ' ' ASN . 66.0 t-80 -120.88 112.14 18.42 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -104.78 127.61 52.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.056 -1.028 . . . . 0.0 109.743 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.5 81.11 13.91 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.082 -1.011 . . . . 0.0 111.025 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.83 148.23 64.18 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.076 1.566 . . . . 0.0 110.139 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -144.95 107.57 4.43 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.925 -1.109 . . . . 0.0 111.689 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -62.3 -45.0 95.21 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.209 -0.932 . . . . 0.0 109.57 178.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -136.57 93.58 2.89 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.635 -0.666 . . . . 0.0 109.892 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -87.5 -151.04 0.17 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.191 -0.943 . . . . 0.0 110.136 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -66.02 -8.52 23.55 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.076 -1.015 . . . . 0.0 111.444 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 174.29 -27.53 0.08 OUTLIER Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -77.97 -179.31 6.0 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.05 -1.264 . . . . 0.0 109.13 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.428 ' O ' ' C ' ' A' ' 56' ' ' ASN . . . -143.76 149.84 37.7 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.173 -0.955 . . . . 0.0 110.988 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.428 ' C ' ' O ' ' A' ' 55' ' ' ALA . 87.6 m-20 29.51 59.31 0.16 Allowed 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 178.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 98.2 m -121.18 128.88 52.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.94 -1.1 . . . . 0.0 110.645 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 95.6 mt -111.13 126.05 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.701 -0.624 . . . . 0.0 110.383 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.1 m -116.5 135.43 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.015 -1.053 . . . . 0.0 109.955 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 35.4 m -103.03 136.15 43.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.141 -0.974 . . . . 0.0 110.053 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.423 ' O ' ' N ' ' A' ' 44' ' ' HIS . 1.4 t-20 -146.95 158.6 43.97 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.074 -1.016 . . . . 0.0 110.987 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 42' ' ' CYS . 53.2 p -139.05 158.25 44.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.447 -0.783 . . . . 0.0 110.236 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.477 ' CD ' ' HA2' ' A' ' 66' ' ' GLY . 26.2 ttmt -142.47 152.7 42.99 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.312 -0.867 . . . . 0.0 110.563 178.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -125.04 94.66 4.24 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.358 -0.839 . . . . 0.0 109.071 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 64.47 28.43 73.13 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.477 ' HA2' ' CD ' ' A' ' 63' ' ' LYS . . . 73.98 24.76 73.15 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.2 -79.03 0.13 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.434 -1.039 . . . . 0.0 110.347 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.41 ' O ' ' HG3' ' A' ' 63' ' ' LYS . 93.5 m95 -141.98 -144.67 0.16 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.341 -0.849 . . . . 0.0 109.66 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 163.76 110.57 0.24 Allowed Glycine 0 N--CA 1.493 2.497 0 C-N-CA 119.67 -1.253 . . . . 0.0 110.078 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.08 71.97 10.12 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.364 -1.08 . . . . 0.0 110.32 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -61.3 143.99 54.7 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.553 -0.717 . . . . 0.0 111.729 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -124.73 -154.38 0.61 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.465 -0.772 . . . . 0.0 109.314 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 78.3 ttt-85 -143.88 116.18 8.5 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.757 -1.214 . . . . 0.0 112.021 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -109.32 122.64 47.79 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.33 -0.856 . . . . 0.0 109.577 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -113.88 88.4 2.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.896 -1.127 . . . . 0.0 110.377 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.6 p -141.33 142.46 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.369 -0.832 . . . . 0.0 110.475 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -151.65 77.87 7.04 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.171 -0.956 . . . . 0.0 109.857 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.479 ' CB ' ' HB2' ' A' ' 102' ' ' ASP . 54.7 Cg_endo -83.3 -0.96 10.11 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.218 1.641 . . . . 0.0 111.934 -178.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.513 ' CE1' ' HG2' ' A' ' 101' ' ' PRO . 44.0 m-85 -139.13 -171.9 3.21 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.912 -1.118 . . . . 0.0 110.357 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.47 ' HB2' ' HD2' ' A' ' 81' ' ' PRO . 2.7 pm0 -143.6 166.66 18.53 Favored Pre-proline 0 C--N 1.301 -1.506 0 O-C-N 121.189 -0.944 . . . . 0.0 110.342 -178.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.47 ' HD2' ' HB2' ' A' ' 80' ' ' GLN . 43.9 Cg_endo -65.7 151.13 85.41 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.931 1.49 . . . . 0.0 109.655 179.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.35 23.75 70.06 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 38.9 t -140.56 143.39 35.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.262 -1.14 . . . . 0.0 109.518 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 20.2 m -78.28 153.63 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.159 -0.963 . . . . 0.0 110.753 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -160.87 147.83 15.31 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.343 -0.848 . . . . 0.0 109.92 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.416 ' HG3' ' O ' ' A' ' 19' ' ' VAL . 78.5 tt0 -122.19 146.78 46.92 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.434 -0.791 . . . . 0.0 108.945 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 71.1 t -126.94 135.2 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.011 -1.056 . . . . 0.0 110.896 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 2.3 t -109.3 129.02 55.53 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.307 -0.871 . . . . 0.0 109.42 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 86.8 mt -129.15 127.33 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.118 -0.989 . . . . 0.0 110.589 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.0 m -115.56 132.12 56.73 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.177 -0.952 . . . . 0.0 109.691 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.431 ' CZ ' ' HB3' ' A' ' 114' ' ' LEU . 47.8 t80 -113.26 123.38 50.03 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.13 -0.981 . . . . 0.0 110.266 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -109.62 147.68 32.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -0.912 . . . . 0.0 109.769 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -58.11 -21.68 47.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.333 -0.854 . . . . 0.0 111.225 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -116.62 -13.34 10.85 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.724 -1.235 . . . . 0.0 110.781 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -147.29 -167.68 2.85 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.08 -1.013 . . . . 0.0 110.981 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.99 HD11 HD11 ' A' ' 43' ' ' LEU . 7.2 tt -151.76 115.63 4.91 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 54.4 m -106.65 130.37 54.4 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.768 -1.208 . . . . 0.0 110.309 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.58 HG23 ' CD2' ' A' ' 96' ' ' LEU . 52.5 t -121.4 132.34 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.458 -0.776 . . . . 0.0 110.185 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -122.68 127.04 48.77 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.851 -1.156 . . . . 0.0 110.659 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.4 mt -95.9 161.27 27.95 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.513 ' HG2' ' CE1' ' A' ' 79' ' ' PHE . 39.4 Cg_endo -65.62 -22.7 57.68 Favored 'Trans proline' 0 C--N 1.301 -1.95 0 O-C-N 123.448 1.236 . . . . 0.0 109.828 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.486 ' OD2' ' CD1' ' A' ' 104' ' ' TYR . 29.0 t70 -63.67 -40.26 96.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.287 -0.883 . . . . 0.0 109.995 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 126.59 -6.57 7.49 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.486 ' CD1' ' OD2' ' A' ' 102' ' ' ASP . 47.2 m-85 -87.07 142.29 28.04 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.005 -1.291 . . . . 0.0 110.224 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -128.43 140.26 51.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.321 -0.862 . . . . 0.0 111.327 -179.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -131.87 150.46 52.15 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 11.7 ptpt -132.9 136.01 45.91 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.798 -1.189 . . . . 0.0 111.384 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 20.1 m-30 -108.44 147.41 35.62 Favored Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 121.533 -0.729 . . . . 0.0 109.648 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.414 ' O ' ' N ' ' A' ' 111' ' ' ARG . 41.2 Cg_endo -65.64 150.68 86.19 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 O-C-N 124.0 1.526 . . . . 0.0 111.017 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -65.82 62.31 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.84 -0.537 . . . . 0.0 111.68 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.414 ' N ' ' O ' ' A' ' 109' ' ' PRO . 20.8 ptt180 -68.74 -24.76 64.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.061 -1.025 . . . . 0.0 109.663 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.721 HD13 ' N ' ' A' ' 113' ' ' ASN . 1.2 tm? -111.21 128.77 56.02 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.297 -0.877 . . . . 0.0 109.107 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.721 ' N ' HD13 ' A' ' 112' ' ' LEU . 8.1 m120 -90.27 69.42 7.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.795 -1.191 . . . . 0.0 110.812 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.669 HD12 ' HE3' ' A' ' 36' ' ' LYS . 53.4 tp -84.84 131.44 34.53 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.377 -0.827 . . . . 0.0 109.35 178.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -92.17 -19.48 22.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.725 -1.234 . . . . 0.0 109.846 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.611 ' O ' HD11 ' A' ' 114' ' ' LEU . . . -171.76 156.6 4.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -0.907 . . . . 0.0 109.479 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 66.5 mt -101.94 116.36 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.884 -1.135 . . . . 0.0 110.76 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 -111.63 -23.97 10.36 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.143 -0.973 . . . . 0.0 109.914 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.476 ' HB3' ' O ' ' A' ' 35' ' ' GLY . 90.2 t80 -106.84 126.75 52.7 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.378 -0.826 . . . . 0.0 111.228 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.507 ' CB ' ' CD1' ' A' ' 9' ' ' LEU . 66.3 ttp -136.67 125.56 24.16 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -141.59 136.76 31.37 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.959 -1.088 . . . . 0.0 110.393 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -147.37 123.46 10.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.351 -0.843 . . . . 0.0 110.204 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.466 ' CB ' ' HA2' ' A' ' 3' ' ' GLY . 20.5 p-10 -151.11 121.93 7.56 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.956 -1.09 . . . . 0.0 110.956 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.427 ' HA3' ' HA ' ' A' ' 30' ' ' PHE . . . 178.28 -148.08 8.3 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.474 ' HB3' ' HA ' ' A' ' 27' ' ' ALA . 80.9 m-20 -81.69 8.72 9.21 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.482 -1.011 . . . . 0.0 110.924 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.459 ' HD1' HG22 ' A' ' 23' ' ' VAL . 43.1 t80 -106.29 142.65 35.62 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.974 -1.078 . . . . 0.0 110.205 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -110.97 125.3 53.56 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 118.945 -1.102 . . . . 0.0 110.91 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.463 HD11 ' CG2' ' A' ' 131' ' ' VAL . 9.0 tt -100.26 121.18 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.162 -0.961 . . . . 0.0 109.601 178.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -101.0 -17.55 16.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.343 -0.848 . . . . 0.0 112.323 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -159.39 147.72 17.7 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.484 -1.385 . . . . 0.0 112.252 -178.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.463 ' CG2' HD11 ' A' ' 128' ' ' ILE . 45.4 t -127.13 127.1 69.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -128.68 129.75 46.23 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.813 -1.179 . . . . 0.0 110.214 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.795 ' CD2' HD21 ' A' ' 11' ' ' LEU . 3.2 m-30 -64.25 -102.76 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.238 -0.914 . . . . 0.0 110.118 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.8 t70 . . . . . 0 N--CA 1.493 1.71 0 O-C-N 120.599 -1.313 . . . . 0.0 110.19 179.64 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.265 0.555 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 2' ' ' CYS . . . . . . . . . . . . . 35.6 t -148.27 83.31 1.49 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.356 -0.84 . . . . 0.0 110.148 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' GLY . . . . . 0.468 ' HA2' ' CB ' ' B' ' 123' ' ' ASP . . . 93.9 38.85 5.07 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 120.198 -1.001 . . . . 0.0 111.1 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 60.5 tp -61.69 132.26 52.65 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.729 -1.454 . . . . 0.0 109.906 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 3.1 t -117.16 154.58 18.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.643 -0.66 . . . . 0.0 110.602 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' ALA . . . . . 0.444 ' HB3' ' HB3' ' B' ' 120' ' ' MET . . . -141.99 156.53 45.45 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.423 -0.798 . . . . 0.0 110.548 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' SER . . . . . 0.457 ' O ' ' HB3' ' B' ' 8' ' ' ASN . 7.9 p -151.89 170.04 20.81 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.579 -0.701 . . . . 0.0 109.579 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . 0.457 ' HB3' ' O ' ' B' ' 7' ' ' SER . 16.1 t30 60.79 32.99 20.2 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.521 -0.737 . . . . 0.0 109.287 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.507 ' CD1' ' CB ' ' B' ' 120' ' ' MET . 73.2 mt -86.15 -11.59 52.18 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.622 -0.674 . . . . 0.0 111.834 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' ASN . . . . . 0.491 ' C ' ' O ' ' B' ' 9' ' ' LEU . 53.5 p-10 -0.28 66.14 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.486 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -178.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.801 HD21 ' CD2' ' B' ' 133' ' ' PHE . 11.6 mt -93.37 126.54 38.55 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.087 -1.008 . . . . 0.0 109.202 178.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -90.83 165.3 22.68 Favored Pre-proline 0 C--N 1.3 -1.566 0 O-C-N 121.345 -0.847 . . . . 0.0 110.402 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . 0.426 ' HA ' ' O ' ' B' ' 91' ' ' PHE . 48.9 Cg_endo -68.65 152.64 74.4 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.967 1.509 . . . . 0.0 110.548 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.08 -20.73 42.25 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -100.04 152.84 19.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.184 -1.186 . . . . 0.0 110.047 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' CYS . . . . . . . . . . . . . 2.2 m -98.16 139.12 34.43 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.185 -0.947 . . . . 0.0 110.708 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.419 ' CD1' ' HA ' ' B' ' 133' ' ' PHE . 58.7 tp -124.18 131.38 53.53 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.253 -0.904 . . . . 0.0 110.063 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 95.5 mtm-85 -128.93 139.87 51.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.878 -1.139 . . . . 0.0 110.937 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.409 ' O ' ' HG3' ' B' ' 86' ' ' GLU . 91.4 t -129.33 122.65 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.09 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 47.3 ttp180 -107.13 127.69 53.72 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.15 -0.969 . . . . 0.0 110.665 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -142.86 -159.25 7.87 Favored Glycine 0 N--CA 1.49 2.269 0 C-N-CA 119.409 -1.377 . . . . 0.0 110.685 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' B' ' 84' ' ' VAL . 84.6 tt0 -138.03 147.46 44.16 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.822 -0.811 . . . . 0.0 109.215 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.543 ' CG1' ' HB2' ' B' ' 27' ' ' ALA . 50.1 t -108.74 124.11 65.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 O-C-N 120.984 -1.073 . . . . 0.0 110.148 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.411 ' HB1' ' HD2' ' B' ' 25' ' ' PRO . . . -54.71 161.88 2.02 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.103 -0.998 . . . . 0.0 108.985 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . 0.412 ' O ' ' HB2' ' B' ' 81' ' ' PRO . 43.6 Cg_endo -66.76 -19.58 53.11 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 O-C-N 123.7 1.368 . . . . 0.0 110.606 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' B' ' 28' ' ' LYS . 89.2 m-20 -112.64 40.14 2.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.183 -0.948 . . . . 0.0 110.664 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . 0.543 ' HB2' ' CG1' ' B' ' 23' ' ' VAL . . . -53.98 92.53 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.109 -0.994 . . . . 0.0 110.172 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' B' ' 26' ' ' ASP . 87.6 tttt -106.28 -34.28 7.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.125 -0.984 . . . . 0.0 111.588 -179.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 39.7 t -150.52 133.2 15.81 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.848 -1.158 . . . . 0.0 111.312 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' PHE . . . . . 0.431 ' HA ' ' HA3' ' B' ' 124' ' ' GLY . 48.4 t80 -155.54 155.42 33.36 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.52 -0.737 . . . . 0.0 110.632 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.472 ' O ' HG13 ' B' ' 31' ' ' VAL . 9.1 p -139.5 133.64 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.162 -0.961 . . . . 0.0 111.044 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 15.8 tp -126.66 131.02 51.52 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.32 -0.862 . . . . 0.0 109.877 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' ASN . . . . . 0.683 ' HB3' HD22 ' B' ' 41' ' ' LEU . 76.9 m-20 -136.61 137.48 40.17 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.958 -1.089 . . . . 0.0 111.407 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -138.94 109.68 6.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.143 -0.973 . . . . 0.0 109.859 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . 0.474 ' O ' ' HB3' ' B' ' 119' ' ' TYR . . . -160.18 -162.31 12.25 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . 0.692 ' HE3' HD12 ' B' ' 114' ' ' LEU . 99.1 mttt -68.81 -43.85 74.75 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.146 -1.208 . . . . 0.0 110.228 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -153.56 -167.2 2.62 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.786 0.803 . . . . 0.0 111.881 -178.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 11.6 t -59.91 -44.77 94.08 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' ASN . . . . . 0.412 ' HB3' ' N ' ' B' ' 66' ' ' GLY . 83.0 m-20 -89.69 -13.81 36.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.707 -1.246 . . . . 0.0 110.315 -179.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' ASN . . . . . 0.4 ' ND2' ' N ' ' B' ' 40' ' ' ASN . 5.7 m-80 -107.45 71.74 0.84 Allowed 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.913 0.864 . . . . 0.0 109.318 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.683 HD22 ' HB3' ' B' ' 33' ' ' ASN . 95.0 mt -101.12 144.05 30.49 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.782 -0.573 . . . . 0.0 110.13 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' CYS . . . . . 0.425 ' O ' ' CB ' ' B' ' 62' ' ' SER . 0.5 OUTLIER -89.31 -50.42 6.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.168 -0.958 . . . . 0.0 109.636 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.956 HD11 HD11 ' B' ' 96' ' ' LEU . 85.5 mt -128.93 140.19 51.78 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.913 -1.117 . . . . 0.0 110.813 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' HIS . . . . . 0.429 ' N ' ' O ' ' B' ' 61' ' ' ASN . 65.9 t-80 -120.91 112.3 18.61 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -104.86 127.69 52.77 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.165 -0.959 . . . . 0.0 109.664 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.46 80.99 14.08 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 120.989 -1.07 . . . . 0.0 111.06 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.79 148.08 64.12 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.062 1.559 . . . . 0.0 110.132 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -144.8 107.72 4.5 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.879 -1.138 . . . . 0.0 111.628 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -62.51 -44.86 95.34 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.057 -1.027 . . . . 0.0 109.575 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 28.9 t30 -136.63 93.24 2.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.729 -0.607 . . . . 0.0 110.005 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -87.35 -151.08 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.258 -0.901 . . . . 0.0 110.209 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -66.15 -6.93 15.06 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.019 -1.051 . . . . 0.0 111.458 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 171.8 -26.8 0.1 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -78.29 -179.41 6.23 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.994 -1.297 . . . . 0.0 108.997 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.486 ' O ' ' C ' ' B' ' 56' ' ' ASN . . . -141.8 156.7 45.55 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.121 -0.987 . . . . 0.0 110.202 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' ASN . . . . . 0.486 ' C ' ' O ' ' B' ' 55' ' ' ALA . 87.1 m-20 18.51 63.88 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 97.8 m -122.05 128.91 51.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 110.532 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' ILE . . . . . . . . . . . . . 96.1 mt -111.43 126.27 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.698 -0.626 . . . . 0.0 110.356 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 25.4 m -116.55 135.33 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.053 -1.029 . . . . 0.0 110.052 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 35.2 m -103.01 135.88 43.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.21 -0.931 . . . . 0.0 110.255 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' ASN . . . . . 0.429 ' O ' ' N ' ' B' ' 44' ' ' HIS . 1.4 t-20 -146.74 158.45 43.91 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.083 -1.011 . . . . 0.0 111.134 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' B' ' 42' ' ' CYS . 53.3 p -138.85 158.45 44.19 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.454 -0.779 . . . . 0.0 110.266 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . 0.477 ' CD ' ' HA2' ' B' ' 66' ' ' GLY . 26.3 ttmt -142.56 152.7 42.85 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.289 -0.882 . . . . 0.0 110.498 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -124.92 94.73 4.27 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.304 -0.872 . . . . 0.0 109.055 178.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 64.3 28.59 73.22 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . 0.477 ' HA2' ' CD ' ' B' ' 63' ' ' LYS . . . 73.88 24.73 73.45 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.06 -79.0 0.13 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.341 -1.093 . . . . 0.0 110.435 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' TRP . . . . . 0.408 ' O ' ' HG3' ' B' ' 63' ' ' LYS . 93.4 m95 -142.18 -144.69 0.16 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.255 -0.903 . . . . 0.0 109.624 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 163.63 110.4 0.24 Allowed Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.545 -1.312 . . . . 0.0 110.1 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.83 71.99 9.91 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.317 -1.108 . . . . 0.0 110.319 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -61.4 144.09 54.68 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.463 -0.773 . . . . 0.0 111.817 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -124.84 -154.38 0.61 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.318 -0.864 . . . . 0.0 109.314 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 78.3 ttt-85 -143.79 116.24 8.58 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.709 -1.244 . . . . 0.0 111.99 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -109.42 122.74 48.05 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.371 -0.83 . . . . 0.0 109.557 178.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -114.03 88.52 2.87 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.925 -1.11 . . . . 0.0 110.271 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 7.6 p -141.4 142.38 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.309 -0.87 . . . . 0.0 110.53 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -151.47 77.81 7.18 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.139 -0.976 . . . . 0.0 109.899 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . 0.486 ' CB ' ' HB2' ' B' ' 102' ' ' ASP . 54.6 Cg_endo -83.36 -0.65 9.95 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.185 1.624 . . . . 0.0 112.078 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 79' ' ' PHE . . . . . 0.511 ' CE1' ' HG2' ' B' ' 101' ' ' PRO . 44.3 m-85 -139.32 -171.74 3.19 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.955 -1.091 . . . . 0.0 110.439 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.457 ' HB2' ' HD2' ' B' ' 81' ' ' PRO . 2.6 pm0 -143.67 166.9 17.27 Favored Pre-proline 0 C--N 1.302 -1.457 0 O-C-N 121.284 -0.885 . . . . 0.0 110.323 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 81' ' ' PRO . . . . . 0.457 ' HD2' ' HB2' ' B' ' 80' ' ' GLN . 43.2 Cg_endo -65.71 151.2 85.17 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.904 1.476 . . . . 0.0 109.63 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.4 23.61 70.26 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.024 -1.631 . . . . 0.0 109.024 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 38.6 t -140.49 143.43 35.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.333 -1.098 . . . . 0.0 109.572 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' B' ' 22' ' ' GLU . 20.0 m -78.33 153.51 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.126 -0.983 . . . . 0.0 110.834 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -160.72 147.74 15.51 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.383 -0.823 . . . . 0.0 109.917 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 86' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' B' ' 19' ' ' VAL . 78.6 tt0 -122.09 146.66 46.99 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.307 -0.871 . . . . 0.0 108.928 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 70.4 t -126.81 135.21 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.05 -1.031 . . . . 0.0 110.902 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 88' ' ' CYS . . . . . . . . . . . . . 2.4 t -109.14 129.15 55.48 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.362 -0.836 . . . . 0.0 109.498 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 87.0 mt -129.12 127.22 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.148 -0.97 . . . . 0.0 110.617 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 5.7 m -115.48 132.13 56.72 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.15 -0.969 . . . . 0.0 109.816 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 91' ' ' PHE . . . . . 0.428 ' CZ ' ' HB3' ' B' ' 114' ' ' LEU . 47.7 t80 -113.23 123.62 50.61 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.111 -0.993 . . . . 0.0 110.339 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -109.88 147.8 32.71 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.162 -0.961 . . . . 0.0 109.77 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -58.26 -21.54 48.96 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.322 -0.861 . . . . 0.0 111.201 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -116.7 -13.3 10.8 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.704 -1.247 . . . . 0.0 110.829 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -147.39 -167.68 2.85 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.096 -1.003 . . . . 0.0 110.899 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 96' ' ' LEU . . . . . 0.956 HD11 HD11 ' B' ' 43' ' ' LEU . 7.2 tt -151.72 115.75 4.96 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 54.1 m -106.77 130.37 54.49 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.738 -1.227 . . . . 0.0 110.375 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 98' ' ' VAL . . . . . 0.587 HG23 ' CD2' ' B' ' 96' ' ' LEU . 51.8 t -121.58 132.46 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.51 -0.743 . . . . 0.0 110.13 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -122.57 127.53 49.58 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.977 -1.077 . . . . 0.0 110.616 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 3.4 mt -96.41 161.14 27.9 Favored Pre-proline 0 C--N 1.303 -1.454 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 101' ' ' PRO . . . . . 0.511 ' HG2' ' CE1' ' B' ' 79' ' ' PHE . 39.7 Cg_endo -65.54 -22.73 58.24 Favored 'Trans proline' 0 C--N 1.301 -1.952 0 O-C-N 123.448 1.236 . . . . 0.0 109.841 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 102' ' ' ASP . . . . . 0.489 ' OD2' ' CD1' ' B' ' 104' ' ' TYR . 28.9 t70 -63.6 -40.22 96.37 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.337 -0.852 . . . . 0.0 110.02 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 126.44 -6.42 7.57 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 104' ' ' TYR . . . . . 0.489 ' CD1' ' OD2' ' B' ' 102' ' ' ASP . 47.3 m-85 -87.22 142.29 28.01 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.984 -1.304 . . . . 0.0 110.193 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -128.19 140.22 52.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.401 -0.812 . . . . 0.0 111.393 -179.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -131.88 150.61 52.1 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 107' ' ' LYS . . . . . 0.459 ' HA ' ' O ' ' B' ' 96' ' ' LEU . 11.7 ptpt -132.98 135.89 45.75 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 118.757 -1.177 . . . . 0.0 111.394 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 108' ' ' PHE . . . . . . . . . . . . . 20.2 m-30 -108.33 147.54 35.82 Favored Pre-proline 0 C--N 1.304 -1.398 0 O-C-N 121.453 -0.78 . . . . 0.0 109.649 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 109' ' ' PRO . . . . . 0.414 ' O ' ' N ' ' B' ' 111' ' ' ARG . 40.9 Cg_endo -65.63 150.8 86.09 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 O-C-N 123.982 1.517 . . . . 0.0 111.042 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 110' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -65.95 62.46 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.881 -0.512 . . . . 0.0 111.583 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . 0.414 ' N ' ' O ' ' B' ' 109' ' ' PRO . 20.8 ptt180 -68.94 -24.48 64.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.032 -1.043 . . . . 0.0 109.558 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 112' ' ' LEU . . . . . 0.718 HD13 ' N ' ' B' ' 113' ' ' ASN . 1.2 tm? -111.43 128.7 56.07 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.396 -0.815 . . . . 0.0 109.099 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 113' ' ' ASN . . . . . 0.718 ' N ' HD13 ' B' ' 112' ' ' LEU . 8.1 m120 -90.27 69.5 7.09 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.835 -1.165 . . . . 0.0 110.77 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 114' ' ' LEU . . . . . 0.692 HD12 ' HE3' ' B' ' 36' ' ' LYS . 53.4 tp -85.12 131.29 34.47 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.53 -0.731 . . . . 0.0 109.381 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -92.0 -19.58 22.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.717 -1.24 . . . . 0.0 109.775 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 116' ' ' ALA . . . . . 0.613 ' O ' HD11 ' B' ' 114' ' ' LEU . . . -171.83 156.74 4.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.227 -0.921 . . . . 0.0 109.475 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 66.3 mt -101.98 116.36 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.88 -1.137 . . . . 0.0 110.733 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 -111.64 -24.05 10.31 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.155 -0.966 . . . . 0.0 109.817 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 119' ' ' TYR . . . . . 0.474 ' HB3' ' O ' ' B' ' 35' ' ' GLY . 90.1 t80 -106.8 126.75 52.7 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.335 -0.853 . . . . 0.0 111.254 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 120' ' ' MET . . . . . 0.507 ' CB ' ' CD1' ' B' ' 9' ' ' LEU . 66.0 ttp -136.75 125.55 24.03 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -141.59 136.72 31.32 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.034 -1.041 . . . . 0.0 110.388 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -147.27 123.59 10.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.364 -0.835 . . . . 0.0 110.281 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 123' ' ' ASP . . . . . 0.468 ' CB ' ' HA2' ' B' ' 3' ' ' GLY . 20.5 p-10 -151.12 122.13 7.66 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.003 -1.061 . . . . 0.0 110.994 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 124' ' ' GLY . . . . . 0.431 ' HA3' ' HA ' ' B' ' 30' ' ' PHE . . . 178.03 -148.12 8.41 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . 0.463 ' HB3' ' HA ' ' B' ' 27' ' ' ALA . 80.8 m-20 -81.73 8.71 9.33 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.537 -0.978 . . . . 0.0 110.889 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 126' ' ' PHE . . . . . 0.468 ' HD1' HG22 ' B' ' 23' ' ' VAL . 43.7 t80 -106.2 142.67 35.49 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.03 -1.044 . . . . 0.0 110.233 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -111.02 125.13 53.41 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.024 -1.071 . . . . 0.0 110.885 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . 0.454 HD11 ' CG2' ' B' ' 131' ' ' VAL . 8.9 tt -100.2 121.26 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.256 -0.902 . . . . 0.0 109.679 178.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -100.87 -19.53 15.89 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.337 -0.852 . . . . 0.0 112.2 -178.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 130' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -156.8 148.43 22.53 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 118.324 -1.35 . . . . 0.0 112.507 -178.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.454 ' CG2' HD11 ' B' ' 128' ' ' ILE . 45.6 t -127.45 127.05 68.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 177.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 132' ' ' ALA . . . . . . . . . . . . . . . -128.67 129.77 46.29 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.856 -1.152 . . . . 0.0 110.266 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . 0.801 ' CD2' HD21 ' B' ' 11' ' ' LEU . 3.2 m-30 -64.28 -102.76 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.172 -0.955 . . . . 0.0 110.062 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.9 t70 . . . . . 0 N--CA 1.493 1.715 0 O-C-N 120.521 -1.362 . . . . 0.0 110.252 179.697 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 122' ' ' ALA . . . . . . . . 0 N--CA 1.492 2.381 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.771 HD22 HD23 ' B' ' 9' ' ' LEU . 77.7 mt -79.42 144.49 34.05 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.354 -1.086 . . . . 0.0 112.215 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.3 m -110.52 150.35 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.56 -0.713 . . . . 0.0 109.498 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.38 156.32 47.08 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.72 -1.238 . . . . 0.0 112.387 -178.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.458 ' O ' ' HB3' ' A' ' 8' ' ' ASN . 17.3 m -155.39 173.25 16.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.538 -0.726 . . . . 0.0 109.853 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.458 ' HB3' ' O ' ' A' ' 7' ' ' SER . 37.3 t-20 62.25 26.76 16.05 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.137 -0.977 . . . . 0.0 109.768 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.783 HD23 HD22 ' B' ' 4' ' ' LEU . 63.2 mt -82.25 -12.64 57.94 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.832 -0.542 . . . . 0.0 111.669 -178.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.51 ' C ' ' O ' ' A' ' 9' ' ' LEU . 77.0 m-20 16.81 68.39 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.821 0 CA-C-O 121.35 0.595 . . . . 0.0 112.323 -179.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.515 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 34.0 tp -96.07 132.88 40.99 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.53 -0.731 . . . . 0.0 110.404 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.29 169.69 6.61 Favored Pre-proline 0 C--N 1.296 -1.758 0 O-C-N 121.584 -0.697 . . . . 0.0 109.815 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.441 ' HA ' ' O ' ' A' ' 91' ' ' PHE . 54.9 Cg_endo -72.6 155.61 54.43 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.08 1.568 . . . . 0.0 108.882 178.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.64 -10.11 59.02 Favored Glycine 0 N--CA 1.488 2.154 0 C-N-CA 119.359 -1.4 . . . . 0.0 109.965 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -115.12 146.65 41.13 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.084 -1.245 . . . . 0.0 108.921 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.437 ' O ' ' N ' ' A' ' 134' ' ' ASP . 1.6 t -96.55 140.46 31.14 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.969 -1.082 . . . . 0.0 110.723 -179.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.518 HD13 ' CE1' ' A' ' 133' ' ' PHE . 56.1 tp -111.0 126.92 55.3 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.277 -0.889 . . . . 0.0 110.544 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -120.17 126.72 51.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.241 -0.912 . . . . 0.0 109.871 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.3 t -127.95 129.73 69.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.217 -0.927 . . . . 0.0 110.711 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.444 ' HA ' ' HG2' ' A' ' 86' ' ' GLU . 72.1 ttt180 -109.31 130.15 55.5 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.215 -0.928 . . . . 0.0 109.933 178.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.436 ' CA ' ' O ' ' A' ' 127' ' ' LYS . . . -134.35 173.8 21.24 Favored Glycine 0 C--N 1.294 -1.773 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -125.48 121.26 33.25 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.458 HG22 ' HD1' ' A' ' 126' ' ' PHE . 70.9 t -85.36 131.89 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.147 -0.971 . . . . 0.0 109.909 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.04 154.04 90.75 Favored Pre-proline 0 N--CA 1.496 1.863 0 O-C-N 121.309 -0.869 . . . . 0.0 109.996 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.427 ' O ' ' HB2' ' A' ' 81' ' ' PRO . 44.4 Cg_endo -67.48 -22.27 45.3 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.613 1.323 . . . . 0.0 110.736 -179.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -101.31 14.05 33.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.007 -1.058 . . . . 0.0 110.186 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.454 ' HA ' ' HB3' ' A' ' 125' ' ' ASP . . . -63.77 142.3 58.45 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.301 -0.874 . . . . 0.0 111.695 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -129.14 -34.84 1.85 Allowed 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 42.2 t -165.68 139.92 4.65 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 121.377 -0.827 . . . . 0.0 110.538 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.474 ' CZ ' ' HG3' ' A' ' 47' ' ' PRO . 42.2 p90 -143.57 161.09 39.38 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.171 -0.956 . . . . 0.0 109.067 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.411 HG12 ' HB2' ' A' ' 46' ' ' ASN . 10.4 m -126.72 140.52 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 120.662 -1.274 . . . . 0.0 111.935 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 52.7 mt -118.75 133.19 56.02 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.573 -0.704 . . . . 0.0 109.713 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.415 ' CG ' HD13 ' A' ' 41' ' ' LEU . 93.8 m-20 -124.92 135.09 52.52 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.84 -1.162 . . . . 0.0 111.597 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.474 HD11 ' HB3' ' A' ' 43' ' ' LEU . 0.6 OUTLIER -144.69 110.77 5.47 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.693 0.759 . . . . 0.0 109.206 178.526 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -165.02 -142.84 3.53 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.531 ' O ' ' HB2' ' A' ' 119' ' ' TYR . 47.9 pttt -109.15 -32.81 7.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.152 -1.205 . . . . 0.0 109.412 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.426 ' N ' ' CG ' ' A' ' 36' ' ' LYS . 36.5 m-20 -138.52 171.73 13.93 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.946 0.879 . . . . 0.0 110.501 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 42.4 t -60.07 -41.94 93.49 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.786 -0.571 . . . . 0.0 110.931 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.485 ' HB3' ' N ' ' A' ' 66' ' ' GLY . 82.1 m-20 -91.5 -6.41 52.62 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.033 -1.042 . . . . 0.0 111.372 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -115.29 60.46 0.7 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.88 -1.138 . . . . 0.0 111.05 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.415 HD13 ' CG ' ' A' ' 33' ' ' ASN . 61.3 mt -84.88 147.35 26.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.35 -0.844 . . . . 0.0 109.903 179.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 81.6 m -88.55 -41.7 12.54 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.865 -1.147 . . . . 0.0 109.347 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.474 ' HB3' HD11 ' A' ' 34' ' ' LEU . 15.1 tp -132.17 128.98 39.17 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.644 -0.66 . . . . 0.0 110.862 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.402 ' ND1' ' OD1' ' A' ' 33' ' ' ASN . 20.3 t60 -121.37 112.85 19.09 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -104.72 122.18 45.15 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.023 -1.048 . . . . 0.0 110.691 -178.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.411 ' HB2' HG12 ' A' ' 31' ' ' VAL . 3.7 t-20 -139.37 85.75 15.02 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.297 -0.877 . . . . 0.0 111.218 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.474 ' HG3' ' CZ ' ' A' ' 30' ' ' PHE . 55.9 Cg_endo -71.16 145.13 48.39 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.961 1.506 . . . . 0.0 110.193 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -128.21 92.34 3.43 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.763 -1.21 . . . . 0.0 110.425 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -63.37 -40.59 97.66 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.425 -0.797 . . . . 0.0 109.571 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -137.82 92.02 2.64 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.198 -0.939 . . . . 0.0 109.024 178.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.66 -146.9 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.405 -0.809 . . . . 0.0 109.703 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -108.28 31.65 5.41 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.291 -0.88 . . . . 0.0 109.94 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 166.63 -32.17 0.21 Allowed Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.251 -1.452 . . . . 0.0 109.87 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -89.74 -168.86 2.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.134 -1.215 . . . . 0.0 110.285 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.466 ' O ' ' C ' ' A' ' 56' ' ' ASN . . . -150.82 144.94 25.39 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.407 -0.808 . . . . 0.0 109.496 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.466 ' C ' ' O ' ' A' ' 55' ' ' ALA . 95.1 m-20 25.19 64.09 0.06 Allowed 'General case' 0 N--CA 1.506 2.368 0 CA-C-O 121.137 0.494 . . . . 0.0 111.783 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.8 m -127.24 126.79 43.34 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.434 -0.791 . . . . 0.0 110.283 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 83.1 mt -119.96 131.52 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 CA-C-O 121.173 0.511 . . . . 0.0 110.852 -178.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.3 m -124.18 153.03 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 120.996 -1.065 . . . . 0.0 110.135 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 57.1 m -111.03 145.84 37.78 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.058 -1.026 . . . . 0.0 110.453 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -155.91 170.64 21.65 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.271 -0.893 . . . . 0.0 111.393 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.416 ' O ' ' HA ' ' A' ' 68' ' ' TRP . 19.4 m -149.49 157.34 43.2 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.405 -0.809 . . . . 0.0 109.084 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 68' ' ' TRP . 7.7 ttmt -134.67 140.71 46.22 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.766 -1.209 . . . . 0.0 110.479 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -122.07 105.79 10.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.288 -0.883 . . . . 0.0 109.728 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.64 28.9 74.07 Favored Glycine 0 N--CA 1.484 1.834 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.485 ' N ' ' HB3' ' A' ' 39' ' ' ASN . . . 91.45 -2.38 77.71 Favored Glycine 0 N--CA 1.482 1.723 0 C-N-CA 119.323 -1.417 . . . . 0.0 109.583 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.449 ' O ' ' C ' ' A' ' 68' ' ' TRP . . . -106.77 90.33 3.29 Favored 'General case' 0 N--CA 1.483 1.196 0 O-C-N 121.045 -1.268 . . . . 0.0 109.9 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.513 ' HA ' ' HA ' ' A' ' 63' ' ' LYS . 2.0 m-90 -19.66 -104.48 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.444 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 130.63 -99.87 0.45 Allowed Glycine 0 N--CA 1.489 2.199 0 O-C-N 119.863 -1.773 . . . . 0.0 110.941 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.3 t -93.77 143.41 26.36 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.258 -1.142 . . . . 0.0 111.528 -178.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -153.28 108.93 3.27 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.036 -1.04 . . . . 0.0 110.749 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.493 ' NE2' ' CZ ' ' A' ' 108' ' ' PHE . 10.1 pt20 -125.18 -151.19 0.47 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.275 -1.516 . . . . 0.0 111.01 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -140.59 132.92 28.31 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.959 -1.088 . . . . 0.0 111.095 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.431 ' OE2' ' CD1' ' A' ' 106' ' ' PHE . 82.0 tt0 -143.09 81.72 1.73 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.244 -0.91 . . . . 0.0 110.165 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.97 99.8 2.8 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.094 -1.004 . . . . 0.0 110.37 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.2 p -140.24 138.2 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.019 -1.051 . . . . 0.0 109.143 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.588 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 4.1 p90 -153.15 87.04 3.99 Favored Pre-proline 0 C--N 1.303 -1.421 0 O-C-N 120.938 -1.101 . . . . 0.0 110.8 -178.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.47 ' O ' ' CD1' ' A' ' 79' ' ' PHE . 50.0 Cg_endo -86.13 11.01 3.44 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 124.229 1.647 . . . . 0.0 110.577 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.47 ' CD1' ' O ' ' A' ' 78' ' ' PRO . 42.5 m-85 -148.14 -175.31 4.84 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.146 -0.971 . . . . 0.0 110.622 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.475 ' CG ' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -140.45 174.03 4.38 Favored Pre-proline 0 N--CA 1.493 1.69 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.475 ' HD2' ' CG ' ' A' ' 80' ' ' GLN . 41.6 Cg_endo -64.3 145.94 89.31 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.084 1.044 . . . . 0.0 109.782 179.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 75.54 35.86 45.53 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.7 m -130.62 155.23 46.91 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.226 -1.161 . . . . 0.0 111.225 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 53.0 t -104.13 126.24 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.181 -0.949 . . . . 0.0 109.542 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.463 ' HB1' ' HG3' ' A' ' 101' ' ' PRO . . . -145.11 154.79 42.84 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.139 -0.976 . . . . 0.0 110.074 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.444 ' HG2' ' HA ' ' A' ' 20' ' ' ARG . 97.4 mt-10 -121.01 149.23 43.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.133 -0.979 . . . . 0.0 110.836 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.4 t -126.02 127.81 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.206 -0.934 . . . . 0.0 110.895 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 1.7 m -99.38 131.65 45.25 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 95.8 mt -122.32 130.62 74.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.239 -0.913 . . . . 0.0 111.196 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 23.5 m -124.58 128.52 49.03 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.441 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 55.8 t80 -115.66 122.89 46.94 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.345 -0.847 . . . . 0.0 111.447 -178.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 95' ' ' ASN . 79.3 m-20 -115.52 147.64 40.44 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.215 -0.928 . . . . 0.0 110.073 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 64.2 tp60 -59.57 -24.8 64.05 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.193 -0.942 . . . . 0.0 110.78 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.482 ' O ' ' ND2' ' A' ' 95' ' ' ASN . . . -101.52 -13.15 18.01 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.824 -1.172 . . . . 0.0 111.52 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.482 ' ND2' ' O ' ' A' ' 94' ' ' ALA . 0.9 OUTLIER -162.37 163.14 27.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.926 -1.109 . . . . 0.0 111.344 -178.037 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.417 ' HB3' ' HB2' ' A' ' 108' ' ' PHE . 46.3 tp -115.23 130.14 56.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.184 -0.947 . . . . 0.0 108.753 177.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.493 HG23 ' OE2' ' A' ' 105' ' ' GLU . 79.9 m -122.0 130.85 53.65 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.827 -1.17 . . . . 0.0 111.717 -178.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 55.4 t -129.75 128.27 65.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.104 -0.998 . . . . 0.0 110.382 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -114.27 145.87 41.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.031 -1.043 . . . . 0.0 110.172 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.463 ' CG ' ' HD2' ' A' ' 101' ' ' PRO . 0.1 OUTLIER -104.47 169.02 7.69 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.198 -0.938 . . . . 0.0 109.021 178.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.463 ' HG3' ' HB1' ' A' ' 85' ' ' ALA . 42.1 Cg_endo -68.63 -25.5 34.31 Favored 'Trans proline' 0 C--N 1.301 -1.948 0 O-C-N 123.619 1.326 . . . . 0.0 109.382 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -68.62 -28.13 66.63 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.191 -0.943 . . . . 0.0 110.953 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 117.24 -10.59 14.86 Favored Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.687 -1.244 . . . . 0.0 110.049 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -82.15 144.64 30.6 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.856 -1.379 . . . . 0.0 110.601 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.493 ' OE2' HG23 ' A' ' 97' ' ' THR . 73.1 tt0 -135.74 148.16 48.72 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.115 -0.991 . . . . 0.0 111.566 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.431 ' CD1' ' OE2' ' A' ' 74' ' ' GLU . 97.1 m-85 -131.76 151.58 51.55 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.327 -0.858 . . . . 0.0 108.765 178.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -126.02 141.78 51.81 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.749 -1.22 . . . . 0.0 112.283 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.493 ' CZ ' ' NE2' ' A' ' 72' ' ' GLN . 1.9 m-85 -112.55 144.58 31.2 Favored Pre-proline 0 N--CA 1.492 1.631 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 159.99 51.4 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 123.428 1.225 . . . . 0.0 111.745 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 2.5 t-20 -71.96 53.8 0.26 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.565 -0.71 . . . . 0.0 112.254 -178.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 75.5 mtt85 -65.05 -38.25 90.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.768 -1.207 . . . . 0.0 109.102 177.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 97.2 mt -92.05 133.62 35.57 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.638 -0.664 . . . . 0.0 110.87 -178.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -96.08 18.75 12.86 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.587 -0.696 . . . . 0.0 111.038 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 47.9 tp -63.99 131.65 48.25 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.032 -1.043 . . . . 0.0 110.353 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -89.76 -12.96 37.79 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.964 -1.085 . . . . 0.0 111.67 -178.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' A' ' 11' ' ' LEU . . . -160.51 155.51 24.43 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 118.234 -1.386 . . . . 0.0 111.925 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.485 ' HB ' ' HB3' ' A' ' 11' ' ' LEU . 41.1 mm -99.62 119.47 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.227 -0.921 . . . . 0.0 109.486 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.416 ' HB2' ' HA ' ' A' ' 36' ' ' LYS . 25.8 m-80 -111.02 -29.89 7.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.439 -0.788 . . . . 0.0 111.422 -178.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.531 ' HB2' ' O ' ' A' ' 36' ' ' LYS . 57.2 t80 -108.17 129.75 55.16 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.255 -0.903 . . . . 0.0 110.226 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.465 ' HB3' ' CD1' ' A' ' 9' ' ' LEU . 58.1 ttp -140.69 130.99 25.05 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.61 144.91 25.55 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 119.048 -1.061 . . . . 0.0 110.866 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.468 ' O ' ' HA3' ' A' ' 3' ' ' GLY . . . -142.09 124.79 15.92 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -150.62 134.16 16.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.617 -0.677 . . . . 0.0 109.243 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 158.42 -155.32 26.36 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -178.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.454 ' HB3' ' HA ' ' A' ' 27' ' ' ALA . 97.3 m-20 -73.74 -7.21 51.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.767 -0.843 . . . . 0.0 110.061 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.458 ' HD1' HG22 ' A' ' 23' ' ' VAL . 33.5 t80 -98.91 138.43 36.04 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.216 -0.928 . . . . 0.0 110.172 -178.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.436 ' O ' ' CA ' ' A' ' 21' ' ' GLY . 75.5 mmtt -106.78 144.02 34.03 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.046 -1.034 . . . . 0.0 111.967 -178.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.565 ' O ' HD12 ' A' ' 4' ' ' LEU . 5.0 tt -126.27 106.97 16.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -103.45 -4.73 23.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.08 -1.013 . . . . 0.0 111.879 -178.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -154.68 135.34 13.54 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 118.486 -1.286 . . . . 0.0 111.613 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.434 ' CG2' HD11 ' A' ' 128' ' ' ILE . 51.4 t -128.35 131.11 69.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -132.08 139.92 48.67 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.79 -1.194 . . . . 0.0 110.504 -178.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.518 ' CE1' HD13 ' A' ' 17' ' ' LEU . 32.4 m-85 -98.97 120.89 40.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.091 -1.006 . . . . 0.0 110.83 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 16' ' ' CYS . 64.4 t0 . . . . . 0 C--N 1.303 -1.418 0 CA-C-O 118.022 -0.989 . . . . 0.0 110.465 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.316 0.579 . . . . 0.0 110.139 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 2' ' ' CYS . . . . . 0.407 ' N ' ' HB3' ' B' ' 123' ' ' ASP . 0.7 OUTLIER -136.14 84.36 2.07 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.363 -0.836 . . . . 0.0 110.43 179.741 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' GLY . . . . . 0.457 ' HA3' ' O ' ' B' ' 122' ' ' ALA . . . 176.16 170.05 38.4 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.783 HD22 HD23 ' A' ' 9' ' ' LEU . 78.8 mt -80.32 145.08 32.28 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.29 -1.123 . . . . 0.0 111.948 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 29.6 m -110.67 149.79 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.686 -0.634 . . . . 0.0 109.453 178.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.1 155.98 47.5 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.857 -1.152 . . . . 0.0 112.421 -178.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' SER . . . . . 0.46 ' O ' ' HB3' ' B' ' 8' ' ' ASN . 15.2 m -155.02 173.02 17.16 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.34 -0.85 . . . . 0.0 109.774 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . 0.46 ' HB3' ' O ' ' B' ' 7' ' ' SER . 34.8 t-20 62.12 27.84 16.77 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.098 -1.001 . . . . 0.0 109.697 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.771 HD23 HD22 ' A' ' 4' ' ' LEU . 58.1 mt -85.58 -4.32 59.13 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.695 -0.628 . . . . 0.0 111.918 -178.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' ASN . . . . . 0.539 ' C ' ' O ' ' B' ' 9' ' ' LEU . 76.6 m-20 5.5 73.93 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.85 0 CA-C-O 122.0 0.905 . . . . 0.0 112.149 -177.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.52 ' O ' ' HA ' ' B' ' 116' ' ' ALA . 34.5 tp -97.88 132.65 43.28 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.756 -0.59 . . . . 0.0 109.986 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.63 169.64 6.61 Favored Pre-proline 0 C--N 1.29 -1.99 0 O-C-N 121.648 -0.658 . . . . 0.0 109.765 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' B' ' 91' ' ' PHE . 56.4 Cg_endo -72.55 155.7 54.58 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.016 1.535 . . . . 0.0 108.985 178.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.61 -10.37 59.19 Favored Glycine 0 N--CA 1.488 2.146 0 C-N-CA 119.53 -1.319 . . . . 0.0 109.821 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -115.16 147.12 40.66 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.92 -1.341 . . . . 0.0 109.235 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' CYS . . . . . 0.417 ' O ' ' N ' ' B' ' 134' ' ' ASP . 1.6 t -96.51 140.82 30.59 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.937 -1.102 . . . . 0.0 111.041 -178.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.501 HD13 ' CE1' ' B' ' 133' ' ' PHE . 56.1 tp -111.07 126.87 55.28 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.141 -0.974 . . . . 0.0 110.515 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -120.13 126.25 50.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.099 -1.001 . . . . 0.0 109.974 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 32.8 t -127.82 129.23 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.237 -0.914 . . . . 0.0 110.893 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.446 ' HA ' ' HG2' ' B' ' 86' ' ' GLU . 72.7 ttt180 -108.81 129.85 55.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.284 -0.885 . . . . 0.0 110.094 178.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.441 ' CA ' ' O ' ' B' ' 127' ' ' LYS . . . -134.35 173.14 21.53 Favored Glycine 0 C--N 1.297 -1.607 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' B' ' 127' ' ' LYS . 83.6 tt0 -124.86 120.89 32.96 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.525 -0.985 . . . . 0.0 108.844 179.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.456 HG22 ' HD1' ' B' ' 126' ' ' PHE . 69.6 t -84.35 132.63 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.026 -1.046 . . . . 0.0 109.887 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.65 154.59 89.46 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.29 -0.881 . . . . 0.0 110.039 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . 0.42 ' O ' ' HB2' ' B' ' 81' ' ' PRO . 43.7 Cg_endo -67.89 -22.15 42.89 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.422 1.222 . . . . 0.0 110.89 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -101.67 13.73 34.04 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.187 -0.946 . . . . 0.0 109.69 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . 0.462 ' HA ' ' HB3' ' B' ' 125' ' ' ASP . . . -63.54 142.02 58.55 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.154 -0.966 . . . . 0.0 111.617 -178.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -127.74 -37.8 1.93 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 42.7 t -162.13 140.84 9.24 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.345 -0.847 . . . . 0.0 110.645 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' PHE . . . . . 0.457 ' CZ ' ' HG3' ' B' ' 47' ' ' PRO . 42.0 p90 -143.9 161.16 39.41 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.225 -0.922 . . . . 0.0 108.952 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 11.1 m -126.67 140.5 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 120.549 -1.344 . . . . 0.0 111.888 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 56.6 mt -118.06 133.98 55.41 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.502 -0.749 . . . . 0.0 109.599 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' ASN . . . . . 0.425 ' CG ' HD13 ' B' ' 41' ' ' LEU . 93.8 m-20 -124.89 135.08 52.54 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.794 -1.191 . . . . 0.0 111.946 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.465 HD11 ' HB3' ' B' ' 43' ' ' LEU . 0.6 OUTLIER -144.67 106.9 4.34 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.486 -0.759 . . . . 0.0 109.939 178.346 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . 0.4 ' HA3' ' HA ' ' B' ' 41' ' ' LEU . . . -159.42 -142.06 3.3 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . 0.505 ' O ' ' HB2' ' B' ' 119' ' ' TYR . 47.6 pttt -108.82 -32.7 7.2 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.443 -1.033 . . . . 0.0 109.063 178.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . 0.417 ' N ' ' CG ' ' B' ' 36' ' ' LYS . 34.6 m-20 -139.44 171.55 14.1 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.982 0.896 . . . . 0.0 110.462 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 43.9 t -59.89 -41.94 92.7 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.623 -0.673 . . . . 0.0 111.331 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' ASN . . . . . 0.487 ' HB3' ' N ' ' B' ' 66' ' ' GLY . 83.1 m-20 -91.53 -6.21 52.86 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.02 -1.05 . . . . 0.0 111.112 -178.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -115.89 62.92 0.7 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.196 -0.94 . . . . 0.0 110.529 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.425 HD13 ' CG ' ' B' ' 33' ' ' ASN . 55.9 mt -87.19 148.88 24.97 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.357 -0.839 . . . . 0.0 109.29 178.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' CYS . . . . . . . . . . . . . 82.4 m -91.01 -40.27 11.75 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.111 -0.993 . . . . 0.0 109.284 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.465 ' HB3' HD11 ' B' ' 34' ' ' LEU . 15.2 tp -133.31 128.86 36.66 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.52 -0.737 . . . . 0.0 110.437 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' HIS . . . . . . . . . . . . . 18.6 t60 -121.46 113.12 19.4 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -104.62 122.04 44.79 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.056 -1.028 . . . . 0.0 110.942 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -139.03 85.38 16.01 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.159 -0.963 . . . . 0.0 111.444 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' PRO . . . . . 0.457 ' HG3' ' CZ ' ' B' ' 30' ' ' PHE . 57.0 Cg_endo -71.13 144.74 47.59 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.935 1.492 . . . . 0.0 110.031 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -128.65 92.43 3.41 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.738 -1.226 . . . . 0.0 110.286 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -63.94 -39.67 94.68 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.488 -0.757 . . . . 0.0 109.905 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 59.8 t-20 -138.47 91.42 2.54 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.189 -0.945 . . . . 0.0 108.721 178.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.48 -146.12 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.268 -0.895 . . . . 0.0 109.77 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -108.58 31.72 5.4 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.33 -0.856 . . . . 0.0 110.056 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 166.61 -32.14 0.21 Allowed Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.276 -1.44 . . . . 0.0 110.033 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -89.54 -169.13 2.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -1.146 . . . . 0.0 109.983 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.493 ' O ' ' C ' ' B' ' 56' ' ' ASN . . . -148.96 150.94 33.73 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 178.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' ASN . . . . . 0.493 ' C ' ' O ' ' B' ' 55' ' ' ALA . 92.4 m-20 16.67 66.91 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.617 0 CA-C-O 121.689 0.757 . . . . 0.0 112.429 -178.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 12.4 m -127.06 126.1 42.46 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.903 0.859 . . . . 0.0 110.578 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' ILE . . . . . . . . . . . . . 86.5 mt -119.79 131.87 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.542 -0.724 . . . . 0.0 110.555 -178.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 13.9 m -124.26 153.25 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.191 -0.943 . . . . 0.0 110.186 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 58.2 m -110.94 146.88 35.82 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.739 -1.226 . . . . 0.0 110.484 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' ASN . . . . . 0.435 ' HA ' ' O ' ' B' ' 70' ' ' THR . 23.6 t-20 -156.27 170.72 21.61 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.036 -1.04 . . . . 0.0 111.214 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' SER . . . . . 0.42 ' O ' ' HA ' ' B' ' 68' ' ' TRP . 19.8 m -149.26 157.06 43.04 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . 0.515 ' HA ' ' HA ' ' B' ' 68' ' ' TRP . 7.1 ttmt -134.58 140.4 46.07 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.092 -1.005 . . . . 0.0 110.448 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -122.13 105.04 9.9 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.256 -0.902 . . . . 0.0 109.858 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.99 29.42 74.97 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . 0.487 ' N ' ' HB3' ' B' ' 39' ' ' ASN . . . 90.77 -1.37 78.26 Favored Glycine 0 N--CA 1.484 1.839 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' ALA . . . . . 0.436 ' O ' ' C ' ' B' ' 68' ' ' TRP . . . -107.22 89.71 3.08 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.197 -1.178 . . . . 0.0 109.849 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' TRP . . . . . 0.515 ' HA ' ' HA ' ' B' ' 63' ' ' LYS . 1.9 m-90 -19.77 -104.34 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.36 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 130.41 -99.57 0.44 Allowed Glycine 0 N--CA 1.488 2.16 0 C-N-CA 118.641 -1.742 . . . . 0.0 110.795 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 70' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' B' ' 61' ' ' ASN . 13.0 t -94.74 140.83 29.36 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.356 -1.085 . . . . 0.0 112.107 -178.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -150.65 108.7 3.73 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.205 -0.935 . . . . 0.0 111.283 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 72' ' ' GLN . . . . . 0.474 ' NE2' ' CZ ' ' B' ' 108' ' ' PHE . 9.6 pt20 -124.64 -151.86 0.49 Allowed 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.324 -1.485 . . . . 0.0 110.999 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -140.5 132.87 28.37 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.002 -1.062 . . . . 0.0 111.109 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 74' ' ' GLU . . . . . 0.448 ' OE2' ' CD1' ' B' ' 106' ' ' PHE . 82.1 tt0 -142.85 81.64 1.73 Allowed 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.183 -0.948 . . . . 0.0 110.324 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.9 99.9 2.79 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.011 -1.056 . . . . 0.0 110.484 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 4.1 p -140.07 137.65 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.313 -0.867 . . . . 0.0 109.249 178.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 77' ' ' PHE . . . . . 0.605 ' N ' ' CD1' ' B' ' 77' ' ' PHE . 4.2 p90 -152.73 86.91 4.16 Favored Pre-proline 0 C--N 1.302 -1.492 0 O-C-N 121.023 -1.048 . . . . 0.0 110.88 -178.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . 0.472 ' O ' ' CD1' ' B' ' 79' ' ' PHE . 50.5 Cg_endo -86.02 10.98 3.46 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.245 1.655 . . . . 0.0 110.56 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 79' ' ' PHE . . . . . 0.472 ' CD1' ' O ' ' B' ' 78' ' ' PRO . 40.5 m-85 -148.1 -175.58 4.95 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.024 -1.047 . . . . 0.0 110.774 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.477 ' CG ' ' HD2' ' B' ' 81' ' ' PRO . 0.0 OUTLIER -139.81 174.46 4.04 Favored Pre-proline 0 N--CA 1.488 1.446 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.779 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 81' ' ' PRO . . . . . 0.477 ' HD2' ' CG ' ' B' ' 80' ' ' GLN . 41.0 Cg_endo -64.35 145.96 89.12 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 N-CA-C 109.406 -1.036 . . . . 0.0 109.406 178.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 75.45 35.41 47.51 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 33.4 m -130.39 155.06 47.01 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.131 -1.217 . . . . 0.0 111.308 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 58.7 t -103.81 126.37 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.281 -0.887 . . . . 0.0 109.749 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 85' ' ' ALA . . . . . 0.463 ' HB1' ' HG3' ' B' ' 101' ' ' PRO . . . -145.02 154.91 43.02 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.134 -0.979 . . . . 0.0 110.151 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 86' ' ' GLU . . . . . 0.446 ' HG2' ' HA ' ' B' ' 20' ' ' ARG . 97.8 mt-10 -120.79 149.36 42.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.346 -0.846 . . . . 0.0 110.853 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 21.5 t -125.62 128.27 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.132 -0.98 . . . . 0.0 110.734 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 88' ' ' CYS . . . . . 0.436 ' HA ' ' O ' ' B' ' 17' ' ' LEU . 1.6 m -100.11 131.5 46.03 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 96.0 mt -122.43 130.7 74.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.098 -1.001 . . . . 0.0 111.22 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 22.6 m -124.11 128.67 49.62 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 91' ' ' PHE . . . . . 0.432 ' O ' ' HA ' ' B' ' 13' ' ' PRO . 55.6 t80 -115.62 122.76 46.6 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.584 -0.847 . . . . 0.0 111.355 -178.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -115.16 147.08 40.72 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.13 -0.981 . . . . 0.0 110.063 178.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 63.3 tp60 -59.33 -24.3 63.21 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.887 -1.133 . . . . 0.0 110.886 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 94' ' ' ALA . . . . . 0.467 ' O ' ' ND2' ' B' ' 95' ' ' ASN . . . -101.85 -13.7 17.56 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.904 -1.122 . . . . 0.0 111.284 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 95' ' ' ASN . . . . . 0.467 ' ND2' ' O ' ' B' ' 94' ' ' ALA . 0.9 OUTLIER -161.79 163.4 29.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.029 -1.045 . . . . 0.0 111.296 -178.251 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 96' ' ' LEU . . . . . 0.414 HD23 ' HB2' ' B' ' 108' ' ' PHE . 46.2 tp -115.59 129.57 56.56 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.248 -0.908 . . . . 0.0 108.596 177.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 97' ' ' THR . . . . . 0.487 HG23 ' OE2' ' B' ' 105' ' ' GLU . 78.1 m -121.72 131.64 54.19 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.82 -1.175 . . . . 0.0 111.356 -178.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 53.8 t -130.29 127.91 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.398 -0.814 . . . . 0.0 110.108 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -114.65 145.08 42.43 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.948 -1.095 . . . . 0.0 110.203 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 100' ' ' LEU . . . . . 0.469 ' CG ' ' HD2' ' B' ' 101' ' ' PRO . 0.1 OUTLIER -103.96 168.63 8.34 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.353 -0.842 . . . . 0.0 109.023 179.218 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 101' ' ' PRO . . . . . 0.469 ' HD2' ' CG ' ' B' ' 100' ' ' LEU . 41.9 Cg_endo -68.23 -25.28 36.95 Favored 'Trans proline' 0 C--N 1.301 -1.933 0 O-C-N 123.645 1.34 . . . . 0.0 109.376 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -68.27 -28.57 67.31 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.484 -0.76 . . . . 0.0 110.894 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 117.28 -10.65 14.77 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 104' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -81.72 144.55 31.05 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.897 -1.355 . . . . 0.0 110.804 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 105' ' ' GLU . . . . . 0.487 ' OE2' HG23 ' B' ' 97' ' ' THR . 73.5 tt0 -135.88 147.93 48.39 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.178 -0.951 . . . . 0.0 111.955 -179.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 106' ' ' PHE . . . . . 0.448 ' CD1' ' OE2' ' B' ' 74' ' ' GLU . 96.6 m-85 -131.95 151.16 51.9 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -125.74 142.27 51.59 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.718 -1.239 . . . . 0.0 112.07 -178.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 108' ' ' PHE . . . . . 0.474 ' CZ ' ' NE2' ' B' ' 72' ' ' GLN . 1.8 m-85 -113.16 144.65 31.57 Favored Pre-proline 0 N--CA 1.494 1.728 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -69.76 160.28 50.27 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 123.467 1.246 . . . . 0.0 111.652 -178.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 110' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' B' ' 94' ' ' ALA . 2.3 t-20 -72.11 53.78 0.28 Allowed 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.81 -0.556 . . . . 0.0 112.158 -178.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 75.1 mtt85 -65.27 -38.61 90.81 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.847 -1.158 . . . . 0.0 109.056 177.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 98.2 mt -91.5 134.08 34.95 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.358 -0.839 . . . . 0.0 111.157 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -96.13 18.78 12.85 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.414 -0.804 . . . . 0.0 110.997 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 50.6 tp -63.86 131.89 49.15 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.059 -1.026 . . . . 0.0 110.24 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -89.7 -12.83 38.33 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.042 -1.036 . . . . 0.0 111.849 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 116' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' B' ' 11' ' ' LEU . . . -161.2 155.69 23.16 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.372 -1.455 . . . . 0.0 111.787 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 117' ' ' ILE . . . . . 0.502 ' HB ' ' HB3' ' B' ' 11' ' ' LEU . 41.3 mm -100.1 119.8 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.228 -0.92 . . . . 0.0 109.649 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 118' ' ' ASN . . . . . 0.403 ' HB2' ' HA ' ' B' ' 36' ' ' LYS . 23.4 m-80 -111.04 -30.42 7.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.404 -0.81 . . . . 0.0 111.351 -178.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 119' ' ' TYR . . . . . 0.505 ' HB2' ' O ' ' B' ' 36' ' ' LYS . 57.8 t80 -107.03 131.03 54.54 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.013 -1.054 . . . . 0.0 110.219 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 120' ' ' MET . . . . . 0.488 ' HB3' ' CD1' ' B' ' 9' ' ' LEU . 55.5 ttp -141.91 130.89 23.11 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -151.14 144.4 24.75 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.054 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 122' ' ' ALA . . . . . 0.457 ' O ' ' HA3' ' B' ' 3' ' ' GLY . . . -141.68 125.02 16.51 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 123' ' ' ASP . . . . . 0.407 ' HB3' ' N ' ' B' ' 2' ' ' CYS . 65.1 m-20 -150.72 134.33 16.48 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.481 -0.762 . . . . 0.0 109.192 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 158.3 -155.48 26.5 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.044 -1.55 . . . . 0.0 109.554 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . 0.462 ' HB3' ' HA ' ' B' ' 27' ' ' ALA . 96.4 m-20 -73.25 -7.4 51.35 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.584 -0.951 . . . . 0.0 110.294 179.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 126' ' ' PHE . . . . . 0.456 ' HD1' HG22 ' B' ' 23' ' ' VAL . 33.9 t80 -99.09 138.77 35.72 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.525 -0.734 . . . . 0.0 110.092 -178.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . 0.441 ' O ' ' CA ' ' B' ' 21' ' ' GLY . 75.7 mmtt -106.88 144.19 33.87 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 118.945 -1.102 . . . . 0.0 112.074 -178.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . 0.557 ' O ' HD12 ' B' ' 4' ' ' LEU . 5.1 tt -125.88 106.67 16.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -102.84 -5.6 23.42 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.888 -1.132 . . . . 0.0 111.771 -178.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 130' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -153.55 134.99 14.25 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 118.26 -1.376 . . . . 0.0 112.05 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.4 ' CG2' HD11 ' B' ' 128' ' ' ILE . 50.6 t -127.49 131.75 69.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 132' ' ' ALA . . . . . . . . . . . . . . . -131.91 139.91 48.89 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.446 -1.408 . . . . 0.0 110.477 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . 0.501 ' CE1' HD13 ' B' ' 17' ' ' LEU . 32.7 m-85 -98.79 121.08 40.28 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.8 -1.188 . . . . 0.0 110.959 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . 0.417 ' N ' ' O ' ' B' ' 16' ' ' CYS . 62.1 t0 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.407 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.486 ' HA3' ' O ' ' A' ' 122' ' ' ALA . . . . . . . . 0 N--CA 1.485 1.918 0 N-CA-C 107.98 -2.048 . . . . 0.0 107.98 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.578 HD12 ' N ' ' A' ' 4' ' ' LEU . 11.1 mp -93.44 142.21 27.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.071 -1.252 . . . . 0.0 110.43 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.3 t -108.56 131.54 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 121.198 -0.939 . . . . 0.0 110.117 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -130.41 172.61 11.68 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.951 -1.093 . . . . 0.0 111.822 -178.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.416 ' O ' ' CB ' ' A' ' 8' ' ' ASN . 30.5 p -155.07 167.2 31.15 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.45 -0.781 . . . . 0.0 110.001 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' B' ' 3' ' ' GLY . 20.2 t-20 63.43 40.01 8.74 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.384 0.611 . . . . 0.0 110.446 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.476 ' O ' ' C ' ' A' ' 10' ' ' ASN . 56.5 mt -99.66 16.2 24.24 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.314 -0.867 . . . . 0.0 110.316 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.498 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 51.0 t-20 -18.76 88.8 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.381 0 CA-C-O 121.996 0.903 . . . . 0.0 112.674 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.576 HD12 ' CZ ' ' A' ' 133' ' ' PHE . 5.2 tt -100.5 134.68 43.1 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.584 -0.698 . . . . 0.0 109.96 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.465 ' HD2' ' HD2' ' A' ' 13' ' ' PRO . 0.6 OUTLIER -111.55 171.22 4.51 Favored Pre-proline 0 C--N 1.297 -1.695 0 O-C-N 121.069 -1.019 . . . . 0.0 109.784 179.031 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.465 ' HD2' ' HD2' ' A' ' 12' ' ' LYS . 44.2 Cg_endo -66.19 144.63 75.77 Favored 'Trans proline' 0 C--N 1.299 -2.045 0 O-C-N 123.89 1.468 . . . . 0.0 110.278 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 104.44 -24.72 28.04 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -90.08 150.2 22.17 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.241 -1.153 . . . . 0.0 110.471 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.423 ' SG ' ' N ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -106.31 159.34 16.2 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.417 -0.802 . . . . 0.0 109.99 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.635 HD13 ' N ' ' A' ' 18' ' ' ARG . 0.6 OUTLIER -134.77 123.39 23.53 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.682 -1.261 . . . . 0.0 110.364 179.659 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.635 ' N ' HD13 ' A' ' 17' ' ' LEU . 79.5 ttt180 -117.04 132.65 56.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.226 -0.921 . . . . 0.0 109.888 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.492 HG13 ' CD1' ' A' ' 128' ' ' ILE . 54.7 t -122.12 108.99 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.511 -0.743 . . . . 0.0 111.136 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 77.3 ttt-85 -110.0 123.17 49.19 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.764 -1.21 . . . . 0.0 110.575 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -147.11 -161.3 9.3 Favored Glycine 0 N--CA 1.489 2.188 0 C-N-CA 119.365 -1.398 . . . . 0.0 110.172 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -127.31 134.72 49.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.455 -1.026 . . . . 0.0 109.305 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.635 HG22 ' CD1' ' A' ' 126' ' ' PHE . 93.8 t -101.88 129.5 53.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 121.073 -1.017 . . . . 0.0 109.593 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.52 161.89 1.92 Allowed Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.323 -0.861 . . . . 0.0 110.281 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.52 -20.22 54.15 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 O-C-N 123.69 1.363 . . . . 0.0 109.573 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -111.76 44.03 1.44 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.661 -0.65 . . . . 0.0 110.393 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.58 ' HB2' ' CG1' ' A' ' 23' ' ' VAL . . . -71.15 91.09 0.9 Allowed 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 118.918 -1.113 . . . . 0.0 109.563 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -98.71 -20.93 16.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.385 -0.822 . . . . 0.0 109.985 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.1 t -150.11 143.5 25.13 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.882 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.524 ' HA ' ' HA3' ' A' ' 124' ' ' GLY . 40.7 t80 -147.79 134.95 20.44 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.448 -0.782 . . . . 0.0 110.289 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 67.4 t -127.47 131.0 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.824 -1.172 . . . . 0.0 110.307 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.726 HD12 ' N ' ' A' ' 33' ' ' ASN . 5.0 tp -138.58 141.81 39.21 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.519 -0.738 . . . . 0.0 110.383 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.864 ' HB2' HD13 ' A' ' 41' ' ' LEU . 1.5 p-10 -154.25 143.09 20.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.053 -1.029 . . . . 0.0 110.7 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.481 ' O ' HD12 ' A' ' 34' ' ' LEU . 1.5 pp -136.13 118.48 15.69 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.496 -0.753 . . . . 0.0 109.628 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.802 ' HA3' HD23 ' A' ' 41' ' ' LEU . . . -142.85 -136.49 3.19 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.822 -1.18 . . . . 0.0 110.602 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.456 ' CG ' ' N ' ' A' ' 37' ' ' ASP . 24.0 pttt -127.64 -37.14 1.99 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.371 -1.076 . . . . 0.0 111.101 -179.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.456 ' N ' ' CG ' ' A' ' 36' ' ' LYS . 86.3 m-20 -115.25 -83.59 0.62 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.125 -0.985 . . . . 0.0 110.309 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.2 t -151.58 -53.6 0.13 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 60.6 m-20 -93.85 -4.06 50.74 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.343 -0.848 . . . . 0.0 109.004 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.415 ' O ' ' HA3' ' A' ' 35' ' ' GLY . 14.0 m-80 -91.18 68.72 6.05 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.175 -0.953 . . . . 0.0 109.854 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.864 HD13 ' HB2' ' A' ' 33' ' ' ASN . 75.8 mt -106.47 133.02 51.8 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.438 -0.789 . . . . 0.0 110.676 -179.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.528 ' O ' HD23 ' A' ' 43' ' ' LEU . 69.8 m -85.1 -36.01 21.43 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.564 -0.71 . . . . 0.0 110.253 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 1.047 HD21 HD13 ' A' ' 96' ' ' LEU . 79.5 mt -129.97 129.16 43.42 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 119.454 -0.898 . . . . 0.0 111.542 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.46 ' HB3' ' OD1' ' A' ' 61' ' ' ASN . 60.1 t-80 -126.3 123.98 39.3 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.343 -0.848 . . . . 0.0 109.41 178.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -110.79 131.6 54.91 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.177 -0.952 . . . . 0.0 109.443 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -149.27 78.04 8.77 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 120.926 -1.109 . . . . 0.0 111.285 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.428 ' HG2' ' HB3' ' A' ' 30' ' ' PHE . 47.2 Cg_endo -69.78 144.66 54.61 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.779 1.41 . . . . 0.0 110.014 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -144.46 88.18 1.92 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.865 -1.147 . . . . 0.0 110.869 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.48 ' O ' ' HA ' ' A' ' 55' ' ' ALA . 33.0 t80 -61.78 -46.4 89.74 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.332 0.587 . . . . 0.0 110.393 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -133.72 99.12 4.37 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.294 -0.879 . . . . 0.0 110.008 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -118.78 -69.1 0.87 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.003 -1.061 . . . . 0.0 110.893 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -105.13 -15.67 15.01 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.42 -0.8 . . . . 0.0 110.617 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 159.68 -12.91 0.19 Allowed Glycine 0 N--CA 1.494 2.543 0 C-N-CA 119.866 -1.159 . . . . 0.0 110.514 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -75.78 -179.95 5.08 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.849 -1.383 . . . . 0.0 109.444 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 49' ' ' PHE . . . -129.67 -7.46 4.58 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.146 -0.971 . . . . 0.0 111.723 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 43.2 p30 -163.48 72.82 0.29 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.007 -1.058 . . . . 0.0 110.279 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 73.4 m -124.66 130.46 52.46 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.943 -1.098 . . . . 0.0 111.327 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 98.3 mt -121.76 130.64 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.28 -0.888 . . . . 0.0 111.089 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.0 t -114.31 129.98 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.297 -0.877 . . . . 0.0 110.495 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 33.8 m -129.16 122.1 29.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.319 -0.863 . . . . 0.0 110.067 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.525 ' HB3' ' HG2' ' A' ' 71' ' ' GLU . 4.9 p-10 -138.94 175.0 9.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.422 -0.799 . . . . 0.0 109.985 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.3 m -129.9 155.12 46.56 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.536 ' CD ' ' HA2' ' A' ' 66' ' ' GLY . 6.9 ttmt -135.47 149.29 49.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.495 -1.378 . . . . 0.0 112.128 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.587 ' HB2' HD11 ' A' ' 112' ' ' LEU . 56.6 t0 -129.19 100.43 5.61 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.44 21.28 68.51 Favored Glycine 0 N--CA 1.487 2.075 0 C-N-CA 119.801 -1.19 . . . . 0.0 110.62 179.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.536 ' HA2' ' CD ' ' A' ' 63' ' ' LYS . . . 74.52 24.56 72.48 Favored Glycine 0 N--CA 1.488 2.162 0 C-N-CA 119.145 -1.503 . . . . 0.0 110.275 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -105.4 -74.35 0.65 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.897 -1.355 . . . . 0.0 110.742 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -69.22 -178.47 1.33 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.698 -0.626 . . . . 0.0 109.975 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 166.53 44.79 0.02 OUTLIER Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.0 m -62.39 100.39 0.18 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.066 -1.256 . . . . 0.0 110.504 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.525 ' HG2' ' HB3' ' A' ' 61' ' ' ASN . 89.5 mt-10 -84.97 123.15 30.19 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.336 -0.853 . . . . 0.0 110.903 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -101.39 -168.49 1.56 Allowed 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -146.27 122.27 10.71 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 118.04 -1.464 . . . . 0.0 111.695 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -108.67 132.71 53.64 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.59 60.27 0.6 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.795 -1.19 . . . . 0.0 111.234 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.546 HG22 ' HD3' ' A' ' 78' ' ' PRO . 4.6 p -135.23 151.25 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.942 -1.098 . . . . 0.0 110.4 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.497 ' CG ' ' O ' ' A' ' 77' ' ' PHE . 8.4 p90 -144.46 71.98 15.82 Favored Pre-proline 0 C--N 1.302 -1.475 0 O-C-N 121.098 -1.001 . . . . 0.0 109.874 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.546 ' HD3' HG22 ' A' ' 76' ' ' VAL . 39.9 Cg_endo -65.43 -13.8 41.67 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.892 1.469 . . . . 0.0 110.33 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -117.92 167.24 11.6 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.444 -0.785 . . . . 0.0 110.641 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.88 168.02 15.66 Favored Pre-proline 0 C--N 1.297 -1.674 0 O-C-N 121.546 -0.721 . . . . 0.0 109.598 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -65.65 148.66 87.32 Favored 'Trans proline' 0 C--N 1.298 -2.086 0 O-C-N 123.852 1.448 . . . . 0.0 110.671 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 62.29 42.44 99.72 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.6 t -148.32 137.56 21.96 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.097 -1.237 . . . . 0.0 109.988 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.5 m -78.06 140.22 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.01 -1.056 . . . . 0.0 108.997 178.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.98 153.55 38.09 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.158 -0.963 . . . . 0.0 109.707 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -122.46 152.65 40.06 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.234 -0.916 . . . . 0.0 110.044 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.0 t -128.98 139.34 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.489 -0.757 . . . . 0.0 111.503 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . 0.429 ' HB3' ' HB2' ' A' ' 99' ' ' LYS . 4.8 t -114.26 115.73 27.89 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.427 -0.796 . . . . 0.0 109.943 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 86.6 mt -121.22 128.1 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.141 -0.974 . . . . 0.0 110.014 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.479 ' HB ' ' HB ' ' A' ' 97' ' ' THR . 33.5 m -123.06 134.88 54.25 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.033 -1.042 . . . . 0.0 109.426 179.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.513 ' CE1' HD21 ' A' ' 96' ' ' LEU . 80.8 t80 -104.67 118.25 36.11 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.177 -0.952 . . . . 0.0 110.25 -179.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.402 ' HB2' ' OD1' ' A' ' 95' ' ' ASN . 86.7 m-20 -112.52 143.21 44.06 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.399 -0.921 . . . . 0.0 109.452 178.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 71.6 tp60 -59.58 -26.51 65.47 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.522 -0.736 . . . . 0.0 110.668 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.89 -22.48 23.12 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.225 -0.922 . . . . 0.0 111.634 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.402 ' OD1' ' HB2' ' A' ' 92' ' ' ASP . 45.4 p30 -174.61 -171.58 0.58 Allowed 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.093 -1.005 . . . . 0.0 108.981 -178.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 1.047 HD13 HD21 ' A' ' 43' ' ' LEU . 75.9 mt -122.49 135.06 54.57 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.002 -1.061 . . . . 0.0 110.58 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.479 ' HB ' ' HB ' ' A' ' 90' ' ' THR . 29.5 m -109.26 122.72 47.95 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.1 -1.0 . . . . 0.0 109.031 178.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 44.8 t -124.7 128.14 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.742 -1.224 . . . . 0.0 109.611 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.429 ' HB2' ' HB3' ' A' ' 88' ' ' CYS . 98.4 mttt -122.61 147.62 46.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.298 -0.877 . . . . 0.0 110.925 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.431 HD13 ' HG3' ' A' ' 78' ' ' PRO . 27.5 mt -107.28 166.63 10.7 Favored Pre-proline 0 N--CA 1.493 1.696 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -63.31 -24.32 71.86 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.368 1.194 . . . . 0.0 110.92 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.468 ' HB2' ' CB ' ' A' ' 78' ' ' PRO . 36.9 t70 -76.52 -10.26 59.26 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.074 -1.016 . . . . 0.0 110.84 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 104.34 -8.0 47.88 Favored Glycine 0 N--CA 1.496 2.656 0 C-N-CA 119.821 -1.18 . . . . 0.0 110.753 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -73.0 135.41 44.95 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.787 -1.419 . . . . 0.0 110.28 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.431 ' OE2' HG23 ' A' ' 97' ' ' THR . 71.8 tt0 -124.88 142.49 51.41 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.881 -1.137 . . . . 0.0 110.75 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -133.67 146.15 50.59 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 98.1 mttt -121.79 146.36 47.14 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.831 -1.168 . . . . 0.0 112.971 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.564 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 98.0 m-85 -117.22 150.23 45.89 Favored Pre-proline 0 N--CA 1.493 1.722 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.08 149.85 65.43 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.689 1.363 . . . . 0.0 111.142 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -71.04 62.74 0.3 Allowed 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.611 -0.681 . . . . 0.0 111.652 -178.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 79.6 mtp85 -65.39 -39.89 92.79 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.995 -1.066 . . . . 0.0 110.381 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.587 HD11 ' HB2' ' A' ' 64' ' ' ASP . 4.4 mm? -95.75 130.4 42.68 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.131 -0.981 . . . . 0.0 110.361 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -87.95 7.26 31.84 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.501 -0.749 . . . . 0.0 111.026 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.498 HD23 ' O ' ' A' ' 114' ' ' LEU . 3.6 tt -57.82 128.68 38.32 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.224 -0.99 . . . . 0.0 109.222 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -106.32 -5.59 18.98 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.498 -0.751 . . . . 0.0 111.295 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' A' ' 11' ' ' LEU . . . -137.84 132.35 32.43 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.715 -1.24 . . . . 0.0 110.472 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.498 ' O ' ' HA ' ' A' ' 10' ' ' ASN . 95.6 mt -111.29 128.89 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 O-C-N 120.894 -1.129 . . . . 0.0 110.45 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -126.66 -27.62 3.08 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.026 -1.046 . . . . 0.0 111.645 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.412 ' O ' ' N ' ' A' ' 35' ' ' GLY . 69.4 t80 -92.67 126.09 37.6 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.007 -1.058 . . . . 0.0 110.466 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.423 ' HB3' ' CD1' ' A' ' 9' ' ' LEU . 27.1 ttm -141.01 134.73 30.28 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.993 -1.067 . . . . 0.0 109.573 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.442 ' HB3' HD21 ' A' ' 33' ' ' ASN . . . -159.11 147.95 18.34 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.26 -0.976 . . . . 0.0 109.686 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.486 ' O ' ' HA3' ' A' ' 3' ' ' GLY . . . -147.3 156.21 42.71 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -155.74 160.74 40.57 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 179.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.524 ' HA3' ' HA ' ' A' ' 30' ' ' PHE . . . 143.09 -157.27 26.83 Favored Glycine 0 C--N 1.295 -1.725 0 C-N-CA 118.548 -1.787 . . . . 0.0 110.439 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.483 ' CB ' ' HA ' ' A' ' 27' ' ' ALA . 63.1 m-20 -91.34 11.39 23.84 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.845 -0.797 . . . . 0.0 110.753 -179.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.635 ' CD1' HG22 ' A' ' 23' ' ' VAL . 12.3 t80 -107.42 151.25 25.78 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.822 -1.174 . . . . 0.0 110.681 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -120.8 124.8 45.96 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.564 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.492 ' CD1' HG13 ' A' ' 19' ' ' VAL . 17.7 tt -102.49 126.74 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.928 . . . . 0.0 110.329 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 28.0 pttt -118.63 -4.81 10.75 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.795 -1.191 . . . . 0.0 111.053 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.497 ' HA ' ' O ' ' B' ' 131' ' ' VAL . 0.0 OUTLIER -154.35 131.96 11.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.74 -1.225 . . . . 0.0 111.928 -179.32 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' B' ' 130' ' ' CYS . 53.4 t -128.78 134.63 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.569 -0.707 . . . . 0.0 109.658 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.433 ' HA ' ' HB2' ' B' ' 130' ' ' CYS . . . -142.38 142.92 32.49 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.497 -1.377 . . . . 0.0 110.392 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.576 ' CZ ' HD12 ' A' ' 11' ' ' LEU . 3.1 m-85 -76.47 -86.73 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.813 -1.179 . . . . 0.0 111.248 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 46.4 t0 . . . . . 0 C--N 1.296 -1.723 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.384 -179.169 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.85 0 CA-C-O 121.115 0.483 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 2' ' ' CYS . . . . . 0.405 ' O ' ' HA ' ' B' ' 123' ' ' ASP . 34.2 m -114.71 39.29 2.88 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.022 -1.049 . . . . 0.0 109.264 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' GLY . . . . . 0.534 ' O ' ' ND2' ' A' ' 8' ' ' ASN . . . 79.86 168.93 37.97 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 108.031 -2.028 . . . . 0.0 108.031 -178.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.576 ' N ' HD12 ' B' ' 4' ' ' LEU . 11.0 mp -93.07 141.69 28.13 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.965 -1.315 . . . . 0.0 110.751 -179.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 41.9 t -107.82 131.6 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.382 0 O-C-N 121.082 -1.011 . . . . 0.0 110.242 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -130.5 173.11 11.18 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.044 -1.035 . . . . 0.0 112.011 -178.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' SER . . . . . 0.401 ' O ' ' HB3' ' B' ' 8' ' ' ASN . 27.1 p -155.34 168.25 27.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.426 -0.797 . . . . 0.0 109.802 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . 0.436 ' ND2' ' O ' ' A' ' 3' ' ' GLY . 20.2 t-20 62.61 41.09 9.77 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.589 -0.695 . . . . 0.0 110.416 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.472 ' O ' ' C ' ' B' ' 10' ' ' ASN . 54.8 mt -101.19 17.03 23.57 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.437 -0.79 . . . . 0.0 110.04 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' ASN . . . . . 0.479 ' HA ' ' O ' ' B' ' 117' ' ' ILE . 51.2 t-20 -20.0 89.04 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.39 0 CA-C-O 121.95 0.881 . . . . 0.0 112.77 -179.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.576 HD12 ' CZ ' ' B' ' 133' ' ' PHE . 5.2 tt -100.44 134.16 43.8 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.703 -0.623 . . . . 0.0 109.885 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . 0.47 ' HD2' ' HD2' ' B' ' 13' ' ' PRO . 0.5 OUTLIER -111.34 171.09 4.6 Favored Pre-proline 0 C--N 1.293 -1.883 0 O-C-N 121.244 -0.91 . . . . 0.0 109.94 179.126 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . 0.47 ' HD2' ' HD2' ' B' ' 12' ' ' LYS . 44.1 Cg_endo -65.94 144.35 76.25 Favored 'Trans proline' 0 C--N 1.301 -1.942 0 O-C-N 123.919 1.484 . . . . 0.0 110.115 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 104.32 -24.01 30.16 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -90.92 149.83 21.74 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.194 -1.18 . . . . 0.0 110.591 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' CYS . . . . . 0.419 ' SG ' ' N ' ' B' ' 17' ' ' LEU . 0.0 OUTLIER -106.86 159.62 16.12 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.48 -0.763 . . . . 0.0 109.72 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.639 HD13 ' N ' ' B' ' 18' ' ' ARG . 0.6 OUTLIER -135.0 122.64 22.14 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.621 -1.299 . . . . 0.0 110.383 179.845 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.639 ' N ' HD13 ' B' ' 17' ' ' LEU . 80.1 ttt180 -115.77 133.35 56.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.361 -0.837 . . . . 0.0 109.816 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.483 HG13 ' CD1' ' B' ' 128' ' ' ILE . 55.2 t -122.82 109.19 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.29 -0.881 . . . . 0.0 111.13 -178.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 77.2 ttt-85 -109.82 123.28 49.29 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.993 -1.067 . . . . 0.0 110.631 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -147.22 -161.4 9.38 Favored Glycine 0 N--CA 1.487 2.075 0 C-N-CA 119.456 -1.354 . . . . 0.0 110.009 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 71.3 tt0 -127.22 136.38 51.95 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.575 -0.956 . . . . 0.0 109.081 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.649 HG22 ' CD1' ' B' ' 126' ' ' PHE . 90.5 t -103.98 129.15 56.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 O-C-N 121.174 -0.954 . . . . 0.0 109.789 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.04 161.15 1.93 Allowed Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.506 -0.746 . . . . 0.0 110.172 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' B' ' 81' ' ' PRO . 42.7 Cg_endo -66.02 -20.16 57.39 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.802 1.422 . . . . 0.0 109.775 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -112.2 44.31 1.44 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.693 -0.629 . . . . 0.0 110.388 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . 0.565 ' HB2' ' CG1' ' B' ' 23' ' ' VAL . . . -71.84 91.25 1.15 Allowed 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 118.95 -1.1 . . . . 0.0 109.415 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -98.71 -20.58 16.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.491 -0.755 . . . . 0.0 109.777 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 24.8 t -149.65 143.31 25.42 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.076 -1.015 . . . . 0.0 111.046 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' PHE . . . . . 0.527 ' HA ' ' HA3' ' B' ' 124' ' ' GLY . 41.0 t80 -147.69 134.75 20.35 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.508 -0.745 . . . . 0.0 110.162 179.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.428 HG22 ' ND2' ' B' ' 46' ' ' ASN . 76.9 t -127.74 131.05 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.852 -1.155 . . . . 0.0 110.437 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.752 HD12 ' N ' ' B' ' 33' ' ' ASN . 5.1 tp -138.53 142.58 39.3 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.384 -0.823 . . . . 0.0 110.361 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' ASN . . . . . 0.885 ' HB2' HD13 ' B' ' 41' ' ' LEU . 1.3 p-10 -155.11 142.59 19.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.964 -1.085 . . . . 0.0 110.671 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.486 HD12 ' O ' ' B' ' 34' ' ' LEU . 1.5 pp -135.92 119.2 16.69 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.227 -0.921 . . . . 0.0 109.679 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . 0.812 ' HA3' HD23 ' B' ' 41' ' ' LEU . . . -143.53 -137.58 3.28 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 119.922 -1.133 . . . . 0.0 110.392 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . 0.44 ' CG ' ' N ' ' B' ' 37' ' ' ASP . 24.6 pttt -126.86 -37.47 2.12 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.246 -1.149 . . . . 0.0 111.174 -178.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . 0.451 ' O ' ' CD1' ' B' ' 119' ' ' TYR . 88.3 m-20 -114.25 -84.14 0.61 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.976 -1.078 . . . . 0.0 109.958 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 7.7 t -150.76 -54.22 0.15 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.403 -0.811 . . . . 0.0 109.023 178.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 58.3 m-20 -92.6 -4.5 53.29 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.372 -0.83 . . . . 0.0 108.824 178.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' ASN . . . . . 0.421 ' O ' ' HA3' ' B' ' 35' ' ' GLY . 16.3 m-80 -90.96 69.07 6.3 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.271 -0.893 . . . . 0.0 110.017 -178.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.885 HD13 ' HB2' ' B' ' 33' ' ' ASN . 77.5 mt -105.8 135.93 46.33 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.434 -0.791 . . . . 0.0 110.674 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' CYS . . . . . 0.577 ' O ' HD23 ' B' ' 43' ' ' LEU . 74.2 m -88.83 -34.31 17.08 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.336 -0.852 . . . . 0.0 109.561 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 1.027 HD21 HD13 ' B' ' 96' ' ' LEU . 74.6 mt -131.25 129.71 41.92 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.192 -1.003 . . . . 0.0 111.276 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' HIS . . . . . 0.448 ' HB3' ' OD1' ' B' ' 61' ' ' ASN . 61.1 t-80 -127.0 123.28 36.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.506 -0.746 . . . . 0.0 109.297 178.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -110.15 131.31 55.17 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.133 -0.979 . . . . 0.0 109.762 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' ASN . . . . . 0.428 ' ND2' HG22 ' B' ' 31' ' ' VAL . 0.1 OUTLIER -148.51 78.08 9.37 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.074 -1.016 . . . . 0.0 111.506 -179.08 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' PRO . . . . . 0.443 ' HG2' ' HB3' ' B' ' 30' ' ' PHE . 47.8 Cg_endo -69.83 144.96 55.31 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 123.627 1.33 . . . . 0.0 109.839 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -145.26 88.51 1.87 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.898 -1.127 . . . . 0.0 110.566 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' PHE . . . . . 0.497 ' O ' ' HA ' ' B' ' 55' ' ' ALA . 33.8 t80 -61.65 -45.78 92.58 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.277 0.56 . . . . 0.0 110.417 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 27.1 t30 -134.79 98.67 4.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.286 -0.884 . . . . 0.0 110.239 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -118.74 -68.08 0.94 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.056 -1.028 . . . . 0.0 110.977 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -105.63 -15.2 15.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.295 -0.878 . . . . 0.0 110.886 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 159.52 -14.21 0.21 Allowed Glycine 0 N--CA 1.495 2.585 0 C-N-CA 119.913 -1.137 . . . . 0.0 110.277 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -74.45 179.67 4.5 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.752 -1.44 . . . . 0.0 109.045 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' B' ' 49' ' ' PHE . . . -129.03 -11.11 4.77 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.066 -1.021 . . . . 0.0 111.387 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' ASN . . . . . . . . . . . . . 41.1 p30 -158.91 72.89 0.59 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.187 -0.945 . . . . 0.0 110.714 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 80.7 m -124.45 130.93 53.36 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 120.494 -1.379 . . . . 0.0 111.575 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' ILE . . . . . 0.408 ' HA ' ' HA ' ' B' ' 47' ' ' PRO . 98.1 mt -122.15 130.77 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.47 -0.769 . . . . 0.0 111.209 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 12.9 t -114.48 129.62 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.416 -0.802 . . . . 0.0 110.677 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 33.2 m -128.5 121.69 29.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.293 -0.879 . . . . 0.0 110.137 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' ASN . . . . . 0.547 ' HB3' ' HG2' ' B' ' 71' ' ' GLU . 3.8 p-10 -139.32 174.16 10.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.134 -0.979 . . . . 0.0 110.188 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 7.2 m -129.18 155.15 45.97 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.476 -0.765 . . . . 0.0 108.953 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . 0.531 ' CD ' ' HA2' ' B' ' 66' ' ' GLY . 6.8 ttmt -135.14 150.19 50.14 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.508 -1.37 . . . . 0.0 112.114 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' ASP . . . . . 0.559 ' HB2' HD11 ' B' ' 112' ' ' LEU . 54.5 t0 -129.7 100.38 5.48 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 64.52 21.3 66.68 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.843 -1.17 . . . . 0.0 110.435 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . 0.531 ' HA2' ' CD ' ' B' ' 63' ' ' LYS . . . 74.68 25.6 69.44 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.251 -1.452 . . . . 0.0 110.473 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -105.95 -73.27 0.69 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.989 -1.3 . . . . 0.0 110.583 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -70.59 -177.06 1.41 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.653 -0.655 . . . . 0.0 109.887 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 164.94 46.4 0.02 OUTLIER Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 15.8 m -63.85 100.81 0.32 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.271 -1.134 . . . . 0.0 110.462 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . 0.547 ' HG2' ' HB3' ' B' ' 61' ' ' ASN . 86.4 mt-10 -85.49 123.32 30.79 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.274 -0.891 . . . . 0.0 111.017 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -101.23 -167.81 1.47 Allowed 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -147.3 120.7 9.02 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 117.991 -1.484 . . . . 0.0 111.822 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -106.86 132.83 52.37 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.49 60.84 0.6 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.926 -1.109 . . . . 0.0 111.128 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 76' ' ' VAL . . . . . 0.541 HG22 ' HD3' ' B' ' 78' ' ' PRO . 4.6 p -136.51 151.24 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.9 -1.125 . . . . 0.0 110.251 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 77' ' ' PHE . . . . . 0.494 ' O ' ' CG ' ' B' ' 77' ' ' PHE . 9.1 p90 -144.98 71.65 14.84 Favored Pre-proline 0 C--N 1.303 -1.444 0 O-C-N 121.204 -0.935 . . . . 0.0 109.99 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . 0.541 ' HD3' HG22 ' B' ' 76' ' ' VAL . 41.0 Cg_endo -64.71 -14.38 44.39 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.088 1.573 . . . . 0.0 110.422 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -116.89 167.24 11.3 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.191 -0.943 . . . . 0.0 110.408 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.77 167.66 16.9 Favored Pre-proline 0 C--N 1.3 -1.554 0 O-C-N 121.707 -0.621 . . . . 0.0 109.387 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 81' ' ' PRO . . . . . 0.418 ' HB2' ' O ' ' B' ' 25' ' ' PRO . 42.7 Cg_endo -65.94 148.41 85.94 Favored 'Trans proline' 0 C--N 1.297 -2.165 0 O-C-N 123.946 1.498 . . . . 0.0 110.391 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 62.47 43.18 99.4 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 15.9 t -149.32 138.73 21.57 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.196 -1.179 . . . . 0.0 110.043 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.409 ' H ' HG22 ' B' ' 84' ' ' VAL . 15.4 m -79.1 140.08 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.136 -0.978 . . . . 0.0 109.156 178.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.71 154.13 39.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.063 -1.023 . . . . 0.0 109.81 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -123.29 152.66 41.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.049 -1.032 . . . . 0.0 109.993 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . 0.43 HG12 HG13 ' B' ' 89' ' ' ILE . 46.9 t -128.4 138.52 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.399 -0.813 . . . . 0.0 111.457 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 88' ' ' CYS . . . . . 0.435 ' HB3' ' HB2' ' B' ' 99' ' ' LYS . 4.7 t -113.49 114.73 26.95 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.422 -0.799 . . . . 0.0 109.845 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.43 HG13 HG12 ' B' ' 87' ' ' VAL . 87.1 mt -120.69 128.42 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.252 -0.905 . . . . 0.0 110.0 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 90' ' ' THR . . . . . 0.512 ' HB ' ' HB ' ' B' ' 97' ' ' THR . 27.8 m -123.09 134.94 54.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.222 -0.924 . . . . 0.0 109.628 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 91' ' ' PHE . . . . . 0.491 ' CE1' HD21 ' B' ' 96' ' ' LEU . 79.4 t80 -104.84 117.35 33.82 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.326 -0.858 . . . . 0.0 110.246 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -112.17 143.57 43.0 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.058 -1.026 . . . . 0.0 109.402 178.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 72.5 tp60 -60.69 -25.11 66.15 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.533 -0.729 . . . . 0.0 110.833 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.07 -22.35 21.86 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.973 -1.079 . . . . 0.0 111.499 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 45.6 p30 -174.39 -172.5 0.68 Allowed 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.163 -0.961 . . . . 0.0 108.947 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 96' ' ' LEU . . . . . 1.027 HD13 HD21 ' B' ' 43' ' ' LEU . 74.9 mt -121.72 134.93 54.95 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 120.993 -1.067 . . . . 0.0 110.697 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 97' ' ' THR . . . . . 0.512 ' HB ' ' HB ' ' B' ' 90' ' ' THR . 32.9 m -109.4 123.14 48.84 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.233 -0.917 . . . . 0.0 108.989 178.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 46.3 t -125.19 128.37 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.852 -1.155 . . . . 0.0 109.588 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 99' ' ' LYS . . . . . 0.435 ' HB2' ' HB3' ' B' ' 88' ' ' CYS . 98.5 mttt -122.89 146.27 47.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.179 -0.951 . . . . 0.0 110.899 -178.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 100' ' ' LEU . . . . . 0.434 HD13 ' HG3' ' B' ' 78' ' ' PRO . 25.0 mt -105.5 166.67 10.95 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -63.16 -25.43 72.72 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.239 1.126 . . . . 0.0 110.945 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 102' ' ' ASP . . . . . 0.468 ' HB2' ' CB ' ' B' ' 78' ' ' PRO . 36.3 t70 -74.42 -11.94 60.37 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.947 -1.096 . . . . 0.0 110.94 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 106.08 -8.5 42.07 Favored Glycine 0 N--CA 1.493 2.475 0 C-N-CA 119.887 -1.149 . . . . 0.0 110.683 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 104' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -72.3 136.48 46.25 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.933 -1.334 . . . . 0.0 110.25 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 105' ' ' GLU . . . . . 0.432 ' OE2' HG23 ' B' ' 97' ' ' THR . 71.4 tt0 -125.62 142.28 51.59 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.057 -1.027 . . . . 0.0 110.527 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -133.35 146.14 51.02 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.507 -0.746 . . . . 0.0 109.163 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 107' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' B' ' 96' ' ' LEU . 98.1 mttt -122.06 146.13 47.49 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.768 -1.208 . . . . 0.0 112.812 -178.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 108' ' ' PHE . . . . . 0.541 ' HB2' ' HB2' ' B' ' 96' ' ' LEU . 98.0 m-85 -117.09 150.28 45.78 Favored Pre-proline 0 N--CA 1.492 1.671 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.85 148.52 64.66 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.593 1.312 . . . . 0.0 111.261 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 110' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -69.77 62.85 0.19 Allowed 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.586 -0.696 . . . . 0.0 111.621 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 79.3 mtp85 -65.41 -39.78 92.58 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.919 -1.113 . . . . 0.0 110.277 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 112' ' ' LEU . . . . . 0.559 HD11 ' HB2' ' B' ' 64' ' ' ASP . 4.5 mm? -95.87 130.01 42.95 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.18 -0.95 . . . . 0.0 110.702 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -87.38 7.4 29.12 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.643 -0.66 . . . . 0.0 111.069 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 114' ' ' LEU . . . . . 0.484 HD23 ' O ' ' B' ' 114' ' ' LEU . 3.5 tt -58.07 129.2 40.85 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.053 -1.029 . . . . 0.0 109.239 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -106.65 -5.56 18.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.559 -0.713 . . . . 0.0 111.36 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 116' ' ' ALA . . . . . 0.443 ' HA ' ' O ' ' B' ' 11' ' ' LEU . . . -137.82 132.32 32.44 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.74 -1.225 . . . . 0.0 110.418 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 117' ' ' ILE . . . . . 0.479 ' O ' ' HA ' ' B' ' 10' ' ' ASN . 95.9 mt -111.72 128.71 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.927 -1.108 . . . . 0.0 110.269 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -126.1 -28.52 3.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.138 -0.976 . . . . 0.0 111.818 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 119' ' ' TYR . . . . . 0.451 ' CD1' ' O ' ' B' ' 37' ' ' ASP . 66.6 t80 -91.96 127.31 37.38 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.882 -1.136 . . . . 0.0 110.346 -179.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 120' ' ' MET . . . . . 0.425 ' HB3' ' CD1' ' B' ' 9' ' ' LEU . 26.5 ttm -142.0 134.26 27.79 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.115 -0.991 . . . . 0.0 109.592 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 121' ' ' ALA . . . . . 0.469 ' HB3' HD21 ' B' ' 33' ' ' ASN . . . -158.89 147.71 18.53 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.101 -0.999 . . . . 0.0 109.448 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 122' ' ' ALA . . . . . 0.491 ' O ' ' HA3' ' B' ' 3' ' ' GLY . . . -147.14 155.0 41.78 Favored 'General case' 0 C--N 1.29 -1.995 0 O-C-N 121.472 -0.768 . . . . 0.0 108.975 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 123' ' ' ASP . . . . . 0.405 ' HA ' ' O ' ' B' ' 2' ' ' CYS . 9.6 p-10 -154.51 156.53 36.84 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 124' ' ' GLY . . . . . 0.527 ' HA3' ' HA ' ' B' ' 30' ' ' PHE . . . 148.93 -157.17 27.16 Favored Glycine 0 C--N 1.296 -1.693 0 C-N-CA 118.382 -1.866 . . . . 0.0 110.149 178.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . 0.483 ' CB ' ' HA ' ' B' ' 27' ' ' ALA . 63.1 m-20 -91.55 12.1 21.98 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 122.015 -0.697 . . . . 0.0 110.383 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 126' ' ' PHE . . . . . 0.649 ' CD1' HG22 ' B' ' 23' ' ' VAL . 11.5 t80 -108.58 151.4 26.17 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.668 -1.27 . . . . 0.0 110.402 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -121.23 124.57 44.97 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.268 -0.895 . . . . 0.0 110.356 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . 0.483 ' CD1' HG13 ' B' ' 19' ' ' VAL . 18.0 tt -101.86 127.3 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.156 -0.965 . . . . 0.0 110.39 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 29.1 pttt -119.11 -4.3 10.56 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.783 -1.198 . . . . 0.0 111.126 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 130' ' ' CYS . . . . . 0.441 ' HA ' ' O ' ' A' ' 131' ' ' VAL . 0.0 OUTLIER -154.29 130.96 10.71 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 118.947 -1.101 . . . . 0.0 111.91 -179.084 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 130' ' ' CYS . 54.7 t -128.05 133.85 66.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.659 -0.651 . . . . 0.0 109.956 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 132' ' ' ALA . . . . . . . . . . . . . . . -141.45 142.87 33.64 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 120.249 -1.532 . . . . 0.0 110.395 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . 0.576 ' CZ ' HD12 ' B' ' 11' ' ' LEU . 3.0 m-85 -76.19 -88.56 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.096 -1.002 . . . . 0.0 111.084 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 48.4 t0 . . . . . 0 C--N 1.296 -1.749 0 CA-C-O 118.096 -0.954 . . . . 0.0 110.356 -179.388 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.472 ' HA3' ' HB3' ' A' ' 123' ' ' ASP . . . . . . . . 0 N--CA 1.497 2.704 0 CA-C-O 121.851 0.695 . . . . 0.0 112.271 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.933 HD12 HG23 ' A' ' 128' ' ' ILE . 84.2 mt -63.76 137.12 57.93 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.627 -1.514 . . . . 0.0 109.25 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.6 t -110.07 132.46 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.364 -0.835 . . . . 0.0 109.804 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -134.82 161.33 35.51 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.845 -1.16 . . . . 0.0 110.112 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.455 ' O ' ' HB3' ' A' ' 8' ' ' ASN . 15.2 p -153.38 169.95 21.86 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.539 -0.726 . . . . 0.0 109.999 -178.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.455 ' HB3' ' O ' ' A' ' 7' ' ' SER . 57.2 t30 65.74 39.08 4.94 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.263 0.554 . . . . 0.0 109.683 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 11' ' ' LEU . 85.7 mt -104.95 32.41 4.2 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.385 -0.822 . . . . 0.0 109.83 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -40.59 93.87 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.275 0 O-C-N 121.603 -0.686 . . . . 0.0 111.666 -178.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.582 HD11 ' OE1' ' A' ' 15' ' ' GLU . 0.2 OUTLIER -114.77 131.23 56.86 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.347 179.304 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.0 mttt -97.65 171.9 5.46 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.528 -0.733 . . . . 0.0 111.007 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -67.79 150.42 78.88 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 O-C-N 123.911 1.48 . . . . 0.0 110.095 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.59 -15.03 35.22 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.582 ' OE1' HD11 ' A' ' 11' ' ' LEU . 90.3 mt-10 -114.51 150.11 35.38 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.802 -1.41 . . . . 0.0 109.75 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 45.8 t -109.78 145.45 36.64 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.199 -0.938 . . . . 0.0 110.337 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.849 HD12 ' O ' ' A' ' 132' ' ' ALA . 48.1 tp -112.48 134.17 54.16 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -121.86 129.55 52.68 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.934 -1.104 . . . . 0.0 110.108 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.481 HG13 HG13 ' A' ' 128' ' ' ILE . 65.2 t -126.28 127.7 70.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.161 -0.962 . . . . 0.0 111.02 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.448 ' HG3' ' HG2' ' A' ' 86' ' ' GLU . 70.3 ttt180 -107.27 122.12 45.91 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 177.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' A' ' 127' ' ' LYS . . . -135.14 -178.57 15.77 Favored Glycine 0 N--CA 1.487 2.083 0 C-N-CA 118.939 -1.601 . . . . 0.0 111.661 -177.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -126.07 140.53 52.51 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 122.028 -0.689 . . . . 0.0 110.321 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.4 t -101.75 126.88 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.501 -0.749 . . . . 0.0 109.812 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.06 154.82 37.24 Favored Pre-proline 0 N--CA 1.497 1.922 0 O-C-N 120.989 -1.069 . . . . 0.0 110.48 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -67.45 -18.39 49.35 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 124.026 1.54 . . . . 0.0 111.208 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -119.77 52.23 1.12 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.924 -1.11 . . . . 0.0 108.69 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.21 153.01 32.32 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.575 0.702 . . . . 0.0 112.215 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.402 ' N ' ' OD2' ' A' ' 125' ' ' ASP . 98.1 mttt -137.85 -39.66 0.56 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.539 -0.726 . . . . 0.0 109.953 179.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 40.1 p -161.58 160.0 28.37 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.967 -1.083 . . . . 0.0 111.756 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.477 ' HA ' ' HA3' ' A' ' 124' ' ' GLY . 67.3 t80 -153.86 150.82 28.81 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.49 -0.756 . . . . 0.0 109.878 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 45' ' ' PHE . 11.4 p -134.75 150.5 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.047 -1.033 . . . . 0.0 110.94 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.439 HD12 ' HB3' ' A' ' 45' ' ' PHE . 78.2 mt -118.2 147.22 43.6 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.487 -0.758 . . . . 0.0 108.995 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.572 ' OD1' HD22 ' A' ' 41' ' ' LEU . 62.9 t30 -143.25 108.54 5.02 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.015 -1.074 . . . . 0.0 111.004 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.639 HD11 ' HB3' ' A' ' 43' ' ' LEU . 0.5 OUTLIER -131.14 121.28 24.63 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.401 -0.812 . . . . 0.0 109.494 179.254 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.463 ' HA3' ' HA ' ' A' ' 41' ' ' LEU . . . -168.54 -171.5 34.44 Favored Glycine 0 N--CA 1.484 1.843 0 C-N-CA 118.652 -1.737 . . . . 0.0 109.977 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.463 ' HD2' HD13 ' A' ' 114' ' ' LEU . 34.9 mtpt -65.85 -41.52 91.58 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 122.284 1.04 . . . . 0.0 108.53 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.16 -167.33 2.17 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.851 0.834 . . . . 0.0 111.825 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.3 t -57.67 -41.98 82.66 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.636 -0.665 . . . . 0.0 112.766 -177.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -99.92 -7.34 25.35 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.234 -1.541 . . . . 0.0 110.663 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.425 ' HB2' ' HB2' ' A' ' 36' ' ' LYS . 7.1 m-80 -105.03 73.11 1.03 Allowed 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.032 -1.043 . . . . 0.0 109.096 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.572 HD22 ' OD1' ' A' ' 33' ' ' ASN . 60.1 mt -101.68 127.45 48.43 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.332 0.587 . . . . 0.0 110.362 -178.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 3.3 t -84.59 -43.91 14.02 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.123 -0.985 . . . . 0.0 110.488 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.719 HD22 HD21 ' A' ' 96' ' ' LEU . 20.4 tp -129.41 133.79 47.53 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.219 -0.926 . . . . 0.0 110.584 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.414 ' O ' ' HA ' ' A' ' 60' ' ' CYS . 9.3 t60 -126.73 112.77 15.8 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.556 ' CD2' ' HD3' ' A' ' 47' ' ' PRO . 43.2 t80 -111.71 115.77 29.63 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.822 -1.173 . . . . 0.0 110.481 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.402 ' ND2' ' HB ' ' A' ' 31' ' ' VAL . 0.2 OUTLIER -130.45 73.76 80.91 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.348 -0.845 . . . . 0.0 111.601 -179.34 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.556 ' HD3' ' CD2' ' A' ' 45' ' ' PHE . 43.5 Cg_endo -66.5 143.05 67.63 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.416 1.219 . . . . 0.0 109.52 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -137.63 126.32 23.8 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.912 -1.117 . . . . 0.0 110.847 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -72.21 -60.1 2.4 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.113 -0.992 . . . . 0.0 110.005 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -115.47 121.68 43.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.282 -0.886 . . . . 0.0 109.335 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.59 -162.46 0.96 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.838 -1.164 . . . . 0.0 111.123 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -83.45 8.92 12.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.404 -0.81 . . . . 0.0 110.165 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 173.76 -34.07 0.11 Allowed Glycine 0 N--CA 1.487 2.095 0 N-CA-C 108.589 -1.804 . . . . 0.0 108.589 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -80.85 -178.59 6.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.235 -1.156 . . . . 0.0 110.14 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.426 ' O ' ' C ' ' A' ' 56' ' ' ASN . . . -131.18 140.34 49.9 Favored 'General case' 0 C--N 1.293 -1.855 0 O-C-N 121.871 -0.518 . . . . 0.0 110.042 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.426 ' C ' ' O ' ' A' ' 55' ' ' ALA . 3.2 m120 27.81 73.52 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 179.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 96.2 m -127.51 131.18 50.14 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.913 -1.117 . . . . 0.0 110.526 178.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.527 ' HB ' ' HB3' ' A' ' 74' ' ' GLU . 82.4 mt -103.56 129.03 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.894 -0.504 . . . . 0.0 110.656 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 24.6 t -110.84 128.99 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.329 -0.857 . . . . 0.0 109.494 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 44' ' ' HIS . 1.8 t -127.74 131.24 49.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.474 -0.766 . . . . 0.0 110.376 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.402 ' O ' ' CB ' ' A' ' 44' ' ' HIS . 1.5 p-10 -151.19 172.42 15.85 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.973 -1.079 . . . . 0.0 109.835 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.469 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 59.2 p -136.04 153.26 51.4 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.209 -0.932 . . . . 0.0 109.785 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.527 ' CD ' ' HA2' ' A' ' 66' ' ' GLY . 10.0 ttmt -133.29 145.79 50.79 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 120.692 -1.255 . . . . 0.0 111.876 -178.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.504 ' OD2' HD22 ' A' ' 112' ' ' LEU . 30.2 t0 -123.85 107.79 11.77 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.182 -0.949 . . . . 0.0 109.407 178.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 59.2 29.24 65.39 Favored Glycine 0 N--CA 1.485 1.91 0 C-N-CA 119.357 -1.401 . . . . 0.0 110.05 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.527 ' HA2' ' CD ' ' A' ' 63' ' ' LYS . . . 62.41 26.25 67.83 Favored Glycine 0 N--CA 1.488 2.108 0 O-C-N 120.997 -1.296 . . . . 0.0 110.621 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -89.98 -75.12 0.46 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.969 -1.312 . . . . 0.0 110.466 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 43.7 m95 -122.83 -170.46 2.1 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.792 -1.193 . . . . 0.0 110.777 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.469 ' HA2' ' O ' ' A' ' 62' ' ' SER . . . 173.49 114.62 0.35 Allowed Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.408 -1.377 . . . . 0.0 110.555 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 52.9 m -77.2 121.01 23.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.382 -1.069 . . . . 0.0 110.452 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -101.63 123.52 45.78 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.146 -0.971 . . . . 0.0 110.486 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -115.88 -170.27 1.76 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.826 -1.171 . . . . 0.0 110.378 179.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 47.3 ttp180 -144.4 116.4 8.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.952 -1.092 . . . . 0.0 111.587 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.527 ' HB3' ' HB ' ' A' ' 58' ' ' ILE . 77.5 tt0 -103.12 139.45 38.62 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.253 -0.904 . . . . 0.0 110.128 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.72 38.7 2.29 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.927 -1.108 . . . . 0.0 111.712 -179.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.463 ' O ' ' CD1' ' A' ' 58' ' ' ILE . 48.1 t -132.47 130.29 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.622 -1.299 . . . . 0.0 111.625 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -159.21 96.16 1.69 Allowed Pre-proline 0 N--CA 1.5 2.05 0 O-C-N 120.904 -1.122 . . . . 0.0 110.79 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -81.49 45.91 2.1 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.998 1.525 . . . . 0.0 111.7 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -128.85 152.8 48.1 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.615 -1.303 . . . . 0.0 111.725 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 15.4 mp0 -135.87 160.21 68.27 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.688 -0.632 . . . . 0.0 109.682 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -66.22 145.48 78.44 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.855 1.45 . . . . 0.0 110.79 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 64.5 40.25 97.52 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.1 p -133.54 148.77 51.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.976 -1.308 . . . . 0.0 111.627 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.6 p -101.26 136.47 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.505 -0.747 . . . . 0.0 109.233 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -153.91 155.07 35.0 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.121 -0.987 . . . . 0.0 110.368 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.448 ' HG2' ' HG3' ' A' ' 20' ' ' ARG . 99.0 mt-10 -119.36 139.18 52.4 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.896 -1.128 . . . . 0.0 110.597 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.6 t -125.95 132.68 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.411 -0.805 . . . . 0.0 110.68 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 77.8 m -107.77 134.41 50.77 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.176 -0.953 . . . . 0.0 109.107 179.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 89.1 mt -121.22 127.93 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.747 -1.221 . . . . 0.0 111.019 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.409 ' O ' HD12 ' A' ' 96' ' ' LEU . 45.6 m -129.35 128.97 44.18 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.302 -0.874 . . . . 0.0 109.972 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.587 ' HA ' HD12 ' A' ' 96' ' ' LEU . 42.4 t80 -112.43 127.38 56.02 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.104 -0.997 . . . . 0.0 111.868 -179.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 95' ' ' ASN . 88.8 m-20 -119.09 156.02 30.48 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.496 -0.752 . . . . 0.0 109.911 179.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 -60.95 -23.88 65.65 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.454 -0.779 . . . . 0.0 112.73 -178.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -105.36 -26.54 11.93 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.436 -1.415 . . . . 0.0 110.428 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.409 ' O ' ' HB2' ' A' ' 92' ' ' ASP . 34.5 m-20 -152.57 172.61 16.33 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 119.069 -1.052 . . . . 0.0 111.866 -179.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.719 HD21 HD22 ' A' ' 43' ' ' LEU . 54.6 tp -119.13 129.42 55.02 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.798 HG23 ' OE2' ' A' ' 105' ' ' GLU . 17.4 m -114.58 125.25 53.56 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 120.781 -1.199 . . . . 0.0 111.115 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 43.3 t -120.18 127.93 75.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 88' ' ' CYS . 88.2 tttt -114.42 119.24 36.22 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 118.589 -1.244 . . . . 0.0 109.774 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.0 mp -100.35 170.7 6.34 Favored Pre-proline 0 C--N 1.298 -1.645 0 O-C-N 121.91 -0.494 . . . . 0.0 109.755 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.05 -22.13 62.53 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 O-C-N 123.893 1.47 . . . . 0.0 111.122 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -66.04 -34.24 77.64 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.805 -1.185 . . . . 0.0 109.787 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 112.4 -27.0 10.41 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -73.22 145.23 46.37 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.145 -1.209 . . . . 0.0 109.381 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.798 ' OE2' HG23 ' A' ' 97' ' ' THR . 68.9 tt0 -113.64 143.33 44.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.844 -1.16 . . . . 0.0 111.022 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -120.44 147.86 44.55 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 98.2 mttt -120.77 145.11 47.88 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.01 -1.076 . . . . 0.0 111.555 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.463 ' HB3' HD23 ' A' ' 96' ' ' LEU . 15.0 t80 -125.55 129.59 24.35 Favored Pre-proline 0 C--N 1.293 -1.885 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -64.73 140.78 69.31 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 O-C-N 123.02 1.01 . . . . 0.0 109.965 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.51 ' ND2' ' O ' ' A' ' 110' ' ' ASN . 4.1 p-10 -92.02 82.4 5.1 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.023 -1.048 . . . . 0.0 109.473 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -54.72 -27.39 40.37 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.536 -1.353 . . . . 0.0 109.224 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.504 HD22 ' OD2' ' A' ' 64' ' ' ASP . 83.4 mt -104.65 132.33 51.02 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.338 -0.851 . . . . 0.0 109.851 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -87.7 61.06 6.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.009 -1.057 . . . . 0.0 110.415 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.463 HD13 ' HD2' ' A' ' 36' ' ' LYS . 52.0 tp -80.84 129.67 34.65 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.358 -0.839 . . . . 0.0 109.537 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -87.27 -12.36 46.86 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.162 -0.962 . . . . 0.0 111.549 -178.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 11' ' ' LEU . . . -160.23 158.45 29.99 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.794 -1.191 . . . . 0.0 111.661 -178.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 49.9 mm -109.41 126.06 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.525 -0.734 . . . . 0.0 109.891 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -112.09 -26.65 8.74 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.566 -1.334 . . . . 0.0 110.787 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.483 ' O ' ' HA ' ' A' ' 34' ' ' LEU . 10.5 t80 -110.21 126.26 53.95 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.229 -0.92 . . . . 0.0 110.401 -179.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.402 ' CB ' HD12 ' A' ' 9' ' ' LEU . 50.0 ttp -132.98 130.66 39.8 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.5 142.24 21.0 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.026 -1.046 . . . . 0.0 110.521 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.446 ' O ' ' CA ' ' A' ' 3' ' ' GLY . . . -148.02 132.03 17.22 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.35 -0.844 . . . . 0.0 111.391 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.472 ' HB3' ' HA3' ' A' ' 3' ' ' GLY . 15.2 p-10 -148.46 147.6 29.33 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.358 -0.839 . . . . 0.0 110.483 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.477 ' HA3' ' HA ' ' A' ' 30' ' ' PHE . . . 155.79 -145.44 12.34 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.402 ' OD2' ' N ' ' A' ' 28' ' ' LYS . 88.2 m-20 -94.31 11.46 30.31 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.288 -1.125 . . . . 0.0 111.544 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.445 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 24.7 t80 -112.87 143.74 43.62 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.964 -1.085 . . . . 0.0 109.319 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.47 ' O ' ' HA3' ' A' ' 21' ' ' GLY . 51.8 mttp -117.01 140.99 48.82 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.891 -1.131 . . . . 0.0 111.359 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.933 HG23 HD12 ' A' ' 4' ' ' LEU . 4.1 tt -111.57 122.41 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -101.55 -9.94 20.55 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.021 -1.049 . . . . 0.0 112.384 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -158.14 150.12 21.78 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.224 -1.547 . . . . 0.0 112.004 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.427 HG22 HD11 ' A' ' 128' ' ' ILE . 47.9 t -128.86 133.48 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.849 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -136.38 133.1 36.4 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.715 -1.241 . . . . 0.0 111.302 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.51 ' CE1' HD13 ' A' ' 17' ' ' LEU . 47.7 m-85 -110.9 148.22 32.93 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.402 -0.811 . . . . 0.0 111.313 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.409 ' CB ' ' HB3' ' A' ' 15' ' ' GLU . 47.1 t0 . . . . . 0 N--CA 1.496 1.873 0 CA-C-O 118.114 -0.946 . . . . 0.0 111.186 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 1' ' ' ALA . . . . . 0.562 ' HB2' ' HE3' ' B' ' 127' ' ' LYS . . . . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 121.341 0.591 . . . . 0.0 110.441 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 2' ' ' CYS . . . . . 0.512 ' O ' ' O ' ' B' ' 3' ' ' GLY . 1.3 m -96.95 54.88 1.29 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.023 -1.048 . . . . 0.0 110.664 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' GLY . . . . . 0.512 ' O ' ' O ' ' B' ' 2' ' ' CYS . . . 42.43 111.3 0.0 OUTLIER Glycine 0 N--CA 1.497 2.717 0 CA-C-O 121.891 0.717 . . . . 0.0 112.308 178.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.971 HD12 HG23 ' B' ' 128' ' ' ILE . 86.2 mt -63.78 136.99 57.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.571 -1.547 . . . . 0.0 109.458 178.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 37.5 t -109.72 132.35 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.454 -0.779 . . . . 0.0 109.861 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -134.7 161.12 36.05 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.766 -1.209 . . . . 0.0 110.214 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' SER . . . . . 0.469 ' O ' ' HB3' ' B' ' 8' ' ' ASN . 15.8 p -153.2 170.37 20.71 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.293 -0.879 . . . . 0.0 110.038 -178.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . 0.469 ' HB3' ' O ' ' B' ' 7' ' ' SER . 57.2 t30 65.43 39.05 5.36 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.241 0.543 . . . . 0.0 109.756 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' B' ' 11' ' ' LEU . 82.6 mt -104.62 32.27 4.2 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.345 -0.847 . . . . 0.0 109.8 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 -40.24 93.97 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.495 -0.753 . . . . 0.0 111.708 -178.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.586 HD11 ' OE1' ' B' ' 15' ' ' GLU . 0.2 OUTLIER -115.01 131.05 57.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.649 -0.657 . . . . 0.0 110.286 179.603 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -97.75 172.54 4.79 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.506 -0.746 . . . . 0.0 110.765 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.25 150.69 76.75 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 O-C-N 123.95 1.5 . . . . 0.0 110.392 178.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.3 -14.98 36.2 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . 0.586 ' OE1' HD11 ' B' ' 11' ' ' LEU . 90.4 mt-10 -114.37 150.25 34.89 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.822 -1.399 . . . . 0.0 109.668 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' CYS . . . . . . . . . . . . . 52.3 t -109.89 145.62 36.52 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.129 -0.982 . . . . 0.0 110.036 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.843 HD12 ' O ' ' B' ' 132' ' ' ALA . 46.3 tp -112.75 133.92 54.52 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -121.74 129.23 52.55 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.937 -1.102 . . . . 0.0 109.982 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.475 HG13 HG13 ' B' ' 128' ' ' ILE . 61.6 t -125.54 127.2 71.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.32 -0.862 . . . . 0.0 111.122 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.459 ' HG3' ' HG2' ' B' ' 86' ' ' GLU . 70.2 ttt180 -107.02 122.13 45.84 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.475 ' HA3' ' O ' ' B' ' 127' ' ' LYS . . . -135.17 -177.83 15.24 Favored Glycine 0 N--CA 1.484 1.842 0 C-N-CA 118.881 -1.628 . . . . 0.0 111.562 -177.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -126.66 140.76 52.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.697 -0.884 . . . . 0.0 110.203 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 6.4 t -101.92 127.39 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.293 -0.88 . . . . 0.0 109.846 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.35 155.51 36.02 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 120.953 -1.092 . . . . 0.0 110.588 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.77 -18.4 47.51 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 O-C-N 124.122 1.591 . . . . 0.0 111.113 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -119.88 52.62 1.11 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.023 -1.048 . . . . 0.0 108.8 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . 0.409 ' HA ' ' HB3' ' B' ' 125' ' ' ASP . . . -78.59 152.31 31.89 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.585 0.707 . . . . 0.0 112.144 -178.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . 0.403 ' N ' ' OD2' ' B' ' 125' ' ' ASP . 98.0 mttt -137.12 -40.66 0.59 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.671 -0.643 . . . . 0.0 110.105 178.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 35.8 p -160.14 160.9 33.49 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.871 -1.143 . . . . 0.0 111.321 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' PHE . . . . . 0.492 ' HA ' ' HA3' ' B' ' 124' ' ' GLY . 64.8 t80 -154.58 150.52 27.82 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.278 -0.889 . . . . 0.0 109.623 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' B' ' 45' ' ' PHE . 11.5 p -134.41 150.97 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 120.781 -1.2 . . . . 0.0 110.974 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.471 HD12 ' HB3' ' B' ' 45' ' ' PHE . 76.5 mt -118.09 147.12 43.59 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' ASN . . . . . 0.571 ' OD1' HD22 ' B' ' 41' ' ' LEU . 63.2 t30 -143.14 108.11 4.93 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 120.834 -1.166 . . . . 0.0 110.974 -179.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.648 HD11 ' HB3' ' B' ' 43' ' ' LEU . 0.5 OUTLIER -131.29 116.35 17.5 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.283 -0.885 . . . . 0.0 109.835 179.546 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . 0.473 ' HA3' ' HA ' ' B' ' 41' ' ' LEU . . . -161.63 -169.93 25.62 Favored Glycine 0 N--CA 1.485 1.919 0 C-N-CA 118.53 -1.795 . . . . 0.0 110.494 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . 0.487 ' HD2' HD13 ' B' ' 114' ' ' LEU . 36.1 mtpt -66.69 -42.26 86.75 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -156.62 -167.06 2.28 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.75 0.786 . . . . 0.0 111.778 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 38.6 t -57.83 -41.9 83.24 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -100.31 -7.27 24.72 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 120.394 -1.441 . . . . 0.0 110.564 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' ASN . . . . . 0.407 ' HB2' ' HB2' ' B' ' 36' ' ' LYS . 7.3 m-80 -104.92 72.18 1.0 Allowed 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.903 -1.123 . . . . 0.0 109.129 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.571 HD22 ' OD1' ' B' ' 33' ' ' ASN . 60.1 mt -100.32 130.13 46.39 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.231 0.539 . . . . 0.0 110.031 -178.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' CYS . . . . . . . . . . . . . 2.1 t -88.63 -42.58 11.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.066 -1.021 . . . . 0.0 109.919 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.708 HD22 HD21 ' B' ' 96' ' ' LEU . 19.7 tp -129.76 133.91 47.29 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.144 -0.972 . . . . 0.0 110.456 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' HIS . . . . . 0.409 ' O ' ' HA ' ' B' ' 60' ' ' CYS . 9.0 t60 -127.27 112.75 15.44 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.553 ' CD2' ' HD3' ' B' ' 47' ' ' PRO . 43.3 t80 -111.69 115.25 28.79 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.133 -0.979 . . . . 0.0 110.436 -179.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -129.84 73.42 81.47 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 121.372 -0.83 . . . . 0.0 111.413 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' PRO . . . . . 0.553 ' HD3' ' CD2' ' B' ' 45' ' ' PHE . 41.4 Cg_endo -66.24 143.03 69.24 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.263 1.138 . . . . 0.0 109.259 179.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -137.9 126.63 23.78 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.91 -1.119 . . . . 0.0 110.713 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -72.59 -60.97 1.97 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.137 -0.977 . . . . 0.0 109.988 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -114.54 120.99 42.08 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.488 -0.758 . . . . 0.0 109.25 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.09 -162.11 0.92 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.84 -1.162 . . . . 0.0 111.32 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -84.18 11.42 8.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.433 -0.792 . . . . 0.0 110.122 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 170.42 -33.48 0.16 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -81.45 -178.55 6.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.013 -1.286 . . . . 0.0 110.029 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.473 ' O ' ' C ' ' B' ' 56' ' ' ASN . . . -129.6 146.91 51.36 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' ASN . . . . . 0.473 ' C ' ' O ' ' B' ' 55' ' ' ALA . 3.3 m120 17.53 77.36 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.175 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -179.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 97.0 m -128.1 130.86 48.84 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.236 -0.915 . . . . 0.0 110.328 178.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' ILE . . . . . 0.468 ' HB ' ' HB3' ' B' ' 74' ' ' GLU . 82.7 mt -104.01 129.24 56.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 121.775 -0.578 . . . . 0.0 110.818 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 25.0 t -110.29 129.17 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.193 -0.942 . . . . 0.0 109.899 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' CYS . . . . . 0.409 ' HA ' ' O ' ' B' ' 44' ' ' HIS . 1.7 t -127.98 129.6 47.02 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.661 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' ASN . . . . . 0.409 ' O ' ' HB3' ' B' ' 44' ' ' HIS . 1.5 p-10 -149.69 171.75 16.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.151 -0.968 . . . . 0.0 110.194 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' SER . . . . . 0.46 ' O ' ' HA2' ' B' ' 69' ' ' GLY . 60.5 p -135.47 153.61 51.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.243 -0.91 . . . . 0.0 109.56 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . 0.521 ' CD ' ' HA2' ' B' ' 66' ' ' GLY . 10.1 ttmt -132.93 145.9 51.31 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 120.703 -1.248 . . . . 0.0 111.701 -178.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' ASP . . . . . 0.517 ' OD2' HD22 ' B' ' 112' ' ' LEU . 30.4 t0 -123.83 107.48 11.44 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.212 -0.93 . . . . 0.0 109.263 178.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 59.64 28.74 65.78 Favored Glycine 0 N--CA 1.484 1.878 0 C-N-CA 119.576 -1.297 . . . . 0.0 110.15 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . 0.521 ' HA2' ' CD ' ' B' ' 63' ' ' LYS . . . 62.84 25.83 68.12 Favored Glycine 0 N--CA 1.488 2.105 0 O-C-N 120.872 -1.369 . . . . 0.0 110.575 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' ALA . . . . . 0.411 ' HB1' ' CD1' ' B' ' 68' ' ' TRP . . . -89.48 -75.65 0.44 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.835 -1.391 . . . . 0.0 110.236 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' TRP . . . . . 0.411 ' CD1' ' HB1' ' B' ' 67' ' ' ALA . 43.6 m95 -122.46 -166.29 1.4 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.871 -1.143 . . . . 0.0 110.985 -178.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' B' ' 62' ' ' SER . . . 167.87 114.33 0.3 Allowed Glycine 0 N--CA 1.486 2.032 0 C-N-CA 119.359 -1.4 . . . . 0.0 110.546 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 43.2 m -77.31 120.87 22.93 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.946 -0.738 . . . . 0.0 110.531 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -101.29 123.73 45.86 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.266 -0.896 . . . . 0.0 110.396 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -116.03 -171.05 1.91 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.84 -1.163 . . . . 0.0 110.295 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 47.7 ttp180 -143.78 116.02 8.47 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.205 -0.934 . . . . 0.0 111.42 -178.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 74' ' ' GLU . . . . . 0.468 ' HB3' ' HB ' ' B' ' 58' ' ' ILE . 78.1 tt0 -102.98 139.25 38.78 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.215 -0.928 . . . . 0.0 110.035 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.82 39.43 2.13 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.951 -1.093 . . . . 0.0 111.461 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 76' ' ' VAL . . . . . 0.46 ' O ' ' CD1' ' B' ' 58' ' ' ILE . 48.9 t -132.97 129.9 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 120.919 -1.113 . . . . 0.0 111.738 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -159.05 96.43 1.71 Allowed Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 120.922 -1.112 . . . . 0.0 110.809 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -81.66 46.6 2.28 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.925 1.487 . . . . 0.0 111.53 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -129.58 153.06 48.42 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.719 -1.238 . . . . 0.0 111.502 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 15.4 mp0 -136.41 160.5 66.57 Favored Pre-proline 0 N--CA 1.486 1.374 0 O-C-N 121.666 -0.646 . . . . 0.0 109.467 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 81' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -66.68 145.15 74.74 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.75 1.395 . . . . 0.0 110.958 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 64.78 39.95 97.0 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 12.7 p -132.77 147.78 52.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.011 -1.288 . . . . 0.0 111.913 -178.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 12.7 p -100.15 136.64 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.438 -0.789 . . . . 0.0 109.408 178.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -154.02 155.43 35.52 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.051 -1.031 . . . . 0.0 110.171 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 86' ' ' GLU . . . . . 0.459 ' HG2' ' HG3' ' B' ' 20' ' ' ARG . 98.3 mt-10 -119.67 139.07 52.81 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.856 -1.153 . . . . 0.0 110.499 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 55.9 t -125.62 132.78 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.517 -0.739 . . . . 0.0 110.601 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 88' ' ' CYS . . . . . 0.419 ' HB2' ' HB3' ' B' ' 99' ' ' LYS . 75.1 m -107.57 134.98 49.79 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.166 -0.959 . . . . 0.0 109.355 178.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 87.2 mt -121.59 128.26 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.882 -1.136 . . . . 0.0 110.958 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 90' ' ' THR . . . . . 0.415 ' O ' HD12 ' B' ' 96' ' ' LEU . 50.1 m -129.08 128.83 44.34 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.28 -0.887 . . . . 0.0 109.914 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 91' ' ' PHE . . . . . 0.568 ' HA ' HD12 ' B' ' 96' ' ' LEU . 41.1 t80 -112.38 127.35 55.99 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.995 -1.066 . . . . 0.0 111.637 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' B' ' 95' ' ' ASN . 88.9 m-20 -119.59 155.79 31.59 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.4 -0.813 . . . . 0.0 109.805 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -60.76 -23.84 65.28 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.404 -0.81 . . . . 0.0 112.761 -178.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -105.23 -26.95 11.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.366 -1.459 . . . . 0.0 110.474 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 95' ' ' ASN . . . . . 0.405 ' O ' ' HB2' ' B' ' 92' ' ' ASP . 34.5 m-20 -152.36 172.57 16.26 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 122.082 0.944 . . . . 0.0 112.02 -178.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 96' ' ' LEU . . . . . 0.708 HD21 HD22 ' B' ' 43' ' ' LEU . 54.1 tp -119.07 129.25 54.99 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 97' ' ' THR . . . . . 0.807 HG23 ' OE2' ' B' ' 105' ' ' GLU . 18.3 m -114.45 125.44 53.83 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 120.784 -1.198 . . . . 0.0 111.0 -179.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 44.7 t -120.53 128.06 75.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 99' ' ' LYS . . . . . 0.419 ' HB3' ' HB2' ' B' ' 88' ' ' CYS . 88.3 tttt -114.5 118.99 35.32 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 118.542 -1.263 . . . . 0.0 110.142 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 5.1 mp -100.0 170.49 6.67 Favored Pre-proline 0 C--N 1.302 -1.466 0 O-C-N 121.889 -0.507 . . . . 0.0 110.009 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.72 -23.04 63.56 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.788 1.414 . . . . 0.0 110.998 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -64.95 -34.45 78.46 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.667 -1.271 . . . . 0.0 110.039 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 112.07 -27.22 10.42 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 104' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -72.91 144.67 47.26 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.198 -1.178 . . . . 0.0 109.443 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 105' ' ' GLU . . . . . 0.807 ' OE2' HG23 ' B' ' 97' ' ' THR . 68.2 tt0 -113.57 143.71 44.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.958 -1.089 . . . . 0.0 111.221 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -120.72 148.04 44.49 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 107' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' B' ' 96' ' ' LEU . 98.1 mttt -120.78 145.23 47.76 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.05 -1.031 . . . . 0.0 111.173 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 108' ' ' PHE . . . . . 0.429 ' HB3' HD23 ' B' ' 96' ' ' LEU . 15.7 t80 -126.13 129.83 24.13 Favored Pre-proline 0 C--N 1.291 -1.959 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -64.95 141.01 68.88 Favored 'Trans proline' 0 C--N 1.298 -2.131 0 O-C-N 123.071 1.038 . . . . 0.0 110.362 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 110' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' B' ' 110' ' ' ASN . 4.0 p-10 -91.84 82.16 5.19 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.158 -1.017 . . . . 0.0 109.689 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -54.36 -27.38 35.87 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.443 -1.411 . . . . 0.0 109.273 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 112' ' ' LEU . . . . . 0.517 HD22 ' OD2' ' B' ' 64' ' ' ASP . 82.5 mt -104.96 131.86 51.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.476 -0.765 . . . . 0.0 110.008 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -87.01 61.69 6.94 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.138 -0.977 . . . . 0.0 110.431 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 114' ' ' LEU . . . . . 0.487 HD13 ' HD2' ' B' ' 36' ' ' LYS . 51.7 tp -81.24 130.03 34.85 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.247 -0.908 . . . . 0.0 109.571 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -87.18 -13.03 45.11 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.125 -0.984 . . . . 0.0 111.369 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 116' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' B' ' 11' ' ' LEU . . . -159.73 158.89 32.11 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.765 -1.21 . . . . 0.0 111.898 -178.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 49.7 mm -109.39 125.97 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.442 -0.786 . . . . 0.0 109.858 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -111.66 -26.91 8.76 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.542 -1.349 . . . . 0.0 110.667 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 119' ' ' TYR . . . . . 0.489 ' O ' ' HA ' ' B' ' 34' ' ' LEU . 9.5 t80 -110.18 126.4 54.06 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.364 -0.934 . . . . 0.0 110.76 -178.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 120' ' ' MET . . . . . 0.419 ' CB ' HD12 ' B' ' 9' ' ' LEU . 49.8 ttp -133.19 129.83 38.3 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.444 -0.785 . . . . 0.0 108.976 179.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -152.75 142.31 21.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.905 -1.122 . . . . 0.0 110.578 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 122' ' ' ALA . . . . . 0.463 ' O ' ' CA ' ' B' ' 3' ' ' GLY . . . -147.41 132.47 18.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.013 -1.054 . . . . 0.0 111.351 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 123' ' ' ASP . . . . . 0.482 ' HB3' ' HA3' ' B' ' 3' ' ' GLY . 15.3 p-10 -148.58 147.45 29.03 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.091 -1.006 . . . . 0.0 110.551 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 124' ' ' GLY . . . . . 0.492 ' HA3' ' HA ' ' B' ' 30' ' ' PHE . . . 155.97 -144.43 10.89 Favored Glycine 0 N--CA 1.496 2.639 0 C-N-CA 119.808 -1.187 . . . . 0.0 110.177 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . 0.409 ' HB3' ' HA ' ' B' ' 27' ' ' ALA . 87.2 m-20 -95.09 10.82 34.35 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.241 -1.152 . . . . 0.0 111.351 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 126' ' ' PHE . . . . . 0.425 ' HB3' ' CD1' ' B' ' 30' ' ' PHE . 24.4 t80 -112.52 143.71 43.22 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.876 -1.14 . . . . 0.0 109.519 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . 0.562 ' HE3' ' HB2' ' B' ' 1' ' ' ALA . 52.0 mttp -116.56 141.11 48.61 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 118.81 -1.156 . . . . 0.0 111.521 -179.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . 0.971 HG23 HD12 ' B' ' 4' ' ' LEU . 4.1 tt -111.57 122.88 66.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.776 -0.578 . . . . 0.0 109.543 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -101.92 -11.8 18.71 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.078 -1.014 . . . . 0.0 112.196 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 130' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -155.89 150.61 26.14 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.271 -1.518 . . . . 0.0 112.024 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.431 ' CG2' HD11 ' B' ' 128' ' ' ILE . 45.4 t -129.31 133.05 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.588 -0.695 . . . . 0.0 109.162 178.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 132' ' ' ALA . . . . . 0.843 ' O ' HD12 ' B' ' 17' ' ' LEU . . . -136.19 132.66 36.23 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.713 -1.242 . . . . 0.0 111.39 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . 0.489 ' CE1' HD13 ' B' ' 17' ' ' LEU . 47.6 m-85 -110.48 147.98 33.0 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.275 -0.891 . . . . 0.0 111.105 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 47.8 t0 . . . . . 0 N--CA 1.496 1.867 0 CA-C-O 118.137 -0.935 . . . . 0.0 111.127 -179.894 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.453 ' HA ' ' HB3' ' B' ' 8' ' ' ASN . 49.3 tp -59.77 133.7 56.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.88 -1.365 . . . . 0.0 110.7 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.7 t -118.04 130.11 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.361 -0.837 . . . . 0.0 110.071 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -118.81 153.01 35.17 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.325 -0.859 . . . . 0.0 109.555 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.467 ' O ' ' HB3' ' A' ' 8' ' ' ASN . 18.1 p -148.78 171.98 15.37 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.261 -0.899 . . . . 0.0 110.314 -178.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.467 ' HB3' ' O ' ' A' ' 7' ' ' SER . 14.7 t30 61.08 35.49 18.7 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.335 0.588 . . . . 0.0 110.272 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.525 ' O ' ' C ' ' A' ' 10' ' ' ASN . 87.7 mt -91.16 -17.97 25.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.215 -0.928 . . . . 0.0 110.893 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.525 ' C ' ' O ' ' A' ' 9' ' ' LEU . 7.6 m120 11.24 77.47 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.506 0 CA-C-O 121.522 0.677 . . . . 0.0 112.791 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.617 HD21 ' CZ ' ' A' ' 133' ' ' PHE . 19.2 mt -98.93 128.05 45.0 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.686 -0.634 . . . . 0.0 110.765 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -96.35 169.68 8.6 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.18 -0.95 . . . . 0.0 110.47 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.438 ' HD3' ' O ' ' A' ' 115' ' ' GLU . 40.7 Cg_endo -66.13 146.65 82.38 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.976 1.514 . . . . 0.0 110.156 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.23 -7.78 56.84 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -117.92 147.28 43.28 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.953 -1.322 . . . . 0.0 109.998 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.8 m -109.63 145.13 36.97 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.963 -1.086 . . . . 0.0 111.606 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.708 HD12 ' O ' ' A' ' 132' ' ' ALA . 47.5 tp -121.2 133.78 55.18 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -122.94 141.75 51.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.743 -1.223 . . . . 0.0 111.183 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 69.0 t -124.27 120.27 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 119.894 -0.723 . . . . 0.0 110.382 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -116.85 122.06 43.28 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.1 -1.0 . . . . 0.0 109.549 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.526 ' O ' HG13 ' A' ' 84' ' ' VAL . . . -144.71 -150.15 5.17 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.432 -1.365 . . . . 0.0 109.897 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -133.34 147.01 51.82 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.741 -1.446 . . . . 0.0 110.529 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.561 HG22 ' HD1' ' A' ' 126' ' ' PHE . 51.1 t -110.23 128.79 66.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.5 -0.75 . . . . 0.0 109.898 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.94 147.25 74.09 Favored Pre-proline 0 C--N 1.301 -1.528 0 O-C-N 121.061 -1.024 . . . . 0.0 109.2 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.415 ' HA ' ' N ' ' A' ' 82' ' ' GLY . 40.6 Cg_endo -65.89 -20.69 58.04 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.729 1.384 . . . . 0.0 110.141 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -116.77 29.63 7.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.439 -0.788 . . . . 0.0 109.228 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.472 ' HA ' ' HB3' ' A' ' 125' ' ' ASP . . . -63.74 99.09 0.21 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.514 -0.741 . . . . 0.0 110.884 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -66.52 -43.97 83.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.468 -0.77 . . . . 0.0 110.401 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.5 t -165.03 147.61 8.15 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.461 -0.774 . . . . 0.0 110.26 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.489 ' CE1' ' HG2' ' A' ' 47' ' ' PRO . 49.6 p90 -148.95 156.22 41.97 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.567 HG22 ' CB ' ' A' ' 46' ' ' ASN . 53.3 t -133.43 137.85 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.534 -1.354 . . . . 0.0 112.369 -177.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 93.2 mt -112.37 133.09 54.66 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.47 ' OD1' ' CE1' ' A' ' 44' ' ' HIS . 80.8 m-20 -125.78 135.89 52.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.013 -1.054 . . . . 0.0 110.968 -178.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.493 HD11 ' HB3' ' A' ' 43' ' ' LEU . 0.7 OUTLIER -145.17 114.16 6.93 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.077 -1.014 . . . . 0.0 110.934 179.415 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.466 ' O ' ' N ' ' A' ' 119' ' ' TYR . . . -163.45 -132.31 1.33 Allowed Glycine 0 N--CA 1.496 2.66 0 N-CA-C 108.233 -1.947 . . . . 0.0 108.233 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.72 ' HD2' HD13 ' A' ' 114' ' ' LEU . 42.1 mtpt -112.08 -46.03 3.25 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.093 -1.24 . . . . 0.0 108.05 178.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -123.67 164.41 19.15 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.882 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.23 -32.18 68.08 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.339 -0.851 . . . . 0.0 110.982 -179.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.454 ' HB3' ' N ' ' A' ' 66' ' ' GLY . 87.1 m-20 -94.98 -9.07 35.09 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.877 -1.14 . . . . 0.0 111.186 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.439 ' N ' ' ND2' ' A' ' 40' ' ' ASN . 2.9 m-80 -113.56 66.42 0.66 Allowed 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.158 -0.964 . . . . 0.0 110.138 -178.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 47.0 mt -96.24 133.25 40.81 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 2.1 m -85.41 -31.24 23.0 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.993 -1.067 . . . . 0.0 109.784 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.872 HD13 ' CD2' ' A' ' 96' ' ' LEU . 25.3 tp -128.5 129.19 45.7 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.611 -0.681 . . . . 0.0 109.982 -179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.47 ' CE1' ' OD1' ' A' ' 33' ' ' ASN . 63.5 t60 -128.23 127.73 43.4 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.102 -0.999 . . . . 0.0 110.305 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.507 ' CE1' HG21 ' A' ' 58' ' ' ILE . 83.7 t80 -123.39 122.88 39.41 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.975 -1.078 . . . . 0.0 110.043 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.567 ' CB ' HG22 ' A' ' 31' ' ' VAL . 1.4 t-20 -142.71 84.23 11.03 Favored Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 121.154 -0.966 . . . . 0.0 110.954 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.504 ' HD3' ' CD2' ' A' ' 45' ' ' PHE . 52.7 Cg_endo -70.64 142.77 44.84 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.657 1.346 . . . . 0.0 109.489 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -127.0 97.59 5.01 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.921 -1.112 . . . . 0.0 110.394 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -61.03 -45.44 94.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.132 -0.98 . . . . 0.0 109.139 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -159.63 103.36 1.55 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.309 -0.869 . . . . 0.0 109.413 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -113.82 -104.17 0.4 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.045 -1.034 . . . . 0.0 110.695 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -65.88 -41.47 91.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.663 -1.273 . . . . 0.0 109.872 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 168.54 39.54 0.02 OUTLIER Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.402 ' N ' ' OD1' ' A' ' 54' ' ' ASP . 8.9 m-20 -114.08 -179.42 3.63 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.353 -1.087 . . . . 0.0 109.115 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.423 ' O ' ' C ' ' A' ' 56' ' ' ASN . . . -142.14 143.99 33.27 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.977 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.423 ' C ' ' O ' ' A' ' 55' ' ' ALA . 81.2 m-20 27.55 49.4 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 178.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 55.2 m -118.48 130.51 55.98 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.84 -1.162 . . . . 0.0 109.352 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.589 HD12 ' H ' ' A' ' 76' ' ' VAL . 86.8 mt -115.6 135.26 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.203 -0.936 . . . . 0.0 110.933 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 64.6 t -102.05 126.09 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.382 -0.824 . . . . 0.0 110.265 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 80.2 m -116.76 121.27 41.1 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.142 -0.974 . . . . 0.0 109.251 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.461 ' O ' ' HB3' ' A' ' 44' ' ' HIS . 2.5 p-10 -151.63 179.1 8.69 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.952 -1.093 . . . . 0.0 111.163 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.455 ' O ' ' CA ' ' A' ' 69' ' ' GLY . 15.1 m -133.91 154.18 51.25 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.325 -0.86 . . . . 0.0 109.874 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.497 ' CD ' ' HA2' ' A' ' 66' ' ' GLY . 18.3 ttmt -128.53 143.67 51.01 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.491 -1.381 . . . . 0.0 111.277 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.666 ' HB2' HD21 ' A' ' 112' ' ' LEU . 59.4 t0 -122.34 95.61 4.71 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.463 -0.773 . . . . 0.0 109.161 178.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 71.21 19.87 77.68 Favored Glycine 0 N--CA 1.484 1.834 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.497 ' HA2' ' CD ' ' A' ' 63' ' ' LYS . . . 72.29 32.72 62.32 Favored Glycine 0 N--CA 1.486 2.009 0 C-N-CA 119.386 -1.388 . . . . 0.0 110.694 179.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -101.86 -74.55 0.62 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.855 -1.379 . . . . 0.0 111.122 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 14.1 m0 -124.16 -147.83 0.38 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.14 -0.975 . . . . 0.0 110.627 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.455 ' CA ' ' O ' ' A' ' 62' ' ' SER . . . 158.64 144.65 4.01 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.631 ' O ' HG23 ' A' ' 70' ' ' THR . 6.5 t -81.53 80.47 7.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.455 -1.026 . . . . 0.0 109.729 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.452 ' HA ' ' HB3' ' A' ' 61' ' ' ASN . 78.6 tt0 -71.07 111.56 6.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.249 -0.907 . . . . 0.0 110.875 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -122.79 -164.94 1.24 Allowed 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.333 -0.855 . . . . 0.0 109.556 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -137.65 130.92 30.73 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.431 -0.907 . . . . 0.0 110.583 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -131.83 83.43 2.09 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.309 -0.87 . . . . 0.0 109.508 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.74 88.08 0.1 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.216 -0.928 . . . . 0.0 110.611 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.589 ' H ' HD12 ' A' ' 58' ' ' ILE . 6.2 p -134.6 141.49 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.449 -0.782 . . . . 0.0 109.682 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -157.11 89.21 2.57 Favored Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 120.55 -1.344 . . . . 0.0 110.891 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.403 ' CB ' ' OD2' ' A' ' 102' ' ' ASP . 51.0 Cg_endo -77.39 -6.63 16.51 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.845 1.445 . . . . 0.0 111.978 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -142.21 -167.3 2.44 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.79 -1.194 . . . . 0.0 111.293 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.422 ' CB ' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -139.48 172.53 6.3 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.481 -0.762 . . . . 0.0 109.723 179.753 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.422 ' HD2' ' CB ' ' A' ' 80' ' ' GLN . 44.3 Cg_endo -67.22 147.42 78.68 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.807 1.425 . . . . 0.0 111.294 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.415 ' N ' ' HA ' ' A' ' 25' ' ' PRO . . . 78.71 23.56 64.29 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.4 t -137.01 147.45 46.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.083 -1.245 . . . . 0.0 111.113 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.526 HG13 ' O ' ' A' ' 21' ' ' GLY . 73.3 t -79.23 130.26 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.529 -0.732 . . . . 0.0 110.116 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -130.82 142.24 50.38 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.946 -1.096 . . . . 0.0 109.692 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.405 ' O ' ' HG3' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -120.22 127.29 52.29 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.519 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 73.4 t -121.52 132.26 71.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 118.985 -1.086 . . . . 0.0 111.019 -177.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 11.8 t -97.04 117.74 31.9 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.493 -0.754 . . . . 0.0 109.368 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 72.7 mt -111.51 125.24 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.082 -1.012 . . . . 0.0 109.468 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 57.7 m -122.36 129.38 52.06 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.361 -0.837 . . . . 0.0 109.665 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -106.76 118.28 36.27 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.052 -1.03 . . . . 0.0 110.822 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -115.73 152.08 33.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.467 -0.771 . . . . 0.0 109.378 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 69.9 tp60 -62.73 -38.83 92.07 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.968 -1.082 . . . . 0.0 110.521 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.34 -39.35 89.15 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.949 -1.094 . . . . 0.0 110.563 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -166.7 178.8 5.74 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.322 -0.862 . . . . 0.0 110.068 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.872 ' CD2' HD13 ' A' ' 43' ' ' LEU . 49.5 tp -102.08 129.86 48.52 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.375 -0.828 . . . . 0.0 109.197 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 98.9 m -115.4 122.67 46.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.717 -1.239 . . . . 0.0 111.22 -179.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 7.0 m -120.84 129.51 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.382 -0.824 . . . . 0.0 109.36 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -113.53 124.79 53.21 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.797 -1.19 . . . . 0.0 109.396 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.0 mp -85.42 164.37 40.89 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.301 -0.874 . . . . 0.0 109.57 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -66.14 -32.85 42.21 Favored 'Trans proline' 0 C--N 1.302 -1.905 0 O-C-N 123.858 1.452 . . . . 0.0 110.486 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.403 ' OD2' ' CB ' ' A' ' 78' ' ' PRO . 99.7 m-20 -74.45 -25.32 59.34 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.106 -0.996 . . . . 0.0 110.208 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 121.3 3.11 10.66 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.761 -1.209 . . . . 0.0 111.095 178.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -83.9 135.8 34.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.598 -1.531 . . . . 0.0 110.249 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 64.5 tt0 -132.49 148.56 52.39 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.434 -0.791 . . . . 0.0 111.129 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -141.0 156.4 46.05 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.602 -0.686 . . . . 0.0 109.21 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 98.5 mttt -123.92 141.0 52.43 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.007 -1.058 . . . . 0.0 110.867 -178.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -123.71 143.35 41.63 Favored Pre-proline 0 N--CA 1.494 1.733 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.84 144.28 47.88 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.299 1.158 . . . . 0.0 109.184 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.485 ' ND2' ' O ' ' A' ' 110' ' ' ASN . 6.0 p-10 -95.0 82.76 3.84 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 120.934 -1.104 . . . . 0.0 110.584 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.427 ' CZ ' ' HB ' ' A' ' 70' ' ' THR . 98.2 mtt180 -55.77 -22.11 22.51 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.818 -1.176 . . . . 0.0 109.111 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.666 HD21 ' HB2' ' A' ' 64' ' ' ASP . 57.4 mt -96.9 141.92 29.51 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.319 -0.863 . . . . 0.0 108.704 178.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -97.02 62.42 1.83 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.748 -1.22 . . . . 0.0 109.875 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.72 HD13 ' HD2' ' A' ' 36' ' ' LYS . 64.9 tp -82.33 130.04 35.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.353 -0.842 . . . . 0.0 111.08 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.438 ' O ' ' HD3' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -88.94 -17.23 29.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.409 -0.807 . . . . 0.0 109.87 179.487 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.51 ' HA ' ' O ' ' A' ' 11' ' ' LEU . . . -163.22 144.08 9.36 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.723 -1.236 . . . . 0.0 111.682 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.43 HD13 HD12 ' A' ' 34' ' ' LEU . 93.1 mt -98.87 124.59 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.386 -0.821 . . . . 0.0 108.981 178.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.466 ' ND2' ' N ' ' A' ' 118' ' ' ASN . 0.1 OUTLIER -125.59 13.0 8.08 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.592 -0.692 . . . . 0.0 110.772 -179.361 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.472 ' O ' ' HA ' ' A' ' 34' ' ' LEU . 7.8 t80 -131.62 128.82 39.92 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.974 -1.079 . . . . 0.0 110.261 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 62.5 ttp -142.78 130.8 21.79 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.347 -0.846 . . . . 0.0 109.85 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -140.88 144.53 35.32 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.229 -0.92 . . . . 0.0 109.76 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -132.11 108.95 9.64 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.281 -0.887 . . . . 0.0 109.458 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -137.65 129.16 28.19 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.531 -0.731 . . . . 0.0 109.649 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.466 ' HA3' ' HA ' ' A' ' 30' ' ' PHE . . . 154.13 -157.93 27.81 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 108.841 -1.704 . . . . 0.0 108.841 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.472 ' HB3' ' HA ' ' A' ' 27' ' ' ALA . 87.6 m-20 -78.38 -0.22 28.22 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.3 -1.118 . . . . 0.0 110.552 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.561 ' HD1' HG22 ' A' ' 23' ' ' VAL . 42.7 t80 -95.4 142.28 27.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.09 -1.006 . . . . 0.0 109.859 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -112.95 140.12 48.02 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 118.815 -1.154 . . . . 0.0 110.538 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.531 HG23 ' O ' ' A' ' 128' ' ' ILE . 20.6 tt -108.51 122.79 63.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.625 -0.672 . . . . 0.0 109.755 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -105.74 -23.07 12.81 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.328 -0.857 . . . . 0.0 110.97 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.404 ' HA ' ' O ' ' B' ' 131' ' ' VAL . 0.1 OUTLIER -153.03 154.88 35.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.82 -1.175 . . . . 0.0 112.136 -178.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' B' ' 130' ' ' CYS . 42.8 t -123.71 135.91 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.708 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -124.29 146.35 48.84 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.867 -1.145 . . . . 0.0 110.574 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.617 ' CZ ' HD21 ' A' ' 11' ' ' LEU . 0.4 OUTLIER -94.39 -139.92 0.23 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.349 -0.844 . . . . 0.0 109.798 179.786 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 49.0 t0 . . . . . 0 N--CA 1.492 1.673 0 O-C-N 120.631 -1.293 . . . . 0.0 110.437 -179.589 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.218 0.532 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 2' ' ' CYS . . . . . . . . . . . . . 49.6 t -145.17 84.85 1.72 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.095 -1.003 . . . . 0.0 110.608 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 84.84 43.37 6.81 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.42 HD23 HD13 ' B' ' 128' ' ' ILE . 50.1 tp -60.18 133.66 56.31 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.918 -1.342 . . . . 0.0 110.577 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 46.7 t -117.95 130.07 73.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.363 -0.836 . . . . 0.0 110.111 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -118.94 152.51 36.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.926 . . . . 0.0 109.485 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' SER . . . . . 0.486 ' O ' ' HB3' ' B' ' 8' ' ' ASN . 17.1 p -148.6 172.26 14.82 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.102 -0.999 . . . . 0.0 110.25 -179.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . 0.486 ' HB3' ' O ' ' B' ' 7' ' ' SER . 13.6 t30 61.34 35.47 17.96 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.404 0.621 . . . . 0.0 110.303 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.538 ' O ' ' C ' ' B' ' 10' ' ' ASN . 88.5 mt -92.52 -12.51 31.73 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.362 -0.836 . . . . 0.0 111.153 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' ASN . . . . . 0.538 ' C ' ' O ' ' B' ' 9' ' ' LEU . 7.3 m120 2.85 80.42 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.491 0 CA-C-O 122.144 0.973 . . . . 0.0 112.953 -178.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.613 HD21 ' CZ ' ' B' ' 133' ' ' PHE . 18.7 mt -98.96 127.96 45.01 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.642 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -96.35 169.76 8.47 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.204 -0.935 . . . . 0.0 110.549 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . 0.438 ' HD3' ' O ' ' B' ' 115' ' ' GLU . 40.6 Cg_endo -66.16 146.74 82.48 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 124.004 1.529 . . . . 0.0 110.18 178.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.86 -7.48 57.41 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.084 -1.207 . . . . 0.0 110.084 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -117.94 147.5 43.09 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.905 -1.35 . . . . 0.0 109.827 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' CYS . . . . . . . . . . . . . 6.2 m -110.11 145.25 37.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.085 -1.009 . . . . 0.0 111.365 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.711 HD12 ' O ' ' B' ' 132' ' ' ALA . 46.9 tp -121.33 133.83 55.13 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -122.97 141.63 51.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.867 -1.146 . . . . 0.0 111.21 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 69.4 t -124.09 120.91 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 119.902 -0.719 . . . . 0.0 110.354 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -117.44 121.81 42.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.259 -0.901 . . . . 0.0 109.602 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.53 ' O ' HG13 ' B' ' 84' ' ' VAL . . . -144.65 -149.93 5.14 Favored Glycine 0 N--CA 1.494 2.511 0 C-N-CA 119.486 -1.34 . . . . 0.0 109.897 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -133.72 146.47 50.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.814 -1.403 . . . . 0.0 110.685 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.579 HG22 ' HD1' ' B' ' 126' ' ' PHE . 50.9 t -109.71 128.63 65.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.501 -0.749 . . . . 0.0 109.961 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.79 147.01 73.5 Favored Pre-proline 0 C--N 1.299 -1.602 0 O-C-N 121.093 -1.004 . . . . 0.0 109.253 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . 0.427 ' HA ' ' N ' ' B' ' 82' ' ' GLY . 40.4 Cg_endo -66.05 -20.1 57.2 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.714 1.376 . . . . 0.0 110.116 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -117.15 29.44 7.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.292 -0.88 . . . . 0.0 109.246 178.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . 0.465 ' HA ' ' HB3' ' B' ' 125' ' ' ASP . . . -63.53 99.29 0.2 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.51 -0.744 . . . . 0.0 110.898 -179.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -66.46 -45.54 79.38 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.42 -0.8 . . . . 0.0 110.254 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 33.4 t -162.57 148.23 12.5 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.491 -0.756 . . . . 0.0 110.301 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' PHE . . . . . 0.49 ' CD2' ' HB2' ' B' ' 126' ' ' PHE . 49.8 p90 -149.16 156.02 41.54 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 177.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.567 HG22 ' CB ' ' B' ' 46' ' ' ASN . 53.8 t -133.3 138.14 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.372 -1.455 . . . . 0.0 112.373 -177.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 93.6 mt -112.57 133.29 54.7 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' ASN . . . . . 0.455 ' OD1' ' CE1' ' B' ' 44' ' ' HIS . 80.8 m-20 -125.89 136.0 52.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.967 -1.083 . . . . 0.0 110.995 -178.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.537 HD11 ' HB3' ' B' ' 43' ' ' LEU . 0.7 OUTLIER -145.28 111.19 5.5 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.16 -0.962 . . . . 0.0 111.071 179.397 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . 0.461 ' O ' ' N ' ' B' ' 119' ' ' TYR . . . -159.16 -131.18 1.22 Allowed Glycine 0 N--CA 1.495 2.609 0 N-CA-C 108.526 -1.83 . . . . 0.0 108.526 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . 0.708 ' HD2' HD13 ' B' ' 114' ' ' LEU . 42.3 mtpt -112.93 -46.32 3.12 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -123.42 164.42 18.91 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.878 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.34 -32.37 68.47 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.242 -0.911 . . . . 0.0 111.035 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' ASN . . . . . 0.446 ' HB3' ' N ' ' B' ' 66' ' ' GLY . 86.9 m-20 -94.82 -8.98 35.84 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.045 -1.034 . . . . 0.0 111.085 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' ASN . . . . . 0.443 ' ND2' ' N ' ' B' ' 40' ' ' ASN . 3.0 m-80 -113.85 66.19 0.66 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.145 -0.972 . . . . 0.0 110.061 -178.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.416 ' HA ' ' HA3' ' B' ' 35' ' ' GLY . 45.4 mt -95.51 135.53 37.04 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' CYS . . . . . . . . . . . . . 1.7 m -88.81 -29.84 19.43 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.956 -1.09 . . . . 0.0 109.274 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.881 HD13 ' CD2' ' B' ' 96' ' ' LEU . 25.9 tp -128.94 128.99 44.88 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.539 -0.726 . . . . 0.0 109.874 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' HIS . . . . . 0.455 ' CE1' ' OD1' ' B' ' 33' ' ' ASN . 63.0 t60 -128.2 127.51 43.03 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.205 -0.935 . . . . 0.0 110.403 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.516 ' CE1' HG21 ' B' ' 58' ' ' ILE . 83.3 t80 -123.35 122.71 39.0 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.173 -0.954 . . . . 0.0 110.161 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' ASN . . . . . 0.567 ' CB ' HG22 ' B' ' 31' ' ' VAL . 1.4 t-20 -142.47 84.41 11.21 Favored Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 121.157 -0.964 . . . . 0.0 110.958 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' PRO . . . . . 0.508 ' HD3' ' CD2' ' B' ' 45' ' ' PHE . 52.9 Cg_endo -70.76 142.9 44.6 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 123.621 1.327 . . . . 0.0 109.421 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -127.15 97.5 4.96 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.023 -1.048 . . . . 0.0 110.347 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -60.84 -45.18 95.49 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.313 -0.867 . . . . 0.0 109.176 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -159.94 103.54 1.5 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.385 -0.822 . . . . 0.0 109.395 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -114.15 -103.92 0.41 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.052 -1.03 . . . . 0.0 110.73 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -66.08 -41.12 91.12 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.641 -1.287 . . . . 0.0 109.892 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 168.14 39.56 0.02 OUTLIER Glycine 0 N--CA 1.485 1.921 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -113.99 -179.44 3.63 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.485 -1.009 . . . . 0.0 109.134 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.46 ' O ' ' C ' ' B' ' 56' ' ' ASN . . . -140.68 150.3 43.32 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.162 -0.961 . . . . 0.0 110.256 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' ASN . . . . . 0.46 ' C ' ' O ' ' B' ' 55' ' ' ALA . 80.3 m-20 17.09 54.62 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . 0.4 ' N ' ' O ' ' B' ' 55' ' ' ALA . 54.0 m -120.12 130.09 54.47 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.131 -0.981 . . . . 0.0 109.237 178.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' ILE . . . . . 0.59 HD12 ' H ' ' B' ' 76' ' ' VAL . 85.3 mt -115.78 135.23 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.166 -0.959 . . . . 0.0 110.948 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 69.3 t -101.69 126.33 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.433 -0.792 . . . . 0.0 110.36 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 79.0 m -117.26 120.94 39.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.261 -0.899 . . . . 0.0 109.297 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' ASN . . . . . 0.46 ' HB3' ' HA ' ' B' ' 71' ' ' GLU . 2.4 p-10 -151.32 179.03 8.67 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.057 -1.027 . . . . 0.0 111.265 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' SER . . . . . 0.456 ' O ' ' CA ' ' B' ' 69' ' ' GLY . 15.8 m -133.94 153.83 51.5 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.361 -0.837 . . . . 0.0 109.892 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . 0.498 ' CD ' ' HA2' ' B' ' 66' ' ' GLY . 17.8 ttmt -128.4 143.5 51.01 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.453 -1.404 . . . . 0.0 111.228 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' ASP . . . . . 0.668 ' HB2' HD21 ' B' ' 112' ' ' LEU . 58.5 t0 -122.42 94.95 4.45 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.527 -0.733 . . . . 0.0 109.351 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 71.81 19.87 78.38 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . 0.498 ' HA2' ' CD ' ' B' ' 63' ' ' LYS . . . 72.08 32.33 63.27 Favored Glycine 0 N--CA 1.488 2.118 0 O-C-N 120.833 -1.393 . . . . 0.0 110.598 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -101.07 -74.95 0.6 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.737 -1.449 . . . . 0.0 111.174 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' TRP . . . . . . . . . . . . . 13.6 m0 -123.99 -147.76 0.38 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.136 -0.978 . . . . 0.0 110.454 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . 0.456 ' CA ' ' O ' ' B' ' 62' ' ' SER . . . 158.61 145.4 4.23 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 70' ' ' THR . . . . . 0.623 HG23 ' O ' ' B' ' 70' ' ' THR . 6.9 t -81.88 80.08 8.26 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.153 -1.204 . . . . 0.0 109.759 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . 0.46 ' HA ' ' HB3' ' B' ' 61' ' ' ASN . 79.4 tt0 -70.58 111.84 6.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.914 . . . . 0.0 110.858 -179.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -123.06 -165.07 1.26 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.36 -0.837 . . . . 0.0 109.52 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -137.7 130.18 29.56 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.348 -0.941 . . . . 0.0 110.588 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -131.03 83.45 2.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.266 -0.896 . . . . 0.0 109.747 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.66 88.03 0.09 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.124 -0.985 . . . . 0.0 110.74 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 76' ' ' VAL . . . . . 0.59 ' H ' HD12 ' B' ' 58' ' ' ILE . 5.9 p -134.55 141.45 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.518 -0.739 . . . . 0.0 109.864 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -157.24 89.53 2.51 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 120.733 -1.23 . . . . 0.0 110.833 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . 0.404 ' CB ' ' OD2' ' B' ' 102' ' ' ASP . 53.3 Cg_endo -77.65 -6.23 16.0 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 O-C-N 123.884 1.465 . . . . 0.0 112.165 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -142.55 -167.08 2.42 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.858 -1.151 . . . . 0.0 111.401 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.423 ' CB ' ' HD2' ' B' ' 81' ' ' PRO . 0.0 OUTLIER -139.66 172.39 6.49 Favored Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.382 -0.823 . . . . 0.0 109.758 179.77 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 81' ' ' PRO . . . . . 0.423 ' HD2' ' CB ' ' B' ' 80' ' ' GLN . 43.8 Cg_endo -67.09 147.27 79.21 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.789 1.415 . . . . 0.0 111.223 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . 0.427 ' N ' ' HA ' ' B' ' 25' ' ' PRO . . . 78.82 23.65 63.82 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 9.5 t -137.1 147.15 45.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.211 -1.17 . . . . 0.0 111.212 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.53 HG13 ' O ' ' B' ' 21' ' ' GLY . 72.3 t -79.07 130.0 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.619 -0.676 . . . . 0.0 109.979 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -130.53 142.16 50.48 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.108 -0.995 . . . . 0.0 109.736 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 86' ' ' GLU . . . . . 0.402 ' O ' ' HG3' ' B' ' 86' ' ' GLU . 0.2 OUTLIER -120.15 127.14 52.21 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.512 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 76.8 t -121.63 131.93 71.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 119.142 -1.023 . . . . 0.0 111.063 -177.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 88' ' ' CYS . . . . . . . . . . . . . 12.7 t -96.85 117.87 32.05 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.485 -0.759 . . . . 0.0 109.525 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 70.7 mt -111.6 124.89 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.149 -0.969 . . . . 0.0 109.533 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 56.6 m -122.16 129.23 52.12 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.276 -0.89 . . . . 0.0 109.665 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 91' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -106.62 117.98 35.47 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.209 -0.932 . . . . 0.0 110.891 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -115.27 151.76 33.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.686 -0.634 . . . . 0.0 109.465 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 69.6 tp60 -62.67 -38.84 91.93 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.933 -1.104 . . . . 0.0 110.488 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.29 -39.15 89.17 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.967 -1.083 . . . . 0.0 110.589 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -166.91 178.72 5.65 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.265 -0.897 . . . . 0.0 109.917 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 96' ' ' LEU . . . . . 0.881 ' CD2' HD13 ' B' ' 43' ' ' LEU . 46.7 tp -102.08 129.69 48.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.389 -0.82 . . . . 0.0 109.284 179.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 98.8 m -115.23 122.77 47.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.725 -1.234 . . . . 0.0 111.162 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 7.0 m -121.06 129.55 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.408 -0.807 . . . . 0.0 109.312 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -113.46 125.2 53.96 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.757 -1.214 . . . . 0.0 109.342 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 7.9 mp -85.52 165.0 37.97 Favored Pre-proline 0 C--N 1.302 -1.495 0 O-C-N 121.195 -0.94 . . . . 0.0 109.598 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -66.6 -32.81 37.88 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.991 1.521 . . . . 0.0 110.37 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 102' ' ' ASP . . . . . 0.404 ' OD2' ' CB ' ' B' ' 78' ' ' PRO . 99.6 m-20 -74.54 -25.21 59.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.999 -1.063 . . . . 0.0 110.156 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 121.22 2.77 10.86 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.53 -1.319 . . . . 0.0 111.057 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 104' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -83.67 136.01 34.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.581 -1.541 . . . . 0.0 110.123 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -132.58 148.72 52.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.452 -0.78 . . . . 0.0 110.949 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -141.08 156.51 45.98 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -124.1 141.1 52.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.007 -1.058 . . . . 0.0 110.93 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 108' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -123.58 143.76 42.48 Favored Pre-proline 0 N--CA 1.493 1.699 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -71.23 144.17 45.71 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 N-CA-C 109.14 -1.138 . . . . 0.0 109.14 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 110' ' ' ASN . . . . . 0.486 ' ND2' ' O ' ' B' ' 110' ' ' ASN . 6.1 p-10 -94.92 83.19 3.93 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.933 -1.104 . . . . 0.0 110.572 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . 0.43 ' NH2' ' OG1' ' B' ' 70' ' ' THR . 98.1 mtt180 -56.11 -22.23 26.95 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.704 -1.248 . . . . 0.0 109.08 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 112' ' ' LEU . . . . . 0.668 HD21 ' HB2' ' B' ' 64' ' ' ASP . 56.5 mt -97.05 141.61 29.99 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -96.71 61.96 1.92 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.706 -1.246 . . . . 0.0 110.018 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 114' ' ' LEU . . . . . 0.708 HD13 ' HD2' ' B' ' 36' ' ' LYS . 64.3 tp -81.89 129.53 34.79 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.332 -0.855 . . . . 0.0 111.078 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 115' ' ' GLU . . . . . 0.438 ' O ' ' HD3' ' B' ' 13' ' ' PRO . 0.0 OUTLIER -88.5 -17.4 30.38 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.407 -0.808 . . . . 0.0 109.746 179.504 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 116' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' B' ' 11' ' ' LEU . . . -163.05 144.29 9.72 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.76 -1.213 . . . . 0.0 111.765 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 117' ' ' ILE . . . . . 0.428 HD13 HD12 ' B' ' 34' ' ' LEU . 91.7 mt -98.92 124.5 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.37 -0.831 . . . . 0.0 108.908 178.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 118' ' ' ASN . . . . . 0.458 ' ND2' ' N ' ' B' ' 118' ' ' ASN . 0.1 OUTLIER -125.82 13.21 7.95 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.647 -0.658 . . . . 0.0 110.827 -179.319 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 119' ' ' TYR . . . . . 0.467 ' O ' ' HA ' ' B' ' 34' ' ' LEU . 8.0 t80 -131.81 128.73 39.36 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.086 -1.009 . . . . 0.0 110.112 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 62.6 ttp -142.74 130.74 21.8 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.44 -0.788 . . . . 0.0 109.797 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -140.83 144.71 35.52 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.249 -0.907 . . . . 0.0 109.757 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -132.23 108.97 9.59 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.353 -0.842 . . . . 0.0 109.538 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -137.97 128.62 26.68 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.372 -0.83 . . . . 0.0 109.61 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 124' ' ' GLY . . . . . 0.464 ' HA3' ' HA ' ' B' ' 30' ' ' PHE . . . 154.79 -157.74 27.8 Favored Glycine 0 N--CA 1.483 1.794 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . 0.465 ' HB3' ' HA ' ' B' ' 27' ' ' ALA . 87.5 m-20 -78.55 0.02 27.84 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.405 -1.056 . . . . 0.0 110.495 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 126' ' ' PHE . . . . . 0.579 ' HD1' HG22 ' B' ' 23' ' ' VAL . 42.6 t80 -95.79 142.13 28.43 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.984 -1.073 . . . . 0.0 109.73 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -112.8 139.83 48.1 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 118.896 -1.121 . . . . 0.0 110.502 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . 0.52 ' O ' HG23 ' B' ' 128' ' ' ILE . 20.6 tt -108.12 123.08 63.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.61 -0.681 . . . . 0.0 109.685 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -106.03 -23.33 12.66 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.403 -0.811 . . . . 0.0 111.028 -179.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 130' ' ' CYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 131' ' ' VAL . 0.1 OUTLIER -153.05 155.32 36.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.95 -1.094 . . . . 0.0 112.177 -179.071 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 130' ' ' CYS . 44.3 t -123.93 136.02 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 132' ' ' ALA . . . . . 0.711 ' O ' HD12 ' B' ' 17' ' ' LEU . . . -124.53 146.21 49.12 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.518 -1.363 . . . . 0.0 110.666 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . 0.613 ' CZ ' HD21 ' B' ' 11' ' ' LEU . 0.4 OUTLIER -94.08 -139.87 0.22 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.286 -0.884 . . . . 0.0 109.739 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 49.5 t0 . . . . . 0 N--CA 1.493 1.717 0 O-C-N 120.668 -1.27 . . . . 0.0 110.462 -179.6 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.409 ' O ' ' ND2' ' B' ' 8' ' ' ASN . . . . . . . . 0 N--CA 1.503 3.156 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.833 HD22 HD23 ' B' ' 9' ' ' LEU . 48.5 mt -97.9 128.2 44.34 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.946 -1.326 . . . . 0.0 109.265 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.9 t -96.37 135.36 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.106 -0.996 . . . . 0.0 109.741 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.938 ' HB1' HD11 ' A' ' 9' ' ' LEU . . . -124.36 145.03 49.69 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.241 -0.912 . . . . 0.0 111.083 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.414 ' O ' ' HB3' ' A' ' 8' ' ' ASN . 32.9 p -145.74 170.19 17.0 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' B' ' 3' ' ' GLY . 40.0 t-20 59.49 32.21 21.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.338 -0.851 . . . . 0.0 109.189 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.938 HD11 ' HB1' ' A' ' 6' ' ' ALA . 96.3 mt -90.7 2.73 55.7 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.65 -0.656 . . . . 0.0 111.834 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.506 ' C ' ' O ' ' A' ' 9' ' ' LEU . 36.3 t-20 -1.08 76.81 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.564 0 N-CA-C 113.723 1.008 . . . . 0.0 113.723 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.601 HD12 ' HE2' ' A' ' 133' ' ' PHE . 5.7 tt -92.37 130.89 37.93 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.062 -1.024 . . . . 0.0 109.376 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -100.43 165.79 13.78 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.266 -0.896 . . . . 0.0 111.189 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.472 ' HA ' ' O ' ' A' ' 91' ' ' PHE . 52.0 Cg_endo -69.24 147.28 65.87 Favored 'Trans proline' 0 C--N 1.301 -1.94 0 O-C-N 124.165 1.613 . . . . 0.0 110.764 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.33 1.17 59.36 Favored Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.969 -1.11 . . . . 0.0 110.529 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -115.5 147.95 40.05 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.744 -1.445 . . . . 0.0 110.291 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.2 m -97.39 146.83 24.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.066 -1.021 . . . . 0.0 110.647 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.419 ' HB3' ' O ' ' A' ' 89' ' ' ILE . 52.7 tp -133.38 133.83 42.93 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.534 -0.729 . . . . 0.0 109.989 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 78.1 mtt85 -123.03 152.1 41.29 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.202 -0.936 . . . . 0.0 110.387 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 t -141.18 102.06 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 C-N-CA 119.939 -0.705 . . . . 0.0 110.671 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 -99.48 130.3 45.73 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.205 -0.935 . . . . 0.0 110.296 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -144.12 -171.78 14.39 Favored Glycine 0 N--CA 1.496 2.645 0 C-N-CA 119.82 -1.181 . . . . 0.0 110.504 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' A' ' 127' ' ' LYS . 87.1 tt0 -123.85 153.71 40.68 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.468 -1.019 . . . . 0.0 109.317 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.485 HG22 ' HD1' ' A' ' 126' ' ' PHE . 68.9 t -118.58 133.34 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.038 -1.039 . . . . 0.0 111.554 -178.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.464 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . . . -58.99 150.33 61.64 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 120.939 -1.101 . . . . 0.0 109.472 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.43 -18.47 54.87 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.777 1.409 . . . . 0.0 111.309 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -125.01 28.86 6.29 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.977 -1.077 . . . . 0.0 108.811 178.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.504 ' CB ' ' HB3' ' A' ' 125' ' ' ASP . . . -62.67 105.64 0.68 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.287 0.565 . . . . 0.0 111.903 -178.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -64.49 -48.13 76.36 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.519 -0.738 . . . . 0.0 109.922 178.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 86.8 p -166.68 159.84 14.38 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.91 0.862 . . . . 0.0 111.535 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.545 ' CZ ' ' HG2' ' A' ' 47' ' ' PRO . 48.1 p90 -151.22 162.55 40.68 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 45' ' ' PHE . 2.2 p -139.81 138.02 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.444 -1.41 . . . . 0.0 112.688 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.477 ' CD2' ' HB1' ' A' ' 122' ' ' ALA . 90.3 mt -122.95 143.76 49.69 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.667 ' HB2' HD12 ' A' ' 41' ' ' LEU . 26.6 p30 -151.29 162.96 39.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.785 -1.197 . . . . 0.0 110.757 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.672 ' O ' HD12 ' A' ' 34' ' ' LEU . 3.8 pp -154.67 129.6 9.45 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.267 -0.895 . . . . 0.0 110.413 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' A' ' 41' ' ' LEU . . . -166.15 -153.65 7.84 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.432 ' HE2' ' HB3' ' A' ' 40' ' ' ASN . 60.2 pttt -103.36 -30.42 10.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.061 -1.259 . . . . 0.0 110.146 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.481 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 21.9 t70 -143.84 167.8 21.45 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.232 -0.917 . . . . 0.0 110.466 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.536 ' O ' HD23 ' A' ' 41' ' ' LEU . 5.5 t -51.27 -46.93 62.58 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.485 -0.759 . . . . 0.0 112.769 -177.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.441 ' HB3' ' N ' ' A' ' 66' ' ' GLY . 27.9 m-20 -91.12 -2.45 57.58 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.485 -1.384 . . . . 0.0 110.427 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.432 ' HB3' ' HE2' ' A' ' 36' ' ' LYS . 5.5 m-80 -110.41 56.16 0.63 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.111 -0.993 . . . . 0.0 110.51 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.667 HD12 ' HB2' ' A' ' 33' ' ' ASN . 3.6 mm? -86.15 138.62 31.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.316 -0.865 . . . . 0.0 110.085 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.9 m -87.2 -28.14 22.58 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.3 -0.875 . . . . 0.0 110.244 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.5 tp -140.94 136.2 31.99 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 121.207 -0.933 . . . . 0.0 110.82 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.521 ' O ' ' HA ' ' A' ' 60' ' ' CYS . 19.9 m-70 -121.95 117.59 26.8 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.098 -1.001 . . . . 0.0 109.228 178.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.532 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 39.7 t80 -113.55 124.09 51.54 Favored 'General case' 0 C--N 1.293 -1.882 0 O-C-N 121.15 -0.969 . . . . 0.0 108.928 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -156.27 76.48 4.56 Favored Pre-proline 0 N--CA 1.497 1.925 0 O-C-N 120.843 -1.161 . . . . 0.0 111.005 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.61 ' HB3' HG12 ' A' ' 58' ' ' ILE . 56.2 Cg_endo -70.51 147.14 57.37 Favored 'Trans proline' 0 C--N 1.301 -1.96 0 O-C-N 124.256 1.661 . . . . 0.0 110.447 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -122.59 120.42 33.71 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.139 -0.976 . . . . 0.0 109.731 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -59.04 -49.28 78.49 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.843 -1.16 . . . . 0.0 108.011 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -145.8 95.73 2.69 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.26 -136.38 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.244 -0.91 . . . . 0.0 109.329 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 83.0 m-70 -62.04 -28.7 69.78 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 120.78 -1.2 . . . . 0.0 109.014 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 173.82 35.08 0.04 OUTLIER Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.668 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -113.42 -173.57 2.29 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.734 -1.45 . . . . 0.0 109.98 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.488 ' O ' ' C ' ' A' ' 56' ' ' ASN . . . -135.46 135.01 40.18 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.47 -0.769 . . . . 0.0 110.335 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.488 ' C ' ' O ' ' A' ' 55' ' ' ALA . 6.7 m120 18.55 65.79 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.288 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 20.1 m -102.36 115.11 29.88 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.186 -0.946 . . . . 0.0 108.847 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.61 HG12 ' HB3' ' A' ' 47' ' ' PRO . 52.4 mt -96.86 122.46 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.2 -0.937 . . . . 0.0 108.732 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.3 t -114.13 129.69 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.319 -0.863 . . . . 0.0 110.928 -177.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 44' ' ' HIS . 0.9 OUTLIER -107.11 126.39 52.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.378 -0.826 . . . . 0.0 109.899 179.237 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.443 ' O ' ' N ' ' A' ' 44' ' ' HIS . 2.6 t-20 -133.36 150.0 51.84 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.167 -0.958 . . . . 0.0 111.015 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.481 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 54.2 m -123.15 145.57 48.49 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.533 ' CD ' ' HA2' ' A' ' 66' ' ' GLY . 21.5 ttmt -135.45 144.36 46.41 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.688 -1.258 . . . . 0.0 111.22 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -120.84 97.75 5.69 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 69.3 20.15 74.89 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.533 ' HA2' ' CD ' ' A' ' 63' ' ' LYS . . . 79.06 23.78 62.96 Favored Glycine 0 N--CA 1.485 1.962 0 O-C-N 120.763 -1.434 . . . . 0.0 110.403 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.3 -80.31 0.2 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.92 -1.341 . . . . 0.0 111.979 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 2.4 m-90 -130.63 -145.11 0.27 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.173 -0.954 . . . . 0.0 110.67 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.481 ' HA2' ' O ' ' A' ' 62' ' ' SER . . . 164.35 143.61 3.77 Favored Glycine 0 N--CA 1.483 1.781 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 99.8 m -92.66 116.79 29.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.593 -0.946 . . . . 0.0 110.271 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -98.44 120.98 39.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.956 -1.09 . . . . 0.0 109.713 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.412 ' O ' ' CB ' ' A' ' 73' ' ' ARG . 1.0 OUTLIER -165.01 133.54 3.34 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.055 -1.028 . . . . 0.0 110.622 -179.716 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.412 ' CB ' ' O ' ' A' ' 72' ' ' GLN . 2.5 mtt-85 172.55 168.73 0.12 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.249 -0.907 . . . . 0.0 111.333 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -110.92 -179.92 3.87 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.367 -0.833 . . . . 0.0 109.975 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -101.61 100.81 11.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.169 -0.957 . . . . 0.0 109.618 178.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.472 HG22 ' HD3' ' A' ' 78' ' ' PRO . 2.6 p -125.06 134.1 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.097 -1.002 . . . . 0.0 110.121 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.499 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 12.5 p90 -140.52 87.07 11.9 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.029 -1.044 . . . . 0.0 111.951 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.472 ' HD3' HG22 ' A' ' 76' ' ' VAL . 51.5 Cg_endo -85.03 7.94 4.9 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 124.192 1.627 . . . . 0.0 110.498 178.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -144.48 178.01 8.25 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.268 -0.895 . . . . 0.0 110.291 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.442 ' CG ' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -143.08 172.44 5.68 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.438 -0.789 . . . . 0.0 109.794 179.427 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.442 ' HD2' ' CG ' ' A' ' 80' ' ' GLN . 44.8 Cg_endo -66.64 152.49 80.57 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.907 1.478 . . . . 0.0 110.684 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.6 22.67 78.18 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.239 -1.545 . . . . 0.0 109.239 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.8 m -138.0 149.46 46.1 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.199 -1.177 . . . . 0.0 111.087 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.7 m -76.46 138.91 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.603 -0.685 . . . . 0.0 110.466 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -146.0 144.22 29.96 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.083 -1.011 . . . . 0.0 110.473 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -123.96 146.42 48.5 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.207 -0.933 . . . . 0.0 110.414 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 53.7 t -130.42 131.2 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.332 -0.855 . . . . 0.0 110.27 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . 0.419 ' HB3' ' HB3' ' A' ' 99' ' ' LYS . 4.9 t -93.69 126.38 38.83 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.186 -0.946 . . . . 0.0 110.454 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.419 ' O ' ' HB3' ' A' ' 17' ' ' LEU . 97.4 mt -120.34 127.04 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.265 -0.897 . . . . 0.0 109.976 179.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 27.6 m -127.72 134.15 49.55 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.0 -1.063 . . . . 0.0 108.945 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.472 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 69.0 t80 -114.49 116.98 29.71 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.718 -1.239 . . . . 0.0 111.204 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -113.0 146.19 39.52 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 65.3 tp60 -56.1 -37.74 69.79 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.983 -1.073 . . . . 0.0 110.576 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.83 -43.38 68.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.013 -1.054 . . . . 0.0 111.291 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -155.18 179.22 9.36 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.993 -1.067 . . . . 0.0 110.852 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.5 ' HB3' ' HB2' ' A' ' 108' ' ' PHE . 53.4 tp -110.82 124.91 52.95 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.392 -0.817 . . . . 0.0 108.958 178.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.659 HG23 ' OE2' ' A' ' 105' ' ' GLU . 3.3 m -107.3 127.66 53.75 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.164 -0.96 . . . . 0.0 110.966 -179.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.406 ' O ' ' HG3' ' A' ' 105' ' ' GLU . 50.6 t -131.4 130.98 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.219 -0.926 . . . . 0.0 109.712 179.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.419 ' HB3' ' HB3' ' A' ' 88' ' ' CYS . 86.0 tttt -116.69 126.68 53.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.929 -1.107 . . . . 0.0 110.76 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.423 HD12 ' O ' ' A' ' 104' ' ' TYR . 4.0 mt -76.17 160.64 77.64 Favored Pre-proline 0 C--N 1.303 -1.453 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -66.67 -24.19 48.14 Favored 'Trans proline' 0 C--N 1.302 -1.912 0 O-C-N 123.657 1.346 . . . . 0.0 110.289 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -155.99 73.67 0.83 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.354 -0.841 . . . . 0.0 110.134 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -178.91 -166.83 35.56 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.427 -1.368 . . . . 0.0 110.635 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.423 ' O ' HD12 ' A' ' 100' ' ' LEU . 72.3 m-85 -77.17 -165.5 0.58 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.489 -1.007 . . . . 0.0 110.671 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.659 ' OE2' HG23 ' A' ' 97' ' ' THR . 69.3 tt0 -129.07 159.41 36.05 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.313 -0.867 . . . . 0.0 110.821 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -132.25 153.13 50.94 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.256 -0.903 . . . . 0.0 110.921 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 98.2 mttt -129.05 146.51 51.0 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.778 0.799 . . . . 0.0 111.57 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.5 ' HB2' ' HB3' ' A' ' 96' ' ' LEU . 0.4 OUTLIER -118.19 140.42 27.99 Favored Pre-proline 0 C--N 1.302 -1.462 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.579 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -71.4 161.96 43.88 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 O-C-N 123.645 1.34 . . . . 0.0 110.615 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -71.81 59.04 0.33 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.488 -0.758 . . . . 0.0 111.404 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 15.6 tpt85 -62.99 -39.8 95.85 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.056 -1.027 . . . . 0.0 109.022 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.403 HD11 ' HB3' ' A' ' 62' ' ' SER . 82.8 mt -105.9 124.26 49.28 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.681 -0.637 . . . . 0.0 109.533 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -86.71 69.71 10.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.916 -1.115 . . . . 0.0 109.803 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 35.5 tp -95.04 129.73 42.01 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.62 -0.675 . . . . 0.0 110.063 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -92.23 -13.11 30.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.234 -0.916 . . . . 0.0 110.553 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.517 ' HA ' ' O ' ' A' ' 11' ' ' LEU . . . -162.91 153.11 16.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.015 -1.053 . . . . 0.0 110.786 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.653 HD13 HD13 ' A' ' 34' ' ' LEU . 87.0 mt -109.48 128.1 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.997 -1.064 . . . . 0.0 110.663 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -120.52 -21.92 6.61 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.188 -0.945 . . . . 0.0 111.041 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.432 ' HB2' ' O ' ' A' ' 36' ' ' LYS . 83.2 t80 -105.82 125.45 51.0 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.166 -0.959 . . . . 0.0 111.283 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 62.0 ttp -143.13 133.02 24.05 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.305 -0.872 . . . . 0.0 108.759 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -144.12 142.67 30.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.624 -1.297 . . . . 0.0 110.71 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.477 ' HB1' ' CD2' ' A' ' 32' ' ' LEU . . . -140.12 111.26 7.04 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.526 -0.734 . . . . 0.0 109.797 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.474 ' N ' ' OD1' ' A' ' 123' ' ' ASP . 26.5 p-10 -147.0 143.65 28.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.249 -0.907 . . . . 0.0 110.093 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.413 ' HA3' ' HA ' ' A' ' 30' ' ' PHE . . . 152.04 -157.08 27.05 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.504 ' HB3' ' CB ' ' A' ' 27' ' ' ALA . 87.1 m-20 -76.31 -1.16 25.29 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.283 -1.128 . . . . 0.0 110.141 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.485 ' HD1' HG22 ' A' ' 23' ' ' VAL . 28.2 t80 -99.8 133.71 43.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.962 -1.086 . . . . 0.0 109.528 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' A' ' 22' ' ' GLU . 75.7 mmtt -106.18 136.27 46.18 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.956 -1.09 . . . . 0.0 111.322 -178.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.482 HG23 ' O ' ' A' ' 128' ' ' ILE . 15.0 tt -101.04 125.2 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.266 -0.896 . . . . 0.0 110.836 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -103.35 -18.58 14.79 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.268 -0.895 . . . . 0.0 111.655 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -159.31 149.88 19.44 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.402 -1.436 . . . . 0.0 113.258 -179.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 46.2 t -125.81 133.21 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 177.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -146.05 149.71 34.59 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.403 -1.436 . . . . 0.0 111.342 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.601 ' HE2' HD12 ' A' ' 11' ' ' LEU . 59.7 m-85 -105.3 128.07 53.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.624 -0.673 . . . . 0.0 110.453 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 23.1 t0 . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.521 179.342 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.226 0.536 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 2' ' ' CYS . . . . . 0.547 ' HA ' ' HB2' ' B' ' 123' ' ' ASP . 1.3 m -90.05 56.9 3.59 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.224 -0.923 . . . . 0.0 110.653 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' GLY . . . . . 0.532 ' O ' ' ND2' ' A' ' 8' ' ' ASN . . . 32.43 -148.43 0.01 OUTLIER Glycine 0 N--CA 1.505 3.268 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.929 HD22 HD23 ' A' ' 9' ' ' LEU . 49.2 mt -98.53 128.75 44.98 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.652 -1.499 . . . . 0.0 109.053 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 62.9 t -96.63 135.6 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.049 -1.032 . . . . 0.0 109.651 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' ALA . . . . . 0.942 ' HB1' HD11 ' B' ' 9' ' ' LEU . . . -124.7 145.2 49.81 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.184 -0.948 . . . . 0.0 111.023 -178.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' SER . . . . . 0.444 ' O ' ' HB3' ' B' ' 8' ' ' ASN . 33.2 p -145.9 170.38 16.71 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . 0.444 ' HB3' ' O ' ' B' ' 7' ' ' SER . 41.3 t-20 59.36 32.12 21.61 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.186 -0.946 . . . . 0.0 109.276 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.942 HD11 ' HB1' ' B' ' 6' ' ' ALA . 96.6 mt -91.47 5.28 50.05 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.656 -0.653 . . . . 0.0 111.598 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' ASN . . . . . 0.521 ' C ' ' O ' ' B' ' 9' ' ' LEU . 37.3 t-20 -4.47 78.66 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.531 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.594 HD12 ' HE2' ' B' ' 133' ' ' PHE . 5.8 tt -92.95 131.18 38.19 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.223 -0.923 . . . . 0.0 109.258 179.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -100.76 165.51 14.17 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.249 -0.907 . . . . 0.0 111.182 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . 0.475 ' HA ' ' O ' ' B' ' 91' ' ' PHE . 52.3 Cg_endo -68.96 147.31 67.71 Favored 'Trans proline' 0 C--N 1.301 -1.967 0 O-C-N 124.069 1.563 . . . . 0.0 110.736 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.37 0.89 59.4 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.979 -1.105 . . . . 0.0 110.729 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -115.33 147.86 39.96 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.852 -1.381 . . . . 0.0 110.277 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' CYS . . . . . . . . . . . . . 1.2 m -97.29 146.69 24.89 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.175 -0.953 . . . . 0.0 110.806 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.418 ' HB3' ' O ' ' B' ' 89' ' ' ILE . 53.3 tp -133.15 133.8 43.33 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.592 -0.693 . . . . 0.0 110.146 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 78.0 mtt85 -122.88 151.95 41.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.238 -0.913 . . . . 0.0 110.439 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 t -141.22 102.31 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.54 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -99.82 130.52 46.03 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.319 -0.863 . . . . 0.0 109.969 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -144.26 -171.75 14.46 Favored Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.884 -1.151 . . . . 0.0 110.495 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -124.08 153.74 40.97 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.492 -1.005 . . . . 0.0 109.336 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.484 HG22 ' HD1' ' B' ' 126' ' ' PHE . 69.9 t -118.59 133.34 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.908 -1.12 . . . . 0.0 111.422 -178.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.479 ' HB3' ' HB2' ' B' ' 27' ' ' ALA . . . -58.98 150.51 60.64 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.025 -1.047 . . . . 0.0 109.517 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.83 -18.22 52.6 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.817 1.43 . . . . 0.0 111.374 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -125.17 29.29 6.13 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.0 -1.062 . . . . 0.0 108.671 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . 0.5 ' CB ' ' HB3' ' B' ' 125' ' ' ASP . . . -63.14 105.27 0.68 Allowed 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.353 0.597 . . . . 0.0 111.965 -178.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -64.08 -49.86 70.62 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.358 -0.838 . . . . 0.0 109.846 178.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 87.4 p -163.93 160.25 21.8 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.305 -0.872 . . . . 0.0 111.661 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' PHE . . . . . 0.542 ' CZ ' ' HG2' ' B' ' 47' ' ' PRO . 47.9 p90 -151.64 161.75 42.15 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' B' ' 45' ' ' PHE . 2.2 p -139.06 138.69 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.375 -1.453 . . . . 0.0 112.787 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.474 ' CD2' ' HB1' ' B' ' 122' ' ' ALA . 89.4 mt -123.86 143.44 50.35 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.467 -0.771 . . . . 0.0 108.925 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' ASN . . . . . 0.669 ' HB2' HD12 ' B' ' 41' ' ' LEU . 26.6 p30 -151.14 163.14 39.5 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.83 -1.168 . . . . 0.0 110.709 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.707 HD12 ' O ' ' B' ' 34' ' ' LEU . 3.8 pp -154.78 126.32 7.44 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.205 -0.934 . . . . 0.0 110.767 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . 0.47 ' HA3' ' HA ' ' B' ' 41' ' ' LEU . . . -160.98 -152.43 6.6 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . 0.426 ' HE2' ' HB3' ' B' ' 40' ' ' ASN . 60.4 pttt -104.08 -30.58 10.15 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.389 -1.065 . . . . 0.0 109.702 178.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . 0.477 ' O ' ' CD2' ' B' ' 41' ' ' LEU . 22.4 t70 -143.98 167.68 21.79 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.248 -0.907 . . . . 0.0 110.52 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . 0.509 ' O ' HD23 ' B' ' 41' ' ' LEU . 5.7 t -51.37 -46.34 62.72 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.389 -0.819 . . . . 0.0 112.808 -177.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' ASN . . . . . 0.454 ' HB3' ' N ' ' B' ' 66' ' ' GLY . 28.0 m-20 -91.79 -2.66 56.82 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.503 -1.373 . . . . 0.0 110.209 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' ASN . . . . . 0.426 ' HB3' ' HE2' ' B' ' 36' ' ' LYS . 5.7 m-80 -110.15 56.06 0.63 Allowed 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.241 -0.912 . . . . 0.0 110.41 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.669 HD12 ' HB2' ' B' ' 33' ' ' ASN . 3.6 mm? -85.76 139.84 30.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.304 -0.873 . . . . 0.0 110.105 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' CYS . . . . . . . . . . . . . 1.7 m -89.63 -27.01 20.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 109.895 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 14.4 tp -141.44 135.82 30.69 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 121.188 -0.945 . . . . 0.0 110.812 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' HIS . . . . . 0.512 ' O ' ' HA ' ' B' ' 60' ' ' CYS . 20.4 m-70 -121.66 117.49 26.8 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.13 -0.981 . . . . 0.0 109.284 178.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.531 ' O ' ' HA ' ' B' ' 31' ' ' VAL . 39.6 t80 -113.66 122.62 47.73 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.07 -1.019 . . . . 0.0 109.086 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -154.41 76.83 5.52 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 120.955 -1.09 . . . . 0.0 111.104 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' PRO . . . . . 0.589 ' HB3' HG12 ' B' ' 58' ' ' ILE . 55.4 Cg_endo -70.69 147.1 56.13 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 124.119 1.589 . . . . 0.0 110.427 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -122.55 120.59 34.27 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.144 -0.972 . . . . 0.0 109.809 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -59.27 -48.61 80.97 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.92 -1.113 . . . . 0.0 108.199 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -146.69 95.48 2.6 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.46 -136.91 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.447 -0.783 . . . . 0.0 109.097 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -61.75 -26.87 68.33 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.668 -1.27 . . . . 0.0 109.272 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 171.14 35.77 0.03 OUTLIER Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.642 -1.266 . . . . 0.0 110.563 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -113.94 -173.65 2.32 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.836 -1.391 . . . . 0.0 109.79 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.505 ' O ' ' C ' ' B' ' 56' ' ' ASN . . . -134.75 138.51 44.4 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.427 -0.796 . . . . 0.0 109.827 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' ASN . . . . . 0.505 ' C ' ' O ' ' B' ' 55' ' ' ALA . 6.5 m120 13.29 68.09 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.233 0 CA-C-O 121.535 0.683 . . . . 0.0 112.834 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 19.6 m -102.99 114.88 29.54 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.443 -0.786 . . . . 0.0 108.928 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' ILE . . . . . 0.589 HG12 ' HB3' ' B' ' 47' ' ' PRO . 52.0 mt -96.84 122.52 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.111 -0.993 . . . . 0.0 108.729 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.42 HG13 ' HG3' ' B' ' 71' ' ' GLU . 56.0 t -113.82 130.0 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.383 -0.823 . . . . 0.0 111.105 -178.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' CYS . . . . . 0.512 ' HA ' ' O ' ' B' ' 44' ' ' HIS . 0.8 OUTLIER -107.77 125.16 51.07 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.295 -0.878 . . . . 0.0 109.939 179.262 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' ASN . . . . . 0.447 ' HB3' ' HB2' ' B' ' 44' ' ' HIS . 2.8 t-20 -132.06 149.86 52.3 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.189 -0.944 . . . . 0.0 111.109 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' SER . . . . . 0.478 ' O ' ' HA2' ' B' ' 69' ' ' GLY . 54.4 m -123.02 145.52 48.44 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.153 -0.967 . . . . 0.0 108.532 179.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . 0.528 ' CD ' ' HA2' ' B' ' 66' ' ' GLY . 21.4 ttmt -135.12 144.87 47.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.655 -1.278 . . . . 0.0 111.092 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -121.17 97.81 5.69 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 69.32 20.05 74.82 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . 0.528 ' HA2' ' CD ' ' B' ' 63' ' ' LYS . . . 79.38 23.56 62.72 Favored Glycine 0 N--CA 1.487 2.064 0 C-N-CA 119.278 -1.439 . . . . 0.0 110.337 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.27 -80.33 0.2 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.875 -1.368 . . . . 0.0 111.867 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' TRP . . . . . . . . . . . . . 2.4 m-90 -130.54 -144.97 0.27 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.22 -0.925 . . . . 0.0 110.711 -178.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' B' ' 62' ' ' SER . . . 164.05 143.26 3.65 Favored Glycine 0 N--CA 1.483 1.828 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 99.6 m -92.25 117.46 29.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.567 -0.96 . . . . 0.0 110.326 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . 0.42 ' HG3' HG13 ' B' ' 59' ' ' VAL . 81.2 tt0 -98.97 120.91 40.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.013 -1.055 . . . . 0.0 109.646 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -165.04 133.53 3.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.997 -1.065 . . . . 0.0 110.551 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 2.5 mtt-85 172.73 169.11 0.12 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.34 -0.85 . . . . 0.0 111.246 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -111.06 180.0 3.89 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.38 -0.825 . . . . 0.0 109.942 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -101.44 100.6 11.08 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.078 -1.014 . . . . 0.0 109.683 178.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 76' ' ' VAL . . . . . 0.487 HG22 ' HD3' ' B' ' 78' ' ' PRO . 2.6 p -124.76 134.15 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.983 -1.073 . . . . 0.0 110.127 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 77' ' ' PHE . . . . . 0.506 ' N ' ' CD1' ' B' ' 77' ' ' PHE . 11.9 p90 -140.4 87.26 11.98 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 120.942 -1.099 . . . . 0.0 111.782 -179.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . 0.487 ' HD3' HG22 ' B' ' 76' ' ' VAL . 50.3 Cg_endo -85.15 7.56 5.08 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 124.136 1.598 . . . . 0.0 110.427 178.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -144.01 178.18 8.04 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.216 -0.927 . . . . 0.0 110.488 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.434 ' CG ' ' HD2' ' B' ' 81' ' ' PRO . 0.0 OUTLIER -143.09 172.38 5.75 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.351 -0.843 . . . . 0.0 109.792 179.597 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 81' ' ' PRO . . . . . 0.434 ' HD2' ' CG ' ' B' ' 80' ' ' GLN . 44.0 Cg_endo -66.59 152.85 79.87 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.771 1.406 . . . . 0.0 110.764 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.22 22.68 78.66 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 66.1 m -138.06 149.01 45.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.095 -1.238 . . . . 0.0 111.16 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 33.5 m -76.06 139.15 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.663 -0.648 . . . . 0.0 110.614 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -146.32 143.93 29.46 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.055 -1.028 . . . . 0.0 110.431 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -123.69 146.83 47.96 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.228 -0.92 . . . . 0.0 110.445 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 54.4 t -130.78 131.19 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.394 -0.816 . . . . 0.0 110.049 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 88' ' ' CYS . . . . . 0.405 ' HB3' ' HB3' ' B' ' 99' ' ' LYS . 4.5 t -93.79 126.64 39.09 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.168 -0.957 . . . . 0.0 110.404 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.418 ' O ' ' HB3' ' B' ' 17' ' ' LEU . 97.2 mt -120.55 127.11 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.137 -0.977 . . . . 0.0 110.019 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 27.5 m -127.85 134.15 49.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.081 -1.012 . . . . 0.0 109.001 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 91' ' ' PHE . . . . . 0.475 ' O ' ' HA ' ' B' ' 13' ' ' PRO . 70.6 t80 -114.49 116.47 28.9 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 118.813 -1.155 . . . . 0.0 111.491 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -112.92 146.28 39.26 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 65.0 tp60 -56.24 -37.74 70.13 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 120.896 -1.128 . . . . 0.0 110.546 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.48 -43.45 69.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.157 -0.965 . . . . 0.0 111.348 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -155.53 178.91 9.71 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.075 -1.016 . . . . 0.0 110.744 -178.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 96' ' ' LEU . . . . . 0.484 ' HB3' ' HB2' ' B' ' 108' ' ' PHE . 53.5 tp -110.26 124.76 52.21 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.313 -0.867 . . . . 0.0 109.159 178.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 97' ' ' THR . . . . . 0.655 HG23 ' OE2' ' B' ' 105' ' ' GLU . 2.9 m -107.34 127.35 53.49 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.157 -0.964 . . . . 0.0 110.938 -178.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 98' ' ' VAL . . . . . 0.406 ' O ' ' HG3' ' B' ' 105' ' ' GLU . 50.1 t -131.26 130.79 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -0.909 . . . . 0.0 109.81 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 99' ' ' LYS . . . . . 0.405 ' HB3' ' HB3' ' B' ' 88' ' ' CYS . 85.8 tttt -116.58 126.15 52.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.874 -1.141 . . . . 0.0 111.093 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 100' ' ' LEU . . . . . 0.423 HD12 ' O ' ' B' ' 104' ' ' TYR . 4.0 mt -75.46 160.35 79.78 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.392 -0.818 . . . . 0.0 108.849 178.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -66.59 -24.35 48.55 Favored 'Trans proline' 0 C--N 1.302 -1.908 0 O-C-N 123.701 1.369 . . . . 0.0 110.217 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -155.81 75.39 0.9 Allowed 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.336 -0.852 . . . . 0.0 110.177 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 178.54 -167.12 37.41 Favored Glycine 0 N--CA 1.495 2.619 0 C-N-CA 119.407 -1.378 . . . . 0.0 110.548 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 104' ' ' TYR . . . . . 0.423 ' O ' HD12 ' B' ' 100' ' ' LEU . 73.7 m-85 -77.0 -165.4 0.55 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.476 -1.014 . . . . 0.0 110.958 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 105' ' ' GLU . . . . . 0.655 ' OE2' HG23 ' B' ' 97' ' ' THR . 69.4 tt0 -129.53 159.03 37.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.348 -0.845 . . . . 0.0 110.527 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -132.03 153.19 50.63 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.476 -0.765 . . . . 0.0 110.936 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 107' ' ' LYS . . . . . 0.428 ' HA ' ' O ' ' B' ' 96' ' ' LEU . 98.2 mttt -129.2 146.73 51.06 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.354 -0.841 . . . . 0.0 111.537 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 108' ' ' PHE . . . . . 0.484 ' HB2' ' HB3' ' B' ' 96' ' ' LEU . 0.4 OUTLIER -118.29 140.34 27.96 Favored Pre-proline 0 C--N 1.301 -1.537 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.669 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -71.51 162.19 43.05 Favored 'Trans proline' 0 C--N 1.301 -1.938 0 O-C-N 123.575 1.303 . . . . 0.0 110.574 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 110' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -72.0 59.29 0.37 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.559 -0.713 . . . . 0.0 111.266 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 15.3 tpt85 -63.34 -39.58 94.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.099 -1.0 . . . . 0.0 109.015 178.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 112' ' ' LEU . . . . . 0.401 HD11 ' HB3' ' B' ' 62' ' ' SER . 81.2 mt -105.91 124.34 49.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.69 -0.631 . . . . 0.0 109.551 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -86.77 69.88 10.34 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.918 -1.114 . . . . 0.0 109.743 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 36.5 tp -95.09 129.75 42.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.626 -0.671 . . . . 0.0 110.079 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -92.25 -12.92 31.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.18 -0.95 . . . . 0.0 110.7 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 116' ' ' ALA . . . . . 0.538 ' HA ' ' O ' ' B' ' 11' ' ' LEU . . . -162.97 153.44 16.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.016 -1.052 . . . . 0.0 110.626 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 117' ' ' ILE . . . . . 0.652 HD13 HD13 ' B' ' 34' ' ' LEU . 89.4 mt -109.92 128.08 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.072 -1.018 . . . . 0.0 110.707 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -120.36 -21.8 6.75 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.18 -0.95 . . . . 0.0 111.121 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 119' ' ' TYR . . . . . 0.418 ' HB2' ' O ' ' B' ' 36' ' ' LYS . 83.2 t80 -106.09 125.75 51.37 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.032 -1.042 . . . . 0.0 111.18 -179.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 61.5 ttp -143.41 133.04 23.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.352 -0.843 . . . . 0.0 108.728 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -144.28 142.91 30.75 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.65 -1.281 . . . . 0.0 110.686 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 122' ' ' ALA . . . . . 0.474 ' HB1' ' CD2' ' B' ' 32' ' ' LEU . . . -140.48 111.27 6.91 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.566 -0.709 . . . . 0.0 109.701 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 123' ' ' ASP . . . . . 0.547 ' HB2' ' HA ' ' B' ' 2' ' ' CYS . 26.3 p-10 -147.42 142.59 27.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.389 -0.82 . . . . 0.0 109.894 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 124' ' ' GLY . . . . . 0.418 ' HA3' ' HA ' ' B' ' 30' ' ' PHE . . . 153.48 -157.22 27.25 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.821 -1.711 . . . . 0.0 108.821 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . 0.5 ' HB3' ' CB ' ' B' ' 27' ' ' ALA . 86.9 m-20 -76.35 -0.94 24.45 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.263 -1.139 . . . . 0.0 110.161 179.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 126' ' ' PHE . . . . . 0.484 ' HD1' HG22 ' B' ' 23' ' ' VAL . 28.2 t80 -100.03 133.7 44.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.005 -1.059 . . . . 0.0 109.473 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -106.27 135.88 46.97 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.976 -1.078 . . . . 0.0 111.307 -178.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . 0.478 ' O ' HG23 ' B' ' 128' ' ' ILE . 14.9 tt -100.47 125.61 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.267 -0.896 . . . . 0.0 110.877 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -103.43 -19.99 14.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.151 -0.968 . . . . 0.0 111.624 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 130' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -156.87 150.25 24.24 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.345 -1.472 . . . . 0.0 113.456 -179.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 46.3 t -125.81 133.37 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 177.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 132' ' ' ALA . . . . . . . . . . . . . . . -146.13 149.72 34.55 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.278 -1.514 . . . . 0.0 111.13 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . 0.594 ' HE2' HD12 ' B' ' 11' ' ' LEU . 60.2 m-85 -105.52 128.01 53.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.587 -0.696 . . . . 0.0 110.441 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 23.0 t0 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.755 179.346 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.44 ' HA3' ' O ' ' A' ' 122' ' ' ALA . . . . . . . . 0 N--CA 1.493 2.464 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.439 HD21 HG23 ' A' ' 128' ' ' ILE . 1.1 pp -67.7 156.4 37.01 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.264 -1.139 . . . . 0.0 111.615 -178.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.4 t -118.63 132.73 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.6 ' HB3' HD11 ' A' ' 9' ' ' LEU . . . -110.04 178.98 4.24 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.871 -1.143 . . . . 0.0 110.985 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.42 ' O ' ' HB3' ' A' ' 8' ' ' ASN . 27.7 p -155.95 171.08 20.69 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.428 ' HB3' ' HA ' ' B' ' 4' ' ' LEU . 63.6 t30 58.25 35.88 25.27 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.288 -0.882 . . . . 0.0 110.545 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.6 HD11 ' HB3' ' A' ' 6' ' ' ALA . 78.5 mt -87.29 -5.61 58.85 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.488 -0.757 . . . . 0.0 111.156 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.505 ' C ' ' O ' ' A' ' 9' ' ' LEU . 4.9 m120 6.34 66.33 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.748 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.7 HD11 ' CE2' ' A' ' 133' ' ' PHE . 11.2 mt -93.07 129.05 39.15 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.048 -1.033 . . . . 0.0 110.514 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.43 ' CB ' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -98.79 171.74 5.45 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.295 -0.878 . . . . 0.0 110.783 -179.971 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.43 ' HD2' ' CB ' ' A' ' 12' ' ' LYS . 39.4 Cg_endo -65.17 148.13 88.77 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.221 1.643 . . . . 0.0 109.378 178.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.8 -16.01 54.98 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -111.35 142.09 44.04 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.177 -1.19 . . . . 0.0 109.699 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 58.2 m -109.77 153.19 24.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.196 -0.94 . . . . 0.0 110.181 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.493 HD12 ' O ' ' A' ' 132' ' ' ALA . 57.5 tp -118.28 130.7 56.2 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.221 -0.924 . . . . 0.0 110.349 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -110.99 125.75 54.05 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.577 -0.702 . . . . 0.0 109.489 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 74.0 t -121.16 123.29 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.92 -1.113 . . . . 0.0 110.158 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -123.56 128.44 49.73 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.215 -0.928 . . . . 0.0 109.645 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -146.86 -152.83 5.74 Favored Glycine 0 N--CA 1.489 2.226 0 C-N-CA 119.292 -1.433 . . . . 0.0 110.292 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -136.5 142.34 43.51 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.656 -0.908 . . . . 0.0 109.467 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.489 ' CG1' ' HA ' ' A' ' 81' ' ' PRO . 34.8 t -108.48 132.98 54.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 O-C-N 121.334 -0.854 . . . . 0.0 111.131 -178.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.92 152.57 96.73 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.528 -0.732 . . . . 0.0 109.871 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.404 ' HA ' ' HB2' ' A' ' 81' ' ' PRO . 42.9 Cg_endo -65.79 -28.3 51.4 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 123.955 1.503 . . . . 0.0 110.631 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -97.34 16.15 20.89 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.267 -0.895 . . . . 0.0 109.945 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.471 ' HA ' ' HB3' ' A' ' 125' ' ' ASP . . . -61.75 98.76 0.1 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.107 -0.996 . . . . 0.0 110.874 -179.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -95.04 -15.61 23.33 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.513 -0.742 . . . . 0.0 110.682 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 42.1 t -167.38 142.25 3.88 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 118.725 -1.19 . . . . 0.0 111.454 -178.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.532 ' CE2' ' HB2' ' A' ' 32' ' ' LEU . 10.6 t80 -149.34 157.63 43.49 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.429 -0.794 . . . . 0.0 109.993 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.648 HG23 ' CE1' ' A' ' 44' ' ' HIS . 2.5 p -129.09 131.16 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.909 -1.119 . . . . 0.0 110.837 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.532 ' HB2' ' CE2' ' A' ' 30' ' ' PHE . 12.7 tp -131.42 129.68 41.57 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.61 -0.681 . . . . 0.0 109.165 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -161.24 153.19 19.64 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.433 -1.417 . . . . 0.0 111.027 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.779 HD12 HD13 ' A' ' 117' ' ' ILE . 0.4 OUTLIER -143.61 128.09 17.96 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.673 0.749 . . . . 0.0 109.656 179.261 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.457 ' HA3' ' HA ' ' A' ' 41' ' ' LEU . . . -163.79 -160.38 11.67 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.47 ' O ' ' CD1' ' A' ' 119' ' ' TYR . 40.3 mtpt -67.45 -42.17 83.51 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 122.394 1.092 . . . . 0.0 108.212 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -157.45 -168.93 2.73 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.73 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.2 t -62.36 -42.8 99.69 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.781 -0.575 . . . . 0.0 112.296 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.466 ' HB3' ' N ' ' A' ' 66' ' ' GLY . 92.9 m-20 -87.06 -14.5 41.29 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.867 -1.146 . . . . 0.0 110.786 -178.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.441 ' HB2' ' HB2' ' A' ' 36' ' ' LYS . 5.6 m-80 -113.21 70.02 0.71 Allowed 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.867 0.841 . . . . 0.0 108.82 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.457 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 72.5 mt -100.72 139.09 36.89 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.729 ' SG ' HD23 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -83.96 -25.66 29.87 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.944 -1.097 . . . . 0.0 110.723 -179.301 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.729 HD23 ' SG ' ' A' ' 42' ' ' CYS . 2.8 pp -155.71 136.29 13.33 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.265 -0.897 . . . . 0.0 110.216 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.648 ' CE1' HG23 ' A' ' 31' ' ' VAL . 38.6 t60 -133.27 121.46 22.49 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.48 -0.763 . . . . 0.0 109.786 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -115.5 133.69 55.8 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.077 -1.015 . . . . 0.0 110.487 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -137.75 78.1 37.35 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 120.999 -1.063 . . . . 0.0 110.393 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -67.15 142.41 61.05 Favored 'Trans proline' 0 C--N 1.302 -1.88 0 O-C-N 123.865 1.455 . . . . 0.0 109.978 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -128.03 122.5 32.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.115 -0.991 . . . . 0.0 110.189 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -60.23 -46.74 88.72 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 118.605 -1.238 . . . . 0.0 108.403 178.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -147.53 102.15 3.42 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.617 -0.677 . . . . 0.0 110.017 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -84.97 -144.03 0.09 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.301 -0.875 . . . . 0.0 108.977 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -50.14 -29.4 9.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.102 -0.999 . . . . 0.0 109.373 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 170.48 38.64 0.03 OUTLIER Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -112.24 -172.52 2.06 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.035 -1.273 . . . . 0.0 109.917 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.466 ' O ' ' C ' ' A' ' 56' ' ' ASN . . . -139.79 137.19 34.82 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.181 -0.949 . . . . 0.0 110.596 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.466 ' C ' ' O ' ' A' ' 55' ' ' ALA . 92.4 m-20 24.79 60.67 0.05 Allowed 'General case' 0 N--CA 1.509 2.507 0 CA-C-O 121.412 0.625 . . . . 0.0 112.208 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 8.8 m -113.05 141.39 46.93 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.323 -0.86 . . . . 0.0 109.862 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.48 HG23 ' HB2' ' A' ' 74' ' ' GLU . 18.9 tt -136.75 138.85 45.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.211 -0.931 . . . . 0.0 110.318 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 55.4 t -119.57 127.2 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.302 -0.874 . . . . 0.0 110.312 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 47.9 t -96.08 126.94 41.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.368 -0.833 . . . . 0.0 110.337 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.466 ' O ' ' HB3' ' A' ' 44' ' ' HIS . 23.8 t-20 -136.34 148.78 48.07 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.408 -0.807 . . . . 0.0 110.295 -179.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.456 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 71.1 m -125.3 150.45 47.11 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.805 -1.184 . . . . 0.0 108.948 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.477 ' CD ' ' HA2' ' A' ' 66' ' ' GLY . 19.0 ttmt -138.63 148.25 43.85 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.672 -1.268 . . . . 0.0 111.718 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -120.97 97.48 5.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.675 -0.64 . . . . 0.0 110.44 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.403 ' C ' ' HB3' ' A' ' 39' ' ' ASN . . . 66.99 24.11 73.02 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.477 ' HA2' ' CD ' ' A' ' 63' ' ' LYS . . . 75.07 25.12 69.72 Favored Glycine 0 N--CA 1.48 1.606 0 C-N-CA 119.137 -1.506 . . . . 0.0 110.515 178.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -87.08 -81.02 0.24 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.988 -1.301 . . . . 0.0 110.649 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.455 ' O ' ' HG3' ' A' ' 63' ' ' LYS . 41.3 m95 -124.08 -156.59 0.72 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.075 -1.016 . . . . 0.0 110.445 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.456 ' HA2' ' O ' ' A' ' 62' ' ' SER . . . 163.86 114.9 0.31 Allowed Glycine 0 N--CA 1.487 2.05 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.6 m -80.65 121.5 25.93 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.541 -0.976 . . . . 0.0 110.412 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -91.27 129.19 37.29 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.175 -0.953 . . . . 0.0 110.913 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -112.26 -172.36 2.03 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.12 -0.988 . . . . 0.0 109.358 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -147.79 126.31 12.44 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 118.416 -1.314 . . . . 0.0 112.437 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.48 ' HB2' HG23 ' A' ' 58' ' ' ILE . 95.8 mt-10 -115.47 145.59 42.45 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -119.49 48.62 1.48 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.769 -1.207 . . . . 0.0 109.093 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.3 m -119.39 132.39 69.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.426 -0.796 . . . . 0.0 110.931 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -161.51 80.16 2.06 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.392 -0.818 . . . . 0.0 109.57 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -81.17 8.3 4.44 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 124.163 1.612 . . . . 0.0 111.37 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.409 ' CD2' ' HB2' ' A' ' 85' ' ' ALA . 12.2 m-85 -132.14 179.12 6.3 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.937 -1.102 . . . . 0.0 110.212 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.424 ' HB3' ' HD2' ' A' ' 81' ' ' PRO . 0.7 OUTLIER -144.16 177.23 1.87 Allowed Pre-proline 0 C--N 1.296 -1.741 0 O-C-N 121.545 -0.722 . . . . 0.0 109.221 -179.222 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.489 ' HA ' ' CG1' ' A' ' 23' ' ' VAL . 50.3 Cg_endo -71.26 157.29 57.46 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.531 1.279 . . . . 0.0 109.748 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 68.7 26.93 74.2 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.879 -1.688 . . . . 0.0 108.879 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.0 m -133.76 151.99 51.75 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.466 -1.02 . . . . 0.0 110.068 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 69.4 t -95.53 129.63 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.254 -0.903 . . . . 0.0 110.236 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.409 ' HB2' ' CD2' ' A' ' 79' ' ' PHE . . . -149.5 147.1 27.81 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.272 -0.893 . . . . 0.0 110.516 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -122.33 142.87 50.04 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.227 -0.921 . . . . 0.0 109.451 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 39.8 t -127.54 132.64 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.061 -1.024 . . . . 0.0 111.131 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -95.26 140.19 30.51 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.316 -0.865 . . . . 0.0 111.205 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.6 mt -124.64 128.58 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.612 -0.68 . . . . 0.0 110.417 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.534 ' HB ' ' HB ' ' A' ' 97' ' ' THR . 52.5 m -121.98 128.81 51.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.167 -0.958 . . . . 0.0 109.859 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.411 ' HA ' HD12 ' A' ' 96' ' ' LEU . 62.1 t80 -109.3 117.89 35.25 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.216 -0.928 . . . . 0.0 111.087 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -125.29 150.56 46.99 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.509 -0.744 . . . . 0.0 110.418 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.443 ' NE2' ' O ' ' A' ' 114' ' ' LEU . 75.8 mm-40 -62.52 -37.94 88.02 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.349 -0.844 . . . . 0.0 110.252 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.01 -40.84 95.51 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.211 -0.931 . . . . 0.0 110.113 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.437 ' C ' ' OD1' ' A' ' 95' ' ' ASN . 11.0 p30 -169.02 -171.67 1.38 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.378 -0.826 . . . . 0.0 110.521 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 91' ' ' PHE . 20.3 tp -112.12 132.87 54.61 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.409 -0.807 . . . . 0.0 109.599 178.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.534 ' HB ' ' HB ' ' A' ' 90' ' ' THR . 23.2 m -117.14 126.44 52.82 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.871 -1.143 . . . . 0.0 110.94 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 41.2 t -123.21 129.82 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.181 -0.949 . . . . 0.0 109.674 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -115.36 126.93 55.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.169 -0.957 . . . . 0.0 110.735 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.8 mp -100.34 164.55 16.09 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.581 -0.7 . . . . 0.0 109.833 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -64.91 -24.01 61.26 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.732 1.385 . . . . 0.0 110.371 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -77.37 -14.59 59.68 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.243 -0.911 . . . . 0.0 110.478 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.96 -13.2 59.08 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -70.93 135.32 47.87 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.922 -1.34 . . . . 0.0 109.977 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -124.66 138.7 54.29 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.437 -0.79 . . . . 0.0 110.175 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -126.43 134.46 50.98 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.093 -1.004 . . . . 0.0 109.636 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -112.83 145.06 41.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.069 -1.02 . . . . 0.0 111.049 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.52 ' CE2' ' O ' ' A' ' 109' ' ' PRO . 3.1 t80 -134.23 136.95 26.96 Favored Pre-proline 0 C--N 1.301 -1.521 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.52 ' O ' ' CE2' ' A' ' 108' ' ' PHE . 38.5 Cg_endo -64.18 133.98 40.44 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.642 1.338 . . . . 0.0 110.643 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.454 ' ND2' ' O ' ' A' ' 110' ' ' ASN . 6.2 p-10 -85.98 83.58 7.75 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.202 -0.936 . . . . 0.0 110.397 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -55.92 -20.8 17.4 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.937 -1.102 . . . . 0.0 109.657 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 97.5 mt -101.97 133.3 46.98 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.225 -0.922 . . . . 0.0 109.92 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -88.71 67.29 8.33 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.242 -0.911 . . . . 0.0 110.887 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.473 HD11 ' O ' ' A' ' 116' ' ' ALA . 33.8 tp -87.38 120.45 28.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.232 -0.917 . . . . 0.0 109.368 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.418 ' O ' ' HD3' ' A' ' 13' ' ' PRO . 16.6 pt-20 -82.84 -13.73 55.63 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.678 -1.264 . . . . 0.0 110.469 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.473 ' O ' HD11 ' A' ' 114' ' ' LEU . . . -157.59 157.54 33.88 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.806 -1.184 . . . . 0.0 111.267 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.779 HD13 HD12 ' A' ' 34' ' ' LEU . 95.1 mt -108.57 126.81 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.45 -0.781 . . . . 0.0 109.607 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -111.17 -27.74 8.58 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.998 -1.064 . . . . 0.0 111.255 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.47 ' CD1' ' O ' ' A' ' 36' ' ' LYS . 3.0 m-85 -117.15 140.86 49.0 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.935 -1.103 . . . . 0.0 112.503 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.442 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 54.8 ttp -138.76 129.64 26.52 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -136.61 136.42 39.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.398 -1.439 . . . . 0.0 111.097 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.44 ' O ' ' HA3' ' A' ' 3' ' ' GLY . . . -149.5 116.34 5.94 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.533 ' O ' HG12 ' A' ' 31' ' ' VAL . 65.8 t0 -147.02 118.67 8.0 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.611 -0.681 . . . . 0.0 109.384 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 179.62 -151.72 10.34 Favored Glycine 0 N--CA 1.489 2.206 0 C-N-CA 119.612 -1.28 . . . . 0.0 110.385 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.471 ' HB3' ' HA ' ' A' ' 27' ' ' ALA . 99.6 m-20 -74.46 -2.82 27.23 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.96 -0.729 . . . . 0.0 111.122 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.499 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 24.8 t80 -96.62 137.79 35.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.997 -1.064 . . . . 0.0 110.334 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -110.75 120.53 42.72 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 118.43 -1.308 . . . . 0.0 111.098 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.739 HD11 HG22 ' A' ' 131' ' ' VAL . 7.6 tt -101.37 114.26 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.223 -0.923 . . . . 0.0 110.242 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -97.85 -13.58 21.21 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 120.904 -1.122 . . . . 0.0 110.999 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -147.92 148.41 30.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.748 -1.22 . . . . 0.0 112.59 -179.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.739 HG22 HD11 ' A' ' 128' ' ' ILE . 52.6 t -133.42 131.33 57.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.493 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -127.99 146.71 50.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.628 -1.295 . . . . 0.0 110.785 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.7 ' CE2' HD11 ' A' ' 11' ' ' LEU . 10.0 m-85 -109.24 127.65 54.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.567 -0.708 . . . . 0.0 110.106 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 59.5 t0 . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 117.948 -1.025 . . . . 0.0 111.123 179.249 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.813 0 CA-C-O 120.849 0.357 . . . . 0.0 110.687 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 2' ' ' CYS . . . . . 0.452 ' O ' ' O ' ' B' ' 126' ' ' PHE . 99.1 m -141.64 -123.78 0.1 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.812 -1.18 . . . . 0.0 109.91 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 3' ' ' GLY . . . . . 0.44 ' HA3' ' O ' ' B' ' 122' ' ' ALA . . . 176.28 121.56 0.67 Allowed Glycine 0 N--CA 1.494 2.534 0 N-CA-C 108.679 -1.768 . . . . 0.0 108.679 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.433 HD21 HG23 ' B' ' 128' ' ' ILE . 1.2 pp -68.22 156.6 37.26 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.233 -1.157 . . . . 0.0 111.49 -178.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 45.5 t -118.84 132.59 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.706 -0.621 . . . . 0.0 109.399 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' ALA . . . . . 0.572 ' HB3' HD11 ' B' ' 9' ' ' LEU . . . -110.09 178.57 4.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.738 -1.226 . . . . 0.0 111.26 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' SER . . . . . 0.45 ' O ' ' HB3' ' B' ' 8' ' ' ASN . 26.3 p -155.45 170.9 20.88 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . 0.45 ' HB3' ' O ' ' B' ' 7' ' ' SER . 63.5 t30 59.16 35.2 23.58 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.366 -0.834 . . . . 0.0 110.539 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.572 HD11 ' HB3' ' B' ' 6' ' ' ALA . 81.1 mt -88.1 -1.58 58.09 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.29 -0.881 . . . . 0.0 111.306 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' ASN . . . . . 0.505 ' C ' ' O ' ' B' ' 9' ' ' LEU . 4.7 m120 -0.05 69.38 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.751 0 N-CA-C 113.874 1.065 . . . . 0.0 113.874 -178.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.681 HD11 ' CE2' ' B' ' 133' ' ' PHE . 11.1 mt -93.81 128.65 40.17 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.312 -0.867 . . . . 0.0 110.442 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . 0.412 ' CB ' ' HD2' ' B' ' 13' ' ' PRO . 0.0 OUTLIER -98.68 171.73 5.47 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.285 -0.885 . . . . 0.0 110.872 -179.786 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' B' ' 115' ' ' GLU . 40.7 Cg_endo -65.34 147.99 87.97 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.242 1.654 . . . . 0.0 109.501 178.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.11 -16.25 54.0 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -111.17 142.06 43.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.065 -1.256 . . . . 0.0 109.951 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' CYS . . . . . . . . . . . . . 57.7 m -109.46 153.75 23.61 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.162 -0.961 . . . . 0.0 110.277 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.475 HD12 ' O ' ' B' ' 132' ' ' ALA . 56.6 tp -118.68 130.8 56.04 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.245 -0.91 . . . . 0.0 110.366 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -111.05 125.87 54.21 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.553 -0.717 . . . . 0.0 109.483 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 79.1 t -121.06 122.61 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.946 -1.096 . . . . 0.0 110.253 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -123.02 128.62 50.42 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.145 -0.972 . . . . 0.0 109.691 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -147.35 -152.92 5.77 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.42 -1.372 . . . . 0.0 110.349 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 -136.5 142.37 43.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.597 -0.943 . . . . 0.0 109.527 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.494 ' CG1' ' HA ' ' B' ' 81' ' ' PRO . 32.0 t -108.47 132.7 55.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 O-C-N 121.495 -0.753 . . . . 0.0 111.122 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.62 152.36 96.71 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.582 -0.699 . . . . 0.0 110.057 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -65.35 -29.13 54.54 Favored 'Trans proline' 0 C--N 1.303 -1.858 0 O-C-N 124.042 1.548 . . . . 0.0 110.466 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -96.85 16.46 19.21 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.429 -0.794 . . . . 0.0 110.104 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . 0.476 ' HA ' ' HB3' ' B' ' 125' ' ' ASP . . . -62.61 99.13 0.14 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.269 -0.895 . . . . 0.0 110.697 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -95.16 -17.98 21.31 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.399 -0.813 . . . . 0.0 110.785 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 39.4 t -163.82 142.77 7.84 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.977 -1.089 . . . . 0.0 111.452 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' PHE . . . . . 0.528 ' CE2' ' HB2' ' B' ' 32' ' ' LEU . 9.9 t80 -149.74 157.51 43.29 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.381 -0.825 . . . . 0.0 110.017 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.667 HG23 ' CE1' ' B' ' 44' ' ' HIS . 2.5 p -128.89 131.74 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 120.766 -1.209 . . . . 0.0 110.989 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.528 ' HB2' ' CE2' ' B' ' 30' ' ' PHE . 12.7 tp -131.42 129.8 41.73 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.524 -0.735 . . . . 0.0 109.16 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -161.3 153.74 20.26 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 118.287 -1.365 . . . . 0.0 110.851 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.803 HD12 HD13 ' B' ' 117' ' ' ILE . 0.4 OUTLIER -144.57 124.96 13.86 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.636 0.731 . . . . 0.0 109.804 179.411 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' B' ' 41' ' ' LEU . . . -159.7 -159.35 9.72 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . 0.467 ' O ' ' CD1' ' B' ' 119' ' ' TYR . 40.6 mtpt -67.81 -42.34 81.7 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -156.55 -167.59 2.45 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.879 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 8.7 t -62.97 -42.87 99.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.774 -0.579 . . . . 0.0 112.41 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' ASN . . . . . 0.477 ' HB3' ' N ' ' B' ' 66' ' ' GLY . 92.0 m-20 -87.3 -14.52 40.65 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.983 -1.073 . . . . 0.0 110.751 -178.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' ASN . . . . . 0.435 ' HB2' ' HB2' ' B' ' 36' ' ' LYS . 6.1 m-80 -112.67 70.06 0.71 Allowed 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.458 ' HA ' ' HA3' ' B' ' 35' ' ' GLY . 73.0 mt -100.29 142.03 32.32 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' CYS . . . . . 0.69 ' SG ' HD23 ' B' ' 43' ' ' LEU . 0.0 OUTLIER -88.33 -23.5 23.4 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.832 -1.167 . . . . 0.0 110.359 -178.891 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.733 HD21 HD21 ' B' ' 34' ' ' LEU . 2.8 pp -156.57 135.93 12.19 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.26 -0.9 . . . . 0.0 110.154 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' HIS . . . . . 0.667 ' CE1' HG23 ' B' ' 31' ' ' VAL . 37.7 t60 -133.19 121.29 22.31 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.691 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -115.51 133.88 55.61 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.136 -0.978 . . . . 0.0 110.296 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -137.8 78.25 36.73 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.046 -1.034 . . . . 0.0 110.3 178.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -67.14 142.53 61.54 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.851 1.448 . . . . 0.0 109.772 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -128.31 121.98 30.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.126 -0.984 . . . . 0.0 110.014 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -60.12 -46.87 88.19 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 118.35 -1.34 . . . . 0.0 108.344 178.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -147.18 102.35 3.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.699 -0.626 . . . . 0.0 109.97 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.37 -144.02 0.1 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.279 -0.888 . . . . 0.0 108.992 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -50.18 -28.72 7.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.085 -1.01 . . . . 0.0 109.409 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 169.55 38.81 0.03 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -112.25 -172.62 2.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.046 -1.267 . . . . 0.0 109.889 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.499 ' O ' ' C ' ' B' ' 56' ' ' ASN . . . -138.46 142.11 39.45 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.306 -0.871 . . . . 0.0 109.949 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' ASN . . . . . 0.499 ' C ' ' O ' ' B' ' 55' ' ' ALA . 92.0 m-20 16.41 64.33 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.569 0 CA-C-O 121.83 0.824 . . . . 0.0 112.51 -178.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 9.7 m -113.84 141.0 47.87 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.654 -0.654 . . . . 0.0 109.758 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' ILE . . . . . 0.476 HG23 ' HB2' ' B' ' 74' ' ' GLU . 18.7 tt -136.72 138.11 46.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.192 -0.942 . . . . 0.0 110.335 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 55.4 t -118.38 127.76 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.258 -0.901 . . . . 0.0 110.306 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 47.9 t -96.56 126.03 41.45 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.373 -0.83 . . . . 0.0 110.226 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' ASN . . . . . 0.451 ' O ' ' HB3' ' B' ' 44' ' ' HIS . 24.1 t-20 -135.58 148.68 49.16 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.42 -0.8 . . . . 0.0 110.527 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' SER . . . . . 0.447 ' O ' ' HA2' ' B' ' 69' ' ' GLY . 72.1 m -125.06 150.93 46.29 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.677 -1.264 . . . . 0.0 109.042 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . 0.496 ' CD ' ' HA2' ' B' ' 66' ' ' GLY . 18.6 ttmt -138.93 148.03 43.04 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.651 -1.281 . . . . 0.0 111.526 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -120.85 97.67 5.65 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.612 -0.68 . . . . 0.0 110.312 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 67.08 23.65 73.01 Favored Glycine 0 N--CA 1.487 2.061 0 C-N-CA 119.491 -1.338 . . . . 0.0 110.131 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . 0.496 ' HA2' ' CD ' ' B' ' 63' ' ' LYS . . . 75.18 24.85 70.19 Favored Glycine 0 N--CA 1.487 2.081 0 O-C-N 120.846 -1.385 . . . . 0.0 110.305 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -86.55 -81.56 0.22 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.964 -1.315 . . . . 0.0 110.662 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' TRP . . . . . 0.457 ' O ' ' HG3' ' B' ' 63' ' ' LYS . 41.2 m95 -124.05 -156.11 0.7 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.13 -0.981 . . . . 0.0 110.374 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' B' ' 62' ' ' SER . . . 163.35 114.69 0.31 Allowed Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 5.4 m -80.46 120.96 25.14 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.538 -0.978 . . . . 0.0 110.492 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -90.59 128.92 36.74 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.272 -0.892 . . . . 0.0 111.082 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -112.06 -172.14 1.98 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.951 -1.093 . . . . 0.0 109.282 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -147.7 127.36 13.35 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 118.257 -1.377 . . . . 0.0 112.34 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 74' ' ' GLU . . . . . 0.476 ' HB2' HG23 ' B' ' 58' ' ' ILE . 96.0 mt-10 -116.37 145.11 43.47 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -119.48 48.42 1.52 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.986 -1.071 . . . . 0.0 109.112 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 33.8 m -119.37 132.14 70.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-O 121.561 0.696 . . . . 0.0 110.679 -179.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -161.35 81.29 2.01 Favored Pre-proline 0 C--N 1.301 -1.519 0 O-C-N 121.743 -0.598 . . . . 0.0 109.548 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -82.23 8.77 4.31 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 121.843 1.696 . . . . 0.0 111.234 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 79' ' ' PHE . . . . . 0.409 ' CD2' ' HB2' ' B' ' 85' ' ' ALA . 13.8 m-85 -132.79 178.99 6.43 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.918 -1.114 . . . . 0.0 110.403 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.451 ' HB3' ' HD2' ' B' ' 81' ' ' PRO . 0.7 OUTLIER -144.02 177.26 1.87 Allowed Pre-proline 0 C--N 1.297 -1.705 0 O-C-N 121.553 -0.717 . . . . 0.0 109.19 -179.25 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 81' ' ' PRO . . . . . 0.494 ' HA ' ' CG1' ' B' ' 23' ' ' VAL . 54.0 Cg_endo -71.34 157.15 57.5 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.699 1.368 . . . . 0.0 109.412 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 68.5 26.62 74.25 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 6.5 m -133.37 151.73 51.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.505 -0.997 . . . . 0.0 110.039 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 70.7 t -95.72 129.26 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.259 -0.901 . . . . 0.0 110.23 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 85' ' ' ALA . . . . . 0.409 ' HB2' ' CD2' ' B' ' 79' ' ' PHE . . . -149.27 147.3 28.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.221 -0.924 . . . . 0.0 110.473 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -122.12 143.29 49.63 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.243 -0.911 . . . . 0.0 109.4 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 39.5 t -127.41 132.29 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.069 -1.02 . . . . 0.0 111.293 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 88' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -94.78 139.83 30.74 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.344 -0.848 . . . . 0.0 111.166 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 96.8 mt -124.85 128.55 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.675 -0.64 . . . . 0.0 110.254 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 90' ' ' THR . . . . . 0.494 ' HB ' ' HB ' ' B' ' 97' ' ' THR . 52.1 m -122.36 128.75 51.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.157 -0.964 . . . . 0.0 109.811 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 91' ' ' PHE . . . . . 0.414 ' HA ' HD12 ' B' ' 96' ' ' LEU . 61.6 t80 -109.02 118.5 36.94 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.157 -0.964 . . . . 0.0 111.049 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -125.58 150.65 47.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.516 -0.74 . . . . 0.0 110.356 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . 0.431 ' NE2' ' O ' ' B' ' 114' ' ' LEU . 75.2 mm-40 -62.65 -37.62 87.1 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.359 -0.838 . . . . 0.0 110.246 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.27 -40.84 94.44 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.195 -0.94 . . . . 0.0 110.116 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 95' ' ' ASN . . . . . 0.424 ' C ' ' OD1' ' B' ' 95' ' ' ASN . 10.5 p30 -168.77 -171.04 1.29 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.419 -0.8 . . . . 0.0 110.506 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 96' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' B' ' 91' ' ' PHE . 20.3 tp -112.82 132.85 55.09 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.26 -0.9 . . . . 0.0 109.324 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 97' ' ' THR . . . . . 0.494 ' HB ' ' HB ' ' B' ' 90' ' ' THR . 22.1 m -117.24 126.58 52.98 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.979 -1.076 . . . . 0.0 110.831 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 40.8 t -123.18 130.39 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.234 -0.916 . . . . 0.0 109.66 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -115.75 127.53 55.18 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.076 -1.015 . . . . 0.0 110.69 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 mp -101.08 164.29 16.34 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.576 -0.702 . . . . 0.0 109.71 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -64.87 -24.16 61.37 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.696 1.366 . . . . 0.0 110.217 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -77.22 -14.16 59.82 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.312 -0.868 . . . . 0.0 110.567 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.27 -13.08 60.21 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 104' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -71.11 135.84 47.88 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.915 -1.344 . . . . 0.0 109.893 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -124.89 139.18 54.07 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.394 -0.816 . . . . 0.0 110.033 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -127.07 134.5 50.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.085 -1.01 . . . . 0.0 109.452 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -113.03 145.2 41.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.045 -1.035 . . . . 0.0 111.011 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 108' ' ' PHE . . . . . 0.522 ' CE2' ' O ' ' B' ' 109' ' ' PRO . 2.9 t80 -134.34 136.89 26.72 Favored Pre-proline 0 C--N 1.3 -1.56 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 109' ' ' PRO . . . . . 0.522 ' O ' ' CE2' ' B' ' 108' ' ' PHE . 37.6 Cg_endo -64.05 134.8 44.49 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.757 1.399 . . . . 0.0 110.682 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 110' ' ' ASN . . . . . 0.469 ' ND2' ' O ' ' B' ' 110' ' ' ASN . 6.4 p-10 -87.04 83.87 7.41 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.032 -1.042 . . . . 0.0 110.279 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -55.99 -21.37 20.83 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.972 -1.08 . . . . 0.0 109.537 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 97.4 mt -101.57 133.12 46.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.138 -0.976 . . . . 0.0 109.896 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -88.59 67.35 8.45 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.301 -0.874 . . . . 0.0 110.763 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 114' ' ' LEU . . . . . 0.469 HD11 ' O ' ' B' ' 116' ' ' ALA . 36.2 tp -87.14 121.22 29.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.308 -0.87 . . . . 0.0 109.059 178.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 115' ' ' GLU . . . . . 0.428 ' O ' ' HD3' ' B' ' 13' ' ' PRO . 16.5 pt-20 -83.5 -13.97 53.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.624 -1.298 . . . . 0.0 110.474 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 116' ' ' ALA . . . . . 0.469 ' O ' HD11 ' B' ' 114' ' ' LEU . . . -157.05 157.8 35.3 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.965 -1.084 . . . . 0.0 110.904 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 117' ' ' ILE . . . . . 0.803 HD13 HD12 ' B' ' 34' ' ' LEU . 95.5 mt -108.89 126.87 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.288 -0.882 . . . . 0.0 109.532 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -111.2 -27.04 8.87 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.851 -1.156 . . . . 0.0 111.348 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 119' ' ' TYR . . . . . 0.467 ' CD1' ' O ' ' B' ' 36' ' ' LYS . 2.8 m-85 -117.42 141.2 48.62 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.91 -1.119 . . . . 0.0 112.48 -178.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 120' ' ' MET . . . . . 0.461 ' HA ' ' HA ' ' B' ' 34' ' ' LEU . 54.2 ttp -139.07 129.95 26.3 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -136.96 136.56 38.66 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.429 -1.419 . . . . 0.0 111.221 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 122' ' ' ALA . . . . . 0.44 ' O ' ' HA3' ' B' ' 3' ' ' GLY . . . -149.35 116.32 5.99 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 123' ' ' ASP . . . . . 0.534 ' O ' HG12 ' B' ' 31' ' ' VAL . 64.9 t0 -146.68 118.68 8.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.387 -0.82 . . . . 0.0 109.431 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 179.33 -152.27 10.93 Favored Glycine 0 N--CA 1.487 2.084 0 C-N-CA 119.392 -1.385 . . . . 0.0 110.464 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . 0.476 ' HB3' ' HA ' ' B' ' 27' ' ' ALA . 99.7 m-20 -74.28 -2.93 27.13 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.844 -0.798 . . . . 0.0 111.067 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 126' ' ' PHE . . . . . 0.504 ' HB3' ' CD1' ' B' ' 30' ' ' PHE . 24.6 t80 -96.24 138.27 34.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.001 -1.062 . . . . 0.0 110.288 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -111.13 120.3 41.87 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 118.477 -1.289 . . . . 0.0 111.003 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . 0.739 HD11 HG22 ' B' ' 131' ' ' VAL . 7.8 tt -100.9 114.85 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.046 -1.034 . . . . 0.0 110.282 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -98.39 -13.3 20.7 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.739 -1.225 . . . . 0.0 110.957 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 130' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -147.89 148.22 30.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.762 -1.211 . . . . 0.0 112.538 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.739 HG22 HD11 ' B' ' 128' ' ' ILE . 53.1 t -133.28 130.69 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 132' ' ' ALA . . . . . 0.475 ' O ' HD12 ' B' ' 17' ' ' LEU . . . -127.39 146.72 50.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.418 -1.426 . . . . 0.0 110.861 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . 0.681 ' CE2' HD11 ' B' ' 11' ' ' LEU . 10.0 m-85 -108.75 127.65 54.19 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.505 -0.747 . . . . 0.0 110.033 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 58.4 t0 . . . . . 0 N--CA 1.497 1.906 0 CA-C-O 117.876 -1.059 . . . . 0.0 111.354 179.141 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.342 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.488 ' HA ' ' HB3' ' B' ' 8' ' ' ASN . 30.9 tp -61.58 133.43 55.65 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.031 -1.276 . . . . 0.0 110.702 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.1 t -123.15 133.49 68.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.47 -0.768 . . . . 0.0 109.866 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.47 148.56 44.28 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.167 -0.958 . . . . 0.0 110.235 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.453 ' O ' ' HB3' ' A' ' 8' ' ' ASN . 74.4 m -142.02 167.69 21.52 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.32 -0.862 . . . . 0.0 109.397 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.453 ' HB3' ' O ' ' A' ' 7' ' ' SER . 7.4 t30 60.57 32.85 20.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.415 -0.803 . . . . 0.0 109.628 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.645 HD22 ' HB2' ' A' ' 120' ' ' MET . 1.0 OUTLIER -84.65 -2.84 58.06 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.731 -0.605 . . . . 0.0 111.552 -179.393 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.493 ' C ' ' O ' ' A' ' 9' ' ' LEU . 87.9 m-20 11.29 63.73 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.623 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.487 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 14.0 tp -78.55 143.27 36.67 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.846 -1.159 . . . . 0.0 109.824 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.8 mtmt -127.22 158.62 68.67 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 120.969 -1.082 . . . . 0.0 109.915 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -66.49 147.31 82.17 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.83 1.437 . . . . 0.0 110.557 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.53 -9.18 41.2 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -122.98 147.49 46.57 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.927 -1.337 . . . . 0.0 110.204 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 56.8 m -93.3 142.81 26.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.325 -0.859 . . . . 0.0 110.771 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 42.6 tp -120.17 128.5 53.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.394 -0.816 . . . . 0.0 108.908 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -123.37 143.1 50.33 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.878 -1.139 . . . . 0.0 111.656 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.5 t -128.52 116.12 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.641 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -111.79 125.24 53.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.088 -1.008 . . . . 0.0 109.959 178.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.471 ' O ' HG23 ' A' ' 84' ' ' VAL . . . -144.96 -155.78 6.59 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -135.23 145.89 48.07 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.281 -1.129 . . . . 0.0 108.966 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 39.9 t -111.45 130.94 64.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 O-C-N 121.124 -0.985 . . . . 0.0 110.562 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.66 153.15 72.4 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.512 -0.743 . . . . 0.0 110.291 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.407 ' O ' ' HB2' ' A' ' 81' ' ' PRO . 43.5 Cg_endo -67.23 -20.34 49.48 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.992 1.522 . . . . 0.0 110.469 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.401 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 49.9 p-10 -119.11 25.2 10.33 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.293 -0.879 . . . . 0.0 110.416 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.432 ' HA ' ' HB3' ' A' ' 125' ' ' ASP . . . -60.05 104.87 0.34 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.898 -1.126 . . . . 0.0 110.315 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 26' ' ' ASP . 64.2 mttp -95.52 -15.23 23.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.332 -0.855 . . . . 0.0 111.073 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.8 t -160.54 132.94 6.2 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.722 -1.236 . . . . 0.0 111.719 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.502 ' CD1' ' HB3' ' A' ' 126' ' ' PHE . 14.8 t80 -136.72 144.98 44.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.589 -0.695 . . . . 0.0 109.595 178.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.8 t -126.37 131.46 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.03 -1.044 . . . . 0.0 110.836 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.494 ' HB2' ' CZ ' ' A' ' 30' ' ' PHE . 20.9 tp -135.76 135.52 40.03 Favored 'General case' 0 N--CA 1.484 1.235 0 O-C-N 121.47 -0.769 . . . . 0.0 109.997 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.893 ' HB2' HD13 ' A' ' 41' ' ' LEU . 28.5 p30 -142.95 155.37 44.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.787 -1.195 . . . . 0.0 110.508 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.687 HD21 ' HB2' ' A' ' 43' ' ' LEU . 0.6 OUTLIER -153.58 111.84 3.62 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.29 -0.881 . . . . 0.0 110.19 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.487 ' O ' ' CB ' ' A' ' 119' ' ' TYR . . . -161.04 -173.41 29.63 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.634 -1.786 . . . . 0.0 108.634 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.431 ' O ' ' HB2' ' A' ' 119' ' ' TYR . 98.7 mttt -78.61 -44.66 23.43 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.87 -1.37 . . . . 0.0 110.482 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.419 ' HB2' ' HB2' ' A' ' 40' ' ' ASN . 85.3 m-20 -119.8 165.03 15.09 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.761 -177.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.7 t -56.98 -45.7 82.74 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.604 -0.685 . . . . 0.0 112.425 -178.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.45 ' HB3' ' N ' ' A' ' 66' ' ' GLY . 55.6 m-20 -89.46 -0.92 57.84 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.491 -1.381 . . . . 0.0 110.242 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.419 ' HB2' ' HB2' ' A' ' 37' ' ' ASP . 5.2 m-80 -111.52 58.37 0.62 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.269 -0.895 . . . . 0.0 109.713 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.893 HD13 ' HB2' ' A' ' 33' ' ' ASN . 71.9 mt -83.15 134.08 35.0 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.63 ' SG ' HD22 ' A' ' 114' ' ' LEU . 83.6 m -81.73 -40.44 22.72 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.998 -1.064 . . . . 0.0 110.224 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.687 ' HB2' HD21 ' A' ' 34' ' ' LEU . 83.0 mt -131.87 140.21 49.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.218 -0.926 . . . . 0.0 110.262 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.416 ' HB3' ' O ' ' A' ' 61' ' ' ASN . 62.9 t-80 -140.46 139.54 35.2 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.199 -0.938 . . . . 0.0 110.425 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -127.92 146.41 50.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.114 -0.991 . . . . 0.0 110.224 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.411 ' HA ' ' O ' ' A' ' 30' ' ' PHE . 0.2 OUTLIER -152.83 61.07 3.6 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 109.909 179.46 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.486 ' HB3' HD12 ' A' ' 58' ' ' ILE . 52.4 Cg_endo -69.01 147.2 67.15 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 124.144 1.602 . . . . 0.0 110.573 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 91.7 mtm-85 -135.53 125.69 26.21 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.11 -0.994 . . . . 0.0 110.637 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -61.93 -46.81 87.69 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.018 -1.051 . . . . 0.0 108.988 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -148.52 84.51 1.49 Allowed 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.52 -117.41 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.264 -0.898 . . . . 0.0 110.176 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 25.5 m80 -77.97 -13.06 60.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.583 -1.323 . . . . 0.0 110.458 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 164.75 -22.27 0.14 Allowed Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.611 -1.281 . . . . 0.0 110.459 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -60.85 -179.16 0.12 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.777 -1.425 . . . . 0.0 110.118 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.522 ' O ' ' C ' ' A' ' 56' ' ' ASN . . . -122.21 135.66 54.8 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.619 -0.676 . . . . 0.0 109.985 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.522 ' C ' ' O ' ' A' ' 55' ' ' ALA . 1.9 m-20 14.33 74.83 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.48 0 CA-C-O 121.297 0.57 . . . . 0.0 112.122 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' A' ' 47' ' ' PRO . 47.2 m -110.13 130.3 55.56 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.203 -0.935 . . . . 0.0 110.392 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.486 HD12 ' HB3' ' A' ' 47' ' ' PRO . 19.6 tt -128.71 131.0 68.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.596 -0.69 . . . . 0.0 109.975 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 59' ' ' VAL . 21.8 m -125.81 129.34 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.147 -0.971 . . . . 0.0 110.136 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 11.3 t -86.13 130.67 34.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.263 -0.898 . . . . 0.0 109.355 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.416 ' O ' ' HB3' ' A' ' 44' ' ' HIS . 14.1 t-20 -137.21 144.63 42.95 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.004 -1.06 . . . . 0.0 111.327 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.2 m -119.13 153.95 34.03 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.483 ' CD ' ' HA2' ' A' ' 66' ' ' GLY . 16.6 ttmt -136.69 134.97 37.79 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.876 -1.14 . . . . 0.0 110.437 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -114.32 102.38 10.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.267 -0.895 . . . . 0.0 109.34 178.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.11 27.4 72.27 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.483 ' HA2' ' CD ' ' A' ' 63' ' ' LYS . . . 93.08 2.05 66.65 Favored Glycine 0 N--CA 1.484 1.852 0 C-N-CA 119.624 -1.274 . . . . 0.0 110.005 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.463 ' O ' ' C ' ' A' ' 68' ' ' TRP . . . -109.55 84.4 1.92 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.987 -1.302 . . . . 0.0 109.723 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.477 ' O ' ' HA ' ' A' ' 63' ' ' LYS . 60.2 m95 -6.13 -117.94 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.761 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 129.86 -113.39 1.47 Allowed Glycine 0 N--CA 1.488 2.102 0 O-C-N 119.849 -1.782 . . . . 0.0 109.9 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 21.7 m -78.69 121.45 24.73 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.261 -1.141 . . . . 0.0 111.266 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -126.83 131.18 51.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.398 -0.814 . . . . 0.0 109.684 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.51 156.51 38.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.063 -1.023 . . . . 0.0 110.159 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -134.82 88.86 2.47 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.33 -0.856 . . . . 0.0 109.74 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -114.03 125.88 54.5 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.369 -0.832 . . . . 0.0 109.952 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -93.32 85.54 5.02 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.857 -1.152 . . . . 0.0 110.239 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.625 HG22 ' HD3' ' A' ' 78' ' ' PRO . 2.4 p -127.16 132.11 70.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.231 -0.918 . . . . 0.0 110.151 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.524 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 13.0 p90 -144.9 81.67 10.56 Favored Pre-proline 0 N--CA 1.487 1.398 0 O-C-N 121.211 -0.931 . . . . 0.0 110.326 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.625 ' HD3' HG22 ' A' ' 76' ' ' VAL . 49.8 Cg_endo -72.71 -3.38 13.42 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.844 1.444 . . . . 0.0 111.365 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.531 ' CD2' ' HB2' ' A' ' 85' ' ' ALA . 3.8 m-85 -133.95 179.68 6.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.008 -1.058 . . . . 0.0 111.068 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.471 ' CG ' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -131.41 172.39 7.45 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.562 -0.711 . . . . 0.0 109.464 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.471 ' HD2' ' CG ' ' A' ' 80' ' ' GLN . 52.3 Cg_endo -71.11 150.09 59.42 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.634 1.333 . . . . 0.0 110.09 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.03 26.87 63.39 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 44.7 m -131.76 152.05 51.22 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.12 -1.224 . . . . 0.0 111.016 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 21' ' ' GLY . 12.6 p -91.29 133.38 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.452 -0.78 . . . . 0.0 109.564 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.531 ' HB2' ' CD2' ' A' ' 79' ' ' PHE . . . -151.66 155.62 38.73 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.891 -1.131 . . . . 0.0 110.933 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -122.62 149.6 43.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.331 -0.856 . . . . 0.0 109.724 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.9 t -124.26 130.22 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.103 -0.998 . . . . 0.0 110.403 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 1.4 t -98.82 122.73 42.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.506 -0.746 . . . . 0.0 110.051 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 98.0 mt -122.43 128.63 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.105 -0.997 . . . . 0.0 110.841 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 63.7 m -119.37 128.33 53.98 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.585 ' CZ ' HD11 ' A' ' 114' ' ' LEU . 73.6 t80 -109.4 115.11 29.35 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.788 -1.195 . . . . 0.0 111.376 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 95' ' ' ASN . 79.7 m-20 -118.54 142.36 47.68 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -60.28 -29.89 69.11 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.782 -1.199 . . . . 0.0 110.523 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.47 -40.68 80.9 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 120.918 -1.114 . . . . 0.0 109.214 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.413 ' O ' ' HB2' ' A' ' 92' ' ' ASP . 0.4 OUTLIER -169.95 172.23 6.68 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.959 -0.697 . . . . 0.0 110.461 -179.096 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.434 HD22 ' CD1' ' A' ' 43' ' ' LEU . 38.1 tp -102.17 124.53 47.93 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.159 -0.963 . . . . 0.0 110.227 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.442 HG23 ' OE2' ' A' ' 105' ' ' GLU . 11.1 m -107.33 125.35 51.06 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.124 -0.985 . . . . 0.0 109.267 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 36.7 t -131.38 131.61 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.857 -1.152 . . . . 0.0 110.417 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -120.01 143.56 47.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.177 -0.952 . . . . 0.0 110.491 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.51 HD23 ' HD2' ' A' ' 101' ' ' PRO . 0.5 OUTLIER -111.04 169.57 6.17 Favored Pre-proline 0 C--N 1.301 -1.532 0 O-C-N 121.45 -0.781 . . . . 0.0 109.118 179.226 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.51 ' HD2' HD23 ' A' ' 100' ' ' LEU . 39.8 Cg_endo -63.96 -23.79 67.73 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 123.626 1.329 . . . . 0.0 110.858 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.482 ' HB2' ' CB ' ' A' ' 78' ' ' PRO . 20.8 t0 -75.01 -12.31 60.3 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.012 -1.055 . . . . 0.0 110.974 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 99.15 -10.32 61.7 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.708 -1.234 . . . . 0.0 110.66 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.43 ' CE2' ' OD2' ' A' ' 102' ' ' ASP . 19.4 m-85 -79.78 140.68 36.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.815 -1.403 . . . . 0.0 109.843 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.442 ' OE2' HG23 ' A' ' 97' ' ' THR . 85.2 tt0 -120.86 143.43 48.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.307 -0.871 . . . . 0.0 110.679 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -129.94 147.99 51.75 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.458 -0.776 . . . . 0.0 109.599 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.426 ' C ' ' CD1' ' A' ' 108' ' ' PHE . 98.3 mttt -127.58 145.79 50.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.035 -1.041 . . . . 0.0 111.478 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.494 ' N ' ' CD1' ' A' ' 108' ' ' PHE . 19.2 m-85 -129.81 140.35 38.39 Favored Pre-proline 0 N--CA 1.489 1.508 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.5 140.36 39.71 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 123.407 1.214 . . . . 0.0 109.786 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.459 ' ND2' ' O ' ' A' ' 110' ' ' ASN . 6.0 p-10 -102.3 82.85 2.24 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 122.212 1.006 . . . . 0.0 110.178 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 96.6 mtt-85 -57.17 -22.89 43.69 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.535 -1.353 . . . . 0.0 108.963 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.755 ' HB3' HD23 ' A' ' 114' ' ' LEU . 89.1 mt -81.96 143.82 31.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.753 -0.592 . . . . 0.0 110.413 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -101.63 39.03 1.5 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.131 -0.981 . . . . 0.0 109.561 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.755 HD23 ' HB3' ' A' ' 112' ' ' LEU . 0.8 OUTLIER -73.77 128.05 34.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.435 -0.79 . . . . 0.0 110.914 -179.146 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -88.04 -16.19 34.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.067 -1.021 . . . . 0.0 110.215 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' A' ' 11' ' ' LEU . . . -158.23 155.13 28.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.042 -1.036 . . . . 0.0 111.251 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.518 HD11 HD13 ' A' ' 114' ' ' LEU . 31.6 mm -107.1 130.33 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.203 -0.935 . . . . 0.0 110.18 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.508 ' ND2' ' N ' ' A' ' 118' ' ' ASN . 0.5 OUTLIER -108.92 -15.19 14.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.151 -0.968 . . . . 0.0 110.909 -179.205 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.487 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 4.0 t80 -120.21 129.49 54.11 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.973 -1.079 . . . . 0.0 111.487 -178.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.645 ' HB2' HD22 ' A' ' 9' ' ' LEU . 55.3 ttp -141.35 128.44 20.81 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 178.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.07 149.6 30.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.736 -1.228 . . . . 0.0 111.414 -178.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -152.1 129.07 11.02 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.403 -0.811 . . . . 0.0 109.976 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -147.4 114.81 6.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.311 -0.868 . . . . 0.0 109.377 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.484 ' HA3' ' HA ' ' A' ' 30' ' ' PHE . . . -177.03 -145.32 5.67 Favored Glycine 0 N--CA 1.485 1.947 0 C-N-CA 119.174 -1.489 . . . . 0.0 110.327 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.432 ' HB3' ' HA ' ' A' ' 27' ' ' ALA . 80.2 m-20 -89.04 12.89 14.3 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.781 -0.835 . . . . 0.0 110.707 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.502 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 15.1 t80 -105.8 137.47 43.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.008 -1.057 . . . . 0.0 110.401 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.43 ' O ' ' HA3' ' A' ' 21' ' ' GLY . 98.7 mttt -103.9 109.56 21.35 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.244 -0.91 . . . . 0.0 111.758 -178.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.452 HG23 ' O ' ' A' ' 128' ' ' ILE . 8.7 tt -99.67 117.5 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.028 -1.045 . . . . 0.0 109.432 177.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -109.41 -14.39 14.43 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.164 -0.96 . . . . 0.0 111.733 -178.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.54 142.56 30.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.669 -1.27 . . . . 0.0 112.001 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 59.6 t -126.65 132.99 69.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -138.97 143.73 38.66 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.507 -1.37 . . . . 0.0 111.514 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -73.79 -125.9 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.629 -0.67 . . . . 0.0 109.723 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 47.2 t0 . . . . . 0 N--CA 1.491 1.592 0 O-C-N 120.528 -1.357 . . . . 0.0 110.116 179.674 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.448 0.642 . . . . 0.0 110.513 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 2' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -126.93 84.15 2.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.472 -0.767 . . . . 0.0 109.643 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 92.19 34.51 7.1 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 31.0 tp -62.1 133.04 54.75 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.143 -1.21 . . . . 0.0 110.705 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 39.5 t -122.77 133.18 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.558 -0.714 . . . . 0.0 109.944 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.26 148.13 44.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.133 -0.98 . . . . 0.0 110.396 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' SER . . . . . 0.463 ' O ' ' HB3' ' B' ' 8' ' ' ASN . 74.9 m -141.69 167.41 22.21 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.22 -0.925 . . . . 0.0 109.343 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . 0.488 ' HB3' ' HA ' ' A' ' 4' ' ' LEU . 7.6 t30 60.97 33.14 19.89 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.79 0.805 . . . . 0.0 109.509 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.65 HD22 ' HB2' ' B' ' 120' ' ' MET . 1.0 OUTLIER -86.58 3.48 44.2 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.74 -0.6 . . . . 0.0 111.583 -179.476 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' ASN . . . . . 0.496 ' C ' ' O ' ' B' ' 9' ' ' LEU . 87.3 m-20 2.22 67.67 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.612 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -178.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.493 ' O ' ' HA ' ' B' ' 116' ' ' ALA . 14.0 tp -79.45 143.34 35.07 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.228 -0.92 . . . . 0.0 109.605 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 6.8 mtmt -127.71 158.67 69.5 Favored Pre-proline 0 C--N 1.296 -1.755 0 O-C-N 121.178 -0.951 . . . . 0.0 109.873 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -66.57 147.27 81.77 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.846 1.445 . . . . 0.0 110.658 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.4 -8.95 41.46 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 120.105 -1.045 . . . . 0.0 110.498 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -122.99 147.45 46.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.879 -1.365 . . . . 0.0 110.202 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' CYS . . . . . . . . . . . . . 56.9 m -93.22 142.93 26.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.242 -0.911 . . . . 0.0 110.727 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 43.6 tp -120.34 128.17 53.01 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.403 -0.811 . . . . 0.0 109.004 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -123.05 143.07 50.2 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.871 -1.143 . . . . 0.0 111.751 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 2.5 t -128.3 116.25 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.73 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -112.18 124.84 53.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.02 -1.05 . . . . 0.0 109.938 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.466 ' O ' HG23 ' B' ' 84' ' ' VAL . . . -144.66 -155.88 6.61 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.676 -1.369 . . . . 0.0 109.676 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -134.85 146.12 48.96 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.252 -1.146 . . . . 0.0 109.087 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 39.8 t -111.65 130.31 65.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 121.119 -0.988 . . . . 0.0 110.693 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.95 153.12 67.31 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.392 -0.818 . . . . 0.0 110.452 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . 0.414 ' O ' ' HB2' ' B' ' 81' ' ' PRO . 43.1 Cg_endo -67.23 -20.18 49.63 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.936 1.493 . . . . 0.0 110.555 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' ASP . . . . . 0.411 ' O ' ' HG3' ' B' ' 28' ' ' LYS . 49.5 p-10 -119.42 25.06 10.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.284 -0.885 . . . . 0.0 110.408 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . 0.441 ' HA ' ' HB3' ' B' ' 125' ' ' ASP . . . -59.94 104.47 0.3 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.905 -1.122 . . . . 0.0 110.311 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' B' ' 26' ' ' ASP . 64.3 mttp -94.97 -15.92 23.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.355 -0.841 . . . . 0.0 111.157 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 8.0 t -159.63 133.39 7.28 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.724 -1.235 . . . . 0.0 111.686 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' PHE . . . . . 0.506 ' CD1' ' HB3' ' B' ' 126' ' ' PHE . 14.4 t80 -137.08 144.65 43.22 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.569 -0.707 . . . . 0.0 109.565 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 43.1 t -126.36 131.14 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.975 -1.078 . . . . 0.0 110.944 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.492 ' HB2' ' CZ ' ' B' ' 30' ' ' PHE . 20.6 tp -135.38 135.74 40.9 Favored 'General case' 0 C--N 1.308 -1.234 0 O-C-N 121.525 -0.735 . . . . 0.0 110.181 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' ASN . . . . . 0.918 ' HB2' HD13 ' B' ' 41' ' ' LEU . 28.3 p30 -143.02 155.6 44.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.809 -1.182 . . . . 0.0 110.623 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.691 HD21 ' HB2' ' B' ' 43' ' ' LEU . 0.6 OUTLIER -153.79 110.21 3.33 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.277 -0.889 . . . . 0.0 110.276 179.967 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . 0.482 ' O ' ' CB ' ' B' ' 119' ' ' TYR . . . -158.36 -172.98 26.18 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . 0.451 ' O ' ' HB2' ' B' ' 119' ' ' TYR . 98.8 mttt -78.89 -44.57 22.49 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.876 -1.367 . . . . 0.0 110.415 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . 0.418 ' HB2' ' HB2' ' B' ' 40' ' ' ASN . 84.8 m-20 -119.76 164.91 15.25 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.685 -178.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 11.8 t -56.97 -45.85 82.6 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.634 -0.666 . . . . 0.0 112.294 -178.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' ASN . . . . . 0.452 ' HB3' ' N ' ' B' ' 66' ' ' GLY . 54.8 m-20 -89.24 -0.87 57.8 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.473 -1.392 . . . . 0.0 110.294 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' ASN . . . . . 0.418 ' HB2' ' HB2' ' B' ' 37' ' ' ASP . 5.0 m-80 -111.63 58.16 0.63 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.184 -0.947 . . . . 0.0 109.678 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.918 HD13 ' HB2' ' B' ' 33' ' ' ASN . 72.6 mt -82.31 138.25 34.59 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' CYS . . . . . 0.628 ' SG ' HD22 ' B' ' 114' ' ' LEU . 79.5 m -87.42 -38.22 16.32 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.88 -1.138 . . . . 0.0 109.618 -178.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.691 ' HB2' HD21 ' B' ' 34' ' ' LEU . 83.8 mt -132.58 139.78 47.96 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.142 -0.974 . . . . 0.0 110.016 179.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' HIS . . . . . 0.405 ' HB3' ' O ' ' B' ' 61' ' ' ASN . 63.2 t-80 -140.09 140.09 36.01 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.135 -0.978 . . . . 0.0 110.328 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -128.47 146.03 50.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.192 -0.942 . . . . 0.0 110.2 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' B' ' 30' ' ' PHE . 0.2 OUTLIER -152.26 61.16 3.87 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.379 -0.826 . . . . 0.0 109.984 179.472 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' PRO . . . . . 0.492 ' HB3' HD12 ' B' ' 58' ' ' ILE . 52.2 Cg_endo -69.23 146.67 64.21 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.067 1.562 . . . . 0.0 110.69 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 91.5 mtm-85 -134.94 125.83 27.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.164 -0.96 . . . . 0.0 110.681 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -61.93 -46.62 88.54 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.129 -0.982 . . . . 0.0 109.036 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -148.58 84.36 1.48 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.5 -117.2 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.2 -0.938 . . . . 0.0 110.241 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -77.83 -13.97 59.72 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.633 -1.292 . . . . 0.0 110.405 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 165.53 -22.2 0.13 Allowed Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.568 -1.301 . . . . 0.0 110.494 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -60.51 -179.0 0.1 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.881 -1.364 . . . . 0.0 110.162 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.533 ' O ' ' C ' ' B' ' 56' ' ' ASN . . . -121.98 137.47 54.79 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.57 -0.706 . . . . 0.0 109.598 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' ASN . . . . . 0.533 ' C ' ' O ' ' B' ' 55' ' ' ALA . 1.9 m-20 11.25 76.2 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.514 0 CA-C-O 121.451 0.643 . . . . 0.0 112.107 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' B' ' 47' ' ' PRO . 45.2 m -110.46 130.16 55.62 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.381 -0.825 . . . . 0.0 110.328 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' ILE . . . . . 0.492 HD12 ' HB3' ' B' ' 47' ' ' PRO . 19.6 tt -128.79 130.7 68.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.476 -0.765 . . . . 0.0 110.032 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.486 HG23 ' O ' ' B' ' 59' ' ' VAL . 21.5 m -125.4 129.24 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.154 -0.967 . . . . 0.0 110.349 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 11.2 t -86.03 130.64 34.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.142 -0.974 . . . . 0.0 109.343 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' ASN . . . . . 0.405 ' O ' ' HB3' ' B' ' 44' ' ' HIS . 14.5 t-20 -137.2 144.73 43.01 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.059 -1.025 . . . . 0.0 111.266 -179.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 5.3 m -119.36 153.74 34.69 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . 0.483 ' CD ' ' HA2' ' B' ' 66' ' ' GLY . 16.6 ttmt -136.56 134.82 37.88 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.862 -1.149 . . . . 0.0 110.412 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -113.87 102.45 10.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.222 -0.924 . . . . 0.0 109.609 178.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 64.84 27.71 72.46 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . 0.483 ' HA2' ' CD ' ' B' ' 63' ' ' LYS . . . 93.01 1.85 66.97 Favored Glycine 0 N--CA 1.485 1.937 0 C-N-CA 119.561 -1.304 . . . . 0.0 109.99 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 67' ' ' ALA . . . . . 0.454 ' O ' ' O ' ' B' ' 68' ' ' TRP . . . -109.45 86.21 2.25 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.977 -1.308 . . . . 0.0 109.526 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 68' ' ' TRP . . . . . 0.468 ' O ' ' HA ' ' B' ' 63' ' ' LYS . 61.8 m95 -9.0 -116.59 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.828 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -178.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 129.28 -113.37 1.51 Allowed Glycine 0 N--CA 1.488 2.161 0 O-C-N 119.775 -1.828 . . . . 0.0 110.005 -178.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 21.6 m -78.91 121.31 24.7 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.198 -1.177 . . . . 0.0 111.266 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -126.72 131.0 51.45 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.404 -0.81 . . . . 0.0 109.778 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.45 156.51 38.78 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.926 -1.109 . . . . 0.0 110.205 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 -134.64 88.74 2.47 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.247 -0.908 . . . . 0.0 109.727 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 74' ' ' GLU . . . . . 0.401 ' O ' ' CG2' ' B' ' 58' ' ' ILE . 89.3 mt-10 -113.94 126.18 54.86 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.238 -0.914 . . . . 0.0 109.865 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -93.49 85.28 4.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.09 -1.006 . . . . 0.0 110.232 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 76' ' ' VAL . . . . . 0.623 HG22 ' HD3' ' B' ' 78' ' ' PRO . 2.4 p -127.22 132.25 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.324 -0.86 . . . . 0.0 110.203 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 77' ' ' PHE . . . . . 0.509 ' N ' ' CD1' ' B' ' 77' ' ' PHE . 13.6 p90 -144.98 81.7 10.46 Favored Pre-proline 0 N--CA 1.486 1.352 0 O-C-N 121.248 -0.908 . . . . 0.0 110.288 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . 0.623 ' HD3' HG22 ' B' ' 76' ' ' VAL . 52.4 Cg_endo -72.91 -3.12 13.04 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.967 1.509 . . . . 0.0 111.236 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 79' ' ' PHE . . . . . 0.535 ' CD2' ' HB2' ' B' ' 85' ' ' ALA . 3.8 m-85 -134.13 179.6 6.15 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.998 -1.064 . . . . 0.0 111.024 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.487 ' CG ' ' HD2' ' B' ' 81' ' ' PRO . 0.0 OUTLIER -131.2 172.57 7.13 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.574 -0.704 . . . . 0.0 109.521 179.781 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 81' ' ' PRO . . . . . 0.487 ' HD2' ' CG ' ' B' ' 80' ' ' GLN . 51.0 Cg_endo -71.02 150.06 59.88 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.643 1.338 . . . . 0.0 110.105 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 75.95 26.94 63.4 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 45.3 m -131.83 151.94 51.34 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.933 -1.334 . . . . 0.0 111.06 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.466 HG23 ' O ' ' B' ' 21' ' ' GLY . 13.1 p -90.95 133.54 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.437 -0.789 . . . . 0.0 109.59 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 85' ' ' ALA . . . . . 0.535 ' HB2' ' CD2' ' B' ' 79' ' ' PHE . . . -151.69 155.86 39.18 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.808 -1.183 . . . . 0.0 110.894 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -122.91 149.56 44.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.375 -0.828 . . . . 0.0 109.61 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 47.0 t -124.15 130.43 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.128 -0.982 . . . . 0.0 110.386 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 88' ' ' CYS . . . . . . . . . . . . . 1.4 t -99.2 122.91 43.02 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.354 -0.841 . . . . 0.0 110.042 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 98.2 mt -122.55 128.65 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.199 -0.938 . . . . 0.0 110.731 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 63.2 m -119.41 128.29 53.9 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 91' ' ' PHE . . . . . 0.579 ' CZ ' HD11 ' B' ' 114' ' ' LEU . 73.7 t80 -109.23 115.59 30.3 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 118.62 -1.232 . . . . 0.0 111.343 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' B' ' 95' ' ' ASN . 79.2 m-20 -118.89 142.39 47.79 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -60.04 -30.31 69.11 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.668 -1.27 . . . . 0.0 110.491 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.15 -40.48 82.37 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.045 -1.035 . . . . 0.0 109.279 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 95' ' ' ASN . . . . . 0.405 ' O ' ' HB2' ' B' ' 92' ' ' ASP . 0.4 OUTLIER -170.32 171.88 6.45 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.502 -178.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 96' ' ' LEU . . . . . 0.432 HD22 ' CD1' ' B' ' 43' ' ' LEU . 38.8 tp -101.83 125.13 48.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.236 -0.915 . . . . 0.0 110.17 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 97' ' ' THR . . . . . 0.435 HG23 ' OE2' ' B' ' 105' ' ' GLU . 10.5 m -107.93 125.25 51.27 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.099 -1.001 . . . . 0.0 109.266 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 38.8 t -131.43 131.43 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.858 -1.151 . . . . 0.0 110.478 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -119.7 143.9 47.5 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.168 -0.957 . . . . 0.0 110.579 179.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 100' ' ' LEU . . . . . 0.486 HD23 ' HD2' ' B' ' 101' ' ' PRO . 0.5 OUTLIER -111.16 169.69 6.04 Favored Pre-proline 0 C--N 1.3 -1.57 0 O-C-N 121.517 -0.739 . . . . 0.0 109.133 179.222 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 101' ' ' PRO . . . . . 0.486 ' HD2' HD23 ' B' ' 100' ' ' LEU . 38.8 Cg_endo -64.07 -24.11 66.77 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 123.603 1.318 . . . . 0.0 110.772 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 102' ' ' ASP . . . . . 0.47 ' HB2' ' CB ' ' B' ' 78' ' ' PRO . 20.5 t0 -74.83 -11.95 60.27 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.941 -1.099 . . . . 0.0 111.085 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 98.86 -10.42 62.28 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.635 -1.269 . . . . 0.0 110.645 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 104' ' ' TYR . . . . . 0.443 ' CE2' ' OD2' ' B' ' 102' ' ' ASP . 19.5 m-85 -79.73 141.02 36.74 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.754 -1.439 . . . . 0.0 109.657 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 105' ' ' GLU . . . . . 0.435 ' OE2' HG23 ' B' ' 97' ' ' THR . 85.2 tt0 -121.06 143.48 49.05 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.308 -0.87 . . . . 0.0 110.554 -179.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -130.08 148.07 51.89 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.336 -0.853 . . . . 0.0 109.505 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 107' ' ' LYS . . . . . 0.422 ' C ' ' CD1' ' B' ' 108' ' ' PHE . 98.3 mttt -127.7 145.62 50.84 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.079 -1.013 . . . . 0.0 111.454 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 108' ' ' PHE . . . . . 0.502 ' CD1' ' N ' ' B' ' 108' ' ' PHE . 20.1 m-85 -129.64 140.18 37.88 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -70.28 140.18 40.14 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 O-C-N 123.385 1.203 . . . . 0.0 109.83 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 110' ' ' ASN . . . . . 0.46 ' ND2' ' O ' ' B' ' 110' ' ' ASN . 6.1 p-10 -102.16 83.02 2.28 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 122.246 1.022 . . . . 0.0 110.216 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 96.6 mtt-85 -57.11 -22.7 41.73 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.488 -1.383 . . . . 0.0 108.98 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 112' ' ' LEU . . . . . 0.735 ' HB3' HD23 ' B' ' 114' ' ' LEU . 89.7 mt -82.26 143.7 31.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.584 -0.698 . . . . 0.0 110.454 179.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -101.44 38.83 1.52 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.105 -0.997 . . . . 0.0 109.541 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 114' ' ' LEU . . . . . 0.735 HD23 ' HB3' ' B' ' 112' ' ' LEU . 0.8 OUTLIER -73.6 128.07 34.49 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.427 -0.795 . . . . 0.0 110.923 -179.193 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -88.26 -16.05 34.22 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.114 -0.991 . . . . 0.0 110.162 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 116' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' B' ' 11' ' ' LEU . . . -158.25 155.19 28.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.005 -1.059 . . . . 0.0 111.072 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 117' ' ' ILE . . . . . 0.519 HD11 HD13 ' B' ' 114' ' ' LEU . 31.8 mm -107.17 130.2 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.215 -0.928 . . . . 0.0 110.228 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 118' ' ' ASN . . . . . 0.509 ' N ' ' ND2' ' B' ' 118' ' ' ASN . 0.5 OUTLIER -108.85 -15.01 14.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.069 -1.019 . . . . 0.0 110.933 -179.244 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 119' ' ' TYR . . . . . 0.482 ' CB ' ' O ' ' B' ' 35' ' ' GLY . 4.0 t80 -120.28 129.7 54.14 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.993 -1.067 . . . . 0.0 111.461 -178.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 120' ' ' MET . . . . . 0.65 ' HB2' HD22 ' B' ' 9' ' ' LEU . 51.8 ttp -141.47 128.37 20.6 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.21 149.37 30.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.707 -1.246 . . . . 0.0 111.342 -178.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -151.99 129.17 11.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.578 -0.702 . . . . 0.0 110.116 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -147.4 114.63 6.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.366 -0.834 . . . . 0.0 109.453 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 124' ' ' GLY . . . . . 0.502 ' HA3' ' HA ' ' B' ' 30' ' ' PHE . . . -176.95 -145.36 5.67 Favored Glycine 0 N--CA 1.484 1.869 0 C-N-CA 119.069 -1.538 . . . . 0.0 110.209 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . 0.441 ' HB3' ' HA ' ' B' ' 27' ' ' ALA . 79.7 m-20 -88.86 12.87 13.99 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.913 -0.757 . . . . 0.0 110.705 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 126' ' ' PHE . . . . . 0.506 ' HB3' ' CD1' ' B' ' 30' ' ' PHE . 14.9 t80 -105.76 137.66 43.27 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.092 -1.005 . . . . 0.0 110.269 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . 0.422 ' O ' ' HA3' ' B' ' 21' ' ' GLY . 98.5 mttt -103.94 109.45 21.2 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.272 -0.892 . . . . 0.0 111.746 -178.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . 0.44 ' O ' HG23 ' B' ' 128' ' ' ILE . 8.8 tt -99.65 117.41 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.036 -1.04 . . . . 0.0 109.486 177.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -109.32 -14.64 14.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.111 -0.993 . . . . 0.0 111.872 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 130' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.17 143.55 31.14 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.637 -1.289 . . . . 0.0 111.815 -179.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 66.1 t -127.3 133.58 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 132' ' ' ALA . . . . . . . . . . . . . . . -139.48 143.39 37.49 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 119.984 -1.697 . . . . 0.0 111.721 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -73.17 -125.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.633 -0.667 . . . . 0.0 109.821 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 47.1 t0 . . . . . 0 N--CA 1.492 1.628 0 O-C-N 120.515 -1.365 . . . . 0.0 110.161 179.716 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.434 ' O ' HG23 ' A' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.488 2.104 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 34.9 tp -58.54 128.51 37.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.915 -1.344 . . . . 0.0 109.866 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 3' ' ' GLY . 54.5 t -120.43 131.17 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.43 -0.794 . . . . 0.0 109.877 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -124.49 164.18 20.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.926 -1.108 . . . . 0.0 110.98 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.485 ' O ' ' HB3' ' A' ' 8' ' ' ASN . 26.9 p -151.19 172.22 16.16 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.666 -0.646 . . . . 0.0 109.306 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.485 ' HB3' ' O ' ' A' ' 7' ' ' SER . 32.0 t30 61.79 33.01 18.02 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.577 -0.702 . . . . 0.0 109.85 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.525 ' O ' ' C ' ' A' ' 10' ' ' ASN . 94.8 mt -85.09 -9.69 57.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.539 -0.726 . . . . 0.0 111.124 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.525 ' C ' ' O ' ' A' ' 9' ' ' LEU . 0.7 OUTLIER 5.79 67.82 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.686 0 CA-C-O 121.551 0.691 . . . . 0.0 112.829 -179.771 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.508 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 31.8 tp -87.64 139.0 30.98 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.51 167.46 9.03 Favored Pre-proline 0 C--N 1.294 -1.831 0 O-C-N 120.975 -1.078 . . . . 0.0 111.378 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' A' ' 115' ' ' GLU . 44.3 Cg_endo -67.49 147.31 76.8 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 124.266 1.666 . . . . 0.0 110.77 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.81 -4.04 63.1 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -115.99 146.79 41.83 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.937 -1.331 . . . . 0.0 109.827 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.3 m -99.02 142.63 30.27 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.163 -0.961 . . . . 0.0 110.443 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.41 ' HA ' HD12 ' A' ' 17' ' ' LEU . 51.2 tp -118.27 128.2 54.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.405 -0.809 . . . . 0.0 109.698 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -128.92 133.43 47.87 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.008 -1.057 . . . . 0.0 111.17 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 56.1 t -121.1 127.24 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.319 -0.863 . . . . 0.0 109.577 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 53.2 ttt-85 -109.05 124.89 51.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.206 -0.934 . . . . 0.0 110.019 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -148.88 -163.4 10.88 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -137.94 141.81 40.55 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.409 -1.053 . . . . 0.0 110.269 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.663 ' CG1' ' HB2' ' A' ' 27' ' ' ALA . 23.8 t -97.4 130.97 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.198 -0.939 . . . . 0.0 110.809 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.597 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -58.87 168.22 1.56 Allowed Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.448 -0.783 . . . . 0.0 110.096 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.597 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 45.4 Cg_endo -68.68 -19.8 41.2 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.909 1.478 . . . . 0.0 109.89 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 28' ' ' LYS . 48.2 t0 -112.97 57.19 0.67 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.485 -0.76 . . . . 0.0 109.371 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.663 ' HB2' ' CG1' ' A' ' 23' ' ' VAL . . . -69.73 63.62 0.19 Allowed 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.688 0.756 . . . . 0.0 109.797 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.435 ' N ' ' O ' ' A' ' 26' ' ' ASP . 87.8 tttt -63.12 -43.92 97.08 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.702 -0.624 . . . . 0.0 110.401 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.3 t -164.05 137.63 5.4 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.006 -1.058 . . . . 0.0 111.174 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.483 ' HA ' ' HA3' ' A' ' 124' ' ' GLY . 26.1 t80 -134.04 145.54 49.51 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.547 -0.721 . . . . 0.0 109.981 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.543 HG22 ' O ' ' A' ' 123' ' ' ASP . 17.3 m -127.13 133.08 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 120.785 -1.197 . . . . 0.0 110.774 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.1 tp -129.42 135.09 48.24 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.463 -0.773 . . . . 0.0 110.139 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.527 ' HB2' HD13 ' A' ' 41' ' ' LEU . 12.2 p30 -142.19 145.77 34.51 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.763 -1.21 . . . . 0.0 110.78 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.493 HD13 HD13 ' A' ' 117' ' ' ILE . 1.1 pp -149.47 123.87 9.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.366 -0.834 . . . . 0.0 110.679 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.545 ' O ' ' HB3' ' A' ' 119' ' ' TYR . . . -166.11 -160.38 13.3 Favored Glycine 0 N--CA 1.493 2.433 0 N-CA-C 108.959 -1.657 . . . . 0.0 108.959 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.48 ' HD2' HD13 ' A' ' 114' ' ' LEU . 60.2 mtpt -71.85 -40.8 68.76 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.021 -1.282 . . . . 0.0 109.149 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -153.27 -167.02 2.59 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.768 0.794 . . . . 0.0 111.562 -178.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 41.2 t -62.0 -46.03 91.0 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.662 -0.649 . . . . 0.0 112.573 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.457 ' HB3' ' N ' ' A' ' 66' ' ' GLY . 74.0 m-20 -94.5 0.08 55.04 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.762 -1.211 . . . . 0.0 110.437 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -113.03 62.79 0.64 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.245 -0.909 . . . . 0.0 109.378 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.527 HD13 ' HB2' ' A' ' 33' ' ' ASN . 92.1 mt -104.14 133.97 48.18 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.315 0.578 . . . . 0.0 109.917 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.484 ' HA ' HD12 ' A' ' 112' ' ' LEU . 63.3 m -83.62 -40.22 19.3 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.151 -0.968 . . . . 0.0 109.271 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 1.101 HD11 HD13 ' A' ' 96' ' ' LEU . 94.3 mt -131.42 140.89 49.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.213 -0.929 . . . . 0.0 111.337 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.48 ' HB3' ' HB3' ' A' ' 61' ' ' ASN . 82.0 t60 -131.84 103.14 6.16 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -102.36 142.0 34.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -0.931 . . . . 0.0 110.8 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.521 ' CG ' HG12 ' A' ' 31' ' ' VAL . 1.2 t-20 -155.23 85.36 3.49 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.391 -0.818 . . . . 0.0 110.603 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.438 ' CA ' HG12 ' A' ' 58' ' ' ILE . 46.5 Cg_endo -67.48 147.74 77.68 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.891 1.469 . . . . 0.0 110.75 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -132.31 107.99 8.91 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.291 -0.881 . . . . 0.0 111.156 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -62.08 -48.08 81.78 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.248 -0.908 . . . . 0.0 109.486 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 -150.83 97.74 2.52 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.313 -0.867 . . . . 0.0 109.472 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -105.18 -126.61 0.23 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.187 -0.945 . . . . 0.0 110.329 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 40.3 m170 -61.73 -35.38 77.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.72 -1.237 . . . . 0.0 110.843 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 172.61 32.42 0.03 OUTLIER Glycine 0 N--CA 1.493 2.451 0 C-N-CA 119.104 -1.522 . . . . 0.0 111.072 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -117.59 -166.26 1.17 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.852 -1.381 . . . . 0.0 109.469 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 56' ' ' ASN . . . -153.67 144.08 22.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.252 -0.905 . . . . 0.0 110.373 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.475 ' C ' ' O ' ' A' ' 55' ' ' ALA . 87.0 m-20 25.85 56.65 0.05 Allowed 'General case' 0 N--CA 1.504 2.23 0 CA-C-O 120.987 0.422 . . . . 0.0 111.983 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 86.0 m -119.69 133.24 55.71 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.235 -0.915 . . . . 0.0 110.477 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.438 HG12 ' CA ' ' A' ' 47' ' ' PRO . 96.6 mt -119.29 134.06 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.496 -0.753 . . . . 0.0 111.114 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.641 HG11 ' OE2' ' A' ' 71' ' ' GLU . 54.5 t -112.74 127.94 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.211 -0.931 . . . . 0.0 109.025 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 2.2 t -94.57 122.88 37.61 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.185 -0.947 . . . . 0.0 110.313 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.48 ' HB3' ' HB3' ' A' ' 44' ' ' HIS . 6.8 t-20 -121.21 147.52 45.5 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.321 -0.862 . . . . 0.0 109.114 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.3 t -135.65 142.76 45.22 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.022 -1.049 . . . . 0.0 110.141 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.492 ' CD ' ' HA2' ' A' ' 66' ' ' GLY . 27.0 ttmt -142.94 127.39 17.82 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 118.883 -1.127 . . . . 0.0 111.67 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -107.04 103.23 12.6 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 64.48 20.74 66.02 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.492 ' HA2' ' CD ' ' A' ' 63' ' ' LYS . . . 68.89 36.58 82.14 Favored Glycine 0 N--CA 1.488 2.123 0 C-N-CA 119.2 -1.476 . . . . 0.0 110.007 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.51 14.16 6.54 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.731 -1.452 . . . . 0.0 112.263 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -139.63 -74.6 0.36 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.452 -1.405 . . . . 0.0 110.421 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.68 32.85 49.03 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.1 m -59.81 121.36 11.53 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.077 -1.249 . . . . 0.0 109.49 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.641 ' OE2' HG11 ' A' ' 59' ' ' VAL . 83.3 tt0 -116.66 133.36 56.11 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.226 -0.921 . . . . 0.0 112.039 -178.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -127.42 -162.53 1.17 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.369 -0.832 . . . . 0.0 108.971 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -141.83 140.72 33.03 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 118.484 -1.286 . . . . 0.0 112.027 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -127.92 124.29 37.02 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.897 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -101.96 46.33 0.93 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.871 -1.143 . . . . 0.0 111.017 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.432 ' O ' HD12 ' A' ' 58' ' ' ILE . 75.9 t -122.46 127.06 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.063 -1.023 . . . . 0.0 109.716 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.466 ' CD2' ' O ' ' A' ' 77' ' ' PHE . 83.2 t80 -162.23 74.71 2.22 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 120.922 -1.112 . . . . 0.0 110.91 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.485 ' HD2' ' CE2' ' A' ' 79' ' ' PHE . 55.6 Cg_endo -80.2 43.1 1.45 Allowed 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.899 1.473 . . . . 0.0 110.951 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.485 ' CE2' ' HD2' ' A' ' 78' ' ' PRO . 70.6 m-85 -127.6 151.57 48.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.884 -1.135 . . . . 0.0 109.399 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.39 168.71 14.12 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.034 -1.041 . . . . 0.0 110.251 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.75 147.58 63.22 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.958 1.504 . . . . 0.0 110.015 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 56.39 41.38 87.75 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.829 -1.309 . . . . 0.0 109.829 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 37.2 t -134.35 142.15 47.12 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.037 -1.273 . . . . 0.0 110.617 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.424 HG13 ' O ' ' A' ' 84' ' ' VAL . 7.2 p -89.16 136.8 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.387 -0.821 . . . . 0.0 109.65 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -154.66 151.74 29.13 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.109 -0.994 . . . . 0.0 110.035 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.4 ' O ' ' HD3' ' A' ' 101' ' ' PRO . 90.5 mt-10 -116.32 138.38 51.37 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 91.6 t -116.15 128.38 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.909 -1.119 . . . . 0.0 110.823 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 1.7 t -99.64 129.4 45.78 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.3 -0.875 . . . . 0.0 109.837 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 97.8 mt -122.25 127.66 75.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.356 -0.84 . . . . 0.0 110.067 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.426 ' HB ' ' HB ' ' A' ' 97' ' ' THR . 89.2 m -120.56 127.61 52.31 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.242 -0.911 . . . . 0.0 109.286 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -113.85 112.09 22.8 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.06 -1.025 . . . . 0.0 110.854 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -119.59 149.01 42.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.527 -0.733 . . . . 0.0 109.467 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -63.22 -34.4 77.57 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.94 -1.1 . . . . 0.0 109.94 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.54 -40.69 96.05 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.2 -0.937 . . . . 0.0 109.991 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -171.39 178.14 3.32 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.314 -0.866 . . . . 0.0 110.412 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 1.101 HD13 HD11 ' A' ' 43' ' ' LEU . 95.4 mt -105.0 131.53 52.4 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.397 -0.814 . . . . 0.0 110.078 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.463 ' CG2' ' OE2' ' A' ' 105' ' ' GLU . 44.1 m -121.01 129.62 53.46 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.081 -1.012 . . . . 0.0 109.838 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 56.4 t -125.82 129.04 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 120.86 -1.15 . . . . 0.0 109.255 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -116.62 126.14 52.82 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.066 -1.054 . . . . 0.0 109.934 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 12.3 mt -99.08 162.12 22.49 Favored Pre-proline 0 C--N 1.296 -1.746 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 86' ' ' GLU . 39.6 Cg_endo -64.7 -21.61 64.92 Favored 'Trans proline' 0 C--N 1.3 -2.018 0 O-C-N 123.765 1.403 . . . . 0.0 110.223 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -65.52 -32.78 74.57 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.277 -0.889 . . . . 0.0 109.279 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 117.3 -18.25 12.2 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -73.74 136.12 43.65 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.133 -1.216 . . . . 0.0 110.319 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.463 ' OE2' ' CG2' ' A' ' 97' ' ' THR . 78.9 tt0 -127.57 144.25 51.09 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -129.51 156.37 44.26 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.975 -1.078 . . . . 0.0 110.146 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -107.39 131.49 54.19 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.244 -0.91 . . . . 0.0 110.953 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.414 ' CB ' ' HB2' ' A' ' 96' ' ' LEU . 0.5 OUTLIER -121.77 126.4 26.41 Favored Pre-proline 0 C--N 1.301 -1.529 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.753 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -65.7 139.89 59.75 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 123.32 1.169 . . . . 0.0 110.397 -179.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.444 ' ND2' ' O ' ' A' ' 110' ' ' ASN . 4.5 p-10 -97.67 82.58 3.08 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 122.513 1.149 . . . . 0.0 109.791 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -58.05 -24.23 57.6 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 120.368 -1.458 . . . . 0.0 109.371 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.484 HD12 ' HA ' ' A' ' 42' ' ' CYS . 86.7 mt -86.79 144.12 27.19 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.288 -0.882 . . . . 0.0 111.078 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -94.09 30.57 1.86 Allowed 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.718 0.77 . . . . 0.0 109.568 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.588 HD11 ' O ' ' A' ' 116' ' ' ALA . 46.9 tp -61.99 136.17 57.85 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.58 0.705 . . . . 0.0 111.135 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.449 ' O ' ' HD3' ' A' ' 13' ' ' PRO . 10.0 pt-20 -98.29 -13.98 20.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.451 -0.781 . . . . 0.0 110.932 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.588 ' O ' HD11 ' A' ' 114' ' ' LEU . . . -163.45 157.29 19.63 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.44 -1.413 . . . . 0.0 111.972 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.493 HD13 HD13 ' A' ' 34' ' ' LEU . 84.9 mt -104.8 124.8 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.355 -0.841 . . . . 0.0 109.994 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -117.67 -20.95 8.72 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.082 -1.011 . . . . 0.0 110.989 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.545 ' HB3' ' O ' ' A' ' 35' ' ' GLY . 38.9 t80 -110.73 125.67 53.75 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.419 -0.801 . . . . 0.0 110.547 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.466 ' HB3' ' CD1' ' A' ' 9' ' ' LEU . 48.3 ttp -146.93 133.04 19.29 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.237 -0.914 . . . . 0.0 109.818 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.83 154.23 33.56 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.997 -1.064 . . . . 0.0 110.496 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -146.12 120.08 9.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.306 -0.871 . . . . 0.0 109.889 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.543 ' O ' HG22 ' A' ' 31' ' ' VAL . 55.6 t0 -135.29 106.32 6.66 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.347 -0.846 . . . . 0.0 109.594 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' A' ' 30' ' ' PHE . . . -171.54 -144.61 4.51 Favored Glycine 0 N--CA 1.484 1.844 0 C-N-CA 119.237 -1.458 . . . . 0.0 110.02 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.525 ' HB3' ' HA ' ' A' ' 27' ' ' ALA . 94.2 m-20 -90.07 14.1 13.24 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.644 -0.915 . . . . 0.0 110.873 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.43 ' HB3' ' CE1' ' A' ' 30' ' ' PHE . 28.1 t80 -107.89 135.28 49.55 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.899 -1.126 . . . . 0.0 109.748 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -105.15 121.3 43.54 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 118.874 -1.13 . . . . 0.0 110.421 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.618 HG23 ' O ' ' A' ' 128' ' ' ILE . 10.7 tt -93.79 115.92 33.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.511 -0.743 . . . . 0.0 110.592 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.422 ' O ' ' HB2' ' B' ' 133' ' ' PHE . 98.7 mttt -101.54 -18.35 15.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.091 -1.006 . . . . 0.0 110.517 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -157.79 143.99 17.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.82 -1.175 . . . . 0.0 111.484 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.438 HG22 HD11 ' A' ' 128' ' ' ILE . 42.5 t -116.58 132.22 66.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 178.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.41 ' HA ' ' HB2' ' B' ' 130' ' ' CYS . . . -121.95 144.61 48.76 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.738 -1.226 . . . . 0.0 111.906 -177.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -83.37 -136.64 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 61.0 t0 . . . . . 0 N--CA 1.49 1.571 0 O-C-N 120.69 -1.256 . . . . 0.0 110.201 179.831 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 121.272 0.558 . . . . 0.0 110.088 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 2' ' ' CYS . . . . . . . . . . . . . 3.3 t -122.5 -135.65 0.3 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.248 -0.907 . . . . 0.0 108.72 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 3' ' ' GLY . . . . . 0.406 ' C ' ' ND2' ' A' ' 8' ' ' ASN . . . 90.41 23.26 32.02 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.46 ' HA ' ' HB3' ' A' ' 8' ' ' ASN . 36.0 tp -60.0 128.21 35.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.03 -1.276 . . . . 0.0 109.882 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.405 HG23 ' O ' ' B' ' 3' ' ' GLY . 53.7 t -120.34 130.44 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 119.731 -0.788 . . . . 0.0 109.759 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -123.6 164.6 18.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.155 -0.966 . . . . 0.0 110.902 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' SER . . . . . 0.461 ' O ' ' HB3' ' B' ' 8' ' ' ASN . 26.2 p -151.72 172.52 15.99 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . 0.461 ' HB3' ' O ' ' B' ' 7' ' ' SER . 31.8 t30 61.59 32.84 18.53 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.571 -0.706 . . . . 0.0 109.819 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.529 ' O ' ' C ' ' B' ' 10' ' ' ASN . 96.3 mt -85.79 -5.97 59.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.529 -0.732 . . . . 0.0 111.198 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' ASN . . . . . 0.529 ' C ' ' O ' ' B' ' 9' ' ' LEU . 0.6 OUTLIER -0.16 70.53 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.714 0 CA-C-O 121.86 0.838 . . . . 0.0 112.817 -178.62 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' B' ' 116' ' ' ALA . 32.4 tp -88.34 138.61 31.28 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.24 167.53 8.95 Favored Pre-proline 0 C--N 1.292 -1.895 0 O-C-N 120.917 -1.114 . . . . 0.0 111.321 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' B' ' 115' ' ' GLU . 45.6 Cg_endo -67.96 147.05 73.42 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 124.195 1.629 . . . . 0.0 110.584 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.23 -3.96 62.15 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -116.46 147.32 41.83 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.965 -1.314 . . . . 0.0 109.862 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' CYS . . . . . . . . . . . . . 2.3 m -99.27 142.92 30.13 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.168 -0.958 . . . . 0.0 110.497 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' B' ' 17' ' ' LEU . 52.7 tp -118.5 128.1 54.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.474 -0.766 . . . . 0.0 109.618 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -128.96 133.59 47.87 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.994 -1.066 . . . . 0.0 111.155 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 55.7 t -121.38 126.55 75.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.341 -0.849 . . . . 0.0 109.604 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.404 ' HG3' ' HG2' ' B' ' 86' ' ' GLU . 52.9 ttt-85 -108.45 125.06 51.34 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.203 -0.935 . . . . 0.0 110.061 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -148.74 -162.3 10.17 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -139.0 142.74 38.3 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.585 -0.95 . . . . 0.0 110.23 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.672 ' CG1' ' HB2' ' B' ' 27' ' ' ALA . 23.2 t -98.47 130.83 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.308 -0.87 . . . . 0.0 110.721 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.599 ' HB1' ' HD2' ' B' ' 25' ' ' PRO . . . -58.76 167.89 1.67 Allowed Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.41 -0.806 . . . . 0.0 110.16 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . 0.599 ' HD2' ' HB1' ' B' ' 24' ' ' ALA . 45.9 Cg_endo -68.58 -19.55 42.11 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.882 1.464 . . . . 0.0 109.924 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' ASP . . . . . 0.442 ' O ' ' N ' ' B' ' 28' ' ' LYS . 47.4 t0 -113.09 56.93 0.67 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.535 -0.728 . . . . 0.0 109.444 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . 0.672 ' HB2' ' CG1' ' B' ' 23' ' ' VAL . . . -69.51 63.72 0.17 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.488 -0.757 . . . . 0.0 109.791 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . 0.442 ' N ' ' O ' ' B' ' 26' ' ' ASP . 88.3 tttt -63.24 -45.14 92.97 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.713 -0.617 . . . . 0.0 110.201 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 13.6 t -161.97 139.01 8.33 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.087 -1.008 . . . . 0.0 111.438 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' PHE . . . . . 0.497 ' HA ' ' HA3' ' B' ' 124' ' ' GLY . 25.9 t80 -135.08 144.96 47.49 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.356 -0.84 . . . . 0.0 109.925 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.555 HG22 ' O ' ' B' ' 123' ' ' ASP . 18.4 m -126.63 133.2 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 120.905 -1.122 . . . . 0.0 110.761 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 19.9 tp -129.33 135.85 49.27 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 121.55 -0.719 . . . . 0.0 110.069 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' ASN . . . . . 0.536 ' HB2' HD13 ' B' ' 41' ' ' LEU . 12.2 p30 -142.81 145.55 33.32 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.755 -1.216 . . . . 0.0 110.797 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.506 HD13 HD13 ' B' ' 117' ' ' ILE . 1.1 pp -149.89 119.93 7.2 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.3 -0.875 . . . . 0.0 111.008 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . 0.53 ' O ' ' HB3' ' B' ' 119' ' ' TYR . . . -160.81 -158.81 9.51 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.151 -1.579 . . . . 0.0 109.151 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . 0.486 ' HD2' HD13 ' B' ' 114' ' ' LEU . 60.1 mtpt -72.93 -40.36 65.5 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.083 -1.245 . . . . 0.0 108.868 177.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -153.17 -167.28 2.67 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.68 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 40.2 t -61.98 -46.1 90.71 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.602 -0.686 . . . . 0.0 112.531 -178.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' ASN . . . . . 0.43 ' HB3' ' N ' ' B' ' 66' ' ' GLY . 70.7 m-20 -94.65 0.42 55.08 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.644 -1.285 . . . . 0.0 110.5 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -113.15 62.45 0.64 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.256 -0.902 . . . . 0.0 109.536 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.536 HD13 ' HB2' ' B' ' 33' ' ' ASN . 92.1 mt -103.46 136.94 42.26 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 121.249 0.547 . . . . 0.0 109.554 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' CYS . . . . . 0.488 ' HA ' HD12 ' B' ' 112' ' ' LEU . 65.7 m -87.78 -38.64 15.58 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.218 -0.926 . . . . 0.0 108.764 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 1.027 HD11 HD13 ' B' ' 96' ' ' LEU . 94.6 mt -132.06 140.98 49.06 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.158 -0.964 . . . . 0.0 111.096 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' HIS . . . . . 0.466 ' HB3' ' HB3' ' B' ' 61' ' ' ASN . 81.8 t60 -132.03 102.95 6.03 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -102.09 141.83 34.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.234 -0.916 . . . . 0.0 110.727 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' ASN . . . . . 0.511 ' CG ' HG12 ' B' ' 31' ' ' VAL . 1.2 t-20 -154.85 84.97 3.67 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.366 -0.834 . . . . 0.0 110.658 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' PRO . . . . . 0.449 ' CA ' HG12 ' B' ' 58' ' ' ILE . 46.3 Cg_endo -67.23 148.32 80.24 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.847 1.446 . . . . 0.0 110.692 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -132.93 107.86 8.56 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.307 -0.87 . . . . 0.0 111.036 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -61.97 -47.89 82.8 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.414 -0.804 . . . . 0.0 109.496 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -151.05 97.98 2.52 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.499 -0.751 . . . . 0.0 109.653 178.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -105.54 -126.55 0.24 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.074 -1.016 . . . . 0.0 110.333 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' HIS . . . . . . . . . . . . . 41.2 m170 -61.23 -34.35 74.98 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.696 -1.253 . . . . 0.0 110.946 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 170.48 33.12 0.02 OUTLIER Glycine 0 N--CA 1.492 2.397 0 C-N-CA 119.167 -1.492 . . . . 0.0 111.062 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -117.5 -166.02 1.15 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.982 -1.305 . . . . 0.0 109.301 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.503 ' O ' ' C ' ' B' ' 56' ' ' ASN . . . -152.15 149.14 28.44 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.218 -0.926 . . . . 0.0 109.674 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' ASN . . . . . 0.503 ' C ' ' O ' ' B' ' 55' ' ' ALA . 85.6 m-20 16.85 60.24 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.345 0 CA-C-O 121.473 0.654 . . . . 0.0 112.562 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 77.8 m -120.08 132.84 55.58 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.411 -0.806 . . . . 0.0 110.49 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' ILE . . . . . 0.449 HG12 ' CA ' ' B' ' 47' ' ' PRO . 97.0 mt -119.36 133.75 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.498 -0.751 . . . . 0.0 111.386 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.638 HG11 ' OE2' ' B' ' 71' ' ' GLU . 54.9 t -111.9 128.13 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.317 -0.864 . . . . 0.0 109.28 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 1.9 t -94.96 122.46 37.63 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.982 -1.074 . . . . 0.0 110.313 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' ASN . . . . . 0.466 ' HB3' ' HB3' ' B' ' 44' ' ' HIS . 6.8 t-20 -120.52 148.19 44.17 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.42 -0.8 . . . . 0.0 109.211 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 34.8 t -136.4 142.83 43.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.957 -1.09 . . . . 0.0 110.237 -178.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . 0.486 ' CD ' ' HA2' ' B' ' 66' ' ' GLY . 27.0 ttmt -143.17 127.15 17.34 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 118.931 -1.108 . . . . 0.0 111.93 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -106.55 104.13 13.74 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 63.76 20.13 63.79 Favored Glycine 0 N--CA 1.483 1.82 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . 0.486 ' HA2' ' CD ' ' B' ' 63' ' ' LYS . . . 69.57 36.27 76.23 Favored Glycine 0 N--CA 1.487 2.062 0 O-C-N 120.624 -1.515 . . . . 0.0 110.084 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -127.85 12.45 6.76 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.732 -1.452 . . . . 0.0 112.378 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 68' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -138.08 -74.71 0.4 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.615 -1.303 . . . . 0.0 110.505 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.81 32.46 49.89 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -59.58 121.58 11.93 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.134 -1.216 . . . . 0.0 109.486 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . 0.638 ' OE2' HG11 ' B' ' 59' ' ' VAL . 83.5 tt0 -117.12 133.46 55.98 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.156 -0.965 . . . . 0.0 112.062 -178.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -127.31 -162.96 1.21 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.399 -0.813 . . . . 0.0 109.157 178.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -141.44 139.79 33.46 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.676 -1.265 . . . . 0.0 112.066 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -126.75 124.56 40.02 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.969 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -102.29 46.55 0.92 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.834 -1.166 . . . . 0.0 110.945 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 76' ' ' VAL . . . . . 0.446 ' O ' HD12 ' B' ' 58' ' ' ILE . 76.5 t -122.8 127.44 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.097 -1.002 . . . . 0.0 109.739 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 77' ' ' PHE . . . . . 0.469 ' CD2' ' O ' ' B' ' 77' ' ' PHE . 83.4 t80 -162.47 74.13 2.16 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 120.962 -1.086 . . . . 0.0 110.878 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . 0.486 ' HD2' ' CE2' ' B' ' 79' ' ' PHE . 55.7 Cg_endo -79.71 43.63 1.54 Allowed 'Trans proline' 0 C--N 1.302 -1.877 0 O-C-N 123.914 1.481 . . . . 0.0 111.08 179.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 79' ' ' PHE . . . . . 0.486 ' CE2' ' HD2' ' B' ' 78' ' ' PRO . 68.4 m-85 -128.22 151.25 49.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.85 -1.156 . . . . 0.0 109.463 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.24 168.23 15.47 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.095 -1.003 . . . . 0.0 110.329 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 81' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -69.43 147.29 64.63 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.994 1.523 . . . . 0.0 109.959 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 56.76 41.56 90.68 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 37.4 t -134.39 143.01 47.37 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.05 -1.265 . . . . 0.0 110.637 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.429 ' O ' HG13 ' B' ' 84' ' ' VAL . 7.1 p -90.14 136.62 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.38 -0.825 . . . . 0.0 109.614 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -154.34 150.91 28.45 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.121 -0.987 . . . . 0.0 110.043 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 86' ' ' GLU . . . . . 0.404 ' HG2' ' HG3' ' B' ' 20' ' ' ARG . 90.3 mt-10 -115.84 137.59 51.95 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 78.2 t -115.5 128.34 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.925 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 88' ' ' CYS . . . . . . . . . . . . . 1.9 t -99.69 129.48 45.83 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.292 -0.88 . . . . 0.0 109.876 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 98.0 mt -122.38 127.21 75.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.319 -0.863 . . . . 0.0 110.111 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 90' ' ' THR . . . . . 0.421 ' HB ' ' HB ' ' B' ' 97' ' ' THR . 92.7 m -120.3 127.25 52.2 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.135 -0.978 . . . . 0.0 109.137 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 91' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -113.46 112.67 24.0 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.243 -0.983 . . . . 0.0 110.833 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -120.14 148.62 43.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.472 -0.768 . . . . 0.0 109.64 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -63.17 -33.8 76.26 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.021 -1.049 . . . . 0.0 109.91 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.8 -40.85 95.91 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.257 -0.902 . . . . 0.0 109.999 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -171.75 178.22 3.14 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.302 -0.874 . . . . 0.0 110.484 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 96' ' ' LEU . . . . . 1.027 HD13 HD11 ' B' ' 43' ' ' LEU . 94.7 mt -105.09 131.62 52.36 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.349 -0.845 . . . . 0.0 110.134 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 97' ' ' THR . . . . . 0.456 ' CG2' ' OE2' ' B' ' 105' ' ' GLU . 44.6 m -121.05 129.49 53.37 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.171 -0.956 . . . . 0.0 109.779 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 59.9 t -125.63 128.83 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.94 -1.1 . . . . 0.0 109.241 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -116.35 126.51 53.6 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.069 -1.052 . . . . 0.0 109.765 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 12.2 mt -99.67 162.0 22.62 Favored Pre-proline 0 C--N 1.296 -1.736 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -64.57 -21.58 65.59 Favored 'Trans proline' 0 C--N 1.299 -2.046 0 O-C-N 123.757 1.399 . . . . 0.0 110.275 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -65.76 -32.85 74.63 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.287 -0.883 . . . . 0.0 109.268 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 117.92 -18.54 11.48 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 104' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -73.62 136.25 43.89 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.178 -1.189 . . . . 0.0 110.37 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 105' ' ' GLU . . . . . 0.456 ' OE2' ' CG2' ' B' ' 97' ' ' THR . 79.0 tt0 -127.51 143.62 51.16 Favored 'General case' 0 C--N 1.298 -1.63 0 O-C-N 121.443 -0.786 . . . . 0.0 109.001 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -128.99 155.83 44.75 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.887 -1.133 . . . . 0.0 110.221 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -106.96 132.37 52.97 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.21 -0.931 . . . . 0.0 111.003 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 108' ' ' PHE . . . . . 0.409 ' CB ' ' HB2' ' B' ' 96' ' ' LEU . 0.5 OUTLIER -122.8 126.61 26.02 Favored Pre-proline 0 C--N 1.301 -1.51 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.75 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -65.68 139.74 59.19 Favored 'Trans proline' 0 C--N 1.303 -1.844 0 O-C-N 123.286 1.15 . . . . 0.0 110.391 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 110' ' ' ASN . . . . . 0.443 ' ND2' ' O ' ' B' ' 110' ' ' ASN . 4.7 p-10 -97.52 82.64 3.12 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 122.488 1.137 . . . . 0.0 109.653 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -58.05 -24.23 57.61 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 120.263 -1.523 . . . . 0.0 109.433 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 112' ' ' LEU . . . . . 0.488 HD12 ' HA ' ' B' ' 42' ' ' CYS . 87.2 mt -86.84 143.44 27.46 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.355 -0.841 . . . . 0.0 111.218 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -93.39 30.53 1.69 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.612 -0.68 . . . . 0.0 109.579 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 114' ' ' LEU . . . . . 0.584 HD11 ' O ' ' B' ' 116' ' ' ALA . 46.7 tp -62.21 135.62 57.57 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.706 0.765 . . . . 0.0 111.443 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 115' ' ' GLU . . . . . 0.465 ' O ' ' HD3' ' B' ' 13' ' ' PRO . 9.8 pt-20 -97.19 -15.52 20.84 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.485 -0.759 . . . . 0.0 110.974 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 116' ' ' ALA . . . . . 0.584 ' O ' HD11 ' B' ' 114' ' ' LEU . . . -162.36 157.12 22.21 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.47 -1.394 . . . . 0.0 112.129 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 117' ' ' ILE . . . . . 0.506 HD13 HD13 ' B' ' 34' ' ' LEU . 85.0 mt -104.31 124.68 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.373 -0.829 . . . . 0.0 110.006 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -117.68 -20.74 8.81 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.14 -0.975 . . . . 0.0 110.982 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 119' ' ' TYR . . . . . 0.53 ' HB3' ' O ' ' B' ' 35' ' ' GLY . 38.9 t80 -110.87 125.35 53.53 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.264 -0.897 . . . . 0.0 110.638 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 120' ' ' MET . . . . . 0.479 ' HB3' ' CD1' ' B' ' 9' ' ' LEU . 48.5 ttp -146.75 133.21 19.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.226 -0.921 . . . . 0.0 109.878 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -154.01 154.29 33.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.061 -1.024 . . . . 0.0 110.659 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -146.03 120.58 9.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.279 -0.888 . . . . 0.0 109.879 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 123' ' ' ASP . . . . . 0.555 ' O ' HG22 ' B' ' 31' ' ' VAL . 55.0 t0 -135.42 106.57 6.72 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.381 -0.824 . . . . 0.0 109.559 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 124' ' ' GLY . . . . . 0.497 ' HA3' ' HA ' ' B' ' 30' ' ' PHE . . . -171.52 -144.26 4.37 Favored Glycine 0 N--CA 1.486 1.981 0 C-N-CA 119.26 -1.448 . . . . 0.0 110.227 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . 0.525 ' HB3' ' HA ' ' B' ' 27' ' ' ALA . 93.8 m-20 -90.56 14.43 13.2 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.697 -0.884 . . . . 0.0 110.859 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 126' ' ' PHE . . . . . 0.435 ' HB3' ' CE1' ' B' ' 30' ' ' PHE . 27.3 t80 -108.17 135.57 49.29 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.015 -1.053 . . . . 0.0 109.661 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -105.56 120.86 42.69 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.006 -1.077 . . . . 0.0 110.367 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . 0.639 ' O ' HG23 ' B' ' 128' ' ' ILE . 10.3 tt -93.58 116.38 34.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.639 -0.663 . . . . 0.0 110.524 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -102.06 -19.41 15.18 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.104 -0.997 . . . . 0.0 110.497 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 130' ' ' CYS . . . . . 0.41 ' HB2' ' HA ' ' A' ' 132' ' ' ALA . 0.0 OUTLIER -155.93 144.18 19.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.883 -1.136 . . . . 0.0 111.591 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.419 HG22 HD11 ' B' ' 128' ' ' ILE . 40.2 t -116.88 131.87 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 132' ' ' ALA . . . . . . . . . . . . . . . -121.65 144.32 48.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.572 -1.33 . . . . 0.0 111.746 -177.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . 0.422 ' HB2' ' O ' ' A' ' 129' ' ' LYS . 3.0 t80 -83.17 -135.58 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.758 -0.589 . . . . 0.0 109.433 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 61.5 t0 . . . . . 0 N--CA 1.492 1.628 0 O-C-N 120.697 -1.252 . . . . 0.0 110.147 179.504 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.208 0.528 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.432 ' N ' ' OD1' ' A' ' 123' ' ' ASP . 0.5 OUTLIER -158.02 101.4 1.76 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.184 -0.948 . . . . 0.0 110.634 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.43 ' HA3' ' O ' ' A' ' 122' ' ' ALA . . . -176.84 128.25 1.31 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.556 HD23 ' C ' ' A' ' 4' ' ' LEU . 0.3 OUTLIER -67.62 154.67 40.94 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.537 -0.979 . . . . 0.0 111.218 -179.467 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.456 ' N ' ' HG ' ' A' ' 4' ' ' LEU . 76.5 t -118.16 136.92 53.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.397 -0.814 . . . . 0.0 109.666 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.492 ' HB3' HD11 ' A' ' 9' ' ' LEU . . . -119.59 164.4 15.91 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.699 -1.25 . . . . 0.0 111.305 -178.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.4 ' O ' ' HB3' ' A' ' 8' ' ' ASN . 15.0 p -153.08 166.35 32.74 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.477 -0.764 . . . . 0.0 109.898 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.426 ' ND2' ' O ' ' B' ' 3' ' ' GLY . 55.4 t30 60.81 38.54 17.93 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.273 -0.892 . . . . 0.0 109.759 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.536 ' O ' ' C ' ' A' ' 10' ' ' ASN . 61.5 mt -89.74 -3.35 58.23 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.705 -0.622 . . . . 0.0 111.849 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.536 ' C ' ' O ' ' A' ' 9' ' ' LEU . 8.2 m120 6.09 78.1 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.634 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 3.6 tt -100.24 129.78 46.28 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.303 -0.873 . . . . 0.0 110.035 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.3 mtpp -97.95 164.86 16.51 Favored Pre-proline 0 C--N 1.297 -1.694 0 O-C-N 121.445 -0.784 . . . . 0.0 110.37 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -66.93 147.28 80.14 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 123.991 1.521 . . . . 0.0 110.265 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.66 7.84 62.76 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -115.42 146.83 41.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.833 -1.393 . . . . 0.0 110.287 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 48.8 t -106.54 137.93 43.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.341 -0.85 . . . . 0.0 110.438 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.547 HD12 ' O ' ' A' ' 132' ' ' ALA . 45.5 tp -117.84 130.06 56.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.316 -0.865 . . . . 0.0 109.79 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.418 ' CZ ' ' OE1' ' A' ' 86' ' ' GLU . 77.5 ttt180 -118.95 128.74 54.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.941 -1.099 . . . . 0.0 110.633 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 25.1 t -121.13 125.29 73.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.256 -0.902 . . . . 0.0 110.725 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.453 ' HA ' ' HG2' ' A' ' 86' ' ' GLU . 75.8 ttt180 -109.86 129.01 55.69 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -149.19 -170.0 16.34 Favored Glycine 0 N--CA 1.486 1.974 0 C-N-CA 119.146 -1.502 . . . . 0.0 110.131 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -129.59 123.28 30.94 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.786 -0.832 . . . . 0.0 109.709 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.544 HG22 ' HD1' ' A' ' 126' ' ' PHE . 99.1 t -79.19 129.5 37.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.144 -0.973 . . . . 0.0 109.713 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.461 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -54.76 163.16 1.5 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.009 -1.057 . . . . 0.0 110.049 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.461 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 42.7 Cg_endo -67.84 -18.26 47.09 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.977 1.514 . . . . 0.0 110.327 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' A' ' 28' ' ' LYS . 63.9 t0 -113.61 56.76 0.69 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.244 -0.91 . . . . 0.0 109.284 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.8 84.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.602 -0.686 . . . . 0.0 110.227 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.514 ' HA ' ' HB3' ' A' ' 49' ' ' PHE . 85.1 tttt -109.64 -33.94 6.63 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.024 -1.047 . . . . 0.0 111.835 -179.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.2 t -146.22 140.45 26.58 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.626 -1.296 . . . . 0.0 111.671 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.509 ' CE2' ' HB2' ' A' ' 126' ' ' PHE . 83.3 m-85 -139.56 146.47 39.91 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.393 -0.817 . . . . 0.0 110.188 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.421 ' HB ' ' O ' ' A' ' 123' ' ' ASP . 63.7 t -133.44 130.0 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.96 -1.088 . . . . 0.0 109.798 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.709 HD12 ' HB2' ' A' ' 45' ' ' PHE . 94.7 mt -131.75 144.58 51.06 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.027 -1.046 . . . . 0.0 110.374 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -146.13 108.75 4.5 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.232 -0.917 . . . . 0.0 110.122 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.593 HD11 ' HB2' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -124.25 111.27 15.65 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.154 -0.966 . . . . 0.0 110.107 179.511 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -159.81 -122.84 0.67 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.502 ' HD2' HD13 ' A' ' 114' ' ' LEU . 0.1 OUTLIER -130.4 -46.12 1.09 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.396 -1.061 . . . . 0.0 108.864 179.518 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.447 ' HB2' ' ND2' ' A' ' 40' ' ' ASN . 87.6 m-20 -122.18 164.0 18.57 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.8 t -56.46 -42.33 78.03 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.293 -0.879 . . . . 0.0 111.631 -178.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.478 ' HB3' ' N ' ' A' ' 66' ' ' GLY . 92.4 m-20 -92.06 -0.11 57.46 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.89 -1.131 . . . . 0.0 111.002 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.455 ' N ' ' ND2' ' A' ' 40' ' ' ASN . 2.8 m-80 -117.37 61.7 0.75 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.95 -1.094 . . . . 0.0 109.854 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.7 mt -90.3 137.84 32.02 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.742 -0.599 . . . . 0.0 109.795 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.405 ' SG ' ' N ' ' A' ' 43' ' ' LEU . 6.8 p -88.62 -30.0 19.54 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.248 -0.907 . . . . 0.0 109.751 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.71 HD11 HD13 ' A' ' 96' ' ' LEU . 69.6 mt -137.09 138.14 40.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.904 . . . . 0.0 110.963 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -135.84 126.48 27.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.404 -0.81 . . . . 0.0 110.125 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.709 ' HB2' HD12 ' A' ' 32' ' ' LEU . 91.9 m-85 -113.01 141.96 46.26 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.996 -1.065 . . . . 0.0 110.024 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -154.72 69.94 5.86 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 120.996 -1.065 . . . . 0.0 110.986 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.42 147.46 65.13 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.68 1.358 . . . . 0.0 110.081 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.414 ' NH2' ' HB1' ' A' ' 51' ' ' ALA . 82.9 mtp180 -137.82 111.34 8.08 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.007 -1.058 . . . . 0.0 110.66 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.514 ' HB3' ' HA ' ' A' ' 28' ' ' LYS . 85.6 t80 -62.06 -46.31 89.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.312 -0.868 . . . . 0.0 110.03 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -164.64 99.45 0.79 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -0.909 . . . . 0.0 110.078 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.414 ' HB1' ' NH2' ' A' ' 48' ' ' ARG . . . -109.97 -89.81 0.48 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.254 -0.904 . . . . 0.0 109.911 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -63.1 -42.37 99.56 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.927 -1.108 . . . . 0.0 109.075 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 161.81 38.46 0.02 OUTLIER Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -117.54 -171.63 2.08 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.28 -1.13 . . . . 0.0 110.015 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.474 ' O ' ' C ' ' A' ' 56' ' ' ASN . . . -145.22 152.62 40.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.337 -0.852 . . . . 0.0 110.454 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.516 ' HB3' ' CD1' ' A' ' 77' ' ' PHE . 36.2 m120 23.09 56.79 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 45.9 m -112.91 132.62 55.25 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.338 -0.851 . . . . 0.0 109.042 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.432 HD11 ' O ' ' A' ' 76' ' ' VAL . 75.1 mt -117.03 135.55 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.147 -0.971 . . . . 0.0 111.774 -177.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.412 ' CG1' ' OE2' ' A' ' 71' ' ' GLU . 47.4 t -110.9 130.36 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.369 -0.832 . . . . 0.0 109.539 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 75.1 m -130.94 126.17 35.38 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.036 -1.04 . . . . 0.0 110.695 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -151.35 173.29 14.68 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.245 -0.909 . . . . 0.0 110.727 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.454 ' O ' ' CA ' ' A' ' 69' ' ' GLY . 69.0 m -131.77 155.2 48.14 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.506 -0.746 . . . . 0.0 109.858 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.487 ' CD ' ' HA2' ' A' ' 66' ' ' GLY . 8.9 ttmt -135.2 150.45 50.11 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.679 -1.263 . . . . 0.0 111.367 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -124.49 105.51 9.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.426 -0.797 . . . . 0.0 109.937 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 57.58 27.01 58.08 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.487 ' HA2' ' CD ' ' A' ' 63' ' ' LYS . . . 75.46 23.19 74.01 Favored Glycine 0 N--CA 1.488 2.129 0 O-C-N 120.777 -1.425 . . . . 0.0 109.771 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.47 ' HB1' ' CD1' ' A' ' 68' ' ' TRP . . . -81.2 -85.32 0.1 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.189 -1.183 . . . . 0.0 110.835 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.47 ' CD1' ' HB1' ' A' ' 67' ' ' ALA . 10.3 m95 -135.35 -146.89 0.25 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.884 -1.135 . . . . 0.0 109.849 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.454 ' CA ' ' O ' ' A' ' 62' ' ' SER . . . 167.38 129.45 1.07 Allowed Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.641 -1.266 . . . . 0.0 110.544 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.3 m -81.51 80.2 7.93 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.45 -1.029 . . . . 0.0 109.824 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.412 ' OE2' ' CG1' ' A' ' 59' ' ' VAL . 83.5 tt0 -72.37 124.75 25.79 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.201 -0.937 . . . . 0.0 111.134 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -109.53 -162.0 0.79 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.381 -0.824 . . . . 0.0 109.624 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 62.5 ttp85 -145.91 117.38 8.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.185 -0.947 . . . . 0.0 110.697 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -110.4 125.73 53.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.207 -0.933 . . . . 0.0 109.711 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -105.83 45.7 0.96 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.168 -0.957 . . . . 0.0 111.85 -178.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.622 HG12 ' HD3' ' A' ' 78' ' ' PRO . 51.7 t -121.41 133.01 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 120.965 -1.085 . . . . 0.0 109.843 179.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.532 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 11.3 p90 -143.02 82.03 12.32 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.102 -0.999 . . . . 0.0 111.248 -178.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.622 ' HD3' HG12 ' A' ' 76' ' ' VAL . 56.5 Cg_endo -79.99 41.29 1.09 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.495 1.26 . . . . 0.0 111.378 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -149.83 163.24 38.56 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.701 -1.249 . . . . 0.0 110.971 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 13.6 mp0 -129.94 164.58 39.5 Favored Pre-proline 0 N--CA 1.492 1.668 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.79 148.86 65.82 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 123.593 1.312 . . . . 0.0 110.859 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 63.42 41.75 99.26 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 25.1 t -137.36 137.32 38.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.198 -1.178 . . . . 0.0 111.276 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 84' ' ' VAL . 27.6 m -79.18 135.51 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.472 -0.767 . . . . 0.0 109.53 179.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.66 154.58 37.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.974 -1.079 . . . . 0.0 110.6 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.453 ' HG2' ' HA ' ' A' ' 20' ' ' ARG . 97.4 mt-10 -121.05 140.11 52.39 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.473 -0.767 . . . . 0.0 109.65 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.9 t -122.64 130.28 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.101 -0.999 . . . . 0.0 110.36 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 22.2 m -92.73 125.0 37.15 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.439 -0.788 . . . . 0.0 109.821 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 95.8 mt -122.05 125.0 72.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.045 -1.035 . . . . 0.0 110.246 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 53.9 m -121.76 124.55 44.47 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.392 -0.817 . . . . 0.0 108.913 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.414 ' CD1' ' CD2' ' A' ' 96' ' ' LEU . 65.7 t80 -110.51 112.84 25.02 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.142 -0.974 . . . . 0.0 110.333 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -121.04 150.32 41.36 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.612 -0.68 . . . . 0.0 109.226 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -64.35 -33.65 76.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.773 -1.204 . . . . 0.0 110.064 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.74 -46.02 90.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.969 -1.082 . . . . 0.0 109.558 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -168.63 175.59 6.07 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.425 -0.797 . . . . 0.0 109.764 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.734 HD12 ' HD2' ' A' ' 108' ' ' PHE . 79.1 mt -107.71 128.6 54.72 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.158 -0.964 . . . . 0.0 110.414 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.5 m -109.93 126.67 54.14 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.162 -0.961 . . . . 0.0 110.176 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 59.2 t -133.16 128.42 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 120.775 -1.203 . . . . 0.0 110.496 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -123.24 147.7 46.65 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.996 -1.065 . . . . 0.0 111.01 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.492 ' HB3' ' HD2' ' A' ' 101' ' ' PRO . 1.1 mp -100.84 167.73 10.35 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.587 -0.696 . . . . 0.0 109.636 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.492 ' HD2' ' HB3' ' A' ' 100' ' ' LEU . 41.7 Cg_endo -65.97 -22.63 55.21 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 123.408 1.215 . . . . 0.0 110.42 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.419 ' O ' ' HB3' ' A' ' 78' ' ' PRO . 47.7 t0 -152.09 78.23 1.23 Allowed 'General case' 0 N--CA 1.486 1.325 0 O-C-N 121.129 -0.982 . . . . 0.0 109.8 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -177.91 -171.91 41.81 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -87.59 -150.8 0.17 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.379 -1.071 . . . . 0.0 110.009 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 64.3 tt0 -128.92 146.23 51.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.238 -0.914 . . . . 0.0 110.661 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -130.38 134.27 47.02 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.279 -0.888 . . . . 0.0 109.968 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -114.83 144.7 43.11 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.204 -0.935 . . . . 0.0 110.859 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.734 ' HD2' HD12 ' A' ' 96' ' ' LEU . 56.7 t80 -129.17 133.65 25.41 Favored Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.457 ' O ' ' CE2' ' A' ' 108' ' ' PHE . 44.9 Cg_endo -66.83 138.79 49.82 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.359 1.189 . . . . 0.0 110.389 -178.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' A' ' 110' ' ' ASN . 5.2 p-10 -100.39 78.49 2.03 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.318 -0.864 . . . . 0.0 110.263 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.403 ' C ' ' O ' ' A' ' 110' ' ' ASN . 79.6 ttt180 -41.46 -32.65 0.35 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.429 -0.794 . . . . 0.0 110.797 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 95.0 mt -78.93 149.67 32.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.369 -0.832 . . . . 0.0 110.313 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -104.42 40.56 1.45 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.408 -0.808 . . . . 0.0 109.874 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.502 HD13 ' HD2' ' A' ' 36' ' ' LYS . 56.4 tp -71.16 125.93 28.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.203 -0.935 . . . . 0.0 109.766 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -96.75 -5.34 38.81 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.489 -0.757 . . . . 0.0 111.086 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 11' ' ' LEU . . . -141.46 142.0 33.66 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.874 -1.141 . . . . 0.0 111.473 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.47 ' HB ' ' HB3' ' A' ' 11' ' ' LEU . 48.1 mm -102.73 121.29 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.401 ' ND2' ' N ' ' A' ' 118' ' ' ASN . 6.5 m-80 -117.94 -18.82 9.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.993 -1.067 . . . . 0.0 111.465 -178.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.467 ' O ' ' HA ' ' A' ' 34' ' ' LEU . 42.9 t80 -113.71 130.04 56.48 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.907 -1.121 . . . . 0.0 111.14 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.48 ' HB3' ' CD1' ' A' ' 9' ' ' LEU . 48.2 ttp -142.42 114.22 8.05 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -136.05 139.0 42.73 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.95 -1.094 . . . . 0.0 110.905 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.493 ' CB ' HD23 ' A' ' 32' ' ' LEU . . . -141.83 131.92 24.72 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.51 -0.744 . . . . 0.0 109.137 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 2' ' ' CYS . 62.2 t0 -151.35 122.4 7.67 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.567 -0.708 . . . . 0.0 109.246 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.481 ' HA3' ' HA ' ' A' ' 30' ' ' PHE . . . 174.57 -148.98 10.14 Favored Glycine 0 N--CA 1.488 2.153 0 C-N-CA 119.192 -1.48 . . . . 0.0 110.165 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.5 ' HB2' ' CZ ' ' A' ' 30' ' ' PHE . 87.7 m-20 -86.35 9.16 18.78 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.672 -0.899 . . . . 0.0 110.283 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.544 ' HD1' HG22 ' A' ' 23' ' ' VAL . 51.1 t80 -104.06 141.77 35.63 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.122 -0.986 . . . . 0.0 109.662 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -116.08 120.05 37.81 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.168 -1.013 . . . . 0.0 111.108 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.621 HG23 ' O ' ' A' ' 128' ' ' ILE . 19.0 tt -95.47 119.57 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.232 -0.917 . . . . 0.0 109.923 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -100.82 -15.4 17.63 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.128 -0.983 . . . . 0.0 111.571 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -155.54 146.89 22.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.808 -1.183 . . . . 0.0 111.425 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.501 HG22 HD11 ' A' ' 128' ' ' ILE . 43.2 t -124.91 129.37 73.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.547 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -118.96 140.07 50.61 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.961 -1.087 . . . . 0.0 110.521 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -106.36 119.61 39.72 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.415 -0.803 . . . . 0.0 109.976 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.9 t0 . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.538 -179.997 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.162 0.506 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' CYS . . . . . 0.427 ' N ' ' OD1' ' B' ' 123' ' ' ASP . 0.5 OUTLIER -157.71 104.22 1.95 Allowed 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.059 -1.026 . . . . 0.0 110.226 179.898 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . 0.426 ' O ' ' ND2' ' A' ' 8' ' ' ASN . . . 179.51 127.48 1.11 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.555 ' C ' HD23 ' B' ' 4' ' ' LEU . 0.3 OUTLIER -67.27 154.42 41.34 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.728 -0.866 . . . . 0.0 111.342 -179.046 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.46 ' N ' ' HG ' ' B' ' 4' ' ' LEU . 72.7 t -118.11 137.08 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.578 -0.701 . . . . 0.0 109.676 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.474 ' HB3' HD11 ' B' ' 9' ' ' LEU . . . -119.56 164.81 15.27 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.772 -1.205 . . . . 0.0 111.309 -178.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . 0.409 ' O ' ' HB3' ' B' ' 8' ' ' ASN . 14.1 p -153.23 166.37 32.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.292 -0.88 . . . . 0.0 109.645 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . 0.409 ' HB3' ' O ' ' B' ' 7' ' ' SER . 54.8 t30 60.75 38.94 17.88 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.345 -0.847 . . . . 0.0 109.681 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.553 ' O ' ' C ' ' B' ' 10' ' ' ASN . 63.2 mt -91.41 1.32 57.21 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.646 -0.659 . . . . 0.0 111.77 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . 0.553 ' C ' ' O ' ' B' ' 9' ' ' LEU . 7.9 m120 -0.16 80.65 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.565 0 CA-C-O 121.599 0.714 . . . . 0.0 112.715 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.499 ' O ' ' HA ' ' B' ' 116' ' ' ALA . 3.4 tt -100.67 129.9 46.65 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.585 -0.697 . . . . 0.0 109.898 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 3.3 mtpp -98.31 165.18 15.71 Favored Pre-proline 0 C--N 1.295 -1.783 0 O-C-N 121.481 -0.762 . . . . 0.0 110.441 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -66.88 147.38 80.49 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.96 1.505 . . . . 0.0 110.389 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.81 7.06 63.16 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 110.259 -1.137 . . . . 0.0 110.259 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -114.99 146.78 40.87 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.841 -1.388 . . . . 0.0 110.507 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' CYS . . . . . . . . . . . . . 49.4 t -106.44 137.86 43.65 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.413 -0.804 . . . . 0.0 110.561 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.537 HD12 ' O ' ' B' ' 132' ' ' ALA . 45.3 tp -117.86 130.03 56.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.358 -0.839 . . . . 0.0 109.694 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.413 ' CZ ' ' OE1' ' B' ' 86' ' ' GLU . 76.9 ttt180 -118.91 129.4 55.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.02 -1.05 . . . . 0.0 110.498 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 24.9 t -121.75 125.07 72.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.279 -0.888 . . . . 0.0 110.682 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.455 ' HA ' ' HG2' ' B' ' 86' ' ' GLU . 76.1 ttt180 -109.55 128.88 55.51 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.34 -0.85 . . . . 0.0 108.869 178.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -149.4 -170.01 16.49 Favored Glycine 0 N--CA 1.486 1.988 0 C-N-CA 118.997 -1.573 . . . . 0.0 110.086 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -129.54 123.38 31.27 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.678 -0.895 . . . . 0.0 109.774 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.524 HG22 ' HD1' ' B' ' 126' ' ' PHE . 99.2 t -79.36 129.65 37.25 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 121.287 -0.883 . . . . 0.0 109.6 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.457 ' HB1' ' HD2' ' B' ' 25' ' ' PRO . . . -54.77 163.26 1.48 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.16 -0.962 . . . . 0.0 110.027 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.457 ' HD2' ' HB1' ' B' ' 24' ' ' ALA . 42.6 Cg_endo -67.74 -18.81 47.78 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.952 1.501 . . . . 0.0 110.196 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' B' ' 28' ' ' LYS . 64.1 t0 -113.3 56.94 0.68 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.244 -0.91 . . . . 0.0 109.391 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.96 84.89 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.679 -0.638 . . . . 0.0 110.163 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . 0.508 ' HA ' ' HB3' ' B' ' 49' ' ' PHE . 85.2 tttt -109.78 -33.49 6.73 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.065 -1.022 . . . . 0.0 111.777 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 37.1 t -146.58 140.1 25.84 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.674 -1.266 . . . . 0.0 111.535 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' PHE . . . . . 0.505 ' CD2' ' HB2' ' B' ' 126' ' ' PHE . 83.9 m-85 -139.3 146.04 39.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.439 -0.788 . . . . 0.0 110.142 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.413 ' HB ' ' O ' ' B' ' 123' ' ' ASP . 62.9 t -133.04 129.77 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.907 -1.121 . . . . 0.0 109.893 178.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.692 HD12 ' HB2' ' B' ' 45' ' ' PHE . 94.9 mt -131.31 144.64 51.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.103 -0.998 . . . . 0.0 110.565 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -146.07 108.87 4.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.302 -0.874 . . . . 0.0 110.238 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.595 HD11 ' HB2' ' B' ' 43' ' ' LEU . 0.3 OUTLIER -124.19 110.19 14.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.178 -0.951 . . . . 0.0 110.047 179.472 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -157.78 -122.39 0.7 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . 0.497 ' HD2' HD13 ' B' ' 114' ' ' LEU . 0.1 OUTLIER -130.83 -46.12 1.04 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.571 -0.958 . . . . 0.0 108.707 179.177 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . 0.424 ' HB2' ' HB2' ' B' ' 40' ' ' ASN . 87.3 m-20 -122.2 164.14 18.35 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 28.4 t -56.88 -41.99 79.02 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.312 -0.867 . . . . 0.0 111.372 -178.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' ASN . . . . . 0.48 ' HB3' ' N ' ' B' ' 66' ' ' GLY . 92.1 m-20 -92.31 0.02 57.42 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.862 -1.149 . . . . 0.0 111.002 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' ASN . . . . . 0.454 ' ND2' ' N ' ' B' ' 40' ' ' ASN . 2.7 m-80 -117.62 61.88 0.75 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.026 -1.046 . . . . 0.0 109.594 -178.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 95.7 mt -90.33 139.33 30.77 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.757 -0.59 . . . . 0.0 109.651 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' CYS . . . . . . . . . . . . . 7.4 p -90.8 -28.91 17.91 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.183 -0.948 . . . . 0.0 109.557 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.71 HD11 HD13 ' B' ' 96' ' ' LEU . 70.7 mt -137.54 137.62 38.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.359 -0.838 . . . . 0.0 110.954 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -135.42 126.77 28.43 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.388 -0.82 . . . . 0.0 110.094 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.692 ' HB2' HD12 ' B' ' 32' ' ' LEU . 91.6 m-85 -113.44 141.32 47.24 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.93 -1.106 . . . . 0.0 109.994 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -154.2 69.87 6.19 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 120.96 -1.088 . . . . 0.0 111.069 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' PRO . . . . . 0.402 ' HG2' ' HB2' ' B' ' 30' ' ' PHE . 52.6 Cg_endo -69.35 147.09 64.72 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.757 1.399 . . . . 0.0 110.159 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.437 ' NH2' ' HB1' ' B' ' 51' ' ' ALA . 83.0 mtp180 -137.42 111.51 8.4 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.974 -1.079 . . . . 0.0 110.62 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' PHE . . . . . 0.508 ' HB3' ' HA ' ' B' ' 28' ' ' LYS . 85.6 t80 -62.22 -46.31 89.44 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.242 -0.911 . . . . 0.0 109.958 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -164.51 99.33 0.81 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.11 -0.994 . . . . 0.0 110.065 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . 0.437 ' HB1' ' NH2' ' B' ' 48' ' ' ARG . . . -109.88 -89.78 0.48 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.09 -1.006 . . . . 0.0 109.956 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -63.12 -42.17 99.47 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.065 -1.022 . . . . 0.0 109.167 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 161.43 38.92 0.02 OUTLIER Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -118.21 -171.66 2.11 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.254 -1.145 . . . . 0.0 109.93 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.5 ' O ' ' C ' ' B' ' 56' ' ' ASN . . . -143.81 157.83 44.11 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.399 -0.813 . . . . 0.0 109.874 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' ASN . . . . . 0.509 ' HB3' ' CD1' ' B' ' 77' ' ' PHE . 35.8 m120 15.06 59.9 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.423 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -179.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 47.8 m -113.4 132.34 55.66 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' ILE . . . . . 0.427 HD11 ' O ' ' B' ' 76' ' ' VAL . 76.1 mt -116.94 135.99 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.039 -1.038 . . . . 0.0 111.802 -177.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.419 ' CG1' ' OE2' ' B' ' 71' ' ' GLU . 48.3 t -110.94 130.44 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.397 -0.815 . . . . 0.0 109.635 179.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 74.5 m -131.19 124.5 30.76 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.055 -1.028 . . . . 0.0 110.957 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -149.75 173.11 14.08 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.351 -0.843 . . . . 0.0 110.963 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' SER . . . . . 0.452 ' O ' ' CA ' ' B' ' 69' ' ' GLY . 69.7 m -131.16 155.34 47.19 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.464 -0.772 . . . . 0.0 109.919 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . 0.492 ' CD ' ' HA2' ' B' ' 66' ' ' GLY . 8.8 ttmt -135.34 150.33 49.93 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.707 -1.246 . . . . 0.0 111.372 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -124.54 104.77 8.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.389 -0.819 . . . . 0.0 110.149 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 58.24 27.18 59.99 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . 0.492 ' HA2' ' CD ' ' B' ' 63' ' ' LYS . . . 75.34 23.16 74.41 Favored Glycine 0 N--CA 1.488 2.151 0 O-C-N 120.82 -1.4 . . . . 0.0 109.794 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' ALA . . . . . 0.463 ' HB1' ' CD1' ' B' ' 68' ' ' TRP . . . -81.1 -85.04 0.1 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.154 -1.203 . . . . 0.0 110.873 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' TRP . . . . . 0.463 ' CD1' ' HB1' ' B' ' 67' ' ' ALA . 10.8 m95 -135.2 -145.38 0.22 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.915 -1.116 . . . . 0.0 110.057 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . 0.452 ' CA ' ' O ' ' B' ' 62' ' ' SER . . . 165.3 129.34 1.04 Allowed Glycine 0 N--CA 1.49 2.267 0 C-N-CA 119.594 -1.289 . . . . 0.0 110.577 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 18.5 m -81.63 80.21 8.03 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.626 -0.926 . . . . 0.0 109.865 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.419 ' OE2' ' CG1' ' B' ' 59' ' ' VAL . 83.3 tt0 -71.95 125.57 27.55 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.24 -0.913 . . . . 0.0 110.948 -179.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -110.53 -161.94 0.78 Allowed 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.372 -0.83 . . . . 0.0 109.397 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 62.4 ttp85 -146.05 117.04 7.76 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.01 -1.056 . . . . 0.0 110.761 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -109.94 125.82 53.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.305 -0.872 . . . . 0.0 109.768 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -105.86 45.89 0.95 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.054 -1.029 . . . . 0.0 111.776 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' VAL . . . . . 0.61 HG12 ' HD3' ' B' ' 78' ' ' PRO . 51.6 t -121.46 132.66 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.841 -1.162 . . . . 0.0 109.88 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' PHE . . . . . 0.54 ' N ' ' CD1' ' B' ' 77' ' ' PHE . 11.3 p90 -142.74 82.14 12.64 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 120.988 -1.07 . . . . 0.0 111.346 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . 0.61 ' HD3' HG12 ' B' ' 76' ' ' VAL . 56.2 Cg_endo -80.16 41.66 1.17 Allowed 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 123.522 1.275 . . . . 0.0 111.429 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -149.91 163.84 37.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.653 -1.279 . . . . 0.0 110.848 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -130.67 164.53 41.01 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.8 149.3 66.43 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.633 1.333 . . . . 0.0 110.838 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 63.09 41.61 99.74 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 25.6 t -137.04 137.3 39.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.263 -1.139 . . . . 0.0 111.299 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.43 HG23 ' O ' ' B' ' 84' ' ' VAL . 27.5 m -79.1 135.42 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.409 -0.807 . . . . 0.0 109.522 178.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -150.48 154.6 37.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.944 -1.097 . . . . 0.0 110.673 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' GLU . . . . . 0.455 ' HG2' ' HA ' ' B' ' 20' ' ' ARG . 97.3 mt-10 -121.08 140.18 52.31 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.381 -0.824 . . . . 0.0 109.612 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 47.2 t -122.76 129.88 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.068 -1.02 . . . . 0.0 110.502 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' CYS . . . . . . . . . . . . . 24.5 m -92.35 125.06 36.85 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.369 -0.832 . . . . 0.0 109.899 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 96.5 mt -122.2 124.99 72.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.114 -0.991 . . . . 0.0 110.315 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 53.9 m -121.72 124.3 43.92 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.483 -0.761 . . . . 0.0 109.02 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' PHE . . . . . 0.41 ' CD1' ' CD2' ' B' ' 96' ' ' LEU . 65.6 t80 -110.21 112.94 25.23 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.144 -0.973 . . . . 0.0 110.32 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -121.39 149.51 42.88 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.558 -0.714 . . . . 0.0 109.307 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -63.79 -33.16 75.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.796 -1.19 . . . . 0.0 110.088 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.0 -45.96 89.95 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.032 -1.043 . . . . 0.0 109.457 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -168.81 175.49 5.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.524 -0.735 . . . . 0.0 109.766 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' LEU . . . . . 0.719 HD12 ' HD2' ' B' ' 108' ' ' PHE . 79.4 mt -107.48 128.3 54.37 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.211 -0.931 . . . . 0.0 110.685 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 2.6 m -109.67 126.84 54.1 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.014 -1.053 . . . . 0.0 110.358 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 63.6 t -132.96 128.85 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.016 -1.053 . . . . 0.0 110.427 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -123.98 147.03 48.1 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.987 -1.07 . . . . 0.0 110.965 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . 0.488 ' HB3' ' HD2' ' B' ' 101' ' ' PRO . 1.1 mp -100.36 167.85 10.28 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.585 -0.697 . . . . 0.0 109.581 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' B' ' 100' ' ' LEU . 41.0 Cg_endo -66.02 -22.73 54.77 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.564 1.297 . . . . 0.0 110.451 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' ASP . . . . . 0.439 ' O ' ' HB3' ' B' ' 78' ' ' PRO . 47.5 t0 -152.11 80.06 1.25 Allowed 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.122 -0.986 . . . . 0.0 109.751 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 179.41 -172.49 44.42 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -87.13 -150.68 0.16 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.211 -1.17 . . . . 0.0 110.284 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -129.01 146.05 51.09 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.925 . . . . 0.0 110.64 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -130.51 134.34 46.98 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.343 -0.848 . . . . 0.0 109.865 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -114.85 144.62 43.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.296 -0.878 . . . . 0.0 110.891 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' PHE . . . . . 0.719 ' HD2' HD12 ' B' ' 96' ' ' LEU . 56.4 t80 -129.22 133.84 25.61 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . 0.453 ' O ' ' CE2' ' B' ' 108' ' ' PHE . 44.1 Cg_endo -66.93 138.91 49.74 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.312 1.164 . . . . 0.0 110.353 -178.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' ASN . . . . . 0.49 ' ND2' ' O ' ' B' ' 110' ' ' ASN . 5.3 p-10 -100.58 78.58 2.01 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.359 -0.838 . . . . 0.0 110.175 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . 0.406 ' C ' ' O ' ' B' ' 110' ' ' ASN . 79.5 ttt180 -41.61 -32.71 0.39 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.4 -0.812 . . . . 0.0 110.757 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 95.3 mt -78.99 149.2 32.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.274 -0.892 . . . . 0.0 110.452 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -103.78 40.71 1.39 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.323 -0.861 . . . . 0.0 110.035 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' LEU . . . . . 0.497 HD13 ' HD2' ' B' ' 36' ' ' LYS . 56.4 tp -71.29 125.67 27.57 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.124 -0.985 . . . . 0.0 109.862 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -96.58 -4.86 40.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.58 -0.7 . . . . 0.0 111.087 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' B' ' 11' ' ' LEU . . . -142.03 142.04 32.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.868 -1.145 . . . . 0.0 111.499 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' ILE . . . . . 0.472 ' HB ' ' HB3' ' B' ' 11' ' ' LEU . 48.4 mm -102.72 121.15 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -118.02 -18.9 9.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.86 -1.15 . . . . 0.0 111.412 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 119' ' ' TYR . . . . . 0.485 ' O ' ' HA ' ' B' ' 34' ' ' LEU . 43.0 t80 -113.42 129.72 56.47 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.972 -1.08 . . . . 0.0 111.229 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 120' ' ' MET . . . . . 0.472 ' CB ' ' CD1' ' B' ' 9' ' ' LEU . 47.2 ttp -142.06 114.08 8.1 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -135.91 139.15 43.08 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.883 -1.136 . . . . 0.0 110.868 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 122' ' ' ALA . . . . . 0.484 ' CB ' HD23 ' B' ' 32' ' ' LEU . . . -141.96 131.41 23.77 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' B' ' 2' ' ' CYS . 62.2 t0 -150.99 122.14 7.74 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.464 -0.773 . . . . 0.0 109.224 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 124' ' ' GLY . . . . . 0.474 ' HA3' ' HA ' ' B' ' 30' ' ' PHE . . . 174.99 -149.02 9.98 Favored Glycine 0 N--CA 1.489 2.19 0 C-N-CA 118.969 -1.586 . . . . 0.0 110.026 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . 0.491 ' HB2' ' CZ ' ' B' ' 30' ' ' PHE . 87.6 m-20 -86.4 8.95 19.57 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.698 -0.884 . . . . 0.0 110.318 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 126' ' ' PHE . . . . . 0.524 ' HD1' HG22 ' B' ' 23' ' ' VAL . 51.2 t80 -103.86 141.53 35.96 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.136 -0.977 . . . . 0.0 109.768 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -115.93 120.22 38.48 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.119 -1.033 . . . . 0.0 111.089 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . 0.619 ' O ' HG23 ' B' ' 128' ' ' ILE . 18.9 tt -95.86 119.31 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.147 -0.97 . . . . 0.0 109.999 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -100.83 -15.55 17.57 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.021 -1.049 . . . . 0.0 111.591 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 130' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -154.54 146.79 23.8 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.689 -1.257 . . . . 0.0 111.445 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.498 HG22 HD11 ' B' ' 128' ' ' ILE . 42.5 t -124.76 129.04 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 132' ' ' ALA . . . . . 0.537 ' O ' HD12 ' B' ' 17' ' ' LEU . . . -118.79 139.79 51.02 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.564 -1.335 . . . . 0.0 110.504 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -105.98 119.73 39.95 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.429 -0.794 . . . . 0.0 109.955 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 5.7 t0 . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.597 -179.989 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.362 0.601 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 35.9 t -148.36 84.08 1.5 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.291 -0.881 . . . . 0.0 109.95 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.466 ' HA2' ' CB ' ' A' ' 123' ' ' ASP . . . 93.6 38.48 5.26 Favored Glycine 0 N--CA 1.491 2.307 0 C-N-CA 120.121 -1.038 . . . . 0.0 111.135 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.448 ' HA ' ' HB3' ' B' ' 8' ' ' ASN . 60.8 tp -61.44 132.22 52.75 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.719 -1.459 . . . . 0.0 110.032 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.9 t -117.41 154.71 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.49 -0.756 . . . . 0.0 110.599 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.451 ' HB3' ' HB3' ' A' ' 120' ' ' MET . . . -141.92 156.51 45.49 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.345 -0.847 . . . . 0.0 110.573 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.465 ' O ' ' HB3' ' A' ' 8' ' ' ASN . 8.2 p -151.71 170.27 20.14 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.52 -0.737 . . . . 0.0 109.613 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.465 ' HB3' ' O ' ' A' ' 7' ' ' SER . 14.3 t30 60.46 32.89 20.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.456 -0.778 . . . . 0.0 109.529 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.507 ' CD1' ' CB ' ' A' ' 120' ' ' MET . 74.3 mt -84.99 -15.19 45.06 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.554 -0.716 . . . . 0.0 111.991 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.496 ' C ' ' O ' ' A' ' 9' ' ' LEU . 53.4 p-10 5.43 63.06 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.503 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.795 HD21 ' CD2' ' A' ' 133' ' ' PHE . 11.7 mt -92.37 126.61 37.53 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 120.865 -1.147 . . . . 0.0 109.355 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -90.84 165.06 23.41 Favored Pre-proline 0 C--N 1.301 -1.537 0 O-C-N 121.365 -0.834 . . . . 0.0 110.44 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 91' ' ' PHE . 49.7 Cg_endo -68.68 152.63 74.28 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 124.039 1.547 . . . . 0.0 110.554 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.04 -20.73 42.33 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -100.12 152.69 19.96 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.16 -1.2 . . . . 0.0 110.108 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.2 m -97.91 139.02 34.37 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.225 -0.922 . . . . 0.0 110.806 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.411 ' CD1' ' HA ' ' A' ' 133' ' ' PHE . 58.8 tp -124.13 131.41 53.54 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.238 -0.914 . . . . 0.0 110.029 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 95.4 mtm-85 -128.91 139.96 51.89 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.014 -1.054 . . . . 0.0 111.017 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.416 ' O ' ' HG3' ' A' ' 86' ' ' GLU . 90.2 t -129.4 122.51 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.096 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 47.3 ttp180 -107.03 127.84 53.83 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.103 -0.998 . . . . 0.0 110.66 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -143.02 -159.24 7.86 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 119.449 -1.358 . . . . 0.0 110.715 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 84' ' ' VAL . 84.4 tt0 -138.03 147.53 44.23 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.833 -0.804 . . . . 0.0 109.135 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.556 ' CG1' ' HB2' ' A' ' 27' ' ' ALA . 50.3 t -108.78 124.12 65.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 120.903 -1.123 . . . . 0.0 110.123 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.54 162.01 1.88 Allowed Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.166 -0.959 . . . . 0.0 109.024 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.406 ' O ' ' HB2' ' A' ' 81' ' ' PRO . 43.9 Cg_endo -66.95 -19.47 52.11 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 O-C-N 123.833 1.438 . . . . 0.0 110.65 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 28' ' ' LYS . 89.2 m-20 -112.65 40.04 2.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.115 -0.991 . . . . 0.0 110.656 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.556 ' HB2' ' CG1' ' A' ' 23' ' ' VAL . . . -54.0 92.67 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.065 -1.022 . . . . 0.0 110.051 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.423 ' N ' ' O ' ' A' ' 26' ' ' ASP . 87.6 tttt -106.21 -34.43 7.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.164 -0.96 . . . . 0.0 111.612 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 39.5 t -150.48 133.73 16.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.847 -1.158 . . . . 0.0 111.297 -178.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.427 ' HA ' ' HA3' ' A' ' 124' ' ' GLY . 47.1 t80 -156.18 155.27 32.16 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.481 -0.762 . . . . 0.0 110.526 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.476 HG13 ' O ' ' A' ' 31' ' ' VAL . 9.3 p -139.4 133.9 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.096 -1.003 . . . . 0.0 111.007 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.7 tp -126.73 131.08 51.43 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.372 -0.83 . . . . 0.0 109.875 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.696 ' HB3' HD22 ' A' ' 41' ' ' LEU . 76.9 m-20 -136.72 137.21 39.69 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.855 -1.153 . . . . 0.0 111.421 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -138.45 113.64 9.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.241 -0.912 . . . . 0.0 109.648 178.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.476 ' O ' ' HB3' ' A' ' 119' ' ' TYR . . . -165.58 -163.35 18.79 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.669 ' HE3' HD12 ' A' ' 114' ' ' LEU . 99.1 mttt -68.32 -43.99 76.39 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.939 -1.33 . . . . 0.0 110.514 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -153.57 -167.03 2.56 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.779 0.8 . . . . 0.0 111.93 -178.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.3 t -60.28 -44.63 95.18 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.685 -0.634 . . . . 0.0 112.486 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.418 ' HB3' ' N ' ' A' ' 66' ' ' GLY . 82.6 m-20 -89.49 -14.01 36.24 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.763 -1.211 . . . . 0.0 110.317 -179.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -107.27 71.89 0.85 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.342 -0.849 . . . . 0.0 109.348 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.696 HD22 ' HB3' ' A' ' 33' ' ' ASN . 95.6 mt -101.59 141.41 34.5 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.261 0.553 . . . . 0.0 110.388 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.44 ' O ' ' CB ' ' A' ' 62' ' ' SER . 0.5 OUTLIER -85.78 -51.93 6.1 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.24 -0.913 . . . . 0.0 110.049 179.652 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.99 HD11 HD11 ' A' ' 96' ' ' LEU . 84.7 mt -128.07 140.29 52.03 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.994 -1.066 . . . . 0.0 110.914 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.423 ' N ' ' O ' ' A' ' 61' ' ' ASN . 66.0 t-80 -120.88 112.14 18.42 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -104.78 127.61 52.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.056 -1.028 . . . . 0.0 109.743 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.5 81.11 13.91 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.082 -1.011 . . . . 0.0 111.025 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.83 148.23 64.18 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.076 1.566 . . . . 0.0 110.139 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -144.95 107.57 4.43 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.925 -1.109 . . . . 0.0 111.689 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -62.3 -45.0 95.21 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.209 -0.932 . . . . 0.0 109.57 178.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -136.57 93.58 2.89 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.635 -0.666 . . . . 0.0 109.892 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -87.5 -151.04 0.17 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.191 -0.943 . . . . 0.0 110.136 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -66.02 -8.52 23.55 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.076 -1.015 . . . . 0.0 111.444 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 174.29 -27.53 0.08 OUTLIER Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -77.97 -179.31 6.0 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.05 -1.264 . . . . 0.0 109.13 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.428 ' O ' ' C ' ' A' ' 56' ' ' ASN . . . -143.76 149.84 37.7 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.173 -0.955 . . . . 0.0 110.988 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.428 ' C ' ' O ' ' A' ' 55' ' ' ALA . 87.6 m-20 29.51 59.31 0.16 Allowed 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 178.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 98.2 m -121.18 128.88 52.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.94 -1.1 . . . . 0.0 110.645 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 95.6 mt -111.13 126.05 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.701 -0.624 . . . . 0.0 110.383 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.1 m -116.5 135.43 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.015 -1.053 . . . . 0.0 109.955 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 35.4 m -103.03 136.15 43.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.141 -0.974 . . . . 0.0 110.053 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.423 ' O ' ' N ' ' A' ' 44' ' ' HIS . 1.4 t-20 -146.95 158.6 43.97 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.074 -1.016 . . . . 0.0 110.987 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 42' ' ' CYS . 53.2 p -139.05 158.25 44.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.447 -0.783 . . . . 0.0 110.236 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.477 ' CD ' ' HA2' ' A' ' 66' ' ' GLY . 26.2 ttmt -142.47 152.7 42.99 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.312 -0.867 . . . . 0.0 110.563 178.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -125.04 94.66 4.24 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.358 -0.839 . . . . 0.0 109.071 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 64.47 28.43 73.13 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.477 ' HA2' ' CD ' ' A' ' 63' ' ' LYS . . . 73.98 24.76 73.15 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.2 -79.03 0.13 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.434 -1.039 . . . . 0.0 110.347 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.41 ' O ' ' HG3' ' A' ' 63' ' ' LYS . 93.5 m95 -141.98 -144.67 0.16 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.341 -0.849 . . . . 0.0 109.66 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 163.76 110.57 0.24 Allowed Glycine 0 N--CA 1.493 2.497 0 C-N-CA 119.67 -1.253 . . . . 0.0 110.078 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.08 71.97 10.12 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.364 -1.08 . . . . 0.0 110.32 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -61.3 143.99 54.7 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.553 -0.717 . . . . 0.0 111.729 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -124.73 -154.38 0.61 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.465 -0.772 . . . . 0.0 109.314 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 78.3 ttt-85 -143.88 116.18 8.5 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.757 -1.214 . . . . 0.0 112.021 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -109.32 122.64 47.79 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.33 -0.856 . . . . 0.0 109.577 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -113.88 88.4 2.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.896 -1.127 . . . . 0.0 110.377 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.6 p -141.33 142.46 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.369 -0.832 . . . . 0.0 110.475 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -151.65 77.87 7.04 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.171 -0.956 . . . . 0.0 109.857 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.479 ' CB ' ' HB2' ' A' ' 102' ' ' ASP . 54.7 Cg_endo -83.3 -0.96 10.11 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.218 1.641 . . . . 0.0 111.934 -178.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.513 ' CE1' ' HG2' ' A' ' 101' ' ' PRO . 44.0 m-85 -139.13 -171.9 3.21 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.912 -1.118 . . . . 0.0 110.357 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.47 ' HB2' ' HD2' ' A' ' 81' ' ' PRO . 2.7 pm0 -143.6 166.66 18.53 Favored Pre-proline 0 C--N 1.301 -1.506 0 O-C-N 121.189 -0.944 . . . . 0.0 110.342 -178.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.47 ' HD2' ' HB2' ' A' ' 80' ' ' GLN . 43.9 Cg_endo -65.7 151.13 85.41 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.931 1.49 . . . . 0.0 109.655 179.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.35 23.75 70.06 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 38.9 t -140.56 143.39 35.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.262 -1.14 . . . . 0.0 109.518 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 20.2 m -78.28 153.63 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.159 -0.963 . . . . 0.0 110.753 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -160.87 147.83 15.31 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.343 -0.848 . . . . 0.0 109.92 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.416 ' HG3' ' O ' ' A' ' 19' ' ' VAL . 78.5 tt0 -122.19 146.78 46.92 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.434 -0.791 . . . . 0.0 108.945 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 71.1 t -126.94 135.2 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.011 -1.056 . . . . 0.0 110.896 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 2.3 t -109.3 129.02 55.53 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.307 -0.871 . . . . 0.0 109.42 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 86.8 mt -129.15 127.33 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.118 -0.989 . . . . 0.0 110.589 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.0 m -115.56 132.12 56.73 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.177 -0.952 . . . . 0.0 109.691 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.431 ' CZ ' ' HB3' ' A' ' 114' ' ' LEU . 47.8 t80 -113.26 123.38 50.03 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.13 -0.981 . . . . 0.0 110.266 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -109.62 147.68 32.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -0.912 . . . . 0.0 109.769 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -58.11 -21.68 47.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.333 -0.854 . . . . 0.0 111.225 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -116.62 -13.34 10.85 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.724 -1.235 . . . . 0.0 110.781 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -147.29 -167.68 2.85 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.08 -1.013 . . . . 0.0 110.981 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.99 HD11 HD11 ' A' ' 43' ' ' LEU . 7.2 tt -151.76 115.63 4.91 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 54.4 m -106.65 130.37 54.4 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.768 -1.208 . . . . 0.0 110.309 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.58 HG23 ' CD2' ' A' ' 96' ' ' LEU . 52.5 t -121.4 132.34 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.458 -0.776 . . . . 0.0 110.185 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -122.68 127.04 48.77 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.851 -1.156 . . . . 0.0 110.659 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.4 mt -95.9 161.27 27.95 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.513 ' HG2' ' CE1' ' A' ' 79' ' ' PHE . 39.4 Cg_endo -65.62 -22.7 57.68 Favored 'Trans proline' 0 C--N 1.301 -1.95 0 O-C-N 123.448 1.236 . . . . 0.0 109.828 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.486 ' OD2' ' CD1' ' A' ' 104' ' ' TYR . 29.0 t70 -63.67 -40.26 96.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.287 -0.883 . . . . 0.0 109.995 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 126.59 -6.57 7.49 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.486 ' CD1' ' OD2' ' A' ' 102' ' ' ASP . 47.2 m-85 -87.07 142.29 28.04 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.005 -1.291 . . . . 0.0 110.224 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -128.43 140.26 51.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.321 -0.862 . . . . 0.0 111.327 -179.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -131.87 150.46 52.15 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 11.7 ptpt -132.9 136.01 45.91 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.798 -1.189 . . . . 0.0 111.384 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 20.1 m-30 -108.44 147.41 35.62 Favored Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 121.533 -0.729 . . . . 0.0 109.648 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.414 ' O ' ' N ' ' A' ' 111' ' ' ARG . 41.2 Cg_endo -65.64 150.68 86.19 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 O-C-N 124.0 1.526 . . . . 0.0 111.017 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -65.82 62.31 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.84 -0.537 . . . . 0.0 111.68 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.414 ' N ' ' O ' ' A' ' 109' ' ' PRO . 20.8 ptt180 -68.74 -24.76 64.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.061 -1.025 . . . . 0.0 109.663 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.721 HD13 ' N ' ' A' ' 113' ' ' ASN . 1.2 tm? -111.21 128.77 56.02 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.297 -0.877 . . . . 0.0 109.107 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.721 ' N ' HD13 ' A' ' 112' ' ' LEU . 8.1 m120 -90.27 69.42 7.08 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.795 -1.191 . . . . 0.0 110.812 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.669 HD12 ' HE3' ' A' ' 36' ' ' LYS . 53.4 tp -84.84 131.44 34.53 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.377 -0.827 . . . . 0.0 109.35 178.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -92.17 -19.48 22.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.725 -1.234 . . . . 0.0 109.846 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.611 ' O ' HD11 ' A' ' 114' ' ' LEU . . . -171.76 156.6 4.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -0.907 . . . . 0.0 109.479 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 66.5 mt -101.94 116.36 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.884 -1.135 . . . . 0.0 110.76 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 -111.63 -23.97 10.36 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.143 -0.973 . . . . 0.0 109.914 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.476 ' HB3' ' O ' ' A' ' 35' ' ' GLY . 90.2 t80 -106.84 126.75 52.7 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.378 -0.826 . . . . 0.0 111.228 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.507 ' CB ' ' CD1' ' A' ' 9' ' ' LEU . 66.3 ttp -136.67 125.56 24.16 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -141.59 136.76 31.37 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.959 -1.088 . . . . 0.0 110.393 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -147.37 123.46 10.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.351 -0.843 . . . . 0.0 110.204 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.466 ' CB ' ' HA2' ' A' ' 3' ' ' GLY . 20.5 p-10 -151.11 121.93 7.56 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.956 -1.09 . . . . 0.0 110.956 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.427 ' HA3' ' HA ' ' A' ' 30' ' ' PHE . . . 178.28 -148.08 8.3 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.474 ' HB3' ' HA ' ' A' ' 27' ' ' ALA . 80.9 m-20 -81.69 8.72 9.21 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.482 -1.011 . . . . 0.0 110.924 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.459 ' HD1' HG22 ' A' ' 23' ' ' VAL . 43.1 t80 -106.29 142.65 35.62 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.974 -1.078 . . . . 0.0 110.205 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -110.97 125.3 53.56 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 118.945 -1.102 . . . . 0.0 110.91 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.463 HD11 ' CG2' ' A' ' 131' ' ' VAL . 9.0 tt -100.26 121.18 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.162 -0.961 . . . . 0.0 109.601 178.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -101.0 -17.55 16.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.343 -0.848 . . . . 0.0 112.323 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -159.39 147.72 17.7 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.484 -1.385 . . . . 0.0 112.252 -178.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.463 ' CG2' HD11 ' A' ' 128' ' ' ILE . 45.4 t -127.13 127.1 69.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -128.68 129.75 46.23 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.813 -1.179 . . . . 0.0 110.214 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.795 ' CD2' HD21 ' A' ' 11' ' ' LEU . 3.2 m-30 -64.25 -102.76 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.238 -0.914 . . . . 0.0 110.118 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.8 t70 . . . . . 0 N--CA 1.493 1.71 0 O-C-N 120.599 -1.313 . . . . 0.0 110.19 179.64 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.265 0.555 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' CYS . . . . . . . . . . . . . 35.6 t -148.27 83.31 1.49 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.356 -0.84 . . . . 0.0 110.148 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . 0.468 ' HA2' ' CB ' ' B' ' 123' ' ' ASP . . . 93.9 38.85 5.07 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 120.198 -1.001 . . . . 0.0 111.1 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 60.5 tp -61.69 132.26 52.65 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.729 -1.454 . . . . 0.0 109.906 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 3.1 t -117.16 154.58 18.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.643 -0.66 . . . . 0.0 110.602 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.444 ' HB3' ' HB3' ' B' ' 120' ' ' MET . . . -141.99 156.53 45.45 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.423 -0.798 . . . . 0.0 110.548 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . 0.457 ' O ' ' HB3' ' B' ' 8' ' ' ASN . 7.9 p -151.89 170.04 20.81 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.579 -0.701 . . . . 0.0 109.579 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . 0.457 ' HB3' ' O ' ' B' ' 7' ' ' SER . 16.1 t30 60.79 32.99 20.2 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.521 -0.737 . . . . 0.0 109.287 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.507 ' CD1' ' CB ' ' B' ' 120' ' ' MET . 73.2 mt -86.15 -11.59 52.18 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.622 -0.674 . . . . 0.0 111.834 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . 0.491 ' C ' ' O ' ' B' ' 9' ' ' LEU . 53.5 p-10 -0.28 66.14 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.486 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -178.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.801 HD21 ' CD2' ' B' ' 133' ' ' PHE . 11.6 mt -93.37 126.54 38.55 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.087 -1.008 . . . . 0.0 109.202 178.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -90.83 165.3 22.68 Favored Pre-proline 0 C--N 1.3 -1.566 0 O-C-N 121.345 -0.847 . . . . 0.0 110.402 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . 0.426 ' HA ' ' O ' ' B' ' 91' ' ' PHE . 48.9 Cg_endo -68.65 152.64 74.4 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.967 1.509 . . . . 0.0 110.548 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.08 -20.73 42.25 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -100.04 152.84 19.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.184 -1.186 . . . . 0.0 110.047 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' CYS . . . . . . . . . . . . . 2.2 m -98.16 139.12 34.43 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.185 -0.947 . . . . 0.0 110.708 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.419 ' CD1' ' HA ' ' B' ' 133' ' ' PHE . 58.7 tp -124.18 131.38 53.53 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.253 -0.904 . . . . 0.0 110.063 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 95.5 mtm-85 -128.93 139.87 51.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.878 -1.139 . . . . 0.0 110.937 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.409 ' O ' ' HG3' ' B' ' 86' ' ' GLU . 91.4 t -129.33 122.65 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.09 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 47.3 ttp180 -107.13 127.69 53.72 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.15 -0.969 . . . . 0.0 110.665 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -142.86 -159.25 7.87 Favored Glycine 0 N--CA 1.49 2.269 0 C-N-CA 119.409 -1.377 . . . . 0.0 110.685 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' B' ' 84' ' ' VAL . 84.6 tt0 -138.03 147.46 44.16 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.822 -0.811 . . . . 0.0 109.215 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.543 ' CG1' ' HB2' ' B' ' 27' ' ' ALA . 50.1 t -108.74 124.11 65.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 O-C-N 120.984 -1.073 . . . . 0.0 110.148 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.411 ' HB1' ' HD2' ' B' ' 25' ' ' PRO . . . -54.71 161.88 2.02 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.103 -0.998 . . . . 0.0 108.985 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.412 ' O ' ' HB2' ' B' ' 81' ' ' PRO . 43.6 Cg_endo -66.76 -19.58 53.11 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 O-C-N 123.7 1.368 . . . . 0.0 110.606 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' B' ' 28' ' ' LYS . 89.2 m-20 -112.64 40.14 2.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.183 -0.948 . . . . 0.0 110.664 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . 0.543 ' HB2' ' CG1' ' B' ' 23' ' ' VAL . . . -53.98 92.53 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.109 -0.994 . . . . 0.0 110.172 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' B' ' 26' ' ' ASP . 87.6 tttt -106.28 -34.28 7.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.125 -0.984 . . . . 0.0 111.588 -179.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 39.7 t -150.52 133.2 15.81 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.848 -1.158 . . . . 0.0 111.312 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' PHE . . . . . 0.431 ' HA ' ' HA3' ' B' ' 124' ' ' GLY . 48.4 t80 -155.54 155.42 33.36 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.52 -0.737 . . . . 0.0 110.632 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.472 ' O ' HG13 ' B' ' 31' ' ' VAL . 9.1 p -139.5 133.64 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.162 -0.961 . . . . 0.0 111.044 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 15.8 tp -126.66 131.02 51.52 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.32 -0.862 . . . . 0.0 109.877 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' ASN . . . . . 0.683 ' HB3' HD22 ' B' ' 41' ' ' LEU . 76.9 m-20 -136.61 137.48 40.17 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.958 -1.089 . . . . 0.0 111.407 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -138.94 109.68 6.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.143 -0.973 . . . . 0.0 109.859 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . 0.474 ' O ' ' HB3' ' B' ' 119' ' ' TYR . . . -160.18 -162.31 12.25 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . 0.692 ' HE3' HD12 ' B' ' 114' ' ' LEU . 99.1 mttt -68.81 -43.85 74.75 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.146 -1.208 . . . . 0.0 110.228 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -153.56 -167.2 2.62 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.786 0.803 . . . . 0.0 111.881 -178.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 11.6 t -59.91 -44.77 94.08 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' ASN . . . . . 0.412 ' HB3' ' N ' ' B' ' 66' ' ' GLY . 83.0 m-20 -89.69 -13.81 36.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.707 -1.246 . . . . 0.0 110.315 -179.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' ASN . . . . . 0.4 ' ND2' ' N ' ' B' ' 40' ' ' ASN . 5.7 m-80 -107.45 71.74 0.84 Allowed 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.913 0.864 . . . . 0.0 109.318 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.683 HD22 ' HB3' ' B' ' 33' ' ' ASN . 95.0 mt -101.12 144.05 30.49 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.782 -0.573 . . . . 0.0 110.13 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' CYS . . . . . 0.425 ' O ' ' CB ' ' B' ' 62' ' ' SER . 0.5 OUTLIER -89.31 -50.42 6.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.168 -0.958 . . . . 0.0 109.636 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.956 HD11 HD11 ' B' ' 96' ' ' LEU . 85.5 mt -128.93 140.19 51.78 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.913 -1.117 . . . . 0.0 110.813 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' HIS . . . . . 0.429 ' N ' ' O ' ' B' ' 61' ' ' ASN . 65.9 t-80 -120.91 112.3 18.61 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -104.86 127.69 52.77 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.165 -0.959 . . . . 0.0 109.664 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.46 80.99 14.08 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 120.989 -1.07 . . . . 0.0 111.06 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.79 148.08 64.12 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.062 1.559 . . . . 0.0 110.132 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -144.8 107.72 4.5 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.879 -1.138 . . . . 0.0 111.628 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -62.51 -44.86 95.34 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.057 -1.027 . . . . 0.0 109.575 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 28.9 t30 -136.63 93.24 2.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.729 -0.607 . . . . 0.0 110.005 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -87.35 -151.08 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.258 -0.901 . . . . 0.0 110.209 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -66.15 -6.93 15.06 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.019 -1.051 . . . . 0.0 111.458 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 171.8 -26.8 0.1 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -78.29 -179.41 6.23 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.994 -1.297 . . . . 0.0 108.997 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.486 ' O ' ' C ' ' B' ' 56' ' ' ASN . . . -141.8 156.7 45.55 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.121 -0.987 . . . . 0.0 110.202 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' ASN . . . . . 0.486 ' C ' ' O ' ' B' ' 55' ' ' ALA . 87.1 m-20 18.51 63.88 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 97.8 m -122.05 128.91 51.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 110.532 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' ILE . . . . . . . . . . . . . 96.1 mt -111.43 126.27 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.698 -0.626 . . . . 0.0 110.356 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 25.4 m -116.55 135.33 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.053 -1.029 . . . . 0.0 110.052 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 35.2 m -103.01 135.88 43.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.21 -0.931 . . . . 0.0 110.255 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' ASN . . . . . 0.429 ' O ' ' N ' ' B' ' 44' ' ' HIS . 1.4 t-20 -146.74 158.45 43.91 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.083 -1.011 . . . . 0.0 111.134 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' B' ' 42' ' ' CYS . 53.3 p -138.85 158.45 44.19 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.454 -0.779 . . . . 0.0 110.266 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . 0.477 ' CD ' ' HA2' ' B' ' 66' ' ' GLY . 26.3 ttmt -142.56 152.7 42.85 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.289 -0.882 . . . . 0.0 110.498 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -124.92 94.73 4.27 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.304 -0.872 . . . . 0.0 109.055 178.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 64.3 28.59 73.22 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . 0.477 ' HA2' ' CD ' ' B' ' 63' ' ' LYS . . . 73.88 24.73 73.45 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.06 -79.0 0.13 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.341 -1.093 . . . . 0.0 110.435 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' TRP . . . . . 0.408 ' O ' ' HG3' ' B' ' 63' ' ' LYS . 93.4 m95 -142.18 -144.69 0.16 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.255 -0.903 . . . . 0.0 109.624 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 163.63 110.4 0.24 Allowed Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.545 -1.312 . . . . 0.0 110.1 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.83 71.99 9.91 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.317 -1.108 . . . . 0.0 110.319 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -61.4 144.09 54.68 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.463 -0.773 . . . . 0.0 111.817 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -124.84 -154.38 0.61 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.318 -0.864 . . . . 0.0 109.314 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 78.3 ttt-85 -143.79 116.24 8.58 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.709 -1.244 . . . . 0.0 111.99 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -109.42 122.74 48.05 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.371 -0.83 . . . . 0.0 109.557 178.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -114.03 88.52 2.87 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.925 -1.11 . . . . 0.0 110.271 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 7.6 p -141.4 142.38 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.309 -0.87 . . . . 0.0 110.53 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -151.47 77.81 7.18 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.139 -0.976 . . . . 0.0 109.899 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . 0.486 ' CB ' ' HB2' ' B' ' 102' ' ' ASP . 54.6 Cg_endo -83.36 -0.65 9.95 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.185 1.624 . . . . 0.0 112.078 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' PHE . . . . . 0.511 ' CE1' ' HG2' ' B' ' 101' ' ' PRO . 44.3 m-85 -139.32 -171.74 3.19 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.955 -1.091 . . . . 0.0 110.439 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.457 ' HB2' ' HD2' ' B' ' 81' ' ' PRO . 2.6 pm0 -143.67 166.9 17.27 Favored Pre-proline 0 C--N 1.302 -1.457 0 O-C-N 121.284 -0.885 . . . . 0.0 110.323 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' PRO . . . . . 0.457 ' HD2' ' HB2' ' B' ' 80' ' ' GLN . 43.2 Cg_endo -65.71 151.2 85.17 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.904 1.476 . . . . 0.0 109.63 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.4 23.61 70.26 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.024 -1.631 . . . . 0.0 109.024 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 38.6 t -140.49 143.43 35.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.333 -1.098 . . . . 0.0 109.572 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' B' ' 22' ' ' GLU . 20.0 m -78.33 153.51 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.126 -0.983 . . . . 0.0 110.834 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -160.72 147.74 15.51 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.383 -0.823 . . . . 0.0 109.917 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' B' ' 19' ' ' VAL . 78.6 tt0 -122.09 146.66 46.99 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.307 -0.871 . . . . 0.0 108.928 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 70.4 t -126.81 135.21 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.05 -1.031 . . . . 0.0 110.902 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' CYS . . . . . . . . . . . . . 2.4 t -109.14 129.15 55.48 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.362 -0.836 . . . . 0.0 109.498 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 87.0 mt -129.12 127.22 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.148 -0.97 . . . . 0.0 110.617 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 5.7 m -115.48 132.13 56.72 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.15 -0.969 . . . . 0.0 109.816 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' PHE . . . . . 0.428 ' CZ ' ' HB3' ' B' ' 114' ' ' LEU . 47.7 t80 -113.23 123.62 50.61 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.111 -0.993 . . . . 0.0 110.339 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -109.88 147.8 32.71 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.162 -0.961 . . . . 0.0 109.77 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -58.26 -21.54 48.96 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.322 -0.861 . . . . 0.0 111.201 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -116.7 -13.3 10.8 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.704 -1.247 . . . . 0.0 110.829 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -147.39 -167.68 2.85 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.096 -1.003 . . . . 0.0 110.899 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 96' ' ' LEU . . . . . 0.956 HD11 HD11 ' B' ' 43' ' ' LEU . 7.2 tt -151.72 115.75 4.96 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 54.1 m -106.77 130.37 54.49 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.738 -1.227 . . . . 0.0 110.375 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 98' ' ' VAL . . . . . 0.587 HG23 ' CD2' ' B' ' 96' ' ' LEU . 51.8 t -121.58 132.46 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.51 -0.743 . . . . 0.0 110.13 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -122.57 127.53 49.58 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.977 -1.077 . . . . 0.0 110.616 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 3.4 mt -96.41 161.14 27.9 Favored Pre-proline 0 C--N 1.303 -1.454 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' PRO . . . . . 0.511 ' HG2' ' CE1' ' B' ' 79' ' ' PHE . 39.7 Cg_endo -65.54 -22.73 58.24 Favored 'Trans proline' 0 C--N 1.301 -1.952 0 O-C-N 123.448 1.236 . . . . 0.0 109.841 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' ASP . . . . . 0.489 ' OD2' ' CD1' ' B' ' 104' ' ' TYR . 28.9 t70 -63.6 -40.22 96.37 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.337 -0.852 . . . . 0.0 110.02 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 126.44 -6.42 7.57 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' TYR . . . . . 0.489 ' CD1' ' OD2' ' B' ' 102' ' ' ASP . 47.3 m-85 -87.22 142.29 28.01 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.984 -1.304 . . . . 0.0 110.193 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -128.19 140.22 52.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.401 -0.812 . . . . 0.0 111.393 -179.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -131.88 150.61 52.1 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' LYS . . . . . 0.459 ' HA ' ' O ' ' B' ' 96' ' ' LEU . 11.7 ptpt -132.98 135.89 45.75 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 118.757 -1.177 . . . . 0.0 111.394 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 108' ' ' PHE . . . . . . . . . . . . . 20.2 m-30 -108.33 147.54 35.82 Favored Pre-proline 0 C--N 1.304 -1.398 0 O-C-N 121.453 -0.78 . . . . 0.0 109.649 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . 0.414 ' O ' ' N ' ' B' ' 111' ' ' ARG . 40.9 Cg_endo -65.63 150.8 86.09 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 O-C-N 123.982 1.517 . . . . 0.0 111.042 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 110' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -65.95 62.46 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.881 -0.512 . . . . 0.0 111.583 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . 0.414 ' N ' ' O ' ' B' ' 109' ' ' PRO . 20.8 ptt180 -68.94 -24.48 64.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.032 -1.043 . . . . 0.0 109.558 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . 0.718 HD13 ' N ' ' B' ' 113' ' ' ASN . 1.2 tm? -111.43 128.7 56.07 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.396 -0.815 . . . . 0.0 109.099 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 113' ' ' ASN . . . . . 0.718 ' N ' HD13 ' B' ' 112' ' ' LEU . 8.1 m120 -90.27 69.5 7.09 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.835 -1.165 . . . . 0.0 110.77 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 114' ' ' LEU . . . . . 0.692 HD12 ' HE3' ' B' ' 36' ' ' LYS . 53.4 tp -85.12 131.29 34.47 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.53 -0.731 . . . . 0.0 109.381 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -92.0 -19.58 22.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.717 -1.24 . . . . 0.0 109.775 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 116' ' ' ALA . . . . . 0.613 ' O ' HD11 ' B' ' 114' ' ' LEU . . . -171.83 156.74 4.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.227 -0.921 . . . . 0.0 109.475 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 66.3 mt -101.98 116.36 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.88 -1.137 . . . . 0.0 110.733 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 -111.64 -24.05 10.31 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.155 -0.966 . . . . 0.0 109.817 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 119' ' ' TYR . . . . . 0.474 ' HB3' ' O ' ' B' ' 35' ' ' GLY . 90.1 t80 -106.8 126.75 52.7 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.335 -0.853 . . . . 0.0 111.254 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 120' ' ' MET . . . . . 0.507 ' CB ' ' CD1' ' B' ' 9' ' ' LEU . 66.0 ttp -136.75 125.55 24.03 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -141.59 136.72 31.32 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.034 -1.041 . . . . 0.0 110.388 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -147.27 123.59 10.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.364 -0.835 . . . . 0.0 110.281 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . 0.468 ' CB ' ' HA2' ' B' ' 3' ' ' GLY . 20.5 p-10 -151.12 122.13 7.66 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.003 -1.061 . . . . 0.0 110.994 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 124' ' ' GLY . . . . . 0.431 ' HA3' ' HA ' ' B' ' 30' ' ' PHE . . . 178.03 -148.12 8.41 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . 0.463 ' HB3' ' HA ' ' B' ' 27' ' ' ALA . 80.8 m-20 -81.73 8.71 9.33 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.537 -0.978 . . . . 0.0 110.889 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 126' ' ' PHE . . . . . 0.468 ' HD1' HG22 ' B' ' 23' ' ' VAL . 43.7 t80 -106.2 142.67 35.49 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.03 -1.044 . . . . 0.0 110.233 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -111.02 125.13 53.41 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.024 -1.071 . . . . 0.0 110.885 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . 0.454 HD11 ' CG2' ' B' ' 131' ' ' VAL . 8.9 tt -100.2 121.26 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.256 -0.902 . . . . 0.0 109.679 178.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -100.87 -19.53 15.89 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.337 -0.852 . . . . 0.0 112.2 -178.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 130' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -156.8 148.43 22.53 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 118.324 -1.35 . . . . 0.0 112.507 -178.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.454 ' CG2' HD11 ' B' ' 128' ' ' ILE . 45.6 t -127.45 127.05 68.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 177.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 132' ' ' ALA . . . . . . . . . . . . . . . -128.67 129.77 46.29 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.856 -1.152 . . . . 0.0 110.266 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . 0.801 ' CD2' HD21 ' B' ' 11' ' ' LEU . 3.2 m-30 -64.28 -102.76 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.172 -0.955 . . . . 0.0 110.062 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.9 t70 . . . . . 0 N--CA 1.493 1.715 0 O-C-N 120.521 -1.362 . . . . 0.0 110.252 179.697 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 121.164 0.507 . . . . 0.0 110.513 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -136.95 83.57 2.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.289 -0.882 . . . . 0.0 110.615 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 122' ' ' ALA . . . 177.21 169.21 38.1 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.771 HD22 HD23 ' B' ' 9' ' ' LEU . 77.7 mt -79.42 144.49 34.05 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.354 -1.086 . . . . 0.0 112.215 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.3 m -110.52 150.35 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.56 -0.713 . . . . 0.0 109.498 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.38 156.32 47.08 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.72 -1.238 . . . . 0.0 112.387 -178.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.458 ' O ' ' HB3' ' A' ' 8' ' ' ASN . 17.3 m -155.39 173.25 16.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.538 -0.726 . . . . 0.0 109.853 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.458 ' HB3' ' O ' ' A' ' 7' ' ' SER . 37.3 t-20 62.25 26.76 16.05 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.137 -0.977 . . . . 0.0 109.768 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.783 HD23 HD22 ' B' ' 4' ' ' LEU . 63.2 mt -82.25 -12.64 57.94 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.832 -0.542 . . . . 0.0 111.669 -178.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.51 ' C ' ' O ' ' A' ' 9' ' ' LEU . 77.0 m-20 16.81 68.39 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.821 0 CA-C-O 121.35 0.595 . . . . 0.0 112.323 -179.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.515 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 34.0 tp -96.07 132.88 40.99 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.53 -0.731 . . . . 0.0 110.404 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.29 169.69 6.61 Favored Pre-proline 0 C--N 1.296 -1.758 0 O-C-N 121.584 -0.697 . . . . 0.0 109.815 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.441 ' HA ' ' O ' ' A' ' 91' ' ' PHE . 54.9 Cg_endo -72.6 155.61 54.43 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.08 1.568 . . . . 0.0 108.882 178.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.64 -10.11 59.02 Favored Glycine 0 N--CA 1.488 2.154 0 C-N-CA 119.359 -1.4 . . . . 0.0 109.965 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -115.12 146.65 41.13 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.084 -1.245 . . . . 0.0 108.921 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.437 ' O ' ' N ' ' A' ' 134' ' ' ASP . 1.6 t -96.55 140.46 31.14 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.969 -1.082 . . . . 0.0 110.723 -179.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.518 HD13 ' CE1' ' A' ' 133' ' ' PHE . 56.1 tp -111.0 126.92 55.3 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.277 -0.889 . . . . 0.0 110.544 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -120.17 126.72 51.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.241 -0.912 . . . . 0.0 109.871 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.3 t -127.95 129.73 69.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.217 -0.927 . . . . 0.0 110.711 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.444 ' HA ' ' HG2' ' A' ' 86' ' ' GLU . 72.1 ttt180 -109.31 130.15 55.5 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.215 -0.928 . . . . 0.0 109.933 178.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.436 ' CA ' ' O ' ' A' ' 127' ' ' LYS . . . -134.35 173.8 21.24 Favored Glycine 0 C--N 1.294 -1.773 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -125.48 121.26 33.25 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.458 HG22 ' HD1' ' A' ' 126' ' ' PHE . 70.9 t -85.36 131.89 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.147 -0.971 . . . . 0.0 109.909 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.04 154.04 90.75 Favored Pre-proline 0 N--CA 1.496 1.863 0 O-C-N 121.309 -0.869 . . . . 0.0 109.996 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.427 ' O ' ' HB2' ' A' ' 81' ' ' PRO . 44.4 Cg_endo -67.48 -22.27 45.3 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.613 1.323 . . . . 0.0 110.736 -179.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -101.31 14.05 33.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.007 -1.058 . . . . 0.0 110.186 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.454 ' HA ' ' HB3' ' A' ' 125' ' ' ASP . . . -63.77 142.3 58.45 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.301 -0.874 . . . . 0.0 111.695 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -129.14 -34.84 1.85 Allowed 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 42.2 t -165.68 139.92 4.65 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 121.377 -0.827 . . . . 0.0 110.538 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.474 ' CZ ' ' HG3' ' A' ' 47' ' ' PRO . 42.2 p90 -143.57 161.09 39.38 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.171 -0.956 . . . . 0.0 109.067 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.411 HG12 ' HB2' ' A' ' 46' ' ' ASN . 10.4 m -126.72 140.52 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 120.662 -1.274 . . . . 0.0 111.935 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 52.7 mt -118.75 133.19 56.02 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.573 -0.704 . . . . 0.0 109.713 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.415 ' CG ' HD13 ' A' ' 41' ' ' LEU . 93.8 m-20 -124.92 135.09 52.52 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.84 -1.162 . . . . 0.0 111.597 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.474 HD11 ' HB3' ' A' ' 43' ' ' LEU . 0.6 OUTLIER -144.69 110.77 5.47 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.693 0.759 . . . . 0.0 109.206 178.526 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -165.02 -142.84 3.53 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.531 ' O ' ' HB2' ' A' ' 119' ' ' TYR . 47.9 pttt -109.15 -32.81 7.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.152 -1.205 . . . . 0.0 109.412 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.426 ' N ' ' CG ' ' A' ' 36' ' ' LYS . 36.5 m-20 -138.52 171.73 13.93 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.946 0.879 . . . . 0.0 110.501 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 42.4 t -60.07 -41.94 93.49 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.786 -0.571 . . . . 0.0 110.931 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.485 ' HB3' ' N ' ' A' ' 66' ' ' GLY . 82.1 m-20 -91.5 -6.41 52.62 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.033 -1.042 . . . . 0.0 111.372 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -115.29 60.46 0.7 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.88 -1.138 . . . . 0.0 111.05 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.415 HD13 ' CG ' ' A' ' 33' ' ' ASN . 61.3 mt -84.88 147.35 26.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.35 -0.844 . . . . 0.0 109.903 179.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 81.6 m -88.55 -41.7 12.54 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.865 -1.147 . . . . 0.0 109.347 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.474 ' HB3' HD11 ' A' ' 34' ' ' LEU . 15.1 tp -132.17 128.98 39.17 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.644 -0.66 . . . . 0.0 110.862 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.402 ' ND1' ' OD1' ' A' ' 33' ' ' ASN . 20.3 t60 -121.37 112.85 19.09 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -104.72 122.18 45.15 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.023 -1.048 . . . . 0.0 110.691 -178.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.411 ' HB2' HG12 ' A' ' 31' ' ' VAL . 3.7 t-20 -139.37 85.75 15.02 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.297 -0.877 . . . . 0.0 111.218 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.474 ' HG3' ' CZ ' ' A' ' 30' ' ' PHE . 55.9 Cg_endo -71.16 145.13 48.39 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.961 1.506 . . . . 0.0 110.193 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -128.21 92.34 3.43 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.763 -1.21 . . . . 0.0 110.425 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -63.37 -40.59 97.66 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.425 -0.797 . . . . 0.0 109.571 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -137.82 92.02 2.64 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.198 -0.939 . . . . 0.0 109.024 178.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.66 -146.9 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.405 -0.809 . . . . 0.0 109.703 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -108.28 31.65 5.41 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.291 -0.88 . . . . 0.0 109.94 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 166.63 -32.17 0.21 Allowed Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.251 -1.452 . . . . 0.0 109.87 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -89.74 -168.86 2.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.134 -1.215 . . . . 0.0 110.285 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.466 ' O ' ' C ' ' A' ' 56' ' ' ASN . . . -150.82 144.94 25.39 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.407 -0.808 . . . . 0.0 109.496 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.466 ' C ' ' O ' ' A' ' 55' ' ' ALA . 95.1 m-20 25.19 64.09 0.06 Allowed 'General case' 0 N--CA 1.506 2.368 0 CA-C-O 121.137 0.494 . . . . 0.0 111.783 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.8 m -127.24 126.79 43.34 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.434 -0.791 . . . . 0.0 110.283 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 83.1 mt -119.96 131.52 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 CA-C-O 121.173 0.511 . . . . 0.0 110.852 -178.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.3 m -124.18 153.03 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 120.996 -1.065 . . . . 0.0 110.135 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 57.1 m -111.03 145.84 37.78 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.058 -1.026 . . . . 0.0 110.453 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -155.91 170.64 21.65 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.271 -0.893 . . . . 0.0 111.393 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.416 ' O ' ' HA ' ' A' ' 68' ' ' TRP . 19.4 m -149.49 157.34 43.2 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.405 -0.809 . . . . 0.0 109.084 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 68' ' ' TRP . 7.7 ttmt -134.67 140.71 46.22 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.766 -1.209 . . . . 0.0 110.479 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -122.07 105.79 10.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.288 -0.883 . . . . 0.0 109.728 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.64 28.9 74.07 Favored Glycine 0 N--CA 1.484 1.834 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.485 ' N ' ' HB3' ' A' ' 39' ' ' ASN . . . 91.45 -2.38 77.71 Favored Glycine 0 N--CA 1.482 1.723 0 C-N-CA 119.323 -1.417 . . . . 0.0 109.583 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.449 ' O ' ' C ' ' A' ' 68' ' ' TRP . . . -106.77 90.33 3.29 Favored 'General case' 0 N--CA 1.483 1.196 0 O-C-N 121.045 -1.268 . . . . 0.0 109.9 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.513 ' HA ' ' HA ' ' A' ' 63' ' ' LYS . 2.0 m-90 -19.66 -104.48 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.444 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 130.63 -99.87 0.45 Allowed Glycine 0 N--CA 1.489 2.199 0 O-C-N 119.863 -1.773 . . . . 0.0 110.941 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.3 t -93.77 143.41 26.36 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.258 -1.142 . . . . 0.0 111.528 -178.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -153.28 108.93 3.27 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.036 -1.04 . . . . 0.0 110.749 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.493 ' NE2' ' CZ ' ' A' ' 108' ' ' PHE . 10.1 pt20 -125.18 -151.19 0.47 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.275 -1.516 . . . . 0.0 111.01 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -140.59 132.92 28.31 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.959 -1.088 . . . . 0.0 111.095 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.431 ' OE2' ' CD1' ' A' ' 106' ' ' PHE . 82.0 tt0 -143.09 81.72 1.73 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.244 -0.91 . . . . 0.0 110.165 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.97 99.8 2.8 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.094 -1.004 . . . . 0.0 110.37 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.2 p -140.24 138.2 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.019 -1.051 . . . . 0.0 109.143 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.588 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 4.1 p90 -153.15 87.04 3.99 Favored Pre-proline 0 C--N 1.303 -1.421 0 O-C-N 120.938 -1.101 . . . . 0.0 110.8 -178.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.47 ' O ' ' CD1' ' A' ' 79' ' ' PHE . 50.0 Cg_endo -86.13 11.01 3.44 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 124.229 1.647 . . . . 0.0 110.577 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.47 ' CD1' ' O ' ' A' ' 78' ' ' PRO . 42.5 m-85 -148.14 -175.31 4.84 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.146 -0.971 . . . . 0.0 110.622 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.475 ' CG ' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -140.45 174.03 4.38 Favored Pre-proline 0 N--CA 1.493 1.69 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.475 ' HD2' ' CG ' ' A' ' 80' ' ' GLN . 41.6 Cg_endo -64.3 145.94 89.31 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.084 1.044 . . . . 0.0 109.782 179.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 75.54 35.86 45.53 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.7 m -130.62 155.23 46.91 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.226 -1.161 . . . . 0.0 111.225 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 53.0 t -104.13 126.24 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.181 -0.949 . . . . 0.0 109.542 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.463 ' HB1' ' HG3' ' A' ' 101' ' ' PRO . . . -145.11 154.79 42.84 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.139 -0.976 . . . . 0.0 110.074 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.444 ' HG2' ' HA ' ' A' ' 20' ' ' ARG . 97.4 mt-10 -121.01 149.23 43.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.133 -0.979 . . . . 0.0 110.836 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.4 t -126.02 127.81 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.206 -0.934 . . . . 0.0 110.895 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 1.7 m -99.38 131.65 45.25 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 95.8 mt -122.32 130.62 74.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.239 -0.913 . . . . 0.0 111.196 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 23.5 m -124.58 128.52 49.03 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.441 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 55.8 t80 -115.66 122.89 46.94 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.345 -0.847 . . . . 0.0 111.447 -178.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 95' ' ' ASN . 79.3 m-20 -115.52 147.64 40.44 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.215 -0.928 . . . . 0.0 110.073 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 64.2 tp60 -59.57 -24.8 64.05 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.193 -0.942 . . . . 0.0 110.78 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.482 ' O ' ' ND2' ' A' ' 95' ' ' ASN . . . -101.52 -13.15 18.01 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.824 -1.172 . . . . 0.0 111.52 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.482 ' ND2' ' O ' ' A' ' 94' ' ' ALA . 0.9 OUTLIER -162.37 163.14 27.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.926 -1.109 . . . . 0.0 111.344 -178.037 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.417 ' HB3' ' HB2' ' A' ' 108' ' ' PHE . 46.3 tp -115.23 130.14 56.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.184 -0.947 . . . . 0.0 108.753 177.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.493 HG23 ' OE2' ' A' ' 105' ' ' GLU . 79.9 m -122.0 130.85 53.65 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.827 -1.17 . . . . 0.0 111.717 -178.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 55.4 t -129.75 128.27 65.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.104 -0.998 . . . . 0.0 110.382 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -114.27 145.87 41.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.031 -1.043 . . . . 0.0 110.172 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.463 ' CG ' ' HD2' ' A' ' 101' ' ' PRO . 0.1 OUTLIER -104.47 169.02 7.69 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.198 -0.938 . . . . 0.0 109.021 178.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.463 ' HG3' ' HB1' ' A' ' 85' ' ' ALA . 42.1 Cg_endo -68.63 -25.5 34.31 Favored 'Trans proline' 0 C--N 1.301 -1.948 0 O-C-N 123.619 1.326 . . . . 0.0 109.382 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -68.62 -28.13 66.63 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.191 -0.943 . . . . 0.0 110.953 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 117.24 -10.59 14.86 Favored Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.687 -1.244 . . . . 0.0 110.049 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -82.15 144.64 30.6 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.856 -1.379 . . . . 0.0 110.601 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.493 ' OE2' HG23 ' A' ' 97' ' ' THR . 73.1 tt0 -135.74 148.16 48.72 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.115 -0.991 . . . . 0.0 111.566 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.431 ' CD1' ' OE2' ' A' ' 74' ' ' GLU . 97.1 m-85 -131.76 151.58 51.55 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.327 -0.858 . . . . 0.0 108.765 178.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -126.02 141.78 51.81 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.749 -1.22 . . . . 0.0 112.283 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.493 ' CZ ' ' NE2' ' A' ' 72' ' ' GLN . 1.9 m-85 -112.55 144.58 31.2 Favored Pre-proline 0 N--CA 1.492 1.631 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 159.99 51.4 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 123.428 1.225 . . . . 0.0 111.745 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 2.5 t-20 -71.96 53.8 0.26 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.565 -0.71 . . . . 0.0 112.254 -178.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 75.5 mtt85 -65.05 -38.25 90.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.768 -1.207 . . . . 0.0 109.102 177.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 97.2 mt -92.05 133.62 35.57 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.638 -0.664 . . . . 0.0 110.87 -178.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -96.08 18.75 12.86 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.587 -0.696 . . . . 0.0 111.038 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 47.9 tp -63.99 131.65 48.25 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.032 -1.043 . . . . 0.0 110.353 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -89.76 -12.96 37.79 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.964 -1.085 . . . . 0.0 111.67 -178.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' A' ' 11' ' ' LEU . . . -160.51 155.51 24.43 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 118.234 -1.386 . . . . 0.0 111.925 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.485 ' HB ' ' HB3' ' A' ' 11' ' ' LEU . 41.1 mm -99.62 119.47 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.227 -0.921 . . . . 0.0 109.486 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.416 ' HB2' ' HA ' ' A' ' 36' ' ' LYS . 25.8 m-80 -111.02 -29.89 7.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.439 -0.788 . . . . 0.0 111.422 -178.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.531 ' HB2' ' O ' ' A' ' 36' ' ' LYS . 57.2 t80 -108.17 129.75 55.16 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.255 -0.903 . . . . 0.0 110.226 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.465 ' HB3' ' CD1' ' A' ' 9' ' ' LEU . 58.1 ttp -140.69 130.99 25.05 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.61 144.91 25.55 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 119.048 -1.061 . . . . 0.0 110.866 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.468 ' O ' ' HA3' ' A' ' 3' ' ' GLY . . . -142.09 124.79 15.92 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -150.62 134.16 16.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.617 -0.677 . . . . 0.0 109.243 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 158.42 -155.32 26.36 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -178.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.454 ' HB3' ' HA ' ' A' ' 27' ' ' ALA . 97.3 m-20 -73.74 -7.21 51.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.767 -0.843 . . . . 0.0 110.061 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.458 ' HD1' HG22 ' A' ' 23' ' ' VAL . 33.5 t80 -98.91 138.43 36.04 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.216 -0.928 . . . . 0.0 110.172 -178.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.436 ' O ' ' CA ' ' A' ' 21' ' ' GLY . 75.5 mmtt -106.78 144.02 34.03 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.046 -1.034 . . . . 0.0 111.967 -178.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.565 ' O ' HD12 ' A' ' 4' ' ' LEU . 5.0 tt -126.27 106.97 16.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -103.45 -4.73 23.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.08 -1.013 . . . . 0.0 111.879 -178.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -154.68 135.34 13.54 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 118.486 -1.286 . . . . 0.0 111.613 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.434 ' CG2' HD11 ' A' ' 128' ' ' ILE . 51.4 t -128.35 131.11 69.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -132.08 139.92 48.67 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.79 -1.194 . . . . 0.0 110.504 -178.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.518 ' CE1' HD13 ' A' ' 17' ' ' LEU . 32.4 m-85 -98.97 120.89 40.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.091 -1.006 . . . . 0.0 110.83 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 16' ' ' CYS . 64.4 t0 . . . . . 0 C--N 1.303 -1.418 0 CA-C-O 118.022 -0.989 . . . . 0.0 110.465 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.316 0.579 . . . . 0.0 110.139 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' CYS . . . . . 0.407 ' N ' ' HB3' ' B' ' 123' ' ' ASP . 0.7 OUTLIER -136.14 84.36 2.07 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.363 -0.836 . . . . 0.0 110.43 179.741 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . 0.457 ' HA3' ' O ' ' B' ' 122' ' ' ALA . . . 176.16 170.05 38.4 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.783 HD22 HD23 ' A' ' 9' ' ' LEU . 78.8 mt -80.32 145.08 32.28 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.29 -1.123 . . . . 0.0 111.948 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 29.6 m -110.67 149.79 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.686 -0.634 . . . . 0.0 109.453 178.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.1 155.98 47.5 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.857 -1.152 . . . . 0.0 112.421 -178.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . 0.46 ' O ' ' HB3' ' B' ' 8' ' ' ASN . 15.2 m -155.02 173.02 17.16 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.34 -0.85 . . . . 0.0 109.774 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . 0.46 ' HB3' ' O ' ' B' ' 7' ' ' SER . 34.8 t-20 62.12 27.84 16.77 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.098 -1.001 . . . . 0.0 109.697 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.771 HD23 HD22 ' A' ' 4' ' ' LEU . 58.1 mt -85.58 -4.32 59.13 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.695 -0.628 . . . . 0.0 111.918 -178.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . 0.539 ' C ' ' O ' ' B' ' 9' ' ' LEU . 76.6 m-20 5.5 73.93 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.85 0 CA-C-O 122.0 0.905 . . . . 0.0 112.149 -177.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.52 ' O ' ' HA ' ' B' ' 116' ' ' ALA . 34.5 tp -97.88 132.65 43.28 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.756 -0.59 . . . . 0.0 109.986 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.63 169.64 6.61 Favored Pre-proline 0 C--N 1.29 -1.99 0 O-C-N 121.648 -0.658 . . . . 0.0 109.765 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' B' ' 91' ' ' PHE . 56.4 Cg_endo -72.55 155.7 54.58 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.016 1.535 . . . . 0.0 108.985 178.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.61 -10.37 59.19 Favored Glycine 0 N--CA 1.488 2.146 0 C-N-CA 119.53 -1.319 . . . . 0.0 109.821 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -115.16 147.12 40.66 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.92 -1.341 . . . . 0.0 109.235 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' CYS . . . . . 0.417 ' O ' ' N ' ' B' ' 134' ' ' ASP . 1.6 t -96.51 140.82 30.59 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.937 -1.102 . . . . 0.0 111.041 -178.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.501 HD13 ' CE1' ' B' ' 133' ' ' PHE . 56.1 tp -111.07 126.87 55.28 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.141 -0.974 . . . . 0.0 110.515 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -120.13 126.25 50.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.099 -1.001 . . . . 0.0 109.974 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 32.8 t -127.82 129.23 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.237 -0.914 . . . . 0.0 110.893 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.446 ' HA ' ' HG2' ' B' ' 86' ' ' GLU . 72.7 ttt180 -108.81 129.85 55.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.284 -0.885 . . . . 0.0 110.094 178.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.441 ' CA ' ' O ' ' B' ' 127' ' ' LYS . . . -134.35 173.14 21.53 Favored Glycine 0 C--N 1.297 -1.607 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' B' ' 127' ' ' LYS . 83.6 tt0 -124.86 120.89 32.96 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.525 -0.985 . . . . 0.0 108.844 179.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.456 HG22 ' HD1' ' B' ' 126' ' ' PHE . 69.6 t -84.35 132.63 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.026 -1.046 . . . . 0.0 109.887 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.65 154.59 89.46 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.29 -0.881 . . . . 0.0 110.039 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.42 ' O ' ' HB2' ' B' ' 81' ' ' PRO . 43.7 Cg_endo -67.89 -22.15 42.89 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.422 1.222 . . . . 0.0 110.89 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -101.67 13.73 34.04 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.187 -0.946 . . . . 0.0 109.69 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . 0.462 ' HA ' ' HB3' ' B' ' 125' ' ' ASP . . . -63.54 142.02 58.55 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.154 -0.966 . . . . 0.0 111.617 -178.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -127.74 -37.8 1.93 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 42.7 t -162.13 140.84 9.24 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.345 -0.847 . . . . 0.0 110.645 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' PHE . . . . . 0.457 ' CZ ' ' HG3' ' B' ' 47' ' ' PRO . 42.0 p90 -143.9 161.16 39.41 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.225 -0.922 . . . . 0.0 108.952 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 11.1 m -126.67 140.5 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 120.549 -1.344 . . . . 0.0 111.888 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 56.6 mt -118.06 133.98 55.41 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.502 -0.749 . . . . 0.0 109.599 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' ASN . . . . . 0.425 ' CG ' HD13 ' B' ' 41' ' ' LEU . 93.8 m-20 -124.89 135.08 52.54 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.794 -1.191 . . . . 0.0 111.946 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.465 HD11 ' HB3' ' B' ' 43' ' ' LEU . 0.6 OUTLIER -144.67 106.9 4.34 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.486 -0.759 . . . . 0.0 109.939 178.346 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . 0.4 ' HA3' ' HA ' ' B' ' 41' ' ' LEU . . . -159.42 -142.06 3.3 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . 0.505 ' O ' ' HB2' ' B' ' 119' ' ' TYR . 47.6 pttt -108.82 -32.7 7.2 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.443 -1.033 . . . . 0.0 109.063 178.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . 0.417 ' N ' ' CG ' ' B' ' 36' ' ' LYS . 34.6 m-20 -139.44 171.55 14.1 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.982 0.896 . . . . 0.0 110.462 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 43.9 t -59.89 -41.94 92.7 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.623 -0.673 . . . . 0.0 111.331 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' ASN . . . . . 0.487 ' HB3' ' N ' ' B' ' 66' ' ' GLY . 83.1 m-20 -91.53 -6.21 52.86 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.02 -1.05 . . . . 0.0 111.112 -178.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -115.89 62.92 0.7 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.196 -0.94 . . . . 0.0 110.529 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.425 HD13 ' CG ' ' B' ' 33' ' ' ASN . 55.9 mt -87.19 148.88 24.97 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.357 -0.839 . . . . 0.0 109.29 178.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' CYS . . . . . . . . . . . . . 82.4 m -91.01 -40.27 11.75 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.111 -0.993 . . . . 0.0 109.284 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.465 ' HB3' HD11 ' B' ' 34' ' ' LEU . 15.2 tp -133.31 128.86 36.66 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.52 -0.737 . . . . 0.0 110.437 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' HIS . . . . . . . . . . . . . 18.6 t60 -121.46 113.12 19.4 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -104.62 122.04 44.79 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.056 -1.028 . . . . 0.0 110.942 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -139.03 85.38 16.01 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.159 -0.963 . . . . 0.0 111.444 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' PRO . . . . . 0.457 ' HG3' ' CZ ' ' B' ' 30' ' ' PHE . 57.0 Cg_endo -71.13 144.74 47.59 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.935 1.492 . . . . 0.0 110.031 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -128.65 92.43 3.41 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.738 -1.226 . . . . 0.0 110.286 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -63.94 -39.67 94.68 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.488 -0.757 . . . . 0.0 109.905 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 59.8 t-20 -138.47 91.42 2.54 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.189 -0.945 . . . . 0.0 108.721 178.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.48 -146.12 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.268 -0.895 . . . . 0.0 109.77 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -108.58 31.72 5.4 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.33 -0.856 . . . . 0.0 110.056 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 166.61 -32.14 0.21 Allowed Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.276 -1.44 . . . . 0.0 110.033 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -89.54 -169.13 2.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -1.146 . . . . 0.0 109.983 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.493 ' O ' ' C ' ' B' ' 56' ' ' ASN . . . -148.96 150.94 33.73 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 178.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' ASN . . . . . 0.493 ' C ' ' O ' ' B' ' 55' ' ' ALA . 92.4 m-20 16.67 66.91 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.617 0 CA-C-O 121.689 0.757 . . . . 0.0 112.429 -178.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 12.4 m -127.06 126.1 42.46 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.903 0.859 . . . . 0.0 110.578 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' ILE . . . . . . . . . . . . . 86.5 mt -119.79 131.87 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.542 -0.724 . . . . 0.0 110.555 -178.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 13.9 m -124.26 153.25 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.191 -0.943 . . . . 0.0 110.186 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 58.2 m -110.94 146.88 35.82 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.739 -1.226 . . . . 0.0 110.484 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' ASN . . . . . 0.435 ' HA ' ' O ' ' B' ' 70' ' ' THR . 23.6 t-20 -156.27 170.72 21.61 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.036 -1.04 . . . . 0.0 111.214 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' SER . . . . . 0.42 ' O ' ' HA ' ' B' ' 68' ' ' TRP . 19.8 m -149.26 157.06 43.04 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . 0.515 ' HA ' ' HA ' ' B' ' 68' ' ' TRP . 7.1 ttmt -134.58 140.4 46.07 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.092 -1.005 . . . . 0.0 110.448 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -122.13 105.04 9.9 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.256 -0.902 . . . . 0.0 109.858 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.99 29.42 74.97 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . 0.487 ' N ' ' HB3' ' B' ' 39' ' ' ASN . . . 90.77 -1.37 78.26 Favored Glycine 0 N--CA 1.484 1.839 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' ALA . . . . . 0.436 ' O ' ' C ' ' B' ' 68' ' ' TRP . . . -107.22 89.71 3.08 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.197 -1.178 . . . . 0.0 109.849 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' TRP . . . . . 0.515 ' HA ' ' HA ' ' B' ' 63' ' ' LYS . 1.9 m-90 -19.77 -104.34 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.36 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 130.41 -99.57 0.44 Allowed Glycine 0 N--CA 1.488 2.16 0 C-N-CA 118.641 -1.742 . . . . 0.0 110.795 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' B' ' 61' ' ' ASN . 13.0 t -94.74 140.83 29.36 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.356 -1.085 . . . . 0.0 112.107 -178.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -150.65 108.7 3.73 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.205 -0.935 . . . . 0.0 111.283 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' GLN . . . . . 0.474 ' NE2' ' CZ ' ' B' ' 108' ' ' PHE . 9.6 pt20 -124.64 -151.86 0.49 Allowed 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.324 -1.485 . . . . 0.0 110.999 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -140.5 132.87 28.37 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.002 -1.062 . . . . 0.0 111.109 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' GLU . . . . . 0.448 ' OE2' ' CD1' ' B' ' 106' ' ' PHE . 82.1 tt0 -142.85 81.64 1.73 Allowed 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.183 -0.948 . . . . 0.0 110.324 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.9 99.9 2.79 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.011 -1.056 . . . . 0.0 110.484 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 4.1 p -140.07 137.65 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.313 -0.867 . . . . 0.0 109.249 178.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' PHE . . . . . 0.605 ' N ' ' CD1' ' B' ' 77' ' ' PHE . 4.2 p90 -152.73 86.91 4.16 Favored Pre-proline 0 C--N 1.302 -1.492 0 O-C-N 121.023 -1.048 . . . . 0.0 110.88 -178.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . 0.472 ' O ' ' CD1' ' B' ' 79' ' ' PHE . 50.5 Cg_endo -86.02 10.98 3.46 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.245 1.655 . . . . 0.0 110.56 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' PHE . . . . . 0.472 ' CD1' ' O ' ' B' ' 78' ' ' PRO . 40.5 m-85 -148.1 -175.58 4.95 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.024 -1.047 . . . . 0.0 110.774 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.477 ' CG ' ' HD2' ' B' ' 81' ' ' PRO . 0.0 OUTLIER -139.81 174.46 4.04 Favored Pre-proline 0 N--CA 1.488 1.446 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.779 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' PRO . . . . . 0.477 ' HD2' ' CG ' ' B' ' 80' ' ' GLN . 41.0 Cg_endo -64.35 145.96 89.12 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 N-CA-C 109.406 -1.036 . . . . 0.0 109.406 178.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 75.45 35.41 47.51 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 33.4 m -130.39 155.06 47.01 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.131 -1.217 . . . . 0.0 111.308 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 58.7 t -103.81 126.37 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.281 -0.887 . . . . 0.0 109.749 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . 0.463 ' HB1' ' HG3' ' B' ' 101' ' ' PRO . . . -145.02 154.91 43.02 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.134 -0.979 . . . . 0.0 110.151 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' GLU . . . . . 0.446 ' HG2' ' HA ' ' B' ' 20' ' ' ARG . 97.8 mt-10 -120.79 149.36 42.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.346 -0.846 . . . . 0.0 110.853 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 21.5 t -125.62 128.27 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.132 -0.98 . . . . 0.0 110.734 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 88' ' ' CYS . . . . . 0.436 ' HA ' ' O ' ' B' ' 17' ' ' LEU . 1.6 m -100.11 131.5 46.03 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 96.0 mt -122.43 130.7 74.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.098 -1.001 . . . . 0.0 111.22 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 22.6 m -124.11 128.67 49.62 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' PHE . . . . . 0.432 ' O ' ' HA ' ' B' ' 13' ' ' PRO . 55.6 t80 -115.62 122.76 46.6 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.584 -0.847 . . . . 0.0 111.355 -178.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -115.16 147.08 40.72 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.13 -0.981 . . . . 0.0 110.063 178.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 63.3 tp60 -59.33 -24.3 63.21 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.887 -1.133 . . . . 0.0 110.886 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 94' ' ' ALA . . . . . 0.467 ' O ' ' ND2' ' B' ' 95' ' ' ASN . . . -101.85 -13.7 17.56 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.904 -1.122 . . . . 0.0 111.284 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . 0.467 ' ND2' ' O ' ' B' ' 94' ' ' ALA . 0.9 OUTLIER -161.79 163.4 29.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.029 -1.045 . . . . 0.0 111.296 -178.251 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 96' ' ' LEU . . . . . 0.414 HD23 ' HB2' ' B' ' 108' ' ' PHE . 46.2 tp -115.59 129.57 56.56 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.248 -0.908 . . . . 0.0 108.596 177.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . 0.487 HG23 ' OE2' ' B' ' 105' ' ' GLU . 78.1 m -121.72 131.64 54.19 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.82 -1.175 . . . . 0.0 111.356 -178.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 53.8 t -130.29 127.91 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.398 -0.814 . . . . 0.0 110.108 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -114.65 145.08 42.43 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.948 -1.095 . . . . 0.0 110.203 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . 0.469 ' CG ' ' HD2' ' B' ' 101' ' ' PRO . 0.1 OUTLIER -103.96 168.63 8.34 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.353 -0.842 . . . . 0.0 109.023 179.218 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' PRO . . . . . 0.469 ' HD2' ' CG ' ' B' ' 100' ' ' LEU . 41.9 Cg_endo -68.23 -25.28 36.95 Favored 'Trans proline' 0 C--N 1.301 -1.933 0 O-C-N 123.645 1.34 . . . . 0.0 109.376 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -68.27 -28.57 67.31 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.484 -0.76 . . . . 0.0 110.894 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 117.28 -10.65 14.77 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 104' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -81.72 144.55 31.05 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.897 -1.355 . . . . 0.0 110.804 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 105' ' ' GLU . . . . . 0.487 ' OE2' HG23 ' B' ' 97' ' ' THR . 73.5 tt0 -135.88 147.93 48.39 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.178 -0.951 . . . . 0.0 111.955 -179.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 106' ' ' PHE . . . . . 0.448 ' CD1' ' OE2' ' B' ' 74' ' ' GLU . 96.6 m-85 -131.95 151.16 51.9 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -125.74 142.27 51.59 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.718 -1.239 . . . . 0.0 112.07 -178.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 108' ' ' PHE . . . . . 0.474 ' CZ ' ' NE2' ' B' ' 72' ' ' GLN . 1.8 m-85 -113.16 144.65 31.57 Favored Pre-proline 0 N--CA 1.494 1.728 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -69.76 160.28 50.27 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 123.467 1.246 . . . . 0.0 111.652 -178.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 110' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' B' ' 94' ' ' ALA . 2.3 t-20 -72.11 53.78 0.28 Allowed 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.81 -0.556 . . . . 0.0 112.158 -178.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 75.1 mtt85 -65.27 -38.61 90.81 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.847 -1.158 . . . . 0.0 109.056 177.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 98.2 mt -91.5 134.08 34.95 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.358 -0.839 . . . . 0.0 111.157 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -96.13 18.78 12.85 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.414 -0.804 . . . . 0.0 110.997 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 50.6 tp -63.86 131.89 49.15 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.059 -1.026 . . . . 0.0 110.24 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -89.7 -12.83 38.33 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.042 -1.036 . . . . 0.0 111.849 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 116' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' B' ' 11' ' ' LEU . . . -161.2 155.69 23.16 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.372 -1.455 . . . . 0.0 111.787 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 117' ' ' ILE . . . . . 0.502 ' HB ' ' HB3' ' B' ' 11' ' ' LEU . 41.3 mm -100.1 119.8 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.228 -0.92 . . . . 0.0 109.649 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 118' ' ' ASN . . . . . 0.403 ' HB2' ' HA ' ' B' ' 36' ' ' LYS . 23.4 m-80 -111.04 -30.42 7.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.404 -0.81 . . . . 0.0 111.351 -178.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 119' ' ' TYR . . . . . 0.505 ' HB2' ' O ' ' B' ' 36' ' ' LYS . 57.8 t80 -107.03 131.03 54.54 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.013 -1.054 . . . . 0.0 110.219 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 120' ' ' MET . . . . . 0.488 ' HB3' ' CD1' ' B' ' 9' ' ' LEU . 55.5 ttp -141.91 130.89 23.11 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -151.14 144.4 24.75 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.054 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 122' ' ' ALA . . . . . 0.457 ' O ' ' HA3' ' B' ' 3' ' ' GLY . . . -141.68 125.02 16.51 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . 0.407 ' HB3' ' N ' ' B' ' 2' ' ' CYS . 65.1 m-20 -150.72 134.33 16.48 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.481 -0.762 . . . . 0.0 109.192 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 158.3 -155.48 26.5 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.044 -1.55 . . . . 0.0 109.554 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . 0.462 ' HB3' ' HA ' ' B' ' 27' ' ' ALA . 96.4 m-20 -73.25 -7.4 51.35 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.584 -0.951 . . . . 0.0 110.294 179.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 126' ' ' PHE . . . . . 0.456 ' HD1' HG22 ' B' ' 23' ' ' VAL . 33.9 t80 -99.09 138.77 35.72 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.525 -0.734 . . . . 0.0 110.092 -178.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . 0.441 ' O ' ' CA ' ' B' ' 21' ' ' GLY . 75.7 mmtt -106.88 144.19 33.87 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 118.945 -1.102 . . . . 0.0 112.074 -178.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . 0.557 ' O ' HD12 ' B' ' 4' ' ' LEU . 5.1 tt -125.88 106.67 16.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -102.84 -5.6 23.42 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.888 -1.132 . . . . 0.0 111.771 -178.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 130' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -153.55 134.99 14.25 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 118.26 -1.376 . . . . 0.0 112.05 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.4 ' CG2' HD11 ' B' ' 128' ' ' ILE . 50.6 t -127.49 131.75 69.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 132' ' ' ALA . . . . . . . . . . . . . . . -131.91 139.91 48.89 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.446 -1.408 . . . . 0.0 110.477 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . 0.501 ' CE1' HD13 ' B' ' 17' ' ' LEU . 32.7 m-85 -98.79 121.08 40.28 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.8 -1.188 . . . . 0.0 110.959 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . 0.417 ' N ' ' O ' ' B' ' 16' ' ' CYS . 62.1 t0 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.407 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 120.877 0.37 . . . . 0.0 110.745 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.425 ' O ' ' CB ' ' A' ' 123' ' ' ASP . 37.2 m -113.81 37.35 3.3 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.191 -0.943 . . . . 0.0 109.177 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.486 ' HA3' ' O ' ' A' ' 122' ' ' ALA . . . 81.45 169.76 42.76 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 107.98 -2.048 . . . . 0.0 107.98 -178.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.578 HD12 ' N ' ' A' ' 4' ' ' LEU . 11.1 mp -93.44 142.21 27.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.071 -1.252 . . . . 0.0 110.43 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.3 t -108.56 131.54 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 121.198 -0.939 . . . . 0.0 110.117 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -130.41 172.61 11.68 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.951 -1.093 . . . . 0.0 111.822 -178.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.416 ' O ' ' CB ' ' A' ' 8' ' ' ASN . 30.5 p -155.07 167.2 31.15 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.45 -0.781 . . . . 0.0 110.001 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' B' ' 3' ' ' GLY . 20.2 t-20 63.43 40.01 8.74 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.384 0.611 . . . . 0.0 110.446 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.476 ' O ' ' C ' ' A' ' 10' ' ' ASN . 56.5 mt -99.66 16.2 24.24 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.314 -0.867 . . . . 0.0 110.316 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.498 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 51.0 t-20 -18.76 88.8 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.381 0 CA-C-O 121.996 0.903 . . . . 0.0 112.674 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.576 HD12 ' CZ ' ' A' ' 133' ' ' PHE . 5.2 tt -100.5 134.68 43.1 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.584 -0.698 . . . . 0.0 109.96 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.465 ' HD2' ' HD2' ' A' ' 13' ' ' PRO . 0.6 OUTLIER -111.55 171.22 4.51 Favored Pre-proline 0 C--N 1.297 -1.695 0 O-C-N 121.069 -1.019 . . . . 0.0 109.784 179.031 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.465 ' HD2' ' HD2' ' A' ' 12' ' ' LYS . 44.2 Cg_endo -66.19 144.63 75.77 Favored 'Trans proline' 0 C--N 1.299 -2.045 0 O-C-N 123.89 1.468 . . . . 0.0 110.278 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 104.44 -24.72 28.04 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -90.08 150.2 22.17 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.241 -1.153 . . . . 0.0 110.471 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.423 ' SG ' ' N ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -106.31 159.34 16.2 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.417 -0.802 . . . . 0.0 109.99 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.635 HD13 ' N ' ' A' ' 18' ' ' ARG . 0.6 OUTLIER -134.77 123.39 23.53 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.682 -1.261 . . . . 0.0 110.364 179.659 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.635 ' N ' HD13 ' A' ' 17' ' ' LEU . 79.5 ttt180 -117.04 132.65 56.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.226 -0.921 . . . . 0.0 109.888 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.492 HG13 ' CD1' ' A' ' 128' ' ' ILE . 54.7 t -122.12 108.99 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.511 -0.743 . . . . 0.0 111.136 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 77.3 ttt-85 -110.0 123.17 49.19 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.764 -1.21 . . . . 0.0 110.575 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -147.11 -161.3 9.3 Favored Glycine 0 N--CA 1.489 2.188 0 C-N-CA 119.365 -1.398 . . . . 0.0 110.172 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -127.31 134.72 49.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.455 -1.026 . . . . 0.0 109.305 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.635 HG22 ' CD1' ' A' ' 126' ' ' PHE . 93.8 t -101.88 129.5 53.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 121.073 -1.017 . . . . 0.0 109.593 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.52 161.89 1.92 Allowed Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.323 -0.861 . . . . 0.0 110.281 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.52 -20.22 54.15 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 O-C-N 123.69 1.363 . . . . 0.0 109.573 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -111.76 44.03 1.44 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.661 -0.65 . . . . 0.0 110.393 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.58 ' HB2' ' CG1' ' A' ' 23' ' ' VAL . . . -71.15 91.09 0.9 Allowed 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 118.918 -1.113 . . . . 0.0 109.563 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -98.71 -20.93 16.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.385 -0.822 . . . . 0.0 109.985 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.1 t -150.11 143.5 25.13 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.882 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.524 ' HA ' ' HA3' ' A' ' 124' ' ' GLY . 40.7 t80 -147.79 134.95 20.44 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.448 -0.782 . . . . 0.0 110.289 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 67.4 t -127.47 131.0 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.824 -1.172 . . . . 0.0 110.307 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.726 HD12 ' N ' ' A' ' 33' ' ' ASN . 5.0 tp -138.58 141.81 39.21 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.519 -0.738 . . . . 0.0 110.383 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.864 ' HB2' HD13 ' A' ' 41' ' ' LEU . 1.5 p-10 -154.25 143.09 20.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.053 -1.029 . . . . 0.0 110.7 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.481 ' O ' HD12 ' A' ' 34' ' ' LEU . 1.5 pp -136.13 118.48 15.69 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.496 -0.753 . . . . 0.0 109.628 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.802 ' HA3' HD23 ' A' ' 41' ' ' LEU . . . -142.85 -136.49 3.19 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.822 -1.18 . . . . 0.0 110.602 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.456 ' CG ' ' N ' ' A' ' 37' ' ' ASP . 24.0 pttt -127.64 -37.14 1.99 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.371 -1.076 . . . . 0.0 111.101 -179.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.456 ' N ' ' CG ' ' A' ' 36' ' ' LYS . 86.3 m-20 -115.25 -83.59 0.62 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.125 -0.985 . . . . 0.0 110.309 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.2 t -151.58 -53.6 0.13 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 60.6 m-20 -93.85 -4.06 50.74 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.343 -0.848 . . . . 0.0 109.004 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.415 ' O ' ' HA3' ' A' ' 35' ' ' GLY . 14.0 m-80 -91.18 68.72 6.05 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.175 -0.953 . . . . 0.0 109.854 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.864 HD13 ' HB2' ' A' ' 33' ' ' ASN . 75.8 mt -106.47 133.02 51.8 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.438 -0.789 . . . . 0.0 110.676 -179.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.528 ' O ' HD23 ' A' ' 43' ' ' LEU . 69.8 m -85.1 -36.01 21.43 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.564 -0.71 . . . . 0.0 110.253 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 1.047 HD21 HD13 ' A' ' 96' ' ' LEU . 79.5 mt -129.97 129.16 43.42 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 119.454 -0.898 . . . . 0.0 111.542 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.46 ' HB3' ' OD1' ' A' ' 61' ' ' ASN . 60.1 t-80 -126.3 123.98 39.3 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.343 -0.848 . . . . 0.0 109.41 178.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -110.79 131.6 54.91 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.177 -0.952 . . . . 0.0 109.443 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -149.27 78.04 8.77 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 120.926 -1.109 . . . . 0.0 111.285 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.428 ' HG2' ' HB3' ' A' ' 30' ' ' PHE . 47.2 Cg_endo -69.78 144.66 54.61 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.779 1.41 . . . . 0.0 110.014 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -144.46 88.18 1.92 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.865 -1.147 . . . . 0.0 110.869 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.48 ' O ' ' HA ' ' A' ' 55' ' ' ALA . 33.0 t80 -61.78 -46.4 89.74 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.332 0.587 . . . . 0.0 110.393 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -133.72 99.12 4.37 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.294 -0.879 . . . . 0.0 110.008 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -118.78 -69.1 0.87 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.003 -1.061 . . . . 0.0 110.893 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -105.13 -15.67 15.01 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.42 -0.8 . . . . 0.0 110.617 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 159.68 -12.91 0.19 Allowed Glycine 0 N--CA 1.494 2.543 0 C-N-CA 119.866 -1.159 . . . . 0.0 110.514 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -75.78 -179.95 5.08 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.849 -1.383 . . . . 0.0 109.444 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 49' ' ' PHE . . . -129.67 -7.46 4.58 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.146 -0.971 . . . . 0.0 111.723 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 43.2 p30 -163.48 72.82 0.29 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.007 -1.058 . . . . 0.0 110.279 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 73.4 m -124.66 130.46 52.46 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.943 -1.098 . . . . 0.0 111.327 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 98.3 mt -121.76 130.64 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.28 -0.888 . . . . 0.0 111.089 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.0 t -114.31 129.98 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.297 -0.877 . . . . 0.0 110.495 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 33.8 m -129.16 122.1 29.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.319 -0.863 . . . . 0.0 110.067 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.525 ' HB3' ' HG2' ' A' ' 71' ' ' GLU . 4.9 p-10 -138.94 175.0 9.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.422 -0.799 . . . . 0.0 109.985 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.3 m -129.9 155.12 46.56 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.536 ' CD ' ' HA2' ' A' ' 66' ' ' GLY . 6.9 ttmt -135.47 149.29 49.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.495 -1.378 . . . . 0.0 112.128 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.587 ' HB2' HD11 ' A' ' 112' ' ' LEU . 56.6 t0 -129.19 100.43 5.61 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.44 21.28 68.51 Favored Glycine 0 N--CA 1.487 2.075 0 C-N-CA 119.801 -1.19 . . . . 0.0 110.62 179.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.536 ' HA2' ' CD ' ' A' ' 63' ' ' LYS . . . 74.52 24.56 72.48 Favored Glycine 0 N--CA 1.488 2.162 0 C-N-CA 119.145 -1.503 . . . . 0.0 110.275 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -105.4 -74.35 0.65 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.897 -1.355 . . . . 0.0 110.742 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -69.22 -178.47 1.33 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.698 -0.626 . . . . 0.0 109.975 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 166.53 44.79 0.02 OUTLIER Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.0 m -62.39 100.39 0.18 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.066 -1.256 . . . . 0.0 110.504 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.525 ' HG2' ' HB3' ' A' ' 61' ' ' ASN . 89.5 mt-10 -84.97 123.15 30.19 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.336 -0.853 . . . . 0.0 110.903 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -101.39 -168.49 1.56 Allowed 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -146.27 122.27 10.71 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 118.04 -1.464 . . . . 0.0 111.695 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -108.67 132.71 53.64 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.59 60.27 0.6 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.795 -1.19 . . . . 0.0 111.234 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.546 HG22 ' HD3' ' A' ' 78' ' ' PRO . 4.6 p -135.23 151.25 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.942 -1.098 . . . . 0.0 110.4 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.497 ' CG ' ' O ' ' A' ' 77' ' ' PHE . 8.4 p90 -144.46 71.98 15.82 Favored Pre-proline 0 C--N 1.302 -1.475 0 O-C-N 121.098 -1.001 . . . . 0.0 109.874 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.546 ' HD3' HG22 ' A' ' 76' ' ' VAL . 39.9 Cg_endo -65.43 -13.8 41.67 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.892 1.469 . . . . 0.0 110.33 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -117.92 167.24 11.6 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.444 -0.785 . . . . 0.0 110.641 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.88 168.02 15.66 Favored Pre-proline 0 C--N 1.297 -1.674 0 O-C-N 121.546 -0.721 . . . . 0.0 109.598 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -65.65 148.66 87.32 Favored 'Trans proline' 0 C--N 1.298 -2.086 0 O-C-N 123.852 1.448 . . . . 0.0 110.671 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 62.29 42.44 99.72 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.6 t -148.32 137.56 21.96 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.097 -1.237 . . . . 0.0 109.988 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.5 m -78.06 140.22 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.01 -1.056 . . . . 0.0 108.997 178.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.98 153.55 38.09 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.158 -0.963 . . . . 0.0 109.707 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -122.46 152.65 40.06 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.234 -0.916 . . . . 0.0 110.044 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.0 t -128.98 139.34 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.489 -0.757 . . . . 0.0 111.503 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . 0.429 ' HB3' ' HB2' ' A' ' 99' ' ' LYS . 4.8 t -114.26 115.73 27.89 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.427 -0.796 . . . . 0.0 109.943 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 86.6 mt -121.22 128.1 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.141 -0.974 . . . . 0.0 110.014 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.479 ' HB ' ' HB ' ' A' ' 97' ' ' THR . 33.5 m -123.06 134.88 54.25 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.033 -1.042 . . . . 0.0 109.426 179.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.513 ' CE1' HD21 ' A' ' 96' ' ' LEU . 80.8 t80 -104.67 118.25 36.11 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.177 -0.952 . . . . 0.0 110.25 -179.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.402 ' HB2' ' OD1' ' A' ' 95' ' ' ASN . 86.7 m-20 -112.52 143.21 44.06 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.399 -0.921 . . . . 0.0 109.452 178.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 71.6 tp60 -59.58 -26.51 65.47 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.522 -0.736 . . . . 0.0 110.668 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.89 -22.48 23.12 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.225 -0.922 . . . . 0.0 111.634 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.402 ' OD1' ' HB2' ' A' ' 92' ' ' ASP . 45.4 p30 -174.61 -171.58 0.58 Allowed 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.093 -1.005 . . . . 0.0 108.981 -178.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 1.047 HD13 HD21 ' A' ' 43' ' ' LEU . 75.9 mt -122.49 135.06 54.57 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.002 -1.061 . . . . 0.0 110.58 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.479 ' HB ' ' HB ' ' A' ' 90' ' ' THR . 29.5 m -109.26 122.72 47.95 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.1 -1.0 . . . . 0.0 109.031 178.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 44.8 t -124.7 128.14 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.742 -1.224 . . . . 0.0 109.611 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.429 ' HB2' ' HB3' ' A' ' 88' ' ' CYS . 98.4 mttt -122.61 147.62 46.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.298 -0.877 . . . . 0.0 110.925 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.431 HD13 ' HG3' ' A' ' 78' ' ' PRO . 27.5 mt -107.28 166.63 10.7 Favored Pre-proline 0 N--CA 1.493 1.696 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -63.31 -24.32 71.86 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.368 1.194 . . . . 0.0 110.92 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.468 ' HB2' ' CB ' ' A' ' 78' ' ' PRO . 36.9 t70 -76.52 -10.26 59.26 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.074 -1.016 . . . . 0.0 110.84 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 104.34 -8.0 47.88 Favored Glycine 0 N--CA 1.496 2.656 0 C-N-CA 119.821 -1.18 . . . . 0.0 110.753 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -73.0 135.41 44.95 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.787 -1.419 . . . . 0.0 110.28 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.431 ' OE2' HG23 ' A' ' 97' ' ' THR . 71.8 tt0 -124.88 142.49 51.41 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.881 -1.137 . . . . 0.0 110.75 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -133.67 146.15 50.59 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 98.1 mttt -121.79 146.36 47.14 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.831 -1.168 . . . . 0.0 112.971 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.564 ' HB2' ' HB2' ' A' ' 96' ' ' LEU . 98.0 m-85 -117.22 150.23 45.89 Favored Pre-proline 0 N--CA 1.493 1.722 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.08 149.85 65.43 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.689 1.363 . . . . 0.0 111.142 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -71.04 62.74 0.3 Allowed 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.611 -0.681 . . . . 0.0 111.652 -178.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 79.6 mtp85 -65.39 -39.89 92.79 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.995 -1.066 . . . . 0.0 110.381 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.587 HD11 ' HB2' ' A' ' 64' ' ' ASP . 4.4 mm? -95.75 130.4 42.68 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.131 -0.981 . . . . 0.0 110.361 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -87.95 7.26 31.84 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.501 -0.749 . . . . 0.0 111.026 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.498 HD23 ' O ' ' A' ' 114' ' ' LEU . 3.6 tt -57.82 128.68 38.32 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.224 -0.99 . . . . 0.0 109.222 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -106.32 -5.59 18.98 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.498 -0.751 . . . . 0.0 111.295 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' A' ' 11' ' ' LEU . . . -137.84 132.35 32.43 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.715 -1.24 . . . . 0.0 110.472 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.498 ' O ' ' HA ' ' A' ' 10' ' ' ASN . 95.6 mt -111.29 128.89 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 O-C-N 120.894 -1.129 . . . . 0.0 110.45 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -126.66 -27.62 3.08 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.026 -1.046 . . . . 0.0 111.645 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.412 ' O ' ' N ' ' A' ' 35' ' ' GLY . 69.4 t80 -92.67 126.09 37.6 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.007 -1.058 . . . . 0.0 110.466 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.423 ' HB3' ' CD1' ' A' ' 9' ' ' LEU . 27.1 ttm -141.01 134.73 30.28 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.993 -1.067 . . . . 0.0 109.573 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.442 ' HB3' HD21 ' A' ' 33' ' ' ASN . . . -159.11 147.95 18.34 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.26 -0.976 . . . . 0.0 109.686 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.486 ' O ' ' HA3' ' A' ' 3' ' ' GLY . . . -147.3 156.21 42.71 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 2' ' ' CYS . 10.2 p-10 -155.74 160.74 40.57 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.524 ' HA3' ' HA ' ' A' ' 30' ' ' PHE . . . 143.09 -157.27 26.83 Favored Glycine 0 C--N 1.295 -1.725 0 C-N-CA 118.548 -1.787 . . . . 0.0 110.439 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.483 ' CB ' ' HA ' ' A' ' 27' ' ' ALA . 63.1 m-20 -91.34 11.39 23.84 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.845 -0.797 . . . . 0.0 110.753 -179.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.635 ' CD1' HG22 ' A' ' 23' ' ' VAL . 12.3 t80 -107.42 151.25 25.78 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.822 -1.174 . . . . 0.0 110.681 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -120.8 124.8 45.96 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.564 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.492 ' CD1' HG13 ' A' ' 19' ' ' VAL . 17.7 tt -102.49 126.74 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.928 . . . . 0.0 110.329 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 28.0 pttt -118.63 -4.81 10.75 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.795 -1.191 . . . . 0.0 111.053 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.497 ' HA ' ' O ' ' B' ' 131' ' ' VAL . 0.0 OUTLIER -154.35 131.96 11.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.74 -1.225 . . . . 0.0 111.928 -179.32 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' B' ' 130' ' ' CYS . 53.4 t -128.78 134.63 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.569 -0.707 . . . . 0.0 109.658 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.433 ' HA ' ' HB2' ' B' ' 130' ' ' CYS . . . -142.38 142.92 32.49 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.497 -1.377 . . . . 0.0 110.392 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.576 ' CZ ' HD12 ' A' ' 11' ' ' LEU . 3.1 m-85 -76.47 -86.73 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.813 -1.179 . . . . 0.0 111.248 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 46.4 t0 . . . . . 0 C--N 1.296 -1.723 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.384 -179.169 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.85 0 CA-C-O 121.115 0.483 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' CYS . . . . . 0.405 ' O ' ' HA ' ' B' ' 123' ' ' ASP . 34.2 m -114.71 39.29 2.88 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.022 -1.049 . . . . 0.0 109.264 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . 0.534 ' O ' ' ND2' ' A' ' 8' ' ' ASN . . . 79.86 168.93 37.97 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 108.031 -2.028 . . . . 0.0 108.031 -178.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.576 ' N ' HD12 ' B' ' 4' ' ' LEU . 11.0 mp -93.07 141.69 28.13 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.965 -1.315 . . . . 0.0 110.751 -179.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 41.9 t -107.82 131.6 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.382 0 O-C-N 121.082 -1.011 . . . . 0.0 110.242 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -130.5 173.11 11.18 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.044 -1.035 . . . . 0.0 112.011 -178.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . 0.401 ' O ' ' HB3' ' B' ' 8' ' ' ASN . 27.1 p -155.34 168.25 27.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.426 -0.797 . . . . 0.0 109.802 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . 0.436 ' ND2' ' O ' ' A' ' 3' ' ' GLY . 20.2 t-20 62.61 41.09 9.77 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.589 -0.695 . . . . 0.0 110.416 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.472 ' O ' ' C ' ' B' ' 10' ' ' ASN . 54.8 mt -101.19 17.03 23.57 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.437 -0.79 . . . . 0.0 110.04 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . 0.479 ' HA ' ' O ' ' B' ' 117' ' ' ILE . 51.2 t-20 -20.0 89.04 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.39 0 CA-C-O 121.95 0.881 . . . . 0.0 112.77 -179.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.576 HD12 ' CZ ' ' B' ' 133' ' ' PHE . 5.2 tt -100.44 134.16 43.8 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.703 -0.623 . . . . 0.0 109.885 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . 0.47 ' HD2' ' HD2' ' B' ' 13' ' ' PRO . 0.5 OUTLIER -111.34 171.09 4.6 Favored Pre-proline 0 C--N 1.293 -1.883 0 O-C-N 121.244 -0.91 . . . . 0.0 109.94 179.126 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . 0.47 ' HD2' ' HD2' ' B' ' 12' ' ' LYS . 44.1 Cg_endo -65.94 144.35 76.25 Favored 'Trans proline' 0 C--N 1.301 -1.942 0 O-C-N 123.919 1.484 . . . . 0.0 110.115 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 104.32 -24.01 30.16 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -90.92 149.83 21.74 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.194 -1.18 . . . . 0.0 110.591 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' CYS . . . . . 0.419 ' SG ' ' N ' ' B' ' 17' ' ' LEU . 0.0 OUTLIER -106.86 159.62 16.12 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.48 -0.763 . . . . 0.0 109.72 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.639 HD13 ' N ' ' B' ' 18' ' ' ARG . 0.6 OUTLIER -135.0 122.64 22.14 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.621 -1.299 . . . . 0.0 110.383 179.845 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.639 ' N ' HD13 ' B' ' 17' ' ' LEU . 80.1 ttt180 -115.77 133.35 56.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.361 -0.837 . . . . 0.0 109.816 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.483 HG13 ' CD1' ' B' ' 128' ' ' ILE . 55.2 t -122.82 109.19 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.29 -0.881 . . . . 0.0 111.13 -178.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 77.2 ttt-85 -109.82 123.28 49.29 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.993 -1.067 . . . . 0.0 110.631 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -147.22 -161.4 9.38 Favored Glycine 0 N--CA 1.487 2.075 0 C-N-CA 119.456 -1.354 . . . . 0.0 110.009 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 71.3 tt0 -127.22 136.38 51.95 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.575 -0.956 . . . . 0.0 109.081 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.649 HG22 ' CD1' ' B' ' 126' ' ' PHE . 90.5 t -103.98 129.15 56.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 O-C-N 121.174 -0.954 . . . . 0.0 109.789 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.04 161.15 1.93 Allowed Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.506 -0.746 . . . . 0.0 110.172 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' B' ' 81' ' ' PRO . 42.7 Cg_endo -66.02 -20.16 57.39 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.802 1.422 . . . . 0.0 109.775 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -112.2 44.31 1.44 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.693 -0.629 . . . . 0.0 110.388 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . 0.565 ' HB2' ' CG1' ' B' ' 23' ' ' VAL . . . -71.84 91.25 1.15 Allowed 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 118.95 -1.1 . . . . 0.0 109.415 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -98.71 -20.58 16.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.491 -0.755 . . . . 0.0 109.777 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 24.8 t -149.65 143.31 25.42 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.076 -1.015 . . . . 0.0 111.046 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' PHE . . . . . 0.527 ' HA ' ' HA3' ' B' ' 124' ' ' GLY . 41.0 t80 -147.69 134.75 20.35 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.508 -0.745 . . . . 0.0 110.162 179.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.428 HG22 ' ND2' ' B' ' 46' ' ' ASN . 76.9 t -127.74 131.05 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.852 -1.155 . . . . 0.0 110.437 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.752 HD12 ' N ' ' B' ' 33' ' ' ASN . 5.1 tp -138.53 142.58 39.3 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.384 -0.823 . . . . 0.0 110.361 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' ASN . . . . . 0.885 ' HB2' HD13 ' B' ' 41' ' ' LEU . 1.3 p-10 -155.11 142.59 19.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.964 -1.085 . . . . 0.0 110.671 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.486 HD12 ' O ' ' B' ' 34' ' ' LEU . 1.5 pp -135.92 119.2 16.69 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.227 -0.921 . . . . 0.0 109.679 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . 0.812 ' HA3' HD23 ' B' ' 41' ' ' LEU . . . -143.53 -137.58 3.28 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 119.922 -1.133 . . . . 0.0 110.392 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . 0.44 ' CG ' ' N ' ' B' ' 37' ' ' ASP . 24.6 pttt -126.86 -37.47 2.12 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.246 -1.149 . . . . 0.0 111.174 -178.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . 0.451 ' O ' ' CD1' ' B' ' 119' ' ' TYR . 88.3 m-20 -114.25 -84.14 0.61 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.976 -1.078 . . . . 0.0 109.958 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 7.7 t -150.76 -54.22 0.15 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.403 -0.811 . . . . 0.0 109.023 178.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 58.3 m-20 -92.6 -4.5 53.29 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.372 -0.83 . . . . 0.0 108.824 178.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' ASN . . . . . 0.421 ' O ' ' HA3' ' B' ' 35' ' ' GLY . 16.3 m-80 -90.96 69.07 6.3 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.271 -0.893 . . . . 0.0 110.017 -178.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.885 HD13 ' HB2' ' B' ' 33' ' ' ASN . 77.5 mt -105.8 135.93 46.33 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.434 -0.791 . . . . 0.0 110.674 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' CYS . . . . . 0.577 ' O ' HD23 ' B' ' 43' ' ' LEU . 74.2 m -88.83 -34.31 17.08 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.336 -0.852 . . . . 0.0 109.561 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 1.027 HD21 HD13 ' B' ' 96' ' ' LEU . 74.6 mt -131.25 129.71 41.92 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.192 -1.003 . . . . 0.0 111.276 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' HIS . . . . . 0.448 ' HB3' ' OD1' ' B' ' 61' ' ' ASN . 61.1 t-80 -127.0 123.28 36.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.506 -0.746 . . . . 0.0 109.297 178.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -110.15 131.31 55.17 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.133 -0.979 . . . . 0.0 109.762 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . 0.428 ' ND2' HG22 ' B' ' 31' ' ' VAL . 0.1 OUTLIER -148.51 78.08 9.37 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.074 -1.016 . . . . 0.0 111.506 -179.08 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' PRO . . . . . 0.443 ' HG2' ' HB3' ' B' ' 30' ' ' PHE . 47.8 Cg_endo -69.83 144.96 55.31 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 123.627 1.33 . . . . 0.0 109.839 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -145.26 88.51 1.87 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.898 -1.127 . . . . 0.0 110.566 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' PHE . . . . . 0.497 ' O ' ' HA ' ' B' ' 55' ' ' ALA . 33.8 t80 -61.65 -45.78 92.58 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.277 0.56 . . . . 0.0 110.417 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 27.1 t30 -134.79 98.67 4.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.286 -0.884 . . . . 0.0 110.239 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -118.74 -68.08 0.94 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.056 -1.028 . . . . 0.0 110.977 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -105.63 -15.2 15.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.295 -0.878 . . . . 0.0 110.886 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 159.52 -14.21 0.21 Allowed Glycine 0 N--CA 1.495 2.585 0 C-N-CA 119.913 -1.137 . . . . 0.0 110.277 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -74.45 179.67 4.5 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.752 -1.44 . . . . 0.0 109.045 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' B' ' 49' ' ' PHE . . . -129.03 -11.11 4.77 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.066 -1.021 . . . . 0.0 111.387 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' ASN . . . . . . . . . . . . . 41.1 p30 -158.91 72.89 0.59 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.187 -0.945 . . . . 0.0 110.714 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 80.7 m -124.45 130.93 53.36 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 120.494 -1.379 . . . . 0.0 111.575 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' ILE . . . . . 0.408 ' HA ' ' HA ' ' B' ' 47' ' ' PRO . 98.1 mt -122.15 130.77 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.47 -0.769 . . . . 0.0 111.209 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 12.9 t -114.48 129.62 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.416 -0.802 . . . . 0.0 110.677 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 33.2 m -128.5 121.69 29.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.293 -0.879 . . . . 0.0 110.137 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' ASN . . . . . 0.547 ' HB3' ' HG2' ' B' ' 71' ' ' GLU . 3.8 p-10 -139.32 174.16 10.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.134 -0.979 . . . . 0.0 110.188 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 7.2 m -129.18 155.15 45.97 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.476 -0.765 . . . . 0.0 108.953 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . 0.531 ' CD ' ' HA2' ' B' ' 66' ' ' GLY . 6.8 ttmt -135.14 150.19 50.14 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.508 -1.37 . . . . 0.0 112.114 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' ASP . . . . . 0.559 ' HB2' HD11 ' B' ' 112' ' ' LEU . 54.5 t0 -129.7 100.38 5.48 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 64.52 21.3 66.68 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.843 -1.17 . . . . 0.0 110.435 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . 0.531 ' HA2' ' CD ' ' B' ' 63' ' ' LYS . . . 74.68 25.6 69.44 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.251 -1.452 . . . . 0.0 110.473 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -105.95 -73.27 0.69 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.989 -1.3 . . . . 0.0 110.583 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -70.59 -177.06 1.41 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.653 -0.655 . . . . 0.0 109.887 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 164.94 46.4 0.02 OUTLIER Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 15.8 m -63.85 100.81 0.32 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.271 -1.134 . . . . 0.0 110.462 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.547 ' HG2' ' HB3' ' B' ' 61' ' ' ASN . 86.4 mt-10 -85.49 123.32 30.79 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.274 -0.891 . . . . 0.0 111.017 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -101.23 -167.81 1.47 Allowed 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -147.3 120.7 9.02 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 117.991 -1.484 . . . . 0.0 111.822 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -106.86 132.83 52.37 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.49 60.84 0.6 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.926 -1.109 . . . . 0.0 111.128 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' VAL . . . . . 0.541 HG22 ' HD3' ' B' ' 78' ' ' PRO . 4.6 p -136.51 151.24 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.9 -1.125 . . . . 0.0 110.251 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' PHE . . . . . 0.494 ' O ' ' CG ' ' B' ' 77' ' ' PHE . 9.1 p90 -144.98 71.65 14.84 Favored Pre-proline 0 C--N 1.303 -1.444 0 O-C-N 121.204 -0.935 . . . . 0.0 109.99 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . 0.541 ' HD3' HG22 ' B' ' 76' ' ' VAL . 41.0 Cg_endo -64.71 -14.38 44.39 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.088 1.573 . . . . 0.0 110.422 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -116.89 167.24 11.3 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.191 -0.943 . . . . 0.0 110.408 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.77 167.66 16.9 Favored Pre-proline 0 C--N 1.3 -1.554 0 O-C-N 121.707 -0.621 . . . . 0.0 109.387 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' PRO . . . . . 0.418 ' HB2' ' O ' ' B' ' 25' ' ' PRO . 42.7 Cg_endo -65.94 148.41 85.94 Favored 'Trans proline' 0 C--N 1.297 -2.165 0 O-C-N 123.946 1.498 . . . . 0.0 110.391 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 62.47 43.18 99.4 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 15.9 t -149.32 138.73 21.57 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.196 -1.179 . . . . 0.0 110.043 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.409 ' H ' HG22 ' B' ' 84' ' ' VAL . 15.4 m -79.1 140.08 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.136 -0.978 . . . . 0.0 109.156 178.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -148.71 154.13 39.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.063 -1.023 . . . . 0.0 109.81 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -123.29 152.66 41.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.049 -1.032 . . . . 0.0 109.993 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . 0.43 HG12 HG13 ' B' ' 89' ' ' ILE . 46.9 t -128.4 138.52 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.399 -0.813 . . . . 0.0 111.457 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 88' ' ' CYS . . . . . 0.435 ' HB3' ' HB2' ' B' ' 99' ' ' LYS . 4.7 t -113.49 114.73 26.95 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.422 -0.799 . . . . 0.0 109.845 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.43 HG13 HG12 ' B' ' 87' ' ' VAL . 87.1 mt -120.69 128.42 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.252 -0.905 . . . . 0.0 110.0 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 90' ' ' THR . . . . . 0.512 ' HB ' ' HB ' ' B' ' 97' ' ' THR . 27.8 m -123.09 134.94 54.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.222 -0.924 . . . . 0.0 109.628 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' PHE . . . . . 0.491 ' CE1' HD21 ' B' ' 96' ' ' LEU . 79.4 t80 -104.84 117.35 33.82 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.326 -0.858 . . . . 0.0 110.246 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -112.17 143.57 43.0 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.058 -1.026 . . . . 0.0 109.402 178.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 72.5 tp60 -60.69 -25.11 66.15 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.533 -0.729 . . . . 0.0 110.833 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.07 -22.35 21.86 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.973 -1.079 . . . . 0.0 111.499 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 45.6 p30 -174.39 -172.5 0.68 Allowed 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.163 -0.961 . . . . 0.0 108.947 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 96' ' ' LEU . . . . . 1.027 HD13 HD21 ' B' ' 43' ' ' LEU . 74.9 mt -121.72 134.93 54.95 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 120.993 -1.067 . . . . 0.0 110.697 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . 0.512 ' HB ' ' HB ' ' B' ' 90' ' ' THR . 32.9 m -109.4 123.14 48.84 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.233 -0.917 . . . . 0.0 108.989 178.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 46.3 t -125.19 128.37 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.852 -1.155 . . . . 0.0 109.588 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 99' ' ' LYS . . . . . 0.435 ' HB2' ' HB3' ' B' ' 88' ' ' CYS . 98.5 mttt -122.89 146.27 47.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.179 -0.951 . . . . 0.0 110.899 -178.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . 0.434 HD13 ' HG3' ' B' ' 78' ' ' PRO . 25.0 mt -105.5 166.67 10.95 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -63.16 -25.43 72.72 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.239 1.126 . . . . 0.0 110.945 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' ASP . . . . . 0.468 ' HB2' ' CB ' ' B' ' 78' ' ' PRO . 36.3 t70 -74.42 -11.94 60.37 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.947 -1.096 . . . . 0.0 110.94 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 106.08 -8.5 42.07 Favored Glycine 0 N--CA 1.493 2.475 0 C-N-CA 119.887 -1.149 . . . . 0.0 110.683 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 104' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -72.3 136.48 46.25 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.933 -1.334 . . . . 0.0 110.25 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 105' ' ' GLU . . . . . 0.432 ' OE2' HG23 ' B' ' 97' ' ' THR . 71.4 tt0 -125.62 142.28 51.59 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.057 -1.027 . . . . 0.0 110.527 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -133.35 146.14 51.02 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.507 -0.746 . . . . 0.0 109.163 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 107' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' B' ' 96' ' ' LEU . 98.1 mttt -122.06 146.13 47.49 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.768 -1.208 . . . . 0.0 112.812 -178.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 108' ' ' PHE . . . . . 0.541 ' HB2' ' HB2' ' B' ' 96' ' ' LEU . 98.0 m-85 -117.09 150.28 45.78 Favored Pre-proline 0 N--CA 1.492 1.671 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.85 148.52 64.66 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.593 1.312 . . . . 0.0 111.261 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 110' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -69.77 62.85 0.19 Allowed 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.586 -0.696 . . . . 0.0 111.621 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 79.3 mtp85 -65.41 -39.78 92.58 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.919 -1.113 . . . . 0.0 110.277 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . 0.559 HD11 ' HB2' ' B' ' 64' ' ' ASP . 4.5 mm? -95.87 130.01 42.95 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.18 -0.95 . . . . 0.0 110.702 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -87.38 7.4 29.12 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.643 -0.66 . . . . 0.0 111.069 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 114' ' ' LEU . . . . . 0.484 HD23 ' O ' ' B' ' 114' ' ' LEU . 3.5 tt -58.07 129.2 40.85 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.053 -1.029 . . . . 0.0 109.239 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -106.65 -5.56 18.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.559 -0.713 . . . . 0.0 111.36 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 116' ' ' ALA . . . . . 0.443 ' HA ' ' O ' ' B' ' 11' ' ' LEU . . . -137.82 132.32 32.44 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.74 -1.225 . . . . 0.0 110.418 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 117' ' ' ILE . . . . . 0.479 ' O ' ' HA ' ' B' ' 10' ' ' ASN . 95.9 mt -111.72 128.71 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.927 -1.108 . . . . 0.0 110.269 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -126.1 -28.52 3.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.138 -0.976 . . . . 0.0 111.818 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 119' ' ' TYR . . . . . 0.451 ' CD1' ' O ' ' B' ' 37' ' ' ASP . 66.6 t80 -91.96 127.31 37.38 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.882 -1.136 . . . . 0.0 110.346 -179.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 120' ' ' MET . . . . . 0.425 ' HB3' ' CD1' ' B' ' 9' ' ' LEU . 26.5 ttm -142.0 134.26 27.79 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.115 -0.991 . . . . 0.0 109.592 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 121' ' ' ALA . . . . . 0.469 ' HB3' HD21 ' B' ' 33' ' ' ASN . . . -158.89 147.71 18.53 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.101 -0.999 . . . . 0.0 109.448 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 122' ' ' ALA . . . . . 0.491 ' O ' ' HA3' ' B' ' 3' ' ' GLY . . . -147.14 155.0 41.78 Favored 'General case' 0 C--N 1.29 -1.995 0 O-C-N 121.472 -0.768 . . . . 0.0 108.975 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . 0.405 ' HA ' ' O ' ' B' ' 2' ' ' CYS . 9.6 p-10 -154.51 156.53 36.84 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 124' ' ' GLY . . . . . 0.527 ' HA3' ' HA ' ' B' ' 30' ' ' PHE . . . 148.93 -157.17 27.16 Favored Glycine 0 C--N 1.296 -1.693 0 C-N-CA 118.382 -1.866 . . . . 0.0 110.149 178.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . 0.483 ' CB ' ' HA ' ' B' ' 27' ' ' ALA . 63.1 m-20 -91.55 12.1 21.98 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 122.015 -0.697 . . . . 0.0 110.383 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 126' ' ' PHE . . . . . 0.649 ' CD1' HG22 ' B' ' 23' ' ' VAL . 11.5 t80 -108.58 151.4 26.17 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.668 -1.27 . . . . 0.0 110.402 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -121.23 124.57 44.97 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.268 -0.895 . . . . 0.0 110.356 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . 0.483 ' CD1' HG13 ' B' ' 19' ' ' VAL . 18.0 tt -101.86 127.3 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.156 -0.965 . . . . 0.0 110.39 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 29.1 pttt -119.11 -4.3 10.56 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.783 -1.198 . . . . 0.0 111.126 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 130' ' ' CYS . . . . . 0.441 ' HA ' ' O ' ' A' ' 131' ' ' VAL . 0.0 OUTLIER -154.29 130.96 10.71 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 118.947 -1.101 . . . . 0.0 111.91 -179.084 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 130' ' ' CYS . 54.7 t -128.05 133.85 66.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.659 -0.651 . . . . 0.0 109.956 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 132' ' ' ALA . . . . . . . . . . . . . . . -141.45 142.87 33.64 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 120.249 -1.532 . . . . 0.0 110.395 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . 0.576 ' CZ ' HD12 ' B' ' 11' ' ' LEU . 3.0 m-85 -76.19 -88.56 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.096 -1.002 . . . . 0.0 111.084 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 48.4 t0 . . . . . 0 C--N 1.296 -1.749 0 CA-C-O 118.096 -0.954 . . . . 0.0 110.356 -179.388 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.549 ' HB2' ' HE3' ' A' ' 127' ' ' LYS . . . . . . . . 0 N--CA 1.496 1.865 0 CA-C-O 121.226 0.536 . . . . 0.0 110.472 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.51 ' O ' ' O ' ' A' ' 3' ' ' GLY . 1.3 m -96.85 54.11 1.27 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.145 -0.972 . . . . 0.0 110.808 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.51 ' O ' ' O ' ' A' ' 2' ' ' CYS . . . 43.39 111.2 0.0 OUTLIER Glycine 0 N--CA 1.497 2.704 0 CA-C-O 121.851 0.695 . . . . 0.0 112.271 178.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.933 HD12 HG23 ' A' ' 128' ' ' ILE . 84.2 mt -63.76 137.12 57.93 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.627 -1.514 . . . . 0.0 109.25 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.6 t -110.07 132.46 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.364 -0.835 . . . . 0.0 109.804 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -134.82 161.33 35.51 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.845 -1.16 . . . . 0.0 110.112 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.455 ' O ' ' HB3' ' A' ' 8' ' ' ASN . 15.2 p -153.38 169.95 21.86 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.539 -0.726 . . . . 0.0 109.999 -178.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.455 ' HB3' ' O ' ' A' ' 7' ' ' SER . 57.2 t30 65.74 39.08 4.94 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.263 0.554 . . . . 0.0 109.683 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 11' ' ' LEU . 85.7 mt -104.95 32.41 4.2 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.385 -0.822 . . . . 0.0 109.83 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -40.59 93.87 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.275 0 O-C-N 121.603 -0.686 . . . . 0.0 111.666 -178.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.582 HD11 ' OE1' ' A' ' 15' ' ' GLU . 0.2 OUTLIER -114.77 131.23 56.86 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.347 179.304 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.0 mttt -97.65 171.9 5.46 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.528 -0.733 . . . . 0.0 111.007 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -67.79 150.42 78.88 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 O-C-N 123.911 1.48 . . . . 0.0 110.095 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.59 -15.03 35.22 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.582 ' OE1' HD11 ' A' ' 11' ' ' LEU . 90.3 mt-10 -114.51 150.11 35.38 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.802 -1.41 . . . . 0.0 109.75 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 45.8 t -109.78 145.45 36.64 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.199 -0.938 . . . . 0.0 110.337 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.849 HD12 ' O ' ' A' ' 132' ' ' ALA . 48.1 tp -112.48 134.17 54.16 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -121.86 129.55 52.68 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.934 -1.104 . . . . 0.0 110.108 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.481 HG13 HG13 ' A' ' 128' ' ' ILE . 65.2 t -126.28 127.7 70.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.161 -0.962 . . . . 0.0 111.02 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.448 ' HG3' ' HG2' ' A' ' 86' ' ' GLU . 70.3 ttt180 -107.27 122.12 45.91 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 177.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' A' ' 127' ' ' LYS . . . -135.14 -178.57 15.77 Favored Glycine 0 N--CA 1.487 2.083 0 C-N-CA 118.939 -1.601 . . . . 0.0 111.661 -177.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -126.07 140.53 52.51 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 122.028 -0.689 . . . . 0.0 110.321 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.4 t -101.75 126.88 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.501 -0.749 . . . . 0.0 109.812 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.06 154.82 37.24 Favored Pre-proline 0 N--CA 1.497 1.922 0 O-C-N 120.989 -1.069 . . . . 0.0 110.48 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -67.45 -18.39 49.35 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 124.026 1.54 . . . . 0.0 111.208 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -119.77 52.23 1.12 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.924 -1.11 . . . . 0.0 108.69 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.21 153.01 32.32 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.575 0.702 . . . . 0.0 112.215 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.402 ' N ' ' OD2' ' A' ' 125' ' ' ASP . 98.1 mttt -137.85 -39.66 0.56 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.539 -0.726 . . . . 0.0 109.953 179.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 40.1 p -161.58 160.0 28.37 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.967 -1.083 . . . . 0.0 111.756 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.477 ' HA ' ' HA3' ' A' ' 124' ' ' GLY . 67.3 t80 -153.86 150.82 28.81 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.49 -0.756 . . . . 0.0 109.878 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 45' ' ' PHE . 11.4 p -134.75 150.5 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.047 -1.033 . . . . 0.0 110.94 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.439 HD12 ' HB3' ' A' ' 45' ' ' PHE . 78.2 mt -118.2 147.22 43.6 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.487 -0.758 . . . . 0.0 108.995 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.572 ' OD1' HD22 ' A' ' 41' ' ' LEU . 62.9 t30 -143.25 108.54 5.02 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.015 -1.074 . . . . 0.0 111.004 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.639 HD11 ' HB3' ' A' ' 43' ' ' LEU . 0.5 OUTLIER -131.14 121.28 24.63 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.401 -0.812 . . . . 0.0 109.494 179.254 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.463 ' HA3' ' HA ' ' A' ' 41' ' ' LEU . . . -168.54 -171.5 34.44 Favored Glycine 0 N--CA 1.484 1.843 0 C-N-CA 118.652 -1.737 . . . . 0.0 109.977 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.463 ' HD2' HD13 ' A' ' 114' ' ' LEU . 34.9 mtpt -65.85 -41.52 91.58 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 122.284 1.04 . . . . 0.0 108.53 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.16 -167.33 2.17 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.851 0.834 . . . . 0.0 111.825 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.3 t -57.67 -41.98 82.66 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.636 -0.665 . . . . 0.0 112.766 -177.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -99.92 -7.34 25.35 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.234 -1.541 . . . . 0.0 110.663 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.425 ' HB2' ' HB2' ' A' ' 36' ' ' LYS . 7.1 m-80 -105.03 73.11 1.03 Allowed 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.032 -1.043 . . . . 0.0 109.096 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.572 HD22 ' OD1' ' A' ' 33' ' ' ASN . 60.1 mt -101.68 127.45 48.43 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.332 0.587 . . . . 0.0 110.362 -178.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 3.3 t -84.59 -43.91 14.02 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.123 -0.985 . . . . 0.0 110.488 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.719 HD22 HD21 ' A' ' 96' ' ' LEU . 20.4 tp -129.41 133.79 47.53 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.219 -0.926 . . . . 0.0 110.584 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.414 ' O ' ' HA ' ' A' ' 60' ' ' CYS . 9.3 t60 -126.73 112.77 15.8 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.556 ' CD2' ' HD3' ' A' ' 47' ' ' PRO . 43.2 t80 -111.71 115.77 29.63 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.822 -1.173 . . . . 0.0 110.481 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.402 ' ND2' ' HB ' ' A' ' 31' ' ' VAL . 0.2 OUTLIER -130.45 73.76 80.91 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.348 -0.845 . . . . 0.0 111.601 -179.34 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.556 ' HD3' ' CD2' ' A' ' 45' ' ' PHE . 43.5 Cg_endo -66.5 143.05 67.63 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.416 1.219 . . . . 0.0 109.52 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -137.63 126.32 23.8 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.912 -1.117 . . . . 0.0 110.847 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -72.21 -60.1 2.4 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.113 -0.992 . . . . 0.0 110.005 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -115.47 121.68 43.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.282 -0.886 . . . . 0.0 109.335 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.59 -162.46 0.96 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.838 -1.164 . . . . 0.0 111.123 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -83.45 8.92 12.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.404 -0.81 . . . . 0.0 110.165 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 173.76 -34.07 0.11 Allowed Glycine 0 N--CA 1.487 2.095 0 N-CA-C 108.589 -1.804 . . . . 0.0 108.589 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -80.85 -178.59 6.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.235 -1.156 . . . . 0.0 110.14 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.426 ' O ' ' C ' ' A' ' 56' ' ' ASN . . . -131.18 140.34 49.9 Favored 'General case' 0 C--N 1.293 -1.855 0 O-C-N 121.871 -0.518 . . . . 0.0 110.042 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.426 ' C ' ' O ' ' A' ' 55' ' ' ALA . 3.2 m120 27.81 73.52 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 179.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 96.2 m -127.51 131.18 50.14 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.913 -1.117 . . . . 0.0 110.526 178.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.527 ' HB ' ' HB3' ' A' ' 74' ' ' GLU . 82.4 mt -103.56 129.03 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.894 -0.504 . . . . 0.0 110.656 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 24.6 t -110.84 128.99 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.329 -0.857 . . . . 0.0 109.494 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 44' ' ' HIS . 1.8 t -127.74 131.24 49.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.474 -0.766 . . . . 0.0 110.376 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.402 ' O ' ' CB ' ' A' ' 44' ' ' HIS . 1.5 p-10 -151.19 172.42 15.85 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.973 -1.079 . . . . 0.0 109.835 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.469 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 59.2 p -136.04 153.26 51.4 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.209 -0.932 . . . . 0.0 109.785 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.527 ' CD ' ' HA2' ' A' ' 66' ' ' GLY . 10.0 ttmt -133.29 145.79 50.79 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 120.692 -1.255 . . . . 0.0 111.876 -178.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.504 ' OD2' HD22 ' A' ' 112' ' ' LEU . 30.2 t0 -123.85 107.79 11.77 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.182 -0.949 . . . . 0.0 109.407 178.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 59.2 29.24 65.39 Favored Glycine 0 N--CA 1.485 1.91 0 C-N-CA 119.357 -1.401 . . . . 0.0 110.05 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.527 ' HA2' ' CD ' ' A' ' 63' ' ' LYS . . . 62.41 26.25 67.83 Favored Glycine 0 N--CA 1.488 2.108 0 O-C-N 120.997 -1.296 . . . . 0.0 110.621 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -89.98 -75.12 0.46 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.969 -1.312 . . . . 0.0 110.466 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 43.7 m95 -122.83 -170.46 2.1 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.792 -1.193 . . . . 0.0 110.777 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.469 ' HA2' ' O ' ' A' ' 62' ' ' SER . . . 173.49 114.62 0.35 Allowed Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.408 -1.377 . . . . 0.0 110.555 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 52.9 m -77.2 121.01 23.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.382 -1.069 . . . . 0.0 110.452 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -101.63 123.52 45.78 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.146 -0.971 . . . . 0.0 110.486 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -115.88 -170.27 1.76 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.826 -1.171 . . . . 0.0 110.378 179.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 47.3 ttp180 -144.4 116.4 8.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.952 -1.092 . . . . 0.0 111.587 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.527 ' HB3' ' HB ' ' A' ' 58' ' ' ILE . 77.5 tt0 -103.12 139.45 38.62 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.253 -0.904 . . . . 0.0 110.128 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.72 38.7 2.29 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.927 -1.108 . . . . 0.0 111.712 -179.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.463 ' O ' ' CD1' ' A' ' 58' ' ' ILE . 48.1 t -132.47 130.29 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.622 -1.299 . . . . 0.0 111.625 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -159.21 96.16 1.69 Allowed Pre-proline 0 N--CA 1.5 2.05 0 O-C-N 120.904 -1.122 . . . . 0.0 110.79 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -81.49 45.91 2.1 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.998 1.525 . . . . 0.0 111.7 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -128.85 152.8 48.1 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.615 -1.303 . . . . 0.0 111.725 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 15.4 mp0 -135.87 160.21 68.27 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.688 -0.632 . . . . 0.0 109.682 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -66.22 145.48 78.44 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.855 1.45 . . . . 0.0 110.79 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 64.5 40.25 97.52 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.1 p -133.54 148.77 51.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.976 -1.308 . . . . 0.0 111.627 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.6 p -101.26 136.47 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.505 -0.747 . . . . 0.0 109.233 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -153.91 155.07 35.0 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.121 -0.987 . . . . 0.0 110.368 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.448 ' HG2' ' HG3' ' A' ' 20' ' ' ARG . 99.0 mt-10 -119.36 139.18 52.4 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.896 -1.128 . . . . 0.0 110.597 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.6 t -125.95 132.68 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.411 -0.805 . . . . 0.0 110.68 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 77.8 m -107.77 134.41 50.77 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.176 -0.953 . . . . 0.0 109.107 179.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 89.1 mt -121.22 127.93 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.747 -1.221 . . . . 0.0 111.019 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.409 ' O ' HD12 ' A' ' 96' ' ' LEU . 45.6 m -129.35 128.97 44.18 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.302 -0.874 . . . . 0.0 109.972 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.587 ' HA ' HD12 ' A' ' 96' ' ' LEU . 42.4 t80 -112.43 127.38 56.02 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.104 -0.997 . . . . 0.0 111.868 -179.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 95' ' ' ASN . 88.8 m-20 -119.09 156.02 30.48 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.496 -0.752 . . . . 0.0 109.911 179.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 -60.95 -23.88 65.65 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.454 -0.779 . . . . 0.0 112.73 -178.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -105.36 -26.54 11.93 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.436 -1.415 . . . . 0.0 110.428 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.409 ' O ' ' HB2' ' A' ' 92' ' ' ASP . 34.5 m-20 -152.57 172.61 16.33 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 119.069 -1.052 . . . . 0.0 111.866 -179.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.719 HD21 HD22 ' A' ' 43' ' ' LEU . 54.6 tp -119.13 129.42 55.02 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.798 HG23 ' OE2' ' A' ' 105' ' ' GLU . 17.4 m -114.58 125.25 53.56 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 120.781 -1.199 . . . . 0.0 111.115 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 43.3 t -120.18 127.93 75.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 88' ' ' CYS . 88.2 tttt -114.42 119.24 36.22 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 118.589 -1.244 . . . . 0.0 109.774 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.0 mp -100.35 170.7 6.34 Favored Pre-proline 0 C--N 1.298 -1.645 0 O-C-N 121.91 -0.494 . . . . 0.0 109.755 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.05 -22.13 62.53 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 O-C-N 123.893 1.47 . . . . 0.0 111.122 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -66.04 -34.24 77.64 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.805 -1.185 . . . . 0.0 109.787 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 112.4 -27.0 10.41 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -73.22 145.23 46.37 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.145 -1.209 . . . . 0.0 109.381 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.798 ' OE2' HG23 ' A' ' 97' ' ' THR . 68.9 tt0 -113.64 143.33 44.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.844 -1.16 . . . . 0.0 111.022 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -120.44 147.86 44.55 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 98.2 mttt -120.77 145.11 47.88 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.01 -1.076 . . . . 0.0 111.555 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.463 ' HB3' HD23 ' A' ' 96' ' ' LEU . 15.0 t80 -125.55 129.59 24.35 Favored Pre-proline 0 C--N 1.293 -1.885 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -64.73 140.78 69.31 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 O-C-N 123.02 1.01 . . . . 0.0 109.965 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.51 ' ND2' ' O ' ' A' ' 110' ' ' ASN . 4.1 p-10 -92.02 82.4 5.1 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.023 -1.048 . . . . 0.0 109.473 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -54.72 -27.39 40.37 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.536 -1.353 . . . . 0.0 109.224 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.504 HD22 ' OD2' ' A' ' 64' ' ' ASP . 83.4 mt -104.65 132.33 51.02 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.338 -0.851 . . . . 0.0 109.851 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -87.7 61.06 6.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.009 -1.057 . . . . 0.0 110.415 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.463 HD13 ' HD2' ' A' ' 36' ' ' LYS . 52.0 tp -80.84 129.67 34.65 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.358 -0.839 . . . . 0.0 109.537 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -87.27 -12.36 46.86 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.162 -0.962 . . . . 0.0 111.549 -178.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 11' ' ' LEU . . . -160.23 158.45 29.99 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.794 -1.191 . . . . 0.0 111.661 -178.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 49.9 mm -109.41 126.06 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.525 -0.734 . . . . 0.0 109.891 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -112.09 -26.65 8.74 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.566 -1.334 . . . . 0.0 110.787 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.483 ' O ' ' HA ' ' A' ' 34' ' ' LEU . 10.5 t80 -110.21 126.26 53.95 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.229 -0.92 . . . . 0.0 110.401 -179.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.402 ' CB ' HD12 ' A' ' 9' ' ' LEU . 50.0 ttp -132.98 130.66 39.8 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.5 142.24 21.0 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.026 -1.046 . . . . 0.0 110.521 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.446 ' O ' ' CA ' ' A' ' 3' ' ' GLY . . . -148.02 132.03 17.22 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.35 -0.844 . . . . 0.0 111.391 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.472 ' HB3' ' HA3' ' A' ' 3' ' ' GLY . 15.2 p-10 -148.46 147.6 29.33 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.358 -0.839 . . . . 0.0 110.483 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.477 ' HA3' ' HA ' ' A' ' 30' ' ' PHE . . . 155.79 -145.44 12.34 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.402 ' OD2' ' N ' ' A' ' 28' ' ' LYS . 88.2 m-20 -94.31 11.46 30.31 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.288 -1.125 . . . . 0.0 111.544 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.445 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 24.7 t80 -112.87 143.74 43.62 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.964 -1.085 . . . . 0.0 109.319 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.549 ' HE3' ' HB2' ' A' ' 1' ' ' ALA . 51.8 mttp -117.01 140.99 48.82 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.891 -1.131 . . . . 0.0 111.359 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.933 HG23 HD12 ' A' ' 4' ' ' LEU . 4.1 tt -111.57 122.41 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -101.55 -9.94 20.55 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.021 -1.049 . . . . 0.0 112.384 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -158.14 150.12 21.78 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.224 -1.547 . . . . 0.0 112.004 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.427 HG22 HD11 ' A' ' 128' ' ' ILE . 47.9 t -128.86 133.48 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.849 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -136.38 133.1 36.4 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.715 -1.241 . . . . 0.0 111.302 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.51 ' CE1' HD13 ' A' ' 17' ' ' LEU . 47.7 m-85 -110.9 148.22 32.93 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.402 -0.811 . . . . 0.0 111.313 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.409 ' CB ' ' HB3' ' A' ' 15' ' ' GLU . 47.1 t0 . . . . . 0 N--CA 1.496 1.873 0 CA-C-O 118.114 -0.946 . . . . 0.0 111.186 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.562 ' HB2' ' HE3' ' B' ' 127' ' ' LYS . . . . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 121.341 0.591 . . . . 0.0 110.441 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' CYS . . . . . 0.512 ' O ' ' O ' ' B' ' 3' ' ' GLY . 1.3 m -96.95 54.88 1.29 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.023 -1.048 . . . . 0.0 110.664 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . 0.512 ' O ' ' O ' ' B' ' 2' ' ' CYS . . . 42.43 111.3 0.0 OUTLIER Glycine 0 N--CA 1.497 2.717 0 CA-C-O 121.891 0.717 . . . . 0.0 112.308 178.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.971 HD12 HG23 ' B' ' 128' ' ' ILE . 86.2 mt -63.78 136.99 57.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.571 -1.547 . . . . 0.0 109.458 178.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 37.5 t -109.72 132.35 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.454 -0.779 . . . . 0.0 109.861 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -134.7 161.12 36.05 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.766 -1.209 . . . . 0.0 110.214 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . 0.469 ' O ' ' HB3' ' B' ' 8' ' ' ASN . 15.8 p -153.2 170.37 20.71 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.293 -0.879 . . . . 0.0 110.038 -178.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . 0.469 ' HB3' ' O ' ' B' ' 7' ' ' SER . 57.2 t30 65.43 39.05 5.36 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.241 0.543 . . . . 0.0 109.756 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' B' ' 11' ' ' LEU . 82.6 mt -104.62 32.27 4.2 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.345 -0.847 . . . . 0.0 109.8 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 -40.24 93.97 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.495 -0.753 . . . . 0.0 111.708 -178.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.586 HD11 ' OE1' ' B' ' 15' ' ' GLU . 0.2 OUTLIER -115.01 131.05 57.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.649 -0.657 . . . . 0.0 110.286 179.603 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -97.75 172.54 4.79 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.506 -0.746 . . . . 0.0 110.765 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.25 150.69 76.75 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 O-C-N 123.95 1.5 . . . . 0.0 110.392 178.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.3 -14.98 36.2 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . 0.586 ' OE1' HD11 ' B' ' 11' ' ' LEU . 90.4 mt-10 -114.37 150.25 34.89 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.822 -1.399 . . . . 0.0 109.668 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' CYS . . . . . . . . . . . . . 52.3 t -109.89 145.62 36.52 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.129 -0.982 . . . . 0.0 110.036 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.843 HD12 ' O ' ' B' ' 132' ' ' ALA . 46.3 tp -112.75 133.92 54.52 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -121.74 129.23 52.55 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.937 -1.102 . . . . 0.0 109.982 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.475 HG13 HG13 ' B' ' 128' ' ' ILE . 61.6 t -125.54 127.2 71.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.32 -0.862 . . . . 0.0 111.122 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.459 ' HG3' ' HG2' ' B' ' 86' ' ' GLU . 70.2 ttt180 -107.02 122.13 45.84 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.475 ' HA3' ' O ' ' B' ' 127' ' ' LYS . . . -135.17 -177.83 15.24 Favored Glycine 0 N--CA 1.484 1.842 0 C-N-CA 118.881 -1.628 . . . . 0.0 111.562 -177.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -126.66 140.76 52.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.697 -0.884 . . . . 0.0 110.203 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 6.4 t -101.92 127.39 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.293 -0.88 . . . . 0.0 109.846 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.35 155.51 36.02 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 120.953 -1.092 . . . . 0.0 110.588 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.77 -18.4 47.51 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 O-C-N 124.122 1.591 . . . . 0.0 111.113 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -119.88 52.62 1.11 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.023 -1.048 . . . . 0.0 108.8 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . 0.409 ' HA ' ' HB3' ' B' ' 125' ' ' ASP . . . -78.59 152.31 31.89 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.585 0.707 . . . . 0.0 112.144 -178.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . 0.403 ' N ' ' OD2' ' B' ' 125' ' ' ASP . 98.0 mttt -137.12 -40.66 0.59 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.671 -0.643 . . . . 0.0 110.105 178.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 35.8 p -160.14 160.9 33.49 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.871 -1.143 . . . . 0.0 111.321 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' PHE . . . . . 0.492 ' HA ' ' HA3' ' B' ' 124' ' ' GLY . 64.8 t80 -154.58 150.52 27.82 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.278 -0.889 . . . . 0.0 109.623 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' B' ' 45' ' ' PHE . 11.5 p -134.41 150.97 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 120.781 -1.2 . . . . 0.0 110.974 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.471 HD12 ' HB3' ' B' ' 45' ' ' PHE . 76.5 mt -118.09 147.12 43.59 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' ASN . . . . . 0.571 ' OD1' HD22 ' B' ' 41' ' ' LEU . 63.2 t30 -143.14 108.11 4.93 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 120.834 -1.166 . . . . 0.0 110.974 -179.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.648 HD11 ' HB3' ' B' ' 43' ' ' LEU . 0.5 OUTLIER -131.29 116.35 17.5 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.283 -0.885 . . . . 0.0 109.835 179.546 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . 0.473 ' HA3' ' HA ' ' B' ' 41' ' ' LEU . . . -161.63 -169.93 25.62 Favored Glycine 0 N--CA 1.485 1.919 0 C-N-CA 118.53 -1.795 . . . . 0.0 110.494 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . 0.487 ' HD2' HD13 ' B' ' 114' ' ' LEU . 36.1 mtpt -66.69 -42.26 86.75 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -156.62 -167.06 2.28 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.75 0.786 . . . . 0.0 111.778 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 38.6 t -57.83 -41.9 83.24 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -100.31 -7.27 24.72 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 120.394 -1.441 . . . . 0.0 110.564 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' ASN . . . . . 0.407 ' HB2' ' HB2' ' B' ' 36' ' ' LYS . 7.3 m-80 -104.92 72.18 1.0 Allowed 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.903 -1.123 . . . . 0.0 109.129 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.571 HD22 ' OD1' ' B' ' 33' ' ' ASN . 60.1 mt -100.32 130.13 46.39 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.231 0.539 . . . . 0.0 110.031 -178.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' CYS . . . . . . . . . . . . . 2.1 t -88.63 -42.58 11.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.066 -1.021 . . . . 0.0 109.919 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.708 HD22 HD21 ' B' ' 96' ' ' LEU . 19.7 tp -129.76 133.91 47.29 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.144 -0.972 . . . . 0.0 110.456 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' HIS . . . . . 0.409 ' O ' ' HA ' ' B' ' 60' ' ' CYS . 9.0 t60 -127.27 112.75 15.44 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.553 ' CD2' ' HD3' ' B' ' 47' ' ' PRO . 43.3 t80 -111.69 115.25 28.79 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.133 -0.979 . . . . 0.0 110.436 -179.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -129.84 73.42 81.47 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 121.372 -0.83 . . . . 0.0 111.413 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' PRO . . . . . 0.553 ' HD3' ' CD2' ' B' ' 45' ' ' PHE . 41.4 Cg_endo -66.24 143.03 69.24 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.263 1.138 . . . . 0.0 109.259 179.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -137.9 126.63 23.78 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.91 -1.119 . . . . 0.0 110.713 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -72.59 -60.97 1.97 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.137 -0.977 . . . . 0.0 109.988 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -114.54 120.99 42.08 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.488 -0.758 . . . . 0.0 109.25 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.09 -162.11 0.92 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.84 -1.162 . . . . 0.0 111.32 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -84.18 11.42 8.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.433 -0.792 . . . . 0.0 110.122 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 170.42 -33.48 0.16 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -81.45 -178.55 6.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.013 -1.286 . . . . 0.0 110.029 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.473 ' O ' ' C ' ' B' ' 56' ' ' ASN . . . -129.6 146.91 51.36 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' ASN . . . . . 0.473 ' C ' ' O ' ' B' ' 55' ' ' ALA . 3.3 m120 17.53 77.36 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.175 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -179.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 97.0 m -128.1 130.86 48.84 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.236 -0.915 . . . . 0.0 110.328 178.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' ILE . . . . . 0.468 ' HB ' ' HB3' ' B' ' 74' ' ' GLU . 82.7 mt -104.01 129.24 56.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 121.775 -0.578 . . . . 0.0 110.818 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 25.0 t -110.29 129.17 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.193 -0.942 . . . . 0.0 109.899 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' CYS . . . . . 0.409 ' HA ' ' O ' ' B' ' 44' ' ' HIS . 1.7 t -127.98 129.6 47.02 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.661 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' ASN . . . . . 0.409 ' O ' ' HB3' ' B' ' 44' ' ' HIS . 1.5 p-10 -149.69 171.75 16.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.151 -0.968 . . . . 0.0 110.194 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' SER . . . . . 0.46 ' O ' ' HA2' ' B' ' 69' ' ' GLY . 60.5 p -135.47 153.61 51.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.243 -0.91 . . . . 0.0 109.56 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . 0.521 ' CD ' ' HA2' ' B' ' 66' ' ' GLY . 10.1 ttmt -132.93 145.9 51.31 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 120.703 -1.248 . . . . 0.0 111.701 -178.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' ASP . . . . . 0.517 ' OD2' HD22 ' B' ' 112' ' ' LEU . 30.4 t0 -123.83 107.48 11.44 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.212 -0.93 . . . . 0.0 109.263 178.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 59.64 28.74 65.78 Favored Glycine 0 N--CA 1.484 1.878 0 C-N-CA 119.576 -1.297 . . . . 0.0 110.15 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . 0.521 ' HA2' ' CD ' ' B' ' 63' ' ' LYS . . . 62.84 25.83 68.12 Favored Glycine 0 N--CA 1.488 2.105 0 O-C-N 120.872 -1.369 . . . . 0.0 110.575 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' ALA . . . . . 0.411 ' HB1' ' CD1' ' B' ' 68' ' ' TRP . . . -89.48 -75.65 0.44 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.835 -1.391 . . . . 0.0 110.236 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' TRP . . . . . 0.411 ' CD1' ' HB1' ' B' ' 67' ' ' ALA . 43.6 m95 -122.46 -166.29 1.4 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.871 -1.143 . . . . 0.0 110.985 -178.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' B' ' 62' ' ' SER . . . 167.87 114.33 0.3 Allowed Glycine 0 N--CA 1.486 2.032 0 C-N-CA 119.359 -1.4 . . . . 0.0 110.546 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 43.2 m -77.31 120.87 22.93 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.946 -0.738 . . . . 0.0 110.531 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -101.29 123.73 45.86 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.266 -0.896 . . . . 0.0 110.396 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -116.03 -171.05 1.91 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.84 -1.163 . . . . 0.0 110.295 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 47.7 ttp180 -143.78 116.02 8.47 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.205 -0.934 . . . . 0.0 111.42 -178.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' GLU . . . . . 0.468 ' HB3' ' HB ' ' B' ' 58' ' ' ILE . 78.1 tt0 -102.98 139.25 38.78 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.215 -0.928 . . . . 0.0 110.035 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.82 39.43 2.13 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.951 -1.093 . . . . 0.0 111.461 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' VAL . . . . . 0.46 ' O ' ' CD1' ' B' ' 58' ' ' ILE . 48.9 t -132.97 129.9 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 120.919 -1.113 . . . . 0.0 111.738 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -159.05 96.43 1.71 Allowed Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 120.922 -1.112 . . . . 0.0 110.809 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -81.66 46.6 2.28 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.925 1.487 . . . . 0.0 111.53 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -129.58 153.06 48.42 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.719 -1.238 . . . . 0.0 111.502 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 15.4 mp0 -136.41 160.5 66.57 Favored Pre-proline 0 N--CA 1.486 1.374 0 O-C-N 121.666 -0.646 . . . . 0.0 109.467 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -66.68 145.15 74.74 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.75 1.395 . . . . 0.0 110.958 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 64.78 39.95 97.0 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 12.7 p -132.77 147.78 52.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.011 -1.288 . . . . 0.0 111.913 -178.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 12.7 p -100.15 136.64 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.438 -0.789 . . . . 0.0 109.408 178.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -154.02 155.43 35.52 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.051 -1.031 . . . . 0.0 110.171 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' GLU . . . . . 0.459 ' HG2' ' HG3' ' B' ' 20' ' ' ARG . 98.3 mt-10 -119.67 139.07 52.81 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.856 -1.153 . . . . 0.0 110.499 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 55.9 t -125.62 132.78 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.517 -0.739 . . . . 0.0 110.601 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 88' ' ' CYS . . . . . 0.419 ' HB2' ' HB3' ' B' ' 99' ' ' LYS . 75.1 m -107.57 134.98 49.79 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.166 -0.959 . . . . 0.0 109.355 178.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 87.2 mt -121.59 128.26 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.882 -1.136 . . . . 0.0 110.958 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 90' ' ' THR . . . . . 0.415 ' O ' HD12 ' B' ' 96' ' ' LEU . 50.1 m -129.08 128.83 44.34 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.28 -0.887 . . . . 0.0 109.914 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 91' ' ' PHE . . . . . 0.568 ' HA ' HD12 ' B' ' 96' ' ' LEU . 41.1 t80 -112.38 127.35 55.99 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.995 -1.066 . . . . 0.0 111.637 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' B' ' 95' ' ' ASN . 88.9 m-20 -119.59 155.79 31.59 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.4 -0.813 . . . . 0.0 109.805 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -60.76 -23.84 65.28 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.404 -0.81 . . . . 0.0 112.761 -178.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -105.23 -26.95 11.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.366 -1.459 . . . . 0.0 110.474 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . 0.405 ' O ' ' HB2' ' B' ' 92' ' ' ASP . 34.5 m-20 -152.36 172.57 16.26 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 122.082 0.944 . . . . 0.0 112.02 -178.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 96' ' ' LEU . . . . . 0.708 HD21 HD22 ' B' ' 43' ' ' LEU . 54.1 tp -119.07 129.25 54.99 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . 0.807 HG23 ' OE2' ' B' ' 105' ' ' GLU . 18.3 m -114.45 125.44 53.83 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 120.784 -1.198 . . . . 0.0 111.0 -179.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 44.7 t -120.53 128.06 75.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 99' ' ' LYS . . . . . 0.419 ' HB3' ' HB2' ' B' ' 88' ' ' CYS . 88.3 tttt -114.5 118.99 35.32 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 118.542 -1.263 . . . . 0.0 110.142 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 5.1 mp -100.0 170.49 6.67 Favored Pre-proline 0 C--N 1.302 -1.466 0 O-C-N 121.889 -0.507 . . . . 0.0 110.009 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.72 -23.04 63.56 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.788 1.414 . . . . 0.0 110.998 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -64.95 -34.45 78.46 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.667 -1.271 . . . . 0.0 110.039 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 112.07 -27.22 10.42 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 104' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -72.91 144.67 47.26 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.198 -1.178 . . . . 0.0 109.443 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 105' ' ' GLU . . . . . 0.807 ' OE2' HG23 ' B' ' 97' ' ' THR . 68.2 tt0 -113.57 143.71 44.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.958 -1.089 . . . . 0.0 111.221 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -120.72 148.04 44.49 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 107' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' B' ' 96' ' ' LEU . 98.1 mttt -120.78 145.23 47.76 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.05 -1.031 . . . . 0.0 111.173 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 108' ' ' PHE . . . . . 0.429 ' HB3' HD23 ' B' ' 96' ' ' LEU . 15.7 t80 -126.13 129.83 24.13 Favored Pre-proline 0 C--N 1.291 -1.959 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -64.95 141.01 68.88 Favored 'Trans proline' 0 C--N 1.298 -2.131 0 O-C-N 123.071 1.038 . . . . 0.0 110.362 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 110' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' B' ' 110' ' ' ASN . 4.0 p-10 -91.84 82.16 5.19 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.158 -1.017 . . . . 0.0 109.689 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -54.36 -27.38 35.87 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.443 -1.411 . . . . 0.0 109.273 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . 0.517 HD22 ' OD2' ' B' ' 64' ' ' ASP . 82.5 mt -104.96 131.86 51.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.476 -0.765 . . . . 0.0 110.008 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -87.01 61.69 6.94 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.138 -0.977 . . . . 0.0 110.431 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 114' ' ' LEU . . . . . 0.487 HD13 ' HD2' ' B' ' 36' ' ' LYS . 51.7 tp -81.24 130.03 34.85 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.247 -0.908 . . . . 0.0 109.571 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -87.18 -13.03 45.11 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.125 -0.984 . . . . 0.0 111.369 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 116' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' B' ' 11' ' ' LEU . . . -159.73 158.89 32.11 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.765 -1.21 . . . . 0.0 111.898 -178.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 117' ' ' ILE . . . . . . . . . . . . . 49.7 mm -109.39 125.97 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.442 -0.786 . . . . 0.0 109.858 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -111.66 -26.91 8.76 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.542 -1.349 . . . . 0.0 110.667 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 119' ' ' TYR . . . . . 0.489 ' O ' ' HA ' ' B' ' 34' ' ' LEU . 9.5 t80 -110.18 126.4 54.06 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.364 -0.934 . . . . 0.0 110.76 -178.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 120' ' ' MET . . . . . 0.419 ' CB ' HD12 ' B' ' 9' ' ' LEU . 49.8 ttp -133.19 129.83 38.3 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.444 -0.785 . . . . 0.0 108.976 179.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -152.75 142.31 21.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.905 -1.122 . . . . 0.0 110.578 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 122' ' ' ALA . . . . . 0.463 ' O ' ' CA ' ' B' ' 3' ' ' GLY . . . -147.41 132.47 18.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.013 -1.054 . . . . 0.0 111.351 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . 0.482 ' HB3' ' HA3' ' B' ' 3' ' ' GLY . 15.3 p-10 -148.58 147.45 29.03 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.091 -1.006 . . . . 0.0 110.551 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 124' ' ' GLY . . . . . 0.492 ' HA3' ' HA ' ' B' ' 30' ' ' PHE . . . 155.97 -144.43 10.89 Favored Glycine 0 N--CA 1.496 2.639 0 C-N-CA 119.808 -1.187 . . . . 0.0 110.177 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . 0.409 ' HB3' ' HA ' ' B' ' 27' ' ' ALA . 87.2 m-20 -95.09 10.82 34.35 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.241 -1.152 . . . . 0.0 111.351 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 126' ' ' PHE . . . . . 0.425 ' HB3' ' CD1' ' B' ' 30' ' ' PHE . 24.4 t80 -112.52 143.71 43.22 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.876 -1.14 . . . . 0.0 109.519 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . 0.562 ' HE3' ' HB2' ' B' ' 1' ' ' ALA . 52.0 mttp -116.56 141.11 48.61 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 118.81 -1.156 . . . . 0.0 111.521 -179.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . 0.971 HG23 HD12 ' B' ' 4' ' ' LEU . 4.1 tt -111.57 122.88 66.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.776 -0.578 . . . . 0.0 109.543 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -101.92 -11.8 18.71 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.078 -1.014 . . . . 0.0 112.196 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 130' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -155.89 150.61 26.14 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.271 -1.518 . . . . 0.0 112.024 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.431 ' CG2' HD11 ' B' ' 128' ' ' ILE . 45.4 t -129.31 133.05 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.588 -0.695 . . . . 0.0 109.162 178.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 132' ' ' ALA . . . . . 0.843 ' O ' HD12 ' B' ' 17' ' ' LEU . . . -136.19 132.66 36.23 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.713 -1.242 . . . . 0.0 111.39 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . 0.489 ' CE1' HD13 ' B' ' 17' ' ' LEU . 47.6 m-85 -110.48 147.98 33.0 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.275 -0.891 . . . . 0.0 111.105 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 47.8 t0 . . . . . 0 N--CA 1.496 1.867 0 CA-C-O 118.137 -0.935 . . . . 0.0 111.127 -179.894 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 121.138 0.494 . . . . 0.0 109.991 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 50.8 t -144.85 85.02 1.74 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.148 -0.97 . . . . 0.0 110.418 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 84.6 42.81 7.15 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 120.006 -1.093 . . . . 0.0 110.652 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.453 ' HA ' ' HB3' ' B' ' 8' ' ' ASN . 49.3 tp -59.77 133.7 56.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.88 -1.365 . . . . 0.0 110.7 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.7 t -118.04 130.11 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.361 -0.837 . . . . 0.0 110.071 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -118.81 153.01 35.17 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.325 -0.859 . . . . 0.0 109.555 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.467 ' O ' ' HB3' ' A' ' 8' ' ' ASN . 18.1 p -148.78 171.98 15.37 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.261 -0.899 . . . . 0.0 110.314 -178.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.467 ' HB3' ' O ' ' A' ' 7' ' ' SER . 14.7 t30 61.08 35.49 18.7 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.335 0.588 . . . . 0.0 110.272 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.525 ' O ' ' C ' ' A' ' 10' ' ' ASN . 87.7 mt -91.16 -17.97 25.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.215 -0.928 . . . . 0.0 110.893 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.525 ' C ' ' O ' ' A' ' 9' ' ' LEU . 7.6 m120 11.24 77.47 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.506 0 CA-C-O 121.522 0.677 . . . . 0.0 112.791 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.617 HD21 ' CZ ' ' A' ' 133' ' ' PHE . 19.2 mt -98.93 128.05 45.0 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.686 -0.634 . . . . 0.0 110.765 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -96.35 169.68 8.6 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.18 -0.95 . . . . 0.0 110.47 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.438 ' HD3' ' O ' ' A' ' 115' ' ' GLU . 40.7 Cg_endo -66.13 146.65 82.38 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.976 1.514 . . . . 0.0 110.156 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.23 -7.78 56.84 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -117.92 147.28 43.28 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.953 -1.322 . . . . 0.0 109.998 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.8 m -109.63 145.13 36.97 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.963 -1.086 . . . . 0.0 111.606 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.708 HD12 ' O ' ' A' ' 132' ' ' ALA . 47.5 tp -121.2 133.78 55.18 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -122.94 141.75 51.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.743 -1.223 . . . . 0.0 111.183 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 69.0 t -124.27 120.27 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 119.894 -0.723 . . . . 0.0 110.382 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -116.85 122.06 43.28 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.1 -1.0 . . . . 0.0 109.549 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.526 ' O ' HG13 ' A' ' 84' ' ' VAL . . . -144.71 -150.15 5.17 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.432 -1.365 . . . . 0.0 109.897 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -133.34 147.01 51.82 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.741 -1.446 . . . . 0.0 110.529 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.561 HG22 ' HD1' ' A' ' 126' ' ' PHE . 51.1 t -110.23 128.79 66.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.5 -0.75 . . . . 0.0 109.898 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.94 147.25 74.09 Favored Pre-proline 0 C--N 1.301 -1.528 0 O-C-N 121.061 -1.024 . . . . 0.0 109.2 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.415 ' HA ' ' N ' ' A' ' 82' ' ' GLY . 40.6 Cg_endo -65.89 -20.69 58.04 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.729 1.384 . . . . 0.0 110.141 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -116.77 29.63 7.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.439 -0.788 . . . . 0.0 109.228 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.472 ' HA ' ' HB3' ' A' ' 125' ' ' ASP . . . -63.74 99.09 0.21 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.514 -0.741 . . . . 0.0 110.884 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -66.52 -43.97 83.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.468 -0.77 . . . . 0.0 110.401 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.5 t -165.03 147.61 8.15 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.461 -0.774 . . . . 0.0 110.26 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.489 ' CE1' ' HG2' ' A' ' 47' ' ' PRO . 49.6 p90 -148.95 156.22 41.97 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.567 HG22 ' CB ' ' A' ' 46' ' ' ASN . 53.3 t -133.43 137.85 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.534 -1.354 . . . . 0.0 112.369 -177.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 93.2 mt -112.37 133.09 54.66 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.47 ' OD1' ' CE1' ' A' ' 44' ' ' HIS . 80.8 m-20 -125.78 135.89 52.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.013 -1.054 . . . . 0.0 110.968 -178.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.493 HD11 ' HB3' ' A' ' 43' ' ' LEU . 0.7 OUTLIER -145.17 114.16 6.93 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.077 -1.014 . . . . 0.0 110.934 179.415 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.466 ' O ' ' N ' ' A' ' 119' ' ' TYR . . . -163.45 -132.31 1.33 Allowed Glycine 0 N--CA 1.496 2.66 0 N-CA-C 108.233 -1.947 . . . . 0.0 108.233 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.72 ' HD2' HD13 ' A' ' 114' ' ' LEU . 42.1 mtpt -112.08 -46.03 3.25 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.093 -1.24 . . . . 0.0 108.05 178.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -123.67 164.41 19.15 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.882 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.23 -32.18 68.08 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.339 -0.851 . . . . 0.0 110.982 -179.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.454 ' HB3' ' N ' ' A' ' 66' ' ' GLY . 87.1 m-20 -94.98 -9.07 35.09 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.877 -1.14 . . . . 0.0 111.186 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.439 ' N ' ' ND2' ' A' ' 40' ' ' ASN . 2.9 m-80 -113.56 66.42 0.66 Allowed 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.158 -0.964 . . . . 0.0 110.138 -178.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 47.0 mt -96.24 133.25 40.81 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 2.1 m -85.41 -31.24 23.0 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.993 -1.067 . . . . 0.0 109.784 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.872 HD13 ' CD2' ' A' ' 96' ' ' LEU . 25.3 tp -128.5 129.19 45.7 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.611 -0.681 . . . . 0.0 109.982 -179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.47 ' CE1' ' OD1' ' A' ' 33' ' ' ASN . 63.5 t60 -128.23 127.73 43.4 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.102 -0.999 . . . . 0.0 110.305 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.507 ' CE1' HG21 ' A' ' 58' ' ' ILE . 83.7 t80 -123.39 122.88 39.41 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.975 -1.078 . . . . 0.0 110.043 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.567 ' CB ' HG22 ' A' ' 31' ' ' VAL . 1.4 t-20 -142.71 84.23 11.03 Favored Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 121.154 -0.966 . . . . 0.0 110.954 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.504 ' HD3' ' CD2' ' A' ' 45' ' ' PHE . 52.7 Cg_endo -70.64 142.77 44.84 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.657 1.346 . . . . 0.0 109.489 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -127.0 97.59 5.01 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.921 -1.112 . . . . 0.0 110.394 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -61.03 -45.44 94.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.132 -0.98 . . . . 0.0 109.139 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -159.63 103.36 1.55 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.309 -0.869 . . . . 0.0 109.413 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -113.82 -104.17 0.4 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.045 -1.034 . . . . 0.0 110.695 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -65.88 -41.47 91.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.663 -1.273 . . . . 0.0 109.872 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 168.54 39.54 0.02 OUTLIER Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.402 ' N ' ' OD1' ' A' ' 54' ' ' ASP . 8.9 m-20 -114.08 -179.42 3.63 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.353 -1.087 . . . . 0.0 109.115 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.423 ' O ' ' C ' ' A' ' 56' ' ' ASN . . . -142.14 143.99 33.27 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.977 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.423 ' C ' ' O ' ' A' ' 55' ' ' ALA . 81.2 m-20 27.55 49.4 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 178.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 55.2 m -118.48 130.51 55.98 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.84 -1.162 . . . . 0.0 109.352 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.589 HD12 ' H ' ' A' ' 76' ' ' VAL . 86.8 mt -115.6 135.26 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.203 -0.936 . . . . 0.0 110.933 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 64.6 t -102.05 126.09 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.382 -0.824 . . . . 0.0 110.265 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 80.2 m -116.76 121.27 41.1 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.142 -0.974 . . . . 0.0 109.251 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.461 ' O ' ' HB3' ' A' ' 44' ' ' HIS . 2.5 p-10 -151.63 179.1 8.69 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.952 -1.093 . . . . 0.0 111.163 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.455 ' O ' ' CA ' ' A' ' 69' ' ' GLY . 15.1 m -133.91 154.18 51.25 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.325 -0.86 . . . . 0.0 109.874 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.497 ' CD ' ' HA2' ' A' ' 66' ' ' GLY . 18.3 ttmt -128.53 143.67 51.01 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.491 -1.381 . . . . 0.0 111.277 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.666 ' HB2' HD21 ' A' ' 112' ' ' LEU . 59.4 t0 -122.34 95.61 4.71 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.463 -0.773 . . . . 0.0 109.161 178.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 71.21 19.87 77.68 Favored Glycine 0 N--CA 1.484 1.834 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.497 ' HA2' ' CD ' ' A' ' 63' ' ' LYS . . . 72.29 32.72 62.32 Favored Glycine 0 N--CA 1.486 2.009 0 C-N-CA 119.386 -1.388 . . . . 0.0 110.694 179.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -101.86 -74.55 0.62 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.855 -1.379 . . . . 0.0 111.122 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 14.1 m0 -124.16 -147.83 0.38 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.14 -0.975 . . . . 0.0 110.627 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.455 ' CA ' ' O ' ' A' ' 62' ' ' SER . . . 158.64 144.65 4.01 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.631 ' O ' HG23 ' A' ' 70' ' ' THR . 6.5 t -81.53 80.47 7.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.455 -1.026 . . . . 0.0 109.729 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.452 ' HA ' ' HB3' ' A' ' 61' ' ' ASN . 78.6 tt0 -71.07 111.56 6.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.249 -0.907 . . . . 0.0 110.875 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -122.79 -164.94 1.24 Allowed 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.333 -0.855 . . . . 0.0 109.556 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -137.65 130.92 30.73 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.431 -0.907 . . . . 0.0 110.583 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -131.83 83.43 2.09 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.309 -0.87 . . . . 0.0 109.508 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.74 88.08 0.1 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.216 -0.928 . . . . 0.0 110.611 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.589 ' H ' HD12 ' A' ' 58' ' ' ILE . 6.2 p -134.6 141.49 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.449 -0.782 . . . . 0.0 109.682 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -157.11 89.21 2.57 Favored Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 120.55 -1.344 . . . . 0.0 110.891 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.403 ' CB ' ' OD2' ' A' ' 102' ' ' ASP . 51.0 Cg_endo -77.39 -6.63 16.51 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.845 1.445 . . . . 0.0 111.978 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -142.21 -167.3 2.44 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.79 -1.194 . . . . 0.0 111.293 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.422 ' CB ' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -139.48 172.53 6.3 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.481 -0.762 . . . . 0.0 109.723 179.753 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.422 ' HD2' ' CB ' ' A' ' 80' ' ' GLN . 44.3 Cg_endo -67.22 147.42 78.68 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.807 1.425 . . . . 0.0 111.294 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.415 ' N ' ' HA ' ' A' ' 25' ' ' PRO . . . 78.71 23.56 64.29 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.4 t -137.01 147.45 46.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.083 -1.245 . . . . 0.0 111.113 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.526 HG13 ' O ' ' A' ' 21' ' ' GLY . 73.3 t -79.23 130.26 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.529 -0.732 . . . . 0.0 110.116 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -130.82 142.24 50.38 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.946 -1.096 . . . . 0.0 109.692 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.405 ' O ' ' HG3' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -120.22 127.29 52.29 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.519 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 73.4 t -121.52 132.26 71.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 118.985 -1.086 . . . . 0.0 111.019 -177.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 11.8 t -97.04 117.74 31.9 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.493 -0.754 . . . . 0.0 109.368 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 72.7 mt -111.51 125.24 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.082 -1.012 . . . . 0.0 109.468 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 57.7 m -122.36 129.38 52.06 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.361 -0.837 . . . . 0.0 109.665 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -106.76 118.28 36.27 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.052 -1.03 . . . . 0.0 110.822 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -115.73 152.08 33.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.467 -0.771 . . . . 0.0 109.378 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 69.9 tp60 -62.73 -38.83 92.07 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.968 -1.082 . . . . 0.0 110.521 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.34 -39.35 89.15 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.949 -1.094 . . . . 0.0 110.563 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -166.7 178.8 5.74 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.322 -0.862 . . . . 0.0 110.068 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.872 ' CD2' HD13 ' A' ' 43' ' ' LEU . 49.5 tp -102.08 129.86 48.52 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.375 -0.828 . . . . 0.0 109.197 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 98.9 m -115.4 122.67 46.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.717 -1.239 . . . . 0.0 111.22 -179.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 7.0 m -120.84 129.51 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.382 -0.824 . . . . 0.0 109.36 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -113.53 124.79 53.21 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.797 -1.19 . . . . 0.0 109.396 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.0 mp -85.42 164.37 40.89 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.301 -0.874 . . . . 0.0 109.57 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -66.14 -32.85 42.21 Favored 'Trans proline' 0 C--N 1.302 -1.905 0 O-C-N 123.858 1.452 . . . . 0.0 110.486 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.403 ' OD2' ' CB ' ' A' ' 78' ' ' PRO . 99.7 m-20 -74.45 -25.32 59.34 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.106 -0.996 . . . . 0.0 110.208 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 121.3 3.11 10.66 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.761 -1.209 . . . . 0.0 111.095 178.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -83.9 135.8 34.35 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.598 -1.531 . . . . 0.0 110.249 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 64.5 tt0 -132.49 148.56 52.39 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.434 -0.791 . . . . 0.0 111.129 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -141.0 156.4 46.05 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.602 -0.686 . . . . 0.0 109.21 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 98.5 mttt -123.92 141.0 52.43 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.007 -1.058 . . . . 0.0 110.867 -178.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -123.71 143.35 41.63 Favored Pre-proline 0 N--CA 1.494 1.733 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.84 144.28 47.88 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.299 1.158 . . . . 0.0 109.184 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.485 ' ND2' ' O ' ' A' ' 110' ' ' ASN . 6.0 p-10 -95.0 82.76 3.84 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 120.934 -1.104 . . . . 0.0 110.584 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.427 ' CZ ' ' HB ' ' A' ' 70' ' ' THR . 98.2 mtt180 -55.77 -22.11 22.51 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.818 -1.176 . . . . 0.0 109.111 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.666 HD21 ' HB2' ' A' ' 64' ' ' ASP . 57.4 mt -96.9 141.92 29.51 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.319 -0.863 . . . . 0.0 108.704 178.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -97.02 62.42 1.83 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.748 -1.22 . . . . 0.0 109.875 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.72 HD13 ' HD2' ' A' ' 36' ' ' LYS . 64.9 tp -82.33 130.04 35.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.353 -0.842 . . . . 0.0 111.08 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.438 ' O ' ' HD3' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -88.94 -17.23 29.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.409 -0.807 . . . . 0.0 109.87 179.487 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.51 ' HA ' ' O ' ' A' ' 11' ' ' LEU . . . -163.22 144.08 9.36 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.723 -1.236 . . . . 0.0 111.682 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.43 HD13 HD12 ' A' ' 34' ' ' LEU . 93.1 mt -98.87 124.59 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.386 -0.821 . . . . 0.0 108.981 178.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.466 ' ND2' ' N ' ' A' ' 118' ' ' ASN . 0.1 OUTLIER -125.59 13.0 8.08 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.592 -0.692 . . . . 0.0 110.772 -179.361 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.472 ' O ' ' HA ' ' A' ' 34' ' ' LEU . 7.8 t80 -131.62 128.82 39.92 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.974 -1.079 . . . . 0.0 110.261 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 62.5 ttp -142.78 130.8 21.79 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.347 -0.846 . . . . 0.0 109.85 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -140.88 144.53 35.32 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.229 -0.92 . . . . 0.0 109.76 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -132.11 108.95 9.64 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.281 -0.887 . . . . 0.0 109.458 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -137.65 129.16 28.19 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.531 -0.731 . . . . 0.0 109.649 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.466 ' HA3' ' HA ' ' A' ' 30' ' ' PHE . . . 154.13 -157.93 27.81 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 108.841 -1.704 . . . . 0.0 108.841 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.472 ' HB3' ' HA ' ' A' ' 27' ' ' ALA . 87.6 m-20 -78.38 -0.22 28.22 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.3 -1.118 . . . . 0.0 110.552 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.561 ' HD1' HG22 ' A' ' 23' ' ' VAL . 42.7 t80 -95.4 142.28 27.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.09 -1.006 . . . . 0.0 109.859 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -112.95 140.12 48.02 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 118.815 -1.154 . . . . 0.0 110.538 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.531 HG23 ' O ' ' A' ' 128' ' ' ILE . 20.6 tt -108.51 122.79 63.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.625 -0.672 . . . . 0.0 109.755 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -105.74 -23.07 12.81 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.328 -0.857 . . . . 0.0 110.97 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.404 ' HA ' ' O ' ' B' ' 131' ' ' VAL . 0.1 OUTLIER -153.03 154.88 35.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.82 -1.175 . . . . 0.0 112.136 -178.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' B' ' 130' ' ' CYS . 42.8 t -123.71 135.91 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.708 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -124.29 146.35 48.84 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.867 -1.145 . . . . 0.0 110.574 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.617 ' CZ ' HD21 ' A' ' 11' ' ' LEU . 0.4 OUTLIER -94.39 -139.92 0.23 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.349 -0.844 . . . . 0.0 109.798 179.786 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 49.0 t0 . . . . . 0 N--CA 1.492 1.673 0 O-C-N 120.631 -1.293 . . . . 0.0 110.437 -179.589 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.218 0.532 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' CYS . . . . . . . . . . . . . 49.6 t -145.17 84.85 1.72 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.095 -1.003 . . . . 0.0 110.608 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 84.84 43.37 6.81 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.42 HD23 HD13 ' B' ' 128' ' ' ILE . 50.1 tp -60.18 133.66 56.31 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.918 -1.342 . . . . 0.0 110.577 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 46.7 t -117.95 130.07 73.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.363 -0.836 . . . . 0.0 110.111 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -118.94 152.51 36.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.926 . . . . 0.0 109.485 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . 0.486 ' O ' ' HB3' ' B' ' 8' ' ' ASN . 17.1 p -148.6 172.26 14.82 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.102 -0.999 . . . . 0.0 110.25 -179.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . 0.486 ' HB3' ' O ' ' B' ' 7' ' ' SER . 13.6 t30 61.34 35.47 17.96 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.404 0.621 . . . . 0.0 110.303 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.538 ' O ' ' C ' ' B' ' 10' ' ' ASN . 88.5 mt -92.52 -12.51 31.73 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.362 -0.836 . . . . 0.0 111.153 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . 0.538 ' C ' ' O ' ' B' ' 9' ' ' LEU . 7.3 m120 2.85 80.42 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.491 0 CA-C-O 122.144 0.973 . . . . 0.0 112.953 -178.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.613 HD21 ' CZ ' ' B' ' 133' ' ' PHE . 18.7 mt -98.96 127.96 45.01 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.642 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -96.35 169.76 8.47 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.204 -0.935 . . . . 0.0 110.549 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . 0.438 ' HD3' ' O ' ' B' ' 115' ' ' GLU . 40.6 Cg_endo -66.16 146.74 82.48 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 124.004 1.529 . . . . 0.0 110.18 178.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.86 -7.48 57.41 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.084 -1.207 . . . . 0.0 110.084 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -117.94 147.5 43.09 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.905 -1.35 . . . . 0.0 109.827 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' CYS . . . . . . . . . . . . . 6.2 m -110.11 145.25 37.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.085 -1.009 . . . . 0.0 111.365 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.711 HD12 ' O ' ' B' ' 132' ' ' ALA . 46.9 tp -121.33 133.83 55.13 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -122.97 141.63 51.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.867 -1.146 . . . . 0.0 111.21 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 69.4 t -124.09 120.91 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 119.902 -0.719 . . . . 0.0 110.354 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -117.44 121.81 42.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.259 -0.901 . . . . 0.0 109.602 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.53 ' O ' HG13 ' B' ' 84' ' ' VAL . . . -144.65 -149.93 5.14 Favored Glycine 0 N--CA 1.494 2.511 0 C-N-CA 119.486 -1.34 . . . . 0.0 109.897 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -133.72 146.47 50.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.814 -1.403 . . . . 0.0 110.685 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.579 HG22 ' HD1' ' B' ' 126' ' ' PHE . 50.9 t -109.71 128.63 65.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.501 -0.749 . . . . 0.0 109.961 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.79 147.01 73.5 Favored Pre-proline 0 C--N 1.299 -1.602 0 O-C-N 121.093 -1.004 . . . . 0.0 109.253 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.427 ' HA ' ' N ' ' B' ' 82' ' ' GLY . 40.4 Cg_endo -66.05 -20.1 57.2 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.714 1.376 . . . . 0.0 110.116 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -117.15 29.44 7.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.292 -0.88 . . . . 0.0 109.246 178.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . 0.465 ' HA ' ' HB3' ' B' ' 125' ' ' ASP . . . -63.53 99.29 0.2 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.51 -0.744 . . . . 0.0 110.898 -179.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -66.46 -45.54 79.38 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.42 -0.8 . . . . 0.0 110.254 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 33.4 t -162.57 148.23 12.5 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.491 -0.756 . . . . 0.0 110.301 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' PHE . . . . . 0.49 ' CD2' ' HB2' ' B' ' 126' ' ' PHE . 49.8 p90 -149.16 156.02 41.54 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 177.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.567 HG22 ' CB ' ' B' ' 46' ' ' ASN . 53.8 t -133.3 138.14 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.372 -1.455 . . . . 0.0 112.373 -177.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 93.6 mt -112.57 133.29 54.7 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' ASN . . . . . 0.455 ' OD1' ' CE1' ' B' ' 44' ' ' HIS . 80.8 m-20 -125.89 136.0 52.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.967 -1.083 . . . . 0.0 110.995 -178.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.537 HD11 ' HB3' ' B' ' 43' ' ' LEU . 0.7 OUTLIER -145.28 111.19 5.5 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.16 -0.962 . . . . 0.0 111.071 179.397 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . 0.461 ' O ' ' N ' ' B' ' 119' ' ' TYR . . . -159.16 -131.18 1.22 Allowed Glycine 0 N--CA 1.495 2.609 0 N-CA-C 108.526 -1.83 . . . . 0.0 108.526 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . 0.708 ' HD2' HD13 ' B' ' 114' ' ' LEU . 42.3 mtpt -112.93 -46.32 3.12 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -123.42 164.42 18.91 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.878 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.34 -32.37 68.47 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.242 -0.911 . . . . 0.0 111.035 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' ASN . . . . . 0.446 ' HB3' ' N ' ' B' ' 66' ' ' GLY . 86.9 m-20 -94.82 -8.98 35.84 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.045 -1.034 . . . . 0.0 111.085 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' ASN . . . . . 0.443 ' ND2' ' N ' ' B' ' 40' ' ' ASN . 3.0 m-80 -113.85 66.19 0.66 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.145 -0.972 . . . . 0.0 110.061 -178.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.416 ' HA ' ' HA3' ' B' ' 35' ' ' GLY . 45.4 mt -95.51 135.53 37.04 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' CYS . . . . . . . . . . . . . 1.7 m -88.81 -29.84 19.43 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.956 -1.09 . . . . 0.0 109.274 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.881 HD13 ' CD2' ' B' ' 96' ' ' LEU . 25.9 tp -128.94 128.99 44.88 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.539 -0.726 . . . . 0.0 109.874 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' HIS . . . . . 0.455 ' CE1' ' OD1' ' B' ' 33' ' ' ASN . 63.0 t60 -128.2 127.51 43.03 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.205 -0.935 . . . . 0.0 110.403 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.516 ' CE1' HG21 ' B' ' 58' ' ' ILE . 83.3 t80 -123.35 122.71 39.0 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.173 -0.954 . . . . 0.0 110.161 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . 0.567 ' CB ' HG22 ' B' ' 31' ' ' VAL . 1.4 t-20 -142.47 84.41 11.21 Favored Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 121.157 -0.964 . . . . 0.0 110.958 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' PRO . . . . . 0.508 ' HD3' ' CD2' ' B' ' 45' ' ' PHE . 52.9 Cg_endo -70.76 142.9 44.6 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 123.621 1.327 . . . . 0.0 109.421 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -127.15 97.5 4.96 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.023 -1.048 . . . . 0.0 110.347 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -60.84 -45.18 95.49 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.313 -0.867 . . . . 0.0 109.176 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -159.94 103.54 1.5 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.385 -0.822 . . . . 0.0 109.395 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -114.15 -103.92 0.41 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.052 -1.03 . . . . 0.0 110.73 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -66.08 -41.12 91.12 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.641 -1.287 . . . . 0.0 109.892 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 168.14 39.56 0.02 OUTLIER Glycine 0 N--CA 1.485 1.921 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -113.99 -179.44 3.63 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.485 -1.009 . . . . 0.0 109.134 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.46 ' O ' ' C ' ' B' ' 56' ' ' ASN . . . -140.68 150.3 43.32 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.162 -0.961 . . . . 0.0 110.256 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' ASN . . . . . 0.46 ' C ' ' O ' ' B' ' 55' ' ' ALA . 80.3 m-20 17.09 54.62 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . 0.4 ' N ' ' O ' ' B' ' 55' ' ' ALA . 54.0 m -120.12 130.09 54.47 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.131 -0.981 . . . . 0.0 109.237 178.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' ILE . . . . . 0.59 HD12 ' H ' ' B' ' 76' ' ' VAL . 85.3 mt -115.78 135.23 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.166 -0.959 . . . . 0.0 110.948 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 69.3 t -101.69 126.33 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.433 -0.792 . . . . 0.0 110.36 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 79.0 m -117.26 120.94 39.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.261 -0.899 . . . . 0.0 109.297 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' ASN . . . . . 0.46 ' HB3' ' HA ' ' B' ' 71' ' ' GLU . 2.4 p-10 -151.32 179.03 8.67 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.057 -1.027 . . . . 0.0 111.265 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' SER . . . . . 0.456 ' O ' ' CA ' ' B' ' 69' ' ' GLY . 15.8 m -133.94 153.83 51.5 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.361 -0.837 . . . . 0.0 109.892 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . 0.498 ' CD ' ' HA2' ' B' ' 66' ' ' GLY . 17.8 ttmt -128.4 143.5 51.01 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.453 -1.404 . . . . 0.0 111.228 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' ASP . . . . . 0.668 ' HB2' HD21 ' B' ' 112' ' ' LEU . 58.5 t0 -122.42 94.95 4.45 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.527 -0.733 . . . . 0.0 109.351 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 71.81 19.87 78.38 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . 0.498 ' HA2' ' CD ' ' B' ' 63' ' ' LYS . . . 72.08 32.33 63.27 Favored Glycine 0 N--CA 1.488 2.118 0 O-C-N 120.833 -1.393 . . . . 0.0 110.598 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -101.07 -74.95 0.6 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.737 -1.449 . . . . 0.0 111.174 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' TRP . . . . . . . . . . . . . 13.6 m0 -123.99 -147.76 0.38 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.136 -0.978 . . . . 0.0 110.454 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . 0.456 ' CA ' ' O ' ' B' ' 62' ' ' SER . . . 158.61 145.4 4.23 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' THR . . . . . 0.623 HG23 ' O ' ' B' ' 70' ' ' THR . 6.9 t -81.88 80.08 8.26 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.153 -1.204 . . . . 0.0 109.759 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.46 ' HA ' ' HB3' ' B' ' 61' ' ' ASN . 79.4 tt0 -70.58 111.84 6.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.914 . . . . 0.0 110.858 -179.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -123.06 -165.07 1.26 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.36 -0.837 . . . . 0.0 109.52 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -137.7 130.18 29.56 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.348 -0.941 . . . . 0.0 110.588 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -131.03 83.45 2.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.266 -0.896 . . . . 0.0 109.747 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.66 88.03 0.09 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.124 -0.985 . . . . 0.0 110.74 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' VAL . . . . . 0.59 ' H ' HD12 ' B' ' 58' ' ' ILE . 5.9 p -134.55 141.45 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.518 -0.739 . . . . 0.0 109.864 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -157.24 89.53 2.51 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 120.733 -1.23 . . . . 0.0 110.833 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . 0.404 ' CB ' ' OD2' ' B' ' 102' ' ' ASP . 53.3 Cg_endo -77.65 -6.23 16.0 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 O-C-N 123.884 1.465 . . . . 0.0 112.165 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -142.55 -167.08 2.42 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.858 -1.151 . . . . 0.0 111.401 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.423 ' CB ' ' HD2' ' B' ' 81' ' ' PRO . 0.0 OUTLIER -139.66 172.39 6.49 Favored Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.382 -0.823 . . . . 0.0 109.758 179.77 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' PRO . . . . . 0.423 ' HD2' ' CB ' ' B' ' 80' ' ' GLN . 43.8 Cg_endo -67.09 147.27 79.21 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.789 1.415 . . . . 0.0 111.223 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . 0.427 ' N ' ' HA ' ' B' ' 25' ' ' PRO . . . 78.82 23.65 63.82 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 9.5 t -137.1 147.15 45.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.211 -1.17 . . . . 0.0 111.212 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.53 HG13 ' O ' ' B' ' 21' ' ' GLY . 72.3 t -79.07 130.0 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.619 -0.676 . . . . 0.0 109.979 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -130.53 142.16 50.48 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.108 -0.995 . . . . 0.0 109.736 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' GLU . . . . . 0.402 ' O ' ' HG3' ' B' ' 86' ' ' GLU . 0.2 OUTLIER -120.15 127.14 52.21 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.512 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 76.8 t -121.63 131.93 71.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 119.142 -1.023 . . . . 0.0 111.063 -177.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 88' ' ' CYS . . . . . . . . . . . . . 12.7 t -96.85 117.87 32.05 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.485 -0.759 . . . . 0.0 109.525 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 70.7 mt -111.6 124.89 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.149 -0.969 . . . . 0.0 109.533 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 56.6 m -122.16 129.23 52.12 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.276 -0.89 . . . . 0.0 109.665 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 91' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -106.62 117.98 35.47 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.209 -0.932 . . . . 0.0 110.891 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -115.27 151.76 33.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.686 -0.634 . . . . 0.0 109.465 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 69.6 tp60 -62.67 -38.84 91.93 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.933 -1.104 . . . . 0.0 110.488 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.29 -39.15 89.17 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.967 -1.083 . . . . 0.0 110.589 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -166.91 178.72 5.65 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.265 -0.897 . . . . 0.0 109.917 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 96' ' ' LEU . . . . . 0.881 ' CD2' HD13 ' B' ' 43' ' ' LEU . 46.7 tp -102.08 129.69 48.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.389 -0.82 . . . . 0.0 109.284 179.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 98.8 m -115.23 122.77 47.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.725 -1.234 . . . . 0.0 111.162 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 7.0 m -121.06 129.55 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.408 -0.807 . . . . 0.0 109.312 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -113.46 125.2 53.96 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.757 -1.214 . . . . 0.0 109.342 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 7.9 mp -85.52 165.0 37.97 Favored Pre-proline 0 C--N 1.302 -1.495 0 O-C-N 121.195 -0.94 . . . . 0.0 109.598 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -66.6 -32.81 37.88 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.991 1.521 . . . . 0.0 110.37 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' ASP . . . . . 0.404 ' OD2' ' CB ' ' B' ' 78' ' ' PRO . 99.6 m-20 -74.54 -25.21 59.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.999 -1.063 . . . . 0.0 110.156 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 121.22 2.77 10.86 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.53 -1.319 . . . . 0.0 111.057 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 104' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -83.67 136.01 34.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.581 -1.541 . . . . 0.0 110.123 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -132.58 148.72 52.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.452 -0.78 . . . . 0.0 110.949 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -141.08 156.51 45.98 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -124.1 141.1 52.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.007 -1.058 . . . . 0.0 110.93 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 108' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -123.58 143.76 42.48 Favored Pre-proline 0 N--CA 1.493 1.699 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -71.23 144.17 45.71 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 N-CA-C 109.14 -1.138 . . . . 0.0 109.14 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 110' ' ' ASN . . . . . 0.486 ' ND2' ' O ' ' B' ' 110' ' ' ASN . 6.1 p-10 -94.92 83.19 3.93 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.933 -1.104 . . . . 0.0 110.572 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . 0.43 ' NH2' ' OG1' ' B' ' 70' ' ' THR . 98.1 mtt180 -56.11 -22.23 26.95 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.704 -1.248 . . . . 0.0 109.08 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . 0.668 HD21 ' HB2' ' B' ' 64' ' ' ASP . 56.5 mt -97.05 141.61 29.99 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -96.71 61.96 1.92 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.706 -1.246 . . . . 0.0 110.018 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 114' ' ' LEU . . . . . 0.708 HD13 ' HD2' ' B' ' 36' ' ' LYS . 64.3 tp -81.89 129.53 34.79 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.332 -0.855 . . . . 0.0 111.078 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 115' ' ' GLU . . . . . 0.438 ' O ' ' HD3' ' B' ' 13' ' ' PRO . 0.0 OUTLIER -88.5 -17.4 30.38 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.407 -0.808 . . . . 0.0 109.746 179.504 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 116' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' B' ' 11' ' ' LEU . . . -163.05 144.29 9.72 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.76 -1.213 . . . . 0.0 111.765 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 117' ' ' ILE . . . . . 0.428 HD13 HD12 ' B' ' 34' ' ' LEU . 91.7 mt -98.92 124.5 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.37 -0.831 . . . . 0.0 108.908 178.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 118' ' ' ASN . . . . . 0.458 ' ND2' ' N ' ' B' ' 118' ' ' ASN . 0.1 OUTLIER -125.82 13.21 7.95 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.647 -0.658 . . . . 0.0 110.827 -179.319 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 119' ' ' TYR . . . . . 0.467 ' O ' ' HA ' ' B' ' 34' ' ' LEU . 8.0 t80 -131.81 128.73 39.36 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.086 -1.009 . . . . 0.0 110.112 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 62.6 ttp -142.74 130.74 21.8 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.44 -0.788 . . . . 0.0 109.797 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -140.83 144.71 35.52 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.249 -0.907 . . . . 0.0 109.757 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -132.23 108.97 9.59 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.353 -0.842 . . . . 0.0 109.538 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -137.97 128.62 26.68 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.372 -0.83 . . . . 0.0 109.61 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 124' ' ' GLY . . . . . 0.464 ' HA3' ' HA ' ' B' ' 30' ' ' PHE . . . 154.79 -157.74 27.8 Favored Glycine 0 N--CA 1.483 1.794 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . 0.465 ' HB3' ' HA ' ' B' ' 27' ' ' ALA . 87.5 m-20 -78.55 0.02 27.84 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.405 -1.056 . . . . 0.0 110.495 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 126' ' ' PHE . . . . . 0.579 ' HD1' HG22 ' B' ' 23' ' ' VAL . 42.6 t80 -95.79 142.13 28.43 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.984 -1.073 . . . . 0.0 109.73 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -112.8 139.83 48.1 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 118.896 -1.121 . . . . 0.0 110.502 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . 0.52 ' O ' HG23 ' B' ' 128' ' ' ILE . 20.6 tt -108.12 123.08 63.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.61 -0.681 . . . . 0.0 109.685 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -106.03 -23.33 12.66 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.403 -0.811 . . . . 0.0 111.028 -179.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 130' ' ' CYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 131' ' ' VAL . 0.1 OUTLIER -153.05 155.32 36.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.95 -1.094 . . . . 0.0 112.177 -179.071 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 130' ' ' CYS . 44.3 t -123.93 136.02 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 132' ' ' ALA . . . . . 0.711 ' O ' HD12 ' B' ' 17' ' ' LEU . . . -124.53 146.21 49.12 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.518 -1.363 . . . . 0.0 110.666 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . 0.613 ' CZ ' HD21 ' B' ' 11' ' ' LEU . 0.4 OUTLIER -94.08 -139.87 0.22 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.286 -0.884 . . . . 0.0 109.739 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 49.5 t0 . . . . . 0 N--CA 1.493 1.717 0 O-C-N 120.668 -1.27 . . . . 0.0 110.462 -179.6 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.196 0.522 . . . . 0.0 109.968 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.533 ' HA ' ' HB2' ' A' ' 123' ' ' ASP . 1.3 m -90.09 56.23 3.36 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.228 -0.92 . . . . 0.0 110.56 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 2' ' ' CYS . . . 32.87 -149.09 0.01 OUTLIER Glycine 0 N--CA 1.503 3.156 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 179.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.833 HD22 HD23 ' B' ' 9' ' ' LEU . 48.5 mt -97.9 128.2 44.34 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.946 -1.326 . . . . 0.0 109.265 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.9 t -96.37 135.36 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.106 -0.996 . . . . 0.0 109.741 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.938 ' HB1' HD11 ' A' ' 9' ' ' LEU . . . -124.36 145.03 49.69 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.241 -0.912 . . . . 0.0 111.083 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.414 ' O ' ' HB3' ' A' ' 8' ' ' ASN . 32.9 p -145.74 170.19 17.0 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' B' ' 3' ' ' GLY . 40.0 t-20 59.49 32.21 21.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.338 -0.851 . . . . 0.0 109.189 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.938 HD11 ' HB1' ' A' ' 6' ' ' ALA . 96.3 mt -90.7 2.73 55.7 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.65 -0.656 . . . . 0.0 111.834 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.506 ' C ' ' O ' ' A' ' 9' ' ' LEU . 36.3 t-20 -1.08 76.81 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.564 0 N-CA-C 113.723 1.008 . . . . 0.0 113.723 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.601 HD12 ' HE2' ' A' ' 133' ' ' PHE . 5.7 tt -92.37 130.89 37.93 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.062 -1.024 . . . . 0.0 109.376 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -100.43 165.79 13.78 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.266 -0.896 . . . . 0.0 111.189 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.472 ' HA ' ' O ' ' A' ' 91' ' ' PHE . 52.0 Cg_endo -69.24 147.28 65.87 Favored 'Trans proline' 0 C--N 1.301 -1.94 0 O-C-N 124.165 1.613 . . . . 0.0 110.764 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.33 1.17 59.36 Favored Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.969 -1.11 . . . . 0.0 110.529 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -115.5 147.95 40.05 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.744 -1.445 . . . . 0.0 110.291 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.2 m -97.39 146.83 24.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.066 -1.021 . . . . 0.0 110.647 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.419 ' HB3' ' O ' ' A' ' 89' ' ' ILE . 52.7 tp -133.38 133.83 42.93 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.534 -0.729 . . . . 0.0 109.989 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 78.1 mtt85 -123.03 152.1 41.29 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.202 -0.936 . . . . 0.0 110.387 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 t -141.18 102.06 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 C-N-CA 119.939 -0.705 . . . . 0.0 110.671 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 -99.48 130.3 45.73 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.205 -0.935 . . . . 0.0 110.296 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -144.12 -171.78 14.39 Favored Glycine 0 N--CA 1.496 2.645 0 C-N-CA 119.82 -1.181 . . . . 0.0 110.504 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' A' ' 127' ' ' LYS . 87.1 tt0 -123.85 153.71 40.68 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.468 -1.019 . . . . 0.0 109.317 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.485 HG22 ' HD1' ' A' ' 126' ' ' PHE . 68.9 t -118.58 133.34 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.038 -1.039 . . . . 0.0 111.554 -178.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.464 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . . . -58.99 150.33 61.64 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 120.939 -1.101 . . . . 0.0 109.472 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.43 -18.47 54.87 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.777 1.409 . . . . 0.0 111.309 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -125.01 28.86 6.29 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.977 -1.077 . . . . 0.0 108.811 178.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.504 ' CB ' ' HB3' ' A' ' 125' ' ' ASP . . . -62.67 105.64 0.68 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.287 0.565 . . . . 0.0 111.903 -178.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -64.49 -48.13 76.36 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.519 -0.738 . . . . 0.0 109.922 178.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 86.8 p -166.68 159.84 14.38 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.91 0.862 . . . . 0.0 111.535 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.545 ' CZ ' ' HG2' ' A' ' 47' ' ' PRO . 48.1 p90 -151.22 162.55 40.68 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 45' ' ' PHE . 2.2 p -139.81 138.02 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.444 -1.41 . . . . 0.0 112.688 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.477 ' CD2' ' HB1' ' A' ' 122' ' ' ALA . 90.3 mt -122.95 143.76 49.69 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.667 ' HB2' HD12 ' A' ' 41' ' ' LEU . 26.6 p30 -151.29 162.96 39.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.785 -1.197 . . . . 0.0 110.757 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.672 ' O ' HD12 ' A' ' 34' ' ' LEU . 3.8 pp -154.67 129.6 9.45 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.267 -0.895 . . . . 0.0 110.413 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' A' ' 41' ' ' LEU . . . -166.15 -153.65 7.84 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.432 ' HE2' ' HB3' ' A' ' 40' ' ' ASN . 60.2 pttt -103.36 -30.42 10.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.061 -1.259 . . . . 0.0 110.146 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.481 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 21.9 t70 -143.84 167.8 21.45 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.232 -0.917 . . . . 0.0 110.466 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.536 ' O ' HD23 ' A' ' 41' ' ' LEU . 5.5 t -51.27 -46.93 62.58 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.485 -0.759 . . . . 0.0 112.769 -177.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.441 ' HB3' ' N ' ' A' ' 66' ' ' GLY . 27.9 m-20 -91.12 -2.45 57.58 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.485 -1.384 . . . . 0.0 110.427 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.432 ' HB3' ' HE2' ' A' ' 36' ' ' LYS . 5.5 m-80 -110.41 56.16 0.63 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.111 -0.993 . . . . 0.0 110.51 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.667 HD12 ' HB2' ' A' ' 33' ' ' ASN . 3.6 mm? -86.15 138.62 31.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.316 -0.865 . . . . 0.0 110.085 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.9 m -87.2 -28.14 22.58 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.3 -0.875 . . . . 0.0 110.244 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.5 tp -140.94 136.2 31.99 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 121.207 -0.933 . . . . 0.0 110.82 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.521 ' O ' ' HA ' ' A' ' 60' ' ' CYS . 19.9 m-70 -121.95 117.59 26.8 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.098 -1.001 . . . . 0.0 109.228 178.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.532 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 39.7 t80 -113.55 124.09 51.54 Favored 'General case' 0 C--N 1.293 -1.882 0 O-C-N 121.15 -0.969 . . . . 0.0 108.928 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -156.27 76.48 4.56 Favored Pre-proline 0 N--CA 1.497 1.925 0 O-C-N 120.843 -1.161 . . . . 0.0 111.005 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.61 ' HB3' HG12 ' A' ' 58' ' ' ILE . 56.2 Cg_endo -70.51 147.14 57.37 Favored 'Trans proline' 0 C--N 1.301 -1.96 0 O-C-N 124.256 1.661 . . . . 0.0 110.447 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -122.59 120.42 33.71 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.139 -0.976 . . . . 0.0 109.731 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -59.04 -49.28 78.49 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.843 -1.16 . . . . 0.0 108.011 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -145.8 95.73 2.69 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.26 -136.38 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.244 -0.91 . . . . 0.0 109.329 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 83.0 m-70 -62.04 -28.7 69.78 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 120.78 -1.2 . . . . 0.0 109.014 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 173.82 35.08 0.04 OUTLIER Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.668 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -113.42 -173.57 2.29 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.734 -1.45 . . . . 0.0 109.98 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.488 ' O ' ' C ' ' A' ' 56' ' ' ASN . . . -135.46 135.01 40.18 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.47 -0.769 . . . . 0.0 110.335 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.488 ' C ' ' O ' ' A' ' 55' ' ' ALA . 6.7 m120 18.55 65.79 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.288 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 20.1 m -102.36 115.11 29.88 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.186 -0.946 . . . . 0.0 108.847 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.61 HG12 ' HB3' ' A' ' 47' ' ' PRO . 52.4 mt -96.86 122.46 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.2 -0.937 . . . . 0.0 108.732 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.3 t -114.13 129.69 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.319 -0.863 . . . . 0.0 110.928 -177.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 44' ' ' HIS . 0.9 OUTLIER -107.11 126.39 52.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.378 -0.826 . . . . 0.0 109.899 179.237 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.443 ' O ' ' N ' ' A' ' 44' ' ' HIS . 2.6 t-20 -133.36 150.0 51.84 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.167 -0.958 . . . . 0.0 111.015 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.481 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 54.2 m -123.15 145.57 48.49 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.533 ' CD ' ' HA2' ' A' ' 66' ' ' GLY . 21.5 ttmt -135.45 144.36 46.41 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.688 -1.258 . . . . 0.0 111.22 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -120.84 97.75 5.69 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 69.3 20.15 74.89 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.533 ' HA2' ' CD ' ' A' ' 63' ' ' LYS . . . 79.06 23.78 62.96 Favored Glycine 0 N--CA 1.485 1.962 0 O-C-N 120.763 -1.434 . . . . 0.0 110.403 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.3 -80.31 0.2 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.92 -1.341 . . . . 0.0 111.979 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 2.4 m-90 -130.63 -145.11 0.27 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.173 -0.954 . . . . 0.0 110.67 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.481 ' HA2' ' O ' ' A' ' 62' ' ' SER . . . 164.35 143.61 3.77 Favored Glycine 0 N--CA 1.483 1.781 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 99.8 m -92.66 116.79 29.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.593 -0.946 . . . . 0.0 110.271 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -98.44 120.98 39.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.956 -1.09 . . . . 0.0 109.713 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.412 ' O ' ' CB ' ' A' ' 73' ' ' ARG . 1.0 OUTLIER -165.01 133.54 3.34 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.055 -1.028 . . . . 0.0 110.622 -179.716 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.412 ' CB ' ' O ' ' A' ' 72' ' ' GLN . 2.5 mtt-85 172.55 168.73 0.12 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.249 -0.907 . . . . 0.0 111.333 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -110.92 -179.92 3.87 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.367 -0.833 . . . . 0.0 109.975 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -101.61 100.81 11.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.169 -0.957 . . . . 0.0 109.618 178.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.472 HG22 ' HD3' ' A' ' 78' ' ' PRO . 2.6 p -125.06 134.1 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.097 -1.002 . . . . 0.0 110.121 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.499 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 12.5 p90 -140.52 87.07 11.9 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.029 -1.044 . . . . 0.0 111.951 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.472 ' HD3' HG22 ' A' ' 76' ' ' VAL . 51.5 Cg_endo -85.03 7.94 4.9 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 124.192 1.627 . . . . 0.0 110.498 178.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -144.48 178.01 8.25 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.268 -0.895 . . . . 0.0 110.291 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.442 ' CG ' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -143.08 172.44 5.68 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.438 -0.789 . . . . 0.0 109.794 179.427 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.442 ' HD2' ' CG ' ' A' ' 80' ' ' GLN . 44.8 Cg_endo -66.64 152.49 80.57 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.907 1.478 . . . . 0.0 110.684 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.6 22.67 78.18 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.239 -1.545 . . . . 0.0 109.239 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.8 m -138.0 149.46 46.1 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.199 -1.177 . . . . 0.0 111.087 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.7 m -76.46 138.91 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.603 -0.685 . . . . 0.0 110.466 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -146.0 144.22 29.96 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.083 -1.011 . . . . 0.0 110.473 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -123.96 146.42 48.5 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.207 -0.933 . . . . 0.0 110.414 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 53.7 t -130.42 131.2 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.332 -0.855 . . . . 0.0 110.27 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . 0.419 ' HB3' ' HB3' ' A' ' 99' ' ' LYS . 4.9 t -93.69 126.38 38.83 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.186 -0.946 . . . . 0.0 110.454 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.419 ' O ' ' HB3' ' A' ' 17' ' ' LEU . 97.4 mt -120.34 127.04 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.265 -0.897 . . . . 0.0 109.976 179.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 27.6 m -127.72 134.15 49.55 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.0 -1.063 . . . . 0.0 108.945 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.472 ' O ' ' HA ' ' A' ' 13' ' ' PRO . 69.0 t80 -114.49 116.98 29.71 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.718 -1.239 . . . . 0.0 111.204 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -113.0 146.19 39.52 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 65.3 tp60 -56.1 -37.74 69.79 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.983 -1.073 . . . . 0.0 110.576 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.83 -43.38 68.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.013 -1.054 . . . . 0.0 111.291 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -155.18 179.22 9.36 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.993 -1.067 . . . . 0.0 110.852 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.5 ' HB3' ' HB2' ' A' ' 108' ' ' PHE . 53.4 tp -110.82 124.91 52.95 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.392 -0.817 . . . . 0.0 108.958 178.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.659 HG23 ' OE2' ' A' ' 105' ' ' GLU . 3.3 m -107.3 127.66 53.75 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.164 -0.96 . . . . 0.0 110.966 -179.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.406 ' O ' ' HG3' ' A' ' 105' ' ' GLU . 50.6 t -131.4 130.98 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.219 -0.926 . . . . 0.0 109.712 179.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.419 ' HB3' ' HB3' ' A' ' 88' ' ' CYS . 86.0 tttt -116.69 126.68 53.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.929 -1.107 . . . . 0.0 110.76 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.423 HD12 ' O ' ' A' ' 104' ' ' TYR . 4.0 mt -76.17 160.64 77.64 Favored Pre-proline 0 C--N 1.303 -1.453 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -66.67 -24.19 48.14 Favored 'Trans proline' 0 C--N 1.302 -1.912 0 O-C-N 123.657 1.346 . . . . 0.0 110.289 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -155.99 73.67 0.83 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.354 -0.841 . . . . 0.0 110.134 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -178.91 -166.83 35.56 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.427 -1.368 . . . . 0.0 110.635 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.423 ' O ' HD12 ' A' ' 100' ' ' LEU . 72.3 m-85 -77.17 -165.5 0.58 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.489 -1.007 . . . . 0.0 110.671 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.659 ' OE2' HG23 ' A' ' 97' ' ' THR . 69.3 tt0 -129.07 159.41 36.05 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.313 -0.867 . . . . 0.0 110.821 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -132.25 153.13 50.94 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.256 -0.903 . . . . 0.0 110.921 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 98.2 mttt -129.05 146.51 51.0 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.778 0.799 . . . . 0.0 111.57 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.5 ' HB2' ' HB3' ' A' ' 96' ' ' LEU . 0.4 OUTLIER -118.19 140.42 27.99 Favored Pre-proline 0 C--N 1.302 -1.462 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.579 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -71.4 161.96 43.88 Favored 'Trans proline' 0 C--N 1.302 -1.886 0 O-C-N 123.645 1.34 . . . . 0.0 110.615 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -71.81 59.04 0.33 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.488 -0.758 . . . . 0.0 111.404 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 15.6 tpt85 -62.99 -39.8 95.85 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.056 -1.027 . . . . 0.0 109.022 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.403 HD11 ' HB3' ' A' ' 62' ' ' SER . 82.8 mt -105.9 124.26 49.28 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.681 -0.637 . . . . 0.0 109.533 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -86.71 69.71 10.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.916 -1.115 . . . . 0.0 109.803 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 35.5 tp -95.04 129.73 42.01 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.62 -0.675 . . . . 0.0 110.063 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -92.23 -13.11 30.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.234 -0.916 . . . . 0.0 110.553 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.517 ' HA ' ' O ' ' A' ' 11' ' ' LEU . . . -162.91 153.11 16.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.015 -1.053 . . . . 0.0 110.786 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.653 HD13 HD13 ' A' ' 34' ' ' LEU . 87.0 mt -109.48 128.1 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.997 -1.064 . . . . 0.0 110.663 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -120.52 -21.92 6.61 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.188 -0.945 . . . . 0.0 111.041 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.432 ' HB2' ' O ' ' A' ' 36' ' ' LYS . 83.2 t80 -105.82 125.45 51.0 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.166 -0.959 . . . . 0.0 111.283 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 62.0 ttp -143.13 133.02 24.05 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.305 -0.872 . . . . 0.0 108.759 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -144.12 142.67 30.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.624 -1.297 . . . . 0.0 110.71 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.477 ' HB1' ' CD2' ' A' ' 32' ' ' LEU . . . -140.12 111.26 7.04 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.526 -0.734 . . . . 0.0 109.797 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.533 ' HB2' ' HA ' ' A' ' 2' ' ' CYS . 26.5 p-10 -147.0 143.65 28.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.249 -0.907 . . . . 0.0 110.093 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.413 ' HA3' ' HA ' ' A' ' 30' ' ' PHE . . . 152.04 -157.08 27.05 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.504 ' HB3' ' CB ' ' A' ' 27' ' ' ALA . 87.1 m-20 -76.31 -1.16 25.29 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.283 -1.128 . . . . 0.0 110.141 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.485 ' HD1' HG22 ' A' ' 23' ' ' VAL . 28.2 t80 -99.8 133.71 43.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.962 -1.086 . . . . 0.0 109.528 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' A' ' 22' ' ' GLU . 75.7 mmtt -106.18 136.27 46.18 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.956 -1.09 . . . . 0.0 111.322 -178.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.482 HG23 ' O ' ' A' ' 128' ' ' ILE . 15.0 tt -101.04 125.2 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.266 -0.896 . . . . 0.0 110.836 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -103.35 -18.58 14.79 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.268 -0.895 . . . . 0.0 111.655 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -159.31 149.88 19.44 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.402 -1.436 . . . . 0.0 113.258 -179.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 46.2 t -125.81 133.21 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 177.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -146.05 149.71 34.59 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.403 -1.436 . . . . 0.0 111.342 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.601 ' HE2' HD12 ' A' ' 11' ' ' LEU . 59.7 m-85 -105.3 128.07 53.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.624 -0.673 . . . . 0.0 110.453 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 23.1 t0 . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.521 179.342 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.226 0.536 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' CYS . . . . . 0.547 ' HA ' ' HB2' ' B' ' 123' ' ' ASP . 1.3 m -90.05 56.9 3.59 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.224 -0.923 . . . . 0.0 110.653 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . 0.532 ' O ' ' ND2' ' A' ' 8' ' ' ASN . . . 32.43 -148.43 0.01 OUTLIER Glycine 0 N--CA 1.505 3.268 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.929 HD22 HD23 ' A' ' 9' ' ' LEU . 49.2 mt -98.53 128.75 44.98 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.652 -1.499 . . . . 0.0 109.053 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 62.9 t -96.63 135.6 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.049 -1.032 . . . . 0.0 109.651 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.942 ' HB1' HD11 ' B' ' 9' ' ' LEU . . . -124.7 145.2 49.81 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.184 -0.948 . . . . 0.0 111.023 -178.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . 0.444 ' O ' ' HB3' ' B' ' 8' ' ' ASN . 33.2 p -145.9 170.38 16.71 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . 0.444 ' HB3' ' O ' ' B' ' 7' ' ' SER . 41.3 t-20 59.36 32.12 21.61 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.186 -0.946 . . . . 0.0 109.276 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.942 HD11 ' HB1' ' B' ' 6' ' ' ALA . 96.6 mt -91.47 5.28 50.05 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.656 -0.653 . . . . 0.0 111.598 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . 0.521 ' C ' ' O ' ' B' ' 9' ' ' LEU . 37.3 t-20 -4.47 78.66 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.531 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.594 HD12 ' HE2' ' B' ' 133' ' ' PHE . 5.8 tt -92.95 131.18 38.19 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.223 -0.923 . . . . 0.0 109.258 179.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -100.76 165.51 14.17 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.249 -0.907 . . . . 0.0 111.182 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . 0.475 ' HA ' ' O ' ' B' ' 91' ' ' PHE . 52.3 Cg_endo -68.96 147.31 67.71 Favored 'Trans proline' 0 C--N 1.301 -1.967 0 O-C-N 124.069 1.563 . . . . 0.0 110.736 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.37 0.89 59.4 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.979 -1.105 . . . . 0.0 110.729 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -115.33 147.86 39.96 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.852 -1.381 . . . . 0.0 110.277 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' CYS . . . . . . . . . . . . . 1.2 m -97.29 146.69 24.89 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.175 -0.953 . . . . 0.0 110.806 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.418 ' HB3' ' O ' ' B' ' 89' ' ' ILE . 53.3 tp -133.15 133.8 43.33 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.592 -0.693 . . . . 0.0 110.146 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 78.0 mtt85 -122.88 151.95 41.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.238 -0.913 . . . . 0.0 110.439 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 t -141.22 102.31 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.54 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -99.82 130.52 46.03 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.319 -0.863 . . . . 0.0 109.969 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -144.26 -171.75 14.46 Favored Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.884 -1.151 . . . . 0.0 110.495 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -124.08 153.74 40.97 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.492 -1.005 . . . . 0.0 109.336 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.484 HG22 ' HD1' ' B' ' 126' ' ' PHE . 69.9 t -118.59 133.34 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.908 -1.12 . . . . 0.0 111.422 -178.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.479 ' HB3' ' HB2' ' B' ' 27' ' ' ALA . . . -58.98 150.51 60.64 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.025 -1.047 . . . . 0.0 109.517 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.83 -18.22 52.6 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.817 1.43 . . . . 0.0 111.374 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -125.17 29.29 6.13 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.0 -1.062 . . . . 0.0 108.671 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . 0.5 ' CB ' ' HB3' ' B' ' 125' ' ' ASP . . . -63.14 105.27 0.68 Allowed 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.353 0.597 . . . . 0.0 111.965 -178.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -64.08 -49.86 70.62 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.358 -0.838 . . . . 0.0 109.846 178.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 87.4 p -163.93 160.25 21.8 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.305 -0.872 . . . . 0.0 111.661 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' PHE . . . . . 0.542 ' CZ ' ' HG2' ' B' ' 47' ' ' PRO . 47.9 p90 -151.64 161.75 42.15 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' B' ' 45' ' ' PHE . 2.2 p -139.06 138.69 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.375 -1.453 . . . . 0.0 112.787 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.474 ' CD2' ' HB1' ' B' ' 122' ' ' ALA . 89.4 mt -123.86 143.44 50.35 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.467 -0.771 . . . . 0.0 108.925 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' ASN . . . . . 0.669 ' HB2' HD12 ' B' ' 41' ' ' LEU . 26.6 p30 -151.14 163.14 39.5 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.83 -1.168 . . . . 0.0 110.709 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.707 HD12 ' O ' ' B' ' 34' ' ' LEU . 3.8 pp -154.78 126.32 7.44 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.205 -0.934 . . . . 0.0 110.767 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . 0.47 ' HA3' ' HA ' ' B' ' 41' ' ' LEU . . . -160.98 -152.43 6.6 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . 0.426 ' HE2' ' HB3' ' B' ' 40' ' ' ASN . 60.4 pttt -104.08 -30.58 10.15 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.389 -1.065 . . . . 0.0 109.702 178.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . 0.477 ' O ' ' CD2' ' B' ' 41' ' ' LEU . 22.4 t70 -143.98 167.68 21.79 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.248 -0.907 . . . . 0.0 110.52 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . 0.509 ' O ' HD23 ' B' ' 41' ' ' LEU . 5.7 t -51.37 -46.34 62.72 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.389 -0.819 . . . . 0.0 112.808 -177.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' ASN . . . . . 0.454 ' HB3' ' N ' ' B' ' 66' ' ' GLY . 28.0 m-20 -91.79 -2.66 56.82 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.503 -1.373 . . . . 0.0 110.209 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' ASN . . . . . 0.426 ' HB3' ' HE2' ' B' ' 36' ' ' LYS . 5.7 m-80 -110.15 56.06 0.63 Allowed 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.241 -0.912 . . . . 0.0 110.41 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.669 HD12 ' HB2' ' B' ' 33' ' ' ASN . 3.6 mm? -85.76 139.84 30.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.304 -0.873 . . . . 0.0 110.105 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' CYS . . . . . . . . . . . . . 1.7 m -89.63 -27.01 20.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 109.895 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 14.4 tp -141.44 135.82 30.69 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 121.188 -0.945 . . . . 0.0 110.812 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' HIS . . . . . 0.512 ' O ' ' HA ' ' B' ' 60' ' ' CYS . 20.4 m-70 -121.66 117.49 26.8 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.13 -0.981 . . . . 0.0 109.284 178.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.531 ' O ' ' HA ' ' B' ' 31' ' ' VAL . 39.6 t80 -113.66 122.62 47.73 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.07 -1.019 . . . . 0.0 109.086 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -154.41 76.83 5.52 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 120.955 -1.09 . . . . 0.0 111.104 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' PRO . . . . . 0.589 ' HB3' HG12 ' B' ' 58' ' ' ILE . 55.4 Cg_endo -70.69 147.1 56.13 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 124.119 1.589 . . . . 0.0 110.427 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -122.55 120.59 34.27 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.144 -0.972 . . . . 0.0 109.809 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -59.27 -48.61 80.97 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.92 -1.113 . . . . 0.0 108.199 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -146.69 95.48 2.6 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.46 -136.91 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.447 -0.783 . . . . 0.0 109.097 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -61.75 -26.87 68.33 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.668 -1.27 . . . . 0.0 109.272 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 171.14 35.77 0.03 OUTLIER Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.642 -1.266 . . . . 0.0 110.563 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -113.94 -173.65 2.32 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.836 -1.391 . . . . 0.0 109.79 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.505 ' O ' ' C ' ' B' ' 56' ' ' ASN . . . -134.75 138.51 44.4 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.427 -0.796 . . . . 0.0 109.827 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' ASN . . . . . 0.505 ' C ' ' O ' ' B' ' 55' ' ' ALA . 6.5 m120 13.29 68.09 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.233 0 CA-C-O 121.535 0.683 . . . . 0.0 112.834 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 19.6 m -102.99 114.88 29.54 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.443 -0.786 . . . . 0.0 108.928 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' ILE . . . . . 0.589 HG12 ' HB3' ' B' ' 47' ' ' PRO . 52.0 mt -96.84 122.52 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.111 -0.993 . . . . 0.0 108.729 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.42 HG13 ' HG3' ' B' ' 71' ' ' GLU . 56.0 t -113.82 130.0 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.383 -0.823 . . . . 0.0 111.105 -178.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' CYS . . . . . 0.512 ' HA ' ' O ' ' B' ' 44' ' ' HIS . 0.8 OUTLIER -107.77 125.16 51.07 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.295 -0.878 . . . . 0.0 109.939 179.262 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' ASN . . . . . 0.447 ' HB3' ' HB2' ' B' ' 44' ' ' HIS . 2.8 t-20 -132.06 149.86 52.3 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.189 -0.944 . . . . 0.0 111.109 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' SER . . . . . 0.478 ' O ' ' HA2' ' B' ' 69' ' ' GLY . 54.4 m -123.02 145.52 48.44 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.153 -0.967 . . . . 0.0 108.532 179.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . 0.528 ' CD ' ' HA2' ' B' ' 66' ' ' GLY . 21.4 ttmt -135.12 144.87 47.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.655 -1.278 . . . . 0.0 111.092 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -121.17 97.81 5.69 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 69.32 20.05 74.82 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . 0.528 ' HA2' ' CD ' ' B' ' 63' ' ' LYS . . . 79.38 23.56 62.72 Favored Glycine 0 N--CA 1.487 2.064 0 C-N-CA 119.278 -1.439 . . . . 0.0 110.337 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.27 -80.33 0.2 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.875 -1.368 . . . . 0.0 111.867 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' TRP . . . . . . . . . . . . . 2.4 m-90 -130.54 -144.97 0.27 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.22 -0.925 . . . . 0.0 110.711 -178.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' B' ' 62' ' ' SER . . . 164.05 143.26 3.65 Favored Glycine 0 N--CA 1.483 1.828 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 99.6 m -92.25 117.46 29.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.567 -0.96 . . . . 0.0 110.326 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.42 ' HG3' HG13 ' B' ' 59' ' ' VAL . 81.2 tt0 -98.97 120.91 40.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.013 -1.055 . . . . 0.0 109.646 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -165.04 133.53 3.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.997 -1.065 . . . . 0.0 110.551 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 2.5 mtt-85 172.73 169.11 0.12 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.34 -0.85 . . . . 0.0 111.246 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -111.06 180.0 3.89 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.38 -0.825 . . . . 0.0 109.942 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -101.44 100.6 11.08 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.078 -1.014 . . . . 0.0 109.683 178.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' VAL . . . . . 0.487 HG22 ' HD3' ' B' ' 78' ' ' PRO . 2.6 p -124.76 134.15 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.983 -1.073 . . . . 0.0 110.127 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' PHE . . . . . 0.506 ' N ' ' CD1' ' B' ' 77' ' ' PHE . 11.9 p90 -140.4 87.26 11.98 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 120.942 -1.099 . . . . 0.0 111.782 -179.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . 0.487 ' HD3' HG22 ' B' ' 76' ' ' VAL . 50.3 Cg_endo -85.15 7.56 5.08 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 124.136 1.598 . . . . 0.0 110.427 178.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -144.01 178.18 8.04 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.216 -0.927 . . . . 0.0 110.488 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.434 ' CG ' ' HD2' ' B' ' 81' ' ' PRO . 0.0 OUTLIER -143.09 172.38 5.75 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.351 -0.843 . . . . 0.0 109.792 179.597 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' PRO . . . . . 0.434 ' HD2' ' CG ' ' B' ' 80' ' ' GLN . 44.0 Cg_endo -66.59 152.85 79.87 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.771 1.406 . . . . 0.0 110.764 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.22 22.68 78.66 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 66.1 m -138.06 149.01 45.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.095 -1.238 . . . . 0.0 111.16 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 33.5 m -76.06 139.15 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.663 -0.648 . . . . 0.0 110.614 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -146.32 143.93 29.46 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.055 -1.028 . . . . 0.0 110.431 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -123.69 146.83 47.96 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.228 -0.92 . . . . 0.0 110.445 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 54.4 t -130.78 131.19 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.394 -0.816 . . . . 0.0 110.049 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 88' ' ' CYS . . . . . 0.405 ' HB3' ' HB3' ' B' ' 99' ' ' LYS . 4.5 t -93.79 126.64 39.09 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.168 -0.957 . . . . 0.0 110.404 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.418 ' O ' ' HB3' ' B' ' 17' ' ' LEU . 97.2 mt -120.55 127.11 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.137 -0.977 . . . . 0.0 110.019 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 27.5 m -127.85 134.15 49.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.081 -1.012 . . . . 0.0 109.001 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 91' ' ' PHE . . . . . 0.475 ' O ' ' HA ' ' B' ' 13' ' ' PRO . 70.6 t80 -114.49 116.47 28.9 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 118.813 -1.155 . . . . 0.0 111.491 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -112.92 146.28 39.26 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 65.0 tp60 -56.24 -37.74 70.13 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 120.896 -1.128 . . . . 0.0 110.546 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.48 -43.45 69.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.157 -0.965 . . . . 0.0 111.348 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -155.53 178.91 9.71 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.075 -1.016 . . . . 0.0 110.744 -178.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 96' ' ' LEU . . . . . 0.484 ' HB3' ' HB2' ' B' ' 108' ' ' PHE . 53.5 tp -110.26 124.76 52.21 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.313 -0.867 . . . . 0.0 109.159 178.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . 0.655 HG23 ' OE2' ' B' ' 105' ' ' GLU . 2.9 m -107.34 127.35 53.49 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.157 -0.964 . . . . 0.0 110.938 -178.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 98' ' ' VAL . . . . . 0.406 ' O ' ' HG3' ' B' ' 105' ' ' GLU . 50.1 t -131.26 130.79 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -0.909 . . . . 0.0 109.81 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 99' ' ' LYS . . . . . 0.405 ' HB3' ' HB3' ' B' ' 88' ' ' CYS . 85.8 tttt -116.58 126.15 52.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.874 -1.141 . . . . 0.0 111.093 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . 0.423 HD12 ' O ' ' B' ' 104' ' ' TYR . 4.0 mt -75.46 160.35 79.78 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.392 -0.818 . . . . 0.0 108.849 178.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -66.59 -24.35 48.55 Favored 'Trans proline' 0 C--N 1.302 -1.908 0 O-C-N 123.701 1.369 . . . . 0.0 110.217 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -155.81 75.39 0.9 Allowed 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.336 -0.852 . . . . 0.0 110.177 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 178.54 -167.12 37.41 Favored Glycine 0 N--CA 1.495 2.619 0 C-N-CA 119.407 -1.378 . . . . 0.0 110.548 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 104' ' ' TYR . . . . . 0.423 ' O ' HD12 ' B' ' 100' ' ' LEU . 73.7 m-85 -77.0 -165.4 0.55 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.476 -1.014 . . . . 0.0 110.958 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 105' ' ' GLU . . . . . 0.655 ' OE2' HG23 ' B' ' 97' ' ' THR . 69.4 tt0 -129.53 159.03 37.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.348 -0.845 . . . . 0.0 110.527 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -132.03 153.19 50.63 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.476 -0.765 . . . . 0.0 110.936 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 107' ' ' LYS . . . . . 0.428 ' HA ' ' O ' ' B' ' 96' ' ' LEU . 98.2 mttt -129.2 146.73 51.06 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.354 -0.841 . . . . 0.0 111.537 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 108' ' ' PHE . . . . . 0.484 ' HB2' ' HB3' ' B' ' 96' ' ' LEU . 0.4 OUTLIER -118.29 140.34 27.96 Favored Pre-proline 0 C--N 1.301 -1.537 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.669 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -71.51 162.19 43.05 Favored 'Trans proline' 0 C--N 1.301 -1.938 0 O-C-N 123.575 1.303 . . . . 0.0 110.574 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 110' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -72.0 59.29 0.37 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.559 -0.713 . . . . 0.0 111.266 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 15.3 tpt85 -63.34 -39.58 94.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.099 -1.0 . . . . 0.0 109.015 178.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . 0.401 HD11 ' HB3' ' B' ' 62' ' ' SER . 81.2 mt -105.91 124.34 49.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.69 -0.631 . . . . 0.0 109.551 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -86.77 69.88 10.34 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.918 -1.114 . . . . 0.0 109.743 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 36.5 tp -95.09 129.75 42.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.626 -0.671 . . . . 0.0 110.079 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -92.25 -12.92 31.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.18 -0.95 . . . . 0.0 110.7 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 116' ' ' ALA . . . . . 0.538 ' HA ' ' O ' ' B' ' 11' ' ' LEU . . . -162.97 153.44 16.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.016 -1.052 . . . . 0.0 110.626 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 117' ' ' ILE . . . . . 0.652 HD13 HD13 ' B' ' 34' ' ' LEU . 89.4 mt -109.92 128.08 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.072 -1.018 . . . . 0.0 110.707 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -120.36 -21.8 6.75 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.18 -0.95 . . . . 0.0 111.121 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 119' ' ' TYR . . . . . 0.418 ' HB2' ' O ' ' B' ' 36' ' ' LYS . 83.2 t80 -106.09 125.75 51.37 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.032 -1.042 . . . . 0.0 111.18 -179.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 120' ' ' MET . . . . . . . . . . . . . 61.5 ttp -143.41 133.04 23.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.352 -0.843 . . . . 0.0 108.728 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -144.28 142.91 30.75 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.65 -1.281 . . . . 0.0 110.686 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 122' ' ' ALA . . . . . 0.474 ' HB1' ' CD2' ' B' ' 32' ' ' LEU . . . -140.48 111.27 6.91 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.566 -0.709 . . . . 0.0 109.701 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . 0.547 ' HB2' ' HA ' ' B' ' 2' ' ' CYS . 26.3 p-10 -147.42 142.59 27.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.389 -0.82 . . . . 0.0 109.894 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 124' ' ' GLY . . . . . 0.418 ' HA3' ' HA ' ' B' ' 30' ' ' PHE . . . 153.48 -157.22 27.25 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.821 -1.711 . . . . 0.0 108.821 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . 0.5 ' HB3' ' CB ' ' B' ' 27' ' ' ALA . 86.9 m-20 -76.35 -0.94 24.45 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.263 -1.139 . . . . 0.0 110.161 179.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 126' ' ' PHE . . . . . 0.484 ' HD1' HG22 ' B' ' 23' ' ' VAL . 28.2 t80 -100.03 133.7 44.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.005 -1.059 . . . . 0.0 109.473 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -106.27 135.88 46.97 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.976 -1.078 . . . . 0.0 111.307 -178.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . 0.478 ' O ' HG23 ' B' ' 128' ' ' ILE . 14.9 tt -100.47 125.61 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.267 -0.896 . . . . 0.0 110.877 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -103.43 -19.99 14.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.151 -0.968 . . . . 0.0 111.624 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 130' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -156.87 150.25 24.24 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.345 -1.472 . . . . 0.0 113.456 -179.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 46.3 t -125.81 133.37 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 177.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 132' ' ' ALA . . . . . . . . . . . . . . . -146.13 149.72 34.55 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.278 -1.514 . . . . 0.0 111.13 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . 0.594 ' HE2' HD12 ' B' ' 11' ' ' LEU . 60.2 m-85 -105.52 128.01 53.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.587 -0.696 . . . . 0.0 110.441 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 23.0 t0 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.755 179.346 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 120.903 0.382 . . . . 0.0 110.45 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.452 ' O ' ' O ' ' A' ' 126' ' ' PHE . 99.6 m -142.24 -124.1 0.1 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.883 -1.136 . . . . 0.0 110.285 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.44 ' HA3' ' O ' ' A' ' 122' ' ' ALA . . . 176.73 121.17 0.66 Allowed Glycine 0 N--CA 1.493 2.464 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.439 HD21 HG23 ' A' ' 128' ' ' ILE . 1.1 pp -67.7 156.4 37.01 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.264 -1.139 . . . . 0.0 111.615 -178.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.4 t -118.63 132.73 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.6 ' HB3' HD11 ' A' ' 9' ' ' LEU . . . -110.04 178.98 4.24 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.871 -1.143 . . . . 0.0 110.985 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.42 ' O ' ' HB3' ' A' ' 8' ' ' ASN . 27.7 p -155.95 171.08 20.69 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.428 ' HB3' ' HA ' ' B' ' 4' ' ' LEU . 63.6 t30 58.25 35.88 25.27 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.288 -0.882 . . . . 0.0 110.545 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.6 HD11 ' HB3' ' A' ' 6' ' ' ALA . 78.5 mt -87.29 -5.61 58.85 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.488 -0.757 . . . . 0.0 111.156 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.505 ' C ' ' O ' ' A' ' 9' ' ' LEU . 4.9 m120 6.34 66.33 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.748 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.7 HD11 ' CE2' ' A' ' 133' ' ' PHE . 11.2 mt -93.07 129.05 39.15 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.048 -1.033 . . . . 0.0 110.514 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.43 ' CB ' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -98.79 171.74 5.45 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.295 -0.878 . . . . 0.0 110.783 -179.971 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.43 ' HD2' ' CB ' ' A' ' 12' ' ' LYS . 39.4 Cg_endo -65.17 148.13 88.77 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.221 1.643 . . . . 0.0 109.378 178.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.8 -16.01 54.98 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -111.35 142.09 44.04 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.177 -1.19 . . . . 0.0 109.699 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 58.2 m -109.77 153.19 24.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.196 -0.94 . . . . 0.0 110.181 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.493 HD12 ' O ' ' A' ' 132' ' ' ALA . 57.5 tp -118.28 130.7 56.2 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.221 -0.924 . . . . 0.0 110.349 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -110.99 125.75 54.05 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.577 -0.702 . . . . 0.0 109.489 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 74.0 t -121.16 123.29 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.92 -1.113 . . . . 0.0 110.158 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -123.56 128.44 49.73 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.215 -0.928 . . . . 0.0 109.645 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -146.86 -152.83 5.74 Favored Glycine 0 N--CA 1.489 2.226 0 C-N-CA 119.292 -1.433 . . . . 0.0 110.292 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -136.5 142.34 43.51 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.656 -0.908 . . . . 0.0 109.467 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.489 ' CG1' ' HA ' ' A' ' 81' ' ' PRO . 34.8 t -108.48 132.98 54.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 O-C-N 121.334 -0.854 . . . . 0.0 111.131 -178.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.92 152.57 96.73 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.528 -0.732 . . . . 0.0 109.871 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.404 ' HA ' ' HB2' ' A' ' 81' ' ' PRO . 42.9 Cg_endo -65.79 -28.3 51.4 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 123.955 1.503 . . . . 0.0 110.631 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -97.34 16.15 20.89 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.267 -0.895 . . . . 0.0 109.945 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.471 ' HA ' ' HB3' ' A' ' 125' ' ' ASP . . . -61.75 98.76 0.1 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.107 -0.996 . . . . 0.0 110.874 -179.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -95.04 -15.61 23.33 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.513 -0.742 . . . . 0.0 110.682 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 42.1 t -167.38 142.25 3.88 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 118.725 -1.19 . . . . 0.0 111.454 -178.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.532 ' CE2' ' HB2' ' A' ' 32' ' ' LEU . 10.6 t80 -149.34 157.63 43.49 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.429 -0.794 . . . . 0.0 109.993 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.648 HG23 ' CE1' ' A' ' 44' ' ' HIS . 2.5 p -129.09 131.16 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.909 -1.119 . . . . 0.0 110.837 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.532 ' HB2' ' CE2' ' A' ' 30' ' ' PHE . 12.7 tp -131.42 129.68 41.57 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.61 -0.681 . . . . 0.0 109.165 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -161.24 153.19 19.64 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.433 -1.417 . . . . 0.0 111.027 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.779 HD12 HD13 ' A' ' 117' ' ' ILE . 0.4 OUTLIER -143.61 128.09 17.96 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.673 0.749 . . . . 0.0 109.656 179.261 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.457 ' HA3' ' HA ' ' A' ' 41' ' ' LEU . . . -163.79 -160.38 11.67 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.47 ' O ' ' CD1' ' A' ' 119' ' ' TYR . 40.3 mtpt -67.45 -42.17 83.51 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 122.394 1.092 . . . . 0.0 108.212 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -157.45 -168.93 2.73 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.73 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.2 t -62.36 -42.8 99.69 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.781 -0.575 . . . . 0.0 112.296 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.466 ' HB3' ' N ' ' A' ' 66' ' ' GLY . 92.9 m-20 -87.06 -14.5 41.29 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.867 -1.146 . . . . 0.0 110.786 -178.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.441 ' HB2' ' HB2' ' A' ' 36' ' ' LYS . 5.6 m-80 -113.21 70.02 0.71 Allowed 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.867 0.841 . . . . 0.0 108.82 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.457 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 72.5 mt -100.72 139.09 36.89 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.729 ' SG ' HD23 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -83.96 -25.66 29.87 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.944 -1.097 . . . . 0.0 110.723 -179.301 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.729 HD23 ' SG ' ' A' ' 42' ' ' CYS . 2.8 pp -155.71 136.29 13.33 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.265 -0.897 . . . . 0.0 110.216 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.648 ' CE1' HG23 ' A' ' 31' ' ' VAL . 38.6 t60 -133.27 121.46 22.49 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.48 -0.763 . . . . 0.0 109.786 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -115.5 133.69 55.8 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.077 -1.015 . . . . 0.0 110.487 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -137.75 78.1 37.35 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 120.999 -1.063 . . . . 0.0 110.393 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -67.15 142.41 61.05 Favored 'Trans proline' 0 C--N 1.302 -1.88 0 O-C-N 123.865 1.455 . . . . 0.0 109.978 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -128.03 122.5 32.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.115 -0.991 . . . . 0.0 110.189 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -60.23 -46.74 88.72 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 118.605 -1.238 . . . . 0.0 108.403 178.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -147.53 102.15 3.42 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.617 -0.677 . . . . 0.0 110.017 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -84.97 -144.03 0.09 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.301 -0.875 . . . . 0.0 108.977 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -50.14 -29.4 9.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.102 -0.999 . . . . 0.0 109.373 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 170.48 38.64 0.03 OUTLIER Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -112.24 -172.52 2.06 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.035 -1.273 . . . . 0.0 109.917 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.466 ' O ' ' C ' ' A' ' 56' ' ' ASN . . . -139.79 137.19 34.82 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.181 -0.949 . . . . 0.0 110.596 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.466 ' C ' ' O ' ' A' ' 55' ' ' ALA . 92.4 m-20 24.79 60.67 0.05 Allowed 'General case' 0 N--CA 1.509 2.507 0 CA-C-O 121.412 0.625 . . . . 0.0 112.208 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 8.8 m -113.05 141.39 46.93 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.323 -0.86 . . . . 0.0 109.862 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.48 HG23 ' HB2' ' A' ' 74' ' ' GLU . 18.9 tt -136.75 138.85 45.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.211 -0.931 . . . . 0.0 110.318 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 55.4 t -119.57 127.2 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.302 -0.874 . . . . 0.0 110.312 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 47.9 t -96.08 126.94 41.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.368 -0.833 . . . . 0.0 110.337 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.466 ' O ' ' HB3' ' A' ' 44' ' ' HIS . 23.8 t-20 -136.34 148.78 48.07 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.408 -0.807 . . . . 0.0 110.295 -179.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.456 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 71.1 m -125.3 150.45 47.11 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.805 -1.184 . . . . 0.0 108.948 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.477 ' CD ' ' HA2' ' A' ' 66' ' ' GLY . 19.0 ttmt -138.63 148.25 43.85 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.672 -1.268 . . . . 0.0 111.718 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -120.97 97.48 5.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.675 -0.64 . . . . 0.0 110.44 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.403 ' C ' ' HB3' ' A' ' 39' ' ' ASN . . . 66.99 24.11 73.02 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.477 ' HA2' ' CD ' ' A' ' 63' ' ' LYS . . . 75.07 25.12 69.72 Favored Glycine 0 N--CA 1.48 1.606 0 C-N-CA 119.137 -1.506 . . . . 0.0 110.515 178.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -87.08 -81.02 0.24 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.988 -1.301 . . . . 0.0 110.649 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.455 ' O ' ' HG3' ' A' ' 63' ' ' LYS . 41.3 m95 -124.08 -156.59 0.72 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.075 -1.016 . . . . 0.0 110.445 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.456 ' HA2' ' O ' ' A' ' 62' ' ' SER . . . 163.86 114.9 0.31 Allowed Glycine 0 N--CA 1.487 2.05 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.6 m -80.65 121.5 25.93 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.541 -0.976 . . . . 0.0 110.412 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -91.27 129.19 37.29 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.175 -0.953 . . . . 0.0 110.913 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -112.26 -172.36 2.03 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.12 -0.988 . . . . 0.0 109.358 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -147.79 126.31 12.44 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 118.416 -1.314 . . . . 0.0 112.437 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.48 ' HB2' HG23 ' A' ' 58' ' ' ILE . 95.8 mt-10 -115.47 145.59 42.45 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -119.49 48.62 1.48 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.769 -1.207 . . . . 0.0 109.093 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.3 m -119.39 132.39 69.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.426 -0.796 . . . . 0.0 110.931 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -161.51 80.16 2.06 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.392 -0.818 . . . . 0.0 109.57 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -81.17 8.3 4.44 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 124.163 1.612 . . . . 0.0 111.37 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.409 ' CD2' ' HB2' ' A' ' 85' ' ' ALA . 12.2 m-85 -132.14 179.12 6.3 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.937 -1.102 . . . . 0.0 110.212 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.424 ' HB3' ' HD2' ' A' ' 81' ' ' PRO . 0.7 OUTLIER -144.16 177.23 1.87 Allowed Pre-proline 0 C--N 1.296 -1.741 0 O-C-N 121.545 -0.722 . . . . 0.0 109.221 -179.222 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.489 ' HA ' ' CG1' ' A' ' 23' ' ' VAL . 50.3 Cg_endo -71.26 157.29 57.46 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.531 1.279 . . . . 0.0 109.748 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 68.7 26.93 74.2 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.879 -1.688 . . . . 0.0 108.879 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.0 m -133.76 151.99 51.75 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.466 -1.02 . . . . 0.0 110.068 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 69.4 t -95.53 129.63 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.254 -0.903 . . . . 0.0 110.236 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.409 ' HB2' ' CD2' ' A' ' 79' ' ' PHE . . . -149.5 147.1 27.81 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.272 -0.893 . . . . 0.0 110.516 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -122.33 142.87 50.04 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.227 -0.921 . . . . 0.0 109.451 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 39.8 t -127.54 132.64 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.061 -1.024 . . . . 0.0 111.131 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -95.26 140.19 30.51 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.316 -0.865 . . . . 0.0 111.205 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.6 mt -124.64 128.58 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.612 -0.68 . . . . 0.0 110.417 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.534 ' HB ' ' HB ' ' A' ' 97' ' ' THR . 52.5 m -121.98 128.81 51.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.167 -0.958 . . . . 0.0 109.859 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.411 ' HA ' HD12 ' A' ' 96' ' ' LEU . 62.1 t80 -109.3 117.89 35.25 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.216 -0.928 . . . . 0.0 111.087 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -125.29 150.56 46.99 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.509 -0.744 . . . . 0.0 110.418 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.443 ' NE2' ' O ' ' A' ' 114' ' ' LEU . 75.8 mm-40 -62.52 -37.94 88.02 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.349 -0.844 . . . . 0.0 110.252 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.01 -40.84 95.51 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.211 -0.931 . . . . 0.0 110.113 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.437 ' C ' ' OD1' ' A' ' 95' ' ' ASN . 11.0 p30 -169.02 -171.67 1.38 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.378 -0.826 . . . . 0.0 110.521 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 91' ' ' PHE . 20.3 tp -112.12 132.87 54.61 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.409 -0.807 . . . . 0.0 109.599 178.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.534 ' HB ' ' HB ' ' A' ' 90' ' ' THR . 23.2 m -117.14 126.44 52.82 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.871 -1.143 . . . . 0.0 110.94 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 41.2 t -123.21 129.82 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.181 -0.949 . . . . 0.0 109.674 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -115.36 126.93 55.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.169 -0.957 . . . . 0.0 110.735 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.8 mp -100.34 164.55 16.09 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.581 -0.7 . . . . 0.0 109.833 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -64.91 -24.01 61.26 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.732 1.385 . . . . 0.0 110.371 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -77.37 -14.59 59.68 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.243 -0.911 . . . . 0.0 110.478 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.96 -13.2 59.08 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -70.93 135.32 47.87 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.922 -1.34 . . . . 0.0 109.977 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -124.66 138.7 54.29 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.437 -0.79 . . . . 0.0 110.175 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -126.43 134.46 50.98 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.093 -1.004 . . . . 0.0 109.636 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -112.83 145.06 41.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.069 -1.02 . . . . 0.0 111.049 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.52 ' CE2' ' O ' ' A' ' 109' ' ' PRO . 3.1 t80 -134.23 136.95 26.96 Favored Pre-proline 0 C--N 1.301 -1.521 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.52 ' O ' ' CE2' ' A' ' 108' ' ' PHE . 38.5 Cg_endo -64.18 133.98 40.44 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.642 1.338 . . . . 0.0 110.643 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.454 ' ND2' ' O ' ' A' ' 110' ' ' ASN . 6.2 p-10 -85.98 83.58 7.75 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.202 -0.936 . . . . 0.0 110.397 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -55.92 -20.8 17.4 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.937 -1.102 . . . . 0.0 109.657 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 97.5 mt -101.97 133.3 46.98 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.225 -0.922 . . . . 0.0 109.92 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -88.71 67.29 8.33 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.242 -0.911 . . . . 0.0 110.887 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.473 HD11 ' O ' ' A' ' 116' ' ' ALA . 33.8 tp -87.38 120.45 28.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.232 -0.917 . . . . 0.0 109.368 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.418 ' O ' ' HD3' ' A' ' 13' ' ' PRO . 16.6 pt-20 -82.84 -13.73 55.63 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.678 -1.264 . . . . 0.0 110.469 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.473 ' O ' HD11 ' A' ' 114' ' ' LEU . . . -157.59 157.54 33.88 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.806 -1.184 . . . . 0.0 111.267 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.779 HD13 HD12 ' A' ' 34' ' ' LEU . 95.1 mt -108.57 126.81 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.45 -0.781 . . . . 0.0 109.607 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -111.17 -27.74 8.58 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.998 -1.064 . . . . 0.0 111.255 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.47 ' CD1' ' O ' ' A' ' 36' ' ' LYS . 3.0 m-85 -117.15 140.86 49.0 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.935 -1.103 . . . . 0.0 112.503 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.442 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 54.8 ttp -138.76 129.64 26.52 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -136.61 136.42 39.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.398 -1.439 . . . . 0.0 111.097 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.44 ' O ' ' HA3' ' A' ' 3' ' ' GLY . . . -149.5 116.34 5.94 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.533 ' O ' HG12 ' A' ' 31' ' ' VAL . 65.8 t0 -147.02 118.67 8.0 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.611 -0.681 . . . . 0.0 109.384 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 179.62 -151.72 10.34 Favored Glycine 0 N--CA 1.489 2.206 0 C-N-CA 119.612 -1.28 . . . . 0.0 110.385 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.471 ' HB3' ' HA ' ' A' ' 27' ' ' ALA . 99.6 m-20 -74.46 -2.82 27.23 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.96 -0.729 . . . . 0.0 111.122 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.499 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 24.8 t80 -96.62 137.79 35.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.997 -1.064 . . . . 0.0 110.334 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -110.75 120.53 42.72 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 118.43 -1.308 . . . . 0.0 111.098 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.739 HD11 HG22 ' A' ' 131' ' ' VAL . 7.6 tt -101.37 114.26 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.223 -0.923 . . . . 0.0 110.242 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -97.85 -13.58 21.21 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 120.904 -1.122 . . . . 0.0 110.999 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -147.92 148.41 30.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.748 -1.22 . . . . 0.0 112.59 -179.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.739 HG22 HD11 ' A' ' 128' ' ' ILE . 52.6 t -133.42 131.33 57.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.493 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -127.99 146.71 50.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.628 -1.295 . . . . 0.0 110.785 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.7 ' CE2' HD11 ' A' ' 11' ' ' LEU . 10.0 m-85 -109.24 127.65 54.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.567 -0.708 . . . . 0.0 110.106 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 59.5 t0 . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 117.948 -1.025 . . . . 0.0 111.123 179.249 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.813 0 CA-C-O 120.849 0.357 . . . . 0.0 110.687 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' CYS . . . . . 0.452 ' O ' ' O ' ' B' ' 126' ' ' PHE . 99.1 m -141.64 -123.78 0.1 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.812 -1.18 . . . . 0.0 109.91 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . 0.44 ' HA3' ' O ' ' B' ' 122' ' ' ALA . . . 176.28 121.56 0.67 Allowed Glycine 0 N--CA 1.494 2.534 0 N-CA-C 108.679 -1.768 . . . . 0.0 108.679 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.433 HD21 HG23 ' B' ' 128' ' ' ILE . 1.2 pp -68.22 156.6 37.26 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.233 -1.157 . . . . 0.0 111.49 -178.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 45.5 t -118.84 132.59 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.706 -0.621 . . . . 0.0 109.399 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.572 ' HB3' HD11 ' B' ' 9' ' ' LEU . . . -110.09 178.57 4.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.738 -1.226 . . . . 0.0 111.26 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . 0.45 ' O ' ' HB3' ' B' ' 8' ' ' ASN . 26.3 p -155.45 170.9 20.88 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . 0.45 ' HB3' ' O ' ' B' ' 7' ' ' SER . 63.5 t30 59.16 35.2 23.58 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.366 -0.834 . . . . 0.0 110.539 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.572 HD11 ' HB3' ' B' ' 6' ' ' ALA . 81.1 mt -88.1 -1.58 58.09 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.29 -0.881 . . . . 0.0 111.306 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . 0.505 ' C ' ' O ' ' B' ' 9' ' ' LEU . 4.7 m120 -0.05 69.38 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.751 0 N-CA-C 113.874 1.065 . . . . 0.0 113.874 -178.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.681 HD11 ' CE2' ' B' ' 133' ' ' PHE . 11.1 mt -93.81 128.65 40.17 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.312 -0.867 . . . . 0.0 110.442 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . 0.412 ' CB ' ' HD2' ' B' ' 13' ' ' PRO . 0.0 OUTLIER -98.68 171.73 5.47 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.285 -0.885 . . . . 0.0 110.872 -179.786 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' B' ' 115' ' ' GLU . 40.7 Cg_endo -65.34 147.99 87.97 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.242 1.654 . . . . 0.0 109.501 178.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.11 -16.25 54.0 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -111.17 142.06 43.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.065 -1.256 . . . . 0.0 109.951 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' CYS . . . . . . . . . . . . . 57.7 m -109.46 153.75 23.61 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.162 -0.961 . . . . 0.0 110.277 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.475 HD12 ' O ' ' B' ' 132' ' ' ALA . 56.6 tp -118.68 130.8 56.04 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.245 -0.91 . . . . 0.0 110.366 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -111.05 125.87 54.21 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.553 -0.717 . . . . 0.0 109.483 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 79.1 t -121.06 122.61 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.946 -1.096 . . . . 0.0 110.253 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -123.02 128.62 50.42 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.145 -0.972 . . . . 0.0 109.691 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -147.35 -152.92 5.77 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.42 -1.372 . . . . 0.0 110.349 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 -136.5 142.37 43.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.597 -0.943 . . . . 0.0 109.527 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.494 ' CG1' ' HA ' ' B' ' 81' ' ' PRO . 32.0 t -108.47 132.7 55.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 O-C-N 121.495 -0.753 . . . . 0.0 111.122 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.62 152.36 96.71 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.582 -0.699 . . . . 0.0 110.057 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -65.35 -29.13 54.54 Favored 'Trans proline' 0 C--N 1.303 -1.858 0 O-C-N 124.042 1.548 . . . . 0.0 110.466 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -96.85 16.46 19.21 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.429 -0.794 . . . . 0.0 110.104 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . 0.476 ' HA ' ' HB3' ' B' ' 125' ' ' ASP . . . -62.61 99.13 0.14 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.269 -0.895 . . . . 0.0 110.697 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -95.16 -17.98 21.31 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.399 -0.813 . . . . 0.0 110.785 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 39.4 t -163.82 142.77 7.84 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.977 -1.089 . . . . 0.0 111.452 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' PHE . . . . . 0.528 ' CE2' ' HB2' ' B' ' 32' ' ' LEU . 9.9 t80 -149.74 157.51 43.29 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.381 -0.825 . . . . 0.0 110.017 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.667 HG23 ' CE1' ' B' ' 44' ' ' HIS . 2.5 p -128.89 131.74 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 120.766 -1.209 . . . . 0.0 110.989 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.528 ' HB2' ' CE2' ' B' ' 30' ' ' PHE . 12.7 tp -131.42 129.8 41.73 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.524 -0.735 . . . . 0.0 109.16 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -161.3 153.74 20.26 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 118.287 -1.365 . . . . 0.0 110.851 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.803 HD12 HD13 ' B' ' 117' ' ' ILE . 0.4 OUTLIER -144.57 124.96 13.86 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.636 0.731 . . . . 0.0 109.804 179.411 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' B' ' 41' ' ' LEU . . . -159.7 -159.35 9.72 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . 0.467 ' O ' ' CD1' ' B' ' 119' ' ' TYR . 40.6 mtpt -67.81 -42.34 81.7 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -156.55 -167.59 2.45 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.879 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 8.7 t -62.97 -42.87 99.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.774 -0.579 . . . . 0.0 112.41 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' ASN . . . . . 0.477 ' HB3' ' N ' ' B' ' 66' ' ' GLY . 92.0 m-20 -87.3 -14.52 40.65 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.983 -1.073 . . . . 0.0 110.751 -178.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' ASN . . . . . 0.435 ' HB2' ' HB2' ' B' ' 36' ' ' LYS . 6.1 m-80 -112.67 70.06 0.71 Allowed 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.458 ' HA ' ' HA3' ' B' ' 35' ' ' GLY . 73.0 mt -100.29 142.03 32.32 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' CYS . . . . . 0.69 ' SG ' HD23 ' B' ' 43' ' ' LEU . 0.0 OUTLIER -88.33 -23.5 23.4 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.832 -1.167 . . . . 0.0 110.359 -178.891 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.733 HD21 HD21 ' B' ' 34' ' ' LEU . 2.8 pp -156.57 135.93 12.19 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.26 -0.9 . . . . 0.0 110.154 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' HIS . . . . . 0.667 ' CE1' HG23 ' B' ' 31' ' ' VAL . 37.7 t60 -133.19 121.29 22.31 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.691 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -115.51 133.88 55.61 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.136 -0.978 . . . . 0.0 110.296 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -137.8 78.25 36.73 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.046 -1.034 . . . . 0.0 110.3 178.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -67.14 142.53 61.54 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.851 1.448 . . . . 0.0 109.772 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -128.31 121.98 30.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.126 -0.984 . . . . 0.0 110.014 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -60.12 -46.87 88.19 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 118.35 -1.34 . . . . 0.0 108.344 178.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -147.18 102.35 3.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.699 -0.626 . . . . 0.0 109.97 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.37 -144.02 0.1 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.279 -0.888 . . . . 0.0 108.992 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -50.18 -28.72 7.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.085 -1.01 . . . . 0.0 109.409 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 169.55 38.81 0.03 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -112.25 -172.62 2.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.046 -1.267 . . . . 0.0 109.889 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.499 ' O ' ' C ' ' B' ' 56' ' ' ASN . . . -138.46 142.11 39.45 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.306 -0.871 . . . . 0.0 109.949 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' ASN . . . . . 0.499 ' C ' ' O ' ' B' ' 55' ' ' ALA . 92.0 m-20 16.41 64.33 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.569 0 CA-C-O 121.83 0.824 . . . . 0.0 112.51 -178.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 9.7 m -113.84 141.0 47.87 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.654 -0.654 . . . . 0.0 109.758 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' ILE . . . . . 0.476 HG23 ' HB2' ' B' ' 74' ' ' GLU . 18.7 tt -136.72 138.11 46.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.192 -0.942 . . . . 0.0 110.335 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 55.4 t -118.38 127.76 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.258 -0.901 . . . . 0.0 110.306 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 47.9 t -96.56 126.03 41.45 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.373 -0.83 . . . . 0.0 110.226 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' ASN . . . . . 0.451 ' O ' ' HB3' ' B' ' 44' ' ' HIS . 24.1 t-20 -135.58 148.68 49.16 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.42 -0.8 . . . . 0.0 110.527 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' SER . . . . . 0.447 ' O ' ' HA2' ' B' ' 69' ' ' GLY . 72.1 m -125.06 150.93 46.29 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.677 -1.264 . . . . 0.0 109.042 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . 0.496 ' CD ' ' HA2' ' B' ' 66' ' ' GLY . 18.6 ttmt -138.93 148.03 43.04 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.651 -1.281 . . . . 0.0 111.526 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -120.85 97.67 5.65 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.612 -0.68 . . . . 0.0 110.312 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 67.08 23.65 73.01 Favored Glycine 0 N--CA 1.487 2.061 0 C-N-CA 119.491 -1.338 . . . . 0.0 110.131 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . 0.496 ' HA2' ' CD ' ' B' ' 63' ' ' LYS . . . 75.18 24.85 70.19 Favored Glycine 0 N--CA 1.487 2.081 0 O-C-N 120.846 -1.385 . . . . 0.0 110.305 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -86.55 -81.56 0.22 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.964 -1.315 . . . . 0.0 110.662 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' TRP . . . . . 0.457 ' O ' ' HG3' ' B' ' 63' ' ' LYS . 41.2 m95 -124.05 -156.11 0.7 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.13 -0.981 . . . . 0.0 110.374 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' B' ' 62' ' ' SER . . . 163.35 114.69 0.31 Allowed Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 5.4 m -80.46 120.96 25.14 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.538 -0.978 . . . . 0.0 110.492 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -90.59 128.92 36.74 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.272 -0.892 . . . . 0.0 111.082 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -112.06 -172.14 1.98 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.951 -1.093 . . . . 0.0 109.282 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -147.7 127.36 13.35 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 118.257 -1.377 . . . . 0.0 112.34 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' GLU . . . . . 0.476 ' HB2' HG23 ' B' ' 58' ' ' ILE . 96.0 mt-10 -116.37 145.11 43.47 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -119.48 48.42 1.52 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.986 -1.071 . . . . 0.0 109.112 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 33.8 m -119.37 132.14 70.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-O 121.561 0.696 . . . . 0.0 110.679 -179.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -161.35 81.29 2.01 Favored Pre-proline 0 C--N 1.301 -1.519 0 O-C-N 121.743 -0.598 . . . . 0.0 109.548 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -82.23 8.77 4.31 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 121.843 1.696 . . . . 0.0 111.234 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' PHE . . . . . 0.409 ' CD2' ' HB2' ' B' ' 85' ' ' ALA . 13.8 m-85 -132.79 178.99 6.43 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.918 -1.114 . . . . 0.0 110.403 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.451 ' HB3' ' HD2' ' B' ' 81' ' ' PRO . 0.7 OUTLIER -144.02 177.26 1.87 Allowed Pre-proline 0 C--N 1.297 -1.705 0 O-C-N 121.553 -0.717 . . . . 0.0 109.19 -179.25 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' PRO . . . . . 0.494 ' HA ' ' CG1' ' B' ' 23' ' ' VAL . 54.0 Cg_endo -71.34 157.15 57.5 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.699 1.368 . . . . 0.0 109.412 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 68.5 26.62 74.25 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 6.5 m -133.37 151.73 51.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.505 -0.997 . . . . 0.0 110.039 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 70.7 t -95.72 129.26 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.259 -0.901 . . . . 0.0 110.23 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . 0.409 ' HB2' ' CD2' ' B' ' 79' ' ' PHE . . . -149.27 147.3 28.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.221 -0.924 . . . . 0.0 110.473 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -122.12 143.29 49.63 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.243 -0.911 . . . . 0.0 109.4 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 39.5 t -127.41 132.29 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.069 -1.02 . . . . 0.0 111.293 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 88' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -94.78 139.83 30.74 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.344 -0.848 . . . . 0.0 111.166 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 96.8 mt -124.85 128.55 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.675 -0.64 . . . . 0.0 110.254 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 90' ' ' THR . . . . . 0.494 ' HB ' ' HB ' ' B' ' 97' ' ' THR . 52.1 m -122.36 128.75 51.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.157 -0.964 . . . . 0.0 109.811 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 91' ' ' PHE . . . . . 0.414 ' HA ' HD12 ' B' ' 96' ' ' LEU . 61.6 t80 -109.02 118.5 36.94 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.157 -0.964 . . . . 0.0 111.049 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -125.58 150.65 47.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.516 -0.74 . . . . 0.0 110.356 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . 0.431 ' NE2' ' O ' ' B' ' 114' ' ' LEU . 75.2 mm-40 -62.65 -37.62 87.1 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.359 -0.838 . . . . 0.0 110.246 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.27 -40.84 94.44 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.195 -0.94 . . . . 0.0 110.116 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . 0.424 ' C ' ' OD1' ' B' ' 95' ' ' ASN . 10.5 p30 -168.77 -171.04 1.29 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.419 -0.8 . . . . 0.0 110.506 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 96' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' B' ' 91' ' ' PHE . 20.3 tp -112.82 132.85 55.09 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.26 -0.9 . . . . 0.0 109.324 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . 0.494 ' HB ' ' HB ' ' B' ' 90' ' ' THR . 22.1 m -117.24 126.58 52.98 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.979 -1.076 . . . . 0.0 110.831 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 40.8 t -123.18 130.39 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.234 -0.916 . . . . 0.0 109.66 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -115.75 127.53 55.18 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.076 -1.015 . . . . 0.0 110.69 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 mp -101.08 164.29 16.34 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.576 -0.702 . . . . 0.0 109.71 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -64.87 -24.16 61.37 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.696 1.366 . . . . 0.0 110.217 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -77.22 -14.16 59.82 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.312 -0.868 . . . . 0.0 110.567 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.27 -13.08 60.21 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 104' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -71.11 135.84 47.88 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.915 -1.344 . . . . 0.0 109.893 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -124.89 139.18 54.07 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.394 -0.816 . . . . 0.0 110.033 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -127.07 134.5 50.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.085 -1.01 . . . . 0.0 109.452 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -113.03 145.2 41.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.045 -1.035 . . . . 0.0 111.011 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 108' ' ' PHE . . . . . 0.522 ' CE2' ' O ' ' B' ' 109' ' ' PRO . 2.9 t80 -134.34 136.89 26.72 Favored Pre-proline 0 C--N 1.3 -1.56 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . 0.522 ' O ' ' CE2' ' B' ' 108' ' ' PHE . 37.6 Cg_endo -64.05 134.8 44.49 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.757 1.399 . . . . 0.0 110.682 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 110' ' ' ASN . . . . . 0.469 ' ND2' ' O ' ' B' ' 110' ' ' ASN . 6.4 p-10 -87.04 83.87 7.41 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.032 -1.042 . . . . 0.0 110.279 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -55.99 -21.37 20.83 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.972 -1.08 . . . . 0.0 109.537 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 97.4 mt -101.57 133.12 46.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.138 -0.976 . . . . 0.0 109.896 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -88.59 67.35 8.45 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.301 -0.874 . . . . 0.0 110.763 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 114' ' ' LEU . . . . . 0.469 HD11 ' O ' ' B' ' 116' ' ' ALA . 36.2 tp -87.14 121.22 29.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.308 -0.87 . . . . 0.0 109.059 178.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 115' ' ' GLU . . . . . 0.428 ' O ' ' HD3' ' B' ' 13' ' ' PRO . 16.5 pt-20 -83.5 -13.97 53.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.624 -1.298 . . . . 0.0 110.474 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 116' ' ' ALA . . . . . 0.469 ' O ' HD11 ' B' ' 114' ' ' LEU . . . -157.05 157.8 35.3 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.965 -1.084 . . . . 0.0 110.904 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 117' ' ' ILE . . . . . 0.803 HD13 HD12 ' B' ' 34' ' ' LEU . 95.5 mt -108.89 126.87 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.288 -0.882 . . . . 0.0 109.532 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -111.2 -27.04 8.87 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.851 -1.156 . . . . 0.0 111.348 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 119' ' ' TYR . . . . . 0.467 ' CD1' ' O ' ' B' ' 36' ' ' LYS . 2.8 m-85 -117.42 141.2 48.62 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.91 -1.119 . . . . 0.0 112.48 -178.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 120' ' ' MET . . . . . 0.461 ' HA ' ' HA ' ' B' ' 34' ' ' LEU . 54.2 ttp -139.07 129.95 26.3 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -136.96 136.56 38.66 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.429 -1.419 . . . . 0.0 111.221 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 122' ' ' ALA . . . . . 0.44 ' O ' ' HA3' ' B' ' 3' ' ' GLY . . . -149.35 116.32 5.99 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . 0.534 ' O ' HG12 ' B' ' 31' ' ' VAL . 64.9 t0 -146.68 118.68 8.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.387 -0.82 . . . . 0.0 109.431 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 179.33 -152.27 10.93 Favored Glycine 0 N--CA 1.487 2.084 0 C-N-CA 119.392 -1.385 . . . . 0.0 110.464 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . 0.476 ' HB3' ' HA ' ' B' ' 27' ' ' ALA . 99.7 m-20 -74.28 -2.93 27.13 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.844 -0.798 . . . . 0.0 111.067 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 126' ' ' PHE . . . . . 0.504 ' HB3' ' CD1' ' B' ' 30' ' ' PHE . 24.6 t80 -96.24 138.27 34.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.001 -1.062 . . . . 0.0 110.288 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -111.13 120.3 41.87 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 118.477 -1.289 . . . . 0.0 111.003 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . 0.739 HD11 HG22 ' B' ' 131' ' ' VAL . 7.8 tt -100.9 114.85 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.046 -1.034 . . . . 0.0 110.282 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -98.39 -13.3 20.7 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.739 -1.225 . . . . 0.0 110.957 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 130' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -147.89 148.22 30.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.762 -1.211 . . . . 0.0 112.538 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.739 HG22 HD11 ' B' ' 128' ' ' ILE . 53.1 t -133.28 130.69 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 132' ' ' ALA . . . . . 0.475 ' O ' HD12 ' B' ' 17' ' ' LEU . . . -127.39 146.72 50.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.418 -1.426 . . . . 0.0 110.861 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . 0.681 ' CE2' HD11 ' B' ' 11' ' ' LEU . 10.0 m-85 -108.75 127.65 54.19 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.505 -0.747 . . . . 0.0 110.033 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 58.4 t0 . . . . . 0 N--CA 1.497 1.906 0 CA-C-O 117.876 -1.059 . . . . 0.0 111.354 179.141 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.421 0.629 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -126.99 84.33 2.25 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.607 -0.683 . . . . 0.0 109.557 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 92.09 34.51 7.14 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.488 ' HA ' ' HB3' ' B' ' 8' ' ' ASN . 30.9 tp -61.58 133.43 55.65 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.031 -1.276 . . . . 0.0 110.702 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.1 t -123.15 133.49 68.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.47 -0.768 . . . . 0.0 109.866 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.47 148.56 44.28 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.167 -0.958 . . . . 0.0 110.235 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.453 ' O ' ' HB3' ' A' ' 8' ' ' ASN . 74.4 m -142.02 167.69 21.52 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.32 -0.862 . . . . 0.0 109.397 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.453 ' HB3' ' O ' ' A' ' 7' ' ' SER . 7.4 t30 60.57 32.85 20.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.415 -0.803 . . . . 0.0 109.628 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.645 HD22 ' HB2' ' A' ' 120' ' ' MET . 1.0 OUTLIER -84.65 -2.84 58.06 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.731 -0.605 . . . . 0.0 111.552 -179.393 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.493 ' C ' ' O ' ' A' ' 9' ' ' LEU . 87.9 m-20 11.29 63.73 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.623 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.487 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 14.0 tp -78.55 143.27 36.67 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.846 -1.159 . . . . 0.0 109.824 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.8 mtmt -127.22 158.62 68.67 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 120.969 -1.082 . . . . 0.0 109.915 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -66.49 147.31 82.17 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.83 1.437 . . . . 0.0 110.557 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.53 -9.18 41.2 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -122.98 147.49 46.57 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.927 -1.337 . . . . 0.0 110.204 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 56.8 m -93.3 142.81 26.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.325 -0.859 . . . . 0.0 110.771 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 42.6 tp -120.17 128.5 53.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.394 -0.816 . . . . 0.0 108.908 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -123.37 143.1 50.33 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.878 -1.139 . . . . 0.0 111.656 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.5 t -128.52 116.12 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.641 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -111.79 125.24 53.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.088 -1.008 . . . . 0.0 109.959 178.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.471 ' O ' HG23 ' A' ' 84' ' ' VAL . . . -144.96 -155.78 6.59 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -135.23 145.89 48.07 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.281 -1.129 . . . . 0.0 108.966 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 39.9 t -111.45 130.94 64.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 O-C-N 121.124 -0.985 . . . . 0.0 110.562 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.66 153.15 72.4 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.512 -0.743 . . . . 0.0 110.291 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.407 ' O ' ' HB2' ' A' ' 81' ' ' PRO . 43.5 Cg_endo -67.23 -20.34 49.48 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.992 1.522 . . . . 0.0 110.469 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.401 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 49.9 p-10 -119.11 25.2 10.33 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.293 -0.879 . . . . 0.0 110.416 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.432 ' HA ' ' HB3' ' A' ' 125' ' ' ASP . . . -60.05 104.87 0.34 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.898 -1.126 . . . . 0.0 110.315 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 26' ' ' ASP . 64.2 mttp -95.52 -15.23 23.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.332 -0.855 . . . . 0.0 111.073 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.8 t -160.54 132.94 6.2 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.722 -1.236 . . . . 0.0 111.719 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.502 ' CD1' ' HB3' ' A' ' 126' ' ' PHE . 14.8 t80 -136.72 144.98 44.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.589 -0.695 . . . . 0.0 109.595 178.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.8 t -126.37 131.46 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.03 -1.044 . . . . 0.0 110.836 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.494 ' HB2' ' CZ ' ' A' ' 30' ' ' PHE . 20.9 tp -135.76 135.52 40.03 Favored 'General case' 0 N--CA 1.484 1.235 0 O-C-N 121.47 -0.769 . . . . 0.0 109.997 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.893 ' HB2' HD13 ' A' ' 41' ' ' LEU . 28.5 p30 -142.95 155.37 44.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.787 -1.195 . . . . 0.0 110.508 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.687 HD21 ' HB2' ' A' ' 43' ' ' LEU . 0.6 OUTLIER -153.58 111.84 3.62 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.29 -0.881 . . . . 0.0 110.19 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.487 ' O ' ' CB ' ' A' ' 119' ' ' TYR . . . -161.04 -173.41 29.63 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.634 -1.786 . . . . 0.0 108.634 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.431 ' O ' ' HB2' ' A' ' 119' ' ' TYR . 98.7 mttt -78.61 -44.66 23.43 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.87 -1.37 . . . . 0.0 110.482 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.419 ' HB2' ' HB2' ' A' ' 40' ' ' ASN . 85.3 m-20 -119.8 165.03 15.09 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.761 -177.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.7 t -56.98 -45.7 82.74 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.604 -0.685 . . . . 0.0 112.425 -178.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.45 ' HB3' ' N ' ' A' ' 66' ' ' GLY . 55.6 m-20 -89.46 -0.92 57.84 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.491 -1.381 . . . . 0.0 110.242 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.419 ' HB2' ' HB2' ' A' ' 37' ' ' ASP . 5.2 m-80 -111.52 58.37 0.62 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.269 -0.895 . . . . 0.0 109.713 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.893 HD13 ' HB2' ' A' ' 33' ' ' ASN . 71.9 mt -83.15 134.08 35.0 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.63 ' SG ' HD22 ' A' ' 114' ' ' LEU . 83.6 m -81.73 -40.44 22.72 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.998 -1.064 . . . . 0.0 110.224 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.687 ' HB2' HD21 ' A' ' 34' ' ' LEU . 83.0 mt -131.87 140.21 49.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.218 -0.926 . . . . 0.0 110.262 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.416 ' HB3' ' O ' ' A' ' 61' ' ' ASN . 62.9 t-80 -140.46 139.54 35.2 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.199 -0.938 . . . . 0.0 110.425 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -127.92 146.41 50.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.114 -0.991 . . . . 0.0 110.224 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.411 ' HA ' ' O ' ' A' ' 30' ' ' PHE . 0.2 OUTLIER -152.83 61.07 3.6 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 109.909 179.46 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.486 ' HB3' HD12 ' A' ' 58' ' ' ILE . 52.4 Cg_endo -69.01 147.2 67.15 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 124.144 1.602 . . . . 0.0 110.573 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 91.7 mtm-85 -135.53 125.69 26.21 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.11 -0.994 . . . . 0.0 110.637 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -61.93 -46.81 87.69 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.018 -1.051 . . . . 0.0 108.988 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -148.52 84.51 1.49 Allowed 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.52 -117.41 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.264 -0.898 . . . . 0.0 110.176 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 25.5 m80 -77.97 -13.06 60.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.583 -1.323 . . . . 0.0 110.458 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 164.75 -22.27 0.14 Allowed Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.611 -1.281 . . . . 0.0 110.459 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -60.85 -179.16 0.12 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.777 -1.425 . . . . 0.0 110.118 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.522 ' O ' ' C ' ' A' ' 56' ' ' ASN . . . -122.21 135.66 54.8 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.619 -0.676 . . . . 0.0 109.985 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.522 ' C ' ' O ' ' A' ' 55' ' ' ALA . 1.9 m-20 14.33 74.83 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.48 0 CA-C-O 121.297 0.57 . . . . 0.0 112.122 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' A' ' 47' ' ' PRO . 47.2 m -110.13 130.3 55.56 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.203 -0.935 . . . . 0.0 110.392 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.486 HD12 ' HB3' ' A' ' 47' ' ' PRO . 19.6 tt -128.71 131.0 68.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.596 -0.69 . . . . 0.0 109.975 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 59' ' ' VAL . 21.8 m -125.81 129.34 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.147 -0.971 . . . . 0.0 110.136 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 11.3 t -86.13 130.67 34.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.263 -0.898 . . . . 0.0 109.355 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.416 ' O ' ' HB3' ' A' ' 44' ' ' HIS . 14.1 t-20 -137.21 144.63 42.95 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.004 -1.06 . . . . 0.0 111.327 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.2 m -119.13 153.95 34.03 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.483 ' CD ' ' HA2' ' A' ' 66' ' ' GLY . 16.6 ttmt -136.69 134.97 37.79 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.876 -1.14 . . . . 0.0 110.437 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -114.32 102.38 10.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.267 -0.895 . . . . 0.0 109.34 178.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.11 27.4 72.27 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.483 ' HA2' ' CD ' ' A' ' 63' ' ' LYS . . . 93.08 2.05 66.65 Favored Glycine 0 N--CA 1.484 1.852 0 C-N-CA 119.624 -1.274 . . . . 0.0 110.005 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.463 ' O ' ' C ' ' A' ' 68' ' ' TRP . . . -109.55 84.4 1.92 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.987 -1.302 . . . . 0.0 109.723 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.477 ' O ' ' HA ' ' A' ' 63' ' ' LYS . 60.2 m95 -6.13 -117.94 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.761 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 129.86 -113.39 1.47 Allowed Glycine 0 N--CA 1.488 2.102 0 O-C-N 119.849 -1.782 . . . . 0.0 109.9 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 21.7 m -78.69 121.45 24.73 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.261 -1.141 . . . . 0.0 111.266 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -126.83 131.18 51.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.398 -0.814 . . . . 0.0 109.684 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.51 156.51 38.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.063 -1.023 . . . . 0.0 110.159 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -134.82 88.86 2.47 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.33 -0.856 . . . . 0.0 109.74 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -114.03 125.88 54.5 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.369 -0.832 . . . . 0.0 109.952 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -93.32 85.54 5.02 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.857 -1.152 . . . . 0.0 110.239 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.625 HG22 ' HD3' ' A' ' 78' ' ' PRO . 2.4 p -127.16 132.11 70.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.231 -0.918 . . . . 0.0 110.151 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.524 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 13.0 p90 -144.9 81.67 10.56 Favored Pre-proline 0 N--CA 1.487 1.398 0 O-C-N 121.211 -0.931 . . . . 0.0 110.326 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.625 ' HD3' HG22 ' A' ' 76' ' ' VAL . 49.8 Cg_endo -72.71 -3.38 13.42 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.844 1.444 . . . . 0.0 111.365 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.531 ' CD2' ' HB2' ' A' ' 85' ' ' ALA . 3.8 m-85 -133.95 179.68 6.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.008 -1.058 . . . . 0.0 111.068 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.471 ' CG ' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -131.41 172.39 7.45 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.562 -0.711 . . . . 0.0 109.464 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.471 ' HD2' ' CG ' ' A' ' 80' ' ' GLN . 52.3 Cg_endo -71.11 150.09 59.42 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.634 1.333 . . . . 0.0 110.09 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.03 26.87 63.39 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 44.7 m -131.76 152.05 51.22 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.12 -1.224 . . . . 0.0 111.016 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 21' ' ' GLY . 12.6 p -91.29 133.38 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.452 -0.78 . . . . 0.0 109.564 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.531 ' HB2' ' CD2' ' A' ' 79' ' ' PHE . . . -151.66 155.62 38.73 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.891 -1.131 . . . . 0.0 110.933 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -122.62 149.6 43.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.331 -0.856 . . . . 0.0 109.724 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.9 t -124.26 130.22 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.103 -0.998 . . . . 0.0 110.403 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 1.4 t -98.82 122.73 42.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.506 -0.746 . . . . 0.0 110.051 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 98.0 mt -122.43 128.63 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.105 -0.997 . . . . 0.0 110.841 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 63.7 m -119.37 128.33 53.98 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.585 ' CZ ' HD11 ' A' ' 114' ' ' LEU . 73.6 t80 -109.4 115.11 29.35 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.788 -1.195 . . . . 0.0 111.376 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 95' ' ' ASN . 79.7 m-20 -118.54 142.36 47.68 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -60.28 -29.89 69.11 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.782 -1.199 . . . . 0.0 110.523 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.47 -40.68 80.9 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 120.918 -1.114 . . . . 0.0 109.214 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.413 ' O ' ' HB2' ' A' ' 92' ' ' ASP . 0.4 OUTLIER -169.95 172.23 6.68 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.959 -0.697 . . . . 0.0 110.461 -179.096 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.434 HD22 ' CD1' ' A' ' 43' ' ' LEU . 38.1 tp -102.17 124.53 47.93 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.159 -0.963 . . . . 0.0 110.227 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.442 HG23 ' OE2' ' A' ' 105' ' ' GLU . 11.1 m -107.33 125.35 51.06 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.124 -0.985 . . . . 0.0 109.267 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 36.7 t -131.38 131.61 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.857 -1.152 . . . . 0.0 110.417 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -120.01 143.56 47.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.177 -0.952 . . . . 0.0 110.491 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.51 HD23 ' HD2' ' A' ' 101' ' ' PRO . 0.5 OUTLIER -111.04 169.57 6.17 Favored Pre-proline 0 C--N 1.301 -1.532 0 O-C-N 121.45 -0.781 . . . . 0.0 109.118 179.226 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.51 ' HD2' HD23 ' A' ' 100' ' ' LEU . 39.8 Cg_endo -63.96 -23.79 67.73 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 123.626 1.329 . . . . 0.0 110.858 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.482 ' HB2' ' CB ' ' A' ' 78' ' ' PRO . 20.8 t0 -75.01 -12.31 60.3 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.012 -1.055 . . . . 0.0 110.974 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 99.15 -10.32 61.7 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.708 -1.234 . . . . 0.0 110.66 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.43 ' CE2' ' OD2' ' A' ' 102' ' ' ASP . 19.4 m-85 -79.78 140.68 36.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.815 -1.403 . . . . 0.0 109.843 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.442 ' OE2' HG23 ' A' ' 97' ' ' THR . 85.2 tt0 -120.86 143.43 48.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.307 -0.871 . . . . 0.0 110.679 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -129.94 147.99 51.75 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.458 -0.776 . . . . 0.0 109.599 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.426 ' C ' ' CD1' ' A' ' 108' ' ' PHE . 98.3 mttt -127.58 145.79 50.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.035 -1.041 . . . . 0.0 111.478 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.494 ' N ' ' CD1' ' A' ' 108' ' ' PHE . 19.2 m-85 -129.81 140.35 38.39 Favored Pre-proline 0 N--CA 1.489 1.508 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.5 140.36 39.71 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 123.407 1.214 . . . . 0.0 109.786 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.459 ' ND2' ' O ' ' A' ' 110' ' ' ASN . 6.0 p-10 -102.3 82.85 2.24 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 122.212 1.006 . . . . 0.0 110.178 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 96.6 mtt-85 -57.17 -22.89 43.69 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.535 -1.353 . . . . 0.0 108.963 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.755 ' HB3' HD23 ' A' ' 114' ' ' LEU . 89.1 mt -81.96 143.82 31.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.753 -0.592 . . . . 0.0 110.413 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -101.63 39.03 1.5 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.131 -0.981 . . . . 0.0 109.561 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.755 HD23 ' HB3' ' A' ' 112' ' ' LEU . 0.8 OUTLIER -73.77 128.05 34.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.435 -0.79 . . . . 0.0 110.914 -179.146 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -88.04 -16.19 34.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.067 -1.021 . . . . 0.0 110.215 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' A' ' 11' ' ' LEU . . . -158.23 155.13 28.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.042 -1.036 . . . . 0.0 111.251 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.518 HD11 HD13 ' A' ' 114' ' ' LEU . 31.6 mm -107.1 130.33 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.203 -0.935 . . . . 0.0 110.18 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.508 ' ND2' ' N ' ' A' ' 118' ' ' ASN . 0.5 OUTLIER -108.92 -15.19 14.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.151 -0.968 . . . . 0.0 110.909 -179.205 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.487 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 4.0 t80 -120.21 129.49 54.11 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.973 -1.079 . . . . 0.0 111.487 -178.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.645 ' HB2' HD22 ' A' ' 9' ' ' LEU . 55.3 ttp -141.35 128.44 20.81 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 178.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.07 149.6 30.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.736 -1.228 . . . . 0.0 111.414 -178.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -152.1 129.07 11.02 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.403 -0.811 . . . . 0.0 109.976 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -147.4 114.81 6.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.311 -0.868 . . . . 0.0 109.377 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.484 ' HA3' ' HA ' ' A' ' 30' ' ' PHE . . . -177.03 -145.32 5.67 Favored Glycine 0 N--CA 1.485 1.947 0 C-N-CA 119.174 -1.489 . . . . 0.0 110.327 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.432 ' HB3' ' HA ' ' A' ' 27' ' ' ALA . 80.2 m-20 -89.04 12.89 14.3 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.781 -0.835 . . . . 0.0 110.707 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.502 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 15.1 t80 -105.8 137.47 43.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.008 -1.057 . . . . 0.0 110.401 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.43 ' O ' ' HA3' ' A' ' 21' ' ' GLY . 98.7 mttt -103.9 109.56 21.35 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.244 -0.91 . . . . 0.0 111.758 -178.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.452 HG23 ' O ' ' A' ' 128' ' ' ILE . 8.7 tt -99.67 117.5 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.028 -1.045 . . . . 0.0 109.432 177.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -109.41 -14.39 14.43 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.164 -0.96 . . . . 0.0 111.733 -178.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.54 142.56 30.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.669 -1.27 . . . . 0.0 112.001 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 59.6 t -126.65 132.99 69.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -138.97 143.73 38.66 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.507 -1.37 . . . . 0.0 111.514 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -73.79 -125.9 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.629 -0.67 . . . . 0.0 109.723 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 47.2 t0 . . . . . 0 N--CA 1.491 1.592 0 O-C-N 120.528 -1.357 . . . . 0.0 110.116 179.674 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.448 0.642 . . . . 0.0 110.513 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -126.93 84.15 2.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.472 -0.767 . . . . 0.0 109.643 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 92.19 34.51 7.1 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 31.0 tp -62.1 133.04 54.75 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.143 -1.21 . . . . 0.0 110.705 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 39.5 t -122.77 133.18 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.558 -0.714 . . . . 0.0 109.944 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.26 148.13 44.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.133 -0.98 . . . . 0.0 110.396 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . 0.463 ' O ' ' HB3' ' B' ' 8' ' ' ASN . 74.9 m -141.69 167.41 22.21 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.22 -0.925 . . . . 0.0 109.343 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . 0.488 ' HB3' ' HA ' ' A' ' 4' ' ' LEU . 7.6 t30 60.97 33.14 19.89 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.79 0.805 . . . . 0.0 109.509 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.65 HD22 ' HB2' ' B' ' 120' ' ' MET . 1.0 OUTLIER -86.58 3.48 44.2 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.74 -0.6 . . . . 0.0 111.583 -179.476 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . 0.496 ' C ' ' O ' ' B' ' 9' ' ' LEU . 87.3 m-20 2.22 67.67 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.612 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -178.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.493 ' O ' ' HA ' ' B' ' 116' ' ' ALA . 14.0 tp -79.45 143.34 35.07 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.228 -0.92 . . . . 0.0 109.605 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 6.8 mtmt -127.71 158.67 69.5 Favored Pre-proline 0 C--N 1.296 -1.755 0 O-C-N 121.178 -0.951 . . . . 0.0 109.873 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -66.57 147.27 81.77 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.846 1.445 . . . . 0.0 110.658 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.4 -8.95 41.46 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 120.105 -1.045 . . . . 0.0 110.498 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -122.99 147.45 46.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.879 -1.365 . . . . 0.0 110.202 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' CYS . . . . . . . . . . . . . 56.9 m -93.22 142.93 26.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.242 -0.911 . . . . 0.0 110.727 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 43.6 tp -120.34 128.17 53.01 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.403 -0.811 . . . . 0.0 109.004 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -123.05 143.07 50.2 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.871 -1.143 . . . . 0.0 111.751 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 2.5 t -128.3 116.25 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.73 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -112.18 124.84 53.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.02 -1.05 . . . . 0.0 109.938 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.466 ' O ' HG23 ' B' ' 84' ' ' VAL . . . -144.66 -155.88 6.61 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.676 -1.369 . . . . 0.0 109.676 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -134.85 146.12 48.96 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.252 -1.146 . . . . 0.0 109.087 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 39.8 t -111.65 130.31 65.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 121.119 -0.988 . . . . 0.0 110.693 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.95 153.12 67.31 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.392 -0.818 . . . . 0.0 110.452 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.414 ' O ' ' HB2' ' B' ' 81' ' ' PRO . 43.1 Cg_endo -67.23 -20.18 49.63 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.936 1.493 . . . . 0.0 110.555 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' ASP . . . . . 0.411 ' O ' ' HG3' ' B' ' 28' ' ' LYS . 49.5 p-10 -119.42 25.06 10.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.284 -0.885 . . . . 0.0 110.408 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . 0.441 ' HA ' ' HB3' ' B' ' 125' ' ' ASP . . . -59.94 104.47 0.3 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.905 -1.122 . . . . 0.0 110.311 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' B' ' 26' ' ' ASP . 64.3 mttp -94.97 -15.92 23.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.355 -0.841 . . . . 0.0 111.157 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 8.0 t -159.63 133.39 7.28 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.724 -1.235 . . . . 0.0 111.686 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' PHE . . . . . 0.506 ' CD1' ' HB3' ' B' ' 126' ' ' PHE . 14.4 t80 -137.08 144.65 43.22 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.569 -0.707 . . . . 0.0 109.565 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 43.1 t -126.36 131.14 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.975 -1.078 . . . . 0.0 110.944 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.492 ' HB2' ' CZ ' ' B' ' 30' ' ' PHE . 20.6 tp -135.38 135.74 40.9 Favored 'General case' 0 C--N 1.308 -1.234 0 O-C-N 121.525 -0.735 . . . . 0.0 110.181 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' ASN . . . . . 0.918 ' HB2' HD13 ' B' ' 41' ' ' LEU . 28.3 p30 -143.02 155.6 44.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.809 -1.182 . . . . 0.0 110.623 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.691 HD21 ' HB2' ' B' ' 43' ' ' LEU . 0.6 OUTLIER -153.79 110.21 3.33 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.277 -0.889 . . . . 0.0 110.276 179.967 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . 0.482 ' O ' ' CB ' ' B' ' 119' ' ' TYR . . . -158.36 -172.98 26.18 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . 0.451 ' O ' ' HB2' ' B' ' 119' ' ' TYR . 98.8 mttt -78.89 -44.57 22.49 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.876 -1.367 . . . . 0.0 110.415 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . 0.418 ' HB2' ' HB2' ' B' ' 40' ' ' ASN . 84.8 m-20 -119.76 164.91 15.25 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.685 -178.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 11.8 t -56.97 -45.85 82.6 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.634 -0.666 . . . . 0.0 112.294 -178.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' ASN . . . . . 0.452 ' HB3' ' N ' ' B' ' 66' ' ' GLY . 54.8 m-20 -89.24 -0.87 57.8 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.473 -1.392 . . . . 0.0 110.294 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' ASN . . . . . 0.418 ' HB2' ' HB2' ' B' ' 37' ' ' ASP . 5.0 m-80 -111.63 58.16 0.63 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.184 -0.947 . . . . 0.0 109.678 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.918 HD13 ' HB2' ' B' ' 33' ' ' ASN . 72.6 mt -82.31 138.25 34.59 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' CYS . . . . . 0.628 ' SG ' HD22 ' B' ' 114' ' ' LEU . 79.5 m -87.42 -38.22 16.32 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.88 -1.138 . . . . 0.0 109.618 -178.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.691 ' HB2' HD21 ' B' ' 34' ' ' LEU . 83.8 mt -132.58 139.78 47.96 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.142 -0.974 . . . . 0.0 110.016 179.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' HIS . . . . . 0.405 ' HB3' ' O ' ' B' ' 61' ' ' ASN . 63.2 t-80 -140.09 140.09 36.01 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.135 -0.978 . . . . 0.0 110.328 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -128.47 146.03 50.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.192 -0.942 . . . . 0.0 110.2 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' B' ' 30' ' ' PHE . 0.2 OUTLIER -152.26 61.16 3.87 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.379 -0.826 . . . . 0.0 109.984 179.472 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' PRO . . . . . 0.492 ' HB3' HD12 ' B' ' 58' ' ' ILE . 52.2 Cg_endo -69.23 146.67 64.21 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.067 1.562 . . . . 0.0 110.69 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 91.5 mtm-85 -134.94 125.83 27.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.164 -0.96 . . . . 0.0 110.681 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -61.93 -46.62 88.54 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.129 -0.982 . . . . 0.0 109.036 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -148.58 84.36 1.48 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.5 -117.2 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.2 -0.938 . . . . 0.0 110.241 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -77.83 -13.97 59.72 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.633 -1.292 . . . . 0.0 110.405 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 165.53 -22.2 0.13 Allowed Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.568 -1.301 . . . . 0.0 110.494 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -60.51 -179.0 0.1 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.881 -1.364 . . . . 0.0 110.162 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.533 ' O ' ' C ' ' B' ' 56' ' ' ASN . . . -121.98 137.47 54.79 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.57 -0.706 . . . . 0.0 109.598 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' ASN . . . . . 0.533 ' C ' ' O ' ' B' ' 55' ' ' ALA . 1.9 m-20 11.25 76.2 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.514 0 CA-C-O 121.451 0.643 . . . . 0.0 112.107 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' B' ' 47' ' ' PRO . 45.2 m -110.46 130.16 55.62 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.381 -0.825 . . . . 0.0 110.328 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' ILE . . . . . 0.492 HD12 ' HB3' ' B' ' 47' ' ' PRO . 19.6 tt -128.79 130.7 68.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.476 -0.765 . . . . 0.0 110.032 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.486 HG23 ' O ' ' B' ' 59' ' ' VAL . 21.5 m -125.4 129.24 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.154 -0.967 . . . . 0.0 110.349 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 11.2 t -86.03 130.64 34.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.142 -0.974 . . . . 0.0 109.343 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' ASN . . . . . 0.405 ' O ' ' HB3' ' B' ' 44' ' ' HIS . 14.5 t-20 -137.2 144.73 43.01 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.059 -1.025 . . . . 0.0 111.266 -179.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 5.3 m -119.36 153.74 34.69 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . 0.483 ' CD ' ' HA2' ' B' ' 66' ' ' GLY . 16.6 ttmt -136.56 134.82 37.88 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.862 -1.149 . . . . 0.0 110.412 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -113.87 102.45 10.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.222 -0.924 . . . . 0.0 109.609 178.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 64.84 27.71 72.46 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . 0.483 ' HA2' ' CD ' ' B' ' 63' ' ' LYS . . . 93.01 1.85 66.97 Favored Glycine 0 N--CA 1.485 1.937 0 C-N-CA 119.561 -1.304 . . . . 0.0 109.99 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' ALA . . . . . 0.454 ' O ' ' O ' ' B' ' 68' ' ' TRP . . . -109.45 86.21 2.25 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.977 -1.308 . . . . 0.0 109.526 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' TRP . . . . . 0.468 ' O ' ' HA ' ' B' ' 63' ' ' LYS . 61.8 m95 -9.0 -116.59 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.828 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -178.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 129.28 -113.37 1.51 Allowed Glycine 0 N--CA 1.488 2.161 0 O-C-N 119.775 -1.828 . . . . 0.0 110.005 -178.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 21.6 m -78.91 121.31 24.7 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.198 -1.177 . . . . 0.0 111.266 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -126.72 131.0 51.45 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.404 -0.81 . . . . 0.0 109.778 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.45 156.51 38.78 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.926 -1.109 . . . . 0.0 110.205 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 -134.64 88.74 2.47 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.247 -0.908 . . . . 0.0 109.727 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' GLU . . . . . 0.401 ' O ' ' CG2' ' B' ' 58' ' ' ILE . 89.3 mt-10 -113.94 126.18 54.86 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.238 -0.914 . . . . 0.0 109.865 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -93.49 85.28 4.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.09 -1.006 . . . . 0.0 110.232 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' VAL . . . . . 0.623 HG22 ' HD3' ' B' ' 78' ' ' PRO . 2.4 p -127.22 132.25 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.324 -0.86 . . . . 0.0 110.203 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' PHE . . . . . 0.509 ' N ' ' CD1' ' B' ' 77' ' ' PHE . 13.6 p90 -144.98 81.7 10.46 Favored Pre-proline 0 N--CA 1.486 1.352 0 O-C-N 121.248 -0.908 . . . . 0.0 110.288 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . 0.623 ' HD3' HG22 ' B' ' 76' ' ' VAL . 52.4 Cg_endo -72.91 -3.12 13.04 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.967 1.509 . . . . 0.0 111.236 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' PHE . . . . . 0.535 ' CD2' ' HB2' ' B' ' 85' ' ' ALA . 3.8 m-85 -134.13 179.6 6.15 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.998 -1.064 . . . . 0.0 111.024 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.487 ' CG ' ' HD2' ' B' ' 81' ' ' PRO . 0.0 OUTLIER -131.2 172.57 7.13 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.574 -0.704 . . . . 0.0 109.521 179.781 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' PRO . . . . . 0.487 ' HD2' ' CG ' ' B' ' 80' ' ' GLN . 51.0 Cg_endo -71.02 150.06 59.88 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.643 1.338 . . . . 0.0 110.105 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 75.95 26.94 63.4 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 45.3 m -131.83 151.94 51.34 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.933 -1.334 . . . . 0.0 111.06 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.466 HG23 ' O ' ' B' ' 21' ' ' GLY . 13.1 p -90.95 133.54 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.437 -0.789 . . . . 0.0 109.59 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . 0.535 ' HB2' ' CD2' ' B' ' 79' ' ' PHE . . . -151.69 155.86 39.18 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.808 -1.183 . . . . 0.0 110.894 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -122.91 149.56 44.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.375 -0.828 . . . . 0.0 109.61 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 47.0 t -124.15 130.43 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.128 -0.982 . . . . 0.0 110.386 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 88' ' ' CYS . . . . . . . . . . . . . 1.4 t -99.2 122.91 43.02 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.354 -0.841 . . . . 0.0 110.042 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 98.2 mt -122.55 128.65 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.199 -0.938 . . . . 0.0 110.731 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 63.2 m -119.41 128.29 53.9 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 91' ' ' PHE . . . . . 0.579 ' CZ ' HD11 ' B' ' 114' ' ' LEU . 73.7 t80 -109.23 115.59 30.3 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 118.62 -1.232 . . . . 0.0 111.343 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' B' ' 95' ' ' ASN . 79.2 m-20 -118.89 142.39 47.79 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -60.04 -30.31 69.11 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.668 -1.27 . . . . 0.0 110.491 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.15 -40.48 82.37 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.045 -1.035 . . . . 0.0 109.279 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . 0.405 ' O ' ' HB2' ' B' ' 92' ' ' ASP . 0.4 OUTLIER -170.32 171.88 6.45 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.502 -178.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 96' ' ' LEU . . . . . 0.432 HD22 ' CD1' ' B' ' 43' ' ' LEU . 38.8 tp -101.83 125.13 48.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.236 -0.915 . . . . 0.0 110.17 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . 0.435 HG23 ' OE2' ' B' ' 105' ' ' GLU . 10.5 m -107.93 125.25 51.27 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.099 -1.001 . . . . 0.0 109.266 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 38.8 t -131.43 131.43 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.858 -1.151 . . . . 0.0 110.478 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -119.7 143.9 47.5 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.168 -0.957 . . . . 0.0 110.579 179.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . 0.486 HD23 ' HD2' ' B' ' 101' ' ' PRO . 0.5 OUTLIER -111.16 169.69 6.04 Favored Pre-proline 0 C--N 1.3 -1.57 0 O-C-N 121.517 -0.739 . . . . 0.0 109.133 179.222 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' PRO . . . . . 0.486 ' HD2' HD23 ' B' ' 100' ' ' LEU . 38.8 Cg_endo -64.07 -24.11 66.77 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 123.603 1.318 . . . . 0.0 110.772 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' ASP . . . . . 0.47 ' HB2' ' CB ' ' B' ' 78' ' ' PRO . 20.5 t0 -74.83 -11.95 60.27 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.941 -1.099 . . . . 0.0 111.085 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 98.86 -10.42 62.28 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.635 -1.269 . . . . 0.0 110.645 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 104' ' ' TYR . . . . . 0.443 ' CE2' ' OD2' ' B' ' 102' ' ' ASP . 19.5 m-85 -79.73 141.02 36.74 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.754 -1.439 . . . . 0.0 109.657 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 105' ' ' GLU . . . . . 0.435 ' OE2' HG23 ' B' ' 97' ' ' THR . 85.2 tt0 -121.06 143.48 49.05 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.308 -0.87 . . . . 0.0 110.554 -179.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -130.08 148.07 51.89 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.336 -0.853 . . . . 0.0 109.505 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 107' ' ' LYS . . . . . 0.422 ' C ' ' CD1' ' B' ' 108' ' ' PHE . 98.3 mttt -127.7 145.62 50.84 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.079 -1.013 . . . . 0.0 111.454 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 108' ' ' PHE . . . . . 0.502 ' CD1' ' N ' ' B' ' 108' ' ' PHE . 20.1 m-85 -129.64 140.18 37.88 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -70.28 140.18 40.14 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 O-C-N 123.385 1.203 . . . . 0.0 109.83 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 110' ' ' ASN . . . . . 0.46 ' ND2' ' O ' ' B' ' 110' ' ' ASN . 6.1 p-10 -102.16 83.02 2.28 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 122.246 1.022 . . . . 0.0 110.216 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 96.6 mtt-85 -57.11 -22.7 41.73 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.488 -1.383 . . . . 0.0 108.98 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . 0.735 ' HB3' HD23 ' B' ' 114' ' ' LEU . 89.7 mt -82.26 143.7 31.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.584 -0.698 . . . . 0.0 110.454 179.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -101.44 38.83 1.52 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.105 -0.997 . . . . 0.0 109.541 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 114' ' ' LEU . . . . . 0.735 HD23 ' HB3' ' B' ' 112' ' ' LEU . 0.8 OUTLIER -73.6 128.07 34.49 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.427 -0.795 . . . . 0.0 110.923 -179.193 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 115' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -88.26 -16.05 34.22 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.114 -0.991 . . . . 0.0 110.162 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 116' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' B' ' 11' ' ' LEU . . . -158.25 155.19 28.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.005 -1.059 . . . . 0.0 111.072 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 117' ' ' ILE . . . . . 0.519 HD11 HD13 ' B' ' 114' ' ' LEU . 31.8 mm -107.17 130.2 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.215 -0.928 . . . . 0.0 110.228 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 118' ' ' ASN . . . . . 0.509 ' N ' ' ND2' ' B' ' 118' ' ' ASN . 0.5 OUTLIER -108.85 -15.01 14.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.069 -1.019 . . . . 0.0 110.933 -179.244 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 119' ' ' TYR . . . . . 0.482 ' CB ' ' O ' ' B' ' 35' ' ' GLY . 4.0 t80 -120.28 129.7 54.14 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.993 -1.067 . . . . 0.0 111.461 -178.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 120' ' ' MET . . . . . 0.65 ' HB2' HD22 ' B' ' 9' ' ' LEU . 51.8 ttp -141.47 128.37 20.6 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.21 149.37 30.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.707 -1.246 . . . . 0.0 111.342 -178.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -151.99 129.17 11.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.578 -0.702 . . . . 0.0 110.116 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -147.4 114.63 6.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.366 -0.834 . . . . 0.0 109.453 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 124' ' ' GLY . . . . . 0.502 ' HA3' ' HA ' ' B' ' 30' ' ' PHE . . . -176.95 -145.36 5.67 Favored Glycine 0 N--CA 1.484 1.869 0 C-N-CA 119.069 -1.538 . . . . 0.0 110.209 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . 0.441 ' HB3' ' HA ' ' B' ' 27' ' ' ALA . 79.7 m-20 -88.86 12.87 13.99 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.913 -0.757 . . . . 0.0 110.705 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 126' ' ' PHE . . . . . 0.506 ' HB3' ' CD1' ' B' ' 30' ' ' PHE . 14.9 t80 -105.76 137.66 43.27 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.092 -1.005 . . . . 0.0 110.269 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . 0.422 ' O ' ' HA3' ' B' ' 21' ' ' GLY . 98.5 mttt -103.94 109.45 21.2 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.272 -0.892 . . . . 0.0 111.746 -178.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . 0.44 ' O ' HG23 ' B' ' 128' ' ' ILE . 8.8 tt -99.65 117.41 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.036 -1.04 . . . . 0.0 109.486 177.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -109.32 -14.64 14.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.111 -0.993 . . . . 0.0 111.872 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 130' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.17 143.55 31.14 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.637 -1.289 . . . . 0.0 111.815 -179.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 66.1 t -127.3 133.58 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 132' ' ' ALA . . . . . . . . . . . . . . . -139.48 143.39 37.49 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 119.984 -1.697 . . . . 0.0 111.721 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -73.17 -125.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.633 -0.667 . . . . 0.0 109.821 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 47.1 t0 . . . . . 0 N--CA 1.492 1.628 0 O-C-N 120.515 -1.365 . . . . 0.0 110.161 179.716 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.246 0.546 . . . . 0.0 110.018 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 3.6 t -122.62 -134.21 0.29 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.223 -0.923 . . . . 0.0 109.062 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.434 ' O ' HG23 ' A' ' 5' ' ' VAL . . . 89.66 21.51 39.94 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 34.9 tp -58.54 128.51 37.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.915 -1.344 . . . . 0.0 109.866 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 3' ' ' GLY . 54.5 t -120.43 131.17 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.43 -0.794 . . . . 0.0 109.877 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -124.49 164.18 20.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.926 -1.108 . . . . 0.0 110.98 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.485 ' O ' ' HB3' ' A' ' 8' ' ' ASN . 26.9 p -151.19 172.22 16.16 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.666 -0.646 . . . . 0.0 109.306 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.485 ' HB3' ' O ' ' A' ' 7' ' ' SER . 32.0 t30 61.79 33.01 18.02 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.577 -0.702 . . . . 0.0 109.85 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.525 ' O ' ' C ' ' A' ' 10' ' ' ASN . 94.8 mt -85.09 -9.69 57.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.539 -0.726 . . . . 0.0 111.124 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.525 ' C ' ' O ' ' A' ' 9' ' ' LEU . 0.7 OUTLIER 5.79 67.82 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.686 0 CA-C-O 121.551 0.691 . . . . 0.0 112.829 -179.771 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.508 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 31.8 tp -87.64 139.0 30.98 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.51 167.46 9.03 Favored Pre-proline 0 C--N 1.294 -1.831 0 O-C-N 120.975 -1.078 . . . . 0.0 111.378 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' A' ' 115' ' ' GLU . 44.3 Cg_endo -67.49 147.31 76.8 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 124.266 1.666 . . . . 0.0 110.77 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.81 -4.04 63.1 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -115.99 146.79 41.83 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.937 -1.331 . . . . 0.0 109.827 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.3 m -99.02 142.63 30.27 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.163 -0.961 . . . . 0.0 110.443 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.41 ' HA ' HD12 ' A' ' 17' ' ' LEU . 51.2 tp -118.27 128.2 54.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.405 -0.809 . . . . 0.0 109.698 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -128.92 133.43 47.87 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.008 -1.057 . . . . 0.0 111.17 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 56.1 t -121.1 127.24 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.319 -0.863 . . . . 0.0 109.577 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 53.2 ttt-85 -109.05 124.89 51.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.206 -0.934 . . . . 0.0 110.019 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -148.88 -163.4 10.88 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -137.94 141.81 40.55 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.409 -1.053 . . . . 0.0 110.269 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.663 ' CG1' ' HB2' ' A' ' 27' ' ' ALA . 23.8 t -97.4 130.97 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.198 -0.939 . . . . 0.0 110.809 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.597 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -58.87 168.22 1.56 Allowed Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.448 -0.783 . . . . 0.0 110.096 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.597 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 45.4 Cg_endo -68.68 -19.8 41.2 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.909 1.478 . . . . 0.0 109.89 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 28' ' ' LYS . 48.2 t0 -112.97 57.19 0.67 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.485 -0.76 . . . . 0.0 109.371 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.663 ' HB2' ' CG1' ' A' ' 23' ' ' VAL . . . -69.73 63.62 0.19 Allowed 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.688 0.756 . . . . 0.0 109.797 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.435 ' N ' ' O ' ' A' ' 26' ' ' ASP . 87.8 tttt -63.12 -43.92 97.08 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.702 -0.624 . . . . 0.0 110.401 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.3 t -164.05 137.63 5.4 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.006 -1.058 . . . . 0.0 111.174 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.483 ' HA ' ' HA3' ' A' ' 124' ' ' GLY . 26.1 t80 -134.04 145.54 49.51 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.547 -0.721 . . . . 0.0 109.981 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.543 HG22 ' O ' ' A' ' 123' ' ' ASP . 17.3 m -127.13 133.08 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 120.785 -1.197 . . . . 0.0 110.774 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.1 tp -129.42 135.09 48.24 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.463 -0.773 . . . . 0.0 110.139 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.527 ' HB2' HD13 ' A' ' 41' ' ' LEU . 12.2 p30 -142.19 145.77 34.51 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.763 -1.21 . . . . 0.0 110.78 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.493 HD13 HD13 ' A' ' 117' ' ' ILE . 1.1 pp -149.47 123.87 9.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.366 -0.834 . . . . 0.0 110.679 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.545 ' O ' ' HB3' ' A' ' 119' ' ' TYR . . . -166.11 -160.38 13.3 Favored Glycine 0 N--CA 1.493 2.433 0 N-CA-C 108.959 -1.657 . . . . 0.0 108.959 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.48 ' HD2' HD13 ' A' ' 114' ' ' LEU . 60.2 mtpt -71.85 -40.8 68.76 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.021 -1.282 . . . . 0.0 109.149 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -153.27 -167.02 2.59 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.768 0.794 . . . . 0.0 111.562 -178.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 41.2 t -62.0 -46.03 91.0 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.662 -0.649 . . . . 0.0 112.573 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.457 ' HB3' ' N ' ' A' ' 66' ' ' GLY . 74.0 m-20 -94.5 0.08 55.04 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.762 -1.211 . . . . 0.0 110.437 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -113.03 62.79 0.64 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.245 -0.909 . . . . 0.0 109.378 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.527 HD13 ' HB2' ' A' ' 33' ' ' ASN . 92.1 mt -104.14 133.97 48.18 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.315 0.578 . . . . 0.0 109.917 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.484 ' HA ' HD12 ' A' ' 112' ' ' LEU . 63.3 m -83.62 -40.22 19.3 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.151 -0.968 . . . . 0.0 109.271 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 1.101 HD11 HD13 ' A' ' 96' ' ' LEU . 94.3 mt -131.42 140.89 49.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.213 -0.929 . . . . 0.0 111.337 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.48 ' HB3' ' HB3' ' A' ' 61' ' ' ASN . 82.0 t60 -131.84 103.14 6.16 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -102.36 142.0 34.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -0.931 . . . . 0.0 110.8 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.521 ' CG ' HG12 ' A' ' 31' ' ' VAL . 1.2 t-20 -155.23 85.36 3.49 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.391 -0.818 . . . . 0.0 110.603 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.438 ' CA ' HG12 ' A' ' 58' ' ' ILE . 46.5 Cg_endo -67.48 147.74 77.68 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.891 1.469 . . . . 0.0 110.75 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -132.31 107.99 8.91 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.291 -0.881 . . . . 0.0 111.156 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -62.08 -48.08 81.78 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.248 -0.908 . . . . 0.0 109.486 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 -150.83 97.74 2.52 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.313 -0.867 . . . . 0.0 109.472 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -105.18 -126.61 0.23 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.187 -0.945 . . . . 0.0 110.329 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 40.3 m170 -61.73 -35.38 77.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.72 -1.237 . . . . 0.0 110.843 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 172.61 32.42 0.03 OUTLIER Glycine 0 N--CA 1.493 2.451 0 C-N-CA 119.104 -1.522 . . . . 0.0 111.072 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -117.59 -166.26 1.17 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.852 -1.381 . . . . 0.0 109.469 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 56' ' ' ASN . . . -153.67 144.08 22.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.252 -0.905 . . . . 0.0 110.373 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.475 ' C ' ' O ' ' A' ' 55' ' ' ALA . 87.0 m-20 25.85 56.65 0.05 Allowed 'General case' 0 N--CA 1.504 2.23 0 CA-C-O 120.987 0.422 . . . . 0.0 111.983 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 86.0 m -119.69 133.24 55.71 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.235 -0.915 . . . . 0.0 110.477 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.438 HG12 ' CA ' ' A' ' 47' ' ' PRO . 96.6 mt -119.29 134.06 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.496 -0.753 . . . . 0.0 111.114 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.641 HG11 ' OE2' ' A' ' 71' ' ' GLU . 54.5 t -112.74 127.94 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.211 -0.931 . . . . 0.0 109.025 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 2.2 t -94.57 122.88 37.61 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.185 -0.947 . . . . 0.0 110.313 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.48 ' HB3' ' HB3' ' A' ' 44' ' ' HIS . 6.8 t-20 -121.21 147.52 45.5 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.321 -0.862 . . . . 0.0 109.114 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.3 t -135.65 142.76 45.22 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.022 -1.049 . . . . 0.0 110.141 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.492 ' CD ' ' HA2' ' A' ' 66' ' ' GLY . 27.0 ttmt -142.94 127.39 17.82 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 118.883 -1.127 . . . . 0.0 111.67 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -107.04 103.23 12.6 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 64.48 20.74 66.02 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.492 ' HA2' ' CD ' ' A' ' 63' ' ' LYS . . . 68.89 36.58 82.14 Favored Glycine 0 N--CA 1.488 2.123 0 C-N-CA 119.2 -1.476 . . . . 0.0 110.007 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.51 14.16 6.54 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.731 -1.452 . . . . 0.0 112.263 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -139.63 -74.6 0.36 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.452 -1.405 . . . . 0.0 110.421 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.68 32.85 49.03 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.1 m -59.81 121.36 11.53 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.077 -1.249 . . . . 0.0 109.49 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.641 ' OE2' HG11 ' A' ' 59' ' ' VAL . 83.3 tt0 -116.66 133.36 56.11 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.226 -0.921 . . . . 0.0 112.039 -178.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -127.42 -162.53 1.17 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.369 -0.832 . . . . 0.0 108.971 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -141.83 140.72 33.03 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 118.484 -1.286 . . . . 0.0 112.027 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -127.92 124.29 37.02 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.897 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -101.96 46.33 0.93 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.871 -1.143 . . . . 0.0 111.017 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.432 ' O ' HD12 ' A' ' 58' ' ' ILE . 75.9 t -122.46 127.06 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.063 -1.023 . . . . 0.0 109.716 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.466 ' CD2' ' O ' ' A' ' 77' ' ' PHE . 83.2 t80 -162.23 74.71 2.22 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 120.922 -1.112 . . . . 0.0 110.91 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.485 ' HD2' ' CE2' ' A' ' 79' ' ' PHE . 55.6 Cg_endo -80.2 43.1 1.45 Allowed 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.899 1.473 . . . . 0.0 110.951 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.485 ' CE2' ' HD2' ' A' ' 78' ' ' PRO . 70.6 m-85 -127.6 151.57 48.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.884 -1.135 . . . . 0.0 109.399 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.39 168.71 14.12 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.034 -1.041 . . . . 0.0 110.251 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.75 147.58 63.22 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.958 1.504 . . . . 0.0 110.015 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 56.39 41.38 87.75 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.829 -1.309 . . . . 0.0 109.829 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 37.2 t -134.35 142.15 47.12 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.037 -1.273 . . . . 0.0 110.617 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.424 HG13 ' O ' ' A' ' 84' ' ' VAL . 7.2 p -89.16 136.8 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.387 -0.821 . . . . 0.0 109.65 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -154.66 151.74 29.13 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.109 -0.994 . . . . 0.0 110.035 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.4 ' O ' ' HD3' ' A' ' 101' ' ' PRO . 90.5 mt-10 -116.32 138.38 51.37 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 91.6 t -116.15 128.38 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.909 -1.119 . . . . 0.0 110.823 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 1.7 t -99.64 129.4 45.78 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.3 -0.875 . . . . 0.0 109.837 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 97.8 mt -122.25 127.66 75.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.356 -0.84 . . . . 0.0 110.067 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.426 ' HB ' ' HB ' ' A' ' 97' ' ' THR . 89.2 m -120.56 127.61 52.31 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.242 -0.911 . . . . 0.0 109.286 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -113.85 112.09 22.8 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.06 -1.025 . . . . 0.0 110.854 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -119.59 149.01 42.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.527 -0.733 . . . . 0.0 109.467 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -63.22 -34.4 77.57 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.94 -1.1 . . . . 0.0 109.94 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.54 -40.69 96.05 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.2 -0.937 . . . . 0.0 109.991 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -171.39 178.14 3.32 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.314 -0.866 . . . . 0.0 110.412 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 1.101 HD13 HD11 ' A' ' 43' ' ' LEU . 95.4 mt -105.0 131.53 52.4 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.397 -0.814 . . . . 0.0 110.078 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.463 ' CG2' ' OE2' ' A' ' 105' ' ' GLU . 44.1 m -121.01 129.62 53.46 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.081 -1.012 . . . . 0.0 109.838 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 56.4 t -125.82 129.04 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 120.86 -1.15 . . . . 0.0 109.255 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -116.62 126.14 52.82 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.066 -1.054 . . . . 0.0 109.934 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 12.3 mt -99.08 162.12 22.49 Favored Pre-proline 0 C--N 1.296 -1.746 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 86' ' ' GLU . 39.6 Cg_endo -64.7 -21.61 64.92 Favored 'Trans proline' 0 C--N 1.3 -2.018 0 O-C-N 123.765 1.403 . . . . 0.0 110.223 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -65.52 -32.78 74.57 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.277 -0.889 . . . . 0.0 109.279 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 117.3 -18.25 12.2 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -73.74 136.12 43.65 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.133 -1.216 . . . . 0.0 110.319 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.463 ' OE2' ' CG2' ' A' ' 97' ' ' THR . 78.9 tt0 -127.57 144.25 51.09 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -129.51 156.37 44.26 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.975 -1.078 . . . . 0.0 110.146 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -107.39 131.49 54.19 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.244 -0.91 . . . . 0.0 110.953 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.414 ' CB ' ' HB2' ' A' ' 96' ' ' LEU . 0.5 OUTLIER -121.77 126.4 26.41 Favored Pre-proline 0 C--N 1.301 -1.529 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.753 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -65.7 139.89 59.75 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 123.32 1.169 . . . . 0.0 110.397 -179.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.444 ' ND2' ' O ' ' A' ' 110' ' ' ASN . 4.5 p-10 -97.67 82.58 3.08 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 122.513 1.149 . . . . 0.0 109.791 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -58.05 -24.23 57.6 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 120.368 -1.458 . . . . 0.0 109.371 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.484 HD12 ' HA ' ' A' ' 42' ' ' CYS . 86.7 mt -86.79 144.12 27.19 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.288 -0.882 . . . . 0.0 111.078 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -94.09 30.57 1.86 Allowed 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.718 0.77 . . . . 0.0 109.568 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.588 HD11 ' O ' ' A' ' 116' ' ' ALA . 46.9 tp -61.99 136.17 57.85 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.58 0.705 . . . . 0.0 111.135 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.449 ' O ' ' HD3' ' A' ' 13' ' ' PRO . 10.0 pt-20 -98.29 -13.98 20.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.451 -0.781 . . . . 0.0 110.932 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.588 ' O ' HD11 ' A' ' 114' ' ' LEU . . . -163.45 157.29 19.63 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.44 -1.413 . . . . 0.0 111.972 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.493 HD13 HD13 ' A' ' 34' ' ' LEU . 84.9 mt -104.8 124.8 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.355 -0.841 . . . . 0.0 109.994 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -117.67 -20.95 8.72 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.082 -1.011 . . . . 0.0 110.989 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.545 ' HB3' ' O ' ' A' ' 35' ' ' GLY . 38.9 t80 -110.73 125.67 53.75 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.419 -0.801 . . . . 0.0 110.547 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.466 ' HB3' ' CD1' ' A' ' 9' ' ' LEU . 48.3 ttp -146.93 133.04 19.29 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.237 -0.914 . . . . 0.0 109.818 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.83 154.23 33.56 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.997 -1.064 . . . . 0.0 110.496 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -146.12 120.08 9.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.306 -0.871 . . . . 0.0 109.889 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.543 ' O ' HG22 ' A' ' 31' ' ' VAL . 55.6 t0 -135.29 106.32 6.66 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.347 -0.846 . . . . 0.0 109.594 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' A' ' 30' ' ' PHE . . . -171.54 -144.61 4.51 Favored Glycine 0 N--CA 1.484 1.844 0 C-N-CA 119.237 -1.458 . . . . 0.0 110.02 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.525 ' HB3' ' HA ' ' A' ' 27' ' ' ALA . 94.2 m-20 -90.07 14.1 13.24 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.644 -0.915 . . . . 0.0 110.873 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.43 ' HB3' ' CE1' ' A' ' 30' ' ' PHE . 28.1 t80 -107.89 135.28 49.55 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.899 -1.126 . . . . 0.0 109.748 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -105.15 121.3 43.54 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 118.874 -1.13 . . . . 0.0 110.421 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.618 HG23 ' O ' ' A' ' 128' ' ' ILE . 10.7 tt -93.79 115.92 33.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.511 -0.743 . . . . 0.0 110.592 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.422 ' O ' ' HB2' ' B' ' 133' ' ' PHE . 98.7 mttt -101.54 -18.35 15.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.091 -1.006 . . . . 0.0 110.517 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -157.79 143.99 17.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.82 -1.175 . . . . 0.0 111.484 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.438 HG22 HD11 ' A' ' 128' ' ' ILE . 42.5 t -116.58 132.22 66.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 178.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.41 ' HA ' ' HB2' ' B' ' 130' ' ' CYS . . . -121.95 144.61 48.76 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.738 -1.226 . . . . 0.0 111.906 -177.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -83.37 -136.64 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 61.0 t0 . . . . . 0 N--CA 1.49 1.571 0 O-C-N 120.69 -1.256 . . . . 0.0 110.201 179.831 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 121.272 0.558 . . . . 0.0 110.088 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' CYS . . . . . . . . . . . . . 3.3 t -122.5 -135.65 0.3 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.248 -0.907 . . . . 0.0 108.72 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . 0.406 ' C ' ' ND2' ' A' ' 8' ' ' ASN . . . 90.41 23.26 32.02 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.46 ' HA ' ' HB3' ' A' ' 8' ' ' ASN . 36.0 tp -60.0 128.21 35.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.03 -1.276 . . . . 0.0 109.882 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.405 HG23 ' O ' ' B' ' 3' ' ' GLY . 53.7 t -120.34 130.44 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 119.731 -0.788 . . . . 0.0 109.759 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -123.6 164.6 18.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.155 -0.966 . . . . 0.0 110.902 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . 0.461 ' O ' ' HB3' ' B' ' 8' ' ' ASN . 26.2 p -151.72 172.52 15.99 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . 0.461 ' HB3' ' O ' ' B' ' 7' ' ' SER . 31.8 t30 61.59 32.84 18.53 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.571 -0.706 . . . . 0.0 109.819 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.529 ' O ' ' C ' ' B' ' 10' ' ' ASN . 96.3 mt -85.79 -5.97 59.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.529 -0.732 . . . . 0.0 111.198 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . 0.529 ' C ' ' O ' ' B' ' 9' ' ' LEU . 0.6 OUTLIER -0.16 70.53 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.714 0 CA-C-O 121.86 0.838 . . . . 0.0 112.817 -178.62 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' B' ' 116' ' ' ALA . 32.4 tp -88.34 138.61 31.28 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.24 167.53 8.95 Favored Pre-proline 0 C--N 1.292 -1.895 0 O-C-N 120.917 -1.114 . . . . 0.0 111.321 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' B' ' 115' ' ' GLU . 45.6 Cg_endo -67.96 147.05 73.42 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 124.195 1.629 . . . . 0.0 110.584 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.23 -3.96 62.15 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -116.46 147.32 41.83 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.965 -1.314 . . . . 0.0 109.862 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' CYS . . . . . . . . . . . . . 2.3 m -99.27 142.92 30.13 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.168 -0.958 . . . . 0.0 110.497 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' B' ' 17' ' ' LEU . 52.7 tp -118.5 128.1 54.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.474 -0.766 . . . . 0.0 109.618 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -128.96 133.59 47.87 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.994 -1.066 . . . . 0.0 111.155 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 55.7 t -121.38 126.55 75.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.341 -0.849 . . . . 0.0 109.604 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.404 ' HG3' ' HG2' ' B' ' 86' ' ' GLU . 52.9 ttt-85 -108.45 125.06 51.34 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.203 -0.935 . . . . 0.0 110.061 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -148.74 -162.3 10.17 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -139.0 142.74 38.3 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.585 -0.95 . . . . 0.0 110.23 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.672 ' CG1' ' HB2' ' B' ' 27' ' ' ALA . 23.2 t -98.47 130.83 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.308 -0.87 . . . . 0.0 110.721 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.599 ' HB1' ' HD2' ' B' ' 25' ' ' PRO . . . -58.76 167.89 1.67 Allowed Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.41 -0.806 . . . . 0.0 110.16 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.599 ' HD2' ' HB1' ' B' ' 24' ' ' ALA . 45.9 Cg_endo -68.58 -19.55 42.11 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.882 1.464 . . . . 0.0 109.924 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' ASP . . . . . 0.442 ' O ' ' N ' ' B' ' 28' ' ' LYS . 47.4 t0 -113.09 56.93 0.67 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.535 -0.728 . . . . 0.0 109.444 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . 0.672 ' HB2' ' CG1' ' B' ' 23' ' ' VAL . . . -69.51 63.72 0.17 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.488 -0.757 . . . . 0.0 109.791 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . 0.442 ' N ' ' O ' ' B' ' 26' ' ' ASP . 88.3 tttt -63.24 -45.14 92.97 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.713 -0.617 . . . . 0.0 110.201 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 13.6 t -161.97 139.01 8.33 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.087 -1.008 . . . . 0.0 111.438 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' PHE . . . . . 0.497 ' HA ' ' HA3' ' B' ' 124' ' ' GLY . 25.9 t80 -135.08 144.96 47.49 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.356 -0.84 . . . . 0.0 109.925 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.555 HG22 ' O ' ' B' ' 123' ' ' ASP . 18.4 m -126.63 133.2 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 120.905 -1.122 . . . . 0.0 110.761 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 19.9 tp -129.33 135.85 49.27 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 121.55 -0.719 . . . . 0.0 110.069 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' ASN . . . . . 0.536 ' HB2' HD13 ' B' ' 41' ' ' LEU . 12.2 p30 -142.81 145.55 33.32 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.755 -1.216 . . . . 0.0 110.797 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.506 HD13 HD13 ' B' ' 117' ' ' ILE . 1.1 pp -149.89 119.93 7.2 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.3 -0.875 . . . . 0.0 111.008 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . 0.53 ' O ' ' HB3' ' B' ' 119' ' ' TYR . . . -160.81 -158.81 9.51 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.151 -1.579 . . . . 0.0 109.151 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . 0.486 ' HD2' HD13 ' B' ' 114' ' ' LEU . 60.1 mtpt -72.93 -40.36 65.5 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.083 -1.245 . . . . 0.0 108.868 177.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -153.17 -167.28 2.67 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.68 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 40.2 t -61.98 -46.1 90.71 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.602 -0.686 . . . . 0.0 112.531 -178.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' ASN . . . . . 0.43 ' HB3' ' N ' ' B' ' 66' ' ' GLY . 70.7 m-20 -94.65 0.42 55.08 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.644 -1.285 . . . . 0.0 110.5 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -113.15 62.45 0.64 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.256 -0.902 . . . . 0.0 109.536 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.536 HD13 ' HB2' ' B' ' 33' ' ' ASN . 92.1 mt -103.46 136.94 42.26 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 121.249 0.547 . . . . 0.0 109.554 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' CYS . . . . . 0.488 ' HA ' HD12 ' B' ' 112' ' ' LEU . 65.7 m -87.78 -38.64 15.58 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.218 -0.926 . . . . 0.0 108.764 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 1.027 HD11 HD13 ' B' ' 96' ' ' LEU . 94.6 mt -132.06 140.98 49.06 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.158 -0.964 . . . . 0.0 111.096 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' HIS . . . . . 0.466 ' HB3' ' HB3' ' B' ' 61' ' ' ASN . 81.8 t60 -132.03 102.95 6.03 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -102.09 141.83 34.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.234 -0.916 . . . . 0.0 110.727 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . 0.511 ' CG ' HG12 ' B' ' 31' ' ' VAL . 1.2 t-20 -154.85 84.97 3.67 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.366 -0.834 . . . . 0.0 110.658 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' PRO . . . . . 0.449 ' CA ' HG12 ' B' ' 58' ' ' ILE . 46.3 Cg_endo -67.23 148.32 80.24 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.847 1.446 . . . . 0.0 110.692 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -132.93 107.86 8.56 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.307 -0.87 . . . . 0.0 111.036 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -61.97 -47.89 82.8 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.414 -0.804 . . . . 0.0 109.496 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -151.05 97.98 2.52 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.499 -0.751 . . . . 0.0 109.653 178.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -105.54 -126.55 0.24 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.074 -1.016 . . . . 0.0 110.333 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' HIS . . . . . . . . . . . . . 41.2 m170 -61.23 -34.35 74.98 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.696 -1.253 . . . . 0.0 110.946 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . 170.48 33.12 0.02 OUTLIER Glycine 0 N--CA 1.492 2.397 0 C-N-CA 119.167 -1.492 . . . . 0.0 111.062 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -117.5 -166.02 1.15 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.982 -1.305 . . . . 0.0 109.301 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.503 ' O ' ' C ' ' B' ' 56' ' ' ASN . . . -152.15 149.14 28.44 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.218 -0.926 . . . . 0.0 109.674 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' ASN . . . . . 0.503 ' C ' ' O ' ' B' ' 55' ' ' ALA . 85.6 m-20 16.85 60.24 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.345 0 CA-C-O 121.473 0.654 . . . . 0.0 112.562 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 77.8 m -120.08 132.84 55.58 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.411 -0.806 . . . . 0.0 110.49 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' ILE . . . . . 0.449 HG12 ' CA ' ' B' ' 47' ' ' PRO . 97.0 mt -119.36 133.75 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.498 -0.751 . . . . 0.0 111.386 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.638 HG11 ' OE2' ' B' ' 71' ' ' GLU . 54.9 t -111.9 128.13 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.317 -0.864 . . . . 0.0 109.28 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' CYS . . . . . . . . . . . . . 1.9 t -94.96 122.46 37.63 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.982 -1.074 . . . . 0.0 110.313 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' ASN . . . . . 0.466 ' HB3' ' HB3' ' B' ' 44' ' ' HIS . 6.8 t-20 -120.52 148.19 44.17 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.42 -0.8 . . . . 0.0 109.211 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 34.8 t -136.4 142.83 43.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.957 -1.09 . . . . 0.0 110.237 -178.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . 0.486 ' CD ' ' HA2' ' B' ' 66' ' ' GLY . 27.0 ttmt -143.17 127.15 17.34 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 118.931 -1.108 . . . . 0.0 111.93 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -106.55 104.13 13.74 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 63.76 20.13 63.79 Favored Glycine 0 N--CA 1.483 1.82 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . 0.486 ' HA2' ' CD ' ' B' ' 63' ' ' LYS . . . 69.57 36.27 76.23 Favored Glycine 0 N--CA 1.487 2.062 0 O-C-N 120.624 -1.515 . . . . 0.0 110.084 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -127.85 12.45 6.76 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.732 -1.452 . . . . 0.0 112.378 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -138.08 -74.71 0.4 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.615 -1.303 . . . . 0.0 110.505 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.81 32.46 49.89 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -59.58 121.58 11.93 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.134 -1.216 . . . . 0.0 109.486 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.638 ' OE2' HG11 ' B' ' 59' ' ' VAL . 83.5 tt0 -117.12 133.46 55.98 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.156 -0.965 . . . . 0.0 112.062 -178.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -127.31 -162.96 1.21 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.399 -0.813 . . . . 0.0 109.157 178.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -141.44 139.79 33.46 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.676 -1.265 . . . . 0.0 112.066 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -126.75 124.56 40.02 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.969 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' ALA . . . . . . . . . . . . . . . -102.29 46.55 0.92 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.834 -1.166 . . . . 0.0 110.945 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' VAL . . . . . 0.446 ' O ' HD12 ' B' ' 58' ' ' ILE . 76.5 t -122.8 127.44 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.097 -1.002 . . . . 0.0 109.739 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' PHE . . . . . 0.469 ' CD2' ' O ' ' B' ' 77' ' ' PHE . 83.4 t80 -162.47 74.13 2.16 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 120.962 -1.086 . . . . 0.0 110.878 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . 0.486 ' HD2' ' CE2' ' B' ' 79' ' ' PHE . 55.7 Cg_endo -79.71 43.63 1.54 Allowed 'Trans proline' 0 C--N 1.302 -1.877 0 O-C-N 123.914 1.481 . . . . 0.0 111.08 179.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' PHE . . . . . 0.486 ' CE2' ' HD2' ' B' ' 78' ' ' PRO . 68.4 m-85 -128.22 151.25 49.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.85 -1.156 . . . . 0.0 109.463 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.24 168.23 15.47 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.095 -1.003 . . . . 0.0 110.329 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -69.43 147.29 64.63 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.994 1.523 . . . . 0.0 109.959 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . 56.76 41.56 90.68 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 37.4 t -134.39 143.01 47.37 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.05 -1.265 . . . . 0.0 110.637 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.429 ' O ' HG13 ' B' ' 84' ' ' VAL . 7.1 p -90.14 136.62 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.38 -0.825 . . . . 0.0 109.614 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' ALA . . . . . . . . . . . . . . . -154.34 150.91 28.45 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.121 -0.987 . . . . 0.0 110.043 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' GLU . . . . . 0.404 ' HG2' ' HG3' ' B' ' 20' ' ' ARG . 90.3 mt-10 -115.84 137.59 51.95 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 78.2 t -115.5 128.34 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.925 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 88' ' ' CYS . . . . . . . . . . . . . 1.9 t -99.69 129.48 45.83 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.292 -0.88 . . . . 0.0 109.876 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 98.0 mt -122.38 127.21 75.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.319 -0.863 . . . . 0.0 110.111 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 90' ' ' THR . . . . . 0.421 ' HB ' ' HB ' ' B' ' 97' ' ' THR . 92.7 m -120.3 127.25 52.2 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.135 -0.978 . . . . 0.0 109.137 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 91' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -113.46 112.67 24.0 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.243 -0.983 . . . . 0.0 110.833 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -120.14 148.62 43.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.472 -0.768 . . . . 0.0 109.64 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -63.17 -33.8 76.26 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.021 -1.049 . . . . 0.0 109.91 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.8 -40.85 95.91 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.257 -0.902 . . . . 0.0 109.999 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -171.75 178.22 3.14 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.302 -0.874 . . . . 0.0 110.484 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 96' ' ' LEU . . . . . 1.027 HD13 HD11 ' B' ' 43' ' ' LEU . 94.7 mt -105.09 131.62 52.36 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.349 -0.845 . . . . 0.0 110.134 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . 0.456 ' CG2' ' OE2' ' B' ' 105' ' ' GLU . 44.6 m -121.05 129.49 53.37 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.171 -0.956 . . . . 0.0 109.779 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 98' ' ' VAL . . . . . . . . . . . . . 59.9 t -125.63 128.83 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.94 -1.1 . . . . 0.0 109.241 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -116.35 126.51 53.6 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.069 -1.052 . . . . 0.0 109.765 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 12.2 mt -99.67 162.0 22.62 Favored Pre-proline 0 C--N 1.296 -1.736 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -64.57 -21.58 65.59 Favored 'Trans proline' 0 C--N 1.299 -2.046 0 O-C-N 123.757 1.399 . . . . 0.0 110.275 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -65.76 -32.85 74.63 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.287 -0.883 . . . . 0.0 109.268 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . 117.92 -18.54 11.48 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 104' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -73.62 136.25 43.89 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.178 -1.189 . . . . 0.0 110.37 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 105' ' ' GLU . . . . . 0.456 ' OE2' ' CG2' ' B' ' 97' ' ' THR . 79.0 tt0 -127.51 143.62 51.16 Favored 'General case' 0 C--N 1.298 -1.63 0 O-C-N 121.443 -0.786 . . . . 0.0 109.001 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -128.99 155.83 44.75 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.887 -1.133 . . . . 0.0 110.221 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 107' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -106.96 132.37 52.97 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.21 -0.931 . . . . 0.0 111.003 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 108' ' ' PHE . . . . . 0.409 ' CB ' ' HB2' ' B' ' 96' ' ' LEU . 0.5 OUTLIER -122.8 126.61 26.02 Favored Pre-proline 0 C--N 1.301 -1.51 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.75 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -65.68 139.74 59.19 Favored 'Trans proline' 0 C--N 1.303 -1.844 0 O-C-N 123.286 1.15 . . . . 0.0 110.391 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 110' ' ' ASN . . . . . 0.443 ' ND2' ' O ' ' B' ' 110' ' ' ASN . 4.7 p-10 -97.52 82.64 3.12 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 122.488 1.137 . . . . 0.0 109.653 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -58.05 -24.23 57.61 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 120.263 -1.523 . . . . 0.0 109.433 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . 0.488 HD12 ' HA ' ' B' ' 42' ' ' CYS . 87.2 mt -86.84 143.44 27.46 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.355 -0.841 . . . . 0.0 111.218 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -93.39 30.53 1.69 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.612 -0.68 . . . . 0.0 109.579 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 114' ' ' LEU . . . . . 0.584 HD11 ' O ' ' B' ' 116' ' ' ALA . 46.7 tp -62.21 135.62 57.57 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.706 0.765 . . . . 0.0 111.443 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 115' ' ' GLU . . . . . 0.465 ' O ' ' HD3' ' B' ' 13' ' ' PRO . 9.8 pt-20 -97.19 -15.52 20.84 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.485 -0.759 . . . . 0.0 110.974 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 116' ' ' ALA . . . . . 0.584 ' O ' HD11 ' B' ' 114' ' ' LEU . . . -162.36 157.12 22.21 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.47 -1.394 . . . . 0.0 112.129 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 117' ' ' ILE . . . . . 0.506 HD13 HD13 ' B' ' 34' ' ' LEU . 85.0 mt -104.31 124.68 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.373 -0.829 . . . . 0.0 110.006 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 118' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -117.68 -20.74 8.81 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.14 -0.975 . . . . 0.0 110.982 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 119' ' ' TYR . . . . . 0.53 ' HB3' ' O ' ' B' ' 35' ' ' GLY . 38.9 t80 -110.87 125.35 53.53 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.264 -0.897 . . . . 0.0 110.638 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 120' ' ' MET . . . . . 0.479 ' HB3' ' CD1' ' B' ' 9' ' ' LEU . 48.5 ttp -146.75 133.21 19.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.226 -0.921 . . . . 0.0 109.878 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 121' ' ' ALA . . . . . . . . . . . . . . . -154.01 154.29 33.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.061 -1.024 . . . . 0.0 110.659 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 122' ' ' ALA . . . . . . . . . . . . . . . -146.03 120.58 9.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.279 -0.888 . . . . 0.0 109.879 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 123' ' ' ASP . . . . . 0.555 ' O ' HG22 ' B' ' 31' ' ' VAL . 55.0 t0 -135.42 106.57 6.72 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.381 -0.824 . . . . 0.0 109.559 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 124' ' ' GLY . . . . . 0.497 ' HA3' ' HA ' ' B' ' 30' ' ' PHE . . . -171.52 -144.26 4.37 Favored Glycine 0 N--CA 1.486 1.981 0 C-N-CA 119.26 -1.448 . . . . 0.0 110.227 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . 0.525 ' HB3' ' HA ' ' B' ' 27' ' ' ALA . 93.8 m-20 -90.56 14.43 13.2 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.697 -0.884 . . . . 0.0 110.859 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 126' ' ' PHE . . . . . 0.435 ' HB3' ' CE1' ' B' ' 30' ' ' PHE . 27.3 t80 -108.17 135.57 49.29 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.015 -1.053 . . . . 0.0 109.661 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -105.56 120.86 42.69 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.006 -1.077 . . . . 0.0 110.367 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . 0.639 ' O ' HG23 ' B' ' 128' ' ' ILE . 10.3 tt -93.58 116.38 34.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.639 -0.663 . . . . 0.0 110.524 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -102.06 -19.41 15.18 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.104 -0.997 . . . . 0.0 110.497 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 130' ' ' CYS . . . . . 0.41 ' HB2' ' HA ' ' A' ' 132' ' ' ALA . 0.0 OUTLIER -155.93 144.18 19.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.883 -1.136 . . . . 0.0 111.591 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.419 HG22 HD11 ' B' ' 128' ' ' ILE . 40.2 t -116.88 131.87 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 132' ' ' ALA . . . . . . . . . . . . . . . -121.65 144.32 48.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.572 -1.33 . . . . 0.0 111.746 -177.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . 0.422 ' HB2' ' O ' ' A' ' 129' ' ' LYS . 3.0 t80 -83.17 -135.58 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.758 -0.589 . . . . 0.0 109.433 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 61.5 t0 . . . . . 0 N--CA 1.492 1.628 0 O-C-N 120.697 -1.252 . . . . 0.0 110.147 179.504 . . . . . . . . 0 0 . 1 stop_ save_